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This year, 3,395 abstracts(original contributions)were
submittedfor evaluation.Each was graded by eight rec-
ognized authorities in a special area of interest. Ac-
ceptancefor presentationwas based on the relativegrade
rankingin each of the 26 categories.
Ample meeting space combined with the inclusion of
postersessions again this yearpermittedthe 1987Annual
Scientific Session ProgramCommittee to accept 1,010
abstracts,approximately33.5% of thenumbersubmit-
ted. This representsthe largestnumberof abstractsac-
cepted at any Annual Scientific Session of the American
Monday, March9, 1987
10:30AM-12:00PM,Room 16, Second Level
Young Investigators'Awards Competition
The following five abstracts were from thewinning entries
in the YoungInvestigators' Awards Competition. 36th An-
nualScientific Session.
VENTRICULAR OCCURRENCE OF "ATRIAL" NATRIURETIC FACTOR: A
MARKER FOR THE FAILING VENTRICLE. Brooks S. Edwards,
M.O., Douglas M. Ackerman, M.O., Lester E. wold, M.O., and
John C. Burnett,Jr., M.O., Mayo Medical School,
Rochester, MN
In normal mammals, atrial natriureticfactor (ANF) is
present withinatrial myocardialcells but is absent from
ventricularmyocardium. In primit ive organisms,ANF is
present within bothatria and ventricle, suggesting that
the ventricle may participateboth in the synthesis and
re lease of the hormone. The currentstudy was designed to
test the hypothesis that ventricularANF develops as a
response to intravascularvolume overload. Studies were
performedin 6 cardiomyopathichamsters, 6 age- and
sex-matched control hamsters, and in 10 autopsiedhuman
hearts, 5 with congestive heart failure (CHF) and 5
matched controls. The myocardium was examined for the
presence of immunoreactiveANF using a two-stage
immunohistochemicaltechnique. ANF speci fic rabbi t
antisera and peroxidase conjugated goatanti-rabbitIgG
were used to visualize immunoreactiveANFj nonimmune
rabbit sera was employed as a negative control. Two
trained observers reviewed all sections independently and
under blindedconditions. Therewas uniquivocal evidence
of focal subendocardialdeposits of immunoreactive ANF
present in the ventricle of all 6 cardiomyopathic hamsters
and in the right and/or left ventricle in 4 of 5 human
subjects with CHF. No immunoreactive ANF was observed
within the ventriclarmyocardiumof control hamsters or
humans. This study demonstrates for thefirst time that
immunoreactiveANF is present within theventricular
myocardium in cardiomyopathichamsters andhumans with CHF
and suggests that the ventricle may be capable of
responding to chronicvolume overload by producingatrial
natriureticfactor.
Collegeof Cardiology. Many excellentcontributions were
received for thisyear'scompetition,and weappreciate
your supportand interest.
Ralph Shabetai,MD, FACC
Chairman ,1987 AnnualScientific Session
Program Committee
David J. Sahn, MD, FACC
Co-Chairman. 1987 AnnualScientific Session
Program Committee
EXPRESSION OF THE GENES ENCODING THE FETAL
ISOFORMS OF CONTRACTILE PROTEINS AND ATRIAL
NATRJURETIC FACTOR (ANF) IN THE HYPERTROPHIED
ADULT VENTRJCLES. S.Izumo, M.D. A.-M. Lompre, Ph.D.
B. Nadal-Ginard, M.D. Ph.D. FACC, V. Mahdavi, Ph.D .
Chirldren'sHospital, HarvardMedica lSchool, Boston, MA.
To determine the molecular basis of contractileprotein
gene regulation during normal development and in various
petrological states, we analyzed, by gene spec ific cONA
probes, the mRNAs of two isoforms of myosin heavy chain
(MHC), actin and tropomyosin in the fetal, newborn, adult,
hypothyroid, hyperthyroidand hypertrophicrat ventricles (V)
produced by aortic coarctation (AC). In fetal V, there was
co-expression of the two isoforms of MHC ( a and B), actin
(cardiac and skeletal) and topomyosin ( a and B). During
normal development, one of each pair of these genes-
the B -MHC, skeletal actin and B--tropomyosin-- was pro-
gressively de-induced to a barely detectable level in adultV.
However , these three fetal genes were re-induced rapidly in
response to AC. Moreover, high doses of th yroid hormone
prevented the induct ion of B -MHC gene during AC. In
contrast, hypothyroidism, which re-induces B-MHC gene, did
not re-induce skeletal actin and B -tropomyosi n genes.
Simultaneous protein analysis demonstrated that levels of
a -and 6- MHC proteins closely followed the ir corresponding
mRNAs. This indicat es that pre-translationalmechanisms
are responsible for the MHC isoform transitions during AC.
Interestingly,the ANF mRNA, so far beleived to be expressed
only in the atria, was induced in the newborn and
hypertrophic adult V. The c-myc proto-oncogene and heat
sboc k protein gene, implicated to play a role in some models
of cardiac hypertrophy,were not inducedabove controllevels
during AC. These results suggest that re-programmingthe
fetal genes in the adult myocardiummay be a generalfeature
duringadaptation to hemodynamicoverload.
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MEASUREMENT OF REGIONAL MYOCARDIAL BLOOD FLCM IN-VIVO
USING MYOCARDIAL COO1'RAST 2D ECHOCARDIOGRAPHY.
san~iv Kaul, M.D., FACC, John D. Oliner, BA, Paul
Kel y, M.D., Denny D. watson, Ph.D., university of
Virginia School of Medicine, Charlottesville, Virginia
There is no readily available technique of simul-
taneously measuring regional myocardial perfusion and
function in-vivo. 2D echocardiography(2DE) has been
demonstratedto reliably measure regional myocardial
function. The capability of measuring regional myocar-
dial blood flow could make it a readily available tool
for the simultaneous assessment of regional myocardial
perfusion and function in-vivo. Accordingly, we selec-
tively perfused the left circumflex coronaryartery
(Le) of 8 dogs with arterialblood at 4 different flow
rates. At each flow rate, radiolabeledmicrospheres
were injected to measure transmuralblood flow in the
LC bed. Sonicated renografin-76which has microbubbles
of air (mean size 4p) was also injected at each stage
to produce myocardial contrast enhancementduring 2DE.
Computergenerated time-intensitycurves were derived
from the 2DE images using videodensitometeryand para-
meters of these curves correlatedwith transmuralblood
flow. A gamma variate function (y • Ate-- t ) best des-
cribed the curves, and « (which represents the width of
each curve) correlatedwell with transmuralblood flow
at different flow rates in the same dog (average r =
0.81, best r = 0.96), and in all dogs (r = 0.81,
p<.Ol). Other parametersof the curve that represent
its width such as time fromappearanceof contrast to
peak contrast effect and time fromappearanceof con-
trast to half of maximal contrasteffect also cor-
related well with transmuralblood flow (r = 0.85 and
0.81 respectively). Peak contrast intensity had a poor
correlationwith transmuralblood flow (r = 0.39).
We conclude that myocardial contrast 2DE may offer
the unique opportunityof simultaneouslyassessing
regional myocardial blood flow and function in-vivo.
THE Nil'l POSITIVE INCYI'roPICAGENTS FUNCTIONALLY BLCCK N. ,
THE INHIBITORYREGUIATOR OF ADENYIATE CYCLllSE. 1
William J. Parsons, M.D. and Gary L. Stiles, M.D., Duke
University Medical Center, Durham,N:.
Although the new inotropes, such as sulmazo.le , are
knoen to increase cAMP and to inhibit a low Km cN-lP
phosphodiesterase (PO), there is still debate as to the
prirraryrrechanism(s) by which these agents act. In a
rat adipocyte rrembranem:x1el we derronstratethat only
~SO% of sulIPazole's effect on cAMP accumulationcan be
attributedto PO inhibition and that the remaining
productionof cAMP involves stimulationof adenylate
cyclase (AC) activity. 'Two distinct pathways for
stimulationof AC are herein reported. Sulmazo.Ie, lJl)-{:G
212 CL, enoxirrone, piroxirrone, amrinone andmilrinone
are all shONll to be competitive antagonistsof
.inhibi.toryAl adenosine receptors, with ECso's of 11 to909 J,JM. The in vivo antagonismof Al receptors maycontributeto the positive inotropic effect of these
agents. In addition, covalent m:x1ification of the
inhibitory regulatorN. by pertussis intoxication
abolishes the inotrope!rrediatedstimulationof AC
activity. Since sulIPazole's rrechanismof action is,
therefore, N.-dependent and results ill stimulationof
AC, functionh blockade of N. activity is likely the
m:x1e of action. This heretofore unappreciatedrrechanism
of stimulation is observed with all of the new inotropes
studied. Of note, this stimulatoryeffect is reversed
by inhibitory receptoragonists. Thus, the new
inotropes rrediate increases in cAMP accumulatl0nby
rrechanisms other than PO inhibition, including Aladenosine receptor antagonismand blockade of N.. To the
extent that the inotropic effects of these agenEs
correlatewith cAMP accumulation, the functional
blockade of N. appears to be an irrportantrrechanismof
action. 1
OXYGEN FREE RADICALS MEDIATE ARACHIDONATE
INDUCED PLATELET AGGREGATION AND
THROMBOXANEB2PRODUCTION
J.A. Thompson, M.D., Hamilton, M.S., M.L. Hess, M.D.
F.A.C.C. Medical College of Virginia, Richmond,VA
Reactive oxygen species are generatedduring arachidonic
acid (AA) metabolism and oncereleased these species can
potentially participate in local tissue damage. Since
arachidonate acid metabolism is an integral part of
platelet aggregation, we hypothesized that reactive
oxygen species must be generated. Aggregation of
citrate-platelet rich plasma was measuredafter the
addition of AA (0.6 mM), then SOD orCatalase was used
to inhibit the reaction. Platelet aggregation after AA
was 60:8%; whereas AA+SOD reduced aggregation to
8:2% (p ( .05), and AA+Catalasereduced aggregation to
12+2% (p<0.05). ADP aggregationwas 65+12%, whereas
ADP+SOD or ADP+Catalase reduced aggregation to
26:8% and 33:8% respectively. Thromboxane (TxB2)
levels after AA were 584 : 50 pg; whereasAA+SOD the
TxB2 levels were 69 : 16 pg AA+CAT TxB2 levels were
132 + 32 pg. Xanthine-xanthineoxidase was used to
generate superoxide in the presence of platelets and no
aggregation was found. Likewise hydrogen peroxide did
not aggregate platelets. However, usingsubthresholdAA
(.16mM) in the presence of superoxide anion or hydrogen
peroxide producedaggregation. These findings support
the concept that conversion of arachidonic acid to an
activated state is an important step in prostaglandin
synthesis and that electron transfer or oxidation-
reduction reactions are intimately involved in the
developmentof plateletaggregation.
Monday, March 9, 1987
10:30AM-12:00NOON, Room 38, Second Level
Assessment of Congenital Heart Disease by
Echocardiography
DETECTIONAND QUANTlTATIONOFCONSTRICTIONOFTHEFETAL
DUCTUSARTERIOSUSBY DOPPLERECHCJCARDIOGRAPHY
James C,Huhta,M,D" F.A,C,C.•KennethJ. Moise, M,D., David J,
Fisher,M,D" F,A,C,C" Dawod S, Sharif, M,D, and NathanWasserstrum,
M.D.• PhD. From the Departmentsof Pediatricsand Obstetricsand
Gynecology. BaylorCollegeof Medicine, Houston,TX.
Pulmonaryhypertensionmay occur in the fetus in the presence of
constrictionof the ductus arteriosus, Thefeasibility of detection and
quantltanon of fetal ductalconstrictionby Dopplerechocardroqraphy
was assessed by ductalconstrictioncreated in a fetal lamb modelwith a
variable ligature causingvarying degrees of fetalpulmonary
hypertension (fetal pulmonary artery systolic pressure 57-97
mmHg). Continuouswave peak Doppler velocity (Y) measurements of
the ductal gradient (4y2) comparedwell with direct catheter pressure
measurements of instantaneous peak systolic gradient (r=0,99,
catheter-o.ss Doppler+0.6), peak-to -peak gradient (r=0,97), and
mid-diastolic gradient (r=0,85).
The normal human fetal ductus arteriosus bloodflow velocity
pattern wasassessed by pulsedDoppler techniques in 25normal
human fetuses after 20 weeks gestation, The peak systolicflow
velocity in the ductus arteriosus by image-directed pulsedDoppler
ranged from 50-141 crn/s (mean 80 crn/s) and increasedwith
gestational age(r=.50) and was the highest bloodflow velocity in the
fetal cardiovascular system.
Applicationof these techniques to three human fetusesreceiving
indomethacinas a tocolytic agent for premature labor at30-31 weeks
gestationconfirmedthis method to be sensitive for detection of fetal
ductalconstrictionwhich developed in two of three fetuses,
Dopplerechocardiographycan be used toassess the flow velocny in
the fetal ductus in humans and to detect and quantitate the severityof
fetal ductalconstriction in such patients,
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COLOR DOPPLER FLOW MAPPI~G OF PULMONARY ARTFRY FLOW IN
AN ANIMAl. MODFJ. OF PATENT DUCTUS AFTFRIOSlI~(PDA).
kichard Swensson, M.D., FACC, David J. Sahn, M.D., FACe,
WaIter Demhitsky, LP., Bill Elias, Tadashi Tamura ,
C.I'hi I , Frederick Sherman, ~I.D., Lil l Lam Val dea-Cruz,
M.D., FACC Univ of Calif, San Diego, CA.
In order to stu~y the flow patterns encountered in fDA,
we surgically Inserted a variable-size Dacron shunt bet-
ween the aorta (AO) drd the mail! pulmonary arterv (PA)
into 5, 20 Kg "pen chest dogs. El.ect r omagnet tc flow
meters (EM) on the AO and the shunt showed pulmonary/
systemic flow ratios from 1:1 to 3.5:1 (flows 100 to
5500 cc/min). Catheters in the AO and PA provided inst-
antaneous A0 tu PA gradient pressure (GRAD). C"lor flow
Doppler (CD) trnazes and spectra'. smnpling showed retro-
grade "ductal"flow up the lateral wall of the PA with
continuous systol ie and diastolic forward swirling arte-
grade flow on the medial wall and right PA. FM and GRAD
waveforms showed peak AO t o PA shunt flow in mid to late
systole (SYS) just after peak A0 to FA GRAD. Continuous
wave Doppler directed parallel to thE imaged shunt flow
area detected high velocity, SYS and DIAST flow towards
the transducerwith a close temporal relatier.~jp to
measured AO to PA GRAP but with onIv a semiquantitative
relationship of velocity (1'=0.63) and Hernoulli esti-
mated GRADs to measured GRAD. LastlV. the size of the
maximal DtAST CD arEa of image~ shunt flow ir the PA
correldted well with the shunt volume (cc/min)(r=O.SO).
Our studies give in5ight into the complex spatial and
temporal flow patterns seen in PDA and provide a direct
approach to quantitationof PDA shunts. Since the cor-
re latLon of maximal DIAST CD area of imaged shunt flow
to Dacron shunt volume(cc/min) was stil" r=0.84 in =
dogs with both a PDA-like shunt and VSD created, the
potential for CD shunt quantitation might be most useful
when multiple level shunts are present.
SUBSTANrIAL IMPROVEMENI' IN NONINVASlVE DIAGOOSIS OF
COARCTATION, AND DIFFERENI'IATION FRa1 PATENI' oucrts.
OOPPLER EVALUATION OF DESCENDING AORTIC WAVEFORM PATrERNS
J..<;eoffrey S~f;)~n?oJl MP FACC, Jarres W. French MD FACC,
Isarru Kawahori MD, lore Tenckhoff MD, Stanley J. Starrm
MD FACC, Kathleen Conner RI:M3. O1ildren's Hospital
and University of Washington School of Medicine, Seattle,Wa
WA.
'&>0 d:irrensional Doppler echo (2DD) di.aqnosi.s of
coarctation (CoAo) can be da f f acul.t, especaa.LLy In
neonates with kinking of the aortic arch, and patent
ductus (PDAl. The purpose of this study was to evaluate
aortic flow by 200 in patients with CoAO and with PDA,
to detennine whether these Les rons have specific flow
patterns allowing their differentiatlOn. 13 patrents
with CoAo, 20 with PDA, and 7 with CoAo+PDA were evalu-
ated with 2DD, all had independently proven diagnoses.
200 flow recordings were rrade in the descendlng thoracic
aorta proximal to COM or PDA level, and then at the
level of CoAo or PDA. Of the 13 with CoAo, 2D echo
showed the CoAo conclusively in only 5, and Doppler
showed abnorrral velocities in 10, in 3 no abnorrral
velocities were present and no coarctationwas lITBged.
In all 13 however, Doppler aortic waveforrrs revealed
a distwct pattern of exponential decay in diastoll.c
velocity to the point of the next systolic deflection.
In contrast, aortic waveforrrs In all 20 wlth PDA demon-
strated abrupt linear decaleration to baseLane at end
systole, followed by ongoing diastolic flow of constant
velocity. In the 7 wi.th CoAo+PDA, the typical aortic
waveform pattern noted in CoAo was present u! all,
allowing recognition of CoAo even in the presence of
PDA. we conclude that these distinct patternsprovide
sensitive and speclfic (100%) differentiationof isolat-
ed COM from PDA, as well as of COM coexisting with
PDA.
LESSONS PROVIDED BY caLOR I"LCW lMAGIfol;: DISTURBED I"LCW JETS
TEND 'ID ADHERE 'ID ADJACENI'WALLS.
J. Geoffrey Stevenson MP FACe. O1ildren's Hospital
and University of Washington School of Medicine, Seattle
WA.
Color flow imagwg has provided new insights into
spatial di.st r.ibution of di.sturbed flow. A series of
flow disturbances were evaluated to detennine whether
CFI revealed consistent and specific patternsof spatial
distribution: trlcuspid regurgitation (TR,N=36l, patent
ductus( PDA,N=20), pulm:mic regurgitation (PR,N=34),
aortic regurgitation (AR,N=14), mitral regurgitation
(MR,N=24). All daaqnoses were proven by another technique.
Appropriate cn windows were used to atterrptaligrurent
of the cn plane with the expected axis of disturbed
flow. In TR, CFI derronstrated origin of di.sturbed
flow at the valve, and in 86% an abrupt angulation
of the Jet to the atnal septum as it coursed into
the atrium. 75% of MR jets adhered to either the atrial
wall or septum. In 79% of PI jets, CFI derronstrated
the jets to inl>lnge upon the antenor right ventricular
wall as they coursed into the cherroerj only 29% were
central. In 86%of AR Jets, adherence to the ventricular
septum and/or anterior mitral leaflet was shown. In
95%of those wlth PDA, the Jet adhered to the anterior/
superior pulmonaryarterywall These results demonstrate
that in rrany s i tuations , disturbed flow jets tend to
adhere to adjacent walls, in highly saqruficant proportaorv
These vivid CFI observations provide useful le5sons
and guidance for ll.kely locations of disturbed flow
on CFI exanunations , and for sarrple volurre placerrent
dunng conventional two d:irrensionalDoppler examinations.
UTILITY OF COLOR FLOW IMAGING FOR SHUNT VISUALIZATION IN
ATRIAL SEPTAL DEFECT: EXPERIENCE IN 90 PATIENTS.
Bijoy K. Khandheria, M.D., James B. Seward, M.D.,
F.A.C.C., Qatherine L. Taylor, Donald J. Hagler, M.D.,
F.A.C.C., Guy S. Reeder, M.D., F.A.C.C., Clarence Shub,
M.D., F.A.C.C. and A. Jamil Tajik, M.D., F.A.C.C., Mayo
Clinic, Rochester, MN.
Although two-dimensional echocardiography(2DE) allows
visualization of atrial septal defect (ASD), heretofore it
was necessary to use contrast echo or angiography to
visualize shunt flow. Color flow imaging (CFI) permits
noninvasive visualization of intracardiacshunt flow. We
report our experience with CFI in direct visualization of
left-to-right shunt flow in ASD. From January 1985 to
August 1986, ASD was diagnosed in 90 Pt by 2DE and/or CFI
(57 females, 33 males; ages, 2 days to 87 years). In 29
Pt, ASD was not suspected clinically, and diagnosis was
first established by 2DE and CFI. Visualization of a
defect by 2DE was feasible in 77 (86S); pulsed Doppler
echocardiographydetected turbulent flow in the RA,
indicative of left-to-right shunt in 80/83 (96S). CFI
enabled visualization of shunt in 87 (97S). Two of the 3
false-negative CFI examinations occurred in sinus venosus
defect. On combination of information from all three
modalities, the diagnosis of ASD was confidently
established in 89/90 (99S). Diagnosis was confirmed in 47
Pt (52S)--at operation in 39 and cardiac catheterization
in 23. Qp/Qs ranged from 1.4 to 3.2. Surgical repair was
undertakensolely on the basis of 2DE and CFI in 24/39 Pt
(62S). Conclusion: Combined 2DE, pulsed Doppler, and CFI
permits confident diagnosis of ASD in 99S of Pt. CFI not
only enhances diagnostic accuracy of 2D and pulsed Doppler
but also provides a vivid and readily understandable
display of left-to-right shunt in ASD.
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COMPARISON OF HEAStJREMENTS OF LEFT VENTRICULAR FUNCTION
DURING EXERCISE BY FIRST-PASS AND EQUILIBRIUM TECHNIQUES
Hanna Szwed. MD and Robert H. Jones, MD, FACC, Duke Univ.
Medical Center, Durham, NC
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The correlation between FP and MUGA rest EF suggests
both techniques were performed wit h reasonable accuracy.
Lack of agreement i n A EF by the two techniques was
characterizedby fewer negative t.. EF values measured by
MUGA (3 patients) than by FP ( 12 patients). These data
suggest the imaging time of several minutes required by
MUGA i n contrast to several seconds by FP may preclude
appreciation of the maximum amount of ischemic dysfunction
experienced by manypatients.
Exercise induced cardiac dysfunction is one of the most
sensitive prognostic indicators i n patients with coronary
artery disease. We examined the comparability of LV
eject ion fraction (EF) at rest and rest to exercise change
(~EF) by f irst-pass (FP) and multigated equilibrium (HUGA)
radionuclideangiocardiography in 27 patients with heart
disease. FP and MUGA studies were performedwithin two
weeks in every patient, and no patient had an intervening
cl inical event. The average double product for FP was
21432 and for MUGA, 21979 (paNS). Patients exercised to
t he same endpoint criteria, and FP andMUGA studies were
performed by techniques used for cl inical studies.
DIASTOLlC RE TROG RADE RENAL ARTERY BLOO D FLOW IN
PREMATUR E NEON AT ES WITH R ESP IRA TO RY DISTRESS
SYNDRO ME AND PATENT DUCT US ARTER IOSUS.
Vincen t R. Zales, MD, J a mes M. Berry, Stanley Emzrg, MD,
PhD , John L. Bass, MD, Uni vers it y of Min esota, Mmneapohs,
MN.
The nor mal pulsed Doppler flow signalIn the re nal art er y
shows co ntinuous for wa rd flow In systole and diastole, We evalu-
ated the c linica l features and Doppler renal art ery flow prof iles
of 18 premature neo nates (PNB) (mea n bir t hwerg ht 1600 g m,
mean gestatIOnal age 30 wk). Studies were performed on da y 1,
3, an d 7 of life. PNB wrth re spiratory distress syn drom e we re
ma nage d c onven t ronal ly in c lu d m g Intuba ti on and posrt rve
pressure ventila tio n to maintain arterial P02 >50 torr, and
moderate f lurd restriction. Patent ductus arterios us (PDA) was
confirmed by 2-d lmens lOna l Imag lng and pulsed Doppler wit hin
the PD A (Ekolr ne 5500D mechanical sector with a 5 MHz
tr an sduced. F low patterns we re recorde d from the abdominal
aorta and renal arteries utiliz ing a 2 mm sam ple volume. The
rnaxrrnurn sys to lic renal arter y fl ow signa l was recorded from
t he right or left posterior lateral flank posrnon parallel to flow.
In 9 PNB , there was antegrade diasto hc ao rtrc flow (Group I),
and In 9 PNB, there was retrogradedra stohc aortic flow (Group
2). A ratio of trough diastohc to pe ak syst oh c renal artery flow
ve locity was determined. All neonates wit h dias to hc retrograde
ao rt ic f low had retrograde ren al arter y flow WIth th e renal
ar tery flow ve loci ty ratios In Grou p I PNB great er than tho se In
Group 2 (0 .25.0. 03 and -0. 27.0.04 respective ly, mean-S lj,
p -o.oon. Se rum c rea u mnes were also Signif icant ly diffe ren t In
th e 2 gro up s (0 .97.0. 16 and 1.6.0.22 mg/ d l respecnvely,
p <O.OOll . None of 9 Group I a nd 8 of 9 Gr oup 2 PNB underwe nt
P DA cl osure. This st udy show s that th e presence of a sigruhcant
PD A alter s the nor mal flow pattern In th e renal artery and th at
drast o! ic retrog rade renal arter y f low corn pr crruses renal
function. PNB WIt h this abnormal renal blood flow pattern
require P DA closure .
Monday, March 9, 1987
10:30AM-12:00NOON, Room 24, Second Level
Radionuclide Angiography
SIMULTANEOUS ASSESSMENT OF REGIONAL VENTRICULAR FUNCTION
AND PERFUSIDN UTILIZING IRIDIUM-191m AND THALLIUM-201
DURING A SINGLE EXERCISE TEST.
Mario S. Verani. M.D .• F.A.C.C.• Jeffrey L. Lacy. Ph.D.•
Salvador Treves. 1'l.0.. Allen Packard, Ph.D.. Robert W.
Gibson, B.S., A.R.R.T., Mark Ball, Terri M. Boyce, B.S.,
C.N.M.T., Mahmoud Hassanein, M.D., Samuel George, M.D.
and Robert Roberts, M.D., F.A.C.C., Baylor College of
Medicine, Houston, Texas.
Knowledge of the left ventricular functional re-
serve and myocardial perfusion simultaneously obtained
during asingle exercise (EX) test would greatly improve
thp funct iona1 evaluation of pts with coronaryartery
disease but cannot beperformedwith usual nuclear tech-
nology. The high count -rate of the multiwire~amma
camera and theultra-short half-l i fe of iridium (Ir)-
191m (Tl! 2 = 5 seconds), may be ideal ly suited for simul-
taneous use withEX thallium (Tl) scintigraphy. To test
thi s hypothesis, 14 pts initielly underwent resting
f i rst -pass radionuclideangiography (FPRNA) with 30-60
mCi Ir-lglm and then performed upright bicycle EX. At
peak EX they received 3 mCi of Tl-2Dl followed by a sec-
ond inj ect ion of Ir-191m. FPRNA images were acquired on
the multiwire camera at peak EX and Tl-20! emissioncom-
puted tomography (ECT) was begun five minutes later on a
rotating gamma camera. High qual ity images were ob-
tained inall cases. Pts with normal Tl-20! ECT (n = 6)
had normal wall motion and increased ejection fraction
during EX . Pts with coronary disease and perfus ion de-
fects (n = 6) had dyssynergy in corr espondingmyocardial
segments and fall in ejection fraction. Two pts with
coronary disease and normal perfusion had abnormal
FPRNA. Thus, concomitant USE' of the multiwire gamma
camera with Ir-!91m andECT with Tl-201 permits high
quality assessment of regional ventr icular function and
myocardial perfusion during asingle exercise test.
PEAK FILLIlll RATE BY RADIONUCLIDE OOIOORAPHY: EFFECT
OF NORMALIZATION PARAMETERS
James E. Udelson, MD. Robert O. Bonow. MD, FACC,
Stephen L. Bacharach, PhD, NHLBI, Bethesda. Maryland.
Peak filling rate (PFRJ obtained by radionuclide angiO-
graphy is usually normalized to end-diastolic volume
(EDV J. Since apparent changes i n PFR after an interven-
tion may reflect changes in EDV rather than changes in LV
filling per se, alternative normalizationmethods may
yield significantly different results. To assess the ef-
fect of normalizationmethod, we stUdied 2 groups of pts
at rest with interventions preViously shown to enhance PFR
normalized to EDV: 42 pts with hypertrophiccardiomyopathy
(HCM) receiving verapamil, and 25 pts with single-vessel
coronary disease (CAD) undergoing angioplasty (PTCA).
In addit'ion to EDV normalization, PFR was normalized by
stroke volume (SV), end-systolic volume (ESV) and instan-
taneous volume at time of PFR ( VPFR) . Neither interven-
tion altered mean ejection fraction (EF) ; heart rate de-
creased in HCM after verapami l but was unchanged byPTCA.
HCM CAD
control -verapamil Pre PTCA-Post PTCA
PFR EDV!s 3.2+ 1.1 4.1+ 1.2- 2.3+0.6 2.7+0.6-
SV/s 4.3; 1.3 5.6; 1.5- 4.2;1.1 5.0+1.0-
ESV/s 19 .5~26.5 21.3;18.3+ 5.1;1.1 6.3;2.2·
VPFR!s 6.0+ 2.1 7.3; 2.4- 3.4;0.9 4.1;4.1-
Values=mean+ sD .p<.OOl -+ p=NS -
All methods produced similarly significant results, except
the ESV method in HCM pts. This reflected the finding
that in some HCM pts with very high EF. a very small ESV
underwent arelatively large (t hough quantitatively small)
i ncr ease after verapamil. Although quantitatively differ-
ent values may result, we conclude t hat in general, sig-
nificant directional changes in PFR after an intervention
are maintained regardless of the normalization parameter.
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James H. O'Keefe, MD, Andre C. Lapeyre , MD FACC , David
R. HoIm~ MD FACC, Raymond J. Gibbons, MD FACC. Mayo
Cl inic , Rochester, MN.
EARLY RADIONUCLIDE ANGIOGRAPHY IDENTIFIES LOW RISK
PATIENTS FOR LATE RESTENOSIS AFTER TRANSLUHINAL CORONARY
ANGIOPLASTY.
Conclusions:
1) Early exercise RNA identifies subgroups of patients
at low risk and high risk for eventual restenosis.
2) Routine follow-up angiography may not be necessary in
patients with normal RNA early after PTCA.
The purpose of this study was to evaluate the ability
of exer c i se radionuclide angiography (RNA) performed
early after percutaneous transluminalcoronary
angioplasty (PTCA) to predict subsequent late resteno-
sis. Forty-eight patients with initially success ful
PTCA, defined as a > 40% reduction of predilatation
stenosis, underwent-early(within 1 mont h) exercise RNA
and late (3 to 12 months; mean 8 months) corons r y
angiography. Forty-four patients had successful dilata-
tion of 1 vessel, 3 had 2 vessels; 1 had 3 vessels
dilated. The mean predilatations t enos i s of 93% was
reduced to 34% at PTCA. Restenosis was defined as a
return to > 70% reduction in luminal diameter. Normal
exercise RNA was defined as an increase in ejection frac-
tion with exercise of > 5 points or a peak exercise ejec-
t ion fraction of > 70%:
NOK-INVASIVE XONITORING OF ACUTE REJECTION IN THE CARDIAC
ALLOGRAFT, USING RADIONUCLIDE VENTRI CULOGRAPHY . Wl1Uam
!,_._!oll2..~..E!.e-,_..:'tJl_.-,L.~c;..._«. , Joseph M. Kiernan, M-:D:"';"'--
EdwardI. Curti ss , X.D., F.A. C.C., Robert L. HardestY,M.D.,
Bartley P. Griffi th, M.D., Uni ver s i t y of Pittsburgh,
Pittsbur gh, PA.
Because endomyocardial biopsy ( EMB) is both invasive and
subject t o sampl i ng errors, it is desirable t o develop
non-invas i ve par ameters to detect acute rejection of t he
car di ac allogr af t . We evaluated S3 consecutive cardiac
transpl ant recipients wi t h weekly EMS and radionuclide
vent riculog raphy (RNV) during their post-transplant
hospitalization . Twenty-one of the 53 (40%) had an
episode of acute rejection, defined as a probability of
re jection based upon examination of 3 EMB fragments of
> 75%. Of these, 10 had a prior EMB showing no signifi-
cant re j ect i on (pr obabil i t y <25%) , allowing comparison
of the change in left ventricularejection fraction
(LVEF) resulting from rejection. The initial mean LVEF
of t he ten was 60.5+7.8%. Nine of the 10 decreased their
LVEF during rejection (mean -5.8+5.8%, p< 0.025). Seven
patients had an episode of rejection which, after treat-
ment, was followed by an EMS showing no significant
rejection. Of these seven, 6 had an increase in LVEF
following treatment (initial EF=SS.I+9.1%, mean increase
6. 6+7. 9%, p< 0 .10) . ....
W~ conc l ude that measureable changes in LVEF do occur
during acute rejection and subsequent treatment of the
ca rdi ac al l ogra f t . The useof sequential determinations
of le ft vent ricul ar ejection fraction using radionuclide
ventriculography has the potential to decrease the
r equi rement for endomyocardial biopsy.
p<.Ol
25%
5%
41%
Restenosis
Rate
12
11 with
Restenosis
1
11
48
it Pts.
-2-1-
27
Normal
Abnormal
Exercise
RNA
TOTAL
CHARACTERISTICSOF SIl.ENT MYOCARDIAL ISCElDUA DURING MEN-
TAL STRESS: LABORATORY ASSESSMENT USING WUILIBRIUM RADIO-
NUCLIDE VENTRICULOGRAPHY. CN Be.irey, MD; A Rozanski, MD,
FACC; JD Friedman, MD, FACC; J Bietendorf, CNMT; L Hes-
trin, MPH; D K~antz, PhD; DS Bermsn, MD, FACC. Ceda~s ­
Sinai Medical Cente~, Los Angeles, CA
To assess if cha~acte~istics of silent i~chem1a noted
with ambUlatory monitoring can be rep!'oduced in the lab,
26 pts with known/suspected coronary disease and a posi-
tive exercise (Ex) test and 1 no~mals were studied du~ing
provocative mental (M) stresses (math, wo~d st~oop, public
speaking, reading) and Ex using e8uilib~ium radionuclide
vent~iculography (RNV), in the 45 left anterio~ oblique
view. Wall motion (WM) was assessed blindly by a 5-point
sco~e ( 3=normal , -1=dyskinesis) for each of 5 LV segments
(seg ). Seventeen (65~) of the 26 pts had WM abno~mslity
(A) during M tasks. None of the 1 nl~ and 5 pts without EX
WH abno~mslity (A) had WMA du~ing Mtasks. The 21 pts with
Ex WMA were divided into Group 1: WM at Ex stage 1, and
Group 2: onset of WM at stage >2. Response to Mtasks:
Summed 5-seg WM (rest=-peak) Chest
G~oup 0 <1 2 >3 ST Pain
1 (n=8) O( O~) O( O~) 1 ( 13~ ) 1 (~8~) 3(3Ol) 4-r50~ )
2 (n =13) 4<31~) 2( 15~ ) 2 (15~ ) 5 (38~ ) 1( 1S) 0 ( O ~ )
Overall 32 (86~) of the 31 M tasks with WM~ and 25 ( 8 6 ~)
of the 29 M tasks with WM~ >2 we~e silent. Of note, in all
G~oup 2 pts with WHA, t he peak HR x BP du!'i ng Mst~ess was
below the HR x BP at which WHA fi rst occu~~ed du~ing Ex.
Thus, myocardial ischemia indu~during M tasks is:
usual l y silent, occurs at a lowe~ double-p~uct threshold
than for Ex WMA, was not seen in pts without Ex WHA, and
was most frequent and severe in pts with early onset of Ex
WHA. These findings complement those noted during ambula-
tory monitoring and indicate that the study of silent is-
chemia and its ~elationship to mental as well as physical
st~ess can be extended to lab investigation using RNV.
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MyocardialMechanics andFunction
HETEROGENEOUS APEX TO BASE DIASTOLIC LOADING CONDITIONS
IN THE NORMAL HUMAN LEFT VENTRICLE
Andrew J. Feiring, M.D., John A. Rumberger. M.D., Ph.D.,
William Stanford, M.D., Melvin L. Marcus. M.D., F.A.C.C.
Dept of Med, University of Iowa, Iowa City, Iowa 52242
The end-diastolic volume-to-mass ratio (V/MR) is of
prognostic value in patients with cardiac disease and
provides an index of LV diastolic loading conditions.
With conventional imaging methods (contr~st angiography
etc . ) var i ous assumptions about cardiac shape are needed
to calculate V/MR and regional differences in V/MR cannot
be aasessed. With cine computed tomography (CT) both
regional and global LV V/HR can be preciaely measured and
assumptions about LV shape are not needed. To determine
if diastolic loading conditions were heterogeneous from
apex-to-base in the LV of normal humans weassessed the
V/HR from apex-ta-base (se r i a l short axis, 1 cm
tomographic i mages) in 12 male volunteers. CT images
were obtained at 17 frames/second following peripheraliv
contrast injection. We determined both global and level-
to-level V/MR. Meanheart rate was 76~3 ( x~SE ) beats per
minute and peak systolic pressure was 1 2 4 ~ 3 mmHg. The
global LV end-diastolic V/HR was 0.77~0.OS, LV
end-diastolic volume was 75~4 ml/M2, LV mass was 102~5
g/M2 and LV ejection fraction was 70~6%. Data at various
apex-to-base levels for V/MR as shown : (* p , 0.05 vs
levels 5-8 )
Apex 1* 2* 3* 4 S 6 7 8
x 0. 3 0.56 0.72 0.88 0.88 0.92 0.9 1.07
SE 0. 04 0.06 0.01 0.12 0.08 0.07 0.07 0.09
Thi s study demonstrates that in the normal humanLV
diastolic loading conditions are markedly heterogene-
ous. Approaches to assessing V/HR which employ
assumptions about LV shape or obtain information from
only a few LV levels (2D echo) are likely to yield data
of limited quantitativevalue.
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IMPAIRED LEFT VENTRICULAR DIASTOLIC FILLING IN PATIENTS
WITH CORONARY ARTERY DISEASE AND NORMAL SYSTOLIC
FUNCTION: CORRECTION FOR AGE EFFECT
Robert O. Bonow. MD. FACC. Leonardo Pace. MD. Stephen L.
Baehar-ach, PhD. Edward Lakat.oa, PhD. Michael V. Green.
MS. NHLBI. Bethesda. Maryland
Previous studies indicate that many pts with coronary
artery disease (CAD) manifest impaired LV diastolic fil-
ling at rest despite normal LV systolic function. How-
ever. since LV diastolic filling declines as a function
of the normal aging process. it has been suggested that
apparent reduction in LV filling in CAD pts represents
merely the advanced age of such pts comparedto normal
popUlation samples. To address this issue. we studied
66 normal volunteers (age 18-77. mean 42) and 100 pts
with CAD (age 34-70. mean 52) by radionuclide angiography.
All CAD pats had normalejection fraction (EF) and region-
al wall motion at rest. and none had Q-waves onECG. EF at
rest did not differ between the 2 groups and did not vary
with age. In the normal SUbjects. peak LV filling rate
(PFR) significantly declined (r=O.55. p(.OOl) and time to
PFR increased (r=O.53. p(.OOl) as functions of age. where-
as neither PFR nor time to PFR correlatedwith age in the
CAD pts (r=O.lO andr=0.13). Throughout the age spectrum.
PFR was reduced and time to PFR was prolonged in the CAD
pts compared to normal. both of which weresignificant
differences (both p(.OOl) after correction for age by mul-
tivariatelogistic analysis. Hence. impaired LV filling
at rest in pts with CAD and normalLV systolic function
does not represent merely advanced agein CAD populations.
as LV filling is reduced in CAD pts compared to normal
across a wide range of age. These data indicate that re-
duced LV filling in CAD reflects altered LV function under
resting conditions. stemming fromLV ischemia or impaired
coronary flow. in addition to possible aging effects.
EFFECTS OF BLOOD IONIZED CALCllM ON MYOCARDIAL
MECHANICS IN HUMANS.
Poberto M. Lang, M.D., Kenneth M. Borow, M.D., F.A.C.C., Alex
Neumann, B.S., Kirk T. Spencer, B.S., David A. Rushinsky, M.D.,
Susan K. Fellner, M.D., The University of Chicago, Chicago, IL.
Studies in humans have demonstrated a direct relationship
hetween blood ionized calcium concentration[Ca++l and systemic
blood pressure. To determine the mechanism, we studied ~ pt s
who were hemodialyzed (H D) with both a baseline and a low
[Ca++1 bath in random order. Post HD weights were similar.
After completion of HD, simultaneous2D-targeted M-mode echo,
time corrected calibrated carotid pulse tracings, and Ao blood
velocities by Doppler were recorded. Ao annulus size was
measured by 2D echo. Heart rate (HR; blminl, e nd-dia st oll c
dimension (Ded; cm), mean Ao pressure (Pm; mmHg), cardiac
index (Cl; Llmin!~), systemic vascular resistance (SVR; dyne-
seclc,",), LV total power (TP; W) and Ao characteristic
impedance (dyne-seclc,",) were determined. LV function was
assessed by rate corrected velocity of shortening (Vcfc) and LV
a fterload by end-systolic wall stress (aes; gmlcrrf ).
rCa++i Pm Cl TP Ded o e s Vcf e
1.4:!:. 103+6 4.S+.4 2.3+.2 4.7+.7 42+21 1.1+.3
1.0:!:.1· 93!S' 4.2!.6· 1.S+.1· 4.6!.S 51+23' 0.9!.3·
'pi.01
With low [Ca++1 there was a small increase in HR (SO:!:18 to
86:!:18;p<.05), no change In LV preload (Ded), a 10% fall in Pm and
13% decrease in Cl, resulting In a 22% decline in LV energetics
(total power). No associated alterations in SVR (1021:!:139 vs
1 047:!:199) or aortic characteristicimpedance (1 5~!27 vs 166!40)
occurred. However, LV afterloadpes) rose by 21 % in conjunction
with an lS% fall In LVperformance(Vcfc).
Conclusions: Using a clinical model which allowed stable
alterations in blood Ionized calcium concentrations, we
demonstrated that myocardial factors (decreased performance
and Increased LV afterload) rather than changes in peripheral
arterial tone are re s ponstbte for the [Ca++l dependent changes In
systemic pressure.
SA
RELATIONSHIP BETWEEN LEFT VENTRICULAR SYSTOLIC ASYNCHRONY
AND FILLING IN PATIENTS WITHCORONARY ARTERY DISEASE.
Pasquale Perrone-Filardl,M.D., Sandro Betocchi, M.D.,
Alberto Cuocolo, M.D., CHO Indol f i , M.D., Mauri z i.o Cappelll-
Blgazz11 M.D., Federlco Plsclone, M.D., MareD Salvatore,
M.D., Masslmo Chlarlello, M.D., F.A.C.C.
Unlverslty of Naples 2nd Medlcal School, Naples, Italy.
p<.OS
vs G2
1, p<.OS
VS Gl
We s t udre d 58 Pts with hypertension by Tc-99m rad i onucl i de
angiography and M-mode echocardlographyat rest. All Pts
had.no symptoms and were off drugs. Echocardiographlc
measurements were: LVmass i ndex (Mi) and LV i nte rnal dias-
tolic dimenSIon (IDd). By high temporal resolutlon radio-
nuclide anglography we measured: heart rate (HR), ejectIon
fraction (EFl, peak filling rate (PFR), time to PFR (TPFR),
isovolumic relaxation period (IRP), LV SyStOllC asynchrony
as the spread of occurrence of end-systole on radionuclide
images, corrected for HR (SA). Pts were dlvlded Into 3
groups: Cl 25 Pts with normal LVMl; G2 19Pts with Increased
LVMi (>110 for women, >134 for men) and normal LVIDd «S.4},
G3 14Pts with abnormal LVMi and LVIDd. The 3 groups did not
differ as for blood pressure.
Gl G2 G3
HR (min- I ) 70+12 63+10* 65+9
LVMi (gr/M2) 98~12 147~18* ISO~18*
LVIDd (cm) 4.8~.4 S.O~.3* S.6~.2*f
EF (%) 71~9 70~IO 61~7 *'
PFR (EDV/sec) 3.3~.6 2.8~.7* 2.7~.S*
TPFR (msec) 177~38 215:53* 206:28*
IRP (msec) 102~46 139~42* 128~48
SA (%) 31~S 30~S 36~6 "f
Furthermore, llne;r relationships were found between LVMl
and, respectively, PFR and IRP (r=-.39 and .40; p<.OOI). Thus
LV hypertrophy is associated to impaired relaxatlon and
fillIng. lrrespectlve of LV dllatatlon. When this latter
occurrs, EF decreases and LV systollc asynchrony worsens.
LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVES.
Sandro Betocchl, M.D., Alberto Cuocolo, M.D., Pasquale
Perrone-Filardi,M.D.• Ni.c o l a DeLuca, M.D., Bruno t r i marco ,
M.D., Clro Acampora, M.D., Marco Salvatore, M.D., Masslmo
Chiariello, M.D., F.A.C.C., Mario Condorelli, M.D.
UniverSIty of Naples 2nd Medical School, Naples, Italy.
•
4030
PFR
Some extent of LVsys t o l i c asynchrony may be detected in Pts
WIth coronary artery disease (CAD) even WIthout notIceable
LV d1551nergy. As a consequence of such LV asynchrony, some
regIons may stIll be contractIngor may have not completed
relaxation when fllllng beglns. This mechanlsm could
contribute to Impalred fllling In Pts wlth CAD. To verlfy
this hyp o t he s i s we studied 15 Pts with a ng i.og raphi c evidence
of CAD: 8 had normal LVgrams and 7 showed mlld hypoklnesis
at contrast ventriculography.They underwent hIgh temporal
r e s o Lut i on (20msec) Tc-99m radionuclide angiography at rest
withln I week of catheterlzation.FIllIng was evaluated by
computing peak filllng rate (PFR, e nd-id i a s t o l i c counts/sec);
LV systolic asynchrony (SA, %) was estimated by measurIng
the scatter of occurrence of end-systole on cardIac Images.
on a plxel-by-pixel baSIS. Ejection fractlon was subnormal
• In 2 Pts, PFR was reduced
In 5 Pts, and SA was above
our normal value In 4 Pts.
A SIgnIfIcant inverse corre-
l a t i on was found between PFR
and SA (r=.76; p<.OI, fig.)
in that Pts wlth higher SA
had reduced PFR. Thus, SA IS
one of the determlnantsof
PFR depreSSion in Pts wlth
50 CAD.
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VENI'RICULO-ARTERIAL INI'ERACTION IN NORMAL AND FAILING
HEART IN MAN.
Hidetsugu Asano1 , M.D., Tomoki Kameyama, M.D . and
Shiget ake Sas ayama, M.D., F. A.C. C. Toyama Medica l and
Pharmaceutica l Univer slty . Toyama, J apan
ABSTRACTS
HEAI\T BLOCK ASSOCIATEU wITH HIGHf1AGNESIUH CARDI OPLEGIA
\Iil liam C. Buhrman , M.D., David W. Molter , M. D.,
Lawr ence D. German,M, D. , FACC, and James E. Love , M. D. ,
FAC.C, Duke Univ e r s i ty Medi ca l Cent e r , Dur ham, NC 27710
7A
1U determi ne t he i ncidence of persist en t CHE requiring
pacemake r insertion, 710 additonal pati ents undergoi ng
iso lated CABG were ana ly zed. Nine of 375 PT r eceiv i ng
HiMG GP ( 2.4%) developed CHB and none of 332receiving
LoMG CP dove lo ped CHB. (p<. 0I) These data suggest
that there 1S an in cre ased incidence of bot h transient
and permanent conduction sy s t em injury se en in patients
re ceiving hi gh Mg ca r di oplegia.
The purp ose of t bis s t udy " as t o Lnv es t Lgat e t he
as socidtion between heart block and the magnesium (Mg)
cont ent of ca r di opl egi a (CP) . Onehundred randomly
s e l ec ted patients (PT) undergoi ng isolated coronar y
a r te ry bypas s graf t ing (CABG) were retrospectively
ana l yzed . Pre-and p() ~ t ope ra t ive ECG's " e re revie"ed t o
detec t new postoperative abnormal i ties . Each PT
rece i ved e i th e r a l owMg ( 2 mEq/ I), buf fered, balanced
sa l t sol ut io n (J.oMC Gr oup) or high Mg (32 mEq/l)
modi f i ed St . Thomas Hospital Solution (HiMG Gr oup).
The re was no diff e rence cl inical ly be tween t he two
groups. Posto per a tive ECG abnormali t ies:
The concept of optimal coupling between LV and arterlal
system was validated from energetic polnt of Vlew 1n 25
Pt with var yi ng degrees of car dl ac dysfunct lon. Direct
arter1al pres sure and LV eChocardlogram were re corded
slmultaneously as the pres sure was e l evat ed by phe nyl-
ephrine and the slope of the end-systollc pr essu r e-
vo lume relationship (Ees ) was determi ned. The arterial
effective el astance (Ea) was expressed by t he s l ope of
end-systol i c pr essure-stroke volume relaclonshlp. The LV
work (exter nal work (EW) . end-systoli c pot ential energy
(PE» and its effici ency (Eff=EW/ (PE+EW» were determlned
f r om t he t ime-varyi ng el as t ance model. Max1mum EW (maxEW)
for a given end-diastol i c vo l ume was also de t ermi ned
when Ees was as sumedto be equal to Ea. I n 10 normal
subJ ects (ejection fracti on ( E F)<60~) , Ees was nearly
tWlce as much as Ea (Ea/ Ees =0.50±0. 16) resulting ln the
hi ghes t Ef f of 80.3±5.0% with 66.3±9 .6~ of maxlW. In 7 Pt
with moder at e failure (EF: 40-59~) , Ees was almost equal
t o Ea (Ea/Ees =0.97±0 .1 9l and Ef f was decreased (67.6±
4 . 3~ ) due t o an incr ease in PE, whlle EW was near l tS
maxl mum ( 99 . 1 ± 1 . 2~ l . In 8 Pt wlth seve r e failure (EF:
<40~ ) , Ees was less than Ea (Ea/Ees=2 .29±1. 12) , hereby
bot h an lncreas~d PE and decreased EW (85 .7 ±13.5 % of
maxEW) caused a further decrease l n Ef f (48.9±10.2%).
Thus in normal s ubj ect s , LV and ar ter1al propertles wer e
set mOr e towards opt i mi zat i on of Eff t han EW. I n moderat e
cardiac failure, these propertles were matched t o
maxi mize EW at t he expe nce of Ef f, whlle i n s eve re
fallure both EW and Eff could not be mal nt ained properly .
CHB Immediately Pos t Bypass
Transi ent CHB (to 72 hour s )
REBB Transi ent (to 72 hours)
RBBR at Di s charge
LAFB at Discharge
Bifasicular Block at Discharge
LoMG
4. 5%
0%
11.4%
2. 3%
0%
0%
HiMG
23. 2%*
12. 5%*
32.1 %*
25.0%*
10. 7%*
7. 1%
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Myocardial Protection/Valvular Surgery
ATRIAL ACTIVITY DURING CARDIOPLEGI A AND POSTOPERATIVE
ARRHYTHMIAS Joh n C. Mul len MD , Nadeem Khan MD, R1cha r d D.
We1sel MD, FACC, George T. Chr1stak1s MD , Kev1n H. Teoh
MD, M. M1ndy Madon1k BSc, Donald A.G. M1ckl e MD , Jo an
I vanov RN . Toronto Gener a l Hos p1tal , Tor onto, Ont a r 1o .
Car dl opl eg1a prov1des exce l l e nt protect1on for the LV
but t he RA may be poorly protect ed . Myocar d1a l
t emperatures, RA electr1cal act1v1ty, a nd pos topera t 1ve
arrhythmlas were as sessed 1n 103 pat1ents part1clpatl ng
l n two consecutlve r andomi zed t r 1als compar 1ng blood
card10plegia ( BC , n=36) , c ry s t allold card1opl eg1a (CC,
n=38 ) and dllt1az em crys t allo1d cardlopleg1a (DC ,n =29) .
Both RA and RVtemperatureswere s l gnl flcantl y war mer
( p<O. OS) durlng BC de l l very than durlng CC or DC del l very
becaus e t he aortlc root t emper at ure was 9±2°C wlth BC and
S±l oC wlth CC and DC. Atrlal actlvlt y durlng
ca rdlopleg1c ar r est was greatest wlth BC ( 12±3 ) , l ower
wlth CC ( 10±2) , and m1n1mal w1th DC ( S±l beats per
m1nut e , p<O. OS). Per 1operat1ve lschem1C l nJury ( by
creatlne kinase l soe nzyme ana l ys1 s ) was great es t wlth CC
(p<O.OS) . Postoperative supraventrl cular ar r hyt hmlas
(both treated and untreated) were mor e frequent after CC
(CC: 63%, BC: 40%, DC:47%, p<O .OSj . Patlent s who devel oped
supraventrlcular ar rhythm1as had slgnlfl cantly more
pos t operative Ischem1c In jUry ( by cr eatlne kl nase
1s oenzyme analYSI S, p<O.OS).
Blood ca r dl opl eg1a re duced s upr aventr1cul ar
a r rhy thm1as by r educ l ng i schem1c 1nju r y desplt e war mer
lntraoperat l ve temperatures and mor e right atrlal
activ lty . D1l t l azem ca r d10plegla reduced postoper atlve
arrhythm1as by lmpr oving 1nt r aoper atlve myocardlal
protectlon and su ppress1ng 1nt ra- and postoperat1ve
atria l ac t 1v1ty. Cry stallo id cardloplegla cool ed but dl d
not arres t the rlght atrlum lnt r aoperat1 ve l y, had the
mos t perloper at1 ve 1s chemIc 1nJ ur y and had t hehlghes t
lnc1dence of postoperatlve supr aventrIcul ar arrhyt hm1as.
INITIAL EXPERIENCEWITH TRIIODOTHYRONINE(n) THE-
RAPY IN PATIENTSWITH LOW CARDIAC OUTPUT FOLLO'W-
ING OPEN HEART SURGERY.
DlmIlrI NovIlzky, MD., David KC Coope r, MD PhD FACe.,
Alec Swanepoel, MB. Uruversrty of Cape Town Medical School,
Ca pe Town, Sout h Africa.
A s igrufrcan t reduc t ion m plasma freen (1'<0.0001) has bee n
obse rved m patient s undergomg open heart surge ry. Experimen-
ta l stu dies m the pig have conf irmed a major motr opic e ffect
of T3 when adrrurustered to pigs which haveundergonea 2 or 3
hour period of myocardial Ischaemia whilst on ca rdiopulmonary
bypass (CPB). We have t herefore adrrurustered T3 (4-6 ugI.V.)
to 10 pat ients ei t her when drt frcult y was bemg experinced m
wearnng from CPB support (n=4) or m the ea rly pest-opera tiv e
period when myocardia l funct ron remamed poor desp it e massive
motr opic (n=6) and aort ic ba lloon pump (n=2) support. Mean
pre -opera t rve NYHA funct ionalclass of the 10 pat ient s was 3.2,
LVEDP 20 mmHg, EF 43%. Mean myoca rdia l Ischa emic t ime
was 72.4 rnrns (ra nge 40- [20). WIlhln one hour mea n T3 leve l
had men from 1.03 to 3.56 >Jg/mR, MAP from 42 to 78 mmHg,
and HR fro m 90 to 104 beats/mm. LAP had fa llen from 30 to
14 mmHg, and CVP from 20 to 11 cm H2 0. (All cha nges sigru-
f icant a t 1'< 0.000 1). By one hour motropic support had been
reduce d (pg/kg/mm) - dopamin e 16.1 to 6.0(pLO.0005), dobu-
ta rrune 26.2 to 4.6 (pL O.ool), and adrenal me 0.24 to 0.002
(p.c::.O.OOOI). CPB was discontin ued m all 4 cases and balloon
pump support was no longer required by 3 hours. To our know-
ledge , T3 has not bee n adrrumstered prev iously as anmotropic
agent to pat ients who have undergone open heart surge ry. We
beli eve that T3 may have anImportantrole m the rescue of
faIling hearts followmg a pe riod of myocardial ischae mia m
patients who have undergone open hea rt surgery.
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EARLY AND "LONG TERM" PERFORMANCE OF AORTIC HOMOGRAFT
ROOT REPLACEMENT.
Nazir Oballa, FRCS., Asghar Khaghani , FRCS., Rosemary
Radley-Smith, FRCP., and Magdi H.Yacoub, FRCS., FACC.
Harefield Hospital, Harefield, Middlesex, England.
Between October 1974 and August 1986, 129 patients aged
between 2 - 67 (mean 38) years underwent replacement
of the aortic root with a fresh unstented aortic homo-
graft and reimplantationof the coronary arteries.
Indication for operation was aortic stenosis in 110 and
aneurysm of the aortic root in 19. There were 4 early
deaths. With a follow-up of 2 - 140 (mean 84) months.
There were 11 late deaths. Actuarial survival at 5 and
9 years was 89% and 83% respectively. Immediate diastolic
murmurs were noted early in 2% of patients. Valve
degeneration, causing regurgitation occurred in 5 patients,
requiring re-operationbetween 4 and 0 years. Fatal
endocarditis occurred in 1 patien~ 2 months after
operation. The cumulative probabilityof developing
valve degeneration including endocarditiswas 10%at
9 years. No patient developed aneurysmal dilatation
of the homograft wall or ostial stenosis although
linear calcification in the wall of the homograft was
common.
It is concluded that homograft root replacement is an
effective method of treating complicated aortic valve
diaease and gives acceptable late results.
NONINVASIVE ASSESSMENT OF THE RESULTS OF SURGICAL
AORTIC VALVOTOMY IN ADULTS WITH CALCIFIC AORTIC
STENOSIS. Linda J.Crouse, MD, Paul Kramer, MD, William
Reed, MD, FACC, Jeffrey M Piehler, MD, FACC. MidAmerica
HeartInstitute,St. Luke's Hospital, Kansas City, Mo.
In order to evaluate the results of surgical aortic valvotomy
in adults with calcific aortic stenosis, 23 pts undergoing this
procedure between 1972 and 1986 were studied by Doppler
echocardiography 3 months to 14 years (mean 33 months)
after surgery. Thirteenpts underwentvalvotomy in conjunction
with coronary bypass, 5 had mitral valve surgery and aortic
valvotomy, and 7 had aortic valve (AV) surgery only. No
pts had more than mild aortic insufficiency (AI) at initial
evaluation. Noninvasive assessment of AV function was
compared with preoperative invasive measurements in all
pts. Among 8 pts evaluated within one year of valvotomy,
2 had severe AI at follow-up, and these 2 had the highest
preoperativeAV gradients. The gradientsamong the remaining
6 pts were significantly reduced. However, at late follow-up
(>1 year), all 9 pts with moderate or severe preoperative
AV gradients (>40 mmHg) were found to have late mean
gradients of at least 40 mmHg, and 3other pts had moderate
or severe AI. Six of 23 pts had preoperative gradients <40
mmHg. In 2 of these, the gradient was unchanged or slightly
improved, and in the remainder, gradients were more
substantially reduced. Noninvasive evaluation prompted
catheterizationin 5 pts, in all of whom the Doppler findings
were confirmed. We conclude: 1) Aortic valvotomy relieves
calcific aortic stenosis in adults in the short term, but severe
AI is not an uncommonearly complication. 2) Late follow-up
indicates a very high rate of severe aortic restenosis and
a 2096 prevalence of moderate or severe valvar insufficiency.
3) The only pts with small gradients at late follow-up were
those with small preoperative gradients. 4) Doppler
echocardiography is a useful tool for evaluating pts after
aortic valvotomy.
AORTIC VALVE REPLACEMENT USING UNSTENTED DURA OR CALF
PERICARDIUM: EARLY AND MEDIUM TERM RESULTS.
Asghar Khaghani, FRCS., Pankaj Mankad, FRCS., Nazir
Dhalla, FRCS., Rosemary Radley-Smith, FRCP., and Magdi H.
Yacoub, FRCS., FACC. Harefield Hospital, Harefield,
Middlesex, England.
Between December 1978 and December1985, 138 patients aged
between 7-73 (mean 51) years underwent aortic valve re-
placement using unstented homologoua dura or calf peri-
cardium. Homologous dura was used in 90 (65%) and calf
pericardiumin 48 (35%). Sixty six (48%) patients had
aortic regurgitation,42 (30%) had stenosis and 30 (22%)
mixed lesions. Additional procedures included mitral
replacement or repair in 28, coronary artery bypass grafts
in ID, resuspension and other procedures in 5 patients.
There were 4 (3%) early deaths, none of which were valve
related. With a follow-up of 8-84 (mean 52) months,
there were 12 (9%) late deaths, of which 3 were valve
related and 9 non-valve related. Actuarial survival at
6 years was 80%. Ninety-five percent of survivors remain
asymptomatic and are in functional class I NYHA classifi-
cation, the remaining patients being in class 11 or Ill.
Val ve failure occurred in 15 (13%) due to leaflet tear,
occurring at a mean of 3.3 months after operation in 8,
degeneration of cusps at a mean of 47 months after opera-
tion in 4 and endocarditis in 3, mean 20 months after
operation. Freedom from valve failure, including endo-
carditis was 90% at 6 years. Seven (5"!.) developed
thromboembolicepisodes giving a cumulative probability
for this complication of 8% at 6 years. The early and
medium term results of using unstented tissue for aortic
valve replacement are encouraging, furtherexperience is
necessary to establish its exact role as a valve
substitute.
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Mitral Valve Prolapse
VENTRICULAR TACHYCARDIA IN PATIENTS WITH "IDIOPATHIC"MI-
TRAL VALVE PROLAPSE: HISTOLOGICDEMONSTRATION OF ASSOCIA-
TED PRIMARY MYOCARDIAL ABNORMALITIES.
Antonio Nobile, MD, Andrea Frustaci,MO.reoerrco Gianolla,MO,Marina Caldaru-
la,MO,Gerardo Ansalone,MJ,Sandro Montenero,MJ,Enrico Scabbia,MJ,Fulvio
Bellocci,MO, Catholic University Sacred Heart, Rome, Italy.
Mitral valve prolapse (MVP) is a cormonclinical entity. The rare occur-
rence of ventriculartachycardia (vr) in young pts with MVP has raised
questions about the casual relationshipbetween them. We studied 6 pts
(4 females and 2 males, 16 to 38 years old) referred for symptomatic VT
(non sustained VT in 4 pts and incessant VT in 2 pts). With the exception
of click, no pt hadclinically evident organic heart disease. Eco 20 con-
firmed MVP without other abnormalities. To evaluate possible occult myo-
cardial disease, left ventricularendomyocardial biopsy (LVEB) was per-
formed 10 all pts at the end of electrophysiologic study. Programmedven-
tricularstimulation induced polimorphic non sustained VT in only 1 pt ,
In 2 pts with incessant VT, incremental pacing suppressed spontaneous VT.
LVEB specimens were abnormal inall pts: 4 had inflammatorymyocarditis
and 2 significant, although non specific, alterationsconsistent with a
cardiomyopathicprocess. Flecainide completely eliminated episodes of VT
in all pts. All pts were maintainedon chronic antiarrhythmictherapy.
Prednisone was added In 2 pts in whom LVEB had documentedacute myocardi-
al inflammation; after 6 months LVEB was repeated and showeddisappearan-
ce of acute inflammation. Thus Prednisone and antiarrhythmicdrugs were
discontinued without recurrenceof VT for 4 and 6 months respectively.
Conclusion: Our data suggest that VT in young pts who apparentlyhave MVP
as their only clinical abnormality are Independentof MVP and result from
an associated, although occult, primarymyocardiai disorder. In our pts
silent myocarditis and cardiomyopathywere likely to have been etiologic
in VT.
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ECHOCARDIOGRAPHICABNORMALITIES ASSOCIATED WITH
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE.
Kenneth F. Hossack, MD, FACC, Cheryl L, Leddy, MD, FACC,
Robert W. Schrier, MD, Patricia A. Gabow, MD.
University of Colorado, Denver, Colorado.
Patients with autosomal dominant polycystic kidney
disease (ADPKD) have a significant incidence of hepatic
cysts and berry aneurysms. This led to the proposal
that ADPKD involves a generalized connective tissue
defect. The present echo/doppler studies were undertaken
on 87 subjects with ADPKD and 100 normal volunteers (N)
to evaluate possible cardiac involvement in ADPKD. The
echo/doppler interpretationswere done in a random and
blinded manner by two observers. The results indicated
a much higher incidence in the ADPKD patients compared
to N of mitral valve prolapse (30 vs. 6%, p<.OOl) , mitral
incompetence (32 vs. 9%, p<.OOl), tricuspid valve pro-
lapse (5 vs. 0%, p<.05) and tricuspid incompetence (16 vs.
4%, p<.005). Aortic incompetence (7 vs. 1%, p<.05) and
pulmonary incompetence (13 vs. 5%, p=.OS) were also common
in ADPKD patients. The severity of the regurgitant
lesions was trivial in all of the N but was of mild to
moderate severity in 34% of the ADPKD. The mitral valve
prolapse and incompetence was found to occur either toge-
ther or separately in ADPKD. Although ADPKD patients
were slightly older (40±13 vs. 35±13 yrs. p<.05) and had
higher systolic blood pressure (130±15 vs. l18±15 mmHg
p<.OS) neither of these differences provides ?'1 ~d2'1""t·C
explanation for the cardiac abnormalities.
In summary, mitral valve prolapse and/or incompe-
tence occurs in greater than 30% of patients with ADPKD;
tricuspid, pulmonary and aortic valve abnormalities are
also more common in ADPKD. This demonstrationof signi-
ficant cardiac abnormalities in ADPKD lends further sup-
port that the disease involves a generalized connective
tissue defect.
ETIOLOGYOF CHESTPAIN IN PATIENTSWITH MITRAL
YALYE PROLAPSE. FrancisP Day. MD, KennethL Koch, MD,
WilliamR Davidson,Jr, MD and Paul MSpears,MD. University
Hospital,Penn StateUniv., Hershey,PA.
To determinethe incidenceof esophagealmotility disorders in patients
with mitral valveprolapse(MYP) and chest pain (CP) weprospectively
compared20 MYP pts with CP (PAIN) to 7MYP subjectswithout(CP)
(CONTROL)using esophagealmanometryand provocativemanuevers.
Patients(6 M, 21 F, 44±16 yrs.) were includedafter coronarydisease
was excludedon clinical and/orangiographicgrounds. Auscultatory
find-ingsof MYP were presentin 21/27 subjects(6 click/murmur,II
click, 4 murmur). All subjectshad MYP demonstratedby echo (20 pts)
or angiography(7 pts). Pansystolichammocking or late systolic post -
eriormotion of the mitral valve onM-Modeor superiordisplacementof
the leaflets beyondthe plane of the mitralannulusin the 2-dimensional
long axis views were consideredvalid criteriafor MYP. 17/20 PAIN
subjectsdescribedsubsternalor left chest discomfort,11/20 noted chest
pressure. Precipitantsof CP includedemotionalstress (14/20), and
exertion(11/20). 0/8 patientsreportedreliefwith beta-blockersand
9/12 with nitrates. Patientsunderwentesophagealmanometryusing
standardstation pull-throughtechniquewith blindedreview of results.
Patientsreceivededrophonium80 ug/kg IY to andunderwentBemstein
acid perfusiontests, both in single blind fashion inorderto reproduce
symptoms. Resultswere comparedby Fisher'sExact test. Results:
PAIN CONTROL
Manometry 16/20* In
Edrophonium 3/18 on
Bemstein 5/19 on
All tests 16/20* In
(*P<O.OI vsCONTROL). Diffuse esophagealspasm was found in
14/20 PAIN and In CONTROLpts, "Nutcrackeresophagus"and
hypotensiveloweresophagealsphincterwere each found in IPAIN pt.
Thus, esophagealdysmotilitywas presentin 80%of pts and maybe a
commoncauseof symptomsin MYP patientswith nonischemicCP.
HITRAL VALVE PROLAPSE: ADDITIONAL SUPPORT FOR
THE "NOR1IALITY" OF DISPLACENENT IN THE APICAL
4-CHAI'IBER VIEW ONLY Robert A. Levine, HD, FACC,
Evagelos Stathogiannis, ~j 0, Dianne Fiilkelstein, PIi'D," Arthur
E. Weyman, HD, FACC, Hass. General Hospital, Boston, MA.
Although the apical 4-chamber (A4 C) view has been called the
echocardiographic (2 DE) standard for mitral valve prolapse
(NVP), leaflet displacement OIL DIS) in this view appears
with surprising frequency in normals, without DIS in the
parasternallong-axis (PLA) view. We have previously shown
that a nonplanar annular shape can produce apparent N VP in
this view without true DIS above the annulus. This suggests
the hypothesis that pts with DIS in the A4 C view alone have
no higher frequency of associated-abnormalities (ABN)than
those with no DIS ~ any view. We therefore retrospectively
studied 312 consecutive pts without other heart disease by
2DE, measuring ML DIS in the PLA and A4C views; ML
thickness (LT); 3 LA dimensions; and Doppler mitral
regurgitation (N R). Pts were divided into those with no I': L
DIS; with A4 COlS only; and with DIS in at least the PLA
view. The proportions of pts with AB N in each group were
compared (Fisher's test). RESULTS by group:
No hL DIS DIS in A4C only PLA DIS
n, pts -135- - - 57 -- 120-
Increased LT" 1(.7%) 0 29(24%)
Incr. LA dimension" 3(2%) ,;- p>.5 -t 0 ~ p<.005 ~ 19(16%)
Incr. LA volume" 0 0 14(12%)
MR/Doppler n 7/90(8%) 2/31(6%) 35/87(40%)
"Compared to 72 normals; volu meeproduct of dimensions
CONCLUSION: Pt.s with ML DIS in the A4C view only, unlike
those with PLA DIS, are no different than pts witilfio DIS
whatsoever with respect to LT, LA dilatation or MR. This
suggests that A4 C DIS is a geometric variant without
pathologic significance, and challenges the diagnosis of MVP
in that view in many otherwise normal individuals.
ruRE SEVERE MI1RAL REGJRGlTATlCN(MR) IN RHElJMATICHEART DISEASE -
RELATIVE PREVALE:l'a, ME<JiANl::M3 AND RELATlCN TDDISEASE ACITI/lTY.
RidJard Marcus m, TheeMeyer m, Denise Kitchiner ME, MartinBerk ME,
ClaudiaQstermeyer ME. Pinhas Sareli MD. Depar1:Irentof Cardiology,
I3arag11rcmathfuspital and the University of the WitJ.atersrand,
Jd1annesburg,South Africa.
Ncn-rl1euraticmitral valve prolapse (MVP) is the caTI1Dl1€St cause of pure
severe m in develcpedccerrtrtes. m due to meuraticheart direooe
(RHD) has been attributedto retractionof thickened leaflet tissue and
is usually associated with varyingdegrees of canni.ssural fusion and
mitral stenosis. Pure severe MR due to RHO withrutsignificant leaflet
involvement is reportedlyunccnrron. In the present swqy the relative
prevalence of pure severe m in patients with hem:x:jynamicallysigrifi-
cant mitral valve disease of rheuraticorigin was examined. Theclinical
diag)106is of pure MR was correlatedwith the functional pathology of
the lesion and the presence of ongoingrta:rnaticactivity. The swqy
pcpulation included7'18 black patients undergoingmitral \lllve surgery
fran 1932-1\£5 for hem:x:jynamicallysignificant rheuraticmitral valve
disease. Theclinical diagrceis of pure MR was confinred at operation
only \\hen there was no rracrosccpic evidence ofcanni.ssural fusion.
Pure MR was present in 2'S7 pts (326). Iobst of these (8Ef%) were under
the age of 30 yrs. Pure MR cmstituted 59i6 of all h~cally
severe mitral valve lesicns in pts~ 20 yrs. MVP was daocnstratedat
the time of surgeryin 84% of pts with pure MR. MVP was associated
with mitral anrulardilatstionand!or chordal elrngationin 92% of pts.
CI1going active meuraticcarditiswas frundat operation in 128 pts ,
All were '30 yrs and83% hadpure MR. We crnclude: (1)Pure severe MR
is the rrost frequent cause ofhtm:JQyna'nicallysignificant mitral valve
disease in yrungpts with RHD (2) 'Rheuratic'MVP associated with
mitral anrulardilatationandchordal elrngationis the mechanism of
pure severe MR in this disease; (3) Pure MR due to MVP is the rrajor
h€m:x:\yranicallysigrificantlesion in active rheuraticcarditis.
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IS MITRAL VALVULOPLASTY APPLICABLE IN NORTH AMERICA?
Altagracia M. Chavez , M.D., Delos M. Cosgrove, M.D., Bruce
W. Ly tle, M.D., Robert W. S t e wa r t , H.D . , Carl C.
Gill, M. D. , Paul C. Taylor, M.D., Le onard A. R.
Goldi ng, H. D., Floyd D. Loop, M.D., The Cleveland Clini c
Foundation, Cleveland, Ohi o 44106.
The re has been concern expressed that the spectrum of
mi tral di sease in North America would not lend itself to
valvuloplasty. To assess the spectrum of mitral disease
and t h e applicability of mitral valvuloplasty, 247
co ns ec ut i ve patients undergoing native mitral valve
procedures i n 1965 were analyzed.
Mitr a l stenosis was present in 66 <35~), insuffici en cy
in 116 (47$) , and mixed lesions in 45 (16~ ). Rheumatic
valvulitis accounted for 152 ( 6 2 ~ ) , mitral valve prolapse
71 ( 29$ ) , ischemia 14 (5 . 7$ ) , endocarditis 6 0.2$), and
congeni t a l heart disease 2 (1$) .
Val vuloplasty was performed in 1 2 6 (52$) .
Valvuloplasty was empl oy e d in 71 (47 ~) o f rheuma t i c
valves, 46 (65 $) of prolap s e d va lves and 6 (57$) with
ischemic etiology.
Forty-three (4 7$) of the patients with stenos i s, 70
(60$) with insufficiency and 15 03$) with mixed lesions
underwent valvuloplasty.
Operative mortality was 7.7~ ( 19/ 247 ) for the entire
series: 3. 9$ for valvuloplasty and 11. 6~ for mitral
valve replacement (p=0.02). I n patients undergoing
isolated mitral valve operations the operative mortality
rate was 5$ (5/ 99) : 1.6~ for valvuloplasty and 11.4$ for
mitral va l ve replacement (p=0.03).
We conclude that: (1) mitra1 insu f fic i ency is the
mo s t common valve lesion, (2) mitral valve pro l apse i s the
most common cause of mi tral i nsufficiency, (3) the
majority of valves can be repaired, and (4) va l vuloplas t y
has a l ower operative mortality t han replacement.
UNE XPLAINED CARDIAC SYNCOPE - ROLE OF VASOVAGAL SYNDROME
RA Kenny, A Ingram, PVardas, R Sut to n FACC, WestmInster
HospItal, London, England SWl P 2AP
The cause of syncope may re maIn une~plalned despIte full
neurological and car dI ol ogIc a l In vestIgatIon. Head up tIlt
has recently been shown to be usef ul I n th e management of
syncopa l patIents. ThIS s t udy outlInes use of head up tIlt,
repr oducibIlIty of heart rate (HR) and blood pressure (SBP)
response to tIlt, t he clInIcal manIfes tations of mal I gnant
vasovagal sy ndr ome (VVS) as a cau seof unexpl ai ned syncope
and us e of cardI ac paCIng Inmanagement.
24 patIents WI t h une~plai~ed s yncope and 10 age ~atched
controls were studIed (69- 9yr s ) . PatIents had 16-17
s yncope s ove r medIan 2years . Syncope was sudden and 63%
sustaIned injury. Subjects were tIlted head up t o 600 for
60 ~ln with contInuous monItorIngof HR and ~BP . 17 (71%)
patIents and 1 control became s yncopal at 34-19 mln of tIlt
(p( O.OOl) reproducl~g sympto~s pr evI ousl y experIenced. 11
had fall in SBP 148- 21 to 56- l l mmHg (p( O. OOl) and In HR
68:11 to 35:9ppm (p(O.Ol) - vasodepressor plus cardlo-
InhIbItory gro up (VDR+CI ) . 6 had only fall In SBP, VDR
gr oup, HR 60ppm. Res t i ng HR was ~lgher and sync ope ~ore
frequent for VDR th an VDR+CI (21- 19 epI sodes In 108-l0Bmths
VS 5:3 epIsodes I n B:3mthsj pCO.02 and(O.OS). In 6VOR,
repeat t i l t at 24-4B hrs later reproduced s ymptoms, HR and
SBP response (ns between tIlts 1 and 2) .
9 pacemakers were Implanted In VDR+C I : 6 001, 2 DDD and
1 DVI. 8 had repeat tIlt when 7 remaIned asymptomatIc and
1 developed sympt oms but all are asymptomatIc in 10:3mths
follow-up.
VVS IS a common ca use of 'unexplaIned' syncope and IS
revealed by head-up tilt WhICh IS a r eproducI bl etest. VVS
may be VDR or VDR+C I . VDR+CI I S amenabl e todual chamber
paCIng.
INFLUENCE OF VENTRI CULAR RATE AT REST AND EXERCI SE DURING
AV SEQUENTIAL AND VENTRI CULARPACING US I NG RADIONUCLIDE
VENTRICULOGRAPHY.
J.D. HcHeekin, M.D., 5 .5. Gul amhuse i n , M.D., F.A.C.C.,
S. Hans on, D. Lautner, and F. Bertoia, Depts . of Medicine
an d Nuclear Medic i ne, Univers ity Ho sp ., Saskatoon , Sask.
Conclusion : At rest DDD pacing was superior to VVI
pacing s ugges t i ng the importance of atrial cont r i bution
and AV synchrony. With EX, the hemodynamic re sponses im-
proved in both gr oups with no signi f icant difference in
DDD-Ex and VVI - Ex70 , however , with an increase in the rate
during Ex (VVI-ExEq), further signi f i cant increase in CO
was observed (p<0.04) . This su ggests that the ability t o
increaseventricul a r rate during Ex is as important as AV
synchrony alone.
VVI -ExEq
94±10
87±16
8. l± 2t
50±16
VVI-Ex 70
70
~ 9 4 ± 1 7
'f6. 6± It
5l± 12
t= p<0. 04
VVI - R70
70
MO±16*
'f4 . l ± I
42±12
p<0. 005
Atrioventricul a r pacing (DDD ) is reported to be better
than ventricularpacing (VVI ) both at rest (R) and during
exercise (Ex). The influence of increasing the ventricular
rate in VVI pacing during Ex compare d t oDDD Ex pacing, i s
the purpo se of this study . Using ra di onuclide vent r i culo -
graphy (RVG) we studied 10 pts (mea n age 63 yrs) with pr o-
grammable DDD pacemakers t o examine this. RVGwas performed
at rest (DDD- R) and during supine bicycle Ex t o a maximum
workload of 40 Kpm/mi n (DDD-Ex) . Pati ents were then pro-
grammed t o VVI pacing at a heart rate of 70/min . One week
later, RVG was repeated a t rest (VVI - R) and during Ex a t a
heart rate of 70/ min (VVI- Ex70) and at an equivalent DDD-
Ex heart rate (VVI -ExEq) . The r esu l t s obta i ned on all 10
pts ar e t abulated:
DDD-R DDD-Ex
HR 70± 1 92±11
SV 8l ±15* 80±20
CO 5 .7 ± l~ 7. b± 2
LVEF 47±13 49±14
*= p<O.Ol ~ ,~ , 0/=
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New Modes of Cardiac Pacing
LONG-TERM PACING I N SINUS NOOE OISEASE . SUPERIORI TYOF
ATRIAL STIMULATION.
M. Rosenqvlst, J. Bran dt , H. Schul l er .Dept. of MedIcI ne ,
Huddlnge HospItal, Huddlnge andDept. of ThoraCICSurgery,
Lund HospItal, Lund, Sweden.
The study population comprIs ed 166 pat i en t s WIt h sympto-
matIC SND, 89 WIth AAI and 79 WIth VVI. The t wogroups
wer e compar abl e WIthrespect t o conventIonal clInIcal
char ac t e r I s t I cs anddegree of sever I ty of SND. Follow-up
s t udi es were conducted aft er an average of two and fo ur
years.
Treatment wIth vent r I cul ar paCing does not seem t o
Infl uence th e prognosIs i n patIents with SI nus node
disease (SND) . In the present s t udy the natural course
of SND was compared In patients treated With ventrIcular
(VVI) and t hose treated Wi t h atrIal (AAI) paCIng .
AAI VV I P
Results Follow-up Follow-up (afte r 4Yrs)
2 yr s 4 yrs 2 yrs 4 yrs
Devel op. o f AV II 5% 5%
-"- chro n at.ri a.I f ib. Jro 7% 30% 47% <0. 0005
_"- con g heart fa l l . 7% 1 5~o 23% 37% <0 . 005
Deceased 6% 8% 10% 23~, <0. 025
Conc l USIo n : Thus AAI seems to result In fewer cardIac
complI catIons and a lower mortalIty as compared WIt h VVI.
The risk of developing hIgh grade AV-blo ck amongatrl ally
paced patIents IS r el at Ively low.
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EFFECT OF DIFFERENT ACTIVITIES ON THE RATE RE:3PONSE OF
ACTIVITY TFIGGERED RATE RESPONSIVE PACING
[-hu- pp' Iau MB , Davendra Mehta, M.D"D. Wyn Danes , M.B.,
Dav id E. Ward Il.D., F.A .C.C., A. John Camm,)(.D., F.A .C C.,
[Jepar tment of Car dr ovas c u lar Sciences , St. George 's Hospi ta l ,
London, Urn t ed Kingdom.
A c t~vl ty trlgg~red rate responsIve pacemakers lAx' utIlize
body vibrat ion as an indicator of act i vi t ies to deter mine the
pacin g rate rPHRJ. We ot udied t hePHR res pon3e of 8 pat ients
,PtS I fltted with Ax (Medtronic Act.i vttrax : t o different
act i vi ties . Their mean age was 60t'5 year s (meantSEM' and all
had cnmplet e hear t bloc k. Inall Pt.s , Ax were progra mmed t o
ach,elle a PHR of about 100 bpmat t he end or Stage I of t he
Bruce prot ocol rAxpa rameter-s: ra teo7 0 150bpm, re·5 pon3eO tj- 9 .
t.hresho l dv Iow- nedi umI. Act i ve s t awling and ve lsalva
manoeuvre dId not s lgnl f icant ly change t hePHR. I30metrlc
exe rc ls e with han d gnp on either hand didnor s igni ficantly
affect PHR. Sta rtmg from rest rPHR=70bpmJ, br ief exercises
were performed on a t readmill at grad ient s of 0%, '5?" 10%
and 1'5%, at s peed;. of 1.2 and 2.'5 mph for '3 mi nutes at eac h
se ttIng. Maxllnum pacing rate (MPR' at tai ned in bpm were
0% '5% 10% 15%
l ..2mph 10'::t4 l OO±-4 97t 4 99t 4
2.5rnph l 21t3 117i4 1l'5t 3 116t4
At each speed , wal king at a highergredient (whic h requrr ed
s imilar bodily movement I did not i ncr eas e MPR. However , MPR
was signIficantly hIgher when Pts wa l k~d at a faster sp eed
IP<'O.Oll . One Pt hving in a m l l y drs t r ict requir ed a highe r
rate re sp onse for his act Ivi t ies a l though th IS res ulted i n a
rapid ?HR with mi Id exertion. MPR af t er ascend ing 4flights
of s t ai rs was not different from th at after des cend m g
il Olt3 V3 l05 t2 bpm, p=O.3I . We conclu de 1. pbys io logice I
a ct tv i t i e-s not ass ociated wi th s rgn i f Icant movemen t -s ar e not
sen sed by Ax, 2 . dat ect irm of body Vibration to determine
pacing rate does not cor relat e wit h all levels of exert ion.
HEMODYNAMIC EFFECTS OF RATE RESPONSIVE PACING IN
PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION MEASURED BY
2D AND DOPPLER ECHOCARDIOGRAPHY.
Thomas A. Buckingham, MD, FACC, Robert C. Woodruff, MD,
D. Glenn Pennington, MD, FACC, Robert H. Redd, MD,
Denise L. Janosik, HD, Arthur J. Labovitz, HD, FACC,
Harold L. Kennedy, MD, HPH, FACC St. Louis University,
St. LOUiS, HO.
Rate responsive (RR) pacing provides hemodynamic
benefits during exercise in selected pts but has not
been studied in pts with poor LV function. In order to
quantitatehemodynamic changes during RR pacing, 15 pts
with an activity-responsive pacemaker underwent paired
double-blind exercise treadmill t esting (ETT) with
Doppler echocardiographicmonitoring in the VVI mode and
RR modes. Pts' ages ranged from 7 to 83 with a mean
ejection fraction (EF) of 34~. In 12 pts, the EF < 40~ .
The percent change in heart rate (HR) , stroke volume
index (SVI), Cl, end diastolic volume index (EDVI), end
systol1c volume index (ESVI), El", systol1c pressure/ESV
ratio (PV) from rest to peak exercise was calculated and
compared between pacing modes.
PERCENT CHANGE FROM REST TO PEAK EXERCI SE
HR SVI Cl EDVI ESVI EF PV
RR 40~ 34~ 87~ -3~ O~ 9~ 29~
VVI 13~ 33~ 51~ -l~ 3~ 10~ 26J
P value .001 NS .02 NS NS NS NS
Pts exercised a mean of 50 seconds longer in RR mode
(p < .05). These results were similar when the 12 pts
with EF< 40J were analyzed separately.
Thus, in a population with moderate LV dysfunction,
RR pacing provided an increase in exercise duration and
an improved Cl that was primarily related to HR i ncre as e
and not to changes in contractil1 t y , EDVI, ESVI, or
stroke volume.
MONITORING OF PHYSIOLOGICAL VARIABLES FROM MIXED VENOUS
BLOOD FOR USE IN ALGORITHMS TO CONTROL RATE RESPONSIVE
PACEMAKERS.
Stanley A. Rubin, M.D.. F.A .C.C., Tom Nusbickel .
Division of Cardiology, Cedars-Sinai Medical Centerand
Department of Medicine, UCLA, Los Angeles , CA.
In order for a physiologicalvariable to be a useful sig-
nal to control the outputrate of an electronic pacemaker
during exercise, it should have a predictableand consis-
tent relationship to workload and oxygen uptake(VO?) .
We measured four variables in mixed venous blood dUrlng
exercise in 12 adult humans who represented aspectrum of
cardiovascular disease from normal to moderate heart
failure. Core temperature (T~) , pH, oxygen tension
(p02), and carbon dioxide tenslon (pC02) each changed
significantly over a four stage exercise protocol to a
peak workload of 50 Wand a V02 of 967 ± 196 . Predict-
ability within and across subjects was measured by trend
analysis of each variable with workload and showed a
linear relationship with each variable (p<0 .05).
However, the simplest (linear) significant relationship
occurred only with mixed venous pC02 (p<O.OI), whereas
Tc, pH and p02 showed additional significant quadratic or
cubic relationships (p<0.05). Trend analysis of each
variable with V02 showed similar results: only mixed
venous pC02 showed a simple linear relationshipwithout
higher order terms.Consistency between the subjects was
measured by the kurtosis of the distribution of each
variable . Each variable showed a small negative value
(less than -0.5 and usually less than -1 .0) wh ich
indicates a narrow range of values over the stages of
exercise. We conclude that whileany of these variables
may be useful for deVising an algorithm to control
pacemaker rate duringexercise, mixed venous pC02 appears
to offer the simplest relationship.
Monday, March 9, 1987
10:30AM-12:00NOON, Room 6, Second Level
Accessory A-V Pathways
LOSS OF PREEXCITATION FOLLOWING PROCAINAMIDE DOES NOT
PREDICT RISK OF SUDDEN DEATH I N WOLFF-PARKINSON-WHITE
SYNDROME.
Lameh Fananapazir, M.D., Steve Greer. M.D., Douglas Packer
H.D., Lawrence German,H.D., F.A.C.C., Eric N. Prystowaky,
H.D., F.A.C.C.,Duke University Medical Center, Durham, NC.
Cont rover sy exists as t o whether persi stence of
preexcitation (PE) following procainamide identifies pts
with short ac ce ssory pathwa y ef fective refractoryperiod
(APERP) or shor t RR i ntervals dur i ng atrial fibrillation
(AF) regarded at risk of sudde n death. The relation
between APERP and shor t es t RR i nt erv al during AF (SRRPE)
is a l so unclear. We therefore determined the response to
10-20 rng/kg intravenous procainamide (P) was predictive of
pretreatmentSRRPE and APERP in 55 pts. Twenty of 33 pts
who lost PE a f t er P had SRRPE(250 ms. Persistence of PE
after P di d not identify pts with SRRPE or short APERP:
SRRPE APERP
Post P N mean±ISD range mean±ISD range
NO PE 33 233±28 150-3 23 256±27 200-323
PE 22 203±53 110-370 250±51 160-373
Additionally, the relati on of APERP to SRRPE was examined
i n 78 pts. The correlation between APERP and SRRPE was
poor and was not affected significantly by drive pacing
cycle length (PCL):
N PCL SRRPE (mean±ISD) APERP (mean+lSD) r
16 600 245±50 279±33 0.65
35 500 239±58 275±37 0.51
27 400 2l 8±66 240±33 0.63
We conclude that (1) a significant number of pts who lose
PE in response to P have rapid heart rates during AF and
hence this test cannot be used to identify pes with PE at
risk of sudden death, ( 2) the correlationbetween APERP
and SRRPE i s not sufficiently close to permit APERP to be
reliably us ed as a predictorof conduction during AF.
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Kaoru Okishige, M.D., Yoshiki
Hirao, M.D. and KazumazaHiejima,
Dental University, Tokyo, Japan.
THE PHYSIOLOGIC SUBSTRATE FOR ANTIDROMIC RECIPROCATING
TACHYCARDIA: PREREQUISITECHARACTERISTICSOF THE
ACCESSORY PATHWAY AND ATRIOVE~7RICULAR NODE.
Douglas L. Packer, M.D., Stephen Greer, M.D., Lawrence D.
German, M.D., F.A.C.C., Joyce C. Pressley, M.P.H., Lameh
Fananapazir,M.D., Eric N. Prystowsky, M.D., F.A.C.C.,
Duke University, Durham, NC.
To elucidate further the physiologic substratenecessary
for antidromic reciprocating tachycardia (ART), 28
patients with Wolff-Parkinson-Whitesyndrome and "true"
ART were evaluated. 22 patients had left,S had right,
and I patient had an anteroseptalaccessory AV pathway
(AP). No patient had a posteroseptalAP. The ART cycle
length (CL) was 285!33 msec (range 240-355 msec) which
was significantly shorter than the orthodromic tachy-
cardia CL of 324!46 msec (range 250-450 msec) in 25 of
these patients (p = .0005) . The effective refractory
period (ERP) of the AVN and AP as well as the charac-
teristics of anterogradeand retrogradeconduction
(minimum paced CL with 1:1 AV conduction) were deter-
mined where possible and comparedwith those of 39
patients without ART:
AV Node (retrograde) AP (anterograde)
ERP min I : I CL ERP min I: I CL
ART 239!26 270!35 250!28 250!27
CONTROL 278!38 352!113 284!62 334!118
p. .001 .008 .016 .001
The retrogradeERP and minimum 1:1 CL of conduction
through the AV node and anterogradeAP ERP were
significantly shorter in those patients with ART than
those without ART. This suggests that in addition to a
critical AP location away from the AVN, short refrac-
toriness of and a propensity for rapid conduction via
both the anterogradeand retrograde limbs of the ART
circuit may be prerequisites for the development of ART.
ATRIAL FIBRILLATION IN PATIENTS WITH ACCESSORY
PATHWAYS: DIFFERENCES BETWEEN PATIENTS WITH THE
WOLFF-PARKINSON-WHITg SYNDROME AND THOSE WITH
CONCEALED ACCESSORY PATHWAYS.
Paolo Della Bella MD,Pedro Brugada MD,Mario Tala-
jic MD,Pelayo Torner HD,Robert Lemery MD,Thierry
Ougernier MD,Hein JJ Wellens MD FACC,Opt. of Car-
diol, Academic Hosp.,Maastricht,TheNetherlands.
The reasons for the high incidence of atrial fi-
brillation(AF) in patlents{pts) with the Wolff-
Parkinson-White{WPW) syndrome are unclear. There-
fore we related the electrophysiologic findings
to the clinical occurrence of AF in 55 pts with
WPW and in 33 pts with concealed accessory path-
ways(CAP). All pts had documented circus movement
tachycardia(CMT)and/orAF, without other cardiac
abnormalities.Meanage was 34 years in WPW and 39
in CAP p t s , AF occurred cllnically in 30/55 and
1/33 pts(55%vs3% P<.OOI). AF was induced in 40/55
WPW pts and in 13/33 CAP pts(73%vs39% P<.OI)being
sustained in respectively 26 and 5 pts (47%vsI5%
P<.OI). Although WPW pts had shorter cycle length
of induced CMT (331vs361 ms p<.OS) no significant
differences in spontaneous deterioration of CMT
into AF were observed {8 WPW vs 2 CAP pts).Atrial
or ventricular extrastimuli initiated AF in 12
WPW pts and 4 CAP pts(p-ns).There were no signi-
ficant differences in atrial effective refractory
period (200vs213 ms) and retrograde effective
refractory period (242vs26Ims) between WPW and
CAP pts. Location of AP was not different between
the two groups. Conclusions:I.Clinicaloccurrence
and induction of AF is much more common in pts
with WPW than in pts with CAP. 2.0ther mechanisms
than deterioration of CMT into AF have to be
considered as responsible for these differences.
A NEW CRITERION RELIABLY DISTINGUISHES ATRIOVENTRICULAR
NODAL REENTRANT FROM SEPTAL BYPASS TRACT TACHYCARDIAS.
John M. Miller, MD, Mark E. Rosenthal,MD, Charles D.
Gottl1eb, MD, Joseph A. Vassallo, MD, Mark E. Josephson,
MD, F.A.C.C. University of Pennsylvania,Phila., PA
Differentation of atrioventricularnodal (AVN) tachycar-
dias from those incorporating a septalbypass tract (BT)
can be difficult fro~ surface ECG or invasive electro-
physiology testing. Ventriculoatrial intervals have been
used as an aid in distinction but overlap in values
leaves some uncertainty. We studied 38 cases of tachycar-
dia (28 AVN, 10 BT), comparing differences in His-atrial
appendage (HA) intervals between tachycardia and ventric-
lar pacing at the same rate. With ventricularpacing, the
H and A are activated in series in AVN cases, but in
parallel in BT cases; the opposite is true in tachy-
cardIa : Dark line=HA interval)
AVN Cases BT Cases
Tachy PacIng Tachy Pacing
';'9';'9 ';'0 ';'0
HATACHY < HApACING HATACHY > HApACING
Hwas seen with pacing in5 cases ; pacing at the
Wenckebach in 3 AVN cases.
):
-95-- 0 ms
+65 ..... +165 ms
THE EFFECT OF AV SIMULTANEOUS PACING ON THE RETROGRADE
KENT BUNDLE CONDUCTION IN PATIENTS WITH CONCEALED WPW
SYNDROME.
Fumio Suzuki, M.D.,
Kanazawa, M.D., Kenzo
M.D., Tokyo Medical and
To assess the effect of atrioventricular(AV)simultaneous
pacing on retrogradeconduction over a concealed Kent
bundle(KB), we studied 6 patients(pts) with concealed WPW
syndrome ( septal KB in 3, left-sided KB in 3). In each
pt, convent i ona l ventricularextrastimulus (VE) testing
(method(M)-I) and VE testing after 8 beats of AV
simultaneous basic drive (M-II) were performed and retro·
grade conduction time and effective refractory
period(ERP) of concealed KB were measured and compared
between the two M. Simultaneously-pacedatrial site
tested during M-II was high right atrium{HRA) only in 3
pts, HRA and coronary sinus(CS) in the remaining 3 pts.
With M-I, the retrogradeERP of KB was ventricular-
limited in none of the 6 pts and ranged from 280 msec to
600 msec. With M-II whenthe atrial-pacedsite was HRA.
the ERP was shortened in 2 pts, by 80 msec in 1 pt and
by 50 msec or more in the other but remained unchanged in
the other 4 pts. With M-II whenthe atrial-pacedsite was
CS, the ERP was shortened in all of the tested 3 pts
including 2 of 4 pts who showed no decrease of the ERP
when the atrial-pacedsite was HRA. Retrograde conduction
time over the KB was essentially unchanged in all 6 pts.
These data demonstratethat AV simultaneous basic drive
during VE testing in pts with concealed WPW syndrome can
frequently shorten the retrogradeERP of the concealed KB
and suggest that such a shortening may be explained by
the anterograde concealed conduction into the ERp·
determining site within the concealed KB.
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CONCEALED ACCESSORY PATHWAYS: PREVENTION OF
PRE-EXCITATIONBY PER"ANENT ANTEBRADE BLOCK AT THE
VENTRICULAR INSERTION OF THE ACCESSORY PATHWAY
K.rl-Hfin% Kuck, "0,KI.uI-Peter Kun%e, "0, ".nfred
Gelgfr, "0, Univerlity Hospitll Eppendorf, H'lburg,
F.R.G.
To elucid.te whether conce.led (cl Iccessory p.thw'yl
lAP) cln be .ctiv.ted not only in retrogr.de Iretr) but
Ilso in Integrlde (.nt) direction, we recorded AP
potenti.ls (pOtl) in 10 conlecutlve pts with cAP: 7 len,
3 wo.enl le.n Ig. 42 y••rl. All pts underwent It.ndlrd
electrophysiologic Itudy beclule of plroxYlll1
lupr.ventricul.r t.chyclrdia ISVT). AP POtl were recorded
in 2 pt, with right sided cAP by • clolely spiced
el.ctrode catheter 12 ea int.rel.ctrodedistlnce', Ind In
B pts by I cltheter with orthogon.1 electrode
configur.tlon. In .11 pts, .xistence of retr AP pots w.s
proven during ventricullr (V) piclng Ind during SVT.
During r.tr Ictivltlon, AP pot Ilwlys preceded Itrl.1 (AI
pot by 20 IS. Retr block incAP, spontlneous during SVT
or follOWing V prellture belts, occurred .Iwlys It V
r nsert i en of AP (i.e. between V Ind AP potsl, never It A
Insertion (between AP and A pots). In 2 pts In WhOI,
during V pacing, retr effective refr.ctory period (ERPI
of specific conduction systel WiS shorter th.n ERP of
cAP, ant AP pot of cAP follOWing Apot, us recorded. AV
echo be.t w.s prevented by .nt block in AP/V link. During
sinus rhyth. (SR) and A p.cing, .nt .ctiv.tion of cAP
could be delonstr.ted in .11 but 2 pts. AP pot w.s
registered 5 to 15 II after A pot during SR. After A
pr'llture be.ts, it w.s lore cle.rly distinguished fro. A
pot (up to 25 Ill. However, preexclt.tion w.s prevented
by perl.nent ant block in AP/V link. Conclusionl: I.
' Weak' p.rt of cAP in retr direction is link bltween V
Ind AP. 2. Despite .nt .ctivatlon of cAP, preexclt.tlon
is prevented by perlanent ant block in thiS link.
Monday, March9, 1987
2:00PM-3:30PM,Hall C-l, First Level
PercutaneousBalloon Valvuloplasty
PERCUTANEOUS TRANSLL'MINAL AORTIC VALVULOPLASTY IN ADULT
AORTIC STENOSIS : RESULTS IN 130 PATIENTS.
Alain Cribier, M.D •• Jacques ~erland, M.D., Thierry Savin.
M.D ., Rachid Mechmeche, M.D •• Nadir Saoudi, M.D., and
Brice Letsc, M.D •• F.A.C.C., Univ of Rouen. France.
We proposed percutaneous aortic valvuloplasty (PAV) as a
new treatment for aortic stenosis (AS) in non-surgical or
high surgical risk adult patients (Pt s ) , From September
1985, PAY waa performed in 130 Pts, 59 men and 71 women,
mean age 75 + 10 (38 to 91). Most were mar,edly disabled:
92 were f n NYHA class III or IV. 36 had syncopes and 31
severe angina. Balloon diameters were 15 to 20 mm. Infla-
tions lasted an averaKe of 80 sec and werewell tolerated.
~ : Transvalvular systolic gradient decreased from
74 :!: 25 to 31 :!: 14 lIDDHg (p<.OO;) and val vearea increased
from .5 :!: .18 to .91 :!: .39 cm (p<.OOI) . Cardiac output
and ejection fraction were unchanged. Increase in aortic
insufficiency was minor in 57 Pts and moderate in 3. There
was no embolism and no death during PAV. Mean hospital
stay was 6 days. Three Pts died in hospital (2.5 n : 2
complications of catheterismand 1 pulmonary oedema. Early
dramatic improvement was noted i n all severely disabled
Pts. Follow-up (20 :!: 6 weeks): 11 Pts (8 %) died after
discharge (terminal heart failure: 4, pulmonary infection:
3, myocardial infarction: 2, undefined cause: I). In 105
Pts with clinical follow-up >2 months (19 + 8 weeks), there
were no syncopes. angina was markedly improved and 11Pts
only remained in »YHA class ltt or IV. Repeat catheteriza-
tion performed 16 + 9 weeks after PAV in 22 Pts showed
stable hemodynamicresults in 18 and restenosis in 4.
Conclusion: this series confirmed initial results: aortic
valvuloplasty is an effective treatment in adult sortic
stenosis when valve replacement cannot he considered or in
cases of high surgical risk. Further studies and longer
follow-up will define optimal indications of the technique.
BAlJ.(X)N AORl'IC VALVUWPLASTY IN ADULT PhTJENrSWITH
eAU;:IFIC AORl'IC STEN)SIS: AClJl'EAND FOUD~-lJP S'roDIEE
RI) Safian MD, AD Berman ID, DJ Diver m, PC Cane MD,
FAO:, SE Warren MD, WGrossnanMD, FAO:, RG ~k::Kay ID.
Harvard-ThorndikeLaboratory,Reth Israel Hospital,
Boston, MA
We performedballoon aortae valwloplasty (BAV) in 36
patients (pts), age 79 + 5 years, with critical aortic
stenosis. PrimaryBAV was successful in 32 pts (89%) and
unsuccessful in 4 pts (11\\), 3 of whan I'lere treatedby
successful repeat BAV. In-hospitaldeath occurred in 3
pts due to non-BAY causes and there were no procedure-
relateddeaths. BAV was associated with a decrease in
aortic gradient (77 to 39 1lIl1Hg*), an Increasedcardiac
output (4.6 to 5.2 L/min*~, and an increased aortic
valve area (0.6 to 0.9 an *). Post-El/IN, LV pressure fell
(203/24 to 175/19 1lIl1Hg*), as did pulrronarywedge (22 to
16 1lIl1Hg*) and meanpulmonary artery pressure (34 to 27
lTlll!lg*) , while arterialsystol.ic pressure rose (127 to
136 nrnHg*).Aortic valve function was followed
subsequently by imaging and Dopplcr echocardiography:
PRE POOT 6 weeks POST
0.5 0.6 O.B *
80 56 56 *
0.5 O.B 0.9 *
FollCYW-up averaging 3 months was available in 27 pts:
marked syrrptanatic~rovement occurred in 27. pts (B2%),
persistentangina requiringbypass surgery in 1 pt (3%),
and late death or infarction in 4 pts (15%).
roo.uSION: 1. BAV produces significant herrodynamic
inproverrent. 2. Progressive valwlar stenosis appears
unlikely at six weeks. 3. Follow-up at 3 roonths reveals
a high incidence of symptCIuatic i1!prOlleJlEnt. (* p<
0.0001)
TREATMENT OF CALCIFIC AORTIC STENOSIS BY BALLOON VALVULO-
PLASTY.
Jeffrey M. lsner, M.D •• F.A.C.C., Deeb Salem. M.D.,
F.A.C.C., Mark R. Desnoyers, H.D., Thomas J . Hougen, M.D.•
William C. Mackey. M.D., Natesa G. Pandian, M.D •• F.A.C.C.,
Eric J. Eichhorn, M.D., Marvin A. Konstam, M.D., F.A.C.C.,
Herbert J. Levi ne , M.D •• F.A.C.C., Richard J . Cleveland,
M.D., F.A.C.C., Tufts-New England Medical Center. Boston,
MA
Recent reports have established that balloon valvuloplasty
(BV) can accomplish hemodynamicpalliation in patients(pts)
with calcific aortic stenosis (AS). The present report
documents further experience with BV in 10 pts (8 women,
2 men, meanage~76 years). Pre-BV, peak and meanaortic
valve (AV ) gradiencs (mmHg) were 67.9 + B.2 and 57.0 + 6.8
respectively; post-BY. these gradients-were reduced to 2
35.3:!:5.4 (p=0.003) and 29.7 ~ 5.1 (p~0.006). AV area (cm)
increased from 0.42 + 0.04 to 0.81 + 0.06 (p c 0.005). BY
failed to reduce obstruction in 1 pt with a congenitally
bicuspid AV. A second pt with a bicuspid AV required AV
replacement 8 weeks post-BV for persistent symptomatic
pulmonary venous hypertension, despite the fact that BV
decreased AV gradient from 85 to 45, and increased AV area
from 0. 41 to 0.81. One pt suffered an apparentlyembolic
focal brain stem infarct. No significant aortic regurgi-
cation was observed post-BY in any pt. Transfusion re-
quirement due t o arterial blood loss during exchange of
BV catheters too large for presently available introducer
sheaths was markedly reduced by direct arterialexposure
prior to introductionof BY catheter. These findings thus
confirm initial reports regarding the efficacy of By for
treatment of calcific AS. However. BV is not without
hazard, and in occasional pts, such as those with bicuspid
valves. may not be effective in reducing AV obstruction.
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ANTEGRADE BALLOON VALVOTOMY FOR AORTIC STENOSIS
Igor Palacios. MD. FACC, Peter C. Block, MD,
FACC. Massachusetts General Hospital, Boston, MA.
There were no complications and only minimal
blood loss. Thus, PAV can be performed success-
fully in antegrade fashion using transseptal
left heart catheterizationwhich avoids local
arterial complications.
PERCUTANEOUS RA! L(lON MITRAL VALVULOPL~STY: ACUTE
RESllLTS AND T"(lNG TERM FOLLm:-Up. DJ Diver, MD, RD
SRfian, ~ID, AD Berman, ¥D, JE Lock, MD, FACC, PC Come,
MD, FACC, SE Warren, Mn, DS BaiM, HD, FACC, WGrossma'1.,
MD, FAr:C, RG Mcrav, MD. Harvard-Thorndtke Labor at orv ,
Beth Isr~el Hospital, Boston, MA.
Balloon Mitral valvuloplasty (XVP) was attempted via
the transseptRl approach using 25 mm balloons ir 16
patients (mean age ~c = 16 years) with criticul mitral
stenosis. Seven of the 16 pts pad extensive valvular
calcification. che procedure was unsuccessful in ]
patient (failure ~o cross). Percutaneolls /oIVP prodllced
immediate improvement In mitral valve area (~A: 0.9±0.2
to 1.5±0.3 cm2 , p < .001), trans-mitralgradiePt (14~5
to 9!4 mmHg, p < .001), cardiac output (4.4~0.9 to 5.1 i
1.6 l/min, p < .03), mean pulmonary capillary wedge
pressure (23,7 to 18il mmllg, p < .01); r adi onucLfde left
ventricularpeak diastolic filling rate (2.70~1.20 to
2.48±1.17 EDV/sec, p < .03); and echocardirgraphicMVA
(0.9+0.2 to 1.3"0.3 cm2 , p<.OOl), MV excursion (11~5 to
14~6 mm, p<.Ol), EF slope (6±5 to 11±3 mm/sec, p<.Ol)
and LA size (5.B±I.0 to 5.5 ~0.8 cm p <.02). Five of
the 14 pts hac small atrial septal defects after MVP.
There were no embolJc complication., and minimal «1+)
incre~~e in the degree of mitral regurgitation(MR). ~t
follow-up (mear 4.4 months) there was persistence of
improvement in echocardiographicMVA (1.3 to 1.3 cm2 ) ,
11V excursion (14 to 13 mm), EFslope (11 to 11 mm/sec),
and LA size (5.5. to 5.5 cm). Two of 14 patients had
undergone MVR because of insufficient clinJcal
improvement. The remaining patients were well and
showed marked ~mprovement in symptom~. Conclusions:
PercutaneousMVP in adults with critical MS results in
significant and persistent Improvement in valve
function in mORt patients, without major compli.cations.
PAV
4*
.2+
.05*
After
30 ±
4.3 ±
0.8 ±
Aortic Gradient (mm Hg)
Cardiac Output (l/min)
Aortic Valve Area (cm2 )
*p<.OOOl +p<.05
Percutaneous balloon aortic valvotomy (PAV) has
been performed in children and in the elderly
using retrogradearterial catheterization. Since
PAV requires use of large balloon dilating
catheters (BDC), excessive bleeding and local
arterial damage may be potential complications.
We performed PAV using transseptalleft heart
catheterizationfrom the right common femoral
vein in 13 patients (pts) with severe aortic
stenosis. There were 7 males and 6 females
(mean age 78 ± 2). Following transseptalleft
heart catheterization, a 0.035" transferwire
was was advanced from the left atrium through
the left ventricle, across the stenotic aortic
valve and into the descending aorta. The
interatrialseptum was dilated with an 8 mm
BDC to allow antegrade passage of larger
(15 and/or 20 mm) BDC to dilate the aortic
valve. Results follow (mean± sem):
Before PAV
57 ± 4
3.8 ± .3
0.4 ± .05
LATE HEMODY~A}IIC EVALUATION AFTER PERCUTANEOUS AORTIC
VALVULOPLASTY IN ADULTS WITH AORTIC STENOSIS.
Brice Letac, M.D., F.A.C.C., Jacques Berland, M.D., Rachid
Mechmeche, M,D., Thierry Savin, M.D., Nadir Saoudi, M.D.
and Alain Cribier, M.D.
Monday, March9, 1987
4:00PM-5:30PM,Hall Col, FirstLevel
Multivessel Disease PTCA: Follow-Up
EARLY RESULTS, COMPLICATIONS AND RESTENOSIS RATES AFTER
MULTILESION AND MULTIVESSEL CORONARY ANGIOPLASTY.
Marc Lambert MD, Simon Kouz, MD, Catherine Chassat, MD,
Jacques Crepeau, MD, Raoul Bonan, MD, FACC, and David
D. Waters, MD, FACC, Montreal Heart Institute, Canada.
Early results, complications and restenosis rates were
compared in 50 patients undergoing multilesion
(multiple stenoses in one artery) and 156 patients
undergoing multivessel coronary angioplasty (PTCA).
Age, sex, duration and severity of angina, history of
smoking, hypertension, previous myocardial infarction,
pre-PTCA percent stenosis and gradient, post-PTCA
percent stenosis and gradient, maximal inflation
pressure and presence of intimal dissection were
similar in the two groups.
Primary success rate per lesion was 3521377 (93"') in
multivessel patients and 921106 (87".) in multilesion
patients (p<0.05); all stenoses were successfully
dilated in 136/156 (87".) multivessel compared to 39/50
(78"') multilesion patients (p<0.05). No deaths
occurred in either group. Major and minor complications
combined were more frequent (p<O,05) in multilesion
patients, 11/50 (22"), than in multivessel patients,
17/156 (10.8"'), The incidence of serious complications
(myocardial infarction, emergency bypass surgery) was
also higher in multilesion patients, 6/50 (12".), than
ill multivessel patients, 10/156 (6.4"'). Coronary
arteriography was done at 5 . 8±2. 6 months in 60". of
multilesion and 61" of multivessel patients. Restenosis
rates per lesion were similar: multilesion 19/69 (28")
vs multivessel 64/234 (27".).
We conclude that multivessel PTCA is associated with a
higher primary success rate, a lower incidence of
complications and a similar restenosis rate compared to
multilesion PTCA.
Ex2
47"'+'15 **
0.78 + 0.23 NS
5.2+1.4*
62 + 17 *
Percutaneousaortic valvuloplasty (PAV) can be effectively
applied in non-surgical or high surgical risk adult
patients (Pts) with aortic stenosis. It immediately
results in a decrease in transvalvulargradient (G) and an
increase in aortic valve area (AVA) explaining the marked
clinical improvement in most Pts. To assess the stability
of hemodynamic results, a repeat catheterization (Ex2)
could be performed 17 + 9 weeks (4 to 34 weeks) after PAV
in the 23 consenting Pts : G, AVA, cardiac output (CO) and
ejection fraction (EF) were measured. Aortic valve
restenosis was defined as )50% reduction in AVA post-PAV
increment.
Results : restenosis was noted in 5 Pts (22%) : 2 Pts
reverted to pre-PAV G and AVA values with heart failure
symptoms recurrence 3 others had intermediate data
indicating moderate degree of restenosis but remained
clinically improved. Results in 18 non-restenosed Pts :
pre PAV post PAV
G mmHg 80 + 23 38 + 11
AVA cm2 0.48 + 0.14 0.80 +0.25
CO l/mn 4.3 + 1. 2 4.7 + 1.27
EF % 47 + 17 53 ± 15
(** p<.Ol, * p<.05, between Ex 2 and post PAV)
Conclusion : This study confirms a stable hemodynamic
improvement in 78% of the Pts an average of 17 weeks post
PAV. In non-restenosed Pts, moderate increase in G with no
change in AVA are to be related to improvement in cardiac
output and ejection fraction as assessed on late controls.
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EFFICACY OF "ORONARYANGIOPLASTYFOR PATIENTS
WITH MULTIVESSELCORONARYARTERY DISEASE: CLINICAL
STATUS AT SIX MONTHS OFFOLLOW-UP EdwardS. Thomas,
~ Albert S. \lost, MD, F.A.C.C., David O. Williams, MD,
F.A.C .C., RI Hospital, Brown Universit y, Prov , RI
Although the efficacy of coronaryangioplasty (CA) in patients
(PTS) with single vessel (SY) coronary disease IS well
acknowledged,there is less agreementregarding the value of CA
for PTS with multivessel (MV)disease. Thus, we reviewed the
follo w-up data of a series of 281 consecutive PTS (t 89 SV, 92 MY)
in whom CA hadbeen successful and at least 6 months had
elapsed. Multilesion CA was performedwhen te chnicall y feasible
and clinically appropriate.Clinical improvement was noted in
81ss MV PTS as comparedto 95% SVD PTS (P <.00I). More SV PTS
were free of angina (77% vs 60%,P=.02),did not take long acting
antianginal medications(46% vs 22%,P< .00 I) and had repeat
PTCA less often (5% vs 12%, P=.05)than MV PTS. There was no
sig nificant difference (P>.05) m hosprtalizatlons for angina,
myo cardial inf arct ion ,mortalityor need for CABG. To determme
whetherdegree of revascularization(R) accountedfor differences
in outcome, CA for MV was classified as com plet e (CR)i.e., no
residual coronarystenosis >50% or incomplete (IR). MV-CR PTS
had no difference in daily activity, work status,presence of
angina or use of antianginalmedicationsas compa red WIth SV
PTS. Furthermore,the incidence of hospitalizationfor angina,
myocardial infa rc t ions ,repeatCA, need for CABG and mortality
was similar between MV-CR and SV PTS. Of theMV -IR PTS, 63%
were free of angina, I% hadmyocardialinfarcti on or CABG and
no mortalityoccurredduringthe follow-up per iod. A similar
percentage(11 % vs 12%) of MV-IRand MV-CR requiredrepeat
CA. Thus, CA enhances functional status and relieves angina in
PTS with eitherSV or MV althoughimprovement ISobserved m a
greaterproportionof SV PTS. MV PTS m whom CAachie ves
complete revascularizationdemonstratebenefits SImilar to SV
PTS.
<Xl-IPIEI'EVS m:nIPIEI'EREVASCUIARIZATIONIN mLTIVESSEL
DISEASE: A REPORT FRCM rss NHLBI PK:A RmISffiY.
G. S. Reeder, M.D., F.A.C.C., D. R. Ho1Ires, M.D.,
F.A.C.C., K. Detre, Ph.D., T. Costigan, and S. Kelsey,
Ph. D. Mayo Clinic, Rochester, MN and University of
Pittsrorgh, Pittsl::m"gh,PA.
Should PK:A be applied in ltI.lltivessel disease (MVD)
if oamplete ~evascularization (CR; ie no lesion > 70%
remaining) cannot be achieved? Other studies shCM in-
oampletely revascularized(lRl patients (ptsl do less
well rot without correction for baseline differences.
We report 286 MVD pts f'rcm the NHLBI PK:A registry with
successful PTCA followed 26.2 months; analysis end points
were angina status, death, myocardial infarct, and late
revascularization(bypass surgery or second PTCA.l
Patients with lR had moredepressed ejection fraction at
baseline. For this reason, logistic regression was used
to adjust for baseline differences between 127 CR and 159
lR pts. Adjusted relati.ve risk of lR vs CR (>1.0 = in-
creased proportionateriskl for hierarchyof analysis end
points showed:
Risk of: death 0.93 p=NS
death/MI 0•85 p=NS
angina 1. 00 p=NS
late revascularization0.94 p=NS
bypass surgery 3.60 pc,05
second PK:A 0. 59 p=NS
COlplete revascularIzation pts had moresecond PK:AI S and
IR pts had mire bypass operations. We conclude: 1)
Clinical outcorre is similar in CR and lR pts after correc-
tion for baseline differences especially ejection frac-
tion, 2l Although incidence of late revascularizationwas
similar, more lR pts had late surgery and more CR pts had
second PTCA, 3) PK:A can be applied to MVD pts without
increased risk even if CR is not obtained.
FUNCTIONALLY DIRECTED REVASCULARIZATIONUSING CORONARY
ANGIOPLASTY: AN ALTERNATIVE APPROACH IN THE MANAGEMENT
OF MULTIVESSEL DISEASE. Daniel Wohlgelernter, MD, FACe,
Lawrence A. Yeatman, MD, Henry S. Cab I n, MD, FACC,
Mlchael Cleman, MD, UClA Medical Canter, Los Angeles, CA.
For pts with multlvessel coronary artery disease
(MYDl resistant to medical therapy, It Is generally
recommended that all stenotic coronary vessel s be
surgically bypassed or dilated using PTCA. This require-
ment for total revascularlzatlonforecloses the option
of PTCA for those pts with lesions not suitable for
dilatation. We eval uated the efficacy of PTCA limIted to
the Ischemia-producingvessel, In pts with stable angina
and ~1VD, defined as 2 7 0%stenosis In 2 or more major
coronaryarterIes. 35 pts had MY 0 with PTCA I I mIted to
one artery (Group Al. Stress-redistributionthall lum-201
studies were performed prior to PTCA In al I Group Apt~
Reversible perfuslon defects limited to the territoryof
a si ng Ie artery IdentIfled the target for PTCA. Resu Its
and outcomes from Group A were compared to those of
Group B, a set of 35 pts with MYD and dllatlltlon of all
stenoses. Groups A and B were similar In all clinical
and anglographIc parameters.However, Group A pts had
secondary targetscons Idered not amenabIe to PTCA: 15
pts had chronic total occlusions, 20 pts had
Inaccessible le s Ions, In Group B pts all stenoses were
appropriate for dilatation. PTCA was successful for all
pts and for all targetted leslon~ Follow-up data from
Groups A and B, respectively, were as follows: exerclse-
Induced angina at 2-week fol low-up, 6% vs 6%: recurrence
r ete of angina at 6 months, 21% vs 24% (NSl: repeat
PTCA, 15%vs 15%: bypass surgery, 9% vs 12% (NS). We
cone I ude that In pts with MY 0 and anatomy not su Itab1e
for total revascularlzatlon by PTCA, functionally
directed revascuIarIzatIon us Ing PTCA of the Ischem Ia-
producing vessel can be a therapeuticoption.
-
Group n I Yr 2 Yr 3 Yr 4Yr
Total Population 568 91±01 89±02 83±02 75±04
2 Vessel Disease 506 91±01 89±02 83±02 74±04
3 Vessel Disease 62 90±04 89±04 -- --
I Site Dilated 347 92±02 89±02 83±03 73±05
>1 Site Dilated 221 91±02 89±02 84±04 79±06. .The probabil ity of having a repeat PTCA was 29±3% at 4 years
CONCLUSION: In selected patients with multi vessel disease
undergoing successful multiple or single vesseldilatations, prognosis
is excellent with most patients not having a major event or equiring
bypass surgery.
EVENT FREE SURVIVAL AFTER SUCCESSFUL ANGIOPLASTY
IN MULTIVESSELCORONARY ARTERY DISEASE
Gary Roubin M.B.• Ph.D., William S. Weintraub M D., F.A.C.C. ,
Cynthia Sutor, R.N., Erin Davis , Jana Hoffmeister M.D., John
Douglas, Jr ., M.D., F.A.C.C., Spencer B. King Ill, M.D.• F.A.C.C.
Andreas Gruentzig CardiovascularCenter, Emory University School
of Medicine, Atlanta, Georgia
Through December 1985, 1090 pat ients (pts) with multivessel
coronary arterydisease (± 50%diameter stenos is in 2: 2 of the major
coronary arteries) underwent elective PTCA. Pts with prror bypass
surgery (CABG), n=352, wereexcluded. Of the 738 remaming pts,
82% had angiographically successful (all attempted sites < 50% post
PTCA) and complication free PTCA(no CABG, myocardialinfarction
(MI) or death). These 605 successful pts, mean age 56±10 years (tsd),
were 85% male, 41% hadprior MI, 89% had 2 vessel disease, 11%
had 3 vessel disease, and 37% had eje ction fra ction less than 50%
(n-490 for ejection fraction). 61% had I sue dilated . Pts were
followed for a mean of 24 months (range6-64) and follow-up was
94% complete. Event free survival post-discharge for end-points
death (lO=total, 5=cardiac), CABG or MI was computed by the
Kaplan-Meier method .
Four Year Event Free Survival % (+S.E.E.):
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CORONARY ANGIOPLASTY OF A "CULPRIT"LESION IN PATIENTS
WITH KULTIVESSEL CORONARY DISEASE.
Daniel J. Diver. M.D., Carolyn H. McCabe, B.S., Raymond
G. McKay, M.D., Aaron D. Berman, M.D., Beverly H. Lorell,
M.D., F.A.C.C., Julian M. Aroesty, M.D., F.A.C.C., Donald
S. Baim, M.D., F.A.C.C. Harvard-ThorndikeLaboratory,
Beth Israel Hospital, Boston, MA
In patients with multivessel disease, it may not be
possible to revascularize all significant stenoses via
coronary angioplasty. Accordingly, we compared the
strategy of angioplasty of only the "culprit"lesion
(defined as the lesion felt to be most responsible for
myocardial ischemia) to angioplasty of all lesions >70%,
in 165 consecutive patients with multivessel disease and
angina (stable 45%; unstable 46%; post-infarct9%).
Dilation of only the culprit lesion was attempted in 95
patients (Group I), while complete multivessel dilation
was attempted in 70 patients (Group 11). The primary
success rate (dilation of all attempted lesions) was 85%
in Group I and73% in Group 11. Procedure-relatedcompli-
cations included myocardial infarction in 8 patients
(5%), urgent surgery in 1 patient (0.6%) and in-hospital
death in I patient (0.6%), and did not differ between the
2 groups. At follow-up (mean-l yr), 69% of Group I
patients were asymptomatic versus 52% of Group 11
patients. Repeat angioplasty was performed in 6 Group I
patients and 9 Group 11patients, while coronary artery
bypass surgery (CABG) was performed in 7 Group I patients
and 1 Group 11patient. There was 1 late myocardial
infarction in Group 11 and nolate cardiac deaths.
Conclusion: In patients with multivessel disease,
coronary angioplasty of the "culprit"lesion is associat-
ed with a high primary success rate and a low complica-
tion rate, but appears to require more late CABG than
does complete revascularization.
Monday, March9, 1987
2:00PM-3:30PM,Room 38, Second Level
Evaluationof Left VentricularFilling Dynamics by
TransmitralFlow Velocity
VALIDATION OF DOPPLER ECHOCARDIOGRAPHICALLYDERIVED PEAK
FILLING NORMALIZED TO STROKE VOLUME: A COMPARISON WITH
RADIONUCLIDE ANGIOGRAPHICTECHNIQUES.
Leigh K. Bowman MBBS. FRACP, ForresterA. Lee MD, C. Carl
Jaffe MD, Jennifer MatteraRT. Frans J. Th Wackers MD,
FACC, Barry L. Zaret MD, FACC. Yale University, New
Haven. CT.
The noninvasive measurement of left ventricularfilling
has relied predominately on radionuclide angiographically
derived peak filling (PF) normalized to end diastolic
volume. Doppler Echocsrdiography(DOP) has recently been
used to assess PF but its accuracy depends upon
measurement of the mitral annulsr cross sectional area
which may be difficult in some pts. Normalization of PF
to stroke volume (SV) permits the derivation of a DOP
diastolic filling index which is free of geometric
measurements and assumptions. PF normalized to SV was
calculated by dividing early peak velocity of mitral
inflow by the time velocity integral of the mitral inflow
velocity profile (measured at the mitral annulus). This
measurement was compared tosimilarly normalized nuclear
derived PF expressed in SV/sec calculated from Fourier
smoothed time activity curves generated from list mode
gamma camera acquisitions. Comparison between the two
techniques was made in 20 pts with a variety of cardiac
diseases (mean ejection fraction 46%, range 11-73%). Mean
PF by DOP was 5.2+2.1 SVIsec and by nuclear was 4. 92!2
SV/sec (r~.85 SEE~ 1.2, y - .95x + .52)
We conclude that 1) DOP derived PF correlates well with
nuclear PF when both are normalized to SV, 2) DOP PF
normalized to SV is an easily performed measurement free
of geometric assumptions, 3) normalizationof PF to SV
rather than end diastolic volume may be of value in
assessing pts with abnormalitiesof diastolic filling.
INFLUENCE OF AGIt«! ON LEFT VENTRICULAR DIASTOLIC
FUNCTION AS ASSESSED BY DOPPLER ECHOCARDIOGRAPHY
Paolo Spirito. MD, Barry J. Maron. MD. FACC. NHLBI.
Bethesda, Maryland
Reoently. Doppler eoho has been used to assess diastolio
funotion in pts with oardiao disease. This investigation
was performed to assess the influenoe of aging on Doppler
Doppler parametersof left ventrioular (LV) diastol1o per-
formanoe. Six Doppler diastolio indexes were analyzed in
86 normal sUbjeots. aged 20-74 years. and all 6 showed
linear relationshipto age. Durationof both isovolumio
relaxationand early diastolio flow-velooity (FV). and the
maximal late (atrial) diastolio FV inoreased with age (r=
0.4 •• r=0.32. r=0.63; p<O.OOl). Conversely. maximal early
diastolio FV. rate of deoelerationof FV in early diastole
and ratio of maximal early to late diastolio FV deoreased
with age (r=0.40. r=0.42. r=0.66; p<.OOll. Comparison of
Doppler indexes of diastolio performancein different age
groups (20-29, 30-49, 50-74 yrs) also demonstratedan in-
fluenoe of aging. Isovolumio relaxationwas prolonged in
older (84+12 ms) oompared to younger subjeots (72~12 ms;
p<O.OOll.- Both decelerationof FV in early diastole and
ratio of earl~ to late diastolio FV were reduced in older
(4.2 +1.2 m/~ ; 1.2+0.4) oompared to younger subjeots
(5.5+1.2 m/s ; 2.7+0.7; p<O.OOl). In oonolusion, dias-
tolie funotion assessed by Doppler is importantlyaffeoted
by aging. In older sUbjeots, durationof isovolumio re-
laxation is prolonged and rate of early diastolio FV re-
duoed; as an apparentoompensation, the relative contribu-
tion of atrial systole to overall FV increases. These al-
terations in the diastolio waveform qualitatively resemble
those in pts with cardiao diseases associated with dias-
tolio impairment; henoe, effects of age should be consid-
ered in formulating "normal"limits for Doppler indexes of
diastolio performanoes.
INFLUENCE OF SAMPLING SITE UPON THE RATIO OF ATRIAL TO
EARLY DIASTOLIC TRANSMITRAL FLOW VELOCITIES BY DOPPLER
Niksa Drinkovic, Mikel D. Smith, Tom Wisenbaugh, Bruce
Friedman, Oi Ling Kwan, and Anthony N. DeMaria. Univ of
Kentucky and VA Medical Centers, Lexington, Kentucky
Although the ratio of atrial(A) to early(E) diastolic
transmitralflow velocity by Doppler has been used to
identify abnormal LV filling, no data exist regarding the
influence of the sampling site upon these measurements.
Therefore,we performed Doppler in 16 norma1s and 46 pts
with cardiac disease butno mitral stenosis. Transmitral
velocity recordings(cm/sec) were performed in the apical
view with the sample volume at the level of the mitral
annulus(ANN) and at the leaflet tips(TIP) inpulsed mode,
and with the cursorthrough mitral orifice in continuous
wave. The ratio of maximal(MAX AlE) and integrated(INT
AlE) atrial to early velocities were calculated from
Doppler. Results: (modal velocity for pulsed and maximal
for continous wave).
MAX E MAX A MAX AlE Int E Int A
ANN 46.7 52.3 1.12 6.1 4.3
TIP 63.9* 59.0* .91* 8.9* 5.3*
CW 76.8* 69.7* .91* 13.0* 7.3*
(*=p <.001 comparedwith ANN)
AlE ratio values were correlatedwith cath indices ofLV
compliance derivedfrom simultaneous microtip pressures
and cineangiographicvolumes. Measurements included the
slope of the log pressure-volumerelationship(k)and the
ratio of volume to pressurechange. No correlations
existed between anyAlE ratio and any index of
compliance. Conclusions: Values for AlE ratio by Doppler
are markedly dependent upon the sampling site of
transmitralflow. Although both Aand E velocities are
greater at the mitralTIP thanANN, the relative increase
in E is greater. Therefore, theAlE ratio is greater at
the mitral annulus than at theleaflet tips.
JACC Vol. 9. No 2
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EVALUATION OF LEFT VENTRICULAR DIASTOLIC FI LLING IN
ISOLATED AORTICSTENOSIS USING DOPPLER ECHOCARDIOGRAPHY.
Cat herine M. Otto, M.D. ; Alan S . Pearlman, M. D., F.A. C. C. ;
Lee C. Amsler~.; Caro l yn L. Janko, RDMS; Caro l D.
Kr af t , RDMS, Uni versity of Washington, Seattle, WA.
We used Doppler to study LV filling in 49 patients w1t h
i sol at ed aortic stenosis (AS ), selected f r om 155 consecu-
tive AS patients by excluding coex1s t i ng mit ral disease
(n=4l) and/or significant aor t i c i nsu f f iciency (n=8l) .
Age range was 40-89 (mean 66) yrs. LV hypertrophy
(LVH=wall thickness~12 mm) was present in 33/49 pts. For
comparison, we studied 10 elderly subjects (mean age 69
yr s ) wi t h normal 20 echos .
Mitr a l pressure ha lf- time (T~) was l onge r in the AS
gr oup than in normals (88 vs 65 msec, p=0. 03) but there
we re no gr oup meandif f e rences fo r peak ea rly (E) diasto-
l i c f i lling vel oci t y (68 vs 66 cm/ s) , peak atr i a l (A)
fill ing ve l ocit y (80 vs 81 cm/s ) or E/A ratio (1. 01 vs
0 . 83 ; a l l p=NS). There was no cor r e l at i onbetween any LV
filling variabl e and AS severity [valve area by Doppler
continuity equation 0.3-2.5 (mean 0.9)cm2 or mean pressur e
gradient 6-95 (mean 46)mmHg] , but A-velocity was higher i n
those with vs t hose without LVH (86 vs 65 cm/s, p<O.Ol).
Si gnificant LVsystoli c dys funct1 0n (EF<50\ ) was pres -
ent in 6 pts. Comparing AS pts wi th systolic dysfunction
to t hose wi t h normal sys t ol i c fu nction, E was higher (88
vs 65 cm/s , p<O.Ol) , A was l ower (53 vs 83 cm/ s , p<O . Ol) ,
E/A ratio was higher (2 .20 vs 0 . 84 , p<O.Ol ) , and LVEDP was
elevated (23 vs 10 mm Hg, p<O. Ol).
We conc lude that many AS patients have coexisti ng va l -
vular les10 ns t hat themselves may alter LV f illi ng . In
isol a t ed AS, (1) LV fill i ng is not related t o AS severity,
(2) T~ is prolonged compare d t o age-matche d normal s , (3)
A is increased when LVH i s prese nt and (4) there 1S an
apparent "normalization"of LV filling, as sociat ed with a
high LVEDP, when LV systolic dys f unct i on i s present.
DOPPLER ECHOCARDIOGRAPHY IN CARDIAC TAMPONADE:
EXAGGERATED RESPIRATORY VARIATION IN TRANSVALVULAR
BLOOD FLOW VELOCITY INTEGRALS.
David E. Leeman , M.D., Marilyn F. Riley , B.S ., Lisa V.
Carl, ~A., Patricia C. Come, M.D., FACC. Harvard-
Thorndike Laboratory, Beth Israel Hospital, Boston, MA.
Pulsed Doppler echocardiography has been used
previousl y to demonstrate marked changes in
transva lvular blood f l ow velocities during ca r di ac
t amponade i n labora t~ry ani mals and in a small number
of pts. To further as sess t he respiralory change s i n
transvalvular bl ood f lo w during tamponade, we recorded
pulsed Do ppl er trac i ngs of flow velcci ty profiles
ac r oss all 4 card i ac valves during i nspiration (INS)
and expiration (EXP) i n I t pts during tamponade, i n 4
of t he It pts after r e l ief of t amponade by
pericardiocent esis and i n 8 norma l controls. Fl ow
velocity i ntegrals (FVI) were cal cul a t ed using an off -
line comput er sy s t em. Tamponade was confirmed by
hemodynamic measurements. Results:
% i nspi r at or y6 in FVI (INS FVI-EXP FVI!EXP FVI)
Tamponade After relief of tamponade Normals
Tr i cuspi d ~ 80i ... 21% '"5%
Pulmonar v l'86% '" 11% '" 9%
Mitral ' J. 35% .J. 3% ." 8%
Aortic v 33% '"7% ..... 3%
Conclusions : I n pts with tamponade, i nspiration causes
mar ked increases i n flow ac r oss right sided va l ves and
mar ked decreases in flow across left sided valves .
These phasic r es piratory chan ges are markedly re duced
following relief of tamponade (p<. OI compared with
tamponade ) and ar e observed only to a minimal extent in
normal i ndi vi duals (p<. 005 compar ed with t amponade).
The exaggerated phas i c respiratoryvaria t i ons in
transvalvularFVI suggest that Doppler evaluation
may be a valuable tool i n the diagnosis of tamponade.
Normal 72 72 77 75 1.6 59 1.4 75 66
CP 60 89 95 59 1.3 45 1.5 56 54
Post-op 66 66 89 82 1.5 55 1.2 57 63
RCM 59 64 89 84 2.5 41 2.6 40 32
Shorter than normal M~ and T~ were seen in both groups; the
decrease in T~ was more marked and exaggerated by inspiration
m RCM. Velocity at atrial contractionwas decreased in RCM and
normal in CP pts. A marked change in peak mitr al flowvelocity
and IVRT wasseen only in the CP pts and was consistent with an
observed larger decrease in PCW than in LVdrastolic pressure
with onset of inspirat ion. Simultaneous LV and PCW pressure
recording showed this find ing in all 14 pts with CP and none with
RCM. By recording this change in peak mitral flow velocity and
IVRT with respiration, the difference in eff ect of respirationon
extra-and mtracardiacpressures can be ide nt ified andserves to
differentiate pts with CP from thos e with RCM.
. 66±. 1
l6±4
. 63±.1
l5 ±4
. 68± . 2
lo±5
. 66±. 2
l5±5
PV m/s
AR m/s/s
11 PV m/s
AR m/ s/s
GR
Recent wor~ has sugges t ed that Doppl~r evaluation of
a o r ti c f l o w during s t r e s s can detect c oro n a ry disease
(CAD ) but its val ue r emains controversial . We examined t he
aortic fl ow veloc i t y parameters, peak velocity (PV) and
max i mum ac cel e ration rete (AR) i n 60 pt s i n control (C)
and dur i ngstress (S) . 16 pt s undeDOent dipyridamole
Thallium (Th) tes t (CR I), 17 had exercise Tt t es t (CR 11)
and 27 underwent treadmil l exercise (GR Il l) . A t ran s i ent
per fu s i on def ec t on Th imaging and ischelllic E1:C change s on
the treadmill exerci se wer~ t aken as t he independent
standard for the diagnosis of Lsc hemi.a , Result s (X± SD ) :
Ischemia +ve Ischemia -ve
C S C S
. 53±. 1 .98± . 2 . 57±. 1 .87±. 2
13±6 42±28 14±8 40±16
RELIABILITY OF STRESS DOPPLER ECHOCARDICGRAPHY I N THE
DETECTI OJ~ OF I SCHEI<IA IN IlUHANS DURING DIFFERENT FORI-IS OF
STRESS.
Morga~2!i~' Michael Foster, M. D., David Weiland,
M.D., Marvin Konst am, M.D., Natesa Pandian, M.D. Tufts-
New England Medical Center, Boston, Hassachusetts
Monday, March9, 1987
4:00PM-5:30PM, Room 38, Second Level
Evaluation of LeftVentricularFunction by Rest and
Exercise Doppler
III PV m/s . 53±. 2 .7l±.3 . 50±. 1 .72± . 1
AR m/s/s l 4±4 32±4 12±2 32~9
~ot only was there no difference in the pool ed data, but
there was signi ficant overlap be tween normal andische~ic
pts in PV and AR during different f or ms of s t r ess . Neith er
PV nor AR disc r i mi na t ed CAD pts from normaLs , We concl ude
that stre ss Doppl er analysis of aortic flow is not
reliabl e i n t he detecti on of coronary arte ry disease.
TY,
e i
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CONSTRICTIVE PERICARDITIS AND RESTRICTIVE
CARDIOMYOPATHY, DIFFERENTIATION BY DOPPLER
RECORDI NG OF ATRIOVENTRICULAR FLOW VELOCITIES.
LIV K. Hatle, M.D., ChristopherP. Appleton, M.D., Richard L.
Popp, M.D., F.A.C.C., StanfordUmversit y, Stanford,CA.
In an attempt to differentiate between constrictive pericarditis
(CP) and restrictive cardiomyopathy(RCM) flow velocities were
recordedby pulsed Doppler echo together with respirationacross
all 4 valves in 12 pts with RCM, in 4 with CPbefore and after
surgery and in 10 normal subjects. Hemodynamic findings were
analyzed in these and in 10 other pts with proven constrictionat
surgery. Mitral (Ml,cm/secl and tricuspid (Tl , cm/secl flow
velocities and time from aortic closure to mitral opening
(IVRT,ms) were measuredat onset of inspiration(j) and expiration
(e); and pressurehalf-times : M~, T~ (msec) and the ratio of early
diastolic veloc ity to that at atrial contracnon (MI! M2, Tl!T2)
were assessed.
IVRT
e i
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IS AVERACL J:::'A~10LlC !"ITRAL ORl F:LL AR~A lU,r,J:1PED Fot~
~M,CULATTOh OF DOPPll.t.'>D ECIl0 CMUJIAC OU'1!'[I;"
V111iam E.. hJller, MD, r:"nt 1. ki cbar ds , !'.r, IA('C,
,Trrt'lynF. Hil:"" RDMS, ~itchael H. Llc"ford, I'D, I ACC.
I'ni v of '!'{!}.8S H se&: VA. Ii0~ritaJ. f. r. Antomo , TY.
The t echnd que for measuring rest CL· c cross the
mitral valve by comb i ned Doppl e r auc L-D echo if- c1iffi-
cult ber-aur« t l.e mi t ru" l':!lve ori f i ce area vari e s
t l.i oughout cl?as t o l e , CVft roveruy r vI st s as tl' t· l.e t he r
use of max i.muni VtlSUC; tre an df e s t o Ltc rm t rrl orLfi ce n rea
prorluc- s the most nrcurat e ~·(·"l,lts. Ac cor ct nglv , we
studi ec J5 intensive care pati e i t s >rith toEtn,odiluUc.,.
(":D) right h~,;rl c a t.het err, rCO-Tn =7.£-i .3, mear = <;.0
1,/min) ar,' duplex Doppler. Hitral «rii i ce moda l velo-
(.} ty was Lnte-pr a t ed tr drt ermtne t o t a I mf t r a 1 ve LocLty-
time Lnt egr al (\TT); VT "a~ also c i vLced into er r ly
'\'T-l) anr' l,:>te ~VT-L) halves. Mflyif1Ltl, mitral «r i f f ce
area (hI'M.) and max i maI early (A- 1) and Lat e (A-2)
nf t.ra I or Lf Lre r reas weTP r.easured i::-r.Jl" 2-D ec1-:n p<-~rd­
s t e rnal views. The average dt s t r nc e hetwE'f'n n::'tral
ant erI or nnc j-r-s t erLor lerflets (DTI'p<,.,) was dete·,.-ined
in1l"1 parast e rr-a I M-mod~ e chn, The aver age Dmeai. ft1'; the
l~ patients was O.fiR. Eeart rate (FF) was ffie ••ured from
DOpp]FJ- recordn j,s . Nonfnvrs.fve Dopp l e.r er WAS cs l cu-
l at.ec' C} 4 me t hod: crd compa rec; to s LmuLtareou s TD r.p:
IIETHOD x ~ SD SLOPE R sir
(Vl'mHAma,,)(DmeanHHf) ~.5!1.~ 0.94 .78 .83
(VTm) (Amax)(.6£) (HR) 3.5!.9R 0.70 .91 .43
(VTr';\Amax)(HK) 5.l!1.5 I.C: .91 .56
r(VT-1)(Al)"(\·T-·2)(A-2»)(hR) 5.CJ:1.4 1.02 .01 .49
He conc l.ude that resting cardiac output can he
measured accuratel y at the l!'itral ortfi ce iJ, adu Lt s
usJng u.e t hods whf ch use maxim.n, n.i t raI vrlve o r i f ice
area, or f'i:1rly and Late r-Lt r a l va li f::. areas aTL(
ve l oc t t t e s . !-'-TTlode co r r ec t Lon of m:trRl area did not;
improve arccracy.
Rest
rEx
, Rest
LEx
PRO
VER
Control
Control
USE OFEXERCISEDOPPLERTO EVALUATE CARDIACDRUGS:
COMPARATIVEINFLUENCEOF BETAANDCALCIUM
BLOCKERSONAORTICACCELERATIONANDVELOCITY
Michael R, Harrjson,Mikel D, Smith,StevenE, Nissen, AnthonyN,
Delvlaria, Univof Kentuckyand VA MedicalCenter,Lexington,KY
ExerciseDoppler(DOP)providesa potentialmodalityby whichto study
thehemodynamiceffectsof a varietyof cardiacdrugsat rest and with
exertion,Therefore,we performed26 continuouswaveDOP studies
from thesuprasternalnotchin18 norrnaJs(meanage31 yrs) priorto,
during,andimmediatelyaftertreadmillexercise.Controlmeasurements
of maximalvelocity(MAXV), flow velocityintegra!(FVI),and peak
acceleration(ACCEL)wereobtained. Studieswerethen repeated2
hoursafteroraladministrationof I mgikgpropranolol(PRO)(15 pts)or
120 mg ofVerapamil (VER)(11 pts).Results:(MAXV in mlsec;FVI in
cm; ACCELinmlsec/sec).
HR w;y.y FVI ACCa
80 ±15 .62±.2 7,1±2 15.5±6
171±12 1.20±.2 8.7±2 54.9±16
65±9 .51 ±,1 6.9±2 11.3±11
129 ± 11 1.09±.2 14.2±3 34.4±11
Rest 77±12 .59±.2 7.1 ±4 141 ±4
rEx 165±10 1.17±.3 8.8 ±2 50 ±17
tRest 81 ±15 .56±.2 6.6±3 137± 3
LEx 161 ±13 1.16±.3 9.7±4 48.6±15
'p Value S .0005 NS S .OOOS S .0005
tp Value <.OS NS NS NS
PROproducedreductionsin MAXVand ACCELwhichweresmallat
rest, butof greatermagnitudeduringexertion. Despitethesecardiac
depressanteffects,exerciseFVI increasedafterPRO,suggestingthat
strokevolume is augmentedconcomitantwitha HR decreasesecondary
to greatervenousreturn. In contrastto PRO,noalterationsin DOP
valueswere inducedby VER. Thus,exerciseDOPprovidesanexceJlent
methodto evaluatethehemodynamiceffectsof cardiacdrugsat rest and
withexertion. Althoughbothagentshave negativeinotropicproperties,
DOPindicatesthatPROexhibitsa greatercardiacdepressionthan VER
at rest andexercise.
NUCLEAR EJECTION FRACTION AND DOPPLER EJECTION PROFILES
CORRELATE DURING EXERCISE IN PATIENTS WITH CHEST PAIN
Steve M. Teague, MD, FACC, Carolyn Corn, MD, FACC,
Rajesh Prasad, MD, Mukesh Sharma, MD, Jerome L. Ander-
son, MD, Robert Burow, MS, and UdhoThadani, MD, FACC,
Univ. of Oklahoma andVA Medical Centers, Oklahoma City.
To assess the correlation of stress multigated
radionuclear and Doppler responses in patients with
coronary disease, we studied 54 males during supine
bicycle exercise prior to coronary angiography. Simul-
taneous nuclear left ventricularejection fractions and
suprasternal Doppler assements of maximal accelera-
tion and peak modal velocity were obtained at rest and
peak work loads. Responses were characterized as the
percent change in acceleration (%MA) and velocity (7.VP),
and the net change in ejection fraction (deltaEF)
between rest and peak exertion. At catheterization,40
patients had coronary disease (>707.stenosis), while 14
did not. Both 7.MA and 7.VP positively correlatedwith
deltaEF as deltaEF ranged from -30 to +26. The rela-
tionship between deltaEF and 7.VP was linear (y=.7x+lO.6,
r=.67, SEE=13.4), while %MA increased exponentially as
deltaEF increased (y=33e· 098x, r=.83, SEE=2.3).
Utilizing deltaEF < 5, %MA < 80, and 7.VP < 20 as
diagnostic thresholds, sensitivity/specificity for
coronary disease was calculated as follows; deltaEF:-
.80/.86; %MA:.95/.78; 7.VP:.85/.93. However, isolated
measurements of EF failed to correlate with MA and VP
(r=.25, r=.33). We conclude that although Doppler
measurements are not predictive of ejection fraction,
the percentage change in maximal acceleration and peak
modal velocity from rest to peak exertion is related to
the magnitude and direction of the change in ejection
fraction. Doppler examination may be as useful as
multigated nuclear angiography in the assessment of
exercise-induced left ventriculardysfunction.
NON-INVASIVE ASSESSMENT OF LEFT VENTRICULAR PERFORMANCE
BASED ON INITIAL VENTRICOLAR IMPULSE MEASURED BY DOPPLER
ECHOCARDIOGRAPHY.
Karl Isaaz, M.D., Jean L.Cloez, M.D., Aubrey Thompson, B.S
Claude Pernot, M.D., F.A.C.C., Univ. of Nancy-France
The accelerabon (A) of blood out of the left ventrl-
cle (LV) is an expression of the force (F) belng applied
by the contractingmyocardium, and the peak Ao flow ve-
lOClty (Vmax) is determined by this force and the acce-
leratlon tlme (T) during which it acts. The product of
F and T lS the initial ventrlcular impwlse : III = FoT
which appears to be an appropriatelydescriptive term
for the dynamlc propertiesof LV ejection. In thlS study,
we developped a method uSlng Doppler echocardiography
for III measurement, and we compared the results obtai-
ned ln 8 patlents with dllated cardiomyopathy (CM) to
those obtalned in 17 age-matched normal subjects (N). Aa
blood velocity was recorded from the apical wlndow. F lS
obtained from the product m0 A where mis the mass of
blood ejected ~urlng the acceleration tjme and calculated
as m poa oVo T wi th P = 1.06 g/cm ; a = Ao anulus
area measured by 20 echo; V= mean velocity of the Aa
flow during T ; T = time from the onset of ejection to
the peak flow. The acceleration A is derived from the
ratio Vmax/T. In N, III ranged from 18 to 43.3 dynesosolcf
(mean 26.2+7.7) whlle ln pts whith CM, (I) was decreased
to 13+2.7 dynes 0 s 0 102 (p <0.001). There was no over-
lap between the two groups. In concluslon, Doppler echo-
cardiographymay be used for non-invaslve assessment of
ventricularimpulse providing a new method for the eva-
luatlon of systolic LV performance.
lACC Vol. 9, No 2
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OOMPARISON CF DOPPLER AND NUCLEAR MlGNETIC RESONANCE
IMlGII(; FOR MFA'>UREMEN'lS CF VOLUME FLCl'I
Julius M. Gardin, M.D., F,A.C.C•• S.C. Juh,M,S" J,M.
Jo, M,S" Denise Andrews, Steven Ey, Orhan Nalcio-
glu, Ph.D., University of California, Irvine, CA
'!he accuratemeasurementof volLnne flCM (0) has a number
of importantvascular awlications. In this study, we
canparedthe ability of two noninvasive modalities,
pulsed Dowler echocardiograthyand nuclear magnetic
resonance (NMR) imaging, to measure0, A constant flCM
pump calibratedby the volume collection technique was
used to circulate CCM blood in tubes of 12,7 and 9,5mm
diameter at flCM rates varying frrm 1 to 7 1/min. A 0.6
'lechnicarewhole-body NMR scanner was used tospatially
localize the canponent offlCM velocity perpendicularto
the temograthicplane pixel-by-pixel and canpute average
NMR flCM ore: the cross-section of the tube, DewIer
measurementswere made using the echo image of the tube
to correct for the angle between theultrasoundbeamand
blood flCM. DewIer andflCM pump measurementswere
related by the equation: 0 (Doppl.er ) = 0.80 Q (pump) +
1.81 (r=0,92, standarddeviation (SD) = 0.19 1/min), NMR
and pump measurementswere related by: 0 (NMR) = 0.84 Q
(pump) + 0.18 (r=0.97, SD = 0.12 L/min). Pulsed Doppler
tended to CNerestimateactual 0 measurements, presumably
because the interrogatedS<lIIple VOlume representsonly
the highest velocities in the parabolic cross-section.
NMR, on the Other hand,more closely awroximatedactual
Q due to spatial averaging inherent in the technique,
HCMever, NMR estimates of Q became non-linear at 3,4
1/min (80 cmIsec) in the 13 mm tube andat 5.3 1/mm (70
cm/sec) in the 10 mm tube. We conclude that both Dop-
pler and NMR techniques are useful in estimating volume
flCM; hCMever, NMR may at present be limited to the study
of lCMer flCM velocities in smaller vessels.
COMPLETENESS OF REVASCULARIZATION EARLY AFTER CORONARY
ANGIOPLASTY (PTCA) IN THE NHLBI PTCA REGISTRY
Martial G. Bourassa, M.D., Paul Robert David, M.D.,
Timothy Costigan, M.A., Sheryl F. Kelsey, Ph.D., Katherine
Detre, M.D., Dr.P.H., Charles Hollingsworth, M.D., Eugene
Passamani, M.D., Montreal, Quebec, Canada
Excluding 91 patients (pts) with prior bypasss surgery,
85 with PTCA for acute myocardial infarction and 11 with
left main disease, 552 consecutive pts enrolled in the
1985-86 NHLBI PTCA Registry were studied for completeness
of revascularizationearly after PTCA. The Coronary Ar-
tery Surgery Study definitions of significant single (SVD),
double (DVD) , and triple (TVD) vessel disease were used.
Angiographic success (SUCC) was defined as >20% reduction
of attempted lesions (LES) after PTCA. Complete revascu-
larization (COREV) was defined as no vessel with >50%
proximal stenoses post PTCA. Of 284 pts (52%) with SVD,
75% had I, 20% 2 and 5% >3 LES; all LES were SUCC in 90%,
76%, and 73% of pts respectively and in 86% overall; 78%
had COREV post PTCA. Of 173 pts (31%) with DVD' 48% had
1, 34% 2, and 18% >3 LES; all LES were SUCC in 86%, 88%,
and 61% of pts, re;pectively, and in 82% overall. How-
ever, only 30% had COREV; 47% had 1 and 23% 2 vessels
with resiaual stenoses >50%. Of 95 pts (17%) with TVD,
27% had 1, 29% 2, and 43% ~3 LES; all LES were SUCC in
73%, 15% and 63% ofpts, respectively, and in 69% overall.
However, only 16% had COREV; 34% had 1 and 51% ~2 vessels
with residual stenoses >50%.
We conclude that PTCA results in COREV in a high propor-
tion (78%) of pts with SVD, but in only 30% of pts with
DVD and 16% of pts with TVD. These rates of COREV must
be taken into account in day to day clinical practice.
the
COMPARISON OF CURRENT AND EARLIER COMPLICATIONS OF
ANGIOPLASTY: NHLBI PTCA REGISTRY
David R. Holmes Jr., M.D., F.A.C.C., Ronald E. Vlietstra,
M.D., F.A.C.C., Sheryl Kelsey, Ph.D. and Katherine Detre,
M.D., Ph,D., Mayo Clinic, Rochester, MN
2 or
emerg
with
Pt, no.
OCcluslon, %
Emerg CABG, %
MI, %
Death, %
Death, MI, or
emerg CABG, %
1) Despite potentially higher risk in current pts,
incidence of death, MI or emerg CABG has declined
compared with earlier PTCA cases. 2) There was no
significant difference in majorcomp in pts with 1,
3-VD during PTCA. 3) The incidence of death, MI or
CABG was not related to number of vessels attempted
dilatation.
Currentlyused angioplasty (PTCA) equipment has resulted
in increased success rates by facilitating crossing
coronary stenoses. The effect of current equipment on
complications (comp) remains unknown. To evaluate this,
comp of PTCA were compared in the 1978-81 PTCA Registry
(1,226 patients [pts]) and the 1985-86 Registry (642 pts)
in 14 centers. The current cohort includedmore pts with
multivessel disease, prior infarction (MI), andprior
surgery (CA8G) (~<0.0l). Death, MI, or emergency (emerg)
CABG occurred more frequently in the earlier pts than in
current pts (111 pts [9%] vs 40 pts [6%], P(0.05),
Current comp for pts with 1, 2 and 3-vesseTdisease (VD)
and attemptedPTCA in I, 2 and 3 vessels are:
Vessels diseased Vessels attempted
1 2 3 1 2 >3
290 205 147 495 124 23
3.1 4.6 6.8 3.8 7.3 0.0
2.1 4.6 4.1 3.0 4.8 0.0
3.8 5.1 4.1 4.0 4.8 4.3
0.3 0.0 0.7 0.2 0.8 0.0
5.2 7.7 6.8 6.1 7.3 4.3
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PTCA-AcuteResults
PTCA IN 1985: NHLBI PTCA REGISTRY
Katherine Detre, M.D., Dr.P.H., Timothy Costigan, M.A.,
Sheryl Kelsey, Ph.D., Mahdi AI-Bassam, M.D., Lamberto
Bentivoglio, M.D., Peter Block, M.D., Martial Bourassa,
M.D., Michael Cowley, M.D., David Faxon, M.D., Joseph
Galichia, M.D., Arthur Gosselin, M.D., David Holmes, M.D.,
Kenneth Kent, M.D., Spenser King, M.D., Louis Leatherman,
M.D., Richard Myler, M.D., Eugene Passamani, M.D.,
Thomas Robertson, M.D., David Wil1iams, M,D., Univ of
Pittsburgh, Pittsburgh,PA
In 1985, more than 100,000 PTCAs Were performed in the
US. In August, the NHLBI PTCA Registry reopened in 15
major sites to evaluate new results. Compared to 1226
cases before 1982, 723 consecutive cases in 1985 included
significantly more (p<.OOl) elderly, history of: Myocar-
dial Infarction (MI), recent MI, Coronary Artery Bypass
Surgery (CABG), and (p<.05) congestive heart failure,
diabetes, and hypertension. Ejection fraction <50% was
present in 20% vs 7%, mean number of lesions >50~ was
2.6 vs 1.4, and 40% of patients had multiple dilatations
vs 6.5% in the past. (All p<.001)
In spite of marked shifts in the characteristicsof the
illness and aggressiveness of treatment, the rate of
emergency CABG was 3.9% vs 6.1% (p<.01), nonfatal MI:
4.1% vs 5.1% (n.s.), death: 1% vs .7% (nv s , ) (NB: 5 of 7
deaths occurred in PTCAs within 36 hrs of acute MI). At
Leas t 1 successful dilatation and all successful di.Lat a-
tio~ithout above events was achieved in 87% and 79%
vs 67% and 65% earlier. Elect1ve surgery declined from
18% to 2%. (All p<.OOl)
We conclude that patients who under went PTCA in 1985 had
more extensive disease and treatment and had greatly im-
proved early results.
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CLINICAL AND ANATOMIC DESCRIPTORS FOR A MAJOR
COMPLICATIONFOLLOWINGPTCA .
Gary S Roubin MB PhD, Sufen Lin MAMS, AlanNiederman MD,
William S WeintraubMD, John S Douglas Jr MDFACC, Spencer B
King III MD FACe. Andreas Gruentzig Cardiovascular Center,
Emory University School of Medicine, Atlanta, Geo rgia
Analysis of complications associated with PTCA depends upon the
risk profile of the patient (pt ) population stud ied. To determine the
importantclinical and ana tornicdescriptors for a mojor complication
- Emergency Surgery (EMCABG). myocard ial infarction (MI) on
death. we examined 5,873 PTCA procedures. Subsets dependig on
age. sex, prior CABG. indication (elective vs emergent). d isease
status - one vessel disease (IVD) vs multivessel d isease (MVD ).
number of lesions dilated (single vs mult iple) and lesionlength were
analyzed. Of the total 82% were male . 10% hadprior CABG, 98%
were elective, 76% had IVD, and 81% had single lesion dilatat ion.
EMCABG was required in 3.9%, 49% had MI and 0.3% died. For
emergent PTCA (n=105) EMCABG was requ ired in 17% - risk Ratio
(RR) = 4.6. 53% had MI and 6.7% died(RR=33). For females
(n=1265), 5.0% requiredEMCABG (RR=1.5), 4.4% had MI and 0.7%
died (RR=7), p<0.05. Anatomic descriptors of increased risk in
elective PTCA (n=5768) are shown:
DISEASE IVD MVD LENGTH
(mm)
IVD MVD Single Multi Single <10 >10
Lesion Lesion Lesion
n 4407 1361 3883 534 885 4165 1373
CABG (%) 3.3 4.8· 3.2 4.2 5.3· 3.2 4.8·
MI(%) 2.9 5.6· 2.7 4.8· 6.2· 3.4 4.2
Death (%) 0.1 0.4 0.1 0.2 0.6· 0.1 0.3
·p<0.05
For TOTAL ELECTIVE PTCA, 3.6% required EMCABG. 3.7%, had
MI (1.6% Q wave) and 0.2% died . CONCLUSION: Patients having
emergency PTCA. females . pts with mult ivessel disease , multiple
dilatations and long lesions are atincreased risk. Reporting of result s
should include these descriptors.
MORTALITY OF ACUTE CLOSURE FOLLOWING CORONARY
ANGIOPLASTY(PTCA)
H Vemon Anderson MD. William R Cox MD, Gary S Roubin MB
PhD FACC , William SWeintraub MD FACC, John S Douglas MD
FACC , and Spencer B King III MD FACe. Andreas Gruentzig
Cardiovascular Center, Emory Un ivers ity School of Medicine,
Atlanta. Georgia
Acute closure (AC) of a coronary artery following PTCA is
responsible for much of the morbidity and mortality of this
procedure. AC occurred after PTCA in 239 (5%) of 5212consecutive
patients (pts) through July 1986. There were 165 males (69%); mean
age 56±9 years. Dilatation was attemptedin LAD (54%), LCX (10%),
RCA (30%) or branch vessels (6%). Multivessel disease (MVD) was
present in 64 pts (27%) and mult iple sites weredilated in 44 pts
(18%). AC resulted in repeat catheterizat ion with or without repeat
PTCA (n=52. 22%),and/or immediate CABG (n=171 , 72%). An MI
occurred in 67 pts (28%) anddeath in I1 pts (4.6%). Mortality was
higher when PTCA was an emergency procedure (EMERG) for
evolving acute MI than as an elect ive procedure (ELECT).
Managementof AC was similar in both groups:
ELECT EMERG
Management (n=217) (n=22) MI or Death
No re-PTCA or CABG 28 (13%) 4 (18%) 9/32 (28%)
Re-PTCA only 32 (15%) 4 (18%) 10/36 (28%)
CABG only 142 (65%) 13 (60%) 46/155 (30%)
Re-PTCA+CABG 15 (7%) 1 (4%) 8/16 (50%)
MI 60 (28%) 7 (32%) --------
Death 7 (3%) 4 (18%) p<O.OI
In these pts selected for PTCA who had AC,neither age, sex. artery
dilated nor presence of MVD were pred ictors of MI ordeath.
Conclusions: AC following PTCA carried a significant risk of death.
which was greater in pts with evolv ing acute MI. Once AC occurred
other risk factors were not importantin predicting outcome. Failure
of repeat PTCA to re-establish coronary perfusion, necessitating
subsequentCABG, was associated with poor outcome.
MULTICENTER STUDY OF PERCUTANEOUS TRANSLUMINAL ANGIO-
PLASTY FOR RIGHT CORONARY ARTERY OSTIAL STENOSIS.
Eric J. TOpol, M.D., F.A.C,C., Stephen Ellis M.D., Jodi
Fishman-Rosen R.N., M.S., Pierre Leimgruber M.D.,
Richard K. Myler M.D., F.A.C.C., Simon H. Stertzer
M.D., F.A.C.C., William W. O'Neill M.D., Gary S. Roubin
M.D., John S. Douglas, M.D., F.A.C.C., Spencer B. King,
Ill, M.D., F.A.C.C., University of Michigan, Ann Arbor,
MI, Emory University, Atlanta, GA, Seton Medical
Center, Daly City, CA.
Over a 5 yr period at 3 centers, 53 pts underwent per-
cutaneous transluminal angioplasty (PTCA) of a right
coronary artery (RCA) ostial stenosis, defined as a
>501 lesion within 0.3 cm of the orifice. PTCA was
successful in 42 (79S) pts, failed in 11 pts, of whom 5
(9. 4S) required emergency coronary artery bypass
grafting (CABG) because of abrupt closure. As compared
to non-ostial lesions, the stenoses were quite discrete
(4 + 5 mm) and calcified in 40/53 (75S) pts , PTCA
success was associated with the need for high pressure'
balloon inflation (10 + 4 bar) and unconventional RCA
guide catheters in 22 (43S) pts. In the 42 pts who had
successful PTCA, the stenosis was reduced from 75.7 +
16 to 33.5 + 26S and translesional pressure gradient
from 51 + 20~0 12 + 8 mmHg. Long term follow up (mean
12.5 mos, range 4-60 mos ) demonstrated clinical
recurrence in 20 (48S) and angiographic restenosis in
16 <38S) pts with initial success. Repeat PTCA was
successful in 3 of 6 pts for symptom relief > 6 mos.
In conclusion, PTCA of RCA ostial lesions compared to
non-ostial dilatation leads to: (1) a suboptimal
success rate; (2) an apparent increased risk of
emergency CABG; and (3) a high recurrence rate.
Monday, March9, 1~7
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Aortic Valve Disease
INCRF.MENTAL VALVE OF CLINICAL EXAMINATION,
ECHOCARDIOCRAPHYAND CARDIAC CATHETERIZATIONIN THE
EVALUATION OF AORTIC VALVE DISEASE
Adam Kotlewski,M.D.,F.A.C.C., Charles McKay,M.D.,
F,A.C.C., Earl C. Harrison.~.D.,F.A .C,C" David
Kawanishi,M.D.,F,A.C.C., Cheryl Reid,M.D.,F,A,C.C.•
P.A.N. Chandraratna,M.D.,F.A.C.C.,Anil Bhandari,M.D.,
F.A.C.C., Ur i Elkayam,M.D.,F.A.C.C., Joyce Weiss,PhD.,
Sha~budin 11. Rahimtoola,M.D.,F.A.C.C.,LAC-USC Medical
Cent e r , Los Angeles, CA
We performed a prospecttve study of 100 consecutive
pts with symptomatic valvular heart disease to
investigate the relative value of 1)clinica1 examination
(CLIN) with history, physical examination, ECG, and CXR,
2)M-mode , 2D, and Doppl er echocardiography(ECHO), and
3)cardiac catheterization(CATB) in clinical decision
making . Diagnosis (DX ) of aortic stenosis (AS) and/or
regurgitatinn ( AR) and surgical recorr.reendations(REC)
regarding aortic va l ve replacement (AVR) were made
sequentially after CLIN alone, CLIN+ECHO, and
CLI N+ECHO+CATH. The accuracy of the DX (not including
assessment of severity of lesion) and REC for AVR was:
CLIN IMPROVED IMPROVED
N CORRECT BY ECHO BY CATH
DX AS 16 12 (757.) 4 (2 5%) 0 (0 %)
I>X AR 46 29 (6 3%) 8(1 7%) 9( 20%)
REC AVR 25 12(48%) 1(4%) 12(48%)
Conclusions: 1)CLIN was accurate in the DX of AV disease
and REC [ or AVR in 1/2 to 3/4 of pts, emphasizing the
value of good CLIN, 2)ECHO improved DX in 1/4 pts or
less, and 3)REC for AVR was i~proved by CATH in half of
the pts.
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ACCURACY OF DOPPLER IN PREDICTING SEVERITY OF AORTIC STEN-
OSIS: A PRACTICAL APPLICATION OF THE CONTINUITY EQUATION
Mikel D. Smith, Michael R. Harrison,John Gurley, and
Anthony N. OeMaria; University of Kentucky and VA Medical
Center,Lexington, Kentucky
Although the continuity equationhas been domonstratedto
be a useful non-invasive method to estimate aortic valve
area, it is tedious, timeconsuming and involves numerous
assumptions. Therefore,we hypothesized that amaximal
velocity of <3 m/sec or >4 m/sec is sufficiently accurate
in identifying mildand severe aort ic stenosis respec-
tively and that continuity equationeed not be applied.
We analyzed the continuous wave Doppler recordings of 51
pts withaortic stenosis withoutsignificant mitral
regurgitation or aortic regurgitation in whom aortic valve
area was measured at catheterizationby the Gorlin
formula, 45 of whom had aortic valve area calculated by
thermodilutioncardiac outputfrom r ight heart cath in
conjunctionwith Doppler. Estimates of aortic valve area
by continuity equation correlated well with cath for the
entire group, r=0.86. In 27/30 pts wi th max continuous
wa~e velocity >4 m/sec the cath aortic valve areawas <0.8
cm , while aortic valve areawas >1. 10 in 8/10 pts with
maximal velocity <3 m/sec. Linear regression between
continuity equation and cath aortic valve area in the
remaining 11 pts againshowed good correlation, r=0.82.
Importantly,aortic valve areawas concordantbetween cath
and continuity equat~on in 7/7 of these P2s with cath
measurements <0.8 cm and 3/4 over 0.8 cm . Combined r ight
heart cath -Doppler estimation of aortic valve area
correlated best with cath, r=0.91,and accurately
discriminated all pts with velocities2between 3-4 m/secinto valve area above or below 0.8 cm . We conclude that
aortic stenosis may be quantified bypeak velocity in most
pts , and that continuity equation can bereliably applied
to pts with velocity in the intermediate range.
ABSTRACTS
RELATIONS BETWEEN LEFT VENTRICULAR SHAPE. VOLUME AND
MASS IN CHRONIC AORTIC REGURGITATION.
Jean-Luc Vandenbossche, M.D., Barry M. Hassie. H.D.,
F.A.C.C., Nelson B. Schiller, M.D., F.A.C.C., Joel S.
Karliner, H.D.• F.A.C.C. Dept. of Medicine. VAHC, CVRI
and Univ. of California, San Francisco, CA.
To evaluate the relations between left ventricular
shape. volume and mass and their potential clinical
usefulness in chronic aortic regurgitation (AR). we
obtained cross-sectional echocardiographicdetermina-
tions of these measures in 19 patients with moderate to
severe but minimally symptomatic chronic AR. Volume and
mass were significantly larger than normal values (203
ml vs IIIml and 288 gr vs 135gr. respectively, p<O.OOl
for both). Thee were significant correlations between
the volume/mass ratio and diastolic (rz-O.69, p<O.Ol)
and systolic (r=O.73. p<O.OOl) long axis to minor
diameter ratios (L/D). suggesting that maintenance of
normal left ventriculargeometry is dependent on the
adequacy of hypertrophy as expressed by a normal
volume/mass ratio. The relationship between end-
diastolic volume and the volume/mass ratio (V/M)was
linear (V!M=.002V+0.18, r-0.80), indicating that the
increase i n mass is not proportional to the increase in
volume. These data suggest that when myocardial
hypertrophy becomes inadequate and hence unable to
normalize wal l stress, the left ventricle i s transformed
from an ell ipsoidal to a more spherical shape. Since
preoperative volume/mass indices have been shownto have
predictive value regarding the postoperative course of
AR patients. the L/D ratio may have a role in assessing
the progression of AR in asymptomatic patients.
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NATURAL HISTORY OF CHRONIC ASYMPTOMATIC OR MINHIALLY
SYMPTOMATIC AORTIC REGURGITATION
Michael Matilsky. M.D•• Nathaniel NileB, M.D., Clare
Hochreiter. M.D., Richard Devereux, M.D •• F.A.C.C., Paul
Kligfield, M.D., F.A.C.C •• Jeffrey S. Borer, M.D.,
F.A.C.C •• Cornell Medical Center, New York, NY.
To appropriatelytime aortic valve replacement(AVR) in
asymptomatic(ASx) or minimally symptomatic(MSx) pts with
chronic aortic regurgitation(AR),naturalhistory at left
vent r i cul ar (LV)ejection fraction (EF) and its relation to
symptom(Sx) development must be known. Therefore, we have
prospectively followed 52 initially ASx/MSx severe AR pts
with normal LVEFrest(r) . Radionuclide cineangiographic
(RNCA) LVEFr and exercise(ex). 2D and M-mode echocardio-
gr aphy. treadmill exercise tests(ETT) and 24 hr ambula-
tory ECG were performed annually. Durin~ a 3l!17 mo
fol l owup. 11/ 52 pts developed at least moderately sever e
Sx and 1 pt developed subnormal LVEF wi thout Sx; thus,
pts developed surgical candidacy at ~ rate of l O%/yr.
During followup. LVEF(r and ex) did notvary
significantly, but in 6/52 pts LVEF fel l ~ 5% , fall i ng
below normal ( :45%) in 1. By Cox IDoae l Sx were predictable
by enlarged LV end-systolic dimension (IDs), elevated
end-systolic wall stress(ESS). and dimi ni shed fractional
shortening (FS) , but not by other LV f unctional, ETT, or
24 hr ECG findings. Attrition from the stable ASx/MSx
group by 2 years could be predicted by LVIDs~4.6 cm (37% vs
22%; p: . Ol ) , FSs.J2 (51%vs l7 %;p:.005) and ESS~118 (47% vs
21%;p:.005). We conclude that, while LV functional
deterioration can be expected ill 12% of pts with severe,
ASx/MSx AR during a 31 mo followup, LVEF seldom falls
below normal before symptomdevelopment, which in turn can
be predicted from LV performancedata. Any benefit of AVR
prior to Sx in such pts remains to be det ermi ned .
DIURETIC USE: A RISK FACTOR FOR MORTALITY AFTER AORTIC VALVE
REPLACEMENT•
Ilacib Aoun, H.D., L1sa SOule, A. Michael Borkon, H.D., Kenneth
L. Baughman, M.D., F.A.C.C., Johns Hopkins Medical
Institutions, Baltimore, MD.
578 ool18ecutive patientsundergoingaortic valve replacement
(AVR) between 1971 and 1981 were evaluated to determine the
factors influencing long-term prognosis. 317 had aortic
stenosis (AS), 158 had aortic insufficiency and 103 had mixed
AS-AI. Excluded were patientswith significant mitral or
triouspid disease, Marfan'sSyndrome, aortic dissection, prior
valve surgery, acute endocarditisand patients dying within 30
days postsurgery. Mean age was 'IT years and mean follow up
was 4.9 years. The 5 year mortality rate was 25J . 50
preoperative variables (clinical, cardiac catheterizationand
non-invasive testing) were analyzed with univariateand
IIllltivariate Cox regression analysis. Age grester than 60
years (P < 0.0005), New York Heart Association congestive
heart failure class (P < 0.04) and the use of diuretics (P <
0.005) were independent detenninants of increased mortality.
The use of diuretics preoperativelywas associated with a
twofold increase in the relative risk of death. Therisk wae
even higher in those patients who continued diruetics after
surgery, regardlessof t'Unctiolllll claSll (NYHA) 118 shown in the
table.
NYHA -. CLASS
ll:.U ll:.II1 Q:.U
Risk N Risk N RiBk N
Never on Diuretics 1.00 93 1.14 61 1.31 5
PreoperativeDiuretics 1.61 23 1.84 62 2.10 19
Preopar and Postoper 2.04 35 2.33 96 2.66 26
TOTAL 151 219 50
s.tm1lar findings were noted when ejection fraction (EF) was
used in place of NYHA-CIIF class. Our data suggests that in
addition to advancing age and NYHA-CHF claee, the use of
diuretics oonet1tutes a significant independentrisk factor in
patients undergoing AVR.
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There wereID in-fli8ht deaths. All 3 patientsrequiring In-Fl CPR
were receivingCPR Pre-Fl.
ThJs, in-flight cooplicatioos in patientswith AMIare infrequent
ani eaube successfully oenaged en roote to the InterventionalCardiac
Center.
In-Fl
-3-
D
o
1
o
19
12
2
TIV Pre-Fl
CPR ~
CouutersOOck 17
Intubation 8
EXternalPacer 3
TransverousPacer 10
Fluid Bolus 26
Auti--ArrhythnicRx 187
Pressor Rx 21
aME'LICA1'IrnsIXJR:IN;AIR 'lRANSRRI' OF PATIENrSWIll! ADJl'E MYOCARDIAL
INFARCfIll\l.
Rare 1. Bellinger, M.D.. RobertM. Califf, M.D., Patty Collins, R.N.,
Janice Iloeshart, R.N., GaryJ. Collins, M.D., Rits Weber, R.N., ani
Richard S. Stack,M.D., F.A.e.C., fuke UniversityMedical Center,
furhan, North Carolina.
Eirergency air transportof patientswith evolving acute llo/ocard1al
infarctim (AMI) fron camm:l.tybJspitals to centers with cardiac
catheterizationani PICAhas been increasing in the US. The purpose
of this study wasto evaluate the safety ofair transportin patients
duringAMI. Two hundredforty-threepatientswith AMIwere
transported fron camm:l.tybJspitalswithin a ISO mile radius ofDuke
Hospital ani CNer a 15DDnth period. All patientswerewithin 12
hours of the onset ofsyuptans. ThraIbolytic therapywas administered
to 82% prior to or in-fl:Ight. A physicianwas present only during 38%
of flights. Meanpatient age was 58! 12 years ani mean flight time
was 33 + 24 miwtes. The follOOngtable lists patient~lications
(a:MP)am lI1terventions(ITV) at the referringoospital (Pre-Fl) ani
during transport(In-Fl.),
a:MP Pre-Fl In-Fl
W" ----yz -0-
vr-Sustained 14 3
vr~tained 4 4
3
0
AVB 18 7
20AVB 2 0
TransientofBP 26 20
SustainedofBP 14 3
RespiratoryArrest 7 0
Asystole 1 0
REGIONAL VARIATION IN MYOCYTE DIAMETER: A CLUE TO EARLY
LEFT VENTRICULAR DYSFUNCTION IN AORTIC INSUFFICIENCY?
Bruce Goldman, MD, Steven F. Horowitz, MD, FACC,
Deborah Matza, RN, Carol Bosken, MD, Rohit R. Arora, MD,
Josef Machac, MD, Arisan Ergin, MD, Randall Griepp, MD,
Valentin Fuster, MD, FACC. Mount Sinai Medical Center,
New York, New York.
Interstitial fibrosis (IF) occurs late in aortic
insufficiency (AI). No abnormality has yet correlated
with early left ventricular (LV) dysfunction. We studied
regional differences in 6 patients at the time of valve
replacement surgery. Intraoperative biopsies obtained
from LV base (B) and free wall (FW) were compared with
6 controls. Light and electron microscopy (EM) were
done. Mean myofiber diameters (FD) for 60 cells/site
(~±SD) and percent IF(%IF) were determined.
Results:
=;-:-;::--FD-B FD-FW FD-B/FW %IF-B %IF-FW
Patients 26.8±6.5 23.6±4.4 1.14 4.2±2.7 6.2±3.2
Controls 12.7±3.0 14.0±4.0 0.90 4.2±3.6 3.6±1.6
As expected, FD was significantly larger in AI pts
than in controls (p<.OI). However, FD-B/FD-FW ratio
in AI patients was consistently >1, while in controls <I.
The differences in FD between Band FW was significant
in AI pts (p<.OI) but not in controls (p<O.I). No
differences in %IF were found between patient groups
or biopsy sites. EM of AI biopsies showed mild to no
degeneration. LV ejection fractions were abnormal in
4/6 AI pts both pre-op (ffiEF=.4I,nl>.45) and post-op
(ffiEF=.34). -
Conclusion: Findings suggest regional differences in
myofiber diameter occur in symptomatic AI before signi-
ficant IF or cellular degeneration. These differences
are present inAI patients with abnormal pre- and post-op
LV contractility and may represent anearly change in
the evolution of myocardial dysfunction.
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ANGIOGRAPHIC CORONARY MORPHOLOGY AS A PREDICTOR OF
POST-INFARCTIONANGINA
Ying-Sui Lo, M.D., F.R.C.P.C, Pierre Abi-Mansour, MD,
Barry Kramer, M.D., Kerry Kaplan, M.D., LA.C.C.,
Sherldan Meyers, M.D., Mlchael Lesch, M.D., F.A.C.C.
Northwestern Unlversity, Ch1cago, Ill1no1s
Ang10graphically lrregular coronary stenoses (AICS)
usually represent ulcerated atheromatous plaques w1th or
w1thout superimposed thrombi. To 1nvestigate this in
post-infarctlonangina (PIA), we analyzed coronary angio-
grams of 73 acute myocardial infarct (MI) patients (pts)
studled within 30 days of MI. None had >1 prior MI, coro-
nary revascularizationor valvular disease. 36 had PIA at
a mean of 3~2 days and were studied 7~4 days post-MI. 37
non-PIA pts were studied 8+6 days post-MI. 39~ of PIA vs
43$ of non-PIA pts had a totally occluded infarct artery.
58% of PIA vs 19$ of non-PIA pts had AICS (>50% diameter
narrow1ng) in any of the coronary arteries (p<0.002); 77%
vs 24$ had AICS in the patent mf'arct artery (p<0.005).
Other predictors of PIA were: older age (62+12 vs 53+10,
p<O.0u. hypertension (64 vs 32% of pts, p<O.02), angina
before MI (44 vs 14%, p<O.OI), lower peak creatine-kinase
(CK) level (754+655 IU vs 1477+1248 IU, p<O.OI), 3 vessel
disease (58 vs -27% of pts, p<O.Ol) and mod i f'Led Gensini
score (154~69 vs 115~54, p<O.Oll. Sex, number of risk
factors, type of MI, mean lnfarct artery stenos1s, proxl-
mal left anterior descendlng or left main artery dlseaSe,
LV wall mot10n abnormalities and eJect10n fraction were
not predict1ve , Multivariate analysis ranked in order,
AICS, peak CK and mod1fied Gensini score as best 1ndepen-
dent predictors of PIA. Conclusion: Ulcerated coronary
stenoses are more prevalent in PIA than in non-PIA pts
and may be important ln its pathogenesis. Coronary mor-
phology may identify pts at risk for recurrent events
post-MI.
MARGIKAL BENEFITS OF LDR AND LDH ISOENZYMES
IN DTAGNOSIS OF MYOCARDIAL JNFARCT!ON:
ARE THEY wORTH IT?
Gregg J Reis, HD, Harvev WKaUfr.lHn, ~D,
Gary L Horowitz, MD, Richard C Pasrer.,ak, MP, "ACe,
Hnrvard-ThorndikeLaborntorv, Reth Israel Hosp'ta1,
Boston, MA.
The usr- of J.DH and LDH Lsoen zymes (Lso s ) in the
diagnosis of acute myocardial infarctirr (AMI) is
controversiaJ. \ie reviewerl '507 conse cu t Lve pa t Leu r r
(pts) with CK, J.DH and LD1' iROS ordered ovpr a one
",,,nth period. Of these. 249 die not have ade'1\1~te serinl
~nzymeF for an AMI diagnosis. Of the rewaining 258 pts J
82 had ,.<'we el evatf on of CK, CK-MB and/or LDH isos and
had adequate cirta for chart review. Of these, 36 pts
(44%) met standard cl t of ca l criteria for AlofT. OnIv 2
pt s had ahnormal LD1' and LDH Lsos wLtli normal CK a~d
CK-MB. Both p~" had chest pain> 3 davs be'ore
admission; thus return of CK to nonTwl- was po s s i b Le ,
Seven of 258 ptq (2.7%) had false positive LDH i80s
(LD1>LD2 without other clinical criteria for AMI). Had
chprges for the 2035 LDH ane 720 LDH i80s measurem."ts
heen billed, the one month total for these pts would be
$42,450. We conclude 1) LD1' and LDR lsor are not
routinely u,eful for the dia~nosis of A~I. 2) These
tests are often ordered in a way which precludes
adequate unalysis. 3) The number of false positives may
exceed the number of useful true po,itives making the
tests potentially more misleading than helpful. 4)
Routine use of LDH and isos results in considerahle
ur-necessary expense. We reCOMmend that LDH i80S be
measured only whe" AMI presenti,,!, late (>48 hours) is
suspected.
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SIGNIFICANCE OF THE DIRECTION OF ST DEVIATION ON ADMISSION
IN PATIENTS EVOLVING NON-Q-WAVE MYOCARDIAL INFARCTION
Stefan N. Willich. MD, Peter H. Stone, MD, FACC. James
E. Muller, MD, FACC, Geoffrey H. Tofler, MB, James
Crowder, MPH, John D. Rutherford, MD, FACC, Thomas
Robertson, MD, FACC, Eugene Braunwald, MD, FACC, and the
MILlS Study Group, Harvard Medical School, Boston, MA.
SAFETY OF CAROTID ENDARTERECTOMYUNDER REGIONAL
ANESTHESIA IN PATIENTS WITH CORONARY ARTERY DISEASE
Peter F. Pasternack, M.D., F.A.C.C., Anthony M.
Imparato, M.D., F. Gregorl Baumann
i
Ph.D., Thomas S.
Riles, M.D., Patrick J. amparel 0, M.D., Gary
Giango~a, ~.D., !,phraim Glas sman; M.D, F.A.C.C., New
York Unlverslty Medlcal Center, New lork, NY
Since coronary artery disease (CAD) can increase
the risk of certain surgical procedures, we attempted
to correlate the degree of anatomic CAD with the
incidence of penoperative MI's in patients undergoing
carotid endarterectomy(CAE). The coronary angiograms
of 43 patients (pts) who underwent 58 CAE's were
reviewed and the p t s were divided into 3 groups (Grp)
on the basis of coronary anatomy.
Grp I consisted of 26 pts with triple vessel CAD.
Fifteen had a history of preop MI, 14 rest angina, 19
exertional angina, and 8 had ECG evidence of a prior MI.
These 26 pts underwent 35 CAE's (18 bilateral CAE's),
Thirty were performed under local anesthesia (Local)
and 5 under general anesthesia (General). There were 3
pe ri operat ive MI's during CAE performed under Local,
but no cardlac deaths.
Grp II consisted of 10 pts with double vessel CAD.
Three had a history of preop MI, 8 rest angina 9
exertional angina, and 1 had ECG evidence of a prior MI.
These 10 p t s underwent 13 CAE's (6 bilateral CAE's).
Twelve were were performed under Local and 1 under
General. There were no perioperativeMI's during these
13 CAE's and no cardiac deaths.
Grp III consisted of 7 pts with single vessel CAD.
Four had a hi story of pre o p MI, 4 rest angina, 7
exertional anginal and 3 had ECG evidence of a prlor MI.
These 7 p t s unaerwent 10 CAE's (6 bilateral CAE's).
All 10 were performed under Local. There were no
perioperativeMI's during these 10 CAE's.
The data show that under these conditions there
was no statistically signi ficant difference in
peri0rerativeMI between pts with triple, double, or
sing e vessel CAD. The overall results indicate that
even in pts with significant angiographic and cl i nica1
evidence of coronary artery disease, CAE can be
performed with a low incidence of perioperative MI and
cardiac death.
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To de t ermine the significance of tbe di rection of ST
deviation on admission among 304 patients who evolved non-
Q-wave MI (NQMI) , 97 patients with ST depression (ST,,)
were compared to 207 patients with ST elevation (STt):
Baseline Characteristics [IL STt
Age (years) 61 ** 56
Diabetes (t) 39 ** 20
History of MI 0:) 39 * 24
History of angina (%) 62 ** 37
Hospital Course
Infarct size index (CK MB-gEq/m2)
Admission ejection fraction (%)
Infarct extension (t)
Cardiac arrest (%)
Post-infarctionangina (t)
Long-term Course
CHF (3 months) (%) 30
Cumulative mortality (30 months) (%) 43
* p < 0.01, **p < 0.001
Conclusion: TherE' are two subsets of NQMI patients.
Patients with ST" manifest a smaller infarct size than
patients with STt , but have a lower ejection fraction on
admission, an increased complication rate , and a much
higher mortality. These differences may be explained in
part by more severe risk factors and older age of the
patients with ST". In any event, the poor prognosis for
NQMI with ST" suggests that these patients should receive
close surveillance and intensive investigation.
NITRATE RESISTANCE: FAILURE OF INTRAVENOUS NITRATE TO
REDUCE ELEVATED LEFT VENTRICULAR FILLING PRESSURE IN
ACUTE MYOCARDIAL INFARCTION, A COMMON AND UNPREDICTABLE
PHENOMENON.
Uri Elkayam, M.D., F.A.C.C., Arie Roth, M.D., Laura
Weber, R.N., Shahbudin H. Rahimtoola, M.D., F.A.C.C.,
LAC-USC Medical Center, Los Angeles, CA.
We used intravenous (IV) nitrate therapy in 45 patients
(pts) with acute myocardial infarction and elevated left
ventricular filli~g pressure (LVFP) to >18mmHg. IV
isosorbide dinitrate (ISDN) in 29 pts and nitroglycerin
(NTG) in 16 pts were titrated to achieve hemodynamic
response defined as fall in LVFP ~20% or to <15mmRg or
to maximum dose (600 mcg/min NTG and 533 mcg/min ISDN).
Group A (36/45, 80%) responded to therapy and group B
(9/45, 20%) did not. LVFP fell -35±10% in Group A and
-7±8% in Group B (p<0.05). Baseline hemodynamics for the
groups showed no significant difference and were:
Group MBP RA LVFP Cl SVR _
(mmHg) (mmHg) (mmHg) (L/min/m2 ) (dynes.s.cm 5)
A 95±15 10±4 24±6 2.4±0.6 1708±585
B 94±10 13±5 24±5 2.3±0.6 1739±424
MBP = mean blood pressure; RA = mean right atrial
pressure; Cl = cardiac index; SVR = systemic vascular
resistance. In addition, the groups did not differ in
location of AMI and previous treatment with nitrates.
Incidence of resistance was similar to ISDN (21%) and
NTG (19%). CONCLUSIONS: I) Failure of LVFP to respond
to high dose IV nitrate is common (20%) in pts with
acute myocardial infarction. 2) Incidence of resistance
of LVFP to ISDN and NTG is similar. 3) Resistance or
response of LVFP to nitrates in pts with acute
myocardial infarction cannot be predicted from baseline
hemodynamic or clinical data.
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PROGNOSTIC VALUE OF LEfT VENTRICULAR EJECTION FRACTION
IN PATIENTS WITH AND WITHOUT SIGNS OF LEFT VENTRICULAR
FAILURE AFTER MYOCARDIAL INFARCTION.
Pascal Nicod MD, Elizabeth Gilpin MS, Roward Dittrich MD,
Staffan Ahnve MD, John Ross, Jr, MD, FACC, University of
California, San Diego.
A low left ventricular(LV)ejection fraction(EF), commonly
used as an indicator of poor prognosis after myocardial
infarction(MI), is often not accompanied by signs of LV
failure. We therefore assessed the prognostic value of
predischargeLVEF obtained in 915 patients with and with-
out clinical and radiographicsigns of LV failure after
MI. 3 groups of patlents(groupI:LVEF<40,n=248;group 11:
LVEF.4l-.50,n=225; group III:LVEF~.51,n=442)were followed
for 1 year post MI for the occurrence of cardiac death,
new MI, coronary artery bypass surgery(CABG), and angina.
When signs of LV failure were present (any combination of
2 of the following:rales to the scapulae,S3,and intersti-
tial or alveolar infiltrateon chest x-ray) at any time
during the hospital stay, 1 year mortality in groups I,ll,
III was 27%,21%,8%compared to 13%(p<.02), 7%(p<.01) and
3%(p<.04) respectively, when signs of LV failure were ab-
sent. Similarly, 1 year mortality for only those with ra-
diographic signs of failure was 39%,26%,15%in groups I,
11,111 compared to l4%(p<.01),10%(p<.OI),3%(p<.01)when o
tailure was seen. However, the incidence of new MI, CABG,
abnormal exercise test, and angina was not different
whether clinical or radiographlcslgns of LV failure were
present or not. We conclude that l)the prognosticvalue of
low LVEF after MI is markedly enhanced by the presence of
clinical or radiographicsigns of LV failure occurring at
any time during the hospital stay. 2)Even in the absence
of low LVEF, clinical or radiographicsigns of LV failure
predict substantially increased 1 year mortality after MI.
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A NEW NON-INVASIVE INDEX TO PREDICT SUSTAINED VENTRICULAR
TACHYCARDIA AND SUDDEN DEATH IN THE FIRST YEAR
POST-MYOCARDIAL INFARCTION: A PROSPECTIVE STUDY.
J. Anthony Gomes. M.D.! F.A.C.C . ; S. L. Winters. M.D.;
S. Horowitz. M.D .• F.A.C.C. ; D. Stewart. R.N.; P. Barreca.
B.S. Mt. Sinai Med. Ctr.• N.Y. ! N.Y.
We undertook a prospective study of the prognostic
significance of the signal averaged (SA) ECG, ventricular
function and 24-hour Ho1ter ECG in 88 patients (pts)
(age = 62 ± 11 yr s ) post-myocardial infarction (MI) .
The sites of MI were: anterior - 40 pts; inferior -
39 pts; subendocar di a l - 9 pts. The SA-ECG (40 Hz
filtering) was considered abnormal (Ab) if one or more
of the following were present: duration of low amplitude
signals of >38ms ; duration of the QRS complex >1l4ms ;
or an &MS-Voltage of the terminal 40ms of <20~v. Ejection
fraction (EF) was determined by radionuc1ide scanning.
All tests were performed 9 ± 6 days post-HI and within
48 hrs of each other. Results: Ab SA-ECG was seen
in 44%; Ab EF «40%) in 49% and high grade ectopy (HGE)
in 55%. Over 13 ± 6 months of follow up. 13 (15%) pts
had an arrhythmogenic event (L,e . , sustained ventricular
tachycardia (VTs) and/or sudden death (SD). The event
rate in pts with normal or Ab tests was:
SA EF HOLTER SA+EF SA+EF+HGE
Normal 6% 7% ~ ~ 9%
Abnormal 26% 24% 24% 42% 55%
Pvalue <. 02 <. 05 NS <. 001 <. 003
Odds Ratio 5 . 2 3.6 2.1 6.5 8.7
Conclusion: 1. SA defines a high risk group. however ,
the combination of Ab SA + Ab EF with or without HGE
identified a high risk subset for VTs/SD. 2. This study
provides a new non-invasive i ndex for selecting a high
risk subset of pts post-HI for intervention.
EFFECT OF ACUTE OR CHRONIC ADMINISTRATION OF CALCIUM
ANTAGONISTS ON MORTALITY FOLLOWING MYOCARDIAL
INFARCTION
Salim Yusuf, Curt Furberg,NHLBI. Bethesda and Bowman
Gray, winston Salem.
Variance
0.5
76.7
4.8
82.0
B:'C.N:1-fiC BENEFITS OF AN OCCUPATICl'W..w:lR!< E.VALUATICN~
AFTER MYOCARDIAL INFARCTICN
Michael H. Picard, M.D., O1arles Denni.s, M.D., Richard
SChwartz, M.D., ItiJertF. DeBusk, M.D., FJ\CC, Stanford
University, Palo Alto, CA.
To deteIrnine the eeonanic consequences of an occupational
work evaluation (mE) performed 3 weeks after uncanpli-
cated myocardial infarction (MI), 201 enployed rren, aged
49±7 years were rarxlanizedto usual care (OC) (11=102) or
mE (n=99). CM: consisted of a symptan-limitedtreadmill
test follCJ<led by an explicit statementof low risk status
and a reccmnendationfor reenployrrentat 35 days given to
patients and pr:irnal:yphysicians. A significant reduction
in time to reenployrrentoccurred in CM: patients (51 vs 72
days, p<0.002). cardiac death or non-fatal MI occurred in
4% of patientswithout differences between groups. COsts
of medical care in the six months following MIand the in-
cares fron reenployrrentwere corparedbetween groups using
standardcost estimates and equivalent weekly incares for
both groups.
Average COsts/patient uc CM:
~cations $ 71 s 55
Diagnostic Tests 627 524
Revascularization 1365 1671
Rehospitalization 1593 747
Total Costs/patient $3656 $ 2997 $ 659
Incane/patient $7790 $10310 $2520
Difference $4134 $ 7313 $3179
cx:NCUJSlOOS: An explicit statementof low risk status
coupled with a recannendationfor early reenployrrentde-
creased physician use of tests and treatmentsand hastened
reenployrrentafter lJIlaXtplicatedMI withoot changing medi-
cal cutcores. ProjectID:Jthese data to the 400,000 low
risk survivors of MI each year yields an estimated annual
medical cost savings of $260 million and generates $7BO
million in increasedoccupatic:nal incane.
USE OF ESMOLOL IN PATIENTS WITH ACUTE MYOCARDIAL
ISCHEMIA AND CONTRAINDICATIONSTO BETA BLOCKADE.
James M. Kirshenbaum,M.D., Elliott Antman, M.D•• FACC,
Noreen McGowan, R.N., Robert A. Kloner.M.D., Ph.D.
Brigham and Women's Hospital and HarvardMedical School.
Boston, MA.
Because of their negative inotropic effects. beta
blockers (BB) may aggravate congestive heartfailure
(CHF) or precipitate it in pts with compromised cardiac
reserve. Esmolol's (E) rapidpharmacokinetics (t = 9
min) may allow the safer use of BB 1n managing pts1with
both acute ischemia and CHF. We studied the hemodynamic
effects of E (maximum dose 300 mcg/kg/min for up to 48
hrs) in 27 pts with acutemyocardial infarction or
unstable angina,HR~75 bpm, and systolic BP~110 mmHg.
Group I pts (n=16) had relative contraindicationsto BB
(PEW 15-25 mmHg) while Group 11 pts (n=11) did not.
GroE~ I Grou~ II
B OFF B I OFF
Typical Odds Ratio of 1.06; 95%confidenceinterval
(Cl) of .94 to 1.2, N.S .
Conclusion: Overall, the data indicate about a 6%
excess in mortality by treatment. Although the er
TnCTUOe benefit, this is unlikely to begreater than
about 5 or 6%. The results appear to beconsistent
among the different agents. Therefore. routine use of
these agents in patients with MI must await clear
evidence of reduction inmortality.
Subtotal (2) 243/2036 232/2035 +5.5
CC] Acute and Long termstudies
y!!:!pamil (l) 149/1729 145/1718 +1.5
TOTAI (9) 574/6567 545/6572 +14.6
30.7
69.7
100.4
67.2
249.6
HR 100 77* 90** 91 75* 89**
SBP 126 107* 124** 120 98* 113**
PEW 19 19 17 10 12 13
Cl 2.9 2.5 2.8 3.0 2.7 3.0
B=baseline. E'=esmolol infusion. OFF=30 min post E',
HR=heart rate (beats/min). SBP=systolic arterial
pressure {mmHg}'2 ~=mean pulmonar~ capillary wedge (mm
Hg). C1={L/min/m}, {* p<:.05 vs Bl. {** p<:.05 vs E'}.
Adverse reactions (ADR) to E (hypotension-5,
oliguria-I. angina-I) occurred withsimilar incidence in
Group I (5/16) and Group 11 (2/11) (p=NS) andalways
resolved within 30 min after terminating E'.
Thus: 1) E safely lowers HR and BP in pts with
acute ischemia in the presence ofrelative contraindica-
tions to BB. 2} ADR quickly resolve even in high risk
pts because of the rapidoffset of drugeffect.
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MYOCARDIAL INFARCTION ASSOCIATED WITH COCAINE USE.
Henry W.B. Smith, Ill, M.D., Louis L. Battey, M.D., Henry
A. Liberman, M.D., Steven L. Brody, M.D., Bryan C.
Donohue, M.D., Andre Churchwell, M.D., Douglas C. Morris,
M.D., F.A.C.C., EmoryUniversity School of Medicine,
Atlanta, Georgia.
Myocardial infarction (MI; 7 acute, 2 recent) temporally
related ( < 6 hours) to cocaine use, occurred in 9
patients (pts) aged 23-39 years old. MI followed intra-
nasal (4 pts), intravenous (3 pts), and smoked (2 pts)
cocaine use and occurred in habitual (4 pts) and recre-
ational (5 pts) users. Coronary arteriographyand left
ventriculographywas performed in all pts. The infarct-
related artery (IRA) was identified by the presence and
location of a well defined segmental ventricularwall
motion abnormality. The anterior and!or apical wall was
involved in all pts. The left anteriordescending artery
was the IRA in all pts. In 7 pts the IRA was abnormal:
4 pts had obstructive thrombi, 2 pts had coronary artery
disease, and 1 pt had thrombus superimposed on coronary
arterydisease. In 2 pts, the IRA was totally normal.
The noninfarct related arteries were normal in 8 pts.
Three pts received thrombolytic therapy acutely « 4
hours) with rapid lysis of intracoronarythrombi. At a
mean follow-up of 6.9 months (1-22 months), 1 pt has died
of recurrentMI following repeated cocaine use. Two
other pts have had readrnissions for prolonged chest pain
after repeated cocaine use.
In summary, MI mayfollow various routes of cocaine use
in pts with normal and abnormal coronary arteries. The
left anteriordescending artery is frequently involved
with thrombus, suggesting that thrombolytic therapy may
be beneficial in the early phase of acute MI in these
pts.
Monday, March 9, 1987
2:00PM-3:30PM, Room 14, Second Level
Radionuclide Assessment of Perfusion and Viability
EFFECT OF RIBOSE ON POST ISCHEMIC THALLIUM-201 KINETICS.
Debra Angello MD, Richard Wilson MD, David Gee, J David
Bristow MD, FACC, OR Health Sci. Univ., Portland. OR.
Ribose was infused during recovery from acute regional
myocardial ischemia to determine whether metabolic sub-
strate infusion alters Thallium-201 (Tl-201) kinetics post
ischemia. After a 10 min. subtotal coronary occlusion
and 30 min. of reperfusion, 17 swine received i.v. ribose
(n=8) or saline (n=9). Tl-201 was injected during occlu-
sion and Tl-201 activity was continuously monitored 1n
ischemic and nonischemic regions with CdTe miniature
radiation detection probes. Flow and mechanical funct10n
were determined by radiolabelled microspheres and ultra-
sonic crystals, respectively. Triphenyl tetrazolium chlor-
ide staining confirmed absence of infarction. Ischemic!
post ischemic flow and %wall thickening were not signifi-
cantly different between groups. Tl-201 clearance was
significantly higher in the ribose-treatedgroup'
%Tl-201 Clearance (mean±SEM) During and Post InfuSlon
During End 30'post 60'post
RIBOSE:
Ischemic 18.9±6.s] 26'4±9'9~28.0±6.8n29.4±7.7Nonischemic 23.9±7.4* 33.4±11.0 33.S±6.7* 36.0±7.S*SALINE:Ischemic 4.1±0.6 .S.0±1.3 .1O.8±2.S 14.2±3.4Nonischemic 6.1t1.1 8.6t1.6§ 1S.4±2.0 21.0±3.4§
*p<.OS vs ischemic, .01 vs ischemic <.OS· <.03
n oth groups Tl-201 clearance was greater in the non-
ischemic zone than in the ischemic zone. Thus, these data
demonstrate that a brief infusion of ribose post ischemia
affects myocyte exchange of Tl-201 before full recovery
of mechanical function. The capability of post ischemic
myocardium to alter its monovalent cation kinetics in re-
sponse to a metabolic interventionmay be a characteristic
that distinguishes transiently ischemic from infarcted
myocardium prior to functional recovery.
INCREASED SENSITIVITY OF 1-123PHENYLPENTADECANOIC
ACID IN THE IDENTIFICAnON OF EXERCISE-INDUCED
MYOCARDIALISCHEMIA.
ChristopherL. Hansen, M.D., Donald E. Jansen, M.D., James R.
Corbett, M.D., Valentina Ugolini, M.D., John J. Pippin, M.D.,
Eugene B. Henderson, M.D., Padmakar Kulkarnl, Ph. D., L.
Maximilian Buja, M.D., F.A.C.C., Robert W. Parkey, M.D.,
F.A.C.C., and James T. Willerson, M.D., F.A.C.C., Univ TX
Health Science Center,Dallas.
1-123 phenylpentadecanoicacid (IPPA) IS a synthetic fatty acid
useful in the identification of exercise-induced myocardial
ischemia. This study was undertakento test the hypothesis that
IPPA is more sensitive than thallium-20l (TO in the noninvasive
Identification of significant coronary artery disease (CAD) in 19
patients (Pts) (age 54;!:9 [SO) yrs) with ~70% stenosis of at least
one coronary artery. The Pts were imaged With both IPPA and T1
using single photon emission computed tomography (SPECT) after
maximal upright exercise. Short axis sections were quantitated
for segmental distribution and washout. Maximal heart rates
(121+17 IPPAj 118+17 T1, p=NS) and rate-pressure products
(214+38 IPPAj 209+46 T1, p=NS) were similar. 13 Pts (68%)
developed chest pain and/or diagnostic EKG changes with exercise
prior to IPPA versus 16 (84%) with exercise prior to Tl. 17 Pts
(89%) had abnormal IPPA scans versus 12 (63%) with T1 (p=NS).
However, IPPA Identified abnormalities in 22/29 (76%) stenosed
coronarydistributions versus 16/29 (55%) for TI (p<0.05). Of the
19 Pts imaged with IPPA, 13 (68%) had abnormal uptake (U), 13
(68%) had abnormal clearance (C), and 9 (47%) hadabnormalities
of both. TI images demonstrated10 (53%) Pts with abnormalU, 9
(47%) with abnormal C, and 7 (37%) with abnormalitiesof both.
We conclude that IPPA may be more sensitive than Tl in the
noninvasive identification of Significant coronary arterystenoses
in Pts with CAD.
QUAllTITATIVIl ABALYSIS or DIPYlIDAJlOU: TBALLIUX IMAGBS FOR
THI! DIlTICTIOB or COIlOBARY AIlTDY DISEASE
Terrence D. RUddY~ M.D., F.A.C.C., Humberto R. Dighero,
M.D., Gerald M. ohost, M.D., F.A.C.C., H. William
Strauss, M.D., F.A.C.C., Robert D. Okada, M.D., F.A.C.C.,
Charles A. Boucher, M.D., F.A.C.C., Massachusetts General
Hospital, Boston, Massachusetts.
To determine if the detection of coronary artery
disease (CAD) by dipyridamole thallium imaging is
improved by 1) quantitativevs qualitativeanalysis (3
reviewers) and 2) combining quantitativevariables, we
studied 80 catheterized patients with chest pain (53 with
and 27 without CAD). Segmental thallium initial uptake,
linear clearance, monoexponential clearance and
redistributionwere measured from early, intermediateand
delayed images acquired in 3 projections. Normal values
were determined from 13 other clinically normal subjects.
When 5 segments per view were used for quantitative
analysis, sensitivity and specificity were, respectively,
871. and 63% for uptake, 771. and 671. for linear clearance,
60% and 60% for monoexponential clearance and 621. and 56%
for redistribution. Using 3 segments per view (excluding
the basal 2 segments in each view), the specificity of
uptake increased (p <0.05) to 781. without a significant
change in sensitivity, 85%, and did not differ from that
of qualitative analysis.
Stepwise logistic regression analysis demonstrated
that the the best quantitative thallium correlate of the
presence of CAD was a combination variable of either
'abnormsluptake' or 'abnormal linear clearance'. Using
5 segments per view, the regression model's specificity,
851., was greater than that of uptake alone (p < 0.02),
with similar sensitivity, 92%. Using 3 segments per
view, the model's specificity, 931., was greaterthan of
uptake alone (p < 0.05) and of qualitativeanalysis (p <
0.05), with similar sensitivity, 85%.
Quantitativeanalysis of dipyridamole thallium images
using single variables provides results comparable to
qualitative analysis and can be further optimized by
using a combination of quantitative criteria.
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STAGED PERCUTANEOUS TRANSLUKINALCORONARY
ANGIOPLASTY (PTCA) IN PATIENTS WITH "ULTIVESSEL
DISEASE: USE OF STRESS Tlo 0 1 I"AGING.
Warren ft. Breisblatt,~ F. A. C. C.... John V.
Barne., ".0. Leo J. Spaccavento, ".0.,
F.A.C.C., Fred Weiland, ".0. Wilford Hall USAF
Medical Center, Lackland AFB, TX 78236-5300.
In patients (pts) with multivessel coronary
di.ea.e (ftVO), staged(S) PTCA guided by pre and
post exercise thallium imaging (Tl-I) provides
an alternativemeans of managing pts and of
dilating only functionally significant coronary
stenosis. Fifty pts with "VD ( 3 6 - 2 VO, 14-3VD)
undergoing S-PTCA had pre and post T1-I. All
stenosis were graded to be >75% reduction in
ve.sel diameter. Pre PTCA, reversible ischemia
(RI) occurred 1n 44 pts (88X), 39 in one
vascular distributionand 5 in two. ftV
ischemia was suggested in 16 pts (32X) based on
RI or washout abnormalities (WO).
Two weekS post successful PTCA of the culprit
stenosis repeat T1-I identified two pt groups
(G). Group 1 had a normal scan (21 pts) or RI
(6) confined to the PTCA vessel. Exercise t1me
in G1 improved significantly from 7.5 to 10.5
min (P<.05) and only 2 pts developed angina.
G2 identified 23 pts with ischemia in a second
vascular distribution (18 by RI, 5 WO) Exercise
time improved (7.7 to 8 .6 min) and only 8 pts
were 1iaited by angina. G2 pts were considered
for further PTCA; but this accounted for only
46X of pt••
S-PTCA in conjunction with T1-I prOVides an
approach for pt management which may lessen the
need for "V PTCA. The dilation of the culprit
stenosis is sufficient in the majority of pts.
REVERSE REDISTRIBUTIOOIS A GOOD PRClGOOSTIC SIGN FOLLCM-
l~ INTRAVENJUS STREP'roKlNASEDURI~ ACUTE MYOCARDIAL
INFARCfIOO. Dale A. Touchstone, M.O., Sanjiv Kaul, M.D.,
FACC, Tom W. Nygaard M.D., FAce, Denny D. watson, Ph.D.,
Leonard H. Hays, M.O. , Chds Tedesco R.N., George A.
Beller, M.D., FACC, University of Virginia School of
Medicine, Charlottesville, Virginia.
Conventionally, reverse redistribution is rare and
either representsmultivessel coronaryarterydisease or
is artifactual. It has been reported to occur with in-
creasing frequency in patients receiving intravenous
streptokinase (IVSK) during acute myocardial infarction
(AMI). To study the significance of reverse redistribu-
tion in this setting, 20 consecutive patients (15 men
and 5 women, mean age 52 years) who received IVSK within
4 hours of chest pain (mean - 2 hours) and who were able
to exercise, underwent submaximalexercise thallium
imaging at 10 days after AMI. Cardiac catheterization
was performed2 hours and 10 days following IVSK. 2D
echos were obtained prior to and serially over 10 days
after IVSK and blindly interpretedfor regional wall
motion using a 12 segment model. One of 4patients with
closed infarct related vessel demonstratedreverse re-
distribution compared to 5 of 16with open vessels (p -
NS). However, all 5 patients with open infarct related
vessels and reverse redistribution demonstrateda signi-
ficant improvement in wall motion between day 1 and day
10. In contrast, only 1 of 7 patients with persistent
thallium defects and 2 of 6 patients with redistribution
demonstratedimprovementin wall motion at 10 days
(p<. Ol).
We conclude that a) Reverse redistributionis cOlllllOn
(30%) in patients receiving IVSK during AMI; b) Reverse
redistribution denotes imprOVed regional function in
such patients; c) the mechanismof reverse redistri-
bution in segments showing improvedregional systolic
function must be rel at edto preserved blood flow to
predominantlyviable myocardium.
THE SI GNIFICANCE OF r.ECiJlNULA'fION ON REPERFUSIOl< IMAGING
IN ACUTE MYOCARDI AL INFARCTION.
Judith E. Orie , M.D. ; Haytham Jabi , Il. D.; Peggy
Wiederh olt. R.N.: William P. Miller. M.D.; Condon R.
Vander Ark, M.D.; 2nd A. JamcsLiedkte, M.D. Cardiology
Section. Univ of Wisconsin Medical School, Mad~so~, WI.
The purpose of this study was t o r eview theo6ffect of
r ecannul at i on onpredischarge thallium ( Tl)~ perfusion
pat t ern s following acute myocardir.l i nf ar ct i on (AMI).
Thi r ty -five patients sat1s fy~n& ECr. p~d E'nzyme criteria
for tr~nsmural AMI were studied i n whi ch 22 recE'ived
1.5xl0 units s t r eptokinase (STK) intravenously within
194!64.1 min of the onset of ches t pain. Al l pntien~61
were catheterized and exerci FE'd submaximal ly with Tl
scans prior to discharge. Recannulation at 14 days post
MI was 57% in infarct-relatedvessels (68%and 38%.
respectively, i n STK and untreated patient~). Patent
vessels were assoc'at~d with smaller Tl defect scorE'S
(2 .99+C.59 ve 5.75+1.33 in closed vessels, p -e .05) and a
larger percentage (40 vs 13%, p = .08) of small iniarcts
(Tl score < 1.50). This "as accounted for maLri Ly by
trends in patent ves ... l~ from STK-treatedpati~nts which
showed smaller Tl defect scores (2. 64+C . 63 vs 7.25+2.10
in clo sed vessels, p < .025) and a higher p"rcentar,; (47
vs 14% p c .14) of smal l i nf2.rcts. Patency rates in
culprit vessels or residual stenosis by angio gr aphy did
not predict redistr1.bl1t~C1' pa t t erns at submaximal
exercise . The maj ority of patients with both ope" (70~)
and closed ( 13%) ves sel s had >20% Tt reflow to
i nf arc t-rel ated nr ..ps . Thus. recannulation.
partlcu)cr l y thnt ef f ect ed by STK. was significantly
related t o infarct si ze by Tl defect scor es but did not
predict re sidua l i schemia which was present 1.n most
patients .
Monday, March9, 1987
4:00PM-5:30PM,Room 14, Second Level
New Tc-99m Labeled MyocardialPerfusionImaging
Agents
MYOCARDIAL KINEI'ICS OFTEaiNEI'IUM-99rn-HE:xAKIS-2-ME1HOXY-
2-MEIH'iLPOOPYIrSONI'rnIlE: A NE.W CARDIAC IM1IGING AGENl'.
R Okada, S williarns, D Glover, K C!'cMley, amJ Garneau.
Saint Francis Medical Research Institute and University
of Oklahoma, '1\llsa, OK, E.!. duPont de Neroours & CO.,
Inc., N. Billerica, MA 01862
To study the potential usefulness of Technetium-99m-
hexaki.s-2-methoXY-2-methylprcpyl-isonitrile(RP-30) as a
cardiac perfusion iJragi.n:J agent, 12 dogs had partial
OCClusion of the left circumflex coronary artery. RP-30
was injected 30 minutes later into the right atrium.
Normal am isdlemic zone regional myocardial RP-30
activities were continuously ronitored usi.n:J miniature
inplantableradiationdetectors for four hours, then the
dogs were sacrificed. serial garma camera images were
also acquired duri.n:J the study. Heart rate, arterial
blood pressure, pressuredistal to the stenosis, am left
atrial pressure did not chan:Je significantly duri.n:Jthe
experiment. Microsp-tere detennined regional myocardial
blood flow was reduced in the left circumflex
distribution after coronary stenosis am at the ern of
the experiJrent. lIll 12 dogs demonstrated minilnal am
equiValent four hour fractional RP-30 clearances frrm the
normal am ischemic zones (0. 11 ± 0.1 SD versus 0.12 ±
0. 2). '!he final technetium activity ratio
(ischemic/normal zone) measured in a well counterwas not
significantly different from the initial flow ratio at
the time of RP-30 administration confirmirq the absence
of redistribution, since previous studies have
demonstrated a linear relationship between flow am
initial RP-30 uptake. Gamna camera images were of
excellent quality. 'Ihe linear relationshipwith regional
myocardial blood flow, the minimummyocardial washout and
redistribution, and the 140 keV ganrna make RP-30 a
pranisingnew cardiacperfusion iJragi.n:Jagent.
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post-EX 1. 8 2. 2 2.4 Tl-201
RP-30 images wer e of better quality than their compan-
i on Tl-20l images as reflected by better heart/ lu ng
ratio. Thus, RP-3 0 provided hi gh count density, high
quality myocardi al images in man. Based on orga n
distribution the most practica l tim in g of imagi ng is a t
60 min p.r. at R and EX. Timing of RP-30 i maging pos t -EX
appear s not as cr i t i cal as forTl-20l, which may be
another advantage of this pro mi s i ng new agent .
REST- EXERCISE ORG~~ DISTRIBUTION OF RP-30 , A NEW
Tc-99m-LABELED MYOCARDIAL PERFUSION IMAGING AGENT
Fr ans J . Wacker s , M. D. , F.A.C.C. ,David S. Kayden, M.D.,
Robert C. Lange, Ph.D., Jennifer Ma t t era , R.T. Yaie U. ,
New Haven. er
Little is known about organ di stribution and appr opr ia te
timing of myocardial imaging post-injection (p .t. ) of th e
new Tc-99m-isonitrile, RP-30. Consequently, 8 subjects
(4 normals. 4 coronary artery disease (CAD) Pts) were
s tudi ed a t rest (R) (6 studies ) or af ter exercise (EX) (6
s t udies ). For each study, 5-10 mCi of RP-30 was given .
Ser ia l quantitati ve RP-30 imagi ng was obt a ined i n each
s ubject . In addition , all CAD Pt s had Tl-201 str ess
imaging. All RP-30 studi es had 200-300 K t ota l car di ac
cnts/5 min. At R, initial RP-3 0 accumula t ion was highest
i n l iver , and decreased over 120 mi n . Cardiac ac t ivity
was almost cons t ant over 60 min and hi gher than l iver
activ i ty at 120 min . After EX, RP-30 activity was
hi ghes t in the hear tat all times p. i. Average
heart/lung, heart/liver, and heart/spleen ratios at
various times p.i. were:
Heart/Liver Heart/Lung Heart/ Spleen
Time p.i. R EX R EX R EX
5 min 0.6 1.5 2. 1 2. 1 1. 5 1.9
30 mi n 0.7 1. 4 2.2 2.6 1.5 2.5
60 min 0. 9 1.7 2.5 2.6 1.9 2.5
180 min 1.6 2. 3 2.9 2. 5 2.6 3. 3
IRP-30
QUANTITATIVE COMPARISON OF TL-201 IIITH Tc-99m HIBI (RP-
30) . Penny D. lIatson PhD, lIilliam Smith MS, Thomas A.
Kelly MD, Chdstopher M. Rembold MD, C. David Teats MD,
George A. Beller MD, FACe. University of Virginia Medical
Center, Charlottesville, Virginia
Tc-99m labeled 2-methoxyisobutyl isoni trile (RP-30) is
currently being evaluated as a myocardial perfusion agent.
lie undertook a quantitative comparison of regional
myocardial uptake between Tl-201 and RP-30 in 5 Pt with
prior myocardial infarction and residual ischemia as
evidenced by Tl-201 redistribution. Tl-201 images were
obtained 10-20 mi n and 2-3 hr post injection. RP-30 was
injected within 2 vks of the Tl-201 study at the same
exercise heart rate. Myocardial imaging was performed 1 hr
post i nj ect i on and then compared toinitial Tl-201 uptake.
A second RP-30 injection was performed 24 hr later at rest
for comparison with delayed Tl-201 images . Activity in 9
segments was measured after interpolative background
subtraction and computer image registration producing 90
segments for comparison in the 5 Pt. Measurements were
expressed both as a fraction of peak and a fraction of
average myocardial uptake. Linear regression and paired
t-test gave r=.9, p=.94, n=45 comparing exercise studies
and r~.8, p=.99, n=45 comparing delay Tl-201 vs rest
RP-30, indicating no statistically significant differences
between Tl-201 and RP-30 measurements. RHS deviation
between paired Tl -201 and RP-30 samples was 12% and 16%,
respectively for exercise and rest values normalized by
peak. counts, and was 8% and 12% when myocardial counts
were normalized by the average. Thus, for this preliminary
study of 5 Pt wi th multiple defects dominantly of mixed
scar and ischemia, no difference was statistically demon-
strated for either the initial myocardial distribution of
tracer or amount of "redi s t r i but i on" determined from
initial and delayed TI-201 or alternatively from exercise
and rest RP-30 studies.
QUANTITATIVE COMPARISON OF PLANAR AND TOMOGRAPHICTc- 99m
HIBI ( RP- 3D) AND Tl-2Dl MYOCARDIAL PERFUSION SCINTIGRAPHY
IN PATIENTS WITHCORONARY DISEASE FOR PERFUSION DEFECT IN-
TENSITY AND DEFECT REVERSIBILITY. J Maddahi, MD, FACC; R
Merz, MD; KF Van T~in, BS; L Ray, MS; C Wong, BS; OS Ber -
man, MD, FACC. Cedar~-Sina i Med Ct~ , Los Angeles, CA
Tc-99m MIBT (RP- 30) , a newmyoca~ial pa~fusion imaging
agent which does not ~edist~ibute, was quantitatively com-
pa~ed to Tl -201 wi t h ~espect to perfusion defect (PD ) i n-
tensity and ~eversibility on bot h planar (PL) and to -
mographic (SPECT) studies. pt~ wi th angiog~aphic corona~y
disease and exe~cise (Ex) ~d ist~ibut1on (Rd) Tl PL (n=5)
and SPECT (n=2) st udies had ~epeat Ex studies t o t he same
l evel wit hin 2 weeks of Tl t est. Ten mCi of RP- 30 was i n-
jected at 2nd Ex and again at ~est 1 day late~, wi th imag-
i ng by PL and SPECT methods 1 hou~ after injection using
t he same i maging t echni que as fo~ Tl. ActiVi ty of 60 myo-
ca~d ia l sampl es was assessed on each PL view andtomog~m
using c i~cumferentia l pr ofile analysis of maximal counts .
PO intensity was assesse d by di vi di ng activity in ~egions
with PO by that of no~mal zones on both PL and SPECT ima-
ges . PD reversibility was quantitatedby determini ng the %
change in PD i nt ens i t yf~om Ex to Rd (Tl ) and Ex to Rest
(RP-30 ) . PD intensity was significant ly g~eate~ by PL Tl
tha n RP- 30 (77 %+7.7% vs 83%+9.1%, p<. OS) ; however, t he t wo
measurements co~~elated well (r= 0 .77 , Tl = 0 .23 +0.65 RP-
30) . Despita difference i n PO intensity, both Tl and RP-30
studies correct ly id entified 9/ 13 diseased coronary arter -
ies. RP-30 PO wa s mor e intense on SPECT (69%+23%) t han on
PL RP-30 and was s1mila~ to SPECT Tl (67%+22%) . Degree of
PL RP-30 PO rev ersi bi l ity was s imila~ to t hat of Ex-Rd Tl
( 11%+ 8% vs 12%+12%,p=.8). We conclude t hat compared to
Tl, RP-30 ex/rest myocardia l perfusi on stUdi es 1) have
lower defect cont~a st on PL but not on SPECT images, p~b­
ably due to the highe~ energy of Tc- 99m, and 2 ) predict
the degree of perfusion def ect reversibility .
GATED RP-30 PERFUSION STUDY AFTER STRESS PREDICTS MYOCAR·
DIAL VIABILITY. Robert Merz, MD ; Ja~qhid Maddahi , MD,
FACC; Lynne Roy, MS; Daniel S. Be~n, MD, FACC. Ceda~s­
Si nai Medical Cente~, Los Angeles, CA
RP-30 DuPont (MIBI ) i s a Tc-99mimaging agent wit h fav-
orable imaging characte~istics fo~ assessment of myoca~di­
al pe~fusion. Unlike Tl, RP-3D does not redist~ibute to
hypoper fu se dbut viable myoca rd i um. The purpose of this
st udy was to d ete~m1ne i f a single gated RP-30 myoca~dial
sc int igram perfo~med one hour afte~ exe~ise (EX) woul d
al l ow p~ediction of Tl ~versibility based on RP-30 simul -
t ane ously demon st~ating 1) a pe~fusion def ec t , and 2) nor -
mal segmental wal l mot i on . Fiv e pts with angiogra phi ca lly
pr oven coronary di sea se unde~went RP- 30 (10 mCi) planar
i maging afte~ Ex within two weeks of angiog~phy and Tl Ex
testing. Sc intig~ms were visual ly scored for pe~fusion by
consenSus using a 4- point sys t em (O=nl , 3=s evere defec t)
wi th score of >2 conside"ed abno~mal. Gated images from
the Ex RP-30 study were also analyzed by consensus of 3
blinded observe~s using a S- poi nt wall moti on score (3=nl,
-l=dyskinesis ) with sco~e <1 considered abnormal . Overall,
there was 80% agreement between wall motion by gated RP-30
and visually inte~preted contra st vent~iculogram (k =.59) .
Of 18 myocardial seg ments with reve~s ible def ect s by Tl,
16 (89 %) we~e co~~ec tly id entified ( p~sent and viabl e) by
the s i ngle ga t ed RP-30 stud y . The remain i ng 2 r eversi ble
segments were akinet ic both on gated RP-30 imaging and
contrast ventriculography . This discrepancy may be due to
~esting i sc hemia. Of 3 nonreversible T1 se gments , 2 we~e
akinetic on gated RP-3D stu dy, while t he third was sco red
no~mal but was ad j ac ent to aco~~ectly i dentified akinet i c
infarct zone. Thus, t he se p~eliminary result s sugges t that
a single gated perfusion stUdy with Tc-99m RP-30 a fte~
exe~cise i njec t i on may pro ve useful in identifying
abnormally pe~fused myoca~dial segments and in predicting
thei~ viability.
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INITIAL CLINICAL RESULTS WITH 99mTC METHOXY ISOBUTYL
ISONITRILE
Kenneth McKusick MD, George BeIlar MD FACC,Daniel Berman
MD FACC, Charles Boucher MD FACC,Leo Camin, Angelika
Delaloye MD,BernardDelaloye MD,JamshidMaddahi MD,Peter
Manspeaker,HWilliam Strauss MD,Frans WackersMD FACC,
Dennis Watson PhD
Dupont Diagnostic Imaging Billerica Mass
Human biokinetics,safety,dosimetry,andinitial efficacy
of the new myocardial perfusion agent 99mTc-hexakis-
2-methoxy-2-methylpropylisonitrile (RP30) were evaluated
in 16 normal volunteer adults and 19 patients with CAD as
confirmed by T1201 and angiography.Afterinjection of 10
mCi RP30 at rest or stress, one of following imaging
protocols was acquired:wholebody imaging acquired
intermittentlyfor 24hrs for biokinetic data, continuous
acquisition over chest for initial clearance data, static
images of heart in three projections one hour after
injection for myocardial distribution. Early blood
clearance and urine excretion were calculated,and
patients monitored for up to 2 weeks for BP,P, temp.,
blood elements, chemistries,and urinalyses. Safety data
were within normal. Heart uptake at rest 2.84%
i.d.(l 63-3.9) and after stress 3.2%id(2.4s-4.46);
myocardial Tl/2 was longer than 3 hrs. Blood level at 5
min rest 9.3%id and stress 6.3% id. Urine 24 h excretion
was 15.9(3.7-30)% id. Based on these results and the
dosimetric data the allowable dose is greater than 20mCi.
Segmental agreement between T1201 and RP30 on
exercise/rest-orredistributionwas 89%. 2 CAD patients
as determined by angiographyhad neither scar nor
ischemia on T1201 or RP30. The data indicate that RP30 is
safe, comparable to T1201 for myocardial perfusion, and
can be used in doses sufficient for both first pass as
well as myocardial perfusion studies.
Monday, March 9, 1987
2:00PM-3:30PM, Room 41, Second Level
Cardiac Transplantation/Artificial Heart Replacement
SUMMARY OF THE WORLD EXPERIENCE WITH CLINICAL USE OF
TuTAL ARTIFICIAL HEARTS AS CARDIAC SUPPORT UEVICES.
Lvle D. Joyce, M.D., Irvin F. Goldenbery, M.D., Kristen
E. Johnson, R.N., Robert K. Jarvrk, M.D., Wllllam C.
De Vrles, M,D., BJarne Semb, M.D., Jack G. Copeland,
M.D., Bartley P. Griffith, M.D., Denton A. Cooley, M.D.,
O. Howard Frazt er, M.D., William S. Pierce, M.D.,
Professeur Dr. C. Cabro l , W. J. Keon, M.D. and Marc R.
Pritzker, M.D., Minneapolis Heart Institute Foundation
and Abbott Northwestern Hosp1tal, Mlnneapolls, MN.
As of August 15, 1986, 13 centers worldwide have
implanted 33 Total Artlficial Hearts (TAHs) (5 permanent
support, 28 temporary support) in 32 pts with intractable
congestive heart failure (27 males and 5 females, mean
age 38 yrs, range 18-56 yrs). Eight different types of
TAHs have been employed. The longest survivor after a
permanent implant lived 606 days. Of the 27 pts
receiving the TAH for temporary support, 4 pts died whlle
being supported by the TAH, 8 pts died following
transplantation,2 pts are waiting for transplantation
and 14 pts are living after successful transplantation.
Multiple antlcoagulationprotocols were used including
the following agents singly or in combination: heparin,
dipyridamole, warfarin, aspirin and dextran. Three of 27
pts experienced a TIA. One pt experienced a stroke.
There has been only one case of mechanical heart
dysfunction; however, there have been no deaths due to
mechanical tailure. Of the 20 pts receiving the Jarvik
TAH as a bridge to transplantation(BTT), 4 pt s died
awaiting transplantation,1 pt dled 2 months after
transplantationand 13 pts (68%) are alive following
successful transplantat1on. Preliminaryexperience with
the TAH as a BTT suggests that acceptable outcomes can be
achleved 1n criticaly ill heart failure patients.
REDUCING HEMOLYSIS AND STROKE COMPLICATIONS IN HUMAN RE-
CIPIENTS OF THE JARVIK-7 TOTAL ARTIFICIAL HEART: A REPORT
OF FIFTEEN PATIENTS.
MM Levinson MD, JG Copeland MD, F.A.C.C., RG Smith CCE, RC
Cork MD, WC DeVries MD, JB Mays PAC, B Griffith MD, R
Kormos MD, LD Joyce MD, MPritzkerMD, BK Semb MD, B Koul
MD, AH Menkis MD, WJ Keon MD, U of AZ, Tucson, & others.
The degree of red cell destruction in humanrecipients of
the tDtal artificial heart (TAH) has nDt previously been
described. 15 patients implanted with a Jarvik-7 TAH for
either temporary or permanent cardiac replacement were re-
viewed. Clinically significant elevations of plasma hemD-
globln (PHG) and serum tDH weredemDnstrated in pat1ents
receiving the standard (IOOcc) Jarvik-7 powered by pul;es
of compressed air delivered at a dP/dT of 6-8,000 mmHg/sec.
Reduction Df the dP/dT by drive unit mD~lflcation greatly
reduced the mean PHG from 35.85 to Dnly 10. I mg/dl (NL~8.3)
and the LDH from 1,383.7 I.U./L to 681 I.U./L (NL<2Is) 1n
subsequent patients. IntroductiDnDf the smaller (70cc)
TAH was nDt assDciated with greater hemolysis Dnce dP/dT
had been reduced. With the current driver delivering sys-
tolic pulses at less than 4,500 mmHg/sec, bDth size hearts
are free of clinically relevant hemDlysis. In additiDn it
appears that attempts tD eliminate hemolysis completely by
the lowering heart rate or driving pressure are potential-
ly dangerous. The eventual development Df embolic strokes
is associated statistically with heart rates (HR) < 80.
Mean HR in patients eventually suffering cerebral embDl,
is 72.6 cDmparedwith 97.5 (p<O.Os) in the nDn-strDke co-
horts. These data confirm that the updated Jarvik-7 TAH
system dDes not induce worrisome hemDlysis. In additiDn,
we have uncDvered a link between eventual strDke and low
HR, implying that purpDseful applicatiDn Df HR's arDund
100 beats/min may prDvide a significant margln of prDtec-
tlDn against strDke during implant.
THE ARTIFICIAL HEART: BRIDGE TO CARDIAC TRANSPLANTATION
RDbert L. Kormos,MD, Bartley P. Griffith, MD, RDbert L.
Hardesty, MD, Alfredo Trento, MD, and Harvey S. BDrDvetz,
PhD, University of Pittsburgh, Pittsburgh, PA
In Pittsburgh, the number of candidates fDr cardiac trans-
plantation (CT) who are hospital bound and maintained on
intravenous inDtrDpes and/or intraaDrticballoon pump have
increased from 35 to 55%. Many of these patients have
died prior to CT as the waiting period for donor organs
has incr~ased from I to 3 weeks over the past 3 years.
Since Oct. 1985, 6 patients have been supported by the
Jarvik-7 total artificial heart (TAH) for periods between
3 tD 18 days. Five patients were supported with the TAH
prior tD CT, and 1 required its use when hyperacute rejec-
tion Dccurred directly following initial CT. Five of the
6 patients have survived CT fDllowing TAH support and 4
patients are well at home. One patient has died frDm late
rejection and treated mediastinitls and another from multi
organ failure while Dn support priDr to CT. The Jarvik-7
TAH has performed flawlessly but has unifDrmly had f,br,n
and platelet thrombi deposited at the valve housings.
StrDke has not occurred and hemolysis as reflected by the
low serum free hemDglobin has not been a problem. Pa-
tients with normal renal functlon prior to implant retaln-
ed normal functiDn after CT. Systemic anticoagulatlDnhas
been assDciated with pericardial tampDnade in I anddif-
fuse pharyngeal gastric hemorrhage 1n another reciplent.
We conclude that: 1) In carefully selected patients the
use of the TAH priDr to CT can Dften result in a success-
ful outcome; 2) Strict criteria, including the absence of
systemic and pulmDnary lnfection and advanced end-organ
failure, must be adhered tD; 3) The design of the Jarvik
device requires mDdlflcation to avoid areas of platelet
thrombi; 4) Effective use Df a cardiac mechanical suppDrt
devlce requires a high level Df team commitment and
trainlng.
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RETRANSPLAKTATIOHFOR SEVERE ACCELERATED CORONARY
VASCULAR DISEASE IN HEART TRANSPLANT. Shao Zhou Gao,M.D.
Joh n S. Schr oeder , M. D. ,F.A.C.C., Sharo n A. Hunt, M.D.,
L A.C.C., Edwln L. Al der man, M. D. , F.A.C.C. , EdwardB.
Stinso n, M.D. , L A.C. C. Cardiology Dlvi sion and Depart-
ment of Cardl ovascul ar Surge r y, Stanford Unlversity
School of Medlcine , St anfo rd , CA .
The oevelopment of accelerated corona r y vascular di sease
(CVD) m t he t ranspl ant pa t i ent (Tx pt ) l S one of t he
major cause s of graft failure and subsequent mor bi c i t y
and mortallty. 400 hear t Transplant procedures were per-
for med ln 368 pts and 30 heart-lung Transpl ant pro cedu res
m 29 pts prror to 1/86 . 81 pt s have develo ped CVD .
Twenty re t r ansp l ant at i ons ( re- Tx) in 19 pt s lncl udln g two
3rd Tx procedure were performed for the t reatment of CVD .
We rev l ewed t he cl l nical , laborator y and annual arterio-
grams of t he first and se cond Tx hea rt. All of re-Tx pts
were taki ng dlpyrldamole. One-yea r survival rate lS 55~.
Ther e ar e 9 pts currently alive, the longest re-Tx sur-
Vl vor Ilving 5.5 years. Cumulative sur vl val time of the
pati ents ( l ncl udi ng 1st Tx and re -Tx hearts) was a mean
of 6. 11 year s with 3 pts liVing more t han 11.5 years. 5
of 11 re - Tx hearts (45.4~) which survived more than one
year de vel oped subsequent CVD. The morphol ogi ca l fea-
t ures and the progression of dlseas e i n t he 2nd Tx heart
are s i mii ar to the 1st Tx hearts . We conclu de that: 1)
re-Tx for the patlent wit h advanced CVD lS successful ; 2)
t he incidence of recur rent CVD in th e re-Tx pt is sti ll
m gh; 3) anti-platelet ther apy falls to i nhi bi t r e-T x
CVD . These re s ults ar e conslstent wlt h immunolo gic l nJu-
ry as th e pr imar y mechanism.
WE INFLUEOCE OF PRETRANSPLANT IID1JDYNAMIC STA'IUS 00
OPERATIVEl-ORTALITY
Lawrence R. McBride, M.D. , Kirk R. Kanter, M.D., Les lie
W. Mill er, M.D. , FNX, D. Glenn Pennington, M.D., Fl>CC,
V.L. Willnan, M.D. , St . Louis Um.versity Hospital, St.
Louis, MiSSOuri
Recent data suggest t hat pretransplant rrorbida.ty does
not adversly affec t survival after cardiac transplantati on
(Tx ). In order to evaluate the ll1fluence of preoperative
hEJncrlyncrnic status on survival ~ retrospectively revie~
our experience wi t h cardiac Tx . Be~en July, 198 2 and
March, 1986 31 rren and 7 wanen with a mean age of 38.9
yr. (10- 59 yr.) underwent orthot opi c cardiac Tx. Cyclo-
sporan and steroids ~re used for .iJTmunosuppression in
al l. I schelru.c cardianyopathy was present in 33%, idio-
pathic in 34%, and misce l laneous in 33%. The preoperat ive
c l inical status of the patients was as follows:
NATCO STATUS #PTS. DESCRIPTIoo
IX -6- "Mechanicalsupport
I 11 I notropic support (ICU)
II 5 Stable in hospital
III 16 Stable at hane
Overall survival was 74%. Status I & IX survival was
47% and s tatus II & III 95% (Chi square p< 0.002). All
deat hs were perioperative with no late deaths at a rrean
followup of 16 rro, (2- 44 rro . }, Six patients died of sep-
SiS and one each of graft failure, hyperacute reject i on,
pulrronaryhypertension , and multiple organ failure.
These data suggest that cn ticall y ill patients re-
quiring preoperat ive inotropi c or mechanical support have
a higher pe r aope r atave llDrtality after cardiac Tx. The
scarcity of doncr hearts necessitates the juiicious selec-
t ion of potentlal rac ipterrts,
*Ventricular Assist Device (2 pt .), Balloon Punp (2 pt ,} ,
Extracorporeal Ment>raneOXygenation (2 pt i )
Ther e was no signi ficant di f f eren ce in LVEF among t he 4
gro ups, even when t he 7 pat i ent s withhis tologic rejecti on
were excluded. Six pat i ents had an LVEF <50%; 5 of t hes e
6 had histologic evidence of acu t e rej ection .
We conclud e that there is no detectabl e adverse e f f ect
on left ventricul ar ejection f raction of donor hear t
i s chemic times of up t o 250 t o 300 minutes .
Monday, March 9, 1987
4:00PM-5:30PM,Room 41, Second Level
CardiacTransplantation:Heart-LungTransplantation
IMPROVED HEART-LUNG GRAFT PRESERVATION WITH PROSTAGLANDIN
E-1
John C. Ba1dwin, M.D., Ar i Harjula, M.D., Thomas D.
Starkey, M.D., Stuart W. Jamieson, M.B., F.R.C.S.,
F.A.C.C., and Norman E. Shumway, M.D ., F.A.C.C.,
St anford University School of Medicine, Stanford, CA
Because of the need for ef f ect ive graft pr eservat i on
methods for distant procurement in combinedheart and
lung t r ansplantation (HLT), we studied the role of
pr ostagl andin E-I (PGEI) in pulmonary vasodil a t at io n for
enhancement of pulmonar yarterial flush cool i ng . HLT was
carried out i n sixteen cynomolgus monkeys . Donor cardiac
pr eservati on was ac hieved with co ld crystalloid
ca rdiopl egic so lut ion ( 10 ml/kg) i n a l l animals, and
pulmonar y preservationwas achi eved with i nf us io n of a
cold modified Euro-Col lins solution (15 ml/kg x 4 min) .
In Gr oup I, no oth er pharmacotherapy was used. In Group
2, PGE I was given i nt ravenously (0.5 - 4 mcg/ kg/ min,
acco rding to blood pressure t olerance) , beginni ng 15 min
prior t o aortic cross-c lampi ng and continuing dur i ng
administrati on of pulmonary cool i ng so lution . Graf t s wer e
stored at 40 C for 6 hour s (374± 14 min in Gro up I, 371
± 24 min i n Gr oup2); P=NS . Three animals wer e excl uded
f rom the ana l ysis for surgical technical reas ons. Aft er
HLT, arterial blood gases (FI02 40%, 3 cm PEEP) were
measured.
Hours af ter P02 in mmHg
Reperfusion Gro up I (n=6) Gro up 2 (n=7)
I 89 ± 23 1 72±35 ( p ~. 01 )
2 141 ± 34 190 ± 20 (p<. OI)
6 179 ± 17 204 ± 25 (p<.0 7)
PGEI, a potent vasodi lator, an i nhibito r of platelet
aggregatio n, and a complex immunosuppressive agent,
improves heart-lunggraft pr ese rv at i on andfunction after
extended ischemia.
4
247+24
59+8
205+7
59+11
2
179+7
61+12
1
137+28
55~9
I SCH (mm)
LVEF (%)
EFFECT OF ISCHEMIC TIME OF THE TRfu~ SPLANTED HUMAN HEART
ON THE SUBSEQUENT LEFT VENTRICULAR FUNCTION. ;IoP_sep h ~.
~~~_~E~_M~., Wil l i am P. Fol l ansbee, M. D• •F.A. C.C. ,Edward
I . Curti s s , M.D. , F.A. C.C., Robert L. Kormos, M.D. ,
Univer s i ty of Pi t t sbu r gh ,Pittsburgh , PA.
The l imited availabilit y of su i tabl e human hear t t r ans -
plant donors has resulted in the necessity t o f r equently
travel long distances to harvest donor org ans. The effect
of prolonged organ ischemic tim e (I SCH) befor e implanta-
tion on subsequent left ventricularfunction has not been
established . Using radionuclide ventriculography, we
examined left ventricularejection fractions (LVEF) in
54 consecutive cardiac allograft recipients (45 males)
between 6 and 14 days post-transplantation i n or der t o
determine if there was any detectable relati onship betwee n
LVEF and ischemic time. All studies were performed after
patients were out of the i ntensive care unit and off all
i notropic support.
I schemi c t i mes ranged from 61 t o 305 minutes (mean
192+45 minutes) . There was no significant relationsh i p
bet;een LVEF and ischemic time (r =0.02). The populati on
was divided i nto quartiles acco rding to ischemic time .
The LVEFs and i schemi c times for t he four gr oups are
shown.
30A ABSTRACTS lACC Vol 9. No. 2
February 1987:30A
A QUANTITATIVE ASSESSMENT OF THE QUALITY OF LIFE AFTER
COMBINED HEART-LUNG TRANSPLANTATION.
Magdi H. Yacoub, FRCS. , FACC. , Nicho l aa R. Banne r , MRCP. ,
Stuart Gibson, BSc. , Sonal A. Thakkar, BA . , Asgha r
Khagh ani , FRCS. Harefield Hospital, Harefield, Middlesex ,
UB9 6JH, England.
Bet ween December 1983 and May 1986 , 58patients underwent
combined heart-lung transplantation (HLT) for the follow-
ing i ndi cat i ons : pulmonary vascular disease in 45, pul-
monary atresia in 4 and parenchymal lung disease in 9 .
Cyclosporin and azathioprine with no oral steroids we r e
used for i mmunosuppr essi on . Survival at 1 mont h post-
ope r atively was 80% and at 3 mon t hs 67%. There were 3
l ate deaths. The quality of l ife was assessed pre-opera-
t ively and at 3 , 6 and 12 months post-operatively usin~
t he NottinghamHealth Questionnaire, which provides scores
fo r 6 dimensions : physical mobil ity (PM), pain (P) , sleep
(SL) , energy (EN), social isolation (SO) , emotional reac-
t ions (EM) on a range from 0 (unaffected) to 100 (severely
affected) . Only adult patienta wi th English as their
first language are suitable for studies using this
questionnaire. All scores are quoted as mean values. At
the t ime of acceptance for transplantation,74 patients
ha d the following scores: PM = 52 .0 , P = 18.4, SL = 40.1 ,
EN = 74 .9 , SO = 27.3, EM = 37.7 . At 3 mont hs after opera-
tion, 20 of 24 eligible patients completed t he questionn-
aire, t he i r mean scores we re : PM = 17 .8, P = 10 .6 , SL =
18 .4 , EN = 17.1, SO = 7 .4 , EM = 8. 4 . At 6 months al l 16
e li g i ble patients responded, t hei r mean scores were: PM =
4 .9 , P = 2.3 , SL = 5.6 , EN = 7.8 , SO = 4.8 , EM = 1.3 . At
12 months all 6 patients replied , their mean score s were:
PM = 0 , P = 0 , SL = 14 .8 , EN = 0 , SO = 0 , EN = O. These
results i ndicate that combined HLT t ransplantationwi t h
Cyclosporin and azathioprine immunos uppr es s i on canprovide
a mark ed i mprovement i n quality of l i f e 3-12 month s after
operation.
OKT3 MONOCLONAL ANTIBODY FOR EARLY PROPHYLAXIS IN
CARDIAC TRANSPLANTATION. Edward M. Gilbert. M.D.,
Clement C. Eiswirth, M.D., Dale G. Renlund, M.D.,
Colette M. Herrick, R.N ., William A. Gay, M.D., Michael
R. Bristow, M.D., Univ of Utah, Salt Lake City, UT
OKT3 monoclonal antibody (OKT3) is a murine
monoclonal antibodywhich is reactive against the T
lymphocyte T3 cell surface receptorthat mediates
ant igen recognition. We report our experience using
OKT3 for early rejection prophylaxis . 12 patients (pts)
received a rejection prophylaxis protocolconsisting of
OKT3 5 mg i.v. given 24 - 4B hrs postoperativelyand
t hen dai ly for 14 days, along with azathiopr ine 2
mg/ kg/d; prednisone 0.25mg/kg/d , and cyclosporine 6
mg/kg/d beginning day 4 postoperat ively . There were no
episodes of rejection during the period ofOKT3
administration. This compares to a 65% inci dence of >
mild rejection within t hefirst 15 days post-transplant
in a control group of 31 pts treated with anti thymocyte
globulin (ATG) , steroids, cyclosporine and
azathiopr ine. During an 8 week follow-up, the OKT3
grouphad a significantly lower mean biopsy score (p
0.021), and a signi f icantly higher percentage of pts
free from moderate or severe rejection (p = 0.007) and
free from therapy forrejection (p - 0.027) than the
ATG treated group. Adverse react ions t oOKT3 have been
numerous but manageable without discontinuationof
therapy. Infectious compl icat ions have been similar in
t he two groups. There have been no deaths in t he OKT3
groupand 1 death in thecontrol group. For all pts the
12 month actuar ia1 survi va1 is 97 .6%.
CONCLUSIONS: 1) OKT3 is an effective agent for earl y
rej ect ion prophylaxis in cardiac transplantation. 2)
Because histologic data areroutinely available,
cardiac transplantation may be an ideal setting for
evaluat ion of new immunosuppressiveagents.
FREQUENCY ANALYSIS OF THE SURFACE-ECG FOR RECOGNI TI ONOF
ACUTE REJECTION AFTER ORTHOTOPIC HEART TRANSPLANTATION
I N MAN.
Ralph Haberl,M.D., Matthlas Weber, M.D., Hermann Relch en -
spurner,M.D., Bernhard Kemkes, M. D., Gerha rd Steinbeck,M. D.,
Unlverslty of Munich , Federa l Republ i c o f German y
De tection of acute rej ection after heart t ranspl an t a tion
lS mainly ba sed on i nvasi ve met hods tlll no w. As a non -
invas lve technique , we analysed two well -deflned surface
ECG recordlngs by Fast Fourler Tra ns f orm (Bl ackmanHarrlS
wlndo w, 512 points ) after l ow-nois e, hlgh-galn ampllflca-
tlon (0 .5- 300 Hz ) each day for f our week s a f t er hear t
transplantatlonin 23 patlents. Twenty-two rejectl on cri -
ses requiring t rea tment were dlagnosed b y endomyocardlal
bl OpSy and cyt ol mmunol ogi c monltorlng. Si ngl e beat ana-
l yS1S of t he total QRS-complex by Four ler Transform re-
vealed a progresslve increase of t he frequency content In
t he range between 70 and 120 Hz a t t he days of rej ec t l on
I n 20 /22 case s whlle the ECG remalned unchanged l n the
t i me domaln in most patients. The area under the spec t ral
plot s i gn l f i cant l y lncreased durlng t he t ime of rejectl on
compared to postoperative day t wo (p<O . Ol ) . There was a
close c or re l a t i on ln t i me be t ween actlvation of the cyto-
l mmunol ogl c monl t orlng and the change of the sp ec tral plot
(di f f er ence 2 days) . After s uccessful treatmen t t he fre-
quency spectra returned t o con t ro l values within 4 to 7
days . False posltlve results were seen in two cases o f
acute medlastinltis and large perlcardial effusion. A de -
cline of QRS voltage (>20%) was observed in 10 / 22 rejec-
tlon crlses and in 10 cases without rejectlon. The fre-
quency plots of 8 patient s after cardlac surgery, but no t
transplantatl on, were very stable. Thus, f requenc y analy-
sis bu t not QRS amplitude of low-noise ECG recordings is
proml s l ng fo r t he non- l nva s i ve ear l ydetection of ac ut e
rejection after hear t transplantation.
URINARY POLYAMINES ARE MARKERS OF CARDIAC ALLOGRAFT
REJECTION.
M Carrier MD, RW Emer y MD , F.A .C.C., N Perrotta, TP Dav i s
PhD, OH Russell PhD, JG Cope l an dMD , F .A. C.C. , Univ o f
Ari zona, Tuc s on.
Pol yamin es reflect the percen t age o f ce l l s in prolifera-
t ion (ace t yl put r es c i ne- ACPUT) or de generation (acetyl-
sp ermidi ne-ACSPD) and as marker s o f ce l l ul ar metabolic
activ ity may also reflect lymphocyt e proliferation and
or gan reject ion . From July 1985 t o June 1986, 8 patient s
( 7 heart an d I hear t - l ung transplants) were s t udied . Cy-
clos porine, aza th i opr ine and predn isone were us ed as im-
munos uppressive agen t s . Endomyocardial biopsy was per-
fo rmed t wi ce a week an dhistol ogic r e j ec t i on was charac-
terized by s tanda r d criteria. Urinary s pecimens were col-
lected dail y an d analyze d fo r pol yami ne s by high pres-
sure liquid chromatography . Total urinary pol yamin es (AC
PUT+ACSPD) an d ACPUT i nc r eas ed prior t o 12 b i opsy pr oven
reject i ons as compared to 51 negat ive histologic evalua-
tions as shown in th e t ab l e (mean + SEM) :
ACPUT TOTAL POLYAMlNES
(nM/mGor Creatinine)
POSITI VE BIOPSIES
36 .8 + 5 (n=12) 52.6 + 6
NEGATIVE BIOPSIES
22 + 2* ( n=5 1) 34 .3 + 3*
- *P<O .05 from r e ject ion
In or der t o evaluate pot ent i a l cl inical use. a dail y
l evel var ia tion of more t han ~ 35 % fr om base line was chos -
en to i ndi ca t e inc reased metabolic cellular activi ty and
t o pred i c t rejec tion in the next 14 days . Based on th i s
de f i ni t i on , the s ensitivity was 1007. , t hespecificity 87 7.
an d t he accuracy 777. . We have demonstrated that urinar y
pol yamines increase prior to cardi ac allogr a f t rejection
and da i l y levels variabil ity wi ll be a useful non-inva-
s i ve method to predict organ r e j ec t i on .
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TIME COURSE OF RESOLUTION OF PULMONARY HYPERTENSION AND
RIGHTVENTRICl~R REMODELLINGAFTER CARDIAC
TRANSPLANTATION. S. Bhatia, M.D., J. Ki rshenbaum, M. D. ,
R. Shemi n , u.n., L. Cohn , M. D. , J. Collins, M.D., V.
DiSesa , M.D., G. Mudge, M. D., M. St . J ohn Sutton, M. D.,
F.A.C.C. Brigham and Women ' s Hospital , Boston, MA .
The time cour se of regression of pulmonary hypertension
(PHT) and the response of the donor RV t o changes in PA
pressu r es (PAP) after cardiac transplantati on (CT) are
unknown. We followed 22 consecutive pts (18M, 3F; mean
42 yrs) post CT with repeat ri~h t heart ca t het erizatlons
and 20 Doppler echocardiograms (2DE) . Mean RA (RAP), PAP
and pulmonary capillary wedge (PCWP) pres sures(mm Hg)
were as sessed preop, I, 2 , 3 weeks and I , 3, 6, 12 months
after CT, and PVR measur ed preop and at 1 year . 2DE
obt ai ned at 1day, 1 week, 1 month and 1 year after CT
were analyzed for end-diastolic RV ar ea (EDA) in the
apical 4 -chamber view, maxImum RV mi nor dimension (EDD) ,
RV wall thickness (EDT) and severity (1-4 +) of tricuspid
re gur gi t ation (TR). PHT (mean PAP > 20) was present in
94% of pt s prp CT,but had resolved by two weeks postops
RAP PAP PCWP PVR (dynes.sec.cm )
Pre op: 15±6+ 38±9. 29±7. 176±57
2 wks post CT 9±4.. 22±6. 14±5. ••
1 yr post CT 8±5 19±5 12±5 95±29
+P < . 05 vs pre CT; .p < .001 vs pre CT; ••p < . 01 vs pre CT
The fall i n RA cor r e l at edwith the fall in PCW (r=0.80, p
<0 .0 01) . Despite these changes, RVEDA, EDD and EDT were
al l increased above normal (n=IO) at 1 day postop (p <
0.001) and remained unchanged at 1 year(p=ns). TR (1- 3+)
was present in 71% on day 1 and wasunchanged (X, grade)
at 1 year. We conclude that 1) PHT i s re versible and
rap i dl y resolves post CT with concomit ant falls in RAP,
PCWP; 2) the RV dilates immediately post CT and re mains
enlarged at 1 year in spi t e of the fall in PAP and PVR
and probably r ef l ect s the presence of persistent TR.
Monday, March 9, 1987
2:00PM-3:30PM, Room 26, Second Level
Clinical Cardiac Pacing
ABANDONMENT OF PACEMAKER LEADS
Seymour Furman , M. D. , F. A. C. ., Michael Behrens, R.N.,
CarofYii-Andrews- PA- C- anr Peter T. Klement owicz, M. D.
Montefior e Medical Center, Bronx , NY
Increasingly, functionless pacemake r ( PM) leads are being
abandoned i nplace because of fracture , hig h threshold or
i nsulat i on f a i l ur e after prolonged use. Some have question-
ed t he safety of this widely applied pract ice . One hundred
and ni ne ty-six int act or partially r emoved PM leads were
abandoned i nsi tu in 160 pts between January 1, 1965 and
J une 3D, 1986. Some pt s had several abandoned leads. Leads
were deemed uninfected i n 144 pts and cont ami na t ed with
s ta phylococcus epi dermidis in 16 pts . One uninfected and
aban doned lead became i nfe cted early after implant , t he pt
d i ed following open heart r emoval and th at of anadjacent
aband oned lead which was fi brotica l ly adheren t to t he sub-
clavian vei n . One hundr ed t en i nt ercur re ntPM pr ocedures
( PC) were performed wi t hout inci dent .
MEAN
LEADS IIPTS IILEADS IIPC FOLLOW- UP
Cl ean 144 179 103 50 .2 (mo )
Contamina t ed 16 19 7 42 .6 (mo)
TOTAL 160 198 110 49 . 4 (mo)
No other pt deve loped i nfection, thromboemboli sm or other
complication. The first pt wi t h an abandonedlead rema i ns
alive 256 mont hs later, th e second di ed of unrelated caus-
es a fter 116 mont hs . Lead r emoval may be impossible with-
out t hor acotomy or open heart surgery whi l e properly man-
aged aba ndonment of an uninf ect ed l ead ca rries a very l ow
complication rate. Abandoned f ragments contamina t ed with
staphyl ococcus epidermidis i n whi ch t he infect ed portion
ha s been removed can be f ree of l at e infe c t i on. Intercur-
rent PM pr ocedures do not ca use in fec t ion of abandoned
l eads.
SUPER IOR BIPOLAR SENS ING : A PROSPECT IVE STUDY
Peter Klementowlcz, M.O., Cary And rews PA-C and Seymour
Furman , M.f)., F. A.C.C., Mont ef iore Medlcal Center,
Bronx, NY
The senSing of electrical noi s e emlnati ng fr on non-cardiac
musc l e by dual cha mber pacemakers can result in 1n-
appropr1 at einhlbit10n or atr i al tracki ng. [ xperi ence
suggests that blpolar s ensing can elim1nate myopot ential
i nte r fe rence pre valent in unipolar pac ing syste~s . Yet
there are fe w prospective ambulato ry s t udi es whi ch
systematically compare myopotentlal inter f erence in
bipol ar and unlpolar pac i ng systems. We have conducted
pilot s t ud ies 1n 7 pati ents wl t h hiqh degree AVblock, who
were implanted wlt h identical programmabl e pol arity pacing
systems . In a prop sective double blind s tud y, one mont h
post impla nt , t he ODD pacemakers were randomly pr ogrammed ,
on consecut 1ve days, to eithe r a uni polar or b1polar
configuratio n . Ambulator y momtorin g was performed and
the number of episodes/hr o f myopotential inhib1tlon ( "11) ,
myopot ential tracklng (MT), atrial undersensing (AU) and
to tal at r i a l sensing abnormalities ( TAS A) were recorded.
Although rmpl ant data demonstrated no difference m P wave
amplltude (5 .6+3. 0 mV vs 5.7+2.9 mV ) or slew rate (1 .9+1 . 3
mV/ms vs 1. 9 ~1.3 mV/ms), ambulatory monitoring revealed:
UNIPOLOR BIPOLAR P Value *
TA5A (H/hr ) 2 .40+1.4 1 JOf;]J:[ ~
MI (fl/ hr) 1.23:<:'1.25 .00+.00 .04
MT (iI/ hr ) 1 . 05:<:'0 .95 .00+.00 . 03
AU (H/ hr) 0.1 2+0. 20 .01+.02 NS
* Paired t-test , unipo lar vs bipolar
Concl uqions: 1) Atria l s enslng abnormalit1es occur
i nf requently in pts wl t h 000 pac emakers. 2) Bipolar
senslng eliminates myopot ential i nterfer enc e. 3) The Iow
i ncid ence of atrial undersens i ng i s not altered by l ead
configur at i on.
LEAD END OF LIFE AND THE NEED FOR ELECTIVE REPLACEMENT
Osca r Oseroff , M. D., Peter T. Klement owi cz . M. D, Caro lyn
Andrews~ PA~C.~IChae l Benedek, M. S., Seymour Furman , M.D.
Montefiore Medical Center, Bron " , New York
Effecti ve cardi ac paci ng depe nds on hardware i nt egrity .
Sudden pulse generator (PG) or l eadfailure can be le thal .
PG fai lure is progress i ve and predictable. Lead fractur e
( LF) i s sudden with no r eliable predict ive technique. End
of use ful lead life occurs when fracture is likely, not
when i t has already occurred. We re vi ewed 2526 leads of 10
model s each with over 100 i mplant s obse r ved for 5-21 years
with a to ta l of 95 LF. None were polyurethane leads of
known early deterioration. We had impl anted all and deemed
t hem reliable.
LEAD IIOF I1 OF % SURVIVAL
MODEL LEADS L. F. s-n-- - --fQYR--1-5-YR
CL 591 40 94. 4 86 .8 69 .5
2 mm 281 19 92 . 7 87. 3 77 .8
4 mm 181 14 93.8 89.6 86.8
6907 429 7 97 .5 96 .6 96 .6
6901 135 2 100. 0 94.0 94 . 0
I E-65- I 190 8 95.1 91. 9 N/A
6971 273 1 99.3 NI A NI A
6961 141 1 99. 2 N/ A N/A
1 mm 158 3 96. 2 N/A N/A
327-1 52 134 0 100. 0 N/A N/A
Di s t i nct di fferences exis t i n lead longevi t y and failure
ra te. Thes e become more prominent with time. The risk of
LF increases af ter 10 year s . In one model 1/3 of leads had
f ractured 15 yea r s after i mpl ant . I t is unsa fe t o allow a
l ead t o remain in se rvice when f ractu re is l i kely . Pace r
dependent pati ents should be considered f or removal of old
l ea ds f rom service ei ther dur i ng pulse gene ra to r repl ace-
ment or elective i y when substantial l i kel i hood of LFex-
i s t s .
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THE EFFECTS OF EXTRACORPOREAL SHOCK wAVE LITHOTRIPSY ON
PACEMAKER FUNCTION
JonathanLangberg, M.D., Jason Abber, M.D., Joachim W.
Thuroff, M.D., and Jerry C. Griffin, M.D., F.A.C.C.,
University of California, San Francisco.
Extracorporealshock wave lithotripsy (ESWL), a non-
invasive treatment for upper urinarytract stones, is
contraindicatedin the presence of apermanentcardiac
pacemaker because of the unknown effects of the extremely
high pressure transientson pacemaker function. Twenty-
two pacemaker pulse generatorswere exposed to ESWL to see
if detrimental effects could be produced in vitro. The
pulse generator anddistal aspect of the leadwere posi-
tioned 5 cm from the focal point of thelithotripterand
10 cm from each other. Pulse generator functionwas ana-
lyzed during shock wave delivery synchronized with pulse
generator output, during shock waves at a rate faster than
the escape rate, and after exposure to lithotripsy.
During shock waves delivered synchronous with pulse
generator output, only one of 22 pulse generators mal-
functioned. ThisCPI 623 intermittentlyreverted to the
magnet rate, probably due totransientclosure of the reed
switch by very high energyvibration. When subjected to
shock waves at a rate greater than the escaperate, 50% of
pulse generatorswere inhibited by electromechanical
interference from the lithotripter. Both bipolar and uni-
polar devices were affected. However, analysis after ex-
posure to shock waves showed that none of the pacemakers
was damaged or spuriously reprogrammed.
In conclusion, cardiacpacemakers do not appear to be
damaged or reprogrammedby exposure to ESWL. The likeli-
hood of false inhibition appears to be very lowif shock
waves are delivered synchronous with the QRS.
THE EFFECT OF EXERCISE ON THE ATRIAL ELECTROGRAM IN HUMANS
BertrandA. Ross, M.D., F.A.C.C., Alexander Zinner BME.,
Vickie Ziegler, B.S., Peggy Woodall, Paul C. Gillette,M.D.
F.A.C.C., Medical University of South Carolina, Chas.,S.C.
Atrial sensing problems can occur in individuals with
permanently implanted pacemakers during periods of exer-
cise(EX). Recent work in dogs has shown scme decrease in
amplitude of atrial electrograms(AE) with EX. We there-
fore undertook to evaluate the changes in the AE in indiv-
iduals during exercise who had a dual chamber permanently
implanted device capable of telemetry production of a
calibratedAE. Eleven individuals, using the modified
Bruce protocol, were exercised to exhaustion while being
monitored throughout EX using a standard treadmill EKG
machine. All patients(ptsJhad either tined or screw-in
bipolar leads. Nine of the eleven tracings were clear
enough or complete enough for full analysis. Six of the
eleven tracings were seperately measured by two of the
authors with complete concordance in measurement. At
least 10 AE were averaged at rest and each minute of
exercise. The AE decreased in amplitude with each suc-
cessive minute of EX. The AE at rest and at maximal
heart rate were analyzed statistically. There was a
decrease in amplitude in 9/11 AE with EX (p<.05).
This was in the 9 complete tracings. The AE decreased
an average of 38.51 in these 9 pts. (p<.05) with a
range from 18.91 to 77.81.
CONCLUSIONS: The AE in a significant number of pts. in
the study decreased in amplitude with EX. Given the
range of reduction and the degree of reduction in AE
amplitude certain pts. may be at risk of loosing atrial
sensing due solely to a decrease in AE with exercise.
TRANSMURALACTIVATIONS AND POTENTIALS
WITHENDOCARDIALAND EPICARDIALPACING
DaVld W Frazier, BA, Wanda Krassowska, MS, Peng-Sheng Chen,
MD, Patrick D Wolf, MS, Ned D Danieley, MS, Sharon D Bowling,
AAS, Raymond E Ideker, MD, PhD DukeUniversity Medical Center,
Durham,NC
Epicardial(Er) and endocardial(EN) pacing IS widely used, yet little
is known about the 3-dlmensional distnbutionof potentialsgenerated
by the pacing stimulus or the spread of activation from these pacing
sites In 6 open-chest dogs, SImultaneousrecordingswere made from
120 transmuralelectrodes In 40 plunge electrodes within a 35x 20x 5
mm portion of the RV outflowtract during Er and EN pacing at a
strength of 2-3 X diastolic threshold The magnitude of extracellular
potentials (Ps) generated by the stimulus and the activation times
were compared In regions proximal«7 mm) and distal (>7 mm) to
the pacmg site. Local fiberorientatron was histologrcally determined
at each recording electrode For ENpacing: (1) EN Ps were larger
than Er Ps only In the proximal region (p-c O01), whileIII the distal
region EP Ps were larger(p<0.02); (2) EN activation occurred earlier
than EP for both regions(p<O 01) For EP pacing (1)Er Ps were
largcr than EN Ps in both regions(p<O.Ol); (2) EP activation
occurred earlier only in the proximal region (p<005), while EN
activation occurred before EP in thedistal region (p<O 01) The ini-
tial isochrones wereelhpncal in each plane of recordingelectrodes (EP
to EN) With the major axes of the ellipses parallel to the mean fiber
orientation between the pacing site andrecording plane rather than
parallel to local fiberorientation in the recording plane Thus, the
ellipses in each plane rotated With respect to eachother so that in 3
dimensions the activation front was helicoid, yet thetwist of the helix
was less than that of the correspondingtransmuralrotation of fibers.
For pacing from the RV outflowtract, we conclude (1) that beyond 7
mm from EN orEr pacing sites' (a)Er stimulus potentials in both
cases are larger than EN because ofresistivity differences insrde and
outside the heart wall; (b) activation In both cases isprimarilyEN to
Er because of rapid ENconduction: (2) the Initial spread of activa-
t.ion is helicoid anddeterminedby t.ransmural fiberdirection
Monday, March 9, 1987
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Cardiac and Metabolic/Hormonal Interactions
PLASMA LEVEL OE' ATRIAL NATRIURETIC PEPTIDES HI
CONGES'rIVE HEART FAILURE: CORRELATION WITH
HEM0 [)YNAMI C [NDIe E S • !5..2.£~s:!2~ Q9..<:!~~ M. D• ,
F.A.C.C., r a k a y u k i Ito, M.D., Hidekazu
Hashi mot o , M.D., Ta tsuo Sa take, M.D. Depart men t
of Internal Medicine 2, Nagoya University School
of Medicine, Nagoya 466, Japan.
Plasma level of immunoreactive atrial
natriureticpeptides (ANP) was de t e rni ned in 36
healthy subjects and 24 patients with congestive
heart failure (CHI") by r a d i o i mrn un o a s s ay and
correlated with symptoms and hemodynamic
i n d i c e s , Plasma I'.NP level in healthy s u b j e c t s
was l3l±12 pg/rol. Those in patients with CHI"
were 199+42 in NYHA class I, 598+94 1n class 11,
1523+193- in class LII, and 273-7+404 pg/ml in
class IV. Plasma ANP level were slgnificantly
h i q he r in patients in classes 11 (p<0.05), III
and IV (both, p<0.00l), than in healthy
subjects, while those in pat1ents in classes III
(p<0.0l) and IV (p<0.05) were greater than in
11. In patients with CHI", level of ANP
significantly correlated with PCW pressure
(r=0.62, p<0.(5) and mean PA pressure (r=0.62,
p<0.(5), and negatively correlated with Cl
(r=-0.67, p<0.(5) and LVEF (r=-0.54, p<0.(5).
There was a high correlation between plasma ANP
and cyclic GMP levels (r=0.82, p(0.00l). These
findings are compatible with our findings that
plasma level of cyclic GMP was related to the
severity of the heart failure and the pulmonary
artery pressure, and suggest that increased
atrial pressure stimulates the secretion of ANP,
and the plasma level of ANP could be used as an
obJective index of CHE' severity.
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CAN ATRIAL NATRIURETIC PEPTIDE SECRETION BE FURltlER
STIMULATED IN PATIENTS WITH SEVERE CONGESTIVE HEART
FAILURE?
Barry F. Uretsky, M.D., FACC, Joseph G. Verballs, M,D.,
Srinivas Murali, M.D., Anita M. Valdes, RN, Judy A.
Kolesar, RN, P. Sudhakar Reddy, M.D.,FACe. University of
Pittsburgh, PA.
ATRIAL NATRlURETIC "'ACTOR IN ATRIAL nBRILLATION AND
DURING SUPRAVENTRICULAR TACHYCARDIA.
Denis Roy, KO. FACC, Fran~ois Paillard, KO, Dennis
Cassidy, MD, Martial G, Bourassa, MD, FACC, Jolanta
Gutkowska, KO, Jacques Genest, KO, and MarcCantin, KO,
Kontreal Hear-t Institute and Clinical Research
Institute,Montr-eal,Canada.
Plasma levels of atrial natriureticpeptide (ANP) have
been found to be markedly elevated in patients (pts) with
severe congestive heart failure (CHF). To test whether
plasma ANP levels can rise further in response to volume
expansion, 250 ml of 20% mannitol (M) were infused over
30 min in 10 CHF pts. Plasma ANP (pg/ml), mean right
atrial (RA,mmHg) and pulmonary artery wedge (PAW,mmHg)
pressures were measured andpercent change in plasma
volume (PV) was calculated.
M Infusion
B 5 min 15 min 30 min
RA 5+4 7+4 * 7+4** 7+4**
PAW 15+7 16+7 17+7 17+8
ANP 90+55 120+71 150+98* 146+96**
PV 5+5** 8+3** 11+3**
B=baseline, *p<O,05 **<.01 vs B
Each CHF pt increased ANP and PV in response to M.
These data demonstrate that in response to volume expan-
sion in CHF pts, plasma ANP rises further from an already
elevated level (control=23.7+1.4 pg/ml) and do not sup-
port the contention that ANP-secretion is maximized in
CHF.
Plasma inununoreactive atrial natriuretic factor was
measured in 10 patients (pts) with chronic atrial
fibrillation before and after cardtoversIon and in 14
pts during electrophysiologic study of supraventricular
tachycardia, The mean plasma concentrations of AN!" in
at,..;"I fibri llation was 138148 pg/ml and decreased to
I16!4s pg/m) 1 hour after cardiover-sion to sinus
r-hythm (p<0.005). The mean plasma concentration of
ANF increased from 117!s3 pg/ml in sinus rhythm 10
25l!137 pg/ml during Labccat.ocy induced
supraventricular lachycardia (p<O.(05) . Right atrial
pressure was recorded in 12 pts; baseline right atrial
pressure was 4.3!1.9 nmffig and increased to 7.4!3.6
mrnHg during supraventricular tachycardia (p<O,005).
A Lmear relation was noted between the changes in
plasma ANF and right atrial pres sur'e during induced
supraventriculartachycardia (r"0.60, p<O.Os).
We conclude: 1) in pts with chronic atrial
fibrillation plasma AN!" fall rapidly af t er- restoration
to sinus r-hythrn, 2) the laboratory induction of
supraventricular tachycardia is associated with a
parallel rise in plasma AN!" and right atrial pressure.
These findings suggest that the release of AN!" in lhe
circulation is rapid and is modulated by changes in
atrial rhythm andpressure.
EARLY AND £ATE EFFEO'S OF PEROJI'JlNID1S~ MITRAL
VALVOIU4Y 00 PlASMAIEVEIS OF ATRIAL NA.TRIURETIC FACIat.
HawardM. Waldman, lID, PhD,19or F. Palacios, MD, FACC,
Peter C~Block, iID,FAcc,-RobertJ. G3i'Jin, Charles J.
gamey, MD, Robert M. Graham, MD, Michael A. Fifer, MD.
HarvardMedical School and Massachusetts General
Hospital, Boston, MA
To ass~ss the effect of alterationof left atrial
pressure on plasma level of atrial natr i uret.ro factor
(ANF), we measured ANF ':>efore, early (5-10 min) after,
and late (24 hr) after percutaneousballoon mitral
valvotomy (PMV) in 10 ?atients with mitral stenosis.
Pulmonary artery blood samoles ~re drawn, andANF
levels were measured on Sep-Pak extracted plasma by
radioimmunoassay. Mitral gradient fell from 19~6 (SD)
to 7+4 mm Hg (p<.001), cardiac out~ut increased slightly
from-4.5~1.3 to 4.q~1.1 L/min (p=NS), and2mitral valvearea increased from 0.9+0.3 to 1. 9+0. 6 cm (;J<'(01)
after PMV. The effects-on LA (pre::PtIITand early
post-PIN) or PCW (late :")ost-PIW) and RA nressures awl
ANF level are shown:
VT< 5 events/24hr 1795 25 4.3 1.8 48 17
VT> 5 eventsn4hr 7105* 16* 3.9* 1.8 110* 31 *
PRA Aldo PNE EPI DOP ADH
Conclusions: (1) Plasma ANF level is increased early
(5-10 min) after successful percutaneousballoon mitral
valvotomy, possi~ly due to transient rise in LA pressure
associated with balloon occlusion of valve. (2) ANF
level falls markedly late (24 hr ) aftel' percutaneous
mitl'al valvotomy.
VT< 5 events/24hr 1.4 15 451 105 169 4.3
VT>5events/24hr 5.9* 27* 593* 102 115 3.Q
where Lsx= furosemide dose (mg!24hrl, VPC= ventricular
prematurecomplexes/24hr;KCL = oral K supplement(meq/24hr).
Pts with frequent VT had higher levels of PNE, PRA and Aldo
than pts in whom VT was rare orabsent; such enhanced neuro-
hormonal activity may have been related to the lower EF or the
higher dose ofdiuretics. Such aggressive diuresis may haveinter-
acted with high levels of PNE and Aldo tocause the lower serK
in VT pts, even thoughthese pts received higher doses of ora I
KCL. Importantly,functional class did not differ in the 2 groups.
Inconclusion, ventriculararrhythmiasin CHF commonly occur
in pts with neurohormonalactivationand potassiumdepletion.
ANF
~
223+124
338+172*
91+49*#
OQst-PMV
RA
(mmHg)
4+3
3+3
8+4
vs.-early
LA!PCW
(mmHg)
Pre-PI'N 26+6
Early post-P~W 10+5*
Late DOst-PMV 14+3*
*p<.01 vs. pre-PMV-#o<.01
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ALTERED FETAL CIRCULATION IN DIABETIC PREGNANCIES.
Erik J. Meijboom,M.D.,F.A.C.C., Maryse M.C. De Smedt,M.D.
and Gerard H.A.Visser,M.D., Univ of Groningen, the
Netherlands and Univ of Maryland, Baltimore.
Even with good glucose control insulin-dependent t ype I
diabetic pregnancies(tIDP)are complicated by impaired
placental vascularisation. We studied l ongi t udinal l y 17
fetuses of well controlled tIDP's (2 cl a ss B, 5 - C and 10
- D) to evaluate effects on the fetal ci r cul at i on . Doppler
frequency shift tracings, valve diameters and intercept
angles were measured at right and left atrio-ventricular
valve(AVV) orifices at 4 wk intervals starting at 15 wks
gestation. AVV flow was calculated and compared t o normal
fetal data obtained in previous studies. Maximal and mean
temporal velocities (MTV) increase in both groups during
gestation, but significantly more in fetuses of t IDP' s
(p-CO. 05 ) . Combi ned ventricularoutput, absolute and per
kg estimated fetal weight, were also greater in the fetus
of tIDP. In the normal group the ratio of the left/right
ventricularoutput decreased significantly from (1.34+.28
to 1.08+.28 3D) during gestation. In tIDP's this decrElase
did not--occur (1.2+.26 to 1.25+.29 3D). In 10 of these
fetuses (class D) MTV's 4 wks prior to delivery correlated
positively with increased septal
thickness after birth (figure).
We conclude that these data
indicate significant dif-
ferences in the fetal cir-
culation between normal and
well controlled tIDP's and
suggest the existence of a
compensatorymechanism
which increases cardiac
output and causes cardiac
hypertrophy.
EFFECT OF DOBUTAMINE INFUSION ON SERUM ELECTROLYTES AND
ARTERIAL OXYGENATION IN CONGESTIVE HEART FAILURE
Irv;n F Goldenberg. MD, Br;an TLew, MD, Maria-Teresa
Olivari, MD, James A Daniel, f1l, FACC, Richard R Nelson,
MD, FACC, Robert A. Van Tassel, MD, FACC, Robert Ochi,
BA, T Barry Levine,MD, and Jay NCohn, MD, FACC,
Minneapolis Heart Institute Foundation and University of
Minnesota, Minneapolis,MN
Beta-agonist are often used in the treatment of heart
failure but are known to produce arrhythmias. Various
beta-agonists have been shown to cause a decrease in
serum potassium (isoproterenol, epinephrine), serum
magnesium (epinephrine), and arterial oxygenation
(dopamine) in pts without congestive heartfailure.
These drug-inducedchanges in arterial oxygenation and
serum electrolytes could potentially contribute to the
arrhythmia production in heartfailure pts. We therefore
evaluated dobutamine'seffect on serum potassium,magne-
sium, calcium, sodium and arterial oxygenation in 13 pts
with chronic congestive heartfailure. Dobutamine infu-
sions at 9 ± 1 mcg/kg/min produced significant hemodyna-
mic improvement in all pts (Cl 2.1±0.2 to 3.5±0.3,
p<O.OOI, mean±SE; stroke index25±4 to 37±4 ml, p<O.OOI;
right atrial pressure 9±2 to 6±2 mmHg, p<0.05, systemic
vascular resistance 1413±153 to 899±90 dyne-sec-cm-5).
Three pts developed worsening of ventriculararrhythmias
(1 pt ventriculartachycardia,1 pt ventricularcouplets,
1 pt frequentprematureventricularcontractions). There
was a decrease inserum potassium (4.6±0.1 to 4.2±0.2
mEq/L, p<0 .D001), serum magnesiwn (2.0±0.1 to 1.9±0.I,
p<0.05) and serum calcium (9.3±0.2 to 9.0±0.1, p=0.07).
Therewas no change in arterial oxygenation or serum
sodium. We conclude that dobutamine infusions produce
significant changes in serum potassium and magnesium.
The changes in these electrolytes may be responsible for
some of the arrhythmias produced by thi s agent.
Monday, March 9, 1987
2:00PM-3:30PM, Room 6, Second Level
Pediatric Clinical Physiology
TRANSIENT MYOCARDIAL ISCHEMIA OF THE NEWBORN - CLINICAL
AND ECG EVOLUTION.
Sophronia O. Turner-Games,M.D., Teruo Izukawa, M.D.,
Richard D. Rowe, M.D., F.A.C.C., Hospital for Sick
Childrenand University of Toronto, Toronto,Canada
EFFECTS OF INCREASES IN HEART RATE ON LEFT VENTRICULAR
STROKE VOLUME AND CARDIAC OUTPUT IN THE HUMAN FETUS.
John Kenny, M.D., TedPlappert, C.V.T., Peter Doubilet,
M.D. , Ph.D., Martin St. John Sutton, M.D., F.A.C.C.
Brigham andWomen's Hospital, Boston, MA.
Little is known regarding the effects of changes in heart
rate (HR) on LV stroke volume (SV) or on the regulation
of cardiac output (CO) in the normal humanfetus. Such
information is clinically relevant in the treatmentof
intrauterineheart failure and tachycardia, particularly
since the myocardial contractile proteins are different
in the fetus. We used Doppler echocardiographyto
assess the effects of increases in HR on LVSV and CO in
20 normal humanfetuses (mean age 35t3wks). Increases in
HR were at t ai ned byauditory stimulation of the fetus
with a sound generator placed on the maternal abdomen.
Aortic diameter was measured at valve level from 2D ech o-
cardiogramsand cross-sectional area (AA) calculated
assuming it to be circular. Doppler vel oci ty spectra
recorded from the ascending aorta and maximum LV long
axis areas were digitized to obtain flow velocity
integrals (FVI) and LV sizes . LVSV was calculated as:
FVlxAA, and CO as SVxHR both at resting HR before and at
maximum HR after auditory stimulation. Following
stimulation HR increased from 132t8 to 168t8 beats/min (p
<:. 001) . This change in HR resulted in a significant
decrease in LVSV from 3.6±1 .5 to 3.0t1.2 ml (p <c.01) and
a decrease in LV diastolic area from 3.0tl.0 t o 2.5±0.8
cm2 (p ~0.02). However CO did not change, (0 . 47t . 19
l/min at rest and 0.47±.18 l/min at peak HR. We conclude
that in the normal human fetus increases in HR result in
a decrease in LV chamber size and in LVSV, but no change
in CO over the range of HR studied. Knowledge of this
physiologic relationship in the humanfetus may help in
predictinghow chronotropicdrugs modulate CO in the
treatment of heart failure and tachycardia.
The sequelae of transientmyocardial ischaem1a (TMI)
were reviewed in 59 terminfants (37M:22F) with
structurallynormal hearts admitted in1983-85 with a
diagnosis of birth asphyxia (n=23) or with ECG changes
of TMI ' 24 hoursafter birth (n=36). Murmursof
atrioventricularvalve regurgitation(AVVR) detected 1n
28 pts were confirmed in 23/24 by 2DE +/- angiography.
AVVR resolved in 20 pts (86%) over a 2 d - 6mo period
(median 6 d). 5 pts died - (non-cardiaccauses). In 3
pts, AVVR, LV dyskinesia (2DE) and ECG anomalies have
persisted for 2 mo (until death), 4mos, and 48 moo
Silent tricuspid regurgitationwas detected by2DE in
58% of those withoutmurmurswho were studied . Initial
ECGs were abnormal in 57 pts - TMI grade : 2 in 39 (69%)
and grade ' 3 in 18(31%). Twenty ECGs were reviewed -
11 (55%) normalized over a 6 d - 7mo period (median 2
mol . Residual ECG anomalies included 20 A-V block and
ischemia. Neither the presence noresolution of AVVR
correlatedwith the severity of birth asphyxia nor the
ECG - TMI grade. Although the cardiovascularsequelae
or myocardial ischemia are usually transient, the data
should prompt the need for careful reviewafter the
initial admission.
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THE EFFECTS OF ACUTE HYPOXIA AND REOXYGENATION ON FUNCTION
AND METABOLISM OF THE ISOLATED NEONATAL HEART
Antonio Corno, M.D., Hillel Laks, M.D., F.A.C.C., Hakob
Davtyan, M.D., William Flynn, M.D., Davis C. Drinkwater,
M.D., Paul Chang, UCLA Medical Center, Los Angeles, Calif.
The effects of acute hypoxia and reoxygenation were studied
in isolated, neonatal pig hearts. Hearts were perfused by
arterialblood from an adult pig with P02 controlled by a
membraneoxygenator. Function was assessed by measuring
isovolumic peak developed ventricularpressure (DVP) ,
dP/dt, and LVEDP in a balloon inserted in the left ven-
tricle. Coronary blood flow (CBF), and arterio-venous
differences of oxygen content, glucose, lactate and pyru-
vate were also measured. Three groups of 5 hearts were
subjected to one hour of mild (p02=42mmHg, 02 Sat=82%),
moderate (p02=27mmHg, Sat=59%) or severe (p02=20mmHg,
Sat=36%) hypoxia followed by one hour of reoxygenation
(p02=400mmHg, Sat=lOO%). ThefolloWing variations from
baseline (%) were observed at one hour of hypoxia:
MILD MODERATE SEVERE
Heart Rate l19~7* l13~lO 96~7
DVP llO~20 81±15* 63~7*
LVEDP 73~29 l26~22 l41±1l*
CBF 23l~66 334~40* 560~96*
02 Extraction l18~lO 19l~2l* 395~34*
/::, Glucose +13±l* +12±l* +5±l
/::, Lactate -19±lO* +7!5 -3~2
/::, Pyruvate -160~lO* -13~4 +5~3 *p<O.05
After one hour of reoxygenation, all values returned to
baseline except CBF and LVEDP which remained elevated in
the severe hypoxia group (224~42% and l2l~15% respective-
ly). Conclusions: The isolated, blood perfused, neonatal
heart tolerates hypoxia due to an increased CBF and 02
extraction; severe hypoxia depresses the systolic and
diastolic functions, and ventricularcompliance remains
depressed after reoxygenation.
THE CARDIAC MANIFESTATIONS IN DISORDERS OF FATTY ACID AND
CARNITINE METABOLISM.
T. Ino, M.D., L. N. Benson, M.D., G. W. Sherwood, M.B., R.
D. Rowe, M.D., F.A.C.C•• The Hospital for Sick Children,
Toronto, CANADA.
The clinical manifestations and prognosis of patients with
cardiomyopathy(CM) associated with hypocarnitinemia is
uncertain. We retrospectivelyevaluated cardiachemo-
dynamics, histological findings and responses to oral
L-carnitinetherapy in 11 children withCM associated with
abnormal carnitine metabolism. Three had systemic
carnitine deficiency, 2 familial hypocarnitinemia wIth
skeletal muscle myopathy and neutropenia, 3transient
neonatal hypocarnitinemiaand 3 carnitine insufficiency
syndrome. Six had a hypertrophiccardiomyopathy(HCM) and
6 had a dilated cardiomyopathy(DCM). Hypotonia was
present in 7. The cardiothoracicratios were greater than
60% in 9. The most frequent abnormalitieson the
electrocardiogramwere ST-T wave inversion 1n left pre-
cordial leads with various degrees ofleft ventricular
hypertrophy. Echocardiographically, 2 of 5patients with
HCM had decreasedLV function and 3 of 5 patients with DCM
had increased thickness of theleft ventricularwall. The
histological evaluations (2 autopsies and one biopsy)
revealed striking lipid accumulationwithin hypertrophied
myocytes. Five of 8 patients on carnitine replacement had
improvementechocardiographicallyduring 1 to 2 years of
follow-up.
In summary, both HCM and DCM can result from abnormal
lipid carnitine metabolism. The determination ofplasma
carnitine concentration should be required In allpatients
with either type of CM of unknown etiology as
supplementationmay lead to improvement.
LEFT VENTRICULAR FUNCTION AND BLOOD FLOW DURING EXERCISE
IN ACANINE MODEL OF CHRONIC CYANOSIS
Thomas P. Barra~ry, M.D., Stanley Einzig, M.D., Ph.D.,
James W. Blatch ord, M.D., Gil Lewandowski, Lee Williams,
W. Steves Ring, M.D., F.A.C.C. University of Minnesota,
Minneapolis,Minnesota.
To study the effects of chronic cyanosison LV function
and blood flow (BF), dogs underwent inferior vena cava to
left atrial anastomosis. Sixmonths later, 7 cyanotic
(mean hematocrit, 61%; mean arterial P02' 44 mm Hg) and 4
control dogs were instrumented withultrasonic dimension
transducers and micromanometers. Pressure-demensionand
LVBF (ml/min/g) data (mean.:. SE) were obtained at rest and
during exercise (treadmill running at3-4 mph) 7 days
after recoveryfrom surgery.
Control (CNTL) Cyanotic (CYAN)
Rest Exercise Rest Exercise
HR (bpm) 104 .:.10 169 .:.14* 133~ 145 +5
Cl 4.6 +0.5 8.0 +1.3* 6.7 ~0.6* 9.5 ~11-1+
MAP (mmHg) 107 ~6 116 ~4 104 +3 124 +5
LVBF 1.32 +.16 2.27 +.19* 1.24 +.12 2.09 +.21+
Endo/Epi 1. 24 ~. 07 1. 23 ~. 07 1. 25 ~. 05 1. 26 ~. 02
Emax 3.1 +0.7 4.9 +1.0* 2.9 +0.3 2.9 +0.3
* = p < .05 vs. Rest CNTL; + = P < .OS-vs. Rest CYAN
Cyanotic dogs had higher heartrate (HR) and Cl (L/Min/m2)
at rest compared to controls (p < .05). Failure of HR and
contractility (Em~x = end-systolic pressure-volumerela-
tionship, mmHg/cm ) to increase in CYAN with exercise sug-
gests LV dysfunction. LVBF and Cl increased similarly
during exercise inCYAN and CNTL. Exercise did notchange
the subendocardial/subepicardial(Endo/Epi) BF ratio.
Thus, chronically cyanotic dogs manifest LV dysfunction
when exercised which is not due to decreasedLVBF or
relative subendocardial underperfusion.
Monday, March9, 1987
4:00PM-5:30PM,Room 6, Second Level
PediatricDysrhythmias
CARDIAC DOPPLEP FT OWS fll'IU~G FETAL OYSFHYTHMI"S: STUDIES
OF rosr ExTRA5YSTOLIC POTH"lIAT!O!\AKO RFeOVFRY FROM
TACHYCAI<DIA. Kathryn L.Reed, M.D., Davf d .I, 5ahn,M.D.,
FACC, Gerald ~!arx, M.O .• fAce, Lewis Shenker, M.D.,FACC,
('niv of AZ, 1ucson, A7.
Ve Rtudied ~1 fetuses (eRtimated gestational a~e 21-41
wks] with carc1iac dysrhythmias URipf, Poppler echo te
measure RPple corrected flow ve'oc1t1es (VEL) and the
area s under the Lop p Ler curv-- (VEL time Irtegra l (VT:)
acrOhS the tricusFid (TV), mitral (MV), PA, And AO val-
ves. Thp type of d,srhythmia w~~ identified bv X-wode
Doppler s t udf es and was cor-f trme d bypostnatal [er; in 76
infants. For isolated atrial extrasystoles (n=75\, the
most common clysrhythwla, the averap.e incrensc l.P the VTI
for the post ex t rusvst o l t c l.e a t f r oni normal beat s ""clR
3J%±1.8~ SE during diastole (D) (TV or MV) ape 'O%~2.J~
during systole (5) (PA,AO). \o,'hen corrected for t hc
length of the 0 compensatory pansp, watched atrlovent-
r Lcul s r and great artery flOWR showed similar % change-s
for Sand D enhance~pnt on the post extrdhystolic beat.
Further, the I \'TI incYf'rtse/D compensatory pause rela-
tionship was steeper for Fetuses >,4 weeks when cowpared
tn those <34 weeks. For 5 fetuses studic~ c1uring and
af t e r conversion f r om supraventr Lculnr tachycardia, th-
7 increase in S VTI after cprdioverslonwas 387 and mean
VI:L which adj us t s tor the' HR differer.ce Lncr ea sed 327.
after convprRion. Three of these fetuses had tricuspid
insufficiency whir~ disappearedafter conversion. The
VTr changes for post-ectoric beats were ccpcordant for 5
dnd 0 indices and supgest an increa~ing capacity for
POht extrasyRtolic potentiation in late gestdtion
fetuses. Our study shows matur[ltionalresponses for
fetdl extrasystolic potentlation and provides methods
for studying fetal cardiac respons"s to dysrhvthmias.
36A ABSTRACTS JACC Vol. 9. No. 2
February1987:36A
ONLY 8 % OF POST OPERATIVE TETRALOGY PATIENTS
HAVE INDUCIBLE VENTRICULAR DYSRHYTHHIASLeslev
L. Ewing. ICD., Paul C. GiIlette, H.D., Vicki
Zeigler, R.N., Alex Zinner and Ashby Taylor,
H.D., Medical University of South Carolina,
Charleston, S.C.
Pts after Tetralogy of r s i i e e rrr) repair
have a 3% risk of sudden death, thought to be
due to ventricular(V) dysrhythmias(DYS).
The best method of identifying the pt at
risk is not known. Fifty-eight consecutive
p t s had electrophysiologic study(EPS) 3/84-8/86
at routine post operative catheterization.
The EPS included atrial(A) and V stimulation
with single and double extrastimuli, A and V
rapid pacing, and V burst pacing.
The pts ranged from 3 to 24 years. Age at
repair was 4 months to 13 years, median - 2
years. Six pts were studied after a second
procedure for insertion of conduit or prosthetic
valve. RV systolic pressure(RVSP) was 20-105mmHg
and diastolic pressure 3-20. Seven patients
had RVSP>60.
Inducible DYS were found in 5158 (8%) pts;
3-sustained ventricular tachycardia (VT),
I-nonsuatained VT and I-inducible couplets.
RVSP was 28-50, and RVED 5-10. Only 115 had
had PVCa before EPS. Five pts had syncope by
history before EPS, sustained VT was induced in
one.
The lower induction rate compared to
previous studies may be due to younger age at
repair or the unselected population. In an
unselected pt population EPS incidence of
inducible DYS is low, but cannot be predicted by
symptoms or hemodynamics.
TRANSCATHETERELECTRICAL ABLATION OF ACCESSORY
PATHWAYS IN CHILDREN.
Burt I. Bromberg, M.D., i\lacdonald Dick 11, F.A.C.C., 1\1.0.,
Fred Morady, M.D•• F.A.C.C., e.s. Mott Children'S Hospital,
University of Michigan, Ann Arbor.
Recent successful transcatheterelectrical ablation (TEA) in
adults with accessory pathways (AP) prompted us to attempt
the technique in four children, age 15-17 years, weight 33-
101 kg. After placement of standard electrode catheters
including a coronarysinus catheter (CS), each patient received
electrophysiologic study (EP) to confirm and locate the AP.
A posterior septal AP (PSAP) was identified in two, a left
posterior (LPAP) in one, and a left lateral AP (LLAP) in one.
Under general anesthesia three Pts received 300 J 2-4 times
between electrodes at the mouth or the coronarysinus (cathode)
and a patch placed left mid-back (anode). TEA was successful
in one Pt with concealed PSAP, confirmed by EP one week
later. In a second Pt with PSAP transient 3-5 minute loss of
pre-excitation followed each of three shocks but anomalous
conduction returned thereafter. In a third Pt with LPAP a
slightly distal CS location of the AP with resultant lack of
proximity between the electrodes and the AP probably
contributed to railure. After mapping a LLAP through the
CS in the fourth Pt, 100-150 J were delivered througha single
electrode on a catheter in the lert atrium reached via PFO
resulting in loss of anomalous AV conduction for 12 hours.
Although CK-MB rose to 5, 6, 20% in three Pts, no
complications were encountered. This experiencesuggests that
a PSAP may be successfully ablated by TE'\ in the young,
that proximity and energy delivered are importantdeterminants
of successful ablation, and that the two catheter approach in
patients with LLAP may be useful once energy requirements
are determined.
EFFECTOF PROPRANOLOLAND VERAPAMIL DURI NG
INFANT ORTHODROMICRECIPROCATING TACHYCARDIA
Mlchael Sllberbach, MD., Ann Dunrugan, M.D., and D. Woodrow
Benson, Jr ., M.D. ,PhD., University of Minnesota, Mmneapolis .
It is thought that the major action of propranololand vera-
pamrl when administered during or thodrorruc reciprocating
tachycardia (PAT) IS to Impair atrioventricular (AV) node
conduction. We studied the effect of Intravenous propranolol
(0.2 rng/kg) In 18 Infantsand the effect of Intravenousveraparrul
(0 .15 mg/kg) In 10 Infants (age 1 day-12 months) undergomg
transesophagealstudy for evaluationof ECG documentedPAT .
Propranolol Increased PAT cycle length (mean ± SD, pre-
propranolol cy cle length 226±30 ms; post-propranolol 257±28
ms, p<0.OO1). Propranolol Increased the AV Interval (pre -
propranolol 95±21 ms, post-propranolol 124±35 ms, p<0.001l.
No spontaneous PAT terminations occurred followrng propran-
olol. Veraparrul Increased the cycle length of PAT (pre-verapa-
mrl 230±45 rns, post-veraparrul 246±38 rns , p<0.05), n=6. The
change In neither the AV nor the ventrrculoatrral (VA) Interval
was Significant, (pre-verapamrl AV Interval 101±21 ms,
post-verapamrl AV Interval 115±28 rns, NS; pre-veraparrul
VA Interval 128±52 rns, post-verapamrl VA Interval 131±56
ms, NSl. Spontaneous PAT termination followrng veraparrul
was observed in 7/10 Infants. At PAT termination, an atrial
deflection was recorded (5/ 7 infants), a ventricular deflection
(1/ 7 Infants), undetermined(1/ 7 Infants).
Propranolol prolongs PAT cycle length by effecting AV node
conduct ion as demonstratedby prolongation of t he AV Interval.
Veraparrul prolongs PAT cycle length Without Significantly
altering e ith er the AV or VA Interval. Further, termination
of PAT In Infants after veraparrul ma yresult from blo ck In
either the AV or VA interval. Thus, ve rapa m rl mayeffect
either of the t wo limbs of the PAT circurt. These results suggest
a different mechanism of action of propranolol compared to
veraparrul duringPAT InInfants.
TBE ELECTIlOPBYSIOLOGIC EFFECTS OF PIlOPAFEROHE OH
THE IMMATUIlE MAMMALIA. BUilT. Hui Xu, M.D., J.Y.!!.!!.
Y!.ll!!.t!!.!!.~ M.D., Jorge HcCormack, M.D., Adrienne
Stolfi, Henry Gelband, M.D., F.A.C.C., Arthur S.
Pickoff, M.D., F.A.C.C. University of Miami
Miami, Ft
Propafenone (p) is a type IC antiarrhythmic
agent. The effects of this new c lass of drugs
on the immature heart are unknown. The
cumulative electrophysiologic effects of P (I, 2
and 4 mg/kj: LV.) were investigated in 10 canine
neonates (age 5-11 days). The resting heart
rates decreased from mean (iii) 175 to 142 BPH (p
< 0.01) with a proportiona 1 pro1 o n g a t ion in
sinus node recovery times. P caused a
lengthening of AH from 54 to 64 msecs and HV
from 18 to 25 msecs (p < 0.01). Antegrade and
retrogradeWenckebach periodicity occurred at
longer cycle lengths after P. Significant
increases in the effective (E) and functional
(F) refractoryperiods (RP) of the atrium (A),
AV node (AVN) and ventricle (V) were observed (p
<0.01):
_£.2.!!.t~Q.l ~~!.1!&.L!i.&. ~=-£.'!!&.L!s&. ~='~1!&.L!s&.
AERP !!' 63 76 88 117
AFRP m 101 115 126 154
AVN ERP iii 144 164 185 203
AVN FRP in 186 202 225 241
VERP iii 150 164 175 194
VFRP in 172 188 199 214
The effects of P were dose related and included
an increase in refractoriness of the myocardium
and depression of intracardiac conduction times
with a moderate decrease in resting heart rate.
Thus, P exerts significant effects in the
neonatal heart and may be useful in the
treatmentof a wide variety of neonata1 tachy-
dysrhythmias.
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Acetoacetate
+188±78
+S9±38*
EPICARDIAL VEIlTRlCOLAR PACBMlUtER LEAD LCliGEVITY IN
cm:J.lIB<l
GeraJd A Serwer, MD, FA<..'C, Jane M MericJe, BSN, and
Brenda E Armstrong, MD. Duke ~ledical center, Durham, NC.
For ventricular pacing, epicardially inplanted leads
remain the IOOSt widely used in children. Yet, their
expected longevity in children remains unknown. I'picar-
dial lead longevity was evaluate<:lin 81 children who had
126 ventricular epicardial leads inplanted fran 1/70
through 12/85. Age at ini t.i.al, inplant was 1 day to 18
yrs, rredian <1yr. Median age for all lead inplants was 7
yrs. Fach child had fran 1 to 5 leads inplanted during
the study period. Follow-up for each child was fran J to
192 mos, median 120lOOS. 85 leads were sutureless helical
leads. 41 were suture-fixated stab leads. lead failure
was defined as loss of capture with a high pacing
threshold found at cperationor sensing failure. 34 leads
were lost to follCllll-up during the study period. Actuar-
ial life table analysis of lead longevity showed
84.9+3.5% (SE) of the leads survived 1 year. No signifi-
cant-furtberdecrease in survival rate occurred until 53
mos whenthe survival rate declined to 75.3+4.6%, p<0.05.
'lllere was then agradual steady decline in-lead survival
rate to 101 Il!OS at which time the survival rate was
49.4+6.8%. The 50% survival rate was reached at 100 mos.
Fran-101 to 156 mos lead survival rate showed no signifi-
cant decrease being 44.0+7.9% at 156 mos, p> 0.05. The
decline in lead survivarrate was greater within the
first 12 month period post implant -15.1%- than during
any subsequent 12 monthperiod. reads surviving to 12 mos
are highly likely to survive until 53 lOOS as the survival
rate showed no significant decline. Of those surviving to
53 lOOS, 74.1% should survive to 120 mos. Overall epicar-
dial ventricular lead longevity is very good in the
pediatricpopulationwhere prolonged pacing is needed.
Monday, March 9, 1987
2:00PM-3:30PM, Room 16, Second Level
Myocardial Metaholism and Physiologic Function
NlFEDlPiNE ENHANCES GLUCOSE METABOLlSM IN RABB1T
MYOCARDiUM.
Heinrich Taegtmeyer, M.D., D.Phil., F.A.C.C., Merrill
I.. Overturf, Ph.D., University of Texas, Houston. Texas.
1n order to assess the chronic effects of nifedipine
on myocardial energy metabolismwe treated rabbits for
eight weeks with 1.2S mg nifedipine/kg/day in the
drinking water (Nl). Parallel controls of the same
strain received carrier suhstance but no drug (C).
Metabolic rates were measured in isolated hearts
perfused for 4S min with oxygenatedbicarbonate saline
containing glucose (SmM) and J-hydroxybutyrate(SmM) at
90 mmHg afterload and 12 mmHg pre-load. Heart rate.
pressure development and high energy phosphatecompounds
were stable for the entire period of perfusion. Enzyme
activities were measured in fresh tissue. Rates of
substrate utilization (-) or metabolite production (+)
were as follows (umol/h/g dry wt):
Glucose Lactate 3-Hydroxybut.
C -109±64 +77±31 -263±120
Nl -J88±81* +236±20** -247±77
(K ± S.D., n-6, *p<O.OS, **p<O.Oll
lncreased rates of glucose utilization and lactate
productionwere paralleled by increased activities of
glycolytic enzymes in the left ventricle (Nl vs. C, n=4,
units: umol/min/g wet wtat 2S·C): hexokinase (43vs.
7**), phosphofructokinase(19 vs. S*), lactate
dehydrogenase (42vs. J**), whereas the mitochondrial
enzymes 3-hydroxybutyratedehydrogenase, 3-oxoacid-CoA
transferase, acetoacetyl-CoA synthase, citrate synthase
and 2-oxoglutarate dehydrogenase showed no change.
Conclusion: Nifedipine induces profound changes in
myocardial substratemetabolism andits actions on the
heart are not limited to calcium blockade alone.
DICHOTOMOUS MYOCARDIAL SUBSTRATE UTILIZATION REFLECTING
REPERFUSION.
O.W. Myears, M.D" J.E. Bakke, M.S., R.U. Rodriguez, B.S.,
B.L $Obel, M.D., F.A.C.C. and S.R. Bergmann, M.D., Ph.D.
Washington University, St. Louis, MO.
Restoration of oxidative metabolism may be a prerequisite
for return of myocardial contractilityafter reperfusion.
To determine whether specific patterns of utilization of
individual substrates measurable bypositron emission to-
mography identlfy impaired tissue after reperfusion,we
measuredglucose and palmitate metabolism in control (C;
n=5), 1 hr ischemlc (1; n=8), and reperfused myocardium
(R; 1 hr after 1 hr of ischemia; n=9) in intact, open-
chest dogs. 3H-glucose and 14C-pa1mitatewere adminis-
tered t .c .; and regional venous blood was assayed sequen-
tially. With reperfusion, utilization of glucose (463 ±
88 nmo1s/gm min) was 103% greater than it was in ischemic
myocardium and 273% greater than it was in normal tissue
(p < .05 for each). Utilization of palmitate during reper-
fusion (55 ± 10 nmols/gm min) decreased markedly compared
with that in normal tissue (48% of C, p < 0.05) despite
restorationof flow to 80% of baseline. Although glucose
constituted 60% of the substrate oxidized in myocardium
rendered ischemic, its contributionto overall oxidative
metabolism in t i ssue subjected to reperfusion was only
25%. Despite diminished uptake of palmitate, oxidation of
this substrate accounted for 63% of total oxygen consump-
tion in reperfused myocardium. The dichotomy betweenutil-
ization of glucose and utilization of palmitate early af-
ter reperfusion delineated viable though metabolically im-
paired myocardium. Thus characterizationof patterns of
utilization of individual substrates by moda1ities such as
positron emission tomographymay identify affected regions
of myocardium and help to evaluate the metabolic basis for
delayed recovery of myocardial function after reperfusion.
THE EFFECTS OF CHRONIC D08UTAMINE TREATMENT ON THE
NORMOrENSIVE AND HYPERTENSIVE HEART
Peter 8uttrIck, M.D., As~wani Malhotra, Ph.D., Stephen
Factor, M.u., F.A.C.C., DavId Geenen, Ph.D. and James
Scheuer, M.O., F.A.C.C., Montefiore MedIcal Center and
Albert EInsteIn College of MedICIne, Bronx, N.Y.
ChronIC dobutamlnetherapy (0) SImulates some aspects of
phySIcal condItIonIng. To investigate the effects of D on
normotenSIve andhypertenSIve hearts, four groups of
female rats were studied: control (C); 2 mg/kg D sub.q.
2x/d 5 d/wk (D); renovascularhypertenSIve (H); and
combinedD+H (DH). Animals weresacrif rced at 8-10 wks and
cardIac hIstology, function In an Isolated heart
apparatus, and myosinbiochemIstry were studIed.
C 0 H DH
BW (g) 308 312 296 308
HW (mg) 178 196*+ 220* 257*+·
If (0-3+) .4 .7+ 2.1* 1.9*·
CA (um PI/mg'min-1) 1.16 1.31*+ .88* 1.09+·
% V1 myos In 96 100+ 69* 88+·
CF (ml/mg HW'mIn-l) 134 134+ 111* 112*·
CO (ml/mg HW'mIn-l) 391 422+ 361 367
(Means of 8-12 studies; BW=body weIght; HW=dry heart
weight; Ife Interstt t i al fihrosis; CA=Ca++ act ivated myos in
ATPase; CF=coronary flow and CO=cardiacoutput at hIgh
preload and 103 mmHg aortIC pressure. p(O.05:* vs C; +D
or DH vs H; • D vs DH.)
ConclUSIon: D In contrast to Hcauses cardiac hypertrophy
assOCIated withincreased CA and Vl myosin and without IF.
In OH, hypertrophyis additive and CA and Vl normalIzes.
CF and contractIle propertIesare not depressed in D.
Thus, Dlike physical condItioning appears to cause a
physio l oqic hypertrophywhich reverses the bi ochemica l
abnormalItiesof H.
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INDUCTION OF HSP 70 STReSS PROTEIN mRNAS DURI~G CARDIAC
HYPERTROPHY.
David J. Ende, ~I.D., Anne F. Martin, Ph.D., Smilja
Jakovclc, M.D., Raaovan Zak, Ph.D., Rlchard I. Morimoto,
Ph.U., Patrick K. Umeda, Ph.v., University of Chlcago,
Chicago, IL.
The expression of HSP 70, a majormammalian stress pro-
tein, is evoked by various metaoolicstresses. We have
investigated the dynamic nature of this stress response
in pressure overload cardiac hypertrophy inrats, either
induced rapidly oy constriction of the ascending aorta
(AAC), or more gradually byconstriction of the descen-
ding aorta (DAC). Ventricular RNA was analyzed by
Northern blot hybridization, probing withhuman HSP 70
gene sequences. Ventriculartissue constitutively ex-
presses anHSP 70 mRNA of 2.0 kilobases (Kb). Following
AAC, there is an appreciable augmentationof this mes-
age, and the appearanceof 2 new mRNA species of 2.7 kb
and 3.4 kb. This change is evident by 3 hours,rapidly
declines by 6 hours, and is not detectable after 1-2 days.
Sham-operatedcontrols, as well as 1ivers from the banded
animals, fail to demonstratethis response. DAC, which
promotes a more gradualchange in cardiac growth,results
in a similar, albeit more delayed, response,maximal at 18
hours, and dissipating by 24 hours. In conclusion, two
models of cardiac hypertrophyeffect a prompt and tran-
sient expression of stress protein mR~A's. ThlS response
may be relatea to the growth process in cardiac muscle.
SUBCELLULAR DISTRIBUTION AND POTENTIAL LOCI OFRELEASE OF
ARACHIDONATE: IMPLICATIONS FOR MYOCARDIAL ISCHEMIC INJURY
Yutaka Miyazaki, M.D., Richard W. Gross, M.D., Ph.D.,
Burton E. Sobel, M.D., F.A.C.C., and Jeffrey E. Saffitz,
M.D., Ph.D., Washington University, St. Louis, MO
Arachidonic acid (AA) is released concomitant with myo-
cardial ischemia in vivo and hypoxia or inhibition of
oxidative metabolism in neonatal rat myocytes (NRM) in
vitro. Phospholipids rich in AA are the predominant
constituents of rabbit and dog sarcolemma. If release
of AA with ischemia occurs in critical subcellular loci,
residual lysophosphatides would likely contribute to
irreversible ischemic injury. To elucidate potential
subcellular sites of release of AA with ischemia, we
quantified phospholipids and fatty acids in adult rat
myocardial sarcolemma and, with the use of quantitative
ultrastructuralautoradiography,characterizedthe sub-
cellular distributionof 3H-AA in NRM incubated with
5nM 3H-AA for 1-48 hrs. In normal adult rats, the pre-
dominant lipid constituents of sarcolemma were found to
be choline (47.1 ± 3.2%) and ethanolamine glycerophospho-
lipids (32.8 ± 2.4%) but in contrast to other species,
little plasmalogen (5.3 ± 1.4%) or AA (8.0 ± 2.1%) was
pre.ent. Incorporationof 3H-AA in NRM reached a pla-
teau in 24 hrs with 42.5 ± 0.5% of total 3H-AA in choline
and 32.2 ± 2.4% in ethanolamine glycerophospholipids.
Most 3H-AA was localized in sarcoplasmic reticulum and
mitochondria (45% and 46% of total 3H-AA, respectively)
after 24 hrs. Only modest amounts of 3H-AA (below the
sensitivity for accurate quantification) were present in
sarcolemma. Thus, AA released from hypoxic NRM is not
localized primarily in sarcolemma but rather in sarco-
plasmic reticulum and mitochondria, organelles vulnerable
to irreversible ischemic injury.
EHH:TCF~ CN fEI\RI'MI'IOXNlUAL[N', SYNllffiLS
C. Neal Ellis, Jr., M. D.: WillianS. Bl.akan::re,M. D.
Bi{bSt MilkaIcenterS, Bi.nni.rrjmI,A1mra
'lhe effe::t of fldriat¥:i.n (Pdr) 01 rat ha3rtmitcdl:n:lti.al[N', (nfNII.) ;,as
stulierl to p::ssibly explain the cardi.aJ¥::pitl"o/as&riaterl with Pdr Uge.
flats raE..mPdr 10~ TV...~ saliJ:e.l m1;Jq;j~. 'l\o.e1ty-fuJr hxzs
lata:", the anirralsre:Je.l..m [-'l1) tJ¥nidire,2 rrCi.I1«:J TV. 'lhe ratswere
socrificerl at 6, 14, 24, <n:J 36 mza after receivin:l [41) 1:J¥nidire.
Intact ha3rt mit:cx:trrdriawere isolated am CHlt:ri.fu:Jej01fc:manilP-
a.r::rc:se b::u,mtdimity gra:li.EQtsto SEplratethe different ferns of nfNII..
Tci.lle #l S1:xo.6 the iIlO.J1t of [..lfl) 1:J¥nidireiro:xp:t:aterlinto the reert
nfNII.of crrrt:ra1<n:J Pdr treaterl anirrals. Tci.lle #2 S1:xo.6 the pnart: of
the total iro:xp:t:aterl [41) tJ¥nidirein the different ferns of reert
rrt:NI\. 'lhe <hta 3u; thatPdr sla.s the rate of rrt:NI\syntlmis <n:J :imi-
bits syntlmis of a:nplete rrt:NI\mole:llies. 'lhe beert bes hicjl energy
00n:rdsnet ~ mitcdl:n:lti.alAn' syntlmis. rrt:NI\ is initially syntro-
sized as lirmr-fra:}re1ts(IJt1NI.) that are s..tseq.mtly joinerl into a
cimJ1ar mo1a:1lle (Q1[N\). Iata:",aprllelical turns are :i.ntro:l.x:erlinto
the nnlecule, ~ical rrt:NI\ (9rIN\) is req.rirerl fer mitcdl:n:lti.al
An' pxdx:ti01am replicati01. Jld:icrr¥::i.nsla.lS the rateof rrt:NI\srn-
tresis am inhibits the fooratimof circularrrt:NI\mole:llies. Mito-
c:hn:1riallID' am replicati01pxdx:tim cculd be SlfficiErtlY CXII{%D-
miae:l ~ this rrEd<lniBnto leEd to the <Bath of the TI¥X¥tes am caUge
the cardi.aJ¥::pitl"o/as&riaterl with the Uge of Pdr.
Tci.lle#1 Total iro:xp:t:aterl[~] in W'ltrol am Pdr treaterl rrt:NI\at 6,
14, 24, <n:J 36 hrs. after<Yl injecti01 of [..lfl] 1:J¥nidire.
6 Hrs. 14 Hrs. 24 Hrs. 36 Hrs.
central ffiXJ± 9JJ 12,SOJt...llOO 13,4:llil600 13,OCOtJ.:n:J
Id: IDfr-1000 4c:m.t cm 54X»-l2QO 6:n:J!'-l:n:J
Tci.lle #2 Perca1t:a;Jeof [41] iro:xp:t:aterlin the differentferns of
anttol am Pdr treaterl rrt:NI\at 6, 14, 24, am 36 hrs. after an injsctkn
of [4:1) tJ¥nidire.
6 Hrs. 14 Hrs. 24 Hrs. 36 Hrs.
Pdr central Id: Ccntrol Pdr central Pdr central
9rIN\ ~ 0.7±O.2 °117.00.4 14.5H.ol63.8±2.3 17.2+-1.2~7.5+-1.3
Q1[N\ 0 27.7H.9 7.1H.340.8±2.2 17.9±l.318.ill.5 18.5+-1.5 7.5+-1.1
IJt1NI.l 71.6+-1.7 92.9±l.342.2+-1.4 67.6+-1.218.00.2 64.2+-1.9 4.9±l.1
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VentricularMechanics and Energetics
LAW OF CONSTANT HEART VOLUME IN HUMANS: A NON-
INV ASIVE ASSESSMENT VIA X-RAY CT, MRI, ANDECHO.
Eric Hoffman. Ph. D., Richard Ehman, M.D., Lawrence Sinak, M.D.,
Joel Felrnlee, Krishna Chandrasekaran,M.D., Paul Ju lsr ud, M.D..
and Erik Ritman, M.D. Mayo Clinic, Rochester, MN 55905
It has been shown by x-ray CT that total heart volume (THY=
contents of pericardial sac) stays essentially constant throughout
the cardiac cycle in dogs anesthetized with sodium pentobarbital
(AlP 249:H883-H890, 1985). Mechanisms serving to maintain a
constant THY are atrial/ventricular(A-V) volume reciprocity and
myocardial blood volume variations. The significance of this
relationship is t hut the w or k expended by the heart is minimized
by moving only blood and not extra-cardiac tissues. Work in
progress is undertaken to verify this relationship in normal,
awake humans. Data from 6 normal human volunteers studied via
2-0 echo verify that, as in dogs, the epicardial apex remains
fixed and the A-Y valve plane moves piston-like, resulting in a
mechanism for reciprocal emptying and filling of atria and ven-
tricles and a means whereby atria may "sense" ventricular func-
tion. To measure THY in humans, we are using magnetic reso-
nance imaging (MRI). In humans, unlike canine anatomy, 1/3 of
the epicardial surface abuts the diaphragm. X-ray CT cannot
readily distinguish heart from diaphragm while MRI can because
of the high contrast of the pericardium. A normal human volun-
teer was imaged with a 1.5 tesla MR system using ECG gating.
After obtaining 27 contiguous slices 5 mm thick at each of 4
points in the cardiac cycle, THY was measured at QRS onset.
QRS+84, +159, and +234 msec (average cvcie- 800 msec). THY's
were 899. 903, 918, and 873 ml; a variation of <5% which is
withtn the error of measurement and <30% of the combined RV
and LY stroke volumes. Conclusions: I) atria and ventricular
volumes reciprocate, 2) the epicardial apex remains spatially
fixed, and 3) preliminary evidence supports the law of constant
heart volume in humans. (Support: HL-29886, AHA83-965. Doctor
Hoffman is an Established Investigatorof the Am. Heart Assoc.)
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THE RELATIONSHIPOF FUNCTION, eLTRASTRUCTURE, AND ENFRGY
STATE OF flUMAN MYOCARDIUM,
Donald F. Hammer, M.D. , Ruth A. Altschuld, Ph.D., Peter
B. Baker,M.D., and Donald V. Unverferth,M.D., F.A.C.C.,
Ohio State University, Columbus, OH.
Quantitativelight and ultrastructuralcharacteristicsof
endomyocardial biopsies were compared to metabolic pro-
files (adenine nucleotides) and systolic function. Twen-
ty-two patients with angiographicallynormal coronary
arteries were studied. Ejection fractions (EF) ranoed
from 15 to 82%. Hematoxylin and eosin stained slides of
biopsies were examined for cell di ameter bymeasuring the
distance across 50cells of each patient. The %fibrosis
was determined by stereologic techniques on trichrome
stained slides. Computerized image analysis of glutaral-
dehyde fixed samples was used to determine ultrastructur-
al characteristics. These consisted of %ofmyocyte
volume occupied by myofibrils, mitochondria, nuclei or
cytoplasm. Paired biopsieswere also analyzed for nucleo-
tide content (ATP, ADP, AMP, NAD and NADH) using stron~
anion exchange high performance liquid chromatography.
~odest inverse correlationswere found between cell d1am€-
ter and ATP (r=-.44) and between cell diameter andEF (r=
-.51). Correlationsbetween EF and adenine nucleotides
were also found: ATP (r=.72), ADP (r=.54), NAD (r=.76),
and NADH (r=.79). Aweak correlat10n existed between EF
and %myocyte volume occupied by myofibrils (r=.3l), but
not for otherultrastructuralmeasurements. Finally, no
correlationswere found between %fibrosis and ultrastruc-
tural parameters or adeninenucleotides. Thus, systolic
function of human myocardiumappears to bemore closely
related to its energy state tha~ it is to either ultra-
structuralor histologic characteristics.
THE HISTORY DEPENDENCE OF REGIONAL SYSTOLIC PRESSURE-
WALL THICKNESS RELATIONSHIPS IN INTACT HEARTS.
William P. Miller, M.D., F.A.C.C., Stephen H. Nellis,
Ph.D., A. James Ltedtke, M.D., F.A.C.C. Section of
Cardiology, Univ of Wisconsin, Madison, Wisconsin.
The beat-to-beat systolic LV pressure-wall thickness
relationship (SPThR) obtained by the infusion of volume
into the LV is non-linear and appears hysteretic. The
effect of the rate of myocardial stretch on the SPThR
was studied in 8 open chest, paced, swine hearts.
Simultaneous LVP and myocardial wall thickness were
measured in consecutive, variably loaded beats obtained
by the LV injection of blood at constant rates (K).
Randomized infusions at Kl (56 ± 2 ml!sec) vs KZ (27 ± 2
ml!sec, P <0.001) resulted in nearly identical maximal
changes in peak LVP (116 ! 4 to 147 ± 4 vs 118 ± 4 to
152 ± 4 mm Hg), but these occurred over 2-3 beats at Kl
vs 5-7 beats at KZ (P <0.001). The SPThR generated from
data at 20 msec intervals from the R wave of the ECG in
each cardiac cycle was quantitatedby measuring the area
of the loop inscribed by the relationship and by the
slope of the line obtained from the initial and highest
LVP end Th data points. The SPThR at mid-thickening
(t=170±5 msec) , end-thickening (t=Z52±5 msec) , and at
the time of the maximal slope (t=320±10 msec at KI,
t-3l2±IO msec at KZ, P=NS) were compared. The area at
mid-thickening, end-thickening, and maximal slope was
41% (psNS), 97% (P < 0.025) and 548% (P < O.OZ5) greater
at the slower rates of loading (KZ). The slope of the
SPThR was the same at end-thickening (-27!5 vs-26±5 mm
Hg/mm) , but the maximal slope was steeper at the faster
rates of loading (-106±53 vs -60±23 mm Hg!mm, P <a.OlO).
These data demonstrate a history dependence of the area
and maximal slope of the SPThR in the intact heart,
which may be secondary to length dependent activation.
ABSTRACTS
EFFECTS OF VENTRICULAR INTERACTION ON THE
RELATIONSHIPBETWEEN FREE\~ALL DIMENSIONS
AND VOLUME OF THE RIGlfT VENTRICLE
r,~p FeneIey, ow ~'aier, JW Gaynor, SA Gall,
RC Orchard, JS Rankin
Duke University Medical Center, Durham, N. C.
Although right ventricular free wall (RVFVI)
dimensions have been employed as indices of global RV
function, their relationships to the volumes of the right
(RVV) and left (LVV) ventricles have not been
adequately defined. In 7 freshly excised and 3 isolated
perfused beating canine hearts, the septal-RVFW
dimension (S-FW) and paired RVFW segment lengths
(parallel find orthogonal to the LV short-axis plane)
were measured with ultrasonic gauges. RVV and LVV
were varied independently with intraventricularbal-
loons. Linear rerrressiondemonstratedhigh correlations
between RVFW segment lengths and RVV, and between
the product of paired orthogonal lengths (segment area)
and RVV (Table). Increasing LVV also increased RVFW
dimensions, however, while reducing S-FW, resulting in
an upward shift of the relation between all RVFW
dimensions and RVV (p<O.OI). The mean effect of LVV
increments was 25% of that for equal RVV increments.
Thus, due to ventricular interaction, LVV is an
independent determinant of RVFW dimensions at any
given RVV, a factor that must be considered when
RVFW dimensions are employed to assess RV myocardial
performance.
of RVFW dimensions on RVV
P Slo~e Variance
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IR is independent of
Ps (-)dP/dtmin/P
-14+8 -19+5
-24+21+ -17+4
-10+9 -19+5
TO
63+15
73+26
62+19
LEFT VENTRICULAR ISOVOLUMIC RELAXATION IS INDEPENDENT OF
LOADING CONDITIONS IN NORMAl MAN.
Mark R. Starling, M.D., F.A.C.C., G.B. John Mancini,
M.D., F.A.C.C., Daniel G. Montgomery, 13.5. and Richard A.
Walsh, M.D., F.A.C.C., Departments of Medicine, Univ of
Michigan and VA Med Ctrs, Ann Arbor, MI and Univ of Texas
Health Sci Ctr, San Antonio, TX.
(-)dP/dtmin T1n T40
C -1613+388 46+8 50+9
M -1786+282+ 48+9 53+14
N -1243+467++ 45+9 49+8
+p<0.05; ++p<O.OI vs C.
Thus, we conclude that the rate of
loading conditions innormal man.
The effects of loading conditions on measures of left
ventricular (LV) isovolumic relaxation (IR) in man
remains controversial. Accordingly, we studied 14normal
subjects during control (C), methoxamine (M) and
nitroprusside (N) infusions with micromanometer LV
catheters and radionuclide LV volumes during right atrial
pacing. IR was defined as the timefrom peak (-)dP/dt to
5 mmHg above LV end-diasto1ic pressure (EDP) of the next
beat. The rate of IR was calculated as (-)dP/dtmin
(mmHg/sec), the linear regression of lnP vs t (T ,~sec), 1nP vs t during the first 40 msec (T4.o ' mset',lnstantaneous (-)dP/dt vs P ({ , msec), incruding P
(mmHg) , and (-)dP/dtmin/P (sec- P. Mean heart rates an~
(+)dP/dt/DP4~ were unchanged, despite increases in peak
LVP (range lUO-174 mmHg), LVEOP (range 10-20 mmHg)and LV
end-diastolic and end-systo1ic volumes during M(p<0.05
to <0.001 vs C) and decreases during N(p<0.05 to <0.001
vs C). The effects on IR were (mean ~ SO):
LV Mass
73±9
91±5*
LVEDP
10±3
17±5*
Base
CMR
DEPRESSED VENTRICULAR FUNCTION IN CHRONIC EXPERIMENTAL
MITRAL REGURGITATION. Joseph P. Kleaveland,MD, FACC,
William G. Kussmaul, MD, James L. Reckman, MD, Thomas
Vinceguerra, RT, Blase Carabello, MD, FACC. University
of Pennsylvania and Tenp l e University, Philadelphia, PA.
The ejection fraction is not an accuratemeasure of LV
myocardial function in chronic mitralregurgitation(CMR)
because of marked load alterations. Therefore, we deter-
mined the slope of the end-systolic pressure-volume
rel ationship, Emax , as a load independent index of
myocardial funct ion in 6dogs before (base) and 9±5
months after creation of CMR (regurgitantfraction =
.60±.04). Simultaneous high-fidelity LV pressure and
volume from biplane ventriculography(100 frames/sec)
were recorded in the basalstate, and after phenylephrine
and nitroprusside. LV mass was determined from LV wall
thickness and volume at end-diastole. Circumferential(Co)
and meridional stress (Mo) were calculated at 10 msec
intervals, and pressure-, Co-, and Mo- volume loops were
generated foreach loading state. F.max (dyne/emS) was
derived by linear regression of thepeak pressure/volume,
Co/volume, Mo/volume ratio from 3 loops. (*p<.Ol, **p<.05)
End-diasto1ic End-systo1ic
Volume Volume
51±7 20±5
95±12* 32±1*
Ejection Emax
Fraction Pressure Emax(Co) Emax(Mo)
Base 111-(\ S.2i:1.2 lO.9±1.2 7.5±1.4
CMR I) ,j-; 3.3±.13** 7.4±1.1* 5.6±.5**
LV mass, volume and LVEDP all increased inthis model of
CMR. Ejection fraction was unchanged, but Emax derived
from the end-systolic pressure-volume,Co-volume and Mo-
volume relationships declined significantly. The fall in
Emax suggests a depression ofLV myocardial function not
detected byejection fraction.
Monday, March9, 1987
Poster Displayed:2:00PM-5:00PM
AuthorPresent: 2:00PM-3:00PM
Hall C, New Orleans Convention Center
CardiacFunction: Clinical
REVERSAL OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS
WITH ACUTE PULMONARY EMBOLISM AFTER TREATMENT WITF
INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR.
Patricia C. Come, M.D., F.A.C.C., John E. Markis, M.D.,
Reth Israel Hospital and Harvard Med School, Boston
To ascertain whether clot lysis rapidly reverses right
heart abnormalities in pts with large pulmonary emboli
(PE), we performed serial imaging and Doppl~r
echocardiographicstudies prior to and a mean of 1] hrs
after a 6 hr intravenous infusion of 80-90 mg of tissue
plasminogen activator (rt-PA) in 6 Pts with segmental or
lobar acute PE confirmed by pulmonary angiography. Mean
age of the 5 men and 1 woman was 57 years. No Pt had
known prior pulmonary hypertension, and mean RV wa1l
thickness was normal (4.7 mm, range 2-6 mm).
Substantial clot lysis was achieved in all Pts, with
decreases in PA systolic pressure from 40±9 to 27±7 mmHg,
p<.Ol. RV diameter decreased (3.9 ± 1.1 to 2.2±O.4 cm, p
< .05), and LV diam~ter increased (3.8±1.0 to 4.5±O.6 cm,
p<.05). RV wall movement, initially mildly, moderately
or severely hypokinetic in 1, 2, and 3 Pts, normalized in
4 and improved to mild hypokinesis in 2. Tricuspid
regurgitation(TR) was present before lysis in 5 Pts,
including 4 with detectable increased flow velocity
compatible with elevation of RV systolic pressure. Mean
peak RV-RA pressure gradient, estimated from TR, was 30
mmHg (range 25 to 38). TR was detected after lysis in
only 1 Pt. Systolic septal flattening was noted before
lvsis in 3 of 5 Pts with adequate short-axis images, but
in no Pt after lysis. We conclude that large PE may
result in appreciable RV dysfunction and dilatation, with
TR, abnormal septal position, and decreased LV size.
Their early reversibility after rt-PA suggests that this
therapy may be efficacious in the management of Pts with
hemodynamic compromise during acute PE.
PROLONGATION OF ISOMETRIC TWITCH WITH STRETCH OF NORMAL
HUMAN MUSCLE.
Marc D. Feldman MD. Sanford E. Warren, MD, Judith K.
Gwathmey, VMD, PhD, Preston Phillips MS, James J.
Ferguson, MD, James P. Morgan, MD, PhD, FACC. Harvard
Thorndike Laboratory, Beth Israel Hospital, Boston, MA.
The rate of relaxation of nonhuman mammalianworking
myocardium is load dependent and may be markedly pro-
longed in conditions such as heart failure in which
preload and/or afterload are increased. However, it has
been difficult to demonstrate load dependency of the
intact humanheart by examining isovolumic phase indices
of relaxation. Using a different approach, we examined
the effect of increasing load on trabeculae carneae
obtained from 4 patients who died from non-cardiac
causes. Muscles (n-7) were placed in an organ bath,
perfused with physiologic salt solution at 30°C, stimula-
ted at 3 sec intervals, and sequentially stretched from
70% of length at which maximal tension (L ) is generat-
ed to Lma . Peak isometric tension (PT), ~f~e to PT(TPT) , ana time to 50% decline from PT (RT~) were mea-
sured. TPT increased from 332±70 to 434±68 msec*, RT~
increased from 2l4±79 to 365±147 msec*. A representative
tracing from a single trabeculae carneae is shown.
STIMULUS Lmal
~ .....!
L4oom,-J
These data indicate that the rate of relaxation of
isolated human working myocardium can be markedly altered
by changes in loading conditions and suggest that the
same may be true for the human heart in vitro. *P<O.Ol.
JACC Vol 9, No 2
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POSTEXTRASYSTOlIC POTENTIATlllN WORSENS FAST FILlINB OF
THE HYPERTROPHIED LEFT VENTRIClE IH AORTIC STENOSIS AND
HYPERTROPHIC CARDIOMYOPATHY.
WoIIJrJ P!lJIIlIMP PhP•Stsllsl. U.~,Ph.D., Peul Nellens.M.D., Buy
R.~lckx,M.O.,Ph.O ..FAC.C. end Eric AnlFles,M.O., ClIrdlovll9CUlcr
()lnter,a.l.v.Zlekenhuls.B9300Aelst, Belgium.
ImpetredLV fl11lng inAorticStsnosis(AS) end HypertrophicClIrd10my0petby
(1D1) Isexplalnmbyslow LV prasue dBat(, possiblyrelatedto alEficlent
myqllmmlc ClI++ reuptake.POlItextrasvstollcpotentlatloo(PESP) Increeses
myql_tc ClI++.The InflUllfD of PESP on LV ftIltng was therefore
IllY8Stlgllllld in patients with LV hypertrophy ClIUSlld by AS end by 1D1.
Slmultnousrecordtngsof LV pressure end mltrel YlIIveflow veloolty were
obtalnmbymlcromlllOlll8lertipcatheterendhlltlpulge repetitionf~
Dopplercllrlngncrmalsinusrhythm(NSR) end lIfter PESP. Abl8Xponentllll
curvewas fittedtoIlIllYOlumicLV pressure...",to providetimeconstantsT1
lIl1d T2(AS:n-12;1D1:n-12). Earlyd1lBtollc LV pressure"was measured
by PHI (Pheee of thefIrstharmonicof e Fourlertrensfcrmapplied to the
d1lBtollc LV pressure WM)(AS:n-12;ID1:n-12). Peak flow veloolty in
_Iy d1lBtole (PFVE) llIld dIIclIleratlonof _Iy d1lBtollc flow (OEF) were
USlld .1nd1cesofLV inflow(AS:n-9;ID1:n-5).Deta-mlllllltSEM;*.p<O.O1.
AS(NSR) AS(PESP) HCM(NSR) HCM(PESP)
T1 (ms) 53.lt5.6 * 70.1t5.1 55.2:t8.1 53.7:t6.8
T2(mllllC) 45.8:t3.9 * 57.9:t3.3 51.6:t7.0 51.8:t7.1
PHI(__) 38.9:t5.0 * 23.1:t1.5 10.9:t7.2 * 21.1:t6.5
PFVE(m/~) 0.58:t0.06* 0.52:t0.05 0.67:t0.09 • 0.57:t0.l0
DEF(m/~) 1.9:t0.7 * 3.2:t0.8 5.8:t0.8 * 4.3:t0.9
PESP prolongsT1llIldT2InAS butnot In HCM. AfterPESP, PHI IsdIll:r'e8ged
Inboth AS lIldHCM. ThisslowerearlydIastoltcLV pressure"""efterPESP
r«lmlPFVEllIldOEf InAS llIld1D1.
canclualon: The slower dlastDlic LV pressuredIIat(efterPESP Impedes LV
Inflow InAS llIld InID1ll1ld isexplelnmby11 transIentImblllencebetween the
I~ myopl.mlc ClI++ of PESP end the ImpaIredmyopl.mlc ClI++
~Ion ofI'ftpertrophtedmyIDII'dlum.
DIFFERING RESPONSES IN VENTRICULAR FILLING. LOADING AND
VOLUMES DURING POSITIVE END-EXPIRATORY PRESSURE (PEEP) IN
MAN. Douglas S. Schulman, M.D., JimBiondi, M.D••
Jennifer Mattera, R.T., Barry L. Zar et , M.D., F.A.C.C.,
Robert Soufer, M.D. Yale University, New Haven, CT.
PEEP has a variable effect on ventricularloading. Using
a rapid thermistor Swan-Ganzcatheter and nuclear probe
we measured LV peak filling rate (PFR). LV ejection
fraction (EF), transmural (TM) pulmonary capillary wedge
pressure (PCWP), RVEF and CO in 17 Pts during incremental
PEEP (0 , 5, 10, 15 and ZO cm H20). LV and RV end-dlastolic
vol ume (EDV) , systemic and pulmonary vascular resistance
(SVR and PVR, dynes-sec-cm-s) were calculated. For all
Pts, CO declined (7. 8 to 6. 4 L/min p<O. OS) andthe chan ge
in PFR correlatedwith the change in RVEDV (r =- . 67 ,
p<.OOI). Blood pressure, heart rate and PCWP did not
change. In 6 Pts (group 1) LV-RV vol umes i ncr eased with
PEEP (LVEDV + Slml, RVEDV + 61ml) . In II Pt s (gr oup 2)
LV-RV volumes decreased (LVEDV - 39ml , RVEnv - 4Zml) .
Each gr oup had asimilar change in CO (- 12%) but PFR de-
clined in gr oup 1 (-.47 Vi s) and i mproved in gr oup 2
(+. 79 V/s), (p<0.05). Group 1 had a gr ea t erincrease t han
gr oup 2 in PVR (30 vs 15%) and SVR (29 vs 8%) (p<0. 05) .
Baseline characteristics of t he t wo grou ps dif f er ed
(p <.Ol ) only as shown below:
CO LVEF RVEF PFR SVR PVR
Gro up I 4.4 L/min 30% 15% 1.38 1614 278
Group Z 9.5 L/min 54% 30% 3.36 732 141
Thus, two responses to PEEP ar e i dent i f i ed. In gr oup 1,
RV-LV volumes increase with worsening LV fil ling. whi l e
in gr oup 2 vol umes decrease with improved LVfilling.
Group 1 responses are assoclated with augment ed PVR, and
gr eat er abnormalityin baseline CO, LVEF, RVEF, PFR, SVR
and PVR. These data have pathophysiologic and therapeutic
implications, and indicate the need f or appropriate
characterizationof PEEP Pts prior to and during therapy.
QUANTITATIVE REGIONAL WALL THICKENING
ANALYSIS BY TRANSESOPHAGEALECHOCARDJOGRAPHY
RC Orchard, FH Sheehan, MP Feneley, NP DeBruijn,
JS Rankin,JWDavis,EL Bolson,PS Glass,FM Clements
Duke University Medical Center, Durham, N. C. and
University of Washington. Seattle, Washington.
Systolic wall thickening is a sensitive index of
regional left ventricular ( LV) function that. unlike re-
gional wall motion, is not subject to cardiac translational
artifacts. We developed a new method for regional wall
thickening analysis based on the centerline (Cl.) method
of wall motion analysis. The normal range of values for
this method was determined from
short axis transesophagealechocard-
iograms (TEE) recorded 10 and 20
minutes after induction of anesthesia
in 16 young patients during minor
orthopaedic procedures. From the
CL between the epicardial and endo-
cardial contours, 100 wall thickness
chords were generated at end-
diastole (ED) and end-systole (ES)
(figure), Percent thickening (%-Th),
" thickening normalized for ED endo-
N-TH MEAN' 5.0 cardial circumference (N-Th) , and
o so lOO normalized CL endocardial motion
CHORD NuMBERS (N-MOT) were computed. Intrastudy
variability (SDI mean) was less for N-Th (46%) than for
%-Th and N-MOT (both 53%, P <. 001) . The percent
maximal variation of the N-MOT mean about the LV
circumference (92%) exceeded that for %-Th and N-Th
(both 60%). Interstudy concordance of circumferential
distribution of both %-Th and N-Th exceeded that for
N-MOT. Thus. N-Th data provide the best method for
quantificationof regional I.V function by TEE,
CARDIOVASCUIAR RESERVE IN IDIOPATHIC DlIATED
CARDIOMYOPATHY: INFLUENCE OF RIGHT VENTRICULAR FUNCTION
Ricky D. Latham, M.D., John R.Thornton, M.D.,
Cardiology svc , Brooke Army Med Ctr, Ft Sam Houston, TX
Patients with congestive heart failure demonstratea
poor correlationbetween exercise capacity and resting
LV function. Prior studies lack a homogenous population
and invasive systemic and LV pressure measurements. We
have evaluated simultaneous right and left heart hemody-
namics at rest and supine exercise during multimicro-
manometric cardiac catheterizationin patients with pure
idiopathic dilated cardiomyopathy (IDe) to describe rest
and exercise high fidelity hemodynamics in this popula-
tion and investigate possible mechanisms for the
clinically observed variance in exerciae tolerance.
A total of 27 patients were studied, ranging in age
from 16 to 54 years (mean ± SO, 31.8 ± 9.9 ). Group 1
IG-l) comprised patients with a normal exercise factor
(ExF > 600, n = 10); Group 2 (G-Zl, patients with an
abnormal exercise factor IExF < 600, n = 17). There was
nO significant difference at rest between G-l and G-Z
in any other hemodynamic vari abl e measured or calculated
(p > .05). There was a significantly greater increase
in stroke volume index and a greater decrease in sys-
temic vascular resistance i n G-l wit~ exercise, compared
to G-2 (12.1 ± 6.2, 1.8 ± 7.7 mllblm and -614 ± 304,
-406 ± 291 dyn-s-cm-5, respectively, ± SO). The change
in RV end-diastolic pressure with exercise was signifi-
cantly higher in G-2 than in G-1 (7 ± 5 vs. 1 ± 4 mmHg ±
SO, respectively; p < .05 ).
Maintained cardiac reserve in patients with "pure"
lDe appears to be dependent on 2 primary factors: 1)
preservationof systemic vasodilator capability;
thereby, afterload reduction during exer ci se ; and, Z)
preserved RV function, to include the absence of RV
diastolic dysfunction during exercise.
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THE IMPORTANCE OF DIASTOLIC DYSFUNCTION IN THE DEVELOPMENT
OF CLINICALLY SIGNIFICANT ADRIAMYCIN CARDIOTOXICITY.
Arnold Strashun. HO. Stanley J. Goldsmith, MD, FACC,
Steven F. Horowitz, HO, FACC. Mount Sinai Medical Center,
New York, New York.
Adriamycin chemotherapyis monitored by serial measure-
ments of left ventricular ejection fraction (LVEF).
However, symptoms of congestive heart failure do not
necessarily correlate with systol ic dysfunction. A
total of 101 patients underwent serial radionuclide
imaging to monitor adriamycin chemotherapy. Of these,
21 patients developed a fall in LVEF > 15%, fulfilling
previously publi shed criteria for cardiOtoxicity. Group
I (n = 8) consisted of patients without symptoms of
congestive heart failure and 2. 15% LVEF decline, while
Group II patients (n = 13) had symptoms of heart failure
and an EF fall ) 15%. Comparisons (± ISO) were made
for cumulative adriamycin dose (mg/m2), final EF, decline
in absolute EF (tEF), final fast filling rate (FFR)
and decline in FFR (tFFR).
Results:
Group LVEF HVEF HR fFFR Dose
POrENI'IATION OFVASODIUI'I'ORRESPONSE TO MENI'AL S'ffiESS I N
SEVEREHEART FAIWRE.
J . Malcolm O. Arnold, M.D., Paul L. Ludmer , M.D., and
Wilson S. Colucci, M.D., F.A.C.C., University of wester n
Ontario, Canada, Harvard Medica l SChool, Boston, MA
In severe heart fai lure peripheral vasoconstr icti on pre-
vents a full dilat or response t o ischemia and exercise .
Mental anthrretic (MA) is a stress i n wtuch peri pheral
vasodilation is thought to be rrediated by both sympathetic
beta-2 and chol inergi c actions. It is not known if t he
vasodilat or response to MA i s preserved i n heart failure
(CHF). Heart rate (HR), blood pressure (BP), and forearm
blood f Iow (FBF) were measured before and during three
minutes of MA in ten patients with severe CHF and t en age-
matched nonnal subjects without evidence of heart disease .
The heart failure patients received a 24 hour .irrcravenous
infusion of milrinone (0.5 u g/kg/min) and measurerrents
were repeated in both groups at 24 hours. The mcreases i n
HR, s ystol.i.c BP and FBF induced by MA are shown:
Patients tlHR bpn tl Syst BP(rrmllg) tl FBF (rnl/lOO rnl/min)
o hrs 24 hrs 0 hrs 24 hrs 0 hrs 24 hrs
NORMAIS 10+3~ 10+3~ 1.45+0.34 0.97+0.17
CHF 4+1 5+2 4+2 5+3 0. 48+0 .18* 1.44+0.40#
*p-;0.05 vs. control - #p<0.02 vs . pre-milrinone
CAPTOPRIL I N MILD TO MODERATE HEART FAILURE OVER 18
MONTHS; EFFECTS ON MORBIDITYAND MORTALITY.
The meantreatment period before death or deterioration
was 153 days for Cap and 127 days for Pi . Captopril in
addition s i gni f i cant l y reduced the need for diuretics
(Score 1,25 : 0,31 ) compared to Pi (Score 2, 46 ± 0, 47,
p = 0,041 ) by six months .
n=59 n=46 n=36 n=29
Pts. alive
without se- lOO
rious de- - - - - -1
terioration 80 I Captopril•
(X) 60 L_ -- - - 1--- --,
40 ~-----Placebo
FIG. 1 20
F.X. Kl eber , M.D., A. Laube,M.D. , K. Osterkorn, Prof.
Dr. Dr., E. K5NIG, M.D., Krankenhaus Milnchen-Schwabing,
University of Munich. W.-Germany
In an ongoing monocenter, double-blind, placebo-control-
led trial, started 18 months ago , 59 patients with con-
gestive heart failure NYHA I - III randomly received
either Captopril (Cap) b.i.d. or placebo (PI) in addition
to their regimen with digitalis and/or diuretics.
By September 1986, a meanobservation period of 270 days
(median 298 days) 16patients re ached one of the two
major end-points: death (n=8) or severe, with digitalis
and diuretics untractabledeteriorationof heart failure
(n~8). Of these 16 patients 5 were on Cap, while 11 were
on PI (death 3:5, deterioration2:6). A survival curve
i s shown in Fig. 1.
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LEUKOTOXIN, A NEW MYOCARDIAL DEPRESSIVE AGENT
Takayuki Ozawa,M.D., Satoru Sugiy ama,M. D. , Masayoshi
AJioka,M.D., Taizo Kondo,M.D., Akihiko Fukush1ma,M.D.
Univers1ty of Nagoya, Nagoya, Japan
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Poster Displayed:2:00PM-5:00PM
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Hall C, New Orleans Convention Center
CardiacFunction: Clinical
Patient s su f f er i ng from severe burns often d1ed after
r ecover in g from pr1mary shock , and t oxic substances,
vhrch might be responsible for ti n s late death, have been
postulated. We reported that l i nol eate epoxi de exists 1n
human burn ed skin. Using gas chro mato gra phy/mass
spec t romet ry and nuclear magnetic resonan ce measurements ,
i ts chemi ca l s t r uct ure was determined t o be
9 , lo-epoxy-12-oct adecenoate . We also demonstrated that
t his epox1de was bi os ynth esized by human l eukocytes, thu s
nomi nated as leukotoxin. In this expe r iment s , usi ng
ane sthetized mongre l dogs, t he ef fect of leukot oxin on
hemodynamical par amet er s was investigated . Leukot oxin ,
l nJected 1nt ravenous ly , depressed t he cardiac funct10n
dose-dependent ly . Although l eukot oxln, 5 mg/kg, showed
no si gn1ficant car di ot oxi c effect , 10 mg/kg of leukot oxi n
produced significant fall i n aortic flow ( l/mi n) , 0 . 74 ±
0 .04 (mean ± SE) t o 0. 30 ± 0 .04, left ventr1cu1ar peak
dp/ dt (mmHg/sec), 2040 ± 205 to 1280 ± 137, and aort1c
bl ood pr essu r e (mmHg), 110.0 ± 6 .6/66 . 7 ± 6. 3 t o 86 . 7 ±
11. 3/ 54. 2 ± 11.1 at 45 min after t he injecti on.
Leukotoxin, 50 mg/ kg , exert ed more marked
cardiodepress1ve effects and all dogs were dead wi t hi n 45
m1n aft er t he adm1n1s t ra tion. Whereas , adm1ni s t ra t i on of
l inoleic acid, 10 mg/kg, did not show ca rdio depr ess i ve
ef fec t s . L1noleic acid, 50 mg/kg, showed a cardiotoxic
ef fec t, i. e., aortic flow; from 0.74 ± 0 . 10 to 0.46 ±
0.07 at 45 m1n after the injection. From these results,
l eukotoxin 1nduced cardiac f ail ur e , and might be a
responsible factor in the genes1 s of l ate burn shock.
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EffECTS Of HEART RATE ON HYDRAULIC WORK IN HEART fAILURE.
H. Graham Parker, H.D., William G. Kussmaul, H.D.,
Jeffrey Wieland M.D., and Warren K. Laskey, H.D.,
f.A.C.C., University of Pennsylvania, Philadelphia, PA.
Exercise may disturb optimal coupling between LV
pulsatile output and its vasculsr losd by requiring
greater power per unit of flow. Because the exercise
response in heart failure relies on chronotropic
reserve, the effects of exercise and atrial pacing-
induced tachycsrdiaon LV-vascular coupling were compsred
in 5 patients with dilsted cardiomyopathy.High-fidelity
AD pressure a~d flow recordings were signal-averaged and
fourier-analyledto give charscteristicimpedance (lc),
total hydraulic power (WT), and WT/CO, a measureof the
e~ternal powercost per unit of forward blood flow.
Baseline data were obtained prior to each intervention.
Hearl Resis- ---1st Harmonic----
Rate tance lc Pressure flow Power WT/CO
Baseline 1 97 1320 7J 12 204 98 15.5
Exercise 124- 995 70 17* 265 190* 17.1*
Baseline 2 97 1254 74 12 212 88 14.9
Pacing 120* 1291 74 lOt 198 BJt 14.7t
bpm dyn-sec/cm5 IRHg IIll/sec mw mlll/.l7aec
-p<.05 vs Baseline tp<.05 Pacing vs ExerCise
Thus, despite decreased resistance, the exercise
response in hesrt failure occurs at an incressed power
cost, possibly due to increased systemic pressure. In
contrsst, pacing tachycardiadoes not alter lV-vascular
coupling. These findings suggest that tachycardiaalone
does not cause the decreased hydraulic efficiency seen
during exercise in heart failure. furthermore,blood
pressure reductionmsy improvelV-vascular coupling.
CF~GES IN LEFT VENTRICULAR ARCHITECTURF, LOAD AND
FUNCTION FOLLOWING PREGNANCY. Patricia Cole, M.D., Ted
Plappert, CV!, Daniel Saltzman , M.D., Martin St. J ohn
Sutton, M.D. FACC. Brigham & Women's Hospital, Bost on , MA
Pregnancy results in a 30-40% increase in blood volume.
To assess how this increase in volume affects LV
architecture,afterload and function, and to characterize
th e time course of LV remodelling postpartum, we obtained
s erial 2D ec hocardiograms with sy s t ol i c blood pr essure
(SBP) in 11 women (mean age 27) at 3 weeks prepartum, 2
days , 5 weeks and 9 weeks postpartu~. LV end-diastol ic
(EDV) and end-systolic (ESV) vol umes and LV mass (LVK)
were calculated from 2D echos of the shor t axis and
apical 4 chamber views (volume=5/6 area x l engt h) . We
obtained ejection fraction (EF) and end-systolic stress
(ESS = 1.33 x sap x caVity/muscle areas), and cardiac
output (CO = stroke volume x heart rate (HR).
Prepartum 2 Days 5 wks 9vks
EDV 1I0tl6 12lt19 100±13* 105± 8*
EF 57± 5 60± 5 57± 3 6Z:!: 4
LVM 161:!:18 172±22 146±l6+ 144:!:23+
ESS 76± 8 73±14 73± 6 7l ±13
HR BO±!4 79±14 66:!: 8+ 65:!:12+
CO 4. 9±0 .8 5.6:!:0. 7 3 . 8±0 . 8* 4.0±0.6*
[+p (. 05, *p(.OI from 2 days post]. F,DV, LVM, CO and HR
all decreased s i gni f i cant l y by 5 weeks postpartumand did
not change thereafter. The increase in CO i n pregnancy
was achieved by a combinati on of i ncrease d EDV and HR.
The up and downregulation of LVM and EDV in pregnancy
and the postpartumperiod respectively occurred in such a
way that ESS was unchanged throughout. Since ESS is the
major determinant of LV pump f unc t i on , the LV remodell ing
preserved normal EF. We conclude that 1) i n pregnancy
the LV remodels by increasing EDV and LVM to increase CO
with no change in LV load or EF and Z)postpa rtum LV
remodelling is essentially complete by 5 weeks.
~ E. Ginztal, M.D., F.A.C.c., Tim:lthy 'Ihi.g(;a1, B.S.,
Ridlard Q:rnnt, 9\.D., Ml.riame Br:izenline,R.N., Mi.dJael M.
Iaks, M.D., F.A.C.C.,~ Mnical Q:!1t.er 'It:D:raroa
CUifOInia ' ,
~ (H) of the n:ninfarcte:jleft VErItricl.e (l1J) as a
ctu:mi.c resp::me to llI}'lXatdial infarct.ial (MI) has been
oolusuatai in aninals. we have previc:usly dalu5b:ataithat
inprcJe:iejEct.ial frccticn (EFl oorrel.at:es with irrJ:easejDJ IlBSS
p:st-MI in c:b;;s. lbieVer, ro stu:ly has d:xurental~ Dl
ITBSS p:z;t-MI in 1'urar5 , am tre furl::t:imUsigni£icarreof p:z;t_
Mr DiH is a stlbje± of~. '1hep.n:p::se of this stu:ly IW'lS to
~ v.het:herp:5t-MI H of tren::ninfatcte:i~U1I <XI:Ur'S
111 l1Jrar5 am to assess its fiJrI::t:.imal.signifi.caroe. SJIxx5t:a1.
vi.Ew 2~erel ed1cx::aIt1i.cg (2lE) were II3COIded at rest
am ~ ~ise 6~ arrl 6 Ilalths IXEt-MI in 45 pili.ents
(pts) (16 anterior, 20 inferior, 9 s.Jl:en:b:mdi.a)for neasurarent
of VI IlBSS am EF. '1he DJ!laSS inEx: (UMI) in:::reased fran
73~47 to 1182:27~ (p < 0.05)~ the 2 st:uli.es. 'lhere
~ a signi.f~cant rorrelaticn~ tre~ in UJMI am
rest:in;JEF (r = 0.48, P < 0.001) am el<&Cise EF (r =
0.48 , P < 0.001) at the folla.>-ql st::uty. Of the 26 pts \olD
irr:::ra'lsedtiErllIMI > 25%, 16 inprove:ltreirrest EF> 5% am 15
inprcJe:i thili' E!lImcise fF > 5%. ~y, of the 19 pts \olD
fai.la:i to irc.rrese tOOk UMI I::7f 25% franthe fUs1: stu:ly, CI1lY 5
inprcJe:i thili' rest EF am 5 inpro.Ie::l treir el<&Cise EF (d1i
9:JBJ:e p < 0.05) •
a:N::Il5ICl5: (1) In lu1Br5 significant hypertJ:qtJyof the
rarlnfarct.ai~un can be det:Ected by 2l:E 6 m::nthsp:5t-MI.
(2) pts v.ro daralstIate H of the nninfan:::ta:l.DJ are ncre l:iJt.ely
to datalStIate i.npro.oa:i rest am exen::ise EF than t:ln;e v.ro cb
rot. (3) R:st-Mr IMI rray, trerefore. Iepresent a bEmficial
d1rcrIi.c <rl3ptati01to the Ioss of ~1Jll fal.1.OOrgMr.
DOES INCREASED HEART RATE ALTER LVCONTRACTILE STATE IN
HlIMNS ?
Lonny ~e isman,M .D., Roberto ~. Lang, M.D., Al ex Neumann,
8.5 .. Kirk T. Spencer, 8.5., and Kenneth M. Boro"', M.O. ,
F.A. C.C., The Uni ve r si t y of Chicago, Chicago, IL.
Previous studies hiVe sho wn a direct relationship be t we en
overall LV performance and heart rate (HR). Ho we ver, the
relative contribution of changes In load and contrac t illtv to the
HR induc ed improvement in LV f unc t ion remains unknown.
Accordingly , 8 no,,,, al SUbjects ",ere studied using the
load independent end-systolic stress p )-rate
corrected veloc ity of flber shorteninges(Vcf)
relation obtained by simultaneously recording 2D
t a r get ed M-mode echo and c a li brated caro t id
pul se tr ac Ings. Data were ac qu ir ed 1nltially at
HR = 621:3 bpm over a wide range of afterload -'
us"ing m e thoxa-n in e (rnethox line), thus defining
baseline LV co n rr actltfty, Additional data were
obtained after increasing HR with
transe so ph a ge al LA pacing and atrop ln e before
(control) and after dob uta-n in e (5 Ilg/kg/mln).
The effec t of changes in HR on contractility(1I
cont) ",as assessed usi ng the vertical deviation of each a - Vcf
point from th e methox line, thereby eliminating afterlo15 as i
confoundi ng variable (se e fi gur e from a r epre sen tatlve subject).
CONTROL (Cl OOIlUTMlIr--.E (D)
HR ~s ~ HR ~s ~
62+3 55+13
77+3 52+8 0.00+0.01 70+8 45+11 0.26+0.13
91+4 45+10 0.02+0.02 95+4 35+9 0.26!0.12
111+2 39+9 0.01~0.02 110+4 30+8 0.26:0.11
133~3 30+8 0.0010.04 130~4 24~9 0.28:0.12
Under control c o ndi t ions , lncr e a se s in HRresulted in Improved LV
performance (Vd ) that was solely due to a decrease In LV
a f t er lo ad wit houtCa significant change in contractility. With
dobuumine, LV contractil ty was augmented at all HR; however,
frequency ind uc ed differences in LV performance were again
attributedsolely to afterload reduction. ThUS, In normal humans,
there is no frequency dependent al t era t ion in c o nrra c t ll j t y over
the phys/ologlc range for HR.
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DIGITAL ANGIOGRAPHIC TRANSFER FUNCTION
ANALYSIS OF MYOCARDIAL FLOW AND CORONARY
RESERVE: COMPARISON WITH CONVENTIONAL TIME-
DENSITY CURVE PARAMETERS
Ne31 £ igler MD, Andreas Zeiher MD, J Mart in Pfaff, James
Whiting PhD, Jarnes Forr ester MD,FACe. Cedar s-Sina l Medical
Center, Los Angeles , CA
We developed transfer function anal ysis(TFA) of digital
ang iographic time-density curves(TDC) to evaluate regional
myocard ial flow(Q) and coronary flow reserve(CFR). TFA
measure s the transit time of the coronary microcirculatory
compartment (Tmic 0) which is inversely proportional to
flow (distri bution vofume andindependent of contrast injection
technique. We compared both TFA and conventional TDC
parameters to left circumflex electromagnetic flowmeter
measur ements of Q and CFR dur ing 102hand-injected left
coron ar y angi ograms in 6open-chest dogs. Conventional TDC
parameters(time of arrival(TOA), tim c to peak (TP), washout
rate (K)} and T icro were obta ined over the left circumflex
myocard ium aslJ was manipulated from 0· 525 ml/m in/lOOgm by
stenosis and/o r hyperem ia. A mode rate line ar correlation was
found between Q and bothTOA·I and TP-j (r=0.71 and 0.70).
K-1 exh ibited a bimodal relationship: dur ing hyperemia it
COrrelated with Q (r=0.85,5££=6.3»)but at rest, it correlated with
CFR (r=0.84, S££=5.5). Tmicro - showed a similar bimodal
relation sh ip , however, it was more closely correlated with Q
during hyperemia (r=0.93, S££=4.0), and with CFR during rest
(r=0.9 I, r EE=2.8). From thesedata, we concluded that: I. Tm·ero
and K- predict fl ow during hyperemia because distribulIOn
VOlume is maximized, however, under resting fl ow conditions,
th ey predi ct coronary flow reserve becau se distribution volume
reflects microcirculation resistan ce, and 2. transfer function
a nalysis is superior to conventional lime-density curve
parameters for assessment of flo w and coronary reserve from
hand -injected coronary angiography.
IN-VIVO VAlIDATION OF AN AUTOMATIC CORONARY QUANTITATION
PROGRAM FOR ON-LINE USE DURING ANGIOPlASTY
G.B. John Mancini, M.D., F.A.C.C., Sandra B. Simon, M.A. ,
Mark J. McGillem, 8.S., Michael T. LeFree, 8.S. and
Robert A. Vogel, M.D ., F.A.C.C. , VAMC, Uni ve rsi t y of
Michigan, Ann Arbor, Ml.
Coronary quantitation has recently been shown to be
useful in predicting the functional importance of
coronary disease, assessing the effects of interventions
and i n r educ i ng measurement variabi 1i ty • For practi ca1
impl ement a t ion during angioplasty or other acute
i nt e r ve nt i ons , methods must be both rapid and accurate.
Accordingly, a rapid method was developed and validated
by i magi ng cylinders with precis ion drilled lumens that
were i nse rt ed into the proximal coronary arteries of
anesthetized, closed-chest dogs. Lumens ranged from
0.83mm to 1.83mm thus mimicking sizes likely to be
encountered cl inically. Orthogonal digital images and
cinearteriograms were obtained and analyzed by the
automated program which required <1 min/view. On-line
images processed in the subtracted and non-subtracted
modes showed a high correlation with known, absolute
lumen diameter (r:.98) and a small standard error
(0.09mm). In contrast, digitized film images yielded
r:.87 with a significantly larger standarderror (0.24mm,
p<O.03) • Inter- and intra-observer vari abi 1i ty showed
r>.90 for all modalities with on-line, nonsubtracted
images having the smallest standard error (0.12 mm).
This method is thus suitable for accurate and rapid
diagnostic coronary quantitation.
TIlE ACCURACY OF <XllONARY liMEN QUANTITATION BY
RAPID, ON-LINE DIGITALANGIOGR.AmICMKl'HOffi
Thomas N. Skelton, MD, KatherineB. Kisslo, RDMS,
Eileen M. Mikat, MD, and Thomas M. Bashore , MD
Duke University Medical Center, Durham, Ne
Reproducibility studies found that intra- and
inter-observer variability was small, averaging 3.2% and
3 .9%, respectively.
These data reveal that accuratemeasurementsof coro-
nary ItDllen size can be achieved using a rapid, on-line
digital angiographic system. These quantitativemethods
appear well-suited for practical clinical applications.
Recent advances in on-line digital angiographic tech-
niques allow for the rapid acquisition and processing of
coronar y angiographic image data. To assess the accuracy
of these methods, 39 coronary artery segments from 5
canine and 4 htlJlll1l cadaveric hearts were evaluated and
the results compared to pathologic (PAllI) measurements.
Digital images were acquired into a 512 x 512 matrix
and coronary diameterdeterminedusing an automatededge
detection algorithm (AR'mEK). A contrast-filledcatheter
was used for calibration. Using a fixed-pressure
perfusion system, digital subtraction angiography was
obtained both during contrast injection (INJECTED) and
following fixation and casting of the coronaryvessels
with barium gelatin (FIXED).
INJECTED diameter measurementscompared favorably to
FIXED (r=0.82; SEE=0.29nm). SimilarlY, digital
measurements correlated well with PATH diameters (range
0,76 to 3.31 DIn) by linear regression:
DIGITAL SUBTRACTION ANGIOGRAPHY FLOW RESERVE lMAGING -
VALIDATION OF A FLOW MODEL AND VOLUME PARAMETERS
Jack T. Cusma, Ph.D., Nicholas J. Hangiandreou, B.S.,
Edward J . Toggart, M.D., John D. Folts, M.D., WaIter W.
PeppIer, Ph.D., Charles A. Mistretta , Ph.D., University
of Wisconsin, Madison, Wisconsin.
A method of producing parametric images of coronary
f low r eserve (CFR) has been developed using Digital
Subtraction Angiography (DSA). The measurement of CFR
by DSA requi r es that the method be sensi tive t o changes
in the coro na ry vascular volume. A flow model relating
image parameters to coronary blood f l ow (F ) includes the
ratio of maximum contrast (CM) values at an i mage loca-
t i on to measure volume change from baseline to hyper-
emia . Calculation of CFR from parametri c images using
CM and changes in arri val time (T) correlate well wit h
EMF probe measurements in a single s tenos is canine
model.
Volume i ncr eases were determined in two ways from
parametric images: 1) a CM ratio was calculated in the
perfusion bed for normal and stenosed arteries, 2) from
values of FxT where F is the EMF measurement and T is
calculated from an arrival time i mage . The CM ratio for
normal arteries in 7 dogs was 1 .79 + 0. 56 and the ratio
of FxT values was 1.98 + 0.82. The-results for stenosed
vessels (CFR<1.5) were 0.98 + 0. 23 (CM) and 1.14 + 0 .19
(FT) . The CM and FTderived-values were in good agree-
ment fo r normal and stenosed cases (r = 0.91 ).
DSA parametric imaging has thus been found to be
sensit ive to changes in vascular volume and to the
consequent reduction in vascular reserve.
r
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SLOPE
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OBSERVER VARIABILITY OF QUANTITATIVE CORONARY
ARTERIOGRAPHY PRE- AND POST-CORONARY ANGIOPLASTY:
SUPERIORITY OF ABSOLUTE DIAMETER MEASUREMENTS.
Mark_L • ..Sanz, M.D:, G.B. John Mancini, M.D., F.A.C.C.,
Michael T. LeFree, B.S., Judith K. Mickelson, M.D., Mark
R. Starling, M.D., F.A.C.C., Eric J. Topol, M.D.,
F.A.C.C. and Robert A. Vogel, M.D., F.A.C.C., Univ of
Michigan and VA Medical Centers, Ann Arbor, MI.
Quantitative coronaryangiography has been proposed as a
means for reducing observervariability in the interpre-
tation of coronaryangiograms, especially pre- and post-
angioplasty (PTCA). To test this, we analyzed 13
consecutively acquired biplane digital subtraction
angiograms pre- and post-PTCA for intra- and inter-
observer variability (VAR) of absolute lesional diameter
(AD), relative videodensitometric cross-sectional area
(RVCSA), automated percent diameterstenosis (%ADS), and
visual percent diameterstenosis (%VDS) using d new fully
automated quantitative computer program. Inter-observer
VAR of AD was superior to RVCSA, :tADS, and :tVDS (pre-
PTCA: r-.95, .83, .86, .70 and post-PTCA: .95, .BB, .81,
.62, respectively). AD also had the least intra-observer
VAR. Both AD and RVCSA of the same 1es ions in the RAO
and LAD projections correlated poorly (r-.59, .46).
These data suggest: (1) quanti attve angiography reduces
VAR compared with visual estimates, (2) of all quantita-
tive angiographicmeasurements, the least int er-observer
VAR is achieved using absolute 1esiona1 diameter both
pre- and post-PTCA, probably because the observerdoes
not need to identify a "normal segment" and (3) single-
view quantitativearteriographyis inadequat e, even using
videodensitometry. Therefore,automateddetermination of
absolute lesional diameter in at least two projections
should be considered the standard of evaluation of
coronarylesions both pre- and post-PTCA.
AcnJRACY CF aJRCNARY SIEN:'SIS QJANI'ITATICNBY DIGITIAL SlBTIlACTICN
<XRCfWlY AR1ERIOCllAPHY: AN INVIVO mo '1lJEL
Ke1nEth G. M:rris,'fl, '!l'l:lnal N. 3<elton, MD, Glem E. NEwna'l, 'fl,
TIDna5 M. Basl1re,'fl, Duke U1ivel"sity Is VA Med ctrs, IM11an, NC
Fixed OO1'OM"y stercses wa"e slrgically created onUlD and
circ\JDflex ocrooary artEries of 6 do~ using lew density plastic
c11l:6. Folloo/ll rea::>..ery; digital slbtractioooorr:;r,;ryarterio-
graj%ly (IBA) was pa-fO!1lBd in a gated I1Dde at 2 !'ranes per cardiac
cycle and a 512 x 512 matrix.Duplicate stu:1ies were obtairedusill!
both 6" ard 4" !Jnage intensifier rm fields and using both 45S
(R45) ard 60S (R60) diazetrcate. The ebgs were sacrificed and oasts
of the a:romrytree <reated by <BlnI1.ating the left main ocrooary
a-tery and ir1Jecti/llRIV sil100ne at 100 llIII P"OOSll'e. After the RIV
_ all~ to CU"e, the arcmry casts W!'re dl8sected !'ran the
he<rt an:! (]"(BS sections were obtaired frcm rormal ard stenceed
segnerts. PlanimEtry of crC5B sectional areas usi/ll Jl"qjectioo
microooopy was perfamedand the actwl S croos sectionala-ea (~­
sec A) stenosis cn1 S lII!an dianeter (SO) stencsis calculated. IBA
le'e analyzed using a Jl"OJl"iEtaryateocsts q.antitatiooalgoritlIn
(ARI'RE10, which estimatesSX-sec A steoosts videedensitanetrically
and SO stermis gronetriCBlly. IEl?reeSiooanalyses of ffiA and <BSt
stenosis q.antitatioodata were perfonred. RtWOO5ion ooefficients
(r) and standardEirr<rs (:R) were as foll=:
S X-sec AStenoe1s S DStenalis
r SEE r SEE
R60 4" II .89 5.2 .8? 7.9
R60 6" II .79 7.0 .64 10.6
R45 4" Il .66 8.5 :70 9.9
R45 6" Il .00 6.8 .76 8.9
Studies acquiredwith ~D ard 4" II Jl"Ovidedthe meat aoou-ate
OOrrelatioowith cast lIlEBSuranentS. The algoritlInwas IID"e accwate
in assessing X-sec A than SO sterosis. The staldarderrorsare less
tJ1an trose generally asrociated withV1SUlI estillBtes. StenCBis
qlEll1titaticn by IBA apP!aT'5 to be suffi ciently aoolrate fer
ClinlCB1 use.
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CardiovascularX-Ray/NMRlCT/PET
ENHANCED BlOOD-POOL CXJNTRAST IN CARDIAC NUCLF.:AR MAGNETIC
RESClNI\NCE IMAGES.
Justin D. Pearlroan, M.D., M.E. , PhD, FredHolrovang, M. D. ,
and1iOwardL. Kantor , H.0., PhD, F.I\. C.C., 1assilchuse t t s
General Hospi t al and Harvilrd Medical School ,Boston.
The NMR signal intens i t y f.ram cardi ac blood pool var i es
with selective-slice thickness, echo time, spin-echo (SE)
versus graoient echo (GE), and t ime i n the cardiac cycle.
IAJring s low flow, such as at end-diastole, intensity fram
blood pool is increased and contrast with myocardiumis
minimal. With very short echo times (e.g. <15 msec for
rapid vol ume imaging and for cinecardiography),contrast
can be problematic durifJJ systole as -...ell. Seeking to
improve contrast we analyzed the effect of conpl.ex
exponential multipIiers on contrast between blood pool
and myocardium in real projections. TI1e maxima are
predicted by a simple analytic expression:
exp!i(ar.ctan(dIm,-dRe)l,
where d Re and dImare the mean local dif ferences in real
and imaginary components, respectively. ~e tested this
prospectively on 20 gated NMR imaqes obt a i ned wit hSE=
14. The table bel ow shows the observed cont ras t between
blood pool and myocard itm (mean + standard error) before
and after use of the computed multiplier. Cont ras t was
comput ed as IDD%AI/i where I is intens i t y scaled 1-1024.
Total number of samples = 97 pel x 2 r~J ions x 20 images.
Contrast Cont ras t Percent
Before After Improvement
8 + 2 69 + 12 1404 + 223
paIred t-t.est, n =-2 0 t-test, n = 20
H :p] = P2' [><0. 001 H :p=O, p<. ool
TheseoreSults demo~strate marked improve2ent in cont ras t
by us i ng our method. \-e conclude that the problem of
poor contrast be twoen blood pool ard myocarditm oJ1ich is
especially problematic with short echo times may be
solved us ing the above method.
ASSESSMENT OF MYOCARDIAL PERFUSION IN VIVO USING NUCLEAR
HAGNETIC RESONANCE IMAGING.
Saul Schaefer, MD, Ronald M. Peshock, MD, Padmakar V.
KUlkarni, PhD, Craig R. Malloy, MD, Robert W. Parkey, MD,
FACC, James T. Willerson, MD, FACC. The University of
Texas Health Science Center, Dallas, TX
We examined the use of nuclear magnetic resonance imaging
(NHRI ) in the assessment of myocardial perfusion. A new
paramagneticcontrast agent, manganese-gluconate(Mn-Glu) ,
was preparedand its relaxation properties in solution and
in rat myocardium weremeasured. Using these data. condi-
tions to optimize contrast between normally perfused (NP)
and hypoperfused (HP) myocardium weredetermined. Imaging
studies were then performed using Mn-Glu in an in vivo
canine model of acute left anterior descending coronary
artery (LAD) occl us i on. RESULTS: In solution, the relax-
ation· pr operti es , ARl /C and aR2/C, of Mn-Glu were 7.8 and
41.6 sec-1 mM- l respectively. The Tl of normalrat myo-
cardium was markedl yshortened with administrationof low
doses of Mn-Glu with relatively small changes in T2,
whereas significantTl and T2 shortening was seen at
higher doses (0.1 mM/kg). After true or shamLAD occlu-
sion and injection of 0.1 mM/kg Mn-Glu, 8 dogs were imaged
i n vi vo us i ng a gated, T2-weighted spin-echo sequence.
All dogs with occl us i on demonstrateda reduction i n inten-
s ity i n the NP myocardium consistent with T2 shortening
with no change i n the HP myocardiumresulting in a con-
trast ratio of 2.1±D.6 (p<. OOl vs control). Six dogs were
then given 0.05 mM/kg Mn-Glu and imagedusing a heaVily
T1-weighted short TR sequence. Under these imaging condi -
tions. NP tissue showed increased intensity consistent
with T1 shortening in the normal myocardium.
CONCLUSION: Nuclear magnetic resonance imaging with Mn-Glu
can be used to detect myocardial perfusion abnormalities
in vivo in a canine model of acute coronary occlusion.
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CONCORDANCE OF RIGHT AND LEFT VENTRIC~~AR STROKE VOLUME
MEASUREMENTS IN NORMAL SUBJECTS BY (,NE MRI
Peter ~7. Pflugfelder, M.D., Udo Sechtem, M.D., Robert R.
Gould, Ph.D., Martin J. Lipton, M.D., FACC, Charles B.
Higgins, M.D., FACC. Department of Radiology, University
of California, San Francisco.
The contrast between endocardiumand blood pool and the
inherent 3 dimensional capabilities provided by MRl make
this technique a potential tool for the determinationof
right and left ventricularvolumes. Conventional MRI how-
ever, is limited by low temporal resolution and long
imaging times. Cine MRI is a new imaging sequence which
employs low flip angles, short TR times, and gradient re-
called echoes. This technique allows the acquisition of
up to 32 images per cardiac cycle at 2 levels within 4
minutes. To assess the ability of Cine MRI to determine
ventricularstroke volumes, contiguous transverse
sections of 10 mm thickness covering the entire volume of
the heart were obtained in 10 normal volunteers. Images
were acquired at a rate of 17 to 24 per cardiac cycle
using a flip angle of 30· and a TR time of 21 msec. Right
(RV) and left ventricular (LV) chambers wereoutlined by
2 independent observers in each section. End-diastole
(ED) was defined as the frame before mitral valve closure
and end-systole (ES) was defined as the frame before
mitral valve opening. Total ventricularvolumes were
determined using Simpson's rule.
RVED was 112±24 ml, RVES 43±12 ml, LVED 103±20 ml, LVES
30±10 ml. RV and LV stroke volumes (SV) correlatedwell:
RVSV = .90 LVSV + 3.97, r = .92 (p< .0001). Between
observers, r = .99 (SEE 4 ml) for LV and r = .98 (SEE 9ml)
for RV volume determinations.The LV/RV stroke volume
ratio approachedunity (.98±.09) in these normal subjects.
Using this technique therefore, it should be possible to
quantitatediscrepant stroke volumes, such as in patients
with valvular regurgitationor cardiac shunts.
MEASUREMENT OF VENTRICULAR VOLUMES BY MAGNETIC RESONANCF
lMAGING (MRI)
WaIter Markiewicz MD,FAC~,Udo Sechtem MD, Robin Kirbv BS,
Nikita Derugin BS, Gary C.CaputoMD, Charles B.Higgins
MD,FACC; University of California, San Francisco.
The value of MRI for measuring ventricularvolumes was
assessed in a dog model. Nineteen hearts were filled with
silicone rubber and imagedusing a multislice spin echo
sequence. Volumes were measured by 2independent ohser-
vers using computer aided edge definition and Simpson's
rule. Best correlationwith cast volumes was achieved
when the endocardial edge of the V was defined as pixels
with intensity (I) = I blood + (I myocardium - Iblood) x
50% (r = .99 for right ventricle (RV) and r •• 98 for
left ventricle (LV). Mean percent interobserverdifferen-
ce was 1.3%for the RV and 0.8 %for the LV. Ventricular
stroke volumes were obtained by thermodilution (TD) in 8
living dogs and compared toMRI measurements obtained
from end-diastolic and end-systolic images using a gated
multiphasic sequence. Correlationbetween the methods was
good (r = .90 for RV and r = .94 for LV). However, MRI
output underestimatedTD output, possibly reflecting in-
ability to obtain a true end-systolic image with present
technique. Differences between TD and MRI stroke volumes
which could not be measuredat the same time may haveal-
so been caused by changes in thehemodynamic state of the
anesthetized animals. As would be expected in normal ani-
mals, RV and LV stroke volumes determined by MRI were
highly correlated (r = .93). MRI provides a new noninva-
sive 3 dimensional technique to measure ventricularvolu-
mes. A higher sampling rate should allow measurement of
true end-systolic volumes and possibly result in a better
correlationwith TD measurements.
AU'IDMATED lEFT VENTRICUlAR MASS, VOLUME AND SHAPE FRJIoI
'lliREE-DIMENSIOOALMArnETIC RESCNANCE IMl\GI~: IN VITIO
VALIDI\TICN
GerardP. Aurigemma MD, Nathaniel Reichek MD, Sushma
Trivedi PhD, Raju Venugq>al1£, ChristineHarris RI',
f1erbert Y. Kressel MD, Gabor lIerman PhD,
University of Pennsylvania, Philadelphia, PI\.
Conputedzedanalysis and three-dimensional (3D) dis-
play of magnetic resonance (MR) images may permit auto-
mated left ventricularmyocardial mass (LVM) and cavity
volume (LVV) determinationand faithful 3D shape represen-
tation. Therefore, we imaged 20 formalin-fixed normal
canine left ventricles in air in a 1.5T MR scanner using
multislice spin echo (TR 500 ms, and TE 20 ms), contiguoos
5 mm sections and .78 x .78 mm pixel size.
An image processing progranperformed interslice inter-
polation to a final slice thickness of 0.78 mm. Voxels
were assigned to air or myocardiumbased on an intensity
histogran compensating for partial volume effect. Operator
input was necessary only to define mitral and aortic valve
planes. LV mass (LVM) and cavity volume (LVV) agreed
closely with anatomic (A) values: 3D LVM = .94A + 4.2g, r
= .99, SEE = 3g (range 58 -119.6g); 3D LVV = .81A + 1.74
ml, r = .90, SEE = 1.4 ml (range 7.6 -28 ml). Slight
cavity volume underestimationmay be due to the marked
endocardial irregularityof the undistended, fixed LV.
Surface generation, smoothing andshaded graphics tech-
niques were used to generate 3D displays of LV. Comparison
of sagittal, axial, and coronal sections of 3D images to
correspondinganatomic sections showed that LV shape was
depicted with remarkablefidelity. Thus, OOl1'!?uterized
analysis and 3D display of MRI images permits reliable LV
mass, volume andshape assessment with minimal operator
input.
SPATIALLY LOCALIZED FLG1 MEASUREMENTBY NUa.EAR MK;NETIC
RESONANCE IMlGIN>.
Qrhao Nalciaglu, Ph.D., S.C. Juh, M.S., J.M. Jo, M.S.,
J.M. Gardin, M.D., F.A.C.C.
University of California, Irvine
Recent studies have suggested that nuclear magnetic
resonance imaging (NMR) may be useful in measuring flCM.
In the currentstudy, we used NMR imaging to spatially
localize and measure flCM in liquids. NMR data were
acquiredwith A 0.6T 'Iechniearewhole body scanner using
a single spin echo technique with an echo time of 18
msec. Non-pulsatile flCM rate was varied fran 1 to 7
I/min using a Bianedicus pump to circulate water or CCM
blood in 1/2 and 3/8 inch diameter tubes. '!he canponent
of flCM velocity perpendicularto the tanograP1ic slice
plane was canputed on a pixel-by-pixel basis after suit-
able data processing. Average flCM rate by NMR was com-
puted as the average flCM distJ::ibutionover the cross-
section of the tube and canparedwith the average flCM
rate obtained fran the collection of a constant volume of
fluid within a given time. A linear least squares fit
was used to relate the two measurementsaccording to the
equation: Q(NMR) =m Q(column) + n, where Qis the flCM
rate in I/min. '!he results are shCMn belCM:
Inner tube diam. 1/2" 3/8" 1/2" 3/8"
Fluid type blood blood water
m (slope) 0.881 0.933 0.917 0.902
n (intercept) 0.238 0.086 0.390 0.228
r lcorr. coef.) 0,998 0.997 0.994 0.996
we conclude that volume flCM rates under these conditions
can be measuredby NMR quite accurately. HCMever, at the
higher flCM rates, non-linear behavior was observed,
probably attJ::ibutableto the ooset of turbulence.
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THE TIME CnURSE rJF [HE !1EDUCTION OF VENTRICULAR
ARRHYTHtUAS DURING AN ORAL AMIODARONE LOADING.
500 G. Kim, M.D., F.A.C.C., Aaron Stein, M.D., Sam L.
Teichman, M.O., Anthony D. Mercando, M.D. and John D.
Fisher, M.D., F.A.C.C., MontefioreHospital, 8ronx, NY
Rasel ine ~~ ~~
VPCs/hour ~73+544-- 92+187 71+184
Couplets/hour22+67 2.2+7.5 1.3+4.0
NSVT/24 hour 77"".+:173 12+'f8 3.9+15.0
(p<0.05:baseline vs day 5; p=NS: day 7 vs 13).
Re~ults of Halters on day 28 were not significantly
different from those on dayn. A significant (>83%)
reduction of VPCs was noted in 17 pts (74%),18 pts (78~')
and 18 pts (78%) on days S, 7 and 13 respectively.
Abolition of NSVT was noted in 16 pts (70%), 20 pts (87%)
and 19 pts (83~Q) on days 5, 7 and 13respectively
(p=NS:day 7 vs day 13). Pts who failed to show a
significant reduction of VPCs hy day 7 failed to show a
siqnificant reduction on day 28.
Conclusions: In pt s takingamiodarone (1.2g/day for 14
days then 0.4g/day), 1)A significant reduction of VPCs and
aholition of NSVT are noted in themajority (>70%) of pts
by day 5. 2)Most pts who do not havesignificant reduction
of VPCs by day 7 also do nothav~ a significant reduction
of VPCs on days 13 and 28. 3)With the maintenance dose
(0.4g/day), effects of the loading persist on day 28.
The time courSA of the reduction of ventricularpremature
complexes (VPC,;) during an oralamiodarone loading period
was studied hy serial Holter monitorings. All 23 pts (20
males, 3 females, age=60+14) had recurrentrefractory
sustained ventriculartachycardia (VT) and frequent
(>30/hour) VPCs before ami.odarone, Ouriogamiodarone
therapy (1.2g/day for 14 days then0.4g/day), serial
Halters were done on 5th, 7th, 13th and 28th days of
amiodarone therapy. ~onsustained VT (NSVT)=triplels or
longer.
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THE AMIODARONE HUMP: RECURRENT SUSTAINED VENTRICULAR
TACHYCARDIA DURING LOADING.
SharonMagro, P.A.C., Jack Krafchek,M.D., Huang-Ta Lin,
M.D., Jayne Hargls, R.N., DennisGoodman, M.D., Antonio
Pacifico, M.D. and ChristopherWyndham, M.D., F.A.C.C.,
Baylor College of Medicine, Houston,TX.
When recurrent sustained ventricular tachycardia (REC
VT) occurs during the first month (mo) of loadinq with
amiodarone (AM), uncertaintymay exist as to whetherthis
represents AM failure, VT aggravation, or insufficient
time for onset of action. To determine the outcome of
continuing AM in such pts, we treated 81 consecutive pts
with oral AM (1400 mg daily) for sustained VT or VF and
continued AM in all 26 pts who had REC VT in the first
month. Fourteen (17%) of these pts continued to have
spontaneousREC VT in weeks 2-4 with 1-100 episodes (mean
12±25) during this time. Of the 14, 3 pts hadVT aggrava-
tion and 6 had no change in frequency of episodes
(>3/wk). Eleven pts hadadjunctive therapy: antitachv-
cardia pacemakers 7 pts , class I drugs 5 pts, surgery'1
pt. No pt died of REC VT in the 1st month. All but 1 pt
were discharged onAM as the only antiarrhythmicdrug.
All pts were followed for 1-48 (mean 16±14) months by
transtelephonicand ambulatoryECG monitoring. Life-table
ana1ysis showed no signi fi cant difference in subsequent
rate of VT recurrence or sudden death in pts with and
without REC VT during weeks 2-4 (58% vs 37% at 24 mo
p=NS). Of importance, the rate of recurrence of
sym~tomatic ~T,or s~dden death (35% vs 30% at 24 mos,
p=N ) was SImIlar In both groups. No other clinical
characteristic distinguished pts in the two groups.
Conclusions: ApparentAM failure or VT aggravation occurs
in 17% of pts during AM loading. With judicious adjunc-
tive therapy, such pts have a similar prognosis to all
other pts. AM need not be discontinued, and can usually
be maintained as the soleantiarrhythmicdrug.
PHARMACOKINETIC INTERACTION BETWEEN AMIODARONE AND
PHENYTOIN. Paul E. Nolan, Pharm.D., Frank 1. Marcus,
M.D., F.A.C.C., Gifford Hoyer, B.S., MarlaBliss, B.S.,
Michael P. Mayersohn, Ph.D., Kathy Gear, R.N. Colleges
of Pharmacy and Medicine, University of Arizona, Tucson,
Arizona.
FACTORS PREDICTINGSAFE EARLY HOSPITAL DISCHARGE
AFTER TREATMENT OF VENTRICULAR TACHYCARDIA OR
VENTRICULARFIBRILLATIONWITHAMIODAROr-.E
Lorenzo A. DiGarla, M.D., M. Gomez, Mary K. Foley,R.N., Susan
sereika, Michael de Buitleir, M.B., Fred Morody, M.D., FACC,
University of Michigan Medical Center,Ann Arbor, Michigon
To examine the mechanism and frequency of apossible
interaction between amiodarone (A) and phenytoin (P), we
administeredIV P,S mg/kg, before andafter 3 weeks of
oral A, 200 mg/day, to 7 healthy non-smoking, male
volunteers aged 23-36 (mean = 27) years old and weighing
66.8-81.1 (mean = 75.7) kg. After each dose of Pserial
blood samples were obtained for up to 96 hours.Serum
samples were analyzed by asensitive and specific HPLC
procedure. The unbound fraction of P was measured by
ultrafiltrationin selected serum samples containing low,
medium &high concentrationsof P. The area under the
serum concentrationvs time curve (AUC) for P was
quantitatedfrom time 0 until the time of the last
measured serum concentration. Six of the seven SUbjects
had an increase in AUC of P while taking A. The AUC
increased an average of 30.9% (range: 6.4-63.7%, p=O.037)
in these 6 volunteers. The free fraction of P averaged
9.72% before A and10.2% after A (p=0.123). These data
suggest that A reduces the total body clearance of P by
metabolic inhibition and that this interactionwould be
expected to occurcommonly when A and P are used in
combination. It is difficult to predict the degree of
this interaction in an individual subject due to the
saturable, non1inear pharmacokinetics of P.From these
findings it would be anticipated that the dose of P
should be reducedwhen P and A are givenconcurrently.
Although amiodarone(A) is on effective antiorrhythmic ogent in
the treatment of refractory ventricular tachycardia(VD or
ventricular fibrillation(VF), prediction of a theropeuticresponse
allowing early hospital discharge remains an important clinical
problem. In this study, 14 clinical variables wereanalyzed in 51
pts with recurrent sustained ( >30 sec)VT or VF to determine
factors predictive of early recurrence of symptomaticVT or VF
after initiation of A in doses of1200 mg qd x 7 d, 800mg qd x 30
d, 600 mg qd x 30 d, then 400 mg qd, Eleven pts (22%) hod
recurrent, symptomaticVT or VF 4-13 (8±4) (±SD) hospital days
after beginning A (8.9±3.2 g); the other 40 pts(78%) were sofely
discharged5-52 (14±8) doys after beginning A (14.1 ±6.5 g) ondhad
no recurrence of symptomaticVT or VF during 2 month
followup. Chi-square analysis identified an EF <0.35 and > 2
episodes of sustainedVT or VF during the week befarebeginning
A as variables associated with recurrent symptomaticVT or VF
(p <0.003 and p<0.04) during A theropy. These 2 variobles were
highly sensitive (100% ond 91%) for recurrentVT!VF and had a
veryhigh negotive predictive volue(100% and95%).
In conclusion, pts with EF >0.35 and infrequentepisdoes of VT or
VF may be safely dischargedsoon ( 2. 5 days) after beginning A.
However, pts with EF < 0.35 and frequentVT or VF should not be
discharged eorly, even if the first 5 days of therapy ore
uneventful.
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AMIODARONE INDUCED SLOWING OF VENTRICULAR TACHYCARDIA:
INSIGHTS FROM ANALYSIS OF RESETTING RESPONSE PATTERNS.
Nicholas J. Stamato, M.D., Mark E. Rosenthal,M.D., Jesus
M. Almendral, M.D., CharlesD. Gottlieb, M.D. and Mark
E. Josephson, M.D., F.A.C.C., University of Pennsylvania,
Philadelphia, PA.
The mechanism by which amiodarone, a type III agent,
slows ventriculartachycardia (VT) has not been estab-
lished. Slowing of VT may be due to slowing of conduc-
tion or prolongingrefractoriness in the VT circuit. VT
resetting responses have been shown to demonstrate3
distinct patterns: flat (F),increasing (I) and flat plus
increasing (F+ I). Any F component is thought to
represent fully excitable tissue within the VT circuit.
An I pattern may represent either delay in the VT cir-
cuit or in interveningtissue. A fully excitable gap
after slowing of VT by amiodarone suggests that amioda-
rone causes VT slowing by slowing conduction in fully
recoveredtissue in the VT circuit. We studied 6 pts
whose VT was slowed by amiodarone. Mean VT cycle length
was 306 + 50 ms before amiodarone and 424 + 62 ms
after amTodarone, p=O.003. Ventricular refractoryperiod
was 238 + 10 ms before and 265 + 21 ms after amioda-
rone, p=~.D5. One and two extrastimuli were delivered
during VT on amiodarone and resetting curves charac-
terized. Response curves demonstrateda flat component
in 3, I in 1 and could not bedetermined in 2.
Conclusion: The finding of some F portion in thereset
curves in 3 VT after amiodarone suggests that slowing of
the rate of these VT by amiodarone is produced by slowing
of conduction velocity in fully recoveredtissue and not
prolongation ofrefractorinesswithin the VT circuit.
Since reset curves were not characterizedbefore amioda-
rone administrationthe mechanism of slowing of the
remaining VT by amiodaronecan not bedetermined.
NEUROPHYSIOLOGICALAND PATHOLOGICALEVALUATION OF AMIO-
DARONE INDUCED NEUROPATHY - AN EXPERIMENTAL STUDY.
Prasad R. Palakurthy, M.D., F.A.C.C., Vasudeva lyeI', M.D.,
Claudio Maldonado, M.S., Randolph Schrodt, M.D., and Joel
Kupersmith, M.D., F.A.C.C., University of Louisville
School of Medicine, Louisville, Kentucky.
Amiodarone (Am), an effective antiarrhythmicagent, is
known to cause many neurological side effects. However,
very little is known about the evolution of the neuro-
toxicity, effects of the different doses of Am and the
earliest predictors of the neurotoxicity. In order to
understandthese aspects, four batches (5 rats in each
batch) were studied. Batch I received Am intraperitone-
ally daily at a dose of 10 mg/kg. Batch 11 received Am at
a dose of 20mg/kg. Batch III received Am at a dose of
30 mg/kg. Batch IV served as the control group. At
weekly intervals, electromyographyand nerve conduction
studies were performed. At the end of the study, the
sciatic nerve along with the gastrocnemius muscle were
removed and subjected to histological examination includ-
ing electron microscopy (EM). Neurophysiological studies
revealed abnormalities in batches 11 and Ill. Major find-
ings included prolonged duration of the muscle action
potential (300 to 500% over baseline) with marked dis-
persion, decrease in amplitude and slowing of the nerve
conduction velocity. Histopathological findings seen in
batch III rats were patchy demyelination of the nerve
fibers, best observed under EM and the presence of group
atrophy along with angulated fibres in the skeletal
muscle. In conclusion, AM induced a dose related peri-
pheral neuropathycharacterizedby demyelination and
axonal loss. Neurophysiological studies predicted the
onset of neuropathyprior to the development of patholo-
gical changes.
AMIODARONE-ASSOCIATEDNEUTROPHILINCLUSIONS.
Philip C Adams MRCP, Philip Sloane PhD, Bruce Goldman MD, Adrian
Morley MD, David W Holt PhD. Mount Sinai Medical Center, New
York, NY
Multilamellar inclusion bodies (MLB) are a typical finding in
amiodarone (A)-related adverse drug reactions (ADR) and are seen
in neutrophils during A therapy. The relationship between plasma
drug levels, neutrophil inclusions and ADR is unknown.
We performed a cross-sectional study of 27pts taking A for a
median of 15m (range:- 2.5-68m). Electron micrographs of
neutrophils in buffy coat specimens (x10 000, randomly selected)
were blindly graded into MLB+ pts (with <!3 MLB in at least one
cell) and MLB- pts. Probable lipidosis-related ADR (AST >x2
pretreatment value; >15% fall in TLc o; frank lung toxicity;
neuropathy) were sought.
11/27 pts were MLB+. A and desethyl-A (DA) levels (AlDA
mg/I, mean±SD) were higher in the 11 MLB+ pts (2.1±1.01
2.3±1.2) than MLB- pts (1.3±1.0/1.1±0.6, p=0.003) as was A
daily dose (421±107 v 279±131mg, p<0.01): age and treatment
duration were the same in the two groups. MLB+ pts had more ADR
(7/11) than MLB- pts, 2/16 (chi 2, p<0.01). AST levels correlated
with A levels (r=0.52, p<0.01). Thyroid and cutaneous ADR were
independentof MLB. A and DA concentrations were higher in pts with
ADR (2.6±1.0/2.5±1.3) than without (1.2±0.7/1.2± 0.5,
p<0.001). Of 6 pts with buffy specimens 2 to 90 d (median 2 d)
after drug withdrawal, MLB were seen in zpts, at 2 and 44 d.
MLB in neutrophils occur commonly during A therapy, associated
with high drug concentrations and ADR. Hepatic, pulmonary and
neuropathic ADR and MLB may reflect a generalized concentration
dependent lipidosis produced by A. This may be persistent, consistent
with the drug's pharmacokinetics. Neutrophils may be used to study
mechanisms of A toxicity and warrant prospective testing in
identification of pts likely to develop toxicity.
A MJLTlCEl'IIER, RAN!Xl<lIZED TRIAL rn TI£ EFFICACY Cl' AMICllAR:l'lE,
F1ECAINIDE Al'D POOPP.F'Ei"l:NEIN PATIDIlS WI1li CARDIAC DISEASE Al'D CXM'IEX
VENIRIaJLARARRHY'lHo\IAS.
R. Latini, M.D.; P. Giani, M.D: L. Cb1d:xli., M.D.; A.P. Maggimi,M.D.;
G. Tognooi, M.D.; A. Volpi, M.D.; P.J. Schwartz, M.D., F.A.C.C. and the
Antiarrljythnic ~ Evaluatien ~, Istituto di Ricerche
Farmacologiche"MarioNegri", Milan,Italy
Proiodarcne (A), flecainide (F) and prcpafencne (p) areeffective in
scppressingventriculararrljythnias(VA); their benefit/riskprofile has
rot been cmpared in a prospective trial. Fron 2:l Centers, l2J patients
(pts) , with cmplex VA and stabilized CHJ (n = 85), dilated (n = 31) and
hypertrcphic (n= 4) cardiaJ1Yq)8thy(99%in NYHA Class I and Il), have
so far entered thetrial, ..mch foresees a 2-year follow-"" with
m:nitaring of plaera drug levels. Runs~3 prmatureventricularbeats
(PVB) were present in lOO/l2Jpts, CCllplets in 119/12:l pts; rourly PVBs
~ 298:: 373 (SEM). Pts are rand:mly assigned to asequence of the 3
drugs, AFP, APF, FPA and Ff'A, each at 2 00se levels. The switch to a
higher dose or to anotherdrug is detenninedby lack of respcnse (NR) at
a 24-rour arl:JulatoryECG or by significant side-effects. ~tenn
(7-28 days) repoose rates for the 3 drugs ~ similar (F, P 81%: A
89%). At 3 Jr01ths follow-tp 77/ff3 pts~ respooders (R), 7 NR and 5
died (4%; 4/5 of cardiovascular causes). Of the 77 R, 63(82%)~
still en their first dng, 10 en the seccod and 4 en thethird. In 10/14
pts the change in drug was due to side-effects. In crnclusicn, in
cardiac pts, with omplex VA and cardiac disease (4'A: n-ortality at 3
rronths)a high efficacy was achieved by each of A, F, and P.The switch
to a 2nd or3rd dng was needed in 14/ff3 pts (18%).
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EFFICACY OF ORAL SOTALOL FOR SUSTAINED VENTRICULAR
TACHYCARDIA REFRACTORY TO TYPE I ANTIARRHYTHMIC DRUGS
Michael G. Kienzle, M.D., James B. Martins, M.D., Luis
Cons t ant in, M.D. and Michael L. McCue, R.N., Uni ver s ity
of Iowa and VAHospitals, Iowa City, Iowa
Our purpose was to study the efficacy of oral sotalol (S)
in a group of 9 patients (pt s ) with sustained ventricular
tachycardia (VT) that persisted on procainamide (PCA) -
8 patients, or quinidine (Q) - 1 patient, during
electrophysiologic testing. We studied 8 men and 1 woman
with a mean age of 56 years (range 38-6 7). Pts had
coronary artery disease (6 pts) or cardiomyopathy (3 pt s)
and documented recurrentsustained VT (5 with cardiac
a r res t ) . The meanejection fraction was .34!.08 (mean!
SD). We measured effective refractory period (ERP) and
i nduced VT from the right ventricularapex using multiple
pacing cycle lengths and up to three extrastimuli.
Results: All pts had sustained VT i n the baseline state
that required double (5 pts) or triple (4 pts)
extrastimuli for induction. On therapeuticPCA or Q the
ERP prolonged 12!14% and VT slowed an average of 41!24%
from a baseline cycle length of 253!33 msec. On S (mean
daily dose 600!103 mg) the ERP was prolonged 17!12% (p=NS
vs PCA). Less than 10 VT beats were induced in 6 pts,
greater than 10 beats but less than 30 seconds in 2 pts,
and 1 patient was not studied on S due t o drug-induced
hypotension. Of 8 pts followed on S for an average of 9
months (range 1-16) one developed presumed drug-induced
polymorphous vr, one died suddenly , and 6 pts remain
symptom free.
We conclude: 1) sotalol is highly effective at
preventing induction of sustained VT previously shown
refractory to Type I drugs; 2) the enhanced efficacy of
sotalol is not explained by greater ERP effects; and 3)
chronic therapy is well tolerated i n the majority of
patients treated with sotalol.
ORAL SOTALOL: ELECTROPHYSIOI.OGICEFf'ECTS AND LONG TEll!!
EFFICACY IN PATIENTS WITH RECURRENT SUPRAVENTRICULAR
TACHYCARDIA.
Dennis M. Cassidy, MD, Angel Arena 1, MD and Denis Roy,
MD, FACC, Montreal Heart Institute, Canada.
Ten patients (pts) with recurrent supraventricular
tachycardia (SVT) (5 AV nodal, 5 AV bypass trael - 4/5
concealed) underwent electrophysiologic studies (EPS)
pr-e and post oral sotalol (2- 6 days, 80- 480 mg/day).
Oral sotalol increased sinus cyclp. length (CL)
(774±I62 RlS liS 1099±357 ms, p<.OOll, pac i.ng CL
inducing antegrade (32St73 ~Ul liS 422±74 ms, pe001)
and retrograde block (295!54 ms vs 414±66 ms,
p<.OOl) . Sotalol increased the effectille refractory
period of the atrium (220tl6 ms vs 268±56 ms,
pe02), the AV node (3IS±63 ms vs 395±63 ms,
p<.OI), the AV bypass tract-retrograde (297±54 vs
3S4±44, p< .OOl) and the IIentricle (232±17 ms vs
266!22 ms. p<.OOl) . The AH i nt er lla l (89±2? ms liS
98±20 ms, p=NS) a..d HV Intervat (42±12 ms vs
4S!11 ms, p=NS) were not altered significantly. Oral
sotalol prevented the induction of sustained (>30
sec) SVT in 8 pts (80") . Three of these pts had only
nonsustained SVT . The SVT- CL was considerably slowed
(3S2±6S ms liS 424!55 ms, p<.OOl) primarily due to
antegrade AV node delay (delta SVT-AH 62!19 ms,
pc001 compa; '"d to delta SVT- VA 4!11 ms, p=NS). Of
the 8 pts ~ith noninducible sustained SVT 7 were
discharged on sotalol. The drug was discontinued
because of sinus bradycardia in 1 pt. After a mean
follow-up of S±4 months 617 pts (85") had no
recurrences (3 pts) or rare episodes of SVT of short
duration (3 pt.s ) . We conclude: 1) Oral sotalol has
potent electrophysiologic effects . 2) pts rendered non-
inducible at EPS by sotalol halle an excellent long term
response.
~~TIARRHYr~~IC EFFECTS OF d·SOTALOL IN PATIENTS WITH RE-
FRACTORY SUPRAVENTRICULARTACHYARRHYTHMIAS .
Davi d I . Sahar, M.D. , James A. Reiffel , M.D., F.A.C .C. ,
Gregor y A. Kidwell , M.D. , J . Thomas Bi gger, J r . , M.D. ,
F.A. C. C., Annmar i e Squatrito, R.N.
Columbia Univ ersit y, New Yor k , NY
The electrophys i ol ogi c effects and antiar rhythmic ef -
ficacy of d'sotalol , a t ype III antiarrhythmic agent i n
pts with supraventricular tachyarrhythmias (SVT) is un-
known. So far we have evaluated the effects of d-sotalol
(1 . 5-2 . 75 mg/ kg) infusion during elect r ophys i ol ogic test-
ing i n 7 pts with recurrent symptomatic SVT refractory to
5 ! 2 standardagents for 2-20 yrs. Thr ee pts had PSVT, 3
had paroxysmal atrial fibrillation, 1 had permanent r e-
c i pro cating j uncti ona l tachycardia (PRJT.) Marked effi ca -
cy was demonstrated in each pt. PSVT was inducible (I) in
3/3 before d-sotalol. After d-sotalol PSVT was non-I in 2
and s l owed from 187 to 75beats/min (wi t h intra AV nodal
block) in 1. Atrial fibrillationwas I or spontaneously
present in 3/3 before d-sotalol; after d-sotalol, 1 be-
came non-I, 1 slowed and 1 slowed and became nonsus-
tained. In the pt with PRJT for 8 yrs, sotalol caused
reversion to NSR. Prolonged refractory periods developed
after d-sotalol in appropriatetissues (AV node in PSVT ,
atri a in a t r i al fibrillation) in all measurable in-
stances. d-Sotalol produced no cons i stent changes i n
s inus node re covery time or PA , AH or HV intervals . Sinus
cycle l ength and sinoatrial conduc t i on t ime always pro-
longed after sot a l ol, when measurable. Because of th ese
f indings. each patient was given oral d· sotalol (400-800
mg/day . ) Susta i ned benefit during chronic oral ther apy
was demonstrated in ea ch pt . Ourdata suggest that d-
sotalol is an extremely ef f ec t ive agent i n t he treatment
of refractor y SVT. Additiona lly intravenous t esting dur -
ing electr ophys iologic study was hi ghl y predi ctive of ef -
ficacy during chr onic oral therapy .
A COMPARISON OF THE CLINICAL ELECTROPHYSIOLOGY
OFI NTRAVENOUS AND ORAL SOTALOL
Harry A. Kopelman, MD, Raymond L. Woosley. MD, FACC ,
J ohn T. Lee , MD, Dan M. Roden , MD, FACC, and Debra S.
Echt, MD. FACC. VanderbiltUniversity, Nashville, TN
Drugs given acutely (iv) and chr onica l l y (po) may
produce different clinical electrophysiologic actions.
The eff ect of iv 1.5 mg/kg load and . 008 mg/kg/min
maintenance (mean±sd, 141±28 mg) and po (612±206 mg/day)
so talol . a beta-blocking dr ug that prolongs action
po t en t i al dura t i o n . were pro s pe c t i v ely evalua t e d in 20
pa t i en t s with sustained ventricular tachyca r di a (6
patients received i v and po) . ECGintervals , s i nus and
AV noda l fu nction indice s (CSNRT, AH , WCL) , HV, and RA
and RV re f ra c t or y pe r io ds were measur ed :
Basel i ne iv SotaloI po Sot a l ol
(mse c) (n-20) (n-l3) (n- l3 )
Sinus CL 825±180 1031±250** 1108±293***
QT 344± 51 415± 34*** 447± 66H "
AH 120± 38 161± 37* 19l± 50"'**
HV 52± 9 53± 11 59± 12
CSNRT 295±149 745±796 465±274
vet, 365± 78 442± 78** 451± 70**
RA·ERP 241± 39 313± 65*** 295± 24***
RV-ERP 240± 18 282± 31*** 287± 23***
*p<. 05 **p<.OI ***p<.OOI compared t o basel i ne
Although t he pl asma sotalol concentrations were higher
i n pat ients r eceiving po compared to i v (2 . 752 ± 1 . 227
vs 1 . 944 ± 0 . 714 ug/ml ,p <.05) , iv and po so t alol
pro duced s i milar changes i n al l parameters tested f or
the entire s tudy gr oup as wel l as in the 6 pat i ents who
received both iv and po dr ug .
In conc l us i on : Intraven ous and oral sot al ol produced
s imilar electrophysiologic effects of bet a -bl ockade and
prolongation of refractory per io ds and repolarization.
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SOTALOL FOR SUSTAINED VENTRICULAR TACHYCARDIA AND/OR
SUDDEN DEATH.
Steven Singh, M.D., F.A.C.C., Andrew Cohen, M.D.,
F.A.C.C., Marc Wish, M.D.,F.A.C.C., Frederick Miller,
M.D., Crystal Harrington, R.N., John Gottdiener, M.D.,
F.A.C.C., Ross Fletcher, M.D., F.A.C.C., VA and
Georgetown Medical Centers, Washington, D.C.
The efficacy and safety of Sotalol (S) were assessed in
17 patients (pts) with sustained V-tach (VT) and or
sudden death, using holter monitoring (HM),
electrophysiologic testing, and radionuclide
ventriculography. Pts were previously refractoryto av.
4.8 antiarrhythmicdrugs. VPBs av.400/hr.
Sotalol (320-960mg/day) reduced VPBs/hr, couplets and VT
events by 86%, 94%, 98% respectively. Inducible VT was
suppressed or successfully modified in 11 of 13 pts
(85%) tested electrophysiologically. Longterm followup
(mean 9 months) shows adequate VPB suppression by HM.
One pt died suddenly after 10 months of treatment with
S. Mean ejection fraction before and after S were
44+20% and 41+16% respectively (pNS). S significantly
reduced heart-rateand prolonged QTc interval on the ECG
(p<=O.OOOO and p<=0.0004) respectively. Side effects
include increased fatigue in 3 pr s , Sotalol is a well
tolerated, effective antiarrhythmicin high risk pts for
sudden death. It appears to be beneficial in the
patients who have failed multiple drug trials.
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AMIODARONE BINDS TO THE TYPE I ANTIARRHYTHMIC DRUG
RECEPTOR ON THE CARDIAC SODIUM CHANNEL.
Robert S. Sheldon, M.D., Ph.D., Nancy J. Cannon, B.Sc.,
Roger J. Hill, Ph.D. and HenryJ. Duff, M.D., University
of Calgary, Calgary, Alberta, Canada
Amiodarone (AMIO) is an important class III antiar-
rhythmic agent whose main electrophysiologic action is
thought to be prolongationof action potential duration.
In contrast, the type I drugs are thought to act by
binding to the sodium channel and slowing action poten-
tial prolongation. Recently AMIO has been shown to
block action potential propagationunder certain condi-
tions in vitro and to prolong QRS duration in vivo
suggestIng--that it binds to the sodium channel.--ve
previously developed a radioligandassay for a receptor
for type I agents on the sodium channel using
['Hlbatrachotoxinin(BTXB) binding to freshly isolated
myocytes. BTXB binds to sodium channels in the ac-
tivated state. Vith this assay we showed that the
dissociation constants (Ko) of AMID and desethyl AMID
are 29 and 51 ~M, respectively. Scatchard analysis
showed that AMIO is a noncompetitive inhibitor of BTXB
binding, indicating that it stabilizes a non-conducting
state of the channel. Other class III agents (N-
acetylprocainamide, bretylium, sotalol) have Ko values
of 1-3 mm, indicating little affinity for tfie sodium
channel. A comparison of KO values and clinically
effective serum concentrations suggest that AMIO and
desethyl AMIO might maximally occupy 6-9% of sodium
channels, while other type III agents are much less
potent. These data suggest that one of the actions of
amiodarone may be binding to the sodium channel.
AMIODARONE - A USE DEPENDENT CALCIUM CHANNEL
BLOCKER?
Mario Talajic, M.D., Michael R. de Roode, B.S.,
Mackenzie A. Quantz, B.S., Stanley Nattel, M.D.,
F.A.C.C., McGill University, Montreal, Quebec, Canada.
The purpose of these experiments was to study the
effects of amiodarone on slow-channel tissue. Fourteen
anaesthetized, autonomically blocked dogs were subjected
to sinus node crush. AV conduction time (AVCT) was
studied as a function of cycle length before and after
infusion of 10 mg/kg or 25 mg/kg of amiodarone (A10 and
A25). Amiodarone prolonged AVCT in a use-dependent
fashion, increasing it by 52 ± 287., M± S.D. (Ala) and
60 ± 237. (A25) at a cycle length of 500 msec compared to
25 ± 117. (AID) and 20 ± 167. (A25) at a cycle length of
1000 msec. The time dependence of amiodarone'seffects
on AV conduction was determined by studying the
conduction of prematureand delayed atrial activations.
Amiodarone's effects on AVCT were completely reversible
by increasing diastolic interval, with a recovery time
constant averaging .92 ± .28 sec. In an additional
group of 3 dogs with epicardialHis bundle electrodes,
all frequency-dependentchanges in AVCT produced by
amiodarone were due to changes in AB interval. Slow-
channel action potentials were produced in vitro by
exposing canine cardiac Purkinje fibers to 25 mM KCl and
0.125 ~M isoproterenol. Amiodarone depressed Vmax of
slow channel action potentials in a frequency dependent
fashion at frequencies comparable to those studied in
vivo. The recovery time constant of Vmax averaged ~4 ±
.42 sec in the presence of amiodarone. We conclude that
amiodarone has use dependent effects on slow-channel
tissues, possibly accounting for its value in the
treatmentof reentrantsupraventriculartachycardias
involving the AV node.
A COMPARISON OF THE ACUTE ELECTROPHYSIOLOGICAND
ANTIARRHYTHMIC EFFECTS OF AMIODARONE AND
DESETHYLAMIODARONE.
Stanley Nattel, M.D., F.A.C.C., Mario Talajic, M.D., and
Michael de Roode, B.S., McGill University, Montreal,
Canada.
Accumulation of desethylamiodarone(DA) may account for
some of the delayed electrophysiologic (EP) and
antiarrhythmiceffects of oral amiodarone (A) therapy.
To evaluate the acute EP effects of DA and A, 10 mg/kg
and 25 mg/kg intravenous doses were administeredto 28
anesthetized, autonomically blocked dogs. DA prolonged
QRS duration (127. and 327.* for doses of 10 mg/kg and 25
mg/kg respectively), ventricularERP (47. and 237.*) and
atrial ERP (77., 577.**) more than did A (37. and 87.
increase in QRS; 97. and 37. in ventricularERP; and 97.,
177.* for atrial ERP; *p < .05, **p < .01 compared to
control). In contrast, A produced greater increases in
Wenckebach cycle length (777.***, 887.**) than did DA
(347.**, 577.**). To evaluate the acute antiarrhythmic
effects of A and DA, these agents were administered
intravenously to 10 dogs with spontaneous ventricular
tachyarrhythmias24 hours after two-stage left anterior
descending coronary artery ligation. Cumulative doses
of 35 mg/kg of each agent substantiallyreduced
ventricularectopic complex frequency: A from 120 ± 43
PVC's/min (control) to 46 ± 33**/min; DA from 136 ± 42
PVC's/min to 5 ± 10** PVC's/min. We conclude that DA
has substantialacute antiarrhythmicand
electrophysiologic actions, with relatively greater
effect on fast channel tissue than A. The accumulation
of desethylamiodaroneprobably contributes to the
changing effects of chronic amiodarone therapy.
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CALCIUM CHANNEL BLOCKING PROPERTIESOF AMIODARONE.
Khi em Nguyen , M. D. , Duke Phan, Ray Zobrist, Ph.D., Bharati
Dave, M. S., Helen Gordon, M. D. , John Giacomini , M.D.
VAMC and Stanford University, Palo Alto, CA .
Despite its widespread clinical use, the precise mechanism
of action of ami odar one has not been def i ned . Recent e l ec-
trophysio l ogic evidence su ggests that ami odarone may bl ock
calcium chan nels; however, no s tu die s have directly ad-
dressed th i s question. This study was designed t o spe c if-
i ca l ly exami ne th e calcium channe l bl ocking pr operti es of
amiodaron e i n both receptor binding assays and pharmaco-
l og i c response s t udi es.
The spec i f i c binding of amiodarone to t he dihydropyridine
and phenylalkylamine calc iu m antagonist r eceptors was as -
sesse d by its ability to displace 3H-nitrendipi ne and 3H-
0600 respectively from rabbit myocar dial membr ane particu-
lates . Amiodarone_9isplaced3H- ni trendipine with a Ki
of_ 6. 2 t .0 4 X 10 Mand 3H-D600 with a Ki of 5.2 t .8 X10 M. Determinationof pharmacologic calc ium channel
blocking actiVity of amiodarone was performed in a tissue
bath using electrically stimulated rabbit right ventricu-
l ar strips and KCl-induced depolarization of rabbit aortic
rings. Amiodarone inhibited contractility of the_light
vent r i cul ar strips with an EC50 of 2. 2 t .1 X 10 M, and
in hibited KCl-ind~§ed aortic r i ng contraction with an EC50
of 4.9 t 2. 0 X 10 M.
In conc l us i on , amiodarone demonstrated high aff ini t y bind-
i ng t o th e dihydropyridine and phenylalkylami ne ca l c i um
channe l receptors, with close cor relation be tween binding
affinit y and pharmacologic pot~gcy . At i ts usual therapeu-
tic plasma concentrationof 10 M, amioda ro ne t hus satis-
f ie s criteria for a calcium channel blocker . It is l ikely
t hat t he cl i ni ca l effects of amiodarone may be partly
mediated through its ca l c i um channel blocki ng pro perties.
ANTI-ARRHYTHMIC EFFECTS OF DESETHYLAMlODARONE AND
AMl ODARONE AGAINST REPERFUSION-lNDUCED ARRHYTHMIAS IN
THE ANAESTHETIZED RAT.
Emma Riva, M·.D. and David J. Hearse, O.Sc., F.A.C.C.,
CardiovascularResearch, The Rayne Institute, St Thomas'
Hospital, London SE1, U.K.
Desethylamiodarone(DEA), the main met abolite of
amiodarone (Al, has been suggested to possess anti-
arrhythmic properties but both experimental and cl in-
ical evidences are laCKi ng. We compared t he anti-
arrhythmic propert ies ofDEA and A in vivo in t he
aneasthetized rat with regionalisc~7 min of
left coronary artery occlusion) and reperfus ion(10
min) . DEA and A (5 mg/ Kg) or vehicle (V) were given
as a s ingle bolus intravenousl y t orats (n = 15 for
each group) 10 min prior to occlusion. The concent ra-
tion of t he two drugs in plasma and myocardi umat t he
end of reperfusion (i.e. 27 min after i. v. dose) was
measured by high pressure liqu id chromatography. DEA
and A reduced the incidence of reperfusion- induced
ventr icular f ibr i l lat ion from it s control value of 75%
t o 47%and 20%(p = less than 0.01) respectively.
Mortality was reduced from 63%t o 7%in both t reated
groups (p= less t han 0.01). Plasma level s of DEA and
A were 0.25 +0.022 (mean +SE) and 1.07 +0.21 ~g/m l
res pect i ve l y~ in myocardium the corres ponding values
were 29 +4 and 23 +3 pg/g. No diff erences in plasma
or myocardial concent rat ions ofDEA or A were observed
between animals which fi brillated and those which did
not. In conclus ion, DEA and A signif icant ly reduce t he
mortality associated with reperfusi on-induced arrhythmias ,
this protection was independentof any hemodynamic
effect s of the drugs.
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Hypertension
FAIUJRE OF EXERCISE BLOOD PRESSURE PARAMETERS TO
PREDICT LEFT VENIRlaJIARMASS -
1HE FRAMI!'l.iHMiHEART SIUDY
JonathanF. Plehn, M.D., F.A.C.C., Daniel Levy, M.D.,
Keaven M. Anderson, Ph.D., Daniel Savage, M.D. , F.A.C.C.
and Joseph Stokes Ill. M. D••
FraminghamHeart Study. Framingham,MA
To test the hypothesis that exercise-induced changes
i n systemic blood pressures (BP) are superiorpredictors
of left ventricularmass (LVM) when compared to resting
measurements, we analyzed 1.965 standard(Bruce Protocol)
treadmill stress tests performedon a population-based
sample (974 men and 991 women)off anti-hypertensive
medication. Good correlationwas found between resting
systolic BP (SBP) and echocardiographically-determined
LVM (Penn criteria) indexed for body surface area
in men and women (r=.12. p < .0002 and r=.28 p <
. 0001 , respectively). Similar correlationswere
observed in both sexes for rraximmSBP attained (r=.1 5,
p < . 0001 and r=.30, p < .0001), SBP at the end of
Stage I (r=.12. p < .0002 and r=.25. p < .0001) and
for double product (DP) i n women (r=.30, p < .0001).
Poorer cor~elationwas seen for DP i n men (r=.08,
p < .007) and for maxillUll resting to peak SBP difference
in both sexes (r=.08, p < .02 and r=.09, p < .005).
Conclusion: Exer c i se blood pressure parametersoffer
no advantage over standardresting measurements in
predicting LVMI i n subjects not being treated for
hypertension.
AGE IS A BETTER PREDICTOROF LEFT VENTRICULAR MASS INDEX
THAN BLOOD PRESSURE IN NORMAL ADOLESCENTS.
Peter Schulman. M.D.. F .A.C.C. , William B. White, M.D . ,
Mary B. Nardone, and E11en McCab e , R.N.• University of
Connecticut School of Medicine, Farmington.
Previous studies in both normotensiv e and hypertensive
adults have shown that peak systolic blood pressure (BP)
determine d by ambulatory BP recordings predicts LV mas s
index (LVHI) better than casual or s l eep BP. To deter-
mine the relationship between LVMI and BP in normal ado -
lescents , we performed echocardiography, casual BP deter-
minations, and ambulatory BP recordings (Accutracker) i n
34 SUbjects . ages 11 -21 , 17 of who m were ath\etica11 y
t rained . Mea~ LVMI ±. SO was 72.7 ±. 21. 7 g/m , range
40 .3-136.2 glm and was 13% higher i n t rain ed v s . un -
t rai n ed sub j ect s (NS) . Casual BP and mean 24 hr. BP
were 105/59 ± 10/8 mmHg and 112/61 ± 8/ 4 mmHg respect -
ivel y . Peak (4 hr) and sleep BP were 121/71 ±. 11/5 mmHg
and 105 / 55 ± 9/4 mmHg resp ec t i vely . Correlat i on of
other parameters test ed with LVM I were:
Parameter R P
Age .4 0 = .0 2
Casual Systolic BP .2 0 = .28
24 h r , Systolic BP . 35 =. 0 5
Peak Systolic BP . 35 = . 0 5
Sl e e p Systolic BP . 3 5 - .05
No measu r e ment of diastol ic BP correlated with LVMI.
Thus , neither diastolic BP nor casual sy stolic BP correl-
ated with LVMI. but s i gn ifi cant cor r el ation s of 24 hr.,
peak , and sleep systolic BP with LVMI were observed i n
normotensive adolescents. That age was the strongest
det erminant of LVHI suggests that adolescent growth is
accompani ed by increasing LV mass that is out of propor-
tion to increasing body s urface area.
52A ABSTRACTS JACC Vol. 9. No. 2
February 1987:52A
GENETIC EFFECTS OF LEFTVENTRICULAR MASS ON
BLOOD PRESSURE IN CHILDREN
Weight has an important genetic effect upon
both systolic blood pressure (SBP) and left
ventricular mass (LVM). We formulated a
sequential genetic model that would test the
hypothesis that genes affecting weight
controlled LVM and that the genes for LVM
controlled SBP. In addition, we sought to
reject the hypothesis that genes for SBP
controlled LVM. We studied 102 monozygotic and
68 dizygotic 11 year old twins. Correlations
were obtained by zygosity for weight, SBP and
LVM on all twin pairs and entered into a LISREL
program to test the models. Parametersof these
models are estimated by maximum likelihood and
the Goodness of Fit using chi-square. The
hypothesis that genes for weight sequentially
controlled LVM which in turn controlled SBP
fit; chi-square ra.e. 34) p>0.45 The
alternative hypothesis that sequential genes
controlling weight control SBP which control
LVM was rejected (p<.OOl). Therefore,
discounting a common genetic effect upon all
variables, sequential genetic analysis suggests
a causal sequential relationship between
weight, LVM and SBP. Left ventricularmass may
have an important genetic effect upon level of
blood pressure.
Richard M. Schieken, M.D. ,FACC,
Ph.D, Joann Bodurtha, M.D. and
M.D. Ph.D Medical College
Richmond
Lindon Eaves,
Walter Nance,
of Virginia,
REGRESSION OF LEFT VENTRICULAR HYPERTROPHY
AFTER RENAL TRANSPLANTAT ION
Ronald B. Himelman MO, Wi11iam Amend MD, Alain
Bouchard MO, Joel 5. Landzberg MD, Robert Merz MO, Jay 5.
5imonson MD, Nelson B. Schilfer MD, FACe University of
California,San Francisco.
To evaluate regression of LV hypertrophy, 19adults
(mean age 40 years, 10 male) were prospectively
evaluated WithQuantitative 20 Echocardiography and ECG
before and after renal transplantation. Before surgerYA
17 of 19 patients were dialyzed via fistula for 2.4 ± 2.L
years and 12 of 19patients treated for hypertension for
5.0 ± 4.4 years. At follow-up ('.2 ± 0.8 years), 18
patients were on prednisone and 9 on cyclosporine. Mean
systolic blood pressure (SBP) decreased by 23 ± 15 mm
Hg and diastolic (OBP) by 10 ± 8 mm Hg on 29% fewer
antihypertensive drugs. BOdy weight increased by 8 ± 5
kg; hematocrit increased by 11 ± 9 %; and closure of
tfstula occurred in 7 patients. Mean echocardiographic
LV mass (LVM) using a truncated ellipse formula, LV
mass index, and average wall thickness (WT) all
decreased Significantly. CO by 5impson's Rule decreased
significantly, reflecting lesser decreases in both heart
rate (HR) and stroke volume (5V). Ejection fraction did
not change (65 ± 6 vs. 63 ± 9 %).
SBP(mmHa)OBP ill1.W YiIl£!!ll SV (cc) -':!!L CQ(Llmin)
Pre 153t 18 90t9 261t 79 1.6%0.3 65t 9 82t17 5.0 t 1.6
Post 130t 12 80t7 188t57 1.4tO.2 52t19 72t 17 36 t 1.1
P <0.001 <0.001 <0.001 0.016 NS NS <0.001
ECG voltage (5Vt + RVs-6) decreased by 8 ± 6 mm and
correlated" modestly with LVM tr = 0.46) Thus LVM
decreased by 28% after renal transplantation, amounting
to approximately 35 grams regreSSion per 10 mm Hg
decrease in 5BP. Another contributing factor was
resolution of the pretransplant high output state with
correction of anemia and closure of fistulae.
THEIMPORTANCEOF BODY WEIGHTAS A DETERMINANTOFCARDIAC
STRUCTUREANDFUNCTIONINADOLESCENTS.
Wjlliam F Graettinger M.D FA CC, Michael A. Weber,MD., FAC.C.,
Deanna Cheung, M.D., and Russell C. Klein, VA MedicalCenter, Long
Beach, and Universityof California,Irvine,California
To evaluatebody weight as adeterminantof cardiacstructureand function,
47 normotensive 8th graders were studied with M-mode echo, duplex
Doppler-echocardiography (DE) and standard blood pressure
measurements(BP). The subjects were separatedby body weight into
Standard(>120 pounds) and Lighter«120 pounds) groups. No SUbject
had a bloodpressure>140/90. The differences between the groups in
systolic (SBP) anddiastollc (DBP) bloodpressures,LVmass, left atrial size
(LA) and peak aortic flow velocity(PAoV) were:
SBP DBP LV Mass LA PAoV
mmHG mmHg G mm cm/sec
Standard(n=30) 116±7 72±7 182±38 3.4±0.5 93±13
Lighter(n=17) 102±8 64±7 144±28 3.1±0.3 83±12
p<.OOI p<.OOI p<.OOI p<.OI p<.02
Body weight was stronglycorrelatedwith systolic BP in the entire study
group (r=0.66, p<0.001), but was slightly less stronglycorrelatedwith DBP
for the entire study group (r=0.48, p<0.001). DE LVfilling indices such as
peak early diastolic flowvelocity,early diastolicfilling integral, peak atrial flow
velocity, and atrialfilling integral were not significantlydifferent between the
groups. No significant differences in bloodpressure,LVmass, LAsize or
peak aortic flow velocity could bedemonstratedwhen the subjects were
subdivided on thebasis of genderor presenceor absence of family history
of hypertension. Body weightappearsto be not only a strong predictor of
blood pressurebut also of cardiac structural and functionalcharacteristicsin
adolescents.
ABNORMAL LEFT VENTRICULAR MECHANICS AND SHAPE IN HYPER-
TENSION IN THE ABSENCE OF VENTRICULAR HYPERTROPHY.
Charles K. Francis. M.D., FACC, Michael Remetz. M.D.,
ForresterLee. M.D., Allan V.N. Goodyer, M.D•• FACC.
Yale University School of Medicine. New Haven. CT.
In chronic hypertension (HTN) alterations in left
ventricular(LV) function and configurationare most
commonly attributedto left ventricularhypertrophy
(LVH). In order to determine whether HTN may effect LV
mechanics and shape when LVH is not present, we studied
40 patients. 21 with chronic HTN and 19 with no
detectable cardiac disease (NML). without LVH and
angiographicallynormal coronary arteries. Using
hemodynamic measurements and single-plane right anterior
oblique contrast left ventriculography,end-systolic
volume index (ESVI). end-diastolic volume index (EDVI),
stroke volume index (SVI), ejection fraction (EF), LV
wall thickness (WTH). LVmass (LVM). end-systolic
circumferentialwall stress (ESS). long and short LV
axis. and eccentricity at end-systole (ESE) and
end-diastole (EOE) were compared.
*p=<.05 ESVI EDVI SVI EF WTH LVM ESS ESE EOE
HTN 23 68 45 66 1.0 261 114 2.2 1.66
SD+ 10 16 10 9 .4 58 31 .3 .12
NML 24 76 52* 68 .93 235 119 1.9* 1,57*
SD+ 7 15 10 5 .13 55 25 .2 .14
LV end-diastolic long axis and short axis were normal in
HTN; end-systolic long axis was normal in HTN. but short
axis was reduced as compared to normal.
Thus. in this group of hypertensives without LVH.
stroke volume index and eccentricity are greater than in
comparable normal patients. These data suggest that HTN
may affect LV mechanics and shape prior to increases in
LV mass.
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Hypertension
DOES HYPERTENSION CAUSE MITRAL REGURGITATION?
S.Parker M.D., A.Marquez-Julio M.D., R.Ogilvie
M.D.,F.!I.Leenen M.D.,C.Poll ick M.B.,F.A.C.C.
Toronto Western Hospital, Toronto, Canada.
While hypertension exacerbates already
existent mitral regurgitation (MR), the role
of hypertension in causing MR is unknown. We
prospectively studied 66 hypertensive pa-
tients, who were referr~d solely for echo
assessment of LV function and who were not
characterisedas having MR , and 20 heal thy
controls, by combined 20 echocardiographyand
pulsed Doppler. Systolic turbulence in the
left atrium was diagnosed as MR -degree jud-
ged by distance from the mitral valve.
Twenty-three patients (357.) had MR vs only
one control (57.) (p<O.OOI). The degree of MR
was judged as mild in 18, mild/moderate in 3,
and moderate in 2 patients. The patient group
with MR was older than the group without MR
(56 vs 48 yrs: p<0.05); their systolic blood
pressure was higher (163 vs 147 mmHg:
p<O.Ol); their interventricularseptum was
thicker (14 vs 11 mm: p<0.05) and their LV
posteriorwall was also thicker 02 vs 11 mm:
p<0.05). Auscultation, performed independent
of the Doppler results, revealed murmurs of
MR in 5 of the 23 MR group, vs I of the 43
non MR group.
CONCLUSION:I.In patients with hypertension
the presence of MR represents a target organ
response that parallels LV hypertrophy. 2.Co-
mbined 20 echo/Doppler is required for detec-
tion of MR as auscultation is insensitive.
THE IMPAcr OF BIroDFLUIDITY CN
OORCNARY RESERVE IN PATIENTS WrIH
HYPERTENSIVE HEART DISEASE
Matthias Leschke,M.D., Wolfgang Motz, M.D.,Heiner
Blanke, M.D., Bodo E. Strauer, M.D., F.A.C.C.
Pep. of Medicine, Univ , of Marburg, FRG.
Coronary reserve is reduced in hypertensive hypertrophy.
The impact of blood viscosity on coronaryreserve was
assessed in 20 patients (pts) (age 61.2.:t7.3) with hyper-
tension and normal coronaries, 30 hypertensive pts (age
57.7+8.8) with coronary artery disease (CAD) and 34
normotensive pts (age 54.6+9.5) with normal ooronaries.
In all hypertensivepts significant left ventricular
(LV) hypertrophy was verified by LV-angiography. In
hypertensivepts with normal coronaries plasma viscosity
(PV) and erythrocyteaggregation tendency (EAT) were
significantly higher than in normotensive pts with nor-
mal coronaries.(PV1.32.:t.0.07 mPas vs.1.27.:t. 0.07 mPas, p<
0.01 and EAT 14.5+ 3,3 vs. 12.0+3.8,p<0.05l. However, no
differences were-observed in-ribrinogenlevel, whole
blood viscosity and hematocrit. In hypertensive pts with
CAD even more increased and higher values of PV and
fibrinogen were found as compared to hypertensive pts
without CAD.(PV 1.37+0.08 mPas vs. 1.32.:t.0.07 mPas , p<
0.05 and fibrinogen'"276.0+ 58.5 mg/100 ml vs. 238.4+
25.1 mg/100 ml,p < 0.05).CONCLUSION:It is conceivable
that increasedPV and EAT cause a decrease in coronary
reserve in pts with hypertension. In hypertensivepts
with additional CAD these rheological factors are even
more pronounced due to increased fibrinogen levels.
INSULIN RESISTANCE IN ESSENTIAL HYPERTENSION.
S.Bevilacqua, MD, R.Bonadonna, MD, G.Buzzigoli, MA Giorico
R.Pedrinelli, MD, L.Graziadei, MD, and E.Ferrannini,MD.,
CNR Institute of Clinical Physiology, Pisa, Italy.
Essential hypertension (EH) is more prevalent in obesity
anddiabetes, both of which are insulin-resistantstates.
To test whether EH per se is associated with insulin resi-
stance, we carried out euglycemic hyperinsulinemic (1mU/
min'kg) clamp studies in 13 young (3B:2 yrs) subjects with
untreatedEH (165:6/112:3 mmHg) but normal body wt (BMI=
26:1 kg/m2) and glucose tolerance, and in 11 controls (C)
matched for age (35:2 yrs) andsize (25:1 kg/m2). Glucose
turnover was measured with 3H-glucose, andsubstrateoxid-
ation with continuousindirect calorimetry. Basally, liver
glucose output, glucoseutilization and oxidation were com-
parable in thetwo groups. During steady-state hyperinsu-
linemia (67:6 vs 5B:3 ~U/ml, C vs EH), glucose output was
completely inhibited in both groups, whiletotal glucose
uptakewas decreased in EH (3.B:0.3 mg/min.kg) compared
to C (6.3:0.4, P<0.01). Since total glucose oxidation was
similar in EH and C(2.7:0.2 vs 2.B:0.3 mg/min'kg), the
impairmentin glucose uptakewas entirely due to reduced
nonoxidative (= glycogensynthesis + lactate production)
glucose disposal (1.2:0.2 vs 3.3:0.4 mg/min.kg, P<0.001).
Accordingly, bloodlactate rose by 0.47:0.0B mM in C but
only by 0.21:0.07 in EH (P<0.02) during theinsulin clamp.
In addition, lipid oxidation was suppressed by 66:B\ in C
and by52:7% in EH (P<0.05). We conclude that a) EH per se
is an insulin-resistantstate; b) this insulin resistance
is located in peripheraltissues; and c) its mechanism(s)
involve a defect in nonoxidative glucosedisposal.
AGE-RELATED CHANGES OF ELASTIN LAMELLAE I~ THE HU!lAN
THORACIC AORTA.
Michael F. O'Rourke11D, FACC, Alberto P. Avolio, PhD.,
Peter D. Lauren, BSc, James Yong, BD. St. Vincent's
Hospital, University of N.S.W.,Sydney, Australia.
The precise structuralbasis for arterial stiffening and
progressive dilation in humans with age has not yet been
established. Tha aim of this study was to investigate
structuralchanges of medial elastin in the aging human
aorta. Deaoem Ing thoracic aortas were collected
postmortem fram 12 subjects (6 ~ales, 6 females) aged 18
to 86 years, pressure-fixed (100 mmllg) ;Iith 10% buffered
formalin, anti stained with Orcein and Giemsa elastic
stain. Results for 'young' (18-40 yrjmean 29.2) and 'old'
(56-86 yrj U18all 72.8) subjects for diameter (D), riall
thickness (UT), Lnter'Lame.lLar- 3pacing (ILS). elastin
£i bre density (EFD) , aedfal, thickness (HT) and average
wall tension per lamellar unit (T/LU) were :
'Young' 'Old' ~ change P
hean SE Hean SE
D (mm) 17•0 1.1 22.4 0.7 31. 8 <0.01
HT (UlJ) 0.94 0.01 1.40 0.03 49.1 <0.001
n.s (um) 8.7 1.1 12.0 0.9 37.8 <0.05
EFD (LU/mm) 125 15 86 6 -31.2 <0.05
lIT (urn) 0.79 0.01 1.00 0.02 26.4 <0.001
TlLU (dyne/en) 1236 162 1891 107 53.0 <0.01
In older subjects elastin fibres were thinner and more
fragmented. Higher T/LU was imposed on thinned fibres.
Findings suggest that aging changes are due to fatigue
and ultimate fracture of elastic elements exposed to
progressively greater tensile stress. This also explauls
progressive increase in arterial calibre and
susceptibility of aged arteries to aneurysmal dilation
and rupture.
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CHANGES INAPOLIPOPROTEINAND HDL SUBFRACTION LEVELS
FOLLOWING PARTIAL ILEAL BYPASS: POSCH 5- YEAR RESULTS.
ChristianT. Campos, H.D. , John P.Hatts, Ph.D., Laurie
L. Fitch, H.P.H., Jane C. Speech, H.S., John M. Long,
Ed.D., Henry Buchwald, H.D., Ph.D., F.A. C.C. and the
POSCH Group, University of Minnesota, Minneapolis.
The Program on theSurgical Control of the Hyperlipid-
emias (POSCH) i s a randomized, secondary i nt er vent io n
trial examin ing t he ef fect of lipid modification achieved
by partial i leal bypass on overall mortali ty and the pro-
gression of atherosclerosis. As of July, 1986, 377 of
t he 838 part i cipants (45S) have been followed for at
least five years. Significant differences i n total
plasma cholesterol (C), LDL cholesterol (LDL) , and HDL
cholesterol (HDL) are observed between t he surgical and
control patients:
HDL
41tl0
39t 8
0.04
HOL-3
3Ot8
32t6
NS
Surgery (n- 65)
Cont r ol (n=53)
p value
C LDL
18Jt 37 104t31
240t37 170t35
<0.001 <0.001
(values in mg/dl; mean t S.D.)
Since July 1985, measurements of apolipoproteins A-I (apo
A-I) and B-100 (apo B-100), and HDL subfractions 2 and 3
have also been performed:
apo A-I apo B-100 HDL-2
121t22 99t22 ~
102t19 130t 20 7t5
< 0.001 <0.001 0.002
(values in mg/dl ; mean t S.D.)
The signi f i cant differences i n apo A-I , apo B-100, and
HDL-2 mirror the differences i n C, LOL, and HOL seen
after f iv e years of follow-uP. Whether t hese changes i n
apolipoprotein or HDL subfraction levels will be more
sensitive predictors of overall mortality or progression
of atherosclerosis remains to be determined.
Surge ry (n=178)
Control (n=199)
p Value
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The relationsh i p of serum triglycer ides (TG) to t racking
of hig h density lipoprotein cholest ero l (HDL-C) was inves -
t i gat ed in a cohort of 1139 chil dr en and youngadults,
ini t i al ly aged 5 to 14 years ol d , who were screened fou r
times between 1973 and 1983. Inorder to obtain baseline
val ues which were not affected by regress i on t o the mean,
all variables from the fi rst t wo examinat ions wereaver-
aged. We observed the expected i nver se r elat i onship of
TG and HDL-C and the assoc iations were s t ronger in whit es .
Correl ations of HDL-C bet ween baseline and two and five
year s of follow-up were greater in blacks ( f ive year s of
fo llow-up: r=0.53, black mal es; r=0. 48, bl ack females;
r=0. 39, whit e males ; r=0.34 , white fenales ). Blacks also
had greater persistence of HDL-C in the extreme quar t i l es
from baseline t o two and five year s of fo l low-up. In
general, more than 50h of blacks remained in the ext reme
quartiles, whereas about 40h of whites remained. These
observations were not signi ficantly altered when HDL-C
was adjusted for TG levels. Therefore, HDL-C appears t o
track independentlyof TG levels, and HDL-C levels may
be a determinant of TG levels and not the conver se . We
concl ude that di r ect measurement ofHDL-C for assessment
of risk of heart disease i s better than us i ng high TG
levels as a marker for low HDL-Clevels .
ARE SERUM TRIGLYCERIDE LEVELS A DETERMINANT OF TRACKING OF
HIGH DENSITY LIPOPROTEI N CHOLESTEROL? THE BOGALUSA HEART
STUDY
Carey G. Smoak , M.S.P .H., Frank A. Franklin, M.D., Ph.D.,
Sathanur R. Srinivasan, Ph.D. , Yu-Kun Chiang, Ph. D. and
Gera l d S. Berenson, M.D., F.A.C.C. , National Research and
Demonstrat i on Center-Arterioscl ero s i s , New Or l eans , LA.
THE RATIO OF APOPROTEIN B TO APOPROTEIN A-I AS THE BEST
PREDICTOR OF PREMATURE CORONARY ARTERY DISEASE IN WOMEN.
Jorge Trejo-Gutierrez, M.D., Carol Derby, A.B., Thomas
Pearson, M.D. , Ph.D., Stephen Achuff, M.D•• Hazel Smith,
M.T.• Paul Bachorik, Ph'D" Alan Sniderman , H.D., Peter
Kwiterovich. H.D., The Johns HopkinsMedical Institu-
tions, Baltimore, Maryland.
Plasma lipids, lipoproteins and their major apoproteins
have been shown to predict coronary arterydisease (CAD)
in men, but l ittle i s known of their relative predictive
value in women. In order to study this, we compared 3
groups of white women under the age of 60: 14 with arter-
i ogr aphical ly def ined CAD, 14 with no CAD by arteri-
ograph y and 17 non-hospitalized women who were asympto-
matic of CAD. In univariateanalyses, apoproteinB of low
density lipoprotein (1OL B) and apoprotein A-I (A-I) of
high density lipopr otein (HDL) were strongly associated
with CAD, as were total cholesterol (TC) and very low
density lipoprotein cholesterol (VLDL-C). The strongest
association with CAD was for the ratio 10L B/Al:
GROUP HEANS (+1 SO)
With CAD No CAD Non-hospitalized p
VLDL-C (mgh) 57 (31) 37 (33) 26 (12) .007
TC (mgh) 248 (61) 214 (31) 193 (40) . 006
A-I (mg%) 140 (29) 159 (19 ) 169 (3 7) .04
LDL B (mg%) 153 (39 ) 118 (36 ) 102 (30) .0009
1OLB/A1 1.16(. 45) .76( .28 ) . 65( .2 8) .0007
Neither low density lipoprotein, high density lipopro-
tein, nor its subfracti ons (HDL2 and HDL3) distinguished
between women with and without CAD . 10L B/A1 remained
the strongest predictor of CAD in multivariate analysis,
after controlling for VLDL, hypertension. diabetes and
smoking. These data suggest that the apoprotein ratio
LDL B/A1 may be a better predictor of CAD in women than
either plasma lipids, lipoproteins or other traditional
risk factors.
NEGATIVEBIAS AND VARIABILITY IN REFLOTRON CAPILLARY
CHOLESTEROL DETERMINATIOIlS
Bruce M. McManus , M. D., Ph.D. , F.A. C.C., Janet E.
Wilson, M.T. CASCP) , William C.Rogler, B.S., Joseph G.
Rogers. B.S •• Nan Tiedeman, M.S.,Philip Sokoloff, Uni v
of Nebraska Medical Center, Omaha, Nebraska
Over a 10-monthperiod of cholesterol testing in 2
communities, a worksite, and a health fair, we have
compar ed values obtained from venous blood by a CDC-
standardizedlaboratoryusing the standardcholesterol
esterase-oxidase-peroxidaseassay (EOP) and values
obtained by the Reflotron (REF) (Boehringer-Mannheim)
analyzer on samples of venous and capillary bl ood. In
comparison of 81 male and 104 female subject s ranging i n
age from 19 to 82 years (mean S2+14 years), t he mean
cholesterol val ues obtained by EOP were stat i st i cally
higher (p <O.OS) than those from the REF (234 vs 213
mg/dl ) . EOP and REF values were highly correl at ed
(r =0. 88) . Similarly, in a different city, a sample of
18 males and 22 females aged 2-71 years (mean 40~19
years) had higher EOP than KEF (p <O.OS) (214 vs 193
mg/dl). As well, venous blood run on REF was lower (p
O.OS) than EOP (180 vs 214 mg/dl). Intermethod
cor r el at i on washigh (r =0.96) . Finally, 10 male and 4
fe male hea l t h fair attendees aged 32-64 year s (mean 48+8
year s ) had higher (p < 0. 05) EOP t han REF (221 vs 208 -
mg/dl) wi th r=O.94. Thus, REF cholesterol values have
underestimat ed EOP by 9%, 10%, and 6%in 3 different
subject groups , respectively. The negative bias of REF
must be considered in all public cholesterol testing,
and must be checked by ongoing validative compar i sons .
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HIGH DENS ITY-LIPOPROTEI N CHOLESTEROL AND APOLIPOPROTEIN
A-I LEVELS IN CHILDREN: INTERRELATIONSHIP AND CORRELATES
IN THE BOGALUSA HEART STUDY.
Dav id S. Fr eedman , Ph.D. , Sa th anur R. Srinivasan , Ph.D.,
Char l es L. Shear, Dr.P.H. , Lar r y S. Webber , Ph.D. and
Ger a l d S. Berenson, M.D., F.A. C.C. Nat i ona l Research and
DemonstrationCenter-Arteriosclerosis, New Orleans, LA.
Cl i ni ca l studies indicate t hat apo l ipoprotein A-I (apoA-
I), the maj or protein moiety of high- density l ipoprotei ns,
may be more strongly (inver se l y) related to cardiovascu la r
disease risk than i s high-dens i t y l i popr ot e i n choles terol
( HDL-C) . Ther ef ore , we examined 1)the re lationship of
HDL-C to apoA-I levels and 2) factor s associated with
level s of both variables i n a blac k-white sampl e of 2849
five- t o l7-year -o l ds. Marked in t er-individual variat i on
was found i n t he composition of HDL, with only 267. of t he
vari at ion in HDL-C levels exp l a in ed by concomi t ant varia-
tion i n apoA-I. Increasing levels of se rum t r i gl ycer i de
cor r esponded moreclosely with decr eases in HDL-C than
with decreases in apoA-I ( r=- 0 . 52 vs -0. 09) , l ikely due to
bidirectional transferof cholesteryl es t er and triglycer-
ide among lipoprotein particles. Both HDL-C and apoA-I
were s imilarly re lated t o se xual maturation (ne gat i vely in
mal es) , ci gar e t t e smoking (negative ly) , and alcoho l i nt ake
( posit i vely). However, as compa red with levels of HDL-C,
apoA-I was more strongly eleva t ed by oral contrac ept ive
use . Fur t her mor e ,obesity was nega t i vel y relat ed t o onl y
HDL-C levels ; this inverse relat i onship was eliminat ed
after trigl yceride l eve l s were cont r ol l ed . These results
emphasize t he heterogeneity i n HDL composition which
exists i n a free-living populat i on. HDL particle number ,
which may be important in atheroscleros is, may not be
accurately assessed by measurement of HDL-C l evels in the
presence of obesity or elevated serum t r iglyceride levels .
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DIABETES MELLITUS AND HYPERGLYCEMIA AS RISK FACTORS
FOR CARDIOVASCULAR OISEASE: INFLUENCE OF AGE ANO SE X.
THE FRAMINGHAM STUDY. Pantel S. Vokonas, M.O., F.A.C.C.,
William B. Kannel , M.D., F.A.c.c. and L. Adrienne Cupples,
Ph.D. Boston University School of Medicine, Boston, MA.
Glucose tol erancebecomes progressively impaired with
advancing age. It remains uncertain, however, whether
blood glucose levels that are elevat ed butremain below
those consideredcharacteristic of diabetes also enhance
ris k for cardiovascul ar disease(CVD) . To study t his
i ssue, t he relative contribut ions of diabete sand moderat e
hyperglycemia (casual blood glucose levels 120-t o-149
mg/dl) t o CVD incidence were compared in younger and older
age groups (35-t o-64 vs 65-to-94) of men and women based
on 30 yr . follow-up data from theFramingham St udy. The
prevalence of diabetes and hyper91ycemia increased with
age in both sexes, however, both factors were more
prevalent i n oldermen. Diabetes, per se, SUbstantially
increased risk fortotal CVD and a broad range of specifi c
CVD outcomes i ncl uding coronary, cerebrovascularand peri-
pheral vascular disease t hroughout l i fe in bot h sexes , but
more so in women at all ages. In contrast ,moderat e
hyperglycemia alone (as compared to normoglycemia) modest-
ly enhanced risk for CVD in younger subject s of both sexes
but hadlittle or no impact in older men. For olderwomen,
this level of hyperglycemia was associated with cl early
increased risk fortotal CVD (Risk ratio = 1.4) as well as
coronary(R .R. = 1.6) and cerebrovascula r(R .R. = 2. 3)
events. Trends inrisk for older women remai ned signi-
ficant evenwhen the eff ect s of other ri sk fact orswere
considered in multivariate analyses. These f indings
suggest that moderate elevations of blood gl ucose are not
an innocuous accompaniment of the aging process but
instead enhance CVD risk, particularlyin older women.
SIGNIFICANCE OF EXERCISE-INDUCED FREQUENT OR REPETITIVE
VENTR ICULAR ECTOPIC BEATS IN APPARENTLY HEALTHY
VOLUNTEERS.
M. Janette Busby, M.D., Jerome L. Flpg, M. D., F.A.C.C.,
and Edward G. Lakatta, M.D., Gerontology Research Center,
National Institute on Aging, NIH, Baltimore, MD
Although the occurrence of frequent orepetitive ventri-
cular ectopic beats (VEB) during an exercise test i n
asymptomatic mil itary cohorts has been associated with
latent i schemi c heart disease (IHD) , the significance of
such beats i n t he general population is unknown. Between
1974 and 1984, of 1160 asymptomatic community dwelling
subjec ts ag ed 21-96 years from the Baltimore Long it udi nal
Study of Ag i ng (BLSA) who underwent maximum t readmil l
testing an average of 2.4 times, 80 (6.9%) developed
frequent VEB (>10%) or salvos (>3 in a row) at least
one test. The group developing -frequent or repetitive
VEB was significantly older than the remaining subjects
(63.8+12 .5 vs 50.0+16.1, p <.0001). Within the former
group-;- an ischemic- ST segment response to exerci se was
observed in only11%. Among the subgroup of 41 individ-
uals who underwent exercise thallium scintigraphy, a per-
fusion defect was noted in 20%. Of the 57 individuals
who have thus far returned for at Ieast onesubsequent
BLSA vis it over a follow-up period of 1.0-10.9 years(x =
4.6+2.6), 4 deat hs have occurred, only one ofwhich was
cardi ac in origi n. One additional subject suffered anon
-fatal myocardial i nfarct ion. The other 52 individuals
have remained asymptomatic without ant i-arrhythmic
therapy. Thus, in apparently healthy volunteers across a
broad age range, frequent or repeti ive exercise- induced
VEB occur predominately in older subjects , are notusual-
ly associated with detectable latent IHD, and do not
appear to presageeither cardiovascular morbidity or
mortality over the subsequent 5years.
SEX HORMONES AND BLOOD PRESSURE LEVELS IN WHITE AND BLACK
CHILDREN: THE BOGALUSA HEART STUDY
Charles L. Shear, Dr.P. H. , David S. Freedman, Ph.D.,
Sat hanur R. Sr i ni vasan, Ph . D. and Gerald S. Bere ns on ,
M.D., F.A.C .C., National Research and Demonstrati on
Center-Arteriosclerosis , New Orl eans , LA .
The r e l at i onshi p of serumtestoste ro ne , estradiol and pro -
gester one levels to systo lic (SBP) and diasto lic (DBP)
blood pressure was investiga t ed i n a sampl e of eight- to
17-year-old childr en. The sample of whi te boys (n=364) ,
black boys (n=363) , white girls (n=187 ) , and black girls
(n=199) was drawn fromparticipants of a cardiovascular
disease risk factor screening of all chi l dren in Bogalusa,
La. Resting SBP and DBP (K4) measurements were made by
t r a i ned nurses us ing mercury sphygmomanometers (mean of 6
mea surements used). Race-sex s pec i fic corre l ations with
SBP were s t ro nges t fo r t estos terone i n both black boys and
white boys ( r =0 . 5l and 0.48 , respect i ve l y , p < 0 . 0001 ) .
I n cont r as t , for f emales of both ra ces , cor re l ations were
strongest f or DBP with estr adi ol (r=0.2 6 black and 0. 38
white, p < 0 . 0001) and pr ogesterone (r=0.42 black and 0. 40
white, p < 0 .0001 ). Us i ng linear regre s ion. and control-
ling for maturationleve l, t he independent ef f ec t of eac h
hormone was test ed . Results f r om t hose analyses showed
testos terone l evels to re main posit i ve l y as sociated with
SBP i n males of each race ( partial r=0. 10, p< 0.05), with
a 2 mmHg dif f er ence fo und between the upper and lower ter-
tiles of t estosterone level. For females, onl y progest er-
one l evels were found to have astatistic al l y significant,
in dependent relationship to DBP (partial r =0.16 and 0.23
for whites and blacks, re sp ec t ively ) wi t h a 3 mmHg di ffer-
ence foun d between t he upper and l ower tertiles of pro ges -
t erone l evel . The data su gges t t hat sex hormones i n
childhood are another impor t ant factor in t he mosai c of
blo od pr essure determi nants .
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CHRONIC CIGARETTE SMOKING INHIBITS TISSUE PLAS-
MINOGEN ACTIVATOR (t-PA) IN PLASMA
PERCENT IN-HOSPITAL MORTALITY
Women have a poorer prognosis than men after acute myocar-
dial infarction. Whether this is a consequence of their
older age or due to other factors is controversial.
Accordingly, we compared in-hospital.and one year mortali-
ty from time of hospital discharge in 1,550 men (age 62 ±
12 yrs) and 538 women (age 69 ± 11 yrs). Overall in-
hospital mortality was 42% greater in women, but by age
group it was not significantly different between men and
women:
Age (years) s 60 61-70 71-80 >80 All Ages
Men (%) 6.2 12.0 21.7 29.9 12.3
ns ns ns ns p < .003
Women (%) 5.7 14.7 23.1 28.2 17.5
BASIS FOR INCREASED MORTALITY IN WOMEN AFTER MYOCARDIAL
INFARCTION
HowardDittrich, M.D., Elizabeth Gilpin, M.S., Pascal
Nicod, M.D., and John Ross, Jr., M.D., F.A.C.C.
University of California, San Diego.
non-smokers
(n=29)
smokers
(n=29)
Freek W.A. Verheugt, M.D., F.A.C.C., Jan Wouter
ten Cate, M.D., August Sturk, Ph.D., Leon
Imandt, Ph.D., Jan P. Roos, M.D. Department of
Cardiology, Free University Hospital, and Divi-
sion of Hemostasis and Thrombosis, Academic Me-
dical Center, Amsterdam, The Netherlands
In 29 chronic cigarette smokers (>5/day) plasma
activity of tissue plasminogen activator (t-PA)
was determined as well as the plasma levels of
t-PA inhibitor. Their data were compared to tho-
se of 29 sex and age matched non-smokers (19 ma-
les, 10 females). All study participantsrefrai-
ned from smoking and vigorous exercise 12 hours
prior to blood collection. Drugs and substances
interfering with fibrinolysis were withheld 14
days before study.
RESULTS (IU/m!)
*p = 0.31 **p < 0.01
Thus, chronic cigarette smoking is associated
with increased t-PA inhibition and, probably,
with decreased t-PA activity in the plasma.
These results might elucidate the role of chro-
nic cigarette smoking in the defective fibrino-
lysis associated with thrombotic vascular dis-
ease.
t-PA activity
t-PA inhibition
0.13 ± 0.22
9.3 ± 5.2
0.20 ± 0.26*
5.6 ± 4.0 **
The difference in late mortality between men and women was
not significant (10.8% vs 13.3%, respectively). Of fac-
tors such as history of prior myocardial infarction,
diabetes, lipid abnormality, hypertension, congestive
heart failure and angina, it was found that male in-
hospital nonsurvivors had a significantly higher incidence
of prior myocardial infarction than women (47.4 vs 27.6%,
p<.OOI). No other factor was significantly different
between sexes for in-hospital or late nonsurvivors,
whether or not age stratificationwas performed. We con-
clude that late mortality does not differ significantly
between sexes. The overall increase of in-hospital mor-
tality after myocardial infarction seen in women is
primarily due to their more advanced age.
RESULTS OF PTCA IN WOMEN IN 1985
Sheryl F. Kelsey, Ph.D., Michael J. Cowley, M.D., Timothy
Costigan, M.A., KatherineM. Detre, M.D., Dr.P.H.,
Eugene Passamani, M.D., ThomasRobertson, M.D., Univ of
Pittsburgh, PA
Among 642 cases without recent myocardial infarction (MI)
from the NHLBI PTCA Registry. 27% were women. Compared
to males, females were older (36% vs 21% > 65 years) had
more diabetes (21% vs 11%) and had moreunstable angina
(65% vs 51%). (All p<.OI). Mean duration of chest pain
was the same but women had less prior MI (31% vs 39%,
p<.05) and less prior bypass surgery (CABG). Multives-
sel disease was equally distributed (55%) but fewer wo-
men had poor ejection fraction. Performance of multiple
lesion dilatationwas the same. Major events (death,
MI or emergency CABG) occurred less often in women (3.5%
vs 7.2%)due to a lower MI complication rate (1.2% vs
5.3%). The rate of success, all attempted lesions re-
duced ~. 20% and no maj or event was higher in women
(83.1% vs 76.2%, p<.I) and adjustment for age increased
the significance of the difference. The current find-
ing contrasts with results before 1982 when men had
higher rates of success.
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Exercise Physiology & Testing
SKELETAL MUSCLE AND CARDIOVASCULAR CHANGES WITH
TRAINING IN HYPERTENSIVES ON AND OFF BETA-ADRENERGIC
BLOCKADE
Philip Ades. M.D.• F.A.C.C., Peter Gunther, M.D.,
John Maddalena B.S., Thomas Orfeo B.A., William Meyer
Ph.D. University of Vermont, Burlington,Vermont
We evaluated theeffect of 12 weeks of aerobic
exercise on VO?max, skeletal muscle oxidative enzyme
activity (Succlnyl Dehydrogenase (SOH)), CO, and
systolic BP in 30 hypertensive adultsrandomized to
either placebo (C), metoprQlol 100mg BID (M) or
propranolol80mg BID (P). V02max measured pre and
post conditioning, off drug, increased24% on C (30±8
to 37±11 cc/kg/min, P<O.OI), 8% on M(32±8 to 35±6,
P<0.05) but noton P (34±7 to 35±8, peNS) (AC > AP,
P<0.05). Skeletal muscle SOH actiVity of vastus
lateralis increased75% in group C (0.059±0.01 to
0.104±0.06 EU/mg, P~0.12) with no change on Mor P.
CO measured at 70% V02max diminished from 13.0±3 to
11.4±2 l/min following ~onditioning on C with no
changes on either Beta-blocker. Resting systolic BP
off drug decreased 11 mmHg in the Cand Mgroups
(146±7 to 135±13, 143±4 to 132±9, both P<0.05), but
did not change on P (144±4 to ~44±7 mm Hg). Thus,
exercise induced increases in V02max and oxidative
enzyme activity (SOH) and decrease in submaximal CO
were attenuated in hypertensiveson Beta-blockade.
Additionally, theBP lowering effects of aerobic
exercise were manifeston both Cand M, but noton P,
suggesting that this effect is mediated through
Beta-2 adrenergic receptors.
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THE ACUTE DYNAMI C FLOW MEDIATED NATURE OF LARGE VESSEL
VASODILATION IN HUMANS.
Lawrence I . Sinoway , M.D., C. Daniel Hendrickso n , Robert
Zel i s , M. D., F.A.C.C., Di v isi on of Card iology, Hershey
Medical Center, Hershey, PA.
In an effort to determine whether conductance vessels di-
late in response to increased blood flow( Q) due to meta-
bolic dilation of downstream resistance ves se ls, brachial
artery area(cm2) and diameter(D,cm) were derived(n =8) by
simultaneous measurement of forearm blood flow (ml/ min x
10Oml) and br achial artery blood flow ve loci ty(V;cm!sec)
f ol l owing the release of arterial occlusion. The ratio
(Q/V) was multipl i ed by forearm volume (H20 displ ac ement)
t o deri ve a r ea and D. Measurement s were made a t rest and
at the t ime of maximal Q after release of 20 sec , 40 se c ,
1, 3 and 10 mi n of arterialocclusion. Resu l t s :
Res t 20 sec 40 se c 1 min 3 min 10 min
Q 2.9 10. 6 17 . 5 26 .7 35.3 42
V 7. 1 19.5 28.7 39. 3 42.8 48.5
D .33 .37 .3 9 .41 .47 . 48
n 8 5 5 5 8 8
All values are statistically greater than r es t in g values.
To determine if this D response was se conda r y to ischemi a
or directly to Q, we measured the D after 20 min of f ore-
arm heating (4 20 C) and noted an i nc r ea se from . 32 t o . 39cm
in D (P<. 05) . We also examin ed th e t ime course of D and Q
after 3 min ut es of occlusion. Q was max imal at 5 sec but
D was max ima l at 15 sec and r emain ed 90% of max f or an-
other 30 sec . We concl ude 1) the brachia l artery dilates
in response to graded flow stimuli; 2) the max imal dila-
t ion occurs after maximal Q i s noted. Our r esults are
entirely cons i s t ent with a large vess el Q mediated r e l ease
of a vasodilating substance with a l onger ~ life t han t he
downstream metabolites which initially in cre ase Q.
PERIPHERAL SYMPATHETIC ACTIVITYAND ANAEROBIC METABOLISM
DURING ISOTONIC MAXIMAL EXERCISE IN MAN.
Angelo Cherchi, 104.0., Giuseppe Mercuro, 104.0., P.Luigi Mont al-
do, 104.0., Lil iana Tocco, 104 .0., Carlo Rivano, 104 .0., MarisaBar>-
de, M.D., Ma ssimo Ruscazio, M.D., P.Paolo Giua Marassi, M.D.,
Instituteof Cardiology, Universityof Cagl iari, Italy.
We previously observed that t he plasma norepin ephrine(NE)!e-
vel during isoton ic e xerc i se inc reases muc h mo r e a f t er 70%VG,
max , In o rde r to e xamine th i s pe cul iar s ympa t he t i c r e spo ns e in
relati on to the metabolic c hanges, ..e studied 8 healthy male
yolunte e rs(20-48 yr) dur i ng a ma x imal, p rog r e s s i ve, up rig ht
bicycle e xe r-c i s e l Ex), Plasma l evel s of NE, e pi nephri ne(E ) and
3 ,4-dihydroxyphenylacetic ac i d (OOPAC, a dc pami ne met abolite)
arteriallactate(LA) and pH..ere measureda t si tting r-es t fRl ,
at the end of 3 min ..ork loads co rrespondin g to 50,70,90 , a nd
100%\rOt max and during t he recovery(Re) . Dat a a r e mean sz Sf ,
R 50% 70% 90% 100%\ro, ma x 10'RE
NE 321 i53 503:!OO 5721:96 6ai!:59 i 11~7H 502±115t
E 48:!:7 00:!fit 101:!:10 t 153!:25 t 201:!:19 i ffi:!:13
OOPAC O.9±.OO 1.0:!:.07 1.0:t.07 1.1:!:.1 1.2:!.1t 1.4i.1 i
LA 14:!:1 25±4 i 34!4 i 67:t5' 76t3 , Ja!:3 i
pH 7.39:t.03 7.35:t.OO 7.35:t.OO 7.32:!:.OOt 7.29:t.04 t 7.33:t.00
NE , E(pg /ml ) ; OOPAC(ng/ml); LA (mg /100ml).tp<.OO; i p<.01;, p<.001
Vo, sh owed a close nonlinear relati on ..ith LA(R=.94, pc . 001) ,
NE(R=.74, p<.001) and E(R=.B1, p<.001) and a linea r rel ati on
with OOPAC( r =. 58, p<.001); t here ..as also a linear r e lati on
betwe en LA and NE(r =.66, p<.001) . These data sugges t t hat the
dramat i c increa se in plasma NE a t pea k Ex would be a r esult of
t he metabol i c c ha nges o c c ur r ing at th i s time. The an a e robic
metabol i smat l evel of peripheral tissues might be responsi-
bl e for fa i I ur-e i n NE reuptake and con se quent r i s e i n pl asma
NEfree amount. The increase at peak Ex and during Re of DOPAC,
expression of dop amine B-hydroJl ilase exhaust i o n, se ems t o be
consistent with this hypothesis.
AN EVALUATION OF THE CARDIOVASCULAR RESPONSES TO DYNAMIC
EXERCISE AFTER COMBINED HEART AND LUNG TRANSPLANTATION.
Nicholas R. Banner, MRCP. , Catherine O'Brien , MSCT.,
Me l i s s a Fi tzgerald, MB., BS., Asghar Khaghani , FRCS. , and
Magdi H. Yacoub , FRCS. , FACC . Harefield Hospital, Harefield
Middlesex, UB9 6JH, England.
Sixteen heart-lung transplants (HLT) recipients were exer-
cised t o s symptom limited maximum using the Bruce tread-
mi l l protocol to study their exercise ca paci ty , ECG and
blood pressur e response to dynamic exercise between 6 and
12 mont hs af t er operation. Control sub jects were 16
orthotopi c car di ac t r ans pl ant s (CT)recipients matched f or
age , sex and time af ter operation. All patients received
Cyclosporin and azat hi opr i ne immunos uppr es s i on and were
clinically well wi t h no evidence of acute rejection at th e
t i me of study . One HLT patient had chronic air-flow limi-
t at i on . The interval be tween operation and testing was
9.9 months (r ange 6-12 ) for HLT and 9.4 mont hs (range 6-12)
for CT. The age of HLT pa tients was 28 .6 years ~ SO 10 .6
years as compared to 30 .5 + SO 12.4 years. Each group
contained 7 men and 9 women. OneHLT patient developed
anteriorT wave invertion during exercise . Resting heart
rates were 103. 1 ~ 12 .3 bpm for HLT and 104.1 ~ 11 .9 bpm
for CT patients (ns) . Peak exercise heart rate was 142 . 2
~ 35 .2 bpm for HLT and 147 .3 ~ 16 .3 bpm for CT patients
(ns) . Exe r cise dur ation was 9.4 ~ 2 .9 mins .for HLT and
9 .6 ~ 2 .1 mi ns.for CT patients (ns) . The heart rates
accelerated slOWl y in both groups compatible wi t h auto-
nomic denervat i on . Systolic blood pressu res wer e 112 ~
14mmHg at r est for HLT and 115 ~ 19mmHg for CT patients
(ns) and at peak exerci se 149 + 24mmHg for HLT and 145 +
21 for CT patients (ns ) . It is concluded that the -
exercise capacity and car di ovas cul arresponses to dynamic
exercise after HLT are s i mil ar to those after CT.
SYSTOlIC AND DIASTOlIC VENTRICULAR PERFORMANCE DURING
SUPINEEXERCISEFOLLOWINGHEARTTRANSPLANTATION.
Peter W. Pflugfelder M.D F. NeilMcKenzie, M.D., William J. Kostuk,
M.D., F.A.C.C., University Hospital, London,Ontario, Canada.
Previoushemodynamicstudies intransplant patients (TP) have shown
that ventricularfilling pressures increase inordinatelyduring supine
exercise. This study was therefore done to examine left ventricular
ejection and till ing characteristics at rest and in response to supine
exercise compared to normal. Study subjects consisted of 25 normal
volunteers mean age 32 years (range 23 to 42) and 21hea~hy TP
patients mean age 44 years (range 14 to 62) 2 to 43 months (mean
10.4 months) after surgery. Radionuclide angiography was done at
rest and during symptom limited supine exercise to obtain cardiac
volumes, and peakLV ejectionandfilling rates .
RESULTS: EXERCISESTAGE
Rest Ex 1 Peak
N TP N If ~ If
HR 66:!:2 91:!:3 9 1:!:2 92±3 127±3 116:!:3
EDVI 112:t5 79±4§ 10BtS B9±4§ 100:!:4 90:!:4
PER 2.0:!:.1 2 . 7:!:. 1 ~ 2.4±.1 2 .7:!:.1~ 3.8:!:.2 3.9±.2
PFR 2.4±,1 3.6:!:.2§ 2.B:!:,1 4.1:!:.2§ 4.2±.2 5.0:!:.3
means presented ±SE;~ p<.05, §p<.Ol vs N; EF = ejectionfraction,
EDVI = end diastolic volume index (mllm2), PER = peak ejection rate,
PFR = peakfill ingrate (end diastolic volumes/sec)
The peak ejection rate increased in TP only during later exercise.
corres ponding to an increase in HR. However. pea k filling rate
increased in TP on initiation of exercise assoc iated with an increase in
the end diastolic volume in the abse nce of an Increase in HR. In 6
patients. studied> 1 year post TP. PER and PFR did not differ from
those studied < 1 year post TP.
Therefore. inTP patients, no defect in myocardialrelaxationis apparent
either at rest or duringexercise. s ystouc performance improves in later
exercise presumably as levels of circulating catecholamines increase.
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f£ClJ!j\TICN CF sr~ Va..lJ>E IXJRING EXER:ISE IN PATIrnTSWITH SEVERE
LEFT VENJ'RICULARDYSFltiCrICN: IM'CRTAN<ECFTHE SThfUNG ~HANISM
Mimael B. Higgintxltham, ril, Martin J. M livan, Ml, R. Ecl.ard
Colanan, Ml, FredErickR. Cobb, Ml, DtJ<e UniVErsity and IXu11am VA
M;!diml Centers,Dtrham, NC
This stLdy exanined the relative roles of LV contraetilityand
fi lling in the oontrol of strokevolune (SV) during exe-otse in
a:rbJlatory pts with he<rtfailure (IF) die to severe LV
dysfl.J'lCtion. Forty pts with ejection fraction(EF) < 35% am
clinically stable NYHA class IT-lII IF receiving digitalis <J1d
diLretics WEre stLdied at rest (R) and during IIBximal upright
bicycle exercise (El<) with slrrultanOOJSmeastremEntof systemic and
pulIron<ryharodynanics, LVEF and volunes, and RVEF. In IF pts, EF
did rot irrrease fran R(21±8%) to Ex ~22.±9%). H::wever SI index
(SlI) irrreased fran25±7 to 35±9 rnl/m. Data for EJld-diastolic
volune index (IDI1), end-systolIc volt.me index (ESV1), pulmonary
artErY...edge p"ffiStre (PAWP) , andRVEF are tabulated for IF ptsam
mrmal(NI) controls (*P<.05 vs NI~, tp<.05 vs R) .
EIJJI mllnf ESVI mllm PAIl!' mm Hg RVEF (%)
R El< 11 R El< 11REl<11 REl<11
HF 153* 187*t 34* 128* 15C*t 22* 9* 2O*t 11* ?f> 38* 2*
NI 68 77t 9 27 19t..,'3 3 lOt 7 3B 45t 7
In IF pts diastolic LV fillitl!, reflected 'rYj the absolute
irrrEaSe inEIJJI (see table), was greater- than NI, as WlS the
in~ase in EDVI pEr mm Hg mange in PAW? <3.8:t6.3 vs 1.4±2.1
ml/nflmmHg (p~.034). In the HF group the mange in SlI withEx (11
SIl) o:rrelateddirectly with 11 EOJI (r~.37, p~.02) and inversely
with 11 PAP (r~-.45; ~.004) and 11 PAIl!' (r~-.39; ~.013), tut did
rot o:rrelatewith LVEF, ESVI or RVEF. 11 RVEF a:rrelatedinversely
with 11 PAP and 11 PAIl!'; all 7 pts withatnonnal RVEF hadEx PAIl!' >
22 mm Hg. Thus 1) pts withseVEre LV dysfmction havelittle or ro
systolic rEl3erve anddepend on the Starlitl! med1ani3ll to irr:rease
SI dwing Ex. 2) The extent to which the Starlingrrect1anismis used
acoxnts for much of the obse-ved variability in Ex SI. 3)
Decreases in RVEF are secondaryto higtl PAP anddo rot appearto be
responsible forinadeqt.atedelivery of blcod to theLV.
RELATIONS BETWEEN GLOBAL DIASTOLIC FUNCTION AND EXERCISE
TOLERANCE IN ISCHEMIC LEFT VENTRICULAR DYSFUNCTION.
Hubert Pouleur. M.D,. F.A.C.C., Claude Hanet, M.D.,
Christianvan Eyll and Michel F. Rousseau, M.D.,F.A.C.C.
University of r.ouvain, Brussels, Belgium.
To assess the relations between left ventricular (LV)
diastolic punction, and (EX) tolerance, maximal bicycle
EX tests were obtained in 34 patients (pts) with
anterior myocardial infarct. No patient stopped .EX for
angina. After EX, LV angiogram (Millar) was performed
and processed to derive the peak filling rate (PFR) and
the diastolic pressurp.-volump.relation. Resting ejection
fraction (range 24-68\) poorly correlated with EX
duration (r=0.37) and did not separate pts with reduced
EX duration (Group A, EX duration < 500 sec) from pts
with a preserved EX capacity (Group B). In contrast, the
resting PFR normalized for resting heart rate (PFR/HR),
correlated with EX duration (r=0.59) and correctly
classified 88\ of A and B pts. Moreover, in A pts, the
depression in (PFR/HR) (4.8 ± 1.0"" vs 7.2 ± 1.6
ml/s.bpm/m2 in B) was accompanied by an excessive EX
tachycardia. Indeed, the HR normalized for EX duration
was markedly increased in A pts: 0.41 ± 0.10"" bpm/sec
of EX vs 0.27 ± 0.03 in B pts. The resting LV
end-diastolic and end-systolic volumes were comparable
in A and B (147 ± 32 vs 153 ± 19 and 85 ± 32 vs 71 ± 21
ml/m2, respectively; NS) but the diastolic LV
presure-volume relation was shifted upward andthe mean
LV pressure during diastole was increased in A pts (19"
vs 14 mmHg in B). In conclusion, impaired diastolic
function appears to affect EX tolerance independently of
the systolic function. The data also suggest that
inappropriate tachycardia during EX might be partially
related to alterations in dynamic diastolic compliance.
"P<0.02 ""P<O.OOl
ABNORMAL VENTRICULAR FILLING IN SICKLE CELL ANEMIA
Ian C. Balfour, MB, BS, FACC; Wesley Covitz, MD, FACC;
FrederickW. Arensman, MD, FACC; Casimir Eubig, PhD;
MariquitaGarrido, MEd; Carol Jones, BS, St. Louis
University, St. Louis, MO
AbnormalLV systolic function is recognized as a cause
of poor exercise tolerance in sickle cell (SS) pts. We
suspected that abnormaldiastolic function might be a fac-
tor because SS pts' end-diastolic volume falls during ex-
ercise. This study was done to prove that diastolic func-
tion is abnormal in SS pts and contributes to their exer-
cise intolerance. LV dimension, rate of change of LV di-
mension and rate of LV posterior wall relaxation in dias-
tole were assessed by M-mode echocardiographyin 38 pts
and 11 normaIs (N). ss pts performed graded, up-right,
maximal, radionuclide exercise tests. Heart rate, blood
pressure, maximal workcapacity, ejection fraction and
relative changes in cardiac output and end-diastolic vol-
ume from rest were measured. Pts were subdivided into
group SSA, who had a normalejection fraction response to
exercise 73±9% (Mean ± 1 SO), and SSB, who had a fall in
ejection fraction 53±9%, (pz.004) with exercise. SS pts
had reduced normalized maximal rate of change of cavity
dimension: N 0.88±.13 sec -1; SSA 0.69±.23 sec -1 (p<.02
SSA vs N); SSB 0.47±.18 sec -1 (p<.OOl SSB vs N). SSB
were slower than SSA (p=.022). Posterior LV wall normal-
ized maximal rate of relaxation was slower in SS pts; N
2.59±.63 sec -1; SSA 0.84±.33 sec -1 (p<.OOl SSA vs N);
and SSB 0.98±.43 sec -1 (p<.OOI SSB vs N). End-diastolic
volume fell during exercise: SSA 0.91±.22, and SSB 0.90±
.13 of their resting values. SSA maximal working capacity
458±160 kg-M/min vs SSB 323±71 kg-M/min, (p=.002). Abnor-
mal LV diastolic function (filling) resulted in end-dias-
tolic volume falling during exercise, and contributedto
poor exercise tolerance. The more affected pts had lower
exercise ejection fractions and lower exercise tolerance.
ABNORMAL SKELETAL MUSCLE METABOLISM IN HEART FAILURE:
LACK OF RELATION,- TO FLOW. Barry Massie, MD, FACC,
Michael Conway, MD, Bheeshma Rajagopalan, MD, Richard
Yonge, D.Phil., Simon Frostick, MD, Peter Sleight, MD,
FACC, John Ledingham,MD, George Radda, D.Phil., Univ.of
California, San Francisco, CA.
We and others have demonstrated excessive muscle
phosphocreatine (PCr) utilization and acidosis in
relation to work performed in congestive heart failure
(CHF). To determine whether thes~lchanges are due to
impaired blood flow, we performed P-NMR on the flexor
digitorum superficialis muscle at rest and during
repetitive finger flexion in 13 CHF patients (PTS) and 8
age-matched controls (CON). Forearm blood flow (FBF)
was measured bystrain group plethysmographyduring the
same exercise protocol on the same day. At loads
between 0.75 and 2.5 kg, PCr, followed as the ratio of
[PCr]/([PCr]+[Pi]),and pH were significantly lower in
the PTS while FBF was nearly identical in the 2 groups.
Since CON achieved greater maximal loads (3.1+0.6 vs
2.3±0.5 kg, p<.Ol), additional comparisons were made at
equal relative loads.
%Max pH PCr/(PCr+Pi FBF(ml/min/lOOml)
Load CON PTS CON PTS CON PTS
Rest 7.02±.03 7.01±.03 .91±.01 .89+.02** 1.4+0.3 1.3+0.4
50% 6.98+.04 6.81+.22*.80+.04 .62+.13** 6.1+2.8 4.1+1.7
100% 6.41+.22 6.40+.35 .44+.09 .42+.14 13.4±6.9 9.0±3.1
- * p<~05 ** p<.Ol- PTS vs CON
Again, significant metabolic differences were found at
submaximal loads;however, though FBF tended to be lower,
probably due to the lesser demand, these differences did
not achieve significance (p>O.l). Furthermore, no
correlation was present between FBF and metabolic
indices in individual subjects. These results suggest
that the skeletal muscle metabolic abnormalities in CHF
are not directly related to reduced flow.
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FUNCTIONAL CAPACITY FOR PROGNOSIS OF SURVIVAL IN MILD TO
MODERATE HEART FAILURE.
Roger D. Blevins, PharmD, Harold J. Willens, MD, FACC,
Denise Antonishen, RN, Dorothy Reinstein, RN. and
Melvyn Rubenfire, MD, FACC. Sinai Hospital, and
Wayne State University, Detroit, MI.
Thirty patients with heart failure of ischemic (n=14) or
idiopathic (n=16) etiology were followed long-term to
determine the prognostic value of entry exercise capa-
city. Baseline studies included radionuclide angiographv,
M-mode echo, 24h Holter and graded exercise testing with
measured maximal oxygen consumption (V02max). Inclusion
criteriawere (I) NYHA Class 11 (n=16) or III (n=14) de-
spite at least 3mos of treatmentwith digitalis and di-
uretics, (2) LVEF <50% (3) LVEDD >50mm, and (4) impaired
exercise tolerance secondarym dyspnea or fatigue. Pat-
ients were treated with diuretics (100%), digitalis (83%)
and vasodilators (60%) and were followed at least 6mos
(mean 15±5). The 1-, 2- and 3-year survival rates were
75%, 70% and 70%.Univariate differences between survi-
vors (Gp A; n=22) and nonsurvivors (Gp B; n=8) were:
Group A Group B P
17.9±5.4 Il.6t4.1 .0026
51+7 65±1O .0013
87. 507..0089
59±12 70tl4 .0159
9±24 198t453.022]
59±142 170t213 .0506
Multivariateanalysis among these variables revealed
that measured V02max was the single best predictor of
survival (p.<.OOI). We conclude that assessment of
exercise capacity provides useful independent prognostic
information in patients with mild to moderate heart
failure.
OXIMETRY DURING EXERCISE IN CHILD~EN WITH CYANOTIC
CONGENITAL HEART DISEASE.
Rae-Ellen W. Kavey, M.D., F.A.C.C., Marie S. Blackman, M.D
F.A.C.C., Craig J. Byrum, M.D., Frank C. Smith, M.D., SUNY
Health Science Center, Syracuse, New York.
To investigate the response to exercise in cardiac hypox-
emia, 20 patients (pts) with complex cyanotic congenital
heart defects (CCHD) were evaluated by treadmill exercise
with simultaneous monitoring of 02 saturation(sat) using
a pulse oximeter which measures transcutaneousarterial
sat spectrophotometrically.A modified Bruce protocol was
used and sats were recorded at rest, terminationand 1,2,
4,6,8 and 10 min. of recovery. Age range was 3-27 yrs
(~=9.3 yrs). In only 3 pts could a history of increasing
cyanosis with exercise be elicited; 17 of 20 were describ-
ed as very active and none were felt to limit their own
activities. Resting sats ranged from 77-94% (~=8470). With
exercise, all pts achieved~70% of predicted maximum heart
rate for age (1l:=8370) but only 2 reached 100%. Not surpris-
ingly, sats fell significantly with exercise in all pts
with a mean decrease of 21% and a wide range of 6-44%. At
termination, mean sat was 64% (range: 38-88%). Endurance
times were below the 10th percentile in all pts with
duration of exercise correlating inversely with exercise
saturation:shortest endurance times were seen with lowest
exercise sats. Degree of resting desaturationdid not pre-
dict the hypoxemic response to exercise: in 11 pts with
similar resting sats of 80-85%, sats at terminationvaried
strikingly from 38 to 68%. Theexercise sat was useful in
the decision to proceed to surgery in 6 pts and to delay
surgery in 7. These results suggest: (1) in CCHD, signif-
icant hypoxemia develops with exercise and it is this
which limits exercise tolerance; (2) the hypoxemic re-
sponse to treadmill provides easily accessible informa-
tion not available historically or from resting sats
which can be used for clinical decision making in CCHD.
Monday, March9, 1987
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HYPERTHYROID PIGS: ABNORMAL EXERCISE RESPONSES
ASSOCIATED WITH REDUCED CORONARY RESERVE
H. Kirk Hammond, M.D. and Francis C. White, M.S.
UCSD, La Jolla, California
Ejection fraction falls during exercise in hyperthy-
roid humans. Mechanisms for abnormal exercise respon-
ses in hyperthyroidismwere studied in 5 pigs before
and after 8 days of triiodothyronine (T3: 1.0 mglkgl
day). Basal and adenosine-stiaulated myocardial blood
flows (MBFI were measured using radioactive micro-
spheres, and myocardial oxygen consumptions (MV02)
calculated. Six euthyroid pigs served as controls (Cl.
Heart rate (HRI, blood pressure (BP), and oxygen con-
sumption (V021 were measured during treadmill running.
Myocardial oxygen demands were estimated by systolic
BP x HR (RPPI. Increased basal HR (T3: 156~13, C:86~13
bpm: p<.0011 and systolic BP (T3: 174~21, C: 137~22
mmHg; p<.001I, confirmed a hyperthyroidstate. V02 and
RPP were significantly higher at matched workloads.
Basal MV02 was higher (T3: 13~3. C: 10~3 ml/min/100
gm; p<.0011. Absolute MBF reserve (adenosine-baBall
tended to be less (T3: 304~132, C: 382~46 ml/minl
100gm: p<.15I, and relative MBF reserve (adenosinel
basalI was reduced (T3: 2.0~0.4. C: 4.6~0.8; p<.001).
Minimal coronary resistance was unchanged (T3:.12~.03.
C:.12~.01 PRUI. Left ventricularto body weight ratios
were increased in hyperthyroid animals (T3: 4.7~0.9,
C: 2.8~0.1 g/kg; p<.001). Increased myocardial mass
and RPP at matched workloads, combined with loss of
coronary vasodilator reserve, may contributeto the
decreased ejection fraction observed during exercise
in hyperthyroidhumans.
SlJR}IO\L (%)
86 p<O.Ol
91 p=NS
84 p=NS
85 p<O.OOl
85 p=NS
86 p<O.Ol
MEDlCAL(%)
77
88
81
58
86
56
OVerall
I-vessel CAD(n=195)
2-vessel CAD(n=238)
J-vessel CAD(n=253)
PreservedLV function{n=527)
ImpairedLV functioo(n=155)
3-vessel CAD and
PreservedLV functioo{n=173) 72 83 p=O.ll
ImpairedLV tunctioo(n=75) 40 88 p<O.OOl
These obserVaticnal data suggest that in patients with
silent myocardial ischemia during exerc~se testing,
survival rates are determined primarily t1t the severity
of CAD and by the LV functioo. survival is enhanced by
coronary bypass surgery in subsets of patients with
3-vessel CAD and with impairedLV function.
MEDICAL VERSUS SlOOICAL THERU'Y IN a\TIENl'S WITH SIImI'
MY<::mRDIALI~ WlUN3 ~ISE TESI'~
Donald A. weiner, M.D., F.A.e.e., ThaDas J. Ryan, M.D.,
F.A.e.e., Carolyn H. ~, B.S., Step'Ulll Luk, Ph.D.,
Bernard R. Chaitman, M.D., F.A.e.e., L. ThaDas
Sheffield, M.D., F.A.e.e., Felix E. Tristani, M.D.,
F.A.e.e., Lloyd D. Fisher, Ph.D., F.A.e.e. Boston
University Medical Center, Boston, M'.
To determine whether coronary bypass surgery ~d
prolOD;! surviVal in patients with ischemic sr depression
without associated chest pain during exercise testing,
we analyzed data on 692 such patients fran the CABS
Registry who were follOlled for 7 years after medical
(0=424) or surgical (n=268) therapy. A Cox multivariate
survival analysis of 17 variables showed: severe
corcnary artery disease (CAD), al:clormal LV wall motion,
and lack of surgery to be significant (p<O.02)
irxlepeIXient predictors of mortality. survival rates at
7 years were:
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EFFECT OF AN "INOTkOPIC"PLACEBO ON THE EXERCISE CAPACITY
OF SEVERE CONGESTIVE HEART FAILURE PATIENTS
Srinivas Murali, M. D., Barry F. Uretsky,M. D., FAce,
JudyA. Kolesar, RN, Anita M. Valdes, RN, P. Sudhakar
Reddy, M. D., FACC, University of Pittsburgh, PA
It has been suggested inuncontrolled studies that in
patients (pts) with severe congestive heart failure
(CHF), the oral phosphodiesteraseinhibitors milrinone
and enoximone acutely improve exercise performance. To
determine if a placebo presented as aninotropic agent
could increase exercise capacity, we studied 2 separate
groups of CHF pts by serial exercise testing and respira-
tory gas exchange. All pts were onstable doses of dig-
oxin, diuretics and/or vasodilators. The treadmill time
(TT, seconds), peakoxygen consumption (V02,ml/min/kg),
and oxygen consumption at anaerobic threshold (AT) mea-
sured at baseline (B), and 4 hours (h) after placebo
therapy (Group I pts) and 1-2weeks (wks) after placebo
therapy (Group 11 pts) were as follows:
GROUP r<n=8) GROUP U(n=9)
B 4h B 1-2 wks
TT 349 + 119 362 + 130 336 + 123 382 + 118
V02 9.3:; 1,1 10.4:; 2.2 11.5:; 3.8 11,9:; 3.4
AT 9.1 :; 1,0 9.3:; 1.1 10.6:; 3.4 10.9:; 2.7
Five pts in group Iand six pts in group 11showed
minor improvements «15%) in TT,V02 and AT. We con-
clude that as a group, CHF pts can achieve true stable
baselines in exercise capacity, although continued
improvement may occur in some pts. Minor improvements in
exercise capacity after inotropic drug administrationin
individual patients must be interpretedwith caution as
they may be due to a placeboeffect rather than to the
inotropic drug itself.
Tuesday, March10, 1987
8:30AM-I0:00AM,Ballroom, First Level
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WESTERN WASHINGTON INTRAVENOUS STREP'roKINASE (SK) IN
MYOCARDIAL INFARCTION TRIAL: RADIONUCLIDE VENTRICULAR
FUNCTION AND INFARCT SIZE.
James L. Ritchie, M.D., F.A.C.C., Manuel Cerqueira,
M.D., Kathryn Davis, Ph.D., CharlesMaynard, Ph.D., and
J. ward Kennedy, M.D., F.A.C.C., Seattle V.A. Medical
Center andUniversity of Washington, Seattle, WA.
Over three years, 367 pts with acute MI (AMI) of <6 hrs
durationwere randomizedto either SK (1.5 million units
IV over 1 hour) orconventional therapy (C) at a mean
time of 3.5+1.4 hrs after onset of symptoms. A subset of
194 survivIng pts living within 100 miles of Seattle
(105) SK, 89C) was studied 8.0+7 weeks post MI. Global
ejection fraction (EF) and regional EF were measuredby
gated blood poolventriculography,and infarct size by
tomographic 201-thallium tomography was performedat
rest at a single institution.
Results EF TL defect (% of LV)
SK C P SK C P
All pts( 194) 50.8 46.6 <.02 15.0 19.2 <.01
All <3 hrs(100) 51.8 47.7 <.05 13.0 18.4 <.01
ANT(62) 43.2 37.0 ~.05 22.9 27.2 -.06
ANT <3 hrs(30) 48.3 37.2 .11 19.0 28.6 -.07
INF (132) 54.0 51.7 NS 11.6 14.6 = NS
INF <3 hrs(66) 53.1 52.6 NS 11 13 NS
Regional EF was similarly improved in SK pts.
We conclude that, in contrast to our intracoronarySK
trial, IV SK, given early, results in significant
preservation of LV function and reduction in infarct
size when compared to controls. Benefit was greatest in
pts treated <3 hrs of symptoms and in pts with anterior
infarction. EF was 30% higher, and TL infarct size 33%
smaller in ANT MI <3 hrs.
EXCESS RISK OF REINFARCTIONAFTER STREPTOKINASE : EXPE-
RIENCE FROM I.S.A.M., APROSPECTIVE PLACEBO CONTROLLED
DOUBLE BLIND MULTICENTERTRIAL IN ACUTE MYOCARDIAL INFAR-
CTION.
Alain LEIZOROVICZ,M.D., Rolf SCHROEDER, M.D., Karl L.
N£UHAuS, M.D., Thomas LINDERER, M.D., Ulrich TEBBE, M.D.
and the I.S.A.M.STUDY GROUP. Unite de PharmacologieCli-
nique, Hopital Neuro-Cardiologique,Lyon, FRANCE.
1741 patients with suspected M.I. wererandomized within
6 hours after onset of symptoms to either I.V. Streptoki-
nase (SK) (1.5 million units) or Placebo (PL). Mortality
and non fatal cardiac events weredocumented up to 7 mon-
ths. At 7 months there was no statistical difference for
death between the SK and the PL groups (94/859 vs 98/882).
In the SK group, reinfarctions (R.I.) were observedmore
frequently than in the PL group (7.16 vs 4.5, P = 0.02).
During the first 2 months, the difference in cumulative
probabilityof R.I. was continuously increasing. R.I.
occured mainly in thesame localization as the initial
infarct (87 %and 90 %in the SK and PL groups respecti-
vely). The risk of death at 7months after R.I. was high
but similar in both treatmentgroups (18 %). Baseline
characteristicswhich were significantly associated with
an excess risk of R.I. were: age below 50, history of
previous M.I., history of angina pectoris, treatmentafter
the third hour of symptoms, inferior infarction. Despite
full anticoagulationduring the hospital phase for all
I.S.A.M. patients, an excess of R.I. was observed in pa-
tients treated with SK which could counterbalancethe po-
tential benefits of treatment. The interest of thrombo1y-
tics should be evaluated in the long term in combination
with other interventions for preventing reocc1usions.
INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL
INFARCTION-SIX MONTH FOLLOW~P: THE NHLBI THROMBOLYSIS IN
MYOCARDIAL INFARCTION (TIMI) TRIAL. James E. Dalen, MD,
for the TIMI Investigators NHLBI, Bethesda, MD
In TIMI Phase I, 290 patients (pts) were randomized
within 7 hoursafter the onset of acute myocardial
infarction (MI) to either intravenous tissue plasminogen
activator (TPA) (n=143) or streptokinase (n=147) (S).
The purpose of TIMI Phase I was to compare the efficacy
of these two IV thrombolyticagents. TPA was shown to be
effective 62% of the time in opening occluded coronary
arteries as compared to 31% for S.
After six months (6 H) of follow-up, the incidence
of recurrentHI (14.7% vs 15.0%) use of PTCA and/or CABG
(29% vs 31%) and the incidence of angina (67% vs 62%)
were similar for both groups. However, the lower
mortality seen at twenty one days in ptstreated with TPA
(4.0% vs 5.0%) persisted up to six months of follow-up
(7.7% vs 9.5%).
The results were analyzed withrespect to pts with
early reperfusion and subtotal occlusions prior to
therapy, irrespective of which agent was given. The
hospital discharge (HO) (4.3% vs 9.4%) and 6 M(5.6% vs
12.5%) mortality was lower in 161 pts in whom the infarct
related artery (IRA) was patent 90 min post drug infusion
than in 128 pts inwhom the IRA was occluded at 90 min.
There were nosignificant differences in the incidenr.e of
recurrentMI or frequency of PTCA/CABG prior to HO or
during 6 Mfollow-up in thesetwo groups.
Conclusion: Apatent IRA 90 min after treatment
with a thrombolytic agentwas associated with a lowerHO
and 6 Mmortality. Pts with early reperfusiondid not
have an increased risk of reinfarctionor PTCA/CABG. The
lower mortality at 6M in pts treated with TPA is
consistent with the thesis that early reperfusion
decreases mortality of acute MI.
lACC Vol. 9, No. 2
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RURAL HOSPITAL ADMINSTRATION OF INTRAVENOUS TISSUE
PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION:
IMPROVED TIMING, EFFICACY AND VENTRICULAR FUNCTION
EJ Topol MD, FACC, L Gorman RN, E Kline RN, ER Bates
MD, FACC, JA Walton MD, FACC, G Baumann MD, J Maino MD,
S Wolfe MD, FACC, L Bayer MD, B Pitt MD FACC, WW
O'Neill MD, University of Michigan, Ann Arbor MI, Foote
Hospital, Jackson, South Macomb Hospital, Warren, MI
Three strategies of administering intravenous tissue
plasminogen activator (t-PA) to patients with acute
myocardial infarction (HI) were compared in regard to
thrombolytic efficacy and acute ventricular function.
Group I (n=15) consisted of pts who were brought to the
cardiac catheterization lab before t-PA was admin-
istered; Group II (n=67) pts had the helicopter team
bring the t-PA to the outlying hospital; and Group III
(n=36) pts received t-PA supplied in the referring
community hospital emergency room. The time from the
onset of chest pain to t-PA administrationwas 3.9 +1
hrs for Group I, 3.7 +1.3 hrs for Group 11 and2.2 + ~8
hrs for Group III Pts (l> <O.OOn. Infarct artery
patency at the 90 min angiogram was: Grp I 66$ (10/15);
Grp II 65.6$ (44/67); Grp III 80.5$ (29/36), p<0.10.
Initial left ventriculographic ejection fraction was
increased in Grp III pts: Grp I 49.3 +8.9$; Grp 11 49.8
+ 10$; Grp III 53.9 + 8.2$ (p <0.01-: one-way ANOVA).
One Grp I pt, 3 Grp II-pts, and 2 Grp III pts failed to
develop enzymatic evidence of infarction (p=ns).
Thus, community hospital administrationof intravenous
t-PA to pts with acute MI minimizes the time delay of
initiating therapy, resulting in significantly improved
thrombolytic efficacy and acute global left ventricular
function.
SERIAL ANGIOGRAPHIC ANALYSIS OF VENTRICULAR FUNCTIONALRECO-
VERY AFTER INTRACORONARY STREPTOKINASE
WolfgangG.Schmidt, M,O" Florence H. Shaehan, M.O.". Rainer Uebis, M.O., Rainer
v. Essen, M.O., Harold T. Dodge. M.O.*, S. Effert, M.O.
Oapt, of Internal Medicine I, RWTH Aachan. West Germany and Cardiovascular Re-
search and Training Center. University of Wa.hington,Seatlle*.
To .tudy the time course anddeterminantsof recovery of ventricular (LV) function
after thrombolytic therapy, wa performed angiography immediately, 3 day. and 6
months afterstreptokinasetherapy. 266 patients (pts) were treated at ourinstitution
and had complete occlusion of the LAD or RCA, Hypokinesia in the infarct (MI) area
(hypo) and hyperkinasia in the non MI area(hyped were analyzed by the centerline
method and axpressed in standard deviations (SO) from tha normal mean. After
reperfusion (Rap) hypo wa. not altared at 3 days (from - 2.8.±.O.9to-2.7 ± 0.9 SO,
n = 135, NS), but imprOVed et 6 months if the vessel remainedopen (from -2.8:!
0.9 to -1.7 ± 1.2 SO, n = 83, p < 0.0011. Hyper regressed by day 3 in both repsr'
fused (from 1.3±1.5 to 0.5 ±1.4 SO. n = 135, p < 0.0011 and non reparfused pts
(from 1.1 ± 1.4 to 0.2 ± 1.4 SO. n = 33, p < 0.0011. Global ajection frection (EFl
fell slightly 3 days after Rep (from 53.4± 12 to 51.2 ± 12 %,n = 135, p < 0,05) but
fell more if thrombolysi.failed (from 52.3 ± 13 to 46.2 ±11 %,n· 33, p < 0,0011.
Six month.after MI the EF was improved in anterior MI after Rep (from 46.8±9.2 to
52.5 ±12.7 %, n = 38, p <: 0.011. In infarior MI EF was normal ecutely and tharefore
did not change further (from 59.3±10.4 to 58.9 ±11.3 %.n = 45. NS).
Conclu.ions:
Recovery of ischamically Impaired myocardium in man taka. mora than 3 day., but
compensatory hyperkinasia regre.... aarlier. Ifreperfu.ionfail., global LV function
deteriorate.by tha third day. This result has some interestingpathophy.iological
aspects: daterioretionof LV function after MI, which often cau... death dua to pump
failure in the first week after MI. need notbe a sign of infarct axtension but maybe
due to ragression ofhyperkine.iain the non MI araa.
PREVENTION OF LATE VENTRICULAR DILATATION AFTER
MYOCARDIAL INFARCTION BY SUCCESSFUL THROMBOLYSIS.
James H. O'Keefe, MD, James H. Chesebro, MD FACC, Alfred
A. Bove, MD FACC, Ian P. Clements, MD FACC, Raymond J.
Gibbons, MD FACC. Mayo Clinic, Rochester, MN.
34 patients (pts) from Mayo in the NHLBI Thrombolysis
in Myocardial lnfarction (TIMI) Trial received intrave-
nous thrombolytic therapy (streptokinase in 10, tissue
plasminogen activator in 24), during acute myocardial
infarction. 25 pts had angiographicallyconfirmed imme-
diate reperfusion that persisted at 24 hours (Group R), 9
pts were not reperfused (Group NR). Gated radionuclide
angiography was performed within 12 hours of thrombolysis
and at 1 and 6 weeks. End-systolic and end-diastolic
volumes (ESVI, EDVI) and ejection fraction (EF) were
determined using a count-based method.
Time Group EF(%) EDVI (cc/M2) ESVI (cc 1M2)
Acute R ~ 121:> - 14 65
NR 37> p=.02 139 p-. 89> p=.04
wk R 54 103 50
NR 32>P=.001 l20>P=.08 84>P=.002
6 wk R 52 113 58
NR 30>P=.001 l62>P=.001 120>P=.001
Change R -2 +10 +8
(1-6 wks) NR -2 >p=NS +42> p=.005 +36>P=.001
Thus, marked left ventriculardilatation occurred bet-
ween 1 and 6 weeks in pts with unsuccessful thrombolysis
when compared to those who reperfused the infarct related
artery. These volume increases were inversely propor-
tioned to EF at 1 wk (r=.60).
Conclusion: Major left ventriculardilatation occurs
between one to six weeks after myocardial infarction and
appears to be significantly reduced by successful early
reperfusion.
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IS ST SEGMENT ELEVATION A VALID ECG CRITERION FOR
THROMBOLYSIS SELECTION IN ACUTE MYOCARDIAL INFARCTION?
William E Boden, MO,FACC, Robert E Kleiger, MD,FACC,
Robere S Glbson, MD,FACC, David J Schwartz, MD,FACC,
Kenneth BSchechtman, PhD, Robert J Capone, MD,FACC,
Joel E Cutler, MD, Robert Roberts, MD,FACC, and the
Diltiazem Reinfarction Study Research Grou~, Harper
Hospital and Wayne State University, Detrolt, MI
Prolonged chest pain(CP)and acute ST segment
elevation(Sr+) ~ 1 mm in 2 or more contiguous ECG leads
representmajor selection criteria for randomized
thrombolytic trials of acute MI. It is assumed that
these patients(pts),if treated conventionally,will
evolve classic Q wave(Q)MI. We studied 439 pts with CP
and MB-CK confirmed acute MI in the prospective
multicenter Diltiazem Reinfarction Study.Initial ST+on
the entry ECG,utilizing the above criteria,was present
in 187 pts(43%),of whom 162 showed ST+ localized to a
single lead group. Only 34 pts(21%)progressedto QMI
while 128(79%) exhibited non-Q wave (NQ)MI only. Mean
ST+ per elevated lead,sum(l:)ST+per lead group, and peak
CK values for the respective NQMI locations, showed:
Anterior Inferior Lateral
(Vi - V4 ) (l1,III,aVF) (I,aVL,Vs- \tl
ST+ 1. 4mm 1. 3mm 1. Imm
1:ST 4. Omm 3. 4mm 2. 6mm
CK 586 I.U. 736 I.U. 980 I.U.
QMI 18(111(16%) 13(39(33%) 3(12(25%)
No significant differences existed in peak CK among
NQMI subgroups with ST+ ;CKvalues in NQMI pts with SIt
(650I.U.) and without initial ST+ (624 I.U.) were
similar. Of note, even in pts with peak ST+~ 3mm in ~ 1
lead,only 2/22(9%)progressed to QMI. We conclude: l)over
40% of all NQMI pts exhibit initial ST+ ,of whom 80% do
not progress to QMI; 2)prolonged CP associated with
significant early ST+ does not reliably predict
subsequent Q wave evolution; 3)ST+ criteria in acute
thrombolysis selection should be used with caution.
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4 (17%)
SK i .c .
25 (68%)reperfusion at 90 min.
(N=37 APSAC/N=37 SK)
reocclusion at 24 (± 6) hours
(N=23 APSAC/N=24 SK)
No major bleedingwas observed despite a compar able
systemic lytic state in both treatmentgroups which lasted
for up to 48 hours. 2patients died because of severe LV
failure. These results indicate that APSAC (30U i .v. ) is
as .ef fect ive and safe as SK (250,000U i .c. ) . The major
advantages of APSAC in AMI are its r apid, convenient
administration,low rates of arterial reocclusion and good
pat ient tolerance.
*On behalf of the Dutch Invasive Reperfusion Study Group.
INTRAVENOUS (i .v.) APSAC VERSUS 1NTRACORONARY (i .c .)
STREPTOKINASEIN THE TREATMENT OF ACUTE MYOCARDIAL
INFARCTION.
Johannes J.R.M. Bonnier, M.D., ' JohannesB.R.M. de Swart,
M.D., Johannes J.M.L. Aottmann , M.Sc ., Catharina Hospital,
Eindhoven, The Nether lands.*
A random ized trial compared the eff icacy and safety of
anisoylated plasminogen streptokinase activator complex
(APSAC) i .v . and st reptokinase (SK ) i .c , in patients with
proven acutemyocardial infarct ion (AM I). The occlusion of
the infarct - rel at edvessel, reperf usionand reoccl usion
were all assessed angiographically. Fibrinolytic therapy
was st arted within 4(mean: 2.26) hours of the onset of
symptoms. 85 patients enter ed the study; 42were treated
with a single i.v , bolus inj ection of APSAC (300) given
over 3-5 mi n. and 43 with an t .c , infus ion of SK
(250, 0000 ) given over 60 min. 11 pat ient s were excluded
because of deviations from the protocol. The results of
the remaining 74 patients analysed are:
APSAC i .v .
24 (65%)
( 4%)
HEMORRHAGIC MYOCARDIAL INFARCTION AFTER THROMBOLYTIC
THERAPY: INTRAOPERATIVEOBSERVATIONS.
Allan S. Lew MD, Myles Lee MD , FACC, Sojan Cercek MD,
Harry Marshak and William Ganz MD, FACC. Cedars-Sinai
Medical Center, Los Angeles, CA.
Hemorrhage (HEM) into the area ofmyocardial infarction
(MI) following thrombolytic therapy is a frequentpost
mortem finding . In order to determine the incidence of
HEM-MI in surviving Pts following thrombolytic therapy,
we reviewed the intraoperativefindings of 80 consecutive
Pts with HI who were treated with intracoronarystreptok-
inase (n=22) , IV streptokinase(n=50) or IV tissue plasm-
inogen activator (n=8) within 4 hrs of the onset of chest
pain and who underwent cardiac surgery on day9±6 (range:
1-21) of the acute admission. 76 Pts had coronarybypass;
3 had ventricularseptal defects and 1 Pt had a ruptured
mitral papillarymuscle. On inspection, 41 of the 80 Pts
had transmuralMI. HEM-MI was present in 12 of the 41 Pts
with transmuralMI but it was not seen in any of the 39
Pts without transmuralMI. Compared to the Pts without
HEM-MI , the 12 Pts with HEM-MI had a significantly higher
rate of failed reperfusion or reocclusion of theinfarct
artery (5/12 vs 7/68); evolution of QS complexes (11/12
vs 24/68) and a history of hypertension (5/12 vs 12/68).
All 4 pts with myocardial rupture had transmuralHEM-MI ;
in 2 the infarct artery had not reperfusedand in 2 it
had reoccluded. Incontrast, HEM-MI was not observed in
any of a cohort of 38 Pts with transmuralHI who under-
went cardiac surgery11±8 days after MI but had not rec-
eived thrombolytic therapy.Our data suggest that visual -
ly apparenthemorrhage into an area of transmural necros-
is does not occurafter conventional management of MI but
is frequent following thrombolytic therapy: 1) in Ptswho
evolve QS complexes and 2) in Pts with failed reperfusion
or reocclusion; in whom it may accompany cardiac rupture .
ANGIOSCOPY GUI DED CORONARY THROMBOLYSIS
Kiyo s hi Inou e , M.D., F. A.C.C. , Ke iichi Kuwaki, M. D.,
Keiko Ueda, M. D. and Tetsuro Sh~ rai , M. D. Cardiovascular
Disease Cen t er , Tokyo Metr opol itan Police Hospital,
Tokyo .
Translumi nal cor onar yangioscopy is applied for intralu-
minal moni tori ng during PTCR of acute myocardial
i nfarction in early hours from the onset. Angioscopi c
ca thet er devel oped by us and us ed i n this study i s
so ft , t hi n , F#3 in size, of having cat he t er-ti p anglat i on
mechanis m and of allowing entry i nt o major pr oximal
por t i on of RCA , LCX and LAD using F#8 guide shea t h
in antegrade f ashion vi a f emor al artery . The ca t heter
conta i ns fi ne optic fiber bundles of both i maging
and lighting . The image guide i s cons i sted of 3000
pi xels of gl as s f i bers to t ransmi t t he r eflected
i mage bac k t o the eye piece whi l e light gui de cons isted
of 100 optic plas t ic bundles fo r illumination. The
catheter-tip has tiny r ote- l ens of 55' in visual fi el d
and of 2 t o 20 mm in f ocal dj s tance . The ey e piece
can be connect ed to VTR and 35 mm camera head . Following
r out i ne coronar y angiogram, a radiopaque t ip of angi o-
scop i c catheter is advanced toward 5- 10 mm proximal
t o t he occ l uded segment unde r f l uoroscopy . A sess ile
r ed thrombus , mixed mural t hro mbus cover ed by red
thrombus and athe ro sclerotic endothelium are c l ea r l y
seen . Repeat ed monitorin g of t hr ombolyli c proce ss
a nd j ud ge ment o f ei t her successf u l o r unsuccessful
thrombolysis ar e safely done thr oughout PTCR in 7
pati ents by f lushing of uro kinase solus i on. We conc l ude
th at ang i oscopy guided intr acoronar y thrombol ysi s
cou l d eliminate repeated a ng i og r a m and provide a
saf e method of direct moni t or in g of the outcome
of PTCR.
COST BENEFIT ANALYSIS OF INTRACORONARY THROMBOLYTIC
THERAPY; 12 MONTHS FOLLOW-UP REPORT OF A RANDOMIZED TRIAL.
Frank Vermeer MD, Maarten Simoons MD, FACC, Frits Baer MD,
Jan Res MD, Jacobus Lubsen PhD, Paul Hugenholtz MD, FACC.
The InteruniversityCardiology Institute, The Netherlands.
In a randomized trial early thrombolytic therapy with
intracoronarystreptokinase (T, 269 pts) was compared to
conventional therapy (C, 264 pts). Allocation to T led to
30% limitation of infarct s i ze , improvement of left
ventricular function, and decreased one year mortality
(10% i n T vs 16% in C); but also to more frequent bypass
surgery or angioplasty (26% in T vs 12% in C), and to a
higher incidence of recurrent i nfa rction (13% in T vs 5%
in C). The benefit of T in t erms of reduction of one year
mortality and morbidity was compared to the costs of
medical therapy, including hospital stay, cardiac
catheterization, bypass surgery, and angioplasty.
The table presents costs , mean survival in the first year
after myocardial infarction, and aver age number ofdays in
functional Class I-IV (angina or dyspnoe), or in hosp ital
for patients in both treatment groups.
Ant er i or Inferior
Number of patients C (116 ) T ( 130) C ( 148) T ( 139)
Class I (days) 183 239 232 225
Class II (days) 69 56 59 76
Cla ss Ill/IV (days) 19 10 10 8
In hospital (days) 26 27 26 28
--------------------------------- ---- -----------
Mean s ur vival (days) 297 332 327 337
Average cost in Dfl. 19,000 28 ,0 00 20, 000 27 , 000
In pts with inferior infarct improv ed survival after T was
not as soc i a t ed with lower morbidity. In snterior infarct T
resulted in longer mean survival (35 days) in the first
year and 56 days more without symptoms (Class I) at the
expense of Dfl. 9,000 per patient. The cost benefit ratio
of T compares favourably to that of other interventions.
JACC Vu!. 9, No. 2
February 1987:63A
ABSTRACTS 63A
EIECI'ROC'ARDICGRAmICINFARCl' E.VOWI'ION IS AexnERATED
BY SUCCESSFUL 'IlmoIOOLYSIS: A Report fran the NHIBI
'lhrombolysis in Myocardial Infarction (TIMI) Trial.
George B. Bren, M.D., Alan G. Wasserman,M.D. , F.A.C.C.,
Allan M. Ross, M.D., F.A.C.C., for the TIMI Irwestiga-
tors, Washin;)ton, DC
ElectrocardiograrXric evolution after infarction and
thranbolysis was characterized in 273 TIMI patients.
Mean R and Q wave anqJlitudeswere digitized in lead rr,
III and aVF (inferior MI5) and Vl-V6 (anteriorMIs) on
tracings fran admission (adm) , 2 hours (2h), 10 days
(lOd) and 6 weeks (6wk) post thrc::1:rbolytic therapy
(streptokinase or rt-PA). Time fran pain onset to
initiation of lytic therapy was 4.8 hours. R wave
anqJlitudes (mean ± SO in mv.) for initially occluded
patients who reperfused (Rep) and did not reperfuse
(NoR) were: (*=P<.03)
Mm 2h lad 6wk
Rep .6~.3 .3~.2 * .28±.2 * .31±.2
NoR .67±.4 ns .5Qt.4 .37± .3 .39±.3 ns
'Ihus, R loss is rapid with Rep and slow with NoR though
at 6wk no significant difference remains. Similar
t;enporal patternswere seen in Q wave development which
occurred nore rapidly after successful reperfusion.
'!here were 52 patients with i1=nplete coronary occlu-
sion at initial arqiogra~y. In contrast to initially
occluded patients they had slower ard lesser loss of R,
mean R anqJlitude .44 ± . 3 at 6 wks (p < .03 oornpared
with the REP group). R anqJlitudeand ejection fraction
at lad correlated significantly (P<. 004) Wt weakly
(r-:. 22) • Conclusion: Reperfusion after occlusion
accelerates loss of R and recruitmentof Q waves. one
may hypothesize that ralat.ively l ate reperfusion
accelerates the necrosis of irreversibly injured
myocardium.
EARLY RESTENOSIS AND REPEAT CORONARY ANGIOPLASTY
H Vemo n Anderson MD, Alexander J Black MD, Stephen W
Powelson MD, Steven G Ellis MD, Gary S Roubin MB PhD FACC,
John S Douglas Jr MD FACC, and Spencer B KingIII MD FACe.
Andreas Gruentzig Cardiovascular Center, Emory Universit y School
of Medicine, Atlanta, Georgia.
Restenosis (RS) after 1st coronary angioplasty (PTCA) is often
managed by a repeat dilatation. Predictors of RS afte r this 2nd PTCA
are not known. We therefore analyzed 3523 consecutive patients(pts)
with successful t st PTCA to a native coronary arterial site. Of these,
1814 (52%) had angiographic restud yand 539 (15%) required repeat
dilatation. Ar teriograp hic follow-up was available in 189 redilated
pts .
Overall, RS afte r 2nd PTCA was 30% (56/189) . Factors known to
influence RS after a 1st PTCA (gender, diameter stenosis, final
gradient, intimal tear, vessel dilated) did not emerge as significant
predictors for RS after 2nd PTCA. However, of 91pts with 1st
PTCA - 2nd PTCA intervalS 5 months RS occurred in 36 (40%),
wh ile only 20 of 98 pts (20%) with an interval> 5 months had RS
(p<O.OI).
Conclusions: Overall restenosis rate after 2nd PTCA was the same as
after 1st PTCA. Patientsrequiring a 2nd PTCA soon after their
initial procedure were more likely to have anotherresteno sis, and
these pts may constitute an ideal group for therapeutic intervention
trials.
Tuesday, March 10, 1987
10:30AM-12:00NOON, Hall C-l , First Level
PTCA: Restenosis
INCIDENCE OF RESTENOSI S AT 1, 2 , 3 AND 4 MONTHS AFTER
SUCCESSFUL CORONARY ANGIOPLASTY: AqUANTITATIVE
ANG IOGRAPHIC FOLLOW-UP STUDY IN 345 PATIENTS.
P.W. Serruys, M.D., R. Geuskens, M. D., P.J. de Feyter,
M.D., M. vd Brand, M.D., H. E. Luijten, M.D.,
Thoraxcenter, Rotterdam, The Netherlands .
REPEAT RESTENOSIS : EFFICACY OF THE THIRD AND
FOUR TH CORONARY ANGIOPLASTY .
Paul S . Teirstein, M. D. , Cra ig Hoov e r . Bob Ligon , LeeV.
Giorgi , M. D.• F.A .C .C. , Barry O. Ruthe r ford. M.D.,
F .A .C .C. , David R. McConahay, M.D., F.A.C.C.,
Warren L. Johnson, Jr. , M. D" F.A .C.C. , Geoffrey O.
Hartzler, M.D., F.A.C.C. Mid America Heart Institute,
Kansas City, Missouri
Of 5,000 consecutive PTCA procedures, 74 pts had a
2nd restenosis and returnedfo r a 3rd PTCA - successful
in 69 pts (93%). Proceduralcomplications induded urgent
CABG (3 p t s ) and in-hospital death (2 pts). At late follow-
up (FU) ( 5-50 mos , m = 18 mos) of all 69 pts, there were 2
(3 %) late deaths and no Mls . Twenty-eight pts (41 %) had
a 3rd re s te nos is treated with either 4th PTCA (16 pts) ,
CABG (11 pts) or med ical management (1 pt) . Thirty-nin e
pts (56 %) had no restenosis on t he basis of follow -up
angiography or absence of s ymp toms previously attributed
to restenos is .
S ix teen p t s with a 3r d restenosi s u nd e rw e n t a4th PTCA.
Procedural s ucces s was 93%(complica tions = 1 urgen t CABG ) .
At la te FU (5- 38 mos , m = 15 mos), there we re no deaths
or MI5. Eight pts (5 3%) had a 4th restenosis treated with
either 5th PTCA (1 pt) , CABG (5 pts) , or med ical man -
agement ( 2 pts). Seven pts (4 7%) remained angina-free.
Conside ring all 74 pts presenting with a 2nd restenosis,
42 (55 %) we re asymptomatic at late FU following a 3r d or
4t h PTCA.
Conclus ion : Resteno s is rates following 3rd and 4th PTCA
are inc r ea sed . However, in t h is study, multiple repeat
PT CA provided effective long- term therapy for 55%of
pts , Consequently , re p ea t PTCA should be considered in
the managementof pts with multiple r es te nos es .
103
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23%
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22%
17%
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13%
Current data s ugges t that r estenos i s (R) may occ ur within
the first Rweeks fol lowing pe r cut aneous trans l uminal
coronary an gioplasty (PTCA). To assess th e true i nciden ce
of R, 4 successive grou ps of pat ients were recathet erized
a t 30 , 60, 90 and 120 da ys (d) after PICA. Post-PICA all
pat ients received nifedipine 10 mg 3 t o 6 t i mes a da y and
salicylic acid 500 mg once a da y until repe ~ t angi ography
was performed. Out of 381 co ns ecut i ve patient s 'Jith a
su ccessful PTCA « 50% stenos is post-PI CA) 345 had
angiogr aphic fo llow-up (FU%= 91) . Diameter s t enosis (Ds)
was an a l yz ed quantitati vely u s in~ an aut omated edge-
detec t ion technique, and R waF angiographically define d
ac cordi ng t o 5 dif ferent pr oposed cr i t er i a (NHLBI 1-4, Ds
.. 50%) .
Results :
Number of dilntat i ons
Inci dence of recurrent stenosis at :
I ... 30% incr eas e in Ds at' FU
2. Increa se i n Ds f ro m< 50 to:;'70%:
3. Ds at FU;> pre-PTCA Ds - 10%
4. Ds at FU:;.Ds gain at PTCA / 2
5 . Ds :;' 50 %at FU
Conc lus i ons :
1) Up to at l ea s t 4 month s the i ncide nce of restenosis
inc reases wi th time; 2) The i nc i de nce of resteno s i s
va ries cons i de r abl y depending upon th e angi ogr aphi c
de f i n i t i on us ed .
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* p <.001
Restenosis was proven by angiography in pts that became
symptomatic and/or had a positive exercise tolerance
test. The follow-up period was 7 to 30 months. We
conclude that long Inf times combined with conventional
antiplatelet therapy is associated with a significantly
lower incidence of restenosis.
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY:
RELATIONSHIP BETWEEN RESTENOSIS AND INFLATION TIMES.
Jacob Shani, M.D., F.A.C.C., Joseph Gelbfish, M.D.,
Marcos Rivera, Gerald Hollander, M.D., F.A.C.C.,
Alvin Greengart, M.D., F.A.C.C. and Edgar Lichstein, M.D.,
F.A.C.C., Maimonides Medical Center, SUNY, Downstate
Medical Center, Brooklyn, New York.
Restenosis at the site of percutaneous transluminal
angioplasty (PTCA) is reported to occur in 20-30% of
patients (pts) maintained on antiplateletagents. We
studied the effects of long balloon inflation (Inf) times
and total Inf time on the rate of restenosis. There were
187 pts in the study. All pts had single vessel PTCA and
each vessel had 4 Inf. Group (gp) Apts had short Inf
( <60sec/lnf) and gp B pts had long Inf c>90sec/lnf) .
There were no significant differences in the demographic
characteristicsor in the distributionof the lesions
between the 2 gps.
CAN ORAL FISH OILSUPPLIMENT MINIMIZE RE-STENOSIS AFTER
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY?
John D. Slack, M.D., F.A.C.C., Cass A. Pinkerton, M.D.,
F.A.C.C., James VanTassel, M.D., F.A.C.C., Charles M. Orr,
M.D., F.A.C.C., Mary Scott, R.N., Beverly ALIen, R.N.,
William K. Nasser, M.D., F.A.C.C.
St. Vincent Hospital, Indianapolis, Indiana.
Fish oil suppliment (maxEPA; R.P. Sherer, Clearwater,
FL) provides a high concentrationof omega III fatty acids
recognized to lower serum triglyceride (tri) level while
elevating the HDL cholesterol fraction and prolonging
bleeding time. To study whether these ch~nges mig~t
favorably influence the rate of re-stenoS1S follow1ng
percutaneous transluminalcoronary angioplasty (PTA),
162 patients (pts) undergoing PTA between Sept., 1985 and
Feb., 1986 were randomly assigned to take EPA (6-9 cap/
day) (group I = 80 pts), in addition to.our usual ~o~t-PTA
regimen of a calcium-channel blocker, n1trate, asp1r1n,
and dipyridimole (group 11 = 82). Clinical assessment and
treadmill stress testing was performed every two months
for six months after PTA. Total cholesterol (TC), HDL,
and tri were measured before PTA and at six months. Thir-
teen pts in group I and 11in group 11 were lost to
follow-up. MaxEPA produced the expected effects on blood
lipids in group I: TC 232 ± 44 to 228 ± 55*, HDL 42 ± 10
to 51 ± 19*, tri 196 ± 113 to 141 ± 97*(mean ± SD).
Clinical restenosis (CR) occured in 21 of 63 (33%) pts
with single vessel PTA in group 11 but only 8 of 50 ~16%)
of single vessel PTA pts in group I. There was no d1f-
ference in CR in pts who had multivessel PTA: group 11, 11
of 19 (58%) vs group I, 20 of 30 (67%). By artery
dilated, the effect of maxEPA was limited to the left
coronary: PTA artery, CR group 11 vs I [circ, 7 of 20
(35%) vs 0 of 13 (0%); LAD, 10 of 29 (34%) vs 5 of 23
(22%); RCA, 4 of 15 (27%) vs 3 of 15 (20%); grafts 0 of
vsOof2].
CONCLUSION: MaxEPA administered in clinically tolerated
doses for six months following single vessel PTA is
associated with a decrease in clinical re-stenosis from
33% to 16%.
Group B
101
136 (90-360)
544 (360-940)
16 (6%) *
Group A
86
47 (20-60)
188 (l00-2l5)
21 (24%)
Number of patients
Inf Time (mean,range)
Total Inf Time
Restenosis (n,%)
*p" .05
IBUPROFEN: A POTENT ANTITHROMBOTICAGENT FOR ARTERIAL
INJURY AFTER BALLOON ANGIOPLASTY.
Jules Y. T. Lam, M.D., F.A.C.C., James H. Chesebro, M.D.,
F.A.C.C., Mrinal K. Dewanjee, Ph.D., Lina Badimon, Ph.D.
Valentin Fuster, M.D., F.A.C.C., Mount Sinai Medical
Center, New York, NY, and Mayo Clinic, Rochester, MN.
Effective antithromboticagents may be beneficial to
prevent the acute and late complications of angioplasty
which are related to platelet-thrombus formation. How-
ever, many of the common antiplateletagents have not been
found to be useful for angioplasty when tested in vivo.
Ibuprofen can decrease platelet-thrombusdeposition in
polytetrafluoroethylene(Gore-tex) arterialgrafts, but
whether it is also antithromboticafter the deep arterial
injury that follows balloon angioplasty of the common
carotid arteries (5 inflations to 6 AIM, 30 seconds each,
1 minute apart) was assessed in heparinized normal pigs
blindly randomized to receive intravenous ibuprofen
(12.5 mg/kg bolus followed by 75-100 ug/kg/min infusion)
or intravenous vehicle (placebo) starting 30 minutes
before the procedure and continuing until animal sacri-
fice. Animals sacrificed immediately after angioplasty,
when motrin levels averaged 53.9 t 10.4 ug/ml, showed
macroscopic white mural thrombus formation at the site of
dilatation in 0/9 (0%) treated pigs and in 8/9 (89%)
control pigs (P (0.001). Quantitative lllIn-labeled
autologous platelet deposition (xl06/cm2) at the site of
angioplasty was 36.2 t 6.1 in the controls, and this was
significantly reduced to 9.7 t 0.9 (p < 0.001) by
ibuprofen.
Thus, ibuprofen appears to be a potent antithrombotic
agent for decreasing platelet thrombus deposition after
deep arterial injury induced by balloon angioplasty; this
may have important clinical implications.
Tuesday, March 10, 1987
8:30AM-I0:00AM, Room 38, Second Level
Advances in Color Doppler Flow Imaging
VARIABILITY OF COLOR FLOW MAPPING DOPPLER I~AGING OF
REGURGJTANT JETS IN AN ANIMAL ~ODEL OF MITRAL
INSUFFICIENCY. Micheal Jones, M.D., Rrian Hoit, M.D.,
Elling Eidbo, Theo Meyer, M.D., David J. Sahn, M.D., FACC
Bill Elias,RnMS. Veterans Admin. Hospital, La Jo11a, CA.
In order to define the variables which influence the
imaging of regurgitant(REG)jets by calor flow mapping
Doppler (CD) systems, we imaged regurgitant mitral in-
sufficiency flows with a Toshiba SSH65 (2.5 and 3.75~z)
and an Aloka 880 (2.5 and 5.0MHz) at varying gains and
4-8KHz pulse repetition frequency(PRF) in 4 open chest
sheep after 4-7mm holes had been created in the anterior
mitral leaflet (9 flow states). Two blinded observers
measured CD jet width 2mm behind the mitral leaflet and
REG jet area in the left atrium as defined by the distri-
bution of (turbulent) variant CD REG flow in peak systole
and the 2 observers' determinationswere averaged. REG
jets were consistently larger in area on the Toshiba than
on the Aloka on paired studies both for REG jet width
(0.98cm ± 0.12(SD) vs 0.87cm ± 0.12) and for REG area
(5.2 cm2 ± 3.1 vs 3.2 cm2 ± 1.2), respectively (p <0.05).
REG flow area increased in both systems from 1.7 ± 0.7
cm2 to 3.7 ± 1.4 cm2 , from low to high gain and with
decreasing PRF from 8 to 4 KHz, meanjet area also
increased from 2.2±0.8 cm2 to 3.4 ± 1.1 cm2 (p< 0.05).
CD REG jets were also larger at 5.0MHz than at 2.5MHz (p<
0.05). At present for cn systems there is significant
variability in the appearance and spatial distributionof
imaged REG flow, between systems and with changing gain,
pulse repetitiOn frequency, and frequency of interroga-
tion. Unless standardizationof variance algorithms and
reproducible instrument setup is achieved, it will be
difficult to compare serial studies or studies performed
in different labs. At the present time CD can be viewed
as only semiquantitativeat best for assessing the sever-
ity of regurgitantlesions.
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DOES THE SPATIAL ORIENTATION OF JETS ON COLOR DOPPLER
STUDIES PERMIT ACCURATE ANGLE CORRECTION OF CWVELOCI-
TIES? Franco Recusani , M. D., LiIliam M. Val des-Cruz,
M.D.,FACe, Ar t ur oRaisaro, M.D. , Car l a Bertucci , M.D.,
Gi or gi o Cecchet, Ph.D., Giansiro Bargiggia, M.D.,
Gabr i el l a DiPieri, M.D., Luigi Tronconi, M.D ., David J.
Sahn, M.D.,FACC, IRCCS Pol. S. Matteo, Pavi a, Italy
We performed continuous wave (CW) Doppler, guided by
color Doppler(CD) flow mapping i n 11 catheteri zed (CATH)
and 25 non CATH patients (pt s) with mi t ra l s te nos i s (MS,
n=21) , aortic and/ or mitral regurgitati on (AR, n=18, MR,
n=12) using a Toshiba SSH6SA scanner . J e t position and
MAX CW j e t velocity (VEL) at O·incident angle wer e
r ecor ded. Jets were then deliberately i maged at i ncr ea -
sing intercept angles (9=14- 80· ) and th e angl es , based on
th e CD i mage , as well as the highest CW VEL env~ lop e at
these angles was recorded. VELs were correct ed for the
cosine of t he apparent angles (ANGLE cVEL) and compared
to the MAX VEL at 0·. For the CATHpts, Doppl er grad-
ients (GRAD) derived from 4 ~AX VEL' at O· correlated
strongly with peak instantaneous CATH GRADs (r=0.90,SEE=
7.1 mmHg) fo r MS (n=5) , AR (n- 7) and MR (n-5) . As 9
increased, ANGLE cVEL increasingly overestimated the MAX
VEL at 0·. At 9 =40· th e over es t imat i on wasminimal
(mean 3.5%) and ranging up t o 14%in MS (low VEL) , and
the % ove restimation was a mean of 8 .3 % ranging up to 25%
i n AR/MR (high VEL) . Beyond 40· overestimation increased
to as much as 110%for 9=80· with resulting significant
over es t i mat i on of gr adi ent s i nthe cath pt s . In our
study, the information on the CD permitted accur at e angle
correction of VELs at angles of up to 40·. However,
beyond 40· angle correction of CW VELs based on th e color
Doppler led to significant over es t i ma tion of VEL and
GRAD. The %GRAD error of a S· angle error can be pred-
icted from cos' (9 - S°) / cos' 9 -1 and suggests errors
>10%for 9's >40· .
ABSTRACTS
<X>LOR OOPPLERASSESSMEN1' OFllDRl'IC VALVE STENOSIS
Po-Hoey Fan, M.D., Mee-Nin Kan, M.D., FrederickHe1lrcke,
M.D., John W. <:=per, Navin C. NaI'x2, M.D. , F.A.C.C.
Color D::>ppler (CD) and cardiac catheterization (CC)
studies were perfonned in 36 pts (31 males, 5 ferrales,
mean age 53 years) with aortic valve stenosis (AS) in
whom we could measure maximum width of the stenotic jet
(SJ) at aortic valve level by CD. only Ptis with no more
than mild aortic regurgitationwere included in this
study. SJ was best seen from right parasternal/supra-
sternal views. CD guided continuous wave Doppler (Qol)
cursor line was aligned parallel to visualized SJ to
obtain more accuratetransvalvularvelocities. Maxi::'al
Velocity in left ventricularoutflCM tract (LVOT) was
rreasuredby pulse I::q:pler (IW). Aortic valve area (AVA)
was calculated by using the IICdified continuity equa-
tion. SJ width (~e 0 .4 cm to 1.6 cm, mean 0.94 ± 0 . 4
cm) by CD sh<7..'edgood correlationwith AVA calculated by
CC (~e 0.4 em2 to 1.7cm2, mean 0.95 ± 0 .5 cm2)
(r=O.90). AVA by I:k:lpplertechnique (~e 0.5 cm2 to
1.8 cm2, mean 0.82 ± 0.4 cm2) using velocities obtained
by aligning the cursor line parallel to SJ seen by CD
also correlatedwell with AVA by CC (r=O.90) . Mean
pressure gradientsby Doppler correlatedwell with those
obtained by CC (r=O.93). In additional 7 patients in
whom SJ width (~e 0.5 cm to 0.8 cm, mean 0.6 ± 0.1
cm) was visualized by CD, the LV could not be entered
during CC. In this group AVA by Doppler technique (with
the cursor line in SJ) rarqedfrom 0.32 an2 to 0. 9 em2
(mean 0. 5 ± 0.1 cm2). In all of them, surgerywas
perfonned on the basis of noninvasive Doppler data and
confinned presence of severe AS. Both SJ width by CD
and AVA by CD/Qol D::>wlerare useful in accurateestima-
tion of AS severity and can be reliably used to refer
pts for surgery in the group in whom CC is not success-
ful.
65A
VERI FI CATIONOF VELOGITY ASSIG~r\ENT BY COLOR D~PPLER
FLOW}~PPING : DEVELOPMENT OF A COMPUTER METHOD FOR ANGLE
CORRECTION OF COLOR DOPPLER VELOCI TIES. Kimberly A.
Krabi l l , M.D . Tadashi Tamura, C.Phil, Davi d J . Sahn,
M.D. , FACC, Erhan Gunday. Univ. of Calif, San Diego,CA.
We evaluated the accuracy of calor velocity (VEL)
assignment in a prototype Hewlett-Packard77020 calor
Doppl er (CD) flow scanner (5 MHz transducer) . A closed
f l ow system of Latex tub i ng (i nter nal diameter = 9. 5 mm)
was connected to a motor, to pump a suspe nsion of 0 .5%
cornstarch-water at a s t eady flow rate wi t h a spat i a l
mean VEL of 48 cm/sec, central s t r eam VEL assuming a
par abolic f l ow profile was 96 cm/sec. The CD i mages
obt a i ned were digitized using a Sony RGB video di giti z-
ing computer to encodethe color VEL ass igned pixel s
wi t h integers from 0- 7. The col or VEL calibrati on bar
( 16 steps eac h direction) was digitized , yieldi ng a
l i near relationship between the color intensity and row
number (y=O . l Sx + 0.74; r=0. 96) 5 0 that a numeri cal VEL
range could he assigned t o colors at dif f ering pulse
repetition frequencies. We re corded the tub e f l ow at
varying orientations and distances (4-1 0 cm) f r omthe
transducer, digitized areas of interest with uniform
VEL, and determined the angular or i ent ation of t he
direction ef interrogationfrom the transducer . From
th e Doppl er pr i nciple, t he ratio of th e cos i ne ef the
angl es at 2 peints = the ratio of tbe net flow VEL' s
to wards t he transducer at th ose 2 points. Combini ng 2
VEL assignment ar eas , there was a cl ose linea r relation-
ship between expect ed anp-ular central t ube VEL and colo r
coded VEL (r - 0.82) suc h that ac tu a l VEL at 10 certral
tube l ocations w~s estimat ed t o be 86±9 (SE)cm/ sec aft er
angle correction. Our metho d al l owsdetermination of
calor codi ng accuracy and prov i des a system f or recomp-
utation of color VEL assignments so as t o showactual
angle independent VEL's in CD.
QUANTlflCATIO:-'; OF J ET ENERGY BY COMPUTER
ANALYSIS OF COLOR DOPPLER IMAGES.
Ann F. Bolger M.D., Neal L. Eigler, M.D., J. Mart in Pfa ff, 8.S.•
Gerald Maurer, M.D., F.A.C.C. Cedars -Sina l Medical Center, Los
Angeles, CA.
Our goal was todetermine if CD spatial and velocity data can be
used to measure energ y trans fer by flu id jets th rough anorifice
into a closed chamber, and to examine the effects of CD gain
se tt i ngs. acce le rat io n, o ri fice a rea . a nd c hamber si ze o n th ese
measure ments. Power injecti ons of cornsta rch solution (2-42 ml
over I sec; accelera tion times 0.1 and 0.5 sec) were made into 40
and lOO ml sf,h erical chambers via cir cular orifi ces (areas 0.12,
0.28, 0.50 cm ). Jets were irnaged by CD using 3 different gain
sett ings, and acquired in real-time on an image processing
computer. Aliased pixels along the jets' long axis were
automatically corrected for tr ue veloci ty. Wc postulated that the
area (number of pixcls) of a slicethrough a symmetric jet would
be a curv ili nearfunction of its volume and therefo re mass. Since
kineti c energy is a function of mass x velocity2, we defined jet
energy (JE) as the sum of (pixel velocities)2, int egrated over the
inje ction period.We then compared JE to observed energy(OE),
which is pressure-volume work, calc ulate d as injection volume x
change in chamber pressure. As predicted, JE was a curvili near
and reproducible (±5%) fun ct ion of OE over a large range (0.2·
11.0xl 05 ergs). Th is relatio nship was unaf fected byorifice area,
acceleration time and chamber size. CD gain did not aff ect JE
except at the highest sett ing where noise was visibly excessive.
CONCLUSIO N: Computer analysis of color Doppler images
provides are a and velocity info rmation that allows accurate and
repr oducible est imat ion of energy in model jets. Furthermore, jet
energy measurements are independent of acceleration time, gain
setting, ori fic e area and chamber size.
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NON INVASIVE ANALYSIS OF LEFT VENTRICULAR BLOOD-FLOW
DYNAMICS IN LEFT VENTRICULAR ANEURYSM BY COLOR FLOW
MAPPING
Ryozo Omoto, MD, Maylene Wong, MD, FACC, Makoto Matsumura,
MD, Shiro Yamagata, MD, Teruyoshi Ishiguro, MD, Saitama
Medical School, Saitama, Japan
To analyze left ventricularblood-flow dynamics in left
ventricular aneurysm, we studied 21 patients (pts) with
angiographicallydocumented abnormal contraction segments
using color flow mapping (CFM); 14 ventricles with
aneurysm of one to three segments (Group-I) and 7
ventricles with dyskinesis of one or two segments (Group-
2). Two-dimensional blow-flow images by CFM were obtained
mainly from apical two-chamber and four-chamber views.
Blood-flow velocities were measured at inflow tract, apex,
and outflow tract by pulsed-wave Doppler. Blood-flow
dynamics of the left ventricule in the two groups were
classified into two characteristicpatterns (type A and
type B). In type A, CFM revealed normally directed flow:
red during diastole toward the apex and blue during
systole, away from the apex and toward the outflow tract.
In this type, systolic outflow was maintainedat normal
peak velocities (0.70±0.17 m/sec). Type B was completely
opposite to systolic flow in type A (P<O.OOI); at the apex
within aneurysm, both diastolic and systolic flows were
red and outward, toward the transducer. In this type,
peak systolic outflow velocities (0.57±0.14 m/sec) was
decreased compared to type A (P<O.I). In Group-I,ll pts
showed type Band 3 pts type A. In Group-2, 6 pts showed
type A and one patient type B. Conclusion: color flow
patterns within aneurysms revealed localized outward
systolic flow associated with reduced peak systolic
outflow velocities. These systolic abnormalities appear
to distinguish the LV aneurysm of one to three segments
from dyskinesis of one or two segments (P<0.05).
Tuesday, March10, 1987
10:30AM-12:00NOON,Room 38, Second Level
Evaluationof ValvularRegurgitationby Color
Doppler Flow Imaging
THE CURVILINEAR RELATION BETWEEN AORTIC REGURGITANT
FRACTION AND COLOR FLOW JETS: INTRAOPERATIVE2-DIMENSIONAL
DOPPLER AND ELECTROMAGNETICFLOWMETER CORRELATION
Makoto Matsumura, MD, Maylene Wong, MD, FACC, Ryozo Omoto,
MD, YUji Yokote, MD, Shinichi Takamoto, MD, Shunei Kyo,
MD, Saitama Medical School, Saitama, Japan
Color flow (CF) mapping of aortic regurgitantjets is used
to approximate regurgitant fraction (RF). We found a
linear relation between jet area and RF estimated from
invasive data; but, because of a shallow slope we
postulated a curvilinear relation. Intraoperative
electromagnetic flowmeter (EMF) measurements of aortic
flow (AF) and CF imaging of jets allow a direct
examination of the relation. Eleven patients underwent
surgery who had aortic regurgitation. Before bypass
circulation, jets were imaged with the transducer placed
on the right ventricle to simulate parasternallong axis
views of the LV outflow tract. Ten minutes later, AF
signals were recorded from the EMF probe. Mean data:
cardiac output=5.5 l/min, blood pressure=121/60(92), heart
rate=92 bpm. The difference between forward and reverse AF
was averaged from 5 beats to obtain RF. Jet areas were
measured by planimetry; jet volumes were calculated using
an area-length formula. RF compared to jet length, area
and volume: y(length) 120.7x(RF)o.33 (r 0.883)
y(area) 26.7x(RF)o.77 (r 0.949)
y(volume) 4.7x(RF)I.23 (r 0.926)
Cath-angio: y(area) 14 x(RF)-0.87 (r 0.722)
The jet area-RF relation is curvilinear, concave toward
the RF axis. The slopes of the two area equations are
similar, intersectingat coordinates 4.9cm 2 and 0.40. By
comparison, jet length-RF relation is more curvilinear;
jet volume-RF, more linear. Thus, the shape of the jet
area-RF relation is geometrically determined, limiting the
sensitivity of color flow jets as estimators of RF.
QUANTIFICATION OF AORTIC INSUFFICIENCY USING COlOR DOPPLER
FLOW lMAGING.
BenoH Diebold, M.D., Hanna Raffoul, M.D., Francof s
Amiel, M.D., Jean-Paul Guglielmi, B.S., Cyril Degroote,
M.D., Pierre Ourbak, M.D. and Pierre Peronneau, Ph.D.,
INSERM U. 256 et Clinique Cardiologique, Hopital
Broussais, Paris, France.
Experimental data demonstrate that the cross sectional
area of a jet at its origin is equal to the area of
the leak and hemodynamic considerations suggest that
this area is the most important determinant of the
severity of aortic insufficiency (AI). Therefore, an
evaluation of the section of the regurgitant jet at
its origin could provide a quantification of AI. This
approach was tested on a series of 47 patients who
underwentfor clinical reasons a supravalvularaortography
allowing for a 4 grade semi-quantification (ag) of AI.
They were investigated through a parasternal approach
using either (29 pts) a multigate pulse Doppler or ns
pts) color flow mapping (CFM). With CFM, the M mode
imaging of the jet appeared morereproducib1e than the
two-dimensional one. Thus, the jet diameter (jd in mm)
was measured using Mmode Doppler imaging. Thejet cross
sectional area (js in mm2) was calculated and normalized
by BSA (jn = js/BSA). Those parameters were compared
to ag : jd = 4 x ag + 2.2, r = 0.90, js = 51 x ag -
5, r = 0.88, jn = 30 x ag, r = 0.86. The differences
between the mean values of the groups were highly signi-
ficant between grade 0 and I, and 1 and 2 (p < .001)
and but 1ess si gni ficant between grade 2 and 3+ 4 (p
< .05), thus demonstrating a particular interest for
the evaluation of mild to moderate AI.
In conclusion, the Doppler imaging of the regurgitant
jet of aortic insufficiency at its origin offers an
additional approach of the severity of the leak.
QUANTITATIVEASSESSMENT OF AORTICINSUFFICIENCYBY
COLOR DOPPLER
Eric K. Louie, ~.D., F.A.C.C., Irvin Krukenkamp, M.D., Robert
J. Hariman, M.D., F.A.C.C., Sidney Levitsky M.D., F.A.C.C.,
University of Illinois, Chicago, nIinois
To relate the spatial extent of the color Doppler (CD) signal
of aortic insufficiency (AI) to regurgitant fraction (RF), 9 dogs
with varying degrees of AI created by partial excision of the
aortic valve were studied. Right heart bypass was instituted
with a calibrated roller pump to control LA venous retum
(=forwardLV output) and total L Voutput was measured by aortic
electromagnetic flow probe. Loading conditions were varied with
phenylephrine infusion and changes in LA venous returnresulting
in mean diastolic pressure gradients ( I:P) accross the aortic
valve of 23-114 mmHg, forward LVoutput of 0.75-2.50 !lmin,
and diastolic filling periods (DFP) of 162-320 msec. CD images
of the LV and outflow tract in two orthogonal planes were
obtained by placing a 3.5 MHz transducer directly upon the LV
apex. The area of the CD regurgitant signal as a percent of LV
end diastolic cavity area (CD%) was measured andthe results
from the two planes averaged. In 44 CD measurements of
varying degrees of AI (RF 0-85%), regurgitant volume per beat
correlatedwell with CD% (r=0.77). Neither t:,p (r=.09) nor DFP
(r=.12) alone correlated with CD%. RF correlated best with
CD% (r=.88, CD%=.40RF-.49, SEE=5.1). Regurgitant aorticvalve
area (AVA-R) from the Gorlin equation ranged from 0-.37 cm2•
For data selected from each experiment for constant AP (40 ± 3
mmHg) and DFP (229 ±21 msec), AVA-R correlated well with
CD% (r=.78). Thus, CD% is proportional to the volumetric
severity of Al over a wide range of loading conditions and
proportional toAVA-R when those conditions are heldconstant.
These findings suggest that noninvasivequantitation of valvular
regurgitation by color flow Doppler is possible.
JACC Vol. 9, No. 2
February1987:67A
ABSTRACTS 67A
HEMODYNAMIC IMPLICATIONS OF JET SIZE BY COlOR DOPPLER
FLOW IMAGING IN PATIENTS WITH MITRAL REGURGITATION
Michael Spain, Mikel Smith, Michael Harrison,Paul
Grayburn,Oi ling Kwan, Mary O'Brien, and Anthony N.
OeMaria; Univ of Kentucky &VA Med Cntr, Lexington, KY
It has been suggested that the size of the jet on color
Doppler flow imaging(DFI) may act as anindependentdes-
criptor of the severity of a regurgitantlesion. To test
this hypothesis, we analyzed the OFI recordings in19 pts
with mitral regurgitation,and compared jet size with
hemodynamic measurementsobtained by cardiaccatheteri-
zation. Mitral regurgitationwas due to variable etiol-
ogy. OFI was performed from the cardiac apex using com-
mercial and prototypeequipment with a 2.5 mHz trans-
ducer. Jet size was measured in calibrateddistance units
as the largest area of systolic flow disturbance in the
left atriumimaged in any apical view (4 and 2 chamber or
long axis). The mean value of 3 beats was calculated.
Measurementsderived from cath includedpulmonarycapil-
lary wedge pressure(PCW), LV end-diasto1ic pressure(EOP),
thermodilutionand angiographic cardiacoutput(CO), ejec-
tion fraction(EF), regurgitantvolume(RV), regurgitant
fraction(RF) and end-diastolic volume index(EDVI). Meas-
urements of jet size ranged from 0.50 to 4.20. There was
a tendency for RV and RF to increase withjet size, but
the correlationwas poor (r=.42 and .45). No correlation
was observed between jet size and PCW, LVEDP, CO or EF.
However, a general correlationexisted between LV volume
and jet area, with acorrelationcoefficient of r=0.55
for EDVI. Conclusions: Only a weak relationshipwas ob-
served between jet size and regurgitantvolume or frac-
tion. No correlationexisted between jet size and any
measurementof cardiac pressure or flow.However, a gen-
eral correlationwas observed between jet size and end-
diastolic volume index, suggestingthat DFI may well re-
flect the volume overload imposed by mitral regurgitatio~
COLOR FLOW DOPPLER STUDY OF THE EFFECTS OF AFTERLOAD ON
THE SPATIAL DISTRIBUTION OF MITRAL REGURGITANT JETS.
Carla Bertucci, M.D., Lilliam Valdes-Cruz, M.D.,FACC,
Franco Recusani, M.D., Giansiro Bargiggia, M.D.,
Gabriella DePieri, M.D., Arturo Raisaro, M.D., Luigi
Tronconi, M.D., David J. Sahn, M.D.,FACC. IRCCS Pol. S.
Matteo, Pavia, Italy
We studied the effect of varying LV afterload on the
color Doppler (CD) area of mitral regurgitant (MREC) jets
in 10 patients (pta) who did not have aortic stenosis.
All patients had thick and rigid mitral valves such that
changes in actual regurgitantorifice area were unlikely
to occur. Studies were performed from apex views using a
Toshiba SSH6SA at baseline (BASE) and during amyl nitrate
(n~5) and/or Angiotensin II (N~lO) administration. At
each steady state of arm cuff blood pressure (BP), the
MREG jet images (with constant PRF and calor gain) and
the maximal (MAX) jet continuous wave spectral velocity
(VEL) and velocity time integral ('~I) parallel to the
direction of the jet were recorded Two observers meas-
ured MAX MREG jet CD area (as turbulence-definedarea),
jet length (L) and width (W), LA area, MAX jet VEL, and
heart rate (HR). Jet Wat the inlet (an estimate of REG
orifice size) did not change significantly. No change
(A) in LA area or HR occurred. MAX jet VEL correlated
with BP (r~ 0.95) following Bernoulli equation. %A BP
(-21 to +58% of BASE, mean=13%) also correlated linearly
with %A VTI (-17 to +97%, m=13% (r~ 0.75, SEE l6%,slope
=0.9) and with %A MREG CD area (-33 to +2ll%,m~29%) (r~
0.7l,SEE ~30%,slope=1.72) but the higher slope of MREG CD
area relationship implied a greater effect of BP on MREG
CD area. Our study shows that the spatial distribution
of MREG turbulence imaged on color Doppler systems, ex-
pands more rapidly than a VTI x BP index of mitral insuf-
ficiency would predict. CD REG area may, therefore, have
a nonlinear relationship to the severity of MI.
THE PHYSIOLOGY OF MITRAL REGURGITATION: VORTEX FORMATION
IN THE LEFT ATRIUM
.!!:!.l.!i~!!!_~Bo!!!!!!~M.D .. LA.C.C., Kevin L Rebeck,
University of California, Davis, California.
Both cineangiography and standardDoppler techniques
have shown the presence of retrograde flow in mitral
regurgitation. However, these techniques are limited in
displaying both the spacial and velocity information. To
more fully evaluate flow velocity patterns within the
entire left atrium during mitral regurgitationwe used 2D
flow imaging to define flow velocity patternsin mitral
regurgitation. 20 patients (p t s ) with mitral
regurgitation were evaluated with 2D color flow ImagIng,
Results showed that in 19/20 pts a retrogradejet (mean
area 339 mm2) was detected (posterior 20%, mid-posterior
30%, mid 30%,mid-anterior20%). Pulsed-wave tracings
from this flow area revealed high velocity with apparent
aliasing. A second, lower velocity retrogradestream (299
mm2) could be seen extending to the roof of the left
atrium (19/20 pts ), In all pts ~20/20) a large antegrade
low velocity flow stream (290 mm ) flowed from the roof of
the left atriumtoward the mitral annulus and created a
large vortex in the left atrium which rotated counter
clockwise in the long axis views and clockwise in the
apical four-chamber views independent of pulmonary venous
flow.
Thus, in mitral regurgitation, 2D flow imaging reveals
3 distinct flow streams with vortex formation. In
occasional pts, the detection of this antegrade vortex
stream may be the only Doppler indication of mitral
regurgitation. Further advances in the detection and
quantificationof mitral regurgitationby Doppler may
require a greater understandingof the flow physiology of
mitral regurgitation.
Tuesday, March 10, 1987
8:30AM-I0:00AM, Room 24, Second Level
Silent Ischemia
DOES NONINVASIVE TESTING PREDICT 3-VESSEL OR LEFT MAIN
DISEASE IN PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT
VENTRICULAR DYSFUNCTION?
Gianfranco Mazzotta, MD, Robert O. Bonow, MD, FACC,
Leonardo Pace. MD, Stephen L. Bacharach, PhD, Stephen E.
Epstein, MD, FACC, NHLBI, Bethesda, Maryland.
Patients with coronary artery disease (CAD) and LV dys-
function who have 3-vessel disease (3VD) or left main dis-
ease (LMD) have impaired long-term survival that is im-
proved by surgery. To determine whether such pts who are
mildly symptomatic (FC 1-11) can be identified noninva-
sively, we studied 85 CAD pts with ejection fractions (EF)
of 25-40J by exercise ECG and exercise radionuclide angio-
graphy. There were 29 pts with 3VD and 2 with LMD. Sta-
tistical analysis indicated the following discriminant
factors during exercise in segregating pts with 3VD or
LMD: extent of ST segment depression (p<.OOl), magnitUde
of change (6) in EF (p<.005), and onset of angina (p<
.001). In distinguishing one or two vessel CAD from 3VD
or LMD, the following values were obtained by univariate
and multivariate analysis:
Sensitivity Specificity Predictive Accuracy
(%) (J) Positive Negative
6 EF<+5J 90 22 40% 80J
AEF<-5% 17 83 65J 76J
ST >lmm.. ai 66 55% B6%
Multivariate 73 75 6U B4%
Whereas a single factor had either a low sensitivity or a
low specificity, the multivariateanalysis predicted fair-
ly well the severity of CAD. Nonetheless, this method did
not identify 27J of 3VD and LMD pts. These data indicate
that noninvasive testing alone in mildly symptomatic pts
with CAD and LV dysfunction is not adequate in identifying
pts at risk of 3VD or LMD, and hence that more definitive
evaluation by coronary arteriographyis required.
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SILENT ISCHEMIA AFTER MYOCARDIAL INFARCTION
Thomas Bigger, Jr. , MD, FACC, Arthur Moss , MD , FACC, and
the Multicenter Diltiazem Post Infarction Trial
Investigators
About 25%of patients with angi na pectoris and positive
exercise t es ts have episodes of ST depression detected in
a single 24-hour ECG recording and >75% of these epi sodes
are asymptomatic . To determine t he preval ence and
characteristics of s ilent ischemi a (SI) after myocardial
infarction (MI) , we studied 50 patients (34 men , 16 wom-
en) aged 57±11, 3 months after HI when their medical
therapy had been stabilized (70% were on beta blockers,
58% on nitrates and 50% on calci um channel blockers) .
Only 18% had angi napectori s between di scharge and 3
months after MI . A 24-hour Holter was recorded and
analyzed for SI , i .e . , >1 mm ST depressi on for ~l min,
with a sensitive computer pr ogram; al l epi sodesdetected
by comput er were reviewed by a cardi olo gi s t . One to 21
episodes of SI were recorded in 28% of th e patients.
None of t he epi sodes of SI detected by 24-hour ECG
recordings was symptomatic. The median durationof SI
was 11 min (range 1 to 22 min) and th emaximum ST depres-
sion was 1 to 4.5 mm. The heart rate at the onset of SI
was 80+16 (range 60 to 110 per min) . Patients who ex-
perienced angina pectoris any time between discharge and
3 mo after HI were 2.2 time s as likely to have SI; pa-
tients with positive exercise te sts were 5.4 times as
l ikely to have SI . Therelationsh ip bet ween drug therapy
and SI was complex and ambiguous . Thus , stable patients
3 mont hs after HI had a prevalence of SI similar that
se en in pati ents with symptomat i c angina pectoris ; the
characteristics of SI i n pos t HI pa t i ents also were simi-
lar t o tho se in symptomatic angina patients.
SILENI' AND SYMPTGIATIC ISCHEMIA AFTER ANGIOPLASTY: DETECT-
ION WITH CONTINUOUS AND REAIr-TIMESTS~ ~I'IDRIN:;.
Mi tchell W. Krucoff, M.D., James E. Pope, M.D.,F.A.C.C.,
Galen S. Wagner, M.D., Isabelle M. !\dams, M.S., Randy K.
8ottner, M.D., Lowell F. Satler, M.D., F.A.C.C., Susan W.
Ahmed Ph.D., Charles E. Rackley, M.D., F.A.C.C., Kenneth
M. Kent, M.D., Ph.D., F.A.C.C. GeOrgetown University,
Washington, D.C.
Is chemia after success ful angioplasty (TCA) may identify
pat i ents at higher risk of early or late morbidity, but
may not be accoepani.ed by angina. Usi ng precalibrated
contin uous 3-channel recorders and/or a prograrrrnable 12-
lead electrocardiographwith real-time ST segment analysis
i n 12 leads every 30 seconds, we performed 3744 hours of
ST segment monitoring in 196 patients immediately after
success f ul TI:A. ST deviation (DEV) was fourd in 44 (22%)
patients. Of these 44, 21 (48%) had someassociated
angina: of the 152 patients with no STDEV, 5 (3%) were
treated for angina (p < .000001). Myocardial infarction
(MI ) occ ur red in 9/44 with ST DW, and in 0/152 with no ST
DEV (p < .000001 ). Of the 44 patients with ST DEV, 10 had
ST elevation (ELEV) and 34 had ST depression
(DEP). (P<. 0001) . Anginaoccurred in 9/10 (90%) with ST
ELEV, but only in 12/34 (35%) with ST DEP (p < .01). MI
occurr ed i n 8/10 (80%) with ST ELEV, but only in 1/34 (3%)
with ST DEP. Thus, after successful TI:A: 1) there is a
s ignificantly lower incidence of angina and MI in patients
who have no STchanges, 2) ischemia with ST segment
depression is frequently s ilent, and rarely associated
with MI, 3) ST elevation is generally associated with the
evolution of angina and MI. Real-time ST segment
monitoring could allow for earlier interventionin such
high risk patients.
PROGNOSTrC IMPORTANCE OF MYOCARDIAL ISCHEMIA DETECTED BY
AMBULATORY ~ON ITORING IN PATIENTS WITH CORONARY DISEASE.
Michael B. Rocco , M.D., Elizabeth G. Nabe1, M.D.,
Stephen Campbell, M.D., Lee Go1dman, ~1.D., Joan Barry,
KimberlyMead and Andrew P. Se1wyn , M.D., F.A.C.C.
Brigham and Women's Hospital, Boston, Massachusetts.
Frequent asymptomatic episodes of ischemic ST-segment
depression (STD) have been reported inambulant patients
out of hospital with chronicstable coronaryartery
disease~ however, the prognostic import ance ofthis
f inding is unknown. Therefore 69males and 17 females
(aged = 59±10 years) underwent48 hours of continuous
frequencymodulated ST-segment monitor ing off
medications and were prospectively foll owed for a mean
of 9 ± 6 (range 1 to 20)months to determinewhether STD
(11"Vll at 80msec and1.30 sec duration) was correlated
with adverse cardiacoutcomes. Clinicians were blinded
to the monitorresults. Cardiac death,myocardial
infarction or hospitalization for unstable angina
occurred in seven of the 52patients with STD on
monitoring but innone of the 34 patients without
STD. This difference was significant by life table
analysis with p=0.03. When revascularizationprocedures
were inc1uded,events occurred in13 patients with STD
but i n only onepatient without STD;p=O.Ol. For both
outcome categories, multivariateCox analysis
demonstratedthat STD was a significant independent
correlate of poor outcome even after controlling for
age, sex, NYHA angina class and angina frequency. This
study demonstratesthat ischemia detected byambulatory
monitoring is associated with adverse cardia c events in
patients with CAD. Assessment of ambulatory ischemia
may add import ant incre~enta1 information to the
cli nical history when assessing these patients.
EF'F'EX:TSOFTITRATIN:;BETA ADRENERGIC BLOCKADE toss
ON SILENI' MYOCARDIAL I9::HEMIA IN AMBULA'IDRY PATIENrS
Greg ~~ M.D., Kevin Coy, M.D., Charles R.
Lambert, M.D., Carl J. Pepine, M.D•• F.A.C.C., University
of Florida, Gainesville
When beta blockers are given to control angina,
considerable silent ischemic type ST segrent depression
(SI ) remains. This finding suggests t hat a myocardial
oxygen supply decrease r at her than demandincrease
accounts for residual SI. The purpo se of this stooy was
to assess effects of dose titration of a beta adrenergic
blocker t o optiIral y reduce SI detected by arrbulatory
EX:G rronitoring (AEM). Ten patients with docurentedCAD
were entered in a stooy wi t h open and blinded phases.
Each atudy period cons ist ed of 3 days of AEM and diary
recordings . In open phase t here were 4 study periods:
no drug, rretoprolol (Ml'P) at 100 mg, 200 mg, and 400
mg/day . OptiIral dose was defined as t he dose producing
maxiIral reduction in frequency and duration of SI by AEM
without side effects. The double blind phase then
canparedplacebo and Ml'P at optiIral dose assessed by
ABM. Aver age heart rate during AEM periods was reduced
at all three doses of MI'P and at optimaL dose fran 80 ±
7 t o 59 Z 4 bpn (p<.005). The SI episodes (mean. 3.3
episodes lasting 66.5 min/ABM period ) were reduced
( ~. 05) in frequency to 1.8, 1.3 , am 0 episodes /AEM
period and duration t o 25. 8. 3, and 0 min/ABM period by
Ml'P at 100. 200 and 400 mg r espective l y .
These data suggest that L) beta blockade eliminates
or significantly reduces both the frequency and duration
of SI ~n dose titrationto an obj ec t i ve end point is
used. 2) repeated AEM is required, am 3) changes in
myocardial oxygen demandappear t o have pathophysiologic
significance in SI.
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DIPYRIDAMOLE-THALLIUMPREDICTS COMPLICATIONS IN DIABETICS
UNDERGOING PERIPHERALVASCuLAR SURGERY. John J. Pippin,
MD, Roland T. Phillips, MD, Steven E. Lane, MD, Edward
Perper, MD, David Campbell, MD, Thomas Hill, MD, Stanley
M. Lewis, MD, FACC, Edward J. Kosinski, MD. New England
Deaconess Hospital, HarvardMedical School, Boston, MA.
Pre-operativequantitativedipyridamole-thalliumtesting
(DT) was performed in 63 diabetic patients undergoing
peripheralvascular surgery. DT results were correlated
with peri-operativecardiovascularcomplications (CVC).
defined as Mr, CHF,unstable angina, or death. 16 CVC
occurred in 9 of '63 surgeries. The presence of one or
more reversible perfusion defects on DT was the only
reliable predictor of CVC risk (9/44 v. 0/19; p<0.05).
The presence of "mixed" DT defects (fixed and reversible)
reflecting combined infarction and ischemia, was a par-
ticularly strong predictorof CVC risk (8/33 v. 1/30;
p<0.03). In the 44 pts with ischemic DT, there was a
statistically insignificant trend favoring the use of
peri-operativeprophylactic iv nitroglycerin. There were
nO CVC in the 19 pts whose DT were normal or had only
fixed defects. CVC occurred only in lower extremity major
vascular reconstructionsand aortic aneurysm resections.
Risk was unrelated to age, gender, peri-operativevolume
status, or type and durationof anaesthesia. Clinical
predictors of CVC were less helpful in this high-risk
population. We conclude that in diabetic patients under-
going peripheralvascular surgery: 1) DT is an important
predictor of CVC risk; 2) clinical predictors of CVC risk
are less helpful; 3) CVC risk appears to be limited to
major vascular procedures; 4) peri-operativeprophylactic
iv nitroglycerinmay reduce CVC risk for pts with high-
risk pre-operativeDT results.
Tuesday, March 10, 1987
10:30AM-12:00NOON, Room 24, Second Level
Myocardial Perfusion and Ischemia
IMPACT OF DISTAL CORONARY PERFUSION ON EJECTION FRACTION
RESPONSE TO BALLOON INFLATION DURING PTCA.
C. Carl Jaffe, M.D., Daniel wohlgelernter M.D. FACC,
Henry Cabin, M.D. FACC, H. Ainsley Highman PA, Michael
Cleman M.D. Yale Univ. School of Medicine, New Haven CT.
Balloon inflation (BI) during PTCA causes transient total
occlusion of the coronary artery with resultant ischemic
left ventricular (LV) dysfunction. To evaluate the
cardioprotective efficacy of distal coronary perfusion,
31 patients (pts) underwent transcatheter infusion of
oxygenated Fluosol-DA 20%, a perfluorochemical oxygen
transport fluid during BI. All pts had isolated proximal
left anterior descending (LAD) artery stenosis with
normal baseline LV function and no visible collaterals.
LV function during PTCA was continuously monitored by 20
echo and global LV ejection fraction (EF) was calculated
using computerized quantitative analysis of the echo
images. Each pt had both non-perfused and perfused
(oxygenated Fluosol delivered at 60 cc/min. through the
distal lumen of the balloon catheter) Bls lasting>45
secs. Heart rate remained within 8% of baseline during
Bls. LV EF results (mean +/- SO) were:
Baseline EF At 45 sec of BI p value
Non perfused 59% +/-8 39% +/-9 < .005
Fluosol perfusion 58% +/-10 54% +/-8 ns
Recovery of LV EF to baseline after balloon deflation
occurred within 2.5 minutes in all cases. We conclude
that a profound fall in LV EF occurs during PTCA of
proximal LAD stenoses for balloon inflation times >45
secs. Distal perfusion with a perfluorochemical oxygen
transport fluid significantly mitigates the BI related
ischemic dysfunction.
MEASUREMENT OF ABSOLUTE CORONARY BLOOD FLOW USING A
STANDARD ANGIOPLASTY CATHETER.
Robert A. Vogel, M.D., F.A.C.C., Harold Z. Friedman,
M.D., Glenn J. Beauman, M.S., Gary R. Viviano, B.S. and
Cindy L. Grines, M.D., Veterans AdministrationMedical
Center, Ann Arbor, MI
The hemodynamic consequences of coronaryangioplasty are
difficult to assess during theintervention. To overcome
this, we have developed a new method for measuring
absolute coronary blood flowwhich uses steady-state
dilutional analysis, a hydrogen-saline flow indicator,
and a standard angioplastycatheter. A 100% saturated
hydrogen-saline referencesolution is infused at 5ml/min
through a port locatedjust proximal to the dilating
ball oon. Hi gh impedence voltage measurements are
obtained from a platinum electrode located at the
catheter tip during 20 second reference solution
infusions to determine reference solution dilution.
Standard yuiding catheters and moveable guidewi res are
used to introduce the flowcatheter. We have compared
the accuracy of absolute flowmeasurements against timed
collection in arterial phantoms with diameters ranging
from 1.5 to 3.0 mm and now rates ranging from 0 to 240
ml/min. Electrode potentials were found to closely
correlate with absolute flow (r = 0.97, n = 45) overthis
range and were not affected by arterial diameter.
Adequacy of mixing was suggested by a close
correspondence between observed and predicted
concentration response curves. Canine studies have
demonstrated that this low reference solution infusion
rate was associated with minimal changes in intrinsic
coronary blood flow. These findings suggest that this
technique should be useful for monitoring coronary flow
changes during angioplasty.
ATHEROSCLEROSIS DETERMINES THE RESPONSE OF CORONARY
ARTERIES TO COLD PRESSOR STI~ULATION.
Elizabeth G. Nabel, M.D., Peter Ganz, M.D., Joh~ B.
Gordon, M.D., RichardW. Wayne, B.S., Andrew P. Selwyn,
M.D. Brigham andWomen's Hospital andHarvardMedical
School, Boston MA
The cold pressor test (CPT) is generally considered a
vasoconstrictorstimulus in the coronaryvasculature.
To examine the effects of atherosclerosison this
reaction, we studied the separate response toCPT in
normal coronaryarteries (NCA, n=12), irregularvessels
with no stenoses (ICA, n=29), and stenosed coronary
arteries (SCA, n=14) in 19 patients with angina
pectoris using quantitativea~iograp~ Du~ CPT'_3
the double productincrea~d 4B±11! (!Q.1_14.9 x 10
mmHg) and PCWP increased 70±16% (10-.18 mmHg).
Stenosed coronaryarteries constricted from 1~7±.23 to
O.98±.24 mm (-I/±4%)(p< 0.01) at maximum response.
Similarly, i~ular coronaryarteries constricted from
l:9O±.40 to r:7O±.35 (-~±7%)(p< 0.0l) . ...J!1 contrast,
normal coronaryarteries dilated from 1.91±.35 to
W±.32 (+TI±9%)(p<0.01)...:. All vesse]j dilated to
intracoronaryNTG: SCA +37±11%, ICA +11±4%, NCA
+23±6%. The percent change between control andmaximal
response was significantly different between NCA and
ICA (p< 0.01) and NCA and SCA (p< 0.01). tbus , contrary
to previous reports, smooth and angiographicallynormal
coronaryarteries dilate to CPT. In contrast,
atheroscleroticcoronarysegments appear to lose this
normal dilator response andparadoxicallyconstrict
with the sympathetic stimulus and increasedMV02 of the
CPT. This could be due toaltered sensitivity to
catecholamines and/or a loss ofendothelial dependent
relaxing factor(s).
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BLOOD VELOCITY MEASUREMENTS DURING SELECTIVE CORONARY
ANGIOGRAPHY BEFORE AND AFTER PERCUTANEOUS TRANSLUMINAL
CORONARY ANGIOPLASTY
Rick A. Nishimura, M.D., F.A.C.C., David R. Holmes, .Jr , ,
M.D., F.A.C.C., Alfred A. Bove, M.D., F.A.C.C., Erik L.
Ritman, M.D., Ph.D., F.A.C.C.; Mayo Clinic, Rochester, MN
Previously published coronary arteriographicstudies
in dogs suggest that the velocity of blood flowing down
a coronary artery provides an index of myocardial per-
fusion, independent of the need for measuring the amount
of myocardium supplied by a vessel. This velocity of
coronary blood flow can be quantitatedby measuring move-
ment of the leading edge of contrast utilizing digitized
images from routine coronary angiography. We used this
approach to quantitate improved perfusion following per-
cutaneous transluminalcoronary angioplasty (PTCA).
Coronary velocity was measured before and after PTCA in
15 pts who underwent successful PTCA of a single discrete
coronary stenosis. Changes in stenosis size were
assessed using a videodensitometric technique. The ve-
locity (mean ± SO) before PTCA in the 15 pts was 11.9 ±
6.0 cm/sec. Following PTCA, the velocity increased to
21.7 ± 8.7 cm/sec (p < 0.01). The mean percent stenosis
was 73 ± 20% before PTCA, decreasing to 29 ± 14% after
PTCA (p < 0.01). There was a direct correlationbetween
the percent change in velocity versus the change in per-
cent stenosis before and after PTCA (p < 0.01). The
mean absolute interobserverand intraobservervariabili-
ties for the velocity measurements were 2.1 cm/sec and
1.8 cm/sec, respectively. Measurement of coronary flow
velocity from data obtained at the time of routine coro-
nary angiography is an easily performed, reproducible
technique. It appears to provide an index of the ab-
solute coronary blood flow per gram of myocardium in man
and can be used to assess the result of an intervention
such as PTCA.
DETECTION OF SUBENDOCARDIr,L ISCHEMIA BY RECORDHlG
ENDOCARDIAL ELECTROGRAMS DURING PACING INDUCED ANGINA
Elizabeth G. Nabel, M.D., Thomas L. Shook, M.D., Peter
Ganz, M.D., Andrew P. Selwyn, M.D., F.A.C.C., Peter L.
Friedman, M.D., Ph.D. Harvard Medical School, Boston, MA
Provocation of angina pectoris (AP) by rapid atrial
pacing (RAP) confirms ischemia in ~atients wit~ coro~ary
artery disease (CAD) if left ventr1:ularend-~1astol1c
pressure (LVEDP) rises after cessat10n of pac1ng. RAP
may be inconclusive, however, if LVEDP rem~ins un~hanged
or if AP is not provoked. We tested the d1agnost1c value
of recording local unipolar endocardial electrograms
(UEE) during RAP in 6 patients (PTS) with CAD and AP.
UEE's were recorded from the tips of .025 mm guide wires
passed through catheters used to measure.LVEDP.and .
positioned against endocardiumof potent1ally 1schem1c
regions. RAP was then performed in standard fashion,
with continuous recording of LVEDP, UEf and three sur-
face electrocardiographicleads (ECG) chosen to reflect
1ikely regions of ischemia. Before RAP, UEE's in all 6
patients were free of significant ST elevation (STt ).
RAP provoked AP in 6/6 PTS! but was associated w~th a
ri~e in post-pacing LVEDP 1n only 5/6 PTS. Pers1stent
srt ~I mV was apparent in the UEE in 6/6 PTS after RAP,
and could be abolished by nitroglycerin. ST changes
during or following RAP were apparent in the surface ECG
in only 1/6 PTS, appeared as ST. rather than t , and was
much less in magnitude than in UEE. The single PT with
AP and STt in UEE after RAP who did not have a rise in
LVEDP subsequently underwent angioplasty of a right
coronary artery stenosis. RAP in this PT after angio-
plasty failed to provoke AP or STt in UEE. We conclude
that STt in UEE is a sensitive indicator of subendocar-
dial ischemia during RAP, may be seen in the absence of
any change in the surface ECG or in LVEDP, and can
clarify the nature of chest pain in PTS with CAD.
GATEDDIGITALROADMAPPING:A NEW COMPUTER-BASED
!MAGINGSUPPORTSYSTEMFOR CORONARYANGIOPLASTY
JonathanL Elion, M D" Steven E. Nissen, M,D., P.L. Charles
Fischer,and David C. Booth, M,D., F.A,C.C., University of
KentuckyCollege of Medicine,Lexington,Kentucky.
Although several recentadvances have !mprovedthe instrumentation
used in theperformanceof coronaryangioplasty(PTCA),few changes
have been made in theimaging modalities used duringthe procedure.
While digital angiographictechniques have develo~d to the.point
where image quality is at least comparableto thatof cme film, Its full
potentialhas yet to beexploitedfor PTCA. Theref~re? we d~veloped a
computer-basedimaging supportsystem f~r. assistmg wI!h ~c;A,
using software implemented~~ an unmodlfle~. com":!erctaldlg,ltal
angiographic system. In addition ~o the tradIt~onal Image review
features (digital freeze frame, zoommg, and split-screen), a method
was developedfor combininga cine loop representationof the coronary
anatomywith the live fluoroscopi~ images: Theroadm~~ is ~reated ?y
digitizing an image sequence dunngroutmecontrastI~JeCtlOn, while
automaticallymarking those frames which are takendunngan Rvwave.
Backgroundstructuresare removedby gated digital subtraction(mask
frames are selected from the correspondingportions of the cardiac
cycle), and a cine loop ,of the is?lat~d coron~ anat?myc~e~ted. !"
very high contrastversion of th~s ~me loop ,IScombme~ dl~Itally m
real-timewith the live fluoroscopicImages, Withsynchronizationto the
cardiac cycle maintainedusing the ECG. Unlike "static"ro~dmap
techniques (using a single contrastf~ame), our,approachprov,ldes a
representationof the coronarytree which moves In synchronyWith the
live fluoroscopic image of the cardiacsilhouette, Trials have shown
that the resulting images provide anexcellent facs!mile ?f the a:teries as
they would appear with actual contrast dye mjection, WIth close
correspondanceof the roadmapwith coronaryanatomy ~s,sessed by
traditionalangiography, This system thereby can facilitate Wire
manipulationto distal vessels, assist with optimal balloon placement
across a lesion, minimize the amountof contrastagent needed, and
provide a useful clinical adjunct to theperformanceof PTCA.
Tuesday, March 10, 1987
8:30AM-I0:00AM, Room 14, Second Level
Drug Treatment of Ventricular Arrhythmias
VALUE OF DOSE-TITRATION IN THE CARDIAC
ARRHYTHMIA PILOT STUDY (CAPS). Raymond L. Woosley,
MD, PhD, FACC, Eisa-Grace Giardina, MD, FACC, Dan M.
Roden, MD, FACC, Richard W. Henthorn, MD, ~ACC! Alfred
Hallstrom, PhD, and CAPSInvestigators,YanderbiltUniversity,
Nashville, TN 37232.
CAPS randomized 502 patients with ~ 10 VPDs/hr post-MI to
receive placebo (P la) or 11 drug treatments: Encainide (Enc),
flecainide (Fie), imipramine (Irnl) and moricizine (Mor),
Because of the known variability in dose-response relationships
with these drugs and the lack of such data in a po~t-MI
population, a dose-titration strategy w~s adopted. Patients
were advanced from low to medium to high dosage every 7-10
days if the dosage was not effective and if there were no
adverse reactions (AR). Efficacy (EFF) was defined as! 70%
decrease in VPDs and '90% decrease in episodes of non-
sustained VT. The dosages (mg/8hr) for Enc, Fie, Imi and Mor
respectively were: 35/50/60; 67/100/133; 50/75/125; and
200/250/300. The cumulative % of patients with EFF and AR
at each dosage level are compared:
%AR %EFF
Drug Low Med High Low Med High
Eoc 5 7 7 W n W
Flec 11 12 12 68 811 811
Imi 26 31 31 110 52 53
Mor 9 11 11 51 65 65
Pia 7 15 15 23 35 36
Incremental efficacy was seen between low and medium
dosages (mean=+III%)but the highest dosage did not incre~se
the overall response (meane-s l %). Significant AR occurredWith
the low dosages. Conclusions: Dose-titrationwas essential to
the successful conduct of CAPS. Any subsequent study of this
type should use more than one dosage to maximize efficacy and
minimize adverseeffects.
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DO BAS ELINE CLINICAL CHARACTERISTICS PREDICT I NI TIAL
RESPONSE TO ANTIARRHYTHMIC THERAPY?
Jeffre y L Anderson MD FACC, Lawr enc e S C Gr iffi th :-m FACC,
Alfred P Hallstrom PhD, Robert R Ledingham, Sa l im Yusuf
MD, Allan H Barker MD, James A Reiffel un FACC, Robert E
Fowles MD FACC, James B Young MD FACC, f or the CAPS
Investigators. University of Uta h, Salt Lake City, UT.
In the Cardiac Arrhythmia Pi l ot S tudy (CAPS) , early (6-6 0
day) pos t - i nf a r c t (HI )patients with ven t r i cu la r arrhyth-
mi as (VA) >lO/h we re rand omlz ed to blinded therapy with 1
of 4 a n t lar r hy thmic dr ugs ( n~40Z) or pl ace bo (n=lOO). I f
the first acti ve drug was inef f ective a se cond was given.
If p l acebo was ineffective, a second pl ac ebo was given .
The i nves tiga t or s selected I n bas eline fa c to r s which migh t
relate to th e endpoint of initial ac t i ve treatment success
(>707. ~ to tal VA , >90 7. ~ runs): age, >1 MI , time f rom CAPS
HI to ra ndomlz a t i on, e j ection frac tion, baseline VA fre-
quency , presence of runs (>100 bpm} , be ta -b lo cke r thera py ,
digitalis therapy, MI transmurality, and MI location .
Three variables were fo und to be re Lated toefficacy by
s tepwise logis tic regression. In order of s ig nif i cance .
these were (with incremental p values) : old HI (p=.003),
runs (p=.003), and VA frequenc y (>50 vs <SO/ h) (p=.05B).
The odds ratios for successful therapy were 1.5 in th e
absence of >1 MI, 1.7 for a bse nce of ru ns , and1,3 fo r
hi gher VA f r eq uency (>50/h) . Succes s was 3.5 times mor e
likely for th ose wi t h all 3 characteristics vs t hose with-
out. One baseline c hara c t eris tic was weak ly related t o
sp ontaneous initial chan ge in VA in t he placebo gro up: >1
HI ( p=.044) . Thus, ce r t a i n characteristics of MI patients
with VA may predict the chance of i niti a lly achieving a
successful response to antiarrhythmic dru g t he ra py: >1 MI
may relate in part to spontaneo us VA re gr ess i on, bu t high-
er VA frequenc y and especial l y absence of run s suggested
an increased likelihood of a true initial dr ug response.
ELECTROPHYS IO LOG I C EPPE CTS AND CLIN ICAL
EFFICAC Y OF FLECAI N1DE I N PATI ENTS WITH
VE NTRI CULAR TACHYC ARDIA .
Thierry Dugernier MD, Pe d r o Br ug a d a MD , Robert
Lemery MD, Gerard Linssen, Paolo Della Bella MD,
Hein .]J Wellens MD, FACC, Dept. of Ca r d i ol. ,
Maastricht, The Netherlands.
El e c trophysiolo gical effects a nd clinical
efficac y of fl e cai nide ( F) we r e e va luated in Z3
pa t ie nts ( pts ) wi t h d o cu mente d s us ta i ned
mon omorphi c ve ntric ular tachycar dia ( SMVT) an d 3
pts wi th no n- s u stained monomorphic ven t ricular
tachycardia( NSMVT).The r e were 21 male s ,5f ema les;
mea n age 5 2±l B y e a r s s Cor o na ry disease was
pres ent i n 17pts(me an LV ej e ctio n f ractio n 33 %).
hypertrop h i c card iomyopathy I n 1 pt,RV d ysplasia
in Ip t a nd no s truc tural hea r t di s e a se i n 7 pts .
In 13 / 26 p ts( 50%) at l east one e pi s od e of abort e d
sudden d eath was do cumented bef o r e study .
Resul t s r On electrophysiologic study (EP) of f
drugs SMVT was induced in 14/20 p t s. On F 4/1 4
SMVT pts (2 8% ) be c a me non- i n duci ble . Mean SMVT
cyc l e length was 292 ms be f o r e and 32 1 ms on F
( p =ns ) . Ince s s ant VT devel o ped i n 1 pt wh i l e o n
40 0 mg F/ d a y . At 12±7 months follow- up 3 pts h a d
died( Z arr h y t hmi c death s ). F(me a n d o s e : 2 1Bmg /day)
co n t r oll e d sympt o ms i n 14 of 26 pts ( 54%) . F was
d i sco ntinued by 9 / 26 pts , because of recurrent VT
in 7 ,and side e ff ec t s in 2 p t s , 7 /10 p t s sti ll
induci ble on o ral F had no VT r ecurr e nce.
Con clus i ons : 1.- Oral F i s e f fec tive in con tro l -
ling VT i n 54% of pt s , 2 . -V T rec u r r en c e could
no t be p r e d i c t e d by EP .
ABSTRACT S
ACUTE ANTIARRHYTHMIC EFFECT OF FLECAINIUE IN
VEN TRICULAR TACHYARRHYTHMIA5 IN RELATION TO LEFT
VENTRICULAR FUNCTION
Andrea Podczeck, Martin Bo rggrefe , GUnte r Breithardt ,
Med.Hospital a,Un iversity of OUsseldor f ,Germany
60 pts with documented ventricular tachycardia
(n=55) or syncope of unknown origin (n=5) were
studied by t he use of programmed ventricular
st imula t ion ( 52,5253 duri ng si nus rhyt hm and/or
ventri cula r dri ve of 500,430,370 and 330ms )
before andafter oral flecai nide (F) . Mean age
was 52+1 0 yrs . Coronaryartery disease was pre-
sent in 78 %. LV aneurysms were present in 22/60
Pt s (37%) . Mean EF was 39+1 6 %. All pt s had
i nduci ble sustained VT ( n~58) or VF (n=2) off
ant iarrhythmic drugs . After ora l F (300mg per
day) VT was no longer inducib le in 12 pt sand
renderedmore diff icult to Induce in 5 pts
(overall ef f icacy 28 %) ,whereas in 43 pt s (72%)
no change in inducibi l i ty was observed. Rate of
VT decreased from 218+ 52 t o 175+47 bpm (p<.Ol )
after F. The ERP-RVincrea sed from 252+27 t o
269+33 ms (p( . Ol ) . Mean EF of responders was
40+17 %and of non- responders 39+16%, respec-
t ively (n.s .). Only 3 of 22 pts TI4%) wi th
aneurysms responded to oral F, compared to 38 %
of t he remaining pt s (p( .05).
ThUS, oral F proved to be ef fective i n 28 %of
pt s undergoi ng serial drug te st ing. The EF did
not discriminat e between responders and non-
responders, however the presence of LV aneurysm
was correlated to a lack of response of t herapy
usi ng fl ecainide .
BETA-BLOCKER THERAPY FOR PATIENTS WITH
VENTRICULAR TACHYARRHYTHMIAS AND IMPAIRED
LEFT VENTRICULAR FUNCTION
Michael Brodsky. M.D. . FACC; Byron J. Alien,
M.D. University of California, Irvine.
Although several studies suggest beta-
blockers (BB) are e ffective for ventriCUlar
arrhythmias, little is known about their role
for ventricular tachyarrhythmias associated
with i mpaired left ventriCUlar function. To
assess the tolerance and efficacy of BB in
this subgroup, we studied 32 patients
presenting with v e nt r i c u l a r fibrillation (19)
or sustained ventriCUlar tachycardia (VT)
(13) . Left ventriCUlar ejection fraction
ranging from 14-40 (mean 28) percent was
present as a consequence of coronary disease
(26) or cardiomyopathy (6). Base line
noninvasive and i nva s i v e assessment revealed
recurrent VT in 31 patients (9 4%). BB were
empirically added to the most effective
antiarrhythmic program and given in
combination with amiodarone (15), class I
drugs (14 ) or as sol itary therapy (3). Over
a follow-up of 3-45 months there were 3
deaths, 2 due to progressive heart failure.
BB were discontinued in 6 patients due to
symptomatic heart failure. Recurrent
symptomatic VT developed in 7 patients with
one fatality. Twenty-two of 32 patients
(69%) have remained on BB with no recurrent
arrhythmia. ThUS, BB alone or i n conjunction
with other antiarrhythmic agents can be
effecti ve and wel l tolerated for life-
threatening arrhythmias in patients with
impaired left ventricularfunction.
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EFFECT OF ORAL MEXILETINE-QUINIDINECOMBINATION THERAPY
ON VENTRICULAR FUNCTION.
Robert S. Sheldon, M.D., Ph.D., Henry J. Duff, M.D., L.
Brent Hitche11, M.D., D. George Vyse, M.D., Ph.D., and
Dante E. Manyari, M.D., University of Calgary, Calgary,
Alberta, Canada
Combination therapy with mexiletine (M) and
quinidine (Q) is more efficacious than monotherapywith
either drug in suppressing ventricular ectopy and
preventing ventricular tachycardia (VT). The effect of
combination mexiletine-quinidine (MQ) therapy on
ventricular function is unknown. Radionuclide angiog-
raphy (RNA) was used to assess left ventricular and
right ventricularejection fractions (LVEF and RVEF) in
14 patients (age 62±8 yrs) with sustained or symptomatic
VT while drug-free (OF) and while receiving Mand Q
monotherapies and MQ combination therapy. To assess
ventricular reserve five of these patients also had
symptom-limited exercise RNA. During monotherapy, the
mean serum drug levels were: H, 3.4±1.8 ~M/l; Q, 8.3±2.6
~M/l. Vith combination HQ therapy, the serum drug
levels were: M, 3.3±1.2 ~H/l; Q, 9.5±2.3 ~M/1. None of
the drug therapies significantly changed resting LVEF or
RVEF, exercise duration, peak heart rate, peak systolic
blood pressure, double product or exercise LVEF or RVEF.
REST RNA RNA LVEF Double Product
LVEF RVEF REST EX (mm/minxlO')
OF 36±19 33±12 43±17 44±14 19.7±3.8
M 34±18 34±13 39±12 41±11 20.7±7.6
Q 36±20 35±14 45±14 43±14 20.9±4.8
HQ 35±29 35±12 43±12 46±10 l8.2±1.9
Anova p NS NS NS NS NS
Thus, combination therapy with mexiletine and quinidine
is not only efficacious but does not depress LVEF or
RVEF at rest or during exercise in patients with VT.
IN VIVO PHOSPHORUS 31 AND SODIUM 23 MAGNETIC RESONANCE
SPECTROSCOPY DURING CORONARY OCCLESION AND REPERFUSION IN
CAT HEARTS
Richard D. White, MD; Michael F. Wendland, Ph.D; Nikita
Derugin, MA; Martin J. Lipton, MD, FACC; Charles B.
lIiggins, MD, FACe. University of California-San
Francisco, San Francisco, CA.
To assess metabolic indicators of irreversible
myocardial injury, effects of coro~ary occl~!ion followed
by reperfusion on high e~~rgy phosphorus (P ) and
i~iracellu2~r sodiuw (RA ) were studied usin~ in-vivo
P and NA magnetic resonance spectroscopy (MRS). A
doubly-tuned coil was implanted on the hpart surface
overlying the distributionof the left anterior
descendin~ (LAD) coronary artery in 10 cats, and multiple
sequential spectra were obtained during up to 1 hour each
of LAD occlusion and reperfusion. Enzymatic myocardial
staininR confirmed infarction. Cumulatively, occlusion
spectra indicated: (1) rapid early decrease in 31
phosphocreatine (PCr) and increase in in~3ganic P (Pi)
with drop in pH, and an early rise in NA (approximately
20%) which then plateaus; and (2) gradual decline in
adenosine triphosphate (ATP). Reperfusion spectra
indicated: (1) rapid washout of Pt despite normalization
of pH and negligible recov~3Y of per and ATP peaks; and
(2) an additional early NA- rise (approximately 30%),
f02~owed by another plateau. The persistent rise in
Na and failure of PCr and ATP to recover after
reperfusionmay be a metabolic marking of irreversible
myocardial injury. This study indicates the f~fsibilit~3
of simultaneously monitor1n~ both myocardial P and MA
in vivo during acute isch~mia and reperfusion.
PROTECTIVE EFFECT OF PRETREATMENTWITH ANIPAMIL IN THE
ISCHEMIC-REPERFUSEDRAT HEART; A 3l-P NMR STUDY.
J. Hans Kirkels, MD; Tom J.C. Ruigrok, PhD FACC; Cees J.A.
van Echteld, PhD; Pieter van der Meer; Dirk de Moes;
Cornelius Borst, MD; Frits L. Meijler, MD FACC. Interuni-
versi~y Cardiology Institute, Utrecht, The Netherlands.
The effect of anipamil, a new calcium antagonist, on intra-
cellular pH (pH-int), high-energy phosphates and mechanical
function during global ischemia (30 min) and reperfusion
(30 min) was studied in isolated perfused rat hearts (37'C)
paced at 5 Hz. The rats (n=5) received for 5 days twice
daily 5 mg/kg i.p. anipamil in 5% glucose (ANI); controls
received only the solvent (UNTR). pH was measured from the
chemical shift of the P.peaks. Developed pressure (6P) did
not indicate a negative1inotropiceffect in pretreated
hearts. During ischemia pH fell from 7.06±0.05 to 5.86±0.06
(mean±SD) in UNTR and from 7.06±0.03 to 6,40±0,10 in ANI.
NMR-spectra after reperfusion are shown, In UNTR part of
the myocardium remained acidic, whereas in ANI pH recovered.
Recovery of ATP, CP and 6P was better in ANI than in UNTR:
40±26% vs l4±6%, 90±2l% vs l5±7% and90±22% vs < 5%, respec-
tively. In conclusion, pretreatmentwith anipamil improves
biochemical and functional recovery after ischemia in
isolated rat hearts.
UNTREATED
1 :pH-'Jd=7.41
2a:pH-int;:6.91
2b:pH -int =5.93
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NMR and PET: Assessment of Myocardial Metabolism
SODIUM-23 NMR PREDICTION OF REVERSIBILITY OF FUNCTION
FOLLOWING HYPOXIA IN THE ISOLATED PERFUSED RAT HEART
Robert E. Foster,BS, Robert C. Canby,MEE, Joseph Shin,BS,
Gabriel A. Elgavish, PhD, Gerald M. Pohost, MD,FACC,
University of Alabama at Birmingham, Birmingham, Alabama
Severe hypoxia(HO) results in depression of mechanical
function which mayrecover upon reoxygenation(RO). We have
carried out shift-reagent-aidedsodium NMR studies of HO
in isolated rat hearts perfused with Krebs-Henseleit
buffer. Hearts(lO in each group) were subjected to varying
periods of HO (5, 10, IS, 20, 30 and 40 min, p02<50 mmHg) ,
followed by 20 min RO. 3l p and 23Na NMR spectra were
collected alternately every 2.5 minutes preHO, during HO
and during RO. Intra- and extracellularsodium signals in
the 23Na spectra were differentiated by using the shift
reagent (SR) dysprosium bis-triphosphate dissolved in
HEPES buffer. Heart rate (HR) and LV developed pressure
(LVDP) of recovering RO hearts were at preHOlevels. HR of
hearts during SR perfusion was also at near-control
levels, whereas LVDP was depressed (74% of control).
Intracellular sodium levels (ICS), as observed by NMR,
increased to l46±l3% of control (p<O.OOl) in five out of
ten hearts subjected to 30 min HO, whereas in the other
five no significant increase was observed (lOl±5%). RO did
not alter these ICS, and while hearts without increased
sodium recovered full mechanical function, those with
increased ICS did not. The 3lp spectra at 30 min HO
displayed the anticipated decrease in PCr and ATP and
increase in Pi but, unlike the sodium spectra, did not
differentiate between recoverable and non-recoverable
hearts. In hearts with less than 30 min HO no increase in
ICS was observed. All hearts in the 40 min HO group had
elevated ICS(l56±l6%,p<O.005), and indeed none recovered
upon RO. In conclusion, NMR monitoring of ICS predicts HO-
induced irreversible loss of heart function.
15 ppm -15
ANIPAHIL
pretr,oted
1:pH·ext=7.39
2:pH-iM:7.08
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METABOLIC IDENTlf'ICATION Of' STUNNED CANINE MYOCARDIUM BY
POSITRON EMISSION TOMOGRAPHY
M. Schwaiger, M.D., L.J. Araujo , M.D., D.B. Buxton, Ph.D.,
J. Krivokapich, M.D., S Schwenk, 8.S., M.C. f'ishbein,
M.D., M.E. Phelps, Ph.D., H.R. Schelbert, M.D., LA.C.C.,
University of California, Los Angeles.
Tntermittent myocardial ischemia results in prolonged
impairment in regional function which is paralleled by
sustained decrease in high energy phosphate levels
(ATP). To correlate myocardial glucose metabolism,
function and ATP levels, 5 dogs were studied 24 hrs after
a 30 min balloon occlusion of a coronary artery with f'-18
deoxyglucose as marker of exogenous glucose utilization..
Regional function was followed by 2-D echocardiographyand
bloodflow measured by microsphere technique. Tissue
levels of ATP were determined from drill biopsies. At 24
hrs after ischemia regional f'-18 deoxyglucose uptake was
1.65±. 78 (p<o.ol) times higher in the post-ischemic than
in control myocardium. ATP levels were 22% lower averag-
ing 3.9i.35 ~mol/g wet in postischemic and 4.99i.71 ~mol/g
wet in control myocardium, paralleling a 20% decrease in
total adenine nucleo t i de s . There was no signi ficant
difference in regional bloodflow between both segments.
Regional function remained depressed in 4/5 dogs at 24 hrs
after ischemia. Post mortem TTe stains did not reveal
evidence for myocardial necrosis. Thus, stunned
myocardium is characterized by increased f'-18 deoxyglucose
uptake, decreased AT? concentration, but normal
bloodflow. Prolonged functional recovery, therefore, is
paralleled by a regional shift of substrate metabolism
toward glucose utilization suggesting enhanced anaerobic
glucose utilization in the presence of mitochondrial
dysfunction. PET allows noninvasive detection of stunned
myocardium which will be clinically important to detect
compromised but viable myocardium in patients with
coronary artery disease.
ABSTRACTS
INCREASED EXOGENOUS GLYCOLYTIC FLUX IN ISCHEMIC
MYOCARDIUM DETERMINED BY POSITRON EMISSION TOMOGRAPHY.
Yoshiharu Yonekura, M.D., Michio Senda, M.D., Nagara
Tamaki, M.D., Hideo Saji, Ph.D., Tetsuro Fudo, M.D.,
Tetsuo Hashimoto, M.D., Hirofumi Kambara, M.D., Chuichi
Kawai, M.D.• LA.C.C., Yutaka Konishi, M.D., Toshihiko
Ban, M.D., and Kanji Torizuka, M.D., Kyoto University
School of Medicine, Kyoto. Japan.
In order to study glucose metabolism in ischemic
myocardium, we compared regional accumulation of
2-deoxy-2-(F-18)fluoro-D-glucose (FDG) with myocardial
perfusion at rest and during exercise loading using
positron emission tomography (PET). Seventeen patients
with coronary artery disease documented by coronary
angiography were studied. Myocardial perfusion PET was
performed with intravenous injection of N-13 ammonia at
rest and during submaximal exercise with supine
ergometer at 2 hours interval. FDG PET study was
performed on the other day at rest with fasting
condition. Exercise PET detected abnormal hypoperfusion
in 26 (81%) of the 32 segments with significant coronary
artery stenosis. Regional increase in FDG uptake was
observed in 17/26 segments (65%) with myoca rdia I
ischemia, including 5 with normal resting perfusion and
8 cases which showed increased accumulation of FDG in
the more extensive area than resting ischemia. The
latter regions corresponded well to the stress induced
ischemic area determined by exerise PET. These results
indicated that exogenous glycolytic flux is increased
not only in the resting ischemic area but also in the
stress induced ischemic myocardium, suggesting the
presence of metabolic alterations in the ischemic
myocardium.
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ASSESSMENT OF REGIONAL MfOCARDIAL OXYGEN UTILIZATION BY
POSITRON TOMOGRAPHY WITH 1 C-ACETATE
M. A. Brown, M.D, O. W. Myears, M.D., D. R. Marshall,
~. Sobel, M.D., F.A.C.C., and S. R. Bergmann, M.D.,
Ph.D., WaShington University, St. Louis,MO
Myocardial metabolism of admixtures of physiologic sub-
strates in varying proportions through aerobic and
anaerobic pathways precludes accurate estimation of
oxygen utilization from turnover of individual conven-
tionally labeled substrates such as glucose or fatty
acid. Because we have found that metabolism of acetate is
virtually exclusively a~robic and proportional tooverall
oxygen utilization (MV02), we evaluated its use as an
index of MV02 with positron emission tomography (PET).
In preliminaryeXDeriments with buffer perfused rabbit
hearts (n = 10) 14C-and llC-acetate were administered by
aortic infusion. Myocardial clearance of llC-radioactiv-
ity was measured externally. l4C02 efflux was measured
by direct assa{ of coronary venous samples. External
clearance of lC-acetate over a wide range of conditions
including ischemia (tl/2 = 15.5 ± 3.3 min (± SO), flow =
2 ml/min) and stimulation of normal hearts with isopro-
terenol (tl/2 = I.g ± 0.5 mi n, flow = 20 ml/min) cor-
related closely with efflux of l4C02, reflecting oxida-
tion of acetate (r = 0.99, Y = .01 + .93 X). Further-
more, external clearance of lIC-acetate corre1ated
close 1y with MV02 (r = 0.98). To determi ne whether
MV02 could be estimat~d tomograph~cally, PET was ?er-
formed with anesthet i zed dogs qi ven 10-25 mCl of
lIC-acetate i .v. Ini tial myocardial extraction was 57:l:.
Clearance assessed with serial, 2 min tomQgrams (tl/2 =
8.5 ± 2.7 mini was similar to efflux of llC02 (coronary
sinus sampling, tl/2 = 6.4 ± 1.1 min). Thus, PET with
llC-acetate appears likely to permit accurate estimation
of regional myocardial oxygen consumption and hence myo-
cardial viability in patients.
Tuesday, March10, 1987
10:30AM-12:00NOON,Room 41, Second Level
NMR Imaging inMyocardialIschemia andInfarction
CHANGES IN PROTON NMR RELAXATION TIMES WITH REFLOW AFTER A
BRIEF MYOCARDIAL ISCHEMIC INSULT
Robert C. Canbv. M.E.E. and Gerald M. Pohost, M.D.,
F.A.C.C., University of Alabama at Birmingham.
Myocardial proton Tl and T2 increase following 30 or more
minutes of coronary artery occlusion, with a greater
increase if occlusion is followed with reperfusion. These
prolongations in Tl and T2 correlate with increases in
total tissue water (TTW) content, not with intravascular
(IVW) or interstitialwater spaces. T1 and T2 changes with
a brief ischemic episode have not been defined. Canine
models of 15 min of coronary artery occlusion with and
without 15 min of reperfusionwere examined for changes in
Tl and T2, blood flow using radiolabeled microspheres,
TTW, extracellular water (ECW) using 58Co(III)-EDTA, and
intravascularwater (IVW) using 5lCr labeled red cells. No
significant alterations in Tl, T2, TTW, ECW. intracellular
water (ICW) , or IVW water are observed with 15 min of
occlusion only. After reflow, however, Tl and T2 increased
(.76±.01 vs .ni.Ol s, p<.OOl and 56.2±.7 vs 52.0i.6 ms,
p<.OOI) in ischemic-reperfusedvs NI tissue. TTW (4.37i.09
vs 3.80i.05 ml/g dry weight, p<.OOl) and ECW (2.04i.12 vs
1.42i.09 ml/g, p<.OOI) also increased compared with
nonischemic (NI) myocardium. In contrast to longer
ischemic insults (1 hour or more), no change in ICW is
observed. These changes can only be attributedin part to
reactive hyperemia, for the increase in IVW (0.19±.02 vs
O.09±.02 ml/g, p<.005) accounted for only 17% of the ECW
increase. Tl and T2 correlatedwith interstitial (ECW-IVW)
water (r-.82,p<.OOI and r-.74, p<.OOI, respectively). This
study suggests that while Tl and T2 change significantly
with reflow after brief ischemia, these changes are small.
Nevertheless, this study relates the Tl and T2
prolongations specifically to interstitial edema and thus
provides further insight into the mechanism of relaxation
time changes following a myocardial ischemic insult.
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MAGNETIC RESONANCE IMAGING VERSUS 11IALLIUM-20I ~1YOCARDIAL PERFUSION
SIUDIES IN PATIENIS .1111 ARECENI MYOCARDIAL INFARClION
X. Hanno Krauss, M.D.; Albert de Roos, M.D.; Joost Doornbos, Ph.D.;
Ernst van der Wall, M.D.; Adriaan van Voorthuisen, M.D.; Albert
Bruschke, M.D. Departments of Cardiology and Radiology, University
Hospital, Le Lden , The Netherlands.
Twenty patients (p ts ) with cardiac disease underwent spin-echo Tl-(TE
30 ms) and 12-(IE 60-150 ms) weighted Magnetic Resonance Imaging (NRJ)
of the heart. Multislice images were acquired in transverse and
oblique crientet Ions with a 0.5 Tes La Philips Gyroscan, thus permit-
ting long and short axis t omograms• By this method all parts of the
LV-myocardium could be investigated. 15 pts suffered a first myocar-
dial infarction (HI) 2-14 days before MR.I, whereas 5 pts vt thout
coronary artery dise-ase served as controls (C).
The MR.I of the 15 l-lI-pts was compared to 11-201 myocardial perfusion
(MP) studies, all of which showed clear defects. Cardiac catheteriza-
tion was performed in 11 Ml-pts. On TI-MR.I the site of the MI appeared
as a thin and outward bulging segment of the LV during systole in 8
MI-pts, of whom two showed a l.v-aneurysm at angiography. In 7 MI-pts
and the 5 C-pts no abnormalities were found on Tl-\./eigthed MR.!. In 2
Nf -p ta Gadolinium DTPA-infusions did not improve the detection of a MI
by TI-HRI. This might have been due to the special pharmacokinetic
properties of this agent in men.
The T2-weighted HRI showed a high signal intensity (SI) in subendocar-
dial areas in 9 pt s and this finding corresponded with the segments
that showed TI-201 MP defects. In 5 MI-pts no clearly defined areas
wi th high SI were found. The extent of the area with high SI was
considerably larger than the corresponding TI-201 defect in 6 of 10
MI-pts. This might have been caused by the high intracavitary SI due
to flow-effects which hampers accurate delineation of the endocardium,
especially on even echoes. In addition, 2 out of 5 C-pts showed areas
with high SI, which indicates a low specificity of this finding. These
observations demonstrate a limited diagnostic accuracy of T1- and
T2-weighted HR! of recent HI in comparison with Tl-201 MP studies.
Whether Gadolinium DTPA will improve the diagnostic value of MR.I
remains to be investigated.
DETERMINATION OF OPTIMAL TIME /I,ND PULSe Si:QUHCt ~OR. E~­
HANCED DETECTION OF ACUTE MYOCARDIAL INJURY FOLLOWING GAD-
OLINIUM-DTPA: A NUCLEAR MAGNETIC RESONANCE IMAGING STUDY
Roxann Rokey, M.D., F.A.C.C., Donald L. Johnston,M.D., G.
Wesley Vlck, ttl, M.D., Ph.D., R. Nick Bryan, M.D., Ph.D.,
Rcbert Roberts,M.D., F.A.C.C. Baylor College of ~edicine,
Houston, TX
Detection of myocardial injury with nuclearmagnetic reso-
nance imaging(NMRI) may be improve-d using the contrast
agent Gadolinium-DTPA (Gd-DTPA). However, the optimal time
and pulse sequence yielding the largest contrast. effect
after Gd-DTPA infusion is not estab I i shed. Thus, seri aI
NMR! was done to determine the effect of time and pulse
sequence on Gd-DTPA induced contrast differences between
ischemic and normal myocardium. The anterior artery was
occluded in the dog(n=13) for 4 hours followed by IV
Gd-DTPA(O.34m~/kg). The hearts were excised 5 min(n=3), 30
min(n=5) or 60 min(n=3) later for NMRI. Three spin echo
pulse sequences were used: TR 500, 1058 or 2000 ms; each
TR with train of 4 spin echos (TE 34,68,102,136 ms).
RESULTS: At 5,30 and 60 min the signal intensity ratio(SI)
or-iSCnemic to normal myocardium generally increased with
increasing TE values. Results of SI data forimages with
TE 34 and 136ms are shown (mean±SD).
TIME TE(ms) TR 500(ms) TR 1058(ms) TR 2000(ms)
-;mTn~ I.IB±.D? 1.14±.15 1.21±.D?
136 1.29±.48 1.59±.17 1.33±.16
30min 34 0.71±.31 1.24".09 1.20±.05
136 1.46±.26 1.75±.41 1.79±.40
60min 34 0.89±.09 1.11±.OI 1.13±.03
136 0.78±.28 1.70±.22 1.28±.05
The SI was greatest at 30 min with a TR of 1058 or 2000
ms and longer TE. CONCLUSION: Early after coronary occlu-
sion, optimal demonstration of injured myocardium after
Gd-DTPA infusion occurs at 30min using a T weighted
nuclear magnetic resonance late spin echo pUlse~equence.
+11%
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NUCLEAR MAGNETIC RESONANCE IMAGING OF MYOCARDIAL ISCHEMIA
DURING DIPYRIDAMOLE EFFECT IN A PARTIAL CORONARY ARTERY
STENOSIS MODEL.
D. Douglas Miller,M.D.,F.A.C.C., Godtfred Holmvang,M.D.,
John B. Gill,M.D., Donna Dragotakes,B.S.,Howard L. Kantor,
M.D.,F.A.C.C., Thomas J. Brady,M.D., Robert D. Okada,M.D.,
F.A.C.C. Massachusetts General Hospital, Boston, MA.
Tl AND T2 CHANGES WITH SEVERE FLOW REDUCTION AT 24 AND 72
HOURS AFTER CORONARY OCCLUSION IN DOGS, RC Reeves, RC
Canby, WT Evanochko, RE Foster and GM Pohost. Division of
CardiovascularDisease, Departmentof Medicine, University
of Alabama at Birmingham, Birmingham, AL.
Increases in the NMR proton Tl and T2 occur with
myocardial infarction (MI). This study evaluates Tl' T2
regional myocardial blood flow (RMBF) , and wet to dry
weight ratio (W/D) after MI created by coronary artery
embolization. Animals were sacrificed at 24 (n-12) and 72
(n-B) hours after occlusion. Endocardial, mid-wall, and
epicardial samples were obtained from the visually
identified central infarct and control zones. Tl and T2
were determined at 20 mHz and RMBF using radiolabeled
microspheres. Flow reduction was considered severe (SEV)
if the RMBF was <.1 ml/gm/min moderate (MOD) if "':.1
ml/gm/min and <.4 ml/gm/min. Samples with RMBF "':.4
ml/gm/min were considered nonischemic (NIl.
24hr occlusion 72hr occlusion
SEV MOD...li!.- ~ MOD NI
Tl .70±.02 . n±.Ol .70±.03 .73±.02 .78±.01 .7l±.01
T2 59±2 62±1 56±.4 65±2 68±2 55±1
WID 5.8+.2 5.5+.1 5.0+.1 5.60+.2 5.5+0.1 4.8+.1
For both the 24-hour and 72-hour groups, Tl and T2 andW/D
for MOD were increased compared to control (p<. 001 for
each). However for the SEV groups, no elevation in Tl was
observed but W/D was significantly elevated (p<.05). The
SEV T2 at 72 hours was significantly increased compared to
control. Both T1 and T2changes were more markedat 72 as
compared to 24 hours. These data suggest that Tl weighted
images in MI associated with severe reduction in blood
flow would be anticipated to demonstrate a doughnut
pattern wi th an area of abnormal signal intensi ty
surrounding a central zone with more normal intensity.
Further, the data show that factors in addition to tissue
water can influence Tl'
To examine the potential of conventional nuclear
magnetic resonance imaging(NMR-I) for detecting regional
myocardial ischemia without the use of paramagnetic
contrast agents, we performed NMR-I in 7 closed-chest dogs
with an experimental left anteriordescending(LAD) artery
stenosis. Serial gated Tl-weighted spin-echo(TE=20ms)
multislice tomograms were acquired(l study/min x 5) at
baseline, after partial inflation of a proximal occluder
to reduce distal LAD pressure by 50-75%(mean=57±8%), and
after infusion of dipyridamole(0.08mg/kg/minx 4min) to
produce resting coronary hyperemia. Microsphere myocardial
blood flow(MBF) was measured at each stage. The changes
from baseline in MBF and NMR-I signal for regions-of-
interest in the stenosed LAD and normal circumflex(LCX)
perfusion beds are given in the table(*= p<0.05):
f, MBF f, NMR-I
LAD LCX LAD
r -43% * -15%1 r +1%
* * *
L +96% * +190% J L +13%
OCCLUSION only
OCCLUSION plus
DIPYRIDAMOLE
NMR-I signal did not change significantly during occlusion
alone. In 2/4 dogs with ischemic EKG changes,a significant
(45±5%) increase in NMR-I signal and anteroseptalwall
dysfunction occurred during dipyridamole effect. Occlusion
MBF and distal LAD pressure drop did not correlatewith
NMR-I changes. We conclude that significant intrinsic NMR
signal changes are not observed in the absence of a
dipyridamole-inducedischemic coronary 'steal' phenomenon.
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MAGNETIC RESONANCE AND THALLIUM 201 MYOCARDIAL IMAGING: A
SEGMENT TO SEGMENT COMPARISON IN PATIENTS WITH MYOCARDIAL
INFARCTION AND ISCHEMIA. Masood Ahmad, M.D., F.A.C.C.,
Raleigh F. Johnson,Jr., Ph.D., H. Daniel Fawcett, M.D.,
Dennis J. Dornfest, and Melvyn H. Schreiber, M.D., Uni-
versity of Texas Medical Branch, Galveston, Tx.
To determine whethermagnetic resonance imaging (MRI) can
distinguish reversibly ischemic myocardium from normal and
from infarcted myocardium, stress thallium scintigraphy
(Tl-201) and gated multisclice MRI were performed in 27
patients (pts). Nine pts were imaged within 2 weeks of
acute myocardial infarction (AMI) and 18 pts from 4 to 12
weeks of AMI. Multiple Tl-201 views and multiple MRI sli-
ces along the left ventricularshort axis allowed precise
comparison of a total of 108 segments. Based on Tl-201,
EKG and cardiacenzyme data, 65segments were classified
as normal, 14 as AMI, g as old myocardial infarction (OMI)
and 20 as reversible ischemia (RI). Mean T2 relaxation
times in MRI segments are tabulated.
Segments/ %increase in T2 p(compared
Total No. T2 (msec)± SD from normal to normal)
Normal/65 37 ± 9
AMI/14 60 ± 15 62 <0.001
OMI/9 52 ± 13 41 <0.001
RI/20 51 ± 10 38 <0.001
Signal intensity ratios (abnormal/normal)increased from
echo 1 to echo 2 in AMI and in RI (p<0.005) but were not
significantly different in OMI. These data confirm thepr~
viously reported prolongation ofT2 in AMI. Prolonged T2
in OMI may be related to the age of MI (all <12 wks). Re-
versibly ischemic myocardium in pts post AMI is character-
ized by prolongation ofT2 and increased signal intensity
ratio from echo 1 to echo 2. These changes are similar to
those observed in AMI andmay be of prognostic significance
ABSTRACTS
LONG-TERM RESULTS OF PERCUTANEOUSBALLOON
ANGIOPLASTY (PBA) FOR NATIVE COARCTATION.
Robert H. Beekman, M.D•• F.A.C.C. and Albert P. Roeehinl,
M.D., C.S. Mott Children's Hospital, University of Michigan,
Ann Arbor, Michigan.
The long-term results of PBA for native coarctation (COA)
were evaluated at cardiac catheterizationin 12 children 12-
26 months after PBA. All had undergone PBA for a discrete
COA, at 0.6-14.7 years of age. Balloon size was equal to
isthmus diameter + 1-2mm in 10 children. and was 4mmsmaller
than the isthmus- in 2. PBA acutely decreased the COA
gradient from 47.9+3.6 to 12.8+3.7mmHg (mean+SEM). At
follow-up (f/u) the mean residuaCgradientwas lC8+4.3mmHg.
Two groups (Gp) were identified based on flu data: Gp I) 7
children with a gradient < 20mmHg (2.4+2.0mmHg) and no
aneurysm (A); Gp 2) 4 children with a gradient> 20mmHg (31+
2.7mmHg) and 1 with a smallfusiform A at the dilatation site-:-
In both groups the flu diameter of the COA site related to
balloon size (Y= 1.04X-2.12, r=0.92. p<.OI). In Gp I, but not
Gp 2, the flu diameter exceeded the diameter immediately
post-PBA 01.7+2.4 vs 10.5+2.5mm, p=.02). There was no
difference between groups fii age, isthmus or balloon size.
However, the pre-PBA COA gradient was significantly lower
in Gp 1 compared to Gp 2 (40.0+3.7 vs 59.0+2.5mmHg, p<.Ol).
6/6 children with a pre-PBA gradient < 50mmHg were in Gp
I, While 5/6 children with a pre-PBA gradient> 50mmHgwere
in Gp 2 (X2 = 8.6, p<.OI). Insummary, a good result was
documented in 7 of 12 children following PBA for a native
COA. Four children had a residual gradient> 20mmHg (2 with
undersized balloons), and 1 had a small A. Thedata suggest
that a pre-PBA gradient> 50mmHg may identify those at risk
for a poor long-term result.
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INTERMEOIATE FOLLOWUP OF BALLOON Oll.ATA110N
ANGIOPLASTY OF NATIVE COARCTA11ON
William R. Morrow, MD, G. Wesley Vick,Ill,MD, Michael R.
Nihill, MD, FACC, Charles E. Mullins, MD, FACC, Thomas
Hedrick, MD, Dan G. McNamara, MD, FACC. Texas Children's
Hospital and Baylor College of Medicine, Houston, TX.
Balloon angioplasty is effective in the immediate relief of
obstruction due to coarctation (COA) of the aorta. Long-term
benefits and complications of this procedure have not been
established. Percutaneousballoon angioplasty of native COA of
the aorta was performedin 31 pts (2 mos-an yrs, m=6 yrs). High
quality cineangiograms of the thoracic aorta were performed
with a calibrated angiographic catheter both before and after
angioplasty. Balloon sizes were 1-2mm greater than the aortic
isthm us diameter just below the subclavian artery (balloon
diameters=6-18mm). To achieve obliteration of the COA waist,
2-8 dilatations were performed at 3-5 atm. Arm and leg BP
was obtainedat follow up (> 8 rnos) in 17 with catheterizationin
9 and magnetic resonance imaging (VI RI) in 8. Average systolic
gradient (LIP) fell from 46mmHg to 8mmHgat angioplasty. There
was no significant change in LIP on follow up: Average LIP was
10mmHgat (8-31 mos, m=18 mos) and 6mmHgat catheterization
(6-25 mos, m=16 moo). One pt had COA repair following
angioplasty and has subsequently developed restenosis. Femoral
thrombectomy was performed in 2 pts for reduced leg pulses.
There was no evidence of COA restenosis on follow up
angiographyor MRI in 16 pts, Twopts developed small aneurysms
at the site of angioplasty demonstrated by angiography on
follow up. Balloon angioplasty for native COA is effective and
provides good relief of obstruction on intermediate follow up.
Femoral artery obstruction and aneurysm formation are
infrequent complications. High quality cineangiography at the
time of angioplasty is necessary to avoid confusing pre-existing
abnormalities with aneurysms which may develop following
angioplasty.
REGRESSION OF THE INFUNDIBULAR HYPERTROPHYAFTER
PULMONARY VALVULOPLASTY IN PATIENTS WITH SUPRASYSTEMIC
PRESSURE OF THE RIGHT VENTRICLE.
Valmir F.Fontes,M.D.;J.E.M.R.Sousa,M.O.,F.A.C.C.;CesarA.
Esteves,M.D.;M.V.Dias da Silva,M.O.-InstitutoDante Pazza
ne se de Cardiologia-Sao Paulo-SP-Brazil. -
Transluminalballoon valvuloplasty(TBV)is acceptedas an
alternative non surgical procedure in the treatment of
pulmonary valve stenosis(PVS).According to many surgeons,
in the group of patients with suprasystemicpressurein the
RV and severe infundibularhypertrophyinfundibulectomyis
a complement of valvulotomy.
From May 1983 to August 1986,70 TBVs were performed at
the Instituto Dante Pazzanese of Cardiology,Sao Paulo,
Brazil. Twenty two patients had suprasystemicpressure in
the RV and severe infundibularhypertrophy.In this group
the age ranged from 2 to 36 yrs(mean 14 yrs)~eaksistolic
pressure gradient between RV and PA fell after
valvuloplasty from 148 ± 32.1 mmHg(SD) to 15.5 ± 15~mmHg.
(P'- 0.0005), ranging from 110 to 260 mmHg. In 19 patients
after the procedure ,we measured and infunbibular pressure
gradient ranging from 10 to 120 mmHg(44.1 ± 26.9 SO). The
angiographic study showed a severe infundibular
hypertrophywith increased sistolic contraction after
valvuloplasty.Thirteen patients were restudied in a mean
period of 10 months.Residual transvalvarsystolic gradient
was present in all,ranging 7 to 47 mmHg(20.5 ±14.4 SD).
No infundibulargradient was detected.The angiographic
study revealed complete regression of the RV infundibular
hypertrophy.Comparing the immediate and late results of
the transvalvargradient no statisticallydifference was
observed (p ~ 0.05).
The authors concluded that TBV is an effective method
to be used in treatment of PVS withsuprasystemicpressure
in RV and the infundibularhypertrophyof RV is totally
reversible.
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DOUBLE BALLOON TECHNIQUE FOR DILATA110N OF
VALVULAR OR VESSEL STHII06JS IN COIIGHllITAL AND
ACQmRm HEART DIBKASK
Charles E. MUllins, MD, FACC, Michael R. Nihill, MD, FACC,
G. Wesley Vick , JII, MD, Achi Ludomirsky, MD, Martin P.
O'Laughlin, MD, J. Timothy Bricker, MD, FACC, Victoria E.
Judd, MD. Texas Children's Hospital and Baylor College of
Medicine, Houston, TX.
Technical difficulties sometimes prevent satisfactory results
with balloon dilatation for the stenotic lesions of congenital
and acquired heart disease. Such technical dif ficulties inc lude
(1) a large diameter of the annulusof the stenotic lesion relativ e
to available balloon diameter (2) difficulty in the insertion or
removal of the larger balloon catheters (3) permanent damage
to or obstruction of the femoral vessels by the redundant
material of large balloons. We have initiated a double balloon
technique to resolve these difficulties. With this method,
percutaneousballoon angioplasty cathetersare inser ted in right
and left femoral vessels, placed side-by-side across the stenotic
lesion and inflated simultaneously. Patient ages ranged from 1
to 75 yrs (mean = 17.8 yrs) and patient weights ranged from
8.9 to 89kg (mean = 42.3kg) . Individual balloon sizes ranged
from 10 to 20mm in diameter. Dilatation procedures using two
balloon technique were performedin 41 patients: pulmonic valve
stenosis (PVS) - 18, aortic valve s tenosis (AVS) - 14, mitral
valve stenosis (:viVS) - 5, vena cava obstruction (VCO) - 3,
tricuspid valve stenosis (TVS) -1. Average maximal pressure
gradient in mm Hg prior to dilatation was: PVS - 61, AVS - 68,
MVS - 21, TVS - 12, and VCO - 25. Average maximal pressure
gradient post dilatation was: PVS - 13, AVS - 24. :vIVS - 4mm,
TVS - O. and VCO - 1. No major compllctions were encountered
during the procedures. We conclude that the two balloon
technique of percutaneousballoon dilatation is effective and in
selected cases superior to techniques employ ing large single
angioplasty balloons.
BALLOON DILATION VALVULOPLASTY OF BIOPROSTHETIC VALVES IN
EXTRACARDIAC CONDUITS.
Thomas R. Lloyd. M.D., William J. Marvin. J r.• M.D .•
FACC. Larry T. Mahoney. M.D ., FACC and Ronald M. Lauer,
M.D .• FACC. Un iversity of Iowa . Iowa City. lA.
Conduit obstruction is a frequent and impor t ant sequela
of varied Rastelli operations . Ralloon di lation
valvuloplasty (BDV) of bioprosthetic valves i n such
conduits has not been reported.
Six consecutive patients (age 8-20 years) were
catheterized for conduit obstruction. Their repaired
defects were transpositionwith ventricularseptal defect
and pulmonic stenosis (3). pulmonic atresia with
ventricularseptal defect (1) . and tetralogy of Fallot
(2 ). The va l ves , porcine (4) or homograft (2). had been
implanted 4-14 years prior to catheterization. Ca lci fic
degeneration with valvular r egur gi t at i on was evident in
all. Right ventricularpressure e xceeded 90 mm Hg or 90%
systemi c in all . Five patients underwent BDV, using
balloon s ize within 3 mm of prosthesis diameter at
pressures up to 5 ATM. One patient's obstruction was
secondary to peel formation along the conduit length and
BDV was not performed. In two patients, the balloons
rupturedrepeatedly at calcifi c sites and BDV was not
effective. In the remaining 3 patients, r ight
ventricularpressure was reduced to 30-50% systemic and
the residual valve gradients were 20-35 mm Hg. Valvular
regurgitationwas not notably increased. Iliac vein
exploration was required to r emove an avulsed fragment
from a rupturedballoon in one patient. No other
complications occurred.
Although calcific degeneration can cause balloon
rupture, resulting in technical failure or complication.
BDV can relieve conduit obstruction secondary to
bioprosthetic valvular stenosis and postpone conduit
replacement.
ACUTE COMPLICATIONS OF THERAPEUTIC CATHETER
PROCEDURES IN CONGENITAL HEART DISEASE
®lfK.ang Radtke MD. I{enneth EFellows :vID, John F Keane,
James E Lock MDFACC. Departmentof Cardiology,Children's
Hospital, HarvardMedical School, Boston, MA
Therapeuticinterventionsin cardiaccatheterizationare an
expandingand still improvingalternativein the treatmentof
congenitalheartdisease. By now, the numberof procedures
performedbegins to lend itself to a preliminary stati sti cally
relevantreview of early complications.
Between January84 and July 86 we performed317 therapeutic
calheterizations at our institution(balloon atrioseptostomies
excluded). 235 dilations, 60 embolizationsand 22 Park blad e
septostomies or foreign body retrievals. 73% (231) were
successful by hemodynamic,angiographieor clinical criteria.
Overall there were 34 (11%)acute complications which were
defined as occurringat the time of or within a week after
intervention. 18 (6%)were :tlajor (cardiacarrest, severe valvar
regurgitation, embolism of occluder devices, vascularrupture)
including 3 deaths (mortality' 1%) due to car-lacarrestbefore
dilation, PA-rupturein a moribundpostoperativepatient and
sepsis. 16 (5%) were minor (femoral pulse loss , iliac vein
occlusion or transientEKG abnormalities). Complicat ionrates
varied significantlybetween the individualprocedures:5% (3/56)
in pulmonar yvalve dilation. 9% (7/7 8) in peripheralpulmonary
arterydilation (2 deaths), 10% (3/31) in recurrentcoarctation
dilation, 33% (14/43) inaortic valve dilation (1 death), 15%
(4/27) in double umbrelladevice applications and 6% (2/3 3) in
steel coil embolizations. The incidence of mostcomplications
decreasedwith increasingexperlenee,
Care fulplanning, meticulous monitoringof positions of
catheters and therapeuticdevices and specific trainingin
interventional techniquesremains mandatory.
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EPIDEMIOLOGY AND PREVENTION OF CARDIAC FAILURE: FRAMINGHAM
STUDY INSIGHTS.
Wi1liam B. Kannel. MD. MPH, FACC. FACE. Boston University
School of Medicine, Boston. Massachusetts.
The prevalence, incidence. secular trends. precursors
and prognosis of cardiac failure (CHF) is examined over
30 years of biennial surveillance of 5,209 subjects of
whom 232 men and 229 women developed initial episodes
of CHF. The annual i nc i dence doubled with each decade
of age beyond age 35 from 3per 1.000 at age 35-64 to
10 per 1,000 at age 65-94 years; with a slight male
predominance because of higher rates of coronary disease.
Half of those deve10pin9 CHF had coronary disease. which
conferred a 6-fo1d increased risk. However. only 10%
were free of concommitant hypertension which was the
dominant CHF precursor. Antecedent hypertension was
present in 70%. Hypertension increased CHF risk 2-6
fold with systo1ic pressure more predictive than
diastolic. Concurrent ECG abnormalities further added
to risk of CHF including left ventricularhypertrophy.
intraventricularconduction disturbanceand non-specific
S-T and T-wave abnormalities. Other independent risk
factors include: low vital capacity. rapid heart rate.
diabetes. cardiac enlargement. obesity (in women),
serum cholesterol (in men), cigarettes, proteinuria
and hematocrit. From profiles made up of these
independent risk factors CHF risk can be estimated
over a 3D-fold range. In this way a tenth of the
population from which 80% of the CHF will evolve can
be identified for preventive measures. CHF continues
to be a lethal end-stage of heart disease with a 50%
five year mortality rate. There has been only a modest
decline i n its occurrence over the past three decades.
Sudden death is a prominent terminal feature of CHF
occurring at 6 times the general population rate.
JACC Vul. 9. Nu. 2
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THE IMPACT ON CORONARY DISEASE MORTALITY OF AN I~TERVENING
NONFATAL MYOCARDIAL INFARCTION DURING PP.TlENT FOLLO\riUP
Kerry L. Lee, Ph.D., Jane M. Boswick , 8.5., Frank E.
Harrell. Ph.D., Robert A. Rosati. M.D., Robert M. Califf.
M.D., Daniel B. Mark, M.D., Mark A. Hlatky, M.D.,
F.A.C.C.• David B. Pryor, M.D.. Duke University Medical
Center, Durham, N.C.
The prognostic importance of baseline clinical and
angiographic descriptors in predict1ng survival of
patients (PTS) with coronary artery disease (CAD) is wel l
documented. Following initial treatment. however. the
course of PTS with CAD is punctuatedby clinical changes
during followup that may profoundly affect subsequent
outcome. This investigation studied how such information
could be incorporated into estimates ofPT survival and
determined the prognosticconsequences of one important
manifestation ofchange - a nonfatal myocardial infarction
(NFM!) .
Between 1969 and 1985. significant CAD ( ~75%
stenosis) was diagnosed in 3,085 consecutive medically
treated PTS. Of these 586 have died. 285 have suffered a
NFMI, including 87 who subsequently died. The prognostic
effect of the intervening NFMI cannot be estimatedby
directly comparing survival curves of PTS who did and did
not have a NFMI (because of response-time bias). The Cox
proportiona1 hazards model, wi th occurrence of an
intervening NFMI as a time-dependentcovariate. provides
an appropriate basis for incorporating this information.
Based on this model, the relative risk of deathafter all
intervening NFMI compared to the ris k before its
occurrence is 2.45 (unadjusted , p'< , 0001) and ~ .16 (ad-
justed for 24 baseline variables. p<.OOOl). Thus,
independent of other base1ine prognostic factors , an
intervening NFMI more than doubles the risk of death.
Methods that incorporatechanges in patients over time can
refine risk assessments and aid in clinical decisions.
PREVALENCE OF MITRAL VALVE PROLAPSE BY TWO-DIMENSIONAL
ECHOCARDIOGRAPHY: A POPULATION-BASED STUDY.
Bijoy K. Khandheria,H.D., A. Jamil Tajik, ~.D., F.A.C.C.,
James H. Naessens, Vernon P. Weber, Rick A. Nishimura,
H.D., F.A.C. C., Clarence Shub, ~.D., F.A.C. C., and James
B. Seward, M. D., F.A.C.C. , Hayo Clinic, Rochester, MH .
Reported incidences of mitral valve prolapse (MYP )
syndrome in t hegeneral population are based on clinical
and autopsy data which have inherent sample bias.
Two-dimensional echocardiography(2DE) is an established
technique for diagnosis of MVP. To determine the rate at
which HVP is diagnosed by 2DE. we analyzed data from Pt
undergo ing 2DE in a large referral practice and in the
population of Rochester. Between July 1980 and June 1985,
38,851 Pt (521 males) ages 0-99 yr underwent 2DE at Mayo
Clinic. MVP was diagnosed by 2DE in 5,627 Pt (14.51);
3,363 (601) were females. The frequency of occurrence of
MVP was significantly higher in females than in males ages
10-79 yr (P < 0.02). MYP was present in 231 in ages 20-29
and 221 in-ages 30-39 yr. The rate of detection tapered
off after age 40 yr to 10-141. Associated tricuspid valve
prolapse was present in 307 Pt (5.41). The range
prevalence of MVP was estimated in the population of
Rochester (981 of residents obtain health care at our
institution). When adjusted for age and sex, using total
Rochester population as denominator, the conservative
popUlation prevalence rate is 860 per 100,000. In the
3.166 Pt from Rochester who had 2DE. MVP was diagnosed in
484 (151). Conclusion: 1) Frequency of occurrence of MVP
is 14.51 in an overall 2DE population with prevalence
ranging from 8.6-14.51. 2) The conservative population
prevalence rate of MVP is 860 per 100.000. 3) Females
have a significantly higher incidence of MYP than males
(1.5:1). 4) The highest rate of detection i s in ages
20-39 yr .
These distributions for the presence and extent of coron-
ary disease were not altered after adjustment for age and
sex in these CVD-PVD categories .
PVD and PVD-CVD identifies PT with a high prevalence of
CAD and a strikingly high prevalence of left main disease
(a 3.4-fo1d increase comparing CVD-PVD present vs CVD-PVD
absent groups p~O.OOl). This high prevalence of CAD and
left main disease in PTwith PVD and CVD may explain, in
part, their increased coronary risk.
PVD-CVD
PRESENT
134
87.3
7.5
17.2
38.8
23.9
PVD
ONLY
292
86.7
10.2
18.6
38.9
19.0
CVD
ONLY
452
65.8
11.0
13.0
31.2
10.6
6895
68. 2
12.3
21.7
27.3
7.0
N
7. CAD
7. 1-vessel disease
%2-vessel disease
%3-vessel disease
%left main disease
EXTENT OF CORONARY DISEASE IN PATIENTS WITH
CEREBROVASCULAR AND PERIPHERALVASCULAR DISEASE.
Frederic R. Kahl, M.D., F.A.C.C., John R. Crouse, M.D.,
Wi1liam P. Santamore. Ph.D•• Alfred J. Rufty. M.D.•
Bowman Gray School of Medicine, Winston-Salem. N.C.
Patients (PT) with cerebrovasculardisease (CVD) and
peripheralvascular disease (PVD) have an increased
risk of coronary events. Since coronary prognosis is
related to the presence and extent of coronary disease.
we analyzed coronary angiograms in 7,773 cardiac PT in
whom there was clinical data regarding the presence or
absence of CVD and PVD alone or combined . The presence
of obstructive coronary disease [stenosis >507. (CAD)) and
coronary disease extent graded as 1-vessel.2-vesse1.3-
vessel or left main disease was noted for the four CVD-
PVD categories as follows:
PVD-CVD
ABSENT
Prior studies have shownthat a significant number of
patients hospitalized with coronary disease (CAD) do not
have cholesterol (TC) levels evaluated or appropriate
interventions initiated. To determine the cholesterol
practices and related attitudes of primary-carephysicians
in ambulatory care settings, we examined the office
records of 80 post myocardial infarction (MI) patients in
a rehabilitationprogram andsurveyed their 24 pr imary
care physicians. Medical record audimrevealedthat only
344 of patient notes mentioned TC. either by laboratory
value or history, although 444 of records contained
laboratorylipid reports. Although screening in the
rehabilitationprogram identified 264 of patients with TC
>260 mg4, only 44 of those with elevated lipid levels were
placed on a diet and 124 on hypolipidemic agents by the
primary physician. The survey of physicians caring for
these patients showed that 674 agreed that cholesterol
reduction significantly lowers CAD risk. However.71% of
physicians believe that patients are inat t entive to life-
style recommendationsand are unlikely to follow dietary
and pharmacologic regimens. Insufficient time (38%) and
concern over drug side effects (54%) were also cited as
major barriersto lipid management in the office. The
majority of primaryphysicians felt t hey needed better
skills in behavior change (78%) and improvedguidelines
for nutritionalmanagement (70%)to appropriatelycare for
patients with elevated TC. These findings reinforce the
need for educational programs to address skills in lipid
managementfor physicians in practice.
POST MYOCARDIAL INFARCTION CHOLESTEROLMANAGEMENT BY
PRIMARY PHYSICIANS.
Brad Boekeloo. Sc.M•• Diane Becker, Sc.D., Edna Yeo, M.D.,
Thomas A. Pearson, M.D., Ronald Gillilan, M.D., The Johns
Hopkins Hospital, Baltimore, MD.
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TOTAL PATIENTS 38 50
There was a poor correlationof both positive and
negative results between the RQ and T20l. The sensitivity
was 44%, specificity 46% and predictive value 38%.
CONCLUSION: When compared with reversible thallium-201
defects induced by exercise, the Rose Questionnairedoes
not accurately predict ischemic coronary artery disease.
Therefore, the use of this questionnaire to indicate the
prevalence of ischemic coronary artery disease in epidem-
iological studies must be seriously questioned.
EXERCISE-ENHANCED RISK FACTORS FOR CORONARY HEART DISEASE
VERSUS AGE AS CRITERIA FOR MANDATORY RETIREMENT OF
ASYMPTOMATIC HEALTHY MEN.
RobertA. Bruce, M.D., F.A.C.C. and Lloyd D. Fisher,
Ph.D., F.A.C.C., University ofWashington, Seattle, WA
To test appropriatenessof age as criterion for manda-
tory retirementfrom occupations involving publicsafety
we ascertained annual coronary heart disease eventrates
in relation to exercise-enhancedrisk assessment in 4105
asymptomatic healthy men observed in Seattle community
practice. Conventional risk factors were recorded along
with responses to symptom-limitedmaximal exercise.
Annual incidence of primary coronary events (i.e.,
angina pectoris, coronary bypass surgery, myocardial in-
farction, cardiac arrest and resuscitation, sudden and
nonsudden cardiac deaths) is0.22% in 1792 men (43.6%)
without risk factors, and 0.42% in 2269 men (55.3%) with
ri sk factor{ s ) andless than two abnormal responses to
exercise. Among 44 (1.1%) at high risk, defined as any
risk factorfs ) and two or more abnormal responses to ex-
ercise, annual incidence is 5.2% (p < .001). Abnormal
exercise responses include chest pain withtesting (de-
spite negative history), duration less than 6 min,max-
imal heart rate less than 90% of age-predicted value and
one or more mm of ST depression. Case fatality rates
are 9.1%, 19.2% and 40.0% for these 3 risk groups. Pro-
portion of men 60-64 years at low risk with a 98% 3-year
survival is 16 times that of men of 55-59 years at high
risk with a 78% survival. Conclusion: Exercise-enhanced
risk assessment is abetter predictor than age alone to
determinemandatoryretirementof healthy men.
23 (46%)21 (55%)Negative
R
o Positive
S
E
POOR PREDICTIVE VALUE OF THE LONDON SCHOOL OF HYGIENE
CARDIOVASCULAR (ROSE) QUESTIONNAIRE FOR THE DIAGNOSIS OF
ANGINA PECTORIS COIWARED WITH THALLIUM-20l lMAGING.
Carol Ewing Garber, M.A., Gary V. HelIer, M.D., Ph.D.,
Lisa Warren, 11. S., Mark A. Connolly, 11.S. and Richard A.
Carleton, M.D., FACC. Brown University, Providence RI
The Rose Questionnaire (RQ) has often been used in
epidemiological studies for the diagnosis of angina pec-
toris, and therefore ischemic coronary artery disease
(ICAD). Although RQ compares favorably with physician
judgement and resting electrocardiograms,validation with
more objective measures of ICAD has not been performed.
Therefore, we compared RQ with exercise thallium-201
imaging (T20l) in 88 patients (48 males, 40 females) re-
ferred for clinical evaluation. RQ was considered posi-
tive by standardcriteria. T20l was considered positive
for ICAD if a reversible thallium defect was found. Fixed
thallium defects or normal images were considered negative
for ICAD. Results are the following:
Reversible Thallium-20l Defect
POSITIVE NEGATIVE
17 (45%) 27 (54%)
Tuesday, March 10, 1987
10:30AM-12:00NOON, Room 6, Second Level
Prevention: Risk Factor Analysis
FIBRINOGEN, CIGARETTE SMOKING ANO RISK OF CARDIOVASCULAR
DISEASE: INSIGHTS FROM THE FRAMINGHAM STUDY.
William B. Kannel, MD, MPH, FACC, FACE. Boston
University School of Medicine, Boston, Massachusetts.
During the tenth biennial exam 1,315 Framingham
Study participantsfree of cardiovasculardisease had
fibrinogen measured along with other majorcardiovascular
risk factors, including cigarette smoking. Fibrinogen
values increased with age andwere higher in women
than men at all ages from 47-79 years. Cigarette smoking
decreased with ageand was greater in men than in women
at all ages. Age-adjustedfibrinogen values were signif-
icantly higher in smokers than non-smokers and increased
with amount smoked in each sex. Over 10 years of follow-up
165 men and 147 women developed cardiovasculardisease,
the risk in both sexes increasing progressively with
antecedent fibrinogen values over the 1BO-450 mg/dl.
range. Cardiovasculardisease risk gradients in relation
to fibrinogen in men diminished withadvancing age.
Risk of coronarydisease increased progressively over
more than a 2-fold range with a diminishing impact
with advancing age in both sexes. Inmen, cardiovascular
disease and coronarydisease risk in particularwere
each related to cigarette smoking. As for fibrinogen,
the risk diminished with advancing age. Fibrinogen
contributedto risk of cardiovasculardisease taking
both cigarette smoking and other risk factors into
account. Also, at any level offibrinogen, cigarettes
contributedto risk. Some 29% of the effect of cigarettes
was mediated throughraised fibrinogen, providing another
mechanism whereby cigarettes influence occurrence of
cardiovasculardisease.
ALCOHOL AND STROKE
Arthur L. Klatsky, M.D., F.A.C.C., Mary AnneArmstrong,
M.A., and Gary D. Friedman, M.D., Kaiser Permanente
Medical Center, Oakland, California.
We prospectively studied stroke incidence among 107,139
white and black men and women who supplied alcohol use
data at health examinations. Subsequently, in the years
1978-84, 80 persons were hospitalized for hemorrhagic
stroke and 292 persons were hospitalized for occlusive
stroke. A Cox regression analysis included age, sex,
race, adiposity, coffee, blood pressure, baseline heart
disease, smoking, and alcohol use (never; ex; <1, 1-2, 3+
drinks/day). With all variables in the analysis alcohol
use was not significantly related to hemorrhagic stroke;
e.g., 3+ drinks/day vs. never drinkers had relative risk
= 1.3, P = 0.58. However, alcohol use showed a relation
to hemorrhagic stroke in an analysis not controlled for
blood pressure in a subset (n = 48 cases) of persons free
of heart disease (relative risk = 3.3, p<O.04; 3+ drinks/
day vs. never drinkers). Alcohol USe showed a progres-
sive inverse relation to occlusive stroke (e.g., for 1-2
drinks/dayvs. never drinkers, relative risk = 0.5,
p<O.Ol; for 3+ drinks/dayvs. never drinkers, relative
risk = 0.4, p<O.Ol). Type of beverage preferred (wine,
liquor, beer) was not significantly related to hemorrhag-
ic or occlusive stroke. These data suggest that heavier
drinking may be related to hemorrhagic stroke, perhaps
via an alcohol-blood pressure link, but that abstinence
is associated with a higher risk of occlusive stroke.
lACC Vo!. 9. No. 2
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PHYSICIAN RECCX;NITION OF CORONARY RISK FACTORS: A DISPARITY
BETWEEN APPROACH TO HYPERTENSION AND HYPERCHOLESTEROLEMlA IN
PATIENTS HOSPITALIZEDON A MEDICINE SERVICE.
Ezra A. Amsterdam, M.D., F.A.C.C., Nancy Walker, Michael
Ridgeway, B.S., Jeffrey Tanji, M.D., Larry Baker, R.C.V.T.,
Zakauddin Vera, M.D., F.A.C.C. University of California,
Davis, California.
To determine physician recognition of and attention to risk
factors for coronary heart disease (CHD) in patients (pts)
hospitalized on a general medical service for a wide variety of
conditions, we reviewed the records of a random sample (every
7th admission) during a 6 monthinterval. The records of 234
pts were thus assessed (124 men, 110 women, mean age 52yr,
range 17-93). We compared recognition of hypercholesterolemia
with that of hypertension, as indicated by physician notation in
the pt record and evidence of amanagement plan. Of the 235
pts, 54 had hypertension (BP consistently > 150/90 mmHg), of
whom 45 (83%) had prior diagnosis and therapy. Of the nine pts
(17%) without a prior diagnosis, 8 were diagnosed and provided a
management plan while in only 1 pt washypertension, documented
by recorded elevation of blood pressure, neither noted nor
treated. In contrast to these findings, 47 of the 235 pts had
serum cholesterol > 240 mg% (range 240-600 mg%). In only 5 pts
(11%) did these levels receive recognition and management
(primarily diet). Thus hypertension is a well recognized and
frequently treated coronary risk factor which, in this sample of
pts, was attended to by the system of medical care in 53 of 54
pts (98%) with this condition. By contrast,
hypercholesterolemia, even at levels well above those
recommended as indicative of elevated coronary risk, is
infrequently attended to by either physicians in training or
medical faculty. These data support the need for physician
education to increase awareness of hyperlipidemia, related risk
of coronary artery disease and approaches tomanagement.
CHOLESTEROLSCREENING IN PATIENTS UNDERGOING CORONARY
BYPASS SURGERY
Phillip Watt. B.A., Diane M. Becker, Sc.D., M.P.H.,
Kathy Salaita, M.S., Thomas A. Pearson, M.D., Ph.D.
Prior studies have demonstratedthat cholesterol level
is a significiant predictorof progressive athero-
sclerosis in both native and grafted vessels follOWing
coronary artery bypass surgery (CAB). To determine the
extent to which CAB patients are aware of hypercholes-
terolemia (HC), under treatmentand under control, we
examined admission total cholesterol (TC) levels and
conducted medical record reviews in 105 randomly
selected patients undergoing CAB. Of the 49 patients
(407.) with admission TC > the 75th percentile, 26(537.)
had no prior knowledge of HC. Half of the 13 patients
with TC >300 mg/dl were unaware of HC. Of the 36
patients who reported a history of HC, 4(117.) were
treatedwith a lipid lowering drug only, 2(67.) with
diet only and 2(67.) with both. Of the 8 people under
treatment, only 2(257.) had TC levels below the 75th
percentile. Two patients with TC >400 mg/dl were aware
but were not receiVing any treatment. Although 667. of
patients had long-standing atheroscleroticcardiovas-
cular disease, prior history, referralsource, age,
gender, or education, were not associated with TC
level, HC awareness, treatmentor control. The high
prevalence of HC and the low percentage of people
aware, under treatmentand under control suggest that
lipid screening at the time of CAB is worthwhile.
A PROSPECTIVE STUDY OF OBESITY AS A RISK FACTOR FOR FATAL
AND NON-FATAL CORONARY HEART DISEASE IN WOMEN.
JoAnn Manson, M.D., Meir stampfer, M.D., Graham
Colditz, M.D., Walter Willett, M.D., Bernard Rosner, Ph.D.,
Frank Speizer, M.D., Charles Hennekens, M.D., Channing
Laboratory, Brigham and Women'sHospital, HarvardMedical
School, Boston, MA.
The influence of obesity on risk of coronary heart
disease (CHD) in women was examined prospectively in a
cohort of 120,345 female nurses aged 30-55 in 1976. All
subjects were free from CHD at baseline and reported
height, weight, and risk factors by questionnairein 1976.
Quetelet's index (QI) (weight/height2) waS calculated and
subjects were classified by QI quintile. Non-fatal
myocardial infarction (MI) and angina, as well as updated
exposures, were reported on follow-up biennial question-
naires in 1978, 1980, 1982 (96% response). Fatal CHD was
ascertained by searches of vital records. Coronary end-
points were documented by medical record review and self-
reportedweights were found to be highly correlatedwith
measured weights in a sample of participants (r=0.96).
There were 240 cases of non-fatal MI, 64 cases of fatal
CHD, and 166 cases of angina in 675,240 person-years of
follow-up. The age- and smoking-adjustedrelative risks
(RR's) of non-fatal MI and fatal CHD for increasing quin-
tiles of QI were 1.0, 1.1, 1.1, 1.4, 2.5 (X, trend =5.7,
p < 0.001). RR's for angina were 1.0, 1.4, 1.9, 1.4, 2.0
(X, trend = 2.0,p < 0.05). These data indicate that
obesity confers a substantiallyincreased risk of both
myocardial infarction and angina in middle-aged women.
Tuesday, March 10, 1987
8:30AM-10:00AM, Room 16, Second Level
Mechanisms in Experimental Myocardial Infarction
LEFT VENTRICULAR HYPERTROPHY AND HYPERTENSION ACCELERATES
THE RATE OF INFARCTION.
Kevin C. Dellsperger, M.D., Ph.D.,Jane A. Hartnett,
Jennifer L. Clothier and Melvin L. Marcus, M.D.,
F.A.C.C., Department of InternalMedicine, University of
Iowa, Iowa City, Iowa 52242.
We have shown previously that left ventricularhyper-
trophy (LVH) and hypertension (H) increases completed in-
farct size by 35%. In addition, to determine if the
spread of the wave front of infarctionwas accelerated by
LVH-H, we studied II dogs with single kidney Goldblatt
hypertensionand 12 controls (C). We measured aortic
pressure (AoP), heart rate, left atrial pressure and
myocardial perfusion (microspheres) in awake dogs during
a I'hour circumflex occlusion followed by 4 hours of
reperfusion. Infarct size (triphenyl tetrazolium
chloride stain) and risk area size (postmortem barium
angiography) were determined for each layer of the
myocardium. endocardium (Endo), midwall (Mid) and epi-
cardium (Epi). Results (x + SEE, *p<0.05, RH vs C):
LV/body wt AoP INFARCT/RISK (7.)
(g/kg) (mmHg) ENDO MID EPI
C 4. 6±0. 3 94±4 64±9 9±4 D±D.I
LVH-H 5.7±0.3* 143±5* 65±8 25±11* 3±2*
Thus, in dogs with LVH-H after I hour of coronary occlu-
sion more than twice as muchmidwall was infarcted.
Regional myocardial blood flow in the norma] area and
risk area was equivalent in the LVH-H and control groups
of animals. We conclude that the wave front of infarc-
tion across the left ventricularwall is accelerated in
the presence of LVH-H. This may have important implica-
tions for the potential efficacy of even slightly delayed
thrombolytic therapy in patients with left ventricular
hypertrophyand hypertension.
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EFFECTS OF ACUTE ISCHEMIA AND REPERFUSION ON MYOCARDIAL
jl-ADRENOCEPTORSAND ADENYLATE CYCLASE ACTIVITY
Joel S. Karliner, M.D., F.A.C.C., Michael Stevens, M.D,
WondaWoloszyn, Norman Honbo, Gabrielle Blaug and Julien
I.E. Hoffman, M.D., F.A.C.C. VAMC, CVRI and Dept. of
Medicine, University of California, San Francisco.
The effects of varying grades of ischemia and
reperfusion on jl-adrenoceptors (jl-AR) and adenylate
cyclase (AC) activity are controversial. We ligated the
left anteriordescending coronary artery in 19 beagles
for 1-2 hours. Although endocardial and epicardial
blood flow was reduced by >75% in the center of the
ischemic zo~e (microsphere method), jl-AR density and
affinity (H-dihydroalprenolol) were unaffected (8
endocardial and 9 epicardial determinations).
(-)-Isoproterenol-stimulated AC activity in the
endocardium in the presence of 0.1mH GppNHp was reduced
from 1224 ±822 to 471±297 (SD) pmol cAMP/mg protein/30
min (ne8, p<.005); results in epicardiumwere similar.
In areas of heterogeneous perfusion, where blood flow
was reduced by 68 to 29%, jl-adrenoceptordensity and
affinity were unchanged (n=5), while (-)-isoproterenol-
stimulated AC activity was reduced (p<.05). After 20
min of reperfusion jl-AR endocardial density and affinity
were unchanged in the preViously ischemic area, while
both NaF- and (-)-isoproterenol-stimulatedAC activity
remained depressed (n=5, both p<.005). We conclude that
contrary to prior reports, neither jl-adrenoceptors nor
jl-adrenoceptormediated signal transductionas measured
by (-) -isoproterenol-stimulated AC activity are
increased in myocardium renderedmoderately or severely
ischemic for 1-2 hours or in myocardial tissue
reperfused for 20 min after 2 hrs of ischemia.
BAROREFLEX SENSITIVITY AND SUDDEN DEATH IN CONSCIOUS DOGS
BEFORE AND AFTER MYOCARDIAL INFARCTION.
Emi1io Vanoli MD, Marco Stramba-BadialeMD, Gaetano De Fer-
rari MD, Donatella Cerati MD, George Billman PhD and
Peter J. Schwartz MD,FACC.
HSC, Dept.Physiol.Univ.Oklahoma,OklahomaCity,Oklahoma.
Our demonstrationthat a decreased baroreflex sensitivity
(BRS)in dogs with a myocardial infarction(MI)is associated
with a higher risk of sudden death(SD) has stimulatedclin-
ical studies. However,the direct effect of MI on BRS can-
not be proven by group comparison because of the high inter
individual var i abi l i t y . Accordingly,we have studied BRS in-
24 dogs before and 30 days after a MI. The heart rate(HR)
response to blood pressure(BP)increases by i.v.Phenylephri
ne was analyzed. BRS was expressed as the slope of the re=
gression line relating R-R intervals to BP changes. BRS was
reevaluated 30 days after an anteriorMI. In each dog a 2
minute occlusion of the circumflex coronary artery was ini-
tiated during the last minute of a submaximal exercise
stress t es t . In 11 dogs t hi s protocol provoked vent r i cul ar
fibrillation(VF),while 13 dogs survived. BRS was clearly
reduced in the post MI condition(12.2+6.4 vs 17.9+5.3 msec/
mmHg,r,=24:p<0.001)and was strongly correlatedwith-mortali-
ty.lndeed,the BRS of the dogs with VF was 6.7+2.4 msec/mmHg
compared of that of survivors(16.9+4.e msec;-mmHg:p<O.OOl).
Among post HI dogs with BRS below ii msec/mmHg the mortali-
ty was 91\ (10/11) compared t o e\(1/13)among animals with BRS
above 11 msec/mmHg(p<O.OOl). BRS decreased in 75\ of dogs,
did not change in 21\ and increased in 4\. Of biological in-
terest is the fact that already prior to the HI the BRS of
the 11 dogs which subsequentlydied during the exercise+is-
chemia test was 10wer(15.l+3.2vs20.3+5.6 msec/mmHg;p<0.02).
These data definitely demonstrate that MI reduces BRS in
the majority of cases and confirm the predictive value of
depressed BRS for the identificationof SUbgroups at high
risk for SD. The novel concept of a relationshipbetween
BRS before MI and susceptibility to SD after HI raises
intriguingpossibilities. ------
TENSILE STRENGTH AND PROTEIN COMPOSITIONOF HEALING
MYOCARDIAL INFARCT IN TIlE PIG.
M. Janet MacLean, B.Sc., Diane Kauldin, B.Sc., Mary
Edwards, M.Sc., Peter J. Anderson, Ph.D., and George P.
Biro, M.D., Ph.D. University of Ottawa, Ottawa, Canada.
The purpose of this study was to follow the temporal
changes in healing infarcted myocardium (IM). Permanent
occlusion of the prOXimal circumflex artery was performed
on 36 anesthetized swine. Sacrifice occurred at I, 3, 7,
14, 21, and 28 days post occlusion. 6 animals had sham
surgery prior to sacrifice. Hearts were removed. The
mechanical properties, protein composition and blood flow
(BF) were studied in both IM and noninfarctedmyocardial
(NIH) regions. BF was determined 10 minutes pre- and
post-occlusion, and prior to sacrifice, by radionuclide-
labelled microsphere distribution. Ten minutes post-
occlusion, the SF to the IH was 13.3 ± 7.1%(±SD) of that
to the NIM. This increased to 51.4 ± 18.0% at day 3 and
then declined. In vitro stress-strainanalysis showed
the elastic strength of the IH increased with infarct
age. Average maximum strain was 158.5 ± 19.0% of the
length at zero tension. The ratio of stiffness of IM:NIM
was <1 for infarcts under 7 days, and rose to 2.4 ± 0.7
for older infarcts. The plastic strength also increased
with infarct age. 75% of strips from IM S3 days tore
completely when strained. After 3 days no IH or NIM
strip rupturedwith the strain applied. 4-hydroxy-
proline, an amino acid marker for collagen, increased
steadily with infarct age. The IM:NIHratio rose from
1.2 ± 0.4 at day 3 to 7.4 ± 0 .4 in the oldest infarcts.
The rates of actin and myosin disappearanceand collagen
cross-linking were also followed. We conclude that
although both tensile strength and collagen content
increased, the increases do ·not appear to be in parallel,
tensile strength lagging the appearanceof collagen.
PIRIPROST (U-60,257B) MODULATES EICOSANOID FORMATION AND
REDUCES MYOCARDIAL NEUTROPHIL ACCUMULATION IN INFARCT
SIZE IN RATS.
Thomas~ Wargovich, M.D., JawaharMehta, M.D., F.A.C.C.,
Wi1mer W. Nichols, Ph.D., F.A.C.C., Mary Beth Ward,
Daniel Lawson, Car 1 J. Pepine, M.D., F.A.C.C. VAMC and
the University of Florida, Gainesville, Florida.
Neutrophil (PMN) accumulation and release of arachidonic
acid metabolites may adversely affect infarct size after
acute coronary ligation. To study the effects of a new
5-lipoxygenase inhibitor, piriprost, 129 Sprague-Dawley
rats were treated with saline or piriprost (10 mg/kg)
i.v. 30 min prior to and 1 hr after left coronary
ligation. At 48 hrs, i nf a r c t size, expressed as % of
left vent r i c l e (LV), was determined from serial H&E
stained sections of myocardium. A subset of rat hearts
were homogenized and total LV CK measured. Myocardial PMN
accumulationwas assessed by counting PMNs/IO HPFs (4 0x)
in infarct areas. In the saline-treated group, infarct
size was 43.7±3.4% (mean ± SE) and LVCK 1.79±.21 IU
mg/ pr ot ei n . Piriprost reduced infarct size to 34.3±3.5%
(P ( 0.05) and tissue CK loss to 2.82 ±. 37 IU mg /protein
(P (0.02). Infarct tissue in the saline-treated group
contained ) lOO PMNs/HPF but only 31±4 PMNs /HPF in the
piriprost group (P (0.01) . Heart rate or BP were
similar in both groups. Thus effects of piriprost were
not mediated by changes in myocardial oxygen demands .
In vi t r o , piriprostwas found to inhibit PMN leukotriene
B4 production and chemotaxis as well as platelet
aggregation and thromboxane A2 formation. Thus.
piriprost inhibits both cyclooxygenase and lipoxygenase
products of arachidonic acid and reduces infarct size in
rats following coronary ligation. Reduction in infarct
size may also relate to inhibition of neutrophil
accumulation in the infarct zone by piriprost.
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LIDOCAIRI, AB IIIIIIIITOI. or IlIUT10PRIL SUPBI.onDl ARIo"
RELEASE, SIGRIPICAm.YREDUCES IIJPAI.CT SIZE III PIGS.
Nobuo Hatori,MD
d
Robert Roberts,MD,PhD,J.KevinDrurY,MD.
FACC, Kimi6 5 tomura MD Micnael C.Fishbein,MD,FACC
Eliot Corday.MD,FACC.... f!:.Rlchard Stiehm,MD, Cedars-Sinal
Medical Center and U~LA ,Los Angeles. CA.
Oxygen free radicals have been shown to play an
important role in reperfusion injury. Lidocaine, a
c01lllll0nly used antiarrhythmicagent. has been shown to
inhibit the release of oxygen free radicals by human
neutrophils, and it has been suggested that lidocaine
therapy may result in infarct size reduction in the
setting of acute coronary occlusion and rererfusion.
To test this hypothesis we studied 4 open chest
anesthetized pigs with 60 min. LAD occlusion followed by
3 hours reperfusion. Lidocaine (82±25 mg/kg) was
administeredprior to and during coronary occ IusIon and
after reperfusion in 7 pigs (group A). 7 other rigs
served as controls (group B) and received brety ium
(164±35 mg/kg) administered as in group A. for the
prevention of maiignant ventriculararrhythmias.
Infarct size is tabulated; (mean±SD.*P(O.Ol)
Group Area at risk(AR) Necrotic area(NA) ~A/AR
A 32.0±4.5% 4.9±4.2%* 15.8±13.6%*
B 32.4±7.0% 22.0±5.4% 62.4±7.S%
This difference could not be explained by hemodynamic
effects of the two drugs.
To drtermine the effects of lidocaine and bretylium on
porcine neutrophil oxygen free radical release
chemiluminescence (CL)d an indicator of superoxide anion
(i}i0806 :tSatm~78g.re Lia~cal~~ }%~~~/~i) °i~htbi\~~e~~~
peak CL response (3.aO.05 to Y.23±0.21 mY. P<O.OS)
whereas bretylium (200 pg/ml) had no effect (3.1±Q.05 to
3.25±0.05 mY). Adherence of porcine neutrophils to
plastic was also inhibited by lidocaine but not
bretylium.
Conclusion: Lidocaine significantly reduces infarct size
in pigs in the setting of acute coronary occlusion
followed br reperfusion. The observed reduction in
infarct s ze may be secondary to the demonstrated
inhibition of porcine neutrophil superoxide anion release
by lidocaine.
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Thrombolysis:New ExperimentalApproaches
CAN INTRINSIC TISSUE TYPE PLASMINOGEN ACTIVATOR
DE CONCENTRATED AT THE SITE OF A THROMBUS ?
ChristophDode,M.D.,Marschall S.Runrre,M.D.,PhD,
Gary R.Matsueda,PhD,HermanK.Gold,~I.D. and
Edgar Haber,M.D.,F.A.C.C.,CardiacUnit,
Massachusetts General Hospital and Harvard
Medical School.Boston MA 02114
The normal concentrationof tissue type plas-
minogen activator (tPA) in human plasma is often
insufficient to impact significantly on thrombo-
lytic rates.In order to concentrate endogenous
tPA at the site of a thrombus a bifunctional
antibody was constructed by chemically lim,ing
a monoclonal antibody (mAB) specific for the
amino-terminus of the beta chain of fibrin to a
mAB specific for tPA.The tPA mAD bound but did
not inhibit the enzyme.This bifunctional mAB
captured tPA and enhanced its fibrinolytic rate
up to tenfold at concentrations of tPA equal or
lower than those present in plasma.(O.3,1.0,5.0
ng tPA/ml).The degree of enhancement of fibrin-
olysis increased as tPA concentrationsdecrease~
This may be attributedto the fibrin-specific
mAD's higher affinity for fibrin than tPA's.
The results suggest that intrinsic concentra-
tions of tPA may be sufficient to induce
thrombolysis when targeted to fibrin.If these
observations can be extended in vivo,thrombosis
could be treated without administering
exoGenous plasminoGen activators.
HEPARIN ENHANCES PLASMINOGEN PRO-ACTIVATOR-INDUCED
EXPERIMENTALCORONARY THROMBOLYSIS
Takashi Susawa, M.D.. Yoshiki Yui,M.D., Ryuichi Hattori,
M,D.. Yoshiki Takatsu, M.D., Natsuko Yui, M.D., Mamoru
Takahashi, M.D., Takeshi Aoyama, M.D.• Yoshi haru
Murohara, M.D., Manabu Shirotani, M.D.. Chuichi Kawai,
M.D., F.A.C.C•• Kyoto University Hospital, Japan.
This study was designed to clarify the effect of
heparin (H) on plasminogen pro-activator(PPA)-induced
coronary thrombolysis using canine model (n=15). One
hour after the coronary occlusion by a copper coil in
the anteriordescending coronary artery, PPA was admini-
stered by intravenous route with or without H (300
U/kg).
Plasma fibrinogen levels (Fbg) and alpha2-
antiplasmin activities (AZ-PI) were determined before
and after PPA treatmen~
Five or 20 fl9/kg/min of PPA with H could induce
more rapid reperfusion than 20 fl9/kg/min of PPA without
H. A2-PI was slightly reduced in 20 fl9/kg/min of PPA
without H. Fbg was not changed in three groups.
PPA Time Fbg Ar)!()Jg/kg/min) H ~m %
1) 20 \-") 41 ± 6 ~ I 98 ± 5 92 ± 5 #
2) 5 (+) 31 ± 4 j. j 95 ± 7 95 ± 6
3) 20 (+) 14 :!: 2 100 ± 4 99 ± 2
(Values in Fbg and A2-PI indicated percent changes from
the values before P~ infusion. Each group consisted of
f i ve dogs. Ti me= time to reperfusion, * p<O.OOl by
multiple comparison tes~ # p<Q05 as compared with the
control value, 100%. Values are mean + SO.)
Conclusion: 1) Heparin di minished the dose of PPA
required for the reperfusion. 2) This effect of heparin
seems to be due to the reduction of new fibrin
formation.
INFARCT SIZE REDUCTION AND RECOVERY OF SYSTOLIC FUNCTION
FOLLOWING CORONARY THROMBOLYSIS (TISSUE-TYPE PLASMINOGEN
ACTIVATOR) COMBINED WITH BETA-ADRENERGIC BLOCKADE
(METOPROLOL)
Frans Van de Werf, M.D., Johan Vanhaecke, M.D., Ik-Kyung
Jang, M.D., Willem Flameng, M.D., Desire Collen, M.D.,
and Hilaire De Geest, M.D., University of Leuven, Belgium.
We studied the ability of beta-adrenergicblockade (BB)
to enhance salvage and functional recovery of reperfused
myocardium. In 36dogs, immediately following thrombotic
occlusion of the LAD coronary artery, metoprolol was given
i.v. (0.5 mg/kg). After 1 hr of occlusion recanalization
was attempted by i.v. infusion of rt-PA (10 pg/kg).
Anatomical infarct size (% of the LV mass, I!LV), global
ejection fraction (EF) and meansystolic shortening of the
segmental radii (SS) of the infarcted area were measured
at 24 hr and 1 wk in 6 groups of 6 dogs: I (rt-PA + BB!
24 hr), 11 (rt-PA + BB!l wk). III (rt-PA alone/24 hr),
IV (rt-PA alone/l wk), V (persistent occlusion/24 hr) and
VI (persistent occlusion/1 wk). Although the smallest
infarcts were found in reperfusion dogs that in addition
received BB, the differences with reperfusion alone were
statistically not significant (I!V in %: 5.5 ~ 0.9 in I,
6.7 + 1.9 in ll, 15.4 + 5.0 in Ill, 11.4 + 3.5 in IV,
23.6-+ 2.5 in V and 26~9 + 2.3 in VI) (mean + SEM). At
24 hr-a significant recov;ry of SS of the infarcted area
was observed only in reperfused dogs that received BB
(SS in %: 7.29 + 3.1 in I, - 0.27 + 2.5 in III and - 1.15
+ 1.5 in V), This earlier recovery-preventeda further
decrease in global EF during the first 24 hr observed in
the other groups. At 1 wk no differences in global or
segmental LV systolic function were found between reper-
fusion alone or reperfusion combined with BB. Thus BB
combined with rt-PA results in an earlier functional
recovery of the infarcted area without long-term dif-
ferences in global or regional LV function at rest.
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IMPROVED CLOT LYSIS AND I.FARCT SIZE REDUCTION WITH
COROWARY YE.OUS COMPARED WITH IBTUYEWOUS IBFUSIOW OF
S'l'RBPTOKIHASE
Akira Miyazakl,M.D., J.Kevin DrurY,M.D.,F.A.C.C., Nobuo
Hatori, M.D., Eliot Corday,M.D.,F.A.C.C., Cedars-Sinai
Medical Center, Los Angeles, CA.
The relative efficacy of coronary venous vs. systemic
administrationof streptokinasewas studied in 20 closed
chest dogs with a copper coil induced thrombus in the
left anterior descending coronary artery.
Streptokinase(100 IU/kg/min) was administered 60 minutes
postocclusion by continuous infusion either via the great
cardiac vein (GCV) using a retroinfusion balloon
catheter, or via a peripheral vein (IV), for 60 minutes.
Coronary angiography was performed at 5 minute intervals
to determine clot lysis time.
Clot lysis occured in 8 of 10 (80%) of the IV treated
dogs compared with 10 of 10 (100%) of the GCV treated
dogs. Time to lysis was 62t26 min.(n-8) with IV therapy
and 23t7 min.(n-lO) with GCV therapy(p(.OOl). Regional
systolic LV function determined by computer-assisted two
dimensional echocardiographywas expressed as %
fractional area change (%FAC) and %wall thickening
change (%W-Th). Infarctsize (IS) expressed as %of risk
area, and ischemic area %FAC and %W-Th 3 hours
postreperfusionare tabulated(mean+SD, *p(.05 vs. IV
group).
IS(%) %FAC kW-Th
GCV 7.7t12.3* l6.5tll.6* 8.7tll.3*
IV 32.0±24.9 -1.8t16.4 -3.7t12.l
Conclusion: In this study, coronary venous retroinfusion
of streptokinasewas superior to intravenous therapy
resulting in more rapid clot lysis, improved myocardial
function 3 hours postreperfusion, and significant infarct
size reduction.We suggest that since the coronaryvein
can be easily catheterized in the human, coronary venous
retroinfusion of streptokinase may be an important
therapeuticalternativefor the treatmentof patients
with myocardial infarction.
THROMBOLYSIS - COMBINED ROTATIONAL CATHETER THROMBECTOMY
FOLLGIED BY INTRA-ARTERIALSTREPTOKINASE: EVALUATlOO BY
ANGIOSCOPY AND ANGIOGRAPHY
James L. Ritchie, M.D., F.A.C.C., D. Dennis Hansen,
M.D., MargaretHall, M.D., Michael J. Intlekofer, M.D.,
Rudolf Vracko, M.D., David Auth, Ph.D., VA Medical
Center and the University of Washington, Seattle, WA.
We have developed an angioplasty-like catheterwhich,
through rotation, selectively wraps fibrin about its
shaft, resulting in mechanical thrombolysis. Femoral
artery thrombosis (n-ll) was generated by forceps crush
~nJury, temporary occlusion and thrombin injection in
anesthesized dogs. Total or subtotal thrombosis (TIMI
flow Class 0 or 1) was created. After rotational
thrombectomy (with fibrin retractionby the catheter),
contrast angiography (CA) showed 6 arteriesWNL, 1 min
irreg, and 4 with 30 to 50% stenosis (TIMI Class 3). By
angioscopy, none were WNL, 6 had thrombuslining the
walls, and 5 had lining plus partiallyocclusive thrombi
(p<.Ol vs CA). Intra-arterial streptokinase (250,000
units) over one-half hour resulted in no changes by
either CA nor angioscopy. Histology documented luminal
thrombi rather than lining hemorrhage.
We conclude that rotational catheter thrombectomyis
effective in reopening thrombotic occlusions, that
residual thrombus lining the arterialwall is common and
detected best by angioscopy. Streptokinase, applied
directly to these residual thrombi, had no effect. The
concept that streptokinase may "clean up" residual
thrombi after mechanical thrombectomy was not
demonstrable in this model.
1-123 BIPTADECAMOICACID U-BDA) IS AN EARLY MARIER
or IIIocm VIABILITY IN ISCBIIIIC-REPERFUSED
MYOCARDIUM
FrancoisChappuis.R Lerch. P Luthy.B. Meier. I Papageorgiou A
Schubiger W Ruushauser
CardiologyCenter UniversityHosp..Geneva.Switzerland
Toexamine therelationshipof'fattyacid analoglI-HDA) and thallium-
201 (TlJ uptake to viability inischemic-reperfusedmyocardium.6 dogs
had a left anterior descending coronary occlusion induced by an
intracoronarycopper coil Thrombolysis was achieved 5 hrs later
with iv tissue plasminogen activator or ic streptokinase
Microspheres I-HDA (100 uCil and TI<50 uCil were given after Ihr
reperfusionand the dogs were sacrificed 2 minutes later. Myocardial
blood flow (MBF) was measured withmicrospheres The reperfused
area was determined by iclatex/BaS04 Viability was assessed by
triphenyltetrazohumstaining (TICl. For each range of flow.I-HDA-
uptake wassignificantlylower in necrotic (TIC-)than in viable (TIC·)
samples Data are expressed aspercentage of activity in normal
myocardium
"7. MBF %123I-HDA P
Viable Necrotic
04 59 + 29 31~IO '00001
11 4-079 S4~21 49~10 100001
1.l!l-1l9 90~27 77 + 22 '005
12-16 110 ~22 75~ 2 ,001
Contrary to I-HDA. It-uptake was not significanUy different in
necrotic and viable samples BothI-HDA and Tl-uptake correlated with
MBrin necrotic and viable samples
Thus. early after reperfusion I-HDA-uptake may help to predict
myocyte viability over a wide range ofMBF using conventional
gammascintigraphy
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ValvularDisease
PERCUTANEOUS DOUBLE-BALLOON MITRAL VALVOTOMY:
RESULTS USING DIFFERENT SIZED BALLOON CATHETERS
Mua~ed Al-Zaibag MRCP, Paulo A Ribeiro MD, Saad
Al- asab MRCP, - Murtada Halim MRCP. Riyadh
Military Hospital, Riyadh, Saudi Arabia
To compare the results obtained by different
sized balloon catheters, our previously
described technique for percutaneous
transatrialdouble balloon mitral valvotomy was
used in a prospective study of 21 consecutive
pts in sinus rhythm, with severe symptomatic
rheumatic mitral stenosis! (mitral valve area
(MVA)<lcm2 ) . In Group (Gr) I (7 pt s ) , we used
two 15mm diameter balloon catheters; Group 11
(7 pts), 15mm+18mm diameter; Group III (7 pts),
15mm+20mm diameter, (all Meditech, 3cm length
balloon, 9French (F) shaft). The mean pt a$e in
Gr I was 23 yrs; in Gr 11, 25 yrs and in Gr
111,28 yrs. All pts were taking beta-blockers
and warfarin for 6 weeks prior to, and given
intravenous heparin during valvotomy. The study
protocol included right and left cardiac
catheterisation, (MVA calculated by Gorlin
formula),oximetry and angiography, before
balloon valvotomy and at 6 weeks follow up. We
used 12F transseptal sheaths to introduce the
15 mm balloon catheters, and 14F for sizes 18
mm and 20 mm. Both balloons were positioned
across the mitral valve under bi-plane
fluoroscopy and simultaneously inflated to 5
atmospheres for 8-10 seconds with continuous
aortic pressure recording. Following valvotomy,
in Gr I the MVA increased from 0.7~O.2 cm2
(mean ~ SD) to 1.4~ 0.3 (p<O.Ol); Gr II from
0.7~0.2 to 1.4~0.2 (p<O.Ol) and in Gr III from
0.8~ 0.2 to 1.6~ 0.3 (p<O.Ol). Six weeks post
valvotomy there was marked symptomatic
improvement in all pts. There were no thrombo-
embolic complications. In each Gr, one pt
developed grade 1/4 mitral regurgitation; left
to right atrial shunting was detected by
angiography - though not by oximetry, in one I't
from Gr I and Ill. We conclude that doub e
balloon mitral valvotomy, using two 15mm to
20mm balloons, achieves a 100% increase in MVAi
the increase may be slightly larger (p=NS)
when using the 20mm+15mm combination.
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PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY INELDERLY
PATIENTS WITH SEVERE CALCIFIC AORTIC STENOSIS WHO ARE
POOR CANDIDATES FORVALVE REPLACEMENT SURGERY
John F. Schneider, M.D.,F .A.C.C., Michae1 Wi1son, M. D.,
andThomas E. Gallant, M.D. Un iversity of Cincinnat i
Medical Center, Cincinnati, Ohio
Five men and one woman (mean age 74 years) with severe,
symptomatic calcific aortic stenos is underwent
percutaneous balloon aort ic valvuloplasty (PBAV ) be-
cause valve replacement surgerywas deemed t oo ri sky
due to severe coex ist ing cardiac or other medical
problems (5 patients) or because the patient refused
surgery (1 patient). Sequential 20-60 second inf lat ions
at 2-3 atmospheres pressure utilizing bal loons ranging
from 12-20 mi 11imet ers in inf lated diameter resulted in
a significant reducti~n in t he mean aort ic valve gradient
from 47±13 ll1l1Hg to 32-12 mmHg (%6-32%, P<O.Ol), and
a s i~nificant increas; inmea~ aort i c valve area f rom
0.64-0.12 cm2 to O. 90-0. 17 cm (%A +40%, P<O. 00l) .
As ide from blood loss from the femoral puncture si t e ,
there were no hemodynamic or neurologic complications
from the procedure and nomajor increase in the degree of
aortic regurgitation. All patients were discharged from
t he hospital within four days of the procedure. At amean
follow-up of one month post-p rocedure al l patients were
al ive and pre-proceduredyspnea had improved by two
New York Heart Association (NYHA) funct ional classes in
four patients and byone NYHA funct ional class in two
patients. We conclude that a significant short -term
increase in aort ic valve areaand improvement in
symptoms can be achievedsafely by PBAV in el derly
pati ents wi th severe symptomatic calc if ic aorti c ste nosi s
who are at high ris k forcomplications from valve re-
placement surgery orwho refuse to have surgery .
PERCUTANEOUS TRANSSEPTAL BALLOON MI TRAL VALVULOPLASTY:
THE CHINESE EXPERIENCE IN 21 PATIENTS
Chuanro ng Chen, MD , Jiyan Chen , MD , Zhendong Huang , MD,
Zhengxi ang Lo, MD, and Tsung O. Cheng, MD, FACC, Guangdong
Pro vi nci al CardiovascularInstit ut e , Guangzhou, Guangdong,
China and The GeorgeWashi ngton University, Washington,D.C.
From Nov 19B5 t o June 19B6, 21 pat i ents (pts) with rheu-
matic mitral s t enosis underwent percutaneo us transseptal
bal l oon mitral valvuloplasty (PTBMV). Their ages were 15-
51 year s (mean=33. 6) ; duration of illnes s was 1/ 3- 20 year s
(mean=6.4); functional status was New York Heart Associa-
tion Class 11 in 13 pt s and Clas s III i n B. One pt also
ha d mil d mitral regurgitat i on (HR) and 2 pt s al so hadmild
aort i c re gur gitation. The balloon size was based on two-
dimens io nal echocardiography (2DE) and at l east 2- 3 mm
smal ler t han the mitral valve anulus . Each inflation was
a t a pressure of 1-2 a tm for 3-4 se c. The procedure was
terminated before balloon ca t he te r inse rti on in 2 pts due
t o atrial wall injury; bo t h underwent uneventfu l surger y.
All 19 pts had successful PTBMV. The mean left atrial
pres sure decreased from 20.33±6.9l mmHg to 6 .Bl t 4 . 34 mmHg
(peO. OOl) ; mitral valve gradi ent decreased f ro ml6.97±6. 40
mmHg to 3.0 4t 3.40 mmHg (peO.OOl) ; pulmonary systol ic pres-
s ure decreased f r om 46. 95±19.56 mmHg t o 27.70t12. l7 mmHg
(peO.OOl ~ . Mitral orifice area by 2DE increased fr om1.32
±O.32 cm to 2.1l±O . 4l cm2 (peO. OOl) . Func tiona l status
improved to Clas s 1 in all except one who improved from
I I I to 11. Twel ve pts had an apical diastol i c t hr ill pre-
PTBMV and no thrill post-P TBMV. One pt had mild HR pos t -
PTBMV. There was no evidence of post- PTBMV l eft-to - right
shunt at t he atrial l evel by either oximetry (B pts) or
pulmona ry angiography (2 pts) .
Our preliminary results a re very en couraging and l ead
us to conclude that PTBMV is a safe and ef fective non-
surgical method of reliev ing mitral stenos i s .
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Valvular Disease
EARL Y DlASTOLlC INTERACTION BETWEEN THE AORTIC
REGURGITANT JET AND MITRAL INFLOW. A PULSED
DOPPLERSTUD Y
Eric K. Laule, M.D., F.A.C.C., Terry J. Mason, M.D. , Rupa Shah,
M.D., Teresa Blenlarz, 8.5 ., Anna Marie Moore, B.A., Bruce H.
Brundage, M.D., F.A.C.C., University of Illinois, Chicago, mlnols
Aortic regurgltant (AR ) flo w competes with mitral Inflow for
f flUng of the LV. DlastoU c fluttering (F+) of the anterior mitral
valve (AM V) on M- mode echo reflects th is Interaction but may
be absent (F-) even In moderateto severe AR. Westudied 15 pts
(49 !. 16 y/o) with AR (9 F+, 6 F-). AR was graded by
aortography (12 pts) or PWDoppler(PWD) (3 pts): 2+(4 pts), 3+(9
pts), 4+(2 pts) , AR grade was ~3+ In 619 AR F+ pts and in 516
AR F- pts , PWD of the LV showed the AR jet to be directed
against AMV In F+ and awa y from AMV In F- . To examine the
Impac t of AR jet upon mitra l Inf low, t he duration of early
dlastollc mitral inflow (D-F ) and the de celeration of mitral
inf low in early diastole (DECEL) were measuredfrom the PWD
mitral Inflow recording sampled at the mitral annulus (to avoid
spurious signals from AR) in AR pts and 15 age-matched normals
(N) (48 !. 14 ylo): * =p<.05 * *=p< .02
n D-F (msec) DECEL(c m!sec 2)
AR F+ 9 291 !. 82J ** 269 + 99] *N 9 179 + 72 420 :; 147
AR F- 6 214! 13] NS 460:; 75 ] NSN 6 206 + 39 420:; 166
Whereas In AR F- pts early mitral Inf low Is relatively
undisturbed, In AR F+ pts (In whom regurgitation was of
compara bledegree) the AR j et is directedaga inst AMV resulting
In prolongation of the early diastolfc fillfng period and slower
decelerat ion of mitral Inflow, findings Indicat ing relative
obstruction to early trans-m ltral filUng of the L V.
IDES IEPRmSmLEl'T VDmUmLAR SiS'RLIC~~
m lUIW. LM'B APD!RHRl'ICV1DIE REl'UO!IHfJ.'feR HRl'IC
9lDDiIS?.D.oniWI~ Rediker. &. Olarles A. Boucher, MD,
FN:::C, Peter C. Block, MD, FN:::C, cary W. Mins, MD, FN:::C,
MortimerJ. Buckley, MD, FN:::C, Michael A. Fifer, MD,
MassachusettsGeneral Hospital, Boston, MIl.
To determinewhether a lCM preoperativeLV ejection
fraction (EF) returnsto mnnal late after aortic valve
replacement (AVR) for aortic stemsis, we studied 23
patients with preoperative aortic valve ar ea ~ 0.7 aD2, EF
~ 0.45, mnnal coronary arteries, and m other significant
valvular disease. Patientswere studied at 10-84 months
postoperatfvely with radionuclideangiograIbYand DoWler
echocardiograIbY.At follc.w-up, 21/23 patientswere
aBylllft.anatic. EF returnedto mnnal !2.O.50) in 14 patients
(Group 1) but renainedlCM in 9 (Group2). IXlWler peak
prostheticvalve gradientwas 24±8 nm Hg i n Group 1 and
25±l 0 nm Hg i n Group 2 (poNS). Six of the 9 patients in
Group 2 hadearly postoperatdveradionuclide imaging, and
EF was mnnal in 4 (O.65±O.14 early vs 0.41~.06 late,
p=O.02). Of 77 preoperativeand surgical parameters
evaluated, only the presence of paroxysmal mcturnal
dysll1ea (PND) (0/14 vs 4/9, p=O.Ol) distinguished Group 1
fran Group 2. Multiple regression analysis of EFas the
dependent continuous variable shCMed that the presence of
preoperative RID (p=O.002) and E(I; left axis deviation
(p=O.007), and dJ.rationof aortic clanp time (p=O.04)
correlatednegatively with EF (regression p=O.OOl, F=11.5,
percent variance explained'"65) . rmc;J!lsiqw;1) EF ckles
not always mnnalize after AVR for aortic stenosis,
implying impairedcontractility. 2) Contractile
dysfunction may be masked early after AVR~ low wall
stress, I, e. "reverse afterloadmisnatch". 3) Preoperative
RID and E(I; left axis deviation, and longer aortic clanp
time predict a lCM postoperatdveEF. 4) Clinical results
are excellent and independentof postoperataveEF.
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AN EXPERIMENTAL PLEA FOR THE USE OF NITROGLYCERIN IN THE
TREATMENT OF ACUTE AORTIC INSUFFICIENCY. Harald Klepzig,
M.D., Kenneth G.Warner, M.D., Samer Y. Siouffi, M.D.,
Assad J. Saad, M.D., Martin Kaltenbach, M.D., Shukri F.
Khuri, M.D. West RoxburyVAMC and HarvardMedical School,
Boston, MA
To elucidate the role of nitroglycerin (NTG) infusion
in the treatmentof acute aortic regurgitation,a valved
conduit was constructedbetween the descending thoracic
aorta and the LV apex in 18 dogs. Aortic, pulmonary ar-
tery, regurgitantand left anterior descending coronary
flows, along with the LV septal-lateraldiameter were
measured. Stability of the model was established in 8
control studies. In 10 dogs, NTG was infused to reduce
mean aortic pressure by 40% for 20 minutes. Placebo (95%
ethanol) was then infused at a similar dose for 20 min-
utes. Compared to placebo, NTG reduced systemic vascular
resistance (230l±168 to l468±173 dyne-sec/cm5 p<.OOl),
aortic flow (3939±3ll to 3345±340 cc/min p<.Ol), regurg-
itant flow (1300±129 to 783±98 cc/min p<.OOl), LV end
diastolic diameter (47.5±1.8 to 46.l±1.8 mm p<.Ol),LV end
systolic diameter (4l.5±1.9 to 40.8±1.9 mm p<.Ol), LVEDP
(7.0±0.6 to 6.0±0.6 mmHg p<.05) and LV stroke work (19.0
±1.6 to 10.8±1.7 gm-m, p<.OOl). Heart rate, pulmonary ar-
tery and left anterior descending coronary flows, and
systolic shortening of the minor axis did not change dur-
ing either NTG or placebo. The reduction in regurgitant
flow correlatedwith the fall in LVEDP (r=.74). The
change in end diastolic diameter correlatedwith the de-
cline in systemic vascular resistance (r=.67). Thus, NTG
effectively reduces LV volume overload and work by de-
creasing both LV pre and afterload, while preserving
coronary flow. These data provide an experimental
rationale for the clinical use of NTG in the treatmentof
acute aortic insufficiency.
QUANTIFICATIONOF VALVULAR REGURGITATIONBY CINE MRI
Udo Sechtem, M.D., Peter W. Pflugfelder, M.D., Richard D.
White, M.D., William Holt, M.D., Mark M.Cassidy, M.D.,
Nelson B. Schiller, M.D., Martin J. Lipton, M.D., FACC,
Charles B. Higgins, M.D., FACC. University of California,
San Francisco.
The magnitude of discrepant stroke volumes in patients
with isolated valvular regurgitationreflects the severity
of the lesion. Conventional MRI, although potentially
suited to determine ventricularvolumes, is limited by low
temporal resolution and long imaging times. Cine MRI is a
new imaging sequence which employs low flip angles, short
TR times, and gradient recalled echoes. This technique
allows the acquisition of up to 32 images per cardiac
cycle at 1 to 4 levels within 4 minutes. To assess the
ability of cine MRI to determine the LV/RV stroke volume
ratio (SVR) and regurgitantfraction (RF), contiguous
transverse sections of 10 mm thickness covering the entire
volume of the heart were obtained in 10 normal volunteers
(NL) and 12 patients with documented isolated mitral (n=8)
or aortic (n=4) regurgitation.Lesions were classified
by Doppler echocardiographyto be mild (n=5) or moderate
to severe (n=7). Right (RV) and left ventricular (LV)
chambers were outlined by 2 independent observers in each
aection at end diastole and end systole. Total ventricular
volumes were determined using Simpson's rule. In normals,
the SVR was 0.98±.09. In patients with mild mitral or
aortic regurgitation, the SVR was not different from
normal, 1.00±.20 and the RF was -4±25%. In moderate to
severe lesions, SVR was 2.05±.63 (p< .01 vs NL and mild)
and the RF 45±15% (p<.05 vs mild). Correlationbetween
observers for the SVR, r=.98 (SEE.ll) and for the RF r=.96
(SEE 10%). In this preliminarystudy, cine MRI shows
promise for the detection and estimation of the severity
of regurgitantvalvular lesions.
Importantly, LV EF and antero-and posteroseptal
contractility fell significantly only in MVR pt.
MVA, alone or withCBG, maintainedfunction even with
low baseline LV EF ( < 0.30). Apparently,
preservation of valvular apparatus is vital to
maintaining LV function. Therefore, MA or MVR with
preserved valvular apparatus should be the surgical
procedureof choice for MR.
MITRAL REPAIR IS THE PROCEDURE OF CHOICE FOR MITRAL
REGURGITATION: AN INTRAOPERATIVE 2-D ECHO STUDY.
Martin E. Goldman, M.D., F.A.C.C., FranciscoMora,
M.O., Theresa Guarino, B.S., Arthur Schwartzbard,
B.A., Bruce P. Mindich, M.D., F.A.C.C., Mt. Sinai
Hospital, New York, New York.
LV function falls significantly following valve
replacement (MVR) for pure mitral regurgitation
(MR). The mechanism may be increased afterload or
altered anat~ due to papillary (P) muscle and
chordae (C) removal. Thus we evaluated regional
contractility (wall thickening) and global LV
ejection fraction (EF) by intraoperative 2-D echo
immediately pre- and post procedurein 70 pt: 36 with
MR - 8 who had MVR, 10 had mitral valve
annuloplasties (MVA), 3 who had MVR with PAC intact,
15 MVA with coronarybypass (CBG); and 34 control pt
17 with CAD, 17 with mitral stenosis (MS). 2-D
echos were blindly digitized for end-diastolic,
end-systolic areas and EF. No postoperative
infarction nor postoperativeMR was seen in any pt by
contrast intraoperativeecho. (* = p < 0.001).
1HE m1'lEFICIALHEMIJYNAMICEFFECl'CF RAPID ATRIAL PACm; IN SEVERE
AaJ'IEAalTlC REWlGITATIrn(AR)
Thee Meyer M'l, RichardMarcus M'l, Martin Berk roll, Jay Patel M'l, Giuseppe
Di Nicola, Pirtlassareli ID. Depar1lTlentof' cardiology,Baragwanath
Ibspital and Universi1;y of the Win.atersrood,JOOamesI::urg,Sooth Africa.
The~tic value of atrial pacing(AP) in AR has rot been estab-
lished. Previws studies have fecused en varyingdegrees r:f chrcrtic AR.
\tie investigated the hemx\ynaniceffect of AP in 8 pts (aged Z7-47 yrs)
with acutesevere AR, all of 1Ah:m de!oct1strateddiastolic closure of' the
mitral valve (LOIV) en M-mxle echo. Pressureswere recorded after 2
minutes of stabilizatiooat each incrementof 10 bpn in the pacingrate.
The cptinal pacingrate (<FR) was defined as the heart rate at I'ohich
the best overall l1em:l<:lYnanic inprovementwas observed. LOIVpacingrate
was defined as the R-R interval that is equal to interval fran preceding
R-...ave of the El)} to LOIVpoint enM-mxle echo. This rate lAO.l1d shorten
the length of diastole withcut affecting the duratien ofmitral valve
cpening. CXl were rreasured at rest and<FR. The results of AP are
SlJTITBrizedin the foll~ table:
(Values: rrean :: SIl) Resting <FR %change
Heart rate (bpn) 851-12 122+13 +M
Pressures in rmtIg
LVED 44+4 1&Ki -64
Pulm:nary Wedge 29t4 1&Ki -45
AorticDias~lic !.D+Q 67+9 +34
Cl (l/minlm ) 2.2+1-:-2 2.31-1.4 +5
LOIVpacingrate (bpn) 1l&Ki +37
C<n:lusiC11S: (1) Rapid AP results in immediateczeral.Il1em:l<:lYnanic
inprovementin pts withsevere acute AR. (2) LOIV pacingrate is near
<FR ald cenbe predeterminedby M-mxle echo. (3) <AJr results diff'er
frcm others in that a rrorel'x::mJgernE gro.JP of pts were studied (acute
severe AR). (4) AP is a practicalsafe anergency measure that may be
used to l1em:l<:lYnanicallyinprovethese patientspriorto surgery.
Pre EF
Post EF
CAD
~
.60
MS MVR
-;04 -:04
.67 *.40
MVA
-:1if
.49
MVA+CBG
~
.47
MVR+P+C
:;0-
.54
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INABILIT'i OF'lliE mI>-SYS'IOLICS'!RESSjENl>-SYS'IOLICVOIIlME
INDEX RATIO 'TO PREDIcr FOS'roPERATIVEc:mmlE IN OiroNIC
MITRALRmJroITATIOO.
William J. Corin, M.D., TcmJyuki. M..Irakami., M.D., E. scott
Monrad, M.D., otto M. Hess, M.D., Hans P. Krayenblehl,
M.D., universityHospital, zurich, SWitzerlani.
We evaluated the ability of the ern-systolic circumferen-
tial stress/ern-systQlicvolume i.rrlex ratio [ESS/ESVI,
(dyne'103/Cm2)/(ml;m2)] to predictpostoperative(~)
clinical arx:l left ventricular(LV) functional ooto::me in
patients (pta) with chronic mitral regurgitation(MR).
UsiIq biplane LV cinean;JiograPli'ani si.nultaneous LV
micranananeterani aorticpressure measurementsin 8 con-
trols (C) arx:l20 pta with MR, the ern-systolic volume in-
dex (ESVI, ml;m2), ESS/ESVI (11 pta >2.4, GlA; 9 pta ~2.4,
G2A) ani ejection fraction (EF, \, 11 pta ~60, GlB; 9 pta
<60, G2B) weredetenuined. NYHA class arx:l LV ernocardial
shorteniIq (FS) by M-rro:ie echo wereassessed preoperative-
ly (PRE) arx:l~ (mean followup 36 IIOnths). 'l\Ielve pta
l.II'rlerNentmitral valve replacement (7 GI A arx:lB, 5 G2 A
arx:lB), 8 pta had mitral valve reconstroction (4 GI A ani
B, 4 G2 A arx:lB) •
NYHA FS NYHA FS
PRE rosr mE ~ mE rosr mE rosr
C.~ .~
GlA 2.3 1.4** .41& .29*+ GlB 2.2& 1.2** .43&& .34**&&+
G2A 2.8 1.3** .34++ .29*+ G2B 2.9 1.6** . 31++ .23**++
+p<0.05 vs C; ++p<0.01 vs C; *p<0.05 mE vs ~; **p<0.01
mE vs ~; &P<0.05 Gl vs G2; &&p<0.01 Gl vs G2.
Conclusions: Patients with an ESSjESVI >2.4 arx:l~2.4 had
the same~ NYHA arx:lFS. 'Ihus, the ESS/ESVI cannot be
reoc::Il'Illel'as a predictor of~ clinical or LV func-
tional ooto::me. In contrast, the~ ejection perfor-
mance was superior in pta with a mE EF ~60 than in those
with a depressed PRE ejection fraction.
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CardiacSurgery
MANAGE}IENT OF PATIENTS WITH HEPARIN ASS OCIATED
THROMBOCYTOPENIAAND THROMBOSIS REQUIRING CARDIAC SURGERY
Raymond G. Makhoul . M.D• • Richard L. McCann. M.D. Char l es
S. Greenberg, M.D., James E. Lowe. M.D.• F.A.C. C.
Duke Univ e rsi ty Medical Cent er . Durham,Ne
Heparin associated thrombocytopenia and thrombosis (HATT)
i s an immune-mediated complication of heparin therapy
which results in intravascularplatelet aggregation and
vascul ar thrombosis . Cessation of hepari n with avoidance
of reexposure are recommended in the management ofHATT.
Some patients. however. require heparinization for
emergency cardiac surgery while still demonstrating a
platelet aggregating factor. Two patients developed
HATT, confirmed by in vitro platelet aggregation to
heparin. Both required emergency myocardial
revascularizationat a time when the platelet aggregating
factor was still present. Preoperatively. in vitro
addition of heparin (1 u/ml to patient plasma and
platelets resulted in platelet aggregati on (45% and 70%
respectively). Treatment of platelets with aspirin
totally abolished aggregation. Therefore. each patient
was given aspirin and dipyridamole and coronary
revascularizationwas performed with f ul l heparinization
without perioperative intravascular thrombosis or
bleeding. Thus. despite the presence of a
heparin-dependent platelet aggregating fac t or . patients
with HATT may be safely reexposed to heparin for
emergency cardiac surgery with the use of perioperative
aspirin and dipyridamole.
EARLY AND LATE HEALING RESPONSES OF CANINE ARTERIAL WALL
TO EXCIMER LASER IRRADIATION
Louis G. Prevosti, MD, Martin B. Leon. MD. FACC. Joseph
T. Dodd. MD.. Paul D. Smith. PhD. Robert F. Bonner-, PhD.
Hax Robinowitz. MD. FACC. RenuVirmani. MD. FACC. NHLBI.
Bethesda. Maryland
Although the Excimer laser (Ex) causes precise microabla-
tion without surroundingthermal tissue injury. the im-
portance of early and late healing responses must be de-
termined prior to safe therapeuticvascular applications.
In this stUdy. 180 craters (C) of varying depths (15-l05u)
were formed in 9 normal canine femorB2 artery segments ex-
posed in vivo to a 308nm Ex @36mJ/mm /pulse thrOUgh
600u silica fibers. After Ex injury. animals were sacri-
ficed (at 2 hours. 10 days. and 6 weeks). arterial seg-
ments were in situ perfusion fixed. and Ex sites were ana-
lyzed by light. scanning and transmission electron mi-
croscopy. At 2 hours. C endothelium was desquamatedand
covered by platelets and entrappedred blood cells. By 10
days. C depth was unchanged but a smoothmonolayer of
axially aligned normal endothelial cells was present with-
out surface organizing thrombus. At 6 weeks. there were no
aneurysms and only mild surface hyperplasticresponsesj C
were barely visible due to fibrointimal ingrowth consist-
ing of smooth mUSclecells in a mucopolysaccharidematrix
around a central core of granulationtissue. In this
first report of healing to Ex injury of normal canine fem-
oral arteries. we found: (1) early platelet adhesion with
rapid reendothelia1izationand no surface thrombus forma-
tion. and (2) late fibrointimal ingrowth without surface
damage or aneurysmformation. Thus, these favorable
acute and chronic pathologic responses in vascular tissue
suggest that the Ex is suitable for clinical laser angie-
plasty procedures.
FACTORS RF.LATED TO ATHEROSCLEROSIS OF SAPHENOUS VIHN
CORONARY BYPASS GRAFTS.
B. Charles Solymoss. KO. Parise Nadesu and Lucien
Campeau. MD, FACC. Montreal Heart Institute, Montreal.
Canada.
F.xamination of 210grafts (C) excised at reoperation in
193 patients (P) revealed atherosclerosis (A)
(lipid-laden foam cells in the intima) in 125 C (601.)
from 115 P (71'-) . 67'- of atherosclerotic grafts (AG)
had one to several complicated lesions (necrosis,
cholesterol c l ef t s or calcifications). AG differed from
NAG as follows: age of G (98 vs 77 mths . p<O.OOIl,
thickness of intima (645 vs 385U. p<O.OOl), external
diameter (6 vs 4.5. p<O.OOl). aneurysmal dilatation (9
vs 0). thrombosis (80 vs 44'-) . Patients with AC as
compared to P without had higher values for total
cholesterol (266 vs 246 mg/dl, 1'<0.01), LDL-chol (182
vs 159, p<O.Ol) and LDL-/HDL chol (5.1 vs 4.4. pe05)
(apolipoprotein B not studied). No difference in ase at
first grafting (48 yrs) , sex (KIF: 6 vs 5), frequency
of family history for A. smoking. systemic hypertension
nor diabetes. In stepwise logistic regression analysis,
total serum cholesterol was chosen as best
discriminator for A (p for improvement of chi square
test: 0.004, p for goodness of fit : 0.87) . The second
choice was age of graft (p=0.018 and 0.189
respectively). The combination of in itial blood flow of
graft and total cholesterol was the best discriminator
for thrombosis (p=0.025 and 0.439 respectively).
Thus factors related to GA in this population are age
of the G. elevated serum cholesterol and LDL-chol ,
increased thickness of the intima (hyperplasia) and
greater external diameter.
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CLINICAL FEATURES WHICH PREDICT HIGH COST OF
CORONARY ARTERY BYPASS SURGERY (CABS)
George Taylor,M.D.,F.A.C.C., Shezad Malik,M.D., Jerry
Colliver,Ph.D., Frank Mikell,M.D.,F.A.C.C., Weston Moses,
M.D.,F.A.C.C., James Dove,M.D.,F.A.C.C., John Batchelder,
M.D.,F.A.C.C., Joel Schneider,M.D.,F.A.C.C., Harry Wellons,
M.D.,F.A.C.C.,Prairie Cardiovascular Center, Southern
Illinois University, Springfield, Illinois
We prospectively evauated 500 patients (pts) having
CABS alone, with valve surgery (N=23), aneurysmectomy
(N=5) or carotid endarterectomy (N=6). Hospital charges
were assessed for each patient from the time of surgery
to hospital discharge.
Four of the 500 pts (0.8%) were "extreme outlyers"
with hospital charges exceeding 2 standard deviations of
the mean (charges ranging from $84,000 to $230,000).
These pts had complications of surgery (wound infection
in 2, respiratory failure in 2) that could not be predicted
from pre-operativevariables.
The other 496 pts were in hospital 9±4 days. Mean cost
was $1O,900±$3,100 (range $6,000-$28,000). Multiple re-
gression analysis showed that age and associated valve
surgery were the best predictors of high cost (p=.OOI)
followed by history of stroke or TIA before surgery (p=.004),
chronic obstructive lung disease (p=.006), left ventricular
ejection fraction (EF)<40% (p=.02) and hypertension (p=.03).
Sex, recent myocardial infarction, smoking, obesity, previous
CABS, diabetes, numberof vessels bypassed and pre-operative
angioplasty did not predict increased cost.
A cost equation was derived: Above a basic cost of
$6,800, age raised the cost by $55 x age in years, valve
surgery by $3,100, history of stroke-TIA by $2,400, chronic
lun!?, disease by $1,200, EF < 40% by $1,100 and hypertension
by 5570. Screening for these clinical features thus identifies
the potential high cost patient, and should aid in developing
logical reimbursementsystems.
'lHELEt'!'VENffiIQJLl\R Em-DIAS'roLICVOLUME 1>S A MARKER CF
HIGH MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY.
Daniel l'lilkioson. MA, Jaekyeong Heo, MoP-, Abdu1massih
S. Iskandrian,M.D., F.A.C.C. and Wi1liam Frank1, M.D.,
F.A.C.C., Hahnemann University, Philadelphia,
Pennsylvania.
This study examined the predictorsof post-operative
mortality among patients (pts) with severe left
ventricular (LV) dysfunction undergoing coronary artery
bypass surgery (CABG). 'lbe study group comprf.sed of 55
pts (48 men, 7 women) with a contrast angiographic
ejection fraction (EF) .$ 35%; DOne had aneurysmectomy or
associated valve replacement. At a follow-up of up to
46 months (mean 19), 11 pts died of cardiac causes
(20%). There were no significant differences between
the survivors and those who died in age (59±11 vs
58+12), number of diseased vessels (2.7±O.6 vs 2.6,±1.0),
number of grafts (3.0±0.7 vs 3.5±1.0), EF (29±6 vs
29,±5), LV end-diastolic pressure (23±9 vs 20±6), cross-
clamp time (43±12 min vs 46±17 min), and bypass time
(78±32 min vs 10~1 min). 'lbe LV end~iastolic volume
index (EDlTI, ml/m) (measuredpreoperative1yby contrast
angiography) wassignificantly differentbetween the two
groups; thus 7 of the 11 pts (64%) who died had
moderate-to-severeLV dilation (EDlT12120 ml/m2) while 35
of the 44 f,urvivors (80%) had no or mild LV dilation
«120 ml/m). Perioperativeinfarctionwas present in 3
of ~e remaining 4 r;atientswho died but had EDIlI < 120
m1/m. SUrvival analysis showed that the risk of dea~
was significantly higher among pts with EDIlI 2 1?£ ml/m
(7/16, 44%) than among pts with EVDI < 120 ml/m (4/39,
10%; Mantel-COx, p=O.002)~ 'lbe conclusion or severe LV
dilation (EDlT12 120 ml/m ) identifies a subgroup of pts
with severe LV dysfunction at high risk after CABG
(mortality rate 29%/year).
PREOPERATIVE NON-INVASIVE CAROTID EVALUATION OF
CORONARY ARTERY BYPASS PATIENTS
James W. Frederiksen,M.D., and 8etsy Finkelmeier,
R.N., M.S., Northwestern University Medical
School, Chicago, IL
To determine whether preoperativecarotid Doppler
ultrasoundimaging (CDUI) can predict the
occurrence of a postoperative neurologicdeficit
(ND) in patients (pts) undergoing coronary artery
bypass graft (CABG) operations, we reviewed 515
consecutive CABG pts during a12-month period who
were neurologically asymptomatic at the time of
operation. PreoperativeCDUI was performed on 158
pts (31%) in whom significant carotid disease was
suspected. Normal luminal size or < 50% stenosis in
one or bothcarotids was demonstratedin 131
pts, > 50% stenosis in 25, and unilateral occlusion
in 2. Fifteen pts (2.9%) developed a postoperative
ND: 13 had strokes, 1 of which was fatal, 1 a tran-
sient ischemic attack, and 1 a retinal artery embo-
lus. CDUI showed normal luminal size in 8 ND
pts, < 50% stenosis in 4, and severe unilateral steno-
sis in 1. Digital subtraction carotid arteriograms
were normal in the other 2 pts. Carotidarterio-
gram confirmed the CDUI findings in the pt with
severe stenosis (who died from the stroke) but
postmortemexamination showed that the ND was
caused by bilateral, symmetrical fibrin emboli.
Thus, in this group of 515 consecutive patients
not a single postoperativeND occurredwhich either
(1) resulted from significant carotid stenosis or
(2) could have been predicted by CDUI. This study
does not support theperformanceof extensive caro-
tid artery evaluation prior to coronary revascular-
ization in neurologicallyasymptomatic patients.
THE INCIDENCE OF PERSISTENT HYPERLIPIDEMIAS
AFTER CORONARY ARTERY BYPASSGRAFTING
J.S. Rankin, M.D. (FACC), P.D. Poe, .
L. H. Muhlbaier, Ph.D., S. H. Quarfordt,M.D.
Duke University Medical Center, Durham. N. C.
Since hyperlipidemias represent significant risk
factors for coronary atherosclerosis, therapy to control
lipid abnormalities after coronary revascularization
seems indicated; however, little is known about the
incidence and character of hyperlipidemias in
postoperative patients. Over a 2 year period. 400
patients undergoing coronary artery bypass grafting
were returnedto the clinic 2-12 months postoperatively
for fasting serum lipid determinations. Each patient
had low fat diet counseling once after surgery by a
dietitian, and none were receiving lipid-lowering drugs.
The upper limits of normal serum lipid values were
defined as: LOL cholesterol (CH) 190 mg/dl;
triglyceride (TR) = 170 mg/dl; apolipoprotein B-IOO =
90 mg/dl. Abnormalities were categorized as: Type II =
elevated (EL) CH, normal (NL) TR; Type lIB = EL CH
and TR; Type IV = NL CH, EL TR; and Type ApoB =
isolated elevation of apolipoprotein B-I00. Of the 400
patients tested, 86% had persistent hyperlipidemias in
the first postoperative year. The incidence of Type II
was 5%. Type lIB was 11%. Type IV was 50%, Type
ApoB was 20%, and NI. was 14%. Thus, persistent
hyperlipidemias are quite common in the post-coronary
bypass population, with Type IV predominating. Initial
postoperative dietary counseling alone seems to be
ineffective in controlling hyperhpidemias, and adequate
therapy probably will require frequent long-term
dietary consultation, periodic determination of serum
lipid values. and perhaps pharmacologic therapy in the
majority of patients.
lACC Vo!. 9, No. 2
February1987:87A
ABSTRACTS 87A
MYOCARDIAL REVASCULARIZATIOIJUSING BOTH INTERNAL MAMMARY
ARTERIES
W. Dudley Johnson, M.D., F.A.C.C., Kenneth Kayser, M.S.,
Jerold Brenowitz,M.D.
St. ~ary's Hospital, Milwaukee, WI
SERIAL EVALUATIOOS OF LATE 0lANGES IN 337 VEIN GRAF'l'S
UP 'ID 132 MCNl'HS AF'l'ER cnroNARY BYPASS
GeraldM. Lawrie, M.D., F.A.C.C. George C. Morris, Jr.,
M.D., F.A.C.C., Nan Earle, B.S., Baylor College of
Medicine, Houston, 'IX
From January1971 throughDecember, 1979, 585 patients
(pts) were revascu1arized using bothma~nary arteries
(MA). We generally reserve this operation for relatively
young, otherwise healthypts. (Average age was 54; 93%
were male.) Despite overall good prognosis, 89(15.2%)
pts had at 1east one of the fo11 owi ng: age over 70,
previous surgery, severeventriculardysfunction,
requirement for extensive endarterectomy.Coronary
disease was extensive: average number of grafts required
was 4.3; 408 (70%) pts received grafts to all three
systems. The left MA was placed to the circumflex(C)
system in 37% of the pts, to the LAD system in 63%. Tne
right MA was placed to the C8%, the right 6%, and the
LAD 86%. Actuarial survivalwas 97.6%, 92.5%, and 81.1%;
at one, five, and ten years. Present status is known on
499(85%) pts: 101 (20%) are dead, 17(3%) have been
reoperated, 18(3%) have severe angina, 100 (20%) have
mild angina, 263 (53%) have no angina; 168(34%) have no
angina and requireno anti-anginal medication. Average
followup of living patients was 119 months. Patency
studies after one year (average 54months) showed 132/183
(72.1%) vein grafts open, and177 of 194 (91.2%) MA
grafts open. This study supports the long termbenefits
of double mammary bypass.
Because of concern regarding late changes in saphenous
vein grafts (VG) a review was made of sequential
studies of 337 VG in 202 pat.ients (pts) up to 132 no,
after coronary bypass. At the first post-operative
study (FOS-l) at a mean interval of 42.5+1.8 (SE) mo.
after operation, 80.1% (270/337) of VG -were normal,
3.6% (12/337) were stenotic (>20%) and 16.4% (55/337)
were occluded. IDS-2 was at a mean interval of
87.4±2.2 mo. and of the 270 VG patent at FOS-l, 71.5%
(1931270) were normal, 10.0% (27/270) were stenotic,
and 18.5% (50/270) were occluded. Of the same group
of 337 grafts, 85 VG underwent POS-3,107.7+3.2 no,
after operation. In this subgroup, 58.8% (50/85) VG
were normal, 5.9% (5/85) VG were stenotic and 35.3%
(30/85) were occluded. The annual VG attrition rates
between POS-l andPOS-2 for the 270 VG normal at POS-l
were for stenosis - 1. 9%, and occlusion, 3.3%. Total
~~trition rates for the interval between operation and
FOS-2 for all 337 VG were: stenosis, 1.2%, and
occlusion, 3.9%. Statistical analysis showed that the
no. of VG performed (p<0.03), poor preop. ventricular
function (p<0.04l absence of preop. angina (p<0.004)
VG to right or circumflex artery (p<0.05), higher
triglyceride levels (293j:28 vs 228±13 llXJ/dll (p<0.03)
were all predictive of VG abnormalitybut cholesterol
levels were similar: 256±4.4 vs 255±7.6 llXJ/dl
(p>0.05). In conclusion, clinical factors influence
late graft patency, Triglycerides also influenced
late patency, Late patency in our experience is
better than previously reported.
Unstable angina pectoris at rest despite maximal medical
therapy represents the highest risk group with unstable
angina pectoris. Analysis of single variables influenc-
ing survival suggests age, ejection fraction «40%) & 3
or more diseased vessels independently influenced mor-
tality in a 10 year follow-up of 1,012 pts from 1973 to
1983 with refractoryunstable angina pectoris. At an
average of 5.1 years, the total mortality was 13.2%. To
better understand factor interaction, we performed
multivariate stepwise discriminate analysis to define
variables predicting survival. These included age, sex,
# of vessels diseased, # of grafts, left main disease,
global ejection fraction, LVEDP, Xclamp time, diabetes,
hypertension, cardiomegaly, previous myocardial infarc-
tion, intra-operative myocardial infarction & reqional
abnormalities of contraction. The variables were
weighted by importance.
RESULTS:
Variable F Statistic P Value
1. Age 12.6 .05
2. Ejection Fraction 11.5 .05
3. Left Main Disease 10.5 NS
4. Hypertension 9.6 NS
Thus, whether univariate or multivariate stepwise dis-
criminate analysis is employed, age and global left
ventricular function (independent of the # of vessels
diseased) are the major factors associated with long
term survival.
SURGICAL TREATMENT OF PROGRESSIVE REST ANGINA PECTORIS;
MULTIVARIATE STEPWISE DISCRIMINANT ANALYSIS OF FACTORS
INFLUENCING TEN YEAR SURVIVAL.
Marcus A. DeWood, MD, Ronald P. Grunwald, MD, FACC, Lloyd
W. Rudy, MD, FACC, Samuel L. Selinger, MD, FACC, Sacred
Heart and Deaconess Medical Centers, Spokane, WA.
A COHPARISON OF HORPHOLOGICAND ANGIOGRAPHIC FINDINGS IN
LONG-TERM INTERNAL HAHHARY ARTERY AND SAPHENOUS VEIN
BYPASS GRAFTS.
Harc E, Shelton, H.D., Hervyn B. Forman, M.D., F.A.C.C.,
Renu Virmani, M.D., F.A.C.C., William Stoney, M.D.,
Barrett Brantley, H.D., James B. Atkinson, M.D., Ph.D.
VanderbiltUniversity, Nashville, TN.
Internalmammaryartery grafts (IMAG) are currently
considered the conduits of choice for myocardial
revascularization. Comparisons of long term morphologic
changes in IMAG and saphenous vein grafts (SVG) and
correlationwith pre-mortem angiography have not been
reported. Grafts which had been in place for 12-118
mos. (mean 56) in 18 patients (pts) (mean age 56 yrs)and
which were removed either surgically or at necropsy were
examined. Angiograms were performedwithin 1 month of
histology. Risk factors included hyperlipidemia (16
pts) smoking (13 pts), hypertension (7 pts), and
diabetes (2 pts).
Morph Angio Ath FIP Organized
narrowing narrowing Thrombus
1 2 3 4 1 2 3 4
IMA (n-18) 3 4 1 10 4 2 1 8 l( 6%) *12(67%) 5(28%)
SVG (n-14) 1 1 3 9 1 1 3 9 *7(50%) 3(21%) 4(29%)
Stenosis:l-0-25%; 2-26-50%; 3-51-75%; 4->75%.
Ath-atherosclerosis, FIP-fibrointimalproliferation.
*P<.05. Total cholesterol tended to be higher in
atheroscleroticSVG (240 vs. 222 mg%). Hypercholestero-
lemia induced atherosclerosis in SVG but not in IMAG. A
good correlationwas noted between both the cause and
extent of narrowing angiographicallyand histologically.
Early IMAG and SVG closure probably occurs from post
operative thrombus. Accelerated atherosclerosis rarely
occurs in IMAG, but is common in SVG. FIP is commonly
associated with graft narrowing in IMAG, and may be an
important factor in late graft closure.
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IMPROVED DISTRIBUTION OF CARDIOPLEGIAWITH PRESSURE CON-
TROLLED INTERMITTANT CORONARY SINUS OCCLUSION (PICSO)
Harold L. Lazar, M.D., F.A.C.C., ThomasKhuri, M.O. and
Arthur J. Roberts, M.O., F.A.C.C., Boston University
Medical Center, Boston, MA.
When coronary occlusions are present, cardioplegic distri-
bution is heterogenous and ischemic damage occurs. This
study was undertakento determine whether pressure con-
trolled intermittantcoronary sinus occlusion (PICSO)
improves cardioplegic delivery and reduces ischemic injury
when coronary occlusions are present. Twenty pigs were
placed on cardiopulmonarybypass and subjected to 120
minutes of ischemic arrest with antegrade, multidose,
potassium, crystalloid cardioplegia. During arrest, the
mid left anteriordescending artery (LAD) was occluded
with a snare which was released upon reperfusion. In 10
pigs, a 07 French balloon-tippedcatheter was positioned
in the coronary sinus and PICSO was performed during each
cardioplegic dose. Parametersmeasured included tempera-
ture and tissue pH beyond the LAD occlusion, end-diastolic
pressure (EDP) - volume (EDV) curves (2'0 echo), and
stroke work index (SWI). PICSO treated hearts had faster
arrests (27+5 SE vs 102+21 sec*) and lower distal LAD
temperature;(16.7+3 vs-18.2+.50C*). Tissue pH increased
following each dose of cardioplegia inPICSO hearts (6 .73
+.05 to 6.78+.06*) whereas pH decreased in non-PICSO
hearts (6.7~.07 to 6.72+.07 NS). As a result of this
better cardioplegic distribution, postischemic EDV** was
unchanged in PICSO hearts (66+5 vs 67+5 ml NS) but de-
creased in non-PICSO hearts (58+4 vs 50+3 ml *). PICSO
hearts also generated a higher postischemic SWI+ (.70+.08
vs .3l~.06 g-m/kg*). We conclude that PICSO improves -
cardioplegic distributionthus reducing ischemic injury.
EFFECT OF CLINICAL STATUS AFTER FAILED ANGIOPLASTY ON
SURGICAL MORBIDITY AND MORTALITY.
Ann R. Connor, M.D., Ronald E.Vlietstra, H.B., Ch.B.,
F.A.C.C., Hartzell V. Schaff, M.O., F.A.C.C., Jeffrey M.
Piehler, H.O. and James R.Pluth, M.O., F.A.C.C., Mayo
Clinic, Rochester, MH.
To assess the effect of clinical status after unsuccessful
angioplasty (PTCA) on the likelihood of Q-wave infarction
(QMI) or death after immediate coronary bypass, we studied
145 Pt with failed PTCA between 1979 and 1986. QMI
occurred in 60 (41S), and 4 (3S) died. Groups: 1, PTCA
vessel unaltered; 2, vessel further narrowed or occluded
without symptoms; 3, also angina or ST changes; 4, Pt
became hemodynamically unstable. The frequency of
single-vessel disease (SVD) and multivessel disease (HVO)
and the incidence of QMI and death were:
2 3 4
No. S No. S No. S No. S
Total 39 15 57 34
SVDIMVD 18/21 11/4 32/25 16/18
QMI:
Total 4 10 4 27 29 51 23 77-
In SVO 0 2 18 17 63 10 71-
In MVO 4 19 2 50 12 48 13 72
Death 0 0 0 4 12-
-~ < 0.05 ( x 2) for differences between groups.
There is a greater risk of QMI when failed PTCA is
complicated by increased narrowing or occlusion. However,
this risk was no greater in HVD than in SVO in our select
Pt group andcaused increased hospital mortality only when
hemodynamic instability resulted. *p (.02 **EDP=lOmmHg +EDV=6Oml
We conclude that allopurinol helps preser vemyocardial funct ion
after cross-clamping and reperfusion either when administered
systemically beginning 90 minutes before cross-clamping or
when added to astandardcrystalloid cardioplegic solution.
MYOCARDIAL FUNCTION PRESERVED BY ALLOPURINOL
GIVEN SYSTEMICALLY OR IN CARDIOPLEGIC SOLUTION
Misaki Miyamoto, MD., GregQry A. Misbach. M.D., F.A.CC
Koichi Tabayashi, M.D., Robert ThQmas, RA., Andrc w
Luedtke , B.S.E., Tom D. Ivey, M.D., Uni versit y ofwashingron.
Seattle, WA
Oxygen free radicals generated by xanthine oxidase (XO)
react ion may contribute to myocardial ischernia/reperf'usion
injury after aortic cross-clamping during card iac surger y. Wc
studied whether inhibition of XO by allopurinol given
systemically or in eard ioplegic solution helped preserve
myocardial function. Three groups (n=7 each) of dogs werc
studied : I (control), II (allopurinol pretreatment50 mg/kg IV
given as a I hour infusion completed 30 minutes beforecross-
clamping and 250mg/L in the pump prime),III (allopurinol in
cardioplegic solution 250 mg/L). All dogs weresubjected to 120
minute s of aortic cross-clamping with cold crystalloid
cardioplegic solurion maintaining an average myocardia!
temperatureof 16°C. Left ventr icularf'unct ion was evaluated by
sonomicrometry and solid-state micrornanomcrers before
cardiopulmonary bypass and after weaning from bypass
Following 60 minutes of reperfusion.
meanvcr
65:!:20
98 ±19 **
114± 12 **
Emax
73±22
108±30*
113±36*
% Recovery of Control Value (± 5.0.)
Stroke Percent
Group Work Shortening
I 46±20 73±32
II 127±38** 112t32*
III 81:!:18** J23±28**
·p<0.05; ··p<O.OI vs Group 1
ENHANCEMENT OF ISCHEMIC MYOCARDIAL RECOVERY BY CORONARY
VASODILATORY EFFECTS OF PRDSTACYCLIN
Edward S. Yee, M.D.,M.P.H. &Wen-Ren Hsieh, M.D.
University of California, San Francisco
Recent studies demonstrated the importance of immediate
antithromboticeffects of prostacyclin (PGI2) in mediatingthe intravascularplatelet deposition and improving myo-
cardial performance after global ischemia.
METHODS: Fourteen isolated canine hearts were supported
by non-pulsatile coronary blood flow at 100 mmHg and were
studied for peak systolic pressure (PSP), DP/DT, and cor-
onary sinus catheters for coronary blood f low (CBF),
oxygen extraction (02 EXTR). Each heart s ustained onehour global ischemia with potassium cardioplegia at 25°C
and one hour reperfusion.
RESULTS: RECOVERY PERIOD (MINUTES)
POST ISCHEMIA 15 30 60
PSP 77 + 19 90 + 31 118 + 18
+PGI2 97 ~ 18 116 ~ 35 137 + 37*DP/DT 65 + 17 93 + 47 125 + 32
+PGI2 110 ~ 58* 130 ~ 55* 145 + 54*CBF 151 + 571, 114 + 51 101 r 55
+PGI2 129 ~ 62* 129 ~ 73 158 + 77*O2 EXTR 60 + 42 91 + 48 117 r 99+PGI2 82 + 40 133 ~ 113* 139 ~ 42
* P < 0.05 (All values are %pre-ischemic controls).
CONCLUSION: Myocardial recovery after global i schemia is
a time-dependentwith maximal resuscitation after one hour
of supported reperfusion. PGJz modified this time course
by the coronary vasodilatory effects during the second
half hour with increased coronary blood flow and subse-
quent improved oxygen extraction and associated myocardial
performance (PSP, DP/DT). PGI 2 can play an important rolein offering maximal or sustained vasodilatory effects to
enhance the recovery of post-Ischemic myocardium.
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PRE 22 t 10 55 t 18/34 t 14 40 * 10 1.6 * 0.3
3 Mo 16 *4 52 *6/22 *6 24 t 6 2.2 *0.2
All pts improved at least one functional class and the
average weight loss associated with improved ambulation
and diuresis was 31 pounds (24-51). Only one pt has
required rehospitalization for CHF. Ambulatory
Dobutamine therapy is well tolerated and provides a
significant improvement in measured hemodynamics and
functional class. This clinical improvement may
increase chances for optimal results with
transplantationin same pts.
AMBULATORY INOTROPIC THERAPY AS A BRIDGE TO CARDIAC
TRANSPLANTATION.
Leslie W. Miller, M.D, St. Louis University, St. Louis,
MO.
Congestive heart failure (CHF) refractory to
conventional medical and surgical therapy is the main
indication for cardiac transplantation. An increasing
number of transplant candidates are unable to be
maintained out of hospital prior to the transplant due
to the severity of their heart failure. Four pts who
were hospitalized at least twice in three months for
CHF, or demonstrated an inability to be weaned from IV
inotropes, are currently being maintained at home
preoperatively with the use of an ambUlatory IV pump
which infuses Dobutamine at a rate of 5 mg/kg/min for a
mean of 3.1 days per week (2-5). The mean age of these
pts is 45 years <38-56). Three pts had an idiopathic
cardiomyopathy and one had an ischemic etiology. All
pts were functional Class IV and 40 pounds over ideal
weight. Hemodynamic parameters were obtained prior to
initiating the ambUlatory Dobutamine (PRE) and after 3
months of therapy (3 Mo).
AA N ~W cr
y
acyl carnitine, ATP=adenosine triphosphate,CP=creatine
phosphate (expressed as ~mol/g dry wt); LVdp/dt (% con-
trol), LVEDP (mmHg). (*p<.05, compared to -NA).
These results suggest that thesignificant accumula-
tion of FFA and their acyl derivatives are potential
mediators of ventriculardysfunction following hypo-
thermic crystalloid cardioplegia, and this can be
improved by the addition ofNA.
VENTRICULAR DYSFUNCTION FOLLOWING HYPOTHERMIC CRYSTALLOID
CARDIOPLEGIA, IMPROVEMENT BY ANTILIPOLYTICTHERAPY.
Haiime Otani~ Ph.D., M.D., Richard M. Engelman, M.D.,
F••A.C., Su haJlt Datta, M.D., John A. Rousou, M.D.,
Robert H. Breyer,M.D., Gerald Cordis, M.A., Randall M.
Jones, B.A., Dipak K. Das, Ph.D. University of
Connecticut,Farmington, CT and BaystateMedical Center,
Springfield, MA.
Myocardial ischemia results in inhibition of a-oxida-
tion and activation of lipolysis. We examined whether
abnormal lipid metabolism is associated withmyocardial
dysfunction following cardioplegic arrest using isolated
in-situ pig hearts (n=26) undergoing 120 min hypothermic
potassium crystalloid cardioplegia and 60 min reperfu-
sion. The experimental group (n=13) received 0.08 mM
nicotinic acid (NA) 15 min prior to ischemia to inhibit
lipolytic activity. The following results were obtained:
FFA FACoA FACarn ATP CP LVdD/dt LVEDP
Cont .659 .164 1.85 28.2 76.1 100 12.6
'"Preisct .667 .165 1.85 26.9 77.2 106.7 12.4z:
I Isch .948 .292 3.94 25.2 10.6 - -
ReDer .964 .204 2.65 21.4 63.6 40.8 32.4
Cont .684 .165 1.86 26.6 83.0 100 12.2
'" Preisct .674 .164 1.82 24.9 80.0 105 11.8z:
+ Isch .642* .236* 3.15* 26.1 20.5* - -
Reoer .701* .176 2.06* 21.4 77.6 65.8* 20.2
FFA=free fatty acid, FACoA=fatty acyl CoA, FACarn=Fatt
POSTISCHEMICATP LEVELS FAIL TO CORRELATE WITH REGIONAL
FUNCTIONAL RECOVERY AFTER SURGICAL REVASCULARIZATIONOF
ACUTE INFARCTION.
Jakob Vinten-Johansen, Ph.D., Kim Hansen, M.D., T. Arthur
Edgerton, M.D., Stephen A. Mills, M.D., Harold R. Howe,
M.D., and A. Robert Cordell, M.D., Bowman Gray School of
Medicine, Winston-Salem, N.C.
The preservationof tissue ATP stores has been used as an
index of myocardial viability and adequacy of protection
in cardiac surgery. This study tests the hypothesis that
ATP depletion after coronary occlusion dissociates this
correlationbetween ATP levels and functional recovery
after surgical reperfusion. Thirty-seven anesthetized,
open-chest dogs underwent 1 hour of left anterior descend-
ing coronary artery occlusion, which abolished contractile
shortening in the involved segment (25.2 + 2.2% to -5.8 +
1.2%*, ultrasonic crystals) and depleted subendocardial-
(ENDO) ATP by 80%* (28.0 + 0.6 vs 5.5 + 1.4 nM/mg
protein). After occlusio~, the ischemIc segments were
non-surgically reperfused (NSR) by releasing the ligature,
or surgically on bypass using either blood (BCP) or
crystalloid (CCP) cardioplegia. Postischemic ENDO ATP
levels were comparable regardless of mode of reperfusion,
averaging 8.5 + 2.7* (NSR) , 12.6 + 2.8* (CCP) and 12.0 +
3.2* nM/mg protein (BCP). No contractile function was -
restored in NSR (-6.9 + 2.0%) or CCP (0.2 + 1.7%) seg-
ments. In sharp contrast, BCP segments recovered 32% of
preischemic function (8.0 + 1.9%), despite its 57% de-
pressed ATP. We conclude that ATP does not correlate
with postischemic function in the setting of evolving
infarction.
*p<0.05 vs Control
ANTIBIOTIC STERILIZATIONIN THE PREPARATION OF HOMOVITAL
HOMOGRAFT VALVES: IS IT NECESSARY?
Lorenzo Gonzalez-Lavin, M.D., F.A.C.C., Lynn B. McGrath,
M.D., F.A.C.C., Debra Graf, R.N., Marta Alvarez, R.N.,
Deborah Heart and Lungcenter, Browns Mills, New Jersey.
Antibiotic immersion has been an established method of
sterilizing homograft valves collected at autopsy (fresh)
since 1968. However, antibiotics negatively affect the two
factors thought to influence long-term valve survival; cell
viability and host ingrowth into and onto the implanted
leaflets. The source of homograft valves has expanded to
include hearts obtained under sterile conditions from brain
dead, multi-organ donors (homovital). It has been postu-
lated that hornovital valves are sterile and may be stored
in nutrientmedia alone.
In order to examine this possibility, we modified our homo-
graft protocol to include microbiological cultures prior
to immersion in antibiotic solution (Cefoxitin 240 mcg/ml,
Ticarcillin 2.5 mg/ml, Polymixin 100 mcg/ml, Neomycin 250
mcg/ml, Nystatin 500 Vlml. Cultures performed for aerobic
and anaerobic organisms were subculturedevery third day
and observed for a period of 10 days. Fungal cultures were
observed for 1 month. Ten homovital valves were procured.
Eight had positive cultures within 48 hours (80\): anaero-
bic diptheroids (4), staph aureus (2), and proprionibacte-
rium (2). Of the 8 contaminatedvalves, 6 had negative
cultures following 48 hours exposure to the antibiotic
solution. We have implanted 10 antibiotic treated homo-
vital valves; 1 patient developed a retrosternalinfection.
We conclude that in spite of careful procurementunder
aseptic conditions, homovital tissue should be considered
contaminated. Antibiotic exposure is an essential step
in the preparationof all homograft valves, and should not
be disregarded.
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AMIODARONE THERAPY IN CARDIAC AND NONCARDIAC
SURGERY
Ildefonso J. Mas, M.D., MaryHarlan, R.N., Ali Massumi,
M.D., F.A.C.C., John J. Seger, M.D., F.A.C.C., Robert J.
Hall, M.D., F.A.C.C. Clayton Foundation for Research -
St. Luke's Episcopal Hospital, Texas Heart Institute,
Houston, Texas.
Amiodarone (A) therapy has been associated with post-
operative bradyarrhythmias,hypotension, and the adult
respiratory distress syndrome (ARDS). We fol Iowed 23
consecutive patients (pts) on A undergoing 30 general
anesthetic procedures (19 cardiac, 11 non-cardiac).
Cardiac surgeries (CS) were transplantation (CTX) (12
pts), coronary bypass ± LV aneurysmectomy (5 pts), and
other (2 pts). Mean pre-op ejection fraction was 28 ± 14
on a mean A dose of 450 ± 120 mg for 6.4 ± 10 mos. Ven-
tricular tachycardia was the indication for A in 22/23
pts, Factors analyzed were serial ABGs, chest x-rays,
intubation and ICU time, arrhythmias, hemodynamics and
mortality. Postoperative isoproterenol infusion time and
rejection parameterswere also followed in CTX pts. No
episodes of post-op ARDS occurred. There was no differ-
ence in post-op hemodynamic parameters, bradyarrhythmias,
ICU days, intubation days, isoproterenol infusion time,
rejection parameters, or mortality (all p > 0.05), as
compared to a control group of similar pts not on A
undergoing CS (n=15), non-CS (n=15), and CTX (n=15).
During follow-up of 13.5 ± 9 mos, no difference was noted
in mortality or biopsy evidence of rejection for the CTX
pts on A vs. CTX controls not on A (p >0.05).
We conclude (l) there was no significant difference of
cardiac or pulmonarycomplications in A treated pts vs.
controls, (2) pre-op A did not influence mortality or
rejection parametersof CTX pts.
INFLUENCE OF ORTHOTOPIC CARDIAC TRANSPLANTATION ON CIRCU-
LATING ATRIAL NATRIURETIC FACTOR (ANF) IN HUMANS.
James A. Arrowood, M.D.. Pramod K. Mohanty, M. D., FACC,
James R. Sowers. M.D., Marc D. Thames, M.D., FACC, V.A.
Medical Center andMed. ColI. of Va., Richmond, Virginia
Patients with congestive heart failure (CHF) have high
circulating levels of ANF due to atrial distension. We
hypothesized that removal of the stimulus for the release
of ANF would result in decreased levels of the circulating
hormone. Thus, we determined the basallevels of ANF pre-
sent in heart failure and following cardiac transplanta-
tion (CT). We also determined the responses ofthese
groups to the application of lower body negative pressure
(LBNP; -20 and -40 mmHg) which acutely reduces atrial
pressure and thus the stimulus for ANF release. The data
are summarized in the table. (*p<0.05, CT vs. CHF; t
p<O.OI, base1i ne vs. LBNP)
LBNP
Base1i ne -20 -40
ANF CHF (n=7) 179±17 93.4±16t 83±12t
(fmol/ml) CT (n=4) 76.6±16* n.7±17* 77.5±17
These data show that ANF can be reduced in heart failure
patients acutely by application of LBNP as well as chron-
i ca11 y by cardi ac transp1antation whi ch returns cardi ac
function and cardiac filling pressures to normal. Our
data also suggest that the basal secretion of ANF in sub-
jects with normal cardiac function is related to factors
other than cardiac distention since application of LBNP
with reductions in cardiac filling pressure and atrial
dimension failed to reduce levels of ANF in the transplant
subjects.
No recipient-relatedfactor (age, diagnosis, PVR) had im-
pact on RHF. D-age and ischemic time had no, ECC border-
line significant influence. Weight difference between D and
R was strongly correlatedwith RHF.
Conclusion: Weight mismatch between D and R represents the
main factor for postoperative RHF. Therefore, D of greater
weight than R should be selected for HTX whenever possible.
Both PVR and ischemic time in the ranges described had no
impact on postoperativecardiac performance.
RISK FACTORS OF RIGHT HEART FAILURE (RHF) AFTER ORTHOTOPIC
HEART TRANSPLANTATION (HTX).
Th. Wahlers, M.D., A. Haverich, M.D., H.-J. Schafers, M.D.,
G. Herrmann, M.D., H.-G. Fieguth, M.D., H.G. Borst, M.D.,
Hannover Medical School, Hannover FRG
In HTX recipients RHF remains a predominantcourse of post-
operative morbidity. Of 51 pts undergoing HTX since 10/1985
10 pts (group I) required no or minimal inotropic support
«3 days). In 7 pts (group 11) moderate to severe RHF com-
bined with renal dysfunction occurred and extensive ino-
tropic and diuretic treatment «5 days) was necessary. To
investigate risk factors for RHF, donor (D) and recipient
(R) relatedandoperative variables were evaluated: Age (D,
R), weight (D, R), weight difference (R minus D), R-pul-
monary vascular resistance (PVR) , R-diagnosis (COCM vs.
CAD), D-heart ischemia, cardiopulmonarybypass time (ECC).
D age (yrs)
D weight (kg)
Rage (yrs)
R weight (kg)
Difference (kg)
Ischemia (min)
ECC (min)
CAD/COCM
gJ:"O.4> I
25 + 10
73.3 + 8.9
38 +11
64 +15
+9.3 +13
110 + 48
73 + 7
3/7
gJ:"O.4> II
25 + 9
66.7 + 4.5
39 +12
75.1 + 8.3
-7.1 + 8
ill + 47
f57 + 19
1/6
p-value
n,s,
0.05
n.s.
n,s
0.01
n.s,
0.05
n,s ,
ASSESSMENT OF THE TIME COURSE OF PRIMARY BIOPROSTHETIC
VALVE FAILURE. John Kenny, MD, Ted Plappert, Satinder
Bhatia, MD, FrederickSchoen, MD, PhD, Martin St. John
Sutton, MD. Brigham and Women'sHospital, Boston, MA.
To determine the onset and compare the rates of primary
failure between AVR and MVR, we performed Doppler
echocardiograms (DE) on 161 pts with bioprostheses, 97
aortic (AVR) and 64 mitral (MVR). Pts with endocarditis
and paravalvarleaks were excluded. DE was used to
detect morphologic abnormalities such as calcification
(CA), immobile and flail leaflets, quantify regurgitation
(1-4+), and calculate peak aortic, peak and end-diastolic
mitral gradients and mitral areas. Pts who had DE
studies within 3 months of valve implant and normal
leaflets were used as controls. In the normal AVRs
(n=24) peak gradients were 24±12 mm Hg, and in normal
MVRs (n=14) peak and end-diastolic gradients were 9±2 and
o mm Hg, and meanarea 2.1+O.7cm2 • An AVR gradient )48
mm (mean+ZSD) and an MVR area ( 1.4 cm2 were considered
indicative of stenosis. Pts were divided into 3 groups,
group I 0-4 yrs , II 4-8 yrs, and III>8 yrs from valve
implantation. Leaflet CA and flail cusps in AVR and MVR
occurred overall in 6570 vs 7170 and 1370 vs 19% respective-
ly, both increasing with time. Of the AVRs, 1170 of group
I, 1670 of group II and 4370 of group III had gradients)48
mm, while 1970, 4870 and 3570 respectively had ) 1+
regurgitation. Of the MVRs 070 of group I, 24% of group
11 and 1370 of group III had valve areas (1.4 cm2 while
ZI70, 4170 and 8070 respectively had )1+ regurgitation.
Thus by 4 yrs 3070 of AVRs and 2170 of MVRs were hemo-
dynamically abnormal which increased to 6470 and 6570 at 8
yrs. We conclude that 1) primary failure is detectable
by DE in almost 2570 of pts at 4 yrs: 2) the failure rate
of AVR and MVR is similar, and is asssociated with
leaflet CA; 3) all bioprostheses should be regularly
screened by DE to identify primaryvalve failure early.
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RECENT IMPROVEMENTS IN LATE SURVIVAL AFTER DOUBLE VALVE
REPLACEMENT AND TRICUSPIDANNULOPLASTY.
Charles J. Mullany, M.B., M.S., Bernard J. Gersh,
M.B.,Ch.B., D.Phil., F.A.C.C., Thomas A. Orszulak, M.D.,
Hartzell V. Schaff, M.D., F.A.C.C., James R. Pluth, M.D.,
F.A.C.C., Francisco J. Puga, M.D., F.A.C.C. and Gordon K.
Danielson, M.D., F.A.C.C., Mayo Clinic, Rochester, MN.
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Improved late postoperative survival during the more
recent interval may be due to better myocardial protection
or to improved medical care during follow-up.
Between 1965 and 1984, 109 Pt (67 women and 42 men)
underwent double valve replacement plus tricuspid
annuloplasty. Mean age was 54 yr (range, 12-82 yr).
Perioperativemortality (PM) was 21~. On univariate
analysis, severe (NYHA class IV) preoperativedisability,
pulmonary hypertension, and elevated serum creatinine were
significant predictors of PM. Late survival was
influenced by age and NYHA class preoperatively;also,
those who underwent operation after 1975 had significantly
improved late survival compared with before 1975. This
improvement occurred despite the older age (58 yr vs 50
yr; P < 0.01) and greater disability (32~ class IV vs 14~;
P < 0.05) in Pt undergoing operation after 1975. The 5-yr
actuarial survivals (mean Z SE) were:
'f < 0.05; tK=0.08 (vs 1965-74).
Year of
operation
1975-84
1965-74
All
80+7'
68~6
By
>60 yr
76+10'
40~15
Survival, ~
age
<60 yr
By preop.
NYHA class
IV <IV
51+16t 89z625~21 73z7
SERIALANALYSIS OF SPONTANEOUS AND INDUCED VENTRICULAR
ARRHYTHMIAS IN A CANINE MODEL OF MYOCARDIAL INFARCTION
Akihiko Nogarni, M.D., Noritami Tashiro, M.D., Ronald
Sampsell, D.V.M., Jose Pinero, M.D., F.A.C.C., John J.
Rozanski, M.D., F.A.C.C., ArthurJ. Gosselin, M.D.,
F.A.C.C., John W. Lister, M.D., F.A.C.C. Miami Heart
Institute, Miami Beach, FL.
To study the time course of spontaneous ventricular
arrhythmias (VA) and VA inducibility after myocardial
infarction (MI), MI was created in 13 dogs by ligation of
the left anteriordescending coronary artery and ligation
and reperfusion of the obtuse marginal branch. Halter
monitor was recorded on days 1 to 29. There were 3 early
deaths «36 hours) related to large mass of MI (p<0.05).
Spontaneous ventriculartachycardia (VT) occurred in all
dogs on days 1 to 3. After day 10 no dog had VT and after
day 13 none had couplets. VT cycle length on day 2 was
significantly shorter (274±36 ms) than day 1 (308±27 ms:
p<0.007) or day 3 (303±44 ms:p<0.04). For 10 survivors,
noninvasive electrophysiologic study was carried out on
days 8, 15, 22 and 29, via an implanted antitachycardia
pacemaker (Cordis, Orthocor 11) using 1-3 extrastimuli
and burst pacing. On day 8, 4/10 dogs had inducible VT
and 3/10 had ventricularfibrillation (VF). On day 15 two
more dogs became negative, and previously negative dogs
remained negative. A large MI size was the only variable
associated with inducible VT/VF after day 15 (14.7±2.3%LV
vs 5.8±3.8%LV:p<0.005). There was no difference in Halter
VA grade, effective refractoryperiod of LV, QRS, QT and
QTc between inducible VT/VF and negative group.
CONCLUSION: (1) Spontaneous sustained VT occurred in
all dogs on day 1 to 3 with the shortest cycle length on
day 2. (2) There was no relationshipbetween Halter VA
grade and inducibility. (3) Inducibility after day 15
remained constant and was associated with large MI.
THE CARPENTIER-EDWARDSSUPRA-ANNULAR PORCINE BIOPROSTHESIS
- NEW GENERATION TISSUE VALVE WITH EXCELLENT CLINICAL
PERFORMANCE
WoRoEo Jamieson, MoD., FoA,CoCo, AoNo Gerein, MoDo, Po
Allen, MoD., A.!. Munro, M.D., F.A.C.C., R.T. Miyagishima,
M.D., L.H. Burr, M.D., F.Chan, J. MacNab, E. Germann,
G.F.O. Tyers, M.D., F.A.C.C. University of British
Columbia, Vancouver, Canada.
This investigational valve was implanted in 1176 patients
(1185 operations, 1270 valves) November 1981-December 1985
(age 13-85 years, mean 61 years). Early mortality was
7.0% (with concomitant procedures 10.6%, without 4.7%); (
previous operation 10.2%, without 6.4%). Latemortality
was 4.5%/pt yr (AVR 4.0%, MVR 4.8%, MR 0.4%). Total
cummulative follow-up was 2288 years. Thromboembolism
(TE) 2.6%/pt yr (fatal 0.3%/pt yr), (major 1.4%, minor
1.2%). Anticoagulant hemorrhage (ACH) 0.7% (fatal 0.04%).
Hemolyses 0.04%. Prosthetic valve endocarditis (PVE) 0.3%
(fatal 0.1%). Periprostheticleak (PPL) 1.0% (fatal
0.04%). Prosthesis failure (PF) (primarytissue failure/
structural failure) 0.09%/ptyr. Reoperation 0.6%/pt yr
(TE 0.09%, hemolysis 0.04%, PVE 0.04%, PPL 0.3%, PF 0.09%).
TE incidence reduced after 2 years, ACH throughout
observation, PVE early, PPL throughout, PF late, Survival
79.2 ± 3.3% ( 5 years). Freedom from (5 years) TE 91.8 ±
2.5%, ACH 96.5 ± 2.4% (4 years), PVE 95.7 ± 6.1%, PPL
88.5 ± 8.2%, PF 98.8 ± 1,6%, reoperation97.6 r 1,8%.
Freedom from all complications (5 yrs) 85.5 ± 3.7%,
complication mortality 98.8 ± 0.8% and valve failure
(mortality and reoperation) 96.7 ± 1.6%. This investiga-
tional Carpentier-Edwards,supra-annularporcine bio-
prosthetic valve has providedexcellent clinical perfor-
mance and remains ouroverall prosthesis of choice.
CURRELAr1O~ OF AiJlWPT C,IA"GES U REfRACTURUESS At'[)
FUNCflONAL CUNDUCTiUN BLOCK llY ,11Gll RGSULUTIUN ELECTi,ODE
RGCUR:JUGSI, THE PUST L,FARCTED CAI'rNE dr:ART
Mark Re s t i vo , HS, William B. Cough , PhD, «a bi I ~l-ShE"ri[,
MO:-'ji\cc-;--i;UNY:lealthScience and VA Medical Cerrt e r s ,
Brooklyn1 New York
Happi ng studies from our lab have shown in 4 day post
infarction canine ue a rt s rha t an arc of functional con-
duction block (FCll) occurs bervecn recordings sites (6-1(;
mm) whi~ll differ in pffective ~efractoriness (EKP) by 20
msr-c or more. St nce it has also been proposed that a re-
duced safety [actor along fiber orientation i, ani~otro­
pie t i s sue may be res ponsi nl e for FCJi, we designed a nigh
density (1 mm interelectrode spacing) oipolar electrode
p l aque (dDE) to record simultaneous electrograms and mea-
sure ERP at 32 si t e s , EKP was l1'Il?r1sured at '2 times r ure s -
hold. Unly si tes where threshold wag less than 1. 5 lIlA
were studied to avoid engaging adjacent sites. In 7
hearts INhere whole ventricle mapping at CJ4 si tes showed
epicardial re e n r r a n r activation, tile i-1DE was placed be-
rwee n sites be l l e ved to exhibit FCll. FCll occurred 'illdden-
l y , within 1 mm) be tween sites showing an abrupt change
in £RP of 1U-25 msec . Conducti on preceding FCll wag not
dec r eme nt a l and vas greater than 0.1 m/sec in all trials.
Electrotonic deflections present in electrograms recorded
both proximal and di s t a I to FCll were synchronous with
corre.pondi~g activation recordpd on the opposite side of
the FCll. Elpctrotonus seen at multiple sites decreased in
a mpl i t ude with dis t a nce from the site of FCll. The site of
FCll wa, shifted by varying the premature interval.
Simi l a r f I ndi ngs were consistently observed wl,pn the IiDE
was moved along the arc of FCll. ThE're fore: 1) abrupt ERP
changes, within 1 mm, torm the basis tor functional
conduction block in the ischemic heart; 2) multiple high
density recordl~gs demonstrate ~Iat a continuous arc of
block exists during reentrantactivation.
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Thus the dogs with compensatory increased LV function hod 0
srncller extent of circumferential LV dysfunction and 0 higher
area EF, despite similar myocardial areas at risk by
autoradiography. These data suggest that the extent of
compensatoryincreased LV function determinesthe global impact
of acute coronary occlusion and through interaction with the
functional borderzone, modifies the extent of circumferentialLV
dysfunction.
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COMPENSATORY AUGMENTATION OF NORMAL REGIONAL
FUNCTIONFOLLOWINGCORONARYOCCLUSION: RELATION
TO MYOCARDIAL AREA ATRISK ANDEXTENT OF ISCI-EMIC
DYSFUNCTION
Charles A. Lefkowitz, M.D., Kim P. Gallagher, Ph.D., Diane P.
Pace, B.S., Laurel A. Wright, B.S., Usa C. Krause, M.A., Andrew
J. Buda, M.D., FACC, University of Michigan Medical Center,
Ann Arbor, Michigan
Compensatory increased regional LV function frequently
occurs in the non-ischemic myocardiumfollowing acute coronary
occlusion. To further define the effects of compensatory
increased function in the ischemic LV, we studied 22 dogs before
and I hour after left circumflex coronary artery occlusion. The
dogs were classified into those with and without compensatory
increased regional LV function (defined os regional wall-
thickening (wn-!) greater than 2 SD above baseline). The
following results (mean ± SD) were found after occlusion:
COMP(n=ll) NO COMP(n=ll)
76±15 45±14*
-8+13 -9+1 I
41±6 37tl2
Nonischemic WTH(%)
Ischemic WTH(%)
Myocardialarea at risk (%)
Extent of circumferential
dysfunction(degrees) 136±33 179±43*
Area EF (%) 38±9 27t6*
*p < 0.001; COMP=compensatory increased LV function;
EF=ejection fraction
CORONARYEFFECTSOF ATRIALFIBRILLATIONANALYZED
BY PRESSURE-FLOW RELATIONS
Georg Ertl, M.D., Win,fr,ied S~hor~, ..Joh~nnes Bittorf, Kurt
Kochsiek, M.D., Med. Kllnlk, UnlversitatWurzburg,FRG
Atrial fibrillation may influence coronary blood flow (CBF) in
myocardial ischemia. Due to the dependence of CBF on perfu-
sion pressure (CP), CP-flow relations (PFR) provide informa-
tions superior to simple CBF measurements. Antegrade PFR
show autoregulation,and effects in and below the autoregula-
tory range may be tested. RetrogradePFR allow the evaluation
of collaterals and the terminal ischemic vascular bed. Ante-
grade (ne l 0) and retrograde(n=6) PFR were analyzed following
cannulation of the LAD in anesthetized dogs at sinus rhythm
and atrial fibrillation, respectively. Regression equation of
antegradePFR was CBF = 1.59CP -20 (R=0.67, P 0.05) dur~ng
sinus rhythm and CBF =2.53CP -58 (R= 0.80, p 0.05)* during
atrial fibrillation. At low CP (33 + I mmHg), CBF was 28 + If
ml/min x 100 g at sinus rhythm and 23 .!: 3* at atrial
fibrillation, subendocardialsegment shortening5.3 .!:0.7 and 3.1
+ 0.6* and myocardial lactate production 28 .!: Ilf and 70 .!:
28%*, respectively. Following interruptionof antegr~de CBF,
peripheralcoronary pressure (PCP), measured by a trp mano-
meter in the LAD, was 21 + I mm Hg (sinusrhythm)and 20 .!:I
mm Hg (atrial fibrillation;ns vs sinus rhythm), respectively.
After complete occlusion of the LAD bed by microspheres(25 .!:
5 u), PCP (now = collateral perfusion pressure) was 52 .!: 3
(sihus rhythm) and Iflf + 2 (atrial flbrillatlon)e, respectively.
RetrogradeCBF was 1f.05.!:2.10 at sinus rhythmand fell to 61f .!:
11%* at atrial fibrillation while slope of the retrogradePFR
(collateralconductance)was unchanged.Thus, atrial fibrillation
reduced CBF, depressed myocardial function, and increased
lactate production in myocardial ischemia. CollateralCBF fell
by a decrease in collateral perfusion pressure and, since a
proportionalfall of PCP in the ischemic bed did not occur, by
an effect of atrial fibrillationon the ischemic terminalvascular
bed. *p < 0.05 vs sinus rhythm
HYPOKAIEMIABY J3-ADRENERGIC STIMillATIrn IN THE COID<ARY
CIocr.JLATIrnOF THEOOG
Dietmar Elsner, M.D., HaraldHollnberger, EckhardP.
Kroner, M.D., Glinter A.J. Riegger, M.D., Medizin. Univ.
Klinik, Wiirzburg, FRG
A decrease in plasma potassium (K+) induced by J3-adrener-
gic stimulatioo may be the cause for ventriculararrhyth-
mias after myocardial ~farction. HONever, the J3-adrener-
gic effects on plasma K in the coronary bed itself are
not known, Therefore, during stimulationwith the B:j:adren-
ergic agonist isoproterenol (ISO) ~ measured the K -up-
take in the heart as ~culated fron the aortic-coronary
sinus difference in K concentrationand coronary ~low.
ISO (10 and 30 ng/kg/min, n=17) Lowered arterialK from
3.48+.11 mrol./L by .212:.09 and .362:.10, increasing K+-up-
take-in the heart fron 2.81+1.45 IlIOCll/min to 2.45+1.80 and
7.23+2.12. Unselective J3-blOckade (propranolol, 0-:-1 m:J'/kg,
n=9)-significantly attenuatedthe fall in arterialK+ and
the increase in K+-uptake, shifting the dose response
curves to the right (ISO 30f. 100, 300 ng/kg/min: K+: .072:
.07, .22+.11 and .222:.09; K -uptake fron -2.222:2.64 to .63
+1.75,6-:-79+2.51 and 9.71+2.53). In cootrast, B1-selective
blockade (rretoprolol0.1 ilg/kg, n=8) did not significantly
influence the decrease in arterialK+, not the increase in
K+-uptake in the heart (ISO 10, 30, 100 ng/kg/min: K+:
.30+.08, .40+.09 and .55+.07; K+-uptake fron -.852:.96 to
4.35+3.04, 2-:-04+2.46 and-n.6+7.97). We conclude: 1. Beta-
adrenergicstimUlation decreaSes plasma K+ in the coronary
bed in addition to causing a systemic hypokalemia. 2. This
effect is mediated predaninantlyby J3Z-adrenoceptors.
GREATER DYSFUNCTION OF NON-ISCHEMIC MYOCARDIUM DURING ACUTE
ANTERIOR VS. INFERIOR TRANSMURAL ISCHEMIA, Paol0!b. MaMi~o,
M.D. Lewis C. Becker, M.D'1 F.A.C.C., Joao 1I.C7-T1ma, .•• ,Jaiii"es L. Weiss, M.D., F.A.C.C. Johns Hopkins MedlCal
Institutions,Baltimore, MD , "
Prior studies have shown dysfunctlon of .non-lschemlc
myocardiumadjacent to the ischenic zone. To def ine the effect
of the site of the ischemic region on the function of no~­
ischemic myocardium, 18 dogs underwent open-chest 2-3 mln
circumflex (CIRC) and left anterior descending (LAD) coronary
artery occlusions in randanorder. Cross-sectional 2D echoes at
the chorda1 1eve 1 recho s 1ice) were obtai ned, and percent
systo1ic thickening TH) in 16 equally spaced se(}TlE!nts around
the left ventricle ( V) was correlatedwlth mlcrosphere blood
flow Th and flow measurE!1lentswere grouped by location: Risk(flo~ < 50% of control) Adjacent 1 (Adj I, 2 segments on
either side of Risk) Adj ~ (the next two se(}TlE!nts), and Remote
(the 1-7 segments directly oppos i te Risk). F~r,LAD and CI.RC
occlusions baseline TH and hemodynafTIlCS were s lmi lar, and R1Sk
sizes matched for both the echo sl ice and the entire LV. TH
during transmural ischemia is shown for each region during LAD
or CIRC occlusion:
Risk Adj 1 Adj 2 Remote
LAD 2.2+3.3 14.3+3.2 29.1+3.9 35.4+4.3
CIRC -4.9+2.6 16.0+.3.0 42.3!4.0, 61.9+7.2,
There was asignificant;-stepwise increase In TH ffan R1Sk
to Remote after both LAD and CIRC occlusions, but this increase
was markedly steeper for CIRe tha~ for L~ (p < 0.002, ANOVA).
However microsphere blood flow dtd not dlffer between LAD and
CIRC for any region fran Risk to Remote.
Despite matched Risk sizes within the echo slice, 3-D
distribution of ischemia outside this sl ice differed between
CIRC and LAD occlusions: during CIRC occlusion ischemia was
1imited to the posterolateralwall
i
whereas with LAD occlusion
ischemia invol ved the anteriorwa1 but a1so wrapped around the
apex to inc 1ude the posteroapica1 territory.
Thus canpensatory hyperfunction of non-ischemic myocardium
is greater for CIRC than for LAD occl usion even when Risk sizes
and hemodynamics are equiva.lent. This, discreoancy ,may refIect
interferencewith the function of non-tschenic terrttory dur tnq
LAD occlusion by its greater proximity to ischemic territory.
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DISSOCIATION BE'lWEEN INFARCT REOOCfION AND MYOCARDIAL
EXPANSION wrm REPERFUSION
Bennett J. Shatkin, M.D., Rita D. Swinford, B.S.,
Stanton C. Honig, M.D., EdwardJ. Brown, sc. ,
M.D., F.A.C.C., Peter F. Cbhn, M. D. , F.A.C.C. , SUNY
Heal t h SCiences Cent er , Stony Brook, New York.
re have ctanonstratedthat when coronary ar tery
reperfusion (R) salvages myocardiun , early myocar -
di a l expansion is reversed. Our purpose was to test
the e f fec t of reperfusion on myocard ial expansion
when t here is no salvage. re have shown that pre-
t reatment with the angiotensin-converting enz yme
i nhibitor enal april (E) results in no myocardial sal -
vage with 3 hr reperfusion. Acute dogs with left
anterior descending coronaryocclus ions were ran-
danized into control (C) (n=9) and R&E groups (n=9) .
Area at risk (AR) was determined by autorad iography
and infarct size by triphenyltetrazolium stain . In-
farct size is expresed as %AA. Ultrasonic crystals
were placed circumferentiallyin the infarct zone mid
myocardiun. End diastolic crystal separation (EDS)
was expressed as a %changefran pre-occlusion EDS.
R}st-occlusion EDS' are shown (mean + SEM):
15min. Ihr. 2hrs. 3hrs. 4hrs. 5hrs. 6hrs.
C(%) 18+3 14+3 14+3 13+3 13+3 13+3 12+3
R&E(%) 18+2 12+2 9+3 10+4 - 12+4*- 14+4*- 13+4*
*pcpO.OOl OiOOIJA)-as canPared t o 15 mTn EDS- R&E. -
Infa rct size was 93+3% i n C and 83+6% in R&E
dogs ( pNS) . Thus, reperfusion reverses-early myo-
cardial expa ns ion and reduces systolic bulge even
when there i s no myocardial salvage .
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REDUCTION OF REPERFUSION I NJURY BY RAPID ACTING COENZYME
Q10 ADMINISTERED INTRAVENOUSLY JUSTPRIOR TOREPERFUSION
Shinichi Takamoto , M. D., Kiy ozo Morita, M.D. Takaaki
Matsuda, M.D. , Shunei Kyo, M.D., Yuji Yokote , M. D.,
Ryozo Omoto , M.D. Sait ama Medica l School , Saitama,
Japan
Thi s study was performed t o evaluat e ef f ect s of rapid
ac t i ng Coenzyme Ql0(CoQl0 ) administered intravenously
just pri or to reperfusion(R) on r eduction of R injury
by using reginal LV function r ecovery i n
quantit atively cont ro l l ed Rmodel . Twenty t wo dogs
underwent 2 hours of l ef t anterior coronary artery cl amp
f ollowed by 30 mi n of parti al R(25% of cont ro l flow) and
30 min of full R. Regi onal LV f uncti ons : % se gmental
shortening (%SS) , %active shor t ening (%AS)=syst ol i c
shortening / total shorteni ng , were evaluat ed dur ing R.
Dogs were di vi ded i nt o 2 gro ups , G-I : cont ro l and G-II:
CoQl0 was admin st er ed 15mg/ Kg i nt r avenously befo r e R.
Measured LV segment was classified by t emper at ur e dr op
i n thermography into marginal « 2 CC ) and centr al ( ~ 2°C)
zones. After partial R sign if ic ant i mpro vement of
regi nal LV fun ction was not seen i n both G-I and G- I I .
Aft er full R regional fun ction was i ndi cat ed bel ow.
mar gi nal cent r al
I
G- I I G-II G-I G-II
%SS - 3. 0± 3.4 2.5 t 6. 3 - 6. 2t 4.8 0 .6 ± 5. 7**
%AS 38. 0±18. 7 66.0 ±18 . 8* 10. 0±20. 7 9. 0±21. 1***
* pc . 05 , ** pC. OI , *** pc.OOl G- I vs G- I I
In concl us i on CoQl0 administered j ust prior to R had
improve d regional LV functi on recovery during f ull R
both i n the centr al and mar gi nal zones . I t is sugge st ed
that rapid acting CoQl0 might benef i t in reduction of R
injury in t he clinical R procedur e even after the onset
of acute myocar di al infarcti on.
AUGMENTED UPTAKE OF 2-C14-D DEOXYGLUCOSE (2-DG) IN
REVERSIBLY-INJURED MYOCARDIUM.
J es us A. Bianco , M. D. , Jo se ph Bakanauskas , M. Sc . ,
MarkCarlson, B. Sc . , Andr ew Moring, B.S c . , Jo seph
Alpert . M.D . , F.A.C.C., Henri Cuenoud, M.D. , Univ ersit y
of Massachusetts Medical Cent er , Worces ter, MA.
Positro n t omogr aphy (PET)may dif f erenti ate myocar dial
ischemia from infar ct ion based on a t echnique us i ng
t he t rapping of radiolabel ed deoxyglucose (2-DG) pri or
t o glycolysis. We s tu died 2- DG uptake and phos phor y-
l a t i on in eight dogs subjected t o 15 min . lef t anterior
descending arter y occlusio n fo l lowed by 30 min. reflow.
In 6 dogs , flows during occ lusion were determined
with Sc-46 microspheres. After r ef l ow, 50 ~Ci 2-DG
were given into the l eft atrium. For ty-five minut es
elapsed be tween the 2-DG pulse and animal sacr i f i ce .
Sc-46 counts wer e obtai ned in gamma and beta counters.
Quenching was determined f or bot h isotopes in the
beta count er . Contribution of Sc-4 6 count s to the
C14 channel were subtracted. C- 14 counts were expressed
as DPM/ g. In 5 of the eight dogs there was higher
2-DG DPM/g in the ischemic endocardial or epicardial
r egi on (ra nge of ischemic /nonischemic DPM/g: 1.8-8.1).
In th eee of t he animals there was an inverse curvilinear
relation between 2-DG upt ake andocclusion flow. Con-
cl us i on: 2- DG uptake i n re versibl y i nj ur ed myocar dium
may be a usef ul marker fo r continuing glycoly t ic anaero-
bi os i s in reperfused myocar dium. This may be a charac-
te r i stic of "st unned myoca rdium." 2- DG uptake in
the ischemic myoca rdium may heterog eneously vary as
a function of re gi onal blood flow.
ISOVOLUMIC RELAXATION AND SYSTOLIC CONTRACTION OF
POSTISCHEMIC STUNNED MYOCARDIUM: DIVERGENT EFFECTS OF
VERAPAMIL. Karin Przy klenk, Ph. D. , Bharat Patel , M.D. ,
and Robert A. Klo ner, M.D., Ph .D. , F.A. C.C. , Wayne State
University and Harper Hospi tal , Det r oit , Mi chigan.
Depressed systol ic function produced by a brie f period
of coronary arter y occ l usion (myocardial ' s t unni ng' ) can
be attenuated by various pharmacologic i nt erventions.
However , changes i n other phases of t he car di ac cycle
associated wi th stunning-rand their re spons i venes s to
interventio n- -r emai n po rl y defined. Sys tolic contrac-
tion and isovolumic relaxation (IVR) were assessed using
s onomicrometry in 9 dogs subj ec t ed t o 15 minof coronary
occl usion and 3 hrs of r eperfus ion: 4 r ec e i ved verapamil
30 min postr eper f us i on and 5 re ceived saline . The s lo pe
(k: mmHg/mm) of IVR was measured from pl ots of global LV
pressure (P) vs se gmen t l engt h (L: se parati on be tween
t he ultrasonic crystals ) . and segment sh or t ening (SS)
was used to quant i fy sys tolic contract i on . Prior to
occ lusion, SS averaged 17. 8+1.7%, and IVR was trul y
i sovol umi c (k--1128+131. maki ng an angle of 90. 1+0. 1"
wit h the x-axi s ) . SS was signif i cantly depresse d ~fter
3 hrs of reper f usion i n saline controls (4 .8±1 .7%;
p<. OOl vs Pr e) . I n addi t i on .'IVR' had been resolved
int o 2 phases ( i . e. was not i sovo l umic ) : ear l y (P>30
mmHg), where L decreased s l i ght l y with decreasing P (k E"
3l7±5 7) and late (P<30 mmHg), where L decreas ed markedl y
(k C 16l±5 0; p< .05 vs kFJ . Dogs treated with verapamil
exhibited improved SS at 3 hrs pos t r eperfus i on (13. 0±
4 .1%; p-NS vs Pre) , but ' IVR' r emained biphasic (kE"
l41 ±36 , kC31±7; p<.05 ) . Thus, t he stunned myocar dium
is characterized by both depressed SS and abnormal ,
bi phasic IVR. Treatment with verapami l impr oved con-
tractile functi on , but di d not restor e normal IVR, of
the pos t i schemi c canine hearts .
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RlNCl'IONAL 0VERSH00l' AFI'ER BRIEFCX)~ OCCllJSICNS rn
SlUNNED AND NORMAL MYOC\RDIUM
Lloyd Stahl, M.D., Thomas Aversano, M.D., Lewis C.
Becker, M.D., F.A.C.C., J Ch;1S Hqlkins Medical Institu-
tions, Balto., MD.
Hyperemia inluced by vasodilators improves function
of post-ischemic stunne:i myocardium but has little
effect on nonnal myocardium. To determine whether
reactive hyperemia follCMirq brief coronaty occlusions
produces a silnilar effect, 6 open-chest dogs were
~ted with sonomicrometer crystals am an UID
flCM prcl:le. '!he mid-UIDwas occlUded for 10; 30, 45 am
100 sec with 10 min reflCM periods, before am after
sturl!li.rq with a 10 min U\D occlusion. Percent systolic
shorteni.rq was measured 30 sec after release of each
brief occlusion am values before am after stunnirq
were compared amare shc:Mil belCM. Prior to each occlu-
sion, flCM am function had returned to baseline
levels. *P<.05 vs baseline.
D.lration of OCClusion
Baseline ID" 3D" 45" lOO"
Before stunnirq 23.2 26.7 26.1 25.3 25.7
After Stunnirq 8.2 10.5 15.0* 18.3* 23.5*
After stunnirq', functional overshoot duri.rq reactive
hyperemia increased progressively with occlusion dura-
tion, in parallel with flCM, but was prevented if
reactive hyperemia was restricted durirq reperfusion.
Em diastolic segment len:;Jthwas not increased durirq
reactive hyperemia. In six other dogs, beta-adrenergic
blockade with propranolol, failed to prevent the func-
tional overshoot.
COnclusion: Despite nonnal restirq flCM, function of
stunned myocardium is enhanced durirq post-occlusion
reactive hyperemia while function of normal myocardium
is unc:hanJed.'!his effect appears to be irxiepen;ient of
beta-adrenergicstimulation.
EFFECTS OF CYCLELENGTH AND ACTIVATION SEQUENCE ON
CANINE VENTRICULAR REFRACTORY PERl OOS .
Makoto Hirai. MD. Charles W. Haws, M.D., Bruce M.St einhaus,
Ph.D.• Mary Jo Burgess, M.D.• Univ of Utah. Salt Lake City. UT.
The effect of cycle length (CL) on refractory period (RP)
during activation front coll ision (CO) and 0 n e - wa y
propagation (OW) was studied in IS pentob arb it al
anesthetized dogs. Complete A-V block was produced by
injecting formaldehyde into the His bundle. A 64 lead plaque
electrod e (8x8 unipolar electrodes. 2 mm intergrid distance)
was sutured to the ep icardium of the right ventr icular
outflow tract. Two electrodes of the plaque electrode or ient ed
along the long axis of the myocardial fibers were used for
pacing at CL of 900. 700, 500. 300 msec. RPs were measured at
a third site midway between the pacing electrodes. Basic
sti muli were delivered to each pacing electrode singly to
make OW at the test site or to both electrodes to make C0
within I mm of the test site . The collision site was
determ ined from isochrone maps. RPs during CO we r e
shorter than those during OW at all CL. The difference of RP s
(t. RP) between OW and CO was greater at longer CL and was
greatest at 700 msec (p<.05). Values below are mean±SD.
CL (msec) 300 500 700 900
RPs (OW) 148±10 182±15 201±20 209±23
RPs (CO) 146±10 178±15 195±20 205±22
t.RPs 2.5± 1.7 4 .0±2 .0 6.4±3.2 4.0±3 .3
% change I.7± 1.0 2.1±O.9 3.1± 1.5 1.8± 1.5
Computer simulat ions supported these result s and indicated
greater specific membrane resistance du rin g repolarizat ion
at long CL was responsible for the greater effect of CO on RP
at long CL. The findings demonstrate that elect rotonic
effects on repolarization are greater at long CL. Collision of
activation fronts might cause greater disparity of RPs at Iong
than at short CL.
ERP (msec)
(CAT nMol/g/hr)
58~9
35~4t
30~5 t
46±1l
EPI Over Control VNS
Remote Sites 158±6 SEM 163±6*
Basal SEl 169±7 167±5
Apical Septal SEI 177:10 178±9
Apical Lateral SEI 164±6 1 66~8
* p<0.05 vs control, t p<0.05 vs re mote EPI
Sham s t udi es revealed equivalent CAT activity and prolon-
gation of ERP with VNS in all sites. Conclusion: Infarc-
tion of the immediate 1-2 mm of subendocardiumproduced
by only a 40 min coronary occlusion i s sufficient to
produce parasympatheticdenervation of the overlying
normal epicardium.
A THIN SUBENDOCARDIAL INFARCTION PRODUCES CHOLINERGIC
DENERVATION OF OVERLYINGNORMAL EPICARDIUM. James B.
Martins, M.D., Rita M. Lewis, B.A., Donald D. Lund,
Ph.D., and Phillip G. Schmid, M.D., Department of Inter-
nal Medicine and CV Center, University of Iowa and VA
Hospitals, Iowa City, Iowa .
We have previously shown that cholinergic denervation
occurs in the thin rim of normal epicardium (EPI) overly-
ing a subendocardialinfarction (SEI) produced by a > 2
hour coronary artery occlusion. The purpose of this-
present study was to determine if a thin SEI produced by
a 40 min coronary occlusion would also produce choliner-
gic denervation since it would interruptcholinergic
nerves travelling in the immediate subendocardium
enroute to the epicardium. We studied 6 dogs after a 40
min coronary occlusion and reperfusionand 6 dogs after
coronary dissection alone (sham) 24 hours following sur-
gery. Effective refractoryperiod (ERP) responses to
vaga l nerve stimulation (VNS) were measured in EPI over-
l ying normal tissue or SEI. EPI samples were taken for
choline acetyltransferase(CAT). Results: SEI thick-
ness measured only 1-2 mm. Yet cholinergic denervation
was evident:
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MECHANISMOF FAILUREOF SUBTHRESHOLD
DEFIBRILLATIONSHOCKS
P eng- Sheng Ch en MI2. Patrick D W olf MS, Sharo n D Bowling
AAS. Ned D Danieley MS, William M Smit h PhD, Raymond E
Idek er MDPhD. Duke Univ Med Ct r, Durham, NC
T o determine the mechanism of defibrillat ion, we recorded
simultaneo us ly from 120 bipolar electrodes on 40 plunge needles
in a 20x35x5 mm volume of the righ t ven t ric ula r o ut flowtract
immediat ely befor e and after de fibrillation shoc ks of 190 to 350
volts were give n to 6 op en-chest dogs with elect rically ind uced
ventricular fibrillation (VF). For 20 unsuccessfu l shoc ks 100
vo lts be low t he de fibrillation t h resh o ld , t he site of ea rliest
activation followin g the shoc k was near t he center of th e
ma pped regio n. Activat ion at t he early sites was record ed with
a mean postshock inter val of 41± 15 ms afte r which \'F
regen er ated eit he r by figure of 8 reentry (12 episodes) or by
ot he r patterns (8 episodes). R eentry was also prese nt in t he
mapped regi on immedi at ely before t he shoc k in 9 of t he 20
episodes . Compariso n of activat ion pat tern s im medi at ely before
and afte r th e shock revealed that (1) all presh ock ac t lvnrion
fronts wer e annihilated by t he sho ck , (2) th e site of earliest
postshock activation was distant from t he activat ion fro nts
present just before the sho ck, a nd (3) t hese early sites of
postshock activat ion had si milar pr eshock in ter vals , l.e. , t he
in terval between the las t act ivati on at t he ear ly site be fore t he
shoc k and t he t ime of t he shoc k. At t he ea r ly sites the mean
pr esh ock in te rva lwas 64± 11 ms. At th e sites of t he tail of th e
figu re of 8 reentry pathway afte r t he sh ock , th e pr esh oek
in t er vals were eit he r > 70 ms or < 40 ms, imp lying that
un idirection al block could occ ur because t he ti ssue was eith er
direct ly depolarize d (> 70 ms) or still refractor y « 40 ms) at th e
t ime of the shoc k. We conclude that subt hresho ld defibrillation
sh oc ks an nih ilate all activation fron ts d uring VF but are
unsuccessf ul because the shocks sui gen eris give rise to new
ac t ivation fronts that reinitiate VF because of the dispersion of
refra ctori ness atthe time of the sh ock.
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IMPEDlIOCE CHANGES DURING CATHETERABlATION BY
RADIOFREXXlENCY ENER(,"Y: A rormI'IALMEI'HOD FOR
MJNITORINGEFFICACY OF lESION GrnERATION.
E. WayneGroqan, Jr., M.D., F.A.C.C., Stephen H. Nellis,
Ph.D., Ramiah Subramanian,M.D. University of
Wisconsin, Madison, Wisconsin
Radiofrequency (RP) energy produces lesions which may be
useful in ablation of AV junction, accessory pathways,
or sites of origin of ventriculartachycardias. To
study basic mechanisms of RF ablation, we produced
lesions on the endocardial surface of excised portions
of dog LV in saline and observed changes in voltage and
current during lesion generation. An RF generator
delivered a 500 kHz sine wave between the distal
electrode of a 6F quadripolarcatheter in contact with
tissue and an indifferentelectrode. Voltage and
current were rreasuredat beginning and erd of 15 seconds
of ablation at power levels of 3-20 watts, at cont r ol
level of 0.05 watts, too leM to result in visible tissue
damage, and at control of 10 watts delivered to saline
alone. Impedance (lMP) decreased during lesion
generation (87.6 + 8.0 to 79 + B.9 ohms, P <.001), but
not during leM~r control or control ablation to
saline alone (164 + 16 to 163 + 18 and 63.9 + 1. 2 to
64.3 + 1.7 ohms, ~). lMP change was iJrlePeJrlentof
lesion size or pa.er. Histologic examination of the
ablated zone revealed eJrlanyocardialcanpressionwithout
cell disruptionin this i n vitro nodel, we conclude:
(1) creation of endocardial lesions by RPenergy in
vi tro is associated with a 10% decrease in measured IMP:
(2) RF energy delivery without tissue damage does not
alter IMP; and therefore, (3) monitoring of IMPduring
RP lesion generationmay be helpful in confirming
productionof tissue damage.
BAROREFLEX- INDUCED HEART RATE CHANGES DEMONSTRATE A
RATE DEPENDENT MULTICENTRIC ORIGIN OFTHE ATRIAL
ACTIVATION WAVE
Ri chard B. Schuessl er , Ph.D., Jo hn P. Boi nea u, M.D. ,
James L. Cox , M.D., Washingt on Universit y School of
Medicine, St . Louis, MO.
The effects of blood pressure changes on heart rate and
on the s i te of or i gi n of t he a t rial activa t i on wav e were
s t udi ed i n 10 dogs . Activat i on t i mes (max -d V/d t ) were
determin ed f rom 360 un i polar e l ectrograms r ecord ed f r om
t he right a trium. Blood pr ess ur e was r egul ated by
t i trating dose s of phen yl ephr i ne (P) andnitropr us s i de
(N) . Chang es i n blood pressure cor r elated wi th changes
i n heart rate (r = -.875 ) . Act ivation time maps demon-
s t r a t ed multicentric atri a l pacemake r s (APM) , wi th eac h
an imal having 2-4 sites of origi n. The a trium was di -
vided i nto 3 zones (Z), each of 1 cm, from SVC t o I VC
a l ong th e cris t a termina l i s. Hea r t rat es gener a t ed by
the individual APMs located in each of th e sepa r at e zones
were significantly different (Zl: 148 + 31 bpm, Z2: 102 +
25, Z3: 68 + 19, P < .05) . Parasympatheti c blo ckade with
at rop i ne abol i shed reflex decreases in heart r ate (At :
142 + 11 bpm, At + P: 137 + 13, p > .2). Sympa t he t i c
blockad e with pro pr anolo l a bo l ished r efl ex i ncreases i n
heart r ate (Pr: 113 + 14, Pr + N: 112 + 15, p > .2 ) .
Acute baroref lex-induced changes in heart r a t e wer e
medi ated exclus ively by either incr eased sympathe t ic or
par asympa t he t i c t one and were not assoc i a t ed wi th
i nh i bi t io n of the oppos i te sys t em. The system of
mul tiple atr i a l pacemakers demonstrated a si t e of origin-
r at e relati ons hi p , with t he f as t es t pacemake r s l oca t ed i n
t he most cr ani al area s and th e slowes t l ocated i n t he
most caud a l areas. Thus, t he data demonstrate that
physiologic rate response is r egulated by an ext ens i ve
system of right atrial pacemakers.
ELECTROPHYSIOLOGICALAND PATHOLOGICAL ASSESSMENT OF
CHRONIC FIRST DEGREE ATRIOVENTRICULARBLOCK CAUSED BY
CLOSED-CHEST CATHETER ABLATION WITH RADIOFREQUENCY ENERGY
IN DOGS. Frank I. Marcus, M.O., F.A.C.C., Leonard T.
Blouin, Ph.D., Kelth wharton, B.S. and Saroja Bharati,
M.D., F.A.C.C. University of Arizona,Tucson, Arizona.
For treatment ofpatients with refractorysupraventric-
ular tachycardiait would be desirable to reproducibly
modify AV nodal conduction withouttotally ablating the
AV node to avoid the need for permanentpacing.
The efficacy and safety of partial AV nodal ablation
was investigated in 6 dogs. 5 watts of radiofrequency
energy (RFE) was applied to thedistal pole of a USCI 6F
quadripolarelectrode for 5-60 seconds until the PR
interval was prolonged by 25t or more.
Electrophysiological measurements including atrial
refractoryperiod, AV nodal conductionand AV effective
and functional refractoryperiods were measured after IV
atropine, 0.1 mg/kg and propranolol, 1mg/kg before and
after ablation and 1 week, 1 month and 4 months later.
Results : In 4 of 6 dogs,PR interval prolongation
averaged 48t at 4 months follow-up prior to autonomic
blockade. The A2-H2 intervals were similarly
increased, but there was no consistent Change in AV nodal
refractoryperiods. PR interval prolongation could not be
i nduced in 1dog and persistentcomplete AV block
occurred in the otherdog necessitating permanent
pacemaker implantation. Gross pathological examination in
2 dogs with first degree AV block sacrificed at 4 months
showed whitish scars involVing the lowerpreferential
atrial pathways, the approaches to the AV node and the AV
node itself. Conclusion: Modification ofAV block can be
produced in a maJorIty ofdogs using RFE. The
applicability of this technique to treatment of
refractoryPSVT needs to be evaluated.
ELECTROCARDIOGRAPHI C EFFECTS OF SYMPATHETI C IMBALANCE.
David E. Euler, Ph. D. , Will i am J. Littman, M.D. , Dian e E.
Wallis , M. D. , and Patrick J . Scanlon, M.D. , F.A. C.C.,
Loyola Unive r s i t y Medical Cent er , Maywood, Illinois.
The effects of sympathetic imbalance with left dominan ce
on the el ec t r oca r di ogr am werestudied in 12 open-chest
anesthetized dogs . Heart rate was held cons t ant (80 and
ISO beats / min) by right vag al stimulation and atrial
pacing . To minimi ze vagal- s ympatheti c i nter ac t i ons, vagal
s t imulat i on i ntens i t ies we r e well below those nee ded to
cause as ys t ole . Reco r di ngs wer e obt a i ned f r omthree
surface ECG l eads (11 , X and Z) . Tr ans ec t i on of t he
right stellate increased the T- wav e amplitude i n l ead 11
(0 . 12±.05 mv , P<0.05) but had no significan t effect on the
QT i nterval in any l ead . Lef t s t e l l ate transection after
right s tel1 a t e t ransection decreased the T-wave amplitude
in lead 11 (- 0 . 13±0. 06 mv, P<0. 05) but did not alter the
QT inte r va l . El ectrical s t i mul a t i on of th e left an sae
subclavi a a f t e r right and left stellate transection fo r
periods of three or 15 seconds resulted in QT interval
prolongation by as much as 21msec, but the aver age changes
did not re ach stat i stical s igni f i cance . Left ansae s t im-
ulation for pe r i ods of 30 and 60 seconds r esulted i n QT
shortening of up t o 30 msec . The average QT s hortening
was statis t i ca l l y s ignifica nt (P<0.05) i n l ea ds X and Z,
hut not i n l ead n . All per i ods of l eft ansae s t imulation
r esult ed in s ignif icant i nc r eases in arterial blood pr es-
sur e and T-wave ampli t ude i n lead 11 (max imum i ncrea se 0 .6
±0. 2 mv). The elec trocardiogr aphi c changes induced by
sympa t hetic imbalance we re s i mi l a r a t bot h heart rates .
The r esults indic at e t ha t QTinterval prolongation does
not neces sa rily accompany stat es of sympa t he t i c imbalance.
The data do not supp ort t he pr esence of a signi f ic ant de-
gree of "silent" repolarization occurring af t e r the end of
the T wave i n the normal cani ne electrocardiogram.
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EFFECT OF ANTIHISTAMINES ON SINUS NODEFUNCTION
AND ATRIOVENTRICULARCONDUCTION IN RESPONSE TO
RAPID ATRIAL PACING IN CARDIAC TRANSPLANT
PATIENTS. Andrew E. Epstein, M.O., F.A.C.C., James K.
Kirklin, M.O., F.A.C.C., Oavid C. McGiffin, M.O., G. Neal
Kay, M.O., Basil I. Hirschowitz, M.O., UAB, Birmingham,AL.
The transplantedhuman heart is denervated, providing an
opportunity to study sinus node (SN) function and
atrioventricular(AV) conduction in the absence of autonomic
influences. We have previously shown that HI and H2
antagonists slow the sinus rate in transplantedhearts. Using
temporaryepicardialwire electrodes placed on the donor right
atrium at the time of transplantation,the responses of the SN
and AVconduction to rapid atrial pacing (RAP) were evaluated
in 14 heart transplantpatients in the presence and absence of
diphenhydramine (0, an HI blocker, 50-75 mg IV) and
cimetidine (C, an H2 blocker, 4 mg/kg IV). Although the SCL
increased from 673 .:':: 100 msec to 724 .:':: 86 msec after 0 (p <
0.05) and to 683.:':: 109 msec after C (p < 0.05), the SN recovery
time (SNRT) and corrected SNRT (baseline 944 and 232 msec,
respectively) changed significantly only in the presence of 0
(1027 and 271 msec, respectively, p < 0.05) but not C (933 and
235 msec, respectively, p=NS). In the presence of 0 and C, the
AV interval increased from 163 msec to 167 msec (p < 0.05)
and 165 msec (p=NS), respectively. During RAP, AV
Wenckebachoccurredat a lower rate in the presence of 0 (152
bprn) than in the baseline state (164 bpm, p < 0.05) but Chad
no effect (166 bpm, p=NS). The longest AV interval measured
before AV Wenckebach occurred (163 msec at baseline) was
unchanged by 0 (167 msec, p=NS) or C (168 msec, p=NS).
Conclusions: I) Prolongationof the SNRT and correctedSNRT
by D provides further evidence that HI receptors modulate SN
function; 2) HI (but not H2)blockade slows AV conduction, a
previously unreportedobservation; and 3) These changes are
small and may be observed only by virtue of absent autonomic
innervationof the transplantedheart.
ELECTROPHYSIOLOGICCORRELATES OF INDUCIBLE SUSTAINED
VENTRICULAR TACHYCARDIA DURING CORONARY OCCLUSION IN
DOGS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY.
lames B. Martins, M.D., CV Division, Department of Medi-
cine, University of Iowa and VA Medical Center, Iowa
City, Iowa.
We have preViously reported that chronic hypertension
and left ventricularhypertrophyfacilitate induction of
sustained ventriculartachycardiain dogs 3 hours after
circumflex coronary occlusion. The purpose of this
study was to characterizethe electrophysiology of this
sustained ventriculartachycardia. We studied 9 hyper-
tensive dogs with reproducibly inducible sustained ven-
tricular tachycardiain the open chest chloralose
anesthetized state. Bipolar electrograms were recorded
and pacing was performed from 3-6 multipolarplunge elec-
trodes placed in the ischemic zone. Results: Sustained
ventriculartachycardia (cycle length=120-250 msec) was
inducible from multiple sites in the normal anteriorand
posterior (ischemic) zones. Prematurestimuli prolonged
endocardial to epicardial activation time from 49±7
(SEM) msec with SI to 79±7 msec with S3 (p<O.OI) in the
site where earliest endocardialelectrical activity was
recorded during sustained ventriculartachycardia. Dur-
ing ventriculartachycardia, epicardial composite elec-
trodes demonstratedpandiastolic actiVity and occasional
sites showed epicardial to endocardialactivation.
Entrainmentof sustained ventriculartachycardia (includ-
ing progressive fusion except for the last entrained
QRS) was also present. Conclusion: These endocardial
and epicardial findings suggest intramuralreentry dur-
ing sustained ventriculartachycardia in this model.
ANODAL AND CATHODALEXCITATION
WITHLOWAND HIGH CURRENTS
ILl!Y..irlYY.. Frazier BA, Wanda Krassowska, MS, Peng-Sheng Chen,
MD, Patrick D Wolf, MS, Ned D Danieley, MS, Sharon D Bowling,
AAS, Raymond E Ideker, MD, PhD. DukeUniversity Medical Center,
Durham,NC
To determine if the mechanism of anodal (A)stimulation differs from
cathodal (C) stimulation for low current densities which occur with
pacing or for highcurrentdensities which occur during cardioversion
and defibrillation, simultaneous recordings were made from 120
transmuralelectrodes in a 35x 20x 5 mm region of the RV outflow
tract in 6 open-chest dogs. Stimuli at twice diastolic threshold(mean
0.6 mA) with pulse widths of 0.2-40 ms and from 5-70 mA with
pulse widths of 2-40 ms were delivered to one edge of the mapped
region during electrical diastole. For twicethreshold stimulation, the
interval from the make of the pulse to the time ofactivation was 3-11
ms longer for A than Cstimulation (p<O.OOI) for each pulse width
at all recording sites. For 5-70mA stimulation:(I) the interval from
the make of the pulse to the time ofactivation did not differ for A
and C stimulation for each current and pulse width at all recording
sites (p<O.OOI); (2) the area directlydepolarized for a given stimulus
current was identical for A and C polarities (p<O.OOI), with direct
depolarizationdefined as direct excitation by the stimulus field versus
later excitation by the propagating wavefront; (3) the stimulation
thresholds, expressed as potential gradients, were not significantly
different for A and Cstimulation (p<0.001). Excitation prior to the
break of pulses 2: 10 ms was observed for both polarities at low and
high currents, disproving A or C break excitation. These results are
consistent. wit.hone-dimensional periodic models indicating that, for
more than a few mm from thestimulation electrode, periodic oscilla-
tions of the transmembranepotential from cell to cell cause depolari-
zation. Thus, for currents 2: 5 mA and at distances 2: 5 mm from
the stimulating electrode, the mechanism of A and Cstimulation of
fully repolarized cells isidentical, while close to the stimulatingelec-
trode at lowcurrentsthe mechanism differs.
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PROGRAMMED ELECTRICAL STIMULATION IN HYPERTROPHIC CARD ID-
MYOPATHY: STIMULATION RESULTS IN PATIENTS WITH AND
WITHOUT CARDIAC ARREST OR SYNCOPE
Karl~Heinz Kuck, MD, Angelika Costard, "D, "anfred
Geiger, MD, Klaus-Peter Kunze, MD, University Hospital
Eppendorf, Hamburg, F,R,G.
As part of a prospective study to evaluate progralled
electrical stimulation (PES) in hypertrophic
cardiolyopathy (HC), we analyzed the stilulation resultl
of 51 ph with HC. 3 ph (group AI had a hiltory of
cardiac arrelt (CA) due to doculented ventricular
fibrillation (YF) in 2 pts and to sUltained (SUI) rapid
lonolorphic (mon) ventricular tachycardia (YT) in 1 pt. 7
ptl (group 8) had a hiltory of Iyncop. (S), and 41 ph
(group C) were uneventful al to doculent.d or IUlpected
IYlptolatic v.ntricular arrhythlia (YA), pts of all 3
groups did not differ in age, NYHA functional clall,
family history of sudden death, helodynamic,
echocardiographic and 72h Holt.r lonitoring data, No pt
had coronary artery dileale, All ptl were off drugl at
th. tile of Itudy. PES includ.d Itilulation with a
maxilum of 2 extrastiluli of RA and LA (via coronary
linuI), RY and LY during sinus rhythl, at thr.e balic
cycle lengthl (CLl, and at increasing rates, Induced
nonlustained (nsus) YA were repetitive ventricular
rlsponle (RYRI and nlUS YT, SUI YA were SUI YT and YF,
Endpoint of stilulation was initiation of IUI YA, Nsus YA
were induced in 1/3 ptl of group A, 1/7 ptl of group 8,
and 5/41 pts of group C. Sus YA were induced in 1/3 ptl
of group A <Ion YT of 200 ms CL), 1/7 ptl of group 8 (Ion
YT of 190 IS CL), .nd 6/41 ph of group C (2 Ion YT of
190 IS CL; 2 polYlorphic YT of 200 IS CL; 2 YF),
Conclusions: In HC, incidence and type of induced YA do
not differ a_ong ptl with CA, S, or uneventful history of
sy_ptol.tic YA, Induced SUI YA were always YF or very
rapid YT.
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EXTENT OF ENDOCARDIAL EXCISION DURING VENTRICULAR TACHY-
CARDIA SURGERY GUIDED BY SINUS RHYTHM LATE POTENTIAL
MAPS VERSUS VENTRICULAR ACTIVATION MAPS.
LawrenceJ. Gessman, M.D., John D. Gallagher, M.D.,
Deborah Heart& Lung Center , Browns Mills, NJ
We comparedsinus mapping for late potentials and
activation mapping for sites of origin of ventricular
tachycardia (VT) to the actual extent of surgical
excision when either activation mapping or sinus mapping
guided aneurysmectomy. In11 of 19 patients studied
(group 1) both activation mapping andsinus mapping
were performed. In 8 patients (group 2) VT was not
induced during surgery and sinus mapping only guided
excision. Sites of origin were defined as all areas
recording mid-to-late diastolic activity during VT.
Late potentials were defined as local electrograms
which extended beyond the end of surface QRS. In group
1, activation mappingidentified 29% of the endocardial
perimeter of the left ventricularaneurysm for excision
and sinus mappingidentified 31% (P=NS). The actual
extent of excision was 52% (P<.05 versus activation
maps or sinus maps). In group 2, 33% of the endocardial
perimeter of the left ventricularaneurysm showed late
potentials (P=NS versus sinus maps group 1) and41% was
excised (P=NS versus group 1). 9 group 1 and 7 group 2
patients survived. 2 weeks later, VT was induced in 1
group 1 (11%) and 2 group 2patients (28%) (P=NS). No
survivors have had clinical VT recurrences, and all are
alive after 23.0 ± 2.1 months. The positive predictive
accuracy of sinus mappingfinding the samesite of
origin as activiation mapping was 68.9%. We conclude
that the extent and accuracy of sinus rhythm mappingis
comparable to VT activation mapping to guide left
ventricularaneurysmectomy.
QUALIFICATION RATES OF VARIOUS HOLTER MONITORING CRITERIA
IN PATIENTS WITH VENTRICULAR TACHYCARDIAS.
500 G. KilO, M.D., F.A.C.C., Gillian Katz, AS, Anthony D.
Mercando, M.D. and John D.Fisher M.D., F.A.C.C.,
Montefiore Medical Center, Bronx, New York
To determine what proportionof pts could be managed by
Holter monitoring, 150 pts with sustained ventricular
tachycardia (VT) or ventricular fibrillation referred to
our ArrhythmiaService were studied. All pts (107 males,
43 females, coronary artery disease in 119, cardiomyopathy
etc. in 31) had VT (n=131) or ventricular fibrillation
(n=19) not associated with acute myocardial infarction or
remediable causes. From the frequency of ventricular
prematurecomplexes (VPCs) on baseline Holter, the number
of pts who qualify for Holter assessment was determined.
Baseline ventricularectopy necessary to be qualified for
Holter assessment is defined for 4 previously reported
Holter criteria: Criterion I = )30 VPCs/hour;Criterion11
= )10 VPCs/hour; Criterion III ~ nonsustained VT (NSVT=
trIplets or longer) present; Criterion IV = )30 VPCs/hour,
)30 VPCs/hourduring )50% of total monitored-hoursand
couplets or NSVT during ~3 hours. Mean VPCs/hour was
215+350, couplets/hour was 10.3+23 and NSVT/24 hour was
45+187. By CriterionI, 99 of 150 pts (66%) qualified for
Holter assessment with )30 VPCs/hour and 51(34%) had <30
VPCs/hour and couldnot-be assessed by Holter. By
Criterion 11, 117 pts (78%) qualified and 33 (22%) did
not. By CriterionIll, 94 pts (63%) qualified and 56
(37%) did not. By Criterion IV, 85 pts (57%) qualified
and 65 (43%) did not.
Thus, in pts referred to a tertiaryarrhythmiacenter for
VT or ventricular fibrillation, 1) a significant number of
pts cannot be managed by Holter monitoring;
2)"Qualificationrates" of Holter efficacy Criteria I, II,
III and IV are 66%, 78%, 63% and 57% respectively.
PREDICTORSOF ARRHYTHMICRECURRENCEINSURVIVORS
OF VENTRICULARFIBRILLATIONRENDEREDFREE OF
INDUCIBLEVENTRICULARTACHYCARDIA.
Thomas Mattioni, M.D., Terry Zheutlin, M.D. FACC, Michele
Parker,RN, M.S., Russell Teagarden, R.Ph., Richard F. Kehoe,
M.D., Northwestern University Medical School, Chicago,ll.
The factors related to late arrhythmic recurrence were
examined in 55 survivors ofventricularfibrillation (VF) who were
rendered free of inducible ventricular tachycardia (VT) by
antiarrhythmic(AA) therapy. All pts had heart disease: prior
infarctionin 44 and cardiomyopathy in l l ,
At control programmedelectrical stimulation, 53 had inducible
VT while 2 developed spontaneousVT/VF duringdrug-withdrawal.
All were rendered free of inducible VT« 6 repetitiveresponses) on
predischarge therapy:endocardialresection in 26; AA drugs in 29.
At 30 ± 24 (mean ± SD) months of follow-up, 44(84%) remained
free of arrhythmicrecurrence(Groupl) while 9 (16%)experienced
subsequent arrhythmic events (GroupII): sudden death in 8 and
sustained VT in1.
Using Fisher's exact test; Groups I and II did not differ
significantly with respect to type of heart disease, presence of
prior infarction, prior congestive failure,NYHA functional class,
treadmill exercise time, percent VPB suppression and presence of
VT on predischarge 24 hour ambulatory monitoring, andtreatment
modality employed.
The groupsdiffered significantly only with respect to the inci-
dence of LV aneurysm: 27 of 46(59%) vs 8 of 9 (89%) (p< 0.03) and
mean LV ejection fraction: 34 ± l~% vs 26 ± 6% (p< 0.05) for
Groups I and IIrespectively. No Group II pt had anejection fraction
in excess of 35%.
We conclude that in VF survivors rendered free of inducible VT
by therapy:1) the absence of LV aneurysm andpreservationof LV
ejection fraction to greater than 35% definedpatients at low risk
for arrhythmicrecurrence and 2) other clinical and non-invasive
electrocardiographicparameterswere of limited value in further
defining arrhythmic risk.
CAN RESULTS OF ANTIARRHYTHMIC DRUG TRIALS USING
PROGRAMMED EXTRASTIMULUS TECHNIQOES BE REPRODUCED IN
PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS?
Peter J r'lIdepcbllk, Jack r:ron,Charles Wal ance, John H.
McAnLllty Oregon Health ScIences University, Portland, OR
PreVIOUS work Indicates that significant day-to-day
variability (VAR) In Induced sustained ventricular
tacbyarrhythmlas(VT) occurs In 7-27% of patients IPTS)
undergOing repeated electrophysiologlc studies (EPS) in
the absence of antlarrhythmic drugs (RX). Whether there
is comparable VAR in repeated EPS on RX is unknown. We
tested RX efficacy in PTS Hith clinical sustained VT.
THO EPS were performed 6-24 hours apart on comparable
levels of procalnamlde(PR),quinldlne(QD). dlsopyramlde
(DY) or phenytoin(PH). The EPS protocol was identical for
each study (1 to 4 extrastlmuli at 2 cycle lengths and
rapid pacing from the nght ventncle). Induced (IND)
rhythms were graded on a scale of 1 to 8 with l=No
arrhythmia, 2=1 to 3 repetitive ventricularresponses,
3=4 to 6 beats of nonsustalned VT (NSVn, 4=>6 beats
NSVT, 5=VT rate 100-166 beats/minute (f)PMl, 6=VT rate
161-200 BPM, 7=VT rate 201-300 BPM, 8=VF. A score
difference of ~3 points between separate EPS defined a
nonreproducible (NONR) rhythm. Results:
RX *PTS MEAN RX LEVEL~SD(.g%) %IND SUSTAINED VT %NONR
*IEPS *2EPS
PR 44 12.8~4.3 10.3~4.5 86% 23%
QD 24 4.0~0.9 3.6~O.9 71% 29Y.
DV 9 4.9~O.9 3.8~1.4 89% 29Y.
PH 19 15.0~3.0 15.3~3.6 79% 32%
The VAR In RX EPS approximates that seen In the drug-
free state. Such VAR IS not limited Just to PTS who
manifest NONR rhythms during repeated EPS testing In the
RX-free state. The perSistent VAR in EPS must be
conSidered when evaluating RX using EPS.
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SURVIVAL IN PATIENTS WITH SUCCESSFULLY TREATED
VT: MEDICAL VERSUS SURGICAL RESULTS. PaulJ. Schmidt,
M.S. M.D., Marilyn D. Ezri, M.D.,F.A.C.C., Bruce E. Lewis,
M.D., Marshall Goldin, M.D., and Pablo Denes, M.D.,F.A.C.C.,
Rush-Presbyterian-St.Luke's MedicalCenter,Chicago, IL
Patients with ischemic heart disease (IHD) and sustained
ventricular tachycardia (VT) who after therapy become
noninducible by standard programmed ventricular stimulation
(PVS) have an improved prognosis. Wecomparedthe results of
long-term follow-up of 35 patients who became noninducible
following medical (M) orsurgical (S) therapyfor VT. All M (22
pts.) underwentdrug selection by serial PVS studies. All S (J3
pts.) had a discrete ventricular aneurysm and underwent
mapping guided regional endocardial resection with
aneurysmectomy. The M and S groups weresimilar in: age,
(mean ± SO) M=61.5± 11, S=61.2 ± 9 years and sex(7796 male in
both). Presentationof M and S were alsosimilar: sudden death
(S.D.) (M=3696, S=3196), syncope (M=1496, S=896), palpitations
(M=27%, S=3196), and other (M=23%, S=3196). Neither ejection
fraction (M=.31 ± .13, S=.39 ± .08) nor VTcycle length (M=280±
81, S=289 ± 64) were significantly different (NS). Mean follow-
up was: M=21 ± 20 and S=26 ± 18 months. The cumulative
survival probabilities of the two groups were: at 6 months
(M=7296, 5=9196); 12 months (M=6696, S=8296); and 24 months
(M=5196, S=8296). The cumulativearrhythmiaevent (VTand SO)
free survival were: at 6 months(M=8496, S=I0096); 12 months
(M=8496, S=9096); and 24 months(M=7596, S=9096).
These datasuggest that patients with sustainedVT and IHD who
are noninducible after electrosurgicaltherapyhave an improved
survival compared to patients who are noninducible on
antiarrhythmicdrug therapy.
DISCRIMINATIONOF VENTRICULAR TACHYCARDIA ELECTROGRAMS BY
SYNTACTIC METHODS
Frank Pannizzo, M.S., Mark Wanliss, Seymour Furman, M.D.,
F~A.C~:,--Montef1ore Medical Center , Bronx, New York
Antitachycardiapacemakers rely solely upon rate-related
criterion for detection. This is inadequate for discrimi-
nation between rapid normal sinus rhythm (NSR) andventri-
cular tachycardia (VT). In order to test the use of elec-
trogram (EGM) discriminationusing morphological charac-
teristics, NSR and VT ventricular EGMs were recorded dur-
ing cardioverterimplant and digitized using a 1 kHz
sampling rate. The ratio of peak-to-peakamplitude to the
interval between peaks (C) and the ratio of the positive
peak to the negative peak(B) were computed using a Digital
LSI 11/23 computer, and the NSR-VT differences for these
indices (B,C) were compared for each patient. Mean values
(+ std. dev.) for C (mV/ms) were 45.4 (+48.8) for NSR and
8:0 (11.0) for VT. NSR-VT difference in-C was a mean of
50.3 (+44.6). In 5 of 6 cases, this was> 90% of the NSR
value.--Mean of B was 4.8 (+3.9) for NSR and 2.2 (+1.8) for
VT, with NSR-VT difference-of 2.8 (+2.3). In 5 of-6 cases
this difference was> 49% of the corresponding NSR value.
Mean values NSR-VT amplitude difference was 62% (+29%) of
NSR value while mean of difference of interval between
positive and negative peaks was 18% (+18%) of NSR value.
These indices and measurements were sufficient for elec-
tronic discrimination. This approach does not require com-
parison of entire EGM complexes as does the template mat-
ching method, thus requiring less computing power and
storage capacity. This technique should be evaluated for
implantable antitachycardia pacemaker systems.
PROLONGED LATENCY AND INDUCTION OF POLYMORPHIC
VENTRICULAR TACHYCARDIA DURING ELECTROPHYSIOLOGIC
TESTING.
Boaz Avitall. M.D. Ph.D.,Thomas E. Rump, M.D. F.A.C.C.,
Petrit A1iba1i, University of Chicago, Chicago Illinois
Polymorphic ventricu1ar tachycardia (PVT) can be
provoked by multiple extrastimu1i (ES) even in normal
hearts, and is a frequent non-specific finding during
clinical el ect ropnystoloqt c studies (EPS). We examined
mechanisms of induction of PVT in 10 anesthetized, open-
chest dogs. Using a standard EPS protocol with up to 3
ES (2 ms , and up to 3mAmp) following basic drive at 150
BPM, 38 episodes of PVT were induced in 8110 dogs. All
inductions were associated with markedly prolonged
1atency between the fi na1ES and its captu red responses,
measuri ng at 1east 275% of the 1atency of 1ate diasto1i c
ES. Pri or to inducti on of PVT, 1atencies became steadi1y
longer as ES were made increasingly more premature.
There were no apparent discontinuities in curves re1at-
i ng coup1i ng interva1 to 1atency; thus there was no
indication of multiple pathways for propagation from the
stimulating electrodes. All stimuli which provoked PVT
were at least 50 ms more premature than required to
produce the closest possible coupling of ventricular
responses.
In summary, induction of PVT might be avoided by not
increasing the prematurity of stimuli once latency has
increased beyond 250% of the late diasto1ic value. Sensi-
tivity of EPS might not be affected, since increasing
prematurity does not lead to closer coup1i ng of vent ri-
cu1ar responses, once latency is prolonged to this
extent.
PROGNOSTIC SIGNIFICANCE OF PROARRHYTHMIC EFFECTS
DURING ELECTROPHYSIOLOGICTESTING.
Mario Talajic MD, Pedro Brugada MD, Paolo Della
Bella MD, Thierry Dugernier MD, Robert Lemery MD
and Heln JJ Wellens MD,FACC, Dept. of Cardiology,
Academic Hospital, Maastricht, The Netherlands.
To study the clinical significance of proarrhyth-
mic effects(PAE) of antiarrhythmicdrugs(AAD) du-
ring programmed stimulation(PS),outcome of base-
line and post-drug PS is reported in 65 pstients
(pts) (75% with CAD) with sustained ventricular
tachycardia(75%)or fibrillation.Drug therapy was
only altered after clinical recurrence or side
effects,but not because of results of PS.Pts were
treated with the follOWing AAD(propafenone in 22,
amiodarone in 8, sotalol in 8, bepridil in 8, lA
drugs in 5, other drugs or combinations in 14).
Results: PAE were noted in 14 pts (groupl,22%),
defined as conversion of a non-sustained to a
sustained arrhythmia (A) (2 pts), induction of a
sustained A with fewer premature beats(8 pts) or
with a faster rate (4 pts).Groupl pts were older
than pts without PAE(Group2)(61±11 vs 50Z14) and
had a higher incidence of 3 vessel CAD(78%vs39%,
p<0.05). No significant differences were noted in
EF(41%±12% vs40t26), exercise tolerance, previous
cardioversion or number of previous AAD.Mean fol-
low-up (FU) of all pts was 15t14.4 months. 58% of
all pts reached an endpoint:death(9.2%),clinical
recurrence(43%) or side effects(6%).The FU of pts
not reaching an endpoint was 24±16 months. Sudden
death occurred in 1 pt in each gr~up (pans) while
clinical arrhythmia recurrences occurred in 43%
of group 1 and 43% of group 2 (p=ns).
We conclude that PAE of AAD during PS are common
(22%) but do not predict a poorer outcome.
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SELECl'IVECATHEI'ERABLATICN CF CANINE VENI'RICULAR
MYOCARDIOMvlITl:! R!\Dlm~ CURRENl'.
Gerald V. Naccarelli, H.D., F.A.C.C., Karl-Heinz Kuck,
M.D., Jan Pitha, M.D., lee canren, and WarrenM.
JackrPan,M.D. Univ of Cklaharaand VA Medical center,
CklaharaCity, OK, Univ Hospital Eppendorf, Harrburg, FRG
and Univ of Texas Medical SChool at Houston, Houston,TX.
Catheterablation of arrhythrrogenicventricularsites
using OC shocks has been limited by canplications
including hypotension, cardiac perforation, thranbus
fonnation and developnent of new arrhythrrogenicfoci.
TO detennine if catheterdelivered radiofrequency
current (RFC) could safely destroy ventricularmyocar-
dium, 6F quadripolarcatheterswere inserted into the RV
and LVendocardiumof 11 heparinized, closed-chest dogs.
RFC (continuous wave, 625 KHz) was delivered for 10-20
seconds between the cathetertip and a surface electrode.
V delivered was 42±8 with a I of .23±.07 mA, a resis-
tance of 182±32 n and delivered energy of l12±60 J. The
catheterswere repositioned in the FN and LVapices and
RFC was delivered between the two tip electrodes for
10-20 sec. V delivered was 44±7 with a I of .20±.07 mA,
a resistance of 241±49 n and delivered energy of 106±29
J. At necropsy 2 to 9 days later, lesions were
identified in 5/11 FN and 9/11 LV free wall sites and
7/11 RV and 11/11 LV apical sites. Lesion size ranged
frcrn 4-8 mn in depth to 3-9 nm in diarreterand did not
correlatewith energy delivered. The endocardial sur-
face was grossly intact in all. No henodynamic canpro-
mise, electrode pitting or changes in post-shock catbe-
ter resistance were noted. However, one dog had spon-
taneous VF after a transeptalshock. Although no large
thrari::>iwere noted, a thin layer of endocardial thranbus
fonnation was frequently present. we conclude that
catheterdelivered RFC can selectively damage myocardial
tissue with minimal carplications.
ABSTRACTS
CATHETER ABLATION AT TIlETRICUSPID ANNULUS USING RADIOFREQUENCY
CURRENT IN CANINES.
Warren H. Jackman. H.D., Karl-Heinz Kuck, H.D., Gerald V.
Naccarelli, M.D., F.A.C.C., Jan Pitha, M.D., and Lee Carmen,
Univ of Oklahoma andVA Medical Center, Oklahoma City, Univ Hospital
Eppendorf, Hamburg, FRG, and Univ of TexasMedical School at Houston.
The purpose of this study was to test in dogs the ability of low
power radiofrequencycurrent(RFC)to produce discrete right atrial(RA)
and/or ventricular{RV) necrosis adjacent to the tricuspid annulus for
potential application in ablating right free-wall accessory AV path-
ways. In 7 anesthetized, closed chest dogs, a 16 French quadripolar
electrode catheter(6 DIll spacing) was inserted through the right
jugularvein and looped in the RA. The loop was passed into the RV
with the catheter tip oriented towards the RA. The catheter was with-
drawn until the tip was secured in close proximity to the AV groove
fat-pad on fluoroscopy in the RAO projection. Two sites were tested in
each dog. The distal bipolar electrogram revealed: large atrial poten-
tial(AP) and small ventricularpotential(VP) or AP = VP at 8 sites
(group I); large, sharp AP but much larger VP at 2 sites(group H); or
small, rounded AP vfth large VP at 4 sites(group HI). RFC (continuous
wave, 625 kHz) was delivered between the catheter tip electrode and a
large chest electrode at 27-40 volts(median 3~.8) for 6-20 seconds
(median ll). Resistance ranged 143-330 ohms(median 16~, only 2 sites>
22~), resulting in power ranging 3.0-9.4 "atts (median 7.6) and total
energy ranging 20-1~8 Joules(median93). Dogs "ere sacrificed 6-9 days
later. Lesions "ere identified at 10/14 sites(7/8 group I, 1/2 group
II, 2/4 group Ill). Group I had transmuralRA necrosis, centered 7-16
RID above the annulus and .!!Q!: extending to the annulus(no closer than
4...). One had large mural thrombus. The group H and IH lesions "ere
located in the RV, centered 0, 3 and 5 IIID below the annulus, respec-
tively. The first two lesions were transmuralinvolving the epicardial
aspect of the ventricularcrest. The valve was not damaged and there
was no gross thrombus. We conclude: 1) RFC can produce discrete,
transmuralRA or RV necrosis; 2) injury through the plane of the
annulus might best be achieved by a catheterelectrode positioned
beneath the tricuspid valve, high against the annulus; and 3) large,
sharp AP with larger VP identifies this electrode location.
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Electrophysiology: Clinical
TRANSVENOUS ABLATION OF THE ATRIQ-VENTRICULARJUNCTION IN
HUMAN WITH HIGH-FREQUENCY ENERGY.
Thomas Lavergne, M.D., Louis Guize, M.D., Jean-Yves Le
Heuzey, M.D., Marie-ThereseCousin, M.D., Pierre Carcone,
M.D., Jacques Ges1in, M.D., Guy Khaznadar, M.D.,
Jean-Paul Coueti1, M.D., Pierre Ourbak, M.D. Opt de
Cardio1ogie, Hopita1 Broussais, Paris, FRANCE.
Closed-chest ablation of the atrio-ventricu1ar (AV)
junction using high-frequency (HF) energy has been
reported effective and safe in dogs. We performed trans-
catueter His bundle ablation with HF energy in two
patients: 1) an 80-year old female with disabling chronic
atrial fiLrillation, 2) a 59-year old female with
recurrent junctiona1 tachycardia related to an
atrio-noda1 reentry. In both patients, all the
anti arrhythmic drugstested were ill-tolerated. As the
patient was conscient, the HF pulse (6 Wx 30 sec) was
delivered between a suction 8 Fbipolar catheter (USCr)
and a 1ar1e external electrode. A vacuum depression (85
kPa) was app1ied to the centra 1 catheter 1umen with the
simultaneous recording of a stable His electrogram.
During the HF pulse, complete AV block occurred in the
first patient and a right bundle branch block in the
second patient. The HF pu1 se was painless and
hemodynamically well-tolerated. There was no sustained
ventriculararrhythmia duringeither the procedure or at
the subsequent 48 HHo1ter monitoring. During the
clinical follow-up (10 and 8 weeks, respectively) the
patients, in which a pacemaker was implanted, remained
asymptomatic and the complete AV block was persistent in
the first patient. Conclusion: transcatheterAV junction
ablation can be achieved in human with HF energy without
si gnifi cant adverseeffects. This method seems to be an
attractive alternative to direct current shock ablation
of AV junction. Absence of barotraumamight explain its
good acute hemodynamic tolerance.
RADIOFREQUENCY CATHETER ABLATION IN THE CORONARY SINUS
JonathanLangber
A
, M.D., Jerry C. Griffin, M.D., F.A.C.C.,
SaroJa Bharat1, .D., F.A.C.C.,Maurice Lev, M.D.,
F.A.C.C., Michae1 Chin, B.S., andMe1vin M. Scheinman,
M.D., F.A.C.C., University of California, San Francisco.
Ablation of left-sided accessory atrioventricularpath-
ways with high energydirect-currentshocks delivered via
a catheter in the coronary sinus(CS) is associated with
the risk of CS rupture. The safety and efficacy of
closed-chest catheter dessication in the CS was assessed
using radiofrequency(RF) energy in 6 dogs. RF was ap-
plied between the dista1 electrode of a standard bipolar
or quadripo1arcatheter introduced percutaneously into
the CS and an external patch on theleft posteriorchest
wall. The power source (Oscor Medical HAT 100) produced
50-75 volts at 500 kHz. One to 3 CS lesions at varying
sites were produced in each of the 6 dogs. Totaldeliv-
ered energy for eachCS lesion ranged from 81-697 Joules.
No arrhythmias orhemodynamic changes were observed during
or after ablation. All animals recovered without compli-
cations and were sacrificed after 10-14 days. Antemortem
angiography showed occlusion of the CS in one dog. Patho-
logic exam revealed well-circumscribedlesions in the
atrioventricularsulcus ranging in size from .2x.4cm to
1x2cm as viewed from the epicardial surface. Scarring
extended onto theepicardial surface of the left atrium
in 4 and the left ventricle in 3 cases. None of the
hearts showed involvement of the endocardium. None of
the lesions resulted in damage to the circumflex coro-
nary artery, mitral valve orperforationof the CS.
Conclusion: Large amounts of RF energy can besafely ap-
plied to the CS. The size and location of the lesions
produced suggests that this technique may be useful for
the interruptionof left-sided accessory atrioventricular
connections in man.
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Rapid biatrial stimulation had no adverse effects on sinus
rhythm or ventricularrate. In the 8 dogs with post-
operative sinus rhythm. occlusion of the SN artery caused
rhythm deteriorationincluding sinus rhythm slowing with
prolonged sinus node recovery time (4 dogs), sinus brady-
arrhythmia (2 dogs) and atrio-ventricularnodal rhythm
(2 dogs). Thus, biatrial isolation is feasible for the
treatment of SVT. but it is essential to preserve SN blood
supply in order to maintain normal sinus rhythm in the
remainder of the heart.
BIATRIAL ISOLATION WITH PRESERVATION OF NORMAL SINUS NODE
FUNCTION AND SINO-VENTRICULARCONDUCTION: A SURGICAL
TREATMENT FOR SUPRAVENTRICULAR TACHYCARDIAS
Atsushi Harada. M.D .• Harry J. D'Agostino. Jr.• M.D.,
Richard B. Schuessler, Ph.D .• John P. Boineau. M.D.,
James L. Cox, M.D., Washington University School of
Medicine. St. Louis, MO.
Biatrial isolation was developed to confine supraventricu-
lar tachycardias (SVT) to both RA and LA, while preserving
the blood supply and function of the sinus node (SN) and
sino-ventricularconduction. Nine adult mongrel dogs were
subjected to cardiopulmonarybypass and the RA and LA were
isolated, exclusive of the SN, crista terminalis and
atrial septum. thus leaving the SN in continuity with the
ventricles. Moreover. of the right and left SN arteries,
the predominant one (right in 7 dogs, left in 2 dogs) was
spared. Pre- and post-operative electrophysiologic mea-
surements showed that normal SN function and SN-RV conduc-
tion were preserved in 8 out of 9 dogs. (Data below
expressed as M± SEM msec.)
Sinus rhythm cycle length
Sinus node recovery time
SN-RV conduction time
Pre-op
446 + 26
488 :+: 28
124 :+: 6
Post-op
434 + 22
487 :+: 32
124 :+: 4
P
NS
NS
NS
WPW SURGERY INTERRUPTS EFFERENT VAGAL INNERVATION TO THE
CANINE LEFT VENTRICLE
Hiroshi Inoue, M.D., Yousuf Mahomed, M.D. and Douglas P.
Zipes, M.D., F.A.C.C., Krannert Institute of Cardiology,
Indiana Univ. School of Med., Indianapolis, Indiana.
We tested the hypothesis that cardiac surgery to inter-
rupt accessory pathways (APs) also interruptedneural in-
nervation to the ventricle. We measured effective refrac-
tory period (ERP) during norepinephrineinfusion (NE: 0.5
ug/kg/m), bilateral stellate stimulation (SS: 4 ms, 3 Hz,
3 mAl and bilateral vagal stimulation (VS: 4 ms, 20 Hz,
0.4 mAl in 6 open chest, neurally decentralized dogs 4-13
days after dissection of the fat tissue and application
of a cryoprobe at -60 0C for 2 min along 2.5-3 cm of the
lateral left ventricular (LV) AV groove. The procedure
was the same as in WPW patients with a left free wall AP.
Changes in ERP at right ventricle (RV), anteriorLV(LVa),
posterior LV (LVp) and 3 lateral LV sites each separated
by 1 cm and extending apically directly beneath the dis-
section (LV #1, 2, 3) were (ms, mean! SO):
RV * LVa* LV #l #2 * #3 * LVp*
SS -15.8 -22.8 -18.3 -17.3 -17.2 -14.0
!3.7* !5.0* !7.3* !5.3* !6.I* !3.4*
NE -18.0 -21.3 -21.8 -23.2 -20.2 -22.3
!6.4** !6.4** !5.5 !6.4 !7.5 !8.3
VS 4.8 5.3 0.2 - 0.5 0.3 2.3
!I.7 !0.8 !I.O !0.8 !1.0 !3.4
SS and NE shortened ERP significantly at each test site
(*p<0.002). Supersensitive shortening of ERP to infused
NE was not induced at any test site. VS lengthened BRP at
RV and LVa (**p<O.Ol), but not at LVp or at LV #1, 2, 3.
We conclude that this surgical approach to interruptWPW
APs also interruptsvagal efferent fibers innervating the
lateral LV, but not sympathetic efferent fibers in the
canine heart.
TOTAL ATRIOTOMY IMPROVES RESULTS OF TRANSECTION OF
MULTIPLE ACCESSORY PATHWAYS.
Huang-Ta Lin, M.D. Gerald Lawrie,M.D., F.A.C.C., Sharon
Magro, p.A.C., Jack Krafchek,M.D., Karen Beckman, M.D.,
Nancy Robertson, R.N., Christopher Wyndham, M.D.,
F.A.C.C. Raylor College of Medicine,Houston, TX.
Recurrent supraventricular tachycardia (SVT) after
transection of accessory pathways (APs) may reflect
presence of multipleAPs. Techniques capable of identify-
ing and/or ablating multiple APs should yield 100% cure
rates. To determine if an extended"total atriotomy"on
the side of the AP would improve surgical results, total
atriotomy in 37 patients (pts)(17 with multiple, 20
single APs) was compared with localized at~iotomy in 16
pts (4 with multiple, 12 single APs). MUltlpl~ APs ~ere
defined as sites separated by at least 2 mapprnq potnts
with later activation. Of the 21 pts with multiple APs,
16 had at least 1 anterior or posterior septal AP, as
compared with 5 of 32 pts with single APs. Of the 16 pts
having localized atriotomy, 4 had recurrent SVT due to
res idua1 AP and were reoperated upon successfully. In 2
pts the residual AP was only identifiable after success-
ful ablation of the known APs. In contrast, none of the
37 pts having total atriotomy had recurrentSVT (p<.OI).
His bundle mapping was performed in 8 pts with septal APs
(8 posterior, 3 anterior). Total atriotomy and septal
dissection were performedduringnormothermicbypass with
ECG monitoring of atrioventricular(A-V) conduction. No
pt developed A-V block.
Conclusion: Total atriotomyfacilitates ablation of all
accessory pathways and prevents recurrentSVT. His bundle
localization and intraoperativemonitoring ofA-V conduc-
tion appear to protect against development of A-V block
when extensive septal dissection is required.
THE QUALITY OF LIFE AND ARRHYTHMIA STATUS AFTER SURGERY
FOR WOLFF-PARKINSON-WHITESYNDROME: AN 18 YEAR
PERSPECTIVE.
Eric N. Prystowsky, M.D., F.A.C.C., Joyce C. Pressley,
M.P.H., John Gallagher, M.D., F.A.C.C., James E. Lowe,
M.D., F.A.C.C., Will Sealy, M.D., James Cox, M.D.,
F.A.C.C., Edward Pritchett, M.D., F.A.C.C., David Pry or ,
M.D., Lawrence D. German, M.D.F.A.C.C., Duke University
Medical Center, Durham, NC
We performed this study to determine whether surgery for
Wolff-Parkinson-WhiteSyndrome (WPW) substantially improv-
ed quality of life, decreased arrhythmiaoccurence, or was
associated with an increase in new onset of atrial fibril-
lation (AFib) during long-term mean follow-up of 6 yrs
(2 mos-18 yrs). From May, 1968 to May, 1986 357pts
underwent WPW surgery, and follow-up data were obtained in
88% by questionnaireand telephone. Before surgery, pts
had arrythmiafor an average of 13.8 yrs and had 3.0 anti-
arrhythmic (AA) drug trials. Surgical deaths (5 intra-,
9 post-op) occurred in 4%, with 5/14 pts having other
heart disease.
Following surgery, quality of life was markedly
improved: 93% of pts had less frequent hospitalization,
92% were satisfied (75% completely, 17% incompletely) with
results of surgery and 98% would recommendsurgery to
other pts. AA therapy was taken in 100% of pre-op but in
only 23% of post-op pts. New AFib was seen in only 2% of
pts of which half required AA therapy. Although 52% of
pts reported an arrythmiaafter surgery, only 37% of those
take AA drugs, and episodes are usually short lasting
("seconds" in 60%, 1-5 min in 22%. and 5 min in 18%).
We conclude that WPW surgery (1) markedly improves
quality of life and is rarely associated with new onset of
AFib, and (2) should be considered as early therapy in
symptomatic pts and not merely therapy of last resort.
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ELECTROPHYSIOLOGIC DIFFERENCES OF ATRIOVENTRICULAR
NODAL REENTRANT TACHYCARDIA WITH DISCONTINUOUS AND
CONTINUOUS ANTEGRADE CONDUCTION CURVES.
Llaqat Zaman. MD, Agustln Castel lanos, MD. FACC, Carlos
Rlzo-Padron, MD, Alberto Interlan, Jr, MD, Richard G.
Trohman, MD, FACC, Robert J. Myerburg, MD, FACC,
University of Miami, Miami, FL
Atrioventricularnodal reentranttachycardia (AVNRT)
requires the participationof dual AVN pathways,
usually demonstrable by dlscontlnous antegrade AVN
conductIon curves. In this study, we determined the
functIonal propertiesof AVN In Pts wIthAVNRT, and the
relationship to the presence of discontinuous or
cont Inuous conduct Ion curves. The study group
consisted of 19 pts, 11 with discontInuous (Group Al
and 8 with continuous conduction curves (Group B).
DiscontInuous curves were defined as aL50 ms Jump In
the AVN conduction time (A2-H2) for 10-20 ms decrementsIn the atrial extrastlmulus. The maximum A2-H2 (A2-H?max), the magnitude ofmaximum Increment (n) from th~
mlnumum A2-H2 and AVN conduction during sinus rhythm(A-H), ana fne AVNRT cycle length (CL> were compared
between groups A and B.Resu Its (measurements In ms,
expressed as ± SO):
A2-H? max 6A2-H2 6A-H AVNRT CLGroup A (n=11) 352!77 243±6T 265±70 401±79
Group B (n=9) 250±32 126±46 158±23 330±48
p=0.002 <0.001 <0.001 0.04
The A2-H2 max, bA2-H2 and bA-H correlatedsIgnificant-ly wrth AVNRT CL: fOr the whole study group (R=0.74,
0.58 and 0.67 respectively). In conclusion: 1) A2-H2max, b A?_-H2 and M-H are sign If IcantIy shorter In Ptswith AVNRT who have continuous antegradeAVN conduction
curves; 2) these measures of AVN function are related
to AVNRT CL, and 3) A -H max Is the best predictor of
AVNRT CL, regardless df fhe type of conductIoncurve.
PACING AT AN ATRIOVENTRICULARINTERVAL THAT INCREASES
RIGHT ATRIAL PRESSURE ALSO INCREASES ATRIAL
REFRACTORINESS.
Lawrence S. Klein. M.P•• William M. Miles, M.P.,
F.A.C.C., Pouglas P. Zipes, M.D., F.A.C.C. Krannert
Institute of Cardiology, Indiana University School of
Medicine, VA Med. Center, Indianapolis, Indiana.
Reciprocating tachycardiacommonly disorganizes into
atrial fibrillation in patients (pts) with atrio-
ventricular (AV) reentry. We investigated in 6 pts the
effect of varying the AV interval from 0 to 360 ms, in 40
ms increments, during AV pacing at cycle length 400 ms on
peak and mean right atrial (RA) pressure, right atrial
effective refractoryperiod (RA-ERP), mean blood pressure
(BP) and left atrial (LA) size measured by 2-P echo-
cardiography. As the AV interval increased from 0 to 360
ms, RA peak and mean pressure, RA-ERP, and LA size all
decreased to minimal values at a mean AV of 120 ms (Max
~, and subsequently increased to maximal values as the
AV interval increased and approached 400 ms. The weighted
mean correlationcoefficient of RA-ERP (r-RA-ERP) with
the other variables was significant for RA peak. Results:
MU Aitsp) peAl r-RA-ERP P(r)
RA peak(mmHg) 11.7±2.6 <'001 0.49 <.01
RA mean(mmHg) 3.7±1.8 <'005 0.16 NS
LA size(cm) 0.53±0.18 <'001 0.18 NS
RA-ERP(ms) 25±10 <'005
The BP response did not correlatewith the RA-ERP
(r=-0.08; p=NS). We conclude that during alterationof
the AV interval 1) changes in right atrial pressure and
refractorinessare concordant, and 2) this reduction in
the RA-ERP at AV intervals characteristicof RT may be
responsible, in part, for the susceptibility to AF in pts
with AVR.
TREATMENT OF AV NODAL REENTRANT TACHYCARDIA WITH
ENCAINIDE: REVERSAL OF URUG EFFECT ON THE AV NODE WITH
ISOPROTERENOL
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Imran Niazi, MD~ Patrick Tchou, MU, Gerald Naccarelli,
MD, FAce, Rober Rinkenberger, MD, Anne Dougherty, MD,
FACC, Masood Akhtar, MD, FACC, University of Wisconsin,
Milwaukee Clinical Campus, Milwaukee, Wisconsin, and
University of Texas, Houston, Texas.
The clinical efficacy of Encainide (EN) in AV nodal
reentranttachycardias (AVNRT) is chiefly dependent upon
its effectiveness in producing AV nodal (AVN) block (H)
particularlyin the retrogradedirection. Since
Isoproterenol (ISO) facilitates AVN conduction (C), we
stUdied its effect on antegrade and retrogradeAVNC in 11
patients (PTS) with documented inducible AVNRT who were
treated with EN. Our PTSincluded 8 females and 3 males,
aged <0-71 (mean 54). Electrophysiologic studies were
performed on no medications, on EN 75-2UU mg/day, and
during the infusion of ISO (in the EN loaded state) at a
rate sufficient to increase heart rate by at least lU%
above baseline (mean 25%+7%),using an infusion rate of
1-3 mcg/min. -
RESULTS: Sinus Shortest Atrial
CL CL with 1:1 AV
Conduction
374+63
415+75
31b!42 §
Atrial latency (AL) is referred to as conduction delay
that occurs between atrial stimulus and atrial response
at the atrial pacing site within atrial relative refrac-
tory period (RP). It has been implicated as one of the
factors related to the genesis of atrial arrhythmias. To
systematically assess effects of catecholamines on AL,
we studied electrophysiologic properties of the atrium
hefore and during intravenous infusion of isoproterenol
(Iso) at 2-5ug/min in 12 patients (pts) who exhibited AL
of more than SOmsec with programmed atrial stimulation.
In all pts, Iso consistently diminished the extent of AL
(maximal AL decreased from 87~19 to 64+15 msec; p<O.005).
This was accompanied by significant shortening of both
effective and functional RP of the atrium (effective RP
decreased from 225+48 to 176+41 msec; functional RP de-
creased from 267+43 to 218+34 msec; hoth p<O.005). Of
note, by diminishing AL, Iso abolished gap phenomenon
of anomalous bypass tract conduction in 1 pt. Furthermore,
of 4 pts with atrial vulnerability, Iso prevented
induction of atrial fibrillation in 1 pt and suppressed
repetitive atrial responses J.n 2 pts , Thus, we conclude
that catecholamines should improve atrial conduction
and may thereby halt certain atrial arrhythmias.
Edward Huyeke, M.D., Ngai Nguyen, M.D •• EdmundKeung, M.D.
and Ruey Sung, M.D •• F.A.C.C., San Francisco General
H0spital and CVRI, Univ. of California, San Francisco, CA
EFFECTS OF ISOPROTERENOLON ATRIAL LATENCY AND ATRIAL
ARRHYTHMIAS.
*p < .Ul vs control §p < .01 vs EN
While on EN, sustained AVNRT was induced in 2 PTS at a
much slower rate than oaseline. Following ISO infusion,
AVNRT became inducible in 7 PTS (mean CL 353+42 vs control
of 38U+49, p=NS). During a mean followup of-6.3 ~ 4.5
months~ j of these 7 PTS had clinical recurrenceof
AVNRT. In 1 of these j PTS, further recurrenceswere
prevented by the addition of beta blockers, while in the
remaining 2 PTS, therapy was not altered due to the
infrequency and brevity of the recurrences.
CONCLUSIONS: 1) ISO completely reverses EN induced
depression of AVNC, especially in the retrograde
direction, and facilitates induction of AVNRT. 2) Beta
blockers can potentially be an important adjunct to EN in
selected PTS for preventing clinical recurrence.
I02A ABSTRACTS lACC Vol. 9. No, 2
February1987:I02A
IHTRAVEHOUS AND O.Al FlECAINIDE IN ECTOPIC
SCPRAVENrRICUl~R TACHYCARDIA
' l a u ,- P ~ t ~r Kun: e ".D., "anlrejG,i~er ".D., "i,hael
K,ntsch M.D., Karl-Hein: K~ck ro.D. Uni v, r s i ty ~~spita :
EFpendorf, ~alburg, F.R.a.
;n the treatment of ectopic suprav,ntricular
~ichycar~ia IES.TI conventional artiarrhythaicdrugs IAA i
have been shOHn to f ai l . We studied the effect of
intravln~us (i. v. ) and oral (0 1 Illcainidl IF) in 10 pts
lh, 6f: ..an age 39 yrsl Hith ESVr. 9 ph had atrial
ectoFlc tachycardia (AETI, 2 had junctio~al ectop :c
tachycardi I <JET I . ESVT had been docuunted for 10 ! 4
years and Has ur.respons ive to 3 to e AA. 9 ~ts had
p.lpitations, pt h. d exertional dyspnea. All pts
under..,r.t ECG at rest ( R ) , at lXercin lEx), 24h Hclter
m~nitoring (HOl I . ar.delectrophysiclogic st ~dy ; E ~ S I . HOl
shoH~d persi£tent (persl ESVT in 3 pts "d lntermittert
(ir~, ;'1: hId ) ESVT ir 7 pts. Irt ESVT Has inducible in 4
pts (all AET l by Ex, in 4 pts (3 AET, I JETl by i.v.
Isoproterenol, in 2 pts (AETI by rapid atria!
stlm~l.tion. ESVT cycle length rar-ged bet ..eer. 300 inc 560
.s. Aft,r i.v. F (0.5-2.0 ag/kg bH ) ESVT t,rajnltedand
_,c.~e r.~r.-I~duclble in all pts. During follow-up of :2 !
q .onths pts Here controllEd by Po, Ex, and HOl. Uncer 0 F
(20~- 300 Ig/d) ir no pt Esvr HaS inducible ty E,. 6 pts
15 AET, I JETI Here free of palF:tat:ons and Hel shoH,di
30/ h supraver.tricuia- pre~.tur, beats .nd r.o SVT. 4 pts
<; AET, I JET) had recurr,nces Hith aax. 3 !~ short
listing episodes cl SVT d~r i~g HOl. 3/ 4 pts <AET) beca~e
asyapto•• t ic ~nd,r • co.~i n.ti~n of F (~OO ag/d) .nd
Detcprolol ( ~ ; 10Q Iq/d) .nd shoHed n~ recurr,nc.s of svr
d~ring HO~ . I pt H'3 ,syl,toaati: duri r.qr':Lrr,ntJET .t
a : o n ~ er cycl. len~th. ~2Hl!l!i2~1: Lv. and 0 flee is
highly Iffecti~e In suppres5i ~g ectopic activity in pts
"ith ESVT. In pts wi th rec.rrent ESVT a coabl ~.t:o ~ of F
and ~ .ppe.rs to be beneflcl.l.
APPARENTLY 1010PATHIC SUSTAINEO VENTRICULAR TACHYCAROIA
RESPONSIVE TO METOPROLOL IN YOUNG PATIENTS, HISTOLOGIC
EviDENCE or SILENT CAROIOMYOPATHY.
Federlco Glanolla,I(),AndreaFrustacl,l(),AntonloNobUe,l(),CtrardoAnsa-
lone,l(),MarlnaCall1arulo,I(),SllndroIlontenero.l(),rulvloBelloccl,l(),
CsthollclW'IlversitySacred Heart, Rone, Italy.
Sustainedventriculartachycardia(SVT) is unc()lllll()f'l in yOU'lg pts and Is
usuallyassociated _ith organic heart disease(00). It may occur, hotoe-
ver, without clinically evident 00. To evaluate possible occult00 in
5 pts (4 Nles and I female, 18 to )7 years old) lOhose onlymanHestation
of heart disease _as pont~ SVT, an echocardiographlc, I\aeftlOClynanllc,
elecUophysiologlc and histologic study _as perrormed. The morphology or
SVT ... s LB8B in 2 pts ancl RIBl in , prs. Chest radiographs,echocardlo-
gr;ons ancl ECes during sinus rhytmwere normal in all ots. Cardiaccathe-
terizationdoclJllllltedonlymUdly elevatedLVEOP in 2 pts, AU pts had Er
>50 x. Althclu41" in no pt signalaveraged late potentialswere fOOSld,pro-
gr~ ventricularsti....lation induced SVT In all pts, Metoprolol (H)
was successrul in preventingInductionor SVT In all pts, .....Ile class I
antiarrhytmicdrugs faUed to prevent inO.JclbUity in , pts, Lert ventri
cularendomyocardialbIopsy specimens (LVE8S) ..ere abnormal in all pts,
shooing non specific cardiomyopathicprocess. All ptswer~ maintainedon
H therapyand none had sudden death orSvT after amean rollow up of 14
months. Conclusion: Apparently IdiopathicSVT may be the rirst and only
cUnlcal manifestationor 00 in YOU'lO pts. Abnormalitiesin LVEBS In our
pts areIndistinguiShablefrom those seen in Idiopathic dUated cardio-
myopathy. H ...s effective Inpreventingrecurrenceof SVT in theseets.
Although It is conceivable that our ptshave been identHied at arelati-
vely early stage of disease,it Is uncertainwhether the cardiomyopathlc
process representsa seH 11lDited conditlon or a progressiveprocess.
Longer rollow up study ..Ul be necessary to detefllline the natural histo-
ry.
Tuesday, March 10, 1987
4:00PM-5:30PM,Ballroom, First Level
Drug Treatmentof CardiacFailure
THE ACUTE HEHODYNAMIC EFFECTS OF INTRAVENOUS CAPTOPRIL
AND INTRAVENOUS DIGOXIN IN PATIENTS WITH HEART FAILURE.
Hihai Cheorghiade, H.D., F.A.C.C., Peter J. Hacander. H.D.,
Veronica B. Hall, R.N., Jeffrey B. Lakier, H.D•• F.A.C.C.,
and Sidney Coldstein, H.D., F.A.C.C. Henry Ford Heart&
Vascular Inscitute, Detroit, HI.
In ord~r to study the individual and combinedeffects of
intravenous (IV) Captopril (C) and IV Digoxin (D), 7 pa-
tients in sinus rhythm andheart failure due to dilated
cardiomyopathywere instrumentedand rest and exercise
hemodynamics, including: pulmonarycapillary wedge pres-
sure (PCWP), cardiac output (CO), cardiac index (Cl),
systemic vascular resistance (SVR). stroke work index
(SWI) and radionuclide ejection fraction (REF) wer~ ob-
tained 1) at baseline, 2) 2 hours after a 15 mg bolus of
C followed by continuous infusion of 6 mg per hour and 3)
4 hours after 1 mg of D while receiVing a constant in-
fusion of C at 6 mg per hour. Results: meantSD
INEFFICACY OF ORAL TOCAINID! IN SUSTAINED VENtRICULAR
TACHYCARDIA A/fl) FIBRILLATION
Gur C Adhar,HO, Charles Swerdlow, MD, FACC, Ilarbara
Lance, ItN, Deborah Clay, RN, Gust K Bardy, HO, FACC. K
Leon Greene, KO, FACC, Seattle, Washington andStanford,
CaUfornia.
Tocainide was adeinistered to 44 patients (pts) with
clinical sustained ventriculartachycardiaand
ventricularfibrillation (VT/VF), who also subsequently
had suatained VT/VF induced at baseline EPS. The
clinical arrhythmiawas VF in 21 and sustained VT in 23
pta. Cardiac diagnoses were coronary artery disease in
40, valvular disease in 2, and cardio.yopathyin 2 pts.
The Han age was 61 + 11 yrs and the ejection fraction
waa 0.28 + 0.11. "'n-averageof 3.6 antiarrhytheicdrugs
were unsucceasful in controlling VT/VP prior to uae of
tocainide.
Tocainide was discontinued in 9 patients because of
spontaneous recurrenceof the arrhythmiawhile in
hospital. In an additional 5 pts. it was discontinued
because of intolerable side effects. Therefore, 30 pts
underwent repeat EP study on tocainide. Twenty-seven
(90%) of the pts continued to have inducible VT/VP while
on tocainide. Tocainide wss effective by EPtesting in
only 3 pta, but these 3 had to have tocainide
discontinued secondary to late side effecta (rash-l,
atada-l, treaors-l). Thus at the end of one lIOnth,
none of the 44 pta evaluated were taking tocainide.
PCWP
....Hg
CO
L/min
Cl
L/H/H2
SVR
dyn.sec.
-5cm
SWI 2
g.m.m
EF
Conclusion: Tocainide, as assessed by EP testina, is
rarely effective in the ..nage.ent of drug refractory
suatained ventriculartachycardiaand ventricular
fibrillation.
B
C
D+C
32t6 3. zei , 2
24t6* 3.5t!.5
20t6* 4.7tl.2**
*p <0.01 compared
1.7tO.7 l462t700 15t8 13%t3
1.9tO.4 lS12tS16 16tS
2.4tO.3** 1348t288 24t4**17%t4
to B up <0. 01 compared to B or C.
We conclude that IV C causes a significant reduction in
PCWP and SVR at rest without an increase in Cl and SWI.
The addition of 1 mg of IV D to IV C caused asignificant
increase in Cl and SWI. It appears that the combination
of C and Dinduce a more pronouncedhemodynamic effect
than C used alone.
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A RANDOMISEO COMPARISON OF HYDRALAZINE ANiJ CAPTOPRIL
IN THE TREATMENT OF SEVERE CARDIAC FAILURE
Peter M. Schofi<!ld, MRCP, G. Lawrence, BSc, T. Testa,
FRCR, C. Ward, MD, N.H. Brooks, MD, Wythenshawe
Hospital, Manchester, England.
We report a randomised, single-blind trial of
captopril or hydralazine added to the optimal
conventional therapy of 30 patients with severe
chronic cardiac failure (25 coronary disease, 5
cardiomyopathy). The dose was titrated; 15 received
hydralazine 63 ± 13 mg ( mea n ± SO) 8 hourly and 15
captopril 21 ± 7 mg 8 hourly. Dyspnoea and tiredness,
assessed by a visual analogue scale (0-100) before and
after 12 weeks treatment, improved with captopril
(mean 47.7 to 13.3, SO 6.9, and 40.5 to 9.9, SD 8.7
respectively) and hydralazine (44.1 to 28.5, SO 6.9,
and 27.8 to 17.7, SO 8.7) but the improvement was
better with captopril (p<O.OOl). The i nc r ea s e in
symptom limited exercise tolerance (modified Bruce
protocol) was significantly greater for patients
treated with captopril (5.3 mins to 8.9 mins, SO 0.9
mins) than hydralazine(5.7 mins to 7.1 mins, SO 0.9
mins), p(O.OOl. Right and left ventricularejection
fractions (RVEF and LVEF) were measured blindly using
radionuclide angiography. RVEF increased following
treatment with captopril ( 26.4% to 33.7 %, SO 5.64,
p( 0.05) but not with hydralazine (28.0%to 29.0%, SO
5.6%). LVEF increased following treatment with both
captopril (23.9 % to 28.6 %, SO 2.7%) and hydralazine
(21.4 %to 24.4%, SO 2.7%) but the difference between
drugs was not significant. In these patients with
severe cardiac failure treatmenr with c ap t op r Ll
produced a greater improvement in symptoms, exercis<!
capacity and RVEF than hydralazine.
INCIDENCE OF EARLY TOLERANCE TO CONTINUOUS INTRAVENOUS
NITROGLYCERIN INFUSION IN PATIENTS WITH CORONARY ARTERY
DISEASE AND HEART FAILURE.
Uri Elkayam, M.D., F.A.C.C., Daniel Kulick, M.O., Nancy
Mclntosh, R.N., Arie Roth, M.D., Shahbudin H.
Rahimtoola, M.D., F.A.C.C., LAC-USC Medical Center, Los
Angeles, CA.
Sustained therapy with nitroglycerin (NTG) has been
reported to pro voke the development of early tolerance.
Since continuous intravenous (IV) NTG infusion is
commonly used in pts with coronary artery disease (CAD)
and heart failure (CHF) , we evaluated the incidence of
early tolerance development in 31 such pts. Hemodynamic
response to NTG defined as >30% reduction in mean
pulmonary artery wedge pressure (PAW) lasting >1 hour
was first established in all pts. 15 pts were then
continued on same dose NTG and 16 pts re ceived placebo
for 24 hours (HRS). After initial response 7/15 pts
receiving NTG developed a >30% increase in PAW lasting
>4 HRS (group A) and 8/15 did not (group B). A
comparison of changes in PAW (mmHg) from cont r ol between
pts in these two NTG groups and pts on placebo (p) at
peak NTG titration (PT) and 2, 4, 8, 12, 20 and 24 HRS
after randomizationshowed: (p(O.OI vs. placebo)
PT 2 HRS 4 HRS 8 HRS 12 HRS 20 HRS 24 HRS
P =t1:t3 -4:t5 -4:t5 -3:t5 -216 -4:t4 -2:t4
Group A -10:t4 -10:t5* -1 1:t6* -1 2:t6*-6:t7 -0.4:t6 -3:t3
Group B-I2:t5 -I2:t4* -12:t4* -12:t6* -I I:t5* - 9:t4* -I I:t6*
No significant differences were seen between P and group
A 12- 24 hours after randomization while the difference
between P and group B persisted throughout the study.
CONCLUSIONS: This study provfdes further evidence for
the development of tolerance to continuous NTG adminis-
tration. Tolerance is developed in approximately half
of pts with CAD and CHF treated with IV NTG and is seen
as early as 12 hours after initiation of therspy.
DOES Tl-E INTERMITTENT ADMINISTRATION OF
NITROGL YCER IN PREVENT n-£: DEVELOPMENT OF
I-EMODYNAMIC TOLERANCE IN PATIENTS WITH SEVERE
I-£ART FAILURE? Milton Packer MD, FACC, Paul D.Kessler
MD, Woi H.Jng Lee MD,Norma Medina RN, Modeline Yushok RN,
Stephen S. Gottlieb, MD. Mt Sinai School of Med, New York, NY
To determine if intermittent therapy prevents the develop-
ment of toleronce to nitroglycerin(NTG), we administeredNTG
to 2 groups of pts with heart failure (CHF): 8 pts received NTG
by continuous l.v, infusion (3.2-6.4 Ilg!kg/min) for 48h (Group
CONn and 10pts received the same dose intermittently(I2h on-
12h off-12h on-12h off) for the same periad (Group INTER).
Stroke volume index (SVI, ml/m2 ), mean arterial, LV filling and
mean right atrial pressures (MAP, LVFP & RA, mm f-g), heart
rate (HR, bprn), and systemic vascular resistance (SVR, d-s-e)
were measuredbefore NTG (Pre), after 2h & 48h of i.v. therapy,
and 2hafter NTG withdrawal(Off): where * =P <.05 vs Pre:
Group Pre-NTG 24 90 26 16 82 1928
CONT NTG-2h 28* 77* 17* 11* 80 1450*
NTG-48h 25 91 26 16 90* 1649*
Off-NTG 22 93 28 17 91* 2007
Group Pre-NTG 21 98 27 12 96 2294
INTER NTG-2h 24* 82* 15* 6* 94 1722*
NTG-48h 25* 83* 17* 7* 92 1756*
Off-NTG 21 98 27 12 96 2270
In Group CONT, the initial t in SVI and + in MAp, LVFP and
RA seen at 2h became completely lost after 48h, as HR t. In
contrast, in Group INTER, the initial NTG effects were sustained
after 48h, and HR did not t. In addition, all pts responded to
isosorbide dinitrate(ISDN, 40 mg p.o.) before the study, but 2h
after NTG-Off, ISDN was without effect in Group CONT but
produced t in SVI and + in MAP, LVFP and RA inGroup INTER.
In conclusion, a 12-hour drug-free interval is sufficient to
maintain responsiveness to NTG in pts with CHF and mayavoid
the developmentof cross-toleranceto otherorganic nitrates.
FAILURE OF INTRAVEOUS AMRINONE TO UIPROVE RENAL
HEMODYNAMICS AND NEUROHUMORAL STATUS IN PATIENTS WITH
SEVERE CHRONIC HEART FAILURE.
Arie Roth, M.D., Vito M. Campese, M.O., Willa Hsueh,
M.D., Nancy Mclntosh, R.N., Shahbudin H. Rahimtoola,
M.D., F.A.C.C., Uri Elkayam, M.D., F.A.C.C., LAC-USC
Medical Center, Los Angeles, CA.
Intravenous (IV) amrinone has been widely used to
augment ca r di ac output in patients (pts) with heart
failure (CHF). Although the central hemodynamic effects
of amrinone have been well established, only little is
known on its renal and neurohumoral effects. We
administered IV amrinone in a dose titrated to increase
cardiac i ndex (Cl) >25%in 14 pts with severe CHF. Cl,
mean blood pressure (MBP) , renal blood f l ow (RBF), renal
vascula r resistance (RVR) and glomerular filtration rate
(GFR) were measured a t baseline (B) and on amrinone (A)
and were as fol l ows : (*P(.OOOI)
Cl MBP RBF RVR GFR
(L/min/m') (mmHg) (ml/min) (dynes.S.cm-S) (ml/min)
B 2.0:t0.5 95:t13 556:t239 13649:t5934 42:t20
A 2.6±0 . 7* 94±I3 565±205 14714:t9442 48±28
In addition, amrinone did not change plasma levels of
norepinephrine (603:t370 pg/ml vs 585:t384 pg/ml), epine-
phrine (66:t49 pg/ml vs 73±69 pg/ml) and renin (36±26
ng/ml/min vs 34:t21 ng/ml/min).
CONCLUSIONS: Anr i none therapy results in a significant
increase i n cr in pts with severe CHF. However, the
augmentation of Cl is not associated with any
improvement in RBF or GFR or in reduction in elevated
levels of se r umcatecholamines and renin.
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PERSIsrENT HEMODYNAMIC EFFECTS OF LISINOPRIL AFTER
CHRONIC lliERAPY IN CONGESflVE HEART FAILURE Charles K.
Stone, M.D., Barry F. Uretsky, M.D., F.A.C.C., ThomasJ.
Linnemeier, M.D., F.A.C.C., Devendra K. Amin, M.D.,
F.A.C.C., Prediman K. Shah, M.D., F.A.C.C., Steven M.
Snapinn, Ph.D., and Chang-seng Liang, M.D., Ph.D.,
F.A.C.C., University of Rochester Medical Center,
Roches ter, NY.
To test the effect of chronic therapy upon the acute
hemodynamic response to lisinopril (L), an angiotensin-
converting-enzyme inhibitor, 15 Pt with Class III and IV
congestive heart failure were randomized to a single oral
dose of L in the acute phase. In the chronic phase, Pt
were titrated to L and were restudied after 12 wk of
therapy. The mean dose of L in the acute phase was 6.7
vs. 5.5 ~ after 12 wk. At 12 wk, control values of Cl
(L/minlm ) and pulmonary capillary wedge pressure (PCWP,
mmHg) at 24-28 h after the last dose of L were compared
to peak post-lisinopril (pos t-L) values. Ejection
fraction (EF, %) was determined by radionuclide angio-
graphy before the acute phase and at 12 wk. (Mean+SE)
Acute Phase 12 wk -
Control Post-L Control Post-L
Cl 1.9+0.1 2.4+0.2* 2.2+0.1# 2.5+0.1*
PCWP 2&;1 17;2* 19;2# 15;2*
EF 20;2 - 2J;3I/-
*p<0.05 vs. Control; #p<0.05 vs. Acute Phase Control
The results at 12 wk show: 1) significant improve-
ment in Cl, PCWP and EF in the 12 wk control compared to
the acute phase control; 2) a persistentacute hemo-
dynamic response to L administrationcharacterizedby
furtherreduction in PCWP and increase in CL Thus,
chronic administrationof L in congestive heart failure
may improve cardiac performance, and Lcontinues to exert
acute hemodynamic effects in congestive heart failure
despite longterm therapy with L.
Tuesday, March10, 1987
2:00PM-3:30PM,Room 38, Second Level
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LASER PROBE ABLATION OF NORMAL AORTA ANDPLAQUE:
CORRELATION OF THERMOGRAPmC AND mSTOLOGIC
FINDINGS.
Arlene B. Bradley, M.D., Ashley J. Welch, Ph.D., Jorge H.
Torres, Massoud Motamedi, John J. Ghldonl, M.D., John A.
Pearce, Ph.D., Roberto J. Bayardo, M.D., Hany Husseln, Ph.D.,
and Robert A. O'Rourke, M.D., F.A.C.C. Univ, of Tx. at Austin
and Unlv. of Tx. Health Scl. Ctr. at San Antonio, Texas.
Although the laser probe has been studied In clinical trials,
its mechanism of action is not clear. Our aim was tocorrelate
the thermal events and histologic results of probe ablation
of human aorta in air. Thus an Argon (Ar}laser heated probe,
Le. a metal-tipped optical fiber, was applied to 6 strips of
normal aorta.and to 5 strips with fibro-fatty plaque. Probe
temperature(T) was varied by raising the power (0.2-4W) or
the duration (l-IOsec) of the laser pulse, and was monitored
via thermocouples or 8-12 urn thermography. Tissue surface
T in 32 probe applications to normal aorta and 8 to fibro-fatty
plaque was thermographically analyzed, and vessel T at the
probe edge, at 0.20 and 0.32 mm from the probe edge was
correlated with histologic findings. We observed that: (I)
The laser probe attains a uniform surface T in 5 seconds, and
T is inversely related to the thermal conductivity of the
surrounding media. Probe T rises linearly with applied power
and exceeds simultaneous tissue T by <x2. (2) Ablation (crater
formation) requires tissue T >180oC,-and the adventitia may
reach 70°C. Ablation increases with higher laser energy and
with greater pressure of the probe on tissue. (3) Compared
to normal aorta, plaque exposed to the probe attains higher
tissue T and is more extensively ablated. (4) Whereas low
power direct Ar laser irradiation via bare fiberoptics causes
an explosive disruption of tissue, probe ablation is controlled
without extensive subintimal dissections. In summary, laser
probe ablation requires tissue T >180oC, is more effective
in plaque than normal vessel wall, and occurs in a histologicaIly
nondisrupttvefashion.
PEROJTANEX:XJS(X)RCNARY LASER ANJIOPLAS'IY IN A LARGE ANIMAL
KlDEL OFHUMAN OJRCNARY A'lHERCSCLERCSIS.
Warren D. JdlDston M;>. Kenton Gregory MD, Roger Nahas MD,
David Sato ID, Robert Berkley m, Jdm Mallery ID, Walter
L Henry ID, Fl\fX. University of California, Irvine.
To evaluate the potential clinical use of a heated-tip
laser angioplasty catheter, we performedpercutaneous
laser angioplasties in a large animal model of human
atherosclerosisdeveloped in our laboratory. In this
model an atherosclerotichuman coronary artery (CA) seg-
ment is inserted via plastic connectors in the mid-
portion of a bypass graft created between the aorta and
distal LADof large adult pigs. '!he bypass graft was
cannulatedwith a standard angiograItliccatheter and the
laser catheter was passed via a guidewire into the human
CA segment. Laser energy was delivered in 5 second
incrementsvia a metal-tipped 300u silica optical fiber
(Trimedyne-LaserProbe)heated by 9 watts of laser power.
Ten laser angioplasties were performed in six separate
pigs. '!he atheroscleroticCAs were 3-5 cm in length. '!Wo
CAs were totally occluded and one CA had a severe sub-
total occlusioo. '!he other CAs had varying degrees of
significant atherosclerosis. '!he heated-tiplaser cath-
eter was successful in reestablishiW luminal blood flCM
in the total and subtotal occluded CAs as well as improv-
ing luminal diameters in the other seven CAs. Only one
perforatioowas observed related to a technical prd:>lem
with the model. No el.ectrocardtoqragnfcor hemodynamic
changes occurred after lasing suggesting the lack of
toxic effects on the lI¥ocardium fran laser by-products.
'!hus, preliminaryexperience with the heated-tiplaser
catheter suggests that it has potential for treating CA
stenoses without untCMardeffects. In relatively straight
CAs, perforationdces not awear to be a major prd:>lem.
Further study is underway to determine its utility in
tortuous and bifurcating coronary arteries.
PERCUl'ANIDUS (X)~RY JASIDl. fliERMU. ~IOPIA~:h'Y t'lI'rH A
Mh"TIU.LICCAPPED FlBER.
'fimothy A. 5anborn, M.D., David P. Faxon, M.D.,
F.A.C.C., Mirle A. Kellett, M.D., F.A.C.C., Alice K.
Jacobs, M.D., Thanas J. Ryan, M.D., F.A.C.C., Boston
University Medical Center, Boston, M>..
Percutaneous laser thennal angioplasty (PJJfA) using a
rounded metallic capped fiber heated via argon laser
energy has now been demonstratedto have clinical safety
and efficacy as an adjunct to balloon angioplasty in
patients with total occlusions in the peripheral
arterial system which may be difficult or impossible to
treat by conventional means. 'fherefore, a clinical trial
of PI.JrA was initiated in patients with coronary artery
disease to determine the feasibility of this technique
as a potential adjunct or alternative to conventional
balloon angioplasty (PfCA).In this initial series, PJJi'A
was first attempted in five patients with high grade
coronary stenoses (2 lAD, 3 a::A) prior to elective
Pl'CA. A 1.7 QllI metal capped fiber (300 mieroo core
diamater) was advanced through the lesion over a
conventional P"fC'l. exchange guidewire (0.012-0.014 incn)
While delivering 1-3 five second pulses of 8 watts of
argon laser energy. PLTA successfully recanalized 3
lesions with a reductionof stenosis from a meanof tid%
to 47%. In two lesions tortuosity precluded canplete
recanalization and transcient OCclusion (? spasm) was
successfully treated by IC NI'G and PI'CA. '!'here were no
perforations, dye extravasations, emboli, or CPK
elevations related to PLTA. PfC'l. was then successfully
performed in all five patients. To date, (1-3 mo) there
has been no restenosis.
In conclusion, PLfA is feasible and can partially
recana.lize coronary stenoses. Catheter IOCdifications
should improve flexibility and trackabilityso that the
clinical role of PLTA can be determined.
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LASER BALLOON ANGIOPLASTY: THERMAL PROFILE FOR IN VITRO
WELDING OF NEOINTlMAL ARTERIAL SEPARATIONS.
Ronald D. Jenkins M.D" I, Nigel Sinclair, M,D" Raj
Anand, M.D" and J, Richard Spears, M,D" F,A,C,C" Betb
Israel Hospital, Boston, MA.
Dehiscence of atheromatousplaques during percutaneous
transluminalcoronary angioplasty (PTCA) may contribute
to both reclosure and gradual restenosis, Laser balloon
angioplasty (LBA) has been shown to be effective in
welding neointimal-arterial separations in vitro by
heating tissues with a Nd-YAG laser during balloon
inflation. To define the potentially useful therapeutic
range of tissue temperaturesrequired to achieve thermal
welds, 100 one cm diameter human postmortem atheromatous
aortic segments were exposed to multiple levels of Nd-YAG
laser energy for 20 seconds. The neointima was separated
from the media, and held in place under 4 lbs of pres-
sure. A range of 3.0 to 25.1 watts of Nd-YAG laser Energy
was delivered over a 5 mm area via a 400u core optical
fiber perpendicularto the plaque surface. Strength of
tissue welds was measured in grams required to sheer
opposing sides of welded segments. Tissue temperatures
below BOoC gave no appreciable weld, while temperatures
between 95
0C
and l400C consistently welded aortic separa-
tions effectively with weld strengths increasin§ linearly
from 25 to 110 grams. Temperaturesover 150 C caused
macro and microscopic tissue charring. Laser energy
produced uniform temperature elevation to a depth of 2
mm, with rapid decrement thereafter. The relationship
between power (ll\tPllt and tissue temperature suggested
that the thera!"",le range of energy which gave adequate
tissue welding ·.,as between l5B and 367 joules when
delivered in a stepwise fashion. These data provide
important information regarding relationships between
power output, temperature, and efficacy of tissue welding
of neointimal-arterialseparations,
QUANTITATION OF LUMEN ENLARGEMENT DURING CORONARY ANGIO-
PLASTY USING PRESSURE-VOLUME CURVES VS. ARTERIOGRAPHY
Linda L. Demer, M.D., Ph.D., Richard L. Kirkeeide, Ph.D.,
Avanindra-Jain,M.D., Craig J. Hartley, Ph.D., Albert E.
Raizner, M.D., F.A.C.C., K. Lance Gould, M.D., F.A.C.C.
University of Texas and Baylor Medical Schools, Houston,
Texas.
To quantitativelyassess the degree of lumen enlargement
during coronary angioplasty, we instrumentedthe infla-
tion syringe to measure the pressure (P) and volume (V)
within the balloon. P was plotted vs. V throughout each
inflation in 9 pts undergoing angioplasty. Balloon V was
greater at each pressure in the final P-V curve compared
to the initial, indicating lumen enlargement. The degree
of dilatationwas measured as the maximum difference
between initial and final balloon volumes over the entire
pressure range (AVmax), that is, the difference in
balloon impingement by the stenosis during the first com-
pared to the last inflation. As an independent measure
of increase in lumen volume at the stenosis, arterio-
graphic stenosis length and mean cross-sectional area
were measured by automated, digital computer analysis,
providing lumen volume before and after angioplasty. The
change in volume by the P-V method correlated to arterio-
graphic improvement quantitatively (r= .84, slope =1.2,
n=9). These results verify that pressure-volume record-
ing during angioplasty directly reflects improvement
in lumen size, permittingon-line
assessment of adequacy of dilation.
This method may also prevent excess
repeat inflations and excessively
high pressures, thus reducing
procedure time and complications.
v
REDUCTIONS IN PEAK PULSE ENERGY DIMINISH PARTICULATE
DEBRIS RESULTING FROM EXCIMER LASER PLAQUE ABLATION.
Stephen T. DeJesus, B.S., Jeffrey M. Isner, M.D.,F.A.C.C.,
Anthony Rongione, Kim Halaburka, B.S., Richard H. Clarke,
Ph.D., Tufts-New England Medical Center, Boston, MA
Recent studies have demonstratedthat substantial amounts
of particulatedebris are generated during excimer laser
(EL) irradiationof atheroscleroticcoronary arteries(CAs).
Accordingly, this study tested the hypothesis that reduc-
tion in EL pulse energy (PE) could diminish the extent of
resulting particulatedebris, while at the same time per-
miting an adequate degree of luminal recanalization. Ac-
cordingly, 16 CA segments, each 3-mm in length and narrowed
> 90% in cross-sectional area, were irradiatedin saline
with a XeF (351 nm) EL. Four segments were irradiatedat
one of 4 PE's: 80, 55, 35, and 15 mJ. Frequency was con-
stant (25 Hz). The experimental endpoint was a recanalized
CA lumen narrowed < 25% in cross-sectional area. Follow-
ing completion of EL recanalization, the aqueous residual
was passed through a series of graded filters 00-1240 u )
in size. Random-field point-counting was then performed on
20 microscopic fields of each filter. Total particulate
elements collected decreased from 991 at 80 mJ/pulse; to
851 at 55 mJ/pulse; to 467 at 35 mJ/pulse; to 394 at 15 mJ/
pulse (p < 0.001 by analysis of variance). Furthermore,use
of 80 mJ/pulse generated particles up to 1240 u in size;
in contrast, at 15 mJ/pulse, size of particulateelements
did not exceed 50011, and most were < 105~. Conclusion:
Optimization of the energy profile appropriatefor in vivo
EL angioplasty must take into account the size and quan-
tity of particulatedebris as a function of PE employed.
These findings indicate that reduction in peak PE can ac-
complish a statistically significant reduction in parti-
culate debris resulting from EL irradiationof athero-
sclerotic CA without compromising the adequacy of luminal
recanalization.
Tuesday, March 10, 1987
4:00PM-5:30PM, Room 38, Second Level
Intracoronary Devices
EFFICACY OF CORONARY ARTERY PERFUSION CATHETERS IN
PATIENTS WITH FAILED ANGIOPLASTY AND ACUTE MYOCARDIAL
ISCHEMIA
John S. Douglas, Jr., M.D., F.A.C.C., Spencer B. King Ill,
M.D., F.A.C.C., Gary S. Roubin, M.B., Ph.D., Douglas A.
Murphy, M.D., David L. Namay, M.D., H. Vernon Anderson,
M.D., Andreas Gruentzig CardiovascularCenter, Emory
University School of Medicine, Atlanta, Georgia
To determine the safety and efficacy of a multiple side
hole coronary artery perfusion catheter in patients (pts)
with failed coronary angioplasty (PTCA) associated with
chest pain and/or ST segment elevation, we analyzed
results in 20 consecutive pts comparing them with 20
matched pts (vessel dilated, chest pain, ST changes) who
underwent emergency bypass surgery for failed PTCA without
placement of a perfusion catheter. Following introduction
of the perfusion catheter, chest pain symptoms improved in
14 of 19 pts and ST segments were normalized in 12 of 17
pts. One pt with cardiogenic shock requiring closed chest
massage could not be stabilized with a perfusion catheter
and balloon pump and died following surgery. No deaths
occurred in matched pts. The frequency of Q wave
infarction (2 of 19), intraaorticballoon pumping (6 of
20), use of internal mammary artery grafts (6 of 20),
time to cardiopulmonarybypass (157 minutes), and peak
CPK-MB (87mu/ml) in pts with perfusion catheters was not
different from matched pts. No perfusion catheter
complications were recognized.
Conclusion: In failed PTCA associated with chest pain
and/or ST segment elevation, perfusion catheters appear
to be safe and effective in reducing signs and symptoms
of myocardial ischemia. Perfusion catheters may not
prevent infarction in some pts and may be ineffective when
systemic hypotension occurs.
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1lIEPERFUSIrnJlAU.C(J; CA1llEl.'ER: A NEW MEllUl FUl. SAFE I'IllJl1NE)
aRJWlY DIlATATIrn.
Gary J. Collins, M.D., Nonnan M. Ran1rez, M.D., Taooaki Itirohara,
M.D., ZenaidaK1cpoIIic, M.D., HarryR. Ph1l.lIps, M.D., lD! Richard S.
Stack, M.D., F.A.C.C.,fuke University M!dical Center, nnhan, North
Carolina.
A contirllOus perfus:lonballooo catheterlol!lS developed to prollide
coronary bloodflai~ prolongedballooo inflations. The perfus:lon
ballooo catheter (PBC) is a 4.5 French polyethyl.erecatheterwith
linear sidelx>lesa1<xl! the distal 7 an of the catheterpn:admaland
distal to the balloon. Bloodenters the prcndma1sidelx>les fran the
aortaand praximalcoronaryartery, passes throogh the central l.unen
within the inflatedballoon, and exits t:hroJghthe distal sidelx>les to
alla.r contirllOus coronary perfus:lon~ prolongeddilatations.
To test the effectiveness of coronary perfus:lon~ inflation,
the PBC was caJtl8Rdto control inflationswith a standardballoon
lqioplasty catheter (SAC) at the SlIDe coronarysite in 6 dogs. Serial
electrocard:lography,left ventriculographyand coronaryarteriography
was perfOl:llEd. Results wereas fol1ais:
AVFPJCE sr SEn1ENI: vmIlUaJI.AR LEIT vmIlUaJI.AR
IJ INFUITICN ELE.VATICN AR1lHY'llMIA WAIL AINR1ALl'lY
SAC 6* 3 + 1 min. 5/6 5/6 6/6
PBC 5 37 + 10 min. 0/5 0/5 0/5
*1 dog h8d ventricularfibrillat:lon~ SAC inflat:lonand
died before PBC insert:lon.
~ SAC inflat:lon, angiographyslnied total occhJs:lonof the
coronaryartery, Serial selective arteriography~ PPC inflation
slnied excellent distal perfus:lon of the coronaryarteryinvolved.
The PPC cathetercan prollide adequatedistal perfus:londuring
balloon inflat:lonto preventmyocardial ischemia for at least 30
ndrotes. nus, the PBC may prollide aIIEthod for investiaat1I1! the
effectiveness of vety proloogedballooo angioplasty dilatationsin man.
THE AUTOPERFUSION BALLOON ANGIOPLASTY CATHETER PREVENTS
ISCHEMIA DURING PROLONGED BALLOON INFLATION.
Zoltan Turi, M.D., F.A.C.C., Col in A. Campbell, Ph.D.,
and Robert A. Kloner, M.D., Ph.D., F.A.C.C., Harper
Hospital and WayneState University School of Medicine,
Detroit, Michigan.
As coronary angioplasty evolves to treat more complex
lesions, there is a need to provide nutrients to the
myocardium distal to the occluding balloon. We studied
a new type of autoperfusionballoon angioplasty catheter
(USCI) which has 8 side holes proximal to the balloon
and 3 side holes and an end hole distal to the balloon,
therefore allowing distal blood flow during inflation.
The circumflex coronary artery of anesthetized dogs
(n-5) was first catheterizedwith either the autoperfu-
sion balloon catheter or a standardangioplasty catheter
in a randomized manner. The balloon was inflated for 3
min during which the ECG (lead 11) was continuously
monitored and regional myocardial blood flow (RMBF) was
determinedusing the radioactive microsphere technique.
At least 20 min later the other type catheter was in-
flated for 3 min. The ST segment was similar before
inflation of the balloons (-0.06+0.02 vs -0.08+ 0.04 mY,
p-NS); however, after 3 min of balloon inflati~n the ST
segment was markedly elevated to 0.28±0.04 mV with the
standardcatheter and unchanged (-0.08±0.04 mY, p<O.Ol)
for the autoperfusionballoon catheter. RMBF in the
subepicardiumand subendocardiumof the circumflex per-
fused area was impaired at 0.19±0.03 and 0.15±0.06
ml/min/g with the standard catheter and significantly
higher (p<0.05) at 0.78±0.11 and 0.94±0.25 ml/min/g for
the autoperfusionballoon catheter. Thus, use of the
autoperfusionballoon angioplasty catheter allows for
prolonged balloon inflation without producing ischemia,
and may eliminate the need for complex perfusion systems.
PERCUTANEOUSLY IMPLANTABLE ENDO-CORONARY PROSTHESIS :
PRELIMINARY RESULTS IN THE TREATMENT OF POST-DILATION
RE-STENOSIS.
J. Puel, U. Sigwart, F. Joffre, H. Rousseau, A. Courtault,
J.P. Bounhoure, H. Wallsten. CHU, Rangueil, Toulouse.
A promising new approach to reducing post dilation coro-
nary restenosis is the use of a self-expanding endo-coro-
nary scaffolding or Wallstent device. In vivo studies
demonstratedgood biocompatabilityand haemodynamics. 10
coronary patient (pt) implants have been made by our group.
6 pts for post dilatation coronary restenosis, 1 pt for
venous C.A.B.G. primary stenosis and 3 pts had restenosis
with complicating C-V history. Of the seven, non-complica-
ted cases, 6 had a smooth implant procedure with excellent
angiographic follow-up at 3 months. In one case, where too
large a prosthesis was implanted into a 2 mm vessel, acute
asymptomatic thrombosis was seen. As regards the complica-
ted cases : in one case stenting of the 90% restenosis of
an original lesion which had induced myocardial infarction
and had been recanalised by thrombolytics in an asympto-
matic pt, led to acute occlusion. In the second case
stenting after unsuccessful mechanical recanalisation24
days previously led to asymptomatic reocclusion. Finally
in the third case with previous M.I., occluded C.A.B.G.,
occluded R.C.A., and restenosis of the L.A.D., it was
noted at redilation that thrombogenesis and diagonal
branch occlusion occurred just prior to introductionof
the prosthesis into the lumen. The prosthesis occluded.
Conclusion : Appropriateprosthesis calibre for a given
vessel size and good distal run-off appear to be determi-
ning factors for success. The absence of angiographic
evidence of restenosis at three month follow-up of all 6
pts is encouraging.
FIRST FOLLOW-UP DATA ON THE TRANSLUMINALLYIMPLANTED
CORONARYENOOPROSTHESIS
Ulrich Sigwart, M.D.. F.A.C.C., Milan Grbic, M.D.,
Axel Essinger, M.D., Lukas Kappenberger, M.D.
Centre Hospitalier Universitaire Vaudois, Lausanne,
SWitzerland
A unique self-expanding stainless steel multi-filament
prosthesis (Medinvent S.A., Lausanne. Switzerland)
which can be transluminally placed into any artery,
was implanted in 14 patients after repeat transluminal
coronary angioplasty for restenosis of a major
coronary vessel. There was one failure of ejection of
the prosthesis and one patient was treated surgically
for persistance of ischemia following maximal stress
testing.
Six prostheses were implanted in the left anterior
descending coronary artery, four in the right coronary
artery and one in the circumflex branch. Three
prostheses were placed in coronary bypass grafts. The
dimensions were 2.5 to 4 mm in diameter and 15 to 20
mm in length. Drug treatment consisted of heparin at
the time of implantation and coumadin + aspirin during
the first 3 months of follow-up.
There were two acute closures, one being permanently
reopened with urokinase. No patient has presented
angiographic or clinical signs of restenosis during a
median follow-up time of 12 weeks.
We conclude that stenting of coronary arteries with
self-expandable endoprosthesies may present a rational
approach to the prevention and treatment of restenosis
after transluminal angioplasty.
lACC Vol. 9. No. 2
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REMOVAL OF ANGIOPLASTY DEBRISFROM THE CORON-
ARY AND SYSTEMIC ARTERIAL CIRCULAT ION - IS IT
NECESSARY?
Geoffrey O. Hartzler, M.D., F.A.C.C., Barry D.
Rutherford,M.D., F.A.C.C. and David R. McConahay,
M.D., F.A.C.C. Mid America Heart Institute, Kansas
City, Missouri
Retention of balloon and guide-wire components is a rare
complicationof PTCA. Of 5,500 procedures, 10 pts had
retained metallic components including guide-wire segments
within the coronaryartery (Cor) - 7 pts, segments within
the coronaryand segments within the abdominal aorta -
1 pt, within the abdominal aorta - 1 pt , and a "gold band"
balloon markerwithin the coronary- 1 pt, Percutaneous
transarterialextractionof intracoronaryguide-wire seg-
ments with portions extending into the ascending aorta
was successful in 2 of 2 attempts utilizing a pigtail cathe-
ter. Extractionof guide-wire segments totally within the
coronary was successful in 1 of 2 attempts utilizing a
unique balloon catheterapproach. All guide-wire segments
within the abdominal aorta and iliofemoral arteries were
successfully removed using a bioptome. One pt with intra-
coronary retained guide-wire died 48 hours after PTCA
with acute closure of the contralateralcoronaryartery. At
follow-up of 3-60 mos , m =28 mos , 5 of 6 pts with guide-
wire retainedcompletely within the coronary have had no
clinical sequelae attributedto wire retentionalthough 1 pt
underwentlate CABG for multivessel disease.
Conclusion: Broken, retained PTCA guide-wire segments
can be extractedfrom the coronary if portions extend into
the ascending aorta. Removal from the abdominal aorta,
iliac or femoral arteriescan be consistently accomplished
with use of a bioptome. Guide-wire segments totally con-
tained within the coronaryare difficutt to extract with
currenttechniques, however these guide-wire segments
may be well tolerated without adverse clinical sequelae.
PROGNOSTIC SIGNIFICANCE OF PROGRAMMED VENTRICULAR
STIMULATION IN PATIENTS AT "LOW-RISK" TWO WEEKS AFTER
ACUTE MYOCARDIAL INFARCTION
Anil Bhandari,M.D., Robert Hong,M.D., Phillip Au,M.D.,
Anthony Sankoorikal,M.D., Sharon Blue,R.N., Adam
Kotlewski,M.D., Shahbudin Rahimtoola,M.D.,F.A.C.C.,
LAC-USC Medical Center, Los Angeles, California
We prospectively performed programmed ventricular
stimulation (PVS), cardiac catheterization and 24-hour
holter in 75 pts with acute myocardial infarction (AMI)
14±3 days afrer AMI. These pts were at "low-risk", that
is, were without easily controlled angina, heart failure
or ventricular tachyarrhythmias. The protocol for PVS
consisted of triple extrastimuliat 2 RV and 1 LV sites,
and the end point for stimulation was induction of
sustained ventricular tachycardia (VT) or fibrillation
(VF). Sustained VT/VF were induced in 33 pts (19 VT, 14
VF) and were not inducible in 42 pts , During a mean
follow-up of 16±7 (3-26) months, there were 5 deaths (4
sudden, 1 nonsudden), and 3 pts developed spontaneous
sustained VT. The occurrence of these events was not
significantly different between pts with and without
inducible sustained VT/VF. Stepwise regression analysis
showed that both the presence of congestive heart
failure and inducible sustained VT were univariate
predictors of subsequent total mortality and of late
sudden deaths and spontaneous sustained VT. Induction
of VF appeared to be of limited significance as only 1
of the 14 pts (7%) with inducible VF had sudden death or
spontaneous sustained VT compared with 4 of the 19 pts
(21%) with inducible sustained VT.
We conclude that in "low-risk" survivors of AMI,
induction of sustained VT identifies a subgroup at
"higher risk" for late sudden death and spontaneous
sustained VI, but inducible VF appears to be a
nonspecific response to PVS.
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VALUE OF ELECTROPHYSIOLOGIC STUDY IN PATIENTS WITH
IDIOPATHIC DILATED CARDIOMYOPATHY AND SUSTAINED VENTRICU-
LAR TACHYARRHYTHMIAS
L. Bing Liem, 0.0., Marc Ovadia, M.D., Zion Sasson, M.D.,
Michael R. Franz, M.D., Charles 0 Swerdlow, M.D., F.A.C.C.
Stanford University, Stanford, CA.
Conclusions: In pts with dilated cardiomyopathy, sus-
tained VT is induced more frequently in those with clini-
cal sustained VT than those with cl inical VF. The in-
cidence of AR is lower in pts who receive EP-guided drugs
than in those for whom no drug is predicted effective at
EP testing. The incidence of SO is low in NI-pts and in
I-pts who receive EP-guided drugs.
We studied 62 pts with idiopathic dilated cardiomyopathy
and sustained VI (30 pts) or VF (32 pts). Pacing included
3 extrastimuli from 2 RV sites. Sustained VT was induced
in 43 pts (69%): 25/30 pts (83%) with clinical sustained
VT vs 18/32 pts (56%) with clinical VF (p=0.04). Elec-
tropharmacologic (EP) testing was performed in 36 in-
ducible (I) pts, and a drug predicted effective «15
beats) was identified in 16 (37%). Drug therapy was EP-
guided in 16 I-pts, empiric in 25 I-pts (type I drugs in
17, amiodarone in 8), and empiric in 16 noninducible (NI)
pts , Automatic defibrillators were implanted in 9 pts ,
During mean follow-up of 2.2 yr, 29 pts had arrhythmia
recurrence (AR) and 11 had suddendeath (SO). At 2 years,
the actuarial incidence of AR was 44+7% and SO was 23+7%.
The table shows the actuarial incidence (%) of AR and so
at 2 year with p values for the entire actuarial curves:
PROGRAMMED VENTRICULAR STHlULATION DURING MYOCARDIAL
ISCHEMIA INDUCED BY RAPID ATRIAL PACING.
Michael JE Davis MB BS, Charles A Boucher MD, FACC
Hasan GaranMD, Jeremy NRuskin MD, FACC, Massachusetts
General Hospital, Boston, USA and Royal Perth Hospital
Perth, Australia.
To assess whether sustained ventriculartachycardia (VT)
or fibrillation (VF) are more readily induced by program-
med ventricularstimulation (PVS) in the setting of acute
myocardial ischemia, PVS was performed during rapid
atrial pacing in a select group of 9 pts aged 49-79 y.
All had previous myocardial infarction and >60% stenosis
in at least I non-infarct-relatedcoronary artery. Two
had spontaneous VT, 5 spontaneous VF and 2 syncope. Ihe
clinical event followed angina or exertion in 6 pts. In
none could sustained VT or VF be induced by PVS using
1-2 extrastimuli at the RV apex. PVS using 1-2 extra-
stimuli was then performed at the peak heart rate achiev-
ed by continuous incremental pacing to a target of 85%
of the maximum predicted rate. Peak rates of 110-150 bpm
for 5-12 mins resulted in myocardial ischemia (at least
2 of chest pain, ST depression or reversible thallium-201
perfusion defect) in 7 pts. In no patient was sustained
VT or VF thus initiated.
All pts also underwent PVS with 3 extrastimuli, before or
at least 5 mins after cessation of rapid atrial pacing
and in the absence of overt ischemia. Sustained VT (6
pts) or VF (1 pt) was induced in 7 pts.
These data suggest that acute myocardial ischemia does
not render sustained VT/VF more easily inducible by PVS.
The use of multiple ventricularextrastimuli is a more
sensitive technique for the induction of sustained VT or
VF, even in pts in whom ischemia may have contributedto
the spontaneous occurrence thereof.
p.
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FACTORS ASSOCIATED WITH TIME TO ARRHYTHMIC
RECURRENCEIN SURVIVORS OF VENTRICULAR FIBRILLATION
Richard F. Kehoe, M.D., Terry Zheutlin, M.D. F ACC, Thomas
Mattioni, M.D., Michele Parker,RN, M.S., Russell Teagarden,
R.Ph., NorthwesternUniversity Medical School, Chicago,Il.
The clinical, angiographic, ambulatorymonitoringand program-
med stimulation(PS) responses of 139 consecutive pts surviving
non-acute infarction related ventricular fibrillation(VF) were an-
alyzed to determine the relative importance of factors signifi-
cantly associated with time to arrhythmicrecurrence.Therapywas
directed by PS responses. At a follow-up of 28.0±22.6 (mean±SD)
mos, 113 pts (81%) remained free of arrhythmicrecurrence(GpI)
while 26 pts (19%) recurred(GpII):16 sudden death; 5 sustained
ventriculartachycardia(VT);4 late VF; 1 syncope.
Univariate analysis revealed Gps I and II weresimilar for heart
disease type, prior heart failure, rem ote VFepisodes, percent VPB
suppression and persistent VT on predischargeambulatorymonit-
oring, exercise treadmill time, and angina or heart failure during
follow-up. Gps I and IIdiffered significantly(p<0.025) for incidence
of prior infarction(57%vs85%),NYHA Class 3 or 4(45%vs81%),pre-
sence of LV aneurysm(LVAN)(41 %vs77%), mean LVejection frac-
tion(EF) (39%vs30%) andpercent with inducible VT(IVT) at either
control(60%vs85%)or predischarge(15%vs46%)PS.
Using the stepwise Cox proportionalhazardmodel, the combina-
tion of factors most signficantly associated with time to arrhyth-
mic recurrencewere: IVT at predischarge PS, presence of LVAN
and depression of LVEF(p<O.OOOl). The relative risk ratio for re-
currenceover time for pts with vs those without IVTat PS was 7.5
fold and for pts with vsthose without LVAN 2.6 fold. For pts with
LVEF 25% vs LVEF 50%the risk ratio was 4.2 fold. At 12 and 36
mos, recurrence rates were 37% and 60% for pts with vs 5% and
10% for those without IVTat predischargePS.
We conclude: 1) persistence of VT at predischargePS, depression
of LVEF and presence of LVAN were, in decreasing significance,
the factors most predictive of time to arrhythmicrecurrenceand
2) percent VPB suppression and persistentVT on predischargeam-
bulatorymonitoringwere not predictiveof arrhythmicrecurrence.
INDUCTION OF NON-CLINICAL VENTRICULAR TACHYCARDIA AFTER
MAP-GUIDED SURGERY FOR REFRACTORY VENTRICULAR
TACHYARRHYTHMIAS: INCIDENCE AND CLINICAL SIGNIFICANCE
Martin 80rggrefe,Andrea Podczeck, Jorg Ostermeyer,
Joachim Schwarzmaier,GUnter Breithardt
Medical and Surgical Hospital B, University Hospital of
DUsseldorf, West Germany
Post-operative electrophysiologic evaluation in pts
undergoing map-guided surgery for VT is essential to
identify pts in need for further antiarrhythmic
therapy. The induction of the clinical VT in the post-
operative state is associated with a high incidence of
VT recurrences during follow-up,whereas non-
inducibility predicts a good outcome. The incidence and
clinical significance of non-clinical VT as defined as
rapid and often polymorphic VT not present prior to
operation is notknown. We therefore prospectively eva-
luated this finding in 75 pts undergoing either partial
or complete encircling ventriculotomy. Perioperative
mortality was 6.6 %. 69 of 70 post-operative survivors
underwent electrophysiologic testing. VT was not indu-
cible in 41 pts (60%), whreas the clinical VT was
inducible in 13 pts (19%). Non-clinical VT was induced
in 15 pts (21%), of whom only 2 pts were treated using
anti arrhythmic dru9s.
During a follow-up period of36+20 months, the cumula-
tive rate free of VT or sudden death at 2 yearswas
100 %for pts with induciblenon-clinical VT, 92 %for
pts with non-inducibleVT and 50%for pts with indu-
cible clinical VT.
Thus, the incidence ofnon-clinical VT after map-
guided surgerywas 21 %. Non-clinical VT is associated
with a good prognosis not requiring anti arrhythmic drug
therapy.
QUALITY OF LIFE IN SURVIVORS OF VENTRICULAR TACHYCARDIA
OR FIBRILLATION WHO HAVE UNDERGONE INTENSIVE ELECTRO-
PHYSIOLOGIC EVALUATION.
Alex Malter, CharlesWalance, Karen Griffith RN, ANP, Joel
Cutler MD, Jack Kron MD, John McAnulty, MD, FACC. Oregon
Health Sciences Univ., Portland,OR.
Electrophysiologic (EP) evaluation of victims ofclin-
ical ventriculartachycardia orfibrillation (VTVF) may
enhance survival. It is less clear that evaluation and
prescribed therapyresults in a subsequentsatisfying or
productive life. While a positive effect on survival may
outweigh other considerations, subsequentsatisfaction
could influence management.
Of 285 VTVF survivors studied, 69 were known to be dead.
Questionnaireswere sent to the remainder.68% of this
group returned thequestionnaire. 81% were men with an
average age of 62 years. They received the survey an
average of 3.4 years after EP evaluation.
When compared to the general population usingCampbell's
indices (scales of 1-7) VTVF patients did not differ from
normals in regards totesting of "general psychologic"
or "we11 being" status (P=NS). The VTVF pat ients' "Iife
satisfaction"scores differed slightly but significantly
from normals (5.17 vs 5.55,p=.003). Variables including
side effects with medicines, persistant cardiac symptoms,
and sexual dissatisfaction were associated with lower
"well being" scores. PreEP work status, age, type of
heart disease, and performancelevels did not predict
post-evaluation "well being"(p=NS).
Quality of life in patients who have had VTVF and subse-
quent intensive EP testing are not clearly different from
normals. Thus, theassumption that these arrhythmia sur-
vivors will somehow be more "miserable" is not a reason
to defer intensive evaluation and treatment of the
arrhythmias.
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PROGNOSTIC IMPLICATIONS OF CONCORDANCE BE'IWEEN THE
INVASIVE AND NONINVASIVE APPROACHES TO THERAPY FOR
VENTRICULAR TACHYARRHYTHMIAS.
L. Brent Mitchell, M.D., Henry J. DUff, M.D., Claire E.
Koskoski, R.N. and D. George Wyse, M.D.,Ph.D., F.A.C.C.,
University of Calgary, Canada
Chronic drug therapy for ventriCUlar tachyarrhythmias
(VT) may be guided by suppressing arrhythmia detected
noninvasively by ECG monitoring and exercise testing
(ECG) or VT provoked invasively by programmedstimulation
(PES). A randomized trial in 57 patients (pts) with
symptomatic VT eligible for both approaches revealed that
therapy selected by PES prevented VT recurrence better
than that selected by ECG. To determine the prognostic
implications of agreement between the approaches these
same patients had their chronic therapy assessed by the
alternative approach prior to discharge.
Predicted effective therapy (PET) by ECG was defined
as that reducing frequency of VPB >80\, couplets >90\ and
runs by 100\ with no runs on exercise testing. PET by
PES was defined as that preventing VT induction «5 com-
plexes) . All of the 29 pts randomized to ECG had PET
identified and 24 of these consented to predischargePES.
Fift~en of the 28 pts randomized to PES had PET identi-
fied and all consented to predischargeECG monitoring and
exercise test. Thus, 39 pts had PET assessed by both
approaches. Actuarial probabilities of subsequent VT
recurrence after 1 and 2 years are tabulated (*=p<O.05):
I YEAR 2 YEAR
39\tI0\ 58\tI2\
7\±6\ 7\±6\
17\tll\ 17\tll\
Therefore, identificationof therapy concordantlypre-
dicted effective by both approaches is an unnecessary
clinical goal in that it provides no more protection than
that identified by the invasive approach alone.
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PREDICTIVE VALUE AND EFFICIENCY OF PROGRAMMED
ELECTRICAL STIMULATIONAND HOLTER MONITORING IN
THE MANAGEMENT OF VENTRICULAR TACHYCARDIAAND
FIBRILLATION AFTER MYOCARDIAL INFARCTION.
Paolo Della Bella MD,Pedro Brugada MD,Thierry Du-
gernier MD,Mario Talajic MD,Robert Lemery MD,Hein
JJ Wellens MD FACC, Dept. of Cardiology, Academic
Hospital Maastricht, The Netherlands.
The positive(+) and negative(-) therapeutic pre-
dictive value(PV), and the efficiency(E)of pro-
grammed electrical stimulation(PES) were assessed
in 84 patients(pts) with clinically documented
and inducible paroxysmal ventricular(V) tachycar-
dia(T)(n-64)or fibrillation(F)(n-20)aftermyocar-
dial infarction. Data from Hol ter(H) were asses-
sed in 29/84 pts who had Lown 4B arrhythmias at
baseline H. Endpoints were recurrence of VT or
sudden death(SD). During treatment with antiar-
rhythmic drugs(AAD)68/84 pts remain inducible for
sustained VT or VF and 8/29 continued to exhibit
Lown 4B on H. By study deSign these data did not
modify treatment wit AAD("parallel" study). At a
mean follow up of l6+l5(1-68)months sustained VT
or VF recurred in 25768 inducibl~ s and in 2/16
non-inducible pts(p(.05);SD occurred in 3 induci-
ble pts and in I non-inducibl,- ' -nq). VT recurred
in 4 /8 pts with a positive H ana in 9/21 with a
negative H on AAD(p-ns).The +PV,-PV,and E of PES
were respectively .37, .87 and .46,and of H.50, .57
and .55. Conclusions: 1.PES identifies a subgroup
of pts with a low incidence of recurrent VT,how-
ever the +PV and the E of PES are low because 64 %
of pts with persistent inducibility after AAD do
well on follow up. 2. H was not useful to predict
drug efficacy.
IMMEDIATE REPRODUCIBILITYOF INDUCED SUSTAINED MONOMORPH-
IC VENTRICULAR TACHYCARDIA.
Marlon S. Rosenbaum M.D., David Wilber M.D., Charles
Freeman R.N., Hasan Garan M.D. F.A.C.C., Jeremy N. Ruskin
M.D . F.A.C.C., Massachusetts General Hospital, Boston, MA
The immediate reproducibilityof sustained monomorphic
ventriculartachycardia (SHYT) was exa mined prospectively
during 176 electrophysiologic studies in 84 pts present-
ing with sustained ventriculartachyarrhythmias.
Coronary artery disease was present in 73 pat i ent s (87%) .
132 (75%) electrophysiologic studies were performed on
antiarrhythmic therapy. Patients requiring cardioversi on
for terminationof ventricular tachycardi a were excluded .
Immediately following the electrical i nduction and
successful t er mi nat i onof SHYT wi t h pacing , programmed
car di ac stimulation from the sa me site was r epeat ed .
SHYT was re initiated in 164/176 studies , resul t i ng in an
immediate reproducibility of 93% . 14 (8%) of these re-
quired additional extrastimul i . SHYT could not be reini-
t i at ed in the remaining 12/176 studies (7%); however, no
additional extrastimuliwere employed in 11/ 12.
The cycle length (CL) and morphology (M) of i nduced
t achycar di as werecompared. CLs were considered similar
i f they were within 40 ms. Ms were consider ed s i milar if
mean frontal and horizontal axes varied by <45 degrees .
Induced tachycardias were similar in both CL and Min 114
(70\ ) . differed in CL alone in 5 ( 3%) , differed in M
al one i n 28 ( 17%) , anddiffered i n both CL and Min 17
( 10%) . These proportionswere not s ignif icantly influ-
enced by the presenting arrhythmia, re quirement for tri-
ple ventricular extrastimuli, or presence of antiar-
rhythmic therapy. In this selected populat ion , the im-
mediate reproducibilityof induced SHYT i s ~9 3 % , but the
characteristics of the induced t achycardi as will differ
in M or CL in 30% of studies.
REPlmU::lBILIlY OFARmYlllMIA IlrncrlCN IN mE ABSOCE OF
ANI'IARmiYlliMICMIDIC'ATl(H)
.lW)D At ¥eCi&L4..M.D., DeirdreVictor Walsh, B.A., Steven
P. Kutalek,M.D., Scot t R. Spi elman, M.D., FAO::;
Leonard N. Horowitz, M.D., FAD:; HahnemannUniversity,
Philadelphia, Pennsylvania.
Of 1148 pt s who had baseline electrophysiologic testing
(EPS) without antiarrhythmicmedications, 9 returnedwith
clinical indications for repeat EPS, again without
antiarrhythmicmedications, at 2-307 days (mean 97 days)
after their initial stUdies. Eight pts were male, mean age
was 59 (42-71), and mean ejection fraction was 30%(12-
54%). Cl inical indications for basel ine EPS included
sustained ventricular tachycardia (SuVT) in 3 pts,
ventricular fibrillation (VF) In 2, syncope in 2,
unwltnessed cardiac arrest in 1 and asymptomatic nonSuVT
in 1. EPS was repeated for drug failure in 5 pts, drug
intolerance in 1, recurrentsyncope in 1, presyncope in 1,
to demonstrate reproducibilityof VF in 1, and to
document non-inducibllity In 1 pt with VF.
.1Ju1w:wI BbnlIm ill blilll
f.U. Initial and follow-Up stUdies
6 SuVT
1 VF
2 none
SuVT or VF was reproduclbly initiated in both initial and
follow-up studies at the same RV site in 6 pts and at a
different RV site in 1. Induction' mode (paced cycle length
and number of extrastimuli) was identical in initial and
follow-up EPS in 4 pts, VT cycle length varied by 10-100
msec (mean 39) on repeat Induction In SuVT pts. These data
demonstrate a high degree of reproducibilityof induction
and induction site for pts who have repeat EPS off
antiarrhythmicmedications for clinical indications, even
wi th intervals between studies of up to 10 months.
DOES INDUCED "NON-CLINICAL" MONOMORPHIC VENTRICULAR
TACHYCARDIA BECOME MANIFEST CLINICALLY?
Richard W. Henthorn M.D F.A C,C , Dalmo A. R.
Moreira, M.D., Brian Olshansky, M.D ., F.A.C.C., Andrew
E. Epstein, M.D., F.A.C.C. , Albert L. Waldo, M.D.,
F.A .C.C. Case Western Reserve University, Cleveland, OH
and Uni versity of Alabama at Birmingham , Birmingham, AL
Th e significa n c e of non- cl ini cal mon omorphic
ventri cular t achycar di a (VT) i nduced i n t he car di ac
e l ec t r ophysio l ogy laborator y i s controve rsial . Some
investigators have suggested that non -clinical
monomorph i c VT, i .e . , monomorph i c VT morphologi cally
different th an t he spontaneous episode (s } , may l ater
occur spont aneously , yet othe r s f eel it is a laboratory
artifac t . To as se ss our hypoth esis that induced,
non-clinical monomorphic VT can occur spontaneous l y at a
l at er time , we i dentified 25 patients (pt s ) with 36
mor phologically distinc t spontaneous monomorphic VTs
(mean 1 .4/ pt ; r ange l -5/pt) who underwent serial
electro phys iologica l testing (2±1 study/pt) and who
subsequently had a spont aneo usmonomor phi c VTepisode (s }
document ed wi t h a 12lead ECG. At electrophysiological
testing, 22 pts ha d 27 cl inical monomorphic VTs induced .
and 20 pt s had 33 non-cl in i cal monomorphic VTs i nduced .
At follow up, 32 ep i s odes of spontaneous monomor phi c VT
occurred in t hese 25 pt s : 19 pts manif ested 20 of th e
original monomorphic VT morphologies, 9 pts manifes ted
10 of th e i nduced non-clinical morphologies , and 2 pts
each manifes t ed a newmonomorphic VT mor phol ogy. Thus ,
45% of pts (9 of 20) with i nduced non-c linical
monomorphi c VT later clini cally expressed such a VT .
CONCLUSION: Induced, "non-clinical" monomorphic VT ver y
well may become manifest as a spont aneous clinical even t
during fo l l ow up.
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INDUCTION OF VENTRICULAR TACHYCARDIA IN PATIENTS WITH LEFT
VENTRICULAR ANEURYSMS AND NO HISTORY OF ARRHYTHMIA
Alan Woelfe l , MD, FACC; PJK St ar ekMD, FACC; J RFoster MD,
FACC; JW Noneman MD, FACC; TC Ni chol s MD; LS Get t e s MD ,
FACC. Divi sions of Cardiology and Cardiothor aci c Surger y ,
Uni ver sity of North Carol i na , Chapel Hil l , NC.
Our expe rience wi th patients (pts) who have developed
vent r i cular t achycardi a (VT) after a conventional
aneurysmectomy fo r non- ar r hythmic indi cations, prompted us
to det e rmine how of t enaneurysms provide a substrate fo r
VT. We attempted to induce VT by progr ammed electrical
st imulation (PES) in 10 pts (8M,2F) with a left ventric-
ular aneur ysm from a pr evious myocardial i nf arction (mean
e ject ion f racti on 34\) but with no clinica l hi st ory of VT .
PES wa s performed pr i or t oplanned cardiac surgery f or
angina and/or hear t fail ure. Monomor phic VT (mean rate
243 beats /min) was i nduced in 9/ 10 pts ; i n 7 pts VT was
sust ained in the absence of drugs, while in 2 pts nonsus-
tained VT (18 and 26 beats) became sustained after
administration of procainamide. VT was induced by either
2 (6 pts) or 3 (3 ptsJ ventricular extrastimuli. Seven
of the inducible pts underwent surgery which included
aneurysmectomy and extended endocardial resection. After
institution of cardiopulmonary bypa s s in the operating
ro om, sustained VT was induced i n each pt , but was no
longer i nducible after ventriculotomy ; endoca r di a l
r e section wa s therefore performed visually . Postoper-
ativel y , ablation of the VT sub strate wa s con f i rmed in a l l
7 pts by t he ab senc e of i nducible VT dur i ng r epeat PES.
Conclusions: 1) Ventricular aneurysms f r equently are
capabl e of supporting su s tained monomor phi c VT; 2) The
substrate f or VT is apparently removed by aneurysrnectomy
wi t h extended endoca rdia l resection ; and 3) Preoperati ve
PES may be us eful in pts undergoing cardiac surgery fo r
r ea son s other t han arrhythmia.
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In-Vitro Studies of Color Doppler Flow Imaging
ANALYS IS OF COLOR DOPPLER: AN 1l:J V1.TEQ STUDY
OF THE EFFECl'S OF JETVELOCITY ON DOPPLER COLOR FLOW
MAPPING. Michele Nanna, M.D~, Xie Feng, M.D., Jarle
Hol e n , M.D., Raymond Gramiak, M.D., Richard S. Meltzer,
M.D., F.A.C.C. university of Rochester, Rochester, NY.
The influence of velocity (V) on jet area as depicted
by a color flow Doppler instrument (Toshiba SSH 65A) was
studied in vitro by performing constant flow rate
injections of an acqueous suspension of Sephadex
particles into a 350 cc compliant phantom via an
orifice. The axis of the incident sound was aligned
wi t h the axis of the orifice and the transducer-orifice
distance was 12 an. Three orifice areas were used: 1.4
(S), 8.5 (M) , and 14.5 (L) mn~. For each orifice, the
total vol une of injectate varied from 1-50 cc and the
flow rate ranged from 1-50 cc/e, resulting i n a total of
146 tes t runs. For each run the fluid V was calculated
assuming a flat profile. The images of the jets were
obt a i ned at a rate of 10 frames/s and jet areas were
determined off-line with the aid of an off-line
comput e r . For orifice S, at a given vol ume of injectate
V ra nged from .7-35 nv's ; a weakcorrelation was f ound
bet ween V and jet area (r=.58, p< .001, SEE=2.6). For
the orifice M, injection resulted i n V from .47-5.8 nv's ;
a good cor re l a t i on was found between V and jet area
(r=. 72 , p< . 001 , SEE=5.1). For orifice L, inj ections
resulted i n V from .2-3.4 nv's; an excellent correlation
was found between V and jet area (r =. 84 , p< . 001 ,
SEE=5.2) . Each vol ume injection performed through
orifice S at a given f low rate generated higher V and
larger jet areas than those performed through 'M & L
orifices. CONCLUSIONS: 1. Doppler color flow jet areas
a re directly related to flow V at the origin of the
jet. 2. Identical injection volumes for a given orifice
may yield different Doppler color flow areas if driven
by different V (=pressure gradients)•
THE SHAPE OF REGI~GITANT JETS: IN VITRO FLOW Vl SUALI ZA-
TIOl' AND COLOR FLOWDOPPLER STUDI ES. Ki.,b"r ly A.
Krabil l , M. D. ,Tadashi Tamura, C.Phil. ,David J. Sahn ,
~i .D . , FACC, Kyung J. Chung , M.D ., FACC, Ajit P.
Yoganat ban , Ph .D. Brian Hoi t . M.D . Uni v . e f Calif , San
Diego, CA .
A hydrodynamic relationship exi s ts between l ami nar jet
l engt h (L) and widt h (W) for stenoti c orifice s . as s t en-
os i s bec omes mor e severe with i ncreasing Reynol ds num-
bers (NR) >800 , the L of t he jet decreases but L/W s t ays
near 5: 1. Clini ca l color flow mapping Doppl er (CD)
studies of mitral and aortic i nsufficiency (MI .AI) , have
rarely shown such l ong. nar r owjets. We studied an i n
v i t ro mode l with optical visualization and CD imaging-of
i nk-(0- 40%) gl ycer ol - wat er j e t s (Viscosi ty 1 to 3 . 5 cP)
from 1.4 mm and 3. 4 mm or i fices . The 3 CO's we use d
(Al oka , Toshiba , and Hewlett-Packard, 5 MHz) imaged in
vi t ro jets within 2-3 mm of ac t ua l jet Wand 3 mm of--
actUal jet L (2- 6 cm). Jet fl ows with NR of 350-2500
i nj ec t ed i nt o still fluid yi e l ded L/W ratios which
decreased with increasing NR, l eveling of f to L/W 5-6:1
near NR of 2500. An experimental exponential curve fit
was appl i ed to NR vs L/W and a close correlation (r=
0.9 9) was found. Next. to better mimi c AT, the waterbath
was swirled along the direction of the jet as in mitral
i nf low, and f or MI. water was s l owl y swir l ed t owards and
against th e jet. With swirling . j ets showed diminution
of jet L/W ratio, deceleration and spr eading on CD, and
a transition to turbulence i nt o t he expanded j et . As
velocity fur t her decreased despite continued visualized
turbulence, CD vari ance encoding was no longer seen . The
L/W relationship for jets is gr ea t er in still f l u i d t han
for clini ca l MI and AI, but f ree j ets encountering swir-
ling break up into turbulentareas . Our study provides
informati on about factors governing valvul ar insuf fici-
ency as i maged by CD.
REGURGITANT VOLUMES BY COLOR FLOWOV ER EST I~ATE INJECTED
VOLUBES IN AN IN VITRO BODEL
Ravin navidof f , MB, BCh, Gerard T Wi lkins , ~ffi, ChB; Ja mes
D Thomas. MD, Donna M Achorn. RTR; Arthur E Weyman, MD ,
FACC; Massachuse t t s Genera l Hospital , Boston, MA
It has been sugge s t ed that th e maxi mum area of the
r egurg itant jet imaged by color Do ppl er can be used as a
measur e of the regurgitant volume. The val id i t y of this
relati onship, however, has not been clearly established.
We, therefore, constructed an i n vitro flow system to
simulate valvular regurgitati onln which both flow rate
and volume could be controlled. Regurgi tation was
modelled as a jet passing t hro ugh a fixed orifice into a
r eceiving chamber (17 cm depth). Fi xed vol umes of blood
(zcc , 6cc , 12cc, 20cc ) were in j ected at car efully
contro l led fl ow rates ranging fr om 0.2cc/ se c t o 20cc/ s ec.
The calor fl ow transducer was positioned pa ra l l e l to t he
jet and t he Doppler defined area of fl ow continuous ly
re corded. The area of t he color jet was planimetered for
each frame and compared to fl ow rate . The resultant jet
area showed an excel l ent correlati on (r =. 92 ) with
instantaneo us fl ow rate for al l fl ow durat i ons , Assuming
symmetry, the area of th e f low j e t was rotated about its
long axis and jet vol ume cal cul ated. The ca l or volume per
f rame was di r ectly propo rtiona l t o t he fl ow rate (r =. 95) .
The jet vol ume measured by color flow however, greatly
exceeded th e actual volume injec ted fo r a comparable
per i od. Conclusions : Jet area by color fl ow cor r el a t es
well with vol ume flow r at e in vitro. Int egrat ed jet
volu me by color flow, however, dramatically exceeds
actua l i nj ec ted vol ume. Withshort injecti on intervals
( .3 se c ) (co mpar a ble t o a systolic period) th e maximal
j et area and vol ume s hould not cor rel a t e with regurgitant
volume. Use of t he color flow jet area and vol ume from a
single maximal frame as a measur e of regurg i tant vol ume
appears i nappr opriate .
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DETERMINANTS OF SPATIAL RESOLUTION OF COLOR DOPPLER FLOW
MAPPING SYSTEMS: I N VITRO I ~VESTI GATJ ON . Tadashi Tamur a ,
C. Phil. , Kimber ly-A. Krabill, M. D. , David J. Sahn, M.D.,
FACC., Uni v. of Calif, San Di ego , CA.
lie evaluated the spatial. resolution of 2 commercially
available color Doppler (CD) f low mapp i ng sys t ems (Al oka
880 , Toshiba SSH65A), and a protot ype Hewlett - Packar d
(HP) 77020 (a l l a t 3 . 5 and 5MHz) i n an in vi t r o f low
model . Lat ex tubing (interOAI d iameter;9."5~5. 8 mm)
was connected t o a motor to pump a susp ension of 0 . 5%
corn-starch-water at steady mean veloci ties of 31 cm/
sec , 49 cm/sec, or 57 cm/sec . The Al oka (Wi t h far t rans-
mi t f ocus se t t i ngs) started to overes t imat e t he ac t ual
f l ow diameter a t a distance 10 cm fro~ t he transducer
with as much as 10 mm over es t i mat io n r f t ube size at a
depth of 14 cm, mainl y due to bea m spre ad in azimut h .
The Toshiba at a range of 4-1 4 cm i maged th e tube within
2 mm of actual size but often with s l ig ht underestima-
tion which occurred when the tailing edge of the imaged
internal tube wall encoded image pixels and the scan
convert er functioned to give B-mode image pixel s
priority over color flow, resulting i n smaller color
dIameters. The HP showed excellent spati al resolution
of color fl ow (within 2 mm) over depths 4-22 cm but
showed some irregular, jagged edpes on t he fl ow images
due t o video pixel size at high sampl i ng rates , but this
appearance could be minimized by decrea s in g f r ame rate
and using a high density data matr i x , or by utilizing
t he spatial fi l t er of the i ns trument. The spatial
res olution of CD is depende~t on beam f ocus (Aloka) , the
scan conver t er al gorithm (Toshiba) , pi xe l di.stribution
(Toshi ba and HP) andspatial f ilterin g (HP) . Tra deoff s
exist in t he implementationof th es e parameter s but each
can be optimi zed for j et imaging or , as in our model ,
f or yi el di ng an accurate, true fl ow diame ter of laminar
flow.
AREAS OF JETS BY COLOR FLOW DOPPLER VARY WITH ORIFICE
SIZE. Feng Xie, M.D., MicheleNanna, M.D., Jar le Holen,
M.D. , Raymond Gramiak, MD, Richard S. Melt zer , MD,
F.A.C.C. university of Rochester, Rochester, NY
It is not known whether the area of a jet on color
flow Doppler echocardiography can be reproducibly
measured and whether it behaves as wouldbe expected
according to known fluid mechanical principles. we thus
designed an in vitro flow system that could create a jet
in a water tank and allow variation of the following
parameters:size of the orifice at the origin of the
jet, flow rate and velocity (pressure dr op) across the
orifice. The fluid in the system was a 4:5mixture of
glycerin:water and sephadex was added to provide
ultrasonic scatterers. Tt~ jets so creat ed were imaged
with a ToshibaSSH 65A color flow Doppler instrunent
with a 3.75 MHz transducerpositioned so that the jet
was centered within the focal reg ion. Jet areas on
color DOppler display were measured by off-line
planimetry. A total of 725 area measurement s was made.
Jet area was measuredat orifice di amet er of 1,2,3,4,5
and 6 mm. Flow velocities at the or ifice of 20, 40,60,
80,100,120,140,160,180, and 200 cm/sec were used.
RESULTS: Stable jets could be imaged and recorded at all
vel oci t ies and orifice sizes studied . At each f lowrate
and orifice size studied 15 repeat jet ar ea measurements
were made by the same observer. The coefficient of
variation of these jet area measurements ranged from 0.5
to 10.6% (mean 2.9%). At all veloci t i es studied, the
orifice size was highly correlated with jet area (r
ranging from .97 to .99, all p val ues < 0. 001).
Conclusions: 1. An in vi t ro model can be created t o
allow colorDOppler flow imaging of f l uid jets. 2. Jet
area measurements have excellent intra-observer
variability in this model. 3. Areas of jets by eclor
flow Doppler vary withorifice size .
Mm:>ING COIDR DOPPlER IMi'\GING wrrn 4 DIMElISIOOAL
EX:HOCARDICXiRAMREa::NS'IRJCI'ION
AmitabhaGhosh , Ih.D. , JohnR. Schott, Ih.D. , Sally
Moos , Navin C. Narrla, M.D.,F.A.C.C. university of
AlabaIta at Birmin:Jham, Birmin:Jham,AI.
A It'ethodhas been developed and described for
canbinin:Jaxially rotated2""1ilirensionalecho in'ages into
a 3""1ilirensionaltime deperdentm:xiel. 'Ihe It'ethod
involves digitiz~ the 2-dimensional iIrages, SlTOOth~
to minimize noise and then applicationof a specialized
radial edge enhancementto highlight the left ventric-
ularwall which is c:utlined as a wire frame. '!heroot
mean square errorassociated with this It'ethodwhen
tested on 26 t issue saIlllles was 0.24 an2. '!he method
has been applied to 8 iIrages at various stages in the
cardiac cycle for each of 9 axial rotations. '!he
resultantiIrages are merged into 3-dimensional time
varyirqmodels us~ a special time warpinq routine
developed by us. '!his routine uses interpolation
technique between iIrages at various stages in the
cardiac cycle to generate a simulated period for the
cardiac cycle. '!hese final 4-dimensional models
representa physical m:xiel of left ventricularbehavior.
Near simultaneouscalor D:lppler iIrag~ can be obtained
in the samevideo format. By digitiz~ the red, green
and blue flaN data from the fixed transducers, the flaN
can be recorded in the same spati al coordinatesystem as
the left ventricularwall data. In this study, the
potential for merg~ fluid flaN data reduced to 6
Velocity isopleths to..Iards the sensor and 6 velocity
isopleths away fromthe sensor with the 4-dimensional
reoonstnlction IOCXiels is denonstrated.
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Evaluation of Myocardial Perfusion by Contrast
Echocardiography
SUCCESSFUL TRANSPULMONARY CONTRAST ECHOCARDIOGRAPHY IN
MONKEYS.
Steven B. Feinstein, M.D., Mark W. Keller., M.D., Candace D.
Dick, M.D., Tim R. Bridenstine, M.S •., and Robert W. Wlssler,
Ph.D. , M.D., The Un iv er s i t y of Ch ic a go., Chicago, IL.
Successful transpulmonary appearance of the echo contrast
e ff ec t in the left heart chambers resulted from a single
in tr a ve no us bolus o f 3 to 5 mill il l ters of sonicated albumin
mlcrobubbles (less th an 9 mi<rons In d la m eter] in 6 monkeys.
Forty of 45 injections (89%) of sonic ated albumin microbubbles
resulted in a dense opac if ication of t he left ventricular cavit y.
Vis u al ins pectio n and off- li n e vldeodens ltometrlc analyses
c on t lr-n e d t he appearance of the contrast effect within both
ventricular c ha mb e r s. The appearance of m lcrobubbles w ithin the
myo cardium was noted In 2 o f the 6 monkeys as determinedfro m
s ig n if ic a nt increases in video-Intensity b a c ksc at t er within the
m yo c ar d ia l ti ss u e . The variability of myocardial t issue
enhancement resulting from the Intravenous injection of
son icated albumin microbubbles wi ll be disc us s ed, All an imals
tolerated the procedure without complica tion and were autopsied
at a later date . One monkey was followed for 15 months
follow ing the in tr a v e no us inj ectio n of the sonicated albumin
microbubbles witho u t e vid e nc e of untoward effe cts.
Conclusio ns : (1) Son icated album in mi c r ob ub bl es successfully
pass through the vasculatureof the lungs resulting in a s ign if icant
contrast effec t within the left ventricular cav ity on
echocardiogram. (2) Contrast effect was identified within the
myocardial tissue follow ing a single In t r a v e no us injection of
sonicated albumin microspheres us ing an objective, computerized
video-intensity program. (3) Son icated albumin mlcrobubbles
appear safe for use in rnvo c ar d la lperfuslon Im a g in g.
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ASSESSMENT OF MYOCARDIAL PERFUSION BY aJNTRAST ENHANCED
DIGITAL SUBTRACTION ECHOCARDIOGRAPHY
~~~k J. Monaghan , M. Sc. , Peter J. Quigley , MRCPI , Jenni e
M. Metcalfe, MRCP and David E. Jewitt FRCP FACC.
Ki ng' s College Hospital, London, England.
The potential of Contrast Digital SubtractionEcho (CDSE)
to demonstrate myocardial perfusion (MP) has been
evaluated in 20 patients undergoing routine coronary
a r t er i ography. Intracoronary injections of 5mls of
sonicated omni paque contrast medium (350mg I/ml) were
performed dur i ng 2Decho. Multiple ECG gated LV short axis
frames ( in raw s can line data format) were stored by high
speed, real time data transfer to an on-line minicomputer.
3 frames pre and 20 frames post injection were col l ec t ed
in 2 short axis projections for both right and left
cor onary injections. A digital mask was cr ea t edusing scan
line data in the 3 pre i njection frames and subtracted
from the 20 perfusion frames. Thi s procedure enhanced the
appreciation of areas of increased gray level (GL) and
reduced the effect of instrument settings. The subtracted
frames were anal ysed in both spatial and temporal fashion
using a movable analysis window (approx lcm~) for mean GL,
standarddeviation and CL 1/ 2 time. Analysis was performed
in mul t i pl e segments and t he results compared to the site
of coronary lesions and areas of infarction. Regions of
presumed nor mal MP demonstrateda mean GL of 15.5 (+3.6) ,
mean window standarddeviation of 5.2 and modal time to
1/ 2 peak CL of 12 beats. In myocardial segments affected
by infarction or significant coronary lesions these val ues
were 4. 8, 3.5 and 19 respectively. Data has been collected
in patients pre and post succes s fulPTCA and demonstrates
increased segmental MP . Ut i l i s i ng sonicat ed contrast
medi um and on- l i ne digital capture of scan line echo data,
CDSE can demonstrate the spa t i a l and temporal distribution
of MP and could be of major value during routine coronary
arteriography,PTCA and coronary thrombolyis.
QllANTITATIVE ASSESSMENT OF CORONARY RESERVE IN CIUTICAL
STENOSIS BYSONICATED CONTRAST ECHOCARDIOC,PAPHY:
COMPARISONWTTH MICROSPHERES AND DOPPLER FLOW PROBE.
Jorge Cheirif , M.D., Will iam A. Zoghbi , M.D., Andrew
Zehler, Will iam L. Winters, Jr., M.D . , Roberto Boll i,
M.D., ,leffrey L. Lacy, Ph.D., Miguel A. Quinones, M.D .,
F.A.C.C., Baylor College of Medicine, Houston, Texas.
Myocardial contrast echocardiography (CE) with sonicated
Renograf in-76 i s a promis ing technique for evaluat ion of
regional myocardial flow.We have developed an off- l ine
compute~ '!1etho~ for videodensitometric analysis of ECG-
gated dlgltal lmages of the LV in short axis. Measure-
men~s . of transmural videodensity are made serially in 17
equldlstant LV segments and subtracte d fr om pre-contrast
density. The . m~thod was te~ te d in 5 open chest dogs during
c?ntro l , eritteal stencsts (l anter ior descending, 4
clrc~mf~ex ) crea~ed by partial occlusion to t he point of
abollshlng ~eac~lve hyperemia, critical stenosis plus in-
travenous.dtpyridamole (. 5 mg/kg), and following release
?f stenosls. Transmuralpeak intensity (pkI) , pkI normal-
lzed for number of pixels and time to pkI correlated by
multivariate analysis with coronary f l ow by Doppler in
each of the dogs (r range, .B4-. 97 1, and with regiona1
transmural myocard!al flow .by mi crospheres (r range,
.83 - :96). Follo~lng dipyrldamole in the region of
S~enOS1S , myocardlal flow changed insignif icantl y by
mtcrospheres(20%; NS ) and by CE (?7%; NS) but decreased
76% (pc.02 ) by Doppler. In control region, the increase
in f~ow was B6%by microsphere (pC .05), 76%by CE (pC .02)
~nd . 5%by .Doppler (pC.Ol). A consistent increase (pC.Ol)
1n myocard1al f low was documented by the t hree techniques
in the i nv ol~ ed :egion follOWing release of t he stenosis .
Thus, quantltatlve cont rast echocardiography provides
accurate assessment of regional myocardial f low and can
be used to evaluate regionalcoronary reserve.
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The results indicate that sonicat ed iopamidol 370 shows
physiologic values for M-2DE pa rameters in <50 % S wi th
prolongat i on of MC-2 DE parameters at) 50 % S. MC-2DE can
be used as a potential usefu l method to quantitatively
study myocardial perfusion.
QUA~TITATIVE MYOCARDIAL PERFUSION IMAGING US ING CO~RAST
2-DIMENSIONAL ECHOCARDIOGRAPHY;
Folkert J . Ten Cat e MD , Jan H. Cor ne l MD, Patrick W.
Serruys MD, Wi l l em B. Vl e t ter and J ohannes C. Rei ber PhD.
Thoraxcente r - Erasmus Uni versitYt Rotterdam,
The Netherlands.
Myocardi al contr as t 2- dimensional echocar di ogr aphy (MC-
2 DE) has been applied recentl y i n human be i ngs by
selective i njection of echocon trast into t he coron ary
arter y of the myocardium i nvolved. But whe ther quanti fi ca-
t i on of these segmental contrast enhanced images have any
s ignifi cance in relati on t o coronary arter y (CA) anatomy
is unknown . We studied 14 patients who underwent di agnos-
tic cardiac ca theterization by MC-2DE. Selec t ive CA
injections wi th 2 CC of echocontrast (sonicated iopamidol
370) were made. Coronary arteriograms were made i n 2ortho-
gonal planes . CA s te nosis was analysed quantitativel y by
vi deo- densitometry and expressed as %of total area ( %S).
MC-2 DE echocar di ogr ams f rom api cal vieuws were made du-
ring and after injection. From the MC-2DE di gitized i mages
video-intensity curves were cons t r ucted. Parameters ca l -
cul a t ed were are a under th e curv e (A) , cur ve duration (T)
and halflife of i ntensitydisappearance (Tl ) .
Results: %S
SPATIAL AND ltMPORALHETEROGENEITYOf CORONARY BLOOD fLOW
BY MYOCARDIALCOmRASTECHOCARDIOGRAPHY
Dui,l, ROYaL MD, Massimo Lombardi. M,D,. Steven E. Nissen. M.D..
AI'SS&IldroDistante. M,D.. MarioMarzHIi.M.D.. Anthony N. DeMaria.
M.D. F.A.C.C.. Antonio L'Abbate. M.D.. F.A.C.C.. C.N.R. Clinical
PhysiololY Inst. Univ of Pisa. Pisa. Italy.
It is b,lieved that coronary blood flov is mainly sub,ndocardial
during diastole ud sub,picardial during systole. To assess this
h'terogeneity. th, polysaccharidecontrastaaentSHU·of'of (2 mll vas
inj,cted either into the left uterior descending or circumflu
coronaryartery of of uesth,tizedopen-chest dogs or into the aortic
root 00 mll of 2 dosed-chestdogs. Inj,ctionsvere p,rformedby u
ECG-trillleredapparatusin I, basal conditions . Tvo-Decho inshort
uis vi,v vas performed from the closedrightside of th, ch,st ud
vas digitiz,d off-lin, inw a 2:)612:)6 pilei matril vith 2:)6 gray
l,v,l/pilel. Each ,nd-diastolic imq, vas identified ud subtracted
from the subsequenton,. The sam, procedurevas applied to the
end-systolic imaaes. To maintain uatomic ludmarts. the LV
endocardialud epicardialedges of the non-subtractedframes vere
dilitiz,d ud copied on th, subtracted ones. The frames ofcontrast
appelt&l1cevere identified udthe intensityof 3 regionsof interest
corresponding to th, ENDO-. MID- ud EPI-cardiumvas digitally
measured. The,cho-contrasteffect appeared in diastole in 9 situations
udwas significut1y higher in ENDO (33 1 l' • meu 1 SD) thu in
MID (27111l udin £PI(231 12 gray lev,lIpilell (p <.001 by Anon).
Th, increment in intensity in the following systol, vas not
significut1y diff,rentin MID (of to8). ENDO (-2 110) ud EPI (2a. 7
gray l,v,lIpil811, Th, ,cho-contrast,ffect appeared in systole in 6
situationsud vas high,r in EPI (27 .: 13)thu ENDO (2of ~Iof Bray
lev,1 pilell (p<.O:) . The increment inth, folJowinB diastole vas
hiBh,r in ENDO (2of 1 10) thu £PI 00 1 2 Bray level /pilell (p<.O:) .
The incrementin video density for theentire wall was higher in
diastole 07 1 ,) thu in systole 0 1 7 Bray levell (p<OOIl . Thus.
myocardialcontrastechocardioBraphyallows in vivo imaainB of the
tr&l1smuraJdistribution of coronary blood flow ud confirms its
physiological heterogeneityin the spaceudtim, domain.
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CONTRAST E<HJCARDIOGRAPHYDURINJ CARDIAC CATHETERIZATION
TO ASSESS REGIONAL MYOCARDIAL PERFUSION IN HUMANS.
Steven B. Feinstein, M.D., Roberto M. Lang, M.D., Alex
Neumann, B.S., lafar AI-Sadir, M.D., F.A.C.C., Kok G. Chua,
M.D., F.A.C.C., John D. Carroll, M.D., and Kenneth M. Borow,
M.D., F.A.C.C., The University of Chicago , Chicago, IL.
Contrast echocardiography was performed without
complication at the time of card iaccatheterizationin 14 patients
without significant coronary artery disease to establish t he
relationship between epicardial coronary arteries and regional
myocardial blood flow. Jntracoronaryinje ct ions of small volumes
(1.S to 2.0 ml) of sonicated Renografin-76(microbubblediameter
= 4.S :!: 2.3 I' by laser analysis) wereperformed. In all patients,
the left coronary system supplied the anteroseptal, anterior,
anterolateral and posterior regions. Right coronary injections
showed the inferior and inferoseptal regions perfused in 91% of
patients. The posteromedialpapillary muscle perfused from hoth
the left (S8%) and right (42%)coronary artery systems, whereas
the anterolateralpapillary muscle perfused from the left system
in all patients.
Summary: Overall, in the patients without significant coronary
artery disease, variation in the regional blood flow at the level of
the mid-papillary muscle was limited primarily to the
interventricular septum, the inferior wall and the posteromedial
papillary muscle. However, in an individualpatient, the actual
extent of perfusion could not readily be predicted from the
epicardial anatom y.
Conclusions: (1) Regional perfusion correlated with epicardial
artery distribution, although for individualpatients, perfusion
patterns var ied. (2) Refer euc e data from normalpatients should
facilitate assessment of perfusion in patients with coronary
arterydisease.
TESTING THE ACCURACY OF AUTOMATED AND SEMI-AUTOMATED
SPHYGMOMANOMETERS DESIGNED FOR HOME USE
Leonard Ste infel d, M.D., F.A.C.C., Myr on Cohe n, Ph.D.,
Stewart Kurtz, Ph.D. and Orland ino D. Almeida, M. D.
Mt . Sinai Med ica l Center, New Yo rk , New Yor k
Fifty-five d iffe re nt automated or semi-aut omate d sphyg-
momanomet e rs, ma rke t ed for home use in t he U.S . and Europe
we re tested for accuracy by comparing bl ood press ure (BP)
va l ues measured with t he test i nstrument (IN) aga inst t he
s imultaneousl y recorded i nt ra-a r t e r ial bl ood pressure.
Each IN was tested i n random fashion on three different
subj ec t s from a group of 92 adults. The aggregated data
showed a cor re lation co-effic ient (CC) of .93 for systole
and .62 for diastole with a wide scattering of da t a points
about th e I i ne of identity for diastole and less so f or
systol e. Of the 55 IN, the 5 j udged to be the most acc u-
rate were selected for retesting by direct, indirect com-
parison, but in addition, a simultaneous auscultatory
pressure was recorded by interposing an anaroid manometer
into the system and placing a stethoscope distal to the
arm cuf f . The tests were conducted under a rigorous sta-
tist ical design on a diverse group of 44 adults. To
evaluate accuracy of the 5 IN, two analyses of variance
were performed, one for systole and one for diastole.
Other fa ctors invest igated were age, arm circumference and
gender, but t hei r effects on results we re negl igible .
Among th e 5 IN , the direct-indirect systol ic CC va r ied
between . 91 and .95, and the diastol ic CC between .68 and
.92 . The i nstrument wi t h the best diastol ic CC had the
poorest sys to li c CC. The results were better when com-
paring IN t o auscultatory pressures . Summari z ing the
results, i t can be stated that with in the constraints of
t h is s t udy, none of t he IN tested would mee t t he proposed
American (AAMI) standards for automated BP devi ces.
1.23+ .05*
329+28*
.521+~04*++
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Hypertension:General
PENTOBARBITAL OR EPlNEPHRINE INDUCED HYPOKALEHIA AND
MYOCARDIAL VULNERABILITY IN A CANINE INFARCT MODEL.
Vasilios Papademetrlou,M.D., Richard A. Cooke, M.D., Aldo
Notargiacomo, Ross D. Fletcher, H.D., F.A.C.C., Edward D.
Freis, M.D., F.A.C.C., VA Medical Center, Washington, D.C.
In 11 male mongrel dogs myocardial infarction (MI) was
induced using the open chest technique. 7-10 days post MI
program stimulation (PS) was performed under pentobarbital
anesthesia, using 8 drive beats at a rate of 280 msec and
up to 3 extra-stimuli. PS was performed at baseline,
after epinephrine (EPI) infusion (0.1-0.45 ug/kg/min),
after correction of hypokalemia by KCI infusion and after
administrationof the t 2- specific blocker ICI 1.J.8551
2.5mg LV. In all 11 dogs the pre-anesthesia (A) K was
4.2.:t0.3 mEq/L and 3.6 .:to.3 post A (p<O.OOl). In 5 of
the 11 dogs VT or VF was induced at baseline. Their pre A
K was 4.5 .± 0.2 and post A K was 3.7.:t 0.3 mEq/L (p<O.OOI).
KCl infusion increased K t o 4.7 + 0.6 mEq/L, but all 5 dogs
were still inducible by PS. 4;f the 5 dogs received ICI
118551 which maintained Kat 4.6mEq/L. All 4 dogs were
still inducible by PS. In the remaining 6 dogs who were
not inducible at baseline pr e A KWas 4.0 + 0. 2 mEq/L an d
post A K was 3.5 ± 0.3 (p<0.002). EPI inf;;-sion for 20-40
min decreased K to 2.5 mEq/L (p(O.OOI). In 4 of 6 dogs VF
was induced. KCI infusion, while EPI continued, increased
K to 3.3mEq but inducibility persisted in all 4 dogs. In
3 of these dogs ICI 118551 was given following recontrol.
K remained at 3.6 .:t 0.4 mEq/Ldespite infusion of EPI for
20 min. We conclude t ha t ; I) PentobarbitalA resulted in
a significant decrease of plasma K; 2) In approximately
half of the animals in this model VT of VF could be
induced at baseline, but inducibility was not dependent on
K level or t 2 receptor activity; 3) EPI infusion causedmyocardial electrical instability and marked hypokalemia.
Infusion of KCI did not appear to influence inducibility
whereas specific ~ 2 blockade did.
Left atrial s ize,cm
Posterior wall
thickness,cm
Septal thickness,cm 1.01+.05 1.14+.04
Lef t ventricular mass ,g 241.1+21 343.9+35*
LAEI , units .823+~05 .666+~04+
*p<O.Ol ; +p<0.05 when compared tolean patients
++p<0.0 2 when compared to obese without LAA
Left atrial size, septal thicknes s , and posterior wall
th ickness are significantly elevated i n obese patients,
most markedly in those with LAA by ECG. Although systolic
function as measured by fractional f iber shortening and
e jection fraction were not affected by obesity, the LAEI,
a sens itive marker of diastolic ventricular compliance,
was reduced in obese patients, most markedly in those with
ECG-LAA. The amount of LAA cor r e l a t ed i nver se l ywith the
LAEI (r:0.61, p<O.OOl). Therefore, ECG-LAA indicates
changes in structure (increased atrial s ize and ventricu-
lar wall thickness) and function (decreased diastolic
ventricularcompliance) in the cardiopathy of obesity.
ELECTROCARDIOGRAPHICLEFT ATRIAL ABNORMALITIES INDICATE
DIASTOLIC VENTRICULAR DYSFUNCTION IN OBESITY.
Carl J. Lavie, M.D., Celso Amodeo, M.D ., Guillermo E.
Garavaglia, M.D., Boris D. Nunez, M.D., Franz H. Messerli,
M.D. , F.A.C.C., Ochsner Clinic, New Orleans, LA
We have previously demonstrated that obese patients
have a high prevalence of left atrial abnormalities (LAA)
by ECG and have left atrial enlargement and a decreased
l eft atrial emptying index (LAEI) by M-mode eehocar-
di ography. ECG's and M-mode echocardiograms were eva-
luated in 20 lean patients and 30 obese patients ( over 50%
overweight) - 15 with LAA by ECG criteria and 15 without
th i s ECG sign. The three groups were si mila r with regard
to age and meanarterial pressure. Results are (mean ~
SEM) • Lean Obese
-- Without LAA With LAA
2.86+ . 11 3.67+.22* 3.91+.10*
1.03+.05 1.09~.04 1.21+.06+
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TRANSLUMINALANGIOPLASTVIN RENOVASCULARDISEASE :
LONG-TERMFOLLOW UP,
A. M~£ta{Ae, M,D., C, C~on, M.D., J. Manouvk~~, M.D.,
G. Ducloux, M.D•• P. M~ache, M.D" C~d~o~og~e C, CHU.
UUe, Fkallce
To M-6e.M the ~ong t~m thekapeuucke-6U~t-6 otl kena~ ~te­
ky pekcutaneOu-6tkan-6~m~na~ ang~op~Mty tlok kenOva-6cutak
hypekten-6~on, ang~opta-6ty wa-6 attempted ~n 50 pauent-6 who
~e tloUowed up c~~n~caUy and ang~ogkaph~caay. C.Un~ca~
tlo~~ow up ov~ a p~~od otl 12 to 72 montho (mean, 33
month-6) wa-6 pek60kmed ~n the 42 pat~ent-6 (85 %) who had
und~gone kena~ ang~opta-6ty -6ucce-6-6t1u~~y i the-6e pat~ent-6
~e a~o ~nve-6ugated ang{ogkaph~caay by d{g{ta~ -6ub-6-
tkact~on ang~ogkaphy OVek a pek~od otl 1 to 72 month-6
Imean, 23 lnontM). Among :che-6e 42 pauent-6, hyp~teM~on
kecUkked ~n 17 pat~ent-6 140 %) i 6 06 the-6e pat{ent-6did
not accept the ang~ogkaph{c tloaow up i {n 10 pat~ent-6,
the hyp~teM~on keCUkkence ~-6 ketated to ke-6tetl0-6{-6
wh~ch ~Uh -6ucce-6-66u~~y ked~tated ~n 9 ca-6e-6. By the end otl
the c~~n~ca~ 60~~ow up -6tud{e-6, 34 168 %) otl the 50 pa-
uent-6 had benetl~ted 6kom the pkocedUke ICUked : 28 %;
-<mpkoved : 40 %), Steno-6~ -6econdaky to 6~bkOmU-6Cutak dy-6-
p~M~ 110 pauent-6) ke-6ponded bett~ than -6ten0-6~ tlkom
60ca~ ath~0-6c~~0-6~ (12 pat{ent-6) : 100 % cUked Ok ~­
pkoved V~-6U-6 66 %ke-6pect~ve~y, Pat~ent-6 w~th -6ev~e d{6-
6u-6e atil~O-6C£ekO-6~ ke-6ponded POOk~y and cumutateda££
the majok comp£~caUon-6. Sy-6temauc ang~ogkaph~c 60~£ow up
{n 35 pauent~ -6howed 9 ke-6tenO-6~-6 (26 %) and 6 contkota-
teka~ -6teno-6~-6 118 %) 60k 14 pat~ent-6, among the tatt~
hyp~ten-6~on kecUkked ~n 10 ca./>e-6. 50 %06 the-6e ke-6teno-
-6~ occUked atlt~ the ~n~~~ p~~od otl 24 moll-tM, Thv.,e
ke-6uRt-6 pkove the good ~ong t~m etl6ect otl p~cutaneou-6
tkaM~m~naR d~ta:tauon ~n pat~ent-6 wah kenaR ~teky .sze-
nO-6~. the nece-6-6~ty to de6~ne a gkoup 06 60ca£ ath~o­
-6C~ekO~~-6, and the pO-6-6~b~£~ty 06 tate ke-6tenO-6~.
HYPERTENSION AND LATE SURVIVAL IN ANEURYSM PATIENTS.
M. Reigel, M.D., L.H. Hollier, M.D., F.J. Kazmier, M,D.,
and P.C. O'Brien, Ph.D., Mayo Clinic, Rochester, MN 55905
Hypertension has been implicated as a factor in reduced
late survival of patients with peripheralvascular dis-
ease. We reviewed the relationship of preoperativehyper-
tension, coronary artery disease (CAD). and age to late
survival of 485 patients who underwent abdominal aortic
aneurysm repair. Late survival was compared to late
survival of an age and sex-matched population.
Patients with no hypertension and no CAD had survival
as good as that of a matched population. Patients with
no hypertension but a history of CAD had overall survival
no different from expected, although patients in their
fifties had survival significantly worse than a matched
population.
Patients with hypertension but no CAD had survival no
different from a matched population, regardless of age.
Patients with both hypertension and CAD had survival
significantly worse than expected (pz.02). When this
group was subdivided by age, patients in their seventies
and eighties had survival no worse than expected, while
patients in their fifties and sixties had survival sig-
nificantly worse than expected (pz.OOl). When these
younger patients were classified by whether they had had
coronary artery bypass surgery (CABG), those who had
undergone CABG had survival no different from a matched
population, while those with uncorrected CAD and hyper-
tension did worse than expected (p=.OOl).
These data suggest that hypertension alone does not
reduce late survival regardless of age. but CAD shortens
survival of young vascular patients.
Young patients with both CAD and hypertensionwho
underwent CABG fared better than those with uncorrected
CAD. but CABG did not improve survival in young patients
with CAD in the absence of hypertension.
HYPERTENSIVE LE~T VENTRICULAR HYPERTROPHY. IS THERE A
HIGH RISK SUB-GROUP?
Stuart D. Pringle, M.B, M.R.e.p. Peter W. Macfartane;
Ph.D, James H.McKitlop, M.B,Ph.D, A. Ross Lorimer,M.D,
~rancis G. Dunn,M.B. ~.A.C.C, University Dept. of
Medical Cardiology, Royal Infirmary, Glasgow, Scotland.
Hypertensive patients with electrocardiographicleft
ventricularhypertrophyand strain (ECG-LVH and strain)
have a threefold increase in mortality. This increased
risk is in excess of that due to the level of blood
pressure alone. We have therefore studied two groups
of asymptomatic hypertensive patients. Group I (16
patients) consisted of those with ECG-LVH and strain.
Group 11 (23 patients) included those without this
abnormality. Exercise ECG, 24 hour Holter monltoring
and stress Thallillm scintigraphy were performed in all
patients off therapy while coronary arteriographywas
under-taken in the Group I patients. Only 2 patients
(both Group I) had episodes of non-sustained ventricu-
lar tachycardia on Holter monitoring. Reversible
Thalltun perfusion defects were present in 9/16
patients in Group I but in only 3/23 patients in Group
11. Moreover, of these 9 patients with perfusion
abnormalities, 6 had significant coronary artery
disease (5 triple vessel disease, 1 single vessel
disease). The remaining 10 patients in Group I had
completely normal coronary arteriograms.
Thus, the high mortality in hypertensive patients
with LVH and strain may be partly explained by covert
coronary artery disease. We therefore feel that
coronary arteriography should be considered in these
patients especially if ECG-LVH and strain is associated
with reversible Thallium perfusion abnormalities.
Tuesday, March 10, 1987
4:00PM-5:30PM, Room 14, Second Level
Epidemiology
HOW USEFUL IS DIASTOLIC BLOOD PRESSURE? INSIGHTS FROM
THE FRAMINGHAM STUDY.
William B. Kannel, MD, MPH, FACC, FACE and L. Adrienne
Cupples, Ph.D. Boston University School of Medicine
Entrycriteria for trials, goals of therapyand
success of interventionare generally based on dia-
stolic blood pressure (DBP). This is unjustified
jUdging from 30 years of Framinghamdata on occurrence
of 1878 cardiovascularevents (CVD) in relation to
antecedent systolic and diastolic blood pressure.
For every CV sequela of hypertensionrisk was more
closely related to systolic than diastolic pressure.
Comparing SBP, DBP, mean arterial pressure and pulse
pressure, systolic BP emerges as the best predictor
of CV morbidityand mortality. Taken alone, DBP is
a reasonablepredictorof CV events, but its impact
wanes with advancing age whereas SBP remains highly
predictive. In persons withsystolic hypertension
DBP was unrelated to occurrence ofCVD while in dia-
stolic hypertensionrisk was strikingly related to
accompanying SBP. In personswhose DBP never exceeded
95 mrnHg, CV risk increased sharply inrelation to SBP
at all ages, including theelderly. Also, isolated
systolic hypertensionwas associated with a 2-3 fold
increased CV morbidity andmortality.
Because of the foregoing, and the fact that SBP
is more accuratelymeasured over a wider range,greater
emphasis on SBP is warranted inevaluating the need
for andefficacy of antihypertensivetreatment.
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THE PROGRESSION FROM HIGHNORMAL BLOOD PRESSURE TO HYPER-
TENSIVE LEVELS IN THE FRAMINGHAM HEART STUDY . M. le it-
schuh, M.O., W. Kannel , M.O., F.A.C .C., A. CuPp~.O.,
A. Ch06anian, M.O., F.A.C.C. , Boston Univers i ty Medic al
Cent er , Bos ton, MA.
It is well established that the risk of developing cardi o-
vascular disease (CVO) incre ases with increasing diastol ic
blood pressure (OBP) and systol ic bl ood press ure (SBP),
but controversy exists regardi ng t he approach tomanage-
ment of persons with high normal le vels (OBP 85-89 mmHg,
SBP <140 mmHg ) . We have t herefo re underta ken a st udy
ut ili zing 30 year fol low-up dat a from the Framingham Hear t
Study to moreclosely def ine : 1) the t endency for persons
with hi gh normal BP to develop hypertension as defi ned as
a OBP of 2g0 mmHg on two consecutive biennial fol low-up
vi sits, 2 ) CVO trends in relationship to SBP andOBP, and
3) t he cardiovascula r ri sk associated with mild hypert n-
sion (OBP 90-95 mmHg, SBP 140-160 mmHg). A striking num-
ber of persons with highnormal BP progressed to develop-
ment of hypertension with a OBP of gO mmHg (59% of men
and 61% of women). There was a distinct l inear progres -
sion in the rate of development of CVO wi th increas i ng
SBP, even within the normal range. This wa s i n cont rast
to OBP where no increase in the rat e of CVO occur red until
pressures exceeded the normal range . Furthermore, t he
age-adj ust ed annualrate of development of CVO was nearly
double in persons with mi l dhypertension as compared to
t hose with OBP <90mmHg and SB P <140. These results sug-
gest a marked tendency for personswi th hi gh normal BP to
progress into thehypertensive range . Additional ly , the
CVO r isk does not appear to r isewi t h incr easi ngOBP unt i l
l evel s above 85 mmHg are exceeded.
INFLUENCE OF 30 YEAR MEAN BLOOD PRESSURE LEVELS on LEFT
VENTRICULAR MASS: THE FRAMINGHAMHEART STUDY
Daniel Levy, H.D., Keaven Anderson,Ph.D., Daniel D.
Savage, M.D., Ph.D., Williac B. Kannel, M.D., William
P. Castelli, M.D. FraminghamMA.
In order to detercine the i nf l uence of blo od pr essur e
upon l ef t ventricular uass (LVM) we studied th e
association of echocardiographically (ECHO) measured
L~1 in healthy Fr~inghac Heart StUdy subjects under-
going biennial exam 16 with mean sys toliC blood
pressure measured over the preceding 30 years. Out of
5209 original Heart St udysubjects, 2351 were alive and
available for exam 16. SUbjects with a history of
coronary disease, valvular heart disease, or congesti ve
failure during exam 1-16 and subjects with unevaluable
ECHO at exam 16 were excluded fro~ analysis.
30 YEAR MEAN SYSTOLIC PRESSURE
<110 110-119 120-129 130-139 140-149 150+
MEN
N 7 58 101 77 40 20
llIean LVH lB4 213 226 239 245 282
Std. error 11.5 6.7 5.2 8.0 11.0 13. 1
HOlIEN
N 39 105 175 122 87 29
mean LVl-I 148 161 171 182 188 202
Std. error 3.6 3.3 3.3 4.9 5. 5 10.0
We conclude that L~1 i s s trongly associated with 30
year mean blood pressure in both sexes, and that this
trend is evident at even the lowest mean BP levels.
HERITABILITYOF BLOODPRESSURE IN BLACKS: TWINSTUDIES
C!arenceE Grim MD..GreloryA Harshfield.Ph.D.. Chun
banl.M.D.. Ermelle M.ClaypooI.M.S ..TerryJ OPleaorth,Ph.D..
Charles R. DrevPostlraduateMedicalSchool.LosAnleles.
California.
The prevalenceof hypertensionis Ireaterin blacks thanvhites.
In thevhite population, the majorvariationin bloodpressure(BP)
appears tobe due toheri~le factors . Thepresentstudy uses the
pover of the classic twin model toestimate the contributionof
lenetic factors in"3sets of blact twins: 17 monozYlotic(MZ) and
26 dizylotic lDZ). Blood pressurevu determined intriplicate
after10minutes recumbancyby twocertifiedobservers. Thesesil
bloodpressuresvere averqedthen adjusted for aae.veilht and
sel. Adjustment levelsvere determined for systolicBP (SBP) and
diastolic BPlDBP) separately. Averqe adjustedBP vu 123171 mm
HI in MZand 120/69 mm HI inDZ twins (ns) . Thevithin twin pair
difference in SBP vu 7 mmHl for MZ and 10 mm HI for DZ
(p<O .~) . Thevithintvin pairdifferenceforDBP vu. mm HI for
MZ tvins and 10mm HI for DZ twins (p<O.OO,.) The intraclass
correlation(r) for SBP for MZtvinsvu0.'92 and forDZ twins vu
a 0.190{ . The I' for DBP vu 0.728 for MZ and 0.333 for DZ twins.
Heritability estimates (h2) vere calculated accordinl to the
formula h2• (rMrrDZ)/(J-rDZ) , The h2 for SBP vu0."9 and forDBP
vas 0.'9. Hypertens ion (BP>l40/90 mm H8 on therapy) vas
diaanosed in"setsof MZ twins and inall pairsboth vere affected.
In DZ twins hypertensionvu diagnosed in 3sets. but in each of
these cases only one tvin vu affected. These data indicate
heritablefactors play a major role in thedeterminationof the level
of BPin blacksvhich arenot accounted for by aae. Yeilhtandsel.
BLOODPRESSURE VARIABILITYAND REACTIVITYIN NORMaTENSlVES
AND HYPBlTENSlVES UNDER N(JUW.CONDITIONS
Gre80[y A Uaahfi,ld Ph D ThomasG. Pictorin8. M.D., Guy D.
james. Ph.D., SeymourG. Blant. Ph.D.. Charles R. Drev Postgraduate
Medical School. Los Anaeles, C&1ifornia,CorneU University Medical
Center Nev Yort. NevYort.
Laboratory studies have fouadthat individuals vith borderline
hypertension(BB) differfrom normotensives(NI) iDthe irdelreeof
blood pressure (BP) variab ility andreactivity. In this study ve
attempted toeJtendthese flndiAls to BPresponsesdurinla normal
day. performin8 ambulatory BPrecordinls on ~ normotensives
(BP<120/90) . ,78 borderlinehypertensives (BP>120/9O&<160/l().4) and
66 established hypertensives(EH) (BP>160 /1~) off medication. The
BPfor the 3 ltOups in the clinic(C), at vort (W) at home (H) and
durinasleep (S)areshovn belov :
NI BB EH
C 108/72 138/93 In111'
W 116/79 141190{ 166/108
B 113/76 133/88 m/l02
S 102/66 118/88 137/88
We used BPpatternsu one measure of BPvariabiHty . Once corrected
for level of BP. the 3 ItoUpsshoved sim.iliarpatternselcept the BH
andEH .roupsshoveda pressureresponllCto the C.We also eumined
varianceandt'&lI8e113 2 othermeasures of variab ility . Thevariances
vere:1,7/1~ (HT). 223/99(BB) and 30911'3(EH). The t'&lIlesvere:
38/30(NI)• • 713'(BH)and'1136 (EH). ThellCvere also not different
once corrected for BP level. We used the average' chan8e to 12
different activities 113 a measure of reactivity. The averqe
responses vere:'/3"(HT). 8/3" (BB) and 10/3' EH. These data do
not providesupportfor increasedvariability or reactivity in BP of
borderlinehypertensives. Rather . theysullest BPvariabilityand
reactivityincreaseas a Cunctionof BPlevel
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EIGHT YEAR FOLLOW-UP OF PARTICIPANTS IN THE HYPERTENSION
DETECTION AND FOLLOW-UP PROGRAM: PERSISTENCE OF REDUCTION
IN BLOOD PRESSURE AND MORTALITY IN A TREATED HYPERTENSION
POPULATION
Nemat O. Borhani, M.D., F.A.C.C., University ofCalifor-
nia at Davis, bavis, California, on behalf of the
Hypertension Detection andFollow-Up ProgramCooperative
Research Group
The Hypertension Detection and Follow-Up Program
pr:v!ously report:dthat individuals randomized to speci~
cllnlcs where thelr blood pressurewas treated inten-
sively according to aStepped Care (SC) antihypertensive
protocol had significantly lower five year all-cause
mortality than individuals referred to their usual source
of care (RC). Mortality was observed during apost-trial
surveillance study (PTS). All (SC) participantshad been
transferredto the care of their own physician. The
percent of theSC group on antihypertensivetherapy
decreasedsteadily over the PTS, while for RC, it
increased. However the mean diastolic blood pressure
(DBP) remained slightly lower in SC than in RC. The
mortality rate for SC remained significantly below RC at
the end of the PTS. Two SC subgroups which had not
shown a mortality advantage over RC at five years (those
30-49 years of age and whitewomen) showed appreciable
advantage at the end of thePTS period. However, the SC
advantage for the group now 68-77 years old decreased.
These data suggest that mortality advantage of SC
antihypertensivetherapy extendsbeyond the active treat-
ment period and it encompasses the lower risked young
hypertensives and white women.
Tuesday, March10, 1987
2:00PM-3:30PM,Room 41, Second Level
The Dilated Left Ventricle: AtrialNatriureticPeptide
REDUCTIONS OF VENTRICULAR FUNCTION CORRELATE
WITH IMPAIRMENT OF CORONARY FLOW RESERVE BUT NOT
WITH ENDOMYOCARDIAL BIOPSY FOLLOWING CARDIAC
TRANSPLANTATION.
JQbn MeB. HQdgson. M.P .. Mark D. Coben, M.D.,
Judltb H. Murpby, M.D., S. Szentpetery, M.D.,
Marc D. Thames, M.D., FACC, McGulre VAMC and
MedIcal College of VIrgInia, RIchmond, VA.
Graft rejection (R) after card I ac transpl an-
tatlon (CT> Is assocIated with reduced left
ventricular ejection fraction (LVEF) and hIsto-
logic evidence of diffuse vascular Injury.
Currently used technIques for endomyocardlal
biopsy are subject to samp I I ng error. They may
underestimate both the extent and severity of
chronIc R. We hypothesized that coronary flow
reserve (CFR), (wh I ch I s dependent on norma I
vasculature), and radlonucllde ventrlculographlc
(RNV) wall motion abnormalities (WMA) would be
more sensitive markers for R than biopsIes. CFR
was measured In 13 patients (p t s ) using digital
angiography 14:'9 months after CT. Normal CFR by
this technIque Is a four-fold Increase In flow
after I ntracoronary papaver I ne I nject I on. RNV
and bIopsIes were performed regUlarly. Eight pts
had a fall In LVEF (mean 0.58 to 0.40) with new
WMA. Their average CFR was 2.7:' 1.0 (range 1.7-
4.3). Only 4 of these 8 pts had biopsy evidence
of severe R. Five pts had no drop In LVEF. Their
average CFR was 4.7!- 2.9 (range 2.6-13.6). Of
note, al I fIve of these patients had episodes of
severe R by biopsy and may have received more
Intensive Immunosuppression. Thus, the absence
of biopsy evIdence for significant R does not
exclude functionally Important microvascular
changes resulting In both a low CFR and LVEF.
,<'GHY vS LEFT VENTRiCULAR BIOPSY :N DILATED
CARDIOMYOPATHY.
:;ariO !'1arZIIII,M.D, Gualtlero Pelosl, MD. vittono
eattat, tuciana POZZOIInI, and GlorglO Baroldl, MD.
.nstttute of Clinical PhYSIOlogy, CNR, Plsa (Italy)
uesmte the increasIng use of enoomvccarotal tnopsy for
diagnostIc and therapeutical purposes, controversy still
l:'XISt regarding which ventricle snouro be routinely
bioDsled
we have carried out a system atIC cornpanson of
samples taken from both ventnctes in 40 consecutive
patients (pts) In whom a possible or definite draqnosis
of Dilated Carctomvooatbv (DC) had been clinically
made Three or more samples were obtained from each
ventricle and analyzed for cell hypertrophy (Hl and
mtersnnainorosrseFl, gradlng HandF from absent to
miId,mocerate and severe
In 6 pts no abnormality was found In ettner
ventricle ThIrty-four otshad rnstotoqtca: abnormalities
that were ctstnbuteoas follows
LVH was present in all cases, While RVH only in 20 ots
LVH was graded rnocerateor severe In 21 ots RVH was
c-acec .moderate in 5 ots and severe In none'. LVF was
fOUnd In 27 nts. RVH only In 14 pts.L VF was rated
mocerate or severe in 13 ots, RVF only In 2 The
dlTferences were SIgnifIcant (Wilcoxon test)
Based on these Observations we conclude that
1- InDC rnstoloqrca: aonormaltties are more easuv
recognized In LVthan In RV broosies
2- InDC lesions are more severe InLV than In RV
bioosres
s- InDC LV bIOpsy should be routinelyperformed to
rmrurmze the rtsk of missing the diagnOSIs or
Underestimating myocardial damage
RELATION BETWEEN LEFT AND RIGHT VENTRICULAR
FUNCTION AND NOREPINEPHRINE IN PLASMA AND MYO-
CARDIUM IN PATIENTS WITHPRIMARY DILATEDCARDIOMYO-
PATHY
Joachim ScOOfer, M.D.. Florence F. Sheehan, M.D., Andrea Tews, Detlef
G. Mathey, M.D., F.A.C.C., Dept. of Cardiology, University Hospital
Eppendorf, Hamburg, West Germany and University of Washington,
Seattle, U.S.A.
In the present study the relation between left and right ventricular ejec·
tion fraction (EF) measured from contrast angiograms, and between left
ventricular and right ventricular EFversus norepinephrine in plasmaand
myocardium were analysed in patients [pts) with primary dilated cardio-
myopathy. For his purpose 22 pts with different degree of cardiac dys-
function underwent heart catheterization and transvenousright ventricu-
lar endomyocardial biopsy, Left ventricular and right ventricular EF
were weakly correlated to eachother (r = 0.6, p 0,005). Right ventricu-
lar EF correlated with myocardial norepinephrine content (r =0.55,
p 0,005). Left ventricular EF was, however, much closer correlated
with myocardial norepinephrine (r = 0.87, p ._0.001), although biopsies
were taken from right ventricular septum. Plasma norepinephrine was
inversely related to left ventricular and right ventricular EF which,
however did not reach statistical significance. Conclusions: 1. Left
ventricular EF is only weakly correlated with right ventricular EF in pts
with dilated cardiomyopathy, 2. Myocardial norepinephrine is depleted
in pts with advanced dilated cardiomyopathy asjudged from transvenous
endomyocardial biopsy. 3. The myocardial norepinephrine content
determined from right ventricular biopsies, correlats better with left ven-
tricular than with right ventricular EF, 4. Myocardial norepinephrine
content better reflects ventricular dysfunction in dilated cardiomyo-
pathy than plasmanorepinephrine concentration.
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GFR, ml/mn
RPF,ml/mn
UNaV, IlEq/mn
FENa, %
PRA, ng/mn
ALDO, ng/dl
PNE, pg/ml
ANF, pg/ml
CO(L/min)
4.37±1.00
4.52±0.84
ROLE OF ATRIAL NATRIURETIC FACTOR IN ORTHOSTATIC MEDIATED
SODIUM RETENTION IN ASYMPTOMATIC LEFT VENTRICULAR
DYSFUNCTION. John C. Burnett, Jr., M.D., Denise M.
Heublein, James H. Chesebro, M.D., F.A.C.C., and David M.
Wilson, M.D. Mayo Medical School, Rochester, MN.
Pilot studies have demonstratedthat following ortho-
stasis a transient sodium retention occurs in subjects
with asymptomatic left ventriculardysfunction (ALVD) not
observed in normals. To determine themechanism, the
present studytested the hypothesis that the sodium
retention following orthostasis in ALVD is mediated by
sustained increases invasoconstrictorsystems and/or
decreases in atrial natriureticfactor (ANF), reducing
renal hemodynamic and excretory function. Renal and
endocrine functions were measured in response to
orthostasis in 10 subjects with decreasedLVEF (34t4%)
free of anysymptoms of CHF and medications.
Supine-Control Orthostasis Supine-Recovery
99t5 83t6* 97t6
421t26 323t26* 421t25
249t35 76t17* 147t15*
1.8tO.3 0.6tO.l* 0.9tO.l*
2.4tO.8 4.7t1.2* 2.3tO.6
5.2t2.0 15.5tl.9* 11.6tl.l
233t25 555t64* 272t31
86t22 73t23* 67t20*
* p<.05 compared to supine-control
These studies demonstratethat orthostasis in ALVD
results in (1) decrease in sodium excretion, (2) decrease
in renal hemodynamics, (3) activation of the renin-
angiotensin and adrenergic systems and (4) suppression
of ANF. These studies further demonstratethat post-
orthostatic sodium retention of ALVD may be mediated
by continued suppression ofANF in the presence of
normalization of renalhemodynamic function and
circulating vasoconstrictoractivity.
THE NORMAL PERICARDIUM DOES NOT AFFECT VENTRICULAR
FUNCTION
Steven N. Konstadt, M.D., Daniel M. Thys, M.D., Bruce
Mindich, M.D., Joel A. Kaplan, M.D., Martin Goldman, M.D.
F.A.C.C. Mount Sinai Medical Center, New York, New York
Whether the normal pericardiumexerts a constraining
effect on diastolic compliance and/or systolic function
i8 controversial. We studied LV filling and performance
in 10 patients undergoing elective CABG surgery
immediately pre and post pericardiotomy. Transesophageal
2-D echo was used to measure end-diastolic area (EDa),
end systolic area (ESa), and ejection fraction area
(EFa). Radial and pulmonary arterialcatheters were used
to measure hemodynamics. To limit the influences of
other variables - sympathetic discharge secondary to
surgical stimulation, chest wall constraint, and
autoregulation- measurementswere performed in deeply
anesthetized pts with the chest fully-opened immediately
before and after pericardiotomy.
HR(BPM) MAP(nunHg) PCWP(nunHg)
pre 60±9 85±5 10±)
post 62±8 83±8 10±4
EDa (cm') ESa (cm') EFa
pre 26.76±9.5l l3.95±10.14 0.52±0.2l
post 28.06±11.28 l4.86±11.25 0.52±O.20
After pericardiotomy, no significant changes were
observed. Though we cannot exclude an alteration in the
diastolic compliance curve, there was no significant
change in LV diastolic filling as measured by EDa and
PCWP. Similarly, no change in systolic performance as
measured by CO and EFa was noted. Therefore, we conclude
that the normal pericardiumdoes not exert a measureable
constraining effect on LV performance.
ATRIAL NATRIURETIC FACTOR IS AMARKER FOR CARDIAC VOLUME
OVERLOAD IN HUMANS WITH ASYMPTOMATIC LEFT VENTRICULAR
DYSFUNCTION.
John C. Burnett, Jr., M.D., Pai C. kao, Ph.D., Denise M.
Heublein, Don W. Heser, Raymond J. Gibbons, M.D., F.A.C.C.
Mayo Medical School, Rochester, MN.
Atrial natriureticfactor (ANF) is a peptide hormone
of cardiac origin which is released in response to
increases in atrial pressure and/orvolume. We reported
(Science 231:1145, 1986) that ANF is markedly elevated in
advanced symptomatic congestive heart failure in asso-
ciation with elevated cardiacfilling pressures. To
date, no studies have examined circulating ANF in human
subjects withasymptomatic left ventriculardysfunction
(ALVD). The present studywas designed to test the
hypothesis that circulating ANF, as measured by radio-
immunoassay, is increased in subjects with ALVD.
Circulating ANF was determined in nine humans with ALVD
in which radionuclide angiographydocumented reduced left
ventricularejection fraction (34t4%) and increased left
ventricularend-diastolic volume index (186t23 cc/m2).
In these ALVD subjects, ANF concentrationsranged from
15.3 to 207.3 pg/ml, with amean of 86.0t-22.1, signifi-
cantly (p<.05) increased ascompared to 14 normal human
volunteers inwhich ANF concentrationsranged from 31.1
to 77.4 pg/ml, with amean of 44.6t3.7.
The present studies demonstratethat circulating
atrial natriureticfactor is increased in humans with
asymptomatic left ventriculardysfunction withno
symptoms of congestive heart failure. We conclude that
circulating atrial natriureticfactor may serve as an
important non-invasivemarker for asymptomatic cardiac
volume overload.
Tuesday, March 10, 1987
4:00PM-5:30PM, Room 41, Second Level
Pathophysiology: Hypertrophic Cardiomyopathy,
Pericardial Disease
Ml\Nl'G!MENI'OF ATRIALFIBRlllATICN IN IlYPERIRJPHIC CAIDICMiOPAnlY.
Killian ROOinsonMIO', Ben Stoddns MD, Shau<;i:1an Didd.e 1XR,
William Md<.enna FJlCr..
R<:¥alPostgradJateMedical SChool, r..cncbn, U.K.
Atrial fibrillation (AF) develq:s in 10-15% of patients (pts) with
hypertrq:hi.c cardirnyopathy (HCM) and is often associated with
clinical deterioration.we have retrospectivelyexanined the natural
history in reLaticn to the m:rle of treatmentin 36 pts with HCM who
developed synpt:maticAF of at least 24 hours dJration. Before amio-
darcne was available (1S130) pts received digoxin + quinidine, diso-
P.l"amide and/or propranolol.. Since 1S130 pts with i:.F who were refrac-
tory to ronventicnaltherapfand ""'"pts with synptaraticAF received
aJIIiodarore (median daily maintenance dose 300 rrg). Prior to lS130
dJring follCM up of 7.2+5.8 years, 29 pts received 66 ocnventicnal
drug regirr.es (rte'Ul2.3 p;;r pt) and 37 (rreen 1. 3 per pt) DC oardio-
versions. The predominantrhythnwas sinus in 6 and AF in 23. ThranID
enlnlic events were cbc\I1e1ted in 9 and 12 died: 5 SIrllenly, 3 in
cardiac failure, 2 post-op and 2 ron-cardiac. Since 1S130, eleven of
these 29 patients who renained synptaraticon oonventicnal treatment
were switcffid to amiodarcne. Despite longer fol Ios up on ttniodarcne
(5.8+1.9 VS 4.3+3.6 years) pts requiredfewer drug regiITes (1.6 VS
2.2 Per pt) and cardioversions (0.27 vs 2.2 per pt) and 4 of 11
revertedto sinus rhythn. None e><perienoedthm:nI:o-embolicepisodes.
'I\oK) pts died, 1 in cardiac failure and the other post-eo, Since 1S130,
seven pts received amiodarcne as initial therapf for AF. During a
follCM up of 3.7+1.7 years 1 pt requiredchange in cJro;j theraw and 1
only had DC oarclioversion. Sinus rhythnwas restoredand maintained
in 6 pts and 00 thranI:x:rembolicepisodes were recorded. In cmparahle
pt groops at 3 year follCM up fran cnset of AF, amiodarone cnly vs
conventicnal treatmentonly was associated with restoraticnof sinus
rhythn (6 of 7 vs 3 of 18 P 0.01) despite fewer cJro;j regiITes,
electrical rerdioversionsand thranI:x:rembolicevents. TIus in HCM AF
is <XI1piltible with Icnq survival. Treatna1twith amiodarcne is nnre
effective than conventiooal theraw at maintaining sinus rhythn and
reducingthe in::idenoe of thranI:x:rembolicevents.
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RP1.ATIVE OCCURRENCE OF LEFT VENTRICULAR WALL THICKENING
AND THINNING IN ADULT PATIENTS WITH HYPERTROPHIC
CARDIOMYOPATHY
Paolo Spirito, MD. Barry J. Maron. MD. FACC, NHLBI.
Bethesda, Maryland
Progression and development of left ventricularhyper-
trophy has recently been shown to occur commonly in
children with hypertrophiccardiomyopathy (HCM). showing
that the morphologic features of this disease are often
dynamic. Todetermine whether similar changes in
magnitude of left ventricularhypertrophymay also occur
in adult pts with HCM, serial assessment of left ven-
tricularwall thickness was obtained with M-mode and
2-D echo in 65 pts with HCM. 23-50 years of age. Follow-
up period was 3-6 yrs (mean 4). None of the study pts
showed an increase of >5mm in left ventricularwall thick-
ness. However. 9 (14~T of the study pts demonstrated
a substantial decrease of 5-9mm in wall thickness in-
volving anterior septum (7 pts), posterior septum (6 pts),
lateral free wall (2 pts), posterior wall (1 pt }, In the
9 pts who showed wall thinning. left ventricularend-df.aa-
tolic diameter increased significantly (from 44+6mm to 51+
6mm; p<O.OOl); however. in 7 of the 9 pts, absolute cavity
size remained within normal limits «52mm). Eight of the 9
pts with LV wall thinning and enlarging left ventricular
cavity were severely symptomatic (including 1 who died of
heart failure and 2 who underwent cardiac transplantation)
and 1 was mildly symptomatic. In conclusion. substantial
progression of left ventricularhypertrophydoes not
appear to occur with any significant frequency in adult
pts with HCM. Conversely, an important subset of adult
pts with HCM (about 15~) may show progressive left ven-
tricularwall thinning and relative cavity enlargement
which is usually associated with poor clinical prognosis.
AGE DEPENDANT EFFECT OF VERAPAMIL ON END-DIASTOLIC LEFT
VENTRICULAR FUNCTION IN PATIENTS WITH HYPERTROPHICCARDIO-
MYOPATHY.
P.K.Elanksma, E.v.d.Wall, K.Kruizinga, N.Knop,
Dept.of Cardiology, University Hospital Groningen, The
Netherlands.
To evaluate the effects of intravenous verapamil admini-
stration (IV) in pt with HCM pressure-volumecurves were
obtained before and after IV. Pressure was measured by a
pigtail shaped catheter tip manometer. Volume was mea-
sured by a calibratednuclear probe.
In all p't the negative inotropic effect of IV was demon-
strated by an increase of LV volumes and a decrease of
ejection fraction and of dp/dt (max.). In 4 pt a clear
effect was seen on the diastolic portion of the pressure
volume loop. which was shifted downwards and to the right
(group A); mean age was 26years (18-43), in the other
pt (group E) it was 46 years (33-56). In group Asysto-
lie stroke work decreased after IV (1330t/-565 /
984t/-470mJ) as well as diastolic stroke work (122t/-35>
104t/-13mJ). In group Esystolic stroke work remained the
same (1051+/ - 554> 1009t/- 573mJ) whereas diastolic stroke
work increased (88t/ -65:> 113t/- 73mJ).
No effect of IV on relaxation was observed. No difference
was found in verapamil plasma levels between the groups:
In group Ait was 90t/- 72ug/l. in group Eit was 107t/-
94 ug/l. Also no difference was found between the data
of the pt with or without· obstruction.
It is concluded that in young pt a real improve-
ment of diastolic LV compliance can be observed with a
downward and rightwardshift of the pressure volume
loop, whereas at later age this is rarely found.
These changes are independantof the occurence of ob-
struction and of the changes of early diastolic filling.
SUPERIOR VENA CAVA FLOW VELOCITY PATTERNS CAN
DIAGNOSE CARDIAC TAMPONADE IN PATIENTS WITH
PERICARDIALEFFUSIONS
Christopher P. Appleton, M.D., Liv K. Hatle, M.D., Richard L.
Popp, M.D., F.A.C.C., Stanford University School of Medicine,
Stanford,CA.
In an attempt to non-invasively diagnose cardiac tamponade,
superior vena cava(SVC) flow velocity patternswere recorded in
10 pts with pericardial effusion: 3 malignant, 3 after cardiac
transplantation.and 4 after cardiac surgery. Five pts (GroupI)
had clinical and catheterization findings diagnostic of cardiac
tamponade and 5 (GroupII) had effusions without clinical or
echocardiographicevidence of cardiac tamponade. All Group I
pts underwenttherapeuticpericardiocentesis. SVC flow velocity
patterns were recorded by pulsed Dopplerechocardiographyand
were analyzed for theratio of systolic to diastolic forward flow,
timing and degree of flowreversals, and response torespiration.
A consistent finding in all Group I pts was anexpiratorydecrease
in diastolic forward flow to levels below those seen during apnea.
In contrast,Group II pts hadexpiratorydiastolic flow which was
similar to that seen during apnea. Afterpericardiocentesis,the
expiratorydecrease in diastolic flow disappearedin all 5 Group I
pts, Ratio of systolic to diastolic forward flow, amount of flow
reversals, and response toinspiration was variable in the 10 pts
and did not distinguish those withcardiac tamponade. The
reduction in expiratorydiastolic SVC flow in the Group I pts is
likely a result of exaggerated left heart filling which restricts
right heart filling during expiration. This exaggerated filling is
probably due to thelarger respiratoryvariations in pulmonary
capillary wedge pressure as compared tointracardiacpressures
observed in pts withcardiac tamponade. Therefore, in pts with
pericardial effusions, a decrease in SVC expiratory diastolic
foward flow is asensitive indicatorof hemodynamic compromise.
CAN HEMOPERICARDITISINDUCE ECG INJURY PATTERN?
E. TaliaferroWarren, M.D., F.A.C.C., Angel K. Markov,
M.D., F.A.C.C., Ralph H. Didlake, M.D., Joe Terry, Patrick
H. Lehan, M.D., F.A.C.C. and HarperK. Hellems, M.D.,
F.A.C.C., Univ of Mississippi Medical Center, Jackson, MS.
Investigation concerning possible electrolyte imbalance in
relation to ECG injury observed during acute hemopericar-
ditis was carried out on 16 anesthetized dogs. Via left
thorocotomy, a catheter was placed into the pericardial
sac while ventricular and aortic catheters were introduced
under fluoroscopic guidance. Human and dog blood, 0.9%
NaCI, and 5% dextrose with or without addition of K+ were
injected into the pericardial space in volumes that did
not provoke anycompressive effect in the heart function,
i.e., < 20 ml. Injection of human blood, dog blood and
ultrasonically hemolyzed dog blood (dogK+ erythrocytes
is the same as in plasma), 0.9 %NaCI. and5% dextrose did
not cause any change in ECG pattern. In contrast, addi-
tion of K+ to dog and human blood, 0.9% NaCI, and5% dex-
trose caused S-T segment elevation proportional to the
amount of K+ added. The introductionof ultrasonically
hemolyzed human blood into the pericardial space (K+: 37-
45 mEq/L) caused an immediateelevation of S-T segment
proportional to the concentrationof K+ ion. At the
moment when the S-T segment becameisoelectric, the K+
concentrationof the blood in the pericardiumwas equal to
that of blood of the animal. Addition of insulin and glu-
cose significantly shortened the time for disappearance of
the injury pattern (p<0.005). Conclusion: I) ECG injury
changes in the course of hemopericarditisare probably due
to release of K+ from the hemolyzing erythrocytes. 2) In-
crease in extracellularK+ in the pericardial space will
cause a decrease in the transmembraneelectrical potential
of the myocardiumthat is in contact with the K+ ions re-
sulting in an aberrationof the repolarizationpotential.
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CENTRALVENOUS FLOW VELOCITY PATTERNS CAN
DIFFERENTIATE CONSTRiCTIVE PERICARDITIS FROM
RESTRICTIVECARDIOMYOPATHY
ChristopherP. Appleton, M.D., Liv K. Hatle, M.D., Richard L.
Popp, M.D., F.A.C.C., Cardiology Division, Stanford University
School of Medicine, Stanford,CA.
In an attempt to non-invasively differentiate constrictive
pericarditis (CP) from non-dilated restrictive cardiomyopathy
(RCM), flow velocity patterns were recorded in the SVC and
hepatic vein (HV)in 6 pts with CP and 8 with RCM. Two pts were
NYHA functional Class IV, 4 Class Ill, 7 Class11, and I Class I. At
catheterization, all pts had elevated diastolic pressures and
ventriculardiastolic "dip andplateau"pattern. SVC and HV flow
velocities were recorded by pulsed wave Doppler with
simultaneous respiration,and analyzed for the ratio of systolic to
diastolic filling, timing and degree of flow reversals, and for
response to respiration. Two of 8 pts with RCM and I of 6 with
CP hadinadequateHV tracings for analysis. All RCM pts showed
diastolic venous forwardflow (FF) greater than systolic FF during
apnea, and a decrease in systolic FF velocity and/or increased
flow reversalson the first or second inspiratorybeat. In contrast,
all CP pts showedsystolic FF greater than or equal todiastolic
FF during apnea, and with the 1stbeat of inspiration all had a
normal increase in systolic and diastolic FF and adecrease in flow
reversals. The 2nd beat of inspirationwas abnormalin all CP pts
with decrease in systolic or diastolic FF or increase in flow
reversals. More significantly, during expiration all CP pts
markedly decreased diastolic FF compared to apnea whereas all
RCM pts showed expiratory flow velocity patterns which were
similar to those duringapnea, In the 3 CP pts whounderwent
pericardial stripping the expiratory decrease in diastolic FF
disappeared. Therefore,comparedto pts with RCM, CP pts have
more systolic venous forward flow, a normal increase in forward
flow on the 1st beat of inspiration,and a characteristicdecrease
in diastolic forwardflow with expiration.
Tuesday, March 10, 1987
2:00PM-3:30PM, Room 26, Second Level
Atrial Natriuretic Peptide and Converting Enzyme
Inhibitors in CHF
KINETICS OF ENDOGENOUS ATRIAL NATRIURETIC PEPTIDE RELEASE
AND METABOLISM IN HUMANS.
Stephen Gunther, M.D., Russell T. Steinman, M.D., Michael
H. Lehmann, M.D., F.A.C.C., James R. Sowers, M.D., Harper
Hospital and Wayne State University School of Medicine,
Detroit, MI.
Atrial natriureticpeptide (ANP) levels increase with
chronic volume expansion, but the ability of ANP
secretory processes to respond to acute changes in atrial
distending pressure is not well-defined. To determine
the time course of ANP release and metabolism in humans
we used simultaneous atrial-ventricular(SAV) pacing to
induce ANP release in 5 patients undergoing diagnostic
electrophysiologic testing. Coronary sinus (CS) and
arterial (Art) levels of ANP and catecholamines were
measured at 30 sec intervals during the pacing protocol
(2 min sinus rhythm, 5 min SAY pacing at 350-500 msec
cycle lengths, 12 min recovery). SAY pacing caused giant
Hall waves, an inunediate and sustained increase in right
atrial pressure (12±1 vs 4±1 mmHg, p<O.OI) and a slower
transient fall in mean arterialpressure (mean change
-18±6 mmHg, p<0.05). CS ANP rose in each patient within
30 secs and continued to increase throughout the 5 min
pacing period. Peak CS ANP occurred 30 secs after SAY
pacing (1627±366 pg/ml vs 533±240 pg/ml pre-pacing,
p<O.OOI) then declined exponentially with a mean ~-time
of 6±2min. Art ANP changed in parallel with CS levels
(peak art ANP 720±310 vs 125±36 pg/ml pre-pacing,
p<O.Ol). CS and Art epinephrine and norepinephrine
levels doubled during pacing, but lagged 2-3 min behind
CS ANP. These results demonstrate rapid release and
clearance of ANP in response to changes in atrial
pressure and suggest that ANP may play a role in the
short-termmodulation of volume and vascular tone.
ATRIAL NATRIURETIC PEPTIDE IN EXPERIMENTAL HEART FAILURE:
ATRIAL CONTENT, PLASMA-LEVELS AND EFFECTS OF VOLUME LOADING
Helmut Drexler, M.D., Rudolf E. Lang, M.D.*, Martin Finkh,
B.S., Helmut Wollschlager, M.D. and Hanjbrg Just, M.D.
Medizinische Klinik Ill, University of Freiburg, *Depart-
ment of Pharmacology, University of Heidelberg, FRG
To examine the role of atrial natriureticpeptide (ANP)
in congestive heart failure we determined cardiac output
(CO, ml/kg/min), mean right atrial pressure (RAP, mmHg) ,
renal blood flow (RBF, radioactive microspheres, ml/min/g)
and plasma ANP-levels (by HPLC controlled radioimmunassay)
before and after volume loading (0.5 ml 0.9% saline i.v.
over 1 min) in rats with heart failure due to chronic myo-
cardial infarction (MI, n=12, meaninfarct size:38% of the
left ventricle) and control animals without MI (SH, n=15).
In MI, CO and RBF were significantly reduced as compared
to SH (CO: 2l0±15 vs 324±23, RBF: 2.9±0.26 vs 4.5±0.32,
both p 0.05) and RAP, LVEDP and ANP plasma levels were
elevated (RAP: 2.2+0.4 vs 0.2+0.3, LVEDP: 26+2 vs 8+1,
l25±11 vs 200±19, ~ll p< 0.01). After volume-loading, CO,
RAP, RBF and plasma ANP significantly increased in SH. In
MI,RBF and plasma ANP were not significantly higher with
volume loading, although CO and RAP increased significant-
ly (CO:2l0±15 to 265±27, RAP:2.2±0.4 t06.6±1.2, p< 0.05).
Total atrial ANP content of MI and SH determined in sepa-
rate groups was reduced in MI with large infarcts (infarct
size 39% of LV, MI:8.5l ~g/g atria, SH: 14.5 ~g/g atriajpe
0.05). We conclude that in cardiacfailure due to MI, high
atrial pressure caused increased ANP-plasma levels, deple-
tion of ANP in atrial myocardium, however, the acute
volume-induced ANP-secretion and renal ANP-effect appear
to be attenuated in cardiac failure.
ATRIAL NATRIURETIC PEPTIDE PRODUCES FAVORABLE HEHO-
DYNAMIC CHANGES AND INCREASES SODIUM EXCRETION IN CON-
GESTIVE HEART FAILURE (CHF). Antonio C. Quiroz, H.D.,
F.A.C.C., Gary E. Sander, H.D., Ph.D., Hichae1 B. Given,
Ph.D., Louise Roffida1, R.N., Safeer Ahmad, H.D.,
F.A.C.C., Haro1d Harder, H.D., Thomas D. Giles, H.D.,
F.A.C.C., Tu1ane and VAMC, New Orleans, LA.
Seven patients with severe chronic CHF (LV stroke work
index (LVSWI)=23+5) received up to 3 one-hour infusions
of atrial natriu~etic peptide (ANP) in a series of in-
creasing dose schedules ranging from 0.03 to 0.6
pg/kg/min. Baseline hemodynamic andurinary parameters
were obtained prior to the initial dose of ANP and at the
end of each infusion. Each experiment was conducted on a
single day; ANP infusions were separated by one hour con-
trol periods. Patients were instrumentedwith Swan-Ganz
thermodilutioncatheters, arterial lines, and urinary
catheters. ANP decreased mean arterial pressure(MAP),
pulmonary capillary wedge pressure (PCWP), and right
atrial pressure (RAP), and increased urine volume and
ANp dose 0.03 0.06 0.1 0.2 0.3 0.6
n 2 234242
LVSWI (g-m1m ) 0 1 - 1 + 2 + 5 - 1
MAP(IDDHg) 1 + 1 - 3 - 12 -10* -24
RAP (DlDHg) 1 1 0 6 - 7* - 8
PCWP(DlDHg) 3 4 - 5 - 13 -11* -15
urine vo1ume(ml/hrl +114 - 24 + 4 +148 +68 -10
urine Na(meq/hr) + 2 + 23 + 8 + 23 +23 +14
All data are mean absolute changes from baseline;
*p<0.05 from matched baseline group.
sodium (Na) excretion; CO, heart rate, and LVSWI did not
change appreciably. Higher ANP doses tended to produce
the largest hemodynamic andrenal changes, but a true
dose-response relationship could not be determined since
doses were variable among patients. Thus, ANP infusion
favorably affects cardiac performance in severe CHF.
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ACTIVATION OF r-e RENIN- ANGIOTENSIN SYSTEM LIMITS
THE LONG-TE RM HEMOOYNAMIC AND CLINICAL
RESPONSES TO THE DIRECT-ACTING VASODILATOR,
FLOSEQUINAN, IN HEART FA ILURE. Paul D. Ke ss le r, MD,
Milton Packer MD, FACC, Norma Medina RN, Madeline Yushak
RN, Stephen Gottlieb, MD. Mt. Sinai Sch of Med , New York, NY
Flosequinan (FSQ) is a once-daily direct-acting vasodilator
with octions on both arterial resistance and venous capacitance
vessels. To determine its uti lity in heart fa ilure (CHF), we
treated28 CHF pts with FSQ (100-150 p.o, da ily) for 1-3 months,
while digo xin & diuretics we re kept constant. Pts were gro uped
based on pre-FSQ va lues for plasma ren in activity (PRA): 15 pt s
had a PRA < 5 ng/ml/h r (LoPRA) & 13 pt s had aPRA~ 5 ng/ ml/hr
(HiPRA). Stroke volu me inde x (SVI, ml/rn"), heart ra te (HR,
bpm), mean arterial, LV filling and mean right atrial pressures
(MAP, LVFP & RA, mm Hg), syst e mic va scular resistance (SVR,
d-s-c), body weig ht (wt, kg) and PRA weremeasured be fore
(Pre), a fter 1st doses of FSQ (01 ) andafter 1-3 months of FSQ
(LTh where * = P <.05 vs Pre ; t = P <0.05,llLoPRA vs llHiPRA:
SVI HR MAP LVFP RA SVR Wt PRA
HiPRA Pre 24 81 82 28 11 1654 73 17.2
01 28* 85 71 * 18* 6* 1279* 73 16.3
LT 24 95* 76* 23* 10 1285* 75* 23.9*
LoPRA Pre 23 86 97 29 12 2214 72 1.7
01 30 * 88 83* 15* 5* 1400* 72 2.3
LT 29*t 94* 82*t 14*t 4*t 1374*t 71t 3.5*
Both LoPRA and HiPRA pts showedsimilar t in SVI and .. in
MAP, LVFP and RAwith Ist doses of FSQ. These initial benefit s
were sustained during LT therapy in LoPRA pts, but became
partially or comple te ly at enua te d in HiP RA pts (01 vs LT,
p <.05), and this wa s ac ompanied by an t in wt . HR t simi lar ly
in both gr oup s. C linica l improve ment wasseen in 13 of 15
LoPRA pt s bu t in on ly 5 o f 13 HiPRA pts (87% vs 38%, p <.05).
In con cl usion, activation of the renin-angiotensin system
before and dur ingtreatmentwith direct-actingvasodilator drug s
may limit the long-termefficacy of these ogents in CHF pts.
THE RENIN ANGIOTENSINALDOSTERONE SYSTEM DOES
NOT CONTRIBUTETO THE DEVELOPMENT OFTOLERANCE
IN HEARTFAILUREDURING PRAZOSINTREATMENT
GUnter A.]. Riegger, M.D., EckhardP. Kro mer , M.D. andKurt
Kochsiek, M.D., Med. Univ, Klinik , WUrzburg,F.R.G.
To determine the effects of the renin-angiotensin-aldosterone
system on the development of to lerance and flu id retention in
patients wi th conge st ive heart failure (n=IO, NYHA Ill) dur ing
prazosin therapy, we measured plasma ren in concentrati on
(PR C), aldosterone (Aldo), norepinephrine (NE) and maximal
exercise capacity (bicycle ergornetry)during a chronic therapy
with digitalis and diuretics (more than 6 months) to which
either prazosin (5 mg tid), captopril (50 mg tid) or a combina-
tion of both drugs was added. Each treatmentperiod lasted for
6 wee ks. Prazosin did not increaseexercise capacit y in con trast
to captopril (p< 0.001). PRC and Aldoshowed a small decrease
dur ing prazosin therapy (PRC: 9.6 .:!: 1.4 to 5.5 .! 1.7 ngAI!m!/h,
p<0.05; Aldo: 533 + 96 to 381 + 74 pg/ml, p<0.05), NE was
increased significantly (282 + 40 to 361 + 45 pg/mHp<0.05) .
When capt oprll was given PRCrose (26.5 .:!: 8.4 ngA!/ml/h),
aldosteronewas normalized(I90 + 42 pg/rnl) and norepinephrine
was reduced(260 + 36 pg/ml; p<O:OO.When prazosin was added
to captopril NE rose again sign. (318 + 33 pg/ml; p<O.OO, renin
and Aldo remainedunchanged. PrazoSl"n wasassociated with an
increase in bodyweight (69.4 + 3.5 to 72.3 + 3.2 kg; p-c0.000
which was reversed by captopril. The inhibition of the renin
system by captopril did not prevent fluid ret ent ion when
prazosin was added (72.4 + 4.7 kg; p<'O.OoO. These findings
suggest that the renin-angiotensin-aldosterone-systemdoes not
contribute to the development of tolerance of prazosin. The
st imulat ion of plasma norepineph rine may be ofdecisive impor-
tance concerning renal effects causing flu id retention and
deterioratinghemod ynam ic parameters, thus preventing an im-
provement of cardiac function.
INFLUENCE OF DIABETES MELLlTUS ON n -E
I-EMOOYNAMIC AND CLINICAL RESPONSES TO
CONVERTING-ENZYME INHIBITION IN SEVERE CHRON IC
HEART FAILURE. Milton Packer MD, FACC, Wai Hung Lee
MD, Normo Medina RN,Madeline Yushak RN, Paul Kessle r MD,
Stephen S. Gottlieb, MD. Mt. Sina i Sch of Med, New York, NY
Diabetes mellitus (OM) is often accompanied by low levels of
renin and a ldost e rone andimpaired reactivity of these hormones
to physiologic st imuli. To determine if such abnormalities alter
the re sponse to conve rt ing-enzyme inhibit ion (CEll, we used CE I
in 129 pt s wi th heart failure (CHF) , of whom 35 we re diabetic.
Cardiac index (Cl, l/min/ m2 ), mean arterial, LV fill ing & r ight
atria l pressures (.'It,AP, LVFP and RA, mm f-g), systemic voscular
resistance (SVR, d-s-c), blood urea nitrogen and se rumcreatinine
(BUN & Cr, rng/d Owere measu redbefore (C), after Ist-dose CEI
(0 1) and after 1-3 months of CE I (LT), wh ile diuretics were
una ltered: * = p <.05 vs Cj t = p <.05, diabetics vs nondiabetic s:
Cl MAP LVFP RA SVR BUN Cr
Non- C l.7 82 27 12 2027 40 1.7
diabetic DI 2.0* 65 * 18* 9* 1465*
LT 1.9* 66 * 18* 8* 1463* 47 1.8
Diabetic C 1.9 88 26 II 1995 43 1.7
01 2.2* 72* 17* 8* 1480 *
LT 2.2* 72 * 13*t 4*t 1508* 69*t 2.I *t
Desp ite lower plasma ren in ac ti vi ty (PRA) in d iabetics,
(3.4 ± 0. 5 vs 7.0 ± 1.1 ng/ ml/hr, p <.05), both groups showed a
similar response t o Ist-dose CE I; yet, PRA predicted the llMAP
in nondiobetics (r = 0.70) but not in diabe t ics (r= 0.29). During
LT-CEI, both groups showed s imila rt in C l and .. in MAP, HR
and SVR, but diabe t ics showe d0 progressive ~ in LVFP and RA
and a .. in we ight (- 1.1 kg), p<.05 ; such changes wer e not see n in
nondiabetic s. Renal functiondeclined onl y in diabetics.
In conc lusion, impa iredaldosterone sec re ti on may predispose
diabetics w ith C HF to an excessive diuresis dur ing CE I; such sa lt
depletion may interactwith the abnormalglomerularautoregula-
tion in diabetics to cause functional renal insuffic iency.
Tuesday, March10, 1987
4:00PM-5:30PM, Room 26, Second Level
Provocationof MyocardialIschemia by Stressful
Interventions
FACTORS EFFECTING THEREPORTED SENS ITIVITY AND SPEC I FICITY
OF EXERCISE THALLIUM SCINTIGRAPHY. A META-ANALYSIS.
Robert Detrano, M.D., Ph.D . , Andras J anosi, M. D.,
Gilberto Marcondes, M.D., Na bil Abbassi, M.D., and
Victor Froel icher, M.D., FACC. Long Beach VA Medical
Center, Long Beach, Ca! ifornia.
Technical factors, patient cha ract e r i sti cs , s e l ec t ion
bias, and non-bl inding of test analysis might effect the
re por t ed accu rac ie s ofdiagnostic tests. To assess the
i nf luence o f these factors on t he reported sens it ivity
(Se) and s pecifi c i t y (Sp) of exe r cise thal l ium
scintig ra phy (Tl l , the med i ca l literature was non-
sel ec t ive l y searched (1977- 86) . Meta- analys i s , a new
stati s t i ca l app roach to literature rev iew was appl ied to
56 re ports on 59 uni que pa t ient study grou ps involvi ng
6112 patients . These were analyzed fo r yea r of
publ ication, ang iograph i c def in it ion of di s ea s e (50% vs
70%} , % men a nd mea n ageof pat i ent s , pr e s enc e and%of
pat ients wit h angina pectoris, prior myocardia l inf a rction
(MI), on B blockers, presence of angiog raph ic referral
(work-up) bias, bl inding of the T1 and angiographic
readings, the use of tomography, background s ubt ract ion
and automated analysis of Tl, exercise prot oc ol used, and
t he numbe r of days between th e angiogram and Tl. The %
of patients wi t h prior MI ha d the highest co rre lat ion
(0 . 45 , p=.0007) and was independently as so c iated with Se .
Other f actor s independentl y as soc iated with Se we re non-
bl i nded read i ng of the ang iogram, %men, use of t omog raphy
and semiqua nti tative d igital analysi s of Tl . Year of
publ icat ion wa s s ignificantl y and i nverse ly co r r e l a t ed
wi t h t e s t Sp(-.30, p=.03) and the presence of referral
bias nega t iv el y i nf l uenced Sp. These resu lts suggest t ha t
t he re po rted Se of Tl is highe r and Sp lower than that
expected i n cli n ica l pract ice because of the i nappropria t e
patient selection and non-bl inded analyses used by many
investigators.
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EARLIER ONSET OF ISCHEMIA AFTER EXPOSURE TO LOW LEVEL
CARBON MONOXIDE IN PATIENTS WITH ISCHEMIC HEART DISEASE.
ABSTRACTS
DOBlITAMINE• AN ALTERNATIVEPOST
INFARCTIONSTRESSORTO EXERCISETESTING
121A
Kirkwood F. Adams, M.D., BenuChatterjee, M.D., Gary
Koch, PhD., Cindy J. Price, R.N, George Gol ds t ei n, PhD.,
David S. Sheps, M.D., F.A.C.C. University of North
Carolina, Chapel Hill, N.C.
We studied the effect of low level exposure t o carbon
monoxide on left ventricularfunction and ischemic thresh-
old during exercise (EX) in patients (pts ) with ischemic
heart disease (IHD). After an initial t raining session,
30 pts with IHD were exposed to Air or CO on successive
days in a randomized double blind crossover fashio n. On
the CO day post exposure mean carboxyhemoglobin was
5.9 ± .1 % compar ed to 1.6 ± . 1% (p<.Ol) after Ai r expos-
ure. EX duration (seconds) was significantly redu ced
after exposure to CO compared to Air (626 ± 50 vs 585 ±
49 p < .05). Angina occurred only during the CO day in 4
pts. Actuarial methods suggested this symptom was likely
to occur earlierafter CO than Air exposure. (p < .05)
There was no difference between resting left ventricular
ejection fraction (LVEF) on Air and CO days (bot h 58).
LVEF at submaximal EX (60 ± 2. 4 vs 62 ± 2. 5, p = .06) and
the submaximal change inLVEF (- 1 .6 ± 1.6 vs 1.6 ± 1.6,
P < .05) were both s ignificantly less after CO compared
to Air. Maximal LVEF was similar after CO or Air expos-
ure (57 ± 2.5 vs 57 ± 2.5).
Conclusion: Earlier onset of ventricular dysfunction and
poorer EX performanceoccurs after low l evel CO exposure
in pts with IRD.
'ffiE SIGNIFlCAN:E OFINDUCEI> "CARDIAC" PAIN I:JURIN:;
DIPYRIJ:W.l)LESCINI'IGRAPHY. Y.Y. Zhu, M.D., W. Lee, M.D.,
M. Dae, M.D., K. Olatterjee, M.D., F.A.C.C., J. Danforth,
M.D., F.A.C.C., T. Ports, M.D., F.A.C.C., E. Eotvinick,
M.D., F .A.C.C., University of california, San Francisco.
'Ib evaluate the significance of dipyridarrole (D) induced
"cardiac"pain(CP) during perfusion scintigraphy(PS) , we
assessed electrocardiographic,peripheralherrodynamic, PS
and coronary angiographic(CA) findings in 73 consecutive
patients(pts) having CA within 3 rronthsof PS. CP included
dull chest, arm or jaw pain induced with D and was present
in 35 pts. '!he heIrodynami.cresponse was graded: absent -
< lOrnn decrease in systolic (S) BP and < 101:pnrise in heart
rate(HR) ; rroderate-..? 10<2Ornn decrease in SBP and/or? 10 <
20bpn rise in HR; marked -? 2lmn decrease in SBP and/or ..?
20 I:pn rise in HR.
CP pts did rot differ in their incidence (33/35 vs 27/
38), extent or severity of coronarydisease(CAD) , or in
the fre;ruency or extent of induced PS abnonralities.
'!hose with CP had a higher incidence of induced ischemic
ST changes (11/35 vs 2/38), a higher incidence of the
marked herrodynamicresponse (18/35 vs 8/38) and a lower
incidence of absent herodynamicresponses (1/35 vs 17/38),
all P < 0.01. Although CP pts did not differ in the induced
incrementof double product, 3 pts with CP and severe CAD
had a marked Diniuced increase in double product.
'!he results indicate that: 1) the absence of D induced
CPor ST changes does not exclude significant and even
severe CAD; 2) D induced CP appears to be a reliable mark-
er for CAD and may relate to myocardial ischemia due eith-
er to reduced coronary perfusion pressureor an induced
increase in myocardial02 derrandsin the presence of sev-
ere CAD; 3) in the presence of significant CAD, PS abnor-
malities may be producedby D in equal incidence by
ischemic and nonischemic nechanisrns.
Dayjd Mannerjne BSc, David Bennett FRCP, GregBoyle ASCT,
GrahamLeech MA,Hannah Valantine MRCPand Nawzer Mehta BSc.
St George'sHospital MedicalSchool, London,ENGLAND.
Exercise testing following acute myocardial infarction is established
as a technique of diagnostic and prognostic value. Certain patients
however can not perform adequate exercise due for example tomusculo-
skeletal abnormalities or anxiety. Dobutamine has been used as a
pharmacologicalalternativeto exercise in 33 patients, 3 weeks post
infarction. A positive(- ve) exercise test (Bruce protocol)was definedas
~l mm ST segment depression in any lead.Blood pressure (BP), heart
rate (HR) and maximum acceleration(M A ) of aortic blood velocity
(transcutaneous Doppler technique) were measured during exercise.
On the following day dobutamine was infused in increments of
5J,tg/kglminup to20J,tg/kgfminwith thepatientsupine.A l2-lead ECG,
HR, BP andMAwererecorded8 minutes after thestartof each infusion
together with an assessment of LV wall motion using 2D
echocardiography.
The peak HR achieved on exercise was l32±6 versus 103±6bpm for
dobutamine (p<O.OOl), the maximal rate-pressureproducts were
l8 .9±1.4 for exercise versus 15.2 ±0.90mmHgfminxl0 3 for dobutamine
(p<O.OOl) and peakMAwas 23.4±2.l on exercise versus 35.8±5.0 mists
for dobutamine(p<O.Ol). Fourteen patients were+vefor both tests, 1 +ve
exercise but-ve dobutamine, 2 +ve dobutamine but-ve exercise and in
16 both tests were -ve; thus, there was a 90%concordancebetween the
tests (p<O.OlJ. Satisfactory echoimageswereobtained in 26 patients, 13
with dobutamine -ve and 13 with +ve tests.Ofthe -ve group overall LV
wall motion improved at peak dobutamine in 10 and was unchanged or
becamehypocontractile in3. In contrast, LVwall motionimprovedin 2
and was unchanged or decreasedin11 +vepatients (p<O.OOl).
These results suggest dobutamine provides a good alternative form of
LV stress to exercise for detecting ischemia in post infarction patients
and couldbe of particular benefit in those previouslyexcluded.
INCIDENCE OF CORONARY ARTERY DISEASE IN MALE VETERAN
PATIENTS WITH EARLY POSITIVE TREADMILL EXERCISE TESTS.
Udho Thadani, M. D. , FACC, Yao- Long Zhang, M.D., Rajesh
Prasad, M.D., Vasu Goli, M.D., Jerome Anderson, M.D.,
Eliot Schecht er , M.D., FACC, Wyatt Voyles, M.D., FACC,
Stephen Teague, M.D., FACC, OUHSC - Oklahoma City, OK.
One hundred thirty three male veteran patients aged 36 to
75 years with first stage Or early second stage positive
exercise (Ex) test characterizedby ST segment depression
(STf) of 1 mm or mor e beyondthe baseline underwent coro-
nary and l ef t ventricular(LV) angiography to evaluate the
severity of coronar y artery disease(CAD). LV ejection
fraction(EF) was cal cul at ed in 124patients(pts) and was
>60% in 53, between 50 and 59% in 37, between 40 and 49%
in 18 and ~4 0% in 12 pt s . Def in in g >50%diameter narrowing
as s ignificant CAD , 87 had triple(T), 37 double(D), and 9
single(S) vessel disease (VD) . No patient had i sol at ed left
main di sease (LMD). Of 21 pts with LMD, 16 had TVD and 5
had DVD. Of the 98 pts with STf between 1 to 1.9 mm during
Ex, 6 had SVD, 38 DVD(l with LMD) and 62 TVD(14 with LMD).
Of the 27 pts with STt between 2 and2.9 mm during Ex, 2
had SVD, 4 DVD(2 with LMD), and 21 TVD(2 with LMD). Of the
8 pts with ~3 mm STf during Ex, one had SVD, 3 DVD (1 . with
LMD) and 4 TVD( l wit h LMD) . Conclusions: l)In male veteran
pts, early positive ETT is indicative of underlying CAD
with a high i nc i dence of TVD(65%) and DVD(28%); 2) The
magni t ude,Jf STt dur ing Ex does notdelineate Sand DVD
from TVD or associated LMD. Since pts with normal resting
EF have a good medi cal prognosis despite severity of CAD,
the hi gh incidence of normal EF(73%) in the present study
would suggest that early positive ETT may not by itself be
an indication for coronary angiography. Further, one needs
a better non-invasive diagnostic test ot her than early
positi ve ETT in order to identify hig h risk pts with LMD
and tho se with TVD and low EF in whom coronar yangiogra-
phy is i ndicat ed .
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These data suggest that in a large group of patients
without previous myocardial infarction, spasm play a si-
gnificant role in ST elevation occurence but not in ST
depression during ExT.
DOES CORONARY SPASM EXPLAIN FALSE POSITIVE RESPONSES
DURING EXERCISE TEST ?
Jean M. Lablanche, M.D., Philippe Pruvost, M.D., Jean L.
Fourrier, M.D., Michel E. Bertrand, M.D., F.A.C.C. Car-
diologic hospital, University of Lille, Lille, France.
To evaluate the possible role of spasm in false positive
(+) ST segment depression during exercise test (ExT), 2
groups of patients (pts) without transmuralmyocardial
infarction were compared: Group (I) 113 pts with spon-
taneous or ergonovine induced spasm during coronary an-
giography. Group (11) 395 pts with a negative ergonovi-
ne test during coronarography.Symptom limited ExT was
performed with the Bruce protocol within the first 3
months after coronarography(70% within 3 days). Positi-
ve ST segment depression (ST dep) response was defined
as horizontal or downsloping ST dep ~ -1 mm, 0.06 sec.
after the J point. ST elevation was defined as eleva-
tion of the J point> 1 mm. ExT was inconclusive in 7
pts (Heart rate ~ 85% maxpredited heart rate without
ST segment depression). Defining significant stenosis
as 50% diameter narrowing, the prevalence of coronary
artery disease (CAD) was 59% in the spasm group.
Spasm No spasm P
ST elevation
True (+) ST dep
(pts with CAD)
False (+) ST dep
(pts without CAD)
11%
36/63(57%)
14/43(32%)
3.8%
69/112(62%)
104/283(37%)
<0.01
NS
NS
ENDARTERECTOMY OF THE LEFT MAIN CORONARY ARTERY USING A
TRANS PULMONARY ARTERY APPROACH. LONG TERM ANGIOGRAPHIC
EVALUATION.
Jean P. Villemot, M.D., Jean P. Godenir, M.D., Jaime
Zamorano, M.D., Jean F. Bruntz, M.D., Thierry Hubert,
M.D., Michel Clavey, M.D., Pierre Mathieu, M.D.,
Cardiac Surgery, CHU NANCY Brabois 54500 FRANCE.
Endarterectomy(END) of the left main coronary artery
(LM) using a transpulmonaryartery approach (TPA) is a
new surgical procedure to treat LM stenosis (st.) +
proximal LAD and/or LCX st. without additional byp~ss
grafting. The aim of this study was to assess the long
term results of this procedure.
Between Feb. 1981 and Jul. 1984, 18 pts (16M-2F, mean
age 52 years range 26-66) presenting with severe angina
pectoris (NYHA class 11 : n = 8, III : n = 4, IV : n = 6)
underwent END. The LM st. (73 + 8 %) was associated with
a LAD st. (69 + 4 %) in 15 pts-and a LCX st. (65 + 3%) in
6 pts. There w~s no operative death or perioperativemyo-
cardial infarction.
All pts but 1 were symptom free during long term follow
up (18,9 + 9 months, range 10 - 43) and 13 underwent re-
peat coronary angiography. The LM was patent in all
cases and the mean diameter of the END was 4,6 mm (range
3 - 7 mm). In 1 pt a 60 %LAD st. appeared at the distal
part of the END and was succesfully treatedby PTCA.
In 2 pts the distal LAD was occluded. The LV ejection
fraction was unchanged before (59 + 15 %) and after
(67+8%)END. -
Conclusion : END of LM using a TPA is a direct recons-
tructive procedure avoiding multiple bypass grafting
which proves to be both safe and effective at long term
evaluation.
Tuesday, March 10, 1987
2:00PM-3:30PM, Room 6, Second Level
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TRIPLE VESSEL CORONARY ARTERY ENDARTERECTOMY AND
RECONSTRUCTION. THE RESULTS OF 144 CONSECUTIVE CASES.
Jerold B. Brenowitz, M.D., Robert Gessert, P.A.,
W. Dudley Johnson, M.D., F.A.C.C.
St. Mary's Hospital, Milwaukee, WI.
Coronary artery endarterectomy(endart) and reconstruction
is a valuable adjunct to conventional bypass surgery when
attempting to revascularize lldiffusely" diseased coronary
arteries. 144 consecutive patients (pts) were operated on
through 2/86, all of whom required endart and
reconstructionof the LAD, circumflex and right coronary
arteries. There were 130 men (90%); age 29-83 yrs
(avg: 55.8); LV ejection fractions ranged from 0.20-0.75
(avg: 0.54); 131 pts (91%) had angina preoperatively, 85
(59%) Class III or IV. All operations were done using
intermittent ischemic arrest. There was an average of 5.0
grafts per pt (range: 3-8), with an average of 3.8
endarterectomizedvessels per pt (range: 3-7). Average
bypass time was 342 min (range: 180-545 min); average
aortic cross clamp time was 195 min (range: 93-358 min).
There were 14 surgical deaths (10%), all cardiac in
origin. Statistically significant risk factors (p<O.Ol)
for increased operative mortality included redo surgery,
ejection fraction<::::.30 and age~ 70 yrs. Nonfatal
complications included 18 perioperativeMI's (14%). Long
term follow up is available on 96 surviving pts (86%) for
an average of 30 months (range: 7-92 months). There were
12 late deaths 1-52 months postoperatively. 65/84 pts
(77%) are symptom free; 19 (23%) have angina: 11 Class
III and IV. Early graft patency (0-6 months) was 218/247
(88%) in vessels where endart was required and 74/80 (93%)
for conventional grafts. Late patency (~6 months) is 8/9
(89%) for vessels with endart and 5/7 (71%) for
conventional grafts. These data demonstrate that coronary
artery endart and reconstructionis a reliable method of
revascularization in otherwise inoperable pts.
DOES EXTENT OF REVASCULARIZATION INFLUENCE PROGNOSIS IN
PATIENTS WITH THREE-VESSEL DISEASE?
Bernard J. Gersh, M.B.,Ch.B., D.Phil., F.A.C.C., William
O. Myers, M.D., F.A.C.C., Guy S. Reeder, M.D., F.A.C.C.,
Lloyd D. Fisher, Ph.D., F.A.C.C., David R. Holmes, Jr.,
M.D., F.A.C.C., Hartzell V. Schaff, M.D., F.A.C.C.,
Michael B. Mock, M.D., F.A.C.C. and participantsof the
Coronary Artery Surgery Study (CASS), Mayo Clinic,
Rochester, MN.
Extent of revascularizationby coronary artery bypass was
evaluated in 3,372 Pt with three-vessel disease (3VD):
894 with mild angina (group 1) and 2,478 with moderate or
severe angina (group 2). The 6-yr cumulative survivals by
number of vessels grafted were:
Survival, ~
2 3 >4 f
Group 1 58 88 90 88 0.0085
Group 2 66 81 84 85 <0.0056
Survival analysis by the Cox model in group 1 Pt did not
identify number of vessels grafted as an independent pre-
dictor of survival; in group 2 Pt, significant predictors
were severity of congestive heart failure (P < 0.00001),
severity of LV dysfuncti~n (P < 0.00001), number of
associated medical diseases CP < 0.0001), number of
vessels grafted .IT.=. 0.0053),-number of proximal ~ssels
diseased (P = 0.009), LVEDP (P = 0.026), and unstable
angina (P; 0.026). -
We conclude that 1) in Pt with severe angina and 3VD,
survival benefit was seen with> two vessels grafted;
additional distal anastomoses reduced late risk of
recurrentevents (death, myocardial infarction, reopera-
tion, and angina) but not overall mortality; 2) prognosis,
however, is primarily determined by preoperativepatient-
related variables.
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ANALYSI S OF SEQUENTIAL SAPHENOUS VEIN GRAFT FAILURE
Edward C Miller, MD, AlIen 0 Soff er , MD, Ronald J Krone,
MD,FACC; Jewish Hosp at Washi ngton U Med Ctr , St Louis , MO
To determine factors associated with sequenti al saphenous
vein (SSV) graft failure we reviewed coronary angiograms
of consecutive patients presenting with ischemia after
coronary ar t ery bypass surgery. 50 patients, mean age 61
yea r s , with 64 SSV grafts and 171 gr af t segment s , were
s tu di ed ~n aver age of 43 mont hs (r ange 1 - 113) post sur-
ger y . Graft s wer e analyzed wi th re spect t o l eng th (cm) .
extent and site of significant (less th an 1. 5 mm diameter )
l esions and total occ l usions , side- to-side (SSA) vs end-
to-side (ESA) anastomosis, number of-myo ca rdia l s egments
suppl i ed , and s ever i ty of l esions in the bypas se d arter y .
Di stal (beyond first ana stomosis ) graft segments wer e more
likely t o have total occlusion , a t least one signi f i cant
l es i on, and mor e significant l esions / cm t han pr oximal
graft se gments; these differences were acco mpani ed by a
higher f~ilure rate of the ESA than the SSA.
Table ;l,.: Graft Failure El. Site and~ of Anastomosis
prox , dist . (.e. value) SSA ESA(.e. value )
total occl us ion 11% 26% (.02) 13% 33% ( . 002 )
s ignif . les i on 17% 35% (. 01) 22% 39% (.01 )
s i gni f . lesions/~ . 02 . 08 ( . 0001) .03 .09 (.0001)
Graft se gment s a t increased risk fo r failur e included
those supplyi ng 1 or less myoca rdia l segments (occ l usion
rate 33% vs 16%, p = . 02; significant l esions /cm = .11 vs
.0 3, p = . 00005) and those bypa ssing nati ve vesse l les i ons
of less than 75% diameter reducti on (occlusion rate 38%
vs 18%, p = .03). We conclude t hat t he d i st~l porti on of
SSV grafts is more prone t o f ailure th an th e pr oxi mal seg-
ment, and that the type of anastomoses and factors associ-
ated with dimi ni shed or competitive graft flow cont r i bute
to SSV graft failure.
OIANGIJll:i PROFILE OF'IHECORONARY BYPASS PATIENT
Keith S. Naunheim, M.D., Gary Roth, R.N. , L. R. McBr ide ,
M. D. , D. G. Pennington, M.D.. H. B. Barner, M.D.
Over t he last decade the rrortali t y for coronary by-
pass (m ) has risen at our institution. We carparedthe
records of the first 100 consecutive CB pa tient s in 1975
with thos e in 1985, and found that the profile of the
CB patient has changed significantly. Patients in 1985
are older ( 61.1 vs. 52.2 yrs., p < .0005 ) and have a
higher incidence of congestive heart failure (11 vs. 3 ,
P <.05), diabetes (20 vs. 6, P < .01), and chronic lung
disease (9 vs . 0, p <:. .005 ) • There is also a higher in-
c idence of past myocardial infarction (61 vs. 44, p z,
(.05), recent (within 1 rronth) infarct i on (20 vs . 3 . P
<.005 J. urgent or energency s urgery (24 vs . 12, P < . 05 )
and history of prior cardiac surgery (7 vs. 0, p < .01 ).
In add ition , the primary cardiac disease is worse with
a higher rate of t riple vessel disease (51 vs . 33 , p<
.05 ) , associated mild mitral or aorti c di sease (10 vs .
0, p < .01 ) and abnonnal ventr iculogrcrns (70 vs . 57, P
< .05 ) as exenplif ied by a · significant increase in LV
s core (8 .7 vs. 7. 2, p '< .Ol).
Despite rrore ag~essive revascularizat i on (average
anastaroses 3 . 6 vs . 2.2, p <. .001 ), t here has been a
greater incidence of postoperative low output (15 vs.
3, P <. .005) with a higher incidence of inotropic (42
vs. 9, P <. .005) or balloon support (14 vs. 2, p'
.005) • Both rrortality (8 vs . I, P ~ .05) and non-ar-
r hythnia rroIbidi t y ( 39 vs . 25, P < . 05 ) are higher with
increased pulrronary (11 vs. 0, p < . 001 ) and pennanent
neurologic carplications (6 vs . I, p< .06 ).
The CB patient has changed narkedly over a decade:
with ~rse cardiac and non-eardiac medical status resul-
ting in a significantly increased rroIbidity and rrortal-
i ty, despit e advances in surgical technology .
CurrentCoronaryArterySurgeryPractices: A National
Survey
Clay E. Beggerly, M.D., Erle H. Austin, HO., W. Randolph
Chitwood, Jr., M.D., FACC, East Carolina University,
Greenville, N.C.
Of 2376 surgeons (S) polled to determine current coronary
bypass (CABG) methods, data are shown for 572 practicing
cardiac S. Frequency of CABG (cases/yr) by these S was
<100, 27%; 100-200, 43%; 200-300, 5%; 300-400, 4%. Only
33% operated routinely on evolVing infarctions.
Crystalloid cardioplegia was preferred by 55%, blood by
28%, 15.5% used a mix and 1.5%used none. Arrest times
for 3 vessel CABG averaged 35-45 min for 68% of Sand
over 55 min for 16%. 21%of S used inotropicsupport in
>15% of cases . Mammary grafts (IHA) were used in >50% of
cases by 78% of S, and 11% used the IMA in <10%. For IHA
selection, 36% and 63%of S had no limit for age or
ejection fraction, respectively. IMA added <15 min to
the CABG in 26%, <30 min in 47% and <45 min in 22%.
Sequential IMA were done often by only 16% of S with 38%
having never done one. Bilateral IMA were done often by
only 18% of S with 19% haVing never done one. Right IHA
grafts were done often by only 21% of S. 47%believed
bleeding > after lMA than all vein cases. Of S doing
bilateral IMA grafts, 20% had related complications.
Postoperatively, as pi r i n and dipyridamolewere used in
combination by 80% of S. However, less than half used a
standard r egi men . I n addition, 3.8% ini tiated
antiplatelet therapy prior to CABG and 3%did not use
these drugs at all. Thus, this study suggests that
although most S use IMA as the graft of choice, many
prefer veins for primary CABG. At present, right,
sequential, and bilateral IMA grafts are not used widely.
Finally, most S use antiplatelet drugs after CABG, but in
a random fashion.
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EMERGENCY SURGERY AFTER FAILED ANGIOPLASTY
Victor Parsonnet, M.D., F.A.C.C., lsaac Gielchinsky,
M.D., F.A.C.C., Mark S. Hochberg, H.D. , Syed Mansoor
Hussain, H.D., F.A.C.C. , Daniel Fisch and LauraRothfeld,
Newark Beth Israel Medical Center, Newark. New Jersey
Emergencysurgery was required after angioplasty (PTCA)
in 55 of 714 cases (7.7%) . Failed PTCA was due to
dissection 29 cases, acute reocclusion 23, coronary
spasm 2, and perforation 1. To comparethese cases with
elective coronary bypass surgery (CABG) . historical
controls were selected by computer, matched i nage, seX,
NHYA class, ejection fraction, other risk factors
(diabetes, hypertension , heredity, smoking, obesity,
serum cholesterol, and remote myocardial infarction) .
The groups were statistically similar. The PTCA/CABG
groups r espective l y included: males 40/ 40; average age
56.7/57, 4; EF 42/38 ; NYHA class III SI/53; and Class IV
4/2. All cases in the PTCA group were i nt ended to have
single-vessel procedures. The number of bypasses actual-
ly done i n that group averaged 1.5 (range 1 to 4). In
the CABG group the average number of bypasses was 2.7
(range 1 to 5). Three or more bypasses were done in
25%/56% of PTCA/CABG respectively. The lABP was used in
11 failed PTCA cases. Postop IABP was required i n 5
additional PTCA cases (total of 18) and 3 CABG. Compari-
son of the PTCA/CABG groups revealed differences in:
avoidance of postop vasopressors 20/29 (p < 0.07 ) ,
length of stay 14. 7/ 13. 3 days, deaths 8/1 (p < 0.02).
AMI 29%/7% (p < 0.01 ) , and peak MB/CPK 68.5/17.8 ( p <
0.02) . Three of the PTCA deaths occurred within a f ew
hours of surgery, and the remaining f ive between the 1st
and 21st day. Complications associated with the 8 cases
were AMI in 8, VT/VF in 2, hemorrhage in 4. multisystem
failure i n 3, and sepsis in 1. We concl ude that emer-
gency surgery after PTCA in patients who otherwise might
have been candidates for elective CABG carries with it a
high risk of postoperativemorbidity and mortality.
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MOBIDITY AND MORTALITY ASSOCIATED WITH
EMERGENCY BYPASS GRAFT SURGERY FOLLOWING
ELECTIVECORONARY ANGIOPLASTY
Gar y S Roubin MB PhD, J David Talle y MD , H vernon Anderson
MD, Douglas A Murphy MD, Robert A Gu yton MD, Ellis L Jones
MD, Joesph M Craver MD, Nicholas Lembo MD , John S Douglas Jr
MD FACC, Spencer B King III MD FACC. Andreas Gruentzig
Cardiovascular Center, Emory Uni versity School of Medicine,
Atlanta, Georgia.
Morbidity and mortality following emergency coronary bypass
surgery (EMCABG) in patients (pts) having elective coronary
angioplasty (PTCA) may be excessive. We analysed the results of
5768 elective PTCA proceduresperformedthrough June 1986.
EMCABG was defined as surgery requiredon the same day as PTCA
with or without ischemia (angina or ECG changes), or surgery
performed on subsequent days for ischemia. EMCABG was required
in 213 pts, (3.7%) and ischemia was present in 189 (89%). Mean age
was 56±9 years, 69% were male, 31% hadmultivessel disease and 9%
had prior coronaryarterybypass surgery.
Myocardial infarction (MI) occurred in 104 (49%) (Q wave in 24%,
and CPK >510 withCKMB in 25%). Four EMCABG pts died (1.9%)
and 7 pts died SUddenly before EMCABG could be performed. Over
all, mortality for elective PTCA was 0.2%.
We conclude that in high volume centers with experienced
angioplasty operators, anesthesiologists and surgeons, the mortality
associated with EMCABG for failed PTCA can be minimized,
allowing for an overall low mortality in elective PTCA .
CARDIOTHORACICSURGICAL SUPPORT IS REQUIRED
DURING INTERVENTIONAL THERAPY OF
MYOCARDIAL INFARCTION: RESULT5 FROM THE
TAMI STUDY GROUP.
W. W. O'Neill, M.D., D. J. Kereiakes, M.D., R. S. Stack,
M,D.,F.A.C.C., B. S. George, M.D., R. M. Califf, M.D" R.
J. Candela, M.D.,F.A.C.C., C. W. Abbottsmith, M,D"
F.A.C.C., E. J. Topol, M.D., F.A,C.C. University of
Michigan Medical Center, Ann Arbor, Mich igan.
We have performed emergency catheterization in 317
patients (pts) who were treated with intravenous tissue
plasminogen activator (t-PA) 2.7 ± 0.9 hrs after symptom
onset of acute myocardial infa rc t ion (MIl. Emergency
coronary bypass (CABG) was required in 23 pts (7.2%)
immediately after catheterization. Indications for CABG
were failed coronary angioplasty (PTCA) in 12/151
attempts (8%), severe mul tivessel diseose (3 prs) and left
main coronary stenosis or its equivalent (8 pts). The
infarc t artery was patent in 18/23 pts at initial
angiography. Failure of PTCA occurred because of
dissection in 4/12 pts and because of rethrombasisin 8/12
patients. In comparison the rate of emergency bypass
duringelective PTCA was 4% (44/1608)
p <0.05, in the 4 canters. We conclude that a significant
number of patients will require emergency CABG after
combined t-PA and PTCA therapy of MI. The need for
CABG is related both to failure of PTCA and to high-risk
anatomy which is identified by catheterization. Failureof
PTCA is higher than during elective PTCA. For these
reasons access to emergency cardiothoracicsurgery must
be Obtained for optimal patient safety during
interventionaltherapyof MI.
SILENT MYOCARDIAL ISCHEMIA IS FREQUENT IN POST CORONARY
BYPASS PATIENTS.
Timothy M. Bateman, MD, FACC, Dhun H. Sethna, MD, James
S. Forrester, MD, FACC, James S. Whiting, PhD, Anthony
Don Michael, MD, FACC, Marjorie J .Raymond, BSN, Daniel
S. Berman, MD, FACC, Jack M. Matloff, MD , FACC, Richard
J. Gray, MD, FACC, HJC Swan, MD, PhD, FACC. Cedars-Sinai
Medical Center, Los Angeles, CA.
Although graft closure may cause symptoms of myocardial
ischemia, the relationship between asymptomaticgraft
closure and documentablemyocardial ischemia is not
known. We compared 23 asymptomatic (21 male, 65±7 yrs)
with 21 symptomatic (17 male, 67±9 yrs) pts using cine CT
to determinegraft patency (131 saphenous veins, 25
internal mammaries), and Tl-201 and radionuclide
ventriculography toidentify exercise-induced ischemia
(Ell). Time from surgery was I month to II yrs; mean time
between radionuclide tests and cine-CT was 3 wks. Most
(71%; 15/21) symptomatic pts had ~ I closed or subtotally
occluded grafts, and of these 12 (80%) had Ell.
Asymptomatic pts also had a high incidence (43%) of graft
closure, and 70% of such pts had "silent" Ell. Only 31%
of asymptomatic pts with all grafts open had any
indication (usually mild) of Ell. Thus in asymptomatic
pts, 4 clinically relevant subsets (grafts open or
closed, Ell present or absent) withpotentially different
management and prognostic value can beestablished from
graft patencystatus (detectable non-invasively by cine-
CT) and presence or absence of Ell . We conclude that :I.
Graft occlusion is common after CABG in both asymptomatic
and symptomatic pts; 2. The frequency of Ell i s nearly
identical in graft closure pts , regardles s of sympt oms;
3. The 4 subsets of graft patency-ischemia in
asymptomatic pts have testable therapeut icand prognostic
implications .
TBB~~ CF PCBrl'ftUCARDIOl'(JfY SYNIHJ4E
I!'CLUJiIR;CARDDC SUGmY: A lWOJIIZIlD PINJm)
cnmnnm'IiUAL
Peter J. Horneffer, MD, Robin H. Miller, MD,
ThCJM.S A. Pearson, MD, Mary F. Rykiel, RN, am
Timothy J. Gardner, MD, FAO::
The Johns Hc:pkinsHospital, Baltimore, MO
Although postpericarditanysyndrane (PPS) is a camon
o::rnplicatiooof cardiac surgery, the efficacy of any
treatmentregimen has yet to be established. 'lbe
effectiveness of nan-steroidalanti-inflammatorydrugs
(NSAIOS) in the treatment of ' PPS was therefore studied
in a double blinded, placeto controlled (PL), randcrnized
trial using a 10 day course of ibupl:ofen (lB) or
ind::Jrethacin(lID). Of 1,019 adult patients undergoing
open heart surgery over a 14 rrorrthperiod, 187 ~e
diagnosed as having PPS am 149 were enrolled in the
study. Diagnosis was based on the presence of at least 2
of the following: fever, anterior chest pain, am
friction rub. Efficacy loBS defined as the resolution of
at least tloO of these criteriawithin 48 hours of drug
initiation. lack of efficacy resulted in treatmentwith
another NSAID in a nonblinded fashioo.
IB and IND were 90.2% and 8B.7% efficacious
respectively, both significantly better than pr, at 62.5%
(p = .003). Side effect rates, including nausea,
vaniting, renal failure, am fluid retentionwere low in
all groups, being 13.1% for IB, 16.1% for INn, and 16.7%
for PL (pens) , Treatedpatients did not have longer
hospital stays, increased incidence in ischanic events or
accumulationof significant pericardialeffusions.
This study d3r0nstratesthat IB and IND provide safe
am effective symptanatic treat:zrentof PPS am avoid the
use of steroids in the perioperativeperiod.
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EffECT Of ANTIPLATELET THERAPY ON EARLY GRAfT PATENCY
AfTER CORONARY ARTERY BYPASS GRAfTING: VA COOPERATIVE
STUDY 1207. Report prepared by Steven Goldman, "0,
fACC, Jack Copeland, "0, fACC, Thomas "oritz, "S, and
William Henderson Ph 0, Tucson VA"C and University of
AZ, Tucson AZ, and VA CSPCC, Hines, Ill.
To determine if specific anti-platelet therapy improved
graft patency after coronary artery bypass grafting
(CABG) we compared 1) aspirin (325 mg qd), 2) aspirin
(325 mg tid), 3) aspirin and dipyridamole (325mg and 75
mg resp. tid), 4) sulfinpyrazone (267 mg tid), and 5)
placebo (tid). Therapy was started 4B hours before CABG
except for aspirin. When aspirin was a treatment, one
325 mg dose was given 12 hours before surgery. Graft
patency data were obtained early, one week, and then
later, one year, after surgery. Preliminarydata, based
on local interpretationof the angiograms at each
center, in the first 496 patients (1711 grafts),
revealed the following early graft patencies: aspirin qd
(93X), aspirin tid (93X), aspirin and dipyridamole
(93X), and sulfinpyrazone (92X). All these therapies
improved (P<0.005) early graft patency compared to
placebo (B4X). Chest tube drainage measured within the
first 35 hours after CABG revealed that the median loss
with aspirin tid (1114 ml) and aspirin and dipyridamole
(972 ml) exceeded (P<0.001) placebo (B02 ml) while
aspirin qd (BBO ml) and sulfinpyrazone (750 ml) did
not. The reoperationrate was greater (P<0.01) in all
the treatmentgroups that contained aspirin (6.1X)
compared to the two non aspirin groups (1.9X). Overall
operative mortality was 2.1X. In conclusion, graft
patency was improved early after CABG with antiplatelet
therapy. Two regimens which included preoperative
aspirin had increased blood loss after CABG and
preoperativeaspirin increased the reoperationrate.
Tuesday, March10, 1987
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Reperfusion Injury:Basic Mechanisms andTherapy
MYOCARDIAL BLOOO FLOW AND OXYGEN CONSUMPTION IN STUNNED
MYOCARDIUM,
David Laxson, M.O" David C. Homans, M,D., Robert J.
Bache, M.D. F,A.C.C. University of Minnesota,
Minneapolis,Minnesota
Reversible post-ischemic dysfunctionalmyocardium -
stunnedmyocardium (SM) - has been reported to be asso-
ciated with abnormalities of regional coronaryand
subendocardial blood flow. The presence andrelation of
persistantly impaired subendocardial blood flow toSM in
the post-ischemic periodwas investigated further by
measuring transmuralmyocardial blood flow distribution
with radionuclide-labelledmicrospheres,myocardial oxy-
gen consumption (MVOZ)' and coronaryvasodilator response
(VR) to systemic adenosine. Studieswere carried out in
8 conscious dogs before and 1 hourafter stunning induced
by a series of three 10 minuteleft anteriordescending
coronaryarteryocclusions. Regional myocardial segment
shortening (SS) was assessed with implanted ultrasonic
crystals. LV systolic pressure, LV EDP, mean AO
pressure, and heart rate were not different after
stunning or duringYR. SS returned to baseline inall
dogs, andtriphenyltetrazoliumchloride staining
demonstratedno evidence of infarct.
SS CBF (ml/min) MV02(ml/min) ENOO
Control 13.2 ± 1.1 17.8 ± 2.5 1.39 ± 0,3 0.77 ± 0.1
SM 5.5 ± 0.4* 19.0 ± 3.1 1. 55 ± 0.2 0.85 ± 0.1
Values are ± SE; *p < 0.05 compared with control;
ENOO=subendocardialflow b micros heres ml/min/ m
VR CBF was unchanged in SM vs. control control = 53;
VR = 55 ml/min). SM was not associated with a decrease
in regional CBF, ENOO flow, or MV02' Thus, persistant
dysfunction in SM is not the result of inadequate per-
fusion. The unexpected finding of unchanged MV02 in
areas of SM suggests a defect in the couplingbetween
energy production andmechanical work.
ENDOTHELIAL CELL DYSFUNCTION: AN IMPORTANT MECHANISM IN
THE EVOLUTION OF REPERFUSION INJURY.
Mervyn B. Forman. M.D .. F.A.C.C., Scott E. Bingham,
M.D., David W. Puett, B.A., Renu Virmani, M.D.,
F.A.C.C., Maria V. Tantengco, M.D., R. Todd Light, M.D.,
Gottlieb C. Friesinger, M.D., F.A.C.C., Vanderbilt
University, Nashville, TN.
To determine the effect of reperfusion on endothelial
cell structureand function, dogs were randomized to re-
ceive either low dose (15 ml/kg) intracoronaryperfluo-
rochemical (Fluosol-DA [FDA]), or Control (saline [Cl)
after 90 mins of proximal LAD occlusion. Vasodili-
tatory reserve (EVR) was assessed in vivo by infusion of
acetylcholine ~ACH) and serotonin (5-HT) into the distal
LAD bed with 1 3Xe at baseline (B) and 1 hr after reper-
fusion (lhrR). In vitro cumulative dose-response curves
to ACH were obtained to precontractedLAD rings proximal
and distal to the snare. Light and electronmicroscopy
was performed on endocardial and epicardial sections
from ischemic and non-ischemic zones. +=least squares
fit p<.05; *~p<.05; #=p<.Ol vs flow prior to agonist.
EVR in vivo EVR in distal
(ml/min/lOO/1) LAD in vitro
ACH 5-HT ED50 Slope
B lhr R B lhr R
C (8)*245±20 80±11 *280±30 120+15 1.3±10-6 0.51
FDA(8)*200±22 #135±10 *250±40 #190~10 +4.7+10- 8 +0.79
Endothelial function is preserved by reperfu;ionwith
FDA. Light microscopy demonstratedneutrophil plugging
in ischemic zones in C only. Electronmicroscopyrevealed
capillary obstructionby endothelial cell protrusions in
ischemic subendocardiumin C but an intact endothelium
in FDA animals. These findings suggest that damage and
dysfunction of endothelium is an important step in evo-
lution of reperfusion injury and strengthen the hypothe-
sis that "no-reflow" may limit myocardial salvage fol-
lowing reperfusion.
EARLY TOXIC EFFECTS OF OXYGEN FREE RADICALS ON MYOCARDIAL
ENERGY METABOLISM FOLLOWING REPERFUSION.
Giuseppe Ambrosio, M.D., Jay L. Zweier, M.D., Myron L.
Weisfeldt, M.D., F.A.C.C., John T. Flaherty M.D.,
F.A.C.C. Johns Hopkins Hospital, Baltimore, MD.
Oxygen free radicals generated during reflow are held
responsible for a specific reperfusion injury. We have
recently shown in isolated perfused hearts that
generation of oxygen radicals peaks within 30 sec of
reflow. It is unknown, however, whether this phenomenon
is accompanied by early cell damage. To study the early
effects of reflow on energy metabolism, rabbit hearts
were perfused within a 31-P-NMR spectrorneter. The hearts
were made globally ischemic at 37 ·C for 30 min. At the
time of reflow, the hearts received ei ther a 60,000 IU
bolus of the oxygen radioal scavenger recombinant human
superoxide dismutase (h-SOD) followed by an infusion of
100 IU/ml for 15 min (n=12), or normal perfusate as a
bolus followed by standard reperfusion (controls; n=12).
Serial standard 5-min NMR spectra were aoquired during
the study. To improve the time resolution during the
first 5 min of reflow, we recorded serial 1-min spectra
from each of the 12 hearts in each group. A more than 3-
fold increase in the signal-to-noise ratio was achieved
by summing the spectra obtained in each of the 1 min time
interval. Phosphocreatine (PCr) recovery in h-SOD treated
hearts was 89+8 %of preischemic value at the end of the
45 min of reflow VS 65.=5 % in controls; p < 0.001). PCr
recovery during the first 5 min of reflow was as follows:
Ischemia 0-1 1-2 2- 3 3-4 4-5 (min)
h-SOD 9.7 45.9 72.4 78.9 85.9 91.9
Contr 8.6 43.5 50.5 51.6 51.6 49.5
ThUS, the rapid and progressive recovery of energy
metabolism seen in the h-SOD treated group arrests within
2 min of reflow in untreated hearts, supporting a very
early oxygen radical mediated cell damage.
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180 min
3.2t3.1
-4.3t1.9
20.5tl3.3**
-24.6tl9
INOSINE IMPROVES RECOVERY OF "STUNNED" MYOCARDIUM AFTER
TRANSIENT ISCHEMIA
Laurence W.V. DeBoer, M.D., F.A.C.C., Steven J Bailin,
M.D., Denis F. Dahmen, Richard M. Byler, M.D., Catherine
R. Clausius, A. James Liedtke, M.D., F.A.C.C., Univ of
Wisconsin, Madison, WI
Following transient coronary occlusions, myocardial
tissue is "stunned"and recovery of systolic thickening
(Th) and of ATP and purine pool concentrations is
delayed. Repletion of purine pools with adenosine has
failed to predictably restore function in such "stunned"
myocardium. Therefore, we investigated the effects of
purine supplementationwith intracoronaryinosine (I,
1.5 ~M/min, N=lO) vs saline (S, N=9). Both agents were
administeredbefore, during and after a 15 min CAO of
the left anterior descending artery in open-chest dogs.
Regional mechanical function was measured by
sonomicrometry and Th was expressed as systolic
thickness/diastolic thickness x 100. Recovery (%R)
during reperfusionwas expressed as percent of control
Th measured before CAO. Before CAO, Th was 17.7t2.5 in
Sand 23.0t2.7 in I (N.S.). After 15 min of ischemia, Th
was 0.2t2.6 in Sand -2.3 t3.9 in I.
During reperfusion:
Time 30 min 60 min 120 min
Th-I 7.2t2.9 5.6t2.4 4.lt1.7
Th-S -3.3t4.9 -2.1t3.3 -1.3tl.9
%REC-I 35.9tll.5** 29.2tll.5* 20.6t9.0**
%REC-S -41.t23.4 -24.7t23.9 -18.7t2.1
*p < .05 vs saline *p < .02 vs saline
We conclude 1) inosine provides no mechanical protection
during ischemia and 2) beneficial effects of substrate
enhancement of purine salvage pathways are apparent
during reperfusion.
INTRACORONARY ADENOSINE MARKEDLY REDUCES INFARCT SIZE
AND IMPROVES VENTRICULAR FUNCTION IN A CANINE
REPERFUSION MODEL.
Blarki Olafsson M.D., Mervyn B. Forman, M.D., F.A.C.C.,
David W. Puett, N.A. Pou, Italo Biaggioni, M.D., Renu
Virmani, M.D., F.A.C.C., Gottlieb C. Friesinger, M.D.,
F.A.C.C., VanderbiltUniversity, Nashville, TN.
Myocardial salvage after successful reperfusionmay
be limited by the "no·reflow" phenomenon. Theeffect of
adenosine (ADO), a potent coronary arteriolarvasodila·
tor, on infarct size limitation is unknown. After 90
mins of proximal LAD occlusion 19 dogs were randomized
to blood reperfusionwith or without ADO into the prOXi-
mal LAD at 3-4 mg/min for 60 mins. Regional myocardial
blood flow (RMBF) in ml/min/g was determinedat baseline
(B) occlusion and reperfusion (R) with microspheres.
Regional wall motion (RWM) was analyzed using a
computerized radial shortening method. At 24 hrs biopsy
samples were obtained from ischemic and non-ischemic
zone for electronmicroscopy. Monastryl blue and
triphenyltetrazoliurnchloride were used to determine
area at risk (AR) and area of infarction (AN). Results
are expressed as mean±SEM; IZ-ischemic zone; RS-change
in radial shortening 0 vs. 24 hrs; *p<0.05; **p<O.Ol.
~NLbRill ~RL1Yill !illlli.ll --Blli.ll RMBF I Z
24hrs B R
ADO (10) **16±5 44±3 **8±3 *11.0±3 l.l±.l *1.6±.2
CONT( 9) 40±7 40±4 -5±2 0.1±2 0.7±.1 0.6±.1
ADO infusion did not cause any hemodynamic effects.
Electronmicroscopydemonstratedpreservationof endo-
thelial structurein ischemic subendocardiurnin ADO dogs
only. ADO given after reperfusionsignificantly reduces
infarct size and improves RWM. These beneficial effects
may be due to improved flow in the IZ, reducing the "no-
reflowll phenomenon, and are associated with endothelial
structuralpreservation.
RAPID ULTRASOUND ENHANCEMENT OF REPERFUSED MYOCARDIUM BY
FLUOROCARBON EMULSION. Yitzchak Hermoni, M.D., Marjorie
Gabel, David C. Eppert, Robert J. Toltzis, M.D., FACC,
Peter J. Engel, M.D., FACC, Ronald W. Millard, Ph.D.
Ilnfv , of Cincinnati Med. Ctr , and VA Med. Ctr , ,
Cincinnati, OH.
Ultrasonic enhancement (USE) of myocardial infarction by
fluorocarbon emulsions has been Seen 4 days after acute
infarction in dogs. USE may result from invasion of
fluorocarbon emulsion-laden macrophages into the ischemic
area. We have recently demonstrated significant accumu-
lation of fluorocarbon emulsion in acutely ischemic
myocardium within hours of acute myocardial infarction in
pigs using 19F-NMR tissue spectroscopy. The present study
was designed to determine the in vivo time course of USE
in reperfused pig myocardium after fluorocarbon emulsion
infusion with standard 2D-echocardiograms. In 6 pigs
fluorocarbon emulsion (FC-43) was exchanged for >50% of
the estimated blood volume 30 min following coronary
occlusion. The artery was reperfused after a 2 hr occlu-
sion and the chest closed. Serial 2D-echocardiograms
recorded at baseline, after ligation, immediately and
periodically after reperfusion on a Diasonics V-3400R
phased array echocardiograph with a 3.5 MIlz transducer
with constant gain and filter settings were reviewed by 3
obvserver s , Wall motion abnormalities (WMA) and chamber
dilatation appeared subsequent to coronary occlusion and
persisted follOWing reperfusion in all animals. USE
localizing in WMA areas occurred as early as 30 min post
reperfusion, became clearly evident within 2 hr and was
striking and unchanged between 1 and 9 days. ThUS, USE
of reperfused pig myocardium is produced by fluorocarbon
emulsion within a few minutes and persists for more than
1 week.
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MyocardialInfarctionand Arrhythmias
RELATIONSHIP AND SIGNIFICANCEOF THE TERMINAL ACTIVITIES
SEEN ON SIGNAL-AVERAGED BODY SllRFACE MAPS AND EPICARDIAL
ACTIVATION MAPS IN CANINE MYOCARDIAL INFARCTION.
Gerard Faug~re MD. Rene Cardinal PhD, Pierre Savard PhD,
Denis Derome MSc, Pierre Page MD, Moharnmad Shenasa MD
PhD. Hopital Sacre-Coeur, Montreal, Quebec.
The relationship between terminal activity recorded
either at the epicardium or torso, and its role during
ventriculartachycardia (VT) were investigated in 12 dogs
3 or 15 days after coronary (LAD) occlusion. Signal
averaged body surface potential maps (BSPM) were
generated from 63 ECG leads filtered at 25Hz and recorded
at several atrial pacing rates. After sternotomy, 63
epicardial electrograms were recorded at the same rates
and during VT induced by programmed stimUlation. We
found: 1) The QRS durations measured at the torso and
epicardium on filtered root-mean-squaresignals were not
statistically different. Beat-to-beat variations of the
total epicardial activation time ranged between 0 and 12
msec. 2) Dogs that showed terminal epicardial activity
at similar sites in the ischemic zone (IZ) also showed
similar filtered BSPM at QRS offset. The BSPM extrema
tended to be located inferiorly on the torso for apical
sites l superiorly for sites near the basal 12 margin, to
the left or to the right for sites at the left or right
IZ margins. 3) The site of terminal epicardial activity
did not change with the pacing rate. 4) The necrotic
area was smaller (p < 0.005) at 3 days (11 + 5% of LV,
endocardial) than at 14 days (22 ~ 3% of LV. transmural),
but the total epicardial activation durations were
similarly prolonged (42~9 and 48~10 ms) when compared to
that of control dogs (25~4 ms). 5} In 4 dogs with
subepicardial reentry during VT, the site of terminal
epicardial activity correspondedwith the area of slow
conduction. In this model, terminal thoracic activity
reflects subepicardial activity involved in reentrantVT.
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SJWlOIAL VARnTIOIII SUDDER AJlJlIIITII([CDEATH II DOOS WITH
ACUTE MrOCAIIDIAL IlIFARCTIOI: A TBIlEE YE.lJl REr1lO-PROSPEC-
TIVE STUDI.
Benjamin J. Scherlag, PhD, FACC, Eugene Patterson, PhD,
and Ral ph Lazzara, MD, FACC, Univ of Oklahoma Health
Sciences Center and VAMC, OklahomaCity, Oklahoma.
The 24-hr tape recorded ECG was analyzed in 184 dogs
subjected to left anterior descending coronary artery
l1gation in a retrospective (2 yr) and prospective (1 yr)
study. Sudden death (SD) varied significantly, from 42~
in the winter months (Nov-Feb) to 12~ in the summer months
(May-Aug). During spring and fall, SD fell between these
values. SD due to ventricular fibrillation (VF) was
triggered by triplets of ventricular ectopic beats at
a rate >270/min which caused sustained ventricular
tachycardia (sus VT) preceeding VF in 38 of 45 recorded
events. Primary VF was found in 5 of the SD and sinus
arrest was the terminal event in 2 cases. All survivors
were anesthetized for electrophysiological study.
Inducibil1ty of Sus VT and the presence of transmural
infarct (TMI) also showed the same seasonal relation (see
Table). In the majority of Sus VT continuous electrical
activity (CEA) was recorded overlying the infarot,
indicative of reentry. Post mortem examination showed no
Jan-Feb Mar-Apr May-JuneJuly-Aug Sept-Oct Nov-Dec
SD 43% 23~ 18%# 5%# 22~ 41~
Sus VT 91~ 50~ 42~ 28%# 56~ 79~
CEA 82~ 50~ 57~ 69~ 40~ 50~
TMI 87~ 84~ 70~# 72~# 78~ 88~
#p(O.05 vs Nov-Feb
signifioant seasonal difference in heart or infarct
size. SD appears to be more common in the winter months
because of the more frequent occurrence of triggering
beats and a higher incidence of TMI which provides the
reentrantsubstrate.
RESPONSE TO PROGRAMMED ELECTRICAL STIMULATION IN
REENTRANT VENTRICULAR TACHYCARDIA AROUND THE CANINE
MITRAL AND AORTIC VALVES: AN IN VITRO MODEL
Robert C. Bernstein, M.D., Lawrence H. Frame, M.D.,
F.A.C.C., University of Pennsylvania, Philadelphia, PA
Evaluation of clinical reentrantventricular tachycar-
dia(VT) is limited by accessibility to the circuit. We
studied an in vitro model of reentrant tachycardia(T) in
a ring of tissue from the base of the canine left ven-
tricle surroundingthe mitral and aortic valves (MAV)
which was completely accessible for recording from all
parts of the circuit. The MAV was dissected, placed in a
bath superfused with 95%OZ/5%COZ Tyrodes solution.
Ten bipolar recording electrodes were placed equidistant
along the endocardial surface. A stable regular VT was
induced with program stimulation(PES) in 6 of 6 intact
rings. Tachycardiacycle length(CL) was constant
(+ 5msec) with repeat induction in the same ring under
constant conditions. CL ranged from 180-385msec as con-
ditions varied (K+4-BmM,34"-38"C).Reentry is support-
ed by: sequential activation around the ring; termina-
tion of T by pressure on the surface of the ring; and
failure to induce T in transsected ring. The behavior of
reentrant rhythms around fixed barriersdepends on the
degree of recovery during the excitable gap. In this
model, late premature impulses(SZ), resetting the VT by
< 30 msec, conducted at the same velocity as the VT im-
pulse and had constant return cycles (RC) (K+4mM,34"C)
indicating full recovery during the excitable gap.
Earlier SZs were conducted slower, through partially
recovered tissue, causing increasing RCs. 8ecause of
full recovery of excitability, the CL of the T following
the RC returns to that of the VT.
This is a model of stable reentrant tachycardia in
ventricular tissue that allows recording, from all parts
of the circuit, the response of reentrant VT to PES.
ABSTRACTS
IONIC DEFIBRILLATIONOF THE CALCIUM OVERLOADED
HEART John C. Meri llat, M.D., Edward G.
Lakatta,-"M-:i5.;-H:A-:-Spurgeon-;-'Ph.D.,Thomas
Guarnieri, M.D., FoA.C.C. Johns Hopkins
University School of Medicine, Baltimore, MD
ca 2+ overload of myocardial cells causes
spontaneous Ca Z+ oscillations (CaOS)
accompanied by ~~Z££~~£££~~ spontaneous
oscillations in transmembranepotential. We
hypothesized that In an intact heart with
s u f f i c i en t mass to sUi t a i n v e n t r i c u I a r
fibrillation (VF), Ca + overload mig~t
initiate spontaneous VF and removal of Ca +
overload state might lead to defibrillation.
Langendorf perfusedz (Hepes buffer at 37
0C;
[K+] = 5.0 and [Ca +j = 1.5mM; perfusion
pressure = 100cm HZO) isovolumic rabbit hearts
were perfused wi th zero K+ buffer. Sustained
VF (documented by extracellular electrograms
and loss of ventricular pressure) occurred
spontaneously z in all hearts. Decreasingperfusate [Ca +j to 80uM (to abol ish CaDS)
caused sustained defibrillation in all hearts
(n=6); similar results were obt~ined in VF
caused by 10uM ouabain. Thus, Ca + overload
causes VF which reverts when the Caz+ overload
is reversed. We suggest that on~ mechanism
for the occurrence of VF during Ca + overload
is asynchrony of transmembranepotential
related to spontaneous asynchronous CaDS;
spontaneous defibrillation could result from
resynchronizationof membrane potential among
myocardial cells as CaDS are abolished.
EPFECT OF LESION SIZE ON VULNERABILITY
J.A. Abildskov, MD, PACC & Bruce ~. Steinhaus, PhD
University of Utah, Salt Lake City, Utah 84112.
The effect of lesion size on vulnerability to
fibrillation was studied with d model of propagated
excitation in a 625 unit 2 dimensional matrix. Cycle
length dependence of refractoriness and slow
propagation during early recovery were modeled.
Pibrillationthreshold (IT) was measured as the minimum
stimUlus train duration required to initiate sustained
reentrant excitation. Repolarization properties (K)
were randomly distributed and ischemic lesions were
simulated by lower mean and greater range of K. Ten
centrally located lesion sizes between 1 and 85% of the
matrix area were tested. Stimuli were applied to 9
units at the matrix center or to all matrix units.
Average PT for 30 different random distributionsof
each lesion size was determined. All lesions decreased
PT with both stimulus modes and the decrease was
directly related to mean K of the lesion. The effect of
lesion size on VUlnerability was dependent on the
characteristicsof the lesion. With backgroundK of 10
to 20 and lesion K of 1 to 30, a lesion size of 8% of
matrix area decreased PT 74%. Purther increase of
lesion size had no additional effect on H. In
contrast, with lesion K of 5 to 20, a lesion size of 8%
decreased PT by 44% and increases of iesion size to 85%
further reduced PT to 57%. Results suggest small
lesions may have equal effects on VUlnerability as
large lesions when repolarization properties are
sufficiently short and disparate. Less severe lesions
have less marked effects on vulnerability but greater
dependence on lesion size.
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CATHSI'ERABLATlOO USING RADIO~ n<ERGY: CXNI'ROL
OF USIOO VOWME AND SHAPE BY VARYING ro'IERAND DURATIOO
OF ABLATlOO.
E. Wayne Grogan , Jr., M.D., F.A.C.C. , St ephenH. Nelli s ,
Ph.D. University of wisconsin , Madison, Wisconsin
Cathet er deliver ed radiofrequency (RF) energy offers
pot ential advantages over OC ene r gy for controlled
ablat ion of endanyocardiumi n the treat:rrent of
arrhyttJnias . In this study we i nvest i gated physical
determinants of lesion generation , lesion size and
geanetry us i ng RE' energy. Using a variable voltage RE'
generator conr.ected to the dist al electrode of a 6F
quadripolar cathet er and a dispersive electrode , we
deliver ed a 500 kHz sine wave to the endocardial surface
of excised dog left ventricles i n normal, saline at 250 C.
Forty-nine endocardial lesions were created in each of 5
ventri cl es . Open circuit voltage was varied fran 40 to
100 vol t s (3 to 20 watts delivered pc:Mer), and tine fran
5 to 180 seconds. Lesion diarreter, depth, and volume
i ncreased with increasingpower and time, and the
relationshipbe~n delivered energy (joules) and
lesion volume (urn ) was linear (r = 0.88, P < .001).
Shallower lesions (radius/depthratio R/D up to 2.5)
were produced by shorterdurationof energy delivery at
all power levels, and equal volume but deeper , more
symnetric l esi ons by lower po.oer and l ongerduration.
R/D approached an asymptot eat 0.7 at highest energies.
We conclude : (1 ) RE' ab lation produces reproducibl e
endocardial lesi ons whose volume i s proportional to
delivered energy, (2) lesions of equal VOlUTe but
varying depth may be produced by delivering equ ivalent
energy in joules but varying pc:Mer and durat i on of
ablat ion, and (3) les i on shape may be in:iependently
controlled by judici ous selection of power and durati on
of energy delivery.
Tuesday , March10, 1987
Poster Displayed:2:00PM-5:00PM
Author Present:2:00PM-3:00PM
Hall C, NewOrleansConventionCenter
PediatricCardiology
LEFT VENTRICULAR FALSE TENDONS AND STILL'S MURMUR OF
CHILDHOOD : A CAUSATIVE ASSOCIATI ON?
Rae- Ellen W. Kavey , M.D., F.A.C.C., Fr ank C. Smi t h , M.D.,
Bonni e Salisbury, R.N., John Dadario. Divis i on of Pedia-
t ric Cardiology, SUNY-Health Science Center, Syracuse, NY
The e tiology of the innocent v i br a to r y musical murmur of
childhood has been unknown since i ts first fo r mal des-
cr i ption by Still in 1915. Recently , l eft vent r i cul ar (LV)
false t endons have bee n r eport ed to occu r mor e commonly i n
patients with innoc en t murmurs. To eva l uate t he i ncidence
of LV false tendons in children wi th Still's murmur , 46
consecuti ve patient s seen i n a 6 month peri od in whomt hi s
auscul tatory di agnos i s was made on aninitial visi t were
evaluated prospective l y by 2- di mens i ona l echocardiography
(2- DE) . Their echos were compar ed with those of al l 34
nor mal children wi t hout pr ecor di al mur murs who had been
eval ua t ed during th e same t i me period. Age r ange was 2-17
year s (~=6 yr s) fo r children with Stil l 's murmur and 2- 18
year s (x=l O yrs) fo r controls. Standard 2-DEstudi es were
performedwith no attempt made to search f or LV false
tendons. Al l 2- DE' s were reviewed by a single reade r un-
aware of t he ausc ul tator y findings . Obvious LV fa lse
tendons were seen i n 39 of 46 (84 .7 %) children with Still's
rnur~r and i n 9 of 34 (26 .5%) chi l dr en with no mur~r
(P < . 001) . Sixty-four percent of the demonstrated LV false
tendons were seen extending hori zontally be t ween the i n-
t erv ent r i cul ar se pt um and t heLV f ree wal l ; 36% had a
more longi tud inal orient ation passing f rom t he LV f r ee
wal l up toward s the se ptum in the subaor t i c ar ea .
Multiple fa l se tendons were seen in 10%. The high inci-
dence of obvi ous LV false tendons demonstrated by echo-
car diogr aphy in this prospecti ve se ries sugges t s that LV
f al s e tendons maywell play a major role in the genesis
of th e Still's murmur of childhood .
SIMULTANEOUSCATHETERAND CWDOPPLERPRESSUREGRADIENTS
WITHPATENTDUCTUSARTERIOSUS: PAPRESSUREPREDICTION
Dawod S Sharif M0 .. James C. Huhta, M.D., F.A.C.C.. Charles E.
Mullins, M.D., F.A.C.C. and Daniel J.Murphy, M.D. The Lillie Frank
Abercrombie Section01 Pediatric Cardiology, Department01
Pediatrics, BaylorCollege01 Medicine, Houston, TX
An accurate method lorassessment 01 pulmonary artery
pressure(PAP) in patients with a patent ductus arteriosus(PDA)
using aortic pressure and the continuous waveDoppler(CWD) wave
lorm would be uselultor the detection01 pulmonary hypertension
particularly in prematures with PDA.
Simultaneous dual catheter measurements of pulmonary
artery and aortic press ures were made during measurement01 the
maximal CWDvelocity pattern across a PDA Irom the parasternal
window in 8 neonates and children age 1wk to 6yr (median 7
months) with isolated PDA-6 or transpos ition01 the great arteries-
2. Peak systolic, diastolic and mean gradients were calculatedIrom
the CWD instantaneous velocities(V) using the modifiedBernoulli
equation(Gradient=4V2). The mean01 the instantaneous aortic
pressure minus PDAgradients byCWD over the cardiac cycle was
the mean PAP.
Maximal systolic, end-diastolic, and mean ductal gradients
ranged Irom 24-103, 3-57, and 16-89 mmHg respectively and
there was excellent correlation01 gradients predicted byCWD
(r=0.99,0.95,0.99). PAP instantaneouschanges could be predicted
by values 01 aortic pressure and instantaneous PDAgradient.
Conclusions: PAP can be measured accurately in patients with
a PDAusingCWD. Peak, diastolicand mean ductal pressure gradient
measurement should allowthe detection01 pulmonary hypertension
when a PDAis present.
ESTIMATION OF PULMONARY ARTERY PRESSURE IN
CHILDREN WITH VENTRICULAR SEPTAL DEFECT:
REAL-TIME COLOR FLOWICONTINUOUS WAVE OOPPLER
APPLICATION. Samuel Rjtter, MD FACC Karen Segal,
Ph.D.. Diana Kawai, R.D.M.S., Rica Arnon, M.D., F.A.C.C..
LeonardSteinfeld, M.D., F.A.C.C., and RichardGolinko, M.D.,
F.A.C.C. MountSinaiSchool of Medicine, New York. NY.
Quantification of pulmonaryartery pressure inchildren
withventricularseptaldefects (VSD) is an essential~uide
to decision makingand patientmanagement.Bccentricityof
VSD jets can make Doppler interrogationtedious and
time-consuming. The true maximal velocity may be
underestimated and the calculated pulmonary artery
pressure overestimated. Real-time Doppler color flow
mapping candemonstrateaccuratelythe area ofmaximal
transseptalflow. Seventeen patients,aged 5 weeks to 6
years(X-3,2 years) withVSD's were studied at the time of
cardiaccatheterization. Muima! trans-VSD velocities were
localized by directing the continuous wave Doppler beam
into the Doppler color flow mapping area of muimal
turbulentflow. Velocities were converted to transseptal
gradients (ll.I'LIH\lJ) by use of a modified Bernoulli
equation. Left ventricular pressure wassumed to be
equal to right armbrachialsystolic pressure obtained by
cuff. The results correlated well (r-.98) with
catheterization; without color flow, r- ,90. These results
indicate that Doppler estimation of pulmonary artery
pressures are reliable in patientswithVSD's. Dopplercolor
flow real-time imagingprovides increased accuracy by
directingthe continuouswave Doppler interrogatingbeam
into areas of true muimalflow andturbulence.
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EFFICACY AND PHARMACOKINETICSOF FLECAINIDE ACETATE IN THE
TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN.
Janice Till.M.B., David Holt i Ph.D,, E.A.Shinebourne.M.D.,
David E Ward. M.D.F.A.C.C., A. John Camm. M.D. F.A.C.C.
Departmentof Paediatric Cardiology. Brompton Hospital,
London, United Kingdom.
We treated 7 children (Ch) aged 0.1 to 13.7 years (mean
age 7.3 years) with Flecainide Acetate (F) to assess the
efficacy and pharmacokineticsof the drug in Ch. All 7 Ch
suffered repeated attacks of supraventriculartachycardia
(SVT) unresponsive to other agents. 3 Ch had Wolff-
Parkinson-Whitesyndrome, 1 atrio-ventricularjunctional
tachycardia, 1 atrial tachycardia, and in 2 the mechanism
was not fUlly established. F was given by intravenous
infusion at a dose of 2mg/kg. over 10 minutes. Flasma
levels were measured using high performance liqUid
chromatography.In the 6 Ch given F during SVT tachycardia
terminated between 1.5 and 10 minutes after commencement
of the infusion. (Mean time to termination5 minutes). In
the 4 Ch with orthodromic atrio-ventricularreentrant
tachycardiaterminationwas in the retrogradelimb. Side
effects were seen in only one child who reported nausea
during the infusion. Plasma terminal half-life (THL) was
calculated in 6 Ch. FollOWing a single intravenous dose
plasma levels decrease rapidly initially, reflecting rapid
distribution. This is followed by a relatively slower rate
of disappearance; the terminal elimination phase.
Ch. 1 2 3 4 5
AGE /years 0.1 3.2 10.8 11.0 11.7
THL /hours 11.95 7.62 7.19 6.88 9.1
This data may reflect changing renal clearance and
metabolism With age. F is effective in the acute
terminationof SVT in Ch but the terminal elimination
half-life differs from that in the adult.
EARLY EXPERIENCE WITH NAIXlWL IN aJILDREN WITH
SUPRAVENTRICULARTAOiYCARDIA
Ashok V. Mehta, M.D•• F.A.C.C., R.L. Vcgel, M.D.• LF.S.
BIaCk.-M.~.y.Ol.ukot.un, M.D., R.M. Donner, M.D., St.
Christopher'sHosp. for Children. Philadelphia, PA.
Nadolol (N) is a new long-acting beta-blocker. The
clwical efficacy and safety of LV. and oral N in
supraventricular tachycardia (SVT) ID c1nldren has not
been reported, Eleven children. ages 3 non-IS yrs (nedian
4 yrs}, were treatedwith N. The rrechanismof SVT was: A-V
nodal reentry (4), accessory bypass (4). SN reentry (1).
auternaticatrial focus (1), intra-atrialreentry (1). Of
11 pts, only 1 pt had IJJ dysfunction and 1 had AV septal
':j.efeet repair. D1goxin was unsuccessful in 9/9 pt.s, Oral
- I.V. propranololwas tried ID 9 pt.s,
Of 7 pts Who received LV. Nadolol during
electrophysiolcgic study (0.05 rrg/kg)r 5 had no SVT and 2
had 20-25% decrease in SVT rate; 6/6 had identical
response to oral N. Of 10 pts Who were maintainedon once-
daily dose of oral N (0.67 to 2.5 rrg/kg/day. rredian 1.5
rrg/kg) 8 were well controlled. 1 had anfrequent, and sla.-..er
rate SVT and 1 had a poor response. Of 8 pts Who had a
trial of propranololand, subsequently. nadoIo.l , 6 had a
good response to both, one had a fair response (infrequent
and slower SVT), and 1 W1th intra-atnalSVT had a poor
response to both. During follow-up of 1-14 mo (median 6
mo) • N dose was decreased in one pt because of easy
fatiguability and headache and discontinued in one infant
because of sleeplessness.
In oonclusion 1) I.V. Nadolol testing predicts the
therapeuticefficacy of oral N therapy, 2) the response of
SVT to propranololtherapyalso predicts the response to
N. 3) once-dai.Iy oral N dose can be used for long-term
prophylaxis of recurrentSVT. and 4) I.V. and oral N
therapyare not associated with significant side effects.
INTRA-ATRIAL REENrRANT TACllYCARDIA IN ClULDREN: CLINICAL
AND ELECTROPHYSIOLCGICFEATURES, MANAGEMENT AND FOILG'HJP
Ashok V. Mehta, M.D., F.A.C.C., R. Lee Vcgel, M.D••
RichardM. D:mner,---r;r.n. St. Christopher'sHospital for
Children. and Temple Umversity. Pni.LedeIpnra, 1>A.
Intra-atnal reentranttachycardia (IARI') 10 children is
unccmron and 1tS naturalhistory is unknown. Therefore.
the records of 8 children - 6 females, 2 males with IART
were analyzed. The age at diagnos1s was 3-15 yrs (rredi.an
6.5 yrs) . of 8 pes, 5 had clinical tachycardia (2
sustained symptomatic, 1 incessant asymptomatic, 2
unsustained) and 3 with sip intra-atrialbaffle repair had
laboratory-induced IARI' only. All had heart disease:
myocarditis-2, sip Fontan-l, sip intra-atrial baffle-4.
sip tetralogy of Fallot repair-I. HerrodynamicS by
catheterization \\ere normal in all. The
electrophysiolcgic (EP) characteristics were: cycle
length 250-480 msec; inducible 8/8; sustained ID 7/8;
activation high to low in 7, low to high in 1, both in 1;
PR/RP <1 in 5. PR/RP >1 in 3; variable in 2; prolonged PA
interval in 2/6; prolonged atrial refractoryperiods in
2/6. Three with sustained clinical IARI' received therapy.
Final successful therapies were: digoxin + quinidine in 1,
anuodarone in 1 (unsuccessful: digoXin, phenytoin.
quinidine. propranolol. I.V. procainamide), cryoablation
of AV rode + pennanentpacemaker in 1 (unsuccessful:
d1goxin. qu1nidine. I.V. procainamide, verapam11,
propranolol. enuodarone, phenytoin. catheterand surgical
ablation, cryoablation and l.solation of high RA). Pts
without clinically sustained or only EPS mduced IARI'
remain tacnycardra-fraawithout therapy.
We ronclude IARI' is <XXlITOl1ly associated with heart di.sease
despite oormal nerrodynarmcs, clinically manifest cases may
requ1re multiple therapy and the significance of EPS
Lnduced but clinically absent IARI' in 3 pts is unknown but
appears bemgn over 155 pat.Ient.-rronthsfollow-up.
BALLOON ANGIOPLASTY FOR NATIVE COARCTATIONS OF THE AORTA:
LONGTERM RESULTS
P. SyamasundarRao, M.D., F.A.C.C., Haitham Najjar, M.D.
King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
It has been said that balloon angioplasty (BA) for unope-
rated coarctationof the aorta (COA) is not beneficial
and that there is aneurysmal formation in some patients
on follow-up. Our experience with 16 patients is con-
trary to such observations. Fifteen patients between
the ages of 19 days and 11 years (median 18 mos) with
native COA underwent BA. Associated defects (in 12)
included aortic stenosis, ventricularseptal defect and
patent ductus arteriosus. Catheters carried 5- to l8-mm
balloons; the balloon size did not exceed the descending
aortic size at the level of diaphragm. Five to 8 atm of
pressure was applied for 5-10 sec. with each BA; the BA
was repeated 3 times. Systolic pressure gradient across
coarctation fell from 44.1 ~ 19.9 mmHg (mean ~ SO) to
8.9 ~ 7.2 (p< 0.001) immediately following BA, and the
diameter of coarcted segment increased from 3.9 ~ 1.7 to
8.4 ~ 3.1 rrnn (p < 0.001). All patients improvedand none
required immediate surgery. Ten to 15 moo follow-up
results were available in 12 patients, Pressure gradient
(9.8 ~ 9.1 mmHg) and size of coarcted segment (9.6 ~ 2.9
mm) remain improved (p < 0.001). None developed aneu-
rysms. One infant required repeat BA 11 months after
initial BA and another infant was operated elsewhere for
restenosis, 4 months after initial BA. Based on this
experience, we would recommendBA as the therapy of
choice for relief of severe, native COA in infants and
children. Limiting the size of balloon to the size of
descending aorta at the level of diaphragmand meticu-
lus care not to pass a catheter or guidewire across
freshly dilated COA appear to prevent aneurysms and are
recommended.
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PULSED DOPPLER ECHOCARDIOGRAPHICDETECTION OF TRICUSPID
INSUFFICIENCY IN CHILDREN.
Gerard R. Martin, M.D., William A. Lutin, M.D., Norman
H. Silverman, M.D., F.A.C.C., Scott J. Soifer, M.D. and
Sarah A. Scagnelli, R.D.M.S., University of California,
San Francisco.
Pulsed Doppler echocardiographymay detect tricuspid
insufficiency (TI) when auscultatory findings are absent.
We compared the frequency of TI in 31 children by 4
methods: 1) auscultation, 2) pulsed Doppler, 3) right
ventricularangiography and 4) right ventricularsaline
contrast echocardiography. TI was detected by pulsed
Doppler echocardiographywhen a high velocity signal
lasting longer than 50% of systole was located in the
right atrium. TI was detected in 3 by auscultation, 20
by angiography, 20 by pulsed Doppler and 21 by contrast
echocardiography. To determine the frequency of TI in
children, we reviewed 5,417 pulsed Doppler examinations
which were performed between 1983 and 1986. TI had been
detected in 331 (8.9%) children. Common lesions and
their incidences of TI were: ventricularseptal defect,
11% of 548; d-transpositionof the great vessels, 14% of
234; pulmonary stenosis, 8% of 290; atrial septal defect,
8% of 175; coarctationof the aorta, 9% of 161; aortic
stenosis, 5% of 173; newborns with lung disease, 20% of
128: double outlet right ventricle, 14% of 65; Ebsteins,
100% of 30; Tetralogy of Fallot 60% of 81: pulmonary
atresia/VSD, 13% of 67 and pulmonary atresia/IVS, 22% of
23. By comparison TI was detected in only 2.8% of 428
normal children. Conclusion: TI is uncommon in normal
children, but its incidence in children with congenital
heart disease is high. Pulsed Doppler echocardiography
is more sensitive than auscultationand as sensitive as
angiography in detecting TI.
FORElGM BODY RETRIEVAL: TRAMSCATBETER REMOVAL
OF EMBOLIZED PATEMT DUCTUS ARTERIOSUS OCCLUSION
DEVICES AMD CATHETER PIECES
Martin P. O'Laughlin M.O., G. Wesley Vick 1lI M.O. Ph.O.,
Michael R. Nihil! M.O., F.A.C.C., J. Timothy Bricker M.O.,
F.A.C.C., Charles E. Mullins M.O., F.A.C.C. The Lillie Frank
Abercrombie Section of Pediatric Cardiology, Texas Children's
Hospital and BaylorCollege of Medicine, Houston, Texas.
The purpose of thisstudy is to describe transcatheter techniques
for removal of intravascularforeign bodies including embolized
patent ductus arteriosus (POA) devices.
Records of catheterizationsat Texas Children's Hospital from
1/84-5/86 were reviewed, and cases of foreign body retrieval
were analyzed. There were 8 foreign bodies retrieved from
patients ranging in age from 6 wks to 48 yrs and weighing from
1.4 to 97 kg. Foreign bodies includedaccidentallysevered pieces
of indwelling catheters in 6 of 8, and embolized POA occlusion
devices in 2 patients. Catheter segments were in the right
atrium in 2, superior vena cava in I, and left pulmonary artery
in 3 patients. Techniques for removal included use of a snare
(a wire doubled on itseIf and placed through an end-hole
catheter), grasping with bioptomes (Cook" or Olympus"),basket
retrieval (Ootter"), and dislodgement with a deflector wire
(Cook") formedinto a tight crook. Two ductal occlusion devices
(12 mm) escaped to the right pulmonary artery and were
retrieved with a grasper device (Mediteeh ")introducedthrough
a sheath. Both patients' POAs were occluded successfully after
removal of the first device. All foreign bodies were removed
without complications.
We conclude that catheterretrievalof foreign bodies is feasible
and safe, that a variety of teehniques are useful in their
retrieval, and that POA occlusion devices embolized to the
pulmonary arteries can be extracted without surgery.
BALLOON VALVULOPLASTY FOR ISOLATED AORTIC STENOSIS IN
CHILDREN - SHORT-TERM RESULTS.
M. Vogel, M.D., L. N. Benson, M.D., F.A.C.C., R. M.
Freedom, M.D., F.A.C.C., R. D. Rowe, M.D., F.A.C.C. The
Hospital for Sick Children, Toronto,CANADA.
Balloon valvuloplasty (BV) for isolated congenital aortic
stenosis (AS) has only recently undergone clinical trials.
We report our experience withthis technique in 15
children, mean age 8.3 (0.8-16.6) years and 4 newborns.
The aortic valve diameters in the olderpatients were
98+33 (73-200%) of normal. The LV could not be entered
retro- grade in onepatient. Balloon tippee catheters
were placed retrograde,percutaneously, chosen to be
within 1 mm of the aortic annulus diameter, and 3cm (13
patients) or more recently 5 cm long (5 patients). In 4
patients, no reduction in pressuregradient across the Ao
valve occurred. One of those patients was dilated on two
separate occasions. In the4 newborns with critical AS,
BV was performed in the first 72 hours of life. In two
cases it was impossible to enter theLV. The hemodynamic
data for all patients are summarized:
before BV(mmHg) after BV(mmHg)
163::26 - P<.O.<Xll 133+22
15+7.6 - <0.001 11+5.5
70+19 - <0.001 29+18
3.7+0.7 - NS 3.6+0.7
2(grade 1) 7(6 (J"ade r,l grooe IV)
All 4 patients in whom BV was not successful had surgery,
two had an Ao valvulotomy; one, a valve replacement and
one, a Kono procedure. The valve was dysplastic in two
and bicuspid in two. Except for the newborns with
critical AS, BV was successful in palliating AS in those
patients who had no valve dysplasia. Mild Ao
regurgitationwas common.
LV systolic pressure:
LVED pressure:
LV-Ao pressure gradient:
cardiac index(L/m/m2):
Ao regurgitation:
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DIASTOLIC FILLING IN LV OUTFLOW OBSTRUCTION PRE
AND POST BALLOON ANGlOPLASTY Elizabeth M. Shaffer,MO,
A. Rebecca Snider,MO,FACC, Albert P. Rocchini,MO, Robert
H. Beekman,MO,FACC, AmnonRosenthal,MO,FACC,MacOonald
Dick !I,MO,FACC, Oennis Crowley.Ml) Univ of MI, Ann Arbor
To assess diastolic filling in children with LV outflow
obstruction (LVO), we studied 8 pts (5 with aortic stenosis, 3
with coarctation) and 8 age-matched norrnals (nl), Each child
had Doppler (Dop) exam of themitral valve and LV M-mode.
The pts underwent cath and balloon angioplasty. Their echoes
were done pre andimmediately post-balloon with simultaneous
measurement of the LVEOP. M-mode diastolic time intervals,
peak rates of increase in LV dimension, and LV mass were
measured. The following Oop measurements were made:
velocities at rapidfilling (E vel) and atrial contraction(A vel),
E/ A vel ratio, total velocity time integral (VTO, triangular
area under A vel (A area), triangular area under E vel (E
area), and area in the 1st 1/3 of diastole (.33 area). The %
of filling occurringin each portionof diastole, the area fraction
(fx), was calculated as the Dop area/total VTI. There were no
differences between nl and pre-balloon pts in M-modeindices.
NI and pre balloon ptsdiffered (p<.02) in the following Oop
indices: E veI(01=.86+.1l, pre=1.l2+.l7m/s), A vel (01=.50+.08,
pre=.86+.20m/s), E/A-vel (nl=1.77+]0, pre=1.34+.23), totalVTI
(01=.14 - + .03, pre=.21 + .04iii). E/A area (01=2.76+.78,
pre=1.87+'54), E fX(01=.66+.08, pre=.72+.04),A fX(01=.26+.06,
pre=.41+-:-i3). and .33 fx(01=.52+.08, pre=.39+.07). LVEOP
correlated with E/A area (R=.70. LV mass correlated with
pre-balloon gradient (R=.92) but not with any Dopindices. In
pts pre and post-balloon, there were significant differences in
LV gradient (pre=65+25, post=34+23 mmHg) but no differences
in LVEOP or echo-indices. Conclusion: Pts with LVO have
abnormal LVdiastolie filling with a diminished % of filling
occurring in the 1st .33 of diastole and increasedfilling during
atrial contraction. These abnormal filling patterns are not
immediately altered following successful relief of LVO.
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DETACHABLE LATEX BALLOON OCCLUSION OF ANOMALOUS SYSTEMIC
ARTERIES IN PATIENTS WITH TETRALOGY OF FALLOT.
Ira H. Gessner, M.D., F.A.C.C., Ronald G. Quisling, M.D.,
an~ J. ~arker Mic~le, M.D., University of Florida,
Gainesville, Florida.
Anomalous systemic arteries arising from the thoracic
aorta occur in about 5% of patients with tetralogy of
Fallo~, many of whom have complete atresia of the right
ventricularoutflow tract. These anomalous arteries
connect with true pulmonary arteries providing
substantial, often excessive pulmonary blood flow.
Surgical elimination of these arteries is difficult.
Various materials, including balloons, have been used and
reported for embolization of numerous vascular
structures. We have used detachable fluid filled latex
balloons to occlude 6 anomalous systemic arteries during
3 procedures in patients weighing 10 to 18 kg. Each
procedure involved occlusion of multiple large arteries.
The balloons are made prior to use according to size of
the vessel to be occluded. Balloon volume is 0.6 ml. and
size is variable, generally about 5 mm. by 8 mm. The
catheter system is introduced into a femoral artery
through a standard 7F sheath. Partial inflation of the
balloon allows blood flow to carry it into the anomalous
artery for a sufficient distance to avoid subsequent
movement of the fully inflated balloon. Immediate
pulmonary arteriographyhas shown no obstruction to flow
through true pulmonary arteries and better visualization
of the pulmonary arterial system by elimination of
washout from the anomalous arteries. Follow up studies
(6 months) have shown obliterationof the embolized
arteries. The system is simple to use and no
complications have occurred in this small series. Some
advantages of this balloon system over other balloon
systems are: I) The balloon can be flow directed into the
appropriatevessel; 2) The balloon cannot detach itself
prematurely; 3) Balloons can be constructed in sizes and
shapes appropriatefor vessels to be occluded.
IIIPLANTA'I1011 OF BALLOOII EXPAIIDABLE
IIfTRAVASCULAR GRAFTS BY CATHETERIZATION IIf
PULMOIIARY ARTERIES AND SYSTHIIIC VHIIIS
Martin P. O'Laughlin, MD, G. Wesley Yick III MD, PhD,
David Mayer,MD, Richard A. Schatz,MD, Julio C. Palmaz,MD,
David J. Fisher,MD, Charles E. Mullins,MD, FACC. Texas
Children's Hosp, &: Baylor College of Medicine, Houston, TX.
The purpose of this investigation was to evaluate the safety
and suitability for implantation of expendable intravascular
stents in pulmonaryarteries(PA's) or systemic veins. Ten balloon
expandable intravascular grafts designed by one of us (JCP)
were placed in five mongrel dogs underanesthesia. A catheter
was passed percutaneouslyfrom the femoral or jugularvein into
the PA or superiorvena cava (SYC). A guide wire wasinserted
and advanced distally. A transseptal sheath and dilator were
introduced over the wire into the PA ortarget vein, and the
dilator removed•. A 3cm long 3.7mm diameter stainless steel
expandable mesh stent was placed on a 12mm diameter balloon
catheter. The catheter and stent were advanced through the
sheath into the PA or systemic vein. The stent expanded as
the balloon wasinflated to a pressureof 4-6 atm, and remained
expanded as the balloon wasdeflated. The stent was expanded
further with a larger balloon (15 or 18mm) in five instances.
Four stents have been placed successfully in PAs (out of six
attempted), and three out of four have been installed in
tributariesof the SYC. Three inadvertent embolizations of the
devices have occurred. All three devices which embolized lodged
in the PA's and did notobstruct flow. To date two dogs have
been recatheterized and the stents were patent and
nonobstructive.One animal has beensacrificed two months after
implantation. The stents (both in the PA) were completely
covered with neointima and were patent, without thrombosis.
These stents hold promise fordefinitive dilatation of congenital
or postoperative vessel stenoses.
CATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS (PDA).
Larry A. Latson, M.D., F.A.C.C." John P. Cheatham, M.D.,
F.A.C.C., John D. Kugler, M.D., F.A.C.C., Carl H.
Gumbiner, M.D., F.A.C.C. and Philip J. Hofschire, M.D.,
F.A.C.C, University of Nebraska Medical Center, Omaha, NE
We used the Rashkind PDA Occluder (Ocldr) to attempt
transcatheterclosure of PDA in 12 pts between 5/85 and
9/86. Pt ages were 8-95 (median 12) mos. and weights
were 6.8 to 21.4 (median 8.5) kg. PDA diameters were
2.5-7 (median 4) mm and Qp/Qs ranged from 1.1-2.9
(median 1.9). The Ocldr was manipulated into the PDA
through an 8F long sheath in all pts. In 1 pt, the Ocldr
could not be firmly positioned (PDA too large) and was
not released. In the remaining 11 pts, an Ocldr was
successfully detached in the PDA.
There were no complications from the procedure. In 1 pt,
an Ocldr embolized to the right pulmonary artery, but was
retrieved with a grasping catheter and removed through
the femoral vein. Another Ocldr was successfully placed
the following day. Complete closure of the PDA was con-
firmed by clinical exam and Doppler in all patients
except the first, who had a persistent, tiny leak around
a suboptimally positioned Ocldr. Slight modification of
the original technique resulted in better visualization
of the PDA in the remaining pts.
The mean length of hospitalizationwas 1.5 days (range
1-4). Hospital stay was ~ 24 hours for the last 7 pts.
All pts were well on follow-up examinations 1-12 months
post implant. We feel that catheter closure of PDA using
the Rashkind Ocldr is a safe and effective means to treat
PDA in selected pts. The technique eliminates the need
for general anesthesia and thoracotomy and can be accom-
plished with one-day hospitalization.
INTRAOPERATIVE BALLOON ANGIOPLASTY OF AORTIC
COARCTATION
John D. Murphy, M.D.,BarbaraL. Sands, R.N., WilliamI.
Norwood, M.D., Ph.D.Children'sHospitalof Philadelphia,
University of Pennsylvania,Philadelphia,PI'..
During a one year period 10children, ages 3 months to 10
years, underwent intraoperativetransluminalballoon angioplasty
of coarctation of the aorta. In 2 patients the angioplasty
catheterswere introducedinto the ascending aortaduringsurgery
to correct intracardiacdefects. The other 8 infants had the
catheters inserted directly into the descending thoracic aorta via
thoracotomy because the catheter size precluded percutaneous
insertion into the femoral artery. In each case after measuring
the systolic pressure gradient across the coarctation the
angioplasty catheters were advanced over the guidewire across
the coarctationsite. The balloons were theninflated 2 to 3 times
with an internal pressure of 3-6 atmospheres. Following the
dilation sequence the angioplasty catheterswere removed and the
pressures were again measuredabove and below the coarctation.
Pre-operative systolic gradients across the coarctation site
ranged from 26 to 85mm Hg, mean 45. Immediately after the
procedurethe gradient decreased in each case ranging from 0-15
mm Hg, mean 5.6. Ineach case the procedurewas uncomplicated.
There were no signs of anydisruption of the aortic wall. The
immediately relief of the pressure gradient persisted in the 8
patients who underwent follow-up cardiac catheterizationafter
the procedure. The patients have been followed for up to 18
months following the procedure and in none has there been any
physical or echocardiographic evidence of recurrent aortic
obstruction. The method of introducingan angioplasty catheter
directly into the aorta may greatly simplify the treatment of
coarctationof the aorta for patients in whom other intracardiac
defects require repair and in small infants who because of their
size are poor candidates for percutaneous transfe.noral aortic
angioplasty.
132A ABSTRACTS lACC Vo!. 9. No, 2February19X7:132A
BALLOON DILATIONANGIOPLASTY FOR UNOPERATED COARCTATION OF
THE AORTA IN CHILDREN : 2 YEAR FOLLOW-UP AND LATE SEQUELAE.
Rubin S. Cooper,M.D.,F.A. C.C, Samuel Kitter , M.D. , F. A. C.C. ,
Robert Boxer, M. D., F.A. C.C., Ri chard J . Golinko,M.D.F.A . C. C.
Brookdale Hos pi t a l Medi cal Cent erlSUNY , Brookl yn , New York
Bal loon coa rc tation angioplasty (BCA) was perf ormed i n 7
consecuti ve pa tient s (5M,2F) ages 18 mont hs t o 18 years
(mean 9.5 yea rs) wi th isolated discrete uno perat ed coarct-
a t ion of t he ao rta. An 8 or 9 French ca t he t e r was chosen
with balloon l engths of 30 or 40 mm, an d maximuminflation
di amet e r s 1 mm less than the smal l es t measur es aortic dia-
meter determined 1 cm proximal t o th e coarctat ion site. A
10 se con d inf lat io n- de flat i on cyc l e of 6-8 a t mos pher es
(90 - 120 PSI ) was performed. The peak sys to l i c pressure
gra di ent (PSG) be fo r e BCA r an ged f rom35-70 mm Hg (mean 58
mmHg) , and i mmedi a t ely a f ter BCA decreased to 0 to 20 mmHg
(mean 7 mmHg). One year to two year fol l ow up (mean 14
months ) i n all patients revealed a PSG range of 10-30 mmHg
(mean 17 mmHg.) Repeat angiograph y was performed immedi-
atel y pr oximal to the coarctation site . 3/7 (43%)patients
had evidence of aneurysm formati on at or i mmedi a t e l y distal
t o the balloon dilatation site. One patient had coarcta-
tion restenosis. Magnetic resonance imaging was obtained
i n a l l patients from 1 t o 24 months (mea n 9.5 ) following
angioplasty and confirmed the presence of aneur ysmform-
ation a t t he ballooned coarctation s ite . One of the three
patients with aneury smformation underwent successful coar-
c t ec tomy without an y s eque l ae . Histologic s ec t ions of the
resected s egment revealed aneury smal dilatation of the
ballooned coa r c t a tion segment wi t h disruption of the in-
tima and elast ic media. Scar t i ssue or cicatrix format-
i on was s pa r s e , leaving th e th i n walled medi a covered
only by t he advent i tia . While initial re sults with BCA
were enc ouraging , current da ta ra i se s erious conc e rns
about i ts l ong term safety and effi cac y.
WHAT IS 'IHE FATE OF 'IHE TRICUSPID VALVE FOLlCMING
PALLIATIVE stJR:;ERYFOR HYroPlASrIC LEFTHEAR!' SYNDROME?
~~, J. Gregg He1ton, Beth A. Aglira, Alvin J.
Chin, John D. MLn:phy, John D. Pigott, William I.
NonJOOd, FACC, '!he Children'sHospital of Philadelphia,
Philadelphia, PA.
Forty-three survivors of palliative surgery for
hypoplastic left heart syndrome urrlexwentpulsed Doppler
examinationof their tricuspidvalve a mean of 1. 7 months
after palliation (range 1 day - 17 months). The degree
of tricuspidregurgitation(TR) was graded as none, mild,
noderate or severe on the basis of mapping of the
regurgitantjet.
'!he preoperative (preop) ampostoperative (postop)
TR data is sunmar.izedin the table below.
mIDP
P I NONE MIlD I MJD 1SEVERE I'IOI'AL
o INONE 11 5 I 3 , 0 , 19
S 'MIlD 4 5 I 2 , 0 ! 11
T 'MJD '2 5 ! 3 , 2 ! 12
o 'SEVERE' 0 1 I 0 , 0 ! 1
P I'IOI'AL' 17 , 16 I 8 I 2 I 43
'lhirty-six patients (84%) have urrlergone multiple
postop I:bWler examinations. '!he mean time from first
postq:J to last postop study was 3.5 months (range 9 days
to 12 months). 'IWenty~ patients have the same degree
of TR on theirmost recent echocardiogramas their first
postq:J echocardiogram;only 1 patienthad a 2 degree
Increase amonly 3 patients had a 2 degree decrease in
their TR.
summary: only 8 out of 33 survivors (24%) with mild or
no TRpreop developed nroerateto severe TR postop, am
only 5 out of 10 survivors (50%) with moderate to severe
TR preop had mild to no TRpostop. '!he severity of TR,
once detected postop, appears to be relatively stable
over the 1st year.
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MECHANISMS OF INOTROPIC AND LUSITROPIC ACTION OF DPI
201· 106 IN MAMMALIAN MYOCARDIUM.
Yasuk i Kihara. M.D. , William Grossman, M.D. , F .A.C.C.,
James P. Morgan, M.D. , Ph .D., F.A.C .C. , HarvardThorndike
Laboratory , Beth Israel Hospital, Boston, Massachusetts
DPI i s a newl y introduced agent for t he treatment of
heart failure that has positive inotropic and negative
lusitropi c actions. We tested the hypothesis that the 2
actions of DPI are due to changes in intracellularCa+
handling, by use of aequorin, a ph~~oprotein that emits
light (L) when it combines with Ca . Papillary muscles
of <l mm diameter were isolated from ferrets (F,n-9) and
guinea.pigs (G,n-5), perfused in a physiologic salt solu·
tion at 300 C and stimulated at 0 .33Hz . Aequorin was
loaded chemically; L and isometric tension (T) were
simultaneously recorded. DPI inc:,ased bot~5peak Land T
in a dose·dependent manner (3xlO to Ix 10 M) . ~n the
presen ce of DPI , any given level of L (i .e . ICa+ ]i )
produced more T than in the absence of DPI , sugg~2 t ing a
sensitization of the.gontractileapparatus to Ca .
Tetrodotoxin (TTX;lO M) decreased both L and T after
DPI , but did not reverse the sensitization. I n G, bu t not
in F, DPI prolonged relaxation of T which was acc ompanied
by t he appearance of a second component in L (L'). 2
prolongation and L' wer e enhanced by ~gcreased [Ca+ Jo
and abol i shed . gy TTX or ver apami l ( 10 M), bu t not by
r yanodine (10 M) . We conclude that: 1) The positive
inol 20pic action of DPI is ?~e i n part t o ~n increase in[Ca Ji, mediated by Na+/Ca exchange (Na channel
agoni s t ) and all2 to a sens i t ization of the contractile
apparatus to Ca ; 2) T prolongationappe~2s to be
mediated by increased transsarcolemmalCa influx vi a
voltage·dependentchannels; 3) Responsiveness to DPI' s
lusitropic action var i es among species .
DOES DIGOXIN ENHANCE EXERCISE LEFT VENTRICULAR FUNCTION
IN PATIENTS WITH CONGESTIVE HEART FAILURE?
Jerome L. Fleg, M.D•• F.A.C.C., Benjamin Rothfeld, M.D.,
Jeanette Wright, Sheldon H. Gottlieb, M.D., and Edward G.
Lakatta, M.D., Gerontology Research Center, National
Institute on Aging, NIH, and Franc1s Scott Key Medical
Center, Baltimore, MD
The ability of cardiac glycosides to improve left ventri-
cular (LV) systolic function during exercise (EX) in
patients with compensated congestive heart failure (CHF)
is controversial. Ten ambulatory patients ages 46-70
years in sinus rhythm with chronic stable CHF due to
ischemic heart disease (rHD) and LV ejection fraction
(EF) <50% underwent gated radionuclide angiography during
maximal upright bicycle EX after 4 weeks of digoxin
Iplacebo administered in a randomized double-blind cross-
over protocol. Maximal heart rate (MHR, beats/min), peak
systolic blood pressure (PSBP, nnnHg). resting EF
(EFr est)' peak EF (EF eak) and max workload (MWL. watts)were as follows: p
Digoxin Placebo Difference P
MHR 131+21 132+18 1+10 is
PSBP 177+25 165+21 11+12 <. 05
EF 32+12 29+12 3+6 NS
EFr es t 32+8 27+9 5+6 <.05
MWfeak 75+32 75+28 0+12 NS
ThUS, in ambulatory patientS-in sinus rhythm with stable
CHF due to !HD, maintenance digoxin modestly improves
EF k despite a higher PSBP but does not alter overall
en83~ance capacity.
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ffiCREASED 10XICITY Wr ffi A NEW SEMISYNIl:IETICCARDIAC
GLYCOSIDE: CCMPARISCt-l WITH DIGOXIN
Bennett J. Shatkin, M.D., Rita D. Swinford, B.S.,
Teresa A. snttn, EdwardJ. Brown, Jr., M. D.,
F.A.C.C, Peter F. Cohn, M.D. , F.A.C.C., SUNY
Health SCiences center, Stony Brook, New York .
Despite a high incidence of toxicity, digoxin
continues to be widely used in the treatmentof
patients with heart disease. we studied a synthe-
tic digitalis glycoside (D-37) that appears t o have
a superior t oxic/therapeuticratio when canpa red t o
digoxin. ~n ches t anesthetized dogs rece ived a
cons t ant i nt ravenousinfusion of either digoxin (25
ug/ min) (n=7) or D-37 (100 ug/min) (n=7) or D-37
(100 ug/min) (n=7). A left vent ricul ar micromano-
meter-tippedcatheterwas used for constant
measurement of pressure and dP/dt. Heart rate was
kept cons t an t with right atrial pacing. The right
ventricle was scanned for repeti t ive ventri cular
response (RVR) at 5 minute intervals during the
infusion periods until the appearanceof RVR. The
maximun %dP/dt increase over baseline (dP/dt-MAX)
was not different in digoxin (103+22%) and D-37
(62+9%) groups , p=NS. All digoxin dogs terminated
with sustained ventriculartachycardia. The total
dose of D-37 infused was 1167+148 ug/kg . The total
digoxi n dose was 145+16 ug/ kg-: In di goxin animals
RVR occur red at 78+10% of dP/dt-MAX dose. In D-37
animals RVR occurredat 123+25% of dP/dt-MAX dose.
Thus, D-37 appears to have s imilar inotropic
properties but less cardiac t oxicity when canpared
t o digoxin.
DIRECT VASOD ILATORY ACT IONOF AMR INONE DEMONSTRAT ED IN
CALVES WITH ARTIFICIALHEARTS
Freda rick L. Gobe l , M.D., F.A.C.C., Char le s R.
Jorgensen, M.D., F.A.C.C., Susanne K. Roe ller, R.N. ,
Pharm.D., J im List, B.A., Lyle D. Joyce, M.D . , F.A.C.C. ,
Kristen E. Johnson, R.N. and Irvin F. Goldenberg, M.D.,
Minneapolis Heart Institute Foundation, Minneapolis, MN.
In the i nt act animal it is di f f i cult to as se ss th e
effects of anr i none (Am) on systemic and pu1nnnary
vascular re sist ances . To as sess whether Am has
vasodilatory propertie s on either t he systemic or
pulmonary vascul atu re , westudie d 3 unanes t heti zed ca l ves
after rep lacement of th ei r natural hearts wi t h a
pneumati cal ly- dri ven ar t i fic ial heart (AH) . Am was
administered as two 0.7 5 mg/ kg bol uses and th en a
contin uous i nf usi on (10 mcg/ ky/rrrtn). Despite unchanged
CD (cardi ogreen i ndi cat or di lution curves 12. 3 + 1. 3 to
12.5 + 1.4 L/rrrtn, mean + SE) and stroke volume TI06 + 9
to 107.:. 11 ml) there was a reduction of systemic -- 5
vascular resistance (530 + 67 to 422 + 47 dyne-see-cm
p<D.D5), pUlmo~~ry artery-resistanceT259.:. 31 to 205.:.
19 dyne-see-cm ,p<0.06 ) , mean pulmonary ar t ery pressure
(39 + 1 t o 31 + 1 mm Hg, p<0.05) and mean aor t i c pre ssu re
(99 + 7 t o 81 + 5 mm Hg , p<O.0 5) i n all ca lves. There
were-no s i gnifTcant changes i n either left atria l (13 + 3
to 14 + 1 mm Hg ) or r i9h t atrial (19 + 6 to 17 + 5 mm Hg)
pressures. This data i ndi cat es t hat c alv es with AH and
thus unchanged i not ropic state respond to Am by
decreasing systerrrtc and pulmonaryresistances. Thi s data
supports the hypothesis that Am exerts a di rect
vasodilatory ef fect on both t he pulmonary and syst emi c
vascul at ure . Theresults of t his study a l so docume nt the
value of the calf AH model as a means of asses s i ng the
peripheral vasc ul ar actions of i not ropic dru9s .
ll- ADRENERGI C RECEPTOR-Gs Il-.'TERAC'I'ION I NPHOSPHOLIPID
VESICLES
I&iiJl~~ ~.E.h.Jlv Elliott N. Ross, Ph.D., Univer-
s ity of Texas Health Science Center , Dallas, Texas
il-Adrenergic (~AR) st.Lrnul.ati.on increases intracellular
cyclic AHP via the activation of Gs' the stimulatoryGTP
binding protei n of adenylate cyclase. Gs-GTP, the active
species, is inactivated by hydrolysis t o Gs-Q)P through a
receptor independent s t ep. In order to study the mecha-
nism of ilAR- ca t alyzed GTP binding, both proteins were
purified and reconstituted by gel filtration into phospho-
lipid ves i cles . The ves i cl e composition was 60%PE/40% PS
Uipid:protein ratio was approximatelyjgO:l). Isopro-
terenol (ISO) st imulat ed the bi1ding of [ Sl-GTPyS to Gs
10-15 f old (ka = 0.3-0.5 min - at 30
oC) and multi pl e Gs
molecules wereP~ctivated ~r receptor. Vesicles preincu-
bated with 10 ~l~1 ISO (0 C, 2 hr) pri or t o addition of
GTPyS demonst rat edbiphas i c nucleotide finding. The ini-
tial "burst"was rapid (ka > 5 miri" at 30°C) and its
extent was proportional to ~e receptor number (burst:re-
ceptor ratio - O.~0.8). The terminalphase was slower
(ka 0.3-0.5 min" at 30
oC). ISO pre-treatmentup to 24ho~ did not increase the burstfraction. At OoC, bot~
phases of the react i on were slored [ka (burs t ) 1-3 min-kaPn.~terminal) 0.03 -0.05 min" l. Tti~~ for ISO was 1
x IO H. The Kd for GTpys was ()-15 x 10 s . For mat I on
of the burst complex was competiti vely antagonized by
al pre nolol. The burst of nucleot i de bi ndi ng gemonstrite<1
bimolecular r eaction ki ne t i c s (k2 = 3.3 x 10 Wmin- at
OoC). These dat a suggest: 1) an If-R-Cs complex is for med
by pre-treat ment with ISO, 2) the nucleotide-free G ra -
pidly binds GTpys as a bim ol ec ular reacti on, and 3Y t he
bi nding of nuc l eot i de to Gs releases IJ-Rto recycle to
other Gs molecul es .
QUANTITATIVE AUTORADIOGRAPHIC DELINEATION OF B- ADRENERGIC
RECEPTORS IN HUMAN VENTRICULARMYOCARDIUM
Sidney Murphree, M.D., James Baker , andJeffre y Saf f i t z ,
M.D., Ph.D., Washing ton Universi ty , St. Louis , MO
Dimini shed myocar di al B- adr ener gi c re ceptor (BAR) density
may be impor t ant in t he pathogenesis of seve r e heart
failure. BAR dens i ty has been measured pr eviously in
membranes prepa red fromhomogenat es of human heart but
this approach precludes analysis of BARdist r ib ut ion i n
specif ic component s of t heheart such as vessel s and myo-
cyt es . Thus, we charact erized bind i ng of [125Iodo]cyano-
pindolol (ICYP) t o t ransmura lslices of LV obt ai ned at
car di ac t ransplant at i on in 4 pt s with coronary artery
disease . LV se cti ons were i ncubated with 0. 3 t o 60 pM
ICYP ± 1 ~M I- propranolol for 60 to 180 min a t 37°C.
Speci f i c bi ndi ng ratios >95%were achieved after se l ect-
iv e removal of nonspe cificall y bound ICYP byrinsing
se ctions for 30 t o 60 min at 22°C. Specific bi ndi ng was
rapid, saturab l e , of high af f i ni t y and exhi bi t edstereo-
specif i ci t y and the r ank order of pot ency expect ed of
BAR (Ki = 1.3 and 168 nM, 1- and d- pr opr anolol; .067 and
3.8 ~M , 1- and d-isoproterenol; 1. 2 and 38 wM, 1- and d-
norepinephrine, re s pectivel y). Among the 4 pts, Kd was
uni form (13. 6 ± 2. 1 pM) but Bmax varied wi dely (11.8 ±
0.4 t o 25.7 ± 3.5 fmol/mg tissue pr ot e in ) and was in-
versely pr opor t i onal t o t heseverity of heart failure.
BAR were l ocalized autoradi ographically in sections i n-
cubat ed wit h 3. 3 or 10. 4 pM ICYP. Epicardial conductance
arte ries had a low BAR densi t y (20-4 0% of myocyte BAR den-
si t y) whereas the res i s t ancearterioles had a greater BAR
dens i t y (60-90% of myocyte dens i t y) . Specific grain den-
si ties of myocytes varied in proportion t o Bmax det er-
mined in binding i sot herms. With t hese methods , BAR can
be l o c a l i z e d qua n t itative l y in cardia c biopsie s permi t -
ting l ongitudinal studies i n pts with heart failure.
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CHARACTERISTICSAND DISTRIBUTION OF SARCOLEMMAL AND
INTRACELLULAR (3 -RECEPTORS IN NORMAL HUMAN MYOCARDIUM.
A.R. Denniss, M.D., W.S. Colucci, M.D., F.A.C.C., P.D.
AlIen, M.D., J.D. Marsh, M.D., F.A.C.C. Departmentsof
Medicine and Anesthesia, Brigham andWomen's Hospital
and HarvardMedical School, Boston, MA.
ISO binding in both SL and ICmodelled best to a single
affinity state. Conclusion: In normal human LV, 6% of
total BAR are IC. These BAR are uncoupled from
adenylate cyclase, but have agonist binding properties
similar to SL BAR. The IC BAR may comprise spare BAR
which can be rapidly inserted into or removed from SL
during agonist or ischemia-induced BAR regulation.
To determine whether uncoupled intracellular(IC)
~ -adrenergic receptors (BAR) exist in human heart, we
studied the characteristicsand distributionof IC and
sarcolemmal (SL) BAR in LV myocardium from 5 young
adults without LV dysfunction. SL and IC (light
vesicle) fractions were preparedby 40000 g and 108000 g
centrifugation, respectively. The SL marker Na/K ATPase
was enriched in SL fractions and absent in IC fractions.
Agonist and antagonist binding propertieswere assessed
by computer modelling of isoproterenol (ISO) - 1251-
pindolol (IPIN) displacement curves. Of total BAR, 6%
(range 4-8%) were IC andthe rest were SL. Antagonist
affinity was similar for SL and IC (SL~ IPIN = 18 ± 5
pM, IC ~ = 21 ± 5 pM). Other propertieswere as
follows \X ± SD; *p<O.Ol vs. basal):
* = P<O.Ol comparedto 0 h and placebo.
Data showthat 1) plasma IS-5MN concentrationswere nearly
double after 40 than after 20 mg dose and 2) single oral
doses of 20 and 40 mg IS-5MN reduced standing systolic
blood pressure and increased exercise time to the onset of
angina and total exercise duration at 2 and 6 h post-dose.
Thus, oral IS-5MN is an effective antianginalagent and
exerts effects for at least up to 6 hours.
IS-5MN 40mg
Oh 2h 6h
0.0 551 376
133 109* 116*
3.7 6.2* 5.8*
4.9 6.8* 6.5*
IS-5MN 20mg
Oh 2h 6h
0.0 300 144
140 118* 123*
3.8 5.9* 5.1*
5.1 6.7* 6.3*
Placebo
Oh 2h 6h
0.0 0.0 0.0
143 138 134
4.2 4.6 4.2
5.2 5.6 5.2
DURATION OF EFFECTS OF ISOSORBIDE-5-MONONITRATEIN ANGINA
PECTORIS.
Udho Thadani, M.D., FACC, Rajesh Prasad, M.D., Stephen F.
Hamiltin, PharmD., WyattVoyles, M.D., FACC, Ralph Doyle,
BA, Serge Karpow,PharmD, Robert Reder, M.D., Stephen M.
Teague, M.D., FACC, OUHSC - Oklahoma City, Oklahoma.
Isosorbide-5-Mononitrate(IS-5MN),an active metabolite of
isosorbide dinitrate, is nearly 100% bioavailable after
oral administration.In a double-blind, crossover study,
the duration of effects of single oral doses of 20 and 40
mg of standard formulation of IS-5MN were compared to
those of placebo in 12 male patients with angina pectoris.
Patients were studied before and at 2 and 6 hours(h) post
drug on three separate days. Mean values for plasma IS-5MN
concentrations(PC),systolic blood pressure(SBP) in the
standing position at rest, exercise time to onset of
angina(Pl) and total exercise time to angina of moderate
severitY(P2) in minutes were:
PC (ng/ml)
SBP (mmHg)
Time to PI
Total Ex Time
Adenylate cyclase
(% stimulation)
GPP + Iso Forskolin + Mn
420 + 90* 510 + 150*
o :+ 20 100 :+ 100= •
~ ISO
(nM)
390 + 146
166:+ 91-
BAR density'
(fmol/mg
protein)
SL 11 ± 7
IC 9 + 2.
RECONSTITUTIONOF MUSCARINIC CHOLINERGIC INHIBITION OF
ADENYLATE CYCLASE ACTIVITY IN EMBRYONIC CHICK HEART.
Bruce T. Liang, M.D., Jonas B. Galper, M.D., Brigham and
Women's Hospital, Harvard MedicalSchool, Boston, MA.
Responsiveness of embryonic chick heart to sympathetic
and parasympatheticstimulation develops non-coordinately.
We have previously shown that the development of coupling
of muscarinic receptors (MR) to inhibition (I) of adeny-
late cyclase (AC) in embryonic chick heart was associat-
ed with an increase in the levels of 39 and 41 kilo-
dalton GTP-binding proteins between 3 1/2 and 10 days
in ovo. In the present study, we showed that an in-
crease in the levels of these two proteins were respon-
sible for the development of the coupling of MR to I of
AC. Mixing of homogenates of hearts 3 1/2 days in ovo
with chick heart membranesresulted in a two-fold increase
in the maximal I of AC by carbachol and a 10-fold in-
crease in the sensitivity of carbachol I of AC. Pre-
treatmentof chick heart with pertussis toxin which
inactivated the GTP-binding proteins abolished I of AC,
formation of high affinity MR in chick heart and blocked
the ability of chick heart membranes to reconstitute
muscarinic I of AC in hearts 3 1/2 days in ovo. Covalent
inactivation of MR and AC did not affect the ability of
hatched chick heart to restore muscarinic I of AC, ruling
out any role for MR or AC from chick heart in
reconstitution. I of AC (pmol/mg/min;n=5, ! SEM)
3 1/2 Days heart 19.7 + 3.6
Mixed with hatched heart 36.7 +3.8
Mixed with pertussis toxin- 15.4 + 3.2
treated hatched heart -
Hence: 1) Early in embryonic development coupling of MR
to I of AC is limited by the availability of GTP-binding
proteins; 2) Embryonic chick heart may be an analog to
Cyc- mutant of the s49 lymphoma cell and a model for
studying I of AC.
RECEPTOR STIMULATED ACCELERATION OF PHOSPHATIDYLINOSITOL
RESPONSE ENHANCES ATRIAL NATRIURETIC POLYPEPTIDE RELEASE
IN ISOLATED ADULT RAT ATRIAL MYOCYTES
Mitsuo Ohni,M.D.,JunichiHayashi,M.D.,YoshihikoSato,M.D.,
Toshio Tohno,M.D.,HideharuManabe,M.D.,TadashiKoide,M.D.,
Hiroshi Ebisu, Hideaki Sato,M.D. and Yoshio Watanabe,M.D.,
F.A.C.C.,FujitaGakuenUniv.,Fukuyu H.,Kyorin Univ.,Japan.
To define transmembraneand intracellular mechanisms of
production/release of atrial natriureticpolypeptide(ANP)
in the absence of mechanical atrial stretch, we studied
direct effects of acetylcholine(A), isoproterenol(I),
methoxamine(M) andvasopressin(V) on adult rat atrial myo-
cytes. Viable atrial myocytes isolated with enzyme perfu-
sion were unstained by trypan blue, and showed electron-
dense granules under electron microscope. These myocytes
were maintained in Eagle's minimum essential culture
medium at 37°C, pH 7.4. After one hour incubation without
(C-gr) or with drugs at 10-GM(L-gr) or 10-4M(H-gr),
released ANP (ANPo) and intracellularANP(ANPi) were mea-
sured by radioimmunoassay. Under A, ANPo in L-gr(319±102
pg/lOO myocytes (mean±SD)) and in H-gr(421±112) were sig-
nificantly higher than in C-gr (244±80)(p<.OS, n=6) with a
dose-dependent increase. ANPi was decreased in H-gr(3SS±
84) compared to L-gr(426±120) and C-gr(49S±lS8) (p<.OS,
n=6). Under M, ANPo was increased from 285±70(C-gr) to 401
±82(L-gr) and 485±140(H-gr)(n=6,p<.05). Under I and V, as
well as under three different culture medium osmolalities
(280, 380 and 480 mOsm) , neither ANPo nor ANPi was affec-
ted(n=6). Atropine and prazosin blocked the aforementioned
effects of A and M, respectively. Conclusions: l)Stimula-
tion of al receptors by M and muscarinic receptors by A
enhances ANP release, but may not affect intracellularANP
production; 2)Phosphatidylinositolresponse appears to be
a common pathway for the A and Maction in the stimulus-
secretion coupling in adult atrial myocytes.
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ANCROD ENHANCES THE THROMBOLYTIC EFFECT OF UROKINASE AND
RECOHBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR.
Bojan Cercek, MD, Hanoch Hod, MD , Allan S. Lew, MD,
Juliana Vano, Nagendra K,N . Reddy, PhD, William Ganz, MD ,
CSc, FACC. Cedars-Sinai Medical Center, Los Angeles.
Incorporationof fibrin i nt o the thrombus continues dur -
ing thrombolytic treatment and may delay thrombolysis . In
this st udy we examined whetherpretreatmentwith ancrod,
a purified protein fraction of Malaysian pit viper known
to prevent thrombus growth by depletion of fibrinogen,
enhances thrombolysis. One hour old thrombi of simila r
weight (64±33 mg , range 28-103), induced by a copper coil
in the carotid arteries, were inserted into the femoral
arteries of t he same dogs. Five thrombi in each group
were exposed for IS min to I) a 7 U/kg bolus of ancrod
and 2) a 25,000 U/kg bolus of urokinase (UK) or 3) to a
10 mcg/kg/min infusion of recombinant t is sue-type plasmi -
nogen act ivato r (rt-PA) , the latter 2 groups either with
or without pretreatmentwith a 7 U/kg bolus of ancrod.
The residual thrombi were then removed, we ighed and the
percent lysi s of the initial thrombus was calculated.
Ancrod UK Ancrod+UK rt-PA Ancrod+rt-PA
%Lysi s : 17+3 17+17 73+13 28+7 68+12
- - p<.OOI - - p<.OOl -
Ancrod depleted f ibrinogen to 7±5% of control but did not
increase plasmin level s ,which were 110+13%of the cont-
rol . FollowingUK and rt-PAfibrinogen decreased to only
78±12%and 81±14%of control . Conclusion: In dogs, pre-
treatment with ancrodmarkedly enhances the thrombolytic
effect of both urokinase and recombinant tissue-type
plasminogen activator. This enhancement is not due to
activation of plasminogen but is probably due to deplet -
ion of fibrinogen which prevents new fibrin incorporation
into the thrombus during lysis.
113 (N-6)
1.1+.09
1.9+.39
1.4+.29*
330+54
350+45**
112 (N=19)
1.5+.11
2.4+.32
2.4+.32*
470+25
450+21**
INTRAVENOUS CYCLOSPORINE IMMUNOSUPPRESSION FOR CARDIAC
TRANSPLANTATION. Robert W. Stewart, M.D ., F.A.C.C. ,
Gustavo Rincon, M.D., F.A.C.C., Robert E. Hobbs, M.D.,
F.A.C.C., GeorgeE. Drogomir, LeonardA.R. Golding, M.D.,
F.A.C.C., Cleveland Clin icFoundation, Cleveland, OH.
Thirty-two orthotopic cardiac transplants performed
between 8/84 and 8/86 received intravenous cyclospori ne
(CYA) for immunosuppressionin addition t o cor t i cos te r-
oids and azathioprine. Group 1 rec eiv ed bolu sIV CYA
ini tiated pre-transplant, Group 2 were given cont i nuous
IV CYA, al so begun pre-transplant. Group 3 received con-
t inuous IV CYA begun immediate ly post-transplant. Whole
bl ood CYA l evel s were measured dai ly usi ng hi gh perf or-
mance liquid chromatographand the dosage of CYA regulat-
ed accordingl y.
Endomyocardial biopsies were performed at least week-
ly, with rej ection being diagnosed by the pres ence of a
l ymphocyt i c in fi l t ra te in conj unction with evi dence of
myocyte inj ury.
GROUPS '1 (N-7)
Cr.(mg/ml) Pretransplant1.4+.17
Cr.(mg/ml) PO '3 3.0+.39
Cr.(mg/ml) PO ' 5 2.9+.70
CYA level (ng/ml) PO'l 350~46
CYA level (ng/ml) PO #3 300+38
Cyc losporine dose (mg/kg/day)
Avg. PO #1,'3,'5 4:6+.56 3.0+ .19 2.8+. 52
Values - Mean + SEM - *p <.05 **p - .05
Azotemia re~iring dia lysis occurred i n 1/ 7, 3/19
and 0/6 i n Group 1, 2,3 respectively (p>.l betwee n groups).
Rejection occur red in 3/7 , 5/1 9 and 3/6 ( p>. l between
groups) .
CYA giv en as a continuous intravenous infusio n begun
post-transplant offers adequate immunosuppress ion when
adjusted to maintain bloodlevels of 350 ng/ml and allows
rapid returnof renal function topre-transplant values.
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A RANDOMISEO PLACEBO-CONTROLLED,DOSE-RESPONSE STUDY WITH
THE THROMBOLYTIC AGENT APSAC (BRL 26921) IN ACUTE CORONA-
RY ARTERY OCCLUSION.
APSAC RESEARCH GROUP presented by AlainLEIZOROVICZ,M.D~
Unite de PharmacologieClinique, Hopital Neuro-Cardiolo-
gique, Lyon, F~NCE.
OBJECTIVES : The objective was to determine the dose-
response relationship of APSAC by means of a between-
groups double blind comparison of t he new agent and pla-
cebo.
DESIGN : .50 patients with symptoms of acute M.I . of l ess
than 6 hours duration andwhose coronary artery occl usion
had been confirmed by coronary angiographywe re randow.ly
allocated to 5 treatmentgroups (15,20,25 ,30 units APSAC
and placebo) andtreatmentwas given as an I.V. injection
over 2 minutes. Angiography was performed again at 15,30,
45,60 and 90 minutes and the films were assessedcentral-
ly by 2 independantcardiologists. 4 patients were exclu-
ded from the analysis because their angiograms revealed
patent arteries before APSAC was administrated and 1 pa-
t ient was excluded becausestreptokinase had been infused
just after randomi sat ion because of cardiogenic shock.
RESULTS: Clini cal and l aboratory examinations car ri ed
out for 72 hoursafter treatment showed that the drug was
well tolerated . The reperfusionrate was as follows
UNANTICIPATEDEFFECTS OF ASPIRINON LYMmOKINES.
JudithHsia. M.D. , an::lAllan L. Goldstein, !'h.D., George
Washin:JtonUniversity, washinjton, DC
Use of aspirin in patients with coronary disease may
have previously unrecognized effects on the iJmume
response. We studied the effects on gamma interferon
(Irn) prcxiuction by hUllaIl periFheraJ.blood lyn'qXlocytes
(PBL) of aspirin an::l thyrrosin fraction 5 (TFS), a bovine
thymic extract. PBL were incubated for up to 72 hours
with Iilytahemagglutinin, 1 ugjml, with or without
aspirin an::l TF5. IFN in the supernatantswas measured
by radioiJranunoassay;interleukin-2 content; was measured
in a bioassay using interleukin-2-depen:l.entCI'-6 cells.
IFN productionby PBL was stimulatedup to 3-fold during
incubation with aspirin; IFN levels peaked at 72 hours.
TF5 stimulated IFN production by mitogen-activated PBL
to a silnilar extent, but highest levels were observed at
24 hours. IFN productionwas not increased by TF5 i f
PBL were not previously mitogen-activated. stimulation
by aspirin an::l TF5 was additive an::l dose deperrlent.
Non-acetylatedsalicylate was ineffective. Mitogen-
stimulatedIFN productionwas attenuatedin macrophage-
depleted PBL, an::l stimulation by aspirin an::l TF5 was
abolished. PBL were preparedfran blood obtainedbefore
an::l after oral aspirin, 325 ng. IFN production was
increased 3-fold 24 hours after aspirin ingestion, an::l
reverted to baseline by 72 hours. In contrast, inter-
leukin-2 production by PBL was optilral 10 hours after
aspirin ingestion an::l returnedby baseline by 24 hours.
conclusion: 1) aspirin an::l TF5 stimulate IFN produc-
tion by PBL in vitro 2) a single dose of oral aspirin
in:::reased production of both Irn an::l IrrtezIeukin-z.
AspirinI s protective benefits in patientswith coronary
disease may be due in part to its inmmorequlatory
effects.
DOSE
NO.
PLACEBO
O(g
15
5/8
20
5/9
25
7/10
30
5/9
CONCLUSION Reperfusionwas achieved in 61.1 %of trea-
ted patients but no dose relationship was revealed.
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LACK OF ANTITHROMBOTICEFFICACY OF HIGH DOSE ASPIRIN
RELATIVE TO LOW DOSE ASPIRIN IS RESTORED BY PGI2 INFUSION.
Jules Y. T. Lam, M.D., F.A.C.C., James H. Chesebro, M.D.,
F.A.C.C., Valentin Fuster, M.D., F.A.C.C., Mt. Sinai Medi-
cal Center, New York, NY, and MayoClinic, Rochester, MN.
Although aspirin (ASA) is an effective platelet inhibi-
tor and a potent antithrombotic agent in vivo, its effi-
cacy may be related to the administered dose. The
potential for inhibition of vessel wall cyclooxygenase and
prostacyclin (PGI2) production by high dose of ASA may
limit its usefulness.
To assess the antithromboticefficacy of ASA and its
potential for PGI2 inhibition, the effects of low dose ASA
(ASA-Lo, 1 mg/kg/d x 3 doses), high dose ASA (ASA-Hi, 20
mg/kg/d x 3 doses), a combination of ASA-Hi and PGI2
infusion (50 ng/kg/min), and the same PGI2 infusion alone
were evaluated in heparinized normal pigs undergoing
arterialwall injury by balloon angioplasty (5 inflations
to 6 ArM for 30 seconds, 1 minute apart) of the common
carotid arteries. The last dose of ASA was given 1 hour
before angioplasty, and PGI2 infusion was started t hour
before angioplasty and continued until animal sacrifice.
The animals were sacrificed immediately after angioplasty,
and the quantitative lllIn-labeled autologous platelet
deposition (PD x 106/cm2) at the site of deep arterial
injury is shown below (p values compare with control):
Control ASA-Lo ASA-Hi ASA-Hi+PGI2 PGI2
n 21 11 9 6----g-
PD 63.0%13.0 19.9%8.0 61.0%20.0 23.9%5.2 60.2
p <0.05 NS <0.02 NS
Thus, in this model, PGI2 and ASA-Hipotentiate each
other; the lack of antithromboticefficacy of high dose
ASA relative to low dose ASA can be restored by PGI2
infusion. The mechanism of this potentiation is unclear.
RESTORATION OF CORONARY BLOOD FLOW BY PEPTIDE 6A IN A
CANINE MODEL OF INTRACORONARY THROMBUS.
Wilmer ~ Nichols, Ph.D., F.A.C.C., Jawahar Mehta, M.D.,
F.A.C.C., David C. Lew, M.D., and Tom Saldeen, M.D.,
Ph.D.. VAMC and the University of Florida, Gainesville,
Florida, and the University of Uppsala, Uppsala, Sweden.
Intracoronary thrombi resulting in myocardial ischemia
can often be lysed by thrombolytic agents, such as tissue
plasminogen activator (t-PA). We examined the potential
of a fibrinogen-degradationproduct pentapeptide6A (Ala-
Arg-Pro-Ala-Lys), which causes marked increase in
coronary blood flow and stimulates prostacyclin release
(Am J Physiol 249:H457, 1985), in lysing experimentally-
induced thrombus in the canine coronary artery. In
anesthetized mongrel dogs, thrombus in the circumflex
coronary artery was induced by electrical current (Thromb
Res 17:841, 1980). After stable zero blood flow for five
minutes without electrical current, t-PA (10 ug/kg/min
for 30 minute intravenously) or peptide 6A (5 umoles/min
for 20 min intracoronary)were administered. Infusion of
t-PA restored coronary blood flow (peak 22±12 ml/min,
mean ± SD) in 5 of 7 animals. The time to flow
restoration was 12.3±9.1 minutes and the reflow
persisted for 20.0±10.9 minutes. Peptide 6A
administration also restored coronary blood flow (peak
20±4 ml/min) in 7 of 8 animals with zero flow. Mean time
to blood flow restoration(4.3±2.9 minutes) was shorter
(P' 0.05) than with t-PA, but the reflow persisted only
for the duration of the infusion (16.3±10.2 minutes).
Peptide 6A administrationwas associated with a marked
increase in plasma 6-keto-PGFlaindicating stimulation of
prostacyclin release as a mechanism of action of this
peptide. This study demonstrates that peptide 6A exerts
coronary thrombolytic effects comparable to those of
t-PA in a canine model of coronary thrombosis.
EFFECTS OF EICOSAPENTAENOICACID (EPA) ADMINISTRATION ON
PLATELET AND NEUTROPHIL FUNCTION, AND EICOSANOID BIOSYN-
THESIS IN CAD.
Jawahar Mehta, M.D., F.A.C.C., Paulette Mehta, M.D.,
Larry M. Lopez, Pharm. D., Mary Beth Ward, andDaniel
Lawson. University of Florida, Gainesville, Florida.
Platelet and neutrophil function may relate to coronary
atherogenesis and myocardial ischemia. It has been
suggested that omega-3 fatty acid EPA could alter the
course of CAD by suppressing platelet and neutrophil
function as well as eicosanoid biosynthesis. We
administeredEPA (3.2 g/day for 4 weeks) or placebo to 8
patients (pts) with CAD in a randomized double-blind,
cross-over fashion over a 12 week period. Changes in
platelet aggregation (PAg), neutrophil function
(aggregation with ionophore A23187, chemotaxis with f-MLP
and LTB4), platelet and serum TXB2 formation
(radioimmunoassay), and neutrophil LTB4 biosynthesis
(HPLC) were quantified. With EPA therapy, platelet and
neutrophil count decreased 8.2±2.2% and 19.8±5%,
respectively (P;NS). PAg in response to epinephrine and
collagen decreased in three subjects. Neutrophil
aggregation and chemotaxis functions decreased in all
subjects (P' 0.05). Whole blood and platelet TXB2
formation decreased 45±6 and 44±12%, respectively, while
neutrophil LTB4 formation declined 23±2% (all P , 0.02).
Although, the angina frequency (2.4±0.9 vs. 2.9±0.9
episodes/week) and NTG consumption (1.7±0.8 vs. 3.2±1.1
tablets/week) were unchanged by short-termEPA therapy,
HR and BP were significantly (P'0.05) decreased. These
data indicate that therapy with EPA rapidly causes
potentially beneficial effects on platelet and neutrophil
function, and indices of myocardial 02 demand in CAD pts.
These alterations over a long-term may alter the natural
history of CAD.
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EFFECT OF PLATELET ACTIVATING FACTOR ON THE ISOLATED
GUINEA PIG HEART.
Btanley R. Jolly, Ph.D., East Carolina University School
of Medicine, Greenville, North Carolina.
Platelet activating factor (PAF) induces significant
vasoconstriction and an associated negative inotropic
effect in the isolated guinea pig heart, but it is not
clear whether PAP has direct actions on cardiac muscle
or produces these effects indirectly. This problem has
been examined in Langendorff-perfused hearts and in
isolated atrial tissue. In paced hearts per fused at
constant pressure, PAF, 0.5-50 08, produced dose-
dependent reductions in flow and left ventricular
developed pressure (LVDP). These doses gave an effective
PAF concentration of 0.1-10 nM. PAF was comparable in
potency and efficacy to vasopressin as a vasoconstrictor
and more potent and active than the peptidoleukotrienes.
In isolated atria, however, PAF 1 nM had no effects on
right atrial rate or left atrial force. At 10 nM, PAF
tended to increase both rate and force, suggesting that
negative inotropism is an indirect effect. To determine
whether flow changes were also indirect, PAF was
examined during infusion of antagonists. During infusion
of vehicle (ETOH 0.01 mlZmin) PAF, 12.5 08, reduced flow
by 71% (and LVDP by 72%). During infusion of the PAF
antagonist triazolarn, PAF reduced flow by 36%, a
significant inhibition. The cyclooxygenase inhibitor
indomethacin, 75% fall, and 5-lipoxygenase inhibitor/-
leukotriene antagonist REV 5901, 71% fall, were ineffec-
tive (n = 5 per group, the test dose 20 ug/min gave
-3uM). Thus, PAF may st imul ate thromboxane and leuko-
triene production, but these are not the primary cause
for reduced flow. PAF may stimulate production of a
novel mediator or may have direct vascular effects in
the guinea pig heart.
lACC Vo!. lJ. No. 1
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THE VASOACTIVE INTESTINAL PEPTIDE RECEPTOR IS COUPLED
TO ADENYLATE CYCLASE AND MUSCLE CONTRACTION IN HUMAN
VENTRICULAR MYOCARDIUM Ray E HershbergerMD, Robert
Ginsburg MD, John RWynn BS, Fred L Anderson MD,
Michael RBristow MD PhD U Utah, Salt Lake City, UT
We have previously shown that vasoactiveintestinal
peptide (VIP) stimulates adenylate cyclase(AC) in
human ventricularmyocardium (HVM) , and that VIP
stimulatedAC in failing HVM is supersensitive compared
to nonfailing controls. AC maximal st imulation for
isoproterenol (ISO) and VIP, and EO-50's of VIP AC dose
response curves were determined in particulate
fractions of left ventricularmyocardium from cardiac
transplantrecipients or potential donors, asfollows:
NONFAILING LV'SIIOl FAILING LV 'S(IO)
net VIP (luM)* 10.53±0.75l 10 .4l±0.467
net ISO (O.lmH)* 4l.45±2.870 30.30±1.807**
Fluoride (lOmMA* 42.22±2.967 38.63±2 .90lED50 [VIPjXIO- M 1.744±.185 1.038±.186**
net VIP/net ISO 25.6% 34.7%
*cAMP in pmoles/min/mg. **p<0.05
To determine if the VIP receptor is coupled to muscle
contraction inHVM, inotropic response was measured in
isolated RV trabeculaefrom eleven failing hearts from
cardiac transplantrecipients. ISO peak tension was
830 mg+/-136.4 (SEM, n=22); VIP peak tension was 344 mg
+/- 54 .5 (SEH, nK24). The ratio of VIP/ISO maximal
tension (344/~3l) is 41%, similar to AC data above.
CONCLUSIONS: 1) VIP is coupled to muscle contraction
through adenylate cyclase stimulation inhuman heart.
2) Failing human heart is supersensitive to VIP
stimulation. 3) Activation of theVIP receptor pathway
may have therapeutic potential in CHF .
ADENOSINE STIMULATES CAROTIDBODY CHEMORECEPTORS
IN MAN.
Italo Biaggioni, M.D., Bjarki Olafsson, M.D., Rose Marie
Robertson M.D., F.A.C.C., David Robertson, M.D. Departments
of Medicine andPharmacology,Vanderb iltUniversity.
We have shownthat continuousiv infusion of adenosine stimulates
respiration in man. We examined the cardiovascular and
respiratoryeffects of iv bolus adenosine and tested the hypothesis
that adenosine stimulatescarotidbody chemoreceptors.
In six normal volunteers, adenosine (20 to 100 ug/kg iv bolus)
producedan initia l increase in blood pressure(+15/+12 mmHg for
100 ug/ kg, p<O.OI), with asubsequentreduction in blood pressure
(-1O/-15 mmHg). Heart rate increased significantly (R-R interval
decreased by /f02 msec after lOO ug/kg, p<O.OI). Transient (I-2
beats) bradycardia was observed only in association with PR
prolongation or ectopic SV rhythm. Adenosine producedtransient
and significant increases in respiratory rate and thoracic
excursion. The observed pressor and tachycardiceffects are due
to sympathetic activation, since in three patients with severe
autonomic failure adenosine produced bradycardia rather than
tachycardia and a reduction in blood pres surewithout the initial
pressor effect. To determineif th is sympathetic activation is due
to chemoreceptorstimulation, four patients undergoing diagnostic
cardiac catheterization were studied . Adenosine (5ug/kg)
produceda +19/+12 mmHg increase in bloodpressurewhen infused
in the aortic arch (p<0.05), while producing a -26/-9 mmHg
reduction in blood pressure when infused in thedescending aorta
(p<0.05 comparedto saline).
We conclude that the hemodynamic and respiratoryeffects of iv
adenosine observed in normal volunteers are due to
chemoreceptor stimulation. These f indings raise the possibility
that adenosine is an endogenous modulatorof respirationin man.
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FLOW- DISTRIBUTION CHARACTERISTICS OF Tc- 99m- HEXAKI S-2 -
METHOXY,2-METHYLPROPYL ISONITRILE INAN IMAL MODELS OF
MYOCARDIAL ISCHEMIA AND REPERFUS ION .
Shaker A. Mousa , Ph.D. , John M. Cooney ,BS , and St ephe n J .
Wi l liams, Ph.D. , E.I. du Pont de Nemours and Co. Inc . ,
N. Bi llerica, MA .
Tc-99m-hexakis-2 -met hoxy-2 -methyl pro pyl i soni t r i l e (RP- 3D)
is an investigationa l agent fo r the dia gnosis of ischemic
heart disease. Miniatur e swine were used t o determine
myocardial distribution patterns of RP- 30 in models of
permanent andtransient coronary ar te ry occ l us i on . With
or without dipyridamole induc ed hyperemia , both RP-30 and
TI- 201 are initially distributed linearly with micro-
sphere- de t ermi nedblood fl ow at up t o 2.4 ml/min/g (nor-
mal f low = 0.5 to 0.8 ml/min / g ) in swi ne . During 2 hour s
of r eperfusion i ni t i ate d 5 minutes post-i nj ection of i so-
tope , RP-3D normal i zes only 17% while 58% normal i za t ion of
is chemic zones i s measur edwith Tl-201. In another se t of
studie s , RP-3D and Tl - 201 were co- i njected 30 mi nutes
following repe r fusion of a 2-hour ligati on i n dogs . In
bot h seve re l y andmodera te l y compromi zedzones with doc-
umente d reper f us ion , t he ischemic t o normal TI-201 ratios
ar e not s igni f i cant ly diffe rent th an unity while RP- 30
rat ios ar e 0 .6 and 0 .7 r espect i ve l y . As a per fus i on
t r acer , th es e results show RP- 30 to be as re l i abl e as
TI-201 but sugges t i t s se nsitivi t y to de t ec t ischemic
zones might be enhanced due to its prol onged retention i n
the normal heart and decreased uptake in damaged t i s sue.
COMPARATIVE MYOCARDIAL TRANSPORT OF TECHNETIUM LABELED
SQ 30.217 (CARD IOTEC) AND THALLIUM-201
Denis Meerdink, Ph.D., Andrew Moring, B.S., Jeffrey
Leppo. M.D., F.A.C.C., University of Massachusetts
Medical Cent er , Worcester, Massachusetts
Technetium-99m (Tc) labeled agents have advantages
over t hal l i um- 201 (Tl) with photon statist i cs . cost,
and clinical availability and have been sugges t ed as
an alt er na tive t o Tl f or myoca rdia l per f us io n imaging.
Accordingly , t he myocardial transcapillary exchange
of the compound Chl or o(Met hylb oro n( I-) - t ris[ I ,2 -Cyclo -
hexanedion edi ox irnel N, N' , N", N" ' , N" " , N" "')Tc
des i gnated SQ 30,2 17 (Squibb Diagnostics) was determined
and compare d t o that of Tl . I n 7 isolated blo od per -
f used r abbit hearts, 15 mul tipl e i ndicator-diluti on
experi ment s were per fo rmedusing radiolabeled al bumi n ,
Tl and SQ 30 ,2 17. Cor onar y bl ood flow wasvari ed from
0. 70 t o 2.65 ml/min /g and myocardial extractions (Emax)
and capillary permeability- surf ace area pr oducts (PS)
f or SQ 30, 217 and Tl weredetermined. Emax for SQ 30,2 17
ra nged f rom 0. 55 t o 0.90 (mean= 0.76 ~ 0.0 9 S.D.) and
was signifi cantl y higher (p<O.OOI) t han Tl which ranged
f rom 0.43 to 0.74 (mean = 0.62 ~ 0.09) . Emax fo r both
i so to pes was related inversely to blood f lo w (F) where:
Emax (SQ 30, 217) = 0. 91 - 0.114F (r = - 0_84) and Emax
(Tl ) = 0.76 - 0. 106F (r = - 0.80). PS (ml/g/mi n) var i ed
from 0. 77 t o 2. 56 (mean = 1.80 ! 0 . 56) for SQ 30, 217
and was signif i cantly gr ea t er t han Tl (range = 0.56
t o 2.05 , mean = 1. 23 ~ . 42, p<O. Ol). These studies
indicate that the average myoca r dial permeation of SQ
30, 217 i s 50% higher than t hat of Tl a t all blood flows
eva l uated. Therefore, SQ 30.2 17 seems to possess the
myocar di a l transportqualities that merit further clinic-
al investigation.
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REST AND EXERCISE MYOCARDiAlPERFUSION SCANS AND ClEARANCE RATES
OF 5030217 , ANEW TECHNETlUM-99m PERFUSION IMAGINGAGENT
Lvnne L Johmr;m M.D.. FAC.C., DlIVidWSeldin M.D., Mich8e1 Muschel M.D.,
Kevin Smith 6.5. , David K. 61cxxl M.D., FAC.C., Paul J. Cannon M.D., FAC.C..
Columbia U,N. Y
Technetium-99m labelled 5030217 is a member of a new class of neutral
I1pophll1c technetium myocardial perfuslon lm~ing ~nts. Inanimals this
egent displays 2 component myocardial exponential clearance withT112's of5
min for the first component (60~) and130 mins for the second component
("10~) . The present stlKt{was designed toevaluate andcompare rest (re) end
exerc ise(ex) scans and washout rates in normal SUbjects . Six healthy male
volunteers (mean ege=26 vrs) uOOlrwenl uprightbicycle ex to 85-90~ ege
predicted mextmel HR. Fifteen mCt of Tc-99m -5030217 was injected as an IV
bolus at peek. ex , efter which exercise was continued for 90 sec . Dynamic
im~ing was performed in three views for "1 mins (ANT), "1 mins (30· LAO),
and 6 mins (60· LAD) at 10 sec/imege . A second injection at re was
performed between 90 to 120 min leter, end the same im8llinllprotocol was
followed. Washout rates were calculated by fitt ing a monoexponentia1 to
myocardial time-activity curves for each view, excluding the first two
minutes of bleed-pool activity. The T 1/2 for the first 2-"1 minof the ex
study was 6.7tO.8 min, significantly shorter than for the re stul1f (9."lt2."l
min,p< .05). 6eyond 5 minthere were no lon!J!rdifferences in washout rates
(1"1.5t1.9 vs 19.9t6 .5 for 5-9 mln: 33 .0tl0."lvs 32 .5tl0.7 for 10-16
min), Activity inthe summed l1fnamic im~ was evaluated in10 anatomical
myocardial segments on each set of three views . 5030217 activity was
uniform in "19/60 segments on the re end53/60 segments on theex studies .
The remaining segments (all inferior orapical) were obscured by hepatic
actiVity. Insummary, this egent clears rapidlyfrom the he8rt in man, re and
ex scans in multipleviews can be performed within 2 nrs, butsaltterfrom
the liver interferes withevaluation of inferoapicaluptake.
RELATIONSHIP BETWEEN 1-123 PHENYLPENT ADECANOI C
ACID MYOCARDIAL UPTAKE AND CORONARY FLOW IN
DOGS WITH PARTIALCORONARY ARTER Y OCCLUSIONS.
James R. Corbett, M.D., Patrick L. Kennedy, M.D., Padmakar
Kulkarni, Ph.D., Marvin S. Akers, R.N., Chr ist opher L.Hansen,
M.D. , Valentina Ugolini, M.D., Donald E. Jansen, M.D., and
Robert W. Parkey, M.D., F.A.C.C., Univ Texas Health Science
Center, Dallas.
Preliminary studies with 1-123 phenylpentadecanoicacid (IPPA )
ha ve demonstratedits utility in th e scintigraphic identificationof
pat ients with ischemic heart disease. However, discrepancies
bet ween pre dicted coronary flow and reg ional IPPAuptake hav e
bee n noted. In this st udy, we tes t ed the hypothesis that the
myocardial distributionof IPPA is nonlinear with coronar y flow.
Twenty-one open-chest dogs were st udied. Each animal
underwent left thoracotomy. A pulsed Doppler flow probe was
placed around the LAD and a partial coronary artery stenosis
created so as to reduce resting coronary blood flow. After
8. 5:5.4 (SO) min, IPPA (2-5 mC i) was injec ted. Coronary flows
were measured continuously beg inning pr ior to coronary artery
constriction. Beginning wit h IPPA injec t ion, 60 images (60
se conds each) were acqui red wit h agamma camera pla ced ag'inst
the can ine heart in a lateral projection. LAD flows were
decreased to 39.5:15.1% (r ange 23- 75%) ofcontrol. The activity
of IPP A in the distal LAD dist r ibut ion was measured and
compared to that in the circumflex dist ribution. Peak IPPA
uptake occurredat 5.3:1.7 min follow ing injec t ion. IPPAactivity
in the LAD distributionwas 82.8 +14.1% of that in the distribution
of the circumflex artery. The reiationship between IPPA activity
at t he time of pea k IPPAuptake to LAD flow was described by
t he equation: Y=17.5 + 27.5 LOGe X, r=0.80, p<O.OOl. The
washout rate of IPPA was generally slowest in those distributions
wit h the lowest flows and the lowes t IPPA activities. ThUS, in
dogs with partial coronary constrictions, the myocardial
distribution of IPPA appears to be logarithmicwith flow.
ASSESSMENI' OF SYMPATHEl'IC INNERITATIONAFTIR TRANS1lJRAL
VERSUS~ MYOCARDIAL INFAOCTION.
Michael Dae, M.D., John Herre, M.D., Elias Ibtvinick, M.D. ,
John Huberty, William O' Connell and Michael oun,
Unive rsity of california, san Fr anc i sco .
Transmuralmyocardial infarction (MI) produces denervat i on
of viab l e myocardiun distal to MI. To assess innervatioo
patternsin nont.ransmiral,MI, \o.Ie carparedthe distribution
of synpathetic nerves using 1-123 netaiodobenzylguanidire
(M:m;) to the distributiooof perfusion using thallium (Tl)
201 in 12 cbgs (6 with transnuralMI produced l7j latex
embolization of the UID, 6 with nontransmuralMI produced
by UID ligation). Color functional maps displayed the si-
nultaneous distributionof both radionuclidesexpressed as
the ratio MIEG/Tl in m.l1tiple projections i n vivo , and in
excised heart slices. TransmuralMI shoeed zones of ab-
sent MIEG and TI, indicating scar. Adjacent and distal re-
gions shoeed reduced MIB:i, but normal, thallium, indicating
vi ab l e but denervatedmyocardium. Distal denervationwas
confinred l7j reduced norepinephrinecontent (ng/grn) ccm-
pared to normal basal myocardium (112+139 vs 698+66, P <
.002). l'bntransmuralMI shaved zones of wall thinningwith
decreased Tl, and a greaterreductionor absence of MIEG,
localized to the region of MI, with minimal extension of
denervationbeyond the MI. 'Ihese findings suggest that, as
opposed to the distal denervation produced by t.ransmiral,
MI, nontransrrnralMI may lead to regional ischemic damage
of synpathet.ic nerves, but may spare s ubepi cardi a l nerve
trunks which course throughthe region o f MI to provi de a
source of innervationto rerote areas of myocardiun. 'Ihese
different patternsof denervationmay help to explain re-
ported differences between transmuraland oontransnuralMI
in the incidence of spontaneous and induced ventri cular
arrhyttrnias•
SCINTIGRAPHIC EVIDENCE OF SYMPATHETIC DENERVATlON IN
CANINE MYOCARDIAL INFARCTION
Joseph D. Minardo, M.D., Mahmoud H. Tuli, H.D., Henry N.
Wellman, M.D. and Douglas P. Zipes, H.D., F.A.C.C., Kran-
nert Institute of Cardiology, Indiana University School
of Medicine, Indianapolis, Indiana.
Transmuralmyocardial infarction (THI) produces sympathe-
tic denervation in normal myocardium apical to the in-
farct. I-123-metaiodobenzylguanidine(MIBG), a guanethi-
dine analogue, is taken up by sympathetic nerve terminals
and pr ovides a scintigraphic image of myocardial sympa-
thetic innervation. We have i nvestigated whether MIBG ca n
detect an area of sympathetic denervation apical to
experimental TMI. Six dogs received 1.7 to 2.4 mCi of
I-I23-MIBG IV before and one to three weeks after latex
embol i zation (LE) of a diagonal coronary artery; three
standard planar images wer e obtained as well as single
photon emission tomography. Prior to LE, all dogs had
normal myocardial images . Post LE, one dog had a normal
scan with a very small, non-THI at post-mortem morpholo-
gi c study. The five remaining dogs all had anteroapical
MIBG defects up to three weeks pos t LE. Four of these
dogs have had open chest studies one to five days after
the last imaging confirming the pr esence of corresponding
anteroapical sympathetic denervation apical t o THI.
Sympathetic denervation was pr oven by lesser shortening
of effective refractory period (ERP) during bilateral
ansae subclaviae stimulation (3Hz,4ms,3mA), at the apex
(-12.6ms}vs base (-24.0ms) (p mO.Oll . There was also a
trend towards a supersenaitive shortening of ERP at the
apex vs base to two norepinephrine infusions:
(O.Smcg/kg/min) apex -2S.1ms, ba se -ISms (p=O.19); (1.0
mcg/kg/min}apex -36.1ms, base -29.6ms (p=O.OJ). We
conclude that MIBG imaging can detect areas of myocardial
sympathetic denervation assoc iated with canine TMI.
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SCINTIGRAPHICPROGRESSION OF CORONARY ARTERY DISEASE AFTER
SINGLE VESSEL ACUTE HYOCARDIAL INFARCTION. ll11liam 11.
lI11son HD, Robert S. Gibson HD, Denny D. lIatson PhD,
Thomas 11. Nygaard HD, FACC, George A. Beller HD, FACC.
University of Virginia, Charlottesville, Virginia
To determine the rate of "functional" progression of
coronary artery disease (CAD) in pts with uncomplicated
HB-CK confirmed acute HI and single vessel disease (SVD),
we evaluated 58 such prs who were consecutively enrolled
in an ongoing natural history study of HI and who had had
~ 2 yrs of follow-up (FlU). E1Iery pt underwent predis-
charge coronary angiography and submaximal quant itat i ve
exercise thallium-201 scintigraphy (Ex Tl); all 58 pts
returned at 3 mos and yearly thereafter for symptom-lim-
ited Ex Tl. All pts were 5 65 yrs of age and 6 had prior
HI; 21 pts had anterior HI; the mean resting LVEF was 51
±ll%. Heanduration of FlU was 46± 13 mos (range 24-60).
During FlU, no pt died, only 3 (5%) had recurrent HI and
18 (31%) were hospitalized for Class HI-IV angina (AP).
In 2 of the 3 pts with recurrentHI, the reinfarction in-
volved the samevascular distributionas the index HI.
Only 4 pts(7%) developed new perfusion abnormalitiesre-
mote from the index infarct zone (IZ) on yearly FlU ExTl;
none had a late ischemic event. Seven pts had worsening of
perfusion in the IZ defined as either new redistribution,
new persistent defect, or an t in defect size; 1 of these
7 pts had recurrentHI. In contrast, 13 pts (22%) had im-
provement in IZperfusion with 3 developing AP.
Thus, at nearly 4 years of mean FlU, the rate of "func-
tional" CAD progression, defined as new Ex Tl defects re-
mote from the infarct zone, is low (7%) in patients with
uncomplicated HI and single vessel disease. This was
associated with no mortality and a low rate of recurrent
infarction. These data should be considered when recom-
mending prophylactic revascularization of an infarct-
related vessel.
large LV
o
5
6
and
normal LV
No MPD ( 0% LV) 3
Small MPD (,. 2% LV) 6
Large MPD (> 2% LV) 1
Mean MPD size in Pts with normal LV was 1+1%
with large LV 8+9% (p<0.05).
Thus, in Pts with LBBB without CA disease Tl-20l MPD
occur frequently. The presence and size of MPD corre-
lates with degree of LV dilation. Altered geometry in
dilated LV and thinning of walls appears a plausible
explanation for this observation. From these data new
lower limits for "normal"Tl-20l distribution in dilated
LV can be derived and used for analysis of Pts with LBBB
and LV dilatation for detection of CAD.
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I1 PATIENTS
FALSE-POSITIVETL-20l DEFECTS IN LEFT BUNDLE BRANCH
BLOCK: RELATIONSHIP TO LEFT VENTRICULAR DILATATION
Jacqueline Hodge, M.D., Jennifer Mattera, R.T.,
Robert Fetterman, R.T., Byron Williams, M.D.,
Frans J. Wackers, M.D., F.A.C.C. Yale. U., New Haven, CT
False-positive Tl-20l myocardial perfusion defects
(MPD) have been reported in Pts with complete left bundle
branch block (LBBB). Pts with LBBB often have enlarged
and dilated LV. We tested the hypothesis that Tl-20l MPD
in LBBB are related to the degree of LV enlargement.
QuantitativeTl-20l stress imaging was performed in 21
Pts with LBBB and either angiographic normal coronary
arteries (CA) (nzll), or low likelihood « 10%) of CA
disease (D) (n=lO). MPD were quantitatedfrom circumfer-
ential Tl-20l distribution profiles and expressed as %of
total LV area. LV size was measured bypixels in LV area
and graded as "normal" or"large". Eighteen Pts (85%)
had MPD, 11 small (,. 2% of LV), 7 large. Typical MPD
showed thinning of LV wall rather than absence of activ-
ity. There was a definite relationshipbetween size of
MPD and LV size:
USE OF THALLIUM STRESS-REDISTRIBUTION SCINTIGRAPHY AS A
DETERMINANT OF PROGNOSIS IN PATIENTS VITH TYPICAL ANGINA
AND NmATIVE EXERCISE ECG RESPONSES. Aran Rozanski, MD,
FACC; Jamshid Maddahi, MD, FACC; Howa~d Staniloff, MD,
FACC; Nicholina Said, Daniel S Berman, MD, FACC. Ceda~s­
Sinai Medical Cente~, Los Angeles, CA
A negative exercise (Ex) ECG response in patient. (pts)
with typical angina r-epr-esents a "dfs cor-dant;"but common
finding. To assess the prognostic usefulness of thallium
st~ess-!'edist~ibutionscintig~phy (Tl) in this pt g~up,
we evaluated one-year cardiac event rate (CER) fo~ ca!'diac
death and myocar-ddeL infarction (MI) ("ha~d" events ) (HE),
and late bypass su~gery (CABa) (>60 days p Tl), a p~xy
for wo!'sening clinical status, in 214 pts with typical an-
gina, negative Ex ECG, and no p!'io~ MI o~ CABa. Nine pt.
with ea~ly CABG we~e excluded. Tl was assessed visually,
by a 4-point scale (O=normal, l=mild, 2=moderate, and
3=ma~ked dec~ease in Tl uptake), with >2=abno~mal.
Results: Overall CER was 8.2%. CER-was 4.2% in the 118
pts with no~mal o~ equivocal and 20% in the 40 pts with an
abno~mal Tl study (p<.Ol). CER by maximal predicted hea!'t
!'ate achieved (MPHR): (E=events)
Tl=no~mal Tl =abno!'mal
MPHR Pt I1 HE All E Pt I1 HE All E
<B5% 25 8:0% 12:01 1'5 20% zor
>85% 94 2. a 2. a 25 16% 20%
Conclusions: pts with typical angina and a negative Ex ECG
a!'e at: 1) high !'isk if Tl is abno~mal, 2) relatively high
~isk if Tl is normal but MPHR <85%, and 3) low risk if Tl
is normal andMPHR > 85%. Of note, this last g~up !'epre-
sents a relatively common subset of pts with typical angi-
na and negative exe!'cise ECGs who a!'e !'efe!'!'ed fo!' test-
ing.
EFFECT OFMAINTENANCEORALTHEOPHYLLINETHERAPYON DIPYRIDAMOLE
THALLIUMMYOCARDIALIMAGINGUSINGSPECTAND DIPYRIDAMOLE-INDUCED
HEMODYNAMICCHANGES
PatrjckJ paley Mp.; VirinderjitS.Bamrah, M.D.,F.A.C.C.; Jason S. Zielonka,
M.D.,ThomasH. Mahn, M.D.;Rashi Akhtar,M.D.;ArnoldJ.Krubsack, M.D.,Ph.D.;
L. SamuelWann,M.D., F.A.C.C.; John Kalbfleisch, Ph.D.;VA MedicalCenterand
MedicalCollege of Wisconsin, Milwaukee, Wisconsin
Manypatientsw~h pulmonary diseasebeing evaluated for CAD arecandidates for
dipyridamole (D)thallium myocardial imaging(DT)becausethey cannot pertorm
adequate exercisestudiesdue to impaired respiretory status. Such patientsare
frequently receiving oraltheophylline (T). In ordertodetermine ~ maintenance T
therapyaffectsthe diagnosticaccuracyof DT, 8 patients w~h angiographically-
provenCADunderwent DTtwice:oncewhileoff T andoncewhiletakingoral T,
achieving meanserumlevelsof 12.2 ~/ml (10-20j!glml, therapeutic). Single
photonemission computed tomography (SPECl) TI imageswerevisually analyzed.
Thallium scores(TS)werederivedusinga scaleof 0 (no defect)through3
(background activity)while3 LV regions(apex,mid andbase)weredividedinto 4
wallsegments (anterior, septal, inferiorand lateral). &TS sumsthe defectscore
from all foursegments in all threeregions. &TSrepresents TSfrom in~ial images
minusTSfromdelayed images. Thus, &TS • 0 represents noTI defectsor fixed
defects,while increasing &TSrepresents an increasing level and extentof
reversible pertusion defects.Cardiacindex (Cl) was determined usingDoppler
echocardiography.
&TS &HR &SBP &DBP &CI ST~1 mm) ANGINA
OffT m 10.3 +21.5 -14.3 -10.0 +0.7 318 718
SD 6.4 4.8 7.4 6.3 0.9
OnT m 0.7 +3.5 -1.5 -2.8 +0.4 0/8 0/8
SD 0.9 3.2 5.6 -1.0 0.5
p <.005 <.001 <.005 <.025 NS
We conclude: 1) Oralmaintenance T completely abolishes D induced reversible TI
defects,while not affectingfixed defects, and consistently results in false negative
DT. 2) D induced changes in HRandBP,as wellas provocation of anginaandEKG
changes byD, are prevented by oral T. 3) Patientson oral T have misleading DT
resultsand should e~her discontinue T priorto OTorundergo anotherdiagnostic
test.
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SAFETY OF OIPYRIDAMOLE THALLIUM-201 IMAGING VERY EARLY
POST MYOCARDIAL INFARCTION IN MAN
Charle s E. Chambers, M.D. and Kennet h A. Brown . M.D. ,
F .Al~'C. , Un IversIty ot vermont College of MedIcine,
Bur Ington, Ver~on t
Dlpyrlda~ole ~DP.) Thall ium-201 ITll imqging is of
groinost,c value 1 oays post myocardial Intarction
(MI. Experimenta datq has shown that Tl kinetics
ref ect the viability of myocardium at 48 hours post
MI; however it i s unknown whether DpTl imaging is safe
in patientslptsl this ear ly post MI. Because of the
potentia l ut il ity of anonlnvasive te st for reversible
ischemia very early post MI , we undertook this st udy to
evaluate t he ~ a fe ty of DpTl in this setting. Ni ne male
pts , age 56+10 yrs Imean+SDl , were studied at73+23
hours (range49 to 101 ) po~t MI {4 anter iQr 4 -
infer ior! an] 1non-Q wave} , A st andard Intravenous
DpTI prOtQco was used and Images were analyzed
quantItat Ive y.
After intravenousDp (0.56ma/kg) heart rate
increased froJ!! a cont rol val ue of71+7 b~m (mean+SO) to
a mean p'eak of 90+11 bpm (p<O .OOIl . - Pea heart f~ t e
occurrea at 8+3 mTnute s fromonset of in usion and
returned to or near basel ineby 30 mi nutes i n all pts.
There was no signifi cant change in systol ic blood
pres~ure. Rate pre~sur~ prod u~~ increased from 8~253+
1,200 to 10 .755+ 1,919 (p<O .OOl . Chest pain and,or -
ischemic electrocardiographic canges w~ re nQted in 5
pts, but resolvedeither spontaneouslY (1 pt ) or within
6 mlnytes after intra~enou$ amiQQphylline (4 p.ts: ~ean
dose 77+48mg) . No maJor sIdeeffects occurreo. MInor
side effects occurred in 4 pt$ (1nquseaj 3 heada~he).
OpTI images revealed a perfuslon defect In t he infarct
terri tory t'n 9/9 pts. 1n 4pts ~ significaQt redis tri-
butIon of I occurredon delayea vIews . Of these, 1 pt
r~gu irfed bYQa~s surgery forunsta~le angina. All 5 pt s
wIth Ixed defects nad an uncomplIcated course.
Conclusions: 1. ) Intravenous DpTl imaging c~n be
performed safely very early PQst MI . 2.l 1scnemla
following ~ar l y Dp m~y occur frequentl y buti~ relieved
promptly wIthout ~ er l o us adverse eff ect s. 3. } Very
early post MI OpTl is sensiti ve for infarctzone
perfUslon defects Our preliminary results suggest
t hqt asUbstantial number of pat ient s with reversi bl e
defectf can be detected;however, whether t his
ident i ies pts at highrisk for early cardiac events
post M will require further study.
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CardiacPacing
ANTITACHYCARDIA PACEMAKER AND AUTOMATIC IMPLANTABLE
CARDIOVERTER DEFIBRILLATORAS SOLE THERAPY FOR VENTRIC-
ULAR TACHYCARDIA.
James D. Ma l oney , M.D•• F,A.C.C., M. Masterson, M.D•• B.
Wilkoff, M. D" T. Simmons, M.D" V. A. Morant, M.D., L.W.
Cas t le, M.D., F.A.C.C., and L. Golding, M.D. Cleveland
Clinic Foundation. Cleve l and, OH.
Two men ( 72 yrs +3l with remote myocardial infarc tion,
le ft ventricu~ar d ys f unc t i on , EF (0 . 40 +0.25), and
sustained monomor phi c ventri cular t achyca rd ia-(VT) (cycle
length 320- 440 ms) (6 . 5 +2 c l inical episodes) with sudden
cardiac death (2 ) were r e s istant/ intole rant to mul t iple
antiarrhyt hmic drugs (6 +0) . Both wer e treated with an
antltachycardia pacemake r - Or t hocorII 284A (RC) - and
the au to mat i c implantable ca rdioverter defibrilla tor
( AICD) as sole therapy. Cardiac e lectrophysiol ogic (EP)
eva luation with t he external RC disclosed t ha t t he VT
could be terminated with auto decrementa1 ext r a stimuli
( 5 +3). Both pt s exhibited VT ac cele ra tion requiring
ex ternal car d i over s i on . Both pts were implant ed with the
AICD-AID BR ( r a t e cut of f 150 +6 bpz ) with pa t ch/patch
de f i bril l ati on conf iguration and 2 l e f t ventricular
epicardial se nsing e l ec t rodes (Med n onic 691 7-35T) .
Def ibrillation thres hol ds were 17 +10 joules. The RC was
i mpl ant ed separately wi th bipolar leads , t in ed (1 ) .
sc re w-i n (1) . AICDdischarge at i mplan t caused dislodge-
ment of th e tined ventri cular lead, which had to be
repositioned. Follow-up a t one mont h without an tiar-
rhythmi c dr ug therapy disclosed that both pts had
mul t i pl e episodes of VT termi na t ed by t he RC which wer e
not perceived. Pt #1 had 1 AICD di s charge for rapid VT.
Pt #2 had 9 disc harges.
ConClusions: 1. Drug resist ant VT can be r egu l ar l y
t e rmi na t ed by antitachycardia pacing unpe rceived by the
pt . 2. AICD backup i s r equired for acce l e rated VT. 3 . VT
prevention therapy also req ui r ed t ooptlmize management.
'" p<O.OI ; BTA-I corrected vs . No BT1-I.
SPCF i n t he pCAD < 5%group was 100% using BT&-l ( n: 231.
SPCF was 54% i n t he norma l cat h gro up s I nce 13/ 18 were
s el ec t ed f or ca t h after an ini t ial abnormal T1-2 01 read-
i ng Nlthout 8TA-I. Conclusion: adjusting f or breast
tissue attenuation in Nomen i mpro ve s specif icity (SPCF)
of SPECT Tl -20 1 WIthout reducing sensitI Vity ( SENS) .
SPECI FI CITY OF SPECT T1-20 1 NYOCARDIAL IMAOINO IN ROMEN:
IMPROVEMENT BY ADJUSTINC FOR BREAST ATTENoATION.
Karen G Cloninger HO; Robert L Eis ner PhD; Joe l Oates
CNHT; Till Noever HS; Dani el Dunn CNHT; Do ugl as C Horri s
MD, FAC e ; Henr y A Liberma n HO. FACe; Andre' L Churchwell
HO; Randolph E. Patterson HO, FACC. Ca r l yl e Fraser Hear t
Cent er / Cr awf or d LongHo s ~ Opts. of Hed. and Radi ol ogy,
Emory um v. Atl a n t a , CA
Nonlnva s i ve diag nosi s o f coronary d1 5ea s e ( CAD) in Mo men
IS not or I ous l ydiffIcult . Al t houg h SPECT Tl -201 Imagi nq
. a y be . ore a ccur ate than t he exercIse ECG i n Mome n .
breast tIssue attenuation ( BTA) can of t en create f a1se-
po s i t i ve results. Re e s t i ma t ed a BTA i ndex ( BTA- I ) of
the severIt y a nd loc a t lon of BTA from ser Ial pl a na r
v l e ws from the SPEC T acqUISIti on: O=n one, to 4( +) =
s eve r e , graded b y 3 bl ind e d observe r s . Po lar bullse ye
maps cons t r uct ed f "om SPECT Tl -201 dat were us ed to
ca l c ul a t e a Tl-20' score i nor mal < 50) as t he SD-
weIght ed s um of pixel s } a given SO bel oWnormal . Using
2.5 SO below nor mal to def I ne a bnor mal BTA-I was used to
adJ us t for BTA by add Ing 0.5-1. 5 SO t o 2.5 SO t o de fine
abnor mal at increaSIng BTA -I. Re studI ed 115 women, 73
normals ( pCAD < 5%) and 42 nth cardiac cath. Fif t y
women wIth pCA D < 5% were assigned t o a normal fil e.
Cath sh owed CAD I n 24 and no CAD I n ' 8 wo men. Sen-
s i t r vi t y i SENS) and sp e c i ri c i t v ( SPCF) wer e calcul ated
a f t er excludI ng 9 WOmen with normall TI-201 , at pea k
heart r a t e < 8 5 ~ age - p r e d i cted ma x i mum.
ADAPTIVE ANTITACHYCARDl A PACING FOR VENTRICULAR TACHY-
CARDIA Edwar d V. Platia, M.D. , F. A.C .C . , Washington
Hospital Cent er , Washington, DC
Th e c ompa r a t i v e ef f i c a c y a nd safe t y o f s ever a l a d a p t i v e
pacing t e chn iques were assessed with a new i mp l ant ab l e
pac emaker designed to detect and automatically termi nate
ventricular t achycardia. Ten patients , age s 36-69 yr , had
sustained vent r i cul ar t achycardia r epeatedl y i nduced and
terminated in t he laboratory using an antitachycardia
pul s e generat or (I nt er medi cs InterTach 262- 14) and a bi -
polar pacing l ead pos i t i oned in the right ven t r i cular apex .
This pa ce r can deliver bursts of 1 to 250 pulses i n a
var i et y of modal i t i es , including scanning and ada ptive
pacing. The number of episodes of induced vent r i cul ar
tachycardi a in each patient ranged from 9 t o 39 (mean 23) ,
whi l e t he ventricular tachycardia cycle length r anged from
240 to 510 msec (mean 360 msec ) . In 8 of 10 patients. ven-
tri cul ar tachycardia coul d be quickly and reliably termi-
nated by at leas t 1 combin ation of programmed settings . In
2 patien ts, both with ven t r icular t achycar di acycle l engths
under 300 msec , ventricular tachycardia acceler a t i on oc-
curred, r equir i ng DC cardi oversion. The s uccess rate of
adaptive scanni ng burst pacing with 8 to 12 s t i mul i de-
l ivered at a cycl e length of 75-85% o f t heventricular
tachycardia cycl e length and that of aut odecr ement a l over -
drive pacing in terminating ventricul ar t achycardi a wer e
compar abl e : 87% and 82%respecti vely. Both wer e s ignifi-
cantl y (p<. 02 ) mor e effective than single and double scan-
ning extrastimuli (2 2% and 59% r es pect i vely).
In conclusion, in selected patients with recurrent s us-
tained ventricular tachycardia, adaptive antitachycardia
pa ci ng is safe and e f f ecti ve, especially when t he ventric-
ular tachyca rdia cycl e length i s above 300 ms ec . Autodec-
rementa l and adaptive scanning overdri ve pacing are the
most ef f ective modaliti es.
SPCF
58% ( 2 3/38 )
83% (3 0 /3 6 ) '"
SENS
95% ( 19/ 20 )
90% ( 18/ 20 )
CRITERION
Without (w/o) BTA-I
BTA-I adjusted
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RATE RESPONS!'mmSS OR ATRIALAlODTATIONAS II>STIMPORTANT
PHYSIOLOOlCAL FAc:I'OR IN ENHANCBD EXERCISE PERFORHANCE IN
PATIOOS IiI1lf DUAL CHAMBER PACDWCERS
~ic~rd~LfW~e,J I '1M~D.~ WillTiamJ. FreCnclh'rM.D" F.A.C.C. ,ar r- l ca en er, orrance, a 1 orn l a
Dual chamber(DDD) pacemakersare physiologi cally superior to
ventricular demand (VVI) pacemakers during exercise.
Whetherthis improvementis due to rateresponsiveness or to an
appropriatelytimed atrial contraction i s unknown. Seven
patients with complete heart block, in sinus rhythm, with
chro notropic com~etence during exercise and ODDpacemakers
were studied. To determine the importance of rat e
responsiveness and atrial augmentati on durin~ exercise
patIent.swererandOlll1y exercised m 3modes : VVI,ODD, and ODD
with a short AV i nt er val that al l ows no ef fe ctive at rial
augmentation but senses atr i al act i vi t y and s i mulates a r at e
res ponsive pacemaker (RR) . Heart r at e , exercise t i me
r es pi r at oryrate,ventilation,oxygen upt ake , end tidal 02 and
C02 , respl r ator y quotient .. oxygen pulse , and anaer obi c
t hreshold were measured during exerClse .
VVI RR ODD
Heart Rate (min-1) 78~I S 124~26 128*26'
End Tidal C02(mmHg) 34%7 37~8 36*6"
Oxygen UP.tak~ 14.5~2 .7 15.7~2.6 15. 6%2 .8"
,ffil/kgi'min )
Anaerobic 8. 1 ~2. 0 9.8%2 .8 10. 2%1. 6' "
Thr eshol d (min)
Oxygen Pul.s e 16~1 0 1 1 ~6 11%5'"
,ffil/beatJ
RR or ODD vs VVI: p<.OOI·j <.OS" ; <.0 1' "
There was nodiffe r ence i nres pi ratory rat e , time of exercise ,
end tidal CQ;>I ventilationor respiratory quotient i n anymode.
SIIIWlY: Hll.~e respons ive and ODD mode s produced similar
phYlli ol ogical resultsduring exercise and both wer e superior
to'VVI ~cing. <XJNCLUSION: Exercise performancewith a rate
responsiveventricular pacemaker i s pnys iologically similar
to a dual chamber pacemaker . This suggests tfiat the benefits
of dual chamber pacing dur i ng exercise are due to rate
responsiveness and not to atrial augmentati on.
INl'ERRPTION OF SPONl'R/EXXJS AND INDOCID
TAQlYARRHYTHolIlIS BY 0CANNIt{; SELF-AmFTIt{; O'£RIlUVE
PJlCOO.
Kul Chodda. M.D.. F.A.e.e., Barry Bloanfield, Penise
Harrington, B.A., Ruth Arbouet, John Neglia, M.S.,
C.C.E., MJnty Bodenheiner, M.D., F.A.C.C., Barolit
Berk<7l1ts, F.A.e.C., ILlng Island Jewish Medical
center. New Hyde paJ:k. N.Y•
In a re:::ent report a n6i' antitcr;:hycardia pacing
technique was shown to be nore efficacious than
existing meth:::ds of termlnating ventrJcular (V)
tachycardia (T) with a IOler incidence of a::celeration.
we testEd the effJcacy of autanatic self-adapting
decrerrental overdrive pacing in 15 ~tients with a
variety of camia:: disease and h8lOdynamic function
duriD3 spontaneous (n=8) or Wuced (n==32) episodes of
sUj;raventricular (sv) ta::hycardia or nononorphic vr.
Eighteen atrial tachycardia episodes at cycle lengths
(CL) 359±38 (260-400) ITS, and systalic BP (SBP) 69±19
(40-120) InITikJ were termlnatEdwithln 8±6 (2-28) secords
with 23±18 (5-81) pacing pulses. In addition 4 episooes
of atrial flutter (Ar) at CL 235±5 (230-240) ITS and S3P
135±15 (110-150) rmHg were termlnatEd withln (1-10)
seconds with (6-45) pulses. Eighteen lIOnorroqilic vr
episcrles at CL 316.t34 (240-390) ITS, and S3P 62±l 7
(50-100) InITikJ were termilatlrlwithln 7±7 (1-26) secords
with 23±22 (5-81) pacing pulses. No episcrles of
fibrillation occurred. In oonclusion, autanated
decrarentaloverdrive pacing was found to be effective
in 100% of svr, including Ar, and vr episodes. secaiee
of its high effJcacy rate and no vr acceleration. it
has decreased the need for cardioversion and/or
defibrillationin our laboratory.
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CardiacPacing
PROSPECTIVE EVALUATION OF VENTRICULAR PACING AND HIGH
ENERGY TRANSVENOUS SHOCKS USING A TRIPLE ELECTRODE ARRAY
FOR CARDIOVERSION OF VENTRICULAR TACHYCARDIA. BD Lindsay .MD.
ST Rothbart , MD, FACC. N Wasty. MO. 0 Pantopo ulos . ME.
S Saksena, MD, FACC. Newark Beth Israel Med Ctr,Newark, NJ.
Comb ined rapid ventricular pacing (RVP) and low energy transveno us cardio-
version [rC) shocks have limited efficacy for term inatio n of rapid ventricular
tachycardia (VT). We have recentl y shown that a triple ele ctrode system
comprised of 2 anodes (a cutan eous patch and superior vena cava catheter
electrode) and a right ventr icular apical cathode reduce energy requ ired of
single shock s for successful TC. The present stud y prospec tively dete rmined
the efficacy of a protocol that sequen tially em ployed RVP.intermediate energy
TC shocks, and high energy TC shocks using the triple electrode array in pts
with sustained VT. A Medtronic 6880 lead placed in the RV apex was used for
pacing and was combined with an R2 skin patch to deliver TC shocks. The
elect rical therapy de livered was determined by the cycle length (CL) of VT.
Slow VT (CL >300 ms) was treated by RVP, followe d by intermediate energy
(5J) TC shocks, Ihen high energy (15 &25J) TC shoc ks. Rapid VT (CL < 300
ms) was treated by high energy TC shocks alone . E ightee n episod es of slow
VT (CL 377 :!:.49) and 17 episodes of fast VT (CL 242!. 37) were induced.
Results of the algorithm were :
VT CL >300 RVP_ ~
SUCCESS: 11 5
FAILURE: 7 2
VT CL <300
SUCCESS: 12 4
FAILURE: 5 1
Each of 18 (100%) slow VT episodes (CL >300ms) was converted. Sixteen
(89%) of these were terminated by RVP or intermediate energy TC shocks and
2 requ ired high energy TC shocks . Sixteen of 17 (94%) fast VT episodes (CL
<300 ms) were term inated by high energy TC shoc ks. The identical CL and
morphology of 12 VT episodes could be re induced and were reproducibly
terminated in all instances. Thus . an algorithm comprised of RVP and TC
shocks delivered by a triple electrode system term inated 34 of 35 (97%) api-
sodes of VT. We conclude that this approach offers pro mise for reliable trans-
venous cardioversion of both slow and rapid VT to sinus rhythm .
DETECTION OF SUSTAINED VENTRICULAR TACHYARRHYTHMIAS USING
RIGHT VENTRICULAR HEMODYNAMIC PARAMETERS: A PROSPECTIVE
STUDY.
Najam Wasty, MD, Demetris Pantopou los, ME. Stephen T Rothbart , MD, FACC,
Larry Cohen , MD. Sanjeev Saksena, MD, FACC.
Newark Beth Israel Med Ctr,Univ of Med &Dent of NJ, Newark. NJ.
Ventricular tachycardia (VD detect ion by current antitachycardia devices
lacks rapidity and specific ity. We have prev iously reported that LV systo lic &
diastolic function are imm ediately altered during rapid vent ricular pacing &
sustained VT. In this study we examined RV systolic &diastol ic funct ion in 13
pts with inducible VT during comb ined hemodynam ic & electrophys iolog ic
studies to determine whether these p arameters could be used to rapidly &
reliably detect VT. RV systol ic pressure (SP). end dlastolic pressure (EDP).
dP/dt &negative dP/dt were measured in sinus rhythm (SR), atrial pacing (AP)
and ventricula r pacing (VP) up to cycle lengthS of 400 ms, as well as in VT.
RESULTS: No sign ificant differences in any RV hemodynam ic parameter
could be identilied between SR and AP (p >.2) . The results during SR & VT
were :
SR VT P (SR vs VT)
Mean RVSP (mm Hg) 28t12 17t13 <.02
Mean RVEDP (mm Hg) 6±3 7±10 >.2
Mean dP/dt (mm Hg/sec ) 265±176 118±94 .001
Mean Neg.dP/dt (mm Hg/sec ) 195±90 104±82 <.005
The observed decline in dP/d t &negative dP/dt was established within 5
beats of VT onset. Using a 25% sustained dec line in dP/dt or negative dP/dt as
a VT dete ction criterion. VT was correctly identified in all pts . At matched cycle
lengt hs in the same pts , there was a decrea se in mean RV dP/ct in VP as com-
pared to AP (from 219 to 172 mm Hg/se c).
CONCLUSIONS: 1. RV compl iance dec lines immediately during VT with a
concomitant decline in RV systolic function. 2. Changes in these RV
hem odynam ic parameters reliably detect sustained VT. and may be monitored
with an indwelling RV catheter transducer system .
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We conclude: 1) In the conscious D, AMINO produces a
significant and durable decrease in DFT.; 2) This effect
is not blocked by PRO; 3) it may be clinically useful if
confirmed in man.
IMPROVED LCM ENERGY DEFIBRILLATIONEFFICACY IN MAN USING
A BIPHASIC TRUNCATED EXPONENTIAL WAVEFORM.
.fiQnr. .A.. Winkle, lW!u. .L.A.Q.Q., R. Hardwin Mead, M.D.,
Miohael A. Ruder, M.D., Vincent Gaudiani, M.D., Wally S.
Buch, M.D., Benjamin Pless, Michael Sweeney, SeqUoia
Hospital, Redwood City, CA
The s.tandardimplantable defibrillatorwaveform is a
truncatedexponential of apprOXimately6 msec duration.
We compared the defibrillationefficacy of a standard
monophasic truncatedexponential (M) to a biphasic 12
msec truncatedexponential with the polarity reversed and
remainingcapacitorvoltage attenuatedby 75J after 6
msec (B) in 21 pts undergoing AICD surgery. Two hundred
thirty episodes of VF were induced wi th 115 "matched
pairs"of Mand B of identical inltial capacitor vol tages
(VI) given over a range of VI from 70 to 600 (.35 to 25.7
joules). If either M or B failed to convert VF a rescue
shock of the other configurationbut same VI was given.
Both M and B were successful in 64 and both failed in 18
pairs of triale, B was successful in 25 of 33 pairs of
trials where M and B were discordant and in 20 of 31
discordant rescue shocks (p<.01). B delivered only 3.5J
more of the energy on the capacitor than M. A percent
defibrillationefficacy ourve showed B was superior to M
espeoially for VI <300 V (6.4 joules).
VI <200 200-290 300-390 400-490 >500
joules <2.8 2.8-6.4 6.4-11.3 11.3-17 >17
M 28J 45J 7aJ 76J 83J
B 64J 6gJ 7aJ 86J 83J
n 14 29 27 21 24
We conclude that a 12 meec biphasic truncatedexponential
is superior to a 6 msec monophasic waveform for defibril-
lation especially at energies <6.4 Joules. This waveform
can be achieved without any increase in capacitor size or
energy consumption and may permit smaller defibrillator
generators.
AFTER AMINO
T Late Effect T
W 11.3.±7.7 135'
Peak Effect
6.8+5.4
DFT(J,n-lOEXP)
DFT(J,n= 9EXP)
DFT(J) 16.0+11.6
LOWERING OF CARDIAC DEFIBRILLATIONTHRESHOLD BY
AMINOPHYLLINE IN THE CONSCIOUS DOG.
Rodolphe Ruffy, M.D., F.A.C.C., Enrico Monje and
Kenneth Schechtman, Ph.D., Jewish Hospital at Washington
University, St. Louis, MO.
We have recently reported the lowering effects of beta
adrenergic stimulation (BAS) on cardiac defibrillation
threshold (DFT) in dogs (D). This study examined the
effects of aminophylline (AMINO), a drug with cardiac
effects akin to BAS, on the DFT of 14 chronically instru-
mented conscious D. calibrated DC shocks were delivered
between left ventricularand superior vena caval elec-
trodes. Ten D underwent 13DFT determinationsbefore and
after IV AMINO (lOmg/kg). The results were (all values
are mean + SD):
BEFORE AMINO
*p<O.Ol T=mean time from drugadministration
Seven D underwent DFT measurementsbefore and after AMINO
with and without prior beta blockade with propranolol
(PRO), 0.4mg/kg IV. Each Dunderwent at least 2 randomiz-
ed experiments (EXP) on separate days. The results were:
CONTROL PRO AMINO
27.1+12.2 ---.-~ 18:0+9.3
24.4~12.7 27.3+12.5 19.9I12.l
AUTOMATIC IMPLANTABLE CARDIOVERTERDEFIBRILLATOR:
PROBLEMS AND COMPLICATIONS
Nazih Kadji. MD, Imran Niazi, MD, Imad Elkhatib, MD,
Rohammadazayeri,MD, Stephen Denker, MD, FACC, Rehan
Mahmud, MD, FACC, PatrickTchou, MD, FACC, Masood
Akhtar, MD, FACC, University of Wisconsin MountSinai
Medical Center, Milwaukee, WI.
The automatic implantable cardioverterdefibrillator
(AICD) is rapidly becoming a major therapeutic
modality. Its efficacy, safety and reliability have
improved with time. However, device refinements are
still needed. To enhance on this process, we report our
experience with 51 patients (pts) who received the AICD
because of ventriculartachycardia-ventricular
fibrillation (VT-VF). The mean age was 6l±11years,
mean followup was 14.5+11.1 months and meanejection
fraction was 34.7±13.3i. Nineteen patients had
documented or suspected VT-VF triggering AICD
discharge. No patient had an arrhythmicdeath. Three
patients died from non-arrhythmiccauses.
The frequency and complications that occurred were
compared between the first 25-AICD pts (Group A) to the
remaining 26 (Group B). Results are illustrated in the
table.
Device Related Technical Othjrs
Group A 9 21
Group B 0 6 1
Device related problems inCluded manufacturerrecall (2
pts), prematurebatterydepletion (4 pts), energy leak
from the device (1 pt), ana unexplained deactivation of
the device (1 pt). Two had sinus arrest post AICD
discharge that necessitated cardiac pacing. Technical
problems included: false positive discharges (D)
occurred in 9 pts, misdirected D in 2 pts, and spurious
(non arrhythmicevent) D in 2 pts. Four pts had
defibrillationthreshold >15 joules. In 2 pts AICD was
not triggered because the VT rate was below cutoff.
Initially lead migration was frequent (4/9 pts) and was
approachedby changing device configurationto
patch-patchwith epicardial sensing lead system.
CONCLUSION: Although the device is certainly effective
in preventing arrhythmicmortality, certain problems
exist which need consideration. Technical and device
related problems were frequent, nonlethal and were
inversely related to experience and device refinements.
Suggested refinements include better arrhythmia
discrimination
i
backup pacing
i
telemetry, event
recording and onger battery ife.
VENTRICULAR FIBRILLATIONDURATION AFFECTS DEFIBRILLATION
James N. Black MD, Jean T. Barbey, MD, Debra S. Echt,
MD, FACe, Vanderbilt University, Nashville. TN
The automatic implantable defibrillatordevice
discharges 5-30 seconds after detection of ventricular
fibrillation (VF). To investigate the importance of the
duration of VF on defibrillation (DF), we compared the
effects of VF durations 5, 15, and 30 seconds on the
energy requirements for successful internal DF in 15
dogs. Single pulses of 2 to 40 Joules were delivered
across a 2-electrode catheter and between the distal
catheter and a subcutaneous patch electrode
simultaneously. A total of 75 DF attempts (25 per VF
duration) were tested in balanced randomized order.
Curves of energy vs. %successful DF were constructed
and logistic regression used to derive 90% and 50%
successful energy doses (ED90 and ED50). The mean VF
cycle length (msec) just prior to DF was determined from
discrete RV endocardial electrograms. Four dogs died
during testing, all due to inability to defibrillate
after 30sec VF duration. In the remaining 11 dogs:
5sec l5sec 30sec
ED90 (Joules) 27±13 36±17** 45±lO*
ED50 (Joules) 19±9 25±4 3l±7*
VF cycle length l07±2l 9l±19* 95±18*
*p<.Ol **p<.05 compared to shorter VF durations (ANOVA)
DF with longer VF cycle lengths were more successful
than shorter VF cycle lengths. Hemodynamics remained
stable throughout the testing period.
We conclude that in dogs there are significant dif-
ferences in the energy required for internal defibrilla-
tion after 5, IS, and 30 seconds of ventricular
fibrillation, with longer durations of VF associated
with more rapid VF rates and higher defibrillation
energy requirements. Modest differences in ventricular
fibrillation durationmay have clinical relevance.
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DECREASEDDEFIBRILLATIONTHRESHOLDSWITH
LARGE CONTOUREDPATCHELECTRODESIN DOGS.
Ellen G. Dixon , MS, An th ony S.L. T ang, MD, FR CP C,Patri ek
D. Wolf, MS, Jo hn T. Meador , DS, Michae l J . Fine, BS,
Richard V. Calfee, P hD, Raymond E. Ideker MD, PhD ., Duke
University Medical Center, Durham,North Carolina
A redu ction in th e shockstrengt h required for defibrillat ion
would be advantageous in that it would allow for a decrease in
th e size of the automatic impl antable defibrillat or (AID)
cur rently used an d would red uce th e possibility of myocardial
da mage by th e shock. Based on previ ousmapping st udies we
designed large titanium defibrillation patch elect rodes which
were contoured to fit over t he RV .jlnd LV of~he dog hear t ,
covering approximate areas of 33 cm- and 3!Jern" ,respectively.
In 6 anest hetlzed open-chest dogs t he electrodes were secu red
direct ly to th e epicardium and fibrillat ion was indu ced usin g60
II z alternating current . T runcated exponential biphasic 10 ms
shocks were given 10 s later and defibrillat ion t hresholds (OFT)
were determined . To allow forthe possibility that the elec-
tro des might inte rfere wit h wall moti on , the experi ment was
repeated in anoth er' 6 dogs in which the electrodes weresecured
to th e pericard iu m. Mea nDFT for th e epicardia l and pericar-
dia l electrodes were 106±22 volts (V), 1.26±OA3 jou les (J) and
116±l OV, 1.55±0.52 J , respectivel y. An unpaired t test did not
show any difference bet ween t he DFT for epicardia l and per i-
cardi al elect rodes. Most in tern al defibrilla tion elect rodes
requ ire 5 - 20 J for successful defibrillation in humans an d 3 •
23 J in dogs. Th e DFT we obtained with eit her epicardia l or
pericardial electrodes fall below th ese ranges, indicating th at
su ccessful in tern al defibrillation may he achieved with lower
shock strength using lar ge contoured patch electrodes. Thls
redu ct ion in shockstrength should aid in t he im plementa tion of
a safer , smaller' an d more efficient AID.
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Myocardial and Pericardial Disease
I NTERLEUKIN- I ( IL- I ) I NDUCED CARDIAC DYSFUNC TION
I N AN I N-V ITRO I SOLATED PERFUSED HEART
PREP ARATION. Jeffrey D. Hosenpud, M.D.,
F. A.C.C., Ste p he n M. Campbell, M.D. and David J.
Mendelso n, M.S . , The Oregon Health Sci e nc e s
Uni versity , Portland.
Mo noc y tes a r e ac t i ve parti ci pants i n the
Infl a mma t i o n asso ci ated wi th chronic myoc ardi t is
a nd c a r d Iac allog r aft reje ctio n. Reversible
myoc ardia l dysfunction h a s been demons t rate d in
bo t h co nd it i o ns . IL - I a mo noki ne h a s been
demo nstrated to al ter protei n metabo l ism in
ske l e t a l a nd cardiac muscle and Ca++ flux ac ross
cell membranes. To test t he hypotheS IS t hat IL-
l may direc tl y a l ter myo cardial f u nc tion, IL - I
<' 8 3 u/sec ) in Med i a 19 9 ( I L- t treat ed- n=I O) o r
MedIa 19 9 a lo ne ( c o n t r o l - n= I O) was i n f u s e d i n t o
the a o r t a s o f Iso l a t e d perfused r at hearts.
Af ter a ~ 5 minu t e s t a b i lizat io n per iod, t he
i n f u s i o n wa s starte d a nd heart rate. generated
fo r ce , cre a t i ne p hosphoki nase release and
l actate product ion we re measured ser ia lly. IL-I
resulted in a signif icant reduction o f force
( ex p r e s s e d a s %base li ne , mean ~ I 5 . 0. )
c ompared t o contro l s ( e . g . 6 0 mln- 7 7 ~ 1 1% vs .
87 ~ 7%. P= . Ot6; 18 0 min- 5 0 ~ 14 % vs . 6 5 ~ 11 %,
P=. 0 18 , r e s pect i ve l y ) . He a r t rates , c reatine
phospho kI nase r e l e a s e , a nd l acta te p r o duct io n
we re not d i f fe r e n t b etween IL-I tre a t e d a nd
contro l g roups. IL - I produces a depr e s s ion in
myocar dIal fo rce In t h i s model wh Ich appears t o
be no t s e conda r y to myocardial nec rosis no r a
change f r om aerobic to anerobic metabolism.
EFFICACY OF PREDNISONE THERAPY FOR NEW ONSET IDIOPATHIC
DI LATED CARDIOMYOPATHY
Ricky D. Latham, M.D., John P. Mulrow, M. D. , Renu
Virmani, M.D., Max Robinowitz, M.D. , Cardi ology Svc,
Brooke Army Med Ctr, Ft Sam Houston, TX
For t y patients with new onset "pure" i diopat hi c
dilated cardiomyopathy (without known secondary causes)
have been studied noninvasively and invasively , and
r andomize d t o 3 months of tapering s teroid therapy prior
t o endamyo card ial biops y results to assess t herapeutic
e f f icacy on morphology, exercise tolerance , and
vent ricular fun ction. Randomizat i on irrespective of
biopsy results allowed test i ng fo r efficacy not
pr edicted by myocardit i s . Nine pa tients have expired or
been transplanted(n=9) and 1 is lost to fo l l ow-up. To
date, follow-up for 15 patients not treated (Group I)
and 15 treated (Group 11) is 8.4±4.8 and 9.1±5.6 months,
respectively (p >.05) . Baseline and follow-up left
ventri c ul a r e j ecti on fraction (LVEF) , t ime on graded
exercise test, echo LV dimens i ons (LVID) , and E-point
septal separationwere not signifi cantly diffe r e nt
(p>.05 ) between groups. Inflammatory (I NF ) cat egory was
determined by light microscopy finding of lymphocyte
infiltration and necrosis or Ig deposition >2+( 0- 4
scale). Nine'had inflammatory changes (4 i~ Group I and
5 in Group 11). There were nOstatistical differences
in changes of LVEF, LVID, E-point septal separationor
graded exercise test dur at i on in the subset with INF.
Patients wi th INF underwent repeat endomyocardial bi opsy
i n 3 months whi ch showed reSOlution of I NF for all
patients i n either Group I or 11, but had pathologic
criteria f or car diomyopathy. Therapy with prednisone
a l one does not appear to significantly alter the morpho-
logic course, LV fu nc tion, or exe r c i se tolerance of
pati ents wi th newly diagnosed i diopa t hic dilated cardio-
myopathy independent of the presence or absence of INF.
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FOLLOW UP mos
Perioperative mortalitywas higher in Gp B (p <.02).Arrhythmic mortality at 18
months in Gp Awas 15%, but did not occur in Gp B,and both groups were
improved over historical control (p <.05).
CONCLUSIONS: 1. Arrhythmicmortalityis decreasedby bothATP &AICD. 2.
Devices withtransvenous electrode systems have lower perioperative
complication rates. 3. These prototypeATD require continued surveillance
after implantto assess efficacy& to ensure proper device function.
LONG-TERMEFFICACYAND COMPLICATIONS OFANTITACHYCARDIA
PACEMAKERSCOMPAREDWITH IMPLANTABLEDEFIBRILLATORS.
N Wasty.MD, S Saksena,MD. FACC. V Parsonnst , MD, FACC, SMHussain,
MD. FACC, IGielchinsky.MD. FACC, MShepherd,
NewarkBeth Israel MedCtr,Univ of Med&Dent of NJ, Newark,NJ.
The efficacyof individual antitachycardia devices(ATD) in pts with refractory
ventriculartachycardia(VT) has been reported. However, the long-term
effi cacy of antitachycardiapacemakers(ATP) has not been compared with
that of the automatic implanlable cardioverter/defibrillator (AICD)in pISwilh
sustained ventricular tachycardia. We compared the efficacy and compli-
cations ofATP withAICD &the respective actuarialsurvival ofpts withthese
devices. ATP were implanted using transvenous catheter electrodes&AICD
using epicardial patch electrodes. Four prototype ATDwere implanted in 52
pts with refractorysustainedVT. ATP (Cordis 234A,Inlermedics 262-01,
Cordis 284A) were implanted in 34 pts (Gp A)&AICD were implanted in 19
pts (Gp B).
RESULTS Followup (FlU)duration ranged from 1 to 55 months in Gp A&from
1 to 33 months in Gp B.Duringthis period,ATD activation was recorded in 16
pts (48%) in Gp A&4 pts (21%) in Gp B, Inappropriate se nsing occurred in 1
pt in Gp A&early battery depletion occurred in 3 pts in Gp B.
lOOr----;-""""*=:::::::I==:::::::==:==::AICDu.. ATPi~
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IN VITROCULTIVATION OF LYMPHOCYTES FROMREJECTI~G CARDIAC---ALLOGRAFTS: CF:LL CHARACTF.:RI ZATION AND CORRELATION \lITH
BIOPSY HISTOLOGY.
John F Car lqu i st, PhD, Jeffrey L Anderson, MD, FACC,
Eliza be th HHammond, MD , Michae l R Sr istow, MD, FACC, LDS
Hospital a nd Uni ve r s i t y of Utah , Sa l t LakeCity, UT .
Under s tandi ng ofcellular mechanisms of cardiac allograft
re j ec t i on (R) and therapy of R might be i mpro ved bybetter
characte r i za t i on of cells re spons ib le for R. In vitro cul-
t i vation of ac tiva ted lymphocytes (Le) has re7;ntly become
possible using interleukin-2 ( IL-2). Thus, we cultured
samples from 58 consecutive endomyocardial biopsy (Sx )
procedur es i n 13 pa t i en t sserially evaluated f or possible
R. Each 2-3mm sample was minced a nd cultured (37') in
med ium containing 50 U/m l IL- 2, 57. huma n AB serum. The
presence or absence of Lc outgrowth within 2 wk was ob-
served and correlated in a blinded fashion with biopsy
hi s t ol ogy . Cul t ured cells were characterized by immuno-
fluorescence using monoclonal antibodies. Concordance be-
tween culture snd histology results was noted in 39 (767.)
of 51 ss mpl es with unequivocsl histology (p<.OOOl,
Fisher's exsct test). Positive concor dance of culture and
hi s t ol ogy were noted in 18 (357. ) and negative concordsnce
in 21 (417. ) . False positive cultures (n- 3) predicted R on
t he next Bx, Fal se negative culture s (n-9) appeared to be
explained in partby technical dif fic ul ties (eg inadequate
sa mples). The T8 (suppressor/cytotox i c ) phenotype predom
predo mina te d in es ch of 11 Le cultur es (83+97. of cells).
I n vitro Lc sensitivity to se rial dlluti~ns of methyl
~e~lone was tested by trypan blue dye exclusion in
5 cultures; cy to toxici ty at 24 h occurred wi t h concentra-
tions > 1 mg/ml. Thus , 1L-2 dependen t cultivstion of
Lc f ro; Bx during R i s a promi s in g technique whi ch
should allow f ur t he r characterization of these Lc, includ-
i ng in ~ sensitivity to i mmunosuppressive sgents.
EOSINOPHILIC MYOCARDITIS IN HEART TRANSPLANT
RECIPIENT HEARTS.
Marc A. Silver. M.D., Gayle L. Winters, M.D.,
Maria Rosa Costanzo-Nordin. M.D . • F.A.C.C., John
B. O'Connell, M.D., F.A.C.C., Patrick J.Scanlon,
M.D., F.A.C.C., and John A. Robinson, M.D.,
Loyola University Medical Center, Maywood, IL.
Eosinophilic myocarditis (EM) may occur in a
variety of settings. In 6 hearts explanted for
transplantationwe found EM without
endomyocard1al disease. All 6 pts. were men
aged 20-58 years(mean 48) with either dilated(4 )
or i s c he mi c (2l cardiomyopathy. Two of the pts.
had undergone right ventricular endomyocardial
biopsy(EMB) prior to transplantand no EM was
f o und . In all 6 hearts multiple areas of EM
were seen and included the RV and LV free walls
and the ventricularseptum. The mean pre-
transplantwhite cell count was 10,233/mm3 and
the mean total eosinophil count was l, 197 /mm3(2
pts.315-760 and 4 pts.>lOOO); post-transplant
these means were 13,267 /mm3 and 320/mm3 ,
respectively. No post-transplantbiopsy has
revealed EM. However, a ll 6 pts. have had
histologic evidence of moderate or severe acute
rejection. Prior to transplant, medications
included digoxin(83%I,furosemide ( 83%),
dobutamine(83%1, and captopril(83%). I n
summary, EM occurs in recipient hearts of
pts. undergoing heart transplantationregardless
of t he etiology of the heart disease. The EM
may not be detected by EMB and is associated
with a pre-transplantperipheraleosinophilia
and a more aggressive post-transplantform of
acute rejection.
ENGYMETRIC MONITORING IN DILATED CARDIOMYOPATHY: EVIDENCE
FOR CARDIACPLATELET ACCUMULATION
Franz We idinger, M.D ., Heinz Sochor, M.D. , Peter Wi t t el s ,
M.D. , Hel mar Bergmann, Ph .D ., Helmut Sinzinger, M.D . and
Dietmar Glogar, M.D., Opt of CardiOlogy, Uni versi ty of
Vienna, Austria
The inci dence of t hromboembolic events in pts wi th dila-
ted cardiomyopathy (DCM) is increasedcompared to a
heal t hy popUlation. Since th is poorl y correlates with the
presence of a LV thrombus detected by echocardiography,
we performed routine platelet imaging fOl l owi ng autologous
label ing using100uCi Indium-ll1 oxineand determined pla-
tel et survival half-time (tl/ 2) in 30 pts with DCM (ej ec-
t ion fra ct ion: group A40-55%, n=8; group B< 40%, n=2 2)
as well as in a control group of non-DCM pts. A LV
t hrombus was found echocardiographically in 9 %of pts.
whereas platelet imaging showed signs of focal LV uptake
in 7 %but revealed adiffusely increased uptake over the
heart in 80 %of all pts and a shortenedtl/2 (41±7 hrs,
p < 0.05 vs control). Therefore, we monitored radioactive
accumulationover> 25 hrs in 12 pts followingplatelet
label ing using two small portable engymetricdetectors
(Novo Memolog 600). one located over the heartand the
background detector over the l i ver. Counts were stored in
a portable digital memory at i nterval s of 4 minutes . After
completion of measurementsdata were t ransfe red to a
computer and activity curves analyzed wi th special pur-
pose software . Engymetric moni torin g showed t hat tracer
uptake over the heart was continuously incr eased sug-
gesting enhanced platelet t rapping over the heart . In
conClusion, pts withDCM have reduced platelet survi val
suggesting increased platelet turnover. Engymetr ic
monitori ng may offer a new tool to character ize platelet
retenti on patte rns inrelation t o cardiac accumulation
of labeled platelets.
CHRONIC EDEMATOUS HEART FAILURE DOES NOT IMPAIR SKELETAL
MUSCLE VASODl LATORY CAPACITY IN THE DOG
John R. Wilson. M.D., Vita Lanoce , M.S . , Nancy Ferraro,
R.N. • Joseph Egler, B.S . • Univers ity of Pennsylvan i a ,
Philadelphia, PA
It is widely assumed that sodium and fluid retention in
he art failure (HF) impairs t he capacity of skeletal mus-
cle arterioles to vasodilate, To test this hypothesis,
We induced chronic edematous HF i n 9 dogs by ventricu-
l arly pacing them at 220- 240 beats/ min fo r 2 months . We
then compared skeletal muscle vascular behavi or in this
group wi t h the vascula r behavio r of 8 contro l dogs (C) .
Vascul ar behavior i n t he intact ani mal was assesse d by
measuring systemic and femoral bed vascular resistance
duri ng t r eadmill exe rci se . Intrinsicmuscle vascul ar be -
havior was assessed by measuring vascular resis t ance dur-
i ng exercise and follow i ng papave rine administration in
vascularly and neur ally i solated gracilis muscle perfused
at 120 mmHg . At r es t , HF dogs exhibited asc i t es ( 2 . 3±2. 3
L) and elevated pul monary wedge pressure (HF: 26±8 vs C:
10±3 mmHg), r i ght atri al pressur e (HF: 9±3 vs C: 4±1
mmHg) and gr acilis muscle percent water (HF: 82±5 vs C:
70±7%) (all p<.Ol) . Desp i t e t his evidence of fluid over -
loading. t he HF and C dogs exhibited comparable peak
t r eadmil l exerc i se systemic vascular resistance (HF: 23±5
vs C: 27±7 units) and femoral bed resistance (HF: .5± .1
vs C: . 5±. 3 units) and compa r able gracilis muscle r es i s-
t ance at peak exe rc i se (HF: 1 .6±O .5 vs C: 1 . 8±0 . 9 x 103
units /lOO gmj and with papaverine (HF: 0 .9±0 . 3 vs C:
O.7±0 .3 x 10 uni t s/lOO gm) (a l l p-NS) . These data sug -
ges t that, in chronic heart failure, f lui d and sodium re -
t en tion does not i mpair ske letal muscle va sodi l a t ory ca-
pacity .
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A MONOCLONAL ANrIOODY AGAINST CDXSAc:I<IEVIIDS B4 WHIOl
CROSS-REACTS WITH THE V-I ISOFORM OF MYOSIN:
IMPLICATIONFOR AUIOIMMUNITY.
Kirk W. Beisel, Ph.D., JeanA. Tharpe, B.S., KennethW.
Sell, M.D., Ph.D., Abner L. Notkins, M.D. and Bellur
Prabhakar/EmoryUniversity, Atlanta, GA.
Irrluctionof autoimmunepathogenesishas been implicated
as a sequela to viral myocarditis. A panel of
Coxsackievirus B4 (CB4) neutralizingmonoclonal
antibodies (mAb) were prepared,and then, screenedby
in:l.irect immunofluorescenceusing various mouse tissues.
One mAb, 356-1, reacted only with heart. An A-band
immunoperoxidasestainingpatternwas found with the
ventriclesof mouse, rat, hamster, weakly with rabbit
and not with guinea pig, monkey or human.
Immunochemicalstudies using Western immunoblotting
showed that 356-1 binds to the VP-l capsid proteinof
CB4. In addition, 356-1 reactedwith murine cardiac
myosin. COmparisons were madebetween 356-1 and other
myosin heavy chain (HC) specific !nAbs for their staining
patternof myosin HC fragments. Similar reactivity
patternswere observed between 356-1 and the !DAb CCM-52.
'Ihe CCM-52 reacts with the 1/3 portionof the c-terminus
of the cardiacmyosin HC. 'Iherefore, this suggests that
356-1 reacts with an epitope in a similar region of the
myosin molecule. These data, together with species
staining patternof atrial and ventriculartissues,
indicate that 356-1 binds to the V-I isoform of cardiac
myosin. Thus, the cross-reactivityof 356-1 with CB4
and cardiac myosin demonstratesthat a shared antigenic
determinantbetween virus and normal heart tissue may be
one mechanism for the induction of virus-induced
autoimmuneheart disease.
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VENTRICULAR FUNCTION AFTER DEFIBRILLATION IS GREATER
WHEN ISCHEMIC, FIBRILLATING HEARTS ARE TREATED WITH
PHENYLEPHRINERATHER THAN EPINEPHRINE.
Mark~ Midei, MD, Alan D. Guerci, MD, W. Lowell
Maughan, MD, Seiryo Sugiura, MD, Kiichi Sagawa, MD, and
Myron L. Weisfeldt, MD, FACC, The Johns Hopkins Medical
Institutions, Baltimore, MD.
Epinephrine (EPI) promotes resuscitation from
ventricular fibrillation (VF) because of its peripheral
vasoconstrictive effects. Beta-adrenergiceffects of EPl
may increase myocardial oxygen demand andischemia. To
test whether functional recovery in hearts treated with
a selective alpha-adrenergicagent is greater than in
hearts treated with EPI, VF was induced in 6 isolated
dog hearts while coronary perfusion pressure was
maintained at 30 mmHg. In randomorder EPI (5 mcg/min),
phenylephrine (PE)(50 mcg/min), or no drug was infused
for 5 minutes. Hearts were then defibrillated, drug
infusion stopped, and coronary perfusion pressure raised
to 100 mmHg.
Coronary blood flow (ml/min/kg), arterial-venous
oxygen difference (ml 02/dl) and myocardial oxygen
consumption (ml 02/min/kg) measured after 4 minutes of
fibrillation was muchgreater with EPI (309 ± 117, 17.5
+ 1.6, 54.2 + 18.9), than with PE (244 + 60, 15.7 +
2.6, 38.0 ± 10.5) ,or no drug (198 ± 52, 12~8 ± 1.8, 25.7
+ 6.8)--(p<.05, p<.05, p<.04).
- The end-systo1ic pressure-volume relationship slope
was depressed (% of control) most by EPI (72% ± 17,
n=6), less by no drug (82% ± 12, n=4), and was actually
increased by PE (143% + 17, n=6)--(p<.002). Volume axis
intercepts (VO) were n~t different (p=NS).
We conclude that left ventricularfunction declines
as a consequence of EPI administrationduring VF. This
impairment likely results from increased oxygen demand
and intensification of ischemia.
NONUNIFORM TRANSMURAL RESPONSE OF THE "STUNNED" MYOCAR-
DIUM TO INOTROPIC STIMULATION.
PadraigG. O'Neill, MB, Martin L.Charlat, MD, Craig J.
Hartley, PhD, Robert Roberts, MD, FACC, and Roberto
Bolli, MD. Baylor College of Medicine, Houston, Texas.
Myocardium reperfusedafter reversible ischemia exhib-
its prolonged dysfunction ("stunning").Although stunning
can be reversed with inotropic stimuli, it is unknown
whetherthis response is uniform in the epicardial (Epi)
and endocardial(Endo) layers. Thus, 16 open-chest dogs
underwenta 15-min occlusion of the LAD; 4 h after reper-
fusion, they were given dopamine (10 ug/kg/min i.v. for
15 min). Regional myocardial function was assessed as
systolic wall thickening (Th) by a pulsed Doppler probe
which, sutured to the epicardium,selectively measures Th
at any depth of theLV wall. PercentTh for the Endo, mid
and Epi layers and the entire LV wall (Trans) was
(§p<.05; ~p<.005 vs baseline):
Ischemic Region
pl
Mid 28±2 -12±2 26±3 21±2 16±4 20±2
Endo 39±2 -8±3 27±4~ 21±2 16±4 20±3
Trans 25±1 -10+1 23+2 14+1 10+2 15+1
Four h after reperfuslon, all layers eXhlblted dyskl-
nesis. Dopamine restored mean transmuralTh to baseline
levels, but this effect was not uniform: Epi Th increas-
ed above baseline (+38%), while Endo Th improved but re-
mained depressed (-31% of baseline). Thus, the apparent
normal response of the stunnedmyocardium to inotropic
stimulation results from Epi hyperfunctioncompensating
for Endo hypofunction. Thisinotropic response indicates
that the severity of stunning is heterogeneous along a
transmuralgradient.
MYOCARDIAL ENERGETICS AND TOLERANCE TO ISCHEMIC ARREST IN
HYPERTROPHIEDHEARTS. MR Zile MD, PK Hoshino MD,
CS Apstein MD FACC, and WH Gaasch MD FACC. Tufts Univer-
sity, Boston University, and VA Med Center, Boston, MA
Abnormal myocardial energetics during the preischemic
(baseline) state may predispose hypertrophiedhearts to
ischemic injury. We studied 16 dogs with LVH (Ao band at
8 weeks; echo-cath studies at 1 yr); 10 remained compen-
sated (LVH-C): circumferentialfiber shortening and LVEDP
were normal (>35% & <20 mmHg); 6 dogs developed LV pump
failure (LVH-F): shortening was <35% & LVEDP was >20mmHg.
LV/body wt ratio (g/kg) was 4.4+0.8 in 11 controls,
7.7+1.0 in LVH-C, 9.8+2.7 in LVH-F. The tolerance to 60
min-of global ischemia followed by 90 ~in of reflow was
studied in isolated blood perfused (37 C) hearts (isovol-
umic LV). LV systolic pressure (SP) and EDP were measured
at constant LV volume; coronary blood flow (CBF, ml/min/gm
dry wt) and myocardial oxygen consumption (MV02, ml/min/gm
dry wt) were measured in the empty beating heart.
Increased sensitivity to ischemia was manifest by isch-
emic contracturein LVH-F group (EDP increased to 25+7
mmHg at 60 min ischemia); in control & LVH-C groups EDP
was unchanged. * = p<0.05 vs control, + = p<O.05 vs LVH-C.
BASELINE REPERFUSION
CONTROL LVH-C LVH-F CONTROL LVH-C LVH-F
SP 94+2 104+3 95+4 54+3 46+3 65+5
EDP 10+2 10+2 11+1 13+2 13+2 31+8*+
CBF 5.4+0.9 5.4+0.5 5.6+0.9 5.6+0.6 4.8+0.5 5.8+0.4
MV02 .25+.03 .29+.03 .29+.03 .22+.03 .21+.02 .23+.03
All he~rts extracted lactate at baseline and 90 min~f
reflow. Baseline ATP levels were similar in the 3 groups:
control = 17.9+1.0, LVH-C = 17.3+0.8, LVH-F = 16.9+2.3.
Despite norm~l energetics during baseline and reTlow,
the LVH-F group developed ischemic contracturewhich
persisted during reflow. The tolerance to ischemia in
compensated LVH is normal.
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MYOCARDIAL PRCYffiCTION BY CALCIUM <liANNEL BI.OCI<EI5 OORINJ
ISQIEMIA AID REPFm'USION
N, Olarle /tlrCQS, M,D.. !'b,D.. and Walter L, Henry, M.D.,
F,A,C,C" University Qf CalifQrnia, Irvine,
It has been proposed that calcium (Ca++) channel~lockers
may protect the Il¥ocardium frtm damage due to Ca influx
d~ing ischemia,lreperfusion. Differences in structureQf
Ca blockers suggest possible differences in their mech-
anism of actioo which may influence their protectfve
ability during ischemia, An isolated rabbitventricular
septum preparatiooperfused with Krebs+fllutioowas used
to examine the protective effect of Ca blockers during
ischemia and reperfus.con, Septa were cannulatedand per-
fused at 3.0 ml/min with oxygenated Krebs at 95% 02' 5%
Q) , through the septal artery as in the naturalcrrcuie-
ti6n and paced at 60 beats/min, Ischemia was produced by
lowering the perfusion rate to 0,3 ml/min while maintain-
ing 95% 02 in the perfusate, Developed tension (PT) as
well as creatine ~os~okinase (CPK) release in the
effluent were measured during one hour of ischemia fol-
lowed by 3 hours of reper~usion. Drugs were introduced
into the perfusate at 10- Mat 70 minutes prior to ische-
mia and maintained through the experiment, Recovery of PT
post reperfusionccepared to pre-ischemic values for con-
trol, nifedipine, diltiazem and nitrendipinewas 67, 75,
90 and 95% respectively at 40 min and 75, 110, 100, and
135% at 180 minutes. CPK release surged and peaked tran-
siently at 20 minutes post-reperfusion.CPK release aver-
aged 230, 170, 100 and 130% respectively CClllpared to pre-
ischemic values but stabilized by 180 min~s at 250, 60,
60 and 100% respectively, Thus, all 3 Ca blockers sig-
nificantly (p<O,05) lowered CPK release and preserved PT
during reperfusionbut to varying degrees, Nitrendipine
and diltiazem awear to afford the best protectioo during
ischemia and reperfusion.
INFLUENCE OF RISK REGION SIZE ON FUNCTION OF NONISCHEMIC
MYOCARDIUM DURING ACUTE TRANSMURAL ISCHEMIA. Pao10 N, Marino,
M,O" ThomasAversano, M.O., Lewis C, Becker, M,O" F.A,C,C,;
James L. lIeiss, M,O., F.A.C.C. Johns Hopkins Medica
Institutions,Baltimore, MD
During transmura1 ischemia, dysfunction exceeds the risk
region (Risk) to invo1 veadjacent non-ischenic l1!YocardilJl1. To
define the effect of the size of Risk on the function of
adjacent non-tschsnic l1!Yocardiun, 24 open-chest dogs underwent
dista1 and proxima1 2-3 min circumf1 ex(CIRC) coronary artery
occl usions while cross-sectional 20 echoes were obtained at the
chordal level. Percent systo1ic thickening (%11i) was measured
in 16 equa11y spaced segments around theLV, Size of Risk was
determined by thenulTber of segments exhibiting> 50% reduction
in transmuralmicrosphere blood flow compared to base1 tne,
Adjacent regions (Adj 1-4) were defined as the pairs of four
sequential segments on either side of Risk, and Remote as the
remaining nonischemic segments opposite Risk, Baseline %TH
averaged 40,9 + l,B% (mean + SE), %rH during transmural
ischemia, groupeO by extent oTRisk size, is shown:
Risk Size (nurrber of sel}ll!nts)
1-3 * 4-5 * 6-7 *
AAddJJ' 21 0.7 + 3.5* 7.4 + 3,5* 14.1 + 3.8
%11i 9,9 +"3,7* 19,7 + 3.9 34,5 + 3,1
Adj 3 22,0 + 3,5 36.8 + 5.0 52,0 ~ 5,6+
AdJ 4 30,7 + 4,1 47,0 + 4,6+ 64,4 + 7,9+
* R~te 49,4 + 7,2 62,0 + 6,4 69,6 + 9,3
reducedI increased c'fupared to baselTne%11i (P < O,OST
With increasing Risk size, %TH in each region (Adj1-
Remote) increased, whi1e the nllTber of regions with depressed
funct1 on decreased (ANOVA, P < 0.001), Subendocardia1 and
subepicardia1 flows in Adj and Remotesegments were not
different fron base1 ine and were comareble O'OOng the 3 Risk
sizes, End-diasto1ic LV cross-sectional cavity area (EOA)
during ischenia correlated with 'UH in Adj 2 throughRemote (r
range = 0.32 - 0.47 P range < 0,04 - < 0.002),
Thus
1
during CIRtOCC1uSlon: (1) the function of nonischenic
myocaro ium improves, and the encroachment of regional
dysfunction into nonischenic areas 1essens, with increasing
Risk size; (2) this irrprovement is associated with increased
EDA and may in part be mediated by pre loadeffects,
EFFECT OF AI.TERAnONS OF AFTERLOAD ON TI-E
FUNCTIONAL BORDERZO!'E
Kevin M, Kavanaugh, M,D" Kim P, Gallagher, Ph,D., Dione P,
Poce, B,S" Andrew J, Buda, M,D" FACC,University of Michigon
Medical Center, Ann Arbor, Michigon
In the setting of acute myocardial lnfcrction, pharmocologic
interventlon resulting in afterlood changes are common, The
circumferential extent of reqloncl dysfunction exceeds that of
the ischemic zone and this difference in area is the functloncl
border zone (FBZ), We studied the effects of afterlood
manipulation on the FBZ in 16 open-ehest anesthetized dogs.
During left circumflex coronary artery occlusion (CAD), 8
an imols were infused with phenylephrine (PE) to increase
afterlood; 8 others received nitroprusside (NP) for afterlood
reduction, Circumferentialflow-function mops at the level of
the midpapillary muscle were performed with simultaneous 20
echo and trocerrnicrosphereinjection. Data was collected during
baseline, after CAO, ond CAO plus infusion of PE or NP,
Followlnq CAD, subendocardial blood flow and wall thickening
decreased in the ischemic zone (p <0.001), In both qroups the
circumferentialextent of the wall thickening abnormality wos
consistently greater thon the extent of hypoperfusion, However,
extent of hypoperfusiondid not differ when CAD wos compared
to PE or NP, respectively, When bloodpressurewas decreasedby
33% wilh NP, the extent of the FBZ did not change relative to
the volue during CAD (22Q±IIO vs 36Q±16° p=ns). Nor did the
extent of the FBZ change with PE (32°±IOb) compared to CAD
(370±IOo, p-ns), despite a 47% mean increase in bloodpressure,
With PE there were increases in subendocardial blood flow in both
the FBZ and normol zone (p<0,05); however, there was no change
in regionol wall thickening in the FBZ (l3±4% to 17±3%, pens),
With NP there were no changes in subendocardial blood flow in
both the FBZ and normal zone and no chonge in regional wall
thickening in the FBZ (l8±S% to 16±2%, p=ns), Therefore,
circumferentialflow-function relations and the spatial extent of
the FBZ are not oltered by changing afterload duringacute CAD.
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LDNG-TERMFUNCTION OF HUMAN CARDIAC ALLOORAfTS
ASSESSED BYTWO-DIMENSIONALECHOCARD100RAPHY
Maria L AntunesMD. Michael B. Clark. M.D., Meyer1. Steinhardt,
B.S., Robert e. Robbins, M.D., Helll)' M. Spotnitz, M.D.,r.x.c.c,
Charles Marboe, M.D., Craig R. Smith, M.D., EricA. Rose, MD.,
KeithReerntsrna,M.D., Columbia University P&S, N.Y., N.Y.
Previous studies from our laboratoriesdemonstratedincreasing left
ventricular mass in cardiac allograft recipients over 30 days following
surgery . The etiology andsignificanceof this change were unclear, but
animal studies suggested a possibleCyclosporine-mediatedeffect. Ac-
cordingly, in order to assess late functional results of cardiac allograft-
ing, we peforrned early (2 and 23 dayspostoperatively)and late (IS
months) quantitative two-dimensionalechocardiographyin 14 patients
treated withCyclosporineand prednisone following cardiac transplant-
ation. Changes in left ventricular ejection fraction (EF), end-diastolic
volume (EDV), and mass were analyzed using three short-axis sections
and one long-axis section by a method validated previously . In II of
the 14 patients, end-systolic wall stress (ESS) was also estimated by
echo and systolic blood pressure. The relation between ESS and EF
was used as a load-independent index of LV contractility.
Comparisonof studiesat2and 23 days revealed statistically significant
increases in EF (54±8[S.D.]% to 62±4%,p<O.OI), EDV (84±32mlto
96±31ml, p<O.OI), and LVM(I18±45g to 136±4Ig, p<O.OOOI).
Comparison of studies at 23 days and IS months revealed no significant
change in EDV or LVM. while EF decreased slightly (62±4 to 57±4%,
p<o.OI). ESS decreased when data at 2 days and IS months were com-
pared (84.3±24.5 to 66.6±17.7 glcm2• p<.OI), but no change in con-
tractility was apparent when the EF-ESS relation was analyzed.
We conclude that observed increases in LVM and EDV during hospit-
alization after cardiac allografting are notpredictiveof adverselong-term
results. Late followup ischaracterizedby relative stability of LV mass,
end-diastolic volume. and contractility.
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REFLEX RESPONSES TO LOWER BODY NEGATIVE PRESSURE ARE MARK-
EDLY IMPAIRED IN HEART FAILURE PATIENTS BEFORE AND AFTER
CARDIAC TRANSPLANTATION.
Pramod K. Mohanty, M. D., FACC, James A. Arrowood, M. D. ,
Marc D. Thames, M.D., FACC, V.A. Medical Center andMed.
Co11, of Va., Ri chmond, Va., 23249
Baroreflex modulation of forearmvascular resistance (FVR)
is abnormal in patients with congestive heart failure
(CHF) probably due to decreased cardiopulmonary barore-
ceptor (CPBR) sensitivity and is associated with increased
neurohumoral drive. We hypothesized that cardiac trans-
plantation (CT) will reduce neurohumoral drive but will
not normalize the reflex responses to LBNP because of ven-
triculardenervation following CT. We determined themean
arterial presence (MAP), FVR and plasma norepinephrine
(NE) responses to LBNP in 5 pat ients with end stage CHF
(class III or IV) shortly before and after (8-12 weeks)
CT. The results (mean±SEM) are illustrated in table.
(*p<0.05, pre vs. post transplantation).
Group Baseline :lQ -20 -40
MAP Pre-CT 90±4 86±5 84±5 85±5
(mmHg) Post-CT 112±6* l15±3* ll2±3* l08±5"
FVR Pre-CT 39±7 36±3 37±5 33±3.8
(units) Post-CT 42±6 43±7 43±6 43±9
NE Pre-CT 652±176 6l6±183 5l3±l07 575±196
:pg/ml) Post-CT l04±23" l22±23" l27±23" l05±18"
MAP is higher after CT likely due to cyclosporin therapy.
Our results show that forearm vasoconstrictor and plasma
NE responses to LBNP are similarly impaired both before
(CHF) and after CT despite markedly decreased plasmaNE
post CT. Reduced CPBR sensitivity in CHF and ventricular
deafferentation that occurs with CT may account for these
findings. We speculate that markedly impariedventricular
baroreflexes account for the reducedFVR responses to LBNP
in heart failure just as ventricular deafferentation im-
pairs the responses to LBNP after CT.
IMMUNE-MEDIATED MYOCARDITIS IN THE GUINEA PIG MODEL:
HISTOLOGY AND MECHANICAL AND SARr~PLASMIC RETICULAR
FUNCTION
Thomas J. Shula,M.D.,Michael L. Hess,M.D.,F.A.C.C.,and
Richard M. Schieken,M.D.,F.A.C.C., Medical College of
Virginia Richmond, Virginia
It has been proposed that inflammatorymyocarditis is an
immune-mediated process, but to date, no animal has been
available to test this hypothesis. We have hypothesized
that inflammatorymyocarditis and subsequent myocardial
failure could be induced by the development of alloanti-
bodies to myocardium. Guinea pigs(n=45) were immunized
once/week X 6 with Freund's adjuvant(n=9), pertussis
vaccine(n=9), gentamycin(n=9), in combination with acetone
dried rat heart(n=9) and compared to saline controls(n=9).
At 8 weeks, light microscopy, isolated,working heart
mechanics, and sarcoplasmic reticular(SR) function were
performed. Light microscopy confirmed both diffuse and
focal aggregates of lymphocytic infiltrationnot present
in any of the control groups. Left ventricularfunction
in the experimental group was significantly depressed
whencompared to the saline controls(experimental=1678±
87 versus 2773~328 ml.·mmHg/min;p<0.05). SR calcium
uptake and ATPase activity were significantly depressed
in the experimental group(experimental=O.23±O.Olversus
0.364~0.013 umoles Ca2+/mg-min. ;p( 0.01 and experimental=
0.32±0.12 versus 0.644± 0.06 umoles P./mg-min.;p(0.05),
respectively. Therefore, immune-mediatedmyocarditis can
be successfully induced in the guinea pig and this
inflammatorymyocarditis is associated with left
ventriculardysfunction. The myocardial failure is due in
part to disruptionof the excitation-contractioncoupling
system.
THE MECHANISM OF POST-EXTRASYSTOLICPOTENTIATION IN
NORMAL AND MYOPATHIC HUMAN MYOCARDIUM.
JUdith K. Gwathmey V.M.D.. Ph.D., Roderick MacKinnon,
M.D., Linda Copelas, B.S., James P. Morgan, M.D., Ph.D.
F.A.C.C. Harvard-ThorndikeLaboratory, Beth Israel
Hospital, Boston, MA.
We tested the hypothesis that post-extrasystolicpoten-
tiation (PEP) is due to an increased availability of
intracellularcalcium ([Ca+ ].) and that th
f
myopathic
state may alter PEP. The bioiuminescent Ca +-indicator
aequorin was chemically loaded into trabecularstrips.s
1.2 mm diameter from control and myopathic hearts. The
muscles were perfuse~ with a physiologic salt solution
and maintained at 30 C. Iso~ftric tension (T) develop-
ment and light (L) (i.e. [Ca ]i) were recorded simul-
taneously. The muscles were stlmulated at 5 second
intervals (C). Test stimuli (TS) were inserted at
various time intervals after C. Control strip~ showed
normal PEP with an associated increase in [Ca +]. but no
summation at short intervals. In the figure belo~
myopathic strips similarly demonstratedPEP with an
increase in [Ca++j., but the inotropic effect of PEP was
greatly diminished1 At short intervals of TS, (.8 sec),
summation occurred resulting in an increased amplitude
of the prematurebeat greater than C. These data indica-
ted that PEP is due to an increased availability of
[Ca++.] for activation of the myofilaments and that
abnor~al calcium handling in the myopathic state results
Ln'_~"~"'~d' .~fl:.:i~hUo"
CHRONIC DOXORUBICIN INDUCED CARDIOTOXICITY IN RABBITS:
INCREASED CATECHOLAMINE RESPONSIVENESS, SHORTER
CONTRACTION AND ACTION POTENTIAL DURATION
Hossein Shenasa, M.D., Jean-Lucien Rouleau, M.D., FACC,
~Vermeulen,~c., Collin Bier, M.D., Hoda Eid,
M.Sc., Pierre Paradis, Carl Juneau, M.D., Jacques de
Champlain M.D., Ph.D. Hop. Sacre-Coeur, Universite de
Montreal, Canada.
Doxorubicin .75mg/kg was injected 3 times a week for 11
weeks to 13 rabbits (D), and compared with 16 controls
(C). Myocardial microscopic examination revealed
widespread damage in group D. In vitro developed tension
was lower in group 0 than group C (1.53~1.19 g/mm2 vs
3.33~1.23. p<.0007), time-ta-peak tension (TPT) was
shorter in group D than C (257~58 ms vs 327~57, p<.Ol).
time to half relaxation (RT 1/2) was shorter in group 0
than C 116l~48 ms vs 247~62, p<.002), action potential
duration IAPO) was shorter ln group D than C (72~17 ms
vs l18~16. p<.02). These dlfferences remained the same
at high calcium 6.35 mM and norepinephrine (NE) lxlO-5M
concentrations. However, the percent change of developed
tension with NE stimulation was greater in group D than
C 1276~l03 vs l08~28. p<.OOOll. The increased
responslveness of group D to NE occurred despite higher
plasma catecholamine levels (15l0~586 pg/ml vs 596 ~294,
p<.OOOl), and no significant alterations in
beta-adrenergicreceptor number and affinity. In
conclusion: in contrast to other chronic models of
heart failure, in this model of Doxorubicin
cardiotoxicity. TPT. RT 1/2. and APD are shortened and
responsiveness to NE is increased despite no change in
receptor number and affinity.
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DECREASED CALCIUM UPTAKE BY CARDIAC
SARCOPLASMIC RETICULUM IN HUMAN
CARDIOMYOPATHY.
Maria TeresaOlivari, M.D., ConstantinosJ. Limas,
M.D., T. BarryLevine, M.D., Irvin F. Goldenberg, M.D.,
David G. Benditt, M.D., F.A.C.C., Adrian Almquist, M.D.
University of Minnesota, Minneapolis, MN.
Although calcium transportby cardiac sarcoplasmic
reticulum (SR) has been reported to bedecreased in
experimental models of heart failure, comparabledata
for humans are lacking. Ca2+ uptakewas determined in
myocardial biopsies from 13 patients with dilated car-
diomyopathy and 7 normal controls. Ca2+ uptake in
ventricularhomogenates from cardiomyopathypatients
was considerably lower (3.5 ± 0.6 nmol/mg/min) than
controls (5.8 ± 0.7 nmol/mg/min, p < 0.01). There was
a weak position correlation (r = 0.6) between
Ca2+ uptake rateand cardiac indexand negative corre-
lation (r = -0.55) with pulmonarycapillary wedge
pressure. Plasma norepinephrinewas significantly ele-
vated (569 ± 101 pg/ml) in the cardiomyopathypatients
and there was a significant negative correlation (r =
-0.7) between simultaneous measurementsof plasma NE
and Ca2+ uptakerates. There was no correlationbet-
ween Ca2+ uptakeand extent of interstitial fibrosis in
the myocardial biopsies. These results indicate that
Ca2+ transportby cardiac SR is depressed in human
dilated cardiomyopathyand that this depression
parallels the sympathetic nervous system activation
associated with heartfailure.
Wednesday, March 11, 1987
8:30AM-IO:OOAM, Hall C-l, First Level
Coronary Surgery
ATHEROSCLEROTICANEURYSM OF AORTO-CORONARY VEIN GRAFT
ASA CAUSE OF RECURRENT MYOCARDIAL ISCHEMIA.
Bruce T. Liang
R
M.D., Elliott M. Antman, M.D., F.A.C.C.,
Rfchard Taus, .0., John J. Collins, M.D, F.A.C.C.,
FrederickJ. Schoen, M.D., Ph.D. Brigham &Women's
Hospital, Boston MA.
Although atheroscleroticlesions of aorto-coronary
saphenous vein grafts are frequentand less than half
such grafts are angiographicallynormal 10 years follow-
ing surgery, atheroscleroticgraft aneurysms (AGA) are
rare. We encountered5 cases of AGA seen 6 to 11 years
postoperatively. Symptomatic myocardial ischemia occur-
red clinically in all cases and was manifested as un-
stable angina in 4patients and m¥ocardial infarction in
1. Repeat operationwas necessary in all five patients
because of recurrentsymptoms. Pathological features
common to all cases includedadvanced atheroma,
dilatations rangingfrom 1 to 2.7 cm in diameter,and
poorly organizedfriable thrombi incompletely filling
the lumen. Up to 3 AGA's were seen in a single graft.
The four cases with trueaneurysms had an angiogra-
phic appearanceof contrastmaterial, swirling within
thrombus, initially misinterpretedas extravasation out-
side the graft lumen. This apparentappearanceof extra-
luminal contrastmaterial, termed pseudo-extravasation,
may represent anovel radiological sign of veingraft
failure. While angiographywas unremarkablein the false
aneurysmcase, there was extensive mural dissection.
Conclusions: 1) AGA is a largely unrecognized but serious
late complfcation of saphenous vein grafts; severe myo-
cardial ischemia and even infarction may result from AGA.
2) AGA with marked dilatation may demonstratepseudo-
extravasationon angiography;this radiological signmay
indicate the presence of AGA. AGA may be seen more
frequently in the future with increasingnumbers of
grafts functioning overextended intervals.
LONG-TERM OUTCOME OF REVASCULARIZATION OF ANTERIOR
CORONARY ARTERIES WITH CROSSED DOUBLE INTERNAL MAMMARY
VS. SAPHENOUS VEIN GRAFTS.
Alexander S. Geha, M.D., F.A.C.C., Graeme L. Hammond, M.D.
F.A.C.C., Rabie N. Stephan, M.D., Robert E. KIeiger,
M.D., F.A.C.C., Ronald J. Krone, M.D., F.A.C.C.,
Cleveland, OH, New Haven, CT and St. Louis, MO.
The direction and location of the LAD and of diagonal
and marginal coronaries allow excellent alignment of
the left IMA with the LAD and the right IMA with the
diagonal or marginal. During 1973-78, 43 pts. (Group 1)
had these crossed double IMAs, while 53 pt s , (Group n)
had vein grafts (SVG) to the same obstructed anterior
coronary arteries; 32 pts. in Group I and 43 in Group 11
also had SVGs to other diseased vessels. The two groups
were similar demographically and epidemiologically.
To analyze and compare the long-term outcome of each
approach, follow-up data were expressed in linearized
(A ,%/pt.yr.) and actuarial terms at 5 and 10 yrs. for
late cardiac death (LCD), reoperation (REOP), recurrent
angina (RA) and infarction (MI).
Group I Group Il
A,% %free %free A,% %free %free
lsszu: !!.2r!: at 10yr lssas; !!.2r!: at 10yr
LCD 0.2* 100 98* 1.6 94 82
REOP 0.7* 98 95* 2.4 98 65
RA 1.4* 98* 93* 7.8 84 37
MI 0* 100* 100* 1.8 94 85
(* p <0.01, Group I vs Group rr)
The long-term survival and functional results indicate
that cross double IMAs have significantly better
prognostic effects than SVGs when revascularization
of the anterior coronary arteries is required.
EFFECT OF CORONARY BYPASS SURGERY ON SURVIVAL OF PATIENTS
WITH RESUSCITATED CARDIAC ARREST: A CASS REGISTRY STUDY
David R. Holmes Jr., M.D., F.A.C.C., BernardJ. Gersh,
M.D., F.A.C.C., Michael B. Mock, M.D., F.A.C.C., Kevin
Cain, Ph.D. and Kathryn Davis, Ph.D., Mayo Clinic,
Rochester, MN
Resuscitated cardiacarrest pts are at high risk for
subsequent cardiac death(CD). The effect of surgical
therapy(CABG) on reducing subsequent CD is uncertain.
In the CoronaryArterySurgery Study (CASS) Registry, 817
pts had survived cardiacarrest before entry intoCASS.
During a mean follow-up of 4.3 years, therewere 152
subsequent CD; of these, 52 were sudden while the
remainderwere nonsudden cardiac death. Forty-five
clinical, ECG, and angiographicfactors were analyzed to
identify variables associated with increased risk of
subsequent CD; the most importantwere heart failure
score and number of vessels diseased (P=.OOOl), and
resting ST ECG depressionand LV score (P<.004). CABG
was associated with asignificantly decreased relative
risk of subsequent CD (P=.004). This effect was
independentof the timefrom cardiac arrest to
enrollment. In pts with 2-vessel disease(VD) and
impaired LV function, withmedical therapy(Med Rx),
5-year survival was 64% versus 87% with CA8G (P=.OOl).
With 3-VD and impaired LV function, the results were more
striking; with Med Rx, 46% 5-year survival; with CABG,
78% 5-year survival (P<.OOOl).
In the subset of 52 ptsdying suddenly during follow-up,
CABG was also associated withdecreased relative risk of
sudden death (P=.02). In conclusion, inthis
observational CASS Registry study, in ptsresuscitated
from cardiac arrest with 2 or 3-VD and impaired LV
function, CABG is associated withsignificantly improved
survival compared with Med Rx.
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ACCELERATED CORONARY VASCULARDISEASE IN THE
HEART TRANSPLANT PATIENT: CORONARY ARTERIO-
GRAPHIC FINDINGS
Shao Zhou Gao, MD, Edwin Alderman, MD, FACC, John
Schroeder,MD, FACC, James Silverman, MD, Sharon Hunt, MD,
FACC, StanfordUniversity Medical School, Stanford,CA
Coronaryvascular disease (CVD) was noted in 41.5% (37/89) of
patients (pts) transplanted (Tx) prior to 1979 and in 33.3%
(44/132) of Tx pts operated on post-1979. Since 1969, annual
coronary arteriograms have been obtained, permitting serial
side-by-side comparisons. Lesions in 81 Tx pts exhibiting CVD
were subdivided into morphologictypes. A) Discrete tubularor
multiple stenoses; B) Diffuse concentric narrowing witheither
abrupt proximal onset of narrowing or gradual tapering and
vessel obliteration. The 81 arteriogramsshowing TxCVD were
contrasted with 32 arteriograms from nontransplantcoronary
disease (CAD) pts for severity, extent and morphologicfeatures
of CVD. The 32 CAD ptangiogramsshowed 178 lesions; all were
type A (discrete or tubular)in character;133 (75%) in the three
primary epicardial coronary vessels and 45 (25%) in secondary
branch vessels. In the TxCVD pts, 349 of 462 (76%) lesions were
Type A; 198 (57%) were inprimary vessels, 146 (42%) were in
secondary branchesand 5 (I.4%) were intertiarybranches. Of
the 133 (24%) Type B lesions (diffuse narrowing, tapering and
obliteration),28 (25%) were located in primaryvessels, 49 (44%)
in secondary vessels and 35 (31%) intertiarybranches(p <.05 for
TxCVD vs CAD pts). Total vessel occlusion was located in
proximal and middlesegments in 28/29 (96%) CAD pts vs 19/37
(5I%) TxCVDpts, Conversely total occlusion was distal in 1/29
(4%) of CAD pts vs 18/37 (49%) TxCVD pts (p <.002). In the
presence of total vessel occlusion, collaterals were poor or
absent in 92% of Tx pts vs 7% of CAD pts (p <.002). We
conclude that CVD in Tx pts may be a mixture of typical
atheromatous lesions and unique Txrelated progressive distal
obliterativedisease without collateraldevelopment.
ABSTRACTS
CAN RECRUITABLE<XlLIATERAIS PRCf1'ECT GWBM. LEFT
VOO'RHI1LARFUOCTION AFTER ABRUP1' CX!lONARY oca.uSION?
~er BrtrV.D'J.John 'lliomton, Phd, Marc Cohen,. ., rIT hens: 1'1.0,
St.V1ncent s and Mt.SlIlai Medical centers, New York NY
We have previously derronstratedreversible apj::1earance
of recruf.tahlecollateralsduring inflation of an
angioplasty balloon. It is not Known whether
recru~table colla~rals can protect left ventricular
function (EF) dunng coronaryclosure. In the present
st~ we correlatedEFduring ballQOninflation with
collateral status and lesion locat1on in 29 pts with
normalbaseline EF and I-vessel di~~l lfll Pts had
proxima+ LAD lesions (~LAD), fIl m1d-LAD (rrr-LAP) and 9
RCA Iesdons, A second"artenalaccess was used for
left ventriculographyand collateral assesSllellt before
balloon placement 1baselre'~) l and Qurjng c.oronary
closure after 45 secs. 0 Da.1l00n inflation
Collateralswere identif ed at baseline in 8~s
(b-col.I}, 14 pts had recruitablecollaterals Which
became v1sible only during balloon inflation (r-coll),
7 pta had no recrultableCollater~li_ (no-eolll".
Differences of EF dur ing balloon inflation between
collateral groups wereaesessed by two-way N.¥:NA
considering 1es1on location and aajusting for baseline
EF.
Res.ul.t.fi: Collateral statys and lesion location were
~o deterllMe EF dunng balloon inflation. Four
Slgn1f1cantly d1fferent grouPe wereidentified (p<.05).
l!~LAD' no-eoll: EF=38.6%; 21~LADi r-coll: EF=53.6%;
3 rrr-LAD, all subclroupsand ReA r-eo 1; EF-64.2%
4 ReA, Q-coll: Er=73'. (StandaJ;;:Qdevllltion=7.fIl)
~US~:l) WS with RCA dlsease and collaterals
i1- f?El e, gl function is carpletelypreserved
irrmed1atelyfollow coronaryclosure. 2) In pts with
proximal LAD lesions, recJ;uitablecol:J,ater;alsJ;llirtially
protect global left ventricularfunct10n immed1ately
after coronaryclosure; only \;hose pta without
recruitablecollaterals e~r1enced-irrmediatecritical
reductionof EF. Althouahthe i1-bility of recruitabl~
colli1-terals to protect LV funct10n QVer a longer per10d
of t1rne after coronaryclosure rema1nsto be assellsed,
these findings may be helpful in the managementof
abru~ cor;onaryocclusion occurringas an angioplastic
cOOillicatlon.
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ADRENERG IC I NFLUENCES ON THE DENERVATED HUMAN
CORONARY CIRCULATION.
John McB. Hodgson. M.p •• Mark D. Cohen, M.D., S.
Szentpetery, M.D., Marc D. Thames, M.D.,
F.A.C.C., McGulre VAMC and MedIcal College of
VirgInia, RIchmond, VA.
SympathetIc nerves normaI IY InnervatI ng the cor-
onary cIrculatIon are Interruptedby cardIac
transplantatIon(Cn. ResIdual adrenergIc Influ-
ences on the coronary cIrculatIonmust be due to
cirCUlatIng catecholamlnes. Our study determIned
whether cIrculatIng catecholamlnes Influence the
denervated coronaries of patients (n=15) after
CT (13!- 9 mol and the adrenergic receptor
type(s) Involved. We used dIgItal angIography to
determIne IndIces of reglonlll c o r c ne r v blood
flow and epIcardIal artery dIameter (DIAM).
Coronary flow reserve (CFR) was calculated as
the ratIo of flow durIng Intracoronary(Ic)
papaverIne-Inducedmaximal vasodilatation to
basal flow. Measurements were made durIng et
(phentolamIne, 3mg l c ) or s(propranolol 2mg l c )
and combIned blockade. Results: (mean + SEM)
(* p<0.05 pre vs post) (DIAM In mm) -
et S et + B
Pre Post Pre Post Pre Post
n 9 9 20
CFR 3.0!..22.7!..3 3.6i.5*4.9!-.7 3.4:!:..33.1!-.3
DIAM 3.2!..4 3.4:!:..5 3.1:!:..23.2:!:..2 3.2:!:..2*3.3!-.2
Thus, cIrculatIng catecholamlnes exert effects
on the coronary cIrculatIonmedIated maInly by
S -receptors. These effects occur dlstal to the
large epIcardIal arteries. We speCUlate that
there Is tonIc S - mediated vasodll atatlon and
that abolitIon of this Influence accounts for
the observed changes In CFR.
Wednesday, March 11, 1987
IO:30AM-12:00NOON, Hall Col,First Level
CoronaryArteryDisease: Long-Term Follow-Up-
PTCA-MedicalTherapy-Surgery
MLVE YEAR FOLLOW-UP OF PATIENTS WITH UNSTABLE ANGINA
PECTORIS RANDOMIZED TO MEDICAL OR SURGICAL THERAPY
Richard O. Russell, Jr., M.D., F.A.C.C., JohnB.~
M.B.A., Edgar D. Charles, Ph.D., Nicholas T. Kouchoukos,
M.D., F.A.C.C., Williaa J. Rogers, M.D., F.A.C.C., The
University of Alabamaat Birmingham, Birmingham, Alabama.
Published studies indicate that the efficacy of medi-
cal (M) vs surgical (S) therapy for the treatmentof
subgroups of pts with rHO must be assessed through
studies with long term followup. The study population
consists of 106 pts randomized to M (N=56) or 8 (N=5l)
therapy at the AL Center of the Nat'l Cooperative Un-
stable Angina Study. Mean age is now 64.9 yrs. At base-
line M&8 pts were not statisticallydifferent based
upon demographic, clinical, and coronary characteristics
(Mean I ves diseased; M=1.9, 8=1.9). Twelve yr survival
rates are 74.5' for 8 pts and 71.4' for Mpts. Among the
Mpts 74.2% of the persistent M and 66.7%of the late S
pts survive. Among the surviving pts 61' of both groups
report their health status to be fair or poor. Mpts
report fewer restrictedactivity days (16.5 vs 42.0) and
bed days to illness or injury (8.5 vs. 14.7). In the
last 3 mos only 22.9% of Mpts reportedangina symptoms
compared to 53.8% of 8 pts (p 5 .05). Mpts were less
likely to perform moderate to strenuous activity (51.4%
vs. 61.5%). Mpts had slightly lower utilization of
hospitals and physicians (51% of Mpts were hospitalized
compared to 57' of S pts; Mpts had 3.9 physician visits
compared to 6.8 for S pts). While most pts were near or
above retirement age, 31.4' of the M and 19.2%of the S
pts were emp (for pts < age 65, 55.6% of M and 50.0' of
8). This study shows "today'a"long term survival is
similar in groups of pts with unstable angina pectoris
who were randomized to Mor 8 therapy. While both groups
were similar in many outcome andlife style variables,
fewer Mpts reportedsymptoms of angina pectoris.
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EFFECT OF COMPLETENESS OF REVASCULARlZATION ON OUTCOME IN
PATIENTS WITH UNSTABLE ANGINA UNDERGOING PERCUTANEOUS
TRANSLUMINAL CORONARY ANGIOPLASTY.
David R. Holmes, MD FACC, Ronald E. Vlietstra, MD FACC,
Guy S. Reeder, MD FACC, John F. Bresnahan, MD FACC,
Dennis R. Bresnahan, MD FACC, LaVon Hammes. Mayo Clinic,
Rochester, MN.
Complete revascularization(CR) has been felt to be
important to achieve maximal symptomatic improvement in
pts undergoing percutaneous coronary angioplasty (PTCA)
for multivessel disease (MVD). To evaluate the importance
of this concept in pts with unstable angina, we analyzed
follow-up in 77 pts with single vessel disease (SVD) and
100 consecutive pts with MVD and unstable Canadian Heart
Association Functional Class IV angina (UA) all of whom
had successful PTCA. CR was defined as successful PTCA
of all significant stenoses (> 70%) in any major epicar-
dial vessel. Incomplete revascularization(IR) was suc-
cessful PTCA of > 1 significant stenosis but> 1 residual
significant stenosis. CR was achieved in all SVD pts and
34 MVD pts; 66 MVD pts had IR. Event free survival was
calculated for each group at 6, 12, 18, and 24 months
using coronary surgery, myocardial infarction, death, or
angina Functional Class III or IV as end points.
MVD SVD
Follow-up CR IR ~
interval n=34 n=66 n=73
6 mos 94% 98% 93%
12 mos 83% 78% 92%
18 mos 75% 73% 92%
24 mos 75% 67% 92%
Conclusion: 1) In selected pts with MVD and UA, IR is
associated with a similar event free survival to that
with CR. 2) Irrespective of completeness of revasculari-
zation, pts with MVD have decreased event free survival
compared to SVD.
FACTORS INFLUENCING THE LONG·TERM (FIVE YEAR) PROGNOSIS
OF PATIENTS WITH VARIANT ANGINA.
Ann Walling, KD, David D. Waters, KD, FACC, D. Douglas
K111er, KO, Den1s Roy, KO, FACC, Guy B. Pelletier, KD,
FACC, Pierre Theroux, KD, FACC, Montreal Heart
Inst1tute, Kontreal, Kontreal, Canada.
The factors influencing survival and survival without
myocardial infarction were assessed in 217 consecutive
patients with variant angina hospitalized in our CCU and
followed for a mean of 65 months (range 2-123). Their
mean age was 51 (range 24-71); 165 were men and 52 were
women. In 161 cases transient ST elevation was detected
during rest angina and in the remaining 56 it was seen
only after ergonovine. Coronary arteriography, done in
all but 9 patientsI revealed no stenoses ~70'- in 87,
one vessel disease m 81 and 2-3 vessel disease in 40;
501192 had abnormal left ventriculograms. Extent score
was calculated by counting the tlumber of coronary seg-
ments with 5-751. stenoses. Initial treatment consisted
of nifedipine, diltiazem or verapamil in 146 patients,
other med1cal treatment in 39 and bypass surgery or PTCA
in 27. Thirty pts (141.) died and 54 others (251.) had a
myocardial infarction. Nine of 30 deaths and 22 of 54
infarctions occurred within the first 3 months. Only 56
pts (261.) had an~ina at latest follow-up.
By stepwise Logi stLc regression analysis, the variable
that best predicted survival (p<0.004) and survival
without infarction (p<O.OOOl) was the number of ves·
sels with ~7ot. stenosis. Other independent variables
that predicted survival without infarction wer-e normal
LV function (p<O.Ol), low extent score (p<O.02), initial
treatment with a calcium blocker (p<0.03) and ST e Ieva-
tion seen only after ergonovine (p<0.03).
Survival (I.~ Survival. no
Years I 3 1 3
<70~ stenosis 9~ 9~ 94 91 8~
1 vessel 98 93 93 85 80
2-3 vessels 88 81 75 66 58
All patients 95 92 89 82 75
Thus, the strongest predictor of long-term prognosis in
variant angina is the number of severely stenotic
arteries. By 5 years over half of those with multivessel
disease have died or had a myocardial infarction.
THE RESULTS OF PERCUTANEOUS TRANSLUMINAL CORONARY
ANGIOPLASTY FOR UNSTABLE ANGINA IN THE ELDERLY
Geoffrey W. Ho1t, M.D., Dec1an D. Sugrue, M.D., John F.
Bresnahan, M.D., F.A.C.C., Ronald E. Vlietstra, M.D.,
F.A.C.C., Guy S. Reeder, M.D., F.A.C.C., Dennis R.
Bresnahan, M.D. and David R. Ho1mes Jr., M.D., F.A.C.C.,
Mayo Clinic, Rochester, MN
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Event-free survival following successful PTCA was 90%at
6 mo and 79% at 18 mo; at last follow-up 58% were free of
angina.
In conclusion: PTCA for UA in the elderly was
safe and effective. Early (0%) and late (7%) mortality
were low and only 4 pts (7%) had persistent severe
angina.
Between December19BO and November 19B5, 60 patients
(pts) >70 years underwent percutaneous trans1uminal
coronary angiop1asty (PTCA) for unstable angina (UA). UA
was defined as recent onset angina (within 1 month [mo]),
new onset of rest angina (>1 episode) or accelerating
Class Ill/IV angina (Ill/IV A). There were 26 males and
34 females with a mean age of 73.6 years. Thirty-four
pts (57%) had single vessel disease. Twenty-six pts
(43%) had mu1tivesse1 disease. PTCA was successful with
>40% increase in luminal diameter stenosis in 48 pts
(80%). PTCA was unsuccessful in 12 pts (20%); 5 had
emergency coronary artery bypass surgery (CABG) and 7
elective CABG. Two pts sustained Q wave infarctions
(QMI). There were no deaths. Follow-up (>6 mo ) was
available in all pts for a mean duration of 20 moo
Follow-up events:
Death
3
EARLY AND LONG-TERM OUTCOME AFTER PTCA IN STABLE
VERSUS UNSTABLE ANGINA
Hans-J.Rupprecht,M.D.,Rudiger Brennecke,Ph.D.,
Raimund Erbel,M.D., Tiberius Pop,M.D., Dieter
Jung,Ph.D., Margarethe Kottmeyer, Rudolf Hering,
Jurgen Meyer,M.D. University of Mainz, FRG.
PTCA was performed in 398 patients with stable
(group A) and 181 patients with unstable angina
(group B). The primary success-rate was 84% in
group A and 78% in group B (ns). A repeated co-
ronary angiography could be performed in 219
patients with stable and 93 patients with un-
stable angina. The restenosis-rate amounted to
25% respectivly 39% (p<O.Ol)six months after
the initial procedure. The complication-rate for
the first PTCA was evaluated in terms of death,
myocardial infarction and emergency bypass ope-
ration. We found a significantly lower incidence
of deaths and emergency bypass operations in
patients with stable angina (p< 0.01) compared
to the group with unstable angina. No serious
complication was seen in 68 patients with a
second PTCA-procedure (p < 0.01) . Within a 3-year-
follow-up period the patients with succesfull
PTCA had significantly higher mortality (p<0.05)
rate of myocardial infarction (p< 0.05) and rate
of coronary bypass surgery (p<O. 01) in group B.
acute chronic
stable unstable p stable unstable p
Death 0,3% 2,8% 0.01 0,6% 2,6% 0.05
Infarction 1,6% 2,2% ns 0,6% 3,9% 0.05
Bypass 0,3% 2,2% 0.01 7,0% 18,2% 0.01
Thus unstable angina was followed by a lower
success-rate, higher restenosis-rate and a high
complication-rate in the acute and chronic stage
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LONG-TERM FOLLOW-UP OF ANGIOGRAPHICALLY DOCUMENTED
CORONARY ARTERY DISEASE IN PATI ENTS UNDER AGE THIRTY.
El l i ot M. Gerber, M.D. , Douglas S. Moodie, M. D. ,
L A.C.C., DonaId A. Under wood , M. D. , LA.C.C., and
Matthew Passalacqua, B.S. Cl eveland Clini c Foundation,
Cl eve l and , OH .
Seventy-six males under ag e 30 wi t h catheterizati on
pro ve n coronary artery disease ( CAD) were fo l l owed for a
mean period of 129 mos. ( r ange 82-185 mos. ) in order to
determine prognosis (PX) and opt i mal t herapy in this
group. After a mean period of 10 . 8 yr s , 33% have died .
Fifty-six percent of the surv i vors co nt inue to have s ymp-
t oms. The most common complaints a re angi na ( 71%) ,
dys pnea (43%) , and fatigue (43%) . Of the 50 survivo rs,
46% ha ve required repeat hosp i tal i zati ons i n the last 5
y rs and 22%are fully disabled. Ther e was a high inci-
de nce of cigarette smoki ng (86%), eleva te d se r umcholes-
t erol (74 %), and positive fa mily history of CAD (6 7%)
among pts with the disease. As would be expected,
mortality was adversely affected by the presence of left
ventricular scar (P(0.006) and by heavy cigarette smoking
(P(0.02) . There was no correlation between mortality and
functional class, number of vessel s i nvol ved , serum
chol es t e rol , hypertension, or family hi story. The
mortality of those treated medically has been 42% vs 21%
fo r tho se treated surgically (P(O .0 56) , despite having
more severe CAD in the surgically t r ea t ed group ( 2 .4
ves sels vs 1.8 vessels involved ) . Twelve yea r actuarial
mortali ty is 51% for the medically treated gr oup vs 25%
for the surgically treated group (P(0 .05) .
We f ee l that CAD in pts under 30 is a malignant
pr oces s with a high mortalit y and continued morbidity for
those surviving the disease. Ris k factor modification a t
an early age is clearly indica ted. Surgical intervention
appea r s to i mpr ove PX.
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VentricularArrhythmias:Signal Averaging and
Mapping
SI<IW.AVEJlACiD B:Xl PIBlICTSnE OOtcIBILl'IY<F SlSl'AINED
vamlICIWTACH'tCAJl)IAIN PATIEm'SldTII S'Cm'AIBXEtm-
SWTAl1fi) TACH'tCAJl)IA
G101a 'l\1r1tto.MoO" JoIn Fa1tldne,HoO.,~ Hec.1na,HoO. El:illlllt!
Caref',B.S., Slanthe lhell,HoO.,F.A.C.C., Chr1lI stawrls,HoO., NEi:l1l
El.-&Ierit,HoO.,F.A.C.C.- state thivoensity of New York, Health S:lieIXle
c;srt:.erllIXl 'leter'fIls Adm1njstretjmMedjca1 c:enter, &"ocklyn,Nr
A~~ B:Xl (SA-a::G) aIX!p~ sUDulatial (PS) were
per1bnIB:l 1n 75 patients (pta) \bl IBl 1llJl-«lSta1ned VIlI'Itrioolar
~:Ia (IS-VI', )3 pl"llllBture vmtrJcular OCIIPlexee at a r9te
>lOO1mln) aI Iblter. 'lb1rty-five pts IBl 00lUlllI'Y artery lU8eBBe
(CAD), 30 jdjopatlJjcdilate:!can:I~ (CW), 2 valwlBr heBrt
dJMBee, llIXl 8 were "oon!Bl". Pts were divided into 2 groups: IlI'tlUPI
(42 pts) IBl short lUllS «10 beets) of m-VI', IlI'tlUPII <33 pta) hsI
1aller lUllS (~O beets,<30 seocnls) • We poUmjals (Ih) were
caIB1dere1 preeEl'ltifroot lIERl IlC/-I8l'ewl~ of the last IlO IllS of the
<Rl ., .E2'jIN llIXl duratialof low a1pl1tude~ of <1lO )IV" ~8
IllS. PS (3 EllCtlWltuul1, 2 rjght vmtr1oo1ar sitee) _ caIB1dered
PCJ!Iitive if susta1lIed VI' (S-W, last~ ~ seocnls or~
tena1llatialby can:I1ovoensialor pac~) _ IDlwai.
IESIUS: GIUF I GIUFII roUL
S-W: Jncjdence 36% 2llS 31%
Ih: Irojdence 24S 15l aJ%
5em1tivity 53S 3IlJ 48S
~ity 93S 92S 92S
+ PmUctive 'lalue alS 60S 73%
- Predictive 'lalue 78ft !l2J alS
!rII\xljbleS-W ., IIDnl freq.mt 1n pts ldth tbln 1n tmle ldtho.lt Ih
[11/15 (73%) vs 12/60 (aJ%),p <0.011. The JroJdenceof Ih llIXl their
predicti'levallIe were oot sjgn1f1oantly d1ffilreDt 1n pts ldth CAD or
O!P. cxx:umOO: In pts ldth llIXJl\:.IDlalSI6-W: 1) SA-a::G predicts the
1lIluoJb1l1tyof S-W,both 1n pts ldth CAD aIX! CH'j 2) the :iJmdemeof
Ih llIXl 1D:loo1ble S-W 15 ~fIlt tron the ~ of spal~
lUll5j 3) 1n the~ with Ih, the :!lIlidence of :In:Iuc1bleS-W is
IUgh ro1 awroacheB the reported 1oojdlD:le 1n pts with l'eCUm!Ilt S-W.
SIGNAL AVERAGING PREDICTS INDUCIBILlT Y OF SUSTAINED
VENTRICULAR TACHYCARDIA IN PATIENTS WITH HIGH GRADE
ECTOPY AND NON-SUSTAINED VENTRICULAR TACHYCARDIA.
J. Ant hony Gomes , M. D. , F. A.C.C. ; St ephen L. Winters ,
M. D. ; Debra Stewart, R.N. ; Phili p Barreca , B. S. Mt .
Si na i Medi ca l Cent er, New York, N. Y.
In duc i bili t y/ non-inducibil i t y of ventricul ar tachycardia
(VT) by prog r ammed e lectrica l s t imul a t i on (PES) are
prognostic mar ke r s in patients (pt s) with hi gh gr ade
ectopy (HGE) and non- susta i ned VT (VTns ). However , which
of t hese pts sh ou l d unde rgo PES, remains undef ined .
To dete rmi ne i f s ig na l averaging (SA) ca n predict the
i nduction of su s tained (S) VT, we s t udi ed 38 pt s (6 1
± 12 yrs ) with HGE (>10 VPB ' s/hr + coupl e t s - 9 pt s )
and VTns ( >3 bea t s - 2 9 pe s I . Twenty-s i x pts (677. ) had
i schemi c h; ar t disease. Al l pt s had PES with t he use
of up to 2 extrastimuli and burst pacing. SA of t he
sur fac e QRS complex was done ~24 hours before PES,
utiliz in g 40 Hz high pass bidirectional filtering. The
dur a t i on of the SA-QRS complex , the l ow amplitude signals
of <401Jv (LAS) and the RMS-Voltage of the terminal 40ms
(V40) wer e determined. Results: Nine pts (24%) had
VTs i nduce d (Group I) (Gr ) and th e remaining 29 pts
( 76%) were non- i nduc i bl e (Gr 11 ) . E. F. was not differen t
be t ween the Gr ' s ( 32 ± 9% vs 37 ± 14% p=n. s.) . The
i nc i dence of ab SA parameters are shown below:
Gr I Gr 11 Pval ue
V40 «ZOlJv) 8/9 (89%) 6/ 29 (2 1%) <. 005
LAS (>38ms) 6/ 9 (67%) 7/ 29 ( 24%) <. 05
SA-QRS ( >l 14ms) 4/ 9 (44%) 8/ 29 (28%) NS
V40 had the best Sensi tivi t y (89%) and Specificity ( 79%).
Conclus i ons : Late potentia l s (V40) are highly se nsitive
and specific fo r i nducti on of VT. Thus , signa l averaging
may be a va l uabl e scr eeni ng test for selection of pts
wi th HGE and VTns fo r PES.
THE NATURAL HI STORYOF VENTRICULAR LATE POTENTIAL
ACTI VITY IN ACUTE MYOCARDI AL INFARCTION
Susan J Lewis BM BS MRCP, Paul T Lander B~c DPhi l ,
Penelope A Taylor , Douglas A Chamberlain MC FRCP and
Richar d Vince nt HI FRCP, Roya l Sussex County Hos pital,
Brighton , Uni t ed Ki ngdom.
Ventricular lat e potentia I s (VLP) may pr edict ventricular
ar r hythmias after acute myocardial infarction (AMI) but
l i t t l e is known of their natur a l histor y . We us ed signal
av er aging t o f ol l ow the evo luti on of VLP in 48 patient s
followi ng AMI with recordings earl y after major symptoms
(4. 4 hours), at 12-18 hours, 24 hours, 2,3 and 7 days,
and 6 weeks. Infarctionwas arter i or in 21 patients and
i nferior in 27. 34 patients r eceived an intravenous
thr ombol yt i c agen t (APSAC) ; 13 patient s devel oped vent ri-
cu l ar f ibrilla t i on withi n 24 hours and 5 pat i ent s suff-
er ed l a t e ventri cular arrhythm i as or sud den death. Hy po-
ka laemia (s erum potassium<3. 5) was noted in 13 patients .
VLP wer e ident i f i ed i n 23 pa t i ent s ; they wer e present in
t he earl iest record i ng i n 16 pat i ent s and persisted in
all s ubsequent r ecordi ngs i n 12 . VLP a~peared late i n 3
patients (2 a t 2 day s and 1 at 6 weeks ) and wer e present
i nt er mi ttent l y in 6. Al l 5 pa t i ent s with late ventricu-
lar a r r hyt hmi as or s udden dea t h exhi bited ei t her inter -
mit t ent or persistent VLP. VLP were present in only 7 of
t he 13 pat i ents with ear l y ventricul ar fi brillation. No
asso c i at io n was found in this study bet ween VLP and
i nfa r ct site, peak enzymE rise, hypokalaemia, or the
administration of thrombolytic t her apy . A s ingl e recor -
ding i s in suff icient t o determine the presenc e of VLP
whi ch may de velop early or lat e after infarction. While
VLP de t ect ed i n any recording are an i mporta nt pr edictor
of l a t e ver.tri cu l a r arrhythmi as and su dden death they do
not id ent i fy r i s k of early vent r i cul a r arrhythmias.
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VENTRICULAR FIBRILLATION AMPLITUDE PREDICTS ABI LITY TO
DEFIBRILLATE Kennet h R.St ults BS, PA-C, Donald D.Brown MD,
FACC, Richard E.Kerber MD, FACC Univ . of Iowa Hospitals ,
Iowa Ci ty , lA.
Our purpos e was to evaluate t he relat i onshi p between
ventricular fibrillation (VF) amplitude and ability t o
defibril late. Cont i nuous VOi ce /ECG r ecord in gs of 172
prehospital car di ac arrests wi t h VF were examined. VF
amplitude was det er mi ned bymeasur i ng the trough-to-p eak
magnitude of deflections in t he 6 secon d period prior t o a
shock. The hi ghest amplitude def l ecti on which occurred at
l east 10 t imes wit hi nthe period was r eported. Defibril -
l ati on outcome was determ inedfor three gr oupi ngs of VF as
fo llows:
5(6%)
22(27%)
54(67%)
16(37%)
Coarse VF
(LQ,}!!\Y)
43
81
32( 74%)
12(13%)
36(19%)
69(3 7%)
82(44%)
Medium VF
(0 .3-0 .6mV)
91
186
29(32%)
0(0%)
16(15%)
24(23%)
66(62%)
Fin e VF
(9 .1,-O.,2I1lVj
38
106
3(8%)
# Patient s
Total # Shocks
Or gani zed rhyt hm
after 1st shock *
Shocks resulting in
organized rhythm*
Shocks resulting in
persist ent VF *
Shocks resulting in
asystole **
Survi val t o hospi t al
di scharge ***
*p<.OOl ; **p<.02 5; ***p<.005
Abili ty t o achieve def i br illati on was much greater for
coarse than for medium VF, whi le f ine VF patients se ldom
def ib rillated and never sur vi ved. This observatio n may
have implications for t he design of VF detection
al gor i t hms for automatic ext er nal defibrillators . 100%
Sensitiv ity for VF may not be clinically i mportant as long
as th e detectio n al gor ithm is insensitive onl y to fine VF.
The effects of antiarrhyth mi c drugs on t he spat i a l
di stribution of low le vel activity at t he end of t he
QRS complex was investig ated in 27 patient s wi t h
document ed ventricul ar t achycardi a . The bodysurfac e
potentiaIs were recorded with 63leads during sinus
rhythmbefore and after medication: amiodarone in 11
pati ents, sot a lol hydrochloride in 6, procainamide in
5 and combinations in 5. Series of i sopot ent ial maps
of th e averaged and fil t er ed (25 Hz ) ECG signal s wer e
drawn at QRS off set . Aft er drug s , t hefil ter ed QRS
dura t ion signif ic ant l y increased from 123~25 mSeC to
1 33~3 2 msec (p<O . Ol ) , while t he average vol t age of the
l ast 40 msec of the QRS (V40) was not signif i cant l y
altered ( 49~ 39 uV and 39~27 uV re spect i vel y) and the
number of pat i ent s withV40 <25 uV changed f rom 12 to
10 only . The maps showed a dipola r potential
di s t ribution wit h pairs of extrema that were cl ose in
10 pati ent s and distant in 17 patients . Af t er drugs,
the locati on of the ext r ema remainedthe same in 26/27
patient s . These resu lts suggest that antiarrhyth mic
drugs may change the conduct i on del ay but do not alter
the l ocati on and or i ent at io n ofthe sour ces of late
act ivity.
ABSENCE OF CHANGES IN BODY SURFACEMAPS OF
SIGNAL-AVERAGED LATE ACTIVITY IN PATIENTS WITH
VENTRICULAR TACHYCARDIA AFTER ANTIARRHYTHMIC DRUGS
Gerard Faugere , M.D. ,Pierre Savard, Ph.D., Regi nald
Nadeau, M. D. , FACC, Mohammad Shenasa , M. D. , Ph.D. ,
Pierre Page , M.D., FAce , Den i s Derorne , M. Se . A. ,
Hopital Sacre-C oeur , Uni versit e de Montreal, Canada.
ELECTROGRAMPATIERNS PREDICTING SUCCESSI'UL CA1lIETER ABLATION OF
VENTRICULAR TACHYCARDIA.
David H.Fitzgerald. !!Il, Xaren J . Friday, !!Il, FAce, John A.Yew>g Lai
Wab, KBO>ll, Ralph Lazzara, !!Il, FAce and Warren H. Jackman ,!!Il, Univ
of Oklabolllll and VA Medical center, OklahOlDll City, OK
We sought to i dent i f y electrogram patterns which would pred ict
effI cacy i n percutaneouscatheterablation of ventriculartachycardia
(VT) . We attempted ablation of 14 monomorphic VTs i n 10patients{pts)
by delivering 1-4 DC shocks of 200 Joules. In 5 VTs, shocks were
deli\'"ered to endocardial sites recording discrete mid-diastolic
potentials which were not continuous with the main ventricular
potential recorded during the QRS complex , but which alWays remained
associated with the VT during initiation, termination, and prograDlDed
extrastimuli ( Pat t ern A). First ablation attempts were successful in
4 /5 , and a repeat attempt at another Pattern A site was successful in
the f ifth . In the remaining 9 VTs, shocks were delivered to s ites of
earl iest ventricular activation continuous with the main potential
during the QRS complex (Pa ttern 8) . "8" potenti als preceded the QRS
by 35-1 20 IISOC (medi an 78 esec ) • First ablation attempts were success-
ful in only 1/9. Ablation attempts were repeated in 5; 2 at sites
recording fiAt! potentials, both successful ,and 3 at s ites recording
"B" potentials with activation beginning 45, 60,and 85 as ec before the
QRS. The latter two attempts were successful.
A total of 8 attempts were made at nAil s ites, 7/8 succe ss f ul. Twelve
attempts were made at 1t8" s i t es , onl y 3/1 2 successfuL Earliest
activation preceded the QRS by 60 -1 20 msec i n the 3 successful "Bit
attempts and by 35-100 msec(median 55) in the 9 unsuccessful attempts.
We conclude that ablatio n i s likely to be succ essful at sites where
"A" poten t ials are identified , and far less likely to succeed at
"B" s ites even when activity precedes the QRS by up t o 100 mlec .
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Arrhythmias: Mechanisms
Q-lARACfERISTICS OF ENTRAINMENT OF OROODRIJvIIC CIRruS
M:l\'FMENT TACHYCARDIA DURING AlITODEClID1ENTAL ATRIAL AND
VENTRIOJLARSTIMULATION
Agustin Castellanos, MD FACC, Liaqat Zaman,MD,FACC,Bolivar
POTtlllo,MD, BaroUh v. Berkovits,EE,FACC, Pedro Fernandez,
MD, and Robert J. Myerburg, MD, FACC, University of Miami
School of Medicine, Miami, Fl orida.
Waldo's defini t i on of entrainment (E) of a c i r cus movement
t achycardia (CMT) during overdri ve atri al (A) and ventricu-
l ar (V) pacing( P) requires that the A-A, V-V and His bundle
(H)-H intervals become equal to t he P cycle l engt h (CL) and
that the CMT r esume upon cessation of P. In the present
st udy, the characteristics of E during autodecremental P
were evaluated by means of a specially-des i gned ext ernal
~~dtronic pacemaker.Wi t h the program usedthe PCL decreas-
ed, st arting from the CL of ~IT, by 3-6 %intervals, unt i l
t he tachycar dia terminated (TT) or 15 stimuli(St ) were de-
liver ed. In 6 patients with mani fes t Wolff-Parkinson-"hite
syndrome, 83 episodes of orthodromic~IT were treated. While
perform ing autodecremental AP in 21 epi sodes , E was seen
in all episodes pr io r t o TT except when t he initial St
penetrat ing the circuit produced TT. Because E invariabl y
took place during Wenckebach sequences t he H-H and V-V in-
t ervals were lon ger than t he correspondi ng St -St in-
t ervals . Thi s finding was not in keeping with the "clas-
s ical" definition of E.Of th e three criteria for di agnos i s
of E,the f irst was unfulfilled because const ant fus iondid
not occur. However , t he second andthi rd criteria wer e met.
On t he ot her hand , dur in g aut odecremental VP,E was prese nt
conceptuall y in all but 1 of 62 episodes, but without de-
most rating any of the three di agnostic cr i t er i a ("conceal -
ed" E). To summarize: 1) autodecremental AP produced a
form of Enot fulfilling the "classical" definition;and2)
autodecremental VP consistently re sulted in "concealed"E.
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INCIDENCE AND PATTERNS Of RESETTING DURING ATRIAl
fLUTTER: ROLE IN IDENTIfYING CHAMBER Of ORIGIN.
Jeaus M. Almendral MD, Angel Arenal MD, Manuel Abeytua
MD, Daniel SanRoman, MD, Javier Soriano MD, and Mark
E. JosephsonMD, FACC, Hospital Provincial de Madrid,
Spain andUniversity of Pennsylvania, Phila. PA.
The frequency andpatternof resetting of atrial
flutter (AF) was studied in 18 pta with inducible AF
using atrial extrastimuli (AES) . Single AES were de-
livered at decreasing coupling intervals from the high
RA (n=18) and the lateral coronary s inus (CS,n=13) .
Double AES were delivered from the same s i t es (high
RA=16; CS=10 ) with the coupling interval of the first
AES fixed above the resetting zone of a single AES. AF
was reset from the high RA in 16/18 pts, and from the
CS in 12/13 pts. The returncycle (measured at the
pacing site) at the high RA was similar to the AF cycle
length (meandifference 4~12 ms ), and exceeded it by
37+23 ms (p<0.001 vs. high RA ) at the CS. AES required
for resetting were less prematurefrom the high RA than
the CS (27+12 vs. 66+22 ms less than the AF cycle
length, p<~001). The resetting pattern was described
as flat, increasing, or mixed defined by whether the
returncycle was constant, i ncreas ing or wasinitially
fixed then increas i ng in response toAES at decreasing
coupling i nt erval s . Ten of 12 AF in which the reset-
ting pattern was characterizedshowed a flat or mixed
pattern. We conclude: 1) HostAF can be reset by AES.
2) Shorter returncycles and longer couplingintervals
required for resetting at the RA suggest this chamber
as the origin of AF. 3) A totally or partially flat
resetting response pattern, suggesting a fully excit-
able gap, i s observed in mostAF. Thus responses to
resetting can be used to characterize the reentrant
circuit and localize the origin of AF.
DOUBLE-SPIKE ELECTROGRAMS IN ATRIAL FLUTTER:
VALIDATION AS A MARKER OF LOCAL ATRIAL CONDUCTION
DELAY.
Francisco G Cosio MD FACC, Fernando ArribasMD, Jose M
BarberoMD, Jose L BarrosoMD, Ramiro Chicote MD.
Hospital Central de la Cruz Roja, Madrid, Spain
Fragmentation oflocal electrograms from the
posterior RA wall (most commonly a double-spike, OS)
has recently been described during atrial flutter (F).
To further assess OS electrograms as a possible marker
of conduction delay in F,we continuously recorded
bipolar electrograms (1 cm electrode separation)
during attempts at entrainment by by pacing fromRA (6
cases) or coronary sinus (CS) (4 cases) sites.
Baseline OS separation of 55-95 ms was reduced
30-50% during RA pacing, suggesting antidromic
penetrationand fusion within theOS site and entrain-
ment of the Fcircuit. CS pacing did not change or
increased OS separation (up to 30%) suggesting
orthodromic penetrationof the OS site without fusion.
In all patients atrial capture was confirmed by
simultaneous recording of multiple electrograms.
These f indings suggest that OS represents activa-
tion on both sides of a conduction delay zone within
the F circuit. Antidromic penetrationof OS site from
the RA and orthodromicpenetrationfrom the CS are
consistent with reports of F circuits rotating coun-
terclockwise (frontal plane) in the posterior RA wall,
and suggest a role of OS sites in the support of F
reentry circuits.
RESETTING Of SUSTAINED VENTRICULAR TACHYCARDIA WITH ECG
FUSION: INCIDENCE AND SIGNIFICANCE
Mark E. Rosenthal, H.D.; Nlcholas J. Stamato,H.D.; Jesus
M. Almendral, M.D.; Charles D. Gottlleb, H.D.; Hark E.
Josephson, H.D., F.A.C.C. Unlv of Pa, Philadelphia, PA
The purpose of this study was to define the Incidence and
characteristicsof ECG fusion In ventricular tachycardias
(VT) res et by single and/or doubleventrlclarextrastlmull
(VES). Fifty-three sustained uniformVT, In 44 patients
with pr ior myocardial Infarction, were reset by single or
double VES del ivered at t heRV apex. Resetting was defined
as being present If the pause following theVES was less
than fuii compensator y. ECG fusion produced by the stimu-
lated Impuise which reset the VT was defined by 1) a VES,
del ivered after the onset of the VT ORS, which reset the
VT or 2) a stimulated ORS IntermediateIn morphology be-
tween VT QRS and a fully paced ORS. Twenty-six of 53 VT
demonstratedresetting with fusion. In 9 of these 26 VT,
the stimulus artifact of the VES causing resetting was
deilvered after the onset of the VT ORS complex. Record-
ings of the iocal electrogramsat the site of VT origin
were obtained duringresetting of 12 VT; In 8 of 8 VT
reset with surface ECG fusion, the stlmulus artifact of
the VES caus ing resetting occurred after the onset of the
site of or igin electrogram, while 2 of 4 VT reset without
ECG fusion demonstratedthis phenomenon. Nineteen of 26 VT
reset with fusion had areturncycle (VES to VT ORS onset)
iess than the VT cycle length compared to 1 of 27 VT reset
without fusion (p<.05) Inconclusion: 1) Half of VT reset
by single or double VES demonstrate ECG fusion. 2) A re-
t urn cycle less than the VT cycle length Is more c~on
when VT is reset with ECG fusion. This finding has not
been observed Intriggered rhythms. 3) VT reset with ECG
fusion requires separate entrance and exit sites at the
site of VT origin. These findings strongly favor reentry
as the mechanism In this subgroup of VT.
ENTRAINMENT AS A GUIDE FOR LOCALIZING lHE SITE OF
VENTRIOJLAR TAOiYCAROIA. .tlU..1.uI a StayenSQn• .MJl.
James N. Welss, MoO., F.A.C.C., l saec Wlener, MoD.,
F.A.C.C., Koonlllwee Nademanee,14.0., F.A.C.C., Daniel
Wohlgelernter, 14.0., F.A.C.C., LawrenceYeatman, 14.0.,
Martin Josephson,14.0., UnIversIty of Callfornlll, Los
Angel e s,
Arells with abnormal endocllrdlal electrogramshave been
shown to be the substrate for ventrlculllr tachycardia
(VTl. We studIed the lib IIlty of sIngle stImulI to
advance VT (entrlllnment) at multiple LV sItes wIth
ebnormat electrograms. In 4 patlents with old
mYOCllrdIal InfarctIon and recurrentVT the card lac eycIe
was scanned wIth 2 msec10 mll stImuli at 16 LV
endocerdl et sItes during VT. In 3 pts a sIngle sIte was
IdentIfIedat which single extrastlmulI reproduclbly
advanced VT with marked conductIon delaywithout
alterIng the surface ECG or ~ electrograms. At one of
these sItes ablative shocks were delIvered and prevented
InducIble VT ImmedIately but notlate (10 days)
afterwllrd. Inthese 4 paflerrts and 8additIonal
plltlents with VT llfter myocardIal InfarctIon, ~
sf lmulef lon dIstant frO/ll the VT focus never advancedVT
without evidence of ventrIcularcapture In the surface
ECG.
These fIndings suggest that entraInmentwIthout
morphologIcalterationof the surface ECG and~
electrograms may Indicate that the pacIngsite Is In
close proximity to the VT circuit. EntraInmentmay be
useful In distIngUishIngareas of abnormlll electrIcal
actIvity which particIpateIn a VT cIrcuIt from dead and
pathways of fractlonatadelectrIcal activIty which are
not InvoIved In the VT.
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CONDUCTION THROUGH AN ISTHMUS OF TISSUE IN VIVO.
K Inoue, M.D., D.P. Zipes, M.D., Krannert Inst. of Car-
diology, Indiana Univ. School of Med., Indianapolis, IN
Antiarrhythmicdrugs preferentially prolong refractori-
ness of accessory pathways (AP), compared to atrial or
ventricularmuscle,due to intrinsic properties of AP or
depressed conduction over an isthmus of tissue. To test
the latter possibility, we surgically isolated right
atrial myocardium in anellipse (10-25 x 8-15 mm) exceP2for a narrow isthmus [cross sectional area (CSA):1-12 mm 1
penetratedby the sinus node artery or its branch. In 10
dogs, effective refractory period inside (ERPI) andoutside (ERP ) of the isolated myocardium was determined
using extras~imuli (2 ms pulse, 2 x diastolic threshold)
at a pacing cycle length (PCL) of 300 ms. The shortest PCL
with 1:1 conduction via the isthmus was also determined.
Diastolic threshold (0.19+ 0.22 vs 0.15+0.10 mAl and ERP
(149±15 vs 148±19 ms) wer; the same inside and outside the
isthmus. The shortest PCL with 1:1 conduction from the
inside to the outside did not differ from the outside to
the inside (169+39 vs 161+31). CSA of the isthmus corre-
lated inversely-with the ;hortest PCL with 1: 1 conduction
in both directions via the isthmus (r=-0.73, p<O.OOl).
Procainamide (10-20 mg/kg, i.v.) prolonged ERPI (172±21,
p<O.Ol) and ERPO (177±13, p<0.05), and the shortest PCL
with 1:1 conduction (inside~outside: 215±84, p<0.02;
outside~inside:203±55, p<O.Ol)in 8 dogs. After procain-
amide, the increase in the shortest PCL with 1:1 conduc-
ti~n in both directions was greate2 in 3 dogs with CSAS4mm than in 5 dogs with CSA>4 mm (82±60 vs 38±18,
p<0.05). Conclusion: in vivo, an isthmus of tissue de-
presses conduction, which is further depressed by procain-
_ideo Depression of conduction by the isthmus and
procainamide is greater if the isthmus is narrower. These
findings help explain the effects of antiarrhythmicdrugs
on AP which acts as an isthmus in patients with WPW.
Wednesday, March 11, 1987
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Myocardial Disease: Clinical Correlates and
Pathophysiology
SENILE CARDIAC AMYLOIDOSIS WITH FUNCTIONAL IMPAIRMENT:
DIAGNOSIS BY MYOCARDIAL BIOPSY AND IMMUNOHISTOCHEMISTRY.
Lyle J. Olson, M.D., Morie A. Gertz, M.D., William D.
Edwards, M.D., F.A.C.C., Ch1n-Yang L1, M.D., David R.
Holmes, Jr., M.D., F.A.C.C., A. Jamil Tajik, M.D., F.A.C.C.
and Robert A. Kyle, M.D., Mayo Clinic, Rochester, MN.
Senile cardiac amyloidosis (ASc) is frequently found at
autopsy in Pt >80 yr old; and it has been associated ret-
rospectively with congestive heart failure (CHF) and fatal
arrhythmias. However, with functional cardiac impairment
by amyloid without an obvious immunocyte dyscrasia, dis-
tinction between ASc and primary systemic amyloidosis
(AL) has not been made ante mortem. This distinction is
important since treatmentand prognosis for ASc and AL
differ. In our study, among 7 Pt with amyloid on
myocardial biopsy (HEx) but no clinical evidence of an
immunocyte dyscrasia, immunohistochemicalstaining was
used to differentiateASc from AL. Five Pt had ASc: 4
with CHF, and 1 with presumptive hypertrophic
cardiomyopathybefore MBx. Two Pt had AL. In no Pt was
cardiac dysfunction explained by coronary artery or other
disease. On the basis of history, physical exam, chest
x-ray, ECG, echocardiography, coronary angiography, and
light microscopy of MBx tissue, Pt with ASc were
indistinguishable from Pt with AL. Only immunohisto-
chemical staining separated the two. Despite marked
functional cardiac impairment, all Pt with ASc are alive
(mean, 16 mo after MBx). In contrast, in previous studies
of AL with similar degrees of cardiac inVOlvement, the
median survival was only 5 moo The 2 Pt with AL in this
study died at 5 and 11 mo after MBx. This report
documents for the first time that immunohistochemical
staining on MBx can distinguish ASc from AL in living Pt.
Therefore, because treatment and prognosis for ASc and AL
are different, this distinction is important.
PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME AND
HISTOPATHOLOGICALMYOCARDITIS FREQUENTLY MANIFEST MAJOR
CLINICAL CARDIAC ABNORMALITIES. Joseph M. Reilly, M.D.,
Robert E. Cunnion, M.D., David W. Anderson, M.D., Renu
Virmani, M.D., Timothy J. O'Leary, M.D., and Joseph E.
Parrillo, M.D., Crit Care Med Dept, NIH, Bethesda, Md.
Acquired Immunodeficiency Syndrome (AIDS) is a severe
viral disease that results in opportunistic infections
involving multiple organs. In general, the heart has been
relatively spared. Recently, several anecdotal cases of
AIDS have been described to have myocarditis, defined as
mononuclear cell infiltrate and myocyte necrosis. To
evaluate whether myocarditis in AIDS patients is function-
ally significant, we extensively reviewed the clinical
courses of 47 consecutive, unselected, autopsied AIDS pts.
Eighteen (38%) met criteria for myocarditis, and 13 of
the 18 had one or morecardiac abnormalities (13 pts, 20
abnormalities): 7 ECG abnormalities, 6 ventricular
dysfunction (4 clinical heart failure; and 2 decreased LV
ejection fraction), 4 ventricular tachycardia (VT), and 3
pericarditisor a pericardialeffusion. Five of the 18
had no clinical cardiac abnormalities. Of the 29 AIDS
patients with no myocarditis, 6 had ECG or pericardial
abnormalities, but none had LV dysfunction or VT. Pts with
clinical cardiac abnormalities had a significantly higher
incidence of myocarditis than pts without such abnormal-
ities (68% vs 18%, p(.OOI). All pts with LV dysfunction
or VT had myocarditis (p(.OOI). Only 1 of the 47 pts had
histologic findings suggesting cytomegalovirus disease.
Thus, myocarditis may be an important cause of clinical
cardiac disease in AIDS. In AIDS pts, serious cardiac
events such as ventriculardysfunction or VT occurred
only in the presence of myocarditis.
THE FOCAL NATURE OF MYOCARDITIS: A LIMl£1~(; FaCrUK IN
ENDOMYOCARDIAL BIOPSY DIAGNOSIS.
Teresa P. Darcy, M.D., Maureen A. Langloss, David
Anderson M.D. Ph. D., Max Robinowitz, M.u., f.A.~.L.,
Renu Virmani, M.D., F.A.C.C., Armed Forces Institute of
Pathology, Washington, D.C.
To determine the limitations of myocardial biopsy in tue
diagnosis of myocarditis, we studied oij autopsy patients
(pts) who died of myocarditis and compared these to LU
sudden traumaticdeath (STD) victims l~age JJ+ij).
Clinical, autopsy records and H&E sections of-heart
(2-12 per case) were reviewed. 4~ pts were >l~ years in
age (iil 32+13) and 23 were < 15 (iD 5+5). All met our
criteriaof myocarditis (myo): The presence of inflamma-
tory foci of at least 5-15 cells and myocyte necrosis.
Cases were classified by the extent of inflammation into
mild (3-5 foci/slide, 5-15 cells/focus), moderate (mod)
(6-20 foci/slide, 16-50 cells/focus), and severe lsev)
myo (diffuse inflammation, > 51 cells/high power
field), and ongoing (ong) myo, defined as fibrosis and
myo in the same section.
Results: Viral Illness Myocarditis
Group (No. days) SO CHF(No. days) Mild Mod Sev Ung
Myo (68) 54(6+6) 55 12 (9+12) 2tl 13 1b 11
>15yrs(45) 33(7+7) 37 8 l14+14) LO 7 7 11
<15yrs(23) 21(6+5) 18 4 (l+.~) tl 2 'I U
Control (STD) - - - *10 U 1 U
*without necrosis; SD 2 sudden death. Occasional foci
of inflammationwere found in 55% of the control pts out
only one had necrosis, therefore to diagnose myocarditis,
necrosis is essential. The majority of pts witn myo
(79%) had a history of preceding viral illness and died
suddenly. Conclusion: Since the maJority of patients
(72%) had mild to moderate myocarditis, endomyocaruia1
biopsy is not a sensitive method for its detection.
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MYOCARDIAL DYSFUNCTION DURING CHRONIC RAPID VENTRICULAR
PACING: ROLE OF MYOCARDIAL ISCHEMIA
Vita Lanoce. M.S., Nancy Ferraro, R.N., John R. Wilson,
M.D., University of Pennsylvania, Philadelphia, PA
Chronic rapid ventricular pacing in the dog produces a
useful model of heart failure associated with
biventricular pump dysfunction and severe depression of
left ventricularwall thickening. To investigate whether
the depressed left ventricularwall thickening is due to
myocardial ischemia, we examined the effect of rapid ven-
tricular pacing on myocardial blood flow and metabolism
in 6 dogs. Following morphine and pentobarbitalanesthe-
sia, Wilton-Webster thermodilution coronary sinus,
femoral arterial, and Swan-Ganz catheters were inserted.
Coronary sinus blood flow, arterial and coronary sinus
blood oxygen saturationand lactate, and systemic hemody-
namics were then measured at 0, 10, and 20 minutes before
pacing and at 10, 20, 30, 40, and 60 minutes during pac-
ing at 260 bpm. Control measurements were averaged. All
measurements after pacing were comparable and therefore
also were averaged. Pacing increased the pulmonary wedge
pressure (9±3 to 20±3 mmHg) and decreased the cardiac
output (1.7±0.3 to 1.2±0.2 L/min) and meanarterialpres-
sure (85±7 to 73±6 mmHg) (all p<.02). Pacing increased
coronary sinus blood flow (38±18 to 113±64 ml/min) and
myocardial V0 2 (5. 0±2. 3 to 14. 3±8. 2 ml/min) (both p-c.01)
but had no significant effect on myocardial lactate ex-
traction (38±9 to 30±8~) or myocardial oxygen extraction
(75±5 to 74±5~). These data suggest that myocardial dys-
function during rapid ventricular pac ing is not due to
myocardial ischemia.
THE EFFECTS OF LONG TERM HEMODIALYSIS ON CARDIAC
METASTATIC CALCIFICATION IN CHRONIC RENAL FAILURE:
ASSESSMENT BY 20 DOPPLER ECHOCARDIOGRAPHY. John S.
Gottdiener, M.D., F.A.C.C., Robert Shalhoub, M.D.,
Marvin Glover, R.D.M.S., Judith Gay, Christopher
McManus. Veterans Administrationand Georgetown
Medical Centers, Washington, D.C.
Ectopic calcification of body tissues has become more
frequent as chronic hemodialysis programs have extended
into their second decade. To evaluate the relation
between hemodialysis and calcium(CAL) deposition in the
heart we did 20 Doppler echo in 45 men (av age 57 9
yrs) of whom 30 (Group I) were on dialysis from 1 mo to
11 yrs (av 6.1 2.2 yrs) and 15 (Group 11) were on
dialysis for greater than 11 yrs (av 15.2 4.3, range
11.5-16.8 yrs) , Mitral annular CAL was found in 3/30
(lO%) Gr I pts vs 8/15 (53%) Gr II pts (p<O.Ol) and was
associated with severe gradients in 2 symptomatic Gr 11
pts. Dense aortic valve echos were found in 5/30 (17%)
Gr I pts and 7/15 (47%, p<0.05) Gr 11 pts; of whom 3 had
aortic valve gradients from 15-5OmmHg. The incidence of
tricuspid (42%) and mitral (40%) regurgitationdid not
differ between groups. Aortic regurgitationwas more
common in Gr II (5/15, 33%) than Gr I (2/30, 7%, p<0.01)
pts. There was no significant difference between groups
in age, serum CAL, serum creatinine or parathormone
levels.
Hence: The incidence of cardiac CAL increases with time.
In pts on dialysis for longer than 11 yrs cardiac CAL
may result in mitral and aortic valve stenosis.
Triscupid and mitral regurgitationare common in both
groups although aortic regurgitationincreases with
time.
ABSTRACTS
ISOLATION AND CHARACTERIZATIONOF A MYOCARDIAL POLY-
PEPTIDE THAT IS MITOOENIC FOR FIBROBLASTS
Ben Calvo, MD, Michael Klagsbrun, PhD, Stephen E.
Epstein, MD. FACC, Edith Speir, BS, Joachim Sasse, PhD,
Judah Folkman. MD, WardCasscells. MD, Children's
Hospital Medical Center. HarvardMedical School. Boston.
MA, and NHLBI, Bethesda. Maryland
Heparin-affinitychromatographyhas allowed the puri-
fication from brain and tumors of a family of polypep-
tides of MW 15-18,000 that are angiogenic in vivo,
chemotactic for capillary endothelial cells in vitro
and mitogenic for capillary endothelial cells. fibro-
blasts, and smooth muscle cells in vitro. To determine
whether such factors were presentinthe ischemic heart.
we excised the infarct zones of foxhounds 3 hours after
left anteriordescending coronary artery ligation. After
homogenization and centrifugation, the supernatantwas
acidified to pH 4.5. and the proteins precipitatedwith
50J. then 95J (NH4)2S04' Theresuspended pellet
was dialyzed against Tris/EDTA, run twice through a
heparin-sepharosecolumn and eluted with NaCl gradients.
In confluent starved Balb/c 3T3 cells fractions eluting
from 1 to 2 Mproduced a growth phenotype and increased
incorporationof tritiatedthymidine. SDS-PA gel elec-
trophoresis showed several bands, from 14-18,000. These
fractions immunoreacted by slot-blot with a polyclonal
antiserum against the N-terminus of cationic fibroblast
growth factor (FGF). A third heparin column yielded
a single band at 14,000 which was mitogenic but not im-
munoreactive. Thus, infarctedmyocardium yields several
polypeptide mesenchymal mitogens, one of which is similar
if not identical to bovine FGF, while the purified mitogen
is not. These polypeptides may influence angiogenesis and
wound healing,
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Pharmacologyof AntiarrhythmicDrugs
A MODEL FOR FREQUENCY DEPENDENT DEPRESSION OF MAXIMAL
UPSTROKE VELOCITY BY TYPE I ANTIARRHYTHMIC DRUGS.
James Coromilas, M.D., F.A.C.C., Gregory A. Kidwell, M.D.
and ChristopherJ. Damm, M.D. Columbia Univ., N.Y., N.Y.
Frequency dependent depression of Vmax (FDD) by Type I
antiarrhythmicdrugs is a direct consequence of differing
affinities of the drugs for the three states of the Na
channel. We used a model of FDD in which drug interac-
tions during the action potential (AP) upstroke, plateau
and recovery time (RT) at resting transmembranepotential
are characterizedby effective association (k) and disso-
ciation (1) rate constants (RC). We used a two mi-
croelectrode voltage clamp to control transmembranepo-
tential and measured Vmax as an index of available Na
current in ovine cardiac Purkinje fibers. Four effective
RC were estimated from conditioning pulse experiments: ku
(moles-l AP-l) for upstroke binding, kp (moles-I sec-I)
for plateau binding, Ip (sec-I) for plateau unbinding,
and lr (sec-I) for unbinding during the RT. During
trains of stimulated AP we used the clamp to control the
voltage and durationof the AP plateau and the voltage
during the RT. Computer simulated AP trains with varying
plateau durations and RT using experimentally determined
RC for lidocaine (L), quinidine (Q), and flecainide (F)
predicted actual train experiments. The decrease in Vmax
during trains is well fitted by an exponential function
with both the magnitude of FDD and the time constant for
the rate of development of block both explicit functions
of the four RC. The rank order for the magnitude of each
of the RC was L > Q > F. The time constant for the rate
of development of block during AP trains at cycle lengths
of 500 msec was 0.3 sec for L, 3 sec for Q and 30 sec for
F. In conclusion, FDD by Type I drugs can be modeled us-
ing effective RC for drug binding and unbinding during AP
upstroke. plateau and RT. The characteristicpatterns of
FDD by each of the subclasses of Type I drugs is well
described using this model.
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DIFFERENTIALEFFECTS OF CLASS I AND CLASS III
ANTIARRHYTHMICDRUGS ON REENTRY IN A CHRONIC CANINE MODEL
OF ATRIAL FLUTTER, Virginia B. Frame, Ph.D. andThomas J.
Colatsky, Ph.D., Wyeth Laboratories, Inc. Philadelphia,PA
The relative efficacy of conduction Class I vs. Class
III antiarrhythmicagents in terminatingreentrant
arrhythmiaswas evalusted in a modified Rosenblueth and
Garcia-Ramosmodel of atrial flutter (AFL). In
anesthetized dogs (n=7), a "Y-shaped"surgical lesion was
made between the vena cavae and extending across the free
wall of the RA. Bipolar epicardial electrodes were
implanted and the leads exteriorized. AFL was induced by
programmedstimulation at least two weeks post op while
dogs were conscious. Drugs were infused i.v. until AFL
terminated (effective dose, Dose). Class III agents
terminateAFL but only prolong cycle length (CL) by
15.6.±1.5% (n-8). Class I agents also terminate AFL but,
in contrast, prolong CL by 62+8.9%. n=14 (p<O.OOl).
(+ proprsnolol, 1 ms/kg, pretreatment)
quinidine(la) 11.0+5.6 145+6.6 52+4.2
disopyramide(Ia) 3.6+0.6 140+1.0 41+1.6
flecainide(Ic) 2.0±0.3 143+5.7 68±10.4
tocainide(Ib) 38 140- 102
ISOLATION AND CHARACTERIZATIONOF CARDIAC Ca++-CHANNEL
PROTEIN.
Jeong H. Im, Ph.D., Byung H. Chung, Ph.D., W.Thomas
Woods, Jr., Ph.D., Elias Meezan, Ph.D., Dale J. Benos,
Ph.D., and William J. Rogers,M.D., F.A.C.C., University
of Alabama at Birmingham, Birmingham, AL.
In the literature,molecular weights (M.W.) of
1,4-dihydropyridinebinding Ca++-channel proteins are
greatly different. They were determinedafter membrane
preparationswere labeled with3H-l,4-dihydropyridine
derivatives containing a highlyreactive group. Thus,
the difference may be due to the labeling of extraneous
membrane protein(s). To obviate this possibility, we
have extracted membrane proteins from isolated cardiac
myocytes, and then Ca++-channel protein was partially
purified. The partially purified Ca++-channel protein
was photoaffinity labeled with 3H-azidopine in the
presence and absence of nimodipine,verapamil and
diltiazem. Upon SDS-PAGE of the sample, a labeled
protein subunit withM.W. of 64,000 under reducing
conditions and 57,000 undernonreducingconditions was
identified. The photoaffinity labeling was blocked by 5
pM nimodipine, verapamil,and diltiazem. The relative
order of inhibitory activity of divalent metal ions on
the photoaffinity labeling was Zn++ > Co++ > Ni++ > Mn++
> Ca++. When the labeled Ca++-channel protein was
chromatographedon a Sepharose CL-6B column, a
radiolabeled complex with a M.W. of 130,000 was found.
This complex was dissociated into a 64,000-Da and
57,000-Da subunit upon SDS-PAGE under reducingand
non-reducingconditions, respectively. These results
indicate that cardiac Ca++-channel protein has aM.W. of
130,000 and consists of two subunits of 57,OOO-Da
(native) to 64,OOO-Da (reduced).
Class III Drugs
sotalol +
bretylium
Class I Drugs
Dose Control Termination
mg/kg AFL CL, ms %l> AFL CL No. dogs
3/3
4/4
5/5
2/3
CLASS III ANTIARRHYTHMICAGENTS DO NOT ALTER RECOVERY OF
PREMATURE ACTION POTENTIAL DURATION IN DOG PURKINJE
FIBERS. Thomas J. Colatsky, Ph.D. and Lesa B. Bird, B.S.
Wyeth Laboratories, Inc., Philadelphia, PA
Abrupt decreases in cardiac action potential duration
(APD) with increasing prematurityof stimulation have
been attributedto residual activation of the delayed
rectifier current Ix. Since block of Ix maymediate the
increased APD produced by some antiarrhythmics,we
studied the effects of the Class III agents clofilium
(CLOF) and bretylium (BRET) on APD restitutionin dog
Purkinje fibers using standardmicroelectrode techniques.
Steady-state APD (measured at -60 mV) at a cycle length
of 1000 msec was maximally prolonged by 0.3 ~ CLOF (%~
=46.±ll, n=5) and 10 llM BRET (%~ =2o.±6, n=5). Recovery of
APDs evoked by prematurestimuli at diastolic intervals
(Dl) <500 msec were well fitted by single exponentials
witht-160-l80 msec. Neither BRET nor CLOF altered APD
recovery time course or the relative degree of APD .
KETANSERIN, A SEROTONERGICAND ALPHA -ADRENERGIC
ANTAGONIST, BLOCKS CARDIAC Na+ CHANNtLS AND LENGTHENS
REPOLARIZATION.
Kaichiro Kamiya, M.D., Nagammal Venkatesh, M.D., Bramah
N. Singh, M.D., F.A.C.C. VAMC Wadsworth, LosAngeles, CA
Ketanserin(Ket), prolongs QTc in man, but, its cellular
electrophysiologic(EP) effects are not defined. wgexam!~ed the acute (AC) (superfusion(SUP) with 10- , 10- 5
& 10 M Ket) and chronic(CH) (40 mg/kg twice daily 1.M.
for 1 wk) effects of Ket on rabbit ventricularmyocar-
dium by microelectrode techniques. EP parameterssuch
as action potential amplitude(APA), resting membrane
potential(RMP), maximum rate of rise of phase 0 (Vmax),
action potential durations at 50% and 90% repolarization
times (APD50 & APD 0) ~nd effective refractoryperiod(ERP) were measurea. Vmax kinetics of Ket follOWing AC
SUP were also determined Results + SD'-
Treatment APA RMP Vmax APD
j O APD-,o
ERP
(mV) (mV) (v/s) (ms (ms (ms)
Baseline 110.0 82.7 212.3 81.0 119.7 120.8
l...iu:!2) t5.9 :t1.9 t31.4 tl0.2 t16.0 U2.4
10 M.Ket 111.1 82.5 188.7 80.7 135.0* 134.2*
rrrt!!i;6) :t7.5 :t2.3 :t33.5 +14.1 :t20.5 +13.6
M.Ket 1107.8 182.8 174.8* 83.2 145.2* 150.0*
(n=6) t4.0 :t3.0 t23.5 U8.0 t27.2 16.4
CH.Ket 109.5 82.5 198.8 199.5** 270.3** 266. 3*~
(n=4) t1.9 +2.6 +40.9 t21. 7 +20.7 34.5
A "C(msec) r2
0.455+0.017 179+13 0.9467
0.491+0.034 182+20 0.8556
0.536~.020 l6l± 8 0.9565
0.521+0.033 152+12 0.9089
APD (Dl)/APD(lOOOmsec)=1. O-A*exp(-Dl/ )
Control
CLOF
Control
BRET
(*p<0.05; **p<O.Ol of difference from baseline)
Ket SUP with trains of stimuli (>1 Hz) led to an exponen-
tial decline in Vmax with a time-constant(T) of onset of
new steady state of 1.52s and 38% reduction in ~max. The
recovery T of Vmax from use-dependent block was 1.3s.
Conclusions: Ket exerts distinct EP effects: reduces Vmax
and prolongs repolarizationand refractoriness. It is
likely to exert significant antiarrhythmiceffects.
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ANTIARRHYTHMIC EFFECTS OF INDORAMIN, AN ALPHAl-
ADRENOCEPTOR ANTAGONIST DURING REGIONAL ISCHEMIA AND
REPERFUSION OF ISOLATED PERFUSED RAT HEARTS.
Cecilia A Muller PhD, Lionel H Opie MD FACC, Joy
McCarthy BSc, MichaeI G Worthington MBC hB, Francis T
Thandroyen MD MRCP, MRC Ischaemic Heart DiseaseResearch
Unit, Departmentof Medicine, University of Cape Town and
GrooteSchuur Hospital, Observatory, 7925,South Africa.
Indoramin (Ind) is a newly introduced alphej-receptor
antagonist used in the treatment of hypertension.The
ventri cular fibri11 ation threshol d (VFT) was determined
by the train stimulus method during 15min of ischemia
(isch) produced by ligation of the anterior descending
coronaryartery in Langendorff non-working perfused rat
hearts. Spontaneous arrhythmiaswere monitored during
reperfusion following 15min of isch in separate
experiments. Heartswere freeze-clamped for biochemical
analysis.
Indoramin VFT (~) VT VF
during isch during reperfusion
Control 2.1 ± 0.5 6/6 6/6
10-6M 5.8±1.4* 4/7 2/7*
10-5M 27.3 ± 2.6*** 0/6** 0/6**
* p<0.05; ** p<0.002; *** p<O.OOOI all vs control.
Ind decreased heart rate. Ind 1O-5M (a) attenuated
the fall in tissue levels of adenosine triphosphate
during iscn and reperfusion; (b) prevented an increase
in tissue levels of lactate and cyclic AMP during
reperfusion. Conclusion: The antiarrhythmiceffects of
ind during isch and reperfusionmay be mediated by an
improved myocardial metabolic status.
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Echo-DopplerStudies in ClinicalCoronaryArtery
Disease
DIGITAL TWO-DIMENSIONAL ECHOCARDIOGRAPHICEVALUATION OF
THE PROXIMAL LEFT ANTERIOR DESCENDING CORONARY ARTERY
Charles F. Presti, M.D., Thomas Ryan, M.D.William F.
Armstrong, M.D., F.A.C.C., Harvey Feigenbaum, M.D.,
F.A.C.C., Indiana University School of Medicine, Krannert
Institute of Cardiology, Indianapolis, IN
Visualization of the left coronary artery has recently
become feasible with the development of annular array sys-
tems and digital analysis. We evaluated 110 adult pts un-
dergoing coronary angiography as part of investigation for
coronary artery disease (CAD), valvular heart disease or
cardiomyopathy. Two-dimensional echocardiograms (2DE) of
the left coronary artery were digitized, displayed in a
continuous loop and analyzed by 2 blinded observers. Of
110 pts evaluated 78 (71%) had adequate visualization of
the proximal left anteriordescending coronary artery
(PLAD). Angiograms were analyzed for the presence of PLAD
obstruction (PLAD-O) (> 50% diameter narrowing), PLAD
disease (PLAD-D) « 50%diameter narrOWing), or CAD in
areas excluding the PLAD. Abnormal PLAD on 2DE (PLAD-D/E)
was characterizedby focal wall thickening, irregularities
or impingement on the lumen. Agreement between observers
was 87%. Onthe basis of these data 4 groups of pts were
identified: 2DE
ANGIOGRAPHY n Normal PLAD-D/E
Normal 23 -1-6- 7
PLAD-O 27 0 27
PLAD-D 8 1 7
CAD - Normal PLAD 20 1 19
PLAD-D/E occurred in all pts with PLAD-O and 53/55 with
CAD. The sensitivity for using PLAD-D/E to detect CAD was
96% with a specificity of 70%. Positive predictive value
was 88%. We conclude that visualization of the PLAD with
2DE is feasible in the majority of pts, allows for detect-
ion of PLAD-O, and consistent with the concept that CAD is
a diffuse process, PLAD-D/E may serve as a marker for CAD.
VASODILATING ABILITY OF SEVERELY ATHEROSCLEROTICCORONARY
ARTERIES: EVALUATION BY EPICARDIAL ECHOCARDIOGRAPHY IN
THE OPERATING ROOM. Sara Sirna, MD, David McPherson, MD,
Steve Collins, Ph.D., Allan Ross,MD, John Moyers, MD,
Loren Hiratzka, MD, Berkeley Brandt,MD, Melvin Marcus,
MD, FACC, Richard E. Kerber,MD, FACC. U of lA, Iowa City,
lA .
Our purpose was to evaluate theability of severely
atheroscleroticcoronaryarteries to vasodilate in re-
sponse to nitroglycerin. A 12 MHz echo probewas placed
on the epicardial coronaryarteries in 14 patients under-
going cardiac surgery. Cross sectional echo recordings of
the arteries were obtained beforecardiopulmonarybypass,
and then repeated during intravenousnitroglycerin, 0.1-
0.4 mg/min. Mean arterial pressure declined15±SE2 mmHg.
The cross sectional arterial images were analyzed in 3
ways: arterial lumen area, %of the arterial wall circum-
ference which was atherosclerotic (wall thickness >0.7mm,
based on our previousstudies), and presence or absence of
an eccentric arterial lumen shape (maximum/minimumlumen
diameter >1.5). Results:Lumen area: 8 patients had small
«5 mm2 ) arterial lumens: x 2.2±SEO.6 mm2 • These lumen
areas increased62±11% (range 24% to 115%) in response to
nitroglycerin. Lumen shape: 12patients had eccentric
lumens; the mean max/min ratio was 2.3±0.2, range 1.5-4.2.
The area of these eccentric lumens increased 54±9% (range
15-115%) with nitroglycerin. %arterial wall circum-
ference which was atherosclerotic:8 patients had 75-100%
involvement of the arterial circumference(94±4%). Nitro-
glycerin increasedlumen area in these patients by 58±11%
(range 24-115%). Conclusion: severely atherosclerotic
coronaryarteries retain vasodilating ability. However,
the absolute and/or percent increase inlumen areas was
often small, especially in the most severely diseased
arteries.
TEMPORAL CHANGES IN WALL MOTlOO FOLLCMOO INTRAVEN:lUS
STREP'roKINASEDURlOO ACUTE MYOCARDIAL INFARCTlOO.
Dale A. Touchstone, M.D.,George A. Beller, M.D., FACC,
'ffiomas W. Nygaard M.D., FACC, Chris TedescoRN, Sanjiv
Kaul, M.D., FACC, universityof Virginia, School of
Medicine, Charlottesville, Virginia.
The temporal sequence of changes in wall motion(WM)
has not been well characterizedin patients undergoing
reperfusiontherapywith intravenousstreptokinase
(IVSK). Accordingly, we performed 20 echo examination
prior to, immediately, 24 hours, 3 days, 10 days,and
6-6 weeks following IVSK. 2DE data were analyzed for
global LV function using a 4 score system(I-normal,
4-severely depressed) and for regional function using a
4 score system (I-normal, 2-hypokinesia, 3-akinesia,
4-dyskinesia) using a 12 segmentmOdel. Regional WM im-
proved significantly in 16 of 21 patients with openves-
sels (76%) and did not improve in any of the 5patients
with closed vessels 2 hours following IVSK (0%) despite
subsequent opening ofvessels in 3 patients (p < .01).
The improvement in WM was enough to cause enhancementof
global LV function in 8 of the 16 patients (50%). In 13
patients demonstratingimprovement in WM (81%) the
improvementoccured on day 10; in 2it occured on day 3.
Only 2 patients showed further improvement in WM on
subsequent studies. All 3 patients with severely de-
pressed global LV function had severe stenoses involving
both infarct and noninfarct related vessels; two of
these patients died.
We conclude that a) improvement in regional WM is
cOlllllOn after IVSK; b) global LV function also improves
in half of the patients showing improvementin regional
WM; c) WM changes are notusually noted within the first
36 hours following IVSK; d) patients who show improve-
ment do so usually by day 10 day; e) echocardiographic
examinationwithin 36 hours and at 10 days following
IVSK should identify patients who will improvetheir
regional and global function and those who might die.
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Predicting on admission of Killip 3 or 4 :
WMS > 6 LVSWI < 40 P\VP > 15
COMPARISON OF PREDICTIVE VALUE OF ADMISSION 2-D
ECHOCARDIOGRAPHY AND HEMODYNAMICS IN ACUTE MYOCARDIAL
INFARCTION.
WybrenJaarsmaM.D., Cees A. Visser M.D., F.A.C.C.,
Freek W.A. Verheugt M.D., Albert J. Funke Kupper
M.D., Jan P. Roos M.D., Interuniversity Cardiology
Institute, Amsterdam, the Netherlands.
To compare the predictive value of admission 2D-echo
and hemodynamics for identification of pts who may
develop severe clinical pumpfailure (Killip 3 or 4), we
studied on admission 77 pts with acute myocardial
infarction. Global LV function was assessed by a wall
motion score (WMS) based on degree of asynergy in 13
segments (hyperkinesis -1, normo 0, hypo +1, a +2,
etc.). LV stroke work index (LVSWI), pulmonary
capillary wedge pressure (PWP) and WMS were obtained
simultaneously. Killip 3 or 4 developed in 27 pts
after 28 + 16 hours from admission.
Results: - Killip 1 or 2 Killip 3 or 4
\MS
LVSWI (gm/~
PIVP (mmHg)
* p < 0.001
sensitivity (%)
specificity (%)
neg.pred.acc. (%)
6.5 + 3.7
47 '+ 10
12 ±6
96
60
97
85
72
90
12.5 + 4.2
34 '+ 8
19 ±8
33
78
68
CORONARY COLLATERALS PRESERVE LEFT VENTRICULAR FUNCTION:
EVIDENCE IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY.
Fareed Khaja, M.D., F.A.C.C., Hani N. Sabbah, B.S.,
James F. Brymer, M.D., F.A.C.C., and Paul D. Stein, M.D.,
F.A.C.C., Henry Ford Heart and Vascular Institute,
Detroit, MI.
Left ventricular (LV) systolic performance was evaluated
noninvasively in 30 patients during coronary angioplasty
(PTCA) based upon peak aortic blood acceleration (Ace)
measured with a continuous wave Doppler (ExerDop) placed
suprasternally. Measurements of Ace were made before,
during and immediately after balloon inflation. Fifteen
patients underwent PTCA of the left anterior descending
coronary artery, 12 of the right coronary artery and 3 of
the circumflex coronary artery. Thirteen patients had
angiographic evidence of collaterals supplying the vessel
undergoing PTCA and 17 had no collaterals. In patients
without collaterals, Acc decreased from 17 ! 3 m/sec/sec
before balloon occlusion to 12 ! 4 m/sec/sec during
balloon occlusion (P<.OOl). In patients with collaterals,
Ace remained unchanged during balloon occlusion relative
to pre-occlusion levels (18 ! 6 vs 16 ! 6 m/sec/sec) (NS).
Conclusions: 1) In patients without collaterals. LV
performance is markedly compromised during coronary
occlusion; whereas patients with collaterals show no
impairment, and 2) If acute coronary occlusion occurs
following PTCA, patients without collaterals have a much
higher risk of ischemic injury.
Both LVSWI and WMS obtained on admission in acute
myocardial infarction reliably identify pts who develop
severe pumpfailure. Thus, 2D-echo can be used for
early risk stratification.
CLINICAL SIGNIFICANCE OF DISAPPEARED a-WAVES FOLLOWING
MYOCARDIAL I~FARCTION; A CORRELATIVE TWO-DIMENSIONAL
ECHOCAROIOGRAPHICAND ELECTROCARDIOGRAPHICSTUDY.
!!!lE!.~2!!.ll~.:Jl~, Cees A. Visser M.D., F.A.C.C., Jan
P. Roos M.D., Interuniversity Cardiology Institute,
Amsterdam, the Netherlands.
Since pathologic a-waves on the ECG may disappear in
time, we determined the relation between presence/absence
of a-waves and incidence/degree of regional wail motion
abnormalities (R~IA) at 1 year after myocardial
infarction(~I). Global LV function was assessed by a
wall motion score (UM5) based on the degree of
RWA(hyper-1,normo 0, hypo.1, a.2, dys.3). All 53 pt s
studied had Q-waves in the acute pllase, whereas after 1
year they had disappeared in 12 pts. There were 28
anterior(ant)MI and 25 inferior(inf) MI.
Resu Lts ant-Ml inf-Ml
q. a- a. a-
n=23 n=5 n=18 n=?
RWA 23 4 18 5
Dyskinesis 18 0 1 0
UM5 9.?~3.8' 2.6~2.2 5.2~3.8 ns 2.?~1.9
'p <0.01
In inf-MI pts the degree of RWA was not related to the
number of Q-waves, whereas in ant-~I ~ 3 Q-waves were
always (15/15) related to dyskinesis. We conclude: 1.
Disappearance of a-waves(12/53) after MI did not exclude
RUA, although dyskinesis was consistently absent. 2.
Presence of O-waves after MI was always associated with
RUA and related to a more depressed LV function. 3. In
contrast to inf-MI dyskinesis was frequently(18/28) seen
in ant-M! and always in those with ~ 3 ant Q-waves.
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DETERMINATIONOF MYOCARDIAL RISK AREA FOLLOWING CORONARY
OCCLUSION WITH CINE COMPUTED TOMOGRAPHY
Craig A. Stark, M.D., John A. Rumberger, M.D., Ph.D.,
Melvin L. Marcus, M.D., F.A.C.C., Department of Medicine,
University of Iowa, Iowa City, Iowa 52242
A relatively noninvasive method of assessing the size of
the entire perfusion field of an occluded coronary vessel
(area at risk [AR]) would be of great value since AR is
an important determinantof infarct size. To determine
if regional wall motion abnormalities (WMA) defined from
LV apex-to-base tomographic images obtained with cine
computed tomography (CCT) could predict AR, we studied 8
closed-chest anesthetized dogs. The dogs had a circ-
umflex coronary artery snare and LA catheter. After
coronary occlusion, following i.v. Iohexol, apex-to-base
scans (.8 cm thick, 6-8 slices/LV, 17 frames per second)
were obtained in the LV short axis orientation. Subse-
quently, Tc-99M microsphereswere injected into the LA,
and the AR was determined from a postmortem autoradiogram
of LV short axis slices (Simpson's rule). From the CCT
scans, epi and endocardialborders were identified for
the end-diastolic and end-systolic images of each tomo-
graphic level, and total LV mass was calculated. Using a
fixed endocardialdiastolic centroid, the LV cavity and
myocardium of each slice, was then divided by computer
into 12 30' radial segments and segmental ejection frac-
tion determined. AR by CCT was determined as the sum of
myocardium associated with the segments with WMA « 30%
ejection fraction) divided by the total LV mass. The AR
by autoradiogram(range = 15-40%, mean=27!3% [x!SE])
and the AR by CCT (range=18-36%, mean=28±2%) were similar
and correlatedwell (r=0.91, SEE=2.8%). Thus, WMA utili-
zing CCT with a fixed diastolic endocardial centroid, can
accurately predict the AR of an occluded coronary artery.
This may be a useful noninvasive means of assessing AR
following acute coronary occlusion in patients.
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COMBINED PERFUSION AND FUNCTIONAL IMAGING OF
THE LEFT VENTRICLE IN PATIENTS WITH RECENT
MYOCARDIAL INFARCTION BY ULTRA FAST COMPUTED
TOMOGRAPHY.
Eva V. Chomkll, M.D., Christopher J. Wolfkiel, M.S.E., Jose
Claudio, R.T. , and Bruce H. Brundage, M.D., F.A.C.C.,
University of Illinois, Chicago, lIIinois.
Uitraias t computed tomography (UF-CTJ was used to
sequentially assess myocardial periusion and le ft ventricular
function in 22 patients (12 male, 10 female, average age = 57
years), day 1-11 post myocardial infarction documented by
symptoms and creatine phosphokinase. Regional wall motion
abnormalities (RWMA) were ident if ied in all 22 patients. A
concurrent perfusion deficit was qualitatively asses sed in the
flow studies of 12 patients. The other ten patients had RWMA
greater than qualitative apparent perfusiondef ic it (QAPD). Six
of the ten patients had flow measured in three myocardial
regions: qualitativeischemic area (1), border zone area (B) with
RWMA and no QAPD, and a remote area (R) distinct from the
ischemic regions with normal wallmotion. The results are:
llil!2!:!.. FLOW (ml/mirv'grn) %Difference of R
I 0.38+ 0.19 74+ 11 *
B 1.04+0.76 40+12*
R 1.69';1.03 * p<0.05
These results show that UF-CT can measure myocardial
blood flow abnormaliti~s associated with RWMA that may not
be identified by QAPD. The measurement of borderzone f l ow
that is significantly less than the rest of the myocardium and
significant ly greater (p < 0.05) than ischemic flow may have
potential impact on assessment and management of pat ients
with recent myocardial infarctions.
HETEROGENEITY OFDIASTOLIC FILLING IN ~ORMAL PATIENTS AS
ASSESSED BY CINE COMPUTED TOMOGRAPHY
John A. Rumberger, Ph.D., M.D., Craig A. Stark, M.D.,
William Stanford, M.D., Melvin L. Marcus, M.D., F.A.C.C.,
Univ of Iowa, Iowa City, Iowa
The poor spatial specificity of projection imaging
methods makes it difficult to carefully quantif y
apex/base regional left vent r i cul ar function. Us i ng Ci ne
computed t omography (CCT) , we have previ ously
demonstrated subs t ant i al heter ogene i ty of LV ape x t o base
contraction in nor mal patients. To determine i f
di as to l i c f i l l i ng (DF) from ape x t o base was also
heterogene ous we evaluated the peak fi l l i ng rate
normalized fo r end- di as to l i c vol umeat 6 short ax i s
t omographic levels in 11 normal male volunt ee r s (a ge
22-36 yr s ) us i ng CCT f ollowing I . V. contrast injection .
CCT LV t omographi c volume ver sus t ime curv es
(1 7 frame s / sec at eac h level) were ana l yzed during the
first 400 msec of diastole and the data f i t (r )0 . 95) to a
third order polynomial. Global peak filli ng rate (mean
of 6 levels in each patient) was 3.2!.15 (end-diastolic
vo l ume/ sec , mea n ! SE). Results per level (expr es sed as
a percentage of global peak fi l l i ng rate) are given below
(level #1 = apex, level #6 = base, * - p<. OI vs leve l
3-6).
Leve l 1* 2* 3 4 5 6
mean ill 120 -95 - 88 - 88 - 79
!S E ! 6 ~ 9 ~ 8 ~ 7 ! 4 z l l
Conclus ions : CCT can be used t oevaluate LV-DF i n
pa t i ents at mul tipl e tomographic l evels . Although LV- DF
is relati vely homogeneous i n the basal LV levels, it is
markedly he t e rog eneous when considering t he LV as a
whole. Thes e data have important implications f or
regional or segmental estimates of LV-DF i n patients
presenting with a variety of cardiac disorders.
ASSESSME NT OF AORTIC DISEASE BY ULTR AFAST
COMPUTED TOMOGRAPHY.
Eva V. Chomkll, M.D., Eulalia Roig , M.D., Stuart Rich , M.D.,
F.A.C .C. , Chha){l Bali, M.D . and Bruce H. Brundage, M.D.,
F.A.C.C., Uni versity of Illinois, Chicago, Illinois.
Forty patients have been evaluated for suspected aortic
pathology utilizing ultrafast computed tomograph y (CT). There
were 20 males and 20 females, from 3-82 yrs. The amount of
contrast admini stered ranged from 24 to 185ml X=85ml. Data
were acqui red in volume,{low, and cine modes. Eight pat ients
were normal . Therapy was altered in 11/40 as a result of the
CT stud y (28%). There were 9 aortic dissections including
discovery of 1 sinus of Valsalva rupture into the pericardiwn, 1
spontaneous right coronary artery dissection with an aortic
thrombus , 3 ascending aortic and 5 descending aortic
disseCtions. Two of the ascending aortic dissections were in
patients with Marf an's s)l'ldrome assessed pre-and
postoperat ively. Unsuspect ed dissect ion was also found in 2
asymptomat ic patients with aortic insuffic iency. Isolated
aneurysms occurred in 17 patients: 1 sinus of Valsalva
aneur)\'lm, 13 ascending aortic aneurysms and 3 descending
aortic aneurysms. Uitroiost CT provided data missed by
angiography in 2/ 40 (5%). In another 2/40 (5 %) cine acquisition
resulted in diagnoses either missed by echocardiograph y or that
would have resulted in morbidity with angiograph y. Four out of
forty (10%) patients were taken directly to surger y after
ultrafast CT. One periaortic tumor, 2 patent ductus arteriosus ,
and 1 coarctation of the aorta were also correctly diagnosed.
We conclude that ultrafast CT, a minimally inwsive procedure,
provides valuable data influencing clinical deci sions in patients
wi th aorti c pathology.
CARDIAC CINE M.a.GNETIC RESOOANCE lMAGItli: DETECl'IOl OF
MITRAL AID A)RI'IC mx;uR;I'rATIO'l
GerardAurigerrmaMD, Nathaniel Reichek MO, Lean Axel MD
PhD, Pamela Douglas MO FI\CC, Herberty, T<ressel MD,
University of Pennsylvania, Philadelphia, PA
CardiacCine lMgnetic resonance imaging (Cine MRIJ uses
flow-dependent blood signal to produce dynamic images of
nultiple simultaneous sections at up t o 32 f rames per
cycle. TO assess the ability of Cine MRI to detect and
quantitate mitral arrl aortic regurgitation(MR, AA), we
perfomed multiple axial scans in 8 normal.s, 5 pts, with
AA arrl 6 with MR. EOO gating, 21 msec repetition time, 12
msec edJo delay and 30· flip angles were used with 3-5
mimte scan times. Pulsed doppler echocardiographywas
also used to mapAA and /oR fl"",. MR and AA were r eadily
detected· in each patient as zones of low signal intensity
(ISZ) extending fran the mitral valve plane into the IA in
systole in MR, and fran the aortic valve plane into the LV
in diastole in AA. MR and AA ffiZs correspondedspatially
arrl temporally to turbulenthigh velocity flow by dbppler.
Trivial MR and AA produced thread-likeshort ffiZs while
severe MR and AA produced broad based, long LSZs. There
were no false positives. '!be size of r.sZs and of dq:>pler
zones of t ur bul e nce rorrelated well, but ISZ were larger
in absolute terms, could be depicted in multiple sections
throoghout the receiving chamber and often showectclynamic
changes in location and direction during the regurgitant
period. In severe MR, reflux into pulnonary veins was
demonstrable. When sections through valve planes were
obtained, the regurgitant orifice could be visualized. we
conclude that Cine MRI is a powerful new technique for the
noninvasive detection arid quantitationof MR arrl AA.
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FAST D'iNAMIC MRI sruorss OF FLGI IN ~ITAL HEAR!'
DISEASE: INITIALEXPERIENCE
R.I. Pettigrew,Ph.D.,M.D.,W.J. Parks, M.D.,
M.G. Baron, M.D., E. Nugent, M.D., F.A.C.C.,
A. Raviele, M.D., W. Plauth, M.D., F.A.C.C.,
J. Todd, M.D., F.A.C.C., K. Dooley, M.D., F.A.C.C.
Em:>ty Univ. SChool of Medicine, Atlanta, Georgia
The recently introdoced technique of fast multiphase
magnetic resonarce imagi!lJ (FMI) can generate high
temporal resolution cine studies in which intracardiac
blood flow patternsard cardiac dynanics can be assessed.
To evaluate the potentialclinical utility of FMI for the
assessment of corqenital, cardiac lesions, 10 ooonals and
10 subjects with a variety of abooonalities were stwied.
In each instarce, ccrrparison was made with contrast
a!lJiographyand/or 2-D echocardiography. In all patients
with known or suspected valvular i nsufficierc y , the
regurgitant jets could be clearly visualized. In one
c ase of total ananalous pulmonary venous return where
steoosis of a si!lJle pulmonary vein was suspected, a
"fast" rrovi!lJ venous jet was visuali zed , eupportirr; the
preliminarydiagoosis. A previously undet ect ed left to
right shunt was also clearly imaged in a case of repaired
t.rurcus arteriosus. In one case of Ebstein's ananaly
where the tricuspidrrorphology and furction was urclear,
fl11 danonstrateda large "sailirg"anterior leaflet with
regurgitation. However, a smal.L VSD shunt with a
pulmonic to systemic flow ratio of 1.6/1.0 could oot be
visualized. Thus, this preliminary experierce suggests
significant utility for FMI as a procedure for
identifyirg and evaluati!lJ valvular insufficiency,
JOOderate intracardiac shunts, and possibly vascular
steooses, without requirirg a contrast agent.
Difficulties may exist in the detection of snall shunts.
REGIONAL MYOCARDIAL FLOW RESERVE IN NORMAL PATIENTS USING
CINE COMPUTED TOMOGRAPHY.
John A. Rumberger,Ph.D., M.D ., Craig A. Stark, M.D.,
Wi lliamStanford, M.D., and Mel vi n L. Marcus, M.D.,
F.A.C. C., Univ. of Iowa, Iowa City, Iowa
We have shown in animals that contrast clearance curves
derived from Cine computed tomographic (CCT) images can
be used to assess myocardial perfusion when comparedwith
microspheres (n-14, r=0. 82) . For this technique to be of
clinical value, changes in myocardial perfusion must be
measurable in patients. We assessed myocardial flow
reserve in normal volunteers (n=6, age 20- 26 years) using
CCT and evaluated subsequent aortic and myocardial
contrast clearance curves under control conditions and
during intense coronary dilation with dipyridamole
(0 . 56mg/ kg , I .V. over four minutes) . Long axis images of
the LV were obtained with CCT following peripheralI.V.
injection of Iohexol (0.5ml/kg/I.V. over three seconds).
The dose of dipyridamole employed has been shown to
increase myocardial perfusion 4-5-fold in normal
patients. Heart rate and meanaortic pressure averaged
65/min and 100mmHg at control and 90/min and 100mmHg
follOWing dipyridamole. The shape and characterof the
aortic and myocardial contrast clearance curves were
similar to those seen previously in dogs. Employing an
algorithm derived from animal studies (ratio of area
under myocardial and aortic clearance curves divided by
myocar di al contrast transit time) myocardial flow during
dipyridamole in the posterior/lateral myocardium was
2.65!0 .5 above control (mean! SO , range 2. 23 to 3.50).
Although flow reserve assessed with CCT was l es s than
expected. thiS study demonstrates the potential to
evaluate regional myocardial flow reserve using CCT and
dipyridamole. Such measurements may allow for
non-invasive detection of physiologically significant
coronary obstructions in man.
The Cine-CT andMSP regional myocardial perfusion
measurements correlated (slope = 0.71, r = 0.8) over the
range of 0.4 - 7.0 ml/min/gm.
VALIDATION OF REGIONAL MYOCARDIAL PERFUSION BY CINE-CT
M.J. Lipton M.D., F.A.C.C., R.G. Gould, Ph.D., M.
McNamara. M.D., S. Koshold, R. Sievers, B.S., C. Higgins,
M.D., F.A.C.C •• D. Boyd, Ph.D. Univ of California, San
Francisco, California.
Blood flow in 8 myocardial quadrantswas measured in
dogs using high speed (Cine) CT and radioactive
microspheres (MSP). For the CT measurements, non-ionic
contrast medium was injected into a peripheralvein and
four contiguous, 1 cm thick 50msec CT scans through the
LV were obtained every other heartbeat for 40 heartbeats.
Measurements weretaken at rest and during hyperperfusion
induced by chromonar. The MSP were injected into the
left atrium simultaneouslywith the contrast injection.
From the .CT images, in each of the 8 quadrants,
time-density curves were obtained and flow per unit mass
was calculated based on the cardiac output, the maximum
iodine concentrationin the quadrantand the delay time
between the peak iodine concentration in the LV and in
the quadrant. Results are summarized in the table.
MSP (n = 6)
Mean flow 1,21 + 0.86
at rest (ml/min/gm) -
1,41 + 0.21
3.96 + 1,57
CT (n = 6)
0.9 + 0.49
0.57 ± 0.23
4.26 + 1, 72Mean maximum
flow (ml/min/gm)
Mean regional
flow variation
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ASSESSMENT OF RELATIVE CORONARY FLOW RESERVE WITH DYNAMIC
POSITRON EMISSION TOMOGRAPHY AND H2150
M.N . Walsh, M.D., H. Serota, M.o ., S.R. Bergmann, M.o.,
Ph .D ., a.E. Sobel, M.D., F.A.C.C., and LM. Geltman, M.D.,
F.A.C.C., Washington University, St . Louis, MO.
To determine whether relative regional coronary flow re-
ser ve can be assessed by positron emission tomography
(PET) in humans,we studied 7 normal subjects and 31 pa-
tients with coronary artery disease with PET after the
r apid i .v. administrationof H2150 and inhal at ion of el 5o.
Oat a were collected in list mode and reconstructed into
sequenti al 10 sec frames andcumulative 120 sec static
scans at rest In = 38) and after i . v , dipyridamole In =
27) . The initial 17 subjects were stud ied to develop
techniques for administration of tracer, data processing
and analysis which were then applied instudies of the
subsequent21 subjects. Tracer distribution was generally
homogeneous in normal s ubjects with t he greatest ratio
between minimal andmaximal myocardial radioactivity
equal to .74 ± .03 (SEM). In contrast, disparities were
striki ng in patients with coronaryartery disease (.53 ±
.04 p < .05). After dipyridamole the distributionof
H21S0 became even more homogeneous in normal subjects
with ratios averaging 0.83 ± .002. In contrast, the
r at ios remainedstrikingly abnormal in patients (.53 ±
.04, p < .05 compared to normals) . Assissment of regional
dynamic rates of accumulation of H2 50 in patients con-
firmed the homogeneity in normal subject s and the hetero-
geneity in pat ients. Reg ional abnormalities in static and
dynamic tomograms of the distributionof H2150 paralleled
abnormalities of angiographic coronaryanatomy. Thus, both
static and dynamic positron emi ssion tomographypermit
the delineation of ·regional abnormalities i n myocardial
perfusion at rest and limited coronary flow reserve in pa-
tients after dipyridamolestress.
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CORRELATION OF D I G I TAL ANGIOGRAPHIC WIT H DO PPLE R
EST IMATION OF CORONARY FLOW RESERVE.
Mark D. Co hen. M• D•• WI I I I am R. Fie I d s , M. D. ,
John McB. Hodgson, M.D., McGul re VAMC a n d
Medical College of Virginia, Ri c hmond, VA.
Although digital angiography ( DAl and dopple r
velocl ty catheters (DVC) estimat e c h a n g e s In
coronary blood flow ( CBF) I n ver y d i f f e r e n t
ways, Ilttle Is known re g ar d I n g t h e ex t e n t t o
which t he s e est i mat e s correla t e . We
hypot he si zed that If b ot h te chn i qu e s p rov id e
a c cur a te est I mate s 0 f ch an g e sin CBF , the n
s imultaneo us deter ml nat l o ns o f cor on a ry f l ow
r es e rve (CFR) s h ou l d be sim ilar. We o btain e d
s i mu ltan eo us DA and DVC d et erml natl ons of CFR I n
2 0 pat ients at card ia c cat hete r iza ti o n. A DVC
was sub selectlvely pl ac ed In t he no nste no t lc
l e f t ante rior de sc en ding ( LAD) c oronary arter y .
DA deter ml natlons were obtained duri ng ECG gate d
power I nject lons of co ntrast th ro ugh the gU ide
catheter. Images wer e acqu I red a t rest and
during papaverine Induced hype remla with
continuous monitoring of the DVC sig n a l . DVC
me a n velo city was compared t o LAD re gi o na l fl ow
Index cal c u lated f rom DA Images. There was goo d
c o rre l a ti o n betwee n DA a nd ov e d e t ermi ned
CFR( r=0.79, OVC=0.76 DA + 0. 4 9, n= 8 0) . Th e
r elat ionshi p was unchang ed afte r cor r ec tion of
DVC CFR for changes In arte r I a I cro s s s ect Ion a I
ar ea . We c o nc lude that bot h OA and DVC prov i de
appropr iate estimates of CBF ch ange s. Althoug h
both te c hniques may be use f u l I n h uma n s, fa ctor s
suc h as safety, ea se o f a cq u is i t i on, a nd
s i mul t an eo us eval uation o f mult ip le ve s s e l s may
make DA more practical than DVC f or measurin g
CFR.
PRECI SE MEASUREMENT OF CONTRAST CLEARANCE CURVE CARDIAC
OUTPUTS US ING CINECOMPUTED TOMOGRAPHY
St even J. Rei ter,M.D. AndrewJ. Feiring ,M.D. , William
St anfor d , M.D. , John A. Rumberger, M.D. , Ph.D., Melvin L.
Marcus , M.D. , F.A. C.C., Departments of In ternal Medicine
&Radiology , Uni versi ty of Iowa , Iowa City , I owa 52242
Previous studies comparing ca rdiac outputs (CO) derived
f r om Cin e Computed Tomography (Ci ne CT) aorti c cont r as t
c l ear ance curves and thermodil ution CO have yielded good
correlations but have wide s t andar derrors of t he
estimate. Major sources of error include use of a
standardK constant, failure t o obt a i n s i mul t aneous
thermodilution and Cin~ CT CO, and use of i onic cont r as t
agents. We hypothesized that a calibr a tion standa r d must
be us ed i n each s t udy to deri ve th e K constant. Dogs
were prepared wi th chroni c proxi mal ao r t a electromagneti c
f l ow pr obes to derive s imul t aneous electromagnetic f low
CO and Cine CT CO. CO was varied from control wi th an
i .v . i nfusion of Dobutamine. As a ca l i br ation s tandard
fo r ea ch s tu dy four markers containing graded amount s of
i odine/ml were placed on th e dog' s chest and wer e compa-
red to the co r r es pondi ng Cin e CT density number . Four
level (20 frames/level ) end-diastoli c scans (50 mse c/
sc an) were acquir ed dur i ng flow mode ( 2 scans / second)
with infusion of Iohexol at the level of t he pr oxi ma l
aorta. In 6 s t udi es , electromagnetic fl ow probes CO
(r ange 2 .3 to 6.3 liters/mi n) cor r e l a t edclosely to Cine
CT CO wi t h a smal l standard er ro r ( r~0 . 9 9, s lope=0 .95 ,
y- i nt er cept =0 .21 , SEE=0 . 13l/min). The K va l ue
cali br ation s tanda r d va ried by !10%between dogs. Thus ,
with careful calibration for the K constant, simul t aneou s
measur emen t of CO byCT and elect r omagnetic f l ow probes,
and usage of non-ioni c contrast agents, accurate CO can
be derive d by Ci ne CT con t r ast clearance curves .
DI G I TA L ANG I OGRAPH I C DETERMI NATION OF ABSOLUTE
CORON ARY BLOOD FLOW.
John M. DIGrazla, M.O, , John McB. Ho dg s o n , M. D.,
McGu lre VAMC a nd Med i ca l Co lleg e o f Virginia
Richmond, VA.
We ha v e developed a method f o r measuring
absolut e volumetric c or o nar y blood flow using
digita l subtraction a ngiography (DSA ). Valida-
t ion was pe rformed using a pUlsatll e flow mode l
simu la t i ng t he co r on a r y circ u lat ion wh i ch
a llowed d i re ct measurement of flow by el e ct ro-
magnet i c flow met er ( EMF). Images were acquired
dur i ng pr e c is e, cycle g a t e d , powe r Injections o f
ra diograp hi c con t r a s t . An Image o f the co ntras t
entering d urIng precIsely one cyc le following
t he onset o f I njec t l o n was crea ted usi ng mas k
mo de subtrac t I o n. A c ont r a s t fI l l e d phantom wl t h
1.0 to 5 .5 mm d iamete r cyl i nd er s of k no wn v o lume s
wa s Im aged a nd p r oce s s e d u n d e r Ident I cal
cond I t I ons and used to estab I I s h a standard
curve re l at i ng volume to radiographic density .
This r e l a t I o n s h l p was lInea r (r=.99) and
reprodu c i b le. The vol ume for one cycle was
determ i ne d by c ompar i ng the rad I ograp h ic density
from th e 5 I ng l e c yc I e I mage t o t h e s tandard
c u rve. OSA f lows wer e c a l c u l a te d a s t he p roduct
of t h e d ens i ty determ I ned vo l ume fo r o ne cyc le
time s the pu lse r at e . The re lationsh ip betwe en
DSA and EMF flows I n the rang e o f 47 to 338
ml / ml n was exce llen t (r= 0.9 5, n=27 , DSA= 1. 0 4
EMF + 7. 5c c l . Cal culatIons I n pat Ie nts h a v e
gi ven ph yslol ogl c resting le f t a nterior
des cend in g flow va l ues of 40 to 100 cc/mi n .
Th is te c h n ique prov ides a method fo r measuring
abso l ute c o r o n a r y blood flow In humans using
standard co nt r a s t Injections.
Wednesday, March 11 , 1987
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New Inotropic Agents
Hf.MODYN&~IC AND ELECTROCARDIOGRAPHIC EFFECTS OF THE FAST
CHANNEL ACTIVATOR, DPI 201-106
Barry F. Ur et s ky , M.D.,FACC, Srinivas Murali, MD, P.
Sudhakar Reddy, M. D, FACC, A.M . Val des , RN, Judy A.
Kol es ar, RN , Un iv ersity of Pi t t sbur gh, PA.
The ex perime nt al i notropic agent OPI 201-106(0 ) pro-
duces a s i gnifi cant improv ement in th e in otropic state
and hemodynamics in experiment al animals. In par t , t hes e
changes may relate to prolonged fast channel activation
and concom i t ant increa sed ac t i v i ty of th e c alc i um- s odium
ex cha nge mechanism . To det e rmi ne its hemodynamic, elec -
trocardi ographic , and i notropic ( peak+dP/ dt) properties
i n man, 9 patients ( pts) with seve re congestive heart
fai lu re (CHF) were studied at baseline ( B) and after
varying bolus doses of iv D (0.03-0 .28 mg/kg) .
HR MAP RA LVEDP Cl +dP/ dt
B 91+15 94+8 9+7 22+7 1.8+ .3 851+159
D 87+11 86+7 6+4* 18+5* 2 .2+ .4* 991+183 *
HR=hear t r at e (beats!min ) ;MAP=mean arterTal ;RA=right
atrial,LVEDP=l eft ventri cul ar end diast ol ic pressure
(mmllg ) ;CI=ca rd i ac ind ex (L/min /m2) ;+dP/dt=peak LV
pressure change (mmHg/sec); *p<.05 B vs D.
The Q-T i nt er val (msec ) i nc r eased (0 .38 +0.04 t o
0 .43~0 .04, p<O .OI) wi t hout signif icant ch;nges in either
the PR(0. 17+. 03 t o 0 .18 +.03 ) or QRS (0 . 12+0.03 to
0 .13+0. 03 ) Tntervals (ms ec) . Although t he- change in QT
in ter va l was rel at ed t o th e change in +dP! dt in
individual pts, the over al l group corre l at i on was quite
modest (r+. 28) . Thi s f inding sugge sts that although D
produces QT pro longation, these ch anges do not predict
wel l the improvement in toe i notropic s tat e . We conclude
t ha t DPI 201- 106 is an i notropic agent in man and th at
its hemodynamic pr of i l e sugges ts potent i al util i t y in CHF
pts.
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I£MODYNAMIC EFFECTS OF DPI, A NOVEL CARDIOTONIC DRUG WITH
NEGATIVE CHRONOTROPIC ACTION:
Thomas Linderer, M.D., Marieluise Heineking, Eva Hadad,
Rolf Schrbder , M.D., F.A.C.C., Klinikllll Steglitz, Free
University of Berlin, FRG.
To assess the hemodynamic effects of DPI 201-106, a
piperazinyl-indole, ~ studied 12 patients with history
of congestive heart failure (5 coronary artery disease, 7
dilative cardiomyopathy) during diagnostic cardiac cathe-
terization. They were randomized into 2 groups (6 in each
group) and received 0.3 mg/kg (group A) or 0.6 mg/kg
(group B) Lv. over 15 min. In group A, heart rate fell
from 95 + 16 to 86 + 18, in B from 84 + 13 to 80 + 16.
In group-B, we observed the following hemodynamic changes
(15 min after infusion): Cl increased frOOl 2.28 + 0.32 to
2.63 + 0.40, stroke volume index (ml/min/M2) fran 28 +
6 to 34 + 10, stroke work index (g. m/M2) fran 36 + 10
to 51 + 19, dP/dt (mmHg/sec) from 1233 + 273 to 1573 +
572, dP!dt/P (sec-I) from 30 + 12 to 46 -+ 17. LVEDP de=-
creased from 20 + 9 to 11 +-10, systemic vascular re-
sistance (dyn.sec-:-cm-5) from-1546 + 403 to 1319 + 372.
Heart rate corrected qr interval wa; prolonged by 20%. In
group A, the obse rved hemodynamic response to DPI was
qualitatively the same, but the changes were less pro-
nounced. In both groups, DPI did not alter arterial blood
pressure, coronary blood flow (measured by the Argon
inert gas technique) and myocardial oxygen consumption.
Conclusion: Like other novel cardiotonic drugs, DPI re-
duces preload and afterload of the LV and increases myo-
cardial contractility without rising myocardial oxygen
consumption. However, the rise of heart rate, as it is
frequently observed with other cardiotonic drugs, is
prevented by the negative chronotropic action of DPI.
This might be of particular value in the treatment of
patients with congestive heart failure.
ACUTE EFFECT OF DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE
ON CORONARY CIRCULATION AND CARDIAC ENERGETICS IN
PATIENTS WITH HEART FAILURE.
Yutaka Arai, M.D., Yumiko Hoshino, M.D., Takashi Tsuda,
M.O., Masaru Yamazoe, M.D. and Akira Shibata,M.D.
Brigham andWomen's Hospital, Boston,MA and Niigata
University Hospital, Niigata, Japan
To study the effect of dibutyryl cyclic-AMP (DBCAMP) on
coronarycirculation and cardiacenergetics, we carried
out cardiac catheterizationin 10 patients with severe
congestive heart failure. Intravenousadministrationof
DBCAMP for 30 minutes (0.1 pg/kg/min) increased heart
rate (HR) by 18.6% (p<0.001) and decreasedmean blood
pressure by10.4% (p<0.005). PA pressure decreased
slightly. Cl increased by24.8% (p<O.OOl). Coronary
blood flow increased inall but one patient (mean,
27.6%), and great cardiacvenous (GCV) blood oxygen
saturationshowed a prominent increase (+40.6%, p<O.OOl).
LV work increased by16.5% (p<O.Ol) with nochange in
myocardial oxygen consumption or lactate extraction.
Systemic and coronary vascularresistances decreased by
30.8% (p<O.OOl) and 26.5% (p,O.OOl). respectively.
Neither peak +dP/dt in AO or central venous pressure
changed. Plasma norepinephrine levels inAO, PA and GCV
increased by35.6% (p<0.005), 34.2% (p,0.005) and 47.4%
(p<O.OOl), respectively, without changes in epinephrine
levels. Thus, DBCAMP has a potent vasodilating effect on
coronary as well as systemicarteries. The improvement
in LV pump function, which may partially be caused by the
rise in norepinephrinelevels secondary to a fall in
blood pressure, was not associated with an increase in
myocardial metabolic cost. A positive inotropic effect
of DBCAMP itself, as reflected by AO dP/dt, was not
detected.
Thus, in patients with CHF, administrationof DPI re-
sulted in short-termhemodynamic improvement.
ACUTE HEMODYNAMIC EFFECTS OF A NEW INTRAVENOUS INOTROPIC
AGENT, DIBUTYRYL CYCLIC AMP, ON PATIENTS WITH CONGESTIVE
HEART FAILURE - A COMPARISON WITH DOBUTAMlNE.
Hisayoshi Nakajima, M.D., Yuko Miyagi, M.D., Shigetake
Sasayama, M.D., F.A.C.C.
Toyama Medical and PharmaceuticalUniv., Toyama, Japan
Dibutyryl cyclic AMP (DB) , a derivative of cyclic AMP,
has characteristicsof easy permeabilityof cell membrane
and is converted to cyclic AMP. We studied the acute
hemodynamic effects of OB in eight pts with congestive
heart failure (CHF) (NYHA of functional class III to IV,
mean EF=23%) and compared its effects with dobutamine
(DOB). The hemodynamicparameterswere obtained by Swan-
Ganz catheter and the thermodilutionmethod. Data at peak
doses were summarized.
HR map PCW Cl SVR DP
(b/min) (mmHg) (mmHg) (l/min) (dyne'sec. cn:-5, (><10 2 )
ContraIl 75!12 85±12 19±92.01!0.71 2214±415 81!9
DB 79!10*82=11 14±7 3.36±0.65**1221±13S** 82±9
Control 2 72±13 8S±11 20±92.04±0.77 2234!S92 76±S
DOB 79±17*93±12* 19±9 2.6Sc1.00* 1884±380* 96±17**
p(DBvsDOB) NS 0.05 0.03 0.01 0.01 0.05
(HR=heart rate, mBP=mean blood pressure, PCW9Pulmonary
wedge pressure,SVR=systemicvascular resistance,DP=double
product, *=p<O.OS, **=p<O.Ol vs control, data=mean±SD)
DB reduced PeW and SVR, and increased Cl more markedly
than DOB. These effects by DB were obtained without
significant change of blood pressure. Also, DOB increased
double product, but DB did not. Thus, the hemodynamic
improvement by DB was achieved without additional oxygen
cost to the heart. No obvious side effects of DB were
observed. DB may be more effective and useful agent in
the treatmentof CHF.
21!2 27!4**
28!3 37!4*
24!3 21!3***
2475!101 1859H20**
5.6!0.3 4.7!0.6***
86±5 86±584±4
22±2***
25!3*
32!3*
85±4
18!2
25±2
25!2
Cardiac Index2(L/min/M )
Stroke Work
2Index(g'm/M )
Stroke Index 2
(ml /beat/M )
LV Filling
Pressure (lIIIIlHg)
Systemic Vascular 2880!172 2362!187*
Resistance Index§
Arteriovenous 5.8!0.34.7!0.6***
Oxygen Difference"
Heart Rate (bpm)
-5 2§-dynes·sec.cm /M; "=ml O2/100 ml
*p<0.005, **p<O.OI, ***p<0.05
DPI 201-106, A NEW INOTROPIC AGENT: HEMODYNAMIC IMPROVE-
MENT IN PATIENTS WITH CONGESTIVE HEART FAILURE.
John B. Kostis, M.D., F.A.C.C., Clitton R. Lacy, M.D.,
Robert G. Warner, M.D., Jack H. Dworkin, M.D., Laurie A.
Casazza, B.S.N., John J. Raia Jr, Pharm.D., UMDNJ-Robert
Wood Johnson Medical School, New Brunswick, New Jersey
DPI 201-106 (DPI) is a new oral inotrope which exerts
its effects by delaying Na+ channel deactivation and by
increasing myofilament sensitivity to Ca++. In a double-
blind, randomized, placebo-controlled study, 15 patients
with Class III congestive heart failure (CHF) received
DPI in doses of 80 mg and lOO mg.
Dose-related improvement in left ventricular function
and evidence of vasodilstion were observed following DPI
administration.Pre-dose and 3 hrs post-dose data shown.
~ DPI 80 mg~ DPI lOO mg
2.0!0.1 2.5!0.2* 2.3!0.1 3.0!0.2*
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COMPARATIVE EFFECTS OF INTRAVENOUS VS. INTRACORONARY
NIFEDIPINE IN MAN: EVIDENCE FOR NEGATIVE INOTROPISM.
David C. Booth,M.D.,F.A.C.C., G. Dennis
Llmon-;-P1la,'iii:-rr:-;--nuarttrOlilis-;-Pllar m•0., R. G.
McA 11 i ste r , Jr.,M. D. ,F. A.C.C. Anth0 ny N. DeMar i a ,
M.D.,F.A.C.C., University of Kentucky and V.A. Medical
Centers, Lexington,Ky.
Intravenousnifedipine acted as a vasodilator but was
accompanied by a disproportionatedecrease in dp/dt,
while IC nifedipine decreased arterial pressure (MAP)
but did not increase cardiac output. Thus,parenteral
nifedipine possesses direct myocardial depressant
effects which are masked during IV administrationas a
result of afterload reduction. With IC dosing, a
negative inotropic effect occurs, and effects of
afterload reduction arenegligible.
Debate exists regarding a negativeinotropic effect of
parenteral nifedipine in man. We studied this question
in 30 patients with coronaryartery disease varyingfrom
single to left main and multivessel involvement.
Fifteen patients divided into threegroups received 1, 2
or 3 mg IV nifedipine at .33mg/min. The remaining 15
were similarly divided and received0.1, 0.2, or 0.3mg
intracoronary(IC) nifedipine at rate 0.2mg/min.
Hemodynamics and plasmanifedipine [N] were obtained
during and at 5 minuteintervals following IV dosing and
at 1 minute intervals post-lC dosing. The following data
are prior to N (Con) andmaximal effect (Max) seen:
O._le
71+1-20 17./-21
102.,-11 100+/·7
1.3+/-o,31.h/... 5
12.3+/-1
-,,-9 stt/~
tt+/-12 tGt-/-14'
2.7+/-0.52.6+/-0.4
'.I+I-1S
O.bIqic
11+1-11
."I-U'
J.J.t/-o.4
,10
O.1IIqic
*/dt I42O-f/-l1'111&#-128+
ttl '1+/~ 70+,_loa 71+/-17
.... 9,+{-14 7~J-.· 97+/-1)
Cl 2.H/-O.J ).0+1-0.5' ).1+/-0.3
\~~'.'3~ ~ '~H2
ORAL MDL17043 IN SEVERE CARDIOMYOPATHY
Thomas L. McKiernan, M.D.,F.A.C.C., Cynthia Pope,R.N.
John B. O'Connell, M.D. F.A.C.C., Patrick J. Scanlon, M.D.
F.A.C.C., Loyola University Medical Center, Maywood, 11.
MDL17043 (Enoximone) is an imidazole compound with signi-
ficant inotropic and vasodilator properties found to be
useful in the treatment of heart failure. To determine its
effectiveness and safety in NYHA, Class IV heart failure
refractoryto conventional therapy 21 patients(P), (8 dil-
ated and 13 ischemic cardiomyopathy), (14 male, 7 female),
age 34 to 86 (mean 66 years) were given oral drug for a
mean durationof 16.4 weeks (range 1-66). All were start-
ed at 1 mg/kg tid. Mean dose was 128 mgs. tid with a range
of 50-200 mgs. tid. Of the 21 P, significant improvement
in symptomatology within 3 weeks after start of treatment
allowed 10 of 15 bedridden inpatients to return home ambu-
latory. Two P showed improvement byat least one NYHA
class and remain stable on maximum drug after 63 weeks.
Three P were treated, stabilized and maintained until
transplantation. Side effects included hypotension in 4 P
diarrhea in 3 P, nausea in 4 P, and runs of ventricular
tachycardiain 4 P. All were treated with concomitant
medication. Severe congestive heart failure reoccurred
in l P resul.t Lng in the death of 5. Sudden death at home
occurred within one week post discharge in 4 P. MUGA was
done pre-treatmentin lIP showing decrease in ejection
fraction in all but 1 who showed a slight increase.
Thus we have found MDL17043 effective and useful in treat-
ment of severe heart failure refractoryto conventional
therapy. Major advantage was seen in short term adjuvant
therapy for bedridden IV inotrope dependant P along with
those awaiting transplant. High incidence of sudden death
along with terminal reoccurence of failure and poor objec-
tive findings overall questions long term benefit.
Wednesday, March11, 1987
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Calcium Antagonists
Conclusion:
At a dose that equally increased coronary sinus flow,
Nicardipine showed little effect on LV inotropy and
relaxation, whereas these parameterswere markedly
affected by Nifedipine.
EFFECTS OF INTRACORONARY NIFEDIPINE AND NICARDIPINE ON
LEFT VENTRICULAR INOTROPY AND RELAXATION.
Cees A. Visser, M.D., F.A.C.C., Jacques J. Koolen, M.D.,
Harry van Wezel, M.D., Remmet Jonges, Ph.D., Gerard Hoede-
maker, M.D., Dept. of Cardiology and Dept. of Anaesthesio-
logy, Academic Medical Center, Amsterdam, TheNetherlands.
To determine the effects of Nifedipine and Nicardipine, a
new calcium antagonist chemically related to Nifedipine, on
LV inotropy and relaxation we injected into the left main
coronary artery, in 12 patients with coronary artery dis-
ease, 20 minutes apart and in random order, 0.2 mg of each
drug. This dosage has preViously shown to increase coro-
nary sinus flow equally. During atrial pacing (90 beats/
min.) % increase (+) or decrease (-) after 1 min. vs. con-
trol were determined of LV systolic pressure, LV end-dia-
stolic pressure, peak + dP/dt, (dP/dt)DP40 and early
(0-40 msec) time constant T.
Results:
LV systolic pressure mmHg
LV end-diastolic pressure mmHg
peak(+)dP/dt mmHg/sec
(dP/dt)/DP40 l/sec
T msec
coronary sinus flow ml/min.
* p<O.OOI
NIFEDIPINE
7% *
+ 79% *
- 34% *
- 37% *
+ 42% *
+ 54% n.s.
NlCARDIPINE
1%
+ 30%
- 13%
- 11%
+ 10%
+ 56%
EVIDENCE THAT THE CORONARY DILATOR EFFECTS OF THE
CALCIUM ANTAGONIST NISOLDIPINE ARE PRESERVED DURING
LONG-TERM TREATMENT.
Michel F. RQusseau, M.D , F.A.C C" Claude Hanet, M.D.,
Paul CherQn, M.D. and Hubert PQuleur, M.D., F.A.C.C.
University Qf LQuvain, Brussels, Belgium.
AlthQugh most calcium antagQnists increase CQronary
blQQd flQW after intravenQus administratiQn, little is
knQwn Qn their CQrQnary dilatQr effects during Qral
dQsing. To determine if the cQronary dilator effects of
nisQldipine (NIS) were maintained during long-term
dosing, coronary sinus (CS) flow and myocardial
metabolism were studied in 21 patients with angina
pectoris, before and after 1 mQnth Qf therapy with NIS
(n=ll, 10-20 .g/day) or prQpranolol (PRO, n=10, 80-120
mg/day). The data befQre and during treatmentwere
compared at fixed heart rate (atrial pacing). After PRO,
arterial pressure (-3\; NS) and CS flow (-14\; NS)
decreased slightly and cQrQnary vascular resistance
tended tQ increase (+9\; NS). In cQntrast, after 1 month
of NIS, mean arterial pressure decreased (113±7 to 95±5"
..Hg), CS flow increased slightly (143±20 tQ 162±13
ml/min; NS) and coronary vascular resistance was reduced
by 30\ (" vs control and" vs PRO). Myocardial 02 uptake
was unaffected with both drugs but the arteria-CS
difference in 02 cQntent improved significantly after
NIS Qnly (13.4 to 12.4" ml\). Further, NIS improved
mYQcardial lactate uptake (frQm 20 to 74 ~M/min; • vs
contrQl and " vs PRO) more than PRO (36 tQ 48 ~M/.in;
NS). Thus, the corQnary dilatQr effects Qf nisoldipine
were still evident after prolonged dosing without being
accompanied by metabQlic signs Qf steal-induced
iSChemia. This suggests that tachyphylaxis of the
cQronary smooth muscle tQ the dilatQr effects Qf
dihydrQPyridinederivatives dQes not occur. "P(O.OI
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CALCIUM ENTRY RLOCKERS AND ALPHA-MEDIATED VASO-
CONSTRICTION:EFFFCTOF VERAPAMIL AND NICARDIPINE
IN HUMAN FOREARM. Poberto Pedrinelli,M.D.,Stefano
Taddei,M.D.,LindaGraziadei,M.D.,AntonioSalvetti,
M.D.; Hypertension Unit,I Clinica Medica,
University of Pisa,Italy.
Peceptor operated calcium channel(FOC)s are acti-
vated during~-stimulation.Thus calcium entry
blocker(CEP)s might blunto(-adrenerj;1ic vasocon-
striction(VC) in man.We have studied two different
CEPs,Verapamil(V) and Nicardipine(N),a dihydro-
piridine(DH) derivative,as re~ards their effect
on forearm(F) VC due to exo~enous Norepinephrine
(NE) in 24 mild untreated hypertensives.The bra-
chial artery was cannulated for drug infusion,
measuring %F blood flow(FEF) changes from basal
(ml/100 ml tissue/min;venous plethysmo~raphy)dur­
ing cumulative infusion of increasin~ NE rates
(.15,.5,1.5 pg/min x 3 min each)in presence of
saline(S) or either V(9.pg/min x 15 min,n=6) or N
(lOpg/min x 15 min,n=6).In spite of comparable
vasodilation(V:from3.6 to 7.3; N:from 3.3 to
6.9), N(S:-25.1;t.7. ,-54.3j;,,4. ,-70.8±5.; N:-2.8,;1;5.,
-14.9,;1;15.,-47.2,;1;11.%;p~.001)butnot V(S:-19.9j;,,6.,
-48.1~4.,-65.7±6; V:-27.7j;6,-47.5±8.,-66.2,;1;4.%)
antagonized NE-mediated VC.At higher infusion
rates,N(30pg/min x 15 min,n=6;FPF from 3.8 to ll.~
further antagonized NE-mediated VC(S:-18.9±5.~54.
+5. ,-69.1±5.; N:-0.4j;1. ,-2.5,±4. ,-35.9j;17%;p<:.001)
;hile a quantitativelysmall adrenolytic effect of
V(31pg/min x 15 min,n=6;FBF from 3.5 to 10) ap-
peared(S:-20.7±8.,-50.4±7.,-64.5j;4.; V:-10.8;t.13.,
-31.±11.,-46.3±15.%;p(.01).At least part of the
hemodynamic effect of DH CEPs in man may be due
to 0{ -antagonisrn.o{-activa ted ROCs may be preferen-
tially coupled with vascular receptors for DH CEB~
EFFECTS OF DILTIAZEM ON VENTRICULAR FUNCTION IN NON-Q
WAVE INFARCTION: RESULTS OF THE MULTICENTER RANDOMIZED
DILTIAZEM REINFARCTION STUDY.
Wi11iam E. Boden, MD,FACC, Edward W. Bough, MD,FACC,
~S:-GTDSOn; ~, George A. Beller, MD,FACC,
Harper Hospital/Wayne State University, Detroit, MI;
Seventy-four pts with enzymatically(MB-CK)confirmed
non-Q wave(NQ)MI were randomized to high-dose
diltiazem(DTZ) 360mg/day vs placebo(PL)within 24-72
hours and underwent mu1tigated radionuclide
ventriculography(RVG)before(m=50.5hrpost-admission)and
after(m=10.2 days)assignment to study drug. A
semi-quantitativeregional wall motion(RWM)score was
obtained by dividing the LV into 10 segments and summing
the number of abnormal regions. LV ejection
fraction(EF)andRWM was compared to the ECG site of NQMI
for early(E) and late (L) RVGs, and analyzed with
respect to drug effect (DTZ vs PL), peak CK values, and
the presence of single (1) vs multiple (~2) NQMI ECG
locations. For anterior(ANT)(leads VI - V 4)NQMI, DTZ
resulted in no change between late EF(48%) and early
EF(48%) or RWM score. Similarly, DTZ did not affect
late EF(54%) vs early EF(52%) in inferior(INF) (leads
II,III,AVF)NQMI. However, for lateral(LAT) (leads
I,AVL,Vs -V6 ) NQMI, DTZ resulted in a significant
improvement in late RWM score (16.3) ,compared to
early(17.2)RWM score(P<O.Ol) despite no change in late
EF(53%) vs early EF(51%). In pts receiving PL, there
were no sequential RVG changes in EF or RWM score among
any ECG subgroup of NQMI.
Of note, neither the ECG extent (single vs multiple
site) of NQMI nor initial ST segment shift (elevation vs
depression) discriminated significant differences in
global or regional LV function, or peak CK values.
We conclude that global and regional LV function is
well-preserved during high-dose di1tiazem treatment
during the early course of acute NQMI.
Wednesday, March 11, 1987
10:30AM-12:00NOON, Room 26, Second Level
Follow-Up of Pediatric Heart Disease
VALVE REPLACEMENT IN CHILDREN; GUIDELINES FOR SELECTION
OF PROSTHESIS
Michel N. Ilbawi, M.D., F.A.C.C., Farouk S. Idriss, M.D.,
Serafin Y. DeLeon, M.D., F.A.C.C., AlexanderJ. Muster, M.D.,
F.A.C.C., C. Elise Duffy. M.D., Samuel S. Gidding, M.D. and
Milton H. Paul, M.D., F.A.C.C., Children'sMemorial
Hospital, Chicago, Illinois.
Between 1/75 and 7/86, 154 Pts ages 4 months to 18 years
underwent 157 valve implantations, excluding cardiac con-
duits. Porcine valve (PV) was used in 101, St. Jude valve
(SJV) in 40, and Bjork-Shiley (BSV) in 16. The valve re-
placed was aortic in 24, mitral (systemic AV valve) in 41,
pulmonaryin 69, and tricuspid (pulmonary AV valve) in 23.
Hospital mortality was 6%. Pts with BSV received warfarin
anticoagulationwhile those with SJV aspirinand Persantine.
Follow-up is available on all Pts 0.6 to 12 years postop-
eratively (mean 6.2!2.3 years). Functional class improved
in 62% and remained unchanged in 38%. Thromboembolic com-
plications occurred in Pts with SJV at a rate of 32!6%
and 1.3!0.4% per Pt year on the right and left side re-
spectively. Bacterial endocarditisdeveloped in 3 Pts, all
with PV. Hemodynamic assessment of valve function by serial
echocardiographyor cardiac catheterizationwas performed
on 133 Pts (86%). Actuarial functional life, free from all
prosthetic-relatedcomplications including significant
hemodynamicabnormalities, was 92!6% for right-sided, 67!
8.6% for left-sided PV at 5 years versus 47!3% for right-
sided, 88!7% for left-sided SJV at 4 years. The data indi-
cate that SJV has excellent durabilityand hemodynamic
function in the left side without need for warfarinanti-
coagulation. The high incidence of thrombotic malfunction
of SJV on the right side deters from its use in that loca-
tion. The good long-term performance of right-sided PV
encourages its continued implantationfor tricuspid and
pulmonary valve replacement. BSV insertion should be lim-
ited to selected cases because of need for anticoagulation.
BP mmHg HR FS % EF% AFA m/sec/sec
ARE CALCIUM ANTAGONISTS AS EFFECTIVE AS BETA
RLOCKERS FOR THETREATMENTOF THYROTOXICOSIS?
Mark R. Milner, MD Robert A Phillips MD, PhD, Kenneth
Gelman MD, Valentin ~uster MD, FACC, MartinE Goldman MD,
FACe. Mt Sinai School of Medicine, New York, NY
Betc blockers are the only proven agents effective in acute
control of thyrotoxicosis. However, they act indirectly, do not
lower oxygen consumption, may precipitate heart failure or
bronchospasmand may result in thyroid storm when withdrawn.
Because thy raid hormones appear to have direct stimulatory
effects on calcium activated ATPase in addition to increasing
serum calcium levels, we evaluated the efficacy of diltiazem in
a randomized, prospective, double-blind crossover pilot study in
five patients with untreated thyrotoxicosis (5 femoles, mean
age=3Iyrs). The pts received both diltiazem (60 mg qid) and
propranolol (40mg qid), each for f week, separatedby a 3 d~y
drug free period. Blood pressure (BP), heart rate (HR), thyroid
hormone levels, ECG, 20 and M mode echocardiograms
(fractional shortening (FS) ond ejection fraction (EFl) and
Doppler (aortic flow acceleration (AF A)l were obtained in
addition to objectively grading 8 clinical signs and 18symptoms
of thyrotoxicosis. Average values were:
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ElECTROPH YSIOlOGICSTUDIES AFTER ARTERIAL
SWITCH REPAIR OF d-TRANSPOSITIONOF THE GREAT
ARTERIES
Victoria Vetter, M.D., F.A.C.C., Carol Tanne r, B.S.,
christian Hardy, M.D.
The Children 's Hospital of Philadelphia, Philade lphia, PA
Electrophysiologi c (EP) abnormalities are common after
the Mustard repair of d-transpos ltion of the great arteries
(TGA). It has been suggested that some of these EP
abnor malit ies are intrinsic to TGA. The purpose of the
curre nt study was todetermine if EP abnor malties are
presentafter the arterialswitch repa ir of TGA. Fifteen TG.A
patient s (pts ) hadcomplete EP st udies I+.38 years after the
art er ial switc h repai r of TGA. All pts had norma l sinus
rhyth m on res tingelectrocardiograms and 24 hour Holter
monitors. Two pts had rare premature ventric ular
contract ions onHolters. Five had right bundle branchblock .
Five pts had mildelevations of corrected sinus node recovery
t ime to 300-370 msec but all pts incl uding these 5 pts had
normal sinus noderecovery time to sinus cycle length ratios.
There were no inducible atrial arrhythmias. AH intervals
were normal in all pts. The mean paced cycle length
producingantegradeAV block was 237:}7 msec , Ventriculo-
atrial (VA) conduct ion was present in 4696 with a mean
retrograde VA blockat 317161 rnsec. All HV intervals were
normal . Double prematureventricular st imulation produced
bundle branch reentry in 4 pts and intraventricular reentry in
I pt , No sustained ventricular ta chyca rdia occurred. We
conclude that electrophysiologic abnormalities present after
art erial switch repair of transposit ion of the great art eries
are inf requent and mild.
ELUCIDATION OF THENATURAL HISTORY OF VENTRICULAR SEPTAL
DEFECTS BY SERIAL COLOR DOPPLER FLOWMAPPING STUDIES.
Lisa K. Hornberger, Kimberl y A. Kr abill, M.D. , David J.
Sahn , M.D., FACC, Sandy Hagen-Ansert, RDMS, Uni v . of
Cali f , San Diego, CA.
Two-dimensional echo aids management of infants with
ventricular septal defect (VSD) but its inabi l i t y to
resolve ve ry small VSD's and pr ohlems with defining VSD
orifi ce s ize (becaus e of overl yi ng muscle or tricusp id
tis sue) has made it unsuitable as a standard f or defi n-
i ng th e nat ural histor y of VSD . We performed 74 serial
2D color flow mapping Doppl er (CFD) s tudies t o defIne
VSD ana tomy , l ocation, and CFD VSD diameter (CFDD) as a
parameter of shunt size i n 45 pt s over a 29 mont h per-
iod. Nineteen pts f irst s tudied < 6 mo of age (mean age
at most recent s t udy 25 1!I0 ) had cardiac failure (CHF)
and 26 (mean age 3.7 yrs) did not. I n t he CHF pts,
there were 17 perimembranous (PMD) , 1 subarterial , and
mus cular VSD. Aneury sm f ormat ion waspresent in 8 CHF
pts. Mean CFDD was 7. 8 + 2.1 mm (SO) and CFDD/AO r oot
rati o was 0 .5 9/1 . In t hose cathet erized (n=23) , CFDD
bore a close relati onship to angiographic diamet er (r =
0 . 98) and Qp:Qs (r=0. 93) . I n t hi s group 3 vsn ' s , all
with aneur ysmpresent or positi oned adjacent to t he
tricus pid valve, became smaller but none closed. Of the
26 pt s wi thout CHF, 14 had PHD's (13with aneurysm) and
12 had musc ular VSO's. Mean CFOD was 3.3 + 1. 2mm SD and
CFDD/AO root rati o was 0.26 (both p< 0.05 compar ed t o
CHF group). Followop CD of non CHF pt s showed t hat
1/14 PHD's and 2/ 12 muscular VSD's had closed , while 5
PMD's and 4 muscul ardefects showed signi fi cant diminu-
t i on of CFDD. We conclude t hat 20 echo and CFD obser-
vat i ons ai d i n predicting whi ch pt s with VSO ' s might
devel op CHF and suggest which VSD' s will become smaller
or close spont aneous l y .
LONG-TE~~ EXERCISE PERFORMANCE IN TRANSPOSITION OF THE
GREAT ARTERIES.
Rober t A. Mathews , M.O. , F.A. C. C. ,Frederick J . Fr i cker,
M. D. , F.A.C.C. , Lee B. Beerman , M.D., F.A. C. C. ,
Donald R. Fischer , M.D ., F. A. C. C. , Children's Hospi tal
of Pittsbur gh , Pittsbur gh, PA .
Fourty-six patients who underwen t Mus t ar doperation fo r
transpositi on of t he great arter i es have had exercise
studies. Mean age at opera t i on was 6.9 years (1.5-15 yr) ;
fo l low- up time averaged 9. 8 years (4-21 yr) . Longitu di -
nal studies were performed in 20 of t hese patients up to
6 year s af t er t heir first study.
Duration of exercise and maximal oxygen consumption
were normal i n th e youngerpatients. However, endurance
and fitness became abnormal (p<. OOl) i n t he ol der pa-
t i ent s over 14 years of age . Li kewi se , blood pres sur e
and heart rat e r esp onses were diminished (p<.OOI) in
these older pa t i ent s . Oxygen des a turation « 92%)
occur r ed dur i ngexercise in 15 patients who were fully
sa t urated at rest. A variety of abnormal rhythms and
arrhythmias were seen. Premature ventr icular con-
tract ions were provoked during exerci s e i n 21% of those
who had normal rhythms a t rest .
Commonly mea sur ed exer ci se parameters may be nearly
normal in many pa t ients ea r l y af te r Mustard opera tion .
With i ncreas i ng age, exerci se performance decreases ,
exemplifi ed by diminished endurance and fi tness. Chr ono-
tropic and blood pr essur e responses may also be blunt ed.
Ar t er i al desaturations, abno rmal cardiac rhyt hms and/or
dys rhythmias may deve l op. Longitudinal s t udies sugge s t
tha t th e right ventricle may become unable to fully
sus tai n sys t emi c fun ction es pecially during exercise.
COMPLEMENTARY FOLE OF MAGNETIC RESONANCE lMAGINGAND
RFAL-TIME DOPPLER CaLORFLOW MAPPING FOR POST- OP EVALUA-
TION AFTER SURGERY FOR TETRALOGY OF FALLOT. Kyung J .
Chung ,M.D. , FACC, David J. Sahn,M. D. , FACC , Pat O. Daily ,
M.D ., FACC, Joel F. Martin,Ph. D., J ohn R. Hesselink,
M. D. Uni v of Calif, San Diego, CA .
Magnetic Resonance Imagin g (MRI) and two-dimensional
Doppler ca l or flow mapping (2DCF) were used to evaluate
th e sept um, right ventricular outflow tract (RVOT), and
pul monary ar t er i es (PA) in 11 pati ents (pt s ) 6-23 months
after repair of tetralogy of Fallot (TOF) . Pts ran ged
f rom 3 t o 12 years in age and were s t udi ed during admis-
s i on fo r pos to p catheterizati on. ECG-gated, spin-echo
HRI (TE: 20 msec, mul t i s lice) images wer e obtained us in g
a 1. 5 Tesla GE system with slice t hi ckness 5- 10 mm and
continuous sec t ioning, or a 5 mm i nt erslice gap. Cor o-
nal, saggital, and transverse views were obtained . For
2CDF, compl e t e mul t i pl anar exams were performed us i ng
one of two phas ed array sys t ems (Toshi ba or Aloka ) with
3.5 or 5 MHz transducer s t o eval uate th e sep t um, atrio-
ventricular valves and gr ea t art eries . HRI pro duced
excel l ent vi sual i za t i on of t he RVOT and PA 's i n al l the
pts. For t hese pos t op pts t he prOXimal RVOT was wider
t han t he val ve annul us i n al l and was aneur ysmal i n 3
pts. In anot her PTthe le ft PA was nar r ow and i n one ,
bot h peripheral PA' s were narr owed . 2DCF detect ed
resi dua l ventri cul ar septal defect in 1 pt, pulmonar y
insufficiency i n all 11, and tri cuspid i nsuf f i c i ency(TI )
in 5 pts . RVOT gradient and RV pr es ure coul d be pred-
i cted from cont i nuous wave Dopler inter rog at i on of th e
RVOT and TI veloci t i es , re spectivel y . In comparison t o
t he postop catheterizati ons i n thes e patients, the
combina t i on of MRI and 2DCF appears to pro vi de a com-
ple t e and potentially seri all y applicable noninvasive
assess ment of the functional and anat omi calresults
af t er surg i ca l repair of TOF.
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CARDIORESPIRATORYRESPONSE TO EXERCISE AFTER DEFINITIVE
REPAIR OF UNIVENTRICULAR HEART.
David J. Driscoll, M.D., F.A.C.C., RobertH. Feldt, M.D.,
F.A.C.C., CarlMottram, R.R.T., FranciscoJ. Puga, M.D.,
F.A.C.C., Hartzell V. Schaff, M.D., F.A.C.C. and Gordon
K. Danielson, M.D., F.A.C.C., Mayo Clinic, Rochester, MN
To determine theeffect of definitive operation on exer-
cise tolerance for patients with univentricularheart, we
compared the results of cycle exercise of four patients
after ventricularseptation and nine patients after Fontan
to that of 38 preoppatlents. As compared to the preop---
group (45%)*, exercise duration was significantly [p<0.05]
longer after a Fontan (66%) but not after septation (45%).
Similarly,patients performedmore [p<0.05] work after
Font~n (47%) than after septation (26%) or preop(28%).
Max V02 was slightly greater [NS] after a Fontan
[25 cc/kg/min], thanafter septation [24 cc/kg/min] or
preop [22 cc/kg/min]. Max exercise HR was blunted in all
three groups. Restand exercise arterial 02 saturation
was ~igher after either o~er~tion than preop.
Resplratoryrate and the VE/V02 were significantly
[p<D.05] lower after a septation operation than preop.
After Fontan these variables were slightly (NS) lower than
preop. Cardiac outputwas below the expectedmean for all
postop patients and below the lower limit of normal for 7
of the Fontan and I of the septation patients. Exercise
stroke volume was reduced in most postop patients.
Exercise arrhythmias occurred in24% of preoppatients,
75% of septation and 44% of Fontan patients.
Definitive operation for univentricularheart results in
improved cardiorespiratoryfunction at rest andexercise.
Exercise tolerance is improved more after a Fontan than
septation but exercise ventilation improves more after
septation than Fontan.
*( )=% of predicted.
MODULATION OF LIDOCAINE EFFECTS ON VENTRICULAR
DEFIBRILLATION. James N. Black MD Jean T. Barbey, MD,
Debra S. Echt, MD, FACC, Vanderbilt Univ, Nashville, TN
Lidocaine (L) increases the energy required for ven-
triculardefibrillationin dogs with internal spring and
epicardial patch electrodes. We investigated the rela-
tionship of plasma L to defibrillationenergy, ventri-
cular fibrillation (VF) duration, and VFcycle length
measured from discrete RV endocardial electrograms. De-
fibrillation energy data were used to derive 90% effec-
tive doses (ED90). Five dogs were tested after 10 secs
VF durationat baseline and during L infusion: L in-
creased ED90 from 11±5 J to 24±12 J (p<.05) and VFcycle
length from 96±3 to 129±20 msec (p<.Ol). Both returned
towards baseline after 1 hr washout. Six dogs were
tested at baseline and during 3 L plasma concentrations:
ED90 (J) VF cycle length (msec)
Baseline 10 ± 4 115 + 10
Low L (2-4I.lg/ml) 12 ± 5 119 ± 9
Mid L (4-6 pg/ml) 16 + 5* 132 + 14*
High L (6-10 pg/ml) 19:;:: 4* 147 :;:: 23*
A linear relationshipwa; found between pla;ma Land
ED90 (r-.69,p<.002) and VF cycle length (r-.59,p-.002).
In 6 dogs the effect of VF durationwas evaluated
after 5 and 15 secs of VF at baseline and during L:
ED90 (J) VF cycle length (msec)
VF duration 5 sec 15 sec 5 sec 15 sec
Baseline 11 ± 4 11 ± 5 106 ± 7 97 + 8
Lidocaine 22 ± 3* 26 ± 9* 124 + 8* 114 :;:: 8*
*p<.Ol compared to baseline - -
Before and during L, longer VF duration shortened VF
cycle length and increased ED90. In conclusion:
lidocaine increases defibrillationenergy and ventri-
cular fibrillation cycle length in a reversible, linear
concentrationdependent fashion, and these changes are
modulated by ventricularfibrillation duration.
Wednesday, March 11, 1987
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Defibrillation: Physiology and Technique
SEQUENTIAL PULSE DEFIBRILLATIONTHRESHOLDS IN MAN: EFFECT
OF PULSE WIDTH VARlAUON. Gust H Bardy,MD,FACC, Tom0
Ivey,MD, Robert B Stewart,BS, Daniel P Fishbein,MD, Jeanne
E Poole,MD, Peter J Kudenchuk,MD, Gur C Adhar,MD,H Leon
Greene,MD,FACC. UnivWashington, Seattle, WA.
The optimal pulse width(PW) for sequential pulse
defibrillationin man using the Medtronic 6880 catheter
and the TX7 left ventricular(LV) patch electrode is not
known. However, based on previous canine work, pulses of
5ms duration traditionallyhave been used. To test
whether 5ms PW was optimal, we examinated defibrillation
thresholds(DFT's) using PW's of 2.5, 5.0 and 7.5ms at
10sec into ventricularfibri1lation(VF) in 5 pts
undergoing surgical implantationof automatic
defibrillators. The first pulae was delivered between the
right ventricularapical(RVA) electrode and the superior
vena caval electrode of the 6880 catheter. The second
pulse was delivered 0.2ms later between the 6880 RVA
electrode and the LV epicardial TX7 patch electrode. Both
pulses for any psrticulartest were of the same PW. The
OFT's for each of the PW's are as follows:
Pulse Leading Edge Leading Edge Total Total
Width Current Voltage Energy Charge
2.5 ms 7.6+3.2A 540+174v 11+8J 29+11mC
5.0 7.7+2.7 542+153 17+10 44+15
7.5 7.9+2.9 584+155 18+11 57+18
p ·-NS p ; NS p fO.Ol p<.-O.OOl
Conclusion: The leading edge voltage and currentOFT's
are not significantly different for any of the PW's
studied. However, total energy and charge is considerably
less with the 2.5ms PW. A 2.5 ms PW would improve battery
life of automatic defibrillatorswith no loss in efficacy.
C
8±5
122±16 134±24*
74±9 74±8*
175±10 186±15*
Procainamide(n-62
A B
8±3 8±3
C
14±3
90±8 88±8* 107±11
66±4 66±5 69±7
150±22 146±19 156±14
94:9
65±6
135±9
PROCAINAMIDE DOES NOT AFFECT VENTRICULAR DEFIBRILLATION
IN DOGS. Debra S. Echt. MD FACC, D. Robertson Coxe,
James N. Black, MD, Elizabeth Sewell, Vanderbilt
University, Nashville, TN
Several antiarrhythmicdrugs including lidocaine have
been shown to increase the energy required to terminate
ventricularfibrillation (VF) in dogs. We evaluated the
effects of procainamide (PA) in acute canine experiments
using the same internal spring and epicardial patch
electrodes used in humans for defibrillation (OF)
testing. Twelve experiments were performed in 3 phases,
with baseline measurements (phase A) and measurements
after 2 PA loading and maintenance infusions or saline
control (phases B and C). OFenergy results were used
to construct curves of energy vs. %successful OF and
derive 90% effective doses (ED90). VF cycle length was
determined from discrete RV endocardial electrograms.
Results (mean±sd):
Control (n-62
Phase A B
ED90 (Joules)15±4 14±5
VF cycle
length(ms)
QRS (ms)
RV-ERP (ms)
PA plasma
cone. (llg/ml) 8±3 13±4
*p<.Ol compared to earlier phases (2-way ANOVA)
ECG intervals and RV-ERP increased with PA compared to
baseline and control values indicative of PA myocardial
effect. The energy requirements for OF were not altered
by saline or procainamide even at high plasma
concentrations. These data raise the possibility that,
in patients, administration of procainamide may be
preferable to lidocaine during emergency treatment of
ventricularfibrillation.
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SEQUENTIAL PULSE DEF IBRILLATlON IN MAN : COMPARISONS OF
ORTHOGONAL SEQUENTIAL PULSE USING 4 PATCHES TO SINGLE
PULSE DEF IBRILLATION USING 2 PATCHES.
Douglas L. Jones, Ph.D., GerardM. Guiraudon, M.D. ,
F.R.C.s.lc), ArJun D. Shanna, M.D . , F.R.C.P.( Cl and
George J . K1ein, M.D., F.R.C.P.ICl, F.A.C .C. , London,
Ontari 0, Canada.
We compared a sequential pulse tec hnique usi ng a 4
patch true orthogonal system to a 2 patch single pulse
system s imil ar to that used for the automati c
impl ant abl e defibrillator. The i nfl uence of patch si ze
was al so assessed. Defibrillati on thresho1ds were
detennined intraoperativelyin 21 anesthetized patients
undergoing accessory pathway ablatio n for
Wo1ff-Parkinson-White syndrome. Ventricu la r
fi brill at i on was i nduced by low energy ACcurrent. Ten
seconds after onset, defibrillation was at t empte d using
singl e or sequential pulse shocks until defibrillation
was accompl i shed (OFT). Selection of a single or
sequentia l pulse as theinitial attempt was randomized.
El ectrodes Single Sequentia1
4 s 24.8 + 24.7 6.7 + 8.3 joules
2 s + 2 L 11.4 + 15.0 2.7 + 1.4 joules
4 L 81"+ 5.3 3.9"+ 2.6 joules
Is = small [6 cm~];l. = large [13 cffi2])
There was a si gni f icant reduction in OFT for the
sequenti al pul se techni que over t he si ngl e pul se
techni que as well as a major eff ect of patch si ze on
OFT for the s i ngl e pulse OFT.
We concl ude t hat orthogonal sequential pulse shocks
provide si gni f icant reductions in OFT regar dl ess of
patch size. Optimal defibrillation requires at least
one large patch per pair for both 4 patch and 2 patch.
Supporte d by theMedical Research Counci l of Canada.
RELAT IONSHIP 8ETWEEN RESETTING AND TERMINATION OF
SUSTAINED VE NTRICULAR TACHYCARDIA:IMPLICAT IONS FOR
ANT ITACHYCARDIA PACING.Mark E. Rosent hal, M.D ., Nicholas
J . Stamat o , M.D., Jesus M. Almendral, M.D. , Mark E.
Josephson, M.O. , F.A.C.C. .Un iv of Penna. , Phil a. , PA
Both res etting and te rminat ion ofreentrant vent ri cular
ta chycardia (VT) by programmed ventricul ar ext rastimuli
(VES) require int er act ion of t he premat ure impulse with
the wavefront within the circuit. The relationship be-
t ween the coupl i ngintervals (Cl) of sin gle or double
VES which reset and/or terminated sust ained uniformVT
was examined in 61 pts. Single VES te rminated 9 of 88VT
(10.2%) . Double VES were delivered in 44 VT ; the first
VES was fixe d at a Cl wh ich did not reset VT whi l e dia-
stole was scanned with the second VES . Fourteen VT (32%)
were termi nat ed wit h 2VES. The corrected Cl was det er-
mined by express ing the Cl of sin gle VES as a fr act ion
of the VT cycle length and the Cl of t he second of 2VES
as a fr action of twice t he VT cycle length. Resetting
occurred at longer Cl than did t ermination in 7 of 9 VT
terminated with 1 VES and 12 of 14 VT t erminated dur ing
the del ivery of 2 VES . Seven of 35 VT were termi nated
with 1 VES i f resett ing had occur red at a corrected
Cl > . 75 wh il e only 1 of 52 VT terminat ed if resetting
was-not seen by thi s corrected CI (p<.Ol) . Twe lve of 30
VT were te rmi nat ed with 2 VES if resetting had occurred
at a correct ed Cl > . 75 compared t o 1 of 13if reset-
ting was not seenDYt hi s Cl (p<.05). Conclu si ons:
l )Resetting of sustained VT wit h s ingle or double VES
usual ly occurs at a longer Cl t hanVT t ermination. 2) It
i s poss ibl e t o identify a critica l Cl of premature
si ngle or double VES where t ermination of susta ined VT
is unl ikely if reset t ing has not been observed at long-
er Cl . 3) This r elationship has pot ential applications
in al gorithms for antitachycardia pacing for VT.
NON -INVASIVE ELECTROPHYSIOLOGY USING PERMANE NT
PAC~~AKERS IN PATIENTS WITH AND WITHOUT VENTRICULAR
TACHYCARDIA OR FIBRILLATION
Andrew Cohen, M. D. , LA.C.C., Ross D. Fle t cher , M.D.,
".A.C.C., Marc Wish, M,D., F.A.C .C., Fred Miller, M.D.,
Alhert DeINegro, M.D., F.A. C.C. , VeteransAdminis tration
and Georgetown Uni vers l t y Medical Cente r s , Washington DC
Permanent demand pacemakers capab le of non-i vasi ve
ele ctrophysiology stud ies (N IEPS ) were utilized to study
26 pat i ent s (pts ) wi th sponta neous sustained ventricul ar
tachycardia(VT) or fi bril lation (VF) (Group A) and 50
pts wi t h no docu ment ed VTor VF ( Gr oup B) . One
ventricular drive rate (60 0msec) fol l owed by 3 ext r a
stimuli, at three energy l evel swere used in all pts , II
pts al so had 2other drive rates (500,400) with 3 extra
stimuli at 2x thr eshold (Thr). 117 episodes of VT or Vf
were induced, 79% at 2x Thr ,IS % at 8x Thr and6% at
maximum out put (MO) .Of 7 episodes of VT/VF induced at
MO,4 wer e nonclinical polymor phi c VT or VF .6 Group B pts
wer e lnduced into VT or VF:4 i nto polymorphic VT,I into
VF and I i nt omonomorphic VT. Di scharge therapy was
based on NIEPS in Group A except I pt inducible from LV
onl y. In Group A pts, NIEPS pre di c ted nonrecurrence
correct l y in 80%,and predicted recur r ence cor r ect ly in
45% (PC03) . No pt inGroup B had an arrhythmi c event
who was induced into VT/ VF. In conclusion, NIEPS has an
accuracy in arrhythmia pre diction simi lar to invasive
studie s . The use of high paci ng outputs decreases t he
specif ici t y of t he test.
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The ImplantedDefibrillator: Clinical Results
FIVE YEAR EXPERIENCEWITH TIlE AUTOMATIC IMPLANTABLE
DEFmRn.LATOR IN 157 PATIENTS.
.RQ&.!U:.A.. Winkle • .!i.Q.... F.A.C.C., R. HardwinMead, M.D.,
Michael A. Ruder, M.D., Paula Sohmidt, R.N., Edward
Stinson, M.D., F.A.C.C., Wally S. Buch, M.D., Vincent
Gaudiani, M.D., SequoiaHospital, Redwood City, CA
One hundredfifty-seven patients 1130 males, 27 females)
with life threateningventriculararrhythmiashave under-
gone CPI/lntec automaticdefibrillator(AICD) implanta-
tion from 3/81 to 6/86 . Their arrhythmiahistory in-
cluded a single VT/VF arrest 51J, more thanone arrest
31J, and recurrenthypotenaive VT 18J. Ninety-five per-
cent of patients failed prior antiarrhythmicdrug trials
(average 3.1/pt). Underlying disease was CAD 68J, cardio-
myopathy 13J, normalheart 7J, andmitral prolapse, other
val vul ar and long QT 3.8J ea oh. The median ejection
fraction was 34J with 67J of patients having an EF <40J.
Leads were spring-patch49J, and patch-patch51J (used
exclusively last 18 eoe), Defibrillation could not be
achieved with any leada in 2J. Rate only units were used
in 98J. Antiarrhythmicswere given to 791. inoluding 32J
on amiodarone. Problematicinappropriateshocks oocurred
in 23 pts (15J) (sinus tach 4 pts, atrial fib 7 pts, SVT
3 pts, NSVT 4 pts, pacer interaotion1 pt, devioe mal-
function 2 pts, and lead fraoture 2 pts). Inappropriate
shooks were ultimately preventedin all 23 pts. Five pt s
(3.2J ) underwent generator/systemremoval due to infec-
tion. Nine (5.7J) underwent generatorremoval for non
infection reasons (failure to sense VT 1 pt, VT accelera-
tion 2 pts, heart transplant2 pta , pt preference 4 pts) ,
Median generator life was 17 mos. Non sudden deaths
occurred in 10.1S of pts (CRF 4.4J, postop 1.9J, other
3.8J). Six patients (3.8S) died suddenly. We conclude
that the AICD is an effective therapyin high risk pts.
Sudden deaths are uncommon and overall mortality/compli-
cations are acceptably low,
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POTENTIAL RISK OF LOW ENERGY CARDIOVERSION ATTEMPTS BY
IMPLANTABLE DEFIBRILLATORS. Gust HBardY,MD,FACC, Robert
B Stewart,BS, Tom D Ivey,MD, Daniel P Fishbein,KD, Jeanne
e Poole,MD, Peter J Kudenchuk,MD, Gur C Adhar,KD, H Leon
Greene,MD,FACC, Univ of Washington, Seattle, WA.
Conclusions: With anticipated multiprogrammable
implantable defibrillators, arguments have been made to
f i r s t attempt low energy cardioversion rather than
proceed with the maximum defibrillatoroutput. Our data,
however, suggest that this approach has the riak of
requiring considerably higher energies for defibrillation
than anticipated should low energy cardioversion fail.
Such demands mayexceed the output limits of the device.
7.9J
E
p<0.05
16.9 + 10.0
10.6 +
1
p<0.05
5.5 + 2.6A
6.9 + 2.8
442 + l35V
p<0.05
Low energy cardioversion of ventricular tachycardia is
considered better than high energy. However, the
r ami f i cat i ons of low energy pulses on subsequent
defibrillstion success if the low energy pulse fails or
leads to ventricularfibrillation (VF) are not known.
Therefore, using the Medtronic sequentisl pulse 68~O
cathetec-TX7 patch electrode system, we determined
defibrillationthresholds(DFT's) intraoperatively in 12
pts. Subsequently we compared these DFT values to thoae
defibrillationvalues that terminatedVF when a "aub DFT"
pulse had been used initially. Eleven of 12 pts (92%) in
this lstter group required higher voltage(V), current(I)
and energy(E) for defibrillation than the DFT values.
The values of V, I and E follow :
V
RESULT OF 573 + 157
"SUB DFT" ATTEMPT
DFT
CLINICAL OUTCOME OF PATI ENTS WITH VENTRICULAR
TACH YARRH YTHMIAS TREA TED WITH AUTOMATIC
IMPLANTABLE DEFIBRIL LATOR WITHOUT CONCOMITANT
DRUG THERAPY.
Enrico P, Vcltri M.D" Morto n M,Mower, M.D" FACC, M, Mirowski,
M.D., FACC, Sara Fisher, Ju anJu antcg uy, M,D., Lcvi Wat kins,
M,D., Philip R, Reid, M,D., FACC, Lawrences. c. Griff ith, M.D"
FACC, Joscph Lcvinc ,M.D., Thomas Guarn ieri , M.D.,FACe. The
Johns Hopkins and Sinai Hospitals, Ba ltimore, Mar yland ,
Th e long-term clinica l outco me of pat ients(pts) wit h recur rent,
ref ract or y ventricular f ibrillat ion (VF)/tachyca rd ia (VT) and
withou tspecific antia r rhythmic drug therap y is not known. Dur ing
February 1980-February 1986, 163 pts with VT/ VFunderwent
implantatio n of aut omat icimplantable defibrillator (A ID) /
autornatic irnplantablc card iovertcr -def ibrillaror (AICD).AID/ AICD
was the sole p roc ed ure in 119, with coronary bypass in 19, and
with subendocardialresect ion in 25, Eight pt s (5%) died prior to
discharg e. Thirt y-sevenpts d ischarg ed with out antiarrhythmic
drug therapy and/or subendocardial resect ion is thepopulation
reported, Patient characteristicsincluded: 23 males, 14
females; age 53; coronarydisease 22, card iomyopathy 4,other 11;
VF 26, VT 11 ; ejection fraction 44%; prio r suddendeaths2;
previous fa iled drugs4. At 20 month s f'ollowup, 33 pts (89%) were
alive, 4 pts (11%) dead (sudden death 1,heart fai lure 2,
myocard ial infar ction I), and 20 pts (54%) experienced at least I
app ropr iate out-of-hospi talAID/ AICD discharge. Actuarial
anal ysis of the "expected VT/ VF mortal it y" (fi rst appropria te
AID/ AICD discharge) at I and 2 years was41% and 68%
respectively. There was I (3%) actu al sudden VT/ VF death. We
conclude that these pts arc indeed at high risk of VT/ VF
recurrence and that AID/AI CD mar kedl y decreases theactual
VT/ VF death inciden ce even in the absence of specif ic
an tiarrh ythmic drugtherapy,
DOES AN AID GENERATOR NEED REPLACEMENT WHEN THE BATTERY
IS DEPLETED?Lawrenee Griffi th. MD,FACC,Thomas Guarnieri,
MD. , FACC,Mor t on Mower,MD,FACC,LouiseGrunwald,BA,Philip
Reid,MD ,FACC,Joseph Levine,MD , Juan Juantaquay,MD,Levi
Watkins,MD,Enrico Veltri,MD.Johns Hopkins and Sinai
Hospitals ,Ba l t i mor e , Maryland
Our treatment for patients(pts) who receive an Auto-
matic ImplantableDefibrillator (AI D) has been to use
"be st" antiarrhythmicdrug(s)and replace a generator
when the battery is depleted, An importan t question is
whether a depleted generatorneeds replacement if a pt
has no Arrhythmic Event(AE ) for a prolonged period.
To assess the risk over time of VTfVF death or AI D
f iring, we examined AE rate for t wo periods : (a) hospita l
di scharge to fi rst AID firing or VTfVF death; (b) first
AID f iring to a se cond AID firi ng 2r VTfVF dea t h .
Between 2/80- 5/ 85, 148 pts were discharged with acti ve
AID. In follow-up , 76 pts had an AID di scharge and 11
pts had VTfVF death. Of t he 76 pt s wi th AID dis charge,
27 had a second AID fi ring and 6 di ed due to VTfVF.
1st AE after implant AE after 1s t fi ring
Lapsed Pts a t Cumul Pts a t Cumul
Time{mons l "Risk" lliL.. ! "Risk" lliL.. !
o 6 148 53 61 76 24 73
6 12 92 15 7B 41 5 BB
12 lB 71 11 91 30 4 100
IB 24 50 4 95 lB 0
24 30 39 2 9B 12 0
30 36 32 1 99 7 0
36 42 24 1 100 2 0
Nine ty-five percent of first AE ' s occur within 2 yr s
of AID placement. Among pts wi th an AI D f i ring ,all subse -
quent AE's occurred within lB mons. These preliminary
f indings suggest that a pt on "best" medical therapy who
is free of AE for 2 yrs after hospital discharge or an
AID firing may not need an AID generator replacement.
THE IMPLANTED DEFIBRILLATOR: DEFIBRILLATION THRESHOLD
STABILITY OVER TIME.
Peter D. Chapman, M.D., F.A.C .C, ,PaUL J. Troup, M.D.,
F.A,C.C., Jule N. Wetherbee, M.D., Sharon E. Ouquette,
R.N., and Gordon N. Olinger, M.D. , F.A.C.C., Cardiology
DiVision, Medical College of Wisconsin, Milwaukee, WI.
Defibrillation thresholds (DFT[s]) were compared in 20
Pt with automatic implantable
cardioverter-defibrillators (AICDs) at the time of
i mpl ant ation of the lead system and at generator
replacement 14.9 + 5.8 months later (mean!. SO). OFT
was defined as the lowest successful energy terminating
AC-induced ventricular fibrillation using and external
ca rdioverter - defi br i l l at or having out put s of 1 to 40
Joules (Jl ; truncated exponential waveform , 60\ t ilt.
The shocking lead configurations employed consisted of a
superior vena cava spring plus an epicardial patch
electrode in 6 Pt and 2 epicardial patch electrodes in
14 Pt . Ovsrall there was no significant difference
between the mean OFT at the t ime of l ead installation
(13.3J) and the OFT at generator placement (14.1Jl. For
2 patch systems, the initial and follow-up mean OFTs
were 11.5 and 10. 9 J and no f ollow- up OFT exceeded
generator output (25J) . For spring- pat ch systems, there
was a trend towards higher OFT0 s at follow-up (17.5 +
5. 2 J i nitial , 21.7 + 12.4 follow-up OFT P = NSl and in
one patient OFT exceeded 25J, r eqUiring l ead revision.
We conclude that 2 patch configuration OFTs are stable
during long-term follow-up. The trend for higher
t hresholds over time for spri ng-patch l ead systems and
the one Pt exceeding the generator output at follow-up
emphasize the importance of carefUlly re-evaluating OFT
i n this group.
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EXERCISE TESTING IN PATIENTS WITHAUTOMATIC
IMPLANTABLE CARDIOVERTER DEFIBRILLATORS:
Rozann DeBorde, R.N., Joseph H. Levine, M.D.,
Lawrence S.C. Griffith, M.D., F.A.C.C. Enrico
P. Veltri, M.D., Mary Fennell, M.S.N., Diana
Aarons, B.S.N., Morton Mower, M.D., F.A.C.C.,
M. Mirowski, M.D., F.A.C.C., Thomas Guarnieri,
M.D., F.A.C.C. The Johns Hopkins University,
Baltimore, MD
Automatic implantable cardioverter
defibrillator (AICD) sensing is dependent upon
preset rate cutoff and probability density
function. Therefore, the AICD may discharge
unnecessarily during benign tachycardiaswhich
occur during exercise stress tests (ETT).
Twelve ETTs in 9 patients were associated with
an AICD charge. In 9, charges were for sinus
tachycardia, in 2, for atrial fibrillation and
in 1, for sustained ventricular tachycardia
(VT). All patients were asymptomatic. All
charges were for heart rates that exceeded the
rate cut-off. Shocks were successfully
diverted in 10/12 patients by applying a
magnet for approximately 2 seconds during the
AICD charge cycle, thereby redirecting the
defibrillating energy to the internal "test
load" rather than to the lead system. In the
other 2, shocks were delivered due to
misdiagnosis of rhythm or technical problems.
Conclusions: 1) The presence of an AICD does
not preclude maximal ETT in this patient popu-
lation. 2) Unnecessary AICD discharges can be
diverted during ETT in asymptomatic patients.
3) ETT may be of benefit for recognition of
supraventricular tachycardias in the
evaluation of out of hospital AICD discharge.
THE MOCHANICS OF CORCNARY GARDEN-HOSE IN INTACT AND
ISOVOLUMIC SWINE HEARI'S.
William P. Miller, M.D., F.A.C.C., Stephen H. Nellis,
Ph.D., A. Jarres Liedtke, M.D., F.A.C.C., Section of
Cardiology, Univ of Wisconsin, Madison, Wisconsin.
Coronaryhyperperfusion (CH) has been reportedto
enhance myocardial function by the "garden-hose"effect,
yet the physiologic importanceof this is uncertain. In
intact ejecting swine hearts (n=ll), coronary blood flow
(CBF) was oontrolledextraoorporeally. Left ventricular
major and minor epicardialdiarretersand wall thickness
(Th) were measuredwith ultrasoniccrystals. Ten minute
randanizedtrials of ooronary perfusion pressures at
control (100 mnHg), CH 1 (155 mnHg), and CH 2 (185 mnHg)
were effected by increasing CBF 36% (CH 1) and 85%
(CH 2) above control (both, p < 0.0001). End-diastolic
Th increased 5% (p < 0.025) and 9% (p < 0.025) while
endsystolic Th increased 3% (p < 0.005) and 5% (p <
0.005) at CH 1 and CH 2, respectively. Small (1-3%)
decreases in LV end-diastolic and end-systolic
epicardialmajor and minor axes occurredat CH 1 and
CH 2. There was no enhancenentof global LV function as
assessed by LVP, LV maxdP/dt or MVO. To determine
whether these small changes in LV d~ions influence
function in isovolumic hearts, swine hearts (n=6) on
cardiopulmonarybypass oontractingagainst a LVballoon
were studied. CBF was controlled extraoorporeallyand
CH 1 and CH 2 were again effected by increasing CBF 36%
(p < 0.005) and 82% (p < 0.001). In contrastto the
intact hearts, LVP increased from 103+10 to 114+12 mnHg
(p < 0.025) at CH 1 and from 101+12to 121+14 mmHg (p <
0.001) at CH 2 with no change in-LVIDP. we conclude
that coronary "garden-hose"is physiologically
insignificant in hearts with an intact circulationand
only becares importantin isovolumic preparations.
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M:R (mnHg/cc/min/gm)
AP 120/min Adenosine
RA LA RA LA
459t256 239t81 31tlO 25tll
*
Heart(gm) lBody(kg)
weight weight
RA/bw LA/bw LVlbw
C .34t.0 .32t.0 4.St.9
* *
H .48t.0 .55t.l 4.5t.4 353t252 171t47 45t8 29t6
Data are mean t S'ID. DEV. (* P < .05)
Minimal Coronary Vascular Resistance in Atrial
Hypertrophy
Robert P. Bauman, M.D., JudithC. Rerrbert, Ph.D., Joseph
C. Greenfield, Jr., M.D., F.A.C.C. ,Duke and VA Medical
Centers, Durham, North Carolina
Minimal ooronary vascular resistance (M:R) is elevated
in dogs with left ventricularhypertrophy;but it is not
known whether atrial hypertrophy is associated with a
similar finding. This study was designed to determine
if M:R was altered in atrial hypertrophy (H). Atrial
blood flow was measured in awake unanesthetized dogs
with 9±l~ radioactive microspheres during atrial pacing
(AP) of 120 beats/min and during M:R induced with
adenosine (1 mg/kg/min). seven foxhounds with
surgically produced aortic or mitral valve disease for
five years and eight control dogs (e) were studied.
These data indicate: 1) H was selective for atrial
tissue since the LV/bw ratio was not altered; 2) H was
not selective for the LA since both the RA and LA
hypertrophied; 3) M:R was not increased in LA
hypertrophy but was increased in RA hypertrophy. This
distinct difference in the maximum vascular dilator
capacity associated with right and left atrial
hypertrophy may imply a difference in angiogenesis
between the two chambers.
CVR
141±58
26±8+
.75±.27 1.6±.2
3.30±1.24+ .6±.2+
4.5±.5
Control
Baseline 3.3±4
Adenosine
CMR
Baseline 5.4±1.5* 5.5±.8* .80±.27 1.6±.3 128±41
Adenosine 2.53±1. 04+ .7±.2+ 29±13+
AO and RA pressures were similar for CMR and control
dogs at baseline and after adenosine. LV volume and mass
were significantly increased in CMR, however, there was
no difference in baseline MBF, Endo/Epi, or CVR.
Adenosine increased MBF and reduced Endo/Epi and CVR to a
similar degree in both groups.Thus, basal MBF and MBF
reserve appear to benormal in volume overload
hypertrophydue to CMR.
TOTAL AND REGIONAL MYOCARDIAL BLOOD FLOW IN CHRONIC
EXPERIMENTAL MITRAL REGURGITATION.
Joseph P. Kleaveland,MD, FACC, Steven Vinciguerra,
Thomas Vinciguerra, Blase Carabello,MO, FACC, University
of Pennsylvaniaand Temple University Hospital, Phila. PA
Myocardial blood flow(MBF) reserve hasbeen found to be
abnormal in several experimentalmodels of cardiac hyper-
trophy, but has notbeen previously investigated in
chronic mitral regurgitation(CMR).Therefore, we studied
basal MBF and MBF reserve after adenosine infusion using
15~ radioactive microspheres in 6dogs with CMR for 9 to
20 months and in 6 control dogs. CMR was created closed-
chest using catheter techniques with amean regurgitant
fraction of .54±.24. LV end-diastolic volume from biplane
ventriculographyand LV mass at sacrifice were normalized
for body weight(kg). Heartrate, mean AO and RA pressure,
LV endo/epicardial MBF ratio (Endo/Epi) and mean MBF
(ml/min/gm LV) were measured at baseline and after
adenosine. Coronaryvascular resistance(CVR)=(AO-RA)/MBF
(mmHg/ml/min/gm LV). *p<.05 vs Control;+p<.05vs Baseline
LV LV Mass Endo/Epi
Volume/kg~ MBF Ratio
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POSTURAL CARDIOVASCULAR REFLEXES INVOLVE FOREARM BUT NOT
CALF RESISTANCE VESSELS. L.K. Essandoh , M.D., D.A.
Duprez, M. D. , and J.T. Shepherd, M. D., D.Sc., F.A.C.C.,
Mayo Clinic and Foundation, Rochester, MN 55905.
The cardiopulmonary mechanorece pt or s have the major
role i n the reflex regulation of humanforearm musc l e
vessels. I t i s gener ally assumed that this applies to
ske l etal mus cles at large and hence this reflex is key
to th e r e~ulat ion of arterial bl ood pressure durin~
postura l changes. To test thi s ass umpti on , s i mul t aneous
measu r ements were made of change s in vascular resistance
i n forearm and calf in response to moving f rom supine t o
s itt i ng or t o head-down tilt. Subjects were healthy
males, 21 t o 63 yea r s old . Blo od flows wer e measured by
veno us occ lusion strain-gau ge plethysmogr aphy. The
gauges were maintained at t he same level relative to the
hea r t dur i ngthe postural changes. Changing f r om supine
to s itting caused a decreas e in f orearm blood f l ow from
4 . 13 + 0.15 to 2.16 + 0.19 ml/lOO ml/min., but no change
in calf flow (4.21 +-0.32 and 4 . 40 + 0 .5 9 ml/lOO ml/min.).
There was no change-in mean ar t erial blood pressure
(auscul t a t i on) andheart rate increased by 8.0 + 9.5
beats /min. Arrest of the circulation to both legs with
occlusion cuf f s on the thighs prior to s i t t i ng , to
prevent pooling of blood in them, reduced the degree of
forearm vasocons t r i c t i on . Neck suc t i on (40mm Hg) during
s itti ng, t o oppose the decrease i n transmural pressure at
the carot i d sinuses, inhibited the va soconstriction . This
i ndi cates tha t t he f or earm vasocons triction was due to
deactivati on of both cardiopulmonary and ca r otid mechano-
r eceptors. Dur i ng head-down t ilt of 10, 20 and 30· there
was dilatation of forearm but not of calf resistance
vessels . A Val salva maneuver caused a s i milar constric-
t ion of bot h va sc ul ar beds. Thus t he refl ex adj us tments
i n vascular r es i s t ance to t hese cha nges i n posture t ake
plac e in t he forearm, but not i n the calf.
ATHEROSCLEROTIC ARTERIES PRODUCE MORE PROSTACYCLIN AN D
THROMBOXANE THAN NORMAL ARTERIES.
J awahar Meh t a , M.D. , F. A.C.C . , Paulet t e Meht a , M. D.,
Mary Beth Ward, Daniel Lawson , and Tom Sa l deen , M. D. ,
Ph.D . VAMC and t he Univers i t y of Fl orida, Gainesv i lle ,
Fl orida and t he University of Uppsa l a, Uppsa l a, Sweden .
It has been thought that ather oscleroti c (AS) arteries
pr oduce less prostacyclin (PGI2) than non-AS arteries
ther eby pre-disposing to vas ospasm and thrombosis. We
r e-examined this concept by measuring spontaneous and
arachidonic acid (AA, 10 uM) - stimulated PGIZ biosyn-
t hes i s in arterial segments f r om chol es terol-fed AS and
non- AS New Zeal and White rabbit s. Thromboxane AZ (TXAZ)
bi os ynthes i s i n arterial s upernates was also measur ed by
RIA.
Resul ts : (mean t SE)
SPONTANEOUS AA 15 min AA 30 min
6- ke to-PG Fla AS 3.0tO.8 24 .hZ.S 2S. St2.7
( ng/ ml ) non-AS Z.1 t O.l 17.0t3.0 23. 0t 3 . 5
TXBZ AS 0. 80tO.lO 0 .9 4tO.lS 1. 60t O.14
(ng /ml) non-AS O.lHO.OS 0 . 65tO. Z2 1. 06tO.35
Pre treatment of arterial segments with i ndomethacin
i nhibited bot h spontaneous as well as AA-st imulated PGI Z
and TXA2 formation , whereas pretreatment with OKY-046
inhibited onl y TXA2 release thus confirming t he i dent i t y
of prostanoids. Thes e data indicate enhanced ( P~ 0 . 02)
fo r mation of PGIZ and TXA2 by AS vs. non-AS ar t er ies both
s pont aneously as well as i n r es ponse t o AA . Exce ssive
TXA 2 biosynthesi s r a t her t han di mi nished PGIZ f ormat i on
may be r esponsible f or vasospasm and in vivo t hrombos i s
in AS-vessels .
SELECTIVE ALPHA AND BETA ADRENERGIC REGULATION OF
PULMONARY INTRAVASCULAR VOLUME.
Leonard Bell , M.D. and David L. Rutlen, M.D. , Yale Uni v.
Sch . of Med., New Haven, CT.
Chang es in pulmonary i nt r avascul a r volume ( PI V) would
be expected to cause changes i n pulmonary venous return,
left vent r i cul ar enddiastolic pressure, and ca r di ac out-
put. Since the influence of selective adrenergic receptor
stimulation on PIV has not been clearly defined, the pul-
mona ry Circulationwas separately perfused at a constant
rate t hro ugh t he pulmonary artery and ent i re ly drained
t hrough the left atrial appendage to a n extracorporeal
reservoir in 6 anesthetized dogs , so that PIV changes
could be determined as reciproca l changes in reservoir
vol ume during alpha adrenergic r ecept or stimulation ( a)
( phenyl ephr i ne 100 mcg/mi n, n=4) or beta adrenergic
stimulation ( a) (isoproterenol 6 mcg/min, n=4). a was
as sociated with a prompt and sustained PIV decrease which
reached 78 + 15 ml (p<.03) below control upon termination
of infusion-at 20 mins. a was associated with a prompt
and sustained PIV increase which re ached 51 + 13 ml (p <
. 05) at 20 mins. Pulmonary artery pressure increased from
28+6 to 32+6 mmHg (p<.05) with a and decreased from 23+3
t o-Zl+3 mmHg (p<.05) with a. Since left atrial pressure
did not change , the a mediated PIV decrease is due to
active vasoconstrictionand the amediated PIV increase
i s due to active vasodilati on . I n the i nt ac t animal, it
would be expected that a would ac t to decrease PIV and
thereby enhance left ventricular end diastolic pressure
and ca rdi ac output, while B would act to increase PIV and
t he reby attenuate the increase in ca rdiac output mediated
by the direct effect of B on the heart.
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ATRIAL NATRIURETIC FACTOR Hl\S NO OIRECT EFFECT ON
MYOCARDIAL CONTRACTlLlTY.
oavid~ M.o., Gad Ker en, M.o., Thierry
reJeiiit~, r:n.C., Joseph M. Capasso, Ph.D.
and Edmund H. Sonnenb1ick, M.D., F.A.C.C. A1 bert
Einstein Co11 ege of Medicine, New York, N.Y.
Atrial natriureticfactor has been reported to
decrease myocardi a1 per fo rmance. To i nvesti gate
whether a direct contracti1e effect of atrial
natriuretic factor exists, we have examined the
mechanical performance of cardiac tissue to
increment al doses of atrial natriuretic factor (L,
2, 5, ID, 20, 40, 80 , 100 ug /ml i. Right
ventricu1 ar papi 11arymusc1es frcrn adu1 t male cats
(N e 61 were removed for mechanical investigation.
Papillary muscles were dr iven electrically at 0.1
Hz , gassed with 95't oxygen - 5't carbon dioxide and
external calcium concentration 4.8 mM .
Throughout the range ofdoses, atrial natriuretic
factor did not change resting tension {~ntreated
22.11 + 4 vs treated 24.21 + 5 mN/mm 1, peak
i scrnetF'lc tensio,fl {un.treated 76:44 ~ 11 vs treated
69.62 + B mN/lTITfl, tIme to peaktension (untreated
280 +'"23 vs treated 302 + 18 msl and t ime to one
hal rre1axation (untreatea325 + 26 vs treated 346
+ 37). In addi tion, peak isotoni c shortening and
veloc ity of shortening r emai nedunchanged i n the
treated group. ThUS, no direct effect of atrial
natriuretic factor on contractile performance was
observed in isolated cat r ight ventricular
papi 11ary musc1e and purported a1 terations in
cardiac performance must be attributed to
peripheral or vascu1 ar effect.
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ATRIOPEPTIN III INDUCES EARLY RELAXATION OF THE VENTRICLE
Ann L.Meulemans,Drs.Sc., Karin R.Sipido,M.D.,
Stanislas U.Sys,Drs.Sc., Dirk L.Brutsaert,M.D.,F.A.C.C.
Department of Physiology and Medicine,
University of Antwerp, Antwerp,Belgium
Atrial natriuretic peptide (ANP) is secreted by the
mammalian atrium in response to volume overload and
induces vasodilation and natriuresis.
We studied the effects of O.l~M synthetic atriopeptin
III (rat sequence) on papillarymuscles isolated from cat
right ventricle (n~18, 29°C or 37°C, 0.2Hz) and from rat
left ventricle (n~20, 29°C or 35°C, O.lHz).
In both species, atriopeptin III induced early
relaxation of isometric and isotonic contractions,
thereby significantly decreasing peak tension, peak
shortening, time to peak contractionand time to reach
half relaxation (p<0.OO5) without affecting velocity of
shortening or of force development. Similarly, increasing
intracellular cyclic guanosine monophosphate (cGMP)
either by addition of dibutyryl cGMP (1 to 100 pM) or by
addition of sodium nitroprusside (0.1 to 10 pM), also
induced early relaxation with significant shortening of
time to peak contraction and concomitant significant
decrease of peak performance.
These observations suggest, in cardiac muscle, both
for ANP and for an increase in intracellularcGMP, a
common intracellular pathway, which may result in a
decreased sensitivity of the cardiac contractile proteins
for calcium binding. The direct action of ANP on cardiac
performance by inducing early relaxation, may represent
another adaptationof the heart to volume overload as it
would induce early pressure fall and improve rapid
ventricular filling. The decrease in peak performance
could also contribute to the hypotension observed in the
intact animal.
ATRIAL NATRIURETIC PEPTIDE RELEASED BY RAPID ATRIAL PACING
IS ASSOCIATED WITH SUPPRESSION OF PLASMA RENIN ACTIVITY
K P WALSH, MRCPI, T D Jot WILLIAMS, MRCP, R CANEPA-ANSON,
MRCP, E PITTS, BSc, S LLIGHTMAN, MRCP, R SUTTON, FRCP,
FACC.
CARDIOLOGY DEPARTMENT, WESTMINSTER HOSPITAL, LONDON,
ENGLAND.
Infusion of synthetic atrial natriureticpeptide (ANP) leads
to suppression of renin secretion in dogs. To see whether
ANP released in vivo is accompanied by suppression of renin
levels, we paced seven chloralose anaesthetised dogs from
the right atrial appendage for one hour at 250 pulses per
minute. Haemodynamic measurementsand arterialplasma
samples were taken before and at 60 minutes of pacing. In
addition blood was sampled from the proximal coronary
sinus (CS) for ANP levels. Rapid atrial pacing raised mean
pulmonary wedgepressure from 2.4 ± 0.9 to 8.0 ± 1.5 (SEM)
mmHg (P<.OD, decreased cardiac output from 4.69 ± 0.33 to
3.75 ± 0.26 L/min (P< .OD and decreased mean arterial
pressure from 151 ± 6 to 139 ± 5 mmHg (P< .OD. Coronary
sinus ANP levels increased during pacing from 86 ± 12 to
515 ± 63 pmol/L and arterial ANP levels increased from 12 ±
3 to 146 ± 41 pmol/L (P<.05). Plasma renin activity
decreased during pacing from 5590 ± 1300 to 2660 ± 330
ngAI/hr/L (P<.05) and showed a marked reboundincrease to
8230 ± 1330 ngAI/hr/L at 60 minutes post-pacing (P<.Ol).
Rapid atrial pacing causes a marked rise in left atrial
pressure, marked release of ANP from the coronary sinus and
elevation of arterial ANP levels. These high levels of ANP
are accompanied by suppression of plasma renin actiVity in
the presence of reduced arterial pressure.
OUABAIN POTENTIATES HYPOXIC CARDIAC CONTRACTURE
Michael J. Cunningham, M.D., Beverly H. Lorell, M.D.,
F.A.C.C., Ellen O. Weinberg, and Carl S. Apstein, M.D.,
F.A.C.C., Harvard and Boston Universities, Roston, MA.
The effect of ouabain (OUB) on myocardial function
during hypoxia is difficult to study in intact animals
since hypoxia elicits autonomic reflexes which may mask
the intrinsic effect of OUR. To study this question, we
measured changes in LVEDP and developed pressure during
15 min of hypoxia (30% O2) and after 15 min of reoxygena-tion wi£9 95% 01 (REOX), in the presence of OUB
(2.5x10 M, n~7) and without drug (C, n~7) using isovolu-
mic buffer-perfusedrabbit hearts. Constant flow (12.4+
0.5 ml/min/gm LV) and HR (3.5Hz) were maintained. This
OUB dose was chosen because it produces a modest rise in
LV +dP/dt (17±4%) and coronary vascular resistance (CVR,
5.3±0.3 to 7.6±0.5 units, p<.Ol) with no change in LVEDP
during prolonged infusion with 95% O2, During hypoxia.hemodynamicdeteriorationwas more markedin the presence
of OUB, although CVR was similar in both groups.
LVEDP (mm Hg) DEVELOPED PRESSURE (mm Hg)
BASEL~HYPOXIA REOX BASELINE PYPOXIA REOX
C 9±1 14±3 9±2 113+7 55±3 101t6
OUB 9+1 32±7* 17+5 105±5 35t4* 76±14*
* ~ p<.05 compared with control.
To assess whether the rise in LVEDP during hypoxia was
due to an increased coronary turgor effect or due to
increased fiber tone, we subjected C and OUB groups to
zero flow for IS sec after IS min of hypoxia. The LVEDP
in the OUB group was significantlv greater than in the C
group (13+4 vs 4±1 mm Hg, p<.05).
We conclude that a modestly inotropic dose of ouabain
1) exacerbates the rise in LVEDP induced by hypoxia by
increasing the fiber (contracture) component of LVEDP, 2)
worsens the decline of systolic function, and 3) impairs
recovery during reoxygenation.
MECHANISMS OF EXPERIMENTAL VENTRICULAR PACING
INDUCED HEART FAILURE: ROLE OF MYOCARDIAL NOREPIN-
EPHRINE AND SARCOPLASMIC RETICULUM CALCIUM ATPase.
GOrdon W. Moe. M.D., Peter O'Brien, D.V.M., Ph.D.,
David Ianuzzo. Ph.D. Robert J. Howard. M.D •• F.A.C.C••
Paul W. Armstrong, M.D •• F.A.C.C. St. Michael's Hosp.,
Univ. of Toronto and York Univ •• Toronto, Canada.
To elucidate the mechanism of chronic rapid ventric-
ular pacing-induced heart failure, we studied 21 male
dogs paced to severe heart failure: pacing was then
discontinued following which the animals were
sacrificed - immediately (Gpl). at 46 hours (Gp2) or 4
weeks (Gp3) after pacing was discontinued. Twelve
normal dogs served as control (C). The table shows
data (means, pooled SO, correlations) for plasma
norepinephrine (pNE,pg/ml), PCWP (mmHg), Cl (ml/k~).
2D-echocardiographic LV diastolic area (XDA, cm).
ejection fraction (EF, ~) obtained immediately prior
to sacrifice. and LV tissue norepinephrine(tNE.ng/g)
and sarcoplasmic reticulum calcium ATPase (ATP.
umol/mg/min). I p<O.05. +p<O.Ol compared tocontrol.
n PCWP Cl XDA EF pNE tNE ATP correlations
C 12 6 169 10 53 266 771 0.26 tNE-ATP 0.85+
Gp1 7 26+ 74+ 17+ 21+ 1561+ 234+ 0.14+ tNE-EF 0.77+
Gp2 7 15' 132' 17+ 29+ 629 290+ 0.16+ tNE-XDA 0.61+
Gp3 7 13 150 14 47 205 562 ATP-EF 0.81+
SO 6 42 2 8 438 220 0.05 ATP-XDA 0.63+
Peak heart failure (Gp1) is characterizedby markedly
increased PCWP and XDA. depressed Cl and EF. accompan-
ied by a parallel reduction of tissue norepinephrine
and calcium ATPase. Recovery from heart failure
(Gp2,3) is associated with replenished tissue
norepinephrine. These data suggest that chronic rapid
ventricular pacing-induced heart failure may be
mediated by a depletion of myocardial norepinephrine
and sarcoplasmic reticulum calcium ATPase.
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ABNORMAL ACTION POTENTIALS AND CALCIUM HANDLING IN
MYOPATHIC HUMAN MYOCARDIUM.
Judith K. Gwathmey V.M.D.. Ph.D., Linda Copelas, B.S.,
G. Maurice Briggs, Ph.D., James P. Morgan, M.D., Ph.D.,
F.A.C.C. Beth Israel Hospital, HarvardMedical School,
Boston, MA.
We tested the hypotheses that altered electrical events
and calcium handling occur in myopathic tissue and may
explain the abnormal contractile function that is pre-
sent. Trabecularstrips of ~1.2 mm diameter obtained from
control (C) (n-5) and dilated (CHF) (n-19) and hypertro-
phic (IHSS) (n-2) myopathic hearts were loaded with
aequorin. The ~uscles were perfused in a physiologic salt
solution at ~~ C. Isometric tension, action potentials
(AP) and [Ca J
i
(L) were recorded. AP*durations (APD)
were prolonged ~n the CHF (706±18.8 ms ~ and*IHSS (650
±12.5 ms ) as compared to C (550±7.2 ms ) (p <.05). The
calcium transients from CHF and IHSS consist of two
components (L and L
2).
Caffeine abolishes L
l
yet a
component of t
2
rema~ns in myopathic tissue. Verapamil
diminished the amplitude of Lo' Isoproterenol increases
the amplitude of L
l
and reduces L and the APD.
Conclusions: 1) These data indica~e that there is a
prolonged action potential duration (APD) in myopathic
mus~le, suggestive of a prolonged I ., 2) LJ is due to SR
[Ca J release and uptake. 3) L2 iss~aused oy a combina-
tion of impaired calcium reuptaRe by the SR from the
cytoplasm and prolonged I ., 4) The alterations in the
APD and L measurements co¥relate with the prolonged
tension response in myopathic tissue.
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CoronaryArtery Disease: Clinical
CORONARY ARTERY SPASM IN PATIENTS WITH COCAINE INDUCED
ACUTE MYOCARDIAL INFARCTION.
Pab10 I. A1tieri, Jose Martinez Toro, HectorBanch,Eduardo
Hernandez Carrion. Departmentof Medicine-University of
Puerto Rico,Medical Science Campus.
Cocaine is an alkaloid with many central nervous system
and cardiovasculareffects mediated through a potent vaso-
constrictormechanism. Although there have been several re-
ports of myocardial infarction due to the drug, few have
been acute and themechanism at present is notclear, We
have seen two patients mean age 23 years who developed se-
vere chest paininmediate1y after inhaling cocaine. They
were admitted inmediate1y to a coronary care unitwhere
the electrocardiogramsdone minutesafter the chest pain
showed prominentelevation of the ST segment compatible
with coronaryartery spasm. These changes developed into
classic infarction patterns (anteriorand inferior infarc-
tions). Both were catheterizedand the coronarieswere
normal and no spasm detected during the procedure.The
ventriculogramshowed hypokinetic areas corresponding
with the patternof the infarcts. The mean ejection frac-
tion was 50% + 5%. Both had post infarction treadmills
which were negative for ischemia.They stopped cocaine
inhalation and they have remained asymptomatic. Serial
Ho1ter monitorings have not shown any elevation or de-
pression the ST segment or arrhythmias.
In conclusion coronaryartery spasm may be one of the
mechanism producing myocardial infarction in cocaine
addiction.
DURATION OF SMOKING-INDUCED ENHANCEMENT OF PLATELET
AGGREGATION.
James W. Davis, M.D. and Joyce Arno1d, B.S., VAMC,
Kansas City, MO and Univ of Kansas, Kansas City, KS.
Platelet activation may mediate anassociation of ciga-
rette smoking with coronaryartery disease. Previous
reports from this laboratoryhave shown the platelet
aggregate ratio (PAR) to be consistently lower immedi-
ately after than beforecigarette smoking. The purpose
of this study was to determinewhether the effects of
smoking on the PAR and on collagen-inducedplatelet
aggregation (CIPA) would last as long as 2 hr. After
12 hr of abstinence, each of 8 male habitual smokers
smoked 2 Winston King Size cigarettes in 20 min. Ante-
cubital venipuncturewas done immediately before, im-
mediately after, 55 min after and 2 hr after smoking was
completed. At these times the mean PAR (± SO) was 0.91
(± 0.01), 0.82 (± 0.03), 0.87 (± 0.02) and 0.90 (± 0.02)
respectively while corresponding values forCIPA were
45 (± 5), 68 (± 5),59 (± 6) and 52 (± 5) chart units.
Mean PAR was significantly (p < 0.001) lower immediately
after and 55 min after smoking. Mean CIPA was signifi-
cantly (p < 0.005) higher immediately,55 min and 2 hr
after smoking. The concentrationof nicotine was deter-
mined in each of the 24 plasma samples obtained after
smoking (3 occasions for each of the 8subjects). Cor-
relation coefficients between the 24 nicotine concen-
trations and corresponding values ofPAR and CIPA were
-0.50 (p < 0.02) and 0.41 (p < 0.05) respectively. PAR
and CIPA were unaffected bysham smoking. We conclude
that cigarette smoking may enhance platelet function for
as long as 2 hrafter smoking ceases and that during
this period there was a statistically significant cor-
relation of the plasma nicotine concentrationwith each
of the platelet function tests used.
MYOCARDIAL INFARCTION IN THE ABSENCE OF
ANGIOGRAPHICALLY SIGNIFICANT CORONARY
ATHEROSCLEROSTICDISEASE: LONG-TERMPROGNOSIS
Michael J Pecora MD,Gary S Roubin MB PhD, B Woodfin Cobbs Jr
MD FACC, William WeintraubMD FACC, Spencer B King III MD
FACe. Andreas GruentzigCardiovascularCenter, Emory University
School of Medicine, Atlanta, Georgia.
To determine late outcome in patients having myocardial infarction
(MI) in the absence ofangiographicallysignificant fixed obstruction,
i.e. no lesion ;:: 50% diameter stenosis (DS) at subsequent
catheterization, we followed 48 such patients (pts) for a mean 69
(range 19-264) months. Patients tended to be young (mean age 45
years), smokers (34 of 48 (71%) pts, with atheroscleroticplaques (40
of 48 (83%) pts) in thearterysupplying the MI zone. Thrombuswas
superimposedin 13 of 40 (32%) pts withatheroscleroticplaques.
Angina persisted in 24 of 48 (50%) pts and was class 3 or 4 in 12 of
these 24. Repeat catheterizationwas performed 15 times in 12 pts, at
a mean of 48 months after index MI, demonstrating progression >
50% DS in 3 pts, recurrentthrombus in 2 pts, and dissection in I pt,
all of which involved the arterysupplying the index MI zone.Fifteen
major cardiac events occurred in 10 pts including necessity for
revascularizationin 3 pts, recurrentMI in 7 pts, and/or cardiac death
in 5 pts, Revascularizationand recurrentMI most commonly (5 of 7
pts) involved the artery supplying the index zone. The 2 autopsies
performedrevealed recurrenceof thrombuswith rapid progressionof
disease over 3 months following the index MI in I pt and diffuse
progression of disease in a second pt. Of the 37 ptscatheterized
within I year of the index MI,cumulative risk of a major event was
23% at 3 years.
Conclusions: Patients suffering MI despite the absence of severe fixed
obstruction are at risk for recurrent thrombosis, progression of
atherosclerosis,persistentsymptoms, and major cardiacevents.
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PERSISTENT ST SEGMENT ELEVATION AFTER UNCOMPLICATED ACUTE
ANTERIOR MI: PREVALENCE AND CLINICAL SIGNIFICANCE.
John C. Lystash, M.D. and Robert S. Gibson, M.D., Univ of
Virginia, Charlottesville, VA.
Ninety-three consecutive pts with MBCK confirmed acute
uncomplicated anteriorMI underwent study at 1~3 d with
24 hr Holter, radionuclide ventriculography(RVG), exer-
cise (Ex) TL-20l scintigraphy and coronary angio. Q-wave
(Q) MI occurred in 61 pts and non-Q-wave (NQ) MI in 32.
Persistent ST seg elevation (STt) of >1 mm in 2 or more
anterior (Vl-6) leads was found on the day 10 rest ECG in
46 QMI and 11 NQMI pts (74%vs34%, p<.05). Among pts in
both groups, the presence vs absence of STt did not iden-
tify differences in: Norris index; Lown grade 3-5 PVCs;
Ex workload or peak rate-pressureproduct; Ex angina, ST.
or TL-20l ischemia; or angio jeopardy scores. In the QMI
group, persistent STt correlatedwith more acute STt (p=
.0001), higher peak CK values (p=.018), longer time to
peak CK (p<.Ol), a lower LAD patency rate (22%vs50%, p=
.055), lower LVEF (38%vs47%, p<.007), more evidence of
scar within the infarct zone by RVG (p=.OOl) or TL-20l
criteria (p<.003) and a higher incidence of death or CHF
requiring treatmentwith digoxin/furosemide within 3 mos
(26%vsO%, p<.05). Similar analysis in NQMI pts revealed
only 3 associations: acute STt (p=.013), LAD patency rate
(45%vs85%,p<.04) and fixed TL-20l defects (p<.04). At 3
mos follow-up, more QMI than NQMI pts had persistent STt
(53%vs26%, p<.05). QMI pts who continued to show STt on
the rest ECG vs those who lost it had higher TL-20l mal-
perfusion scores (p=.Ol), more proximal LAD occlusions
(86%vs47%, p<.06) and a lower LVEF (p=.05). Thus, STt 10 d
after anteriorMI is: 1) more common after QMI vs NQMI;
2) resolves in many pts by 3 mos; and 3) correlates with
greater LV dysfunction, possibly related to sustained LAD
occlusion, and a higher cardiac event rate.
S"iMPTCMATICAW SILENr RIDXWSI<l>J~ a:MBINED STREP'II:l<INAS
AND~ aRllARY Al'QCI'lASTI NACl1lE M'iOCARDIAL INFARCl'Il:tl
Willian G.0'Cal.l.aghan.M.B., TaJDEl1dHinohara,M.D., HarryR.
PhillIps, M.D., Victor S. Behar , M.D., YihJog Koog, M.D., Raye
Bellinger. M.D., Gary J. Collins. MoD., and Richard S. Stack, M.D.,
F.A.C.C.,ful<e UniversityMedicalCenter, IAalan. North Carolina.
Initially successful eJergentcorooary ang1Dplasty (Pl'CA) in acute
~ocardial infarction (AMI:) maybe =t>licatedby late reocclusion of
the infarct-relatedartery. We have assessed the :Incidence of
reocclusion in 86 coosecutivepatients (pts) treatedwith streptokinase
(SK) and initially successful PJrA (resicbll. sterosis< 50%)•
Syuptallatic reocclusion,heralded by recurrence of ischemic syoptalla
and/orfl<G changes occurredin 8 (9.3%) pts. The involved arterywas
the left anterior~ in 5 pts and theright corooary in 3 pts,
At initial angiography,5 pts had reperfused foll.cidrlg SKprior to
PJrA. Themeanresidual corooary stenosisfo~ successful PJrA
was 33.6% (range25 to 63%). Addit:l.oos1 fird\Iwl :lnch.1deda resicbll.
f~ defect (2 pts) ss well ss minor (1 pt) and msjor (1 pt) intims1
dissections at the PJrA site. Themedian t:iJJe intervalbebieen PJrA
and reocclusionwas 11.5 hours (range4.7 to 202 hours). Foorpts were
treatedwith successful repeat PJrA, a reperfusioncatheterwas
inserted in 2 pts with subsequentcorooary arterybypsss graft Emgery.
In 2 pts reperfusionwas rot atteqlted.
Repeat corooary angiography was perfatB in 62 pts with no clinical
evidence of reocclllsion 1 weekfollawing successful PJrA. U1expected
reoccl1lsion was observed in 3 (4.8%) pts. All cases involved the right
corooary arteryand in each instm:e there was brisk collateralflDi to
the distal distributionof the vessel.
We crocllIde thet (1) the overall :Incidence of reocclllsion is abo.1t
14%fo~ initially successful PJrA in AMI: (2) the msjority of
patientshave syoptallatic reocclusion andmsybe !lJCCeSSfully treated
with repeatPJrA (3) silent reocclusim is IlDlXUIIIlD and is assoc:iated
with collateralcorooary blood flDi.
SUSTAINED IMPROVEMENT OF MYOCARDIAL PERFUSION THREE MONTHS AFTER
THROMBOLYSIS ASSESSED BY THALLIUM-201.
Ernst Vander Wall MD, Frank Vermeer MD, Reinoudt Vanden Pol BS, Arnoud
Vander Laarse PhD, Sdmon Braat MD, Paolo Fioretti MD, Jan Res MD, Hanno
Krauss foID, Maarten Simoons MD, FACe. Interuniversity Cardiology
Institute, Netherlands
Limitation of infarct size estimated from myocardial HBDH enzyme release
and preservation of left ventricular function were reported earlier in
269 patients (p t s ) allocated to thrombolytic therapy (T) with intra-
coronary streptokinase compared to 264 con'ventionally treated pts (C).
In order to evaluate myocardial perfusion at rest and the extent of
myocardial ischemia on exercise (X), symptom-limited Thallium (T1)
stress test was performed 10~14 weeks after the acute event in 236 of
these pts with a first infarction (HI) (l08 C, 128 I). Three-view Il
scintigrams were divided into 8 segments. Results in number of segments
per pt (mean ± SD).
In inferior HI the number of segments wi th normal I1 uptake was not
different in I and C in spite of lower HBDH infarct size in T 066 vs
1111 u/n, This may be caused by the higher number of nonfatal reinfarc-
t Lon in 10 T vs 3 C. In anterior HI Tl r-upt ake in the redistribution
scintigram was greater in I than C, which confirms the lower HBDH in-
farct size, 899 vs 1269 U/l, T vs C. Exercise-induced ischemia was not
more extensive in T, which may be explained by acute PICA in 15 pts and
by more frequent PICA or bypass surgery for post-infarct angina in 20 T
vs 12 C. Thrombolysis followed by additional revascularization proce-
dures in patients with anterior infarction leads to sustained Improve-
ment of myocardial perfusion without excessive exercise-induced
ischemia.
C T C T *
5.7±1.6 5.7±1.6 4.8±1.6 5.9±1.6
0.7±1.0 0.6±0.9 0.6±1.1 0.6±0.9
Anterior HIInferior HI
Norma1 T1 segments
X ischemia segments
(*p=O.OOl, T vs C).
RAPID, QUANTITATIVE ASSAY OF ISOFORMS OF THE MM ISOENZYME
OF CREATINE KINASE IN PLASMA
Ryuji Nohara, M.D., Burton E. Sobel, M.D., F.A.C.C. and
Dana R. Abendschein, Ph.D. Washington University,
St. Louis, Missouri
Changes in the proportionsof individual isoforms of
the MM isoenzyme of creatine kinase (MM CK isoforms) in
plasma permit veryearly detection of myocardial infarc-
tion and of reperfusion. However, existing methods for
their quantificationare slow and therefore impractical
for prospective use. Accordingly, we developed and vali-
dated a rapid assay procedureemploying column chromato-
focusing with on-line monitoring of enzymatic activity in
the column effluent that could quantify plasma MM iso-
forms within 30 minutes. Effluentfrom a microbore chro-
matofocusing column (1.8 ml bed volume) was split be-
tween a reaction stream, intowhich CK reagent was added
(1: 1), and a reference stream. "After incubation(35°C)
in a length of tubingselected to permitmaximal reaction
velocity, the streams were monitored at 340 nm and sub-
tracted to obtain astable baseline. Screening of 30sam-
ples indicated that the system is sensitive enough to
detect individual isoformactivities in plasma with to-
tal CK activity> 50 lUlL. When the rapid assay proce-
dure was applied to plasma samples from normal human sub-
jects and patients with infarction, and from dogs with
coronary occlusionand reperfusion (total CK activity 62
to 2731 lUlL), results correlatedclosely with those ob-
tained with conventional, butslow procedures for sepa-
rating and assaying isoforms (r = 0.96, n = 10). Thus,
minicolumn chromatofocusingand on-line monitoring of ef-
fluent enzymatic activity provides a practical, sensi-
tive, and quantitativemethod for rapid assay of CK MM
isoforms in plasma suitable for prospective detection of
myocardial infarction and reperfusion.
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INTRACORONARY THROMBOSIS: A MULTI-FOCAL DISEASE ENTITY
Frank J. Forlini, Jr., M.D., F.A.C.C., Franciscan Medical
Center and The CardiovascularInstitute of North West.ern
IllInoIs, Rock Island, IllInoIs
The current concept of the thrombosIs-infarctionprocess
places a major emphasis on occluslon of a single coronary
artery as a cause of acute myocardial infarction (AMI).
This study reveals the multi-focal nature of coronary ar-
tery thrombosIs. One hundred seventy five patients under-
gOIng Intracoronarystreptokinase infusion within 6 hours
of onset of AMI were carefully analyzed for concurrent in-
SItu coronary thrombosis. Patient age ranged from 32 to
71 years: mean 52. There were 114males and 61 females.
PatIents with atrIal fibrillation, cardiomegaly, intra-
cardIac thrombus, congestive heart failure or embolic epi-
sode were excluded from the study thus reducing the pos-
sibility of coronary embolization. All ~oronary arteries
were visualIzed and Injected with nitroglycerInprior to
streptokinaseadministration. Thrombolysis was initially
attempted In the coronary artery perfusing the wall with
hyperacute ST segment changes and then the contralateral
artery. ThIrty e.ght patients (22%) were noted to have
thrombi in 2 separate coronary art.eries. Fourteen pat.ients
had occlUSIon of the left anterior descend.ng and c.rcum-
flex coronary arteries while 24 patients had right corona~
thrombosls with additional lnvolvement of the left coro-
nary system. All thrombotic sites, in multi-vessel throm-
bosls patients, had underlying plaque formatlon. Spasm,
as an lsolated entity, did not play a major etiologic role.
In conclusion, In-situ coronary thrombosis during AMI, al-
though usually a unifocal occurrence, can in a significant
number of patients present as a multi-focal thrombotic
process. This process probably represents a hypercoagable
e f f ec t. on exposed collagen of remotely situated coronary
plaques and therefore necessitates more intensive thrombo-
lyt.c therapy than Single vessel perfuslon.
IMPORTANCE OF COLLATERAL PERFUSION IN KINETICS OF
CREATINE KINASE RELEASE
Tadakazu Hirai, M.D., Masatoshi Fujita, M.D., Hisayoshi
Nakajima, M.D., Hidetsugu Asanoi, M.D. and Shigetake
Sasayama, M.D., F.A.C.C.
ToyamaMedical and PharmaceuticalUniv., Toyama, Japan
The effects of coronary collateral perfusion on the
kinetics of creatine kinase (CK) release were examined
in 31 patients (pts) undergoing an intracoronary
thrombolysis within 6 hours following the onset of the
first acute myocardial infarction (AMI). Blood sampling
for CK was performed every 2 to 4 hours for a period of
72 hours after the onset of AMI. The cumulative CK
release (CKr) was determined using the integrated
appearance function curve with the individual
disappearancerate. In 18 pts (group A) with successful
thrombolysis, the time to peak CK level was 11.3±O.7
(SEM) hours after the onset of AMI and CKr was 2678±539
lulL. In 6 pts (group B) who had a significant
collateral circulationto the infarct-relatedcoronary
artery and unsuccessful reperfusion, the time to peak CK
was 15.8±1.0 hours (p<O.05, compared with group A) and
CKr was 2329±621 lulL (p N.S., compared with group A).
In the remaining 7 pts (group C) with unsuccessful
recanalizationin the absence of significant collateral
perfusion, the time to peak CK was 20.1±1.4 hours and
significantly (P<O.OS) longer than groups A and B.
CKr(2386±626 lulL) was not different from groups A and
B. Thus, collateral function was an important
determinantof the CK time activity curve during an AMI.
Early peaking of CK levels does not reliably identify
spontaneous or drug-inducedrecanalizationof the
infarct-relatedcoronary artery.
LEFI' VENTRICUIJIRRmDELINGAFI'ERMYOCARDIAL INFARCT100
REIATlOOSHIPTOLEFI' VENTRICUIJIRVOLUME/MASS RATIO
David~ Leeman, M.D., Sanford E. Warren, M.D., Marilyn
F. Riley, B.S., PatriciaC. Care, M.D., FNX:., Rayrrond
G. McKay, M.D. Harvard-ThorndikeLaboratory,Beth
Israel Hospital, Boston, MA.
Dilatationof the LVoc=s camonly following
myocnrdial infarction (MI). Accordingly, LV end-
diastolic vohmes (EDV) were assessed by contrast
ventriculographyon admission and 2 weeks later in 17
pts with their first acute transmuralMI. LV mass
was assessed by 2D echo in all pts on admission and in
14 pts at 2 weeks. All pts received thrClTlbolytic
therapy. Of 17 pts studied, 8 showed substantialLV
dilatation (DIL) defined as >20% increase in LV EDV
index on serial contrastventriculography. The change
in LV EDV correlatedpositively with initial mass
determinedby 2D echo (r=.71, p<.05). Canparedto the
pts without LV DIL, those with LV OIL had smaller EDV
indices on initial ventriculography(71 ml/m2 vs 96
ml/m2,p<.005), smaller initial EDV/mass ratios (.82 vs
l.13,p<.005), and a larger %of LV perilreteron initial
ventriculographythat was akinetic or dyskinetic (26%
vs 13%,p<.05). Echo at 2 weeks post-MI revealed no
change in wall thickness on M-rocde, but 2D echo showed
a significant increase in mass in the pts (n=6) with LV
OIL canparedto those (n=7) without LV DIL (+7.3% vs
-4.3%,p<.01)•
Conclusions: Pts with LV hypertrophy,with a low
EDV/mass ratio, are IIDre likely to undergo LV
dilatationfollowing MI. An increase in LV mass maybe
observed within 2 weeks following MI in sare pts with
LVdilatation.
QUANTIFICATION OF ACUTE MYOCARDIAL INFARCT SIZE USING
THALLIUM-201 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY:
COMPARISON WITH CK-MB SIZING.
John J. Mahmarian, M.D., Mario S. Verani, M.D.,
F.A.C.C., Cralg M. Pratt, M.D., F.A.C.C., Salvador
Borges Neto, M.D., and Robert Roberts, M.D., F.A.C.C.,
Baylor College of Medicine, Houston, Texas.
We prospectively evaluated thallium (Tl)-201 emis-
sion computed tomography for quantifying myocardial in-
farction (MI) size in 22 patients with first acute MI
(10 anterior [A], 12 inferior [I]) who also had MI siz-
ing by CK-MB. All pts were imaged within 36 hours of
chest pain andnone underwent coronaryreperfusion. Tl-
201 tomographywas performedover an 1800 arc and slices
were reoriented in the standard 3 cardiac planes.Gated
radionuclide angiography with calculation of LV and RV
ejection fractions was performed immediately after Tl-
201 tomograms. Tomographic MI size was quantified using
polar maps and expressed as a percentage oftotal left
ventricular volume. Tomographic MI size ranged from 2
to 60% (mean 32%) for A-MI and 8 to 44% (mean 27%) for
I-M!. The correlation coefficient between tomographic
and CK-MI sizes was r = .76 for all pts, but especially
good for A-MI pts (r = .87). Because of a poorer corre-
lation in I-MI pts (r = .61), we calculated the pre-
dicted LV-CK size for any giventomographic size in this
subgroup using the derivedA-MI regression equation. By
subtractingpredicted from measured CK-MI size, we estim-
ated RV-MI size, which correlatedwell with RV ejection
fraction (r = .85). Furthermore,all. pts with I-MI and
greater MI size by CK than bytomography had depressed
RV ejection fraction. Thus, infarct sizing by CK and
thall ium tomography correlate highly in pts withA-M!.
These data also demonstrate that the apparentdiscrep-
ancy between CK and tomographic sizing in I-MI can be
ascribed to concomitant RV infarction.
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LEFT VENTRICULAR EJECTION FRACTION: A PREDICTOR OF
MYOCARDIAL INFARCT SIZE WITH ANTERIOR Bur NOT INFERIOR
WALL INFARCTION
Henry S. Cabin, M.D., F.A.C.C., K. Soni Clubb, B.S.,
Barry L. Zaret, M.D., F.A.C.C., and Frans J. Wackers,
M. D. , F .A.C.C., Yale University, New Haven, CT
Left ventricular ejection fraction (LVEF) by
equilibrium radionuclideangiography (ERNA) is assumed
to be an accurate index of myocardial infarct (MI) size
and is a commonly used endpoint in trials of
interventions to limit MI size . No prior study,
however, has evaluated the relationshipof ERNA LVEF to
accurate MI size determinationat necropsy. We studied
23 necropsy patients (pts) with anterioror inferior MI,
without valve dysfunction, who had ERNA > 1 day post-MI
and within 1 month of death. The hearts were cut
transversely into lcm thick slices from apex to base.
The a rea of the LV and of the MI were planimetered from
the apical surface of each slice and the MIsize was
expressed as the percent of LV wall infarcted. MI size
ranged from 6-75% (mean 37) andLVEF from 7-56% (mean
29) . The cor re l at i onbetween LVEF and MIsize for all
pts was -.67. However, grouped by MI location, LVEF and
MI size correlatedwell in anteriorMI (r=-.85, n=lO),
but not in inferior MI (r= -.14, n=13).
Thus LVEF is an accurate index of MI size in
anteriorbut not inferior MI. This must be cons i de red
when LVEF is used to assess MI size .
REACTIVITY TO MENTAL STRESSORS IN ASYMPTOMATIC PATIENTS
WITH CORONARY DISEASE &SILENT MYOCARDIAL ISCHEMIA.
Nancy Norvell. Ph.D., David Roth, Ph.D., Elizabeth Scott ,
R.N . , &Carl Pepine, M.D., F.A.C.C., University of
Florida, Gainesville.
Coronary artery disease (CAD) patients often experience
episodes of transientmyocardial ischemic episodes without
symptoms during daily activities. Previous reports sug-
gest that certain psychological tasks may trigger episodes
of ischemia, but themechanism for this response is un-
clear. Heartrate (HR), ECG and blood pressure (BP)
responses to three types of stimuli : amental arithmet ic
task, hypothesized to be abeta-adrenergicstressor, white
noise , viewed as an alpha-adrenergic;and a third stimulus
which combined a different math task with white noise,
were examined in 10 subjects. Five subjects had CAD but
were asymptomatic with ST segment depression and were
removed from all medications 36 hrsprior to the experi-
ment. The remaining 5 were age-matched controls with no
history of coronaryartery disease . Results indicated a
striking difference in physiological reactivity to the
stressors between the silent ischemia (SI) patients and
controls. While no episodes of ST depression were
observed, a significant increase in HR was found from
recovery period to themath with white noise task (1(9)
2.83, Q < .05). A striking difference was found with SI
subjects showing a mean HR increase of 4 beats permin &
the contr?l~ showing a mean increase of 13 beats (1(8) =
1.65) . Slmllar trendswere noted for,systolic BP. These
findings suggest that asymptomatic patients with CAD &SI
lack autonomic reactivity to mental stressors. In
addition, given that no SI depressionswere noted during
the tasks, it is possible that such episodes occur only 'in
the presence of significant autonomic arousal. This
altered reactivity deserves further attention.
PROGRESSION OF NATIVE CORONARY ARTERY DISEASE 5 AND ID
YEARS AFTER MEDICAL VERSUS SURGICAL THERAPY FOR ANGINA
Mi ng H. Hwang, M.D., F.A.C.C., Will iam R. Meadows, M.D.,
F.A. C.C., Zhen E. Piao, H.D., Roque Pifarre, M.D., Henry
S. Loeb , M.D. , F.A.C.C. , Rolf M. Gunnar, H.D., F.A.C.C.,
Hin es VA Hospital Hines, IL and Loyola University
Med i cal Cente r Maywood , IL.
disease
10 years
70/286(.24)
87/292( .28)
~3 3 / l 8 l (.18 )• 34/203(.17)~*C7/105(.35)J*
47/ 89(.53)
o f coronary artery
5 years
69/31 2(.22 )
91/396(.23)
Coro na ry a rteriography was performed 5 years after ran-
domization i n 26 medically treated (M) pts and 32 surgi-
ca l ly treated (S) pts and at ID years in 21 Mpts and 21
S pts. Twenty six pts (14 Sand 12 M) had 5 and 10 year
studies. The coronary arteries divided into 15 segments
( seg) were analyzed for progression of disease defined
as appearance of new () 50%) or significant worsening of
ex i s t ing lesions.
Re s ul t: Prog r e s s ion
All Seg
M
S
Disease f ree se g
M ~30/190 ('16 )
S " 36/267(.13 )]
Di sea sed seg ..
11 9/122(.32 ) ll:
S 55/129(.41)
* p < 0. 001 ** p < 0. 02
In S pt s progression occu r red in 38% ofgrafted seg and
18% of non-grafted seg (p<O.OOI) at 10 yea r s but in 24%
and 22% re spec t iv e lyat 5 year s . Conclusions: I. The
progres s i on ra te of atherosclerosis was similar between
5 and 10 years . 2. Diseased seg had a higher incidence
of progre s sion than th e disease f ree seg . 3. Surgical
therapy increased the rate of progression in the
di sea sed and grafted ves sel.
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A SIMPLE CLINICAL ANGINA SCORE STRATIFIES PROGNOSIS IN
PATIENTS WITH DOCUMENTED CORONARY DISEASE
Daniel B. Mark, M.D., Robert M. Califf, M.D., Frank E.
Harrell, Jr., Ph.D., Mark A. Hlatky, M.D., F.A.C.C.,
Kerry L. Lee, Ph.D., David B. Pryor, M.D.
Duke University Medical Center, Durham, N.C.
To derive a clinical angina score (AS) useful for
stratifying prognosis in patients with documented coro-
nary disease (CAD) ( >75%stenosis), we studied 5,886
consecutive CAD patients (pts). Us ing the Cox model in a
randomly selected half of the pts, the prognostically
independentclinical descriptors of ischemia were weight-
ed and arranged into a simpleAS: AS = angina course x(l
+ daily angina frequency) + ST-T changes, where angina
course was equal to 3 for unstable angina, 2 for progres-
sive angina with nocturnal episodes, 1 for progressive
angina without nocturnal episodesand 0 for stable
angina, and 6 points were added for the presence ofST
depression or Twave inversion. ThisAS yielded almost
identical prognostic subgroups in the original training
sample of pts and in the independentvalidation sample.
The AS: a) was a more powerful predictorof prognosis
than any individual anginaldescriptor;and b) added
significant prognostic information to thepatient's age,
sex, coronaryanatomy and left ventricularfunction.
Infarction-free2 year survival forselected subgroups:
N AS 0-2 AS 3-8 AS > 9
1 vesse1, EF > 50 --gg-r -:-9r ---:1'2 -:-90
1 vessel, EF <: 50 394 .93 .88 .89
3 vessel, EF? 50 1,233 .90 .84 .68
3 vessel, EF < 50 1,116 .76 .70 .56
Thus, a careful summarizationof clinical markers of
ischemia in the form of an angina scoreprOVides a
powerful prognostic tool and may aid clinicians in
identifying high-risk pts who are candidates for aggres-
sive therapeutic interventions.
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ANGINA WITH NORMAL ANGIOGRAMS: A DISORDER INVOLVING THE ENTIRE CORONARY
TREE IN VASOMOTION.
R.Bugiardini, M.D., G.Morgagni, M.D., A.Pozzati, M.D., F.Ottani, M.D.,
P.Puddu, M.O., S.Lenzi, 'LD. Clinica Medica I, University of Bologna,
Italy.
A portion of patients (pts) with anginal pain and normal angiograms,
i .«. those with syndrome X (SX), has shown to develop an inappropriate
coronary constriction at arteriolar level, which is regarded as
separate from spasm of the epicardial arteries occurring in variant
angina(VA). This could imply selective pathogenetic mechanisms. To
address this question 29 pts with no or minimal (:io 50%) coronary
narrowings were chosen from a pool initially selected on the bases of
ergonovine and/or exercise induced S1 shifts (i:,O.l mV) in the anterior
leads. Of these 13 were grouped in VA (at least one episode of STt ),
the remainder in SX. Ten pts with stable exertional angina andcoronary
artery disease (CAD) served as control. Great cardiac vein blood flow
(GCVBF). aortic pressure (AoP) and left anterior descending mid
coronary diameters were measured at rest and 2 to 4 min after
hyperventilation (5 min). Testing caused ST elevation and focal spasm
in 7/13 pts with VA. In the remaining pts it induced diffuse epicardial
coronary diameters reduction which was marginal in CAD, but cri tieal
(paired t test: p<.OOI) in VA (X!SD: I.D8!D.21 vs 1.48,0.34 mm) and SX
(D.BS!0.31 vs 1.35,0.23 mm). Concurrent determination of coronary
resistances (AoP/GCVBF; mmHg/ml.min) showed significant (p < .001)
increases in VA (1.66!D.3B vs 1.22!0.32) and SX (1.90!0.30 vs
1.12!0.26), but not in CAD. Thus hyperventilationmay trigger abnormal
constriction of both epicardial and mural coronary arteries, either in
pts with VA or SX. This suggests that pts with angina and normal
angiograms belong to asingle pathogenetic entity with a spectrum of
clinical manifestations.
CC,RONARY ARTERY D1SEASE AFTER CHEST lRRAD1ATlON.
Paul T. McEniery, M.B., Khosrow Do r o st i , M.D., F.A.C.C.,
and Willian C. Sheldon, M.D., F.A.C.C. Cleveland Cl m ic
Foundatro n , Cleveland, OH
Radiation mduced coronary artery d i se ase (CAD) 1S
rare. We i.dentr f i ed 15 patrents (9 females, aged 48
(26-63) years), who presented w1th symptomati,c coronary
ob str uct io n 16 (3-29) years after chest i r r adi ati.on for
IIodgkin's disease (9), breast c ar cmoma 0), lymphoma
(2), or CySt1C hygroma. The mean dose of r adi ati.o n was
4.17 + 6.5 Gray. Ten (67%) presented w1th angina and 3
with myocardial in farc t ion , The majori t y (79%) had <3
risk factors for atberosc Ler o t i.c heart d i se ase (ASHD).
Mean se rim cholesterol was 232 + 54 mg/dl, only 4
patrent s nav mg se r en cholesterol >250 mg/dl. Onl y 40%
of the group were male, 40% smoked cigarettes and 13% had
hypertension.
E1ght (53%) had 50% or greater narrowing of the left
main coronary artery and (20%) had severe r1ght
coronary ostial ateno s i s , AnglOgraph1cally the l es ro ns
were 0 ften long, smooth, concentric, and tubular . Mean
LV e j ec t io n fr act ro n was 67 + 11%. Ei gb t had associated
valvular disease, 4 required pacemakers, and 3 had
pericardial conatr i.ct i.on , Three had severe medi ss t i nal
or pericardial f rb ro si s , which made bypass surgery
difflcult or impossible.
We conclude that pat i en t s w1th CAD after chest
i r r adi.atio n have a hrgh i nc rd enc e of left main and ost i aI
right coronary stenosis. The majority are female. The
subjects have few t r adi t io nal risk factors for ASHD, and
often have other cardiac effects of r adi ati on , Radi ati.on
may enhance a propensity towards CAD.
EFFICACY OF PENTOXIFYLLINE IN CHRONIC STABLE
ANGINA PECTORIS.
Jerald Insel M,D" A. Arthur Halle, M.D., David M. Mirvis, M.D.
Veterans Administration Medical Center and University of
Tennessee-Memphis.Memphis, TN.
All variables were significantly different [p<0.05] after PNT
therapy. Maximum ST depression was not significantly reduced
by PNT [1.65 ± 0.35 vs. 1.24 ± 0.40 mm, p=.13]. Thus, PNT
increases exercise performance in patients with AP and increases
exercise tolerance before development of myocardial ischemia.
Pentoxifylline may therefore be a useful agent in managing
patients with AP.
Pentoxifylline [PNT) improves symptoms of peripheral vascular
disease by reducing blood viscosity. We assessed the value of
PNT therapy in I I patients with angiographically documented
coronaryarterydisease and stable angina pectoris [AP]. Maximal.
symptom limited, treadmill exercise stress tests were performed
before and after treatment with 1200 mg/day of PNT for 6
weeks. PNT was added to prior stable drug therapy. Clinical
symptoms improved and sublingual nitroglycerin need decreased
in 9 [82%) patients; the remaining 2 had no change. Exercise test
results were [mean ± std error):
CORRELATION BETWEEN BENDORPHIN BLOOD LEVELS AND ANGINAL
PAIN IN PATIENTS WITH CORONARY ARTERY DISEASE. Colomba Fal-
cone MD, Luigina Guasti MD, Giovanna Corsico MD~ Silvia Co-
dega MD, Diego Ardissino MD, Giuseppe Specchia MD, Carlo
Montemartini MD, Div Card & Pharmac*IRCCSUniv Pavia Italy.
In order to verify whether Bendorphin blood levels (BEBL)
are correlated to the presence of anginal pain during myo-
cardial ischemia we studied 74 male pts. All pts had a pre-
vious documented coronary artery disease and showed myocar-
dial ischemia at multistage ergometric stress testing (EST).
Group I pts (35; 53!9y) complained of angina during exerci-
se-induced myocardial ischemia, while group 11 pts (39; 54!
7y) was asymptomatic. Blood samples were taken prior to EST
and analyzed by a Bendorphin [I125J RIA Kit.
Results. Baseline blood pressure, double product (DP) at
ischemia threshold (IT), ejection fraction (EF) and LVEDP
were similar between the two groups although group 11 sho-
wed a better tolerance to exercise (DPpeak) in presence of
higher degree of ischemia (w STpeak). Symptomatic and asy~
ptomatic pts significantly differed in BEBL.
Group I GroupII
~ STpeak (mm) -2 1.7!0.7 2.4!0.9 p(O.Ol
DP at IT (mmHg.bpm:~o ) 161!32 158!29 ns
DPpeak (mmHg.bpm.10 ) 192!31 223!70 r<O.Ol
EF (%) 61!1l 60!9 ns
LVEDP (mmHg) 15!6 16!5 ns
BEBL (pg/m1) 22.5!19.1 43.7!28.2 ~<0.01
Conclusion. The results suggest that BEBL might play a
role in the decreased sensitivity to pain in asymptomatic
pts. The decreased sensitivity to pain account for the in-
creased exercise tolerancethough athigher degree of ischemia.
Exercise time(min)
METS performed
Time to onset of AP(min)
Heart rate at onset of AP
Time to onset of ST depression(min)
Heart rate at onet of ST depression
Control
7.73 ± 1.29
4.27 ± 0.74
5.48 ± 0.94
93.43 ± 6.75
5.03 ± 0.81
94.00 ± 5.83
PNT
10.08 ± 1.16
5.46 ± 0.59
7.88 ± 1.02
112.00 ± 10.53
8.20 ± 1.54
115.86 ± 7.44
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EFFECTS OF DI LTIAZEM, NIFEDIPINE, AND THEIR COMBINATI ONoN
TRANSI ENT ST-SEGMENT DEVIATIONS ON nu: AMl\ULATORY ECG IN
PAnr;NTS \tITH STABLE ANGINA PECTORIS.
Wi l liam Fr i shman , M. D';rF.A. C.C., Shlomo Charlap, M.D. ,
sr u ce Kimmel, M.D., Ma Teicher, M.D. • and Joel Strom,
M.D., The Al bert Ei ns te i n College of Me dicine, Bronx, N .Y.
The e f fe ct s of di l t i azem (D) , ni f edipin e (N), and thei r
combina tion (D+N) on painful and painless ep isodes of is-
chemi a , determine d by concur re nt ST- segment depressions
(Epi ST) on t he ambulatory ECG CImm of reversible ST- seg -
ment de pres ion persisting for at l ea s e 1 min) , we re as -
sesse d in 20 patient s (pts) wi th stable angina us in g a
placebo(pl)-controlled, double-blind, r andomized , cros sove r
s tud y des ign . Pts received pI for 2 wks , then in creasing
daily doses of D (90-360mg) or N ( 30- 120mg) in 3 divided
dose s titratedove r 3 wks followed by a p l, "washo ut",
cro ss ove r t o t he other treatrrent t a pI "washout", and com-
bination D+N (9D-360mg D and 3D-12Dmg N). Ambulatory 24
hr ECG exams were performed at the end of each pI and
acti ve t reatment phase. Compared t o pI, D, N, and D+N
redu ced angina episodes and nitroglycerin consumption while
improving exercise (p<O.Ol). The table lists xdata +SD
at maximally tolerated doses (* p<D.D3 pI vs Dor N;
t p<O .Ol D VS N):
Epi ST/24 hr Epi ST/24 hr
pI (2 e ks ) 8.1+6.4 pI (2 wks) 8 . 1+6. 4
D 3. 9+2. 9* t N 8 .1+6.2
pI ( 0 was hout) 8 . 8+6.0 pI (N wash out ) 8.8+5.8
Compa re d t o pI andN, D also reduc ed th e average- length of
ea ch episode and total t ime o f ST-segment depres sion/24 hrs
(p<O.Ol) . There were differen ces i n HR/24 h rs compa r ing
pI with 0 and ~ (p I 79 _ 4~9. 6; 0 74.3~8.3; N 8D.2~13 .7; pl
vs 0 (p<O .Ol). Combinat i on D+N provided little additi onal
impr ovemen t from D except in individual pts . D i s more
ef fe ct i ve than N in re ducing Epi ST on the ambulatory ECG;
combin ation D+N provides no ove ra l l additiona l advantage.
toss TOLERANCE DEVELOP TO THE CORONARY ARTERY DILATION
EFFECTS OF NITRATES?
Barry Rose, H.D., James A. Hill, H.D., F.A.C.C., and
Robert L. Feldman, M.D. • F.A.C .C• • Uni v of Florida,
Gainesville
There i s cont r ove r sy regarding tolerance to the effects
of nitrates which relate t o whether or not t her a py should
be used cont i nuous l y . Toassess whether coronary artery
dilation produced by intravenous (IV) nitroglycerin (NTG)
becomes attenuated, 7 Pt not receiving I V NTG (group 1)
and 8 Pt receiving IV NTG (group 2) for 3 t o 96 hr at a
constant dose for ? 3 hr were studied. Hear t rate, mean
AoP and left coronary arterydiameters were measured.
Group I had repeated measurements before and after
beginning IV NTG (titratedto lower AoP~IO mmHg for 10
min) and agai n after 100 pg intracoronary( I G) NTG. Group
2 had repeated measurements while receiving IV NTG and
again after IG NTG.
As expec t ed , in group I IV NTG lowered AoP (-11+15
mmHg) but le NTG produced no changes i n heart rate or AoP
in either group. IV NTG usually produced coronary
dilation in group 1 [left main 4+4%, (mean +SD).proximal
3+5%, middle 10+15% and distal 15+15% coronary segmentsl.le NTG, however, did not produceadditional detectable
coronary dilation (range of means 0-1%) in any segment
suggesting IV NTG had produced maximal dilation.
Surprisingly, in group 2 as compared to diameters on
Iong- t erm rv NTG, IC NTG usually did not produce
addit i ona l dilation (range of means 0-4 %). This finding
suggests t ha t maximaldilation persisted on long-term IV
NTG and no tolerance to the cor onar y effect had occurred.
In co nclus i on, IV NTG i n doses that lower AoP-lO mmHg,
produces near maximal coronary arterydilation. No atten-
uation of t he coronary arterialdilation effect is de-
tectable when IV infusions are continued for up to 96 hr
supportingcontinuous use for prophylaxis and treatment.
LENSEO FIIlERS FOR LASER ASS ISTED BALlOON ANGIOPLASTY.
Herbert J. Geschwind, M.D.,F.A.C.C., Michael Aira, Stephen
Ramee , M. D., Stephen SlDith, Eugene sanson . George Awai, Michel
Vandormael, M.O.,HaroId L. Kennedy, M.O., F.A.C.C. St.10uis
Unive rsity Medical School, St. Louis, I() and LettermanArmy
Institute of Research, San Franc iscoI CA.
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Nd- VAG(B) Ar(B) Ar(S)
25Wx 2 Sec IOWx 5 Sec IOWx 5 Sec
F L F L F L
V(nm3) . 5+. I 2.1+.4* 1.4+.5 4.1+.5* 1 I.7+. 9 2.2+.6
AE(ran2) .2+. 1 l.i:;.2* 0.6+:.3 2.6+:.4*t 0.4+:.1 1.2+.1*
AX (nrn2) .3+. 1 0.9+.1* 0. 9+. 2 1.6+,7 1.5+.1 1.1+.5
*p<.OOI vs bare fiber. t p<}jOl vs Nd-=YAG. - -
No Ar laser effect was obtained with the L tissue angle <15°
in sa l ine. The siz:e of holes created by L through tube
occlusions allowed easy penetration of the balloon c e t he t er-
for su b s e q ue~ t balloon an$ioplasty. Conclusions: I) V and AE
are greater v i rh L than WIth F regardless of type of laser
sour ce . 2) The device makes holes large enough for balloon
angioplasty. 3) Because of minimal tangential effects, 1
fillers are safe to use with AT in saline media.
To create large channels through arterial occlusions, to
protec t the a~terial wall f rom mechanical pe rforation due to
the c utting edge of bare fibers ( F) and to prevent back
burning of fiber t ip , a lensed fiber tip (L) was developed and
eva luated . The device consisted of a si lica fiber 0.2 mm
diameter at the end ofwhich a lmm diameter lens was made by
hea t ing the silica. The f iber was inserted into s 5 F balloon
c athe t er . The proximal end was c onne c t e d to c ontinuous wave
Argon (Ar) and Nd-YAG la sers . During laser emission, saline
was c i rcuIared through t he cathet er . Thedevice was used 1)
t o c re a t e crater s in v i t ro in section s o f atherosclerotic
human cadaver aorti c walls immersed in blo od (B) or saline
(5 ) , 2) t o recanalize 6 pl astic t ube s into which 6mm
a theroma tous plaque t a r g e ts were i n s e r ted.. Laser was
de l iv er ed with t he tip maintained in contac t withtargets at
90°, 30°, 15° and DO. The ar ea of hole s at theentry (AE) and
exit (AX) of laser crea t ed tunnels and the vol u,,", of t issue
removed (V) were compared to those obtained with bare fibers.
Resul t s (<)0·) mean + SO, n ~ 6 for each val ue:
HI(};.-[:C6E ll'I'mAVEIDJSDTI..TIAZEM IN Mm. HEMXJ'INA'lIC!'l'1D IM'ISQID.'JC
Em:CIS IN IM'AIREDVS toR>1AL LVFUlCfICJ;.
Will"",J. Remne, 101.0 ., Oiederik C.A.V3l1 Hooger./itij2.e, M.D.,
Zuid<>rziekenhlls, Ibtterdatl, 1be Netherlands.
Higj'>-OOse intraverocsOil t iazem, despite iJrprovedantilschemic efficacy .
rraybe detrlm€f\tal in pts with UlIJ8.ired LV funct iond.Je to its negat rv..
irotrcoic prccer-tfes, In 18 coronaryartery di sease pts Wlthout faiIure,
8 (CrI) with rormal and 10 {GrIl) with impairedI-Vfulction (eject im
fraction: 59+3% vs 35+9Yo (x-lSEM), end diastol ic vohrre : :&<Iml/rn' vs 101
+8nl./m' and W: 13+IiiitHg VS 25+amtig, I vs 11, p/ ..eE) 2 identical pa-
cing stress tests wereperfo,.."..,(j3) min before (PI ) andinmediately af-
ter (P2) higj'>-dose intravenousDi l.taazen (O,0g/kg/5 min, followed by
D, 4mg/kg/lOmin}. Despite higl1 plasm level s [737.148(1) and616t84~1
(Illl Oiltiazenwas well tolerated. In both gro~ it sigl ifi cant ly, tJut
eqwlly reducedLV systolic pressure [LVSP: 1<14(1) vs 13'4(II)], systemic
[28Yo(I ) vs 32%(11)] and corcoary resistance [32I',1I) vs 23%(11)], I'.hich
resulted in a similar sigliflcant increase inOJ [20%(1 ) vs 25%(11)].
Stroke index increased in GrIl only(20"10 ) . Heart rate , contraetil i ty,
LVID', stroke -..or'!<, coronary nC>ol and myocardial0, CC<1SLITptioo remained
Lrl<:hanged in both groups. R<ring pacing naximal heart rateswere identi-
cal in both grot.pS during both tests. Myocardial0, ddnand , however, dE--
creasedsiglificantly during pacing after Oilt iazen (16%(1) and 24%<IIl .
ooth p~ .C6 VS central ) dE to s imilar reducticns inLIB? during P2.
Desp i te l>'1C!'anged coronary 0 0'01 a"\d 0, cons>.Jl»tJOO trus resulted in a
sigll flc ant reductioo in pacing induced Iscbema inboth groups evidenced
by an equal decrease in~ frequency and ST-segrent depressicn in
CrI and 11and signif icarrtr-e<i.K:tions in LVEIF post-pacing (18+2(Pl) vs
8+1,:1mtig(P2), CrI and ~3,6 (Pl ) vs 18+2,'mJTtig(P2), Crn). /I<)~, in
pts with irtpaired LVfU1Ctioo D11tiazan- al so nomal i:zed loctate extrae-
tim dJrir€pacin€ [-45+14%(Pll vs 10t6%(P2)], tAlt not in CrI (- 35+22%
(PI) vs - lCtl7'' (P2), GrI vs CrII pc.5;), ....nereas centractility ~O?d
mIy in GrIldurin€pacin€ aft1>r Diltiazen (Vnex 38<1,5 s-l (pl) vs
48+2,6 s-l (P2l, p<,.(6) . Thus , high d:Jsages of Diltiazem haverrorepro-
noU-ced antiischemic effects andbetter iJrprovepurp ftrCt ioo in pts
with iJnpaJredthan with nonnal LVfU1CtiOO. Its adninistratiooapp<'ats
safe 1>klen LV fU1Ctim is reduCed by ischenia and:ormfarctrcn.
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COMPARISON OF ACUTE AND CHRONIC EFFECTS OF ARGON AND EX-
CIMER LASER ENERGY ON CANINE AORTA. Frank Litvack,M.D.,
Warren Grundfest,M.D., Tsvi Goldenberg,Ph.D., Lynn
Ooyle,M.D., Ann Hickey,M.D., James Laudenslager,Ph.O.,
Tom Pacala,Ph.O., Micheal Fishbein,M.D., James Forrest-
er,M.D., FACC. Cedars-SinaiMedical Center, Los Angeles.
We compared acute effects on and healing of infrarenal
aortas in 25 dogs subjected to both argonand excimer ir-
radiation. Via aortotomy a 125 mm2 segment of posterior
aortic wall was ablated by308 nm excimer (13 dogs) and
CW argon (8 dogs), control (4 dogs). Excimer was
delivered at 30-40mJ/mm2/pulse and argon at SW, CW. Dogs
were sacrificed at 0, 1, 24, 48, 72, 106 hr: 1,2,3,4 wk.
RESULTS Two control and 1 excimer aorta had gross
thrombus. No aneurysms or fistulae were grossly
appreciated. Only argon aortas examined at >72 hr had
marked peri-aortic inflammation and adhesion to thevena
cava and surroundingstructures. Histologic examination
showed healing with patchy intimalproliferationin
controls. Acutely excimer aortas show no thermal injury
and craters into the media. Argon aortas had craters in
the media with thermaland blast injury. By 24-72 hr
excimer aortas had RBCs in the media, <20 u localized
fibrin deposition and PMN appearance in the intima. By 2
wk intima was regeneratingand media regenerated. By 3-4
wk the intima completely healed. By 24-72 hr argon
aortas had 80 u fibrin deposition, RBC's in the media and
extensive medial necrosis. At 2 wk there were craters
with intima thickening,SM proliferation in the media and
organizing mural thrombi. At 3-4wks there was medial
scarring, intimal proliferation, transmural necrosisand
localized pseudoaneurysmformation. CONCLUSION Excimer
ablates in-vivo without thermal injury and ablated
arteries appearnormal by 2 wk. Argon causes extensive
thermal injury which results in marked inflammatory
reaction with adhesion into surroundingstructuresand
persistent vascular injury at 4wks.
LASER-ENHANCED ANGIOPLASTY: EARLY CLINICAL EXPERIENCE.
Leonard A. Nordstrom, M.D., Methodist Hospital,
Minneapolis, MN and Gerald Dorros, M.D., F.A.C.C., St.
Luke's Hospital, Milwaukee, WI.
A laser catheter, which utilizes direct argon laser
1 ight exposure, was combined wi t h percutaneous
angioplasty to re-open the lumen of partially and
totally occ luded superficial femoral arteries. The
system consisted of a specially designed balloon
catheter to maintain coaxial fiber position and a quartz
fiber with an optical assembly which diverges emitted
laser light to a cone angle of 40°. Through coaxial
alignment of the fiber by the balloon catheter and the
increased cross-sectional diameter of the ligbt spot
located at a distance close to the fiber tip, beam
direction can be controlled.
Fourteen patients with superficial femoral atheromatous
disease were treated. Five patients had short,
subtotally occluded segments, and 9 had totally occluded
segments ranging from 3-10 cm. Primary success was
noted in 12 patients. Technical failure occurred in 2
patients. These were attributed to subintimal entry
into the vessel wall. In successful patients the mean
ankle/brachial index increased from .64 to .88 post-
laser angioplasty (p<.OS). One patient experienced
early reclosure before hospital discharge. Laser energy
was used as an adjunct to angioplasty. When adequate
removal was not achieved "'ith laser energy, the
remaining occlusion was opened "'ith balloon angioplasty.
There were no perforations and no restenosis has been
noted in a short follo",-up period ranging from I week to
4 months. These data, in a small number of patients,
would indicate that the combination of laser and balloon
angioplasty is safe and of benefit in improving blood
flo'" in the superficial femoral arteries.
DEPOSITION OF SILVER-HEMATOPORPHYRIN IN ATHEROSCLEROTIC
PLAQUE IS HOMOGENEOUS, INTERCELLULAR, AND CONFINED TO
PLAQUE.
G. Michael Vincent, M.D., F.A.C.C., M. Elizabeth Hammond,
M.D., Jolene 8. Fox, R.N., Michael D. Johnson, 8.S.,
Richard C. Straight, Ph.D., University of Utah School of
Medicine, Salt Lake City, Utah.
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P~KCUTANEOUS 8RACHIAL ARTERY APPROACH TO CORONARY
ANGIOGRAPHY, A SAFE ALTERNATIVE TO FEMORAL ARTERY
CATHETERIZATION.
Lucien Campeau, MD, FACC, Pierre Deguise. KO, and
Gilbert Gosselin, KO, Montreal Heart Institute, Canada.
Complications of percutaneous brachial and femoral
artery catheterization techniques for coronarography
were compared in 3 series of unselected consecutive
patients. Two series using the brachial artery approach
comprised patients referl'ed to author L.C., the first
433 performed with French (F) 7-8 Sheath-introducersand
multipurpose or Amplatz catheters (87-8), and the last
311 performed with F5.5-6 material (55.5-6). The femoral
artery series comprised 500 cases performed by other
angiographers using F7-8 Bourassa or Judkins preformed
catheters (F7-8). The age and the proportion of women
were similar in all 3 series.
Complications: Local
No 1;
Laser coronary angioplastymay be a revolutionary thera-
puetic modality. Hematoporphyrin compounds accumulate
preferentially in plaque compared to arterial wall and
markedly enhance the efficacy of plaque laser photoabla-
tion. The mechanism of accumulation in plaque is unknown.
To evaluate the localization of hematoporphyrinderivative
(HpD) in plaque, electron dense silver-tagged HpD (Ag-HpD)
was injected into 3 atherosclerotic rabbits at 30 mg/kg.
After 24 hours, samples of aorta and othertissues were
taken for electron microscopy (EM) and quantitative anal-
ysi s (QA) of HpD levels. QA of ti ssue levels of Ag-HpD
showed no difference compared to previously measured lev-
els of HpD alone, suggesting that Ag tagging of HpD does
not alter the distribution or accumulation of HpD. EM of
aortic samples showed Ag-HpD to be homogeneously distribu-
ted in plaque and absentfrom aortic wall below the inter-
nal elastic lamina. The Ag-HpD was confined to the inter-
cellular matrix and not found in fat cells, smooth muscle
cells, macrophages, or associated with calcium. The data
suggest that the accumulation of HpO in plaque is by a
passive filtering process. The homogeneous distribution
in plaque and absencefrom the arterial wall are ideal for
laser photoablation of plaque.
85 . 5-6 No 311 2 0 .6 2 0 . 6
Local complications were loss of radial pulse (8), false
aneurysm (3), femoral artery occlusion (1), median nerve
trauma (1), of Which 6 required surgery (4 in 87-8 and 2
in F7-8). Systemic complications were neurological (7),
arrhythmias (6), pulmonary edema (4), all without
sequellae, and myocardial infarction (4). No death.
Complication rates were similar in women and men of all
series. Thus, the percutaneous brachial artery approach
to coronarography using FS.S and F6 Sheath-introducer
and catheters is a safe alternative to the more popular
femoral artery technique. having the advantage of an
ambulatorypatient 2 to 3 hours later.
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TRANSESOPHAGEAL 2-DIMENSIONAL ECHO-DOPPLER VISUALIZATION
OF LEFT MAIN CORONARY ARTERIAL ANATOMY AND FLOW
Shunei Kyo, M,D., Shinichi Takamoto, M.D., Makoto
Matsumura, M.D., Yuji Yokote, M.D., and Ryozo Omoto,
M.D., Saitama Medical School, Saitama, Japan
From the transesophagealwindow, a 5 MHz phased array
probe and Aloka 880 system were used to visualize the
left main coronary arterial (LM) anatomy and flow by 2-
dimensional echo (2DE) and Doppler (2DD) in 46 patients
(pts) with angiographicallydefined anatomy. 36 pts had
normal coronary artery (group 1) and 10 pts had coronary
stenosis with aorto-coronarybypass surgery (group 2).
Group 2 included 4 LM disease pts and 6 non-LM disease
pts. The following tabulates the number of successful
visualizations of LM structure (2DE), flow (2DD) and peak
velocity (FFT:pulsedDoppler spectral analysis).
n 2DE 2DD VELOCITY (cm/s)
Group 1 36 35 32 68 ± 33 (n=27)
Group 2 10 9 5 60 ± 24 (n= 5)
LMT 4 3 1 48 (n= 1)
non-Ltorr 6 6 4 63 ± 26 (n= 4)
_.n-=number, VELOCITY=mean peak velocity measured by FFT
In 44 pts (96%) LM structurewas successfully visualized
by 2DE and in 37 pts (80%) LM blood flow image was
clearly visualized by 2DD with simultaneous measurement
of flow velocity in 32 pts (70%) by FFT. LM blood flow
could be detected 50% in coronary heart disease pts and
only 25% in LM disease pts while 89% in patients with
normal coronary artery.
We conclude that normal and abnormal LM anatomy and blood
flow can be visualized and evaluated in most patients
non-invasively with transesophageal2-dimensional echo-
Doppler methodology.
ACCURACY OF ANGIOGRAPHY IN SUBCLASSIFYING CRITICALCORONARY
ARTERIAL STENOSES:IMPLICATIONSFOR BALLOON ANGIOPLASTY
Richard H. Karas, M.D., Jeffrey M. Isner, M.D., F.A.C.C.,
Roberta F. Donaldson, B.S., Kim R. Halaburka, B.S., Eric
J. Eichhorn, M.D., Marvin A. Konstam, M.D.,F.A.C.C.,
Deeb N. Salem, M.D., F.A.C.C., Tufts-New England Medical
Center, Boston, MA
Despite angiographicallysimilar degrees of coronaryarter-
tia1 (CA) narrowing, discrepancies between predicted and
actual difficulty encountered in crossing critical (> 80%
diameter narrowing) stenoses during CA angiop1asty are not
uncommon. This study investigated the possib1ity that such
discrepancies might be due to inaccurate subc1assification
by coronary angiography of CA lesions narrowed>80% in
diameter. The study was biased to provide the best possible
angiographic outcome by post-mortem angiography using high
resolution, maximum magnification. and multiple (including
hemaxia1) ob1iquities. Injection of a concentratedbarium
su1fate gel under >150 mm Hg directly into the CA ostia
accomplished maximum CA filling. The degree of diameter
narrowing for 38 lesions narrowed>80% in diameter was
measured independently using ca1ipers. by 2 observers. The
results for each of the 38 lesions were compared to the
degree of cross-sectional area narrowing (XAN) measured by
planimetric light microscopic inspection of elastic-tissue
stained sections of each lesion. Results: XAN correlated
poorly (r=0.255; p >0.10) with angiographic diameter
narrowing. Among a subgroup of the "tightest"lesions by
angiography (diameter narrowing> 90%), XSA varied from
82 to 99%. Anelliptical lumen w;s the most frequent basis
for angiographic/histo10gicdiscrepancy. Conclusion: con-
siderable error exists in the angiographic subc1assifica-
tion of critical CA stenoses. This finding likely explains
periodic discrepancies between predicted and actual diffi-
culty encountered in crossing critical stenoses during CA
angiop1asty.
COMPARISON OF POSITRON TOMOGRAPHY AND QUANTITATIVE
ANGIOGRAPHY IN STENOSIS ANALYSIS AFTER ACUTE THROMBOLYSIS
AND ANGIOPLASTY IN EVOLVING MYOCARDIAL INFARCTION.
Richard W. Sma11ing, M.D.,Ph.D.FACC, Akira Nishikawa,
M.D., Michae1 E. Merhige, M.D., Francisco Fuentes,
M.D., FACC. Mary P. Haynie, R.N., Ajit Adyanthaya, M.D.,
FACC, Richard L. Ho1mes, B.S., Richard L. Kirkeeide,
Ph.D., Richard A. Goldstein, M.D., FACC, K. Lance Gou1d,
M.D., FACC., Univ of TX Medical School-Houston, Houston,
TX.
Of 19 patients (PTS) with evolving myocardial infarction
(MI) randomized to either intravenous tissue plasminogen
activator or placebo, 12 underwent acute coronary
angioplasty (PTCA). Seven of these were studied ID days
post-procedureby rest (R) and dipyridamole stress (S)
positron tomography (PET) usin~ either Rubidium-82 or
N-13 ammonia. Relative CFR by PET was calculated by
diViding the stress to rest (S:R) activitv of the infarct
zone by the correspondingvalue of a norm~l reference
region in the same PT. APET CFR < 0.9 suggests
significant residual stenosis. The PET CFR in these PTS
was 0.96 t 0.5. An automated orthogona1 border and
densitometric analysis was also performed on post-PTCA
coronary arteriogramsin each PT. Percent diameter
reduction post-PTCA was 53 ± 197 with a calculated
angiographic CFR of 3.5 ± .9 (normal> 3.0).
Conclusion: PET with dipyridamole stress provides
information on stenosis severity post acute intervention
in MI which agrees closely with information obtained by
quantitativecoronary arteriography.
AN ELECTRONICCAll PER METHOD OFQUANTITATIVE
CORONARY ANGIOGRAPHY
Jeffrey S. Osborn, MD, Lee V. Giorgi, MD, FACC,
0. Charles Clark, MD, Robert W. Ligon, Deb L. Webb-
Kuhnlein, RN, Ben D. McCallister, MD, FACC. MidAmer-
ica Heart Institute, St. Luke's Hospital,Kansas City, MO.
A quantitativeangiography(QA) method using an electronic
caliper(EC) and a standardangiographic projectorwas eval-
uated against a modified Brown-Oodge(MBD) QA method,
Minimum area(MA) and %area stenosisl%AS) were calculated
from EC measurementsthat had been corrected for magni-
fication using measured and known catheter tip width as a
scaling device. Accuracy was determined by measuring the
cineangiogram of a machined brass artery of known dimen-
sions. Interobservervariability among 4 observers who
measured 20 coronary artery lesions with EC QA was ass-
essed and compared to results obtained with MBD QA.
Results: Accuracy-Brass Artery(mean:SD)
Actual 2 MBD QA 2 EC QA 2
2.01mm 1.97+. 19mm 1.97+.61mm
74% 73.9+2.4% 75.fj:3.1%
Variability-CoronaryArtery Lesions(£'SD)
MA +266microns +260microns
%AS +3.5% -+3.5%
Conclusions: a) EC QA provides a fast, yet accurate, means
of QA. 2) Interobservervariability for EC QA is compar-
able to MBD QA. 31 EC QAcould be performedat any
center doing coronary angiography.
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COMPLEMENT ACTIVATION AFTER PROTAMINE ADMINISTRATION
FOLLOWING CORONARY ANGIOGRAPHY.
Roger L. Click, M.D., Ph.D., Alfred A. Bove, M.D., Ph .D.,
F.A .C.C. • andHenry A. Homburger, M.D. , Mayo Clinic,
Rochester, Minnesota.
Patients having coronaryangiograms who are unstable,
(severe coronary orvalvular disease) may be at an
increased risk of compl ications with the reversal of
hep~rin.by protamine and the hypotension andclotting
actIvatIon that may result. The etiology of hypotension
following protamineadministration has not been well
defined .
In this . study we evaluated complement activation (C3a
and C4a) In ~5 consecutive patients during and followIng
coronary angIography. There were 34 males and 11 females
ages ranged from 38-87 years . The patients were non- '
diabetic, had no prior exposure to protamine, had not had
a vasectomy, or history of fish allergy. Thirty-nine
patients rec~ived protamine to reverse heparin following
c~ronary angIography, 6patients did not receive prota-
mine.
The results showed that in those patients receiving pro-
tamine a si~nif~can~ increase in C3a occurred compared to
C3a determ1natlon 1n thesame group prior to protamine
administration (P<.OOI) and compared to patients who did
not receive protamine P<.05(807+100 ng/ml vs. 274+ 75
ng/ml) : Therewere no signif icant changes in C4a -
follow1ng protamineadministration.
These results indicate that the alternate complement
pathway is activated from protamineadministration
following coronary angiography. Complement activation can
initiat e events leading to hypotension andactivation of
clotting which can have ser ious consequences inpatients
wit~ critical coronary disease undergoing coronary
angIography.
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Coronary Artery Disease: Clinical
DYNAMIC ANGIOPLASTY AS A TREATMENT MODALITY IN PERIPHERAL
VASCULAR DISEASE:THE FIRST CLINICAL RESULTS.
Kenneth R. Kensey. M.D. Chris Zarins, M.D., Anthony
Whitimore M.D., John Nash. Chicago,Ill.
The Kensey Dynamic Angioplasty Instrument is aflexible
polyurethanecatheter with a rotating cam tip, (60,000-
100,000 R.P.M.) , that dilates arteries and selectively
micropulverizes atherosclerotictissue it contacts. To
evaluate whether the debri created by this device has
detrimental clinical effects on distal vascular beds, 10
patients underwent Dynamic Angiop1asty intraoperative1y
on 15 peripheral vessels prior to amputation or bypass.
Twelve arteries were successfully revascularized. Two
perforationsoccured in severely calcified vessels. These
were attributed to early design defects and operator
technique. The perforations had no effect on the
patients' subsequent procedures or outcome. No patients
developed clinical evidence of dista1 emboli. This study
de~onstrates that products created intravascularlyby
thIS catheterdo not cause clinically significant dista1
limb ischemia . Since this was a safety study, the true
clinical benefits of this procedure could not be
accur~tely evaluated. However, the procedureresulted in
one 11mb salvage, notably improved circulation in two
patients and in one patient reduced an above the knee
amputation to a below the knee amputation . Dynamic
Angiop1asty is simple to perform andsafe. In this
limited patient population, Dynamic Angioplasty has
reduced morbidity and improved quality of life in four of
the ten patients. The Kensey Dynamic Angiop1asty
Catheterwarrants further investigation as a treatment
for vascular disease.
RESIDUAL STENOSIS FOLLOWING CORONARY ANGIOPLASTY:
EFFECTS ONSYMPTOMS, MYOCARDIAL PERFUSION AND LV FUNCTION
Youssef Najm, LM, Adam D. Timmis, MD, MRCP, Michael N.
Mai sey, MD, FRCP, Paul V.L. Curry, MD, FRCP, Edgar Sowton,
MD, FRCP, FACC, Dept. of Cardi ol ogy, Guy' s Hospi t al ,
London, England.
The effe cts of per cutaneous t ransluminal coronary angio-
plas t y (PTCA) on myocardial perfusion and LV funct ion
were ass essed in 53patients undergoingsingle (n = 47)
and two vessel (n = 5l dilatation. Before PTCA, revers-
i ble t hallium (Tl-201) perfusion defects were demonstrated
in every patient and stress-induced reductions in radio-
nuclide LV ejection fraction always occurred (62% t o 56%).
St enoses weredilated to <20% in 46 patients (group 1) and
to between 20 and40% in 7 patients (group 2) . FollOWing
PTCA i ncrements in exerc ise capacity and relief of angina
were similar in both groups. The Thal lium-201 perfusion
scan normal i sed in87% of group 1 and72% of group 2.
Moreover, in group 1LV eject ion fraction was maintained
during stress (63% to 65%). In group 2, however, evidence
of LV decompensationpersisted as evidenced bystress-
induced LV dilatationand reductions i n ejection fraction
fr om 63% to 53% (p<0.0051. The lesions in each of the 3
major coronaryarteries exerted a similar influence on
radionuclide ejection fraction and were evenly distributed
in groups 1 and 2. These data i ndicate that a residual
coronarystenosis of 40% following PTCA is associat ed wit h
sat isfactory symptomatic response al though evidence of
stress - induced LV dysfunct ion usually persists. Residual
st enoses of <20%however, are associa ted with correct ion
of bot h symptoms and l ef t vent r i cular function.
CORRELATION OF THE ELECTROCARDIOGRAMAND SEGMENTAL WALL
MOTION ABNORMALITIES DURING CORONARY ARTERY OCCLUSION
Marc K. Lewen, DO, Michel G. Vandormael, HO, Morton J.
Kern, MD, FACC, Arthur J. Labovitz, MD, FACC. St. Louis
University School of Medicine, St. Louis, MO.
To evaluate the relationship between the surface ECG
and segme~tal wa~l motion abnormalities (WHA) , 27 patients
were studled durlog percutaneous transluminal coronary
angioplasty (PTCA). LV wall motionwas evaluated with
two-dim:nsional echocardiogramsdone continuously before
and dur1ng ballooninflation. WHA consisting of new areas
of akinesis or dyskinesis not present at baseline were
defined as primary(1° WMA) or secondary(2° WMA).
PrimaryWMA were anterior during left anterior descending
(LAD) occlus ion and inferior/posteriorduring right
coronary (RCA)occlusion, all other WMA were considered 2°
WMA. Standard 12 lead ECG, with radiotransparentleads,
~ere p: rformedbefore, and every IS seconds during balloon
1nfla~lon and were classified by region (Anterior - Vl-4;
Infer1o: - 11, II~, aVF; Lateral - I, aVL, VS-6)' A
change 1nECG reg10n duringPTCA occurred if 2 leads had >
1 mm ST segment change frombaseline, and was primary(1°-
ECG) if it corresponded to the1° WMA, all other ECG
changes are secondary(2° ECG).
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1/=P<0.05, ARvsC; *=p<0.001, ARvsC; +=p<0.01, AR-tiVe\r-L
The data suggests that AR is a frequent (10.4%)
CCIIIplication of first PrCA and is associated witn a
significantly increased incidence of acute
revascularization, MI, and death, particularly for AR
occurring out of the lab. 'rhese results imicate that
strategies for prevention and prcmpt; treatmentof abrupt
reocclusion are needed to enhance the efficacy of Pl'CA.
ANGIOPLASTY IN EVOLUTION: SIX YEARS OFCHANGING
INDICATIONS, SUCCESSAND RISKS.
Geoffrey O. Hartzler. M.D., F.A.C.C., Barry D.
Rutherford,M.D., F.A.c.c .. David R. McConahay, M.D.,
F.A.C.C., Warren L. Johnson, Jr., M.D., F.A.C.C.,
Lee V. Giorgi, M.D., F.A.C.C. and Robert Ligon.
Mid America Heart Institute, Kansas City, Missouri
Five cardiologists performedover 5,000 PTCA procedures
in a 6 year period commencing June, 1980. Case volumes
increased from 59 in 1980 to 1,390 in 1985.Frequencyof
multilesion PTCA was 5%, 17%, 36%, 51%, 55% and 61% for
consecutive years (Con Yrs). Absolute numbersof pts in-
creased for pts>-. 70yrs, with poor LVfunction and left
main PTCA, but the relative frequency remainedconstant.
However, pts with prior CABG represented3.4%, 10%, 6.5%,
14%,28.2% and23.9% for Con Yrs. Primarysuccess improved
from 75.8%,87%, 86%, 92.6%, 94.6% and 95.1% for Con Yrs.
PTCA-relatedAMI was< 2.5%per year. Urgent CABG was
3.4%, 1%, 1.6%, 1.7%,2.5%and 1% with proceduralmortality
of 0%, 1%, 2.5%, 1. 1%, 1. 9% and 0.6% for ConYrs.
The 1st 1,000 pts, 3rd 1,000 pts and 5th 1,000 pts were
compared. Frequencyof multilesion PTCA was 31%, 56%,
and 65% per groups of 1,000 pts, respectively. Pts ~ 70 yrs
were 7.5%, 15.6% and 21.8%; poor LVfunction was 7%, 16.2%
and 27.6%;prior CABG was 7%,20.7%, and 22.6%;acute MI-
PTCA was 7.6%,10.1% and 12.4% per groups of 1,000 pts,
Primarysuccess was 86.6%, 94.2% and 95.4%. Complications -
urgent CABG was 1.7%, 2.5% and 1.2%;mortality was 2.1%,
1. 9% and 0.4%per groups of 1,000 pts.
Conclusion: High-volume PTCA concentratedwithin a
small group of invasive cardiologists has yielded steadily
improving results with decreasing risks. In our experience,
contemporaryPTCA requires multilesion dilatation in a
majorityof pts, The frequency of pts with priorCABG,
advanced age, poor LVfunction and acute MI undergoing
PTCA is increasing.
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ABRUPI' R&X::CWSlOO I~ P£CA: ANGIU;R-\PHlC ~R:\Cl'OOsncs
AND CLIN'ICALCOO'~.
Ruth I. Stolz, 101.0., 'rnanas R. Varricchione, BoA., Mirle
A. Kellett, Jr., 101.0., F.A.C.C., ~laine M. Christelis,
M.S., 'rnanas J. Ryan, M.D., F.A.C.C., L6vid P. Faxon,
M.D., F.A.C.C., Boston Univ. Medical <.:enter, Boston, 1oP..
'I'o evaluate abrupt reocclusion (.'1.&) , we examined 240
consecutive patients undergoing first Pl'CA. 25 patients
had AR and were oanpared to 104 consecutive patients
without AR (C). No significant differences were found
between AR and C in age, sex, lesion location and
severity, and prior unstable angina, MI, and CAB3. AR
differed frCIII C in the incidence of single vessel
disease (40% vs. 64%, p<O.05), and Pl'O\-imuced
intimal tears (62% vs. 35%, p< 0.05). Of the 25 l\R
patients, 15 occluded in the lab (AR-L) and 10 later
during their initial hospitalization (AR-H). 8 of 10
AR-H reoccluded within 1 day post-P£CA (8 hrs-5 days).
Prolonged MI Urgent/&nergent Death
Angina prCA Q\OO
AR-L 33%*+ 27%* 7% + 20%11
(5/15) (4/15) (1/15) (3/15)
AR-f1 90%*+ 50%* 90%*+ 20% I1
(9/10) (5/10) (9/10) (2/10)
6% 2% 2% 3%
(6/104) (2/104) (2/104) (3/104)
PERCUTANEOUS
Kimura, MD,
MD, Kokura
EARLY ANGIOGRAPHICAL CHANGES AFTER
TRANSLUMINAL CORONARY ANGIOPLASTY.
Masakiyo Nobuyoshi, MO, FACC, Takeshi
Hiroaki Hosokawa, MD, Hideyuki Nosaka,
Memorial Hospital, Kitakyushu, 802, Japan
In an attempt to further understandthe mechanisms of
restenosis (RES) following PTCA, 137 patients (pts) with
206 angioplastied lesions were analyzed by serial
coronary angiography between Jan. to May 1986. This pt
population reflects 37.7% of 363 pts with successful PTCA
in the sameperiod. Follow up angiographywas performed
on A) next day, B) 1month (mo) and C) 3 mos after PTCA
regardless of pts' symptomatic status. Restenosis (RES)
rate was 5.1% on next day, 12.0% at 1 mo, and 36.4% at 3
mos. Incidence of significant interval deteriorationas
defined by 15% diameter loss was highest from 1 mo to 3
mos (38.3%, p 0.005 vs A and B), secondwithin 24 hrs
(14.1%)(A) and least from next day to 1mo (10.2%)(B).
Eventual RES was observed in 48% of pts showing early
deteriorationwithin 24 hrs(A), in contrast to 94.4% (p
0.005 vs A) of pts having deteriorationbetween next day
to 1 mo(B), and 73.3% (p 0.05 vs A) between 1 mo to 3
mos(C). Conversely, significant interval improvement
similarly defined was found only in the interval between
next day and 1mo (9.0%). Eighty percent of this was
associated with disappearanceof intimal disruption (ID).
Angiographical evidence of ID was observed in 92 lesions
(44.7%). Disappearanceof ID was found in 5.5% on next
day, 60.4% at 1 mo, and 24.2% at 3 mos. Although
presence or absence of ID hadno influence on RES rate
(37.0% vs 36.0%), disappearanceof ID preceded RES, if it
did occur.
ThUS, it appears that reparative processes starting
within 1 mo lead to frequent occurrence of RES between 1
mo and 3 mos post PTCA.
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: TECHNIQUES
AND RESULTS IN ANOMALOUS AORTIC ORIGIN OF THE CORONARY
ARTERIES
John S. Douglas. Jr., M.D., F.A.C.C., Spencer B. King Ill,
M.D., F.A.C.C., Gary S. Roubin, M.B., Ph.D •• F.A.C.C.
Andreas Gruentzig CardiovascularCenter, EmoryUniversity
School of Medicine, Atlanta, Georgia
To evaluate methods and efficacy of percutaneous trans-
luminal coronary angioplasty (PTCA) in patients (pts) with
anomalous aortic origin of the coronary arteries, we
reviewed experiences with 28 dilatations in 13 pts
requiring PTCA of anomalous coronary arteries for relief
of disabling angina pectoris. Difficulty in intubating
ostia of anomalous vessels was encountered in 8 pts. This
was solved in all by catheter reshaping or by utilizing a
different catheter design. Catheter shapes effective in
one pt were usually satisfactory for others with the same
anomaly. All procedures were successful in reducing
diameter stenosis by 30% and improving symptoms without
a major complication. Minor complications were ventric-
ular fibrillation (1 pt), transient confusion (1 pt) and
transient total vessel occlusion treated with repeat PTCA
(1 pt). Three pts had triple vessel PTCA, 3 had double
vessel PTCA, and 7 had single vessel dilatation. Four pts
had an anomalous single coronary artery, 7 pts had
anomalous origin of a coronary artery from the contra-
lateral Sinus of Valsalva, and 2 pts had ectopic anterior
origin of a coronary artery. Six repeat PTCA procedures
were performed. Two pts underwent bypass surgery because
of restenosis; 11 pts achieved good symptomatic results
with angioplasty alone. PTCA is effective in pts with
anomalous coronary artery origin, however unique guiding
catheter shapes may be required.
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OOES CLINICAL INDICATIOOFOR OOImARY~0P!J\S'lY AFFECI'<mCXl1E?
NormanR. Ranirez, M.D•• Robert M. Callif, M.D., William G.
O'Callaghan,M.B., Taooaki Himhara,M.D., Daniel Mark,M.D., Kenneth
G. llirris, M.D., Robert H. Peter, M.D., Victor S. Behar, M.D., Y:I1ulg
Kong, M.D., HarryR. Phillips, M.D. am RichardS. Stack.M.D.,
F.A.C.C., Duke UniversityMedical Center,1Xtrtlan, North Carolina.
To assess the results of percutaneoostransluninalcoronary
angjDplasty (PI'CA) in subsets of patients (pts) withdistinct cardiac
iscIed.c syndrcues, results of 645 P1'CAs performedat fuke University
MedicalCenterbebleen 7/85 am 7/86were examined. InIicatiOllsfor
treatnentwere: (1) acutemyocardisl infarction (AI1I) necessitating
emargentPl'CA; (2) unstableangina (UA), requiring urgent oremergent
Pl'CA; am (3) stable ischemic syuptClllS (SI'BL) treated electively with
Pl'CA. Thefo~ paraneterswere CCJIllaredbebleen gIQIpS: (1)
success of procedure,definedas reductionin lmina1 dianeter of
lesion to< 50%; (2) need for .-rgent eorooary bypass surgery (CABG)
dur1ng theproceduredue to coronary occlusion or :lJIlll!Ildingocclusion;
(3) frequency of syuptalBtic:in-OOspitalreocclusion!restenosis
(In-hosp. rstns) after initially wccessful procedure,requiringurgent
catheterizationam repeatPl'CA or CABG. Results of analysiswere:
No. (%) Success Rate CABG In-Hosp. Rams
STIlL 288 (44.7%) 93.8% 3.1% 3.0%
UA 88 (13.6%) 93.2% 3.4% 3.7%
AI1I 269 (41.7%) 86.6%* 3.7% 9.4%*
'lUfAL 645 90.7% 3.4% 5.6%
*p< 0.01 ceepared to STIlL
In-bosp. rstns was treated with repeatPl'CA in 31/33 pta, with a
aiccess rate of 83.9%. Death as a CQllllicationof PI'CA was rare,
occurring in 3 pts (I in AI1I grwp, 2 in STBL groop),
We conclude: (I) altlnlgh PI'CA can be perfonredwith a high degree
of success in all subsetsanalyzed, there is a higherinc:l.dence of
failed Pl'CA am In-oosp, rstns after emargentPI'CA for AI1I; (2)
emargent CABG am death are infrequentCQllllicationsof Pl'CA, witlnlt
significant differencein incidence aoong subsetsanalyzed; (3) early
rstns after PI'CA can be treated wccessfully with repeatangioplasty ill
the majority ofcases.
RECRUITABLECOLIA'l'EAALS PREDICTED BY LESION SE.VERITY
~er pr~ M,~, John Thornton, Phd6 FredrickFeit,, 'J. rc en"D" Barry Cohen, M, ,
St~ vincent's, M~, Sinai and New York University
Meaical Centers, New York, NY
The correlationbetween extent of collateral (C)
circulationat baseline angiograPhyand degree of
coronary stenosis has been report:ea, We have
demonstrateda~rance of "recruitable"collaterals
during angioplasty ('IQl balloon inflation, In the
present studY, C were vlsualized at baseline and during
coronaryclosure after 45 secs of balloon inflation in
36 pts with one-vessel disease (24 LAD, 12 RCA). A
second arterialcatheter was placed in~o the contra-
lateral vessel for C visualization, Grading of Cfor
each visualizationwas: e=none1 l=filling of side
branches onlY1 2=partial filling of the epicardial
segmeJ)t1 3=col)1plete filling, Group (<;;p) I (no
recruitableCl: less than grade 2 filllng at baseline
and during_ baloon occlusion, (n=7)1 Gp II (recruitable
C): less than grade 2 C at baseline il)1provingto grade
2 or 3 during Balloon inflation (n=l4); Gp Ill: grade 2
C at baseline, (n=8)' Gp IV: grade 3 C at baseline,
(n=7), The degree ot pre-TCAcoronary stenosis was
neasured as_percent diareterreduction by an observer
blinded to c status who traced the magnified image of
the vessel in the projectionwhich showed the rrost
severe reduction of luren~'Lesion severity
was: GP 1-62.8%1,(ran~ 53- ; II-82,8%,(67-93%)1'
Gp 111-91%, (86-9{%l; IV-lee. showed that a 1grou~ were signlflcan ly different from each other
(IX,1II5); there were no vessel effects. In the absence
of C at baseline angiograppy, a lesion of 2 7e%
pred~cted recruitableC Wltfi 85% sensitivity and lee%
speclficity. <;oncluSiOl)~: Whereas there is a wide
overlap orleslOn severi y between pts with and pts
without C at basellne anglograppy, t:he overlap between
pts with and pts without recrultableC is minimal , The
concept of recruitableC enables definition of a narrow
range of lesion severity at Which C growth begins to be
stimulated, The assoclation betwe~ lesion severity
and C filling suggests that this stlmulus ~ncreases
with lesion seventy, Predictionof recrui.tahleC
prior to TCA gppears to be P9ssible on the basis of
reasurementorlesion seventy, This may be iJrportant
for pre-'OCA risk assessment,
SUCCESS OF CORONARY ANGIOPLASTY (PTCA) IN TREATING
SEGMENTAL STENOSES VITH LENGTH GREATER THAN 10 MM.
Ralph A. Boucher, M.D.,Jodi Fishman-Rosen, RN, M.S.,
Richard E. Shaw, Ph.D., Simon H. Stertzer, M.D.,
F.A.C.C., Richard K. Myler, M.D., F.A.C.C. San
Francisco Heart Institute, Daly City, CA
To evaluate the utility of PTCA in treating more
diffusely atheroscleroticvessels, a subset of
patients with longer lesion length stenoses (LL) were
analyzed. Of 936 patients having PTCA since January
1985, 146 (16%) with a total of 170 vessels had LL
greater than or equal to 10 mm. No clinical factors
(e.g., diabetes, hypertension) predicted lesion
length. Vessel success in the LL subset was 85% in the
right coronary artery, 91% in the left anterior
descending, and 92% in the circumflex. Overall
technical success was 89%. Emergency bypass surgery
was required in 3% of patients, myocardial infarction
occurred in 8%, and there was one death in the cohort.
Overall incidence of a major cardiac event was 10%,
significantly higher than in PTCA patients with
lesions less than 10 mm in length (p<.05). Of 132
successful patients, 91 were greater than 6 months
from baseline PTCA. 43 had followup angiography; 23
required repeat PTCA, with re-PTCA successful in 96%.
The LL subset was subdivided into lesion length
10-15mm, l6-20mm and greater than 20 mm and differing
lesion lengths within the subset were not predictive
of success, complications or restenosis. In summary,
longer atheroscleroticsegments can be successfully
treated by PTCA, with comparable primary success rate.
Acute complications and restenosis appear higher than
in morediscrete lesions; restenoses seem amenable to
repeat PTCA.
UNSTABLE ANGINA -. CHANGING CLINICAL, ANATOMIC, AND
THERAPEUTIC ASPECTS. DS Bairn MD FACC, CH McCabe BS, BH
Lorell MD FACC, DP Faxon MD FACC, D Leeman MD, MA Kellett
MD FACC, RG McKay MD FACC. JM Aroesty, MD FACC. Beth
Israel Hospital and University Hospital, Boston MA
To evaluate currentmanagement strategies for patients
(pts) with unstable angina, we prospectively evaluated 811
such pts admitted to the coronary care unit during a 6
month period. Despite triple-druganti·anginal therapy
(Rx) plus ASA/heparin, 34 of 80 pts (43%, Grp I) contin-
ued to have angina, while 46 pts (Grp 11) becameangina-
free on medical Rx. While Grps I and 11 had comparable
coronary anatomy andmedical Rx (inclUding ASA 82% vs
50%; heparin 56% vs 35%), Grp I pts were more likely to
sustain a myocardial infarction (13% vs 0%, p<0.03) and
were less likely to be discharged without revasculariza-
tion (3% vs 35%, p<0.003). While use of CABG was equal in
the 2 Grps (35% vs 37%), angioplasty (PTCA) was used more
often in Grp I (62% vs 28%,p<0.003), with an overall pri-
mary success rate of 94%. Moreover, Grp Ipts underwent
PTCA with less delay than CABG (2.3 vs 5.2 days, p<O.Ol).
To ascertain the broadest use of PTCA in this popula-
tion, coronary angiograrns on 50 consecutive pts were
reviewed. Results showed left main disease >50% in 7
(14%), and normalcoronaries in 3 (6%). Of the remaining
40 pts, 17/17 (100%) with one vessel, 12/15 (80%) with
two vessel, and 5/8 (63%) with three vessel disease were
felt to be amenable to PTCA with either complete revascu-
larizationof all lesions ~70% in 29 pts (72%), or PTCA
of the "culprit"lesion(s) in 5 additional pts.
We conclude 1) 43% of unstable pts continue to have
angina despite aggressive medical Rx, 2) they are more
likely to sustain an infarction or require revasculariza
tion, 3) PTCA can be performedmore promptly than CABG,
with excellent results, and 4) PTCA could be used in as
many as 72% of unstable angina pts.
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VIDEODENSITOMETRY IS INDEPENDENT OF ANGIOGRAPHIC PROJECTION
AND LUMEN SHAPE.
Maryl R. Johnson,M.D., F.A.C.C., David D. McPherson, M.D.,
Miche11e M. Hunt, 8.S., Loren F. Hiratzka, M.D., F.A.C.C.•
Melvin L. Marcus, M.D., F.A.C.C., Richard E. Kerber,M.D.,
F.A.C.C., Steve M. Co11ins, Ph.D., David J. Skorton,M.D.,
F.A.C.C., University of Iowa, Iowa City, lA.
Videodensitometry,a nongeometric method of assessing coro-
nary 1umen area from angiograms, is theoretica11 y i ndepen-
dent of angiographicprojection (if the vascular segment
of interest is parallel to the image intensifier) and lumen
shape. However, in vivo confirmation is limited. There-
fore, we used videodensitometry to define theintegrated
optical density of 33 lesions (located throughout theleft
anteriordescendingand right coronaryarteries) which were
well seen on single plane, orthogonalleft anterioroblique
and right anterioroblique angiographicprojections. Intra-
operative high-frequency epicardial echocardiography was
used to directly visualize the lumen of these same lesions,
and residual lumen shape was evaluated on the echocardio-
graphic images by measuring maximum/minimumlumen diameter
ratios. Shape was classified as circular (ratio <1.5:1,
range 1.07-1.41), oval (ratio >1.5:1, range 1.52-2.92),
or complex (grossly irregular). Left anterior oblique
versus right anterior oblique integrated optical densities
were compared for all lesions and in 2 lesion subgroups.
Results:,-::-:;-:-""',.."".----------n..,---,--,,--..,.-;-.,--
Lesion Group n r Regression Line
All lesions 33 0.94 y=I.04x + 0.002
Circular 19 0.95 y=0.98x + 0.080
Oval/Complex 14 0.94 y=I.09x - 0.022
Conclusion: As long as the vascular segment of interest
is parallel to the image intensifier, the results of video-
densitometry are independent of angiographic projection
and lumen shape.
EFFICACY OF ANGIOPLASTY IN PATIENTS VITH PRIOR BYPASS
SURGERY. David C. Reed HO, Thomas V. Nygaard HO, FACC,
Christine L. Tedesco RN, Denny D. Vatson PhD, George A.
Beller HO, FACC, Lawrence R. Burwell HO, FACC. University
of Virginia, Charlottesville, VA
To assess the role of coronary angioplasty (PTCA) for
recurrent angina after surgery (CABG), we prospectively
evaluated 51 pts (mean 2.3 grafts/pt, age 59±7 yo) post-
CABG with recurrent angina undergoing 123 dilatations
during 85 procedures. The overall initial success rate
(88%) was comparable for native (n=73,86%) and graft
(n=50,90%) stenoses with a ~ in stenosis from 88% to 23%
(p<.OOOl); 11/15 failures were due to inability to cross
the lesion. Four pt s came to re-do CABG, 1 emergently.
Forty-six pts were followed for 1-42 mos (mean 13) after
successful PTCA; 30/39 (77%) were angina free for at least
2 mos but at last follow-up only 21 (46%) were angina free
compared to 64% of 227 pts without prior CABG who under-
went PTCA during the same time period (p=.06); 48% with
residual or recurrentangina had improvement~ 1 function-
al class. Of the 25 medically treated patients, 72% had a
~ in antianginal drugs. Restenosis (30%) was similar for
native (33%) and graft (27%) lesions. The need for 34 re-
peat procedures (range 1-5) in 15 pts, 13 of whom had re-
stenosis at some time, could not bepredicted by progres-
sion of native disease, # of lesions dilated at the ini-
tial procedure, or residual gradient (mean 13 mmHg). Only
5/28 pts undergoing exercise TI-201 scintigraphy had nor-
mal scans after PTCA, although 60% with both pre- and
post-PTCA scans (n=22) showed improvement in TI-201perfu-
sion score. Thus, despite markedangiographic improvement
after PTCA in post-CABG pts, persistent (22%) or recurrent
(46%) angina is common and the need for repeat PTCA is
substantial(33%).Vhile less than 1/2 of pts become total-
ly angina-free, a significant + in angina severity (93%)
and medication needs(85%) occurs, although many fewer post-
CABG pts are asymptomatic after PTCA than non-CABG pts.
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CoronaryArteryDisease: Clinical
MULTIVESSEL~y ~IOPLASTY FOR UNSTABLE VERSUS
STABLE ~INA: LCNT-TER!'I CLINICAL AND ~IOGRAPHIC
RESULTS
Leo Finci, M.D., Bernhard Meier, M.D., Giuseppe
Steffenino M.D., Philip Urban M.D., WilhelmRutishauser,
M.D. F.A.C.C. Cardiology center, university Hospital,
Geneva, Switzerland.
of 100 consecutive pts with multivessel coronary
angioplasty, 23 pts (20 males, mean age 55 years) had
repeated episodes of angina at rest despite medical
treatment. Angioplasty was attempted in a mean of 2.2
vessels/pt. Primarysuccess (angiographic success, no
complications, and improvement by >l NYHA functional
class and/or stress test performance) in pts with
unstable angina was 83% vs 88% in pts with stable angina
(n.s.). Complication rates per pt were 13% (2/23) vs 5%
(4;77) (n.s.): in hospital death 4% (1 pt) vs 0,
emergency surgery 4% vs 3%, and infarction 4% vs 3%,
respectively. At 12+6 months, clinical improvementby >1
NYHA functional class and/or stress test performancewas
found in 89% vs 86% of the pts (n.s.); 47% vs 50% of
patients were in class I. Control angiography was done
in 89% and 86% of pts with primarysuccess at 12+6
months. Angiographic recurrence rate for pts with
unstable vs pts with stable angina was 33% (6/18) vs 44%
(25/57) per patient, and 19% (7/36) vs 36% (38/107) per
vessel, respectively (n.s.). Repeat angioplasty was done
in 50% and 65% of pts with recurrence, and bypass
surgery in 4% vs 5%, respectively.
Multivessel coronary angioplasty in pts with unstable
angina has immediate andlong-term results comparable to
those of pts with stable angina. However, complication
rate appears higher.
Restenosis No Restenosis
(n=44) (n=121)
208.4+5.3 209.5+4.3
193.Jtl3.3 179.1+8.4
35.9+1.3 41.4+2.6*
6.1+0.3 5.7+0.2
mean :!:. S.E. * p<O.lO vs Restenos1S
Hypercholesterolemia (C>250 mg/dl) was present in 11%
of the restenosis group (5/44) and 14% of the group
without restenosis (13/69).
While there was a strong trend for lower HDL levels in
patients experiencing restenosis, this study showed no
significant relationship between plasma lipids and the
incidence of restenosis following P1'Ct\.
C (mg/dl)
'rG (mg/dl)
HDL (mq/dl )
C/HDL
E:F'FOCI' OF PLASM\ .LIPIDS ON RESl'ENOSIS J;'OLLOWING
CORl:N'.RY ANGIOPLASrY.
Alice K. Jacoos, M.D., David J. Folan, Susan M.
~Sweeney, B.S., David P. Faxon, M.D., F.A.C.C., Mirle
A.. Kellett, M.D., F.A.C.C., 'rimothy A. sancorn, M.V.,
am I'hanas J. Ryan, M.D., F.A.C.C., Boston University
Medical Center, Boston, M'\.
Hypercnolesterolemiais a well recognized risk factor in
the devefopnent; of coronary atherosclerosis. However,
controversy exists concerning the influence of plasma
cholesterol on the incidence of restenosis following
coronary angioplasty (PI'Q\). 'I'o study the relationsnip
between plasma lipids am restenosis we measured fasting
plasma lipid profiles [cnolesterol (C), triglyerides
(TG), high density lipoprotein C (HDL)] in 165
consecutive patients undergoing successful (>20%
increase in lumen diameter, <20 mmHg gradient) prCt\.
Restenosis was defined as a return in coronary narrowing
of >50% which occurred later than 1 nontn following
inital prCt\. All patients were followed for a miniumum
of 4 months.
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RESTENOSIS FOLLOWING SUCCESSFUL CORONARY ANGIOPLASTY: A
MULTIVARIABLE ANALYSIS OF PATIENT, PROCEDURE AND CORONARY
LESION-RELATEDRISK FACTORS
Charles A. Simonton, M.D., Daniel B. Mark, M.D., Tomoaki
Hinohara, M.D., Harry R. Phillips, M.D., Robert H.
Peter, M.D., Eric B. Carlson, M.D., Kenneth G.Morris,
M.D., and Richard S. Stack, M.D., F.A.C.C. Duke
University Medical Center, Durham, NC
Restenosis is a major limitation of the long term
success of coronary angioplasty (PTCA), occurring in
30-40% of patients (Pts). To identify patient, procedure
and coronary lesion-related factors predicting a high risk
of RS, outpatient follow-up cardiac catheterizationwas
performed in 123 of 144consecutive Pts (85%) undergoing
successful PTCA. Baseline patient characteristics
included stable angina (15%), progressive or unstable
angina (53%), acute myocardial infarction (MI) (19%), and
atypical chest pain or no symptoms (13%). Multilesion or
multivessel PTCA was performed in 27%. Mean follow-up
interval to follow-up catheterizationwas 7.4 months.
Overall patient and lesion restenosis rates (RR) were
36% and 32%, respectively. In univariable tests, the
factors associated with restenosis were diabetes mellitus
(DM) (p=.03), history of prior MI (p-.002), higher
angioplasty balloon inflation pressure (p-.Ol), difficulty
initially crossing the stenosis (DIFCR) at the time of
PTCA (p-.001), absence of dissection (p-.03) and
angiographicallyslow distal flow (SDFLOW) in the involved
coronary artery prior to PTCA (p-.0001). In multivariable
analysis, DM (RR-63%, p=.007), history of prior MI
(RR=54%, p·.03), DIFCR (RR=56%, p=.03) and SDFLOW (RR=58%,
p-.002) predicted subsequent restenosis.
Hence, the risk of restenosis is increased in the
presence of DM, a previous MI, SDFLOW, or initial
difficulty in crossing the stenosis.
MULTIVESSEL CORC.NARY AN3IOPLASTY: LCHT-TEllJIICLINICAL
AND AN3ICXiRAPHIC FOLLCW-UP
STRESS TESTING AND THALLIUM SCINTIGRAPHY AS PREDICTORS OF
RESTENOSIS AFTER SUCCESSFUL CORONARY ANGIOPLASTY.
Ruediger Simon, M.D.,F.A.C.C., Hans Creutzig,M.D., Ivo
~mende, M.D.,F.A.C.C., Gunhild Herrmann,M.D., Paul
Lichtlen, M.D.,F.A.C.C., Medical University, Hannover,FRG
Exercise electrocardiographic testing(Ex) and stress
thallium scintigraphy(TL) are widely used to follow
patients after coronary angioplasty (CA). We performed Ex
and TL in 152 consecutive patients who had had successful
CA of high-grade (>75%) stenoses in one (n=122) or more
coronary arteries (n=30) 4 to 8 weeks after CA. Patients
were exercised on a bicycle ergometer in upright position
according to a standardized protocol.Scintigramswere
obtained in 3 projections (anterior, lateral and oblique)
immediately and 3 to 4 hours after exercise. All patients
underwentcoronary angiography3 months after CA and
recurrencewas assumed when a loss of more than half of
the gainachieved at CA was present, resultingin>60%
diameter stenosis. Angiograms and Ex and TI were analyzed
by independent investigators.
The comparison of Ex, Tl and angiograms revealed the
following results (Ex+,TL+,Ex-,TI-: positive and negative
Ex and TI tests):
Ex+/TI+ Ex+/TI- Ex-/Tl+ Ex-/Tl- Sum
No recurrence 16 16 24 56 112
Recurrence 10 2 10 18 40
Sum 26 18 34 74 152
Independentcomparison resulted in asensitivity of 30%
for Ex and 50% for TL, and a specificity of 71% for Ex and
64% for TI to predict early restenosis atangiography.
We conclude that standardstress testing and thallium
scintigraphyperformed4 to 8 weeks after CA cannot
reliably assess theincidence of early restenosis.
COJOWrlWEDGE PRESSURE: A PREDIC'roR OF RESTQl)SIS
AFl'ER AN3IOPLASTY
Leo Find, M.D., Bernhard Meier, M.D.,
Steffenino, M.D., Wilhelm Rutishauser, M.D.,
Cardiology Center, University Hospital,
Switzerland.
Giuseppe
F.A.C.C.
Geneva,
Leo Find MD, Bernhard Meier MD, Philip UrbanMD,
Giuseppe Steffenino MD, Wilhelm RutishauserMD, FACC.
Cardiology Center, University Hospital, Geneva,
Switzerland.
In 100 consecutive pts with multivessel coronary
angioplasty, 208 arteries were attempted. Chronic
total occlusion was present in 30 pts; 6 pts had
angiop13sties in different sessions. primary success
(angiographic success of all or at least the strategic
lesion, no complications, and improvement offunctional
class and/or stress test performance)was present in 87
pts. Complications occurred in 8 pts: in-hospital death
in 1%, myocardial infarction in 5%, and emergency
surgery in 3%. Follow-up was available in all pts with
primarysuccess. Clinical improvementafter 12+6 mo was
present in 77 pts, 57 of which were in NYHA class I.
Control angiography was done in 75/86 pts (86%) with
primarysuccess. Angiographic recurrenceat 12+6 mo was
found in 31/75 pts (41%), and 45/143 arteries (31%)
restudied. Repeat angioplasty was done in 17 pts, with
long-term clinical success of 80% (13/16 pts) at 9i6
mol 5 pts underwent surgery, and 9 were treated
medically.
Successful multivessel angioplasty including repeat
procedures achieved a long term clinical success in
about 80% of pts. Restenosis, which may be clinically
silent, remains a major problem, emphasizing the
importanceof follow-up angiograms and better methods
for prevention.
Coronary wedge pressure is the pressure recorded
distally to the stenosis while the inflated balloon
occludes the coronaryarteryduring angioplasty. In 91
pts, we retrospectivelyevaluated the long-term (7+3
months) angiographic results of 100 consecutive
vessels for which coronary wedge pressure had been
measuredat the time of angioplasty.
The overall restenosis rate was 37%. The restenosis
rate was 52% (25/48) in arterieswith a coronarywedge
pressure >30mmHg, and 23% (12/52) in the arteries
with a coronarywedge pressure <30mmHg (p<O.Ol). Mean
coronarywedge pressure was 26+9 for vessels wit\1out
restenosis and 30+10 for -those with restenosis
(p<O.Ol). Theprevalence of angiographically visible
collaterals was 29% vs 42%, respectively (n.s.).
Neither age, sex, functional angina class, LV
function, number of diseased vessels, nor initial and
final transstenotic pressure gradient and degree of
stenosis were significantly associated with
restenosis.
Coronary wedge pressure has been shown to reflect
actual (visible) and potential (recruitable)
collateral flow to the stenosed artery, distally to
the angioplasty site. We observed a significantly
increased restenosis rate with high coronarywedge
pressure. This suggests a negative influence of
competitive collateral flow on long-term angioplasty
results.
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HIGH-DOSE STEROIDS FOR PREVENTION OF RECURRENT
RESTENOSIS POST-PTCA: A RANDOMIZED TRIAL.
Geoffrey O. Hartzler, M.D., F.A.C.C., Barry D.
Rutherford,M.D., F.A.c.c., David R. McConahay, M.D.,
F.A.C.C., WarrenL. Johnson, Jr., M.D., F.A.C.C.,
MarthaM. Calkins. Mid America Heart Institute, Kansas
City, Missouri.
Between Nov 1983 and July 1985, 102 pts with restenoses
following prior PTCA, were randomizedto receive
steroids or no steroids in conjunction with repeat angio-
plasty. Fifty-two pts (STEROIDS) received a one week
high-dose steroid regimen commencing 1 day prior to
re-PTCA including Methylprednisolone125 mg. IM the
night before and morning of the procedurefollowed by
oral Prednisone 60 mg. daily for one week. Fifty pts
(CONTROLS) underwentre-PTCA without steroids. All
pts continued to receive aspirin, dipyridamoleand calcium
channel blockers. From 1-5 restenoses per pt were dilated
(2. l/pt). Despite randomization,groups differed signifi-
cantly only with greaterprevalenceof 2- 3 vessel disease
in STERO IDS(79% vs 56%, P<.01) .
Pt compliance limited angiographicfollow-up (FU) to
27 STEROIDS (52%) and 27 CONTROLS (54%).The per
les ion incidence of restenosis was 36% (STEROIDS) vs
40% (CONTROLS), P =NS. At mean clinical FU of 1.1 yrs,
the absence of angiographicrestenosis plus negative exer-
cise test and class I angina status was 63% STEROID~ 58%
CONTROLS (P = NS). The occurrenceof restenosis, death,
MI, or angina class Ill-IV was 38% STEROIDS , 46% CON-
TROLS (P =NS) .
Conclusion: This prospective randomized trial which was
limited by incomplete angiographicFU showed no signifi-
cant differences in restenosis or other cardiac events be-
tween STEROIDS and CONTROLS. However, the clinical
results suggested a trend in favor of STEROIDS which will
requirea larger trial for definitive characterization.
FOLLOWUP OF SUCCESSFUL MULTIVESSEL CORONARY DISEASE
ANGIOPLASTY PATIENTS: I S SUCCESS SUSTAINED?
Ger al d Dor r os, M.D., F. A.C.C. , Ruben F. Lewin, M.D.,
Lynne J anke , R.N.• St. Luke's Hospi tal, Milwaukee, WI.
Between 1979- 86, 715 multivessel coronary disease (MVD)
patient s (PTS) had a cl i nically successful angioplasty
(PTCA) with 330 PTS having one and 385 PTS having mor e
than one l esion dilat ed . Followup of t hese MVD PTS was
obtained for appar en t sympt om-rel a t ed lesion recurrence,
anginal status, and survival. Within 7.7 mont hs , 183 PTS
(29. 5%) had an apparent sympt om- relat ed recurrence: 38
PTS chose to have elective surgery (CABG), and a 2nd PTCA
was suc cessful ly performed in 137/ 145 PTS (94%) . A sub-
sequent, 2nd apparent symptom- r el at ed recurrence occurred
at 11. 1 months after the 2nd PTCA i n 28 PTS : 3 PTS had
elective CABG , and 22/25 PTS (88%) had a successful 3rd
PTCA. The anginal status in 328 PIS" 12 months (mean,
30 . 3 months) after PTCA showed that 64% were asymptomatic,
and 83% hadless angina. Life table analysis showed that
at 63 months, 91% of PTS were alive . Univariate analysis
showed that survival was not affected by the age of the
patient, ventricularfunction, or number of lesions
dilated. However, PTSwith a history of prior bypass
surgery had a diminished survival (no prior CABG, 94%
versus prior CABG, 84%; p,,"0.05) . These data suggest
that a sus t a i ned clinical improvement with pal l i a tion of
anginal sympto ms coul d be obtained in 92% of successful
PTCA PTS with or without the need for repeat PTCA, and
with a 91%survival at 63 months. However, not unexpec-
tedly, t he ~ resence of prior CABG had an adverse effect
upon survival.
Cholesterol, triglycerides and the total cholesterol: HDL
levels all determinedsimultaneously at theend of the
study fell significantly after marine oil therapycompar-
ed to two baseline measurements. Pts . without coronary
artery disease (CAD) had a significantlr greater response
in BT to MO andMO + APA than CAD pts. lp < .05). ThUS,
given singly, MO andA+DP prolongBT equally. Incombin-
ation, these agents appear tofurther increase the BT. ~
additional hypolipidemic and BT prolongation ofMO in
conjunction with otherAPA makes this combination of
agents appealing as ameans to further inhibi t coronary
angioplasty and bypass restenosis.
THE EFFECT OF MARINE OIL IN CONJUNCTION WITH OTHER ANTI-
PLATELET AGENTS ON BLEEDING TIME AND PLASMA LIPIDS.
Michael H. Davidson, M.D., RajalayniMcKenna, M.D.,
Daniel P. Sullivan, M.D., Philip R. Liebson, M.D.,F.A.C.C.,
James A. Schoenberger, M.D.,F.A.C.C. and Joseph V. Messer,
M.D.,F.A.C.C., Rush Medical College, Chicago, 11.
The anti-plateletagents (APA), aspirin(A) and dipyrida-
mole (DP) are commonly used to inhibit restenosis follow-
ing coronaryan~ioplasty and bypass sur~ery. Marine oils
(MO) enriched wlth theomega-3 fatty aCld have also been
shown to inhibi t platelet aggregation. To compare the
effects of MO and APA (A+DP) singly and in combination,
bleed in~ (BT) and plasma lipids were measured in 20 hyper-
l ipidemlc patients \pts) (cholesterol >24Dmg/ dl ) random-
ized to 4 weeks(wks of MO (five 50%omega-3 fatty acid
capsules t id for atotal of 4.5grams of eicosapentaenoic
acid/day) orAPA (325mg A/day + 75mg DP tid) followed by
4wks washout (w) 4wks crossover therapyand 4wk combin-
at ion therap¥(MO + APA). Results were as follows
(mean: 5.0.), with p value compared to baseline (B):
B
BT(min) 5.3+1.1
p value
MO A+DP W
6.63+1.2 6.3:1.6 5.3+1.2
<'"005 <. 005 (NS)
MO+A+DP
7.36+3.3
< ~025
APPARENT SYMPTOM-RELATED LESIONRECURRENCE IN MULTI-
VESSEL CORONARY DISEASE PATIENTS: DOES THE NUMBER OF
LESIONS DILATED MAKE A DIFFERENCE?
Gerald Dorros, M.D., F.A.C.C., Ruben F. Lewin, M.D.,
Lynne Janke, R.N., St. Luke's Hospital, Milwaukee, WI.
Between 1979-86, 715 multivessel coronary artery disease
(MVD) patients (PTS) underwent 727 procedureswith 1269
attempted angioplasties (PTCA). If needed, more than 1
l es i on was dilated only after succes s f ul (SUe) dilatation
(DIL) of t he cons i der ed-cr i t i ca l - s t enosis (CCS) . Thus,
a priori, the suc cess rate for single dilatat io n (SD) PTS
was l ower than multiple dilatation (MD) PTS. Clinical
characteristics regarding age , sex, prior i nfarction,
ventricular f unct i on , diabe t es , and hype r t ens i on were
similar in t he SD and MD gro ups . The i ncidence of prior
surgery (CABG) was 43% i n SD and 32% i nMD gr oups
( p ~ 0 . 05) . A sue OIL was achieved in 267 (8 0%) of SD and
883 (94%) of MD lesions. A clini ca l i mpro vement was
achieved in 267 (80%) of SD and 368 (94%) of MD PTS.
Significant compli cat ions differ ed between the 2 group s
only in t he incidence of emergenc y CABG [SD gr oup , 2 .5 %
versus MD group , 1.8%; (p( 0 . 05) ]. Within a mean of 7. 7
mont hs , an ap arent symptom-related l es ion recurrence
occurred in 28% of SD and 21% of MD PTS. A restenosis
of t he previously dilated lesion occ ur r ed in 42%, a new
l esion occurred in 26%, and combination of both in 32% of
PIS with no difference between SD and MD gr oups . Ele c-
tive CABG was chosen t o be done in 26% of these SD and
21% of these MD PTS. A SUC 2nd PTCA was per fo rmedin
57/61 (93%) SO and 55/5 7 ( 96%)MD PTS. These data sug-
ges t that despite the dif ferences by defini t i on in
initially clinical suc ce ss rates, the appar ent symptom-
related recurrencerates were similar in single and mul-
tiple dilatationMVD PTS. In 21-28 % of PTS, symptomsare
related to entirely new coronary lesions.
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MyocardialMetabolism
TIME DEPENDENT CONVERSION OF CANINE MYOCARDIAL XANTHINE
DEHYDROGENASE TO OXIDASE ACTIVITY DURING ISCHEMIA AND
REPERFUSION IN VIVO
T. Rosamond,~.~D. Mack, B.S., and S.R. Bergmann,
M.D., Ph.D. Washington University, St. Louis, MO
Oxygen free radicals (OFR) have been implicated in the
pathogenesis of stunnedmyocardium and in reperfusion in-
jury. Xanthine dehydrogenase (XD) to xanthine oxidase
(XO) conversion has been implicated as amechanism par-
tially responsible for OFR production. However the in
vivo time course of XD to XO conversion has notb~en weTT
areTTned during early ischemia and reperfusion. To quanti-
tate this conversion, myocardial samples were taken at
s~lec~ed time intervals after LAD occlusion and reperfu-
Slon 1n 13 open chest dogs. Foranalysis, tissue samples
were homogenized with PMSF and dithiothreitol to prevent
in vitro conversion of enzyme and passed through a Sepha-
aex~umn to remove inhibitors. XD and XO activity were
determ1ned spectrophotometricallyby quantitatingthe
production of urate. TotalXD + XO activity (XOD) did not
differ between normal, ischemic (flow 19% of normal) or
reperfused (flow= 143% of normal) tissue (7.5 ± 2.6, 7.4
± 2.8, 8.5 ± 6 mU/gram wet wt respectively). XO comprised
2.7 ± 3.1% of total XOD activity in normal myocardium.
Within 15 min of occlusion XO rose to 10.9 ± 2.0% and by
45 m1n was 42.8 ± 17.7% of total activity (p < 0.05 com-
pared to normal).No further increase was noted with is-
chemia of 60 min. Thirty minutesafter reperfusion XO ac-
tivity was 25.9% of total XOD activity (NS compared with
45 min of ischemia). Thus,XO conversion occursearly af-
ter coronary occlusion andmay account for DFR produc-
tion in caninemyocardium subjected to brief ischemia. In
addition, the transient production ofOFR early after re-
perfusion is not limited by reconversion ofXO to XD.
ABSENCE OF ARACIDOONICACID METABOLISM INADENO-
SINE TRIPHOSPHATE DEPLETED CARDIAC MYOCYTES.
George E. Revtyak, MD, Kenneth R. Chein, MD, and William
B. Campbell, Ph.D., U of Tx Health Sci Ctr, San Antonio, Tx,
Cultured myocardial cells exposed to metabolic inhibitors
develop irreversible injury characterized by cellular ATP
depletion and arachidonic acid (AA) release from membrane
phospholipid. Since AA metabolism by cyclooxygenase (CO)
and lipoxygenase (LP) yields biologically active products, the
present study was undertaken to identify the major AA
metabolites formed by culturedcardiac myocytes (CMs) exposed
to 2-deoxyglucose (DOG) and oligomycin (OG). AA metabolites
were identified and quantitated by HPLC and RIA. Under
control conditions, CMs incubated with I!lM 'H-AA synthesized
'H-PGE" 'H-lS-HETE, and 'H-6-ketoPGFj indicating that
both CO and LP pathways are present in these
a
cells. Following
exposure to 10mM DOG or O.l!lg/ml OG, CM ATP levels
decreased in a time-dependent manner with maximal ATP
depletion occuring 4 hrs after exposure to both DOG & OG
O.7±0.2 vs 37.2±1.1 nmol/mg protein control). In CMs treated
with DOG-OG for 4 hrs, both 6-ketoPGFj"and PGE, release
were reduced by 71% 08S±20 vs 630±21 pg/ml/4 hr control)
and 52% OIO±IO vs 230±6pg/ml/4 hr control) with no reduction
in cell number. Also, supernatantsfrom CMs prelabelled with
'H-AA then exposed to DOG-OG for 4 hrs contained no
'H-prostaglandinsor 'H-HETEs but 2-fold more unmetabolized
'H-AA than supernatants from control CMs. Melittin (0.5
!lg/ml), a membrane phospholipase (MPL) activator, and 10!lM
AA stimulated 6-ketoPGFj a release from both DOG-OG treated
and control cells by 15- and 50-fold, respectively, Indicating
that CO and MPLare active in ATP depleted CMs. We conclude
that ATP depleted CMs: 1) release AA which is not converted
to CO or LP products; 2) the lack of AA metabolism is not
due to inactivation of CO or MPL bythese inhibitors; 3) AA
released during ATP depletion in vivo may be metabolized
by circulatingplateletsor adjacentand adherentcells.
IMPORTANCE OF 2,3-DIPHOSPHOOLYCERIC ACID TO OXYGEN
TRANSPORT INCONGESTIVE HEART FAILURE Rowt M. Bersln,..11I2.,
Alien I. Arieff,M.D. and Kanu ChetterJee. M.B., F.A.C.C. University of
california, Sen Francisco.
To stUlty' the roleof 2,3-diphosphlJ,j1yceric acid (2,3-DPG) in oxygen
transport in patients withcongestive heart failure(CHF), we measured
arterial, mixed venous and coronary sinus 2,3-DPG levels in eight
patients with NYHA Class IIICHF (meen ejaction fraction 26±9~).
2,3-00P was measured in duplicate using the NAD-NADH assay.
Simultaneous measurements of blood gases, hemoglobin andcirculatory
hemod'/oamics were also obtained.
Whole blood 2 ,3-DPG was found tobe elevated atall three sites tested
(mean erterial=3.18, mixed venous=3.20, coronary sinus=3.0S).
There were no si~lficant differences between sites. Arterial 2,3-DPG
levels were also significantly elevated when corrected for hemoglobin
(meen=26.3±S.2), and were twica normal (mean normal
males= 12.8±2.3 umol/gm Hb) (p<O.OS). PSO was correspondingly
elevated (mean=29.0). The elevation of blood 2,3-DPG could not be
explained by the arterial pH (mean=7.43) or p02 (meen=81).
However, a positive correlation between 2 ,3-DPG and resting systemic
oxygen consumption was found (r=O.S9. p<O.OS). This trend was
independent of rasting cardiac index (mean=2.64) and the heart
rate-blood pressure product (mean=7470).
These data SUC];l8St thet 2,3-DPG is elevated inCHF, and that 2,3-DPG
plays an Important role in systemic oxygen transport in this clinical
setting. The elevation of 2,3-DPG in patients with Class III CHF but
normal resting cardiac indices suggests thet tissue oxygen delivery is
impaired early in CHF before overt hemod'/namic compromise becomes
apparent, and thet 2 ,3-DPG is elevated Incompensation tomeet systemic
oxygen demands.
MODULATION OFCORONARYCONSTRICTIONBY
MYOCARDIAL ISCHEMIA
Georg ErU, M.D., Stephan Lindner, Kurt Kochsiek, M.D., Medi-
zinische Klinik, UnlversitatWLirzburg,FRG
Recent studies have questioned that myocardial ischemia re-
sults in maximal coronary dilatation and suggested that coro-
nary arteriolarconstriction may compete with metabolic dila-
tation. Effects of vasoconstrictors and inhibitors of vasocon-
strictor systems were, therefore, analyzed during myocardial
ischemia. In 28 anesthetized dogs, LAD coronary artery was
cannulatedand perfused at normal (= mean aortic pressure)and
low (= 35 .!. 2 mmHg) pressure (CPP). At low CPP, myocardial
lactate production indicated ischemia and vasoconstrictorsre-
sulted in depression of subendocardialsegment shortening (ul-
~rasonic crysta!s). Angiotensin (A). I a.nd Il (0.1-0.5 lug/kg x min
I.C.), vasopressin (V: 5 ng/kg x mm I.C.), leukotrie'nes (LT) C
and DI< (0.1 lug/kg t.c.), and indomethacin 0: 5 mg/kg i.v.~
reduced coronaryblood flow (CBF) at normal CPP by 40 - 50%.
At low CPP, reduction of CBF by AI, All, LTC and D was
attenuatedto 24 + 7, 33 + 5, 28 + 5 and 30 + 5% 4respectlvely
and reductionof CBF byV and Iwas enhanced to' 66 + 5 and 62
:;: 3% (~ll ~<. 0.05 vs normal CPP). In dogs pretreatedwith I,
Ischemia did not attenuate coronary constriction by LTC and
D4 but.still attenu~ted the effect of AI and A u. At low ~PP,saralasm(I lug/kg Lc.) and captopril(0.25 mg/kg i.v.) increased
CBF from 26.2 .!. 6.9 to 33.3 + 6.7 (p-c 0.0025) and 35.9 + 7.5
(~ < 0.05) mI/min p~r lOO g, respectively, and reduced depres-
sion of subendocardialsegment shortening while a V-antagonist
did not. Thus, myocardial ischemia may attenuateor enhance
coronary constriction. Attenuation of LTC and D induced
coronary constriction by myocardial ischemi~ might ge media-
ted by a cyclooxygenase product, that of AI and All by an
enhanced occupancy of All receptors by endogenous A Il. A
coronary constrictive tone by endogenous All is suggested in
this model of myocardialischemia.
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ARGON LASER ABLATION WITH A NEW SILICA BALL-TIP DEVICE
Stephen RameeMD, Renu Virmani MD, FACC, Mi chael Aita.
Li sa Abrahams MD, Her ber t Geschwind MD . FACe, Fran k
Kolodgi e , Charles Wade PhD, Chr i s top herWhi t e MD, FACC,
Letterman Army Medical Center and In s t itute of Research,
San Francisco, CA .
200 um F 327 1007 0.2 5 130
0.5 mm B 722 1031 0.40 143
1.0 mmB 1230 1256 0.89 186
Wi t h incr easing fiber t i p s i ze . there was increased
widt h andarea of ablat ed tissue with a negl igible change
in t he cra t e r depth and zone of coagul a t i onecrosis. No
t issue damage occurred with ball-tip f ibers when th e
incident angl e was ~ 15". The amount of tissue ablated
with the ball-tip fiber W6S enhanced in the bl ood: sal i ne
mix tu re when compar ed t o saline alone. We conclude that
ball-t ip fibers minimize t her mal i nj ur y andcreat e a more
favo rable crater profi le th an bare fibers.
A self-s teer ing ball-tip fiber was deve l oped t o
maXimize laser ablation of atheromatous tissue and
min imize adjacent thermal i nj ury . We compared t he
hist ol ogi c ap pear ance ofargon l aser irradiation using
0 .5mm (n : 15) and 1. 0mm (n:15) ball-tip fi bers (B) with ZOO
micro n bare fi ber s (F) . ( n: lO) . on swi ne aorta immersed in
a mixture of blood and s al in e ( 1:9 ) a nd saline alone . At
90° , 15''', and 0° , th efi ber was hel d i n cont act with th e
target tissue , and l Z.5 joul es of energy was deliv ered.
Us i ng comput er i zed planimet ry th e followin g measurement s
were made : Crat er depth. width, area, and zone of
coagul at i on necrosis (CN). Results expressed as mean
val ues ( n : 5 for each group), in bl ood and saline mixture
at 90" :
MYOCARDIAL FREE FATTY ACID OXIDATION: 14C
PALMITATEAND 14C OLEATESTUDIES IN HUMANS
Judith A. Wisneski,M.D.,F.A.C.C., EdwardW. Gertz, M.D.,
F.A.C.C., Richard A. Neese, Ph.D.,VAMC and Univ. of California
San Francisco.
Free fatty acids (FFA) are considered to be animportant
substrate for myocardial oxidative metabolism. Many of the
previous investigations in humans have only measured thearterial
(A)and coronary sinus (CS) chemical FFAdifferences. To further
delineate myocardial utilization of circulating FFA, 13 normal
subjects (mean age 22!3 years) and 11patients with ischemic
heart disease (mean age 52!13 years) were studied. CS and A
catheters were inserted. [1_14 C ] palmitate or [ 1 14C ] oleate
bound to albumin was infused intravenously at aconstant rate.
Myocardial oxidation of FFA wasdeterminedby measuring (CS-A)
14 COz • The specific activity of the individual FFA was
determined using thin layerchromatography/gaschromatography.
After baseline samples, heparin was given toelevate FFA.
The baseline A blood level ofpalmitate was 62! 32 nmol/ml
with a myocardialextractionratio of 52! 9%. The 14 COZ data
demonstratedthat 81! 17% of the palmitate extracted by the
myocardium underwent oxidation. These values forleate were
126 ! 34 nmol/ml and 48 ! 10%,respectively. Although the uptake
was greater for oleate compared withpalmitate(p <0.001), the
percentage undergoing rapid oxidation was similar, 86! 18%.
Following heparin, there was a87! 46% increase incirculating
FFA. Over a range of Apalmitate from 32 to 176 nrnol/rnl, a
positive correlationwas presentbetween thecirculatinglevel and
the amount oxidized (r=0.82; pe 0.001). Likewise foroleate 11
similar positivecorrelation(r=O.77; p< 0.001) was present over a
range of 82 to 272nmol/ml,
This study demonstratesfor the first time in humansthat a
very high percentage of FFA extracted by the myocardium
undergoes rapid oxidation andthat the amount oxidized is closely
correlatedwith thecirculatinglevel.
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CoronaryArteryDisease: Basic
A PROTOTYPE CATALYTIC THERMAL TIP CATHETER: DESIGN
PARAMETERS AND IN VITRO TISSUE STUDIES.
David Y. Lu, M.D•• Martin B. Leon. M.D•• F.A.C.C •• and
Hobert L. Bowman. M.D•• NHLBI, Bethesda. MD.
Laser thermal angioplasty (TA) using metal-tippedquartz
fibers has been used successfully to recanalize
obstructed human peripheral arteries and preliminary
studies are ongoing in patients with coronary artery
disease. A new catalytic thermal tip (CTT) catheter has
been designed providing an alternative energy source for
TA without the expense and technical support needed for a
laser operated device. The CTT utilizes the principle of
combustion energy from a stoichiometric ratio of oxygen
and hydrogen gases catalyzed by a small piece of
palladium sponge within the tip. Gas flow regulates CTT
temperature(T) which is monitored by a copper-constantan
thermocouple inside the metal tip. A 3F prototype CTT was
studied in air and saline. alone and with human
atheroscleroticaortic segments. Heating was faster in
air ()3500C in <1sec) than saline (T(max) of 1700C i n
Ssec. ~= O . 6 sec ) . but thermal relaxation was faster in
saline ( ~=1.Ssec) than air (Vj=8sec) due to rapid
heat convection in saline. In both air and saline,
CTT-tissue contact effects were directly related to T at
the t ip; histologic thermal i nj ury beganat T>1800C but
ablation with crater formation, charring, and
polymorphous vacuoles did not occur until T)32Soe.
Effective tissue ablation in saline required initial
vaporizationof the saline at the eTT-tissue interface.
We conclUde that the eTT catheter is safe. inexpensive.
and results in efficacious tissue ablation which can be
regulated by T feedback monitoring and may be preferable
al ternative to laser TA.
!ASffi~ctl OFIU1AN~e~: OllPARISCN OF <D
2
I\Nl MID-oomID lJ\SEllS.
RareL. Bellinger. M.D•• Myron L. Ioblbarsht , Ph.D••E1J.eal M. Mikat .
Ph.D•• am RichardS. Stack, M.D•• F.A.e.C•• M<e WversityMedical
Center, DJrhan, North Carolina.
Qlrrent lasersare limited by thenral., phJtoct-u:al.or lDI!Chan1cal
damge to tissues e:xt~ wtside the zroe of ~t. In theory, as
laser wavelength approachespeak tissue absorption(usually equated to
that of IIz 0 at Z.94}.11l), both depth of ablationam injury to adjacent
tissue are reduced at thresholdlevels. To test this hypothesis,we
laser pbotoehlated5el!JD'!Ilts of fresh lunan coronary atherosclerotic
plaque with a <DZlaser ( A= 10.6 J.IIi>. a hydrogen fluoride (HF) laser( A= Z.8 }.11l) am an erbiun:YAG (Er:YAG) laser (A =Z.94 }JIl). lotJltiple
cuts were made utilizing a zircarlun f1uorlde optic f!barpressed
ar,ainst the plaque In a saline bath. Focal spot power settings were
held constantam depth of cuttingwas a function of the ruIber of
pulses: <DZ 1 lIE pulse. IGnJwtplt; HF SOns pulse. nJ wtplt;Er:YAG 9<Als pul.se with 15 in a train. 2.5 ps IFI. ImJwtplt.
Gross nacroscopfc exanination ofm1d-infrared(mid-IR) ablated
segeents revealed a~ incision withnone of the gross~ or
evidence of residualnecrotic debris characteristicof <D2 laser
exposed SE!!'JII'IlCS. Histopatlx>log1cal exaninat10nof m1d-IR SE!!'JII'IlCS
confirmed the absence of significant adjacent tissuedanage while <D
5el!JD'!Ilts had a significant ban! of coagulative necrosis adjacentto ~
zone of iJJpact. HFablationsappearedllDre irregular am deeper at
each pul.se.
In the abseoce of significant theIm1l danage ~lli1cat1on, m1d-IR
lasers operating at ornear a wave~th of Z.9 ).ID may prove to be the
safest am III)St effective ueans of laser photoablat1onof lunan
atherosclerotic plaque.
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A PULSED ULTRAVIOLETALEXAKlRITE IASERFOR AOOIOPIAS'lY:
EVAUI'\TION OF TISSUEABLATION AID FIBEROP1'ICCONIXmION.
Lawrence 1.Deck.e11:B\D14), Mark L.Stetz BS, Francis W.
CutruzzolaSS, Jeny W.Kl4Jer PhD, MartinC.Baker BS, and
J05eih J.BarrettPhD. VWC; and Yale Univ, \<t!st HCMln, CT.
Pulsed ultralliolet (PtN) excimer laser irradiationis
captble of tissue ablationwithout adjacelt thermal
damage . AlthcJl91 this my be adV<lrltageous for laser
arJgioplasty, concerns regardingthe use of toxic gases,
operationalreliability, and difficult fiberoptic
eotpling have resulted in the search for alternativePUV
laser sources. The solid state desi!J1 and longer pllse
dlrationof the Alexarmite laser mi!llt enable PUV laser
arJgioplastywithout the shortcan.ingsof the excimer
laser. To evaluate tissue ablation, frecpency-doubled
Q-switched Alexoarx1rite laser irradiation(-..elength
378rJ11. pllse durationGOns, repetitionrate 18Hz) was
focused in air to bore 75 full thickness craters in
normal and atherosclerotichuman cadaveric aorta. There
loBS no gross. histologic. or ultrastructuralevidence of
adjacent thermal danEge at pulse ene~ fluences (PEF)
(p.1lse energy per unit area) > 35mJ/nm. IIblation time
was inversely ~lated to PEP, with a marked increase at
PEF < 35 mJ/nm . Fiberoptic coupling efficiency of
freqJellCy"""1b1bledAlexcn:irite laser radiationwas 7~
using 600-1000 P cpartz fibers. Fibe~tic laser
ablationof aortaat PEP of 50--96 mJ/nm in air, saline,
and blood also re'II'e&1edabsence of themal damlIge.
IIblation in blood resulted in =re irregularcraters
problbly due to acwstic shock injury.
In conclusion, the Alexan:irite laser is capable of
vascular tissue ablation t!'lrougl an optical fiber without
adjacent therrtaldanaage in air, saline, or blood. The
Alexoarx1rite laser I1ISY thereforebe the optilllal cOOice for
laser arJgioplastyusing PUV irradiation.
NON-SURGICAL PERCUTANEOUS ENDARTERECTOMYUSING
A MECHANICAL ROTATIONAL CATHETER IN NORMAL
CANINE CORONARY ARTERIES IN VIVO. James Blankenship,
M.D., William Thomas, B.S.,M.S., Gerald Abrams, M.D., R,m
Gallagher Ph.D., Bertram Pitt, M.D., F.A.C.C.and William W.
O'Neill, M.D. University of Michigan, Ann Arbor, Michigan.
We tested a mechanical rotational endarterectomycatheter
(MREC}to determine whether it could be maneuvered and
operated safely in canine coronaryarteries(CA's) in vivo, and to
evaluate the extent of damage to the lumen of normal arteries.
The MREC consists of a guidewire tip connected proximally to a
metal burr coated with abrasive particles. The burrconnects to a
long flexible drive shaft which connects proximally to a motor.
The MREC rotates at high speeds to grind atheromatousplaques
into micron-sized particles. The MREC is effective in several
models but has notbeen tested in CA's in vivo.
The MREC was passed through a 9F guidingcatheter placed in
the caroti d orfemoral arteryof 5 anesthetizeddogs. The MREC
was then passed into one or more CA's, where the MREC burr was
rotatedat 120,000. RPM Coronaryarteriographybefore and after
endarterectomy, and gross and histologic examination of the
endarterectomizedsegments was performed.
The MREC guidewire passed successfully into 18 of 20 major
arteries or branches attempted. Eleven were large enough to
admi t the MREC bur r , These were endarterectanized.
Complications included one dissection visible on arteriography
and 3 small areas of focal subepicardial hemorrhage seen at
autopsy. Histology of all endarterectomized segments
demonstratedno perforations. Damage was limited exclusively to
the intima, internalelastic lam ina, and most superficial cells of
the media. We conclude (l Ithe MREC can be maneuvered and
operated in branches and around acute bends of CA's in vivo,
(2}the MREC produced very superficial damage in the lumen of
normal canine CA's (3)MREC technology appears well suited to
catheterizationlaboratorycoronaryendarterectomy.
IloM.lNOCY'I1X1STRYOF 0BSTRlJCTED SAPHENOUS VEIN-{x)~Y
ARI'ERY BYPASS GRAFI'S.
Jerate1. Brody, M.D., Nancy J. Pickering, M.D., and
Gordon B. Fink, M.D., Medical College of Pennsy.Ivani.a and
west Park Hospital, Philadelphia, Pennsylvania.
'Ibe purpose of this investigation was the inmmocyto-
chemical identificationof CCIllpOnents within saphenous
vein-coronaryarterybypass gr a fts surgically r6lOved f ol -
lowing recurrent,arq.inawith the aim of explaining the
pathogenesis of graft occlusion. Histologic imtunoperoxi-
dase studies were perfonredon 16 paraffin-errbeddedvenous
segrrents incubatedwith primarynonoclonal, antibodies
(Abs) against von Willebrandanti gen (vWl'q), fibronectin
(FN), fibrinogen (FB), leukocyte cemron antigen (IO\),
lysozyme (LZ), viJrentin (VM), desmin (rt1), platelet factor
4 (PF4), and thranbospondin (TSP). In situ antigenic
markerswere made visible by a chrarogenic substratecan-
plex linking to the primaryAbs . Control veins showed
narrowwalls, free lurrens, flat endotheliums, and narrow
bands staining only for WlAg and FN on inner surfaces.
The ll.lll'el'lS and luminal surfaces of 11 grafts stained in-
tensely for vWAg, FN, PF4, and TSP which fonred an irreg-
ular, stranal-likenetwork, In this matrix, containing
several glycoadhesive proteins, were vesicular endothelial
cells, identified by anti-VM, and nonocytes , marked by
anti-IO\and anti-LZ. The 5 other grafts showed enpty,
rot irregularlycontoured, lurrens narrowed by encroaching
myointimal proliferationdenoted by anti-VM and anti-£Xol
stainirq. FB was not detected in any of the sections.
'Ibese data suggest that sane forms of vasocclusion may be-
gin as an inflannatoryresponse, perhaps following vein
transferto a high velocity flow site. Vascular occlusion
may not necessarily require the coagulation cascade.
Functionalgraft longevity may by pr ol onged by the admin-
istrationof anti-inflannatoryagents.
PROLONGED POST-ISCHEMICDYSFUNCTION AFTER REPETITIVEBRIEF
CORONARY OCCLUSIONS INTERSPERSEDVITH REPERFUSIONSTHROUGH
A CRITICAL STENOSIS. Carl A. Moore MD, James Cannon MS,
Denny D. Vatson PhD, George A. Beller MD, FACC. University
of Virginia Charlottesville, Virginia
Ve describe functional and flow alterations in a new
canine model of severe post-ischemic dysfunction ("stun-
ned" myocardium) produced by repetitive brief periods of
left anterior descending (LAD) occlusion (OC) after first
creating a critical LAD stenosis (CS) with a hydraulic oc-
cluder. In 11 dogs (Group I), post-ischemic dysfunction
was produced by 10 successive 5 min occlusions (OC) inter-
spersed by 10 min of reperfusion (RP) through the CS fol-
lowed by an additional 30 min of RP. Five control dogs
(Group 11) with CS, but without OC, were observed a sim-
ilar period of time (180 min). Percent regional systolic
thickening (%KST) was serially assessed by two-dimensional
echo (20&) (n.16) and regional flaws (microspheres) were
available in 8 dogs. In Group I, %RST significantly de-
creased (+) from 37±13% with CS (gradient 47±10) to 14±23%
(p<.005), at 75 min (10' after 5th RP) and decreased fur-
ther to -2±11% (p<.OOOl), at 150'. Thirty min after the
10th RP, %KST was still markedly + at -2±14% indicating no
recovery of function. Release of the CS resulted in only
slight improvement in %KST to 5±14%. In contrast, in Group
11 %KST was 41±15% with placement of CS (grad: 49±4 mmHg)
and did not change significantly at 75 min (39±13%), 150'
(49±11%) and 180' (36±11%). Despite marked differences in
%KST, regional flow (ml/min/g) was comparable in the LAD
zone in Group I (epi: . 74±. 12 (SEM); endo: .61±.15,n.4)
and Group II (epi: .67t.08; endo: .69±.18,n.4) dogs at
150'. Necrosis was not detected in any dog by TTC. Thus,
in the presence of a critical LAD stenosis, repetitive
brief periods of LAD occlusion resulted in prolonged re-
gional dysfunction compared to control dogs, without evi-
dence of necrosis. This myocardial "stun" was not related
to impaired reflow.
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LASER ANGI OPLASTY IN ATHEROSCLEROTIC SWINE:
RECANALIZATION OFOCCLUDED ILIAC ARTERI ES USING
A GLASS "BALL TIP" FIBER
Chris t o phe r ~ Wh i t e , ~ f!££, S t e ve n R. Ra me e ,
MD, Ha l Ca r d , MD, Lisa A. Abrahams, MD, Renu
Vi r ma ni , MD, Cha r l e s E. Wa de , PhD, Mic ha e l Aita,
Ge ne Samson, Herbert Geschwind MD , FACC, Sa mue l
M. Sobol, MD, FACC, Letterman Ar my Medical
Cen ter and Institute of Research, Sa n Francisco.
We ac hieved successful in vi vo l aser
rec an al i zati on i n 11 of 12 totally oc cl uded
i l i a c arterie s , 1.5mm - 3.0mm in s ize , in a
mi ni a t ure sw ine model o f atherosclerosis. An
a rgon las er was coupled to a 200 um quartz s ili ca
f iber with a quartz s ilic a ball f us ed to the
distal e nd. Energy transmission t hrough the
" ba l l tip" was 80 - 90% and a ve r a ge d 2 . 6 watts,
del iv ered in 2 second bursts. The ball tip was
self-guiding, remaining intraluminal in 11
arteries. The single perforation was due to poor
gu ide catheter seating which directed the ball
tip i nto a small branch vessel. Significant
res idual stenoses (>75%) remained after
recanalization with the ball t ip a l on e , but were
reduced t o < 20%if balloon dilation was
performed after initial laser recanalization.
No s t i ck i ng of t he ball t o t he ves s e l wal l
wa s noted a s has been reported using me t a l "hot
ti p" probes. By matching the ball t ip to t he
s ize o f t he artery it may be poss ible t o
el im i nate the need for concomitant balloon
angi oplasty. We feel that t he "ball t ip" fiber
i s a significant improvement ov e r bare fi be rs,
providing a se lf guiding laser delivery s ystem
for recanalizing occluded a r t eries .
SYNERGISTIC INHIBITORY EFFECTS OF ASPIRIN AND ETHANOL ON
EPINEPHRINE EXACERBATION OF ACUTE CORONARY THROMBUS
FORMATION IN STENOSED DOG CORONARY ARTERIES.
Jeff W. Keller, Med1, John D. Folts, Ph.D., F.A.C.C.
Cardiology Section, Univ of Wisconsin Med School,
Madison, Wisconsin.
Ethanol (Et ) and aspirin (ASA) synergistically increase
bleeding t i mes and each decreases platelet activity in
in vitro platelet function (PF) tests . We have shown
t hat cyclical r educt i ons in blood f lo w (CRF's) (EMF
pr obe) occur in dog (D) and pig coro nary arteries (CA)
mechanically s t enosed (MS) 70% and that t hes e CRF's are
caused by r ecur r ent acute platelet thrombus format io n
(PTF) with subsequent emboli zation. These CRF's cause
acute ischemi c episodes. This study i s to determine i f
th e syner gi s t i c effects of Et and ASA on PF, PTF and
CRF's could be observed in our i n vi vo model. In 5 open
chest dogs given a MS of the circumflex coronary artery ,
CRF's were noted at a frequency of 11!4/ hour. Low dose
ASA (1 mg/kg ) abolished CRF's in al l D. An IV
epinephrine challenge (EC) ( . 4 ~ g/kg /min for 15 roin)
after ASA renewed CRF'sat a rate of 10! 3/hour in all D.
Subsequent IV infusion of low dose Et ( . 6 ml/kg) (bl ood
alcohol content at .13+.05 gm/dl ) abolished EC induced
CRF' s i n all 5 D. A r;peat EC after Et failed to renew
CRF's i n any of t he 5 D. We have observed t ha t either
5mg/kg ASA or 1. 2 ml/kg Et alone are capable of
abolishing CRF's i n our model ,but neither agent alone
can prevent renal of CRF's uponEC . Si nce lower doses
of both agent s used together protect against EC we think
Et synergistically potentiates the inhibitory effects of
ASA on PTF. Et may mediate i t s effects via an increase
in th e In vivo PGI~/TXAft ratio, and through its membrane
s t ab i l i zat i~ effe ts a d ability to interfere with
platelet CA mobilization.
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Myocardial Infarction: Clinical
PLATELET INHIBITION, COAGULATION VARIABLES AND LEFT
VENTRICULAR THROMBI IN ACUTE MYOCARDIAL I NFARCTION.
K-A Johannessen,MD,G von der Li ppe ,MD,PhD,E Taulow,MD , PhD.
Diakonissehjemmets Hospital ,Bergen, N-5000 Norway .
Whereas platelet i nhib i t i on have t herapeutic effects on
chronic LV thrombi(LVT),the ef fe ct of s uch t re at ment on
acute thrombi is unknown.In a double blind study, 20
consecutive patients(Pt )were ran domi zed to 150mg aspirin+
225mg dipyridamol e daily(IGroup)or placebo(PGroup)started
wit hi n 24 hrs after onse t of symptoms of an initial
ant erior ac ut e MI. 3 of 9(33%)Pt with conf i rmed MI in
t he PGroup and 8 of11(72.7%) Pt in t he IGroup developed
a LV t hrombus as detected by 2- D echocardiography<10
days after the MI(ns).The gr oups wer e comparable with
r es pect to mean age,peak aspartat e aminotransferase,
platel e t count, bleeding time and apical akinesis and LV
function. Bleedi ng time di d not change i nthe PGroup but
was prolonged f rom 168±20 se conds at baseline t o 254±75 5
days after start of treat ment i n the IGroup (P<O.Ol ) .
In the 11 Pt wi th LVT, fi br in ogen i ncr eased f rom
3.9 +1.0 gld l at baseline t o 7. 3+2. 3 5 days after t he
MI(p<0.025) compared to 4.2±1:8 and 4.8±1. 5(ns)in 9 Pt
wi t hout LYT . I n th e sa me Pt groups, fibrinogen degradati on
product in creased f rom normal t osignificant ly elevated
in 9 of 11(82%) and 1 of 9 (11%) (P<0 .OO5),pl at elet count
changed af t er 3 days f r om 225±55at baseline to 183±42
(P<O.Ol ) and from 219±55 to 243±64(ns) r es pectively . The
combination of f ib r i nogen elevation, develo pment of
positive fi br i nogen degr adation product and decrease d pla-
telet count had s ensitiv ity of 91% and specific ity of
77. 8% i n identifying Pt wi t h LVT.
Conclusions:1)Platel et in hibit io n i s not useful fo r the
prevention of LV thrombi i n acute MI.2) Patient s wit h LV
thrombi may be identified by coagul ation var i abl es.
METABOLIC RESPONSE OF ISCHEMIC MYOCARDIUMTO EARLY REPER-
FUSIONFOR TRANSMURAL MYOCARDIAL INFARCTION.
Marcus A. DeWood, MD, J ul i e Spores , CRNA, Ralph Berg , Jr.
MD, sacred Heart Medical Center, Spokane , WA.
To study t he metabolic effects of early surgical reper-
fusion before and after acute myocardial infarction (MI ) ,
we investigated myocardial metabolism (MM) i n 8 patients
(pt s) undergoing earl y reperfusion for MI within 6 hours
of sympt om onset. Aft er sternotomy , but prior t o car dio-
pulmonar ybypass, simultaneous, coronary sinus (CS) and
arterial (A) sampl es were t aken to measure myocardial ex-
traction (EX) of free fatty acids (FFA) , glucose (Glu) ,
and Lactate i on (Lac) . Li nes r emai ned i n t he coronary
sinus and aorta. Subsequen t measurements were performed
at 6 hrs and 24 hrs following reperfus ion by the formula
A-CSfA in % for each subst rate . (· P<0. 05; · ·P <O.Ol ;P=NS)
Pre (Mean + SO) 6 Hours 24 Hours
FFA ex% - 20. 2+5. 91 • • 18. 0+6.80 •• 26.10+4. 9
Gl u ex% 11. 1+5.4 0 •• 0.42+2 .0 7 • • 01. 96+1. 5
Lac ex% 7. 1+2. 80 NS 5.91+4.52 22.9 0+4.1
Pre-reperfusion-extraction was gro;sly abnormal for-FFA,
Glu , and Lac. Followin g reperfusion, FFA extrac t ion
normalized in 7 of 8 pts and Gl u met aboli sm mostly nor-
malized as well . Lac balance deteriorated at 6 hr s in 6
of 8 pts, but was normal i n 6 of 8pts at 24 hrs. (1)
Thes e data suggest met abolism in acut e MI i s significant-
l y i mpro ved by early reperfusion in most pts. (2) Im-
provement in Lac metabolism lags behind FFA and Glu
metabolism improvement with this in t ervention .
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EARLY ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN
ACTIVATOR (rt-PA), THE NHLBI THROMBOLYSIS IN MYOCARDIAL
INFARCTION (TIMI) STUDY
E. Passamani, M.D., For the TIMI Investigators
NHLBI, Bethesda, Maryland
The effect of l50mg of rt-PA (G-l1035) given over 6
hours (90,20,lOx4) was assessed in 266 patients treated
within 4 hours of onset of acute myocardial infarction
during open label studies done prior to the TIMI Phase
11 randomized study. In 33 patients undergoing
catheterizationan average of one hour after the onset
of rt-PA (early patients), 27 (82%) had TIMIgrade 2 or
3 perfusion of the infarct-relatedartery (IRA); 21/23
(91%) of patients in whom PTCA was attempted were
successfully dilated. In 196 patients who underwent
arteriography a mean of 32 hours after start of
infusion, 170 (87%) had TIMIgrade 2 or 3 perfusion of
the IRA. In 118 patients (60% of patients studied) PTCA
was attempted; the IRA lesion was successfully dilated
in 114 (97%). There was one PTCA related death in the
early group; two early patients and one late patient had
closure of IRA after PTCA resulting in myocardial
injury. Of 266 treated patients, 13 (5%) died, and an
additional 37 (14%) patients suffered recurrent MI by
day 14. Hemorrhagic complications sufficiently severe
to require transfusions occurred in 54 (20%) patients.
Early treatment with rt-PA results in high reperfusion
rates and low hospital mortality. PTCA can be performed
successfully in over 90% of patients with appropriate
anatomy, and in over 50% of patients treated initially
with rt-PA. The effect of PTCA after rt-PA is being
tested in TIMI Phase 11.
THROMBOLYTIC TREATMENT OF ACUTE MYOCARDIAL INFARCTION
WITE INTRACORONARY ADMINISTRATION OF PLASMINOGEN
PRO-ACTIVATOR
H. Kambara M.D. F.A.C.C., C. Kawai, M.D., F.A.C.C.
H. Niitani, M.D., N. Kajiwara, M.D., F.A.C.C.,
S. Sasayama, M.D., F.A.C.C., H. Sato, M.D., K. Kodama M.D.
M. Takahashi,M.D., H. Nakajima, M.D., Y. Takeyama, M.D.
T. Ishimura,M.D., H. Yoshida, M.D., T. Kaburagi, M.D.,
H. Uehata,M.D., R. Katori M.D. (on behalf of the
Japanese MulticenterStudy Group for PPA).
Plasminogen pro-activator(PPA) is a thrombolytic drug
derived from human kidney cells with very highaffinity
to fibrin but noclinical investigation of this agent
has been undertakenpreviously. To stydy the efficacy
of PPA 22 patients with acute myocardial infarction of
less than 6 hr of duration withtotal occlusion of
infarct-relatedartery after intracoronarynitroglycerin
administrationwere treated with intracoronary infusion
of PPA. Seventeen patients are male and five female
age ranged between 45 and 70 with an average58.5. Eight
had right coronaryartery occlusion, 11 left anterior
descending artery and three circumflexartery. PPA
was administered750 u every 10 min followed by coronary
arteriographyup to 3000 u in total. Four patients (18%)
achieved recanalizationwith 750 u, 10 (46%) with 1500 u,
12 (55%) with 2250 u and eventually 15 (68%) with 3000 u.
There was no significant difference in patencyamong
3 coronaries but abetter result in patients with
prOXimal occlusion than those withdistal occlusion
(83% vs 50%). No hemorrhagiccomplications or other
adverse effects occurred inpatients receiving this agent.
No significant reduction of fibrinogenwas encountered.
Thus, this preliminary data suggesthat PPA is very
premising in inducing coronary thrombolysis andis safe
without bleeding tendency.
RESISTANCE TO CORONARY THROMBOLYSIS WITH INTRAVENOUS
TISSUE PLASMINOGEN ACTIVATOR: EVIDENCE FOR A FIBRINO-
LYTIC DEFECT
Eric J. Topol, MD, FACC, Eva Kline RN, David Stump MD,
Desire Collen MD, PhD, Bertram Pitt MD, FACC, Univ of
Michigan, Ann Arbor, MI and Univ of Vermont, Burling-
ton, VT
lI..HS(cm)
-1.6+3.9
+0.5+3.9
P 0:02
between LVEF (HS) on day
R group
ROIO group
ALVEF (AHS)
10 and day 1
Twenty (22%) pta underwent myocardial revascularization
for recurrent ischemia during a fallow-up period of 14.7
(0.4-31) months. Three of the 4 deaths had O.
In summary, survival is excellent in this group' of pts
with MI, treated early with rt.-PA, with only 22%of pta
requiring revascularization for recU1Tent ischemia.
Objective evidence of myocardial salvage was found only
in those pts with R.
IMPROVED LEFT VENTRICULAR FUNCTION
FOLLOWING INTRAVENOUS RECOMBINANTTISSUE-
TYPE PLASMINOGEN ACTIVATOR IN ACUTE
MYOCARDIALINFARCTION
Jennifer A Johns M,B.B.s., F.R.A.e.p., Tsunehiro Yasuda
M.D., Han"Y D Garabed1an S.M., Rebecca A Aaronson
M.A., Robart C Leinbach M.D., F.A.e.C., Cary W Akins
M.D., F.A.e.C., Herman K Gold M.D., F.A.C.C ..
MalSichuaetts General Hospital, Boston MA.
Ninety-one patients (pta) with acute myoeard1al
infarction (MI) underwent acute coronary angiography and
were treated with intravenous recombinant tifeue-type
plasmingen activator (rt,..PA) 3.8 + 1.2(5D) hours from the
onset of MI. Repeat angiography was performed 10 days
post,-MI with quantitative measurement of left ventrtcular
ejection traction (LVEF) and severely hypokinetic segment
length (HS). Stable repert'usl.on (R) was achieved in 63
(70%) pts, with reocclusl.on (R 0) or persistent occlusl.on
(0) in 28 (30%).
Results:
lI.LVEF(%)
+1.3+10.9
-2.8+11.3
p:NS
: difference
P
<0.001
NS
To determine whether patients with acute myocardial
infarction (MI) have a fibrinolytic defect, we obtained
rest and exercise plasma samples for tissue plasminogen
activator (t-PA) antigen in 31 pts who received IV t-PA
therapy acutely. On the basis of the plasma t-PA
response to exercise at 7 days post-MI, pts were
divided into 2 groups: Group I pts (n=21) demonstrated
>25~ increase in plasma t-PA with exercise; Group II
pts (n=10) eXhibited a flat t-PA response as follows:
t-PA level (ng/ml)
Rest Exercise
17.3 + 6.6 26.0 + 7.7
15.4 ~5.6 15.6 ~5.5
Group 1 (n=21>
Group 2 (n=10)
No differences between the 2 groups of pts were
observed for fibrinogen, plasminogen or alpha 2-
antiplasmin. Rest and exercise plasma t-PA functional
levels and t-PA inhibitor values for these pts are
pending.
Of Group 1 pts, 16 of 21 (76~) had coronary thrombo-
lysis after IV t-PA therapy compared to 4/10 (40~)
Group 2 pts (p=O .04). Two Group 2 pt s had subsequent
reocclusion of the infarct vessel.
These results suggest: (1) there may be an intrinsic
fibrinolytic defect in some patients with acute MI; and
(2) those pts who fail to increase plasma t-PA level
with exercise appear to be more resistant to exogenous
t-PA.
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(*=p<0.05)
(l1=p<0.01)
(@=p<0.005)
LACK OF SPECIFICITY OF EARLY POST THROMBOLYTIC
ARRHYTHMIAS AS A REPERFUSION MARKER IN ACUTE MYOCARDIAL
INFARCTION.
Thierry Bontemps, M.D., Patrice Virot, M.D., Denis
Pinaud, M.D., Henri Vergnoux, M.D., Patrick Blanc, M.D.,
Julien Bensaid, M.D., Pascal Gu~ret, M.D., F.A.C.C.,
Department of Cardiology, University of Limoges, FRANCE.
Decisions regarding secondary strategies to preserve
reperfused artery patency after lytic therapy for acute
myocardial infarction (AMI) would be served by a reliable
marker of lysis. For this purpose,a 3 hours Holter
recording~as obtained during and after IV streptokinase
(1,5 x 10 units) in 35 consecutive Am's (10 anterior
and 25 inferior). Treatment was initiated 3.0 + 1.2 h.
after onset of symptoms. Time to peak serumlevels of
creatine kinase was used to distinguish reperfused (R)
(9.9 + 2.5 h) and not reperfused (NR) (20.8 + 3.3 h) pts.
No pts received preventive antiarrhythmic-drugs. Inci-
dence of the following arrhythmias was evaluated :
ventricularpremature beats (VPB), idioventricularrhythm
(IVR), ventricular tachycardia (VT), ventricular fibril-
lation (VF), bradyarrhythmias (B). Arrhythmias were
recorded in 18 of 20 R (80 %) and 12 of 15 NR pts (80 %).
VPB IVR VT VF B
R 50% 10% 15 % 5% 20 %
NR 27 % 13 % 33 % 0 % 7 %
No arrhythmias appeared specific of reperfusion. Similar
results were obtained after stratification by infarct
location.
Conclusion : These preliminary data indicate that early
arrhythmias do not seem to be specific nor clinically
reliable markers for distinguishing reperfused and not
reperfused patients after IV streptokinase in acute
myocardial infarction.
INFLUENCE OF VESSEL INVOLVEMENT AND TIMING OF
STREPTOKINASE THERAPY ON lEFT VENTRICULAR FUNCTION IN
ACUTE MYOCARDIAL INFARCTION.
David G. Fine, M.D., A. Teddy Weiss, M.D., F.A.C.C.,
Shlomo Vinker, B.S., Sima Welber, B.S., Dan Sapoznikov,
Ph.D., Chaim Lotan, M.D., David Applebaum, M.D.,
Yonathan Hasin, M.D., 11ervyn S. Gotsman, M.D., F.A.C.C.
Hadassah University Hospital, Jerusalem, Israel.
750,000 units intravenous streptokinase (SK) was given to
150 consecutive pts with acute myocardial infarction (MI)
<4 hrs after pain onset. On day 6 angiographic ejection
fraction, infarct-relatedartery patency, and number of
diseased vessels were determined. SK pts with no previous
MI were compared to 82conventionally treated MI pts.
Analysis was performed based on infarct location, single
vessel (SV) vs. multivessel (MY) disease, and SK timing.
No SK SK<2h SK>2h SK-closed
ALL Ml SV 49+16 @ 63+10 @ 49+14 49+7
MV 46+1l @5&+13 * 4&+12 50+13
ANT Ml SV 45+16 @ 63+10 @ 44+10 44+12
MV 42+12 @ 58+13 4&+13 48+12
INF MI SV 59+15 11 67+9 65+20 52+ 7
MV 51+8 * 62+10 * 48+10 50+10
SK had a benefi~ial eff;ct in all group~ if given < 2 hrs
after pain onset. In inferior Ml pt s with SV disease the
time limit is 4 hrs. In all other groups, SK give" > 2 hrs
after pain onset had an outcome comparable to those not
given SK and to those in whom the artery was not opened
by SK. Number of vessels involved influenced outcome
significantly only in inferior MI treated >2 hrs after
pain onset (p<0.05). In conclusion, SK effectively
salvages myocardium only if given within 2 hrs of pain
onset, unless isolated right coronary artery disease is
present, in which case the limit is probably 4 hrs.
DIRECT ANGIOPLA5TY IN ACUTE MYOCARDIAL INFARCTION- BENEFIT
OF LATE REPERFU5ION IN PATIENTS WITH COLLATERAL FLOW.
Andrew~ Eisenhauer, M.D •• F.A.C.C. &Larry Moore, M.D.,
Michael Reese Hospital and Dniv. of Chicago, Chicago.
Reperfusion (RP) therapy in acute myocardial infarction
has generally been withheld from patients with more than
4-6hrs of symptoms. However, somepatients with prolonged
symptoms and collateral flow to the infarct related vessel
(IRV) may benefit from late RP. To evaluate this possibil-
ity, we developed a protocol to prospectively identify
these patients and select them for direct PTCA (dPTCA).
Patients with <24 hrs of chest pain and 5T segment eleva-
tion in at least 2 adjacent ECG leads were screened and
selected if: a) 1 or more cycles of fluctuating pain (un-
related to analgesic) or b) documented resolution and
exacerbation of ST segment elevation were present. We
performed left ventriculography,coronary angiography, and
dPTCA in 24 consecutive patients meeting these criteria.
The mean time from onset of pain to RP was 7.4 hrs and
angiographic evidence of thrombus was present in all
patients. 67% of patients demonstratedsignificant collat-
eral flow to the IRV (mean collateral score 2.3 + 1.7).
The mean initial stenosis was 98.9 +2.8%. dPTCA was
successful in 23 of 24 patients with a mean residual sten-
osis of 28.5 ± 22.4%; there was one late in hospital re-
occlusion. 18 patients had repeat angiography on day 9.4
± 4.1 and all IRV's were patent (27.6 ± 26.2% stenosis).
Ejection fraction had risen from 50.0to 54.0 + 13%,
(p<.02). At long term follow-up (9.1 +4.6 months): 1
patient has died of non-cardiac causes, the remainder are
free of ischemic symptoms. We conclude that these
clinical criteria select patients with collateral flow to
the IRV and that late angioplasty is likely to improve
ventricularfunction in this group.
EMERGENT CORONARY BYPASS PRESERVES LEFT VENTRICULAR
FUNCTION FOLLOWING INTRAVENOUS TISSUE PLASMINOGEN
ACTIVATOR THERAPY FOR ACUTE MYOCARDIAL INFARCTION.
D. J. Kereiakes, M.D., E. J. Topol, M.D., F.A.C.C.,
B. S. George, M.D., R. J. Candella, H.D., F.A.C.C.,
C. W. Abbottsmith, M.D., F.A.C.C., R. S. Stack,
M.D., W. W. O'Neil, M.D., R. M. Cal i f f , M.D., The
Christ Hospital, Cincinnati, Ohio.
Emergent coronary bypass (ECB) was performed in 23
of 317 consecutive patients treated with intra-
venous tissue plasminogen activator (TPA) for acute
myocardial infarction. Chest pain onset preceeded
TPA treatment by 2.7 + 0.8 hrs and ECB by 7.4 + 1.9
hrs. Infarct artery a;giogram showed patency in 18
of 23 pts at 90 min of TPA therapy. Indication for
ECB was left main or equivalent (8 pts), 3 vessel
disease (3 pts) and failed PTCA (12 pts). Pts re-
ceived 120 + 21 mg TPA pre, and 5.3 + 2.7 units
packed red cells postoperatively. There were 2 hos-
pital deaths and 2 reoperations for non-surgical
bleeding. Blinded analysis of preoperative and late
ventriculograms (center line chord method) showed
improved global left ventricular (LVEF 49.2 + 9.5
to 58.3 + 9.5%; p=0.004) and infarct zone regional
wall motion (SO/chord) (-2.6 + 0.9 to -1.1 + 1.4;
p<O.OOI). We conclude (I) ECB can be performedwith
acceptable risk following intravenous TPA, (2) pre-
served global and regional left ventricularfunc-
tion follows timely application of TPA and ECB for
acute myocardial infarction.
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UINIG.L crxJRSE OF PATlENTS 1RFATED M11I EMERGENCYP'JU4.
FCR AaJTE MI Dona Id A. Rothbaum, W , FACe, ThOllDs J .
Linnemeier, W . FACC, Ronald J. Landin, W , FACC,
INDIANA HEART I NSTlTIlTE, ST. VINCENTOOSPITAL.
INDIANAPOLlS, IN
The cl inica l course of 184 patients (pt s) treated with
emergency Pn:::4. as prirmry therapy IlllS evaluated with
respect to hospital and fol low up (6 to 48 mos) morbidity
and mortality. P'JU4. was successful in 86%(158/184 pts)
with a success rate of 86% ( 70/ 80 pts) for LAD and 85%
(88/ 104 pt s) for ~CX lesions. Chrdiogenic shock was
present pr ior to Pn:::4. in 18 pt s ; 12 (15%) of LAD pts and
6 ( 4%) of ~cx p t:s ,
Total hospital mortality Illl S 8% (15/ 184 pts). Mbrtality
IlllS 3% (5/ 158 pts) with successful (S ) P'JU4. and 38%
(10/ 26 pts) wi th unsuccessful (V) P'JU4., (P < .001). In
pt s present ingwith cardiogenic shock , mortality IlllS 33%
(6/ 18 pts); but was only 8% (1/ 13 pts) with S-P'JU4. ver-
sus 100% (5/5 pts) with V-P'JU4. (P < .001), Hospital
morta lity due to arrhythmia. subsequent cardiogenic
shock andother infarct complications was 3% (4/15 pts)
with S-Pn:::4. and 24% (5/21 pts) with V-P'JU4. (P < .001).
COronary bypass grafting during acut e hospitalization or
[o !low up was performed in 8% of S-P'JU4. pt s and 36% of
V-P'JU4. pts (P < .001). Of S-Pn:::J\. pts, 31% had restenosis
and 11% had total occlusion of the infarc t - re latedartery,
For S-Pn:::4. pt s with restenosi s , 92% had success fu l
repeat P'JU4.. During follow up. 3 pt s (3%) died, all had
initial LAD occ lus ion, S-P'JU4. and ejection fraction < 20%.
In summary . S-P'JU4. as compared toV-Pn:::J\. i s asso-
ci ated with a s igni fi cant ly lower ho§pital mortality
part i cu lar ly with cardiogen ic shock. However , ~th
S-Pn:::J\., there i s a significant inci dence of recurrent
is chemia and restenosis ~ich is amenable to repeat
P'JU4. Foll ow up mortality is direct ly related to sever-
i tyof left ventricular dysfunctionat discharge.
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Drug Effects in IschemicHeartDisease
A COMPARISON OF CELIPROLOLTO PROPRANOLOL I N
ANGINA PECTORIS: RESULTS OF AN I NTERNATIONAL
DOUBLE-BL IND STUDY.
William H. Frishman, M.D., F . A. C. C., Judith
Soberman, M.D., Jack Eff, M.D. , for the Inter-
national Celiprolol Study Group , The Albert
Einstein College of Medicine, Bronx, N.Y.
The comparative anti-anginal effe cts and safety
o f cel i prolol (Cl , a new high ly 8 I-selective
adrenoceptor blocker wi t h pa rtia l 8z - agon i s t and
nz - adr enoce pt o r blocking act i v i t ies , an d propran-
o lol (P) were assessed in an i nternational mu l t i -
ce nter posi t ive controlle d, double-blind, ran-
do mi ze d titration to e ffec t s tudy o f 14 0 patients
(pt s) wi t h s t ab l e angina. Pts received placebo
f or 2 wks , then either tit r a t e d dose s o f once-
daily C (200, 400, 600 mg ) or t wice-daily P
(t o t a l daily do s e - BO, 16 0 320 mgl over 4 wks,
f o l l owed by a 2 wk maintenance pe riod. Res t and
e xercise HR an d BP, weekl y angi na f requency an d
nitroglycerin consump t i on, an d s ymptom-limited
treadmill e xercise times we r e assessed. Compared
t o baseline, both C and P reduced ang i n a attack
and n i trog lyce r i n consumption rates, whi l e im-
proving e xe r cise t o l e r ance. The re was no differ-
ence betwee n C and P on these parameters. How-
ever, P was associated with a lower HR and HRxBP
t han C, both at rest and during e xercise (p<O. Oll .
Both drugs ha d similar a ctions on BP. Overa l l ,
C and P were well tolerated, however, there was
more s ymptomatic bradycardia with P. Despite
thei r hemodyn ami c differences, on ce - dai l y C is as
effective as twice-daily P in treatmentof pts
with angina pectoris and may be better tolerated.
ANTI ISCHAEMIC ACTIVITY OF ACEINHIBITOR ENALA-
PRIL IN NORMOTENSIVE PATIENTS WITH STABLE
EFFORT ANGINA.
Ca,'lo l a i ,M .D . ,Enrico I1nll i s M. D. ,Elena Orani ,
M. O. • Raimondo P i r l s i , M. O. , A"drea So n J , M. D. a nd
Ang e lo Cherchi, M.D . I n~tit ute o f Ca rdio lo g y .
Un i ve r s i t y of Ca g liari . Ita l y.
I'o .ss s e s s the a ntian g i n a l a lld anti i schaeml c ef-
fi cacy o f ACE-inhibito r Enalaprll in no r motpnsl-
ve co ronary p a t ient s, a d ouble-b l i nd , c r o s s - over,
p l a c ebo c o ntro l l ed study was performed. Eigth
ma l e pati e nts a g e d 4 5 - 68 y r s with s t a b l e effo r t
ang ina were gi ven Enala p r i l 10 mg once a d a y o r
pl acebo fo r 7 days.Maximal e xerci se str ess tes t
I D watt/mi n in uprigtht position was performed
a t the end of each per iod . At the o nset of
ischaem i a (ST depress i o n = 0 . 1 mV) , anrj a ngir1d
( An g . Th . ) , at maximal co mmon work ( MCW) a nd at
maxi mal work (MW), the f ol lo wi n g d a t a were ob -
s er·ve d : (mean.!:,sem; p ( 0. 0 5 *; p ( O. Ol **)
Placebo Enalaprll
S T ~O. l mv l (sec) 322~53 4 38~62 *
Ang • Th . (se c ) 5 0 2 :!:.52 596~77 *
MW (se c) 5 9 2 :!:.58 682.!:,57 **
MCW:HR ( b /m ) I 26:!:.6 1 28~5
MCW :BSP I mmHgI 1 77!~ 17 7.!:,6
MCW :H R x BSP 2 2 7 :!:.2 0 228~14
MCW:ST I (mm) 2 . 3~. 2 1 . 5 :!:.. 3 *
I n conc l usi on Enalapr i l showe d antianginal a nd
anti ischa em i c ac t i vi t y wh i c h wa s not r e l a t e d to
a decre ase o f M~02 consumption ( no s i g n i f i c a n t
d e crease of dou b le prod u c t ) b u t p"obabl y to a n
i nc rease o f c oronary f low to ischaem Ic a reas.
SELECTIVE CORONARY VASODILATOR EFFECT OF E.'lALAPRILAT IN
PATIENTS WITH DILATED CARDIOMYOPATHY :DEMONSTRATION BY A
BILATERAL INTRACORONARY INFUSION TECHNIQUE.
J ean- Mar c Fault, M.D., Alain Nitenberg, M.D. , Oscar
Tovolaro, M.D" I sabelle Antony, M.D. , Universite Paris
7 , INSERM U.251, Paris, France .
The cor onary ef fe ct s of angiotensin conver t i ng enzyme
inhibitors (ACEI) re main a matter of cont roversy . To
delineate t he specific ef f ect a on the coronarycircul a-
tion of a recently devel opped ACEI, enal apr i l at was
directly and simultaneously adminis te red into the right
and l ef t main coronary arterie s of 10 patients wit h
dilat ed cardio myopat hy and normal cor onaryarteriograms
[Lef t ventricul ar (LV) end-diastolic vol ume = 249 :!: 51
ml, ejection f raction 34 :!: 11 %]. Measurements
performed at basal s tate and at t he 15th min of an intra-
coronary infus ion of enalapril at (0 . 10 mg, min-1)
r eveal ed no singi ficant change i n heart rate (93 :!: 18 t o
91 :!: 16 beats. min-l), mean aortic pre ssure (96 :!: 11 to
91 :!: 16 mmHg) , LV end-diastolic pressure (20 :!: 9 to 11 :!:
8 mmHg) or systemic resistances (20. 5 :!: 5. 4 to 21 .6 :!: 5. 5
mmHg,I-I .min) . However, i n all patients, cor onary sinus
bl ood f low (CSBF, ml.min-1) rised after enalaprilat (182
:!: 17 to 219 ! 83 , p < 0.01) , coronary resistance fe ll
(0. 50 :!: 0.15 t o 0.41 ± 0. 13 mmHg. ml-1. min, p< 0.01 ),
myocardial oxygen extraction (M02E) was red uced (11. 57 ±
2.04 t o 10 . 25 :!: 2.27 ml p. 100 ml , p < 0.02) with no
significant change in the myocardial 02 consumption (M02E
x CSBF) fro m 20 .50 :!: 6.55 t o 21.66 ± 6. 75 ml.min-1.
The present study, based on a bilateral intracoronary
i nfus i on technique, demonstrates t hat enalaprilat has
significant coronary vasodilator properties in pat i ent s
with dilated cardi omyopat hy. Thi s ac t i on occurs without
simultaneous alteration of the myocardial metabolic
demand, and is the ref ore likely to reflect an intrinsic
effect of this ACEI on the coronary vasculature .
JACe Vul. 9. No, 2
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INFLUENCE OF NITR OG LY CERIN ON MYOCA RDIAL
METABOLISM MONITORED BY LASER FLUO RIMETRY
DURING HUMAN LEFT HEART CATH ETERISATION
Denis Duboc, M. D., Marcel Toussaln t , M.D., Guy Renault,
M.D., Juli ette Pcmanski, M.S., Daniel Donsez; M. D., Fran cois
Ouertn, M. D., Jean-Jacques Pocidalo, M. D. and Michel
Degeorges, M.D., Universit e Rene Descart es 'Par is FHAN CE.
Continuous and non destructive measurement of Red-ox
state on in situ myocardium has been made possible by t he
industrial develop ment of a reducednlcottnamide adenine
dinucleot ide (N ADH) laser nuori met er. The purpose of this
st udy was to de monstrate the usefulness of NADH laser
nu orimetry in evaluating t he ef fect of drugs on energetic
metabolism of the myocardium in man. A 0.5 mm dia meter
optical fiber (used to guide the e xcita tion and nu ores cent
lights) was inserted in a convent ional catheter and the tip
was posit ioned on the left ventr icular inferior wall during
heart cat het erisat ion in 4 patients (3 cases of coronary
artery disease, 1 case of mitral regurgit at ion). TheN ADH
content of the endo myocardium was mcnitor-ed successively
during 1) baseline conditions 2) during a rapid expansion of
the plasma volume with crystalloid solution in order to
incre ase LV EDP (fro m 10 : 3 up to 19.5 : 1 mm Hg) and
3) during intra venous ad ministration of ' nitro glycerin (rapid
Injec t ion of 0.2 mg, followed by a continuous perfUsion of
50 tJg/min during 8 min). At the end of the filling period
t he N ADH conte nt of 'the endo myocardiu m was slightly
increased in 3 patient (N .S.). At the end of the
nitroglycerin perfUsion the N AD H" content was decreased in
ever y patient (26 : 14 % under baseline values p< 0.05)
and the value of LVE DP was slightly decreased (8.5 ~ '2.5
versus 10 ~ 3 mm Hg). The decrease in NADH fluorescence
ren ects t he intra cellular effec t of nitroglycerin on th e
re d-ox state of the myocardiu m. N ADH laser nuori metry is
a new pro mising method for evaluatio n of the effect of anti
anginal therapy on myocar dial metabolis m.
IMPAIRED PRDSTACYCLIN (PGI2 ) RECEPTOR FUNCTION IN ACUTE
ISCHEMIC HEART DISEASE IN MAN.
Asru K. Si nha , Ph.D., David A. Wi lson, Hiltrud S. Muel l er,
M.D., F.A.C.C. , Montefiore Medical Cent er, Al ber t Ein s t ei n
College of Medicine of Yeshiva Uni versi t y, Bronx, N.Y.
Us ing }H-prostaglandin E1 (} H-PGE1) as a probe , we s t udied
PGI2 re ceptor function in platelets in 16 pat i ent s
(bet ween ages 51-71 years , 12 male, 4 female ) wit h acute
myocardial infarction (AMI) or unstabl e angina (UA) with
average of 2.B+2.6 (SO) hours post ches t pain and compared
it to 10 normal volunteers. The binding of 3H-PGE1 to gel
filtered platelets (GFP) in Tyrode buffer with 5mM MgCl2
was found to be highly specific, reversible and attained
equi l ibri um i n 10 minutes at 23°C. In normal s , Scatchard
analyses of 3H-PGE1 binding showed t he pr esence of one
high affinity (Kd1=9.0 ~1.Z (SO) nM) l ow capac i ty ( n l = 120~
30 sit es/cell ) and one low af f in i ty (Kd2=1. 1+0. 5
~ M) high capac i ty (n2=1400+250 sites/cel l ) recep t or
populations. In contrast (p- < 0 .01), pl atelets from
patients wi th AMI or UA showed dec re ased ligand binding
(n1=40~20 and n2=BOO~210 s ites/cel l) wit h li ttle change of
affinity (Kd1=7.50~1 . 0 nM, Kd2=0 .6B~0 .24 ~ M). The decrease
of 3H- PGE1 binding in UA and AMI was not due to th e
presence of inhihitors or drugs i n the plasma since t he
in cubat ion of normal GFP i n t he plasma ofthese pati ents
up to 2 h pro duced noeffec t on the bind i ng ( n=7) . In a
fol l ow- up s tu dy i nvolv i ng B pat ients (7 mal e and 1
female ) , binding of 3H-PGE1 t o GFP was determi ned . The
binding capacit i es (n1 and n2) of PGE1 r eceptors in
pl at elets from t hes e patients incr ease d from40~10 and
BOO+210 si t es/ pl at elets to 120+20 and 1210+120 sites/ -
platelets ( p<.02 in both cases) re spectivey dur ing 12
weeks of recovery. These re su l t s suggest t hat prostac ycl in
receptors numbers are decreased in plat elet s i n acute
myocardial ischemi a and return t o normal during the
re cover y.
CORONARY ANGIOGRAPHIC AND HEMODYNAMIC EFFECTS OF
INTRACORONARY INJECTION OF ACETYLCHOLINE IN HUMANS
Yut aka Horio, MD. Ken Okumura , MD. Kyoji Takaoka. MD.
Koshi Matsuyama, MD, and Hirof umi Yasue , MD,
Kumamoto University, Kumamoto. Japan.
We have demonstrated tha t in t r acor onary i nj ection of ace-
tylcholine (ACh) induces coronary spasm in pati ents wlth
variant angi na and coronary vasoconstr iction in a s i gnifi-
cant number of patients showing normal or near-norma l
cor onary ar teri ograms and with out angina. To exami ne the
ef fect s of ACh on diameter of epicardial corona ry artery
and on coronar y blood f low in adult humans. we i nj ec t ed
ACh into th e left coronary artery i n 40 patient s (32 men
and 8 women; mean age 51. 1, r ange 20-65 ) showi ng normal or
near-normal coronary arteriograms and wit hout angina.
Systemic hemodynamics were kept constant by right ventri-
cular pacing . Measurement s of coronary si nus blood f low
(CSBF) and coronary vasc ul arresistance (CVR) and quanti -
fic ation of coronaryarterial diameters us ing a computer-
ass i st ed technique were performed before and after eac h
injection of 20, 50, lOO, and 200~g ACh. Significant
increas e in CSBF (control vs 20. 50. lOO, and 200~g ACh:
94.9+ 33. 9 vs 117.0+35.4'~. 134.2+47.2*. 156.5+65.1*, and
212.0±130.0* ml/min. respectively)( **p<.05 and l'p<.OOl)
and s ig nif icant decrease i n CVR (cont ro l vs 20, 50, 100.
and 200 ~g ACh: 1.19+0.4 0 vs 0. 95+0. 31, 0.83+ 0. 34*.
0. 73±0.28*, and 0 . 4 7±0~1 8* mmHg/ml /min. respecti vely )
occurred after ACh. In contrast, mean diameter of
epicardia l coronaryartery decreased after ACh (%changes
fromcontrol i n 20, 50. lOO, and 200~g ACh: +5.0±14.0.
-9 .4+18 . 7, - 16. 5+25. 1, -17 . 3+14.9%. resp ective ly) . The
intrave nous admi nistration of 1~0 mg atropi ne bloc ked all
th ese changes . Conclus ion: Int rac~rona ry i njection of ACh
induces vasoconstriction i n large coronary arter i es and
vasodilatation in cor onaryarterio lar bed through act i va-
t i on of muscar in ic r ece pt or s in adult humans .
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Usefulness of ECG Exercise Testing for Risk
Stratification
SELECTION OF PATIENTS FOR CORONARY ANGIOGRAPHY FOLLOWING
ACUTE MYOCARDIAL INFARCTION.
Elizabeth Gilpin, M.S., Erling Madsen, M.D., Howard
Dittrich, M.D., Pascal Nicod, M.D. and John Ross, Jr,
M.D., F.A.C.C., University of California, San Diego.
A consensus-based scheme has been proposed by DeBusk,
et aI, for the identificationof patients most likely to
benefit from coronary revascularization af t er acute
myocardial infarction (AMI) who should undergo coronary
angiography (CA) (NEJM; 314:161, 1986). We evaluated this
scheme in 1669 patients discharged after AMI. Four groups
of patients were defined: Group 1 : persistent ischemic
pain (CA recommended), Group 2:Killip Class Ill-IV
f ai l ure (CA not recommended). Group 3:predischargeejec-
tion f ract i on <. 35 (CA not recommended), and Group 4:the
remaining patients (exercise test recommended). Predicted
(concensus- bas ed scheme) andobserved group sizes and 1
year mort al i t i es (lYM) were:
GROUP
1 2 3 4
Predicted Group Size (%) 10 10 10 70
lYM eo 20 30 25 5
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VALUE OF SUBMAXIMAL EXERCISE TESTING AFTER FIRST ANTERIOR
INFARCTION IN IDENTIFYING PATIENTS WITH MULTIVESSEL
DISEASE. Gervasio Lamas, MD, Douglas Vaughan, MD, Howard
Hartley, MD, FACC, Marc Pfeffer, MD, PhD, FACC. Brigham
and Women's Hospital, Harvard Medical School, Boston, MA.
In survivors of acuteanteriormyocardial infarction
(AAMI), clinical management is often facilitated by
knowledge of the extent of coronaryarterydisease (CAD).
The purpose of this study was to examine the value of
submaximal exercise testing (SubETT, modified Bruce pro-
tocol) in detecting multivessel coronary disease(MVCD)
in patients with a first AAMI with left ventricular
dysfunction and without overt ischemia.71 patients (64
male, 7 female; age52+11 years; ejection fraction (EF)
35%+11) underwent catheterizationwithin onemonth of
AAMT regardless of SubETT results. All patients had sig-
nificant left anteriordescending (LAD) disease. 59 (83%)
had isolated LAD disease (SVD) and 12 (17%) had MVCD, (2
or more vessels with a >70% stenosis or >50% left main
stenosis). Abnormal responses to SubETT,-definedas >lmm
ST depression, inability to complete test, angina, and
abnormal blood pressure responsewere present in 19, 21,
11, and 10patients, respectively. No single abnormality
discriminated between patients with SVD or MVCD. Indeed,
the inability to complete the test appearedto be more
related to reduced EF than to extent ofCAD. Of the 12
patients with MVCD, 9 had at least one abnormality while
3 had a completely negativetest. Of the 59 patients with
SVD, 27 had at least one abnormality, while 32had nega-
tive tests. The predictive value (PV) of a negative test
was high (91%), but the PV of a positive test was less
helpful (25%). In patients with first AAMI and LV dys-
function, SubETT has a highfalse positive rate. Con-
sequently, a negativetest is more useful than apositive
in providing information about extent ofCAD.
THE PROGNOSTIC ROLE OF EXERCISE TESTING EARLY AFTER
CORONARY ANGIOPLASTY FOR MULTIVESSEL DISEASE
Yogesh Shah, M.D., Bernard R. Chaitman, M.D., F.A.C.C.,
Ubeydu11ah De11gonul, M.D., Morton Kern, M.D., F.A.C.C.,
Sheila Byers, R.N., Michel Vandormael, M.D. St. Louis
University School of Medicine, St. Louis, MO.
To assess the prognostic importance of exercise
treadmill testing (ETT) performed early following
coronary angioplasty (CA), we analyzed 300 patients
(pts.) who underwent an ETT within 4 weeks after CA and
were followed for an average of 10 months. An abnormal
test was defined as ST segment depression > 1 mm or
inability to complete Bruce Stage 11 or reach 85% of age
predictedmaximum heart rate. Cardiac events (CE) were
defined as death, myocardial infarction, the need for a
second revascularization procedure, or recurrent severe
angina (> class 111). CE were significantly more common
in the 2!4 pts. with an abnormal ETT compared to the 76
pts. with a normal ETT (36% versus 22%; p=0.03). In pts.
with an abnormal ETT, a trend towards a greater incidence
of death or non-fatal myocardial infarctionwas noted
when multivessel (MVD) vs single-vessel disease was
present (8% (9/120) vs 4% (4/104». When the 160 pts.
with MVD were stratified by degree of revascularization
obtained at CA, the incidence of CE in pts. with an
abnormal ETT was 25% vs 45% when complete (CR) vs
incom lete (ICR) revascularizationwas obtained ( <0.05).
Pts , Wit MVD CR ICR
ETT Abnormal Normal Abnormal Normal
Event 10 4 36 5
No Event 30 14 44 17
P NS 0.07
Absence of chest pain during the early ETT reduced the
CE rate to 22% vs 38% in pts. with CR vs ICR,
respectively (p<0.05). In conclusion, the prognostic
information contained in an early ETT post CA is (1)
limited in pts. with MVD who have complete revasculariza-
tion and (2) most useful in pts. with multivessel disease
who have incomplete revascularization.
SIGIIIFICAlICE OF PAtIlLESS ST SEGHEIIT DEPRESSIOII DURIIIG
LOW LEVEL EXERCISE TESTING EARLY AFTER ACUTE MYOCARDIAL
IIIFARCTIOII.
Simon Kouz:. lID, Pierre Theroux, lID, FAce, ltavier Bosch,
lID, David D. waters, lID, FACC, and Ihor Dyrda, lID, FACC,
Montreal Heart Institute, Canada.
Treadmill exercise testing, limited to either 707. of
maximal age predicted heart rate or 5 HETS, and
coronary angiography were performed before hospital
discharge in a consecutive series of 383 survivors of
acute myocardial infarction (MI). Painless ST segment
depression ~l mm was observed in 103 pts (27'-). These
patients were compared to pts with angina, with or
without ST depression, and to pts with neither angina
nor ST depression. Age, sex distribution, risk factors,
site of MI and frequency of non Q-wave MI were similar
in the 3 groups. The following differences were
observed:
PROSPECTIVECARDIAC RISK STRATIFICATIONPRIOR TO NON-
CARDIAC GERIATRIC SURGERY. Myron C. Gerson, MD, FACC,
James M. Hurst, MD, Patricia Doogan, RN, Vicki S. Hertz-
berg, PhD, Elizabeth A. Gibson, BA, University of Cincin-
nati Medical Center, Cincinnati, Ohio
Eighty-two patients age 65 years or older were prospec-
tively assigned to high or low perioperativecardiac risk
groups based on 1) the presence or absence of Goldman
cardiac risk indicators (including S3 gallop or jugular
venous distention, myocardial infarction in the preVious 6
months, >5 prematurebeats/min or rhythm other than sinus,
evidence of importantvalvular aortic stenosis, or poor
general medical condition; but excluding advanced age or
abdominal or thoracic surgery which characterizedall
study patients), and 2) ability to perform at least 2 min-
utes of supine bicycle exercise raising the heart rate
above 99 beats per minute (Gerson et aI, Annals of Int Med
103:832,1985). Patients without Goldman indicators and
with satisfactory exercise capacity comprised the low risk
group. Patients with Goldman indicators or poor exercise
capacity were classified as high risk. Ten patients had
cardiac complications (ventriculartachycardiaor fibril-
lation, congestive heart failure, acute myocardial infarc-
tion, or cardiac death). The complication rates were 4.2%
for low risk (2/48) and 23.5%for high risk patients (8/34,
p = 0.0139). Complications in the low risk group were
relatively minor including nonsustained asymptomatic ven-
tricular tachycardia in one patient and a subclinical
myocardial infarct in the other patient. Six of 8 high
risk patients had major cardiac complications requiring
interventionin the intensive care unit. The combination
of Goldman cardiac indicator analysis and objective
assessment of exercise capacity provided a practical, safe
and inexpensive method for separating low risk patients
from patients with high perioperativecardiac risk.
110 angina
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33 (18'-)
47 (26'-)
45 (25'-)
80 (44'-)*
21 (11'-)*
6±2.5
50±13'-
Andna
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33 (34'-)*
53 (55'-)*
50 (51'-)*
68 (707.)
34 (35'-)
5.l:t2.5*
52i13'-
Painless ST
llumber of pts 103
Prior HI 21 (207.)
Prior angina 30 (297.)
Angina post-MI 28 (27'-)
2-3 vessel disease+ 66 (64'-)
3 vessel disease+ 26 (25'-)
Ex. duration (min) 5.7±2.3
Ejection fraction 51±11'-
*: p<.Ol compared to painless ST;
+: ~ 707. lumen diameter reduction
Thus pts with painless ST depression behave clinically
like pts without angina but angiographically show the
same severity of coronary artery disease as pts with
exercise-induced angina. This observation suggests that
painless ST depression is caused by myocardial ischemia
in many post-MI patients.
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ARRHYTHMIAS PROVOKED BY EXERCISE STRESS TESTING ARE
INDEPENDENT OF CLINICAL CHARACTERISTICSOF PATIENTS WITH
VENTRICULAR TACH~ARRHYTHMIAS .
Thomas Casey. M.D.; Byron Allen, M.D.; Michael Brodsky,
M.D., F.A .C.C.; Carl Walker; WalterHenry, M.D., F.A.C.C.
Exercise treadmill stress testing (TMST) has been
commonly used in the evaluation ofpatients with
ventriculartachyarrhythmias.The provocation of arrhyth-
mias duringTMST has not been correlatedwith other
available data. To assess the possible associations, the
results of arrhythmia monitoring during exercise were
retrospectivelyanalyzed in 67 consecutive patients who
were studied off all antiarrhythmic medicat ions .Thirty-
five patients (53%) had coronaryartery disease (CAD),
11 (16%) had dilated cardiomyopathy, and 21 (31%) had a
variety of other conditions. The present ing arrhythmia
was ventricularfibrillation (VF) in 31 patients (46%),
sustained ventriculartachycardia (VT) in 21 patients
(32%) and symptomatic nonsustainedVT in 15 patients
(22%). Twenty-four patients (36%) had exercise inducible
VT (23 beats). The presenti~g rhythm, lef t vent r icular
ejection fraction, and presence ofCAD were not
associated with exercise inducible VT . In addition, VT
seen on ambulatoryECG monitoring orVT provoked with
up to 3 programmedextrastimuli did not correlate with
exercise inducible VT. However, the lack of exercise
inducible VT correlatedwell with the absence of VT on
ambulatory ECG monitoringand te lemetry (p <:.01). Thus,
TMST provides useful independent informat ion in t he
baseline evaluation of patientswi th life threaten ing
arrhythmias. A negativeambulato ry ECG study is predict-
ive of no arrhythmia during exercisetesting.
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PercutaneousBalloon Valvuloplasty
PERCUTANEOUS BALLOON VALVULOPLASTY IN ELDERLY PATIENTS
WITH AORTIC STENOSIS AND LOW EJECTION FRACTION.
Jacques Berland, M.D., Alain Cribier, M.D., Thierry Savin,
M.D . , Rachid Mechmeche, M.D., Nadir Saoudi, M.D. and Brice
Letac, M.D •• F.A.C.C., Univ of Rouen, France.
In 30 patients (Pts) over 70 years old (mean 80 ~ 5) with
aortic stenosis (AS) and left ventricular (LV) angiogra-
phic ejection fraction (El') below 40%, we evaluated the
safety, efficacy and short term clinical and hemodynamic
follow-up of percutaneous aortic val vul opl as t y (PAV) .
Before PAV, 16 pts were in functional NYHA class IV and 11
in class I l l, 9 had angina and 7 syncopes.
Results: No complications, in particular no calcium
em:bOI1: occured during the procedure. Peak sys t olic
ventricul o- aortic gradient decreased from 65 + 28 mmHg to
25 + 10 (1'<.001) and aortic valve area (AoVA) increased
fro; . 46 + . 17 to .80 + .36 cm2 (1'<.001) . Only 5 Pts had
residual AOVA <. 5 cm2 • I mmedi at ely after PAV, El' increased
from 30 + 5 to 35 + 9% (1'<.01) . One Pt died 3 days after
PAV from-iliac arterialcomplication.
Follow-up (mean 19 weeks, range 2- 34): There were 5deaths
(2 infarcts, 1 heart failure, 2 non cardiac events).
Clinical improvement wasnoted in 21 of the 24 remain ing
Pts, 16 resuming a normal life for their age.
Repeat cat het er i zat i oncould be per formed in 7 Pts 24 + 8
weeks later. One Pt had restenosis and was dilated again.
For th e 6 other Pts, when comparedto post PAY val ues , no
change i n the AoVA was found and a markedincrease in El'
was noted fr om 41 + 11 to 55 + 5 :t, 1'<.0 2.
Conclusion : In elderly Pts With AS and LVdysfunction in
whom valve replacement involves a high surgical risk or
cannot be considered, PAY seems to be a safe and effective
method which markedly improves the clinical status. The
lat er impr ovement in El' is comparable to that observed
after surgical valve replacement. These results have to be
confirmed on a larger number of Pt swith longer follow-up.
NATURAL HISTORY OF CANDIDATES FOR BALLOON AORTIC
VALVULOPLASTY.
James H. O'Keefe, Jr., M.D., Ronald E. Vlietstra, M.B.,
Ch.B., F.A.C.C., David R. Hol mes, Jr., M.D., F.A.C.C. and
Kent R. Bailey, Ph.D., Mayo Clinio, Rochester, KN.
Balloon aortic valvuloplasty has recently been proposed
for elderly Pt with severe aortio stenosis (AS) when
aortic valve replacement (AVR) has been declined or
deferred. Previous studies of naturalhistory of severe
AS preceded the moderndiagnostio and therapeutic era and
included Pt of all ages and Pt in whom surgery is now
performed. Therefore, we reviewed records of all Mayo
Clinio Pt with severe AS during 1978-1985 but who had no
surgery because the Pt deolined or the physioian deferred
it . In th e 46 Pt identified ( 30 males, 16 females; mean
age , 77.2 yr, range 61-89 yr), surgery was declined by 25
and deferred for 21 (mild symptoms in 3, advanced age in
5, coexisting serious noncardiac illness in 11, and reoent
myocardial infarct in 2). The diagnosis was established
olinioally hy a cardiologist in all 46, confirmed hy
two-dimensional echocardiographyin 38, Doppler in 15, and
catheterizationin 11. Coronary artery disease was seen
in 7 of the 11 who had catheterization. Symptoms included
angina pectoris in 22, heart failure in 33, and syncope in
10 (20 Pt had morethan one symptom). Thirty-one had LV
hypertrophyby ECG. Complete follow-up, available on all
46, averaged 20. 1 mo (range, 1- 78 mol. Actuarial survival
at 1, 2, and 3 yr was561, 371 . and 251, respectively.
Survival of age-matched controls was 931, 851. and 771,
respectively. At last fol l ow- up, only 10 of the 46 (221)
were alive. Of the 36 deathS, 31 were cardiac-related.
The poor survival of t hi s group of Pt mandatesevaluation
of alternativenonsurgical treatments such as balloon
valvuloplasty when surgery is deolined or deferred in
elderly Pt.
CARDIOPULMONARY IlIERCI5E PERFORIWICE AFTER SUCCESSFUL
PERctrrANBOUS IIITRALVALVULOTOKT.
farouk Salahi , H,D" Alfonso O'Neill, H.D., David J .
Kanarek , H.D. , I gor Palacios , H.O., P.A.C.C. , Peter C.
Block, H.O., F.A.C.C., and Charles A. Boucher, H.D.,
F.A.C.C., Hassachusetts General Hos pi t al, Boston
following percutaneous mitral val vul opl as ty (PHV) ,
objective evidence of functional i mprovement is lacking,
although subj ect i ve and hemodynamic improvement has been
demonstrated. Ve studied cardiopulmonary exercise (EX)
performance before and within 2 months after successful PHV
in 6 patients (1 male, 5 females, ages 28 to 52, mean 41
years), The PHV resulted in a reduct ion in mean lef t
atrial pressure from 32 t 5 to 10t7 mmHg (p<O.OOl), and an
increase in mitral valve area as determined by the Gorlin
formula from 1.OtO.4 to Z.4tO.4 cm' (p<O.OOI). Before PHV,
5 patient s were in class 3 of NYHA classification and one
was class 2. All patients became class I after PHV.
Results of the EX test foll ow : (val ues are mean t SO)
Before PHV After PHV Emm - I64ff8- NS
127t 29 160t1 1 <0.005
76t ll 79tll NS
47t13 73t 24 <0.001
10.4t 2.7 14.6 t2.5 <0.01
The EX rests reveal ed 1) substantial improvement of the
peak systolic BP after PHV with no change in peakHR and
Diastolic BP and 2) improvement in peak workload andan-
aerobic threshold oxygen uptake. Only 3 of 6 patients had a
normal anaerobic threshold ()14ml/kg/min) after PHV, In
conclusio n PHV results can be monitored noninvasivel y and
objectively by cardiopulmonary EX testing. The i mprovedEX
SBP can be explained by an improved CO with ex afte r PHV.
However, the anaerobic threshold is still subnormal in 3
patients, i ndi cating some residual abnormalities may be
present after PHV.
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EARLY FOLLOW-UP OF PERCUTANEOUS TRANSLUMINAL AORTIC
VALVULOPLASTY : a Doppler echocardiographicevaluation.
Jean-Leon Guermonprez, ~, Bernard Lancelin, M.D.,
Benoi t Diebold, M. D., Hanna Raffoul, M. O. , Jean-Paul
Aziza, M.o., Cyril Degroote, M.D. INSERM (U.256) and
Clinique Cardiologique, HOpital Broussais, Paris, and
Hopital A. Mignot, Versailles, France.
Percutaneous transluminal aortic valvuloplasty (PTAV)
has been recently proposed as an alternative to valvular
replacement for elder1y patients. This study was
designed to evaluate its early efficacy. Each ultrasonic
examination included the calculation of the peak (P) and
mean (M) pressure gradients using the s impl i f i ed
Bernouilli formula, of the cardiac output (q) and of the
aortic val ve area (A) using the continuity equation. The
severity of associated aortic regurgitation (AR) II/as
evaluated using flow mapping. Thirty patients (mean age
77 years, range 70 to 91) with severe aortic stenosis
underwent a Doppler echocardiographic examination 24
hours before and 2 to 10 days after PTAV. AR was
modified in only one patient. quantitative data were
compared using a paired t test
P (mmHg) M(mmHg) A (cm2) q (l/mn)
m +/-sd m +/- s d m +/-sd m +/-sd
before 90.9 20.5 56.3 15.7 0.45 0.15 3.75 1.33
after 75.3 23.1 44.5 16 .1 0.60 0.19 3.93 1.25
P < .001 .0001 .0001 .0001
Thus, in 30 elderly patients lIIith severe aortic
stenosis, percutaneous transluminal aortic valvuloplasty
i nduced a significant increase of both the valve area
and the cardiac output and a decrease of the pressure
drop without significant increase of the associated
aortic regurgitation. Nevertheless, in 21 of them, the
aortic valve area remained below 0.75 cm2.
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CoronaryArteryDisease: Morphology
DETERMINANTS OF COLLATERAL RESERVE: CAN BASELINE
CLINICAL OR ANGIOGRAPHICVARIABLES PREDICT THE
DEGREE OF COLLATERAL FILLING OBSERVED
IMMEDIATELY AFTER SUDDEN CORONARY OCCLUSION:
Marc CohedMDt FACC, WarrenSherman, MD, FACC, K.PeterRentrop, M ,F CC, John A. Ambrose, MD, FACC: Mt Sinai
Med Ctr, New York, NY.
We have shown that higher grades of collateral (coil)
circulat ion limit the extent of myocardial ischem io observed
during bolloon inflation (infl) in pts with single vessel coronory
diseose and normal LV-gromsundergoingPTCA. However, the
gr of coli filling observed during sudden coronary occlusion
varies from pt topt, In-orderto assess which pt characteristics
may predict high gr of coli, we correlatedbaseline clinical and
angiogrophicvariobles with the gr of coli filling duringcoronory
occlusion in 51 pts undergoing left onterior (n=34) or right
coronary (n=(7) PTCA. A secondarterial catheter was used to
assess coli fill ing reaching the vessel dilated prior 10 (pre) and
during transienttotal occlusion by the angioplastyballoon.
Results: Durationof angina ranged from I:reek to 36 months.
29--ort1le5 I pts had proximal lesions (pre Is septal or pre RV
branch). % stenosis (sten) of the lesions ranged from 65%-99%.
Using a 0-3 sca le, mean coli gr pre infl was 0.4 vs 1.9 during infl
(p=.oOJ). All 14 pts with 95-99%stenosis pre PTCA had gr of
coli during infl >2. Incontrast, 12 of 15 pts with <80% sten pre
had gr of coli during infl of only 0 orI. There was aSignificant
positive correlationbetween gr of coli during infl and:I) % sten
pre, r=.71, and 2) gr of coli pre, r=.49.There was no significant
correlationbetween coli during infl and: oge, sex,durationof
angina, vessel dilated, or proximal vs distal location of the
lesion.
Conclusions: Among the baseline variables available prior to
PTcA, % sten is the best predictor of coli reserve. The %
stenosis prior to myocordial infarction and the asoociated
collateral reserve may explain some of the var iabilty in infarct
size observed after acute coronaryarterythrombosis.
CORONARY MORPHOLOGY DEMONSTRATES A COMMON
LINK BETWEEN UNSTABLE ANGINA AND NON-Q WAVE
INFARCTION. John A. Ambrose,M.D. F.A.C.C., Craig
Monsen,M.O., Susan Borriea,8.S., Debbie RUdin,B.S., Richord
Gorlin,M.D. F.A.C.C., and ValentinFuster, M.D. F.A.C.C. Mount
Sinai Hospital, New York.
We have described the coronory morphology (CM) of ischemia
producingarteries(IPA) in unstable angina and q waveinfarction.
An eccentric stenosis with overhangingedges or irregularborders
(E2) was seen in the majority of lesions < 100% occluded andprobablyrepresentedplaquedisruptionand/oroverlying thrombus.
The CM of non-q infarction has not been described. Thus, we
prospectively onalyzed the angiograms of 105 consecutive pts,
catheterized with either unstable angina (Gr.l,n=73) or non-q
infarction (Gr.lI,n=32) and anidentifioble IPA. Non q infarction
was diagnosed by prolonged chest pain and new andpersistentST-
T changes or CPK > twice normal. The CM and %stenosis of the
IPA ond the CM of non-I? Astenoses :>50% and<100% occluded in
these same pts were as follows:
IPA 100% E2 in IPA %Stenoses
occluded < 100% in IPA<100%
Gr I 6/73 (8%) 37/67(55%) 89 ±8 8/47 (17%)
p<O.1 NS NS NS
Gr 11 7/32 (21%) 16/25 (64%) 88±7 1/29 (3%)
The incidence of E2 and the %stenosis of the IPA are similar
between unstable angina and non-q infarction. More total
occlusions, however, are found in non-qinfarction. The incidence
of E2 was significantly higher in the IPA than in non-IPAstenoses
(p <,,00 I for both groups). Conclusions: E2 is 0 sensitive and
spec ific markerof < 100%occluded ischemia-producingarteriesin
both unstable angina and non-q infarction. These similarities in
coronary morphology suggest 0 similar pathogenesis which, as
previously suggested, may relate to plaque disruption with
thrombus. Unstable angina and non-q infarction appear to
representa continuousspectrumof coronaryarterydisease.
COMPARISON OF CINEVIDEODENSITOMETRIC AND CALlPER
MEASUREMENTS OF CORONARY STENOSIS AFTER ANGIOPLASTY
AlIen B. Nichols, H.D., FACC, Andrew D. Berke. H.D. ,
Jennifer Han, Dennis S. Reison, H.D. , FACC, Rita H.
Watson, H.D., Belinda Garcia, and Eric R. Powers, H.D.,
FACC. Columbia University. New York, N.Y.
The accuracy, precision, and reproducibilityof caliper
and cinevideodensitometric measurements of coronary
stenotic dimensions were compared in radiographic
phantom models andin 26 patients undergoing angio-
plasty (PTCA). DigitIzed cineframes (512x512 pixels;
256 gray levels) were analyzed with an automated
computer programwhich does not require exact border
recognition. The accuracy (2 .0% meanerror) and
precision (+0.043 mm SO) of ci nevi deodens i t omet r y for
measuring diameters of contrast-filledcalibrated
cyl inders was superior (p(O.OOI) to the accuracy ( 18. 7%
mean er ror ) andprecision (+0.185 mm) of calipers.
Interobservervariabilitywas signIficantly (p(O.OI)
better for videodensitometric (r=O.98; SEE=3.5%) than
for caliper measurements (r=0.89; SEE=7.6%). After
PTCA, %diameter stenosis measured by calipers fell
from 66+13% to 31+12 %. Hean %area reduction measured
by videodensitometryfell from 87~7% to 43~15%~ and
stenotic ~rea increased 4-fold from O.7!O.5 mm to
2.8+0.9mm • Pre- and post-PTCApressure gradients dId
not-correlatewith lesion dimensions. Thus, accuracy,
precision, and reproducibilitywere poor for calipers
and excellent for cinevideodensitometry. Efficacy of
PTCA is best measured by videodensitometrybecause
residual lesions post-PTCA are often eccentric, have
indistinct margins, and are best characterizedby
changes in area rather than diameter.
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Assessment of cotonary flow reserve (CFR) during angio-
plasty using a Dopplertip balloon catheter. Comparison
with digital subtractioncineangiography.
PW Serruys, MD, F Zijlstra, MD, JHC Reiber, PhD, J v
Ommeren, MSc, R de Ruiter, BSc, J Ligthart, BSc,
Thoraxcenter,Rotterdam, The Netherlands.
IntracoronaryDoppler blood flowvelocity (DOP) measure-
ment following intracoronaryadministrationof 12.5 mg
papaverine (pap) is now used as a direct method to assess
coronary blood flow reserve (CFR). To evaluate the
physiological significance of this pharmacological test
we compared in the same individuals the hyperemia induced
pharmacologicallywith that of post transluminalocclu-
sion and related these subselective intracoronarymeasure-
ments to the CFR as assessed by digital subtraction
cineangiography (DSC). In 14 consecutive patients with a
single proximal stenosis CFR was measuredpre- and post
PTCA, by DSC using pap. Also, pre- and post angioplasty
DOP measurementsbefore and after pap were recorded in
the proximal part of the stenotic vessel. The hyperemic
velocity measurementsfollowing the last transluminal
occlusion (LTO) were compared to the velocity measure-
ments after pap. As result of the angioplasty CFR-DSC
increased from 1.1 (range: 0.6-2.0) to 2.3 (range:
2.0-3.0), while CFR-DOP increased from 1.2 (range:
0.9-1.8) to 2.2 (range: 1.0-2.9). ~e correlationbetween
CFR-DSC and CFR-DOP (r=0.82; p<10 ,SEE:0.46) confirmed
the reliability of the intracoronarymeasurements. No
difference (SD of the difference: 0.27) was found between
the magnitude of the hyperemia fter pap as compared to
LTO. Conclusion: 1) Using these two independant techni-
ques CFR was found to be substantially improved but still
abnormal immediatelyafter PTCA, 2) The magnitude of
vasodilation induced bypapaverine is comparable to the
vasodilation due to ischemia induced bytransluminal
occlusion.
CORONARY ANGIOSCOPY:THESPECTRUM OF DISEASE IN THE FIRST
100 PATIENTS.
Ann Hickey, MD, Frank Litvack, MD, Warren Grundfest, MD,
Myles Lee, MD, Aurelio Chaux, MD, Carlos Blanche, MD,
Robert Kass, MD, C. Todd Sherman, MD, David Glick, MD,
HJC Swan, MD, Ph.D., F.A.C.C., Jack Matloff, MD,
F.A.C.C., James S. Forrester, MD, F.A.C.C. Cedars-Sinai
Medical Center, Los Angeles, California.
We have performedintraoperativecoronary angioscopy on
100 pts. A total of 172 vessels (75 LAD, 36 Cx, 12 Diag,
13 RCA, 36 grafts) were examined. In 17 pts withstable
angina only smooth atheroscleroticplaque was seen. In
11 pts with accelerated angina 10 showed plaque
ulceration and 1 pt hadsmooth plaque. In 13 pts with
rest angina 12 showed intraluminal thrombus (2 of these
also showed plaque ulceration) and 1 pt hadsmooth
plaque. In 1 pt with rest angina secondary to a vein
graft lesion, histologic examination confirmedruptured
atheroscleroticplaque with superimposed thrombus. In 6
post-MI pts, all demonstratedulcerated plaque, 1 of
which had superimposed thrombus. In 2pts post-MI and
thrombolytic therapy, 1 had totally occlusive thrombus
and 1 hadcircumferential thrombus. The remaining 51 pts
underwentsurgery for other indications e.g., high risk
anatomy, valvular disease, failed PTCA, or did not yield
diagnostic images for technical reasons.
CONCLUSION: Angiosco~y demonstrates a spectrum of
coronary morphology from smooth plaque to plaque
ulceration and thrombosis. These morphologies directly
correlate with clinical status from stable angina through
the unstable anginal syndromes to acute myocardial
infarction. These data have importantclinical and
therapeutic implications.
DIRECT OBSERVATION OF CORONARY THROMBUS USING A NEWLY
DEVELOPED ULTRATHIN (1.2 mm) FLEXIBLE ANGIOSCOPE
Takashi Susawa, M.D.. Yoshiki Yui, M.D., Ryuichi Hattori,
M.D., Yoshiki Takatsu, M.D., Natsuko Yu t , M.D., Mamoru
Takahashi, M.D.. Takeshi Aoyama, M.D., Yoshiharu
Murohara, M.D., Manabu Shirotani, M.D., Chuichi Kawai,
M.D.. F.A.C.C., Kyoto University Hospital, Japan.
We have developed a new ultrathin (1.2 mm) and
flexible angioscope (A~ 120 cm in lengt~ Olympus Cor~,
Japan) for thedirect observation of coronary thrombus.
In vivo canine studies; Coronary thrombus was formed
in the anterior descending coronary artery by copper
coil. A 8.3F angioplasty guiding catheterwithout any
modifications was introduced via the carotid artery under
the fluoroscopic qut dance, AS was introduced into the
coronary artery through the catheter. A clear Viewing
field was created by infusion of pressurized saline via
the catheter. The direction of viewing field could be
controlled by the guidi ng catheter. AS was adapted to a
video camera and imagesdisplayed on a monito~ We could
clearly observe the endothelial surface, branches (dia-
gona1, septa1), copper coi 1 and thrombus formed in the
copper coil. No vascular damages were accompanied during
coronary angioscopy.
Clinical studies; Coronary angioscopy wasalso per-
formed both during the acute andchronic stages of myoca-
rdial infarction. AS was introduced via the brachial
artery or the femoral artery through the guiding
catheter. The i nt ima1 surface, atheromatousplaque and
thrombus in the proximal portion of the right coronary
arteries were able to be observed in bothstages.
Coronary angioscopy can be performed easily and
safely by this thinnest A~ Thus, coronary angioscopyis
expected to have wide research and clinical applica-
tions.
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Response of TransmitralFlow Velocity to Physiologic
Variables
EFFECTOF ATRIAL PACING ON LEFT VENTRICULARDIASTOLICFILLING
MEASURED BY PULSED DOPPLERECHOCARDIOGRAPHY.
CharlesA. Herzog M.D., K. Joeeph Elsperger,CCPT, Mic:haelManclee, M.D., MaryAnn
Murakami,B.A., RichardAsinger, M.D., F.A.C.C. Hennepin County Medical Center,
Universityof Minnesota,Minneapolis,Minnesota.
Pulsed Dopplerechocardiography(PDE) has been used to assess leftventricular(LV)
diastolic filling. Publishedvalidationstudies of this method, however, have not
examined the effect of increasingheart rate (HR) on LV diutolic filling parameters.
We measuredtransmitralflow at the level of the annuluswith PDE duringincremental
right atrialpacing at HRs of 60 to 120 in 11patients(7 had coronaryarterydisease,
• had arrhythmiaswithout coronaryarterydisease). Blood pressuredid not change
significantly with pacing. Early peak LV filling velocity (E), peak atrialvelocity
(A), time velocity integralfor early (EAR) and late (AAR) LV filling, and half
filling fraction (HFF) were derived from the pulsed Dopplertime velocity curve. In
all patients,fusion of the E and Apoints on the pulsed Dopplertime velocity curve
occurredat heartratesof 100 or above, preventinganalysis at these higher heart
rates.
HeartRate 60 70 80 90
E (rn/.ee) O.7U.13 O.69t.07 O.65t.08 O.6H.H p=NS'
A (rn/.ee) O.68t.09 O.69t.09 O.77t.H O.81±.19 p<.OOI'
EAR (rn/.ee2) 12.9tL6 I1.8t1.2 7.HL7 7.2t3.0 p<.OOOI'
AAR (rn/oee2) 6.3t1.2 6.5tL3 7.6t2.0 9.7±3.6 p<.OO\',
A/E O.99±.19 L02t.16 1.21±.28 L24t.31 p=NS ..
AAR/EAR O.49t.09 O.56t.09 Ll1±4.7 L50tLl5 p=.OI ,
HFF (%) 36t8 4U6 52±7 67t7 p<.OOOI
All value. mean ± SO. Analysi. of variance. Krulkal-WalU.test.
We conclude that pulsed Dopplerderived indices of LV dleeeolic filling aremarkedly
alteredby atrialpacinC and increaaingheart rate•. Therefore,Dopplerderived
measurementsof LV diastolic filling should be correctedfor heartrate.
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QiANGES IN MITRAl FLOW VELOCITY WIIH EXERCISE: AN INDEX
OF STRESS INDUCED ISQiEMIA. ~.o.. Hltchell, .HO.
John S. CbIId, MD, FAce, Janlne Krlvokaplch, MD, FAce,
RIchard Brunken,MD, FAce, Marcus Schwalger, MD, UQA
MedlC81 Canter, Los Angeles, Callfornl&
Exercise Induced myocardIal IschemIa results In dla-
stollc as well as systollc left ventrIcular(LV) dys-
functIon. To Investigate Doppler assessment of LV dla-
stollc function (LVDF) with exercise, 28 consecutIve
patIents (pts) underwent dlgltlll stress echocardlo-
graphy, measurementof mItral flow velocIty (MFV) by
pulsed wave Doppler, andsimultaneous stress thallIum
ImagIng. Mean MFV was the Integratederea undar the MFV
waveform. Thepercent change (%chg) In mean MFV from
baseline (B) to post-exercise (PE), was compared with
the ratIoof peak MFV In early dIastole to peak MFV
durIng atrIal systole (E/Al, at B and PE, In controls
(C), pts with exercIse Induced wall motion abnormalitIes
(EX WMA), pts with stress Induced thallIum perfuslon
defects (+ll-iALl, and pts wIth only restIng WMA (R WMA).
ResuIts are beIow as means ± SO, hp<.005.
N %chg mean MFV E/A B E/A PE
C 10 101±59 1.2±.3 1.3±.5
R WMA 10 78±57 1. 3±. 4 1. 3±. 7
EX WMA 15 30±25 * 1. 6±1. 9 1. 3±.7
+ll-iAL 12 34±24 * 1.8±2.1 1.5.±.9
An Increase In meanMFV wIth exercIse of >50% IdentIfIed
non-IschemIc (9/10 C) pts; a <50% Increase predicted
IschemIa In 10/12 +ll-iAl pts and 13/15 pts with EX WMA.
Conclusion: Doppler assessment of LVDF wIth exercise,
expressed as a change Inthe meanvelocIty of mItral
flow, Is a useful IndIcatorof stress Induced Ischemia,
as opposed to E/A ratIos whIch did not change
signifIcantly wIth exercise. The presence of restIng WMA
wIthout stress Induced WMA did not result In an abnormal
response In this paramete~
00l'HJlR DIlIalS " LIft'VIII'lRIWLMDIAS'DLIC~ ME
J*I+M... (If PILLIIGHtI!IliSLRl lR IN.
OlristoPJer la.~ &..a..... Rba.Da., Howard C. Herrmann,
MoD., Arthur E. weyman, MoD., F.A.C.C., Michael A. Fifer,
MoD., MassachUBettsGeneral Hospital, Boston, M.
To test the hypothesis that iOOioes of left
ventriallar (IN) diastolic function derived fran the
DlItl!er mitral inflw velocity FCofile (MIVP) are
dependent cn LV filling pressure, we measuredthe MIVPand
micranananet:erLV pressure before and cbring nitroglycerin
('00) infusien in II patients with oorcnary artery
disease. 1'UlJDCNry capillary wedge pressure (POn'), IN
end-d1astolic pressure (IJJEtl'), time oonstant of
relaxatien (T) , and ~ppler velocities (Vel) and
velocity-time i.ntegrals (Vl'I) of the mrly (E) and late
(A) ~s of LV filling were (1llllIlJl!:SD):
.wma. 5 ~
Mean POiP (mn fig) 9:i4 4±2 0.001
LVEIP (mn Hg) 15i6 7±3 0.001
T (msec) 5~ 46±8 0.01
Peak EVel (a!V'sec) 56:1;14 44±9 0.001
Peak AVel (a!V'sec) 6l±l6 59:1;13 NS
F/A Vel Ratio 0.97iO.33 0.7710.20 0.02
E Deceleratien (a!V'sec2) 288;t1.38 186±71 0.02
A VTI (an) 4.4:1:1.2 4.3iO.8 NS
TOtal V1'I (an) 14.3i2.7 12.3i2.0 0.002
A VTI;'.rotAl.V1'I (t) 3l±l0 36±8 0.03
'!hIE, '00 lcwered peak E Vel, F/A Vel ratio and E
deoeleratien, and 1D=reued relative atrial oontributien
to LV filling. 'lhese changes mimic those FCeviously
reported with 1mpl1cnent crf IN diastolic functicn, /:ut
oocurred despite faster LV relaxaticn and lwer LvmP en
'00. Qmclmd.Clol '!he MIVP is altered I¥ changes in LV
filling pressure ~ldently crf changes in diastolic
properties. '!his effect IIlIStre considered before changes
in the MIVPare ascribed to changes in diastolic functien.
SUBTHRESHOLD ATRIAL PACING IN THE TERMINATION OF
ORTHODROMIC RECIPROCATING TACHYCARDIA IN PATIENTS WITH
LEFT·SIDED BYPASS TRACTS.
Elt 5 Gan&. MD, FAce, Tom Peter, MD. FACe, Peter e.
Nalos, MD, Malte Meesman, MD, Yilliam J. Mandel, MD,
FACC, Daniel Oseran, MD, Mark Myers, MD. Cedars-Sinai
Medical Center, Los Angeles, CA .
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ImplantedDevices for TachycardiaTherapy
We examined the efficacy of subthresholdatrial pacing
(STP) in the termination of reciprocating tachycardias
utiliz ing left-sided bypas s tracts (BPT) in 7 patients
(pt s) . All pts had readily-inducible sustained episodes
of orthodromic tachycardias (OT) ; 1 patient had a
"conceal ed"BPTwithout antegrade conduction. Mean OT
cycle length was 340±60 ms . Bipolar cathodal pac ing (5
mm interelectrode distance ) was performed from the
coronary sinus at the site of the BPT. The pulse width
was 2 ms . Diastolic 'pacing threshold (DT) was determined
prior to initiation of OT.~: Ventricularpre-
excitation did not occur dur ing STP,neither during OT
nor follOWing its termination. Termi nation of or was
reliably achieved within 8 sec at 64±13% of DT ; failure
to t ermi nate OT occurred at 5l±Zl% of DT (p<0.05) . In
all pts, immediately prior to termination of the OT, an
abrupt shortening of the final pop interval was seen
without a change in the atrial activat ion sequence; mean
p.p shortening was 20±4%. Block of the OT was in i t s
ant egr ade limb in each instance. Initiation of th e
premature atrial impulse which t erminat ed theOT may
have been secondary to summation or t o threshold current
hysteresis. Failure to pre-excite the ventricles during
STP was probably due to "impedance mismatch . "
We concl ude that STP may be an effective method for the
terminationof reciprocatingtachycardias. The lack of
concomitant accelerationof the heart rate may make STP
an attractive alternative to conventional
antitachycardiapacing.
4
16. 2±4.9
17.2±3.3
15.7 ±3.0
DETERMINATION OF MITRAL DOPPLER CARDIAC OUTPUT DURING
EXERCISE. Anis Rassi, Jr. , MD , Kent L, Richards, MD,
FACC, Jacel yn F. Miller. RDMS and Michael H. Crawford,
MD, FACC, U. of Texas H.C.S . and VA Hospital, San
Antonio , TX.
We have previously shown th at maximum mitral valve
orifice area (MVA) increases incrementally during
progressive isotonic exercise, but the need to correct
maximum MVA for changes in meantemporal valve area in
calculating CO during exercise is not defined. Accord-
ingly, we studied 10 normal subjects during graded
supine bicycle exercise. At rest and at each stage of
exercise the following measurements were made: maximum
MVA and aortic cross sectional areas using parasternal
2D echo; diastolic mitral leaflet separation using
M-mode echo; mitral orifice velocity-time integral using
apical pulsed Doppler; ascending Ao velocity-time
integral using suprasternalnotch continuous wave (CW)
Doppler. CO was calculated as the product of peak
velocity-time integral. cross sectional area and heart
rate for both valves. Aortic CO was used as the standard
of reference. During exercise the rat i o of mean to
maximum mitral leaflet separationincreased progressive-
ly (. 55 rest, .61, .61, .64, .68. mean .62). Mitral CO
was calculated using these ratios for each stage(CO-M-S)
or using a constant average ratio for all stages of rest
and exerciae (CO-M-.62) as shown below in L/min±lSD:
E X E R C I S E S TAGE
Rest 1 2 3
COAo 5. 2±1. 2 9.7±2.1 11. 2±3,0 12.5 ±3.0
CO-M-S 5,4±1 .2 9.7±1 .7 11. 2±2. 2 13, 2±2.4
CO-M-.62 6.1±1.4* 9,9±1.7 11. 4±2, 3 12,8±2. 3
*p<'05 vs COAo
We conclude that CO Ao can be accurately estimated
during exercise by pulsed Doppler/ZD echo of the mitral
valve without separate M-mode analysis.
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STABILITY OF ACTIVATION SEQUENCE MEASURED BY TWO
VENTRICULAR ELECTRODES DURING SUPRAVENTRICULAR TACHYCARDIA
Anthony D. Mercando, M.D., Seymour Furman, M.D., F.A.C.C.,
John D. Fisher, M.D., F.A.C.C., and500 G. Kim, M.D.,
F.A.C.C., Montefiore MedicalCenter, Bronx, New York
Measurement of the electrical activation sequence using
two ventricularelectrodes may be useful for differen-
tiating normalsinus rhythm (NSR) from ventricular
tachycardia(VT). Such a technique may be employed by
implantableanti-tachycardiadevices in an algorithm for
automatic detection and differentiationof abnormal
rhythms. To investigate the stability and reproducibility
of ventricularactivation sequence during rhythms of
nonventricularorigin, the sequence and timing of
ventriculardepolarization BS measured with two ven-
tricularendocardial electrodes were examined in 7 pts
undergoingelectrophysiologic study. Baseline recordings
were made in NSR in 7/7 pts and compared to recordings
during AV node reentranttachycardiain 4 pts, during
atrial fibrillation in one pt, during right atrial
tachycardiain 1 pt, and during orthodromicAV tachycardia
associated with the Wolff-Parkinson-Whitesyndrome in 1
pt. Manual measurementsof timing weremade using the
peak of the first rapid deflection of the endocardial
ventricularelectrogram in two leads during NSR (~ beats)
and duringtachycardia(~beats). Results: Timing
differences measured between leads were reproducible
during all rhythms. Mean differences in sequence and
timing rangedfrom 2 to 5 ms. Timing between leads in NSR
was not statistically different from SVT in any pt, in
contrast to the finding in VT where differences between VT
and NSR are generally >20 ms. Conclusion: Multiple
ventricular leads could be used to differentiate SVT from
VT by measurementof sequence of activation independent of
ventricularrate.
USE OF AN AUTOMATIC ANTITACHYCARDIA PACEMAKER IN
PEDIATRIC POSTOPERATIVE PATIENTS
Paul C. Gillette, M.O., FACC, Alexander Zinner, Vicki
Zeigler, RN, Bertrand Ross, M.o.,FACC, South Carolina
Children'sHeart Center, Charleston, SC
The treatment of tachydysrhythmias inpatients after
repair of congenital heart defects remains one of the
major challenges in pediatric cardiology. We report
eight pediatric patients in whom we used an automatic
antitachycardiapacemaker. Age range was from 22
months to 20 years (mean 12.8 years). Six had had
repair of d-transpositionwhile one had hadatrial sep-
tal defect repair and one Fontanprocedure. They had
been taking 1.7 antiarrhythmicsprior to implantation
(including digoxin). The dysrhythmiatreated was
atrial flutter in four, supraventriculartachycardia in
three and ventriculartachycardia in one. Tachycardia
recognition was by rate and sudden onset in each
patient. Tachycardiatreatmentwas adaptive in each
patient and used 1-16 (mean 4) prematurebeats. Four
patients had tachycardiaepisodes the others being
suppresed bybradycardiapacing. Pacingwas successful
in each tachycardia. In no patient was sinus tachycar-
dia mistaken for paroxysmal tachycardia. Automatic
antitachycardia padog may be successfully carried out
in pediatric postoperative patients.
VARIATIONS OF AUTONO~IC TONE IN TRAIN 5TI~ULATION FOR
PREVENTION OF ATRIOVENTRICULAR REENTRANT TACHYCARDIA
~ichael 5chluter, Ph.D., Karl-Heinz Kuck, ~.D., and
Klaus-Peter Kunze, ~.D., University Hospital Eppendorf,
Hamburg, F.R.G.
Atrioventricular reentrant tachycardia ltachl can be
prevented by atrial extrastimulus (E5) delivered within
'preventive zone" following atrial effective refractory
period (AERPI of tach initiating stimulus (SI. This mode
of stimulation is dependent on site and timing of E5 with
respect to 5. Preventive stimulation at site of tach
initiation IS less critically achieved when, instead of
single E5, short train (TI of E5 is delivered, beginning
within AERP of 5 and exceeding it by at least I ES to
achieve single atrial capture. To clarify whether
preventive T stimulation with fixed coupling interval to
S remains effective during drug-induced variations of
autonomic tone, 10 pts (4 wonn, 4 men; mean age 43
years) with symptomatic tach due to accessory AV
connection (3 right-sided, 7 left-sided) were studied.
Tach could be initiated during sinus rhythm fromRA in
all pts, from coronary sinus in 5. Preventive stimulation
during baseline study, after isoproterenol, and after
_etoproiol was performed in all patients at site of tach
initiation with T of 10 E5 la .s apart, delivered 150 IS
after 5. With baseline sinus cycle length (SCLI of 741 !
148 ms T prevented tach (CL 293! 17 msl in all pt,.
Isoproterenol was then infused at 3 to 5 ~g/min until 5Cl
was 589! 126 u. T also prevented tach (Cl 254 ! IS ms).
When SCL had returned to baseline value, .etoprolol
injected intravenously at 0.15 mg/kg body weight
Increased SCL to 974 ! 155 ms, and Tstill prevented tach
(CL 318 ! 21 msl. Conclusion: Independent of variations
of autonomic tone, preventive T stimulation 150 ms after
S remains effective, because length of T exceeds AERP of
S to achieve single atrial capture.
CAN PERMANENTPACEMAKERSBEACCURATELYUSED TO
PERFORMPROGRAMMEDELECTRICALSTIMULATION
STUDIES?
Terry A. Zheutlin,M.D. FACC, Joseph Sarmiento,M.D., Thomas
Mattioni, M.D., Michael Lesch, M.D. FACC, Richard F. Kehoe,
M.D., Northwestern UniversityMedicalSchool, Chicago, IL
We comparedeIectrophysiologic responses obtained by invasive
programmedelectrical stimulation(IPS) to those obtained by non-
invasive programmedstimulation(NIPS) in 16 pts who had under-
gone prior permanent pacemaker(PMK) insertion for symptomatic
bradyarrhythmia. Indications for PES were recurrentsy cope 3 pts
andventr-iculartachycardia(VT) 13 pts,
All 16 pts had heart disease: 8 prior infarction; 3 valvular dis-
ease; 2 cardiomyopathy;2 congenital; 1Long QTSyndrome.In 4 of
16 pts, IPS was compared toNIPS in the drug-free state and in12
during antiarrhythmic therapy. In 14 pts, thecomparisonwas made
within 48 hrs; in 1, at 2 mos; in 1, at 8mos, Therapy was constant
between IPSandNIPS for all pts,
All pts had Intermedics dual chamberPMKs(model281-00. NIPS
was performed byreprogrammingthe PMK to the VVT mode and
shortening the refractory period to 170rns, The PES protocol was
performed by chest wall stimulation usingstandardECG electrodes
connected to an external stimulator. In all 16 pts, thePMK was ap-
propriately triggered inresponse to chest wall stimulation. IPSand
NIPS were done at a pulse width of 1.5 msec and stimulation amp-
litude approximating twice the diastolic threshold for capture.
Ventricular effectiverefractoryperiods (CL600,500,400 rnsee)
for IPS and NIPS did not differ significantly by the pairedt-test,
Of 9 pts with inducibleVT at IPS, 8 hadinducible VT with similar
VTcharacteristicsat NIPS. In all 4 pts with sustainedVT at IPS,
sustained VTcould also be initiated and terminated byNIPS. The 7
pts without inducibleVT at IPS were allnon-inducibleat NIPS.
We conclude:1) Electrophysiologic responses obtained byNIPS
are generally concordant with those ofIPS and 2) Inview of these
findings, many pts with permanentPMKs who develop the need for
PES may be evaluatedusing this non-invasivetechnique.
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NONINVASIVR TEllMINATIOHOF SUSTAINBD SUPRAVENTRICULAR
AHD VBHTRICULAR TACHYCARDIA WITH RXTKRNAL CARDIAC
PROOJWNmSTIMULATION.
H.A. Mark Rste. Ill. M.D.~.A.C.C., Tba.as F. Deering,
M.D'I Bn Hi1 HiD, M.D., 0 Salt!ll, M.D., F.A.C.C.~.Keitn Meek,. R.H., Koen van Opijnen, Paul M. Zoll, IlI.D.,
F.A.C.C. New Kngland Medical Center, Boston, MA
To evaluate. the feasibility of noninvasively
terwinatingsustained supraventricular(SVT) and
ventri:l~r (VT) tachycardiasusing external cardiac
progr stimllation (RePS), a standardprotocol was
~Iorec! in 9 patients (pta) with an external pae-aker
.adif1ed to trsek the out(lut of a pro~le
stiaulator. RCPS was perforwed at 5al over threshold
for ventricularcapturedeterwined at a pube width of
40 _ee. The ~rotocol for SVT or VT terwination
included sC8DD1ng with single then double extrastimlli
followed by overdrive pacing. If RCPS was not
successful in terwinat1ngttie tachycardiaendocardial
pacing or cardioversionwere used.
The ~rotOCQI was c~leted 33 ti~ in 9 ~ts with SVT
'5 pta} or VT (4 pta). Reaulta by arr~ha1!l_.YPe
1nclud1ng intraatrial{IART) and AV nodal (AYNHTI
reentO'I.AV reciprocahngtachycardia (AYR't), and
atrial rlutter(A. flu) are shoWnas auccesafUl
(arrhyt~ia terwination)/totalatteapta (ca.pleted
protocol):
Cycle Length Succesaful/
Pt Arrhrtbaia (_ee) Total Attel!pta
1 AVNRT 360 16/16
~ tm ~~g g~~
3 l~u ¥311 g~¥
6 VT - A 440 1/1
VT - B 300 1/1
7 VT 375 0/1
8 VT 270 0/1
9 VT MO 0/1
In 1/5 pta with SVT and 1/4 pta with VT ICPS was
auccesaful in arrhytbaiaterwination. Thre.hold for
ventricularcapturewas 54+9 IIA. KCPS did not re.ult
in SVT or VT accelerationor atrial or ventricular
fibrillation.
We conclude that KCPS: 1) can tel"llinateaustained SVT
and VT 2) has acceptable aafety using thia protocol.
Wednesday,March11, 1987
4:00PM-5:00PM,Room 14, Second Level
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HIGH I"PULSECARDIOPUL"ONARYRESUSCITATION I"PROVES 24
HOUR SURVIVAL IN A CANINE "ODEL OF CARDIAC ARREST
Karl B. Kern, ".D., George V. ftaier, ft.D., J. V.
Gaynor, ft.D., ftichael P. Feneley, ft.D., S. A. Gall,
Arthur B. Sanders, ft.D., Ken RaBssler, ft.D., F.A.C.C.,
J. Scott Rankin, ft.D., Gardon A. Ewy, ft.D., F.A.C.C.
VAftC and Univ of Arizons, Tucson, Arizona
High iapulse (HI) cardiopulaonaryresuscitation (CPR)
at 120 coapressions/ain and standard (STDI CPR at
60/ain were coapared for their effect on 24 hour
aurviv.l follOWing cardi.c arreat. Twenty-aix aongrel
doga (19~1 kg) were inatruaentedwith aicroa.noaeter
tipped catheter. for aonitoring AO and RA pressures.
All aniaals were voluae-loaded to a RA aean of 7~1
asHg, and given bicarbonateprior to the electrical
induction of ventricularfibrillation. ftanual CPR wa.
begun ia..di.tely, either with HI or STD CPR, .nd
continued for 30 ain. Duty cyclea were siailar for
both CPR ..thoda (54~IXI. Defibrill.tion w.s .tteapted
with ...xiaua of 3 ahocks. Ho aedications, other than
bicarbonate, were used. Defibrillated aniaal. were
followed for 24 hours. Baseline heaodynaaica and pH
were the a.ae for both groupa. Coron.ry perfusion
preaaur.was aignificantly greater with HI CPR
throughout the resuscitation.ffort (21~8 va 11~1 .aHgl
p<O.OOll. Ia..diate r.auscitationaucceaa w••
aignificantly better with HI CPR than with STD CPR
(11/13 va 2/13; p<0.002). Twenty-four hour survival
wa. alao greater with HI CPR (8/13 va 2113; p<O.03).
High iapul.. CPR appears bett.r than STD CPR for
reau.citationand 24 hour aurvival following 30 ain of
cardiac arreat in this canine aodel.
AORTIC PRESSURE FLOW AND DIAMETER IDENTIFY MECHANISM OF
BLOOD FLOW DURING CPR.
61!n Dt G'ir~i. M.D., Charles BeatHe, M.D., Henry R.a per n,. " Rafael Beyar, H.D., Joshua E. TSitl1k,
H.D., EdwardWurmb, B.S.~ Nisha Chandra, H.D., Hyron L.
Weisfeldt, H.D., F.A.l;.C. Johns Hopkins Hospital.
Baltimore, HO.
If blood flow during external chest compression is
due to direct compression of the heart, ascending
aortic pressure (Asc Ao Pr) should rise as a
consequence of ascending aortic flow (Q), Asc Ao Pr
aheul.d increase before descending thoracic aortic
prellsure (Desc Ao Pr) I and aortic diameter (Ao Diam)
should increase as l;he stroke volume is ejected.
Alternatively, if flow is due to intrathoracicpressure
f luctuations. Aac Ao Pr should rise before Q. Asc Ao Pr
and Desc Ao Pr should rise simultaneously as the thor.x
is pressurized and Ao Diem should decrease as blood is
squeezed out of tbe thorax.
Conventional and rapid impulse chest compression
were performed at eqUivalent compression forces (396~10
Newtons) in 7 chloralose-urethaneanestbetized dogs,
wi th internal massage serving as direct cardiac
compression and vest CPR as pure intratboracicpressure
fluctuation. During internal massage, Q and Asc Ao Pr
rose synchronously, while Desc Ao Pr lagged bebind Asc
Ao Pr by 28:t3 uec, During vest CPR Q lagged behind
Aac Ao Pr by 46:t.4 ueo, and Asc Ao ~r and -Deso Ao Pr
rose synohronously. Pressure-flow patterns for
oonventional and rapid impulse CPR were similar to
those for vest ~PR: aortic pressures increased
synohronously and Q lagged by 46t6 and 41:t.4 ueo,
respeotively (p<O.OOl vs internal massage). Tbese
patterns did not ohange after epinepbrina or very bigh
oompreasion foroes (>,00 Newtons). In 4 otber dogs,
Diam deoreased by 12:t.4' during external compreaaion,
and increased by 13:t.4' during internal massage
(p<O.OS) •
We oonolude that the intratboraoic pressure
meobanism is dominant during external ohest
compression. inoluding rapid impulse CPR.
ANALYSIS OF MITRAL VALVE MOTION AND
TRANSMITRAL FLOW IN DOGS DURING MANUAL
CARDIOPULMONARYRESUSCITATION
MP Feneley, GW Maier, JW Gaynor, SA Gall,
JA Kisslo, JS Rankin (FACC)
Duke University Medical Center, Durham, N. C.
The thoracic pump model of forward blood flow
during cardiopulmonary resuscitation (CPR) views the
heart as a passive conduit, implying net antegrade flow
across an open mitral valve during chest compression.
To test this model, two-dimensional echocardiograms
were recorded in 9 dogs (18-26 kg) , from the right
chest wall (n=7) and/or the esophagus (n=4) , during
manual CPR . The heart was fibrillsted electrically
(n=6) or arrested with potassium (n=3). Ascending
aortic pressure (AP) was measured with a micromano-
meter. While the aortic valve opened with the onset of
each chest compression, the mitral valve closed rapidly
with brief. high-velocity (hlgh-impulse) compressions of
the sternum or left chest wall , and re-opened with
release. despite widely varying compression forces
(peak AP range 20 to 200 mmHg). Furthermore, left
atrial injections of echocardiographiccontrast via trans-
thoracic catheters confirmed the absence of antegrade
atrio-ventricularflow during high-impulse compressions
and its presence during release. The mitral valve did
not close , however, during more prolonged, low-velocity
chest compessions, nor during abdominal compressions
or ventilation alone. These observations confirm the
importance of CPR technique in determining the mech-
anism of CPR. The observations during high-impulse
CPR are inconsistent with the thoracic pump model and
strongly suggest direct cardiac compression as the
dominant mechanism of blood flow with this technique.
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DIFFERENCES IN ARTERIAL, VENOUS AND MYOCARDIAL BLOOD
ACID-BASE STATUS DURING CARDIOPULMONARY RESUSCITATION.
E. Capparelli, Pharm.D., M. Chow, Pharm.D., J. Kluger,
M.D.,F.A.C.C., A. Fieldman, M.D.,F.A.C.C., Hartford
Hospital and Univ. of Conn., Hartford, CT.
d I' I,eses es es=509 cm d =509 cm I(, Inn;\ I( Iope) (s l ope)es es 1 s 0 e s 0 e
HNCM 24.6% 0.86 se;;1 0.264 -0.588cm2Tn -0.0192 cm'/gsec
Normals 33.8% 1.09 sec 0.119 -0.249cm'/o -0.0076 ciP!7Csec
p~ .0001 .0001 .0001 .0001 .0001
CONCLUSION: Our data show consistently, that with norma-
lized end-systolic wallstress by afterload challenge the
contractile function is impaired in HNCMcompaped to
normal. Also the altered slopes of the end-systolicstress-
length and stress-shorteningrelations indicated an
impaired contractile state in HNCM.
NON-INVASIVE ASSESSMENT OF THE END-SYSTOLIC STRESS-LENGTH
AND STRESS-SHORTENINGRELATION IN HYPERTROPHICCARDIOMYO-
PATHY.
Gerd Hausdorf,M.D., Volker Siglow, ChristophNienaber,M.D.
UniversityHosp.Hamburg, Dept.Cardiology, Hamburg, FRG.
To investigate the hypothesis of supra-normalcontractile
function inhypertrophiccardiomyopathy,we studied the
end-systolic stress (des)-dimension (Des) and stress-
shorteningrelations in 10 pts withhypertrophicnon-
obstructive cardiomyopathy(HNCM) and in 30 normals by
incremental afterload challenge with angiotensin11 (1-3
~g/min), as angiotensin11 does not effect preload. Serial
measurementsof LV-dimensions and posterior wall thickness
were performed by 2D-echo and M-mode echo, end-systolic
pressurewas assessed by calibratedcarotid pulsetracings.
In HNCM the ejection phase indices (fractional shortening
(FS) and mean fibre shortening velocity(mVCF)) were supra-
normal at rest, but when oes was increased to normal values
(des=50g/cm') FS and mVCF were significantly lowered (p~
.0001), and the slope of the des-Des relation, des-FS
relation, and des-mVCF relation was significantly steeper
compared to normal (p~.OOOl):
FS at mVCF at d -0 d -FS d-mVCF
LACTATE
(mM/L)
1.8+1.0
1.8+0.9
0.9+0.7
02SAT%
98.8+0.6
73.9+13.9
40.4+17 .8
HC03-
21.6+1.6
23.2+2.1
27.3±2.0
The purpose of this study was to compare arterial, mixed
venous and great cardiac vein (GCV) blood gas and lactate
determinationsin dogs during standardcardiopulmonary
resuscitation (CPR) (without bicarbonateadministration).
CPR was Kerformedusing a pneumatic compression device
(Thumper) following 3 minutes of a fibrillatoryarrest.
Simultaneous blood samples were obtained from the AO, PA,
and GCV during sinus rhythm prior to arrest and after 5
minutes of CPR. The results from 11 dogs are:
DURING SINUS RHYTHM
E!! PC02
AO 7.35+.03 39.6+3.9
PA 7.31+.03 45.9+5.6
GCV 7.29+.04 57.2+5.0
DiJRING CPR -
AO 7.42+.09* 15.5i3.1* 9.9+2.9* 99.2+0.4* 6.6+2.9*
PA 7.08+.10 72.9+33.2 20.7+2.2 24.8+7.6 7.5+2.4
GCV 6.79+.14* 122.4+43.0* 18.3+3.5 13.2+11.3 14.0+3.1*
*P<O.05 versus PA and GCV during CPR
tF<b.005 versus PA during CPR
Our data indicates: (1) There is a much larger gradient
in lactate, pH and PC02 determinationsbetween AO, PA
and GCV samples during CPR compared to sinus rhythm. (2)
During CPR arterialpH and blood gases do not reflect
the marked acidosis and hypercapnia seen in venous (and
therefore tissue) samples. (3) Although mixed venous
blood gas and pH measurements are more representativeof
tissue acid-base status during CPR, these measurements
may not adequately reflect the acid-base disturbances
seen by the myocardium, as shown inthe GCV samples.
HEART RATE DEPENDENTLOW·INPUT . LOW OUTPUT CIRCULATORY
FAILURE - THEMECHANISMOF SYNCOPE IN HYPERTROPHYC CARDIO-
MYOPATHY
Chriltoph A. Niellllber,MoD., Slblne HiUer, M.D.,ManfredGeiger, MoD., Rolf P.
Spielmann, M.D.,Dept. of Cerdiology, and Nucelar Medicine,Uniwnity Hospitel
Eppendorf, Hamburg, West Germeny
I In- 171
892 ±.121 ff1 ±18 323 t54 82~34 526+69 48 t.12 8t7
436 69.±.14 136t29 56t3O 362.t 5 22 ±. 5 13:t 5
~
=:.±.91·821 :1:47 76.:t 13 339 i: 49+ 111 ±31 39t. 8+ 10± ~
436 64±2O 273'1:44' 79*30 _±54 • 15± 6' 18 ±. 6'"
To e..luete cerdiac hemodynemics in hypertrophiccerdiomyopethy(HCM)during
techycerdilsimuleting conditions 26 conl8Cllti... HCMpetients (ptl) with history of
anglne/ dyspnoe (group I, 17/26) and Iyncope (group11, 9/26 ) were _jectedto
thermodilutioncetheterizetlonand limuheneolll redlonudicle angiogrephy during
incrementel rightetrill pecing (RAPI. Relallltion, filling and ejection cherecteriltics
were IIlIlIlUred in increments frombueline to Iymptom·llmited mexlmel pecing
hllllrt rete. The2D«hocerdlogrephicextent and location ofhypertrophyexpreued
al Wlglaocore IWSIW81 significantly higher In group11 with syncope (WS - 8.2 ~
1.4181 compered to groupI (WS - 4.1 + 21, (p <: .011.
mPCP
(mmHgI
LVEF PFR (mllll IRP (msl tPFR (ml) SVI
("'I (ml/m2)
CL (ml)
·p..oO.05 VI group I;+pL0.05 VI normell
CL - cyde length; PFR - peek fillingrite; t - time; IRP - ilOvolumetricrelallltion
period; SVI • stroke volume index; mPCP- meen pulmonery cepiUeryp...ure
Conclusion: Decrementlllinulcyde length in HCMleldl to left ... ntricular dlastolic
and systolic functionel impairment with_sequent low input • Iowoutputstate.
The _Itvof circulatory faUure il related toextentof hypertrophyal gl... n by WS.
T~ findinlll mey elucidate the etlology of HeM-related symptoms such al axertlo·
nol angine and explain the mechani,m of syncope al ,ubcritlcelmyocerdia'andbrain
perfusion.
Measurement of the ESPVR requires multiple P-V loops
determined under varying load conditions. For in situ
detel'lllination in dogs this has been practical through
vollllle measurement by conductance catheterand al tering
load using IVC balloon occlusion. We applied this
technique to patients and developed a semi-autanatedon
line system which enabled the collection, editing, and
analysis of PV data at the time of cardiac
catheterization. We studied 9 patients (8 men,l women,
56z. 10.6 yrs). 7 had coronary artery disease and 2
cardiomyopathy. PV loops were easily monitored within
1 minute of catheter placement, and data analysis could
be canpleted in about 10 minutes. Calibrationrequired
cardiac outputs and injection of 10 ml of 10X normal
saline for absolute volume calibration. A balloon
occlusion catheter in the IVC inflated to 3 cm diameter
decreasedLV pressure by 23 z. 10.6 (SD) mmHg in seven
patients, with no detectable decrease in 2 patients. An
average of 7z.1.3 consecutive loops were used to assess
the ESPVR with a mean r value of .942z..004. The slope
of the ESPVR (Ees) averaged 1.49 z.1.17 (SO) mmHg/ml,
and the volume intercept (Vo) averaged -47.5 z.65.2
(SO) ml for the group but included an Ees=1.45, Vo=54.8
with a ventricular aneurysm, an Ees=.45, Vo=-49.2with
idiopathic cardiomyopathy, and Ees=3.71, Vo=-18.8 with
normal ventricularfunction. Thus it is possible to
easily obtain the ESPVR as part of a routine cardiac
catheterizationin most patients.
I1EASUREMENT OF THE LV END-SYSTOLIC PRESSURE-VOLUI1E
RELATIONSHIP (ESPVR) IN PATIENTS BY CONDUCTANCE
CATHETER AND IVC BALLOON OCo..USION. David Kass I1D, Mark
l1idei MD, Wlllard Graves PhD, W. Lowell Maughan MD.
Johns Hopkins University, Bal timore Md. 21205
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MyocardialFunction:Effects of ChronicDisease and
Acute Interventions
202A ABSTRACTS lACC Vol. 9. No. 2
February1987:202A
LVP (rmlig)
LAP (rmlig)
Pmi n (rmlig)
T (msec)
-dP / dt (rmlig/5)
EDD (mm)
+dD/dt (mm/s)
LEFT VENTRICULAR DIASTOLIC FUNCTICtl DURlfIG VENTRICULAR
TAQ-lVCARDIA: EFFECT OF a ADRENERGIC RECEPTOR ACTIVATlCtl
Ctl M'fOCARDIAL RELAXATICtl Ted Feldman M.D., Dwain L
Coggins M.D., John DCarroll M.D. The University of Chicago, IL
Ventricular tachycardia (VT) produces a brief diastole,
potentially preventing complete myocardial relaxation between
contractions.In 6 chloralose anesthetized dogs, VT was simulated
by RV pacing (cycle length=250ms). LV function was assessed
during sinus rhythm and during VTbefore and after Il-blockade
with propranolol(2mg/kg). Micromanometersmeasured peak LVP,
minimum diastollc LVP (Pmin), dP/dt, and LAP. Peak LV
lengthening rate (+dD/dt) and LV end-diastollc dimension (EDD)
were measuredwith antero-posteriorendocardialpiezo crystals.
CCtlTROL Il-BLOCKADE
NSR VT NSR VT
Ti4 94 120"78*
6.4 9.1* 7.5 10.9*
3.9 4.2 6.6 10.2*
23 26 29 41 (p=.07)
2317 1541* 2043 831*
37.7 36.2 39.3 38.6
109 137 89 123
*=p<0.05 vs sinus rhythm
Under control conditions, Immediately after onset of VT there
was severe systollc hypotension. During VT, LVP and+dP/dt
recovered to sinus values. Minimumdiastollc pressure did not
rise and T was not prolonged despite LV asynchrony. After Il-
blockade systollc LVP failed to recover, Pmin and r rese, and max
-dP/dt recovery during VT wasblunted.
CONCLUSIONS: WithIl-adrenergic mediated augmentation of
myocardial relaxation, diastollc pressure remains low during VT
despite the abbreviated diastollc time and asynchronous
relaxation. Hemodynamic recovery during VT requires a
augmented relaxation. This functional response may beclinically
importantsince adrenergicdown-regulationand Il-blockingagents
are com mon inpatients susceptible to VT and suddendeath.
INTERDEPENDENCE OF VENTRICULAR WALL STRESS AND
EJECTION FRACTION IN DETERMININGSURVIVAL IN
SEVERE CHRONIC I-£ART FAILURE. MarrickL. Kukin MD,
Stephen S. Gottlieb MD, Martin E. Goldman MD,FAce, Jonine
L. Bemstein MS, Dovid I. Freilich MD, Milton Pocker MD,
FACC. Mt. Sinai School of Medicine, New York, NY
Heightened ventricularsystolic wall stress (0) has been postul-
ated to accelerate myocardialdeterioration& mortality in heart
foilure (CHF). To verify this, we meosured o by echocardio-
graphy in 116 CHF pts, whowere divided into high- and low-o
subgroups based on a median 0 of 270 dyn/cml • Cardiac index
(Cl, I/min/ml ) , RV and LVstroke work indexes (RSW& LSW, g-
m/ml ) , LV filling pressure(LVFP, mmHg),heartrate (HR, bpm),
systemic vascular resistance (SVR, d-s-c), radianuclide LV
ejection fraction (EF, %) & serum No concentration(sNa, meq/ll
were measuredbefore vasodilatorsin both subgroups(* = p <.05):
Cl RSW LSW LVFP HR SVR EF SNa
0<270 (64 pts) 1.8 8.0 16.6 24 81 1974 17 135
0>270 (52pts) 1.7 7.4 16.2 27* 90* 20.31 13* 137~
Despite higher EF and lower LVFP& HR, pts with a 0<270 did
not have a better survival than pts with higher 0 (41% vs 45%,
r:yr). The unexpectedly poor survival of low-o Cif. pt~ was
related to their low sNa, a markerof neurohormonalactivation.
As expected, 0 varied inversely with EF in CHF pts with a
norma I sNa (r= 0.5 I). In contrast, although hypoNa ~ts had a
lower 0 than pts with a normal sNa (265 vs 292dyn/cm , p <.03),
they did not have ahigher EF (14% vs 17%, p= NS), suggesting a
greaterdepressionof myocardialcontractilityin hypoNa pts,
In pts treated with direct-actingvasodilators, pts with low 0
fared worse than pts with high 0 (18% vs 40%, I-yrsurvival,
p = .05), whereas in pts treated with converting-enzyme
inhibitors,the survival in high- and low-o groups wassimilar.
In conclusion, CI-F pts with a low EF and low 0 have aworse
survival thon pts whose low EF can beattributedto their high 0;
this may relate to a greater impairmentof cardiac contractility
and secondaryneurohormonaloctivation in low-o pts with CHF.
PROGNOSTIC VALUE OF ECHOCARDIOGRAPHICPARAMETERS IN
CHRONIC CONGESTIVE HEART FAILURE: THE VHEFT STUDY
P.M. Shah. M.D.• F.A.C.C.• D. Archibald, B. t.opez , R.N.•
J.N. Cohn, M.D.• F.A.C.C.
VA Cooperative Study Group &Wadsworth VA/UCLA Medical
Center. Los Angeles. California.
Previous reports on role of echocardiographicparametersof
left ventricularfunction to assess prognosis in heart
failure have been conflicting. In a prospective trial of
therapy on survival in 642 patients with heart fai1ure.m-
mode echocardiogramswere obtained at entry prior to ran-
domization. The average duration of follow up was 2.3
years (6 months to 5.7 years). The echo parameterswere
measured at a core laboratoryby one technician. The par-
ameters ana1yzed include: left ventricUlardimension at
end diastole (LVIDd) and end systole (LVIDs). fractional
shortening (FS). ratio of LVID over septal and posterior
wall thickness at end diastole (D/Th-d) and end systole
(D/Th-S) and mitral E point septal separation (EPSS). All
these parameterswere significant univariate predictors of
mortality. the power of prediction being represented by
the p value.
LVlDd 438 68.5 + 10.3 mm 0.003
LVlDs 437 56.8 '+ 10.8 I1Il1 0.0002
FS 435 0.17'+ 0.007 0.003
D/Th-d 426 4.06'+ 1.25 0.0003
D/Th-s 420 2.61 '+ 0.95 0.0001
EPSS 478 23.1 ±: 7.7 mm 0.0001
Conclusion: Two m-mode echo measurements D/Th-s• 1nd1ca-
tive of dilatation without appropriatehypertrophyand
EPSS. a measure of ejection fraction (EF) were moresignif-
icant prognosticatorsof mortality in heart failure.
These parametersmay be useful in design of prospective
trials on survival in chronic congestive heart failure.
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TherapeuticApproaches to the FailingHeart
SKELETAL MUSCLE PERFUSION IN CCF: THE EFFECTS OF
CAPTOPRIL
Adam D. Timmis.MD, MRCP, Lesch M.R. Bojanowski, BSc,
Youssef Najm, LM. Raymond Gosling, Ph.D., Dept. of
Cardiology, GUy's Hospital, St. ThomasStreet, London,
England.
Captopril improves exercise tolerance in congestive cardiac
failure (CCF) but the mechanism of this beneficial effect
is uncertain. We have examined the effects of captopril
on oxygen consumption in the exercising leg using Doppler
measurementsof femoral flow and arteriovenousoxygen
difference. Twenty patients with CCF were randomized to
captopril 25 mg (n = 101 or placebo (n = 10). Maximal
supine exercise of one leg was performed before and 1 hour
follOWing treatment. Captopril increased stroke index
at peak exercise from 26 ~ 8 to 34 ± 10 ml/beat/m2 and
reduced pulmonary wedgepressure from 26 ~ 9 to 16 ~ 10
mmHg (p <0.05). Exercise time increased from 12.5 ~6.3
to 15.5 + 11.4 minutes (p <0.051. Despite the improve-
ment in ~entral haemodynamics andexercise duration there
was no significant change in peak values for femoral flow
(1060 + 564 to 942.t. 421 ml/min I and oxygen consumption
(134 +-S1 to 111 + 58 ml/min) in the leg. Cutaneous
flow,-as reflectedby skin temperature.was also unaffect-
ed (29.9 ~ 1.8 to 29.7~1.70C). Repeat studies after 4
weeks' treatmentwith captopril showed no change in peak
oxygen consumption in the leg. In patients randomized to
placebo neither central haemodynamics nor oxygen consump-
tion in the exercising leg altered significantly. These
data confirm that captopril improves central haemodynamics
in CCF. Nevertheless its effects on oxygen consumption
in the exercising leg are not significantly different
from placebo. Thus the therapeuticbenefits of captopril
in CCF are not mediated by improved flow redistribution
to exercising skeletal muscle.
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All Patients
8 Change
56.5 145**
32.3 2.6**
3.4 -0.5**
1.5 -0.6**
ENALAPRll IN THE CHRONIC TREATI'IENT Of CONGESTIVE HEART FAILURE
PATIENTS.
B.A. Price. B.S.R.N. • S·. Snapinn,Ph.D., P.S. Denny, B.S., E.J.
Ruclnska, 1'1. D. PhD. , J.D. Irvin. 1'1.0. PhD. I'Ierck. Sharp andDohme
ResearchLaboratories,Ilest Point, Pennsylvania .
One hundred and twenty-seven congest iveheart fai 1ure (CHF) patients
(pts) were analyzed in this lB center study. Following a tllO week
baseline (B), pts entered one ofthree groups: (1) The open-label group
(N:46) received an initial dose of 5 mg of enalapril (E), followed by
2.5-5 .0 mg BID; (2) The double-blind BID group (N:33) received 5mg E
in the a.m. and p.m. with a matching placebo in the a.m.; (3) The
double blind QD group (N:34) received 10mg (tllO 5 mg tablets) in the
a.m. and placebo in the p.m.. E could be increased to 20mg/day in
all groups. 721 of the pts received20 mg of E.
After 16 weeks of E therapy, duration of exercise (EX , sec) and
ejection fraction (Ef, I) , increased, heart dilation (Hd, cm) and
1iver enlargement(le, cm) diminished:
Group I Group 2 Group 3
B Change B Change B Change
Ex 63.0 154** 56.6 110** 51.6 170**
Ef 2B.8 2.7* 36.3 2.6 32.0 2.4
Hd 3.1 -0.4 3.6 -0.6* 3.6 -0 .6
le 2.0 -0.8 1. 1 -0.6* 1.1 -0.2
Significant change from B, *P < .05, ** P < .01
No significant differences in efficacy par"""terswere noted between
the 5 mg BID and the 10mg QD groups.
Iq>rovement in NYHA cardiac status occurred in 79 (64) pts (P<.05)
while 5 (4) pts IIOrsened. The signs and syq>toms of CHF iq>roved
from8 in a significant nll10er (I) of patients as follows: dyspnea on
effort (791) . dyspnea at rest (771) and edema (821) .
Dizziness (91) and hypotension (611 were the mostfrequently reported
adverse experiences.
Conclusions: E in doses of 2.5 to 20 mg aaninistered 81D or QD for
sixteen weeks, significantly iq>roves durat ion ofexercise and cardiac
status of CHF pts. E is well tolerated in the long term treatment of
CHf.
BAIJ.OJN AORI'IC VALVULOPLASTYIN PATIENTS WITH IfJI1 LEFT
VENl'RIClJI.oP,REID:TION FRACTION Rn Safian MD, SE Warren
MD, AD BermanMD, DJ Diver MD, HR Royal MD, PC care MD,
FN:C, WGrossmanMD, FAO:, RG ~Kay MD.
Harvard-'TI1orndikeLaboratory.Beth Israel Hospital,
Boston, MA
Balloon aortic valvuloplasty (BAV) was performed in
15 patients (pts), age 79 + 5 years, with critical
aortic stenosis and depressed «50%) left ventricular
(LV) ejection fraction (EF). Serial changes in LV
performancewere assessed by radionuclideventricu-
lography before, imnediately after, and 6 weeks
post-BAV. All pts had marked synptarati c improvement
post-BAV• Ten pts (Group A) derronstratedprogressive
i ncreases in LV EF (36 to 49 to 59%). In these pts
increases also occurred in LV peak f illing rate (PFR1 .8
to 1.9 to 2.2 FIN/sec), while progressive decreases
occurred i n LV end-diastolic volute index (EDVI 138 to
119 to 99 ml /m2); and no change in stroke-volure ratio
(SVR 1. 5 to 1.4 to 1.4). Five pts (Group B) sho.oied no
change in LV EF (41 to 41 to 40%). These pts shoeed
incr eases in LV PFR (1.5 to 2.1 to 1.9 EIJIl/sec), LV EDVI
(113 to 111 to 156 ml /m2) and SVR (1.2 to 1.3 to 1. 7) .
Of note, peak systolic pressure-volumeratio increased
acutely in Group A (1.4 to 1.6) and did not change in
Group B (1.4 to 1.4). Pre-BAV aortic va l ve areas and
gradientswere similar between both groups. Post-BAV,
Group B showedgreater increases in va l ve area carq:>ared
to Group A (1.1 vs 0.8 cn2) and greater reduction in
valve gradients (24 vs 39 nm Hg, p=0 .02).
In conclusion: 1. In pts with low EF, BAV may be
associated with enhancementof LV systolic and diastolic
function and contractility. 2. Patients who achieve
greaterchanges in valve areas and gradientreduction
may also develop valvular regurgitationand mild volume
overload hypertrophy.
COMPARI SON OF EFFECTS OF CAPTOPRI LAND DIGOXIN ON
EJECTIONFRACTION, EXERCISE TOLERANCE, CLINICAL STATUS,
AND ARRHYTHMIAS IN PATIENTS WITH MILD TO MODERATE HEART
FAILURE.
The Captopril-Digitalis Research Group , presented by
Sidney Gol ds t e i n , M.D . , F.A.C.C. and BertramPitt, M.D.,
F.A .C .C •• Detroit, MI .
Pr evi ous s tudies indicate that the combined use of capto-
pril (C) and digoxin (D) improve cardiac function in
patients (pts .) with heart failure. In order to compare
the separate effects of C and D on ejection fraction (EF).
exer cise time (ET) , functional class (FC), and ven t r i c-
ular prematurebeats (VPB/ hr) i n mild to moderate heart
f ail ure, 300 pts. were randomly assigned double-blind t o
3 treatment groups: D. 0 . 25 mg. daily (96 pts. ); C, 50
mg. t .Ld. ( 104 pts.); a nd placebo (P) ( l OO pts.). Pts.
were mai ntai ned on furosemide. Vasodilators and cardi o-
t on i c dr ugs were stopped. Et iology of heart failure was
ischemi c in 63%, cardiomyopathy in 31%, other in 6%.
Basel ine measurements of ET, EF, FC, and VPB/hr were
obtai ne d after 2 weeks of P and furosemide therapy alone,
and a f t er I, 3 and 6 months of treatment. Mean values
were ana l yzed using the last blinded visit within 6 months
of treatment. Fe is expressed as %of patients improving.
CHANGE FROM PRE-TREAMENT
Pre-Treatment C D P
ET 563 sec +17 %* +11 % +9%
EF 26% +1. 8% +4.4%** +0.9%
VPB 67/ hr -15/hr +61/hr +33/hr
FC 2.3 +41%*** +31 % +22%
Difference * from P (p<. 05) . ** from P (p<. 005) and C
(p <.05), *** from P ( p<. Ol) .
This data indi ca t es that when used i n conjunc Ci on with
fu r os emide , ca pt opr i l significantly increases ET and FC
compared t o P whe r eas digoxin increases EF without sig-
ni fi ca ntly affecting ET and FC. Thes e results suggest a
primarily r ole of ca pt opril in t he treatment of mild t o
moderate heart failure.
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Results of PediatricCardiacSurgery
RESULTS OF THE MANAGEMENT OF PATIENTS WITH TRANSPOSITION
OF THE GREAT ARTERIES IN THE CURRENT ERA
George A. Trusler, M.D., Aldo R. Castaneda, M.D.,
F.A.C.C., Amnon Rosenthal, H.D., F.A.C.C., Eugene H.
Blackstone, M.D., F.A.C.C., John W. Kirklin, M.D.,
F.A.C.C. and The Congenital Heart Surgeons Society
245 unselected neonates less than 15 days of age with
transposition of the great arteries (TGA) have entered
( J a n. 1, 1985-June 1, 1986) an ongo ing 20-institution
study of the results of management. 77% were less than
48 hours old. 42 patients have died, and with 100%
follow-up, percent survival at 1 week, 1 month, 6
months, 12 months, and 16 months after entry was 94%,
90%, 87%, 84%, 80% and 77%. 12 patients died before
repair, 9 within 2 weeks of entry. Small birth weight
was a strong incrementa1 r j sk factor for death durj ng
the study regardless of management. 87 patients (17
deaths) have undergone an arterial switch operation, and
60 (6 deaths), an atrial switch operation. In patients
with simple TGA, on a defined management program,
survival 12 months after entry was 85% when the program
i nc l uded arterial switching and 89% with atrial
switching (P for difference >.2). Among the 245
patients, an important VSD was not a risk factor for
death, nor was a Senning vs. Mustard type of atrial
swi ten repai r , Survi va 1 was better more recentIy (no
deaths among 28 patients undergoi ng the arteria I swi tch
operation i n institutions committed to that approach
after Jan. 1, 1986). However, 12-month survival of
neonates entering June 1, 1986, with normal birth weight
on any management program Is predic ted to be on 1y 89%,
i nd ica t i ng the need for further study and improvement.
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RIGHT AND LEFT VENTRICULAR FUNCTION 10 YFARS AFTER
MUSTARD OPERATION FOR TRANSPOSITION OF THE GREAT ARTERIES
Clare Hochreiter, M.D., Nunzia S. Fatica, M.D., Michael S.
Snyder, M.D., Jeffrey S. Borer, M.D., F.A.C.C., Mary AlIen
Engle, M.D., F.A.C.C., CorneIl Medical Center, New York,
NY.
To evaluate right and left ventricular (RV and LV)
function 10 years after Mustard operation for simple
transpositionof the great arteries (TGA) in 7 pts and
complex TGA in 1 pt, we performed examination, ECG, chest
X-rays, exercise treadmill tests (ETT) and radionuclide
cineangiography (RNCA) at rest and during supine exercise
at a mean 10.9(8.2-14.5) yrs after surgery. All pts were
asymptomatic on ordinary activity. The 2 oldest had
undergone Blalock-Hanlon atrial septectomy in the first
10 days of life; the others had Rashkind atrial
septostomy as newborns. Mustard operationwas performed
at ages 2/12 to 6 3/12 years (mean 1 6/12). The pt with
complex TGA had coarctationrepair at 1 moo and Mustard
operation plus closure of large ventricularseptal defect
at 2 moo We found all to be in regular sinus-like rhythm.
All but the one with complex TGA had average
cardiothoracicratio. All had normal endurance time and
heart rate response on ETT without ECG abnormalityor
symptoms. Two had a blunted rise in BP on peak exercise.
Resting RNCA ejection fractions (EF) for RV and LV were
normal in the 7 with simple TGA and low normal in the 1
with complex TGA: mean RV EF=49% (34-66%,nl~35%) and
mean LV EF=57% (45-7l%,nl~45%). On exercise, RV and LV
EF rose in all. We conclude that the right ventricle
functioned adequately, and that its hypertrophydid not
compromise LV function 10 years after Mustard operation
for TGA.
AN ASSOCIATION BETWEEN VASCULAR CHANGES ON LUNG BIOPSY
SPECIMENS AND POSTOPERATIVEMORBIDITY FOLLOWING THE FONTAN
PROCEDURE
Herschel C. Rosenberg, M.D., John G. Coles, M.D., William
G. Williams, M.D., George A. Trusler, M.D., Marlene
Rabinovitch, M.D., University of Toronto, Toronto,Ontario
Successful outcome of the Fontan procedure depends on
the status of the pulmonary vascular bed. Generally this
is extrapolated from preoperativehemodynamic assessments,
but we have in addition evaluated the histology of the
pulmonary vascular bed by morphometricanalysis of a lung
biopsy frozen section. While severe grades of vascular
pathology have helped exclude patients from operative
correction, we speculated that even lesser grades might
predict postoperative morbidity. We, therefore, retro-
spectively analysed the hospital course of 28 consecutive
patients undergoing a lung biopsy prior to completion of
the Fontan procedure. Morphometricfeatures did not dis-
tingUish the 7 perioperativeand 1 late deaths. In the
20 remaining patients, duration of hospitalizationwas
significantly prolonged with increasing severity of biopsy
grade (p <.05 ANOVA). Duration of hospitalizationcor-
related with the period of chest tube drainage postopera-
tively (r, .66, SEE=9.5, p <.01). No preoperativehemo-
dynamic variable correlatedwith postoperative morbidity.
We conclude that morphometricassessment of a lung biopsy
specimen helps identify mild vascular changes which pre-
dict increased morbidity after the Fontan procedure.
pre-\1V .092~.016. .308:.012 .498+.128 .525+.133 .870+.J94 .938+.368
ni-TV .065~plO< .02,353:.022 .473~.073 .517~.063 .838~.162 .978~.273
The pre-MV vs nl-TV comparison showed no difference in
.3F ,EF ,AF,E/A vel or E/ A area, nor were any differences seen
for pre- vs post-LV indicating normal LVdiastolic filling (the
increased pre-mv VTI was attributedto increased pulmonary
blood flow). When pre-TV wascomparedto nl-MV, the .3F was
decreased and the AF was increased indicating a shift in RV
filling to late diastole prior to AS. Similarly, the .3F (.257 vs
.358, P < .05) and EF (.463 vs .633, P < .05) were decreased
for the pre- vs post-TV compar-ison, Conclusion: RV filling is
shifted to late diastole in the systemic RV and normalizes
after AS. LV filling patternsare unchanged after AS.
NORMALIZATION OF RIGHT VENTRICULAR DIASTOLIC
FILLING AFTER ARTERIAL SWITCH PROCEDURE William
A. Scott, MD, A. Rebecca Snider, MD, FACC, Edward L. Bove,
MD, FACC, M. Anthony Schork, PhD, Univ of MI, Ann Arbor
To assess ventricular filling patterns pre- and post-arterial
switch (AS) procedure, 6 infants (age 5.3+4.2 d, wt 3.78+.44
kg) with d-TGA and intact ventricularseptum were comp8red
to 6 normal infants (age 4.0+1.1 d, wt 3.19+.82 kg). The
tricuspid and mitral valve inflows were examTned by pulsed
Doppler to determine the total velocity time integral (VTI),
peak E and A velocities, and the triangular areas under the
E and A waves. To determine the \\\ of diastolic filling in
early and late diastole, the E/ A velocity ratio, E/ A area ratio,
and the area fractions (EF,AF,.3F), determined by E,A, or 1st
third area divided by total VTI, were calculated. Comparisons
were made for the systemic (pre-TV vs nl-MV) and pulmonic
ventricles (pre-MV vs nl-TV) and foreach ventricle pre- and
post-AS (pre-TV vs post-TV and pre-MV vs post-M V). The
results are summarized below:
pre-TV
nlwMV
VTJ(m)
.090+.013-
.055~.OlO
.IF
.257+.040·
.367!:.085
EF
.463+.103
.SOO~.1l3
H
.673·,040·
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EIA vel
.793+.156
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EIA area
.700+.187
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PREDICTIVE FACTORS FOR DEVELOPMENT OF CHRONIC
EFFUSIONS FOLLOWING MODIFIED FONTANPROCEDURE-
DO THEY EXIST?
Angela Romano, M.D., Karen Peyser, M.D.,
John Murphy, M.D., WilliamNorwood, M.D., Ph.D.
The Children'sHospital of Philadelphia,Philadelphia,PA
Forty-two pts, 1.2 to 19 years, who survived longer than 3
weeks following a modified Fontan procedure (FP) were
evaluated retrospectivelyto determine parameterspredictive
of chronic pleural or pericardialeffusions. Chronic effusions
(CE) were defined as requiring three or more
pleuro/pericardiocentesesand/or persisting for greater than
three weeks. Six factors were analyzed: age, preoperativePA
anatomy,preoperativeventricularfOP, type of atrialsurgery,
post-operative RA pressure and mean RA-LA pressure
gradient.
Twenty pts (47%) developed CE. Three of 42 (7%) died; all
had CE. The meanage of pts with CE (7.6 yrs) andwithout CE
(7.9 yrs) was not significantly different. There was no greater
incidence in CE in 11 pts less than 3 yrs of age. The presence
of significant PA stenosis determinedby angiography was not
associated with an increase occurrenceof Cf. Of 6 pts with
ventricularEDP greaterthen 10 mmHg, 3 pts (50%)developed
Cf comparedto 17 pts (47%) withventricularfOP less than or
equal to 10 mmHg. Pts requiringintra-atrialconduit (n=6) or
baffle closure of the atrial septal defect to include the
tricuspid valve (n=8) did not have anincreased incidence of
Cf. Neither mean RA pressure, 14.3 vs 14.1 mmHg, nor mean
RA-LA pressure gradient, 8.1 vs 7 mmHg, was significantly
different in the two groups.
We conclude that age, PA anatomy, hemodynamic status
and type of atrial surgery were not predictive of the pt
populationat risk for the developmentof CE after a modified
FP in this series.
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POST OPERATIVE EVALUATION AFTER END-TQ-END SUBCLAVIAN -
LEFT CORONARY ARTERY ANASTOMOSIS IN BLAND-WHITE-GARLAND
SYNDROME.
Martine Montigny, M.D., Paul Stanley M.D., Claude
Chartrand,M.D., Nieolaas H. van Doesburg, M.D., Eugenio
Selman, M.D., Andre Davignon, M.D. F.A.C.C., Sainte-
Justine Hospital, Montreal, Quebec.
In most instances of anomalous left coronary artery
arising from the pulmonary artery (ALCAPA), surgical
treatment is recommended. Most cases reported to date
have involved ligation of th e ALCAPA or us e of a saphe-
nous by-pass graft. As establishment of a direct
systemic to coronary blood flow is expected t o provide
the best left ventricular function (LVF) recovery,
var i ous other corrective procedures have been proposed.
Subclavian-left coronary artery anastomosis (SLCAA)
appear s to be alogical approach; however, only 19 cases
have been r epor t ed todate and of these only a few have
had comprehensive post operative evaluation. With the
purpose of adding our experience to these isolated
reports, 4 patients operated at Sainte-Justine Hospital
at an average age of 33 months (27 to 44) with end-to-end
SLCAA were evalusted 6 to 46 months post-operatively.
The anastomosis was patent i n all cases. The fol l owi ng
parameters were improved significantly (p<O.05): cardio-
thoracic index (O.56!0.05 vs 0.63!0.05), ve locity of
circumferential fiber shortening (1.70!0 . 11 vs 1.21!
0. 47), cardiac index (3.5±0.7 vs 3.0±0 .7 1/min/m2 ) , end
diastolic volume index (74.6±24.7 vs 122. 7±l 5. 3 ml/m2 )
and ejection fraction (0 .S8±0.07 vs 0.33 ±0.06) . SLCAA
appears to meet the main criteria for an optimal physio-
logical correction of ALCAPA: restorstion of a two coro-
nary artery system, improvement of LVF and hopes of long
term patency. In addition, this technique may easily be
used in very young patients.
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SERIAL DOPPLER ECHOCARDIOGRAPHICASSESSMENT OF TRICUSPID
REGURGITATION FOLLOWING REPAIR OF VENTRICULAR SEPTAL DEFECT
IN EARLY I NFANCY: POSSIBLE RELATION TO OPERATIVE APPROACH.
~. Geoffrey Stevenson MD FACC, Isamu Kawabori MD, Warren
Bailey MD, Gregory MisbachMD FACC, Edward Rittenhouse MD
FACC, Dale Hall MD FACC, Peter Mansfield MD. Children's
Hospital and University of Washington, SeattIe WA
Improved diagnostic and surgical te chni ques have l ed t o
an increasing use of th e trans-tricusp id approa ch for re -
pai r of isolat ed ventricular 'septal defect in i nfan cy . As
this approach commonly i nvol ves sutu re or pat ch placement
in and amongst tri cuspid valve chordae, and mayinvol ve
pl acement of reinfo rc i ng sutures through the t r i cuspid an-
ulus, question ar i s es concerning pos t-operative tri cuspid
va lv e f unction. Conventional two dimens io nal Doppl er echo
was used for pre- and serial post-op assessment fo r t r i cu-
spid r egur gita t i on(TR) and i ts severity, i n 34 i nfants un-
dergoing r epai r of ventr icular sept al defect under 7 mon-
ths of age. All had no mor e t hanmild TR pre-op(angi o and
Doppler). In 22 patients(Group A), repair was via the t ri-
cuspi d valve , and in 12(Group B), via ventriculotomy. On
the day of surgery, the preval ence of TR was 91% i n Group
A and 92% in Group B, r angi ngfrom mild t o sever e but with
no signif i cant difference i n severi ty between gro ups. By
t he 7t h pos t - op day, pr evalence had decl i ned to 73% and
67% r espectively but mode r ate or severe TR was more preva-
l ent i n Group A: 81% vs 50% r espe ct i ve l y. By 3 years post-
op , TR continued t o be mor e pr evalent i n Gro up A(45% vs
33%), and of gr eater volume distributi on(30% vs 17%). Al-
t hough all patients were doi ng well cl in ical ly a t last
followup, t he i ncr eas ed pr eval ence and sever i ty ofTR in
Group A suggests the poss ib i l ity of lo ng term conseq uences
related to operative approach. Thi s coul d be esp ec i ally
important i n those patients with residual right ventricu-
lar hypertens i on.
RESIDUAL GRADIENTS FOLLOWING AORTICCOARCTATION REPAIR
ADVERSELY AFFECT SURV IVAL AFTER SUBSEQUENT REPAIR OF
VENTRICULAR SEPTAL DEFECTS.
Ste ven R. Gundry, Martin J . Elliott, Mar c de Leval ,
Jaroslav St ark. Hos pital fo r Si ck Ch i Idren, London
To determine whether inadequate relief of coarctation
of the ao r t a (COA) adversely affects the clinical course
of subs equent repair of ventricular se ptal defects (VSD),
we rev iewed 35 children who had repair of COA and then
later VSD closure between 1967-1986. Med ian age at COA
repair was 2+27 month s whire age at VSD repai r was 3+2
yrs , Twent y- pt s (57%) hadPA bands. Nine pt s (20%)- had
res idua l grad ients >IOmmHg ; 3 were successfully re-
repaired. At VSD cl osure, 29 pt s had i l0mmHg COA gradi-
ent s (mean 0. 1+1 mmHg) ; al l pt s surv ived ; inot ropes were
used in 7/ 29 (~% ) . Two pts had residual COA gradients
of 10- 20mmHg. Both pt s requi red high dose inot ropes but
died of noncardiac causes. Four pts had residual COA
grad ients >20mmHg (mean 33+5mmHg). All 4 pts developed
renal fa ilure, 2 requiring-dialysis. Al l needed massive
inotropic support. Three of 4 (75%) died while the
fourth required re-COA repair for ongoing failure.
No d i ffe re nces were detected between survivors and non-
su rvivors when compa red for age, pre-op hemodynamics or
ECG.
We concl ude that s ignifi can t res idua l gradients
fo l low in9 COA repa i r may adversely affect th e outcome
of subsequent VSD repair. Our findings suggest that
residual gradient s >30mmHg fo llowing COA repa i r should
be rel ie ved before VSD repa i r .
REPAIR OF ATRIOVENTRICULAR CANAL DEFECTS UTILIZING
CARPENTIER RECONSTRUCTIVE TECHNIQUES
James Narrod, M.D., Aubrey C. Galloway, M.D., Honika
Rutkowski , M.D., Eugenie Doyle... M.D., F.A .C.C. , Stephen
B. Colvin 1• M.D., New York university Medical Center,New York, NI
Ut ilization of Carpentier techniques of valvular
assessment and reconstruct 10n has i mpr ovedthe res ul t s
o f mitral valve repair i n adults. This study applied
the same techniques to the repai r of atrioventricular
canal (AVe ) defects in children.
Sixteen consecut i v e patients ( medi 4n age = 39
moa , ; median wt. = 16 kg) had AVC defects \11 complete
5 incomplete) repaired us in~ a 2-patch technique an~
Carpenti e r methods or valvular assessment and
reconstruction. Three patients had associa~ed
tetrology of Fallot, and 2 patients had double outlet
right v~ntricle. Pul.monary artery pr e a s ur e e q ua Led
s ystemlC 1n 8 patlents pre-operat1vel y . Repa lr
ut ilizecl cardiopulmonary bypass with systemic
hYI.0thermia and cold blood cardi oplegi a i n an but one
in ant in whom c i r c ul a t or y arrest was used. Fourteen
patienta required e ither valvular repair,
commissurotomy. cl;>ord;ae.shortening af)d/or snnuloplasty.
There waS no s i gnifi c a n t ve ri'rri c u La r dys fimct i on ,
valvular incompetence, or heart block post-operatively .
Seven of 8 patients ' wi t h systemic pu~monarl artery
pressures had s greater than 50 % drop r n pu monary
s r t e ry pre s sure post-operative ly , wh11e one had a 30:1:
drop. Average hospi t a l stay was! 1.4 days a nd there
were no d e a t ha , All p a t ae nt e are currently
asymptomQclc andNYHA Clas s I or II (mea n follow-up ~
10 mos.) . Late Doppler echocardi ogr amrevealed minimal
or no valvular insufficiency in all patients.
These results susgest that application of
reconstructive t a chn Lque s to repair of AVC defects
results in excellent valv ular function. Utilization o f
these t e c h n i que s may allow r e pai r i n patient s
previously considered to be onl ymarg1nally operable.
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MITRAL VALVE REPLACEMENT IN HYPERTROPHICCARDIOMYOPATHY -
TEN YEAR FOLLOW-UP IN 80 PATIENTS
Zvonimir Krajcer, MD, FACC, R.D. Leachman, MD, FACC,
Tomislav Azic, MD, Denton A. Cooley, MD, Texas Heart
Institute, Houston, Texas
Eighty consecutive patients, 38 males and 42 females, with
an average age of 49~16 years with hypertrophic cardio-
myopathy underwentmitral valvereplacement (MVR) alone
or in addition to other cardiac surgery at ourinstitu-
tion from 1970 until 1986. We reviewed their NYHA
functional class (FC),LV resting systolic gradient (RSG),
provocable systolic gradient (PSG), and LV end-diastolic
pressure (LVEDP) in mmHg preoperativelyand postopera-
tively, after mean follow-up of 10 years (1-16years).
*=p<0.05; **=p<O.OOl; Mean ~ SO
RSG PDG LVEDP FC I or II
Preop 75+45** 137+50** 20+9* 2.5%**
Postop 7+18 7+13 15+6 88%
Fifteen percent of thepatients had other cardiac surgery
(9 patients had coronary artery bypass surgeryand 3 had
aortic valve replacement) in addition toMVR. There was
1 operative death(1.3%). Actuarial cardiac survivalwas
89% and 85% after one month and one year. Linearized
cardiac deathwas 2.2% per patient year.
Our findings show that MVR as a treatment of hypertrophic
cardiomyopathyoffers low operative and long termmor-
tality. Among surviving patients there was a significant
improvement in FC, LV systolic gradient and LVEDP.
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New Techniquesin Electrocardiography
ECG CRITERIA FOR VENTRICULAR AND SUPRAVENTRICULAR
TACHYCARDIA IN WIDE COMPLEX TACHYCARDIAS WITH LEFT
BUNDLE BRANCH MORPHOLOGY.
Elizabeth Kindwall MD, Joan P. Brown RN, and Mark E.
Josephson MD,FACC. Univ. of Pennsylvania, Phila, PA.
The sensitivity (SN), specificity (SP) and predictive
accuracy (PA) of 5 ECG criteriafor ventricular
tachycaradia(VT) were evaluated in 118 pts who
presented with a wide complex tachycardiawith left
bundle branch block morphology. Criteria included
A) R>30 ms V1 or V2, B) any Q V6, C) >60 ms to 5 nadir
V1 or V2, D) notch on downstroke of 5 V1 or V2 and,
E) left axis deviation. All pts had diagnosis con-
firmed by electrophysiologic study (91 VT, 27 supraven-
triculartachycardia(SVT]). The effect of infarct
location on these criteriawas also evaluated.
All left axis normal axis
Criteria SP SN PA SP SN PA SP SN PA
A 100 36 100 100 39 100 100 30 100
B 96 55 98 94 64 98 100 37 100
C 96 63 98 94 64 98 100 60 100° 96 36 97 94 38 96 100 33 100
E 41 67 79
All ECG criteriaexcept E had high SP and PA for VT.
CriteriaBand C had higher SN than A and 0, especially
in VT with left axis. CriterionE also had relatively
high SN but low SP which limits its use. CriterionA was
more common in VT pts with inferior (74%) than in ante-
rior (25%) infarct, but B was more common in VT pts with
anterior (81%) than in those with inferior infarct (6%).
The combination of an R<30 ms in V1 or V2, ~60 ms to the
nadir of the 5 in V1 or V2, and an R in V6 had a SN of
96%, a SP of 97%, and a PAof 90% for SVT. Thus accu-
rate diagnosis of the mechanism of left bundle branch
block tachycardia is possible by ECG alone.
ACC\JlACV IN THE AUTlJ4ATIC DETECTION (J' VENTRIClLAR FIBRILLATION.
Gavin W.N.Dalzell. M.B., ()nar Beggs,B.Se., AlanBailey,B.Se., John
A!1derson, M.Phi!., andA.A.Jemifer Adgey, M.O., F.A.C.C., Regional
Medical Cardiology Centre,Royal Victoria Hospital, Belfast, BT12 6BA,
NorthernIreland.
The increasing development of semi-automaticand automaticexternal
defibrillatorsrequires that the algorithmS todetect ventricular
fibrillation (VF) lIlJst have a high degree of accuracy.Previouslywe
have reported theresults of a microprocessor based system withECG
sensing duringcardiac arrestsusing disposable pre-gelled defibrillator
pads. For every 8-18 secsanalysis of cardiac arrest rhythmS the
sensitivity for VF was only 741 but thespecificity 99lII. Now, using an
extendeddynamic range the following 2criteriahave to be satisfied
independently: a. absence ofisoelectric segment, b. QRS width,
variability and regularity. Zero content is optimized by input
filtering. If both a and b are met over 2 consecutive analysesi.e. 8
secs, VF is detected. If neither - non-VF is displayed. If only a or b
is satisfied for VF, another 4 secs ECG is analysed. If still only 1 is
satisfied the system will reset and begin analysis again. Excessive
artefact caused bycardiopulmonaryresuscitation (CPR) causes saturation
of the algorithmwhich then resets each sec. The result is displayed
visually every 8-12 secs as non-VF or VF. SilllJltaneously theECG and
system's analysis are recorded on tape. Later the system'sanalysis
is compared with the ECG. Cardiacarrests In 25 patients (pts)(13 male,
12 female) aged 43 to 86 (mean 63.9 yrs) werestudied. Acute myocardial
infarctionhad occurred in 8pts. The initial rhythm in 2 pts was
correctly detected as VF while non-VF wascorrectly detected in 21 of 23
pts. There were 123epiSOdes (eps) of VF (8-12 secs) of which 116 were
correctly detected (sensitivity 94.31). When the rhythm wasnon-VF,
the systemcorrectly detected 2873 of 2945 eps (specificity 97.51). Of
the 7 eps of VF incorrectlydetected 3 wereVF of low amplitude
« 0.5 mV), one hadCPR and in 3 a change ofrhythm to VF occurred
during the 8-12 secsanalysis. False positive identificationas VF was
caused by agonalrhythms andCPR inducedartefact. If is now possible
during thecardiac arrest to detect VF automatically with both a high
sensltivity (94.31) and apecificity (97.51).
HOll GOOD rs THE AHA ARRHYTHMIA DATABASE (AHA-ADB) FOR
EVALUATING CCU MONITORS?
Robert E. llernlkoff, Ph.D., Eugene M. Strand, M.S., L.
Thomas Sheffield, M.D., F.A.C.C., llilliam J. Rogers,
M.D., F.A.C.C., John H. Holt, M.D., F.A.C.C., Sharon M.
Dailey, M.D., llynne Crawford, M.D. and John C. Balcarek,
M.D., Cardiology Division, University of Alabama,
Birmingham, AL
The AHA-ADB was obtained mostly from ambulatory
Holter recordings, and the number of recordings included
for each arrhythmia (AR) was determined by committee
rather than by their relative frequency in a CCU or
other pt population. Also, the AHA-ADB includes
virtually no examples of artifact. Hence the question
in the title.
lie are developing an AR database (UAB-ADB)
collected exclusively from CCU patients. Both the pts
to be recorded, and recording segments to be annotated,
were chosen by a random mechanism; annotation was done
independently by 3 cardiologists (MD). lie have 131
annotated cases; as of this writing, 112 had been
cleared of inter-physician discrepancies and were used
for this preliminarycomparison. In time intervals in
which neither the MD nor monitor were calling artifact,
we found for our Siemens bedside monitors:
AHA-ADB UAB-ADB
Sens. for det. of NL 99.4\ 99.5\
Sens. for det. of PVC 97.9\ 96.9\
False Pos. PVC rate 0.42\ 0.51\
Thus AHA-ADB is useful for predicting performance in
noise-free intervals. But when intervals called
artifactual by MD are retained in the performance
evaluation, the false-positive PVC rate (0.861\) is
double that predicted by using the AHA-ADB. lie conclude
that it is desirable to supplement the AHA-ADB with more
realistic data for CCU monitor evaluation.
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THE HIGH FREQUENCY ECG: AN EVALUATION OF LEAD PLACEMENT,
MEASUREMENTS, AND REPRODUCIBILITY. JonathanMyers MA,
J. Edwin AtwoodMD.FACC, PatrickHall MD, Gilberto
Marcondes MD, Susan Forbes RN, David MortaraPhD, Michael
Sullivan MA, William Pewen MS, Sarb Sandhu MD, Victor
Froelicher MD, FACC, VAMC Long Beach and UC, Irvine.
Late ventricularpotentials (LPs) have been recorded by
computer processing of the surface ECG. These LPs have
been assessed visually and by several computer
algorithms. We noted that LPs vary with changes in
position and electrode placement and that the
measurements do not agree. Therefore, recordings were
obtained from 113 men (mean age 63) referredfor Holter
monitoring using a digital system with a 25-250 Hz
filter. XYZ leads as well as placements on the anterior
and mid-axillary lines, and a left lateral decubitus
position were used. Measurements made were normal and
high frequency QRS duration (QRSD, HFQRSD), difference
between QRSD and HFQRSD (HFDIF), the durationof low
amplitude signals «40 uV) in the terminal QRS (HFD40),
and the root mean square of the last 40 msec of the
HFQRSD (HFRMS). Measurements were reproducibleon
different days within one week. Although mean values
differed little, correlationsbetween leads were poor.
The following r-values were demonstratedin XYZ:
QRSD HFQRSD HFDIF HFD40
HFDIF .04 .60 1. 0
HFD40 .30 .50 .46 1. 0
HFRMS -.53 -.63 -.35 -.47
HFD40 and HFRMS were inversely related but the
correlationswere poor and both were related to QRSD.
Standardcriteriafor HFD40 and HFRMS inconsistently
labeled patients abnormal. Thus, LP measurements are
inconsistent and must be adjusted for QRSD in order to
determine the correct discriminantvalue for abnormal LPs.
ABSTRACTS
ACCURACY AND REPRODUCIBILITYOF HOLTER RECORDINGS
IN TIlE CARDIAC ARRIIYTJlIlIAPILOTSTUDY
Philip Reid, M.D. FAce, Toshio Akiyama; M.D. FAce, Jeff Anderson,
H.D. FACC, Ed Bough, M.D.FAce, Bart Campbell, H.D. FAce, Jim
CoramHas, M.D. FAce, Lean Greene, M.D. FACe, Richard Henthorn,
M.D. FACe. Craig Pratt, l1.D. FAce, Don Romhilt, M.D. FACe, Denis
Ray. H.D. FACe, Israel Stein, H.D. for the CAPS Investigators.
The Cardiac ArrhythmiaPilot Study (CAPS) was a randomized,
placebo-controlled trial to determine if drug therapy could
suppress arrhythmias in 502 patients with >10 ventricular
ectopics (VPD)/hr detected between 5-42 days after myo-
cardial infarction. Because Halter monitors (BM) were an
integral component of CAPS, we prospectively assessed
reproducibilityand accuracy.
The decision to initiate or alter therapy (efficacy) was
determined at 10 sites by >701 reduction in total VPD and
>901 reduction VPD runs (VT) on BM. These tapes were also
read at an ECG reading center. Readings between sites and
center differing by >251 in VPD andlor >50lft in VI vere
resolved by re-reading. Results from these data permitted
evaluation of RH. reproducibility (site vs. center) and an
estimate of incorrect patient classification.
To evaluate true accuracy of HM analysis, 16 tapes were
hand-counted (range, 1-733 VPD/hr; 0-81 vr runs) and
compared to results from all reading sites.
RESULTS: There was 87lft agreement between sites and center
among 2158 BM tapes in the 5 year study. Of 106 discrepant
tapes used to initiate or change therapy, 45 (42.5Xt) final
KM readings remained unchanged. Of those lD1 where readings
changed, the clinical decision remained as efficacious in
42 (39.61) patientsI remained as inefficacious in 12
(11.3%) patients and resulted in different Patient classi-
fications for 7 (6.61) patients.
Analysis of hand-countedHM (site vs. hand counts) revealed
X slope = .90 (95% confidence limits = .78-1.02), X corre-
lation coefficient;: .981 ± .009 (S.D.) and X standarderror
= .042 ± .021.
We conclude: 1) there is 87'4 reproducibilityof KM read-
ings between sites and cent.er; 2) accuracy estimates of
hand-counted BM have a high slope value (.90) with under-
counting of absolute values; 3) of 106 discrepant tapes
(sites vs. center) only a 6.6lft patient misc1assification
rate was observed; 4) reproducibility and accuracy of
critical measurements should be included in clinical trial
design.
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EARLY DETECTION OF SILENT ISCHEMIA USING AMBULATORY
MONITORING AND INTERVENTION TO REDUCE ISCHEMIC BURDEN.
Joan Barry, B.A., Stephen Campbell, M.B., Elizabeth G.
Nabel, M.D., Kimberely Mead, B.S., Michael B. Rocco,
M.D., Andrew P. Selwyn, M.D. Brigham and Women's
Hospital, HarvardMedical School, Boston, MA.
A digital long-term electrocardiographicmonitor (QEKG)
has been previously validated for the detection and
quantitationof ischemic ST-depression episodes (STD)
with an optional tone at the onset (48 sec) of
significant STD. In order to test the utility of this
early warning system 1) 12 patients with angina and known
coronary artery disease underwent exercise tests (ET)
with simultaneous QEKG, and 2) 7 ambulatorypatients with
angina and coronary artery disease underwent 24 hour EKG
monitoring with the tone off using TNG as required,
followed by 24 hrs taking TNG with each tone (QEKG
confirmed with frequency modulated EKG recording). Nine
of 12 ET showed significant STD and in 8 (89%
sensitivity) the tone correctly preceded angina.
Specificity was 92% (one false positive). In the 7
patients undergoing 24 hour EKG monitoring, the number of
ischemic episodes were not significantly reduced from a
mean of 14.7 (tone off) to a mean of 11.7 (tone on).
However, the total durationof ischemia was significantly
reduced from a mean of 104.7 min/24hrs/patientto 57.7
min/24hrs/patient(mean decrease 40%, p = 0.02). Thus,
the tone was sensitive when used to detect ischemia which
permitted a significant reduction in durationof
ischemia. These preliminaryresults show that a real
time digital EKG analyzer can interact with patients
during silent transientmyocardial ischemia to key
treatmentand decrease the ischemic burden.
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The Signal Averaged ECG andVentricular
Tachycardia
IDENTIFICATIONBY FREQUENCY-DOMAIN ANALYSIS OF PATIENTS
WITH BUNDLE BRANCH BLOCK AT RISK FOR SUSTAINED
VENTRICULAR TACHYCARDIA
Bruce D. LindsaYf M.D., H. Dieter Ambos, Joanne Markham,
M.S., and Michae E. Cain, M.D., F.A.C.C.,
Cardiovascular Division,Washington University,
St. Louis, Missouri
Results of advanced signal-processing techniques in the
frequency and time domains have been used to reliably
distinguish patients with from those without sustained
ventriculartachycardia (VT). To date, studies have been
performed in patients during sinus rhythm in the absence
of bundlebranch block (BBB). To determine whether the
presence of BBB during sinus rhythm precludes accurate
differentiationof patients with and without VT, fast
Fourier transforms (FFT) of the terminal QRS and ST
segment of signal-averaged orthogonal ECGs were obtained
from 28 normal subjects and 129 patients with organic
heart disease (OHD) with or withoutVT or BBB. The FFT
was analyzed using animproved method for quantitating
the relative contribution and peak magnitudes of
frequencies in the 20 to 50 Hz range. Results ofFFT
analysis were: N Normal FFT Abnormal FFT
Normal subjects 28 100% 0%
OHD/-VT/-BBB 43 88% 12%
OHD/-VT/+BBB 16 88% 12%
OHD/+VT/ -BBB 38 13% 87%
OHD/+VT/ +BBB 32 9% 91%
These results demonstrate that differentiation of
patients with and without sustainedVT based onresults
of FFT analysis of signal-averaged ECGs obtained during
sinus rhythm is notaffected by the presence of BBB.
Accordf nqly , the approach developed offers promise for
defining the risk for developing sustained VT in
patients having BBB during sinus rhythm.
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1.3±2.5< .05
l' GROUP 3
<.001 22.9±7.2
<.001 O.57±0.98
4.8±7.9NS3.0±33
OPTIMAL INTERVAL TO PREDICT VENTRICULAR TACHYCARDIA BASED
ON FREQUENCY ANALYSIS OF THE SIGNAL AVERAGED
ELECTROCARDIOGRAM.Matthew DeCaro, M.D., KentJ. Volosin,
M.D., Arnold J. Greenspon, M.D., F.A.C.C. Jefferson
Medical College, Philadelphia, PA
We performed fast Fourier transform (FFT) analysis of
various intervals of the QRS and STsegments from signal
averaged electrocardiogramsin 16 pts with transmural
myocardial infarction (MI) and no ventriculartachycardia
(VT) (Group I), 25 pts with MI and sustained VT or
ventricularfibrillation (VF) (Group 2) , and 34nOrmaIs
(Group 3). High frequency power ratios (HFPR) were
calculated as the mean percent ratio of the power from 20-
50 Hz divided by the power from 1-100 Hz using 3 bipolar
leads (X,Y,Z). The onset of the FFT was varied and the
HFPR calculated to determine the interval which provided
the best discriminationbetween groups. HFPR was gener-
ated using: a. total QRS + ST segment; b. QRS + ST segment
beginning analysis 40,50,60,70, and 80 msec fromQRS on-
set; c. QRS + ST segment be~innin~ analysis 20,30,40,50,60
msec back from QRS offset. The HFPR of the most discrimi-
nating interval for each method are listed.
METHOD GROUP 1 .E GFOUP 2
total QRS+ST l8.3±7.5 <.001 7.6±7.2
60 msec from 2.2±3.6 NS 3.4±3.2
QRS onset +ST
40 msec from
QRS offset+ST
While pts with VT have a higher HFPR in the terminal por-
tion of the QRS than normals, their HFPR is similar to
those pts with MI and no VT.VT pts have significantly
less high frequency in their signal avera~ed QRS-ST seg-
ment than normals or those with MI and no VT. Frequency
analysis of the entire signal averaged QRS-ST segment is
the most useful interval for discriminatingbetween pts
with and without VT.
A COMPARATIVE STUDY OF FREQUENCY- AND TIME-DOMAIN ANALYSIS
OF SIGNAL AVERAGED ECG'S IN VENTRICULAR TACHYCARDIA.
Joseph Machac, M.D.; A. Weiss, B.A.; S. L. Winters,
M.D.; P. Barecca, B.S., J. Anthony Gomes, M.D., F.A.C.C.
Mt. Sinai Medical Center, N.Y., N.Y.
Although both time (t) domain analysis (DA) and frequency
(f) DA of signal averaged ECG's (SA) may distinguish
patients (pts) with and without sustained ventricular
tachycardia (VTs), it remains unclear which method is
superior. Thus, we assessed both techniques in 56 pts
who underwent SA (200 beats): Group (Gr) I - 11 normal
subjects (34 ± 10 yrs); Gr 11 - 19 controls with organic
heart disease but no VTs (60 ± 20 yrs); and Gr III -
26 pts with VTs (61 ± 20 yrs). t-DA with high pass
bidirectional filters of 25, 40 and 80 Hz was performed
and considered abnormal if the RHS-Voltages of the
terminal 40ms of the QRS were <25\lv , <20\lv and <17\lv
respectively. f-DA was done by two methods (M): Ml
obtained the frequency spectrum of the last 40ms of
the QRS plus the ST segment for a total of 256ms expressed
as the logarithm of the ratio of summed energy components
of 20-48 Hz and 0-20 Hz (Cain et all; M2 considered
the summed energies in only the terminal 40ms of the
QRS. Results: The incidence of abnormalities by the
two methods is shown below:
TIME DOMAIN ANALYSIS FREQUENCY DOMAIN ANALYSIS
25Hz 40Hz 80Hz Ml M2
GRl 0% 18% 18% 27% 9%
GR2 16% 16% 267. 11'7. 16'7.
GR3 50'7. 56'7. 92'7. 15'7. 387.
Both t-DA and f-DA had similar specificities (74'7. to
897.). However, the sensitivities of t-DA were superior
(50 to 92'7.) to f-DA (15 to 38'7.). Thus, time-domain
analysis is superior to frequency-domain analysis in
differentiatingpts with VTs from those without.
THE SIGNAL AVERAGED ELECTROCARDIOGRAM IN PATIENTS WITH
VENTRICULAR TACHYCARDIA AND BUNDLE BRANCH BLOCK.
J. Anthony Gomes, M.D., F.A.C.C.; Debra Stewart, R.N.;
Stephen L. Winters, M.D.; Philip Barreca, B.S. The
Mt. Sinai Medical Center, New York, N.Y.
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CellularElectrophysiology
Signal averaging (SA) of the surface QRS complex has
detected late potentials in patients (pts) with sustained
ventricular tachycardia (VTs) in the absence of bundle
branch block (BBB). However, whether the SA-ECG can
distinguish pts with BBB and VTs from those without,
remains unclear. We studied 35 pts with either right
(R) or left (L) BBB. All pts had SA of the surface
QRS complex utilizing high pass bidirectional filtering
of 25, 40 and 80 Hz. and the following parameters (para)
were determined: the duration of the SA QRS; the duration
of the low amplitude signals (LAS) of <40\lv and the
RMS-Voltage of the terminal 40 msec (V40). Twelve pts
had spontaneous plus induced VTs (Group I) (Gr), while
23 pts had no VT (Gr rn. Seventy percent of Gr I and
69'7. of Gr Il had an old myocardial infarction (p=ns).
There was no significant difference between Gr I and
Il in any of the SA para. The mean values at 40 Hz
is shown below:
SA-QRS(ms)* LAS(ms)* V-40(\lv)*
Gr I 163±26 49±l9 18±l2
Gr Il 152±18 49±24 2l±25
*p=ns . The location of BBB (R/L) made no difference
(p-ns) in the SA para between Gr's. The incidence
of abnormal V40 for Gr I and II was 50% vs 48% at 25
Hz; 60% vs 65% at 40 Hz and 90'7. vs 88'7. at 80 Hz.
Conclusion: Abnormalities in ventricular activation
due to R or L-BBB can result in abnormal SA para in
pts with and without VT. Thus, pts with BBB (both R
and L) should be excluded from studies assessing the
role of SA-ECG in predicting arrhythmicevents.
RATE-RElATEDCHANGES IN UPSTROKE VELOCITY MEASURED IN
SIOOLE VENrRICUIARMYOCARDIAL CELI.'l.
Morton Kalus, M.D., Michael S. Siegal, M.D., Brian F.
HoffiiBn, M.D., F.A.C.C. Columbia University, College
of Physicians & Surgeons, New York, N.Y.
we used single intracellularmicroelectrode techniques
to record transmembranepotential, inject current, am
study rate-related variations in maximJrn rate of rise
of phase 0 (Vmax) in isolated nrjOCYtes fran free run-
nillJ canine Purkinje strams (PF) am ventricularmy0-
cardium (VM). ~n cycle length is decreased fran
3000 msec to 800 msec, in cells fran both PF am VM,
the "activation curve" relating Vmax to take off l1I!!It'"
brane potential of premature beats elicited during
phase 3 is shifted: Vmax at a given membranepotential
is decreased at sbcrt.er CL. 1be observed shift in
the activation curve increases in magnitude the longer
the duration of stimulation at a aborter CL. After
prolonged injection of hyperpolarizingcurrent, action
potential durationremains soortened am the activation
curve is shifted in the sane direction as it is by
stimulationat a decreased CL. Prolonged injection of
depolarizing current lengthens action potential dura-
tion am shifts the activation curve in the cpposite
direction. 1bese results suggest that changes in [Na] i
loading conditions and electrogenicpo..mp activity affect
steady state Vmax am change the position of the activ-
ation curve along the voltage axis as CL is changed.
Accumulation or depletion of ions in restrictedextra-
cellular spaces need not be invoked to acca.mt for such
effects observed in intact canine ventriculartissues.
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AI.TERNANS OF CARDIAC ACTION POTENTIAL: DIFFERENCES
BETWEEN PURKINJE AND VENTRICULAR IIJSCLE FIBERS.
Hirokazu Saitoh, M.D .. John C. Bailey, M,D., F.A.C.C.
and Borys Surawicz, M,D., F.A,C.C., KrannertInstitute
of Cardiology, Indiana Univ. Seh. Med., Indianapolis.
ABSTRACTS
PROTEIN KINASE C INDUCES CALCIUM-DEPENDENTSLOW
ACTION POTENTlALS IN RAT ATRIAL MYOCYTES.
John Bianchi, Ph.D., James M. Levett, M.D. John D.
Gallagher, M.D. and LawrenceJ. Gessman, M.D,
Deborah Research Institute, Browns Mills, New Jersey
209A
Abrupt changes in cycle length (CL) affect action
potentials (AP) of Purkinje (P) and ventricularmuscle
(V) fiber differently, and these differences may be
arrhythmogenic.The purpose of this study was to
examine alternans (AI) of AP after an abrupt decrease
of CL in P and V, We induced Al in simultaneously
recorded dog P and V(n&ll) by changing CL from Is to
8-14 shorter CL's. We compared: l)characteristicsof
AI; 2)relation between preceding diastolic interval
(DI) and action potential duration (APD) during AI;
3)effect of altering plateau level (PL) bY_Clow inward
current (Isi) blocker, nisoldi~ine (N:2xlO M), and I .activator, Bay-K 8644 (B:3xI0- M). RESULTS: Al was SI
induced at CL's shorter than 500+59ms(mean+SD) in P and
378!91ma in V. I}In P, the first-APD was the shortest
followed by a longer second APD. Plateau duration (Dpl)
was concordant with APD during Al. In V, the first AP
had augmentedPL and longer Dpl followed by the aecond
AP with depressed PL and shorter Dpl. Al of PL and Dpl
continued and Al of APD emerged after the third AP. APD
was discordantwith Dpl. 2)A~s during Al had the same
APD/DI relationshipin P hut not in V. 3)N attenuated
and B enhanced Al of APD by changing APD/DI relation-
ship in P. In V, depression of PL by N abolished Al of
AP. Augmentationof PL by B attenuatedAl without
altering APD/DI relationship. We conclude that Al in P
was controlled by preceding DI, but Al in V was
determined by Al of PL. I . blocker suppressed Al in V
but not in P. al
SOOIUM DEPENOENT PROTON EffLUX IN HUMAN HEART CELLS.
Helge Rasmussen, MD, Robert TenEick, PhD, Edward Cragoe,
PhD, Renee Hartz, MD; NorthwesternUniversitY,Chicago,IL.
The role of Na+-H+ exchange in the control of intra-
cellular pH has been found to be species dependent. We
examined if Na+-H+ exchange can occur in human heart.
Specimens of right atriumwere cooled (20C) for 90 min in
HEPES-Tyrode'ssolution in which NH4Cl was substituted
for NaCl to load cells with NH4+ and then transferredto
warm (30oe) 20mM K+, NH4+-free Na-Tyrode's. After
transferan intracellularH+ load develops because NH4+
dissociates to NH3 + H+; NH3 readily diffuses out of
cells while H+ remains thus creating a H+ load. After
transferresting membrane potential (Em) hyperpolarized
transiently reaching amaximum (Emax= -58.6± 1.3mV,
mean±S.E., n=8 ) more negative (p<O.Ol) than EK in 20 mM
K+ (--51mV); Emax was reached in 10.4±O.8 min.
IncreasingK+ conductance (9K) with acetylcholine caused
a depolarizationwhen E~ was at Emax confirming that Emax
was negative to EK and lmplying that the hyperpolari-
za~ion was Na+ pump induced. Decreasing 9K with 0.5 mM
Ba + increased Em x to -74.0±2.7mV (n=6, p<O.Ol).
Inhibiting the Na~ pump with 0.5~M acetylstrophanthidin
reduced E~ax to -37.6±3.1mV (n=5, p<O.Ol). Inhibition of
the Na+·H exchanger with lO~M 5-(N,N-dimethyl)amiloride
abolished the hyperpolarizationin the presence ofBal+
(Emax = -22.6±1.6mV, n=6) but had no effect on a Na+ pump
induced hyperpolarization ofcells loaded with Na+ rather
than H+. We conclude that Na+-H+ exchange can produce a
Na+ load during recoveryfrom cellular acidosis, and that
the hyperpolarization of theH+ loaded cells arose from
electrogenic pumping of the Na+ exchanged for H+. To our
knowledge, this is the first evidence that Na+-H+
exchange occurs in human heart.
This study was designed to determine if protein kinase C
(PKC) mediates transmembrane Ca2++ flux in atrial myo-
cytes. Hearts were removed fromanesthetized (pentobarb-
ital, 3Omg/kg,i,p.) rats and placed in oxygenated ice-cold
Krebs-Henseleit buffer, pH 1.4. Left atrf.a were resected
and placed in a bath superfused with oxygenated buffer
(pH 1.4, 37"C) containing 10-6M propranolol. Tissue was
electrically stimulated (rectangularpulse, 2X threshold,
lms duration, 0.5Hz), and transmembranepotentials were
recorded by standardmicroelectrode techniques. Addition
of 20mM K+ rendered tissue inexcitable. Atria superfus-
ed with buffer containing to-6M propranolol, 20mM ~,
and 20mM tetraethylammonium+(TEA+) was also inexcitable.
However, additlon of 10-7M l,2-dicaproyl-rac-gll-cerol
(DG) induced slow action potentials that were Ca + de-
pendent, amplitude increasing as buffer Ca2+ level in-
creased. A plot of amplitude vs. log [Ca2+] resulted in
a straight line (y-24.8x+3.4; r=0.9l). The slow action
potentiaIs were abolished by addition of lmM Mn2+ or 10-6M
ve rapandL, However, addition of 10-5M tetrodotoxin did
not eliminate the slow response. Since DG is s PKC activ-
ator in other cells, PKC lnvolvement was confirmed by
addition of polymlxin B (1000 units/ml) to the buffer con-
taining propranolol, elevated K+, TEA+, and DG, The pre-
sence of polymixin B eliminated slow action potential
formation. The ability of a PKC activator to induce slow
action potentials suggests that PKC can mediate cardi ac
myocyte transmembranecalcium flux.
TRANSIENT INWARD aJRRENT OF '!HE RABBIT ATRIOVENTRICULAR
NODE INOOCED BY LOW K+ ro<CENTRATI~
Yoshizumi Habuchi, M.D., Takeshi Noda, M.D., Yoshio
Watanabe, M.D., F.A.C.C.
FUJITA-GIIKUENHElIL'IHUNIVERSITY, 'IOYOAKE, AIOn, JAPAN
When small (.2 x ,2 x .2 mm) space-clamped atrio-
ventricular (A-V) ncdal preparationswere perfused with
a low K+ (1.0 or 0.5 mM) solution, the spontaneous
firing frequency was significantly increased from 178±28
to 258±36( n=8, p<.05), being associated with a decrease
in the action potential amplitude and Vmax' The action
potentialbecame subsequentlyoscillatory. In voltage
clamp experiments using double-microelectrodetech-
niques, a transient inward current (TI) was observed on
repolarizationto the pacemakerpotential range (-40--70
mV) after [K+jo was lowered to 0.5 mM (n=12). When the
membrane potential was held at -65 mV during electrical
diastole of the low [K+]o induced oscillatory action
potentials, TI was superimposedon the decaying outward
current (iR). TI was almost completely eliminated by the
application of 10mM caffeine or by substitutionof 50%
NaCl with LiCl or sucrose. Such a Na+ substitution
concomitantlyrestored the action potential amplitude
toward the control level. A complete blockade of the
ca2+ current by 100uM Cd2+ did not prevent the appear-
ance of TI under still lower [K+]o of O.2mM. However,
furtheradditionof 50UM La3+ abolished the TI. These
results suggest that 1) abnormal automaticityof the A-V
node urrler Na+-K+ pump inhibition is, at least in part,
caused by the development of TI, and 2) the TI is mainly
mediated by the Na+_ca2+ exchange system.
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R
<0.001
<0.001
%MAXlMAL CONTRACTION ± SEM (In Vitro)
Control YHLS ~ OHLS
H 75.8±2.9 84.5±3.7 <.0.05 l18.9±4.2
5-HT 1.5±0.2 35.2±2.4 <0.001 36.9±3.2
NE 3 . 1±0.4 2 .4±0 . 3 NS
Thus, CVR to 5-HT is increased in vitro in HLS. In-
creased CVR to H in vivo and in vitro in HLS is asso-
ciated with increased mast cell numbers in the adven-
titia and outer media of the epicardial coronary artery.
Chol(mg%)
%stenosis
# mast cells/
section(m±SEM) l4.6±1.1 2l.4±2.l* 45. 5±6. 5**
*p<0.05 vs. control; **p<O.Ol vs. YHLS
In vivo. H (200ug ic) produced more COR constriction
in YHLS (p-0.04) and OHLS (p-0.005) than in C. ST
elevation was produced in 4/5 YHLS and 2/3 OHLS. No
significant differences were seen between groups in
response to 5-HT, TNG, or PHE, and no STelevation was
seen.
IN VIVO AND IN VITRO CORONARY VASCULAR REACTIVITY IN
HYPERLIPIDEMICSWINE. Charles R. Prince. M.D, Maria V.
Tantengco, M.D., Renu Virmani, M.D., R. Todd Light,
M.D., Gottlieb C. Friesinger, M.D., F.A.C.C., Rose M.
Robertson, M.D., F.A.C.C. VanderbiltUniv. Nashville, TN
Epicardial coronary (COR) reactivity (CVR) in control
(C) and hyperlipidemic swine (HLS) was examined in vivo
using videodensitometricedge detection before and after
TNG, histamine (H),5-HT and phenylephrine (PHE). The
same COR segments were later studied in vitro by equili-
brating epicardial rings in Krebs-Ringerbicarbonate
(95%02-5% C02; pH 7.4) and performing concentration-
response curves. Young (Y) HLS Were studied at 4-6 mos
and old (0) HLS at 12-15 mos after starting an
atherogeniC diet. Pathologic data was as follows:
Control YHLS OHLS
65-l29(m-86) 390-740(m-534) 234-464(m-356)
0-75(m-9) 0-90(m-37 0-100(m-54)
Ca++-overload has been demonstrated to lead to generation
of transient inward current and delayed afterdepolariza-
tions (DAD), However, the origin of early afterdepolari-
zations (EAD) has not yet been clarified, EAD and related
triggered action potentials (TAP) can be indUced by C8+in
dogs in vivo and in vitro but in guinea-pig ventricular
preparationsTAP occurred without apparent EAD. To assess
the role of Ca++ overload in EAD we replaced 30-130 mM of
extracellularNa+ by Li+. Withdrawal of Na+o is known to
increase [Ca++]i' This enhanced the occurrence of EAD and
TAP in dog and also lead to development of EAD and related
TAP in guniea-pig Purkinje fibers upon Cs+ treatment.
Membranepotentials and the isotonic force of oontraotions
were reoorded by standard methods. The internal Ca++
loading was revealed by the increased force of oontrac-
tions. Cs+ (3.6-5.0 mM) was applied either with Li+ or 3-
5 min after the re-admission of of Na+o follOWing 30 min
of U+ (reduced Na+o) treatment. In either case, immedi-
ately with Cs+-treatment large EAD ( 10 mV) and TAP
oocurred in Purkinje fibers driven at 0.2Hz. About 25-30
min later EAD diminished in the presence of Cs+ in guinea-
pig preparations which do not show EAD without Ca++
loading. We hypothesize that Ca++ overload may be a
mechanism for the generation of EAD by means of Na+:Ca++
exchanger current ll1milar to the meohanism for generation
of DAD. This exchanger current may be relatively more
prominent during repolarization if outward It+ ourrents
are reduced.
IICRI&SBD II'lII&CILLULlICa- MU BB IMPORTAftALSO FOR
IWlLY AftIIlDIPOLUIZlTIOIS
Bela Szabo, MD, PhD, Raed Sweidan, MD, Eugene Patterson,
PhD, Benjamin J, SCherlag, PhD, FACC, and Ralph Lazzara,
MD, FACC, University of Oklahoma Health SCiences Center
and VA Medical Center, OklahomaCity, OK,
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DIFFERENTIALHI AND H2 RECEPTOR MEDIATED HISTAMINE
RESPONSES OF CANINE EPICARDIAL CONDUCTANCE AND DISTAL
RESISTANCE VESSELS. Wayne L. Miller, M.D., Ph.D. and
Alfred A. Bove, M.D., Ph.D., F.A.C.C., Mayo Clinic,
Roehester, MN.
Histamine (HIS) has been implicated in the production of
coronary vasospasm with endothelial damage; in the intact
vessel, however, the contributionof HI and H2receptor
mediation of coronary reactivity is unclear. This study
was designed to evaluate the effects of HIS receptor
blockade on epicardial and resistance vessel responses in
the closed chest, anesthetized dog. HIS, diphenhydra-
mine, and cimetidine were infused (5 min) into the LAD
artery and responses studied by angiography and flow
measurements (133 Xe).
HI blOCkadegreatly increased HIS induced epicardial
vessel dilation while flow was similar. In contrast, H2
blockade prevented HIS induced dilation and reduced flow.
We conclude that HI and H2blockers differentially affect
epicardial vessel tone and that similar to humandata, HI
mediated vasoconstriction predominates in conductance
vessels of the dog, while H2 mediated vasodilation pre-
dominates in resistance vessels. HI blockade may, there-
fore, have a beneficial effect and H2blockade a
detrimental effect in coronary vasospasm.
from Control
LAD Flow
+128+23*
-5+7
-5+8
+115+33*
+31+14*
Percent Change
LAD Area
+13+4*
+13+4*
-9+6
+55+15*
-6+3
10(HIS),-5(Hl), 7(H2)
HIS (45 Ilg/min)
HI (lOO Ilg/min)
H2 (lOO Ilg/min)
HIS + HI
HIS + H2
(x±SEM) *p<.05; n =
CHRONIC TREATMENT WITH COD LIVER OIL FACILITATES
ENDOTHELIUM-DEPENDENTRESPONSIVENESS IN PORCINE
CORONARY ARTERIES.
Hiroaki Shimokawa, M.D., Jules Y.T. Lam, M.D., E.J.
waIter Bowie, M.D., James H. Chesebro, M.D. and Paul M.
Vanhoutte, M.D., Mayo Clinic, Rochester, MN.
To study the effects of dietary fish oil on endothelium-
dependent responsiveness, Yorkshire pigs were fed with a
low (0.6 ml/kg) (n=5) or a high (1.0 ml/kg) (n=5) dose of
cod liver oil or with normal diet (n=lO) for four weeks.
Endothelium-dependentresponses were examined in vitro
in rings of proximal left anteriordescending coronary
arteries taken from treated and control animals. Endo-
thelium-dependentrelaxations to adenosine diphosphate
and serotonin were facilitated dose-dependently in
arteries from the treated but not those from the control
group, while the relaxations to A23l87 were not altered.
Aggregating platelets from control and treated pigs
induced facilitated endothelium-dependentrelaxations in
rings with endothelium taken from treatedpigs, while
they induced comparable contractions in rings without
endothelium from both groups. Arachidonic acid induced
transient endothelium-dependentcontractions in the
arteries from control pigs, whereas such contractions
were significantly diminished in blood vessels from
treated animals. Relaxations to sodium nitroprussideor
contractions to potassium chloride were not different in
rings (without endothelium) from control or treatedpigs.
Bleeding time was significantly increased, while pro-
thrombin time, partial thromboplastintime or in vitro
platelet aggregability to adenosine diphosphatewere not
altered by the treatment. These results indicate that
chronic treatmentwith cod liver oil facilitates endo-
thelium-dependentresponsiveness in porcine coronary
arteries before it may affect platelet function.
(Supported in part by NIHgrants HL 31183 & HL 31547.)
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VIDEOMICROSCOPIC DEMONSTRATION OF DEFECTIVE CHOLINERGIC
ARTERIOLAR VASODILATION IN ATHEROSCLEROTICRABBIT
Hideo Yamamoto, M.D., Claus Bossaller, M.O., Philip D.
Henry, M.O., F.A.C.C., Baylor College of Medicine,
Houston, Texas
We have shown that in cholesterol-fed atherosclerotic
rabbits (A) compared to control rabbits (C) the decrease
in total vascular resistance in response to acetylcholine
(ACH), an endothelium-dependent dilator, is markedly
suppressed,whereas the response tonitroprusside(NP), an
endothelium-independentdilator, is unchanged. To deter-
mine whether defective cholinergic vasodilation in A is
related to altered microvascular regulation. we have
visualized the arterioles (20-200 ~m internal diameter) of
the rabbit cremastermuscle by videomicroscopy. Arterio-
lar internal diameter was monitored during superfusion
(topical administration) of the cremaster with graded
concentrations of ACH or NP which produced no change in
systemic hemodynamics. Between 10 nM and 100 ~M NP,
diameterchanges in A (n = 10) and C (n = 10) were virtu-
ally identical, 100 ~M NP producing approximately110%
dilation. In contrast, dilation induced by ACH was
suppressed in A over awide range of concentrations (l
nM-lOO ~M), 100 ~M ACH evoking 120 ± 10%(SE) dilation in
C and only 55 ± 5% in A (p < 0.001). The difference in
cholinergic responsivenessbetween C and Apersisted after
adrenergicbIockade (phento1amine + proprano101, both 1
~M) and cyclo-oxygenase blockade (indomethacin, 50 ~M).
The microvascular cholinergi c defect in Awas sufficient
to account for the previouslydemonstrated changes in
total vascular resistance in response to ACH. Results
show that in a model of atherosclerosis there is a defect
in microvascular regulationthat may reduce vasodilator
reserve. Such a defect might explain ischemia in the
absence of occlusive disease of large vessels.
REGIONAL AND TRANSMURAL DEPENDENCE OF CARDIAC CYCLE
VARIABILITY IN ULTRASONIC 8ACKSCATTER: EFFECT OF ACUTE
MYOCARDIAL ISCHEMIA.
Kiran B. Sagar , M.D. , F. A. C. C. , Theodore L. Rhyne,
Se.D., David C. Warltier, M.D., Lorie Pelc, and L.
Samuel Wann, M.D., F.A.C.C., Cardiology Division,
Medical College of Wisconsin, Milwaukee, WI.
Heterogeneity in segmental function of subepicardialand
subendocardial regions of normal myocardium exists .
This study tests the hypothesis that similar
heter ogene i t y oc curs i n cardiac CyCle dependent
modulation in ult r a s on i c backscatter. We studied 8
anesthetized open c he s t dogs before and after 1 hour of
100% l e f t anteriordescending coronary artery occlusion.
Integrated backs ca t ter (18) and Fourier Coefficient of
amplitude modulation (FAM) were measured from
subepicardi al, midmyocardial, and subendocardial
regions, from 6 sequential ECG gated intervals
throughout the cardiac cycle with an unfocused
transducer with a bandwidth of 5.0 to 6.8 MHz and ..
carrierburst of 2 US duration.
Subepicardium Mictuyocardiun SUben:locardiun
(dB) --. + SEM
m fM m fM m fM
o::ntrol -59 +. 2 3 + . 4 ..{fJ +.2 2.8 + .3 -58 + .4 5 + . 2-
15 Min Isch - 56 + .4 - 1. 5 + .5- - 57 +.2* 1.1 +.5 -55 +.3- 1. 9 + .3 -
60 Min Isch - 54 + . 3- 1. 2 + .5 -54+.2* 1. 1 + . 4 - 51 +.31.8 + . 4-
- P <.0 1 cmtrol vs i.schemi.a and~un vs sublpicardiun
and miQnyocardiun (FAM)
We conclude that 1) cardiac cycle var i a b i l ity i n
ultrasonic ba cks ca t ter in the normal myocardium has
transmural gr ad i en t which i s abOlished during acute
ischemia, and 2) absolute ultrasonic backscatter shows a
significant increase during ischemia without transmural
variability.
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CLINICAL IDENTIFICATIONOF AMYLOID AND HYPERTROPHIC
CARDIOMYOPATHIESUSING QUANTITATIVE TEXTURE ANALYSIS
OF DIGITAL ECHOCARDIOGRAPHICDATA.
Philip E. Aylward. B.M.B.Ch.• KrishnaswamyChandrasekaran,
M.D.• Steven R. Fleagle, B.S.E.E., Trudy L. Burns, Ph.D.,
James B. Seward, M.D., F.A.C.C., A. Jamil Tajik , M.D.,F.A .C.C.
Steve M. Collins, Ph.D.. David J. Skorton, M.D., F.A.C.C.
University of Iowa. Iowa City. lA .
Ultrasound tissue characterization techniques have been
widely tested in animals. butclinical data are few. Using
a commercial, 16 gray level digitization system, we previ-
ously showed that quantitativetexture analysis of clinical
echocardiograms (echos) was unable to differentiate amy-
loidosis from normal. We hypothesized that a calibrated
256 gray level digitization system would improve the accu-
racy of clinical quantitative texture analysis. We tested
this hypothesis bydigitizing clinical echo videotapes from
11 normals , 10 patients with amyloid, 8 with hypertrophic
cardiomyopathy(HCM), and 6 with other causes ofleft ven-
tricular hypertrophy (LVH) . Quantitative texture analysis
was done on septal and posterior left ventricular wall
regions in diastolic and systolic short and lonq-axis
images. RESULTS:
Diastolic Lonq-Axis Septal Data (X±SD)
TextureMeasure HCM Amyloid LVH Normal
. 28±.04
8±2
15±6
12±3
. 22±.04
ACOUSTICMICROSCOPYOFNORMALAND
MYOPAnDCHUMANMYOCARDIUM:IMPUCATIONS
FORULTRASONICTISSUECHARACfERIZATION
payjdT. Linker, M Du Bjern AJ. Angelsen,Dr.Techn., and RichardL.
Popp, M.D., F.A.C.C.,
Departmentof BiomedicalEngineering, Universityof Trondheim,
Trondheim, Norway
Textureinmyocardialultrasonicimages resultsfrom theinteractionof the
ultrasoundpulsewith the spatiallyvaryingacousticpropertiesof the
myocardium. Ifthe dimensionsof thesevariationsarepredominantly
smallerthanone quarterwavelengthat the frequencyused (about 78
micronsat5 megahertz),it is the statisticalproperties,rather than the
structuresthemselves,whichcause thisapparentexture. In order to
defme the contributionof tissue structuresto such"speckle", we imaged
frozensectionsof left ventricularmyocardiumusinga200MHz acoustic
microscopewith a t.OxO.7 mmfield of view , providinga two dimen-
sional map of the relativeacousticproperties. Two groupsofpecimens
were used: Normal postmortemhearts(NH) from four patientswithout
heartdisease (75 images),and recipienthearts from four patientswith
congestivecardiomyopathy(CMH) receivingtransplants(64 images).
The autoeorrelationfunctionacrosseach imagewas calculatedby
computer, providinga measureof the size distributionof acoustic
structures. The maximumdistance requiredfor a 95% reductionin
amplitudeof theautocorrelationfunctionwasdefinedas theauto-
correlationlength (AL) for each image.For NH the meanAL was 37±18
microns(Il),withno values over921l. The CMH had a mean AL of
51±221l, with none over1ool!. The mean AL for the two groups were
significantlydifferent (p<O.ool). We concludethat: I) NH and CMHcan
be approximatedby "random"processes,with an AL less than or equal to
one quarterof theultrasonicwavelength,at clinicalfrequencies,and 2)
The average AL for CMH was longer than for NH, althoughthere is
considerableoverlap. These findingsindicatethat thevariationsin the
backscatteredsignalresult from the statisticalpropertiesof the
distributionof acousticvariations,rather than particularstructures.
*p<.0083 vs. normal by analysis of variance
We conclude that high gray level resolution quantitative
texture analysis of clinical echos identifies amyloid and
HCM; false positives did not occur in LVH. This technique
may be useful in the clinical environment.
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TRANSESOPHAGEALDOPPLER COLOR FLOW IMAGING:
INITIAL EXPERIENCE.
Fiona Clements, M.~., Norbert de Bruijn, H.D.,
James E. Lowe, H.D., F.A.C.C., Judy Philips,
Hichael Feneley, H.D., Joseph Kisslo, H.D.,
F.A.C.C. Duke University Hedical Center,
Durham, NC
To study the potential use of transesophageal
Doppler color flow imaging during heart surg-
ery, studies were performedduring surgery
using a Hewlett-Packardcolor flow imaging sys-
tem equipped with a manipulable 5 HHz transe-
sophageal probe. Of 9 adult patients, 4 had
s ingle valve replacement (2 aortic; 1 aortic
with repair of Type I aortic dissection; I
mitral). Atrial masses were removed in 2 (1
myxoma; I thrombus) and 3 had coronary artery
bypass alone. Regurgitant flow areas appeared
larger by transesophagealcolor flow when com-
pared to images from the chest wall. Images
of the attachmentsof the masses and detailed
anatomy of the aortic dissection provided im-
portant information for planning surgical
approaches. Immediate evaluations of pros-
thetic valve competence and extensive repair
of an atrial septum were judged so effective
as to obviate need for green dye evaluations.
In many patients, the transesophagealapproach
may provide superior diagnostic informationto
guide surgical therapy and confirm a success-
ful result.
2.52.00.50.0 1.0 1.5
time (sec)
These results indicate that ultrasonic tissuecharacterization in man
with real-time IB imaging delineates myocardial ultrastructure proper-
ties. potentially useful for detection of cardiomyopathic changes and
those associated with ischemia and reperfu sion.
ANALYSIS OF BLOOD FLOWVELOCITY AND THROMBOGENESIS I N
LEFT ATRIAL APPENDAGE BY TRANSESOPHAGEAL TWO-DIMENSIONAL
ECHOCARDIOGRAPHY.
Masunori Matsuzaki ,MD , Yoich i Toma,MD, Masaharu Suetsugu,
MD, Shiro Ono,MD, Kazuyosh i Okada,MD, Junko Hiro,MD ,
Yoshit o Anno ,MD , Kei ko Morimoto,MD, Reizo Kusukawa, MD.
Yaroaguchi University,School of Medicine, Ube 755, Japan
To analyze the blood flow vel oci ty and t hrombogenesis in
left at r i al appendage(LAA), we performed transesophageal
2-D echocardiographycombined wi t h pUlsed Doppler flow-
meter i n 11 normal subjects(N) and 28 Pts with atrial fib-
rillation(Af: 9 Pts with lone Af, 9 with a history of
cerebral thromboembolism(CE) and 10with mitral stenosis
(MS» . In al l subjects the real time image of the triangle
shaped LAA could be clearly obtained and f l owsignal was
sati sfactorily recorded at the vicinity of the junction
between t he left atrium(LA) and LAA . I n N,biphasic flow
signa l was obt a i nedfollowing P wave on ECG and its peak
ej ection f low veloc ity(P EFV) f r omLAA to LA was 34±12cm1sec
In Af, however , the flow of saw-t ooth appearance was
observed t hroughout a cardi ac cyc l e, and averaged PEFV in
LAA was significantly decreased compared with N(p<O.OOl).
PEFV i n Af wi t h CE and that i n Af with MS were 11±4cm/sec
and 1±4cm/sec, respectively, which were significantly lower
than that i n lone Af(2 9±9cm/sec , both p<O.Ol), i ndicating
bl ood st agnat i on i nLAA i n Af with CE or MS. In Af, t he
i mage of th e t hrombus inLAA was clearly obtained in 2 of 9
Pt s with CE and i n 4 of 10 Pt s wi th MS, which was not det e-
cted by conventional appr oach. I n 4 Pt s wit h MS, who has
been t reated with anti-coagulantdr ug, there was no throm-
bus in markedl y dilated LAA, t hough no significant flow
was obse rved in i t . These results indicat e that t he
informat ion s obt ai ned by t hi s met hod mi ght beuseful for
the pr evention from the CE by means of t he anti-coagulant
therapy i n Pts with Af , who have markedly reduced f l ow
veloc ity in LAA.
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A QUANTITATIVE MODEL FOR TRANSMITRAL BLOOD FLOW:
DESCRIPTION WITH IN VITRO VERIFICATION.
James D Thomas,MD. ChristopherY Choong. MB, PhD. Gerard
~k1n~ c~, Maraos NOrtiz, PhD. Arthur E Weyman,
MD, FACC, Massachusetts General Hospital, Boston, MA.
The hemodynamic determinants nf LA emptying and their
relationship to observed Doppler mitral valve (MY) flow
are poorly understood. To gain insight to the meaning of
Doppler MY curves, we have designed a flUid dynamics model
of early diastole. It treats the LA and LV as lumped
chamber s described by compliance terms and initial
pressures with a valve of variable resistance connecting
them. The model reduces mathematically to a series of
three coupled differential equations :
1) dQ/dt = (PLA - PLY - R x Q2)/M
2) dPLA/dt = - Q I CLA
3) dPLV/dt = Q I CLV,
where Qis transmitralblood flow, PLA and PLY are LA and
LV pressure, CLA and CLV are LA and LV compliance, both of
which may vary with time and pressure. R is the convective
"resistance"of the MY, and Mis the inertance of blood
passing through the MV. These equat i ons may be rapidly and
directly integrated to give the time course of LA and LV
pressure as well as MY flow and blood velocity. As an
i nitia l verification of the physical principles. an in
vitro model of the LA and MV was built which allowed PLA
~LA as well as MV area to be varied: HV area. 0.31 to
1.72 cm2; CLA. 28.8 to 63 cc/mmHg; and peak PLA. 1.1 to
9.0 mmHg. Observed pressure and flow curves were compared
with computer-generated curves calculated for these
parameters.demonstrating outstanding correlation (typical
r = 0.9991). The fluid dynamics model thus shows great
promise for exploring the physical determinants of early
diastole and providing the theoretical framework for the
quantitativeinterpretationof MV flow observed by Doppler
echocardiography.
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EVALUATION OF LEFT VENTRICULAR DIASTOLIC FILLING DURING
CORONARY ANGIOPLASTY USING DOPPLER ECHOCARDIOGRAPHY.
Leigh K. Bowman MBBS,FRACP, Micheal W. Cleman MD, Henry
S. Cabin MD, FACC, Barry L. Zaret MD, FACC, C. Carl Jaffe
MD, Yale University, New Haven, CT.
We examined the pattern of diastolic filling and its
relationship to systolic dysfunction during coronary
angioplasty using Doppler echocardiographyin 16 pts with
coronary arterydisease and normal baseline left
ventricularfunction. Angioplasty was performed on the
left anteriordescending artery (LAD) in 12 pts, the
circumflex artery (Cx) in 3 pts and the right coronary
artery (RCA) in 1 pt. Early peak filling rate (EPFR) and
early to late filling ratio (E/A) were measured in group
1 (LAD pts) and group 2 (Cx and RCA pts). The time course
of diastolic change was compared tosystolic dysfunction
measured using a chord shortening method on subsequent
inflations by 20 echo. Results for the two groups at
baseline and following 60 secs of balloon inflation were:
Baseline Inflation p value
Group 1. EPFR (mls/sec) 242+83 160+66 ~.0005
EIA ratio 0.7'6'+.17 0.60+.37 < .05
Group 2. EPFR (mls/sec) 271+109 236+87 ns
EIA ratio 1.09+.26 0.99+.37 ns
There was no significant change in heart rate during
angioplasty. The onset of diastolic dysfunction occurred
15 to 20 secs after balloon inflation and had fully
recovered 15 to 20 secs after deflation. The timing and
magnitude of the changes in diastolic function closely
parallelled changes in regional systolic function.
We conclude: I} acute LAD occlusion during angioplasty
causes a marked abnormality in diastolic function which
fully recovers following balloon deflation, 2} the time
course of diastolic dysfunction parallels systolic
dysfunction, 3) comparable diastolic dysfunction is not
seen with RCA or ex occlusion.
DOPPLER EVALUATION OF LEFT VENTRICULAR DIASTOLIC FILLING
FUNCTION DURING ANGIOPLASTY. Arturo Raisaro,M.D.,
GianSiro Bargiggia, M.D., Stefano deServi, M.D., Ezio
Bramucci, M.D., Franco Recusani, M.D., Lilliam M. Valdes-
Cruz, M.D.,FACC, Luigi Tronconi, M.D., David J. Sahn,
M.D.FACC. IRCCS Pol.Clinico S. Matteo, Pavia, Italy.
Balloon occlusion (OCC) of coronary arteries during
percutaneous transluminalcoronary angioplasty (PTCA)
causes transientacute ischemia. Our study was designed
to evaluate changes in diastolic mitral flow velocity
pstterns as an indicator of LV diastolic function during
PTCA and to relate them to the time of coronary OCC and
to the ECG. We studied 8 patients (pts) with left
anteriordescending (LAD) coronary artery stenosis
(75-99%) during 25 episodes of oce lasting 64±22 (SO) sec
(range = 20-106 sec). We measured the ratio between the
peak velocity at rapid diastolic filling (E) and atrial
contraction (A) every 3 sec during PTCA. The meanbasal
AlE ratio was 0.83±0.3 (range - 0.63-1.22). In all pts
there was a progressive increase of AlE seen in every
inflation beginning 8±5 sec after OCC. After 17±11
(range-4-40 sec), all pts had shownat least 30% increase
in AlE ratio. Onset of ST segment changes was 17±10 sec
(range-3-42sec) after OCC in 6/8; 2 pts had no ECG
changes. After deflation there was a progressive
decrease of AlE with returnto values at, but not
significantly below basal values by 15±11 (range- 2-49
sec). Ischemic ECG changes disappearedafter 22±20
(range 9-89 sec). Balloon OCC leads to early and trans-
ient alterations in diastolic function indices in all
pts, not always accompanied by ECG changes. The Doppler
AlE ratio is a sensitive indicator of these changes in
diastolic filling and their time course in pts with LAD
disease and may be a useful clinical tool to monitor
myocardial ischemia during PTCA.
DOPPLER EVALUATION OF LEFT VENTRICULAR FILLING DYNAMICS
DURING CORONARY ANGIOPLASTY.
WaIter KIodnicki, MD, Alexis B. Sokil, MD, FACC, James
Paul, CVT, Nelson M. Wolf, MD, FACC, Jay A. Shechter, MD,
FACC, Louis Leo, MD, Lamberto Bentivoglio, MD, FACC, and
Steven G. Meister, MD, FACC, Medical College of Pennsyl-
vania, philadelphia, PA., 19129.
Doppler left ventriculardiastolic flow velocity profiles
can provide informationon diastolic function. To deter-
mine howdiastolic function is altered during iSChemia, 13
patients had pulsed Doppler exams performed prior to and
during balloon inflation while undergoing PTCA of the LAD
(9), RCA (2) and circumflex (2) coronary arteries.
TransmitralDoppler peak early (E) and late (A) diastolic
velocities, E/A ratios, early diastolic acceleration (Ace)
times, deceleration rate (DecR), and areas under the time
velocity curve for early (TVI-E), late (TVI-A), and total
filling (TVI-T), as well as the proportionof total
filling occurring during the E and A phases (TVI-E/TVI-T
and TVI-A/TVI-T) weremeasured. Results (mean + sem):
E A Acc/DFP TVI-E/TVI-T TVI-A/TVI-T
Pre-PTCA 64+3 58+5 -:TS+:OT .64+ .02 .33+ .02
During PTCA 60+3 68+5* .19+.01* .59+.03* .38+.02*
cm/sec cm/sec - - *p< .05 -
During PTCA, no significant changes were noted in E and
DecR (317+18 vs. 298+28 cm/sec2). However, ischemia
produceda decrease Tn the E/A ratio (1.1+.1 vs. 0.9+.1,
p<.05), an increase in the proportionof total flow-
occurring during atrial contraction, with prolongationof
time to peak early diastolic filling corrected for length
of the diastolic filling period (Acc/DFP).
Conclusion: Myocardial ischemia during PTCA alters diasto-
lic left ventricularcompliance acutely. These changes are
readily seen in the Doppler transmitralvelocity profile.
DOPPLER EVALUATION OF LEFT VENTRICULAR INFLOW DURING
TRANSIENT MYOCARDIAL ISCHEMIA William F. Armstrong, M.D.,
F.A.C.C., Thomas Ryan, M.D., Harvey Feigenbaum, M.D.,
F.A.C.C., Indiana University School of Medicine, Krannert
Institute of Cardiology, Indianapolis, IN
Coronary occlusion (CO) results in altered LV diastolic
compliance which is reflected by an abnormal mitral inflow
patternwith Doppler echocardiography(DE). To investi-
gate the relationshipof DE and hemodynamicparameters8
open chest dogs were studied with DE and high fidelity re-
cordings of LV pressure from which LVEDP, dP/dT, and time
constant of relaxation (T) were calculated. Dogs were
studied before and during CO alone and with aortic clamp-
ing (AoC). nitroglycerin (NTG) infusion and VOlume infus-
ion (Vol). DE parametersincluded peak early (E) and late
(A) filling velocities and areas, ratio of E to A, time to
E and slope of early velocity. Changes in DE occurred in-
stantly following CO and reversed following release. For
comparison among animals the E/A ratio was normalized to a
value of 1.0 at baseline. The direction of changes in he-
modynamic and DE parameterswas predictable but their
magnitude did not correlate highly.
n LVEDP - dP/dT E/A
Base 43 6.5+3.6 1938+415 1.0+0.0
Occl 22 9.0+3.8# 1604+298* .74+.14*
AoC/Occl 7 15.3+3.2* 1783+520 .76+.54*
NTG/Ocl 8 6+4.2 1460+325* .97~.33
Vol/Ocl 4 11+7.4# 1440+284# .60+.24*
Compared to baseline: * p < .01, # p < .05
We conclude that I} myocardial ischemia causes predict-
able changes in DE parametersincluding the EIA ratio; 2)
the changes in E/A parallel hemodynamicchanges, but 3) do
not correlate highly with individual hemodynamicmeasure-
ments. As such DE may provide a non-invasive guide to
overall diastolic properties of the LV but does not
predict any specific hemodynamicvariable.
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DOPPLER ECHOCARDIOGRAPHICSTUDY OF LEFT VENTRICULAR
DIASTOLIC FILLING IN ISCHEMIA: EFFECT OF REPERFUSION
ON MITRAL FLOW VELOCITY
Shan Shen Wang.M.D •• John Funai. M.D., Maxine Rosoff.
M.D •• Natesa Pandisn. M.D. Tufts-New England Medical
Center. Boston. Massachusetts
Myocardial ischemia (Isc) has been shown to impede
early diastolic filling and to decrease early (E) to late
(A) diastolic filling velocity ratio in mitral flow. To
assess the impact of reperfusion (R) on LV filling
velocities. we used Doppler to obtain mitral flow velocity
recordings and analyzed E/A velocity ratio in 6 heart
rate-controlleddogs in control (C). after 3 hrs of
coronary occlusion (00). and then followed by 3 hrs of R
(R Group). We compared these mitral flow data to 8 dogs
which underwent full 6 hrs of 00 (Isc Group). RESULTS
(x±SE): E/A Ratio was: Isc Group C: 1.6±.2. 3 brs 00: .74±
.3*. 6 brs 00: .26±.2*. R Group C: 1.6±.2. 3 brs 00: .9±
.2*.3 brs R: .9j;,·2*@. (*p<.05 vs C; @p<.05 vs 6 hrs 00).
All dogs in Isc group showed progressive decrease in E/A
ratio during 6 hrs of 00. In the R group. E/A ratio which
had decreased during 3 hrs of 00. fell further in 2 dogs
during 3 hrs of R while in 4 there was no significant
change following R. No dog demonstratedimprovement in
early filling during R. We conclude that reperfusiondoes
not restore LV filling velocity characteristicsto
normalcy but may prevent further deteriorationof ischemia
induced filling dysfunction in some.
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RECONSTRUCTION OF ECHOCARDIOGRAPHIC IMAGES USING FILTERED
TWO-DIMENSIONAL FOURIER TRANSFORMS: A SUPERIOR METHOD FOR
NOISE REDUCTION.
James D Thomas. MD. Linda D Gillam, MD. FACC. John B
Newell.- BS. RobertHogan. PhD. Arthur E Weyman. MD, FACC,
Massachusetts General Hospital, Boston, MA.
The application of automated wall motion analysis to
echocardiographic images has been limited by the spatial
and temporal noise inherent in the video image. Fourier
(spectral) analysis is a natural approach to a periodic
event such as cardiac contraction. 20 normal can1ne
echocardiograms were digitized over complete cardiac
cycles using 72 endocardial rays from a floating centroid
of endocardial area. For cardiac cycles with N frames, the
digitized data were placed in an Nx72 ar~ay and then
transformedusing a two-dimensional fast Four1er transform
algorithm. Analysis of these transforms indicated
significantly greater temporal noise (interframe) than
spatial noise (intraframe) (p<0.001). These high frequency
noise components were set to zero and an inverse Fourier
transform performed yielding a much smoother contraction
than the original digitized image. (See figures)
Such filtering reduced the number of endocardial direction
reversals from 16.9+1.4 to 2.2.!0.7 (mean.!SEM) per cycle
(p<O.OOO1). This dramatic reduction in echocardiograph~c
image noise by Fourier filtering should be of value an
analysis of both normal and abnormal LV wall motion.
AN ELLIPSOIDAL SHELLSUBTRACTION MODEL
FOR DETERMINING RIGHT VENTRICULARVOLUME
M.P. Feneley, J.W. Gaynor, S.A. Gall. G.W. Maier,
R.C. Orchard, J.S. Rankin, (FACC)
Duke University Medical Center, Durham, N. C.
The quantitative evaluation of global right ven-
tricular function has been hampered by the lack of an
accurate method for determining alterations in its vol-
ume (RVV), due to the complex geometry of its cavity.
To circumvent these difficulties, RVV was determined
by subtractingthe volume within the epicardial shell of
the left ventricle (LV) from the total volume within the
epicardial shell of both ventricles. Ultrasonic gauges
were implanted to measure the base-apex (a), antero-
posterior (b) and septal - free wall (c) LV ep~cardial
dimensions, and the septal - RV free wall epieardial
dimension (d) in 4 freshly excised and 3 isolated,
perfused beating canine hearts. Modified ellipsoidal
models were employed to calculate both the biventricular
( 11 /6. ab (e-e ) and LV epicardial shell volumes (11/6
abcj: RVV was calculated as the difference between
these two shell volumes (11/6. abd) minus the volume of
the RV free wall myocardium, which was determined by
water displacement. IntracavitaryLV and RV volumes
were independently variedand measured directly with
intraventricularballoons. The relationship between the
calculated RVV and the actual RVV was highly linear
and independent of LV volume (Calculated RVV = 0.71
±O .17 x Actual RVV + 3.87±7. 74 cc, r =0 .99±0.oH SD},
p<O.001). The regression slope approached unity
(maximum observed slope = 0.92) when "d"most closely
approximated a linear extrapolation of "c". Thus, an
ellipsoidal shell subtraction model, the parameters of
which could also be determined by echocardiography,
accurately representschanges in RVV.
FEASIBILITYANALYSIS OF 3-DIMENSICNALRECX:NS'IRJcrIOOOF
COIDROOPP!.ER FI.CM VEI.OCITIES
John R. SChott. Fh.D•• sally Moos, Rolamo Raqueno,
Amitabha Ghcsh, Fh.D., Navin C. NarXIa, M.D., F.A.C.C.
University of Alabama at Binni.n;Jham, Binni.n;Jham,AL.
'!he feasibility of reconstructi.n:J3~ional (3-D)
color D:Jppler (CD) velocity fields was examined usi.n:J 3-
D time varyi.n:Jreconstruction(R) of the LV fran
conventional video-taped Q) echoes. R process based on
generationof wire frame outlines of LV walls at
nonnalized times in the cardiaccycle fran a reconstruc-
ted model (of a series of rotationalcross sections
usi.n:J a previously described transducerrotational
methcxi) IlIlSt be merged with the same data set represent-
i.n:Jiso-velocity lines. CD echoes 'NeI'e digitiZed into 3
registered512 x 512 image planes representi.n:Jlevels of
colors (red, towards the transducer;blue, away; green,
velocity variation) with brightness (B) varyi.n:Jwith
Velocity variation. To reduce noise effects due to low
spatial resolutionarrl system mise, red arrl blue
channels 'NeI'e separatelySlOOOthed usi.n:J nearest neighbor
averagi.n:JiJ!plementedwith a convolution kernel. B data
'NeI'e color coded by B steps so that each velocity I'aIV;l'e
was delineatedalto 2 separateimages. Six iso-velocity
lines towards arrl 6 away fran the transducer'NeI'e
generatedfran color flow images of a hl.m1an heart. '!he
resultant j.maqeshave clearly defined Velocity contours
that can be ccnverted to wire frames in the same space
as the wire frames for 3-D reconstruc:tion. 'lhe p0ten-
tial for ~i.n:J flow infonnationsinultaneooslywith 3-
D time daDain reconstruc:tionoffers significant advan-
tages in 1IJXleli.n:Jthe fluid dynamics of the hl.m1an heart.
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TWO-DIMENSIONAL ECHOCARDIOGRAPHIC IMAGINr.: IN VITRO COM-
PARISON OF CONVENTIONAL AND DYNAMICALLY FOCUSED ANULAR
ARRAY TRANSDUCERS.
Riccardo Pini, M.D., Luigi Ferrucci, M.D., Mauro Di Bari,
M.D., Barbara Greppi, M.D., Marino Cerofolini, O.EI.Eng.,
Leonardo Masotti, D.El.Eng., Richard B. Devereux, M.D.,
F.A.C.C. Cornel! Medical College, New York, N.Y.
Quantitative two-dimensional echocardiography (2D-E) has
been adversely affected by a tendency to underestimate
cross-sectional areas (CSA) of cardiac chambers. Todeter-
mine if this might be ameliorated by recent advances in
imaging technology, we measured echocardiographic (echo)
CSA of 25 formalin-fixed left ventricular (LV) sections in
vitro using conventional 13mm and 15mm diameter fixed-foc-
used single element transducers, and a 15mm diameter dyn-
amically focused anular array transducerat 2cm, 6cm and
10cm distances between myocardial slices and transducer,
and compared the2D-E and correspondinganatomic CSAs. LV
total and cavity area were measured by computerassisted
planimetryof videotaped echo images and photographedana-
tomic slices; LV myocardial area was derived by subtract-
ion. Comparison of 2D-E total, myocardial, and cavity
areas with correspondinganatomic measurements showed ex"
cellent correlation for each transducerat all depths
(r=0.97 to 0.98 for total area; r=0.98 to 0.99 for cavity
area; r=0.93 to 0.97 for myocardial area). For total and
myocardial CSA, the slope of the relation between echo and
anatomic areas approximatedunity, but for LV cavity area
this was achieved only by the dynamically focused transdu-
cer. In contrast, the conventional 13mm transducersignif-
icantly underestimated larger LV cavity areas in both the
near and middle fields (slopes=0.90 and 0.91 respectively)
and the 15mm transduceryielded slopes from 0.86 to 0.91
in all fields. This study indicates that dynamic focusing
and narrowing of beam width by anular array technoloqy am-
eliorates underestimationof cardiac chamberCSA by 2D-E.
CONTRAST ULTRAS<NlGRAPHY OF THE KIDNEY: A f'£W METHOD FOR
IN VIVO EVALUATION OF RENAL PERFUSION.
Roberto M.Lan~. M.D.,. Steven B. Felnstein., M.D., Charles E.
McCoy., M.b.,. E ward D. Frederlckson, M.D.,. Alex Neumann,
B.S.,. 5eth M. Powsner, M.D.,. Lean I.Goldberg.. M.D.,. Ph.D., and
Kenneth M. Borow, M.D.,. F.A.C.C.,. The University of Chicago,
Chlcago,IL.
The effects of pharmacologlc agents on renal blood flow (RBF)
are clinically Important In many diseasetates Including systemic
hypertension and congestive heart failure. However, due to the
complexities of RBF, quantltatlon In vivo has been technically
difficult. This study assesses the use of ultrasound Imaglng of the
kidney combined with Injection ofsonicated Renografln-76
(mlcrobubblediameter = 4.4!2.81» to determine RBF. Five dogs
were studied. Catheters were placed In the descending aorta for
injection of sonicated Renografln and In the renalrteryfor drug
Infusions. Data werecollected prior to and during
Intrarenal artery Infusions of bradykinin and
norepinephrine. TotalRBF was measured by
electromagneticflowmeter. Video density versus
time curves were generated for comparable
segments of the outer renal cortex and fit to a
monoexponentlal decay curve. This allowed
calculation of the mean exponential decay Index
(T 1/2). An Increase In T 1/2 paralleled
decreased renal perfuslon (I.e.,. longer washout of
contrast material). The opposite was true for a
decrease In T 1/2. Bradykinin IncreasedRBF
from 134 ! 26 to 249 :!: 19 ml/mln (p < 0.01 vs control) while
norepinephrine decreasedRBF from 130! 25 to 51 ! 17 ml/mln (p
< 0.01 vs contref], When campared to controldata, bradykinin
decreased T 1/2 by 2996 (3.8 :t 1.1 vs 2.7 + 1.0 secs; P < 0.01 vs
control) while norepinephrine prolonged T 172 by8896 (3.9 ! 1.3 vs
7.4 + 2.3 secs; p < 0.01 vs control). There was an Inverse linear
relationship between totalRBF and T 1/2 values.
Conclusion: Renalcontrast Ultrasonography Is a new technique
that allows In vivo (1) repetitive real time ultrasound Imaglng of
renal blood flow and (2) quantitative assessment of renal
perfuslon prior to and during pharmacoleg!eInterventions.
NONINVASIVE RENAL BLOOD FLOW BI PULSED DOPPLER
ULTIWlOUIID 11 PIGLETS- ULIDATIOIOF TIll TICIDIIQUI
James M. Berry, John L. Bass MD, Vinoent R. Zales MD,
Stanley Einzig MD, PhD. Univ of Minnesota, Minneapolis.
A noninvasive method for measurementof renal blood
flow(RBF) would have widespread olinioal applioation.
We examined the aoouraoy of transabdominal pUlsed
Doppler(PD) ultrasoundof the renal artery in predioting
RBF in 8 ketamine anesthetized intaot piglets(4.7-5.4
kg., 7-13 day). The PD RBF was oomparedto RBF measured
by sequential injeotions of 15IJm radionuolide labeled
spheres. Eaoh kidney was studied separately and 5 pigs
were restudiedafter aoutely oreating a patentduotus
(balloon oatheter);a total of 24 de terminations.The
left to right shunt via the duotus ranged from 18-55%.
An Ekoline 55000 meohanioal seotor soanner with a 5 MHz
transduoer was used for PD studies. Renal artery
diameterwas measured from 2-dimensional images using
axial resolution. PO was reoorded parallel to flow in
the proximal renal artery with a 2mm sample volume and
RBF was oaloulated by planimeterizingthe entire flow
profile of 5 oardiao oyoles. Peak PO RBF velooities
ranged from 0.26 to 0.56 M/s, with systolio and
diastolio antegrade flow. PO RBF ranged from 21 to
83(mean 4S)ml/min andmiorosphere RBF ranged from 22 to
66(mean 41)ml/min. Post mortem examination showed
single renal arteries to all kidneys. The slightly, but
not signifioantly, higher Doppler RBF values may refleot
partial adrenal flow from the renal artery in some
animals. Regression analysis yielded a signifioant
oorrelation(p<0.01) with a standard error of the
estimate of 8ml/min and a coeffioient of variationof
20.7%. ThUS, transabdominalPO ul trasoundoan be used
to assess RBF noninvasively and would be partioularly
useful for serial evaluation in very young individuals.
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COHPARISON OF EXERCISE 2-DIHENSIONAL ECHOCARDIOGRAPHY
AND HIGH-DOSE DIPYRIDAHOLE-ECHOCARDIOGRAPHYTEST FOR
OIAGNOSIS OF CORONARY ARTERY DISEASE
Eug~nio Picano, HO, Fabio Lattanzi,
HO, Alessandro Distant~, MD. C.N.R.
Institut~, Univ~rsity of Pisa, Pisa,
Fifty-five pts with ~ffort angina pectoris and
technically satisfactory cas~lin~ echocardiogram (~cho)
p~rformed a supin~ exercise-echo test (EET) and a
dipyridamole-~cho test (DET, up to 0.84 mg/Kg i.v.
dipyridamole over 10 minutes). All und~rwent coronary
art~riography: 34 pts had at l~ast on~ major art~ry with
) 70X stenosis (luminal dia.et~r narrowing). For ~ach pt
th~ sam~ physician p~rformed both DET and EET, with th~
same echo instrum~nt. Positivity of both t~sts was
link~d to th~ detection of n~w onset or worsening
r~gional asyn~rgy. Interpr~tabl~ studies w~r~ obtain~d
in 55/55 (100X) of DETs, but only in 40/55 (73X) of EETs
(p (0.01). In th~ 40 pts in whom both t~sts wer~
interpr~tabl~, DET show~d, with r~sp~ct to EET, a
similar sensitiVity (72X vs 76X, P = ns) and sp~cificity
<100X vs Bn, p ns) for d~tecting angiographically
ass~ss~d coronary art~ry diseas~. In the 16 pts in whom
both DET and EET wer~ positiv~ for isch~mia. the sa.~
myocardial r~gion suff~red the reversibl~ asynergy.
Thus, indep~nd~nt of all factors pot~ntially affecting
th~ performance of each test (operator, patient,
instrumentation), DET was significantly more f~asible
than EET, with a comparable sensitivity and specificity.
Dipyridamole provokes regional asynergy in the same
regions demonstrating ischemic dysfunction during
e:<ercise.
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CAN EXERCISE TWO DIMENSIONAL ECHOCARDIOORAPHY
REPLACE EXERCISE THALLIU"I"AOIHO.
Philip Houck M.D., L.o J. Spaccavento, ".0.,
F.A.C.C., Fred Weiland, ".0., Warren
Brei.blatt, M.D., F.A.C.C. Wil~ord Hall USAF
Medical C.nt.r, L.ckland AFB, T.x•• 78236-5300.
The pr.dictive v.lue (PV) o~ Ex.rci•• (EX)
Th.lliu. Im.ging (TI-I) .nd EX two di.en.ion.l
.choc.rdiogr.phy (2DE) ver. comp.r.d in 90
con.ecutiv. patient. (pt.) admitted ~or c.rdi.c
c.th.t.riz.tion~or coron.ry di••••• (CAD) .
2DE .tudi•• v.re comput.r ~orm.tted •••
continuous loop i ••ge vith .iMult.neou. revi.v
o~ pr. .nd po.t EX i ••g.. ~or r.v.r.ibl. wall
aotion abnorm.liti•• (WMA). TI-I v.r••cquir.d
u.ing a bilater.l rotating collimator vith
tomographic recon.truction~or .tre.. and four
hour r.di.tribution. Circua~er.ntial aapping
va. u••d to •••••• rev.r.ibl. i.ch••ia (RI) .nd
va.hout abnormalitie.. Of p.ti.nt. vith
.ignific.nt CAD (~ 75X reduction in luminal
dia••t.r); 91X (66/73) had TI-I .vid.nc. for
RI; 90X (62/69)h.d W"A by EX2DE.
S.n.itivity Specificity PV. PV
EX 2DE 90X 82X 95X 45X
TI-I 91X 71X 95X 70X
Th. EX 2DE va. limit.d in that 10X (9/90) of
the .tudi.. vere t.chnically inadequat.. Th.
••nsitivity and .pecificity of EX 2DE and TI-I
v.re compar.bl. and vh.n po.itiv. v.re highly
predictive of CAD. In this .etting, EX 2DE i.
an acceptable .It.rn.tiveto TI-I.
EXERCISE ECHOCARDIOGRAPHYIN THE EVALUATION OF
CORONARY ARTERY DISEASE.
L.o J. Spaccav.nto, M.D•• F.A.C.C., Philip
Houck, ".0., Virgini.Oonzalez, B.S., W.rr.n
Br.i.bl.tt, ".0., F.A.C.C., Wil~ord H.ll USAF
M.dical C.nt.r, L.ckl.nd AFB, T.x•• 78236-5300.
Supine tvo diaen.ion.l .choc.rdiogr.phy (2DE)
p.rform.d pre .nd po.t .xerci•• (EX) i. u••ful
in the diagno.i. of coron.ry art.rydi•••••
(CAD). Th. pr.dictiv. value (PV) of EX 2DE and
EX .l.ctroc.rdiography(ECG) v•• compar.d in
150 cons.cutiv. p.ti.nt. (pt.) .dmitted for
cardiac cath.t.rizationfor che.t pain. E.ch
2DE va. computer for••t.d a. • continuous loop
i.age. Pre .nd po.t EX iaage. ver. vi.ved
.imult.n.ou.ly. Rever.ibl. v.ll motion
abnor••liti•• (WMA) v.r. con.ider.d di.gno.tic
of CAD. Technic.lly .dequat. ex... ver. 96X
(144/150). Int.rob.erv.rv.riability v•• 8X.
A con~idenc. .cor. v.. c.lcul.t.d on ••ch 2DE
b•••d on the quality of individu.l .egm.nt••
Th. confidence .cor. i. u••d to a••ign .n
objective .core to the qu.lity o~ the .can .nd
directly correlate.vith the .ccur.cy of the
interpr.tation.Of pt. vith signific.nt CAD
(~75X r.duction in lu.in.l di.met.r), 90X
(90/100) h.d rever.ible W"A.
Sen.itivity Sp.cificity PV. PV-
EX 2DE 90X 82X 95X 70X
EX ECG 62X 60X 85X 31X
The EX 2DE i. more .pecific and ••n.itive for
detecting CAD th.n ECG .lon.. A po.itive EX
2DE .lone i. pr.dictiv. of CAD, hov.v.r vhen
negativ., .hould be interpretedvith c.ution. A
confidence score can b. u.ed to determin. the
• ccur.cy of 2DE.
ECHOCARDIOGRAPHIC POSTERIOR LEFT VENTRICULAR DYSKINESIS
SEEN IN THE UPRIGHT POSITION IN HEALTHY VOLUNTEERS
Hiroyuki Sasaki,MD; Yzhar Charuzi,MD,FACC; Yugi Sugiki,MD ;
Enrique Ostrzega,MD; Hiroshi Honms,MD.; Lori Hauser,BA.
Cedars-SinaiMedical Center, Los Angeles, CA
Exercise echocardiography, a relatively new technique for
the diagnosis of myocardial ischemia, is frequently per-
formed on patients in the upright position. Exercise in-
duced segmental dyskinesis of left ventricular wall
(LVW) is considered diagnostic of myocardial ischemia.
However, we observed posterior LVW dyskinesis in the up-
right position in healthy young adults and ot hers reported
the same phenomenonin patients with mitral valve prolapse
(HYP). In order to analyze the effect of upright position
on LVW motion, we studied 60 healthy volunteers (25 males
35 females), age range 17 to 38, none of them with clini-
calor echocardiographic evidence of HYP. Using two di-
mensional echocardiography, parasternal long and short
axis views were obtained in the supine and upright posi-
tions and LVW motion was qualitatively analyzed by two
independent observers. Intra and interobservervariability
was low (3% and 5% respectively). In the supine posi-
tion, 33 volunteers (55%) showed dyskinesis of the poste-
rior LVW. There was no difference in age, sex, height,
weight, and supine blood pressure and heart rate between
volunteers with and without abnormal LVW motion.
In conclusion: 1) isolated dyskinesis of the posterior LVW
was seen frequently on echocardiographic studies in
healthy volunteers in the upright position and 2)this
phenomenon, which is lIlOst probably physiologic, must be
taken into consideration during wall 1I0tion analysis of
echocardiogrsphicstudies done in the upright position.
EXERCISE ECHOCARDIOGRAPHICDETECTION OF ISCHEMIC HEART
DISEASE IN PATIENTS WITH NORMAL WALL MOTION AT REST
Thomas Ryan, MD, Charles G. Vasey, MD, William F.
Armstrong, MD, FACC, Harvey Feigenbaum, MD, FACC,
Indiana University School of Medicine and the Krannert
Institute of Cardiology, Indianapolis, Indiana
To date, most studies investigating the ability of exer-
cise 2D echocardiography(EE) to identify Pt with coronary
artery disease (CAD) have included Pt with resting LV wall
motion abnormalities. To determine the diagnostic utility
of EE in Pt with normal wall motion at rest, 64 Pt (39 men,
mean age 58 yr) w;re-;tudiedwith EE in conjunction with
routine treadmill exercise testing (THE) prior to coronary
cineangiography. All 31 Pt with positive EE had CAD, de-
fined as ~70% narrowing of at least 1 major vessel (100%
specificity). Nine of 33 Pt with a negative EE also had
CAD (78%sensitiVity). Of the 9 false negative EE studies ,
6 Pt had single vessel disease (SVD ) , including 5 with
isolated left anteriordescending artery (LAD) stenosis.
Among Pt with SVD, EE vas positive in 9 of 14 with LAD
s tenosis, 3 of 3 with left circumflex artery (LCX)
stenosis, and 7 of 8 with right coronary artery (RCA)
stenosis . The sensitiVity of THE versus EE as a f unction
of extent of CAD (number of stenotic vessels) was :
# of Vessels THE EE
1 24%(6/ 25) 76% 09/25)
2 63%(5/8) 75%(6/8)
3 71% (5/7 ) 86% (6/ 7)
We conclude: 1) EE is highly specific and moderately sen-
sitive for the detection of CAD in Pt with normal LV wall
motion at rest, 2) the limited se nsitivity is due to a
relative inability to detect isolated LAD stenosis, 3)
EE is significantly more sensitive than THE in Pt with
SVD, most likely due to its ability to identify Pt with
LCX or RCA stenosis, and 4) both THE and EE will identify
most Pt with 3-vessel disease and normal LV wall motion.
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COMPARISON OF PEAK AND POST EXERCISE ECHOCARDIOGRAPHIC
IMAGING IN EVALUATION OF CORONARY ARTERY DISEASE
Charles F. Presti, M.D., William F. Armstrong, M.D.,
F.A.C.C., Harvey Feigenbaum, M.D., F.A.C.C., Indiana
University School of Medicine, Krannert Institute of
Cardiology, Indianapolis, IN
To determine if immediate post bicycle exercise
echocardiography(EE) provides the same information as
imaging at peak exercise, we evaluated 83 consecutive pts
being investigated for coronary artery disease (CAD).
Diagnostic images were obtained from apical views at peak
upright exercise and from supine apical and parasternal
views immediately post exercise. EE were digitized,
displayed in a continuous loop quad screen format and
evaluated by 2 blinded observers. InterpretableEE were
obtained in 76 pts (92%).
Of 76 pts evaluated 32 had a newwall motion abnormal-
ity (WMA) with EE. Of the 32, 7 had a newWMA detected in
the apical views during peak EE that had resolved at the
time of post EE apical imaging. However, 3 of these 7 had
WMA in post EE parasternalviews in the same area of WMA
as the peak EE apical views. Nineteen of 32 pts with new
WMA underwent coronary angiography (Cath) and 18 of these
pts had CAD (~ 50% diameter narrowing) in vessels supply-
ing the area of WMA. Of the 13 pts that did not undergo
Cath, 11 had evidence of CAD as manifested by prior
coronary artery bypass grafting and/or prior myocardial
infarction. Of the 4 Pts with WMA confined to peak EE,
all underwent Cath: 3 had extensive intercoronary
collaterals and the remaining pt had only a 60% stenosis.
These data indicate that the more easily obtained
immediate post EE is comparable to peak EEif all
available windows are utilized; however, a small
percentage of pts with CAD will be missed with post EE
alone; the role of collateral coronary circulation and/or
severity of stenosis in these pts remains to be defined.
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MECHANISM OF INCREASE IN MITRAL VALVE AREA BY DOUBLE-
BALLOON CATHETER BALLOON VALVULOPLASTY IN ADULTS WITH
MITRAL STENOSIS: ECHOCARDIOGRAPHIC-DOPPLERCORRELATION.
Cheryl Re1d,M.D.,F.A.C.C., Charles McKay,M.D.,F.A.C.C.,
P. Chandraratna,M.D.,F.A.C.C., David Kawanishi,M.D.,
F.A.C.C., ShahbudinH. Rahimtoola,M.D.,F.A.C.C.,LAC-USC
Medical Center, Los Angeles, California
To study the mechanism and results of double balloon
catheter balloon valvuloplasty (CBV) in adult pts with
mitral stenosis, Doppler and two-dimensional echocardio-
graphic (2DE) studies were performed pre- and
immediately post-CBV in 8 pts and 3 months post-CBVin 5
pts. Mitral valve area (MVA) was calculated from
Doppler flow tracings. Morphologic changes measured
from 2DE were transverse diameter at the commissures and
angles of anteriorand posterior commissural openings.
Immediately post-CBV, 2DE showed an increase in trans-
verse diameter (1.8:!:.2cm to 2.4±.2cm, p<'05) and angle
of anterior (31±6° to 44±16°, paNS) and posterior (34±9°
to 49±10°, p<.05) commissural openings. MVA by Doppler
pre-CBV correlated with MVA by cardiac catheterization
(r=.85, SEE.13); immediately post-CBV correlation was
poor (r=.3, SEE.4), but again correlatedafter 3 months
(r=.97, SEE.1). Doppler did not identify 2 pts who had
a reduction in MVA at 3 months; 2DE in these 2 pts
showed no increase in transverse diameter in 1 pt and
early decrease in the anteriorangle in another pt.
Summary: 1) The increase in MVA by double-balloon CBV
occurs along the natural planes of the comroissures
resulting in increased commissural angle opening.
Fracture or disruption of the valve leaflets did not
occur. 2) Lack of increase in transverse diameter or an
early reduction in commissural angle is associated with
partial restenosis at 3 months. 3) Doppler provides a
reasonable estimate of MVA pre- and 3 months post-CBV.
AID OF OCIJXARDICXiRAPHYIN BALW)N VAlNUWPLAmY FOR
J\ORI'ICS'l'EN::6ISAND MITRAL S'l'EN::6IS.
Natesa Pandiao, M.D., Shan ShenWang, M.D., Kevin
fotInerney, Jeffrey Isner, M.D., F.A.C.C., Mark Desnoyers,
M.D., Thomas Hougen, M.D., William Mackey, M.D., Deeb
Salem, M.D., F.A.C.C. Tufts-New England MedicalCenter,
Boston, Massachusetts.
Tb assess the role of echocardiographyin the promising
new treatmentmethodof balloon valvuloplasty (BVJ for
aortic stenosis and mitral stenosis, we used 2D echo,
Ilo[.ple~ and col~r fl~ inaging pre~ during and post BV in
8 aortae stenoais patlentsand 3 nutral stenosis pts. The
age range was 49to 89 years. We assessed the value roor-
phol~, gradientsacross the valve (Ilo[.pler), Ilo[.pler
deternunedvalve area (pressurehalf-time methodfor
mitral,stenosis, equation of continuity methodfor aortic
stenoais) , and the presence of regurgitation. RESULTS (x±
SE): BV resulted in the following: In 6/8 AS patients,
the peak andmean gradients (1lIll Hg) decreased from 84±10
to 45±4 and from 53±8 to 28±3; the valve area (cm2 ) in-
cre~ed from 0.5±0.05 to 0.8±0.08 (P<.05). In 2/8
pat1ents, there was no change. In 3mitral stenosis
patients the valve area increased from an average of 0.96
to 1.7crn2. All aortic stenosis and mitral stenosis
patients had trace to 2+ ~egurgitation in pre BV studies
but 1n non7was there an 1nc~ease in regurgitationpostBV. Followmg,BV, th7rewas lI?Creasein leaflet separationon ~ho both m aort1c stenoS1S and mitral stenosis
patlents. The valve roorphology onthe pre BV echo was not
usef~l in.pred~c~ing the outcome. 2D echo inaging during
BV a1ded 1n gU1dmgtranseptalcatheterizationin mitral
~tenos~s and in deroonstratingappropriateballoon
mflat10~ across ~he stenotic valves in mitral stenosis
and aortae sbenosf.s, We conclude that the different
echocardiographicroodalities valuably aid during the
perfornanceof balloon valVUloplasty and in the irrrrediate
evaluation of the results of balloon valvuloplasty.
IIl'DW. RJG]R;rmrIa!IAP'D!R PI!lOl'JMIDJSMImAL VALVI1lOIY
DI llIlJL'1S: .BVALt:Wl'ICIfBY lU.SIID IXJP1'LIR~
Yillian Abascal. .M.D.., Gerard Wilkins, M.B., Christo~~
O1oong, M.B., FtI.D., Igor Palacios, M.D., F.A.C.C., Peter
Block, M.D., F.A.C.C., Arthur Weyrnan, MoD., F.A.C.C.,
MassachusettsGeneral Hospital, Boston, M.
Percutaneous mitral valvotCll¥ (l'MV) pranises to be a
valuable technique in the treatment of adult mitral
stenosis. However, the occurence of mitral regurgitation
(MR) after l'MV, and its relationshipto specific rnor~o­
logic features of the valve have not been described. We
used cross-sectional and Doppler echocardiogra~ to study
19 patients (16 female, 3 male; mean age 55years, range
21 to 88 years) before and after l'MV. '!he severity of MR
was nawed and graded on a scale of 0 to 4+. 'lhe awear-
ance of the valve was assigned scores of 1 to 4 based on
leaflet mobility, valvular thickening/calcification and
subvalvular tethering. Mitral valve orifice was planirn~
tered and LA vollJllle was calculated. After l'MV, mean MR
grade increasedfran 1.2±l.3 to 1.7±l.2 (P=().001). MR did
not dlange in 9 (47%) patients, increased i:¥ 1 grade in 8
(42~) patients, and increased i:¥ 2 grades in 2 (lU)
patlents. '!he number of pltients in each MR grade were:
GRADE 0 GRADE 1+ GRAIE 2+ GRAIE 3+ GRADE 4+
PRE-l'MV 10 3 2 4 0
POOT-l'MV 4 5 4 6 0
Mor~ologic features of the valve, initial mitral
orifice area, and the increase in mitral orifice area
~ter l'MV,did not d;iffer significanUy between pltients
W1th and W1thOUt an mcrease in MR. Despite the increase
in MR, LA vollJllle decreased in all patients (90±39 to 73±35
ml, poO.001). QlnclusiCl1: A snall increase in MR was
found in 53% of patients undergoing l'MV. No patient
developed severe MR. '!he increase in MR after l'MVwas not
associatedwith arrj particularmoq:bologic features of the
valve or with the increase in mitral orifice area.
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DOPPLER ECHOCAROIOGRAPHYBEFORE, DURING AND AFTER
PERCUTANEOUS AORTIC VALVULOPLASTY.
Marc K. Lewen, DO, Michel G. Vandormael, MD, Morton J.
Kern, MD, FACC, Ubeydullah Deligonal, MD Arthur Labovitz,
MD, FACC. St. Louis University School of Medicine, St.
Louis, MO.
Percutaneous aortic valvuloplasty (PAV) offers a
possible alternative treatment for critical aortic
stenosis. Doppler echocardiography(Dop) provides a
noninvasive method of evaluating aortic stenosis and the
result following surgical treatment. To evaluate the
ability of Dop to follow the results of PAY, five patients
with aortic stenosis had Dop before and after this
procedure. Peak and meantransvalvulargradients were
measured from the highest velocity obtained from the
apical, suprasternalnotch and right parasternalwindows.
LV ejection fraction (EF) was measured from the 2Dapical
4-chamber view. Ao valve area (AVA) was calculated as the
product of the cross section area of the aortic annulus
and the ratio of the LV outflow tract to peak Aovelocity.
In addition, 2 of the patients had Dop during balloon
occlusion of the Ao valve to evaluate changes in Aa flow
and monitor insufficiency between balloon inflations.
GRADIENT
Peak Mean AVA EF
Pre PAY 77.8+33 43.0+21 • 70.!.. 09 39.8+15
Post PAY 56.0+24 27.6+15 1.14+.18 47.4+15
Aortic insufficiency did not change signficantly in all
patients following PAY. Correlationwith invasive hemo-
dynamics for peak gradient (r=.8, p<.006) mean gradient
(r=.82, p<.003) and AVA (r=.66, p<.04) were excellent. Ao
flow during valve occlusion was markedly reduced with
immediate returnwith balloon deflation. Thus, it appears
that Dop is a useful, accurate technique in evaluating the
results of PAY. Also, Dop may be helpful in defining flow
dynamics and Ao insufficiency during PAY.
THE TRANSMITRAL PRESSURE HALF-TIME IS SIGNIFICANTLY
AFFECTED BY LEFT ATRIAL PRESSURE AND COMPLIANCE:
OBSERVATIONS IN 21 PATIENTS UNDERGOING PERCUTANEOUS
BALLOON MITRAL VALVOTOMY.
James 0 Thomas, MD, Gerard T Wilkins, MB, Vivian Abascal,
MD, Igor----rPalacios, MD, FACC, Peter C Block, MD, FACC,
Arthur E Weyman, MD, FACC, Massachusetts General Hospital,
Boston, MA.
Transmi.tral pressure half-time (T1/2) has been thought
to be inversely related to the area of the mitral valve
(MVA) and independant of other hemodynamic variables. We
have developed a computer-based fluid dynamics model of
early diastole which predicts that T1/2 should be related
inversely to MVA but also vary directly with combined
LA-LV compliance (CMP) and the square root of the peak
transmitral pressure gradient (p). To test the effect on
T1/2 of acute changes in these parameters, hemodynamic
tracings were reviewed from 21 patients undergoing
percutaneous mitral valvotomy (PMV). T1/2 was measured
directly from LA and LV tracings. Mean LA compliance was
estimated from the systolic rise in LA pressure and LV
compliance estimated from the diastolic rise in LV
pressure, each divided into stroke volume. MVA was
estimated both from application of the Gorlin equation and
by echocardiographic planimetry of the orifice. Observed
T1/2, both pre and post PMV, were compared with
predictions based on MVA alone and those predicted by the
model. Observed T1/2 changed from 239+26.6 msec (mean+SEM)
pre to 119+7.2 post. Predictions based on MVA alone
correlated only modestly with observed T1/2 (r-e , 64 pr-e,
.23 post). Computer-derivedT1/2 (accounting for CMP and P
in addition to MVA) correlated much better with observed
T1/2 (R=.96 pr-e, .67 post). Mathematically, this
relationship was T1/2(msec) = 11.6 * CMP *mMVA. These
observations emphasize the hazard of using T1/2, either
cath or Doppler derived, as a simple estimate for MVA.
F.l1llIIE (F 'l1E JXI'Rnt PRmH: IIAIYl'D£ TO ImllA'!1U 1IIIIfSl'IlA'lE
aME litMrl1lALYAIJIEAID PlIliJIIBGIf:IDJ'1'.AIBlfMl'I.1MLVIL1OrolI.
Gerard WilldnsItl, ChB, Janes TharasMD, Vivian Abascal MD, Jme
Milrshall as, Peter mock /1), FAce, IgCl' Rilacios ID, FAce, ArtI1Jr
W9ynml MD, FAce. MlssachusettsGeneralIbspital, fustal, MA.
Ritients urxlergoill! percutaneous mitral valvotolqy provide an
excellent roodel in W'lich to examine the~ in hem:xlynamic
variables;,hiOO occur W1en mitral stenosis is relieved withoot cardiac
aJrger'y. This proceedure therefbre creates a uni<pe situation W1ere
circulatory readjustmant shoo1d relate only to the dJarl!e in CJlE!
factor Ie , the dJarl!e in mitral valvearea. We have used this settill!
to examine the I:l:lpplerpressurehalft:i.me method (H) of calculatill! the
mitral valve Cl'ifice in relation to direct edl<:lcaro~ralillc
plan:i.metryof the orifice (P) and the Q>rlinmethod (G). We studied 21
IBtients (17 teDBles, 4 DBles) rarging in age fran 21 to 88 years
(mean 56yrs). D:>ppler-ech:lcardicgraJi!icstudies were perfonoodbefbre
and after valvotolqy fran wch H ( area = 220/t112 ), P, heart rate
and LA vollll2 were calculated. D..Ir:ill! the catheterimtionprocedure,
pressures (direct LA and LV), CO an:! Gwere also meaaJl'edbefbrean:!
after valvotolqy. M3an valve area by each method is sIxwl:
P G H
Pre- valvotolqy 0.94cm2 0.84an2 0.94an2
Post-valvotolqy 1.75an2 1.82an2 1.39an2
p: .0001 pe .0001 pe .001
The dJarl!e in mitral valve area by Pand Gdaocrmtrateda highly
significant relationmip( G = 0.9P + 0.2, r:.86, p= .001). N:l 9..100
relationmipooo1d be deoonstrated fbr thecilaIl!e in HClCJlIBl'edto P
(r: 0.33) or G (r=.30). 'lalvotolqy re9..I1ted in a sjgn1ficant decrease
in the mean gradient (p=.001),LA peak presrore (p=.OO1), he:ight of
the Vwave (p=.OOl), LA vollll2 (p:.001) an:!a sJgti.ficant increase in
CO (p=.OO6). N:l significant dJarl!e W!lS observed in heart rate or
LVEll'. It is likely that the discordantre9..I1ts for~ in the
mitral valve area usirg H,reflect~ in presrore, flow an:! LA
volume that are not usually considered to besignificant factors in
the clinical application of this method.
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EFFECT OF GRADED REDUCTIONS IN REGIONAL MYOCARDIAL BLOOD
FLOW ON REGIONAL DIASTOLIC LEFT VENTRICULAR WALL DYNAMICS.
John Funai, M.D., Shan Shen Wang, M.D., Natesa Pandian,
M.D. Tufts-New England Medical Center, Boston,
Massachusetts.
Left ventricularsystolic wall motion and thickening
are closely coupled to myocardial blood flow (MBF).
However, the relationship of diasto1ic wall dynamics to
MBF during various grades of ischemia is unclear. To
assess this, we created graded circumflex coronary
stenoses in 8 dogs and measured regional transmuralMBF
with microspheres. From 20 echo short-axis views of mid-LV
we digitized endo and epicardial borders frame-by-frame
through the cardiac cycle to determine the onset and
extent (% end-diasto1ic value) of segmental diasto1ic wall
motion (DWM) and thinning (DWT) in the central risk area.
(Risk area was determined at the outset by noting the
dysynergic region during a brief test coronary occlusion).
Considering control MBF as 100%, we examined regional
diastolic wall dynamics at control and when MBF was 100-
67%, 66-34% and 33-0%.Results: (xtSD): When MBF fell to
less than 67% of control, the onset of both DWT (13%
delay) and DWM (19% delay) were delayed (p<.05). Such mild
flow deficit also resulted in a decrease in the extent of
DWT: at 25% of diastolic duration only 12±12 of %DWT
occurred compared to 33±20 in control. Furtherreductions
in MBF to less than 33% of control resulted in a decrease
in the extent of both DWT and DWM, not only during early
but also during mid diastole: at 50% of diastole, %DWT was
12±10 and %DWM was 2l±19 compared to control (p<.05).
Thus, diastolic wall dynamics appear to be closely linked
to MBF. Reductions in MBF sensitively affect the onset and
extent of DWT and DWM.
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Thus, the leftward shift and steeper slope i n end-systolic
pressure-wall thickness relations indicate that coronary
stenosis can affect regional LV performanceeven when
resting coronary flow is normal.
EVIDENCE THAT CORONARY STENOSIS ALTERS LEFT VENTRICULAR
END-SYSTOLIC PRESSURE-WALL THICKNESS RELATIONS AT REST
EVEN WHEN RESTING CORONARY BLOOD FLOW IS NORMAL.
EXPERIMENTAL ECHOCARDIOGRAPHICS'l1JDIES.
John Funai, M.D •• Shan Shen Wang.M.D •• Natesa Pandian,
M.D. Tufts-New England Medical Center Hospital, Boston.
Masssachusettc.
Previous investigations have suggested that regional LV
contractilityis not affected by even severe coronary
stenosis (CS) if resting coronary blood flow is normal.
Such studies however utilized load-dependent parametersto
assess LV contractility.We examined LV end-systolic
pressure-wall thickness relations (ESP-TR). which are
load-independent, to evaluate the effect of CS on regional
LV function. To do thia we obtained two-dimensional
echocardiographicand hemodynamicrecordings in 6 dogs and
computed ESP-TR under varied LV pressures during control
and during experimental CS. Coronary blood flow was
measured by electromagnetic flowmetry. Myocardial segments
at risk of ischemia (RISK SEG) were identified by noting
the dysynergic area during a brief test circumflex
occlusion. After recovery we produced circumflex CS severe
enough to abolish reactive hyperemia but with no reduction
in resting flow. LV myocardium onthe short-axis 2D echo
images was divided into 8 wall segments and ESP-TR
parameters.slope (Ees) and thickness-axis intercept (To)
were derived for both RISK SEG and remote normal segments
(REM SEG) in control and during CS.
Results: (x±SD) (*p< .05 vs control)
Ees (mm Hg/mm) To(mm)
sx:
877"20
125-; 62
83 -; 22
64 -; 15**
37 -; "**
Doppler echocardiographi cindices of aortic blood velocity are closely
related to global LV systolic performance. !hlever. the effects
of graded regional myocardial ischenia on the se irdices have not
been established . We therefore subjected4 dogs to 2 mi nut es of
coronary OCclusion in the sequence: I ) left anterior descending
(L\D) , 2) distal ciromflex (OC) , 3) proximal circunflex (pc) , 4)
L\D + OC, 5) L\D + PC. This sequencewas chosen to involve progres-
sively nore myocardiun as later confirned by a differential st aining
technique. Baseline recordingswere obtained prior to each occlusion
and the occlusions were perforned withand without atrial pacing
and afterload control (mamal descending aortic occlusion). furing
the last 30 seconds of each coronary occlusion, Doppler-derived
irdice s including peak velocity (Vp).nean velocity (V), systolic
velocity integral (SVl), and nean acceleration ( foCC ) were obtained.
\omen afterload ani HR were rot cont rolled, there were no signif icant
changes in the Doppler irdices . !hlever. with HR and afterload control ,
the percentages ofbaseline were:
~ y SVl
L\D 90 + 9 91 + R 897"12
OC 85 -; S* 83 ~ 15 73 -; 20
PC 80 -; 7* 78 -; 1** 79 -; 8
L\D/OC 50-; 29** 71-; 9** 58~ 12**
L\D/PC 39 -; 10* 53 -; 7* 31 + 19
(nean +/- SD; -,;=p < .05;-" =p < .025 )
We conclude that !k>ppler--derived indices (part icularl y Vp and V)
can detect changes in LV performance induced by regional myocardial
ischemia i f HR and afterload are controlledand a critical quantity
of myocardiun is involved.
TIlE EFFECT OF REGICtW. MYOCARDIAL ISQlE}UA rn 00PI'1ER ECHO INDICES
OF GLOBAL IUT VENI1UaJLAR PERFl»lAOCE: lNFUJElU: OF HEAR!' HAlE.
AF!ERL(W), AND '!HE SIZE OF'!HEI~C lJH:.
David W. Mathi"s , M.D. , L. Samel Warm, M.D.,F.A.C.C., Kiran B.
Sagar, M.D.,F.A.C.C., U:mna Siegeseurd, B.S. , Jares Roberts,B.5.,
and H. Sidney Klopfenstein, M.D. ,Ph.D. Medical College of Wisconsin
and VA Medical Center, MilwaJkee, Wt.
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VALInmaf (I' DI'IICl'SlZIlIl Br FIlIX:ARIlIIDlA3-D EHXX:ARDW.
3JFD HIPP.IN:l .Ill IIJlIIlAI1l'lPSf IEARI:S.
Gerard Wilkins, Ifl, ChIl, JarJEs SClJthem. RID, 1-1>, Olristo!XJer'0xx11g
lil, RID, John Fai100MDFhD, Iilrtlara/1)IB:Ie, BA, r:avid Qlyer MD, FACC,
ArtluJrE lIeynan MD, FAa:, Mlssachusetts GeneralIbspital, Boston, MA.
we have recently developed a qiantttattveecIxlCartiiq>rarilicmeUm for
mew~ the LV erxlocaroial a.u-tace, 00 ;tllch regioos of
isd1Ern1aIinfarctdysfunction can be aJP"l"inp>sed. This enlocardilll
9Jl'face IlBwing technique (00) provides a umsure of the tota l
erxlocaroial surfucearea (&SA) , area of abnonnal wall llDtion (AW1) ,
ani percent AW1. we rave1X"'Viously dEm:nstrateda good QJlT'elation
between percentAltl aeasure:l by the 00 am rustolrgfc infarct size in
the elqlerimentalaniIIB1. Ibwever, the accuracy of this rrethod has not
been tested in 1IBtl. To determine the aea.zracyof the Em, we CCIllBred
00 rreasurEm31ts with LV size am histolcg1c extent of infarction in
autopsy hearts. Eleven IIItients wJ.th ll\Yocaroial infarction ;ere
studied (6nale, 5 fullBle; rrean age 65yrs) in Iohan an Em study close
to the tine of death (rredian 18 days) ani a detailed cardiac autopsy
...ere perfonne:l. ram of the hearts W'lS cut in 1 an slices fh:m base to
apex, am the followill;~ts derived: total ~ocaroial volure
JMV), total ll\Yocaroial infarctvolure (1MIV), percentageinfarctiooby
volure (~), total emocardial, a.u-tace area (TSA), total infarct
azrface area (TISA), percentage infarctazrfaoe area (%lSA). \ohen the
%A\oM ;as OCJ!Plred to the %MIV a close relatiomttipWlS fun:! (%AItl=
.99~ + 6.6. r = .80, p = .003). Asimilar relatiomtlip W'lS foorxl
Iohen the :lAW1>oas ocrrpuoed to the %ISA (:lAW1 = .85 %ISA - .55, r =
.85, p = .001). The~;as also found to correlatewell with the ESA
(ESA = .92 TSA + 43an , r = .74, p = .009), with the relatively high
interoeptbe~ <lJe to systolic arrest, loss of d1sterx1~ ~,
ani specirren :tlrinkage. The EM!' accurately posi tionedthe infarct00
the endocardial surface .Ihis study confirmsthe accuracy of the 00
in quantitatingthe size of ll\Yocaroial infarction in ean. 1hese
correlationswere essentially identioal to thoSe previously reported
in animal studies.
SPONTANEOUS REDUCTION IN MYOCARDI AL PERFUSION DEFICIT
DEFINEDBY CONTRAST ECHOCARDIOGRAPHY DURING INFARCTION
Robert J Mi ch . MD, Linda D Gillam, MD, FACC, J Luis
Guerrero, Ni na D Wilson, Arthur E Weyman, MD, FACC,
Massachusetts General Hospital, Boston, MA
Previous reports have noted a good general correlation
between i nf ar ct size and perfusion deficit (PD) defined by
contrast echocardiography (CE) at spe cific points dur ing
t he initial 6 hours post infarction (MI). Despite this
close agreement, before changes in the PD can be used as
markers of response to therapy, i t remain s neces sary t o
determine whether t he PD is stable dur i ng the acute phase
post HI or varies wi t h time. Therefore, we studied 8
open-chest dogs at baseline , 5 , 30, 60, 120, 180 , 240 , 300
and 360 minut es after cor onar y artery occlusion ( 2 LAD. 6
LCx). Hid-papillary short axis echocardi ograms where
obtai ned . Sonicated Renogr afin (6- co) was in jected i nt o
the aortic root to prov i de myocardial cont r ast. After
digitizing the pertinent video images, the total
myocardial cross-sectional area and the area of contrast
enhancement were measured. The percent of myocardial area
contrast enhancement (%CE) was determined. Repeated
measures analysis was used t o analyze the changes in %CE
over time. Results:
TIME 0 5 30 60 120 180 240 300 360
JCE 100 63. 9 66.7 68. 6 69. 4 69. 8 70. 0 71.070.0
Following th e initial fall in %CE a t 5 roin , there was a
progressive i ncrease i n %CE whic h reached statistical
signi f i canc e (p < . 01 ) at 120 min. Be t wee n 120 and 360 min
there was no further signifioant change in %CE.
Conclusion: The spontaneous 9%increase in the CE defined
perfusion zone (o r 17~ reduction i n th e PD) dur ing the
first 6 hours of HI must be considered when evaluating the
efficaoy of reperfusion theraPY.
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IS THE "THRESHOLD"PHENOMENON FOR DETECTING
MYOCARDIAL INFARCTION BY REGIONAL LEFT
VENTRICULAR WALL MOTIONANALYSIS ARTIFICIAL?
Andreas M Zeiher M.O.. Helmut Wollschlager, M.O., Hanjorg
Just,M.O., Medical Clinic.Un iversity of Freiburg, F.R.G.
Previous studies comparingenddiastolic(EO) and endsystolic
(E5) quantitative estimates of regional LVfunction suggested,
that the presence of 2-0-echo detected wall motion abnormalities
(WMA) is related to the transmural extent of myocardialnfarc-
tion(MI). Since myocardial funct ion manifests itself in amplitude
and timing of wall motion, we assessed the value ofquantitative
Frame-by-Frame analysis(25frames /sec) of wall motion during the
entire contraction sequence in 2-0-echos of 29patients(pts) with
well documented previous MI: 19 pts had transmural MI, 10 pts
had evidence of non-transmuralMI. To exclude observer bias and
inconsistency in endocardial digit ization, an automatic contour
detection system was used. Segmental area changes relative to EO
were calculated for 48 segments frame-by-frame. Temporal
heterogeneity in wall excursion wasquantitatedby correlating
segmental area changes with corresponding time-points from EO
to ES. The correlationcoefficients thus reflect linearity in wall
excursion during the contraction sequence. Conventional EO to
ES relative segmental area changes were calculated as usual.
B.n!l.lll: The Correlation method demonstratedWMA in all pts,
EO-to·E5 comparison detectedWMA in 18 of 19 pts with trans-
mural MI. The extent ofWMA defined by both methods correla-
ted well (r:0.86) with each other for the group of pts with
transmural MI. In contrast, EO-to-ES comparison failed to detect
WMA in 4 of 10 (=40%) pts with non-transmuralMI. There was
no relation at all between the extent ofWMA as assessed by both
methods in the group of pts with non-transmural MI.
Conclusion: Wall excursion in non-transmural MI ischaracterized
by temporal heterogeneous contract ion.A two-phase-analysis (ES-
to-Elf) does not account for temporal heterogeneity of regional
LV function. Theref'ore.the "threshold" phenomenon appears to be
rather method-of-analysis dependent than true biological.
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OCCURRENCE AND SIDNIFICANCE OF PROORESSIVELEFT VENTRIC-
ULAR WALL THINNING AND RELATIVE CAVITY DILATATION IN
PATIENTS WITH HYPERTROPHICCARDIOMYOPATHY
Paolo Spirito, H,D., Barry J. Maron. H. D., F. A. C.C. ,
Robert O. Bonow, H.D., F.A.C.C. andStephen E.
Epstein, M.D., F.A.C.C•• NHLBI. Bethesda, Md.
This study was undertakento assess the prevalence of
left ventricular (LV) wall thinning. cavity dilatation
and systolic dysfunction in a large population of symp-
tomatic pts With hypertrophiccardiomyopathy (HCM) and
to determine the role of these abnormalitiesin the
natural history of the disease. Of 217 consecutive
patients (pts) with HCH, 197 (911) had LV ejection
fraction (EF) >501 and 20 (91) had depressed EF of
<501, assessed-with radionuclide angiography. Serial
changes in LV wall thickness and transverse cavity
dimension were evaluated with M-mode and 2-D echo,
over 3.6 yrs, in 67 of the 217 pts. A substantial de-
crease (>5mm) in LV wall thickness was identified in 8
(621) of-the 13 pts with depressed EF «501), but in
only 2 (41) of the 54 pt.s with EF >501 (p<O.OOl). LV
caVity dimension. increased signifIcantly in the pts
with depressed EF (44+5 to 49+7mm; p<O.005). However.
absolute cavity size remained-normal«52mm) in 10 of
these 13 pts. Each pt with wall thinning and systolic
dysfunction had severe symptoms, 4 died of progressive
cardiac failure. and 1 underwentcardiac transplanta-
tion. LV systolic impairment, associated with progres-
sive LV wall thinning and enlarging cavity are present
in an importantminority (almost 101) of pts with HCM
and severe symptoms. These functional and morphologic
changes are usually associated With refractorycardiac
failure and poor prognosis, and identify a subset of
pts with HCM who have a distinctive natural history.
AIDS-ASSOCIATED HEART DISFASE: IS IT A DISTIOCT ENl'I'lY?
Evlin L. Kjnney.M.D.• F.A.C.C. and RobertJ Wright, 11.
University of Miami SChool of Medicine, Miami VA Medical
Center, and TheReed Institute, Miami, Ft.
Although severe heart disease has been observed inAIDS
patients (pts), whether suchheart disease is
epiphenanenalis unclear. Thus, we sought to characterize
AIDS-associatedheart disease, using as controls an age
and sex-matched group with AIDS-relatedconpl.ex, Data
were retrieved from an echo database ofpts who were
stud ied for clinical indications between1982 and 1985.
Using Centers for Disease Controldefinitions, we found
15 cases with full-blown AIDS and 43 cases with
AIDS-related conpfex, Pts were nale, mean age 35.1 years
(range 25-45). In the AIDS-cornplex group, the known risk
factor was IV drug abuse. '!beAIDS-complex group had
various echo abnornalitiesin the same proportionas in
our general echo pop.11ation. InAIDS, however, the echo
abnornalitieswere: LV dyssynergy, dilatation, or
evidence of elevated LV diastolic pressure (4/15 pts),
snaIl-moderatepericardialeffusions (7/15), dilated
aortic root (6/15), mitral valve prolapse (MVP) in a
thick HV (6/15), thick MV without MVP (2/15), and
'lV prolapse in a thick 'lV (2/15). LV abnornalities (1 pt
apiece) were: denovo diffuse hypokinesis during staph
aureus sepsis, de novo segmentalhypokinesis, presence of
MV B-bumps, and LV dilatationwith normaI contractility
in a pt with IHSS. These data suggest that: 1) AIDS heart
disease differs from the heart disease found in
AIDS-relatedcomplex, 2) LV dysfunction in AIDS is
uncomnon and nay be dueto the associated infections of
AIDS or coincidental preroorbidheart disease, and 3) the
other cardiac abnormalitiesof AIDS, in light of their
frequency andinter-patientsimilarity, are probably an
inherentbut as yet unexplainedpart of AIDS.
ATRIAL FIBRILLATIONAND SYSTEMIC EMBOLIZATION: LEFT
ATRIAL SIZE STRONGLY PREDICTS RISK OF EMBOLIZATIONIN
PATIENTS WITHOUT MITRAL STENOSIS. Cynthia A. Hall, M.D.,
Sonl Clubb, B.S., Henry S. Cabin, M.D., F.A.C.C., Yale
University, New Haven, CT.
Although atrial fibrillation (AF) in patients (pts)
without mitral stenosis (MS) is associated with an
increased frequency of systemic embolization, the
indications for anticoagulationin this group of pts
have not been adequately defined. In particular,no
prior study has suggested an association between left
atrial (LA) size and embolic frequency. We studied 185
pts with AF without MS who had undergone 2-D andM-mode
echocardiography. Systemic emboli occurred in 30 (16%)
pts: 8 (27%) occurred < 1 month, 5 (17%) from 1 month to
1 year and 17 (57%) > 1 year after the onset of AF.
Embolic frequency was greater in pts with LA size ·>4.Oem
than with LA size < 4.0cm (26/122 pts, 21% vs 4/63-pts,
6%, p<.Ol). Age was also a strong predictor of embolic
frequency. Pts over age 65 had a grester frequency of
embolization than those under 65 (29/143 pts, 20% vs
1/42 pts, 2%, p <.OI). Among pts Over age 65, LA size
4.0cm predicted a higher embolic frequency than LA
size ~ 4.0cm (25/100 pts, 25% vs 4/43 pt s , 9%, p<.05).
Coronary heart disease, hypertension, and non-MS
valvular heart disease were not associated with an
increased frequency of systemic embolization. There
were no embolic events among the 15 study pts who were
chronically anticoagulated.
Thus, among pts with AF, older age and increased LA
size are strong predictors of increased risk of
embolization. Echocardiographys houl d be routinely
performed in all pts over age 65 With AF to assess LA
size and thereby, the risk of systemic embolization.
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INFLUENCE OF RECURRENT REJECTION EPISODES ON LEFT
VENTRICULAR FUNCTION OF THE TRANSPLANTED HEART
Hannah A.Valantine, M.B., ChristopherP. Appleton, M.D., Sharon
A. Hunt, M.D., MargaretE. Billingham, M.D.,F.A.C.C., Edward B.
Stinson, M.D.,F.A.C.C., Richard L. Popp, M.D.,F.A.C.C.,Stanford
UniversitySchool of Medicine, Stanford,CA.
To evaluate the effects of recurrentrejectionepisodes (RE) on LV
function of the human cardiac allograft, hemodynamic
measurements were compared to Doppler echo indices of filling
and ejection in 60 cardiac transplant recipients and 23 normal
subjects. Time from transplantationwas 12-132 months (mean
42). Maintenance immunosuppression was azothioprine and
prednisonein 9 pts andcyclosporine plus prednisonein 51. Pulsed
Doppler echo was performed ~ithin 24 hours . .of cardiac
catheterization and coronary angiography. VelOCities of flow
across the mitral and Ao valves were recorded at lOO mm paper
speed for measurement of: isovolumic relaxation time (IVRT),
peak early mitral flow velocity (M)), pressure half-time OH),
peak Ao velocity, and ejection time index (ET)). The number of
RE (myocyte necrosis on RV biopsy) wascollated for each pt,
IVRT(msec) Y2T(msec) MJ(M/sec) LVED(mmHg)
Normal (n:23) 80.2+ 7.3 52.4+ 8.3 0.64+ 0.15
0-2 RE (n:23) 85.5~ 13.9 50.8~13.8 0.74~ 0.19 9.3+ 3.8
3-6RE(n:27) 82.5~13.7 47.0~12.7 0.76~0.19 9.6~3.9
>6RE(n:10) 68.2+17.9 38.8~12.7 0.73~0.13 l2.5:t5.3
Pts with> 6 RE hada shorterIVRT and PHT, and a higher LVEDP
compared to those with 0-2 and 3-6 RE,~ 0.05 .respectively.
IVRT and Y2T were slightly higher than normal mtransplant
recipients with 0-2 RE (pms), anddecreased with incre?si~& RE,
p50.05 for pts with >6 RE vsnormal. MI showed a.n~)O-slgnlflcant
trend to be higher than normal intransplantrecipients, and did
not change with increasing RE. These indices were not influenced
by the immunosuppressiveregimen, coronary artery disease, or
time from transplantation.ETI and peak Aovelocity were similar
in all groups. Thus pts with >6 RE haveab~ormal LV filling
dynamics reflected in the shorterIVRT,Y2T and higher LVEDP.
IMPROVEMENTOF NOREPINEPHRINEKINETICS ONE YEAR
POST ORTHOTOPICCARDIAC TRANSPLANTATION AND
NORMALIZATION OF RESPONSE TO ORTHOSTATIC STRESS
Roben BaBy M.D" Dwight Davis M.D., Richard Duszak B.S., and
Robert Zelis M.D., F.A.C.C., Cardiology Division, Penn State
University, M.S. Hershey Med.Ctr.,Hershey, PA.
In order to evaluate the effect ofoahotopiccardiac transplantation on
norepinephrine (NE) kinetics in congestive hean failure (CHF) patients
post transplant, steady state infusion oftritiated-Nli(3H-NE) of high
specific activity was administeredto four patients one year post
transplant, for two consecutive 90 minute periods . The first supine (S),
the second at 60' head-up tilt(T) in order to compare orthostatic stress
response pre- and post-transplant. NE clearance (CL) (L/min M2) and
NE spillover (SPL) (nmoVminM2) were calculated from the plasma NE
levels (pglml) and the 3H-NE specific activity.
NE .cL SPL
S T S T S T
Normals n=6 242 570 1.32 1.00 1.99 3.38
Pretransplant n=4 763 0.88 3.93
n=2 767 0.53 2.53
Post-transplant n=4 271 585 1.26 0.93 1.93 3.01
It has been previously shown that NE kinetics supine and tilt are
abnormal in CHF. Normals increase plasma NE levels (136%) and
increase NE SPL (70%), whereas CHF subjects did not change NE
levels significantly and NE SPLparadoxicallydecreased (29%) in
response to tilt. NE CL decreased equally in both groups. The current
data demonstratesimilarity in values for normals and post-transplant
subjects indicating improvement of NE kinetics. M.oreover
abnormalities in response to tilt were found tonormalize post-
transplantation. Since the ab~ormalities in barl?receptorfuncti?n
intrinsic to CHF seem to normalize post-transplantation, either the atrial
remnant or pulmonic vasculature contain sufficient afferent innervation
to regulate the sympathetic neuronal response to orthostatic stress.
ANGIOPLASTY OF THE"SUPPLY VESSEL" IN MULTIVESSEL
CORONARY ARTERY DISEASE
Anthony P. Goldman, M.D., Gardon H. Hutt, M.D.,
John H. Wertheimer, M.D., F.A.C.C., Shahriar
Yazdanfar, M.D., F.A.C.C., Fred K. Nakhjavan,
M.D., F.A.C.C. Albert Einstein Medical Center.
Philadelphia, PA.
Percutaneous transluminalcoronary angioplasty
(PTCA ) of the only remaining patent coronary
artery supplying the viable myocardium ("supply
ve s s e l " ) is controversial because of its
potential high risk. We report our experience
in 35 such patients (pts) aged 30-85 years out
of 274 consecutive PTCA's. In 30 pts the
"supply vessel" collateralized the myocardium of
an occluded vessel(s) (OC). In 5 pts the myo-
cardium was solely dependent on the " s up p l y
ve s s e l" without any collaterals. Three pts
(8.5%) had prophylactic intra-aorticballoon
pumping prior to PTCA. The mean pre-PTCA
stenosis was 90.2% (range 70-99) and the post-
PTCA stenosis was 17.5% (range 0-50). The mean
pre-PTCA transtenoticgradient was 46.2 mmHg
( r a nge 30-68) and the post-PTCA transtenotic
gradient was 5.2 mmHg (0-20). The initial
success rate was 91.4% (32 of 35 pts) and there
were no deaths. Two pts (57 %) had emergency and
1 pt (2 .9%) had elective coronary bypass surger~
Conclusion: PTCA can be successfully performed
in the "supply vessel" without increased risk
and prior PTCA of the OC may not be necessary.
HIGH DOSE DIPYRIDAMOLE-ECHOCARDIOGRAPHYTEST
IN PATIENTS WITH SYNDROME X
Eugenio Picano, HD , Hichele Hasini , HD , Fabio Lattanzi,
HD, Antonio L'Abbate, HD FACC, C,N,R , Clinical Physiology
Institute, University of Pisa, Pisa, ITALY
The aim of the stUdy was to assess whether the high-dose
Dipyridamole-Echocardiographytest (DET : 20 echo and 12
lead ECG .onitoring during dipyridamole infusion, up to
0 .84 mg/kg over 10') might play a role in the
identification of pts with "Syndr ome X" . DET was
performed in 10 control subjects (Group A) and in 19pts
with Syndrome X (Group B) , fullfilling the following
criteria: chest pain on effort; positive exercise stress
test ()O. I mVolt ST segment depression); negative
ergonovine test; normal LV function and coronary
arteriography. During DET , i n Group A, nosubject showed
transient asynergy or ST segment depression , and none
had chest pain; i n Group B, no pt had transient
asynergy. 13 (68:0 had chest pain and 16 (84. ) had ) 0, 1
.Volt ST seg.ent depression . The global ejection
fraction - echocardiographically estimated - was similar
in the 2 study groups, both i n resting conditions (Group
A =,7 ! 7. vs Group B=,9 t 6•. p =ns) and at peak
hyperkinesia during DET (Gr oup A= 74! 9i:; Group B= 77
! 8i: p = ns). In conclusion, dipyridamole-inducedchest
pain and ST segment depression in pts with Syndrome X do
not appear to be associated with impaired regional or
global LV function. This entity of "echocardiographi-
cally silent" ischemia differs markedly from the
previously described mechanical changes, detected by 20
echo , during dipyridamole-induced ischemia in pts with
angiographically proven coronary artery disease, This
response to DET may be a useful way of noninvasively
detecting this syndrome.
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<XJ!O'U\RY ARTERY lJISER AU;1OPlJ\STY WI'lliOUT PERFORATIOO
USINi A SAPPHIRE lENS TIPPED OPTICAL FIBER.
George S. Abela, M.D., Enrico Barbieri, M.D., Adib
Khoury, M. se•, TillOthy Roxey, M. sc., C. Richard Conti,
M.D., F.A.C.C., University of Florida, Gainesville, PL.
Limitation of laser induced vascular perforation is
essential for clinical application. Five normal dCXJs
Ylere catheterized using a IlOdified 9 French guide
catheter via a carotid cut down. A 0.12" guide wire was
advanced to the distal left anterior descending or
circumflex coronary artery (CA). A 2am metal probe
encasing a lam sapphire lens tipped 300umcore fiber was
used. This was advanced over the guide wire through a
0.37am eccentric charrnel in the probe. A focused Argon
laser beam eIrerged fran the probe tip via a central
250um diareter hole. Five 1 sec laser pulses Ylere
delivered at 7 or 10 Watts (W) at 0.2 sec intervals.
Lasing was done while advancing the probe (4 CAs) or on
withdrawal (4 CAs) at !cm/sec. In 1 dCXJ, no guide wire
was used. DCX]s Ylere revived, anqioqramredand sacrificed
between 1 hr and 20 days. RESULTS: No perforation
occurred in 4 dCXJs follC7Ning laser discharge on
advancing or withdrawal over the guide wire. CA
perforation occurred in the dCXJ where no wire was used.
Histoloqi,c examination using light and electron micro-
scopy shoeed areas of thermal necrosis involving the
arterial wall except for the elastica which was dis-
rupted only at the perforationsite. In 2 CAs the probe
adhered to the artery during lasing at IOW with
subsequent thrcxrbus formation and infarction. In 6 CAs
no thrcxrbi occurred at ?W. At 20 days, arteriesYlere
structurally intact without thermal necrosis. Aneursyrnal
dilatation was not noted at angiography. CONCLUSION:
These data suggest that intracoronary discharge of a
focused laser beam does not result in perforationwhen
the probe is stablized over a guide wire.
TEACHING CARDIDVASCULAR PHYSICAL DIAGNOSIS IN A TECHNO-
LOGIC ERA: REQUIEM OR REVEILLE?
Charles E Wgg1ev M.D.. E,A.C.C•• Harisios Boudou1as.
M.D•• F.A.C.C•• Sharon M. 01son. R.D.M.S•• Joseph M.
Ryan. M.D•• F.A.C.C. The Ohio State University.
Co1umbus. Ohio
Teaching detailed cardiovascularphysical diagnosis
in an ambulatorycare-technologic era presents problems.
A patient oriented. CardiovascularTeaching Laboratory
was developed; 71 Students of Medicine (medical students,
house staff. cardiology fellows) participatedin the past
30 months, on monthly rotations. INTRODUCTION (3 day
period): awritten pre-test forms the basis for self-
appraisal and remediation;detailed anatomic physiologic
review includes aprotocol-directedbeef heart dissection
and review of selected video tapes. DAILY STUDIES:
(a.m.): individual, 3 hourout-patientvisits by ambula-
tory cardiac patients begin with history/physical/tenta-
tive diagnosis. Graphic studies - ECG/phono/carotid/
jugUlar/apex recordings are followed byM-mode/2DE/
Doppler studies, with reappraisalof diagnosis at each
step. ANALYSIS (p.m.): datarevieW/interpretation/read-
ing. INDIVIDUAL REVIEW with senior faculty emphasizes:
clarity of presentation;organization/correlationof
clinical-laboratorydata; thediagnostic process.
Patient responses. and studentperformancewith an end
of the month, written, detailed case study, andstudent/
faculty evaluations suggest that a structuredblend of
tradition/technologyin CardiovascularTeaching Labora-
tory permitsintense, clinically relevant teaching of
cardiovascularphysical diagnosis and the diagnostic
process in anambulatorycare/technologicera.
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COMPARISON OF THE TECHNIQUES FOR RECORDING ATRIAL
ELECTROGRAMS OBTAINED USING SWAN-GANZ CATHETERS
Irvin F. Goldenberg, M.D., Pradub SUkhum, M.D., F.A.C.C.,
Constance Siebold, R.N., JohnW. McBride, M.D., F.A.C.C.,
David Dunbar, M.D., Lorie Melby. M.D., Rolf Andreassen,
M.D., F.A.C.C•• Robert A.Van Tassel, M.D., F.A.C.C. and
David Benditt, M.D., F.A.C.C., Minneapolis Heart
Institute Foundation and University of Minnesota,
Minneapolis, MN.
This studycompared techniques for recordingatrial
electrograms using a prepositionedSwan-Ganz catheter.
In 26 pts atrial electrogramswere recorded through the
Swan-Ganz catheter'sproximal port using each of the
following solutions: O.g% NaCI, 3% NaCI, 5% NaCl, 8.4%
NaHCO. Electrogramswere compared to recordingsobtai~ed using a 0.46 mm metal guidewire within the Swan-
Ganz catheter. Atrial electrogramswere ranked as
follows: 5 = no baseline artifact (BA); 4 = < I mm BA; 3
= 1.0-1.5 mm BA; 2 = > 1.5 mm BA and < 2 mm BA; 1 = > 2
mm BA; 0 = not interpretable. Atrial electrograms with
no BA and excellent for rhythmanalysis were obtained in
all pts including 8 pts with asupraventricular
tachycardia inwhich the diagnosis was not obvious by 12-
lead electrocardiogram. The guidewire was rated 5 in all
pts. The atrial electrograms using3% NaCl, 5% NaCl or
8.4% NaHC03 (rated 3.4 + 0.4. 3.5 + 0.6. 3.5 + 0.4respectiveTy) whileinferior to those obtained with a
gUidewire, were comparableto each other. Atrial
electrograms usingO.g% NaCl (I.g + 0.3) were inferior to
atrial electrograms obtained with highersodium
concentrations. We conclude that excellent atrial
electrograms can be obtained rapidlyby converting the
proximal port of the Swan-Ganz catheter into a conductor
with either 3% NaCI, 5~ NaCI, or 8.4~ NaHCO. The
recorded electrogramscompared favorablywi~h those
obtained with ametal conductor.
USE OF ONE HOUR ECG RECORDINGS TO IDENTIFY PATIENTS WITH
VENTRICULAR ECTOPY POST INFARCTION AND TO ASSESS THERAPY
James Coromilas, MD, FACC, Alfred Hallstrom, PhD, Toshio
Akiyama, MD, FACC, Jeffrey Anderson, MD, FACC, Lawrence
Friedman, MD, Richard Henthorn, MD, FACC, Donna Kerns,
RN, Brian Olshansky, MD, Phil Reid, MD, FACC, James Reif-
fel, MD, FACC, Robert Stanyon, RN and the CAPS Investiga-
tors, Columbia University, New York, N.Y.
Patients were eligible for the Cardiac ArrhythmiaPilot
Study (CAPS) if they had ~lO VPD/hr on a 24 hr ambulatory
recording (24-R) done after recent MI. The purpose of
this study was to determine if a one hr recording (l-R)
could be used to identify patients with ~10 VPDjhr on a
24·R and if shorter recordings (1,2,4,8 hrs) could be
used to assess drug efficacy. Baseline 24-R from 501 pa-
tients enrolled in CAPS and a randomsample of 199 pa-
tients who failed to qualify for CAPS were used in this
analysis. There was a significant correlation (r-0.81,
p<O.OOl, slope-Q.87) between the number of VPD in the
first hr of a recording and the average VPD/hr for the
24·R. We evaluated cutpoints of 3,6,10 and 20 VPD in a
l·R for identifying patients with ~10 VPD/hr on a 24-R:
Numberof VPD in the 1st hr
VPD/hr(24-R) >3 <3 >6 <6 >10 <ID >20 <20
>10 455 44 431 68 391 108 316 183
<10 36 166 15 187 9 193 1 201
Sensitivity 91\ 86' 78% 63%
Specificity 82% 93% 96% 99%
Drug efficacy was determinedon 24-R and defined as a 70%
reduction in VPD frequency compared to a baseline 24-R.
Using l-R to assess efficacy correctly identified 94% of
the efficacious 24-R but only 52% of the inefficacious
24·R. As the recording period was increased to 8 hrs,
sensitivity remained unchanged (94%) and specificity in-
creased (52 to 84%). In summary, the presence of ~6 VPD
on a l-R correctly identifies most patients who have ~10
VPD/hr on a 24-R. Shorter recording periods are sensi-
tive but not specific for assessing drug efficacy.
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BEDSIDE DETECTION OF SILENT ISCHEMIA USING A 12-LEAD
PROGRAMMABLE ECG MONITOR: VALUE OF A MULTI-LEAD SYSTEM
James E. Pope, M.D., F.A.C.C., Mitchell W. Krucoff, M.D.,
W. Kenneth Haisty, M.D., Kenneth M. Kent, M.D., F.A.C.C.,
Harry R. Aldrich B.S., Nancy B. Hindman B.S., Michael A.
Kutcher M.D., Isabelle M. Adams M.S., David W. Mortara
Ph.D., Galen S. Wagner, M.D. Bowman Gray School of
Medicine, Winston-Salem, NC.
Holter monitor (HM) studies have demonstrated the
importance of silent ischemia (SI) in certain patients,
however clinical use of HM for detecting SI is limited by
the lack of immediate feedback, and the number of leads
monitored. To improve ischemia monitoring, an
interactive, portable digital 12-lead ECG monitor has
been developed and evaluated by analysis of 11,056 ECGs
recorded from 67 patients fo Ll.ovmg angioplasty (PTCA).
Ischemic events were defined as ST deviation of 1 mm in
any two leads or 2 mm in anyone lead. The monitor
automatically acquired, analyzed and stored a diagnostic
quality 12-lead ECG at 5 min. intervals. The monitor can
also examine an ECG every 30 secs for ST changes as
defined above and if ST threshold is detected, store
additional serial ECGs at 30 secs intervals. Immediate
review of ECGs and a ST magnitudetrend is prOVided on a
liquid crystal display. ECGs were transferredto an IBM
PC for more detailed analysis and storage. Computer
analysis with manual over-read demonstrated 19 ischemic
events with an average duration of 34 mins in 14 patients
(217.).
NUMBER OF EVENTS IN WHICH LEAD DETECTS ISCHEMIC ST CHANGE
I 11 III aVR aVL aVF VI V2 V3 V4 V5 V6
3 13 11 6 7 12 6 10 8 10 8 8
No single lead or combination of any 2 leads would detect
all events reported here. Thus, the frequency and/or
extent of SI may be more than estimated by single or dual
lead monitoring systems.
CQLORED QUADRANT MAPPING ELECTROCARDIOGRAPHYIN THE
EVALUATION OF MYOCARDIAL INFARCTION
TE:tsuroFudo M.D., Hirofumi Kambara M.D., F.A.C.C.,
Tetsuo Hashimoto M.D.,Keijiro Kusunoki M.D.
Chuichi Kawai M.D.F.A.C.C., Shigeru Kumo M.T.*,
Shunichi Tanaki M.D. *
Kyoto University Hospital and TakedaHospital*,
Kyoto, Japan
Colored quadrantmappingelectrocardiography(ECG) was
devised from Franklead vectrocardiographyusing
microcomputer system(NEC-PClOO, CERX-CQ300l). This
new device makes much easy to record ECG mapping
compared to ordinary body surface electrocardiography
and displays eight-colored spatial mappingelectro-
cardiograms at the coordinates equivalent to the points
on the terestrial globe with interval of 20" on longitude
and 10° on latitude. In this study, we evaluated 20
patients with myocardial infarction with abnormal Q
wave on twelve-lead electrocardiography. The extent
and the direction of the Q wave are easily recognizable
with the aid of colored display and mapped electro-
cardiography.
l:Aq (total Q wave area) calculated from this ma~ing
electrocardiographywas correlated closely with~MB-CK
left ventricularejection fraction and thallium defect
score obtained by single photon emission CT (r=0.75,
0.57,0.73, respectively).
This new type of colored mappingelectrocardiographywas
useful for the detection of myocardial infarction and
the evaluation of infarct size.
LAST INFLATION
ECG 10 (0.45) 31"/60" 14
ICE 16 (1.35) 20"/60" 1 (.25) 20"/50" 7
ST-ECG and ST-ICEappearedsignificantly earlierduring the first
inflation, pC::::.005. ST-ICE shifts weregreater during the first
inflation, p< .0001.
In conclusion: 1) ICE is more sensitive than ECG todetect
ischemia during CA; 2) theearlier appearanceof ST-ICEshifts
during transient coronary occlusion mayalert for a faster
recognition of complications. 3) ST-ECG and ST-ICE showed
lesser changes during the last inflation probably as aresult of
recruitmentof collateralsor bettermyocardial tolerance.
CIRCADIAN VARIABILITIES OF MODULATED VENTRICULAR
PARASYSTOLE
Agustin Castellanos, MD, FACC, Nadir S. Saoudi, MD, Ivan
J. Mendoza, MD, Aristides de la Hera, MD, Richard M.
Luceri, MD, FACC, Liaqat Zaman, MD, FACC, and Robert J.
Myerburg, MD, FACC,University of Miami School of Medicine,
Miami, Florida.
Circadian rhythmicity, an ubiquitous phenomenon both
across phylogeny and individual organisms has not been
described in modulated ventricularparasystole(VP). This
report deals with the circadian variabilities observed
while analyzing 24-hour Holter tapes from 4/21 patients
with VP. Cases 1 and 2 had"classical"continuous, non-
modulated VP throughoutmost of the recording time with
directly measured cycle lengths of 1710-1760 and 1920-2150
ms, respectively. During the sleep period, defined as that
between 1 and 6AM, the VP became modulated since non-
parasystolic beats falling within the earlier part of the
cycle lengthened, while those falling later shortened,the
parasystolic cycle lengths. The correspondingphase
response curves were biphasic. Case 3 also had modulated
VP only during the sleep period. In addition, the para-
systole was captured during its supernormalperiod by
beats falling on the very early part (20-22%) of the cycle
so that the parasystolic cycle lengths were very short.
Because the latter occurred before the part of the cycle
(22-55%) which produced increasing parasystolic cycle
lengths,the phase response curve was triphasic. In Case 4,
the modulated VP had a longer cycle length (1040 ms) and
a greater magnitude of lengthening effect (123%) during
the sleep period than during daytime (900 ms and 111%,
respectively). In summary, modulated VP showed circadian
variations not only qualitatively similar to those of
sinus rhythms, but also sui generis for this arrhythmia.
no STA
----ptS
14
315"/53"4 (.85)
M:NITCRING ISClIFMIA BY INI'RAO:KNARYELECIRXRAMAND
SURFACE ELOCI'JD}\RJ)I<XllAMOORING mmARY ANJIOPI.AS1Y.
Miguel Zabalgoitia-Reyes, M.D., Jean-Francois Marquis, M.D.,
F.A.C.C, Lyall A.J.Higginson, M.D., F.A.C.C., Brian C.Morton,
M.D., F.A.C.C., William L.Williams, M.D., Martin S.Green, M.D.
Donald S.Bean1ands, M.D., F.A.C.C. University of Ottawa,
Canada and Northwestern University, Chicago, IL.
Monitoring ischemia during coronary angioplasty (CA) is
important in assessing subsequent balloon inflations and in
detecting possible complications. To aid promptdetection of
ischemia we record anintracoronaryelectrogram(ICE) using the
guide-wire of thesteerable dilating catheteras a unipolar lead. A
simultaneous ICE andsurface ECG were continuously recorded
during balloon inflations in 24patients (20 men, 4 women; mean
age 51 yrs) who underwent successful CA:LAD 19, RCA 2, Cx 3.
ST-shifts were measured in both, ICE and ECG. Thefirst and last
inflations were used for comparison. Time of onset (TO)and time
of maximum(TM) ST-shifts were measured in seconds (").
FIRSTINFLATION
ST elevation ST depression
pts mV TO/TM pts mV TO/TM
ECG 10 (0.49) 26"/60"
ICE 17 (2.69) 14"/60"
224A ABSTRACTS JACC Vo!. 9. No. 2
February19X7:224A
6 8-10
16±11 12±6
112±11 114±1 2
44±11 48±9
9/11 11/11
potentials during the
a norcal filtered QRS
ELECTROPHYSIOLOGICMECHANISHS OF THE "1:2 RESPONSE"
DURING ATRIAL EXTRASTIHULATION: ELUCIDATION IN A
PACING HODEL OF THE WOLFF-PARKINSON-WHITESYNDROME.
Hichael H. Lehmann, H.D., F.A.C.C. and Russell T.
Steinman, H.D., Wayne State University and Harper
Hospital, Detroit, HI.
During atrial (A) extrastimulation in patients with
Wolff-Parkinson-White(WPW) syndrome, a single extra-
stimulus (A2) may occasionally give rise to two
ventricular(V) responses (V2V3). The electrophysiologic
mechanisms underlying this interesting and unusual "1:2
response" phenomenonare not well defined. As the delta
wave during spontaneous V preexcitationcan obscure
precise analysis of events in the normal pathway during
production of a 1:2 response, we studied instead a pacing
model of WPW syndrome in 8 patients (pts) without acces-
sory pathways. V preexcitationwas simulated by using AV
sequential pacing both during the basic drive (A1Vl) and
during extrastimulation(A2V2), such that A2V2 interval =
A1Vl . While scanning diastole of the final basic A1Vl
beat, a 1:2 response following A2 (i.e., A2V2V3) was seen
in 3 pts. By repeating the pacing sequence with selective
omission of either A2 or V2, two distinct mechanisms for
V3 could be identified: (1) macro-reentryin the
His-Purkinjesystem (HPS) induced by V2, proved by
persistence of V3 (with identical V2H interval) when A2
was omitted; and (2) successful anterogradepropagationof
A2 in the wake of bilateral retrogradeHPS block of V2,
with aberrantmorphology of V3 reflecting incomplete HPS
recovery from retrogradeconcealed penetration(proved by
omitting V2). A 1:2 response was not observed when V2
succeeded i n retrogradelypenetratingthe AV node.
Extended to pts with WPW syndrome , our findings suggest
that during A extrastimulation,HPS response to the
preexcited V impulse associated with A2 may play a crucial
role i n genesis of the 1:2 response.
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ELECTROCARDIOGRAPHICAND ENZYMATIC FINDINGS IN NON-Q
WAVE INFARCTION: RESULTS OF THE MULTICENTERPROSPECTIVE
RANDOMIZED DILTIAZEM REINFARCTION STUDY.
William E. Boden, MD, FACC, David J. Schwartz, MD,
~ooerrr::-Klmer,-1'lD, FACC, Kenneth B.
Schechtman, PhD, Robert J. Capone, MD, FACC, and The
DRS Research Group, Harper Hospital and Wayne State
Universi ty, Detroit, MI
The inci dence of non-Q wave (NQ) MI appears to be
rising and may account for up to 1/3 of all Ml pts.
However, few large-scale prospective studies defining
the pr evalence of ECG findings in creatine kinase (CK)
and CK-MB confirmed acute NQMI exist. Entry ECGs (24-7 2
hrs post NQMI) of 544 pts were classified according to
initial ST s egment shift (ST elevation=STt; ST
depression-ST. )and/or T wave inversion into anterior
(ANT) (n=62) , inferior (INF) (n=36) , lateral (LAT)
(n=79) , combination ( ~2 ) l ocations (CL) (n=262) , and
nonlocalizable (NL) (n=105) , ie. NQMI without diagnostic
ST/T wave changes (~) . In spite of the fact that 48%
of NQMI pts had CL ECG ~, their peak CK values (641
I.U.) were not significantly different from isolated ~~T
(646 I.U. ), INF (611 I.U. ), LAT (560 I.U . ) or NL (668
I. U.) NQMI . Similarly, analysis of variance of CK
values showed no differences among CL, ANT , INF or LAT
NQMI locations with respect to STt vs . ST. . The
proportionof all NQMI who showed initial STt by
location was CL (47%) and ANT (47%), INF(44%) and
*LAT(24%), *p < 0.01. In spite of the hi gher prevalence
of CL, ANT, and INF STt , there was no significant
increase in progression to Q wave MI or CK-MB extension
(r ei nf ar c t i on) in NQMI pts with STt compared to ST. or
T' . In conclusion, the early ECG findings in NQMI are
most frequently global, less commonly isolated to 1 ECG
location, are attended by a high incidence of initial
STt and are nonlocalizable in almost 20% of pts.
EVOLUTIOII OF LATE POTENTIALS DURING TIlE FIRST 10 DAYS
APl'ER ACUTE MYOCARDIAL lllFARCTIOll
De nni s Kuchar llB, Hark HcGuire HB,James Ganis BSc,
Char l es ThorburnMB, lkville Sammal MB FACC.
St . Vincent's Hospital, Sydney, Australia.
The presence of late potentials i n patients recovering
from acute myocardial infarctionat the t ime of hospital
discharge has prognostic importance. However, the timing
of their appearance after the i nfar ct has not been
explored. We performed siBOal averaged ECGduring sinus
r hythm in 27 consecutive pat ients on ea ch day after
presentationwith acute infarction. A late potential was
defined as mean voltage <20uV in th e ter~ inal 40 msec of
t he filtered QRS (40-250 Hz).
Res ul t s : Eleven patients had a late potential at the time
of hospital discharge (day 8-1 0). Terminal voltage (V),
QRS duration (QRSd), late potential duration (LPd), and
the number of patients (N) with a late potential are
shown at the time of admission (day I), then on day 3, 6
and 8-10 in patients who had a late potential at the time
of hospital discharge.
Day 1 3
V (uV) 23±18 20t14
QRSd (ms) 106+8 107±12
LPd (as ) 39;9 40t10
N 6/11 7/11
In addition, 2 patients with late
f irst 3 days after infarcti on, had
at the time of hospital discharGe.
Conclusion: Dynamic changes occur i n t he terminal QRS
complex during the first few days after myocardial
infarction. The majority of patients with late potentials
at hOSPi t al discharge can be identified during t he first
3 days after infarction.
THE NATURAL HISTORY OF ST ELEVATION FOLLOWING UNCOMPLI -
CATED ANTERIOR MI.
John C. Lystash, M.D. and Robert S. Gi bson, M.D., Univ
of Virginia, Charlottesville, VA .
Forty-five consecutive pt s (age < 65 yr s ) with MBCK
confirmed acut e uncomplicated anterIorMI who had persis-
tent ST seg elevation (STt ) of >1 mm i n 2 or more anterior
(Vl-V6) leads at discharge underwent study at 1~3 d
with 24 hr Holter, radionuclide ventriculography(RVG),
exercise (Ex) TL-201 scintigraphy and coro nar yangio-
graphy . At 3 mo follow-up, 26 pts ([58%1, Group 1) con-
t i nued to show STt and 19pts (Group 2) resolved their
SIt. Among pts in both groups, th e presence vs absence
of STt at 3 mosdid not identify differences in: admission
or maximum Killip class in the CCU ; Ex-induced angina,
ST~ or TL-201 ischemia at discharge ; extent of coronary
disease; angio jeopardy sc or es ; prevalence of patent
infarct vessels or collaterals. Group 1 pts compar ed to
those i n Group 2, hadgreater LV dysf unction reflected by
lower LVEF (38%vs47%, p<.Ol ) , more akinetic or dyskineti c
left ventricular segment s by RVG ( 3. 9vs2 . 5 , p<.03), and
a higher prevalence of abnormal TL-201 lung uptake on t he
i mmediate post-Ex images (54%vs26%, p< .08) , Coronary
angio data indicated that pts who had persis tent STt at
3 me had mor e proximal LAD occlus i ons (77%vs52 %) than
Group 2 pts . Group 1 pts were also more likely to have
Lown grade 3-5 ectopy, (28%vs6%) and had a hi gherin-
ci dence of death in l ong- t erm fol low- up (l l %vsO%). Thus ,
in pts with uncomplicated anterior wall MI who had STt
at di sc ha r ge , a substantialnumber (42%) resolve their
STt at 3 moo I n pts who continue to show STt. this is
correlatedwith greater LV dys function and infarct-zone
asy ner gy, as well as a higher ca rdiac eve nt rate.
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0.001
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NARROW ORS VENTRICULAR TACHYCARDIA: INCIDENCE AND
IMPLICATIONS. Robert BStewart,BS, Guat H
Bardy,HD,FACC, H LeonGreene,HD,FACC. Univ of
Washington, Seatt1e, WA.
Ventriculartachycardia (VT) is typically thought to
be a wide ORS complex tachycardia. We reviewe d 94
consecutive patients with cl i ni cal VT who had VT
induced during e1ectrophysio10gic study (EPS). Five of
these patients ( 5. 3%) had a narrowORS complex (ORS
duration< 0.11 sec, defined as the widest QRS observed
in any of-the 12 leads of the ECG.) The ventricular
origin of the tachycardiawas confirmed during EPS by
demonstrating ventricu10atria1dissociation and the
presence of a His-ventriculogram (RV) i nt erval that was
shorter than the sinus rhythmHV interval or the
presence of ventricu10-Hisiandissociation.
Two of the patients with narrow complexVT had a
previous anteriormyocardial infarction (MI ) , one had a
previous inferiorMI, one had both a previous anterior
and an inferiorMl, and one had nostructuralheart
disease. Two patients had intraoperativemapping
procedures that confirmed the arrhythmiafocus to be
located in the high ventricularseptal region.
Four of the five patients had been misdiagnosed in
the past as suffering from supraventricular tachycardia
and had beeninappropriatelytreated with verapami1.
Conclusion: Narrow complexventriculartachycardia is
infrequent but must beconsidered i n t he di f f erent ial
di agnosis of narrow ORS complex tachycardia. It
probably occurs as a consequence of high septal VT
f ocus that exits into the His-Purkinje system early,
thereby resul t i ng in a narrow ORS. The misdiagnosis of
nar row complexventriculartachycardia is common.
EFFECT OF ALCOHOL ON DIURNAL HEART RATE VARIATION.
Steven Khan, M. D. , David Gore1ick, M. D. , Koon1awee
Nademanee , M. D, F.A.C.C., Bramah N. Singh, M. D.,
F.A. C.C. VAMC Wadsworth, LosAngeles, CA.
In order to i nves t igat e the effects of alcohol (ETOH) on
the normal diurnal variation (DV) in heart rate (HR) 20
mal es participating in an inpatient study of the effects
of a tricyclic antidepressant (f 1uoxi t i ne) on drinking
patternsunderwent repeated 24 hour Ho1termonitoring
(HLT) during monitored ETOH consumption over a 4 week
period. Patients (Pts) underwent initi al HLT monitoring
after a 1 week inpatient withdrawalperiod and at the
end of weeks 1,2 and 4drinking. Pts were offered up to
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780 cc/day of 47.5 %ETOH, average ETOH consumpti on was
500-780 cc/day. All pts were also on either fluoxetine
or placebo but no other drugs were given. Results are
plotted as mean hourly HR versus time . We conclude that
dur in g ETOH consumpt i on the mean hourly HR progress ivel y
increases, i n cont ras t to the normalpattern of an earl y
morning peak andprogressive decline during the day. The
nocturnal fall in HR per s ists with ETOH however. Thus
there is a shift of the acrophase wit h ETOH consumption .
FREQUENCY AND SIGNIFICANCE OF VENTRICULAR ARRHYTHMIAS IN
PATIENTS WITH REDUCED EJECTION FRACTION (~30\).
Jesaia Benhorin MD , Dan Tziv oni MD, Moshe Schuster MD,
Andr e Ker enMD, Shlomo Stern MD , FACC.
Bik ur Cholim Hospi t al , Jerusalem, Israel.
Ventricular arrhythmia (VA) is known to be morefrequent
in pts with poor LVfunction. However the true incidence
of VA in pt s wi t h poor LV has not been evaluated systema-
t ically. 134 consecut iv e pts were referred for 24 hour
Holt er monitoring after the demonstrationof LVEF~ 30\ on
radi onucl i deventriculography. 115 had ischemic heart dis-
ease (IHD) and 19 dilated cardiomyopath y (DCM) . The pts
were divided i nt o those with EF=21- 30\ and those wit h EFS
20%. 46\ of IHD pts had no or minimalVA (0-2 VPB' s/ h) ,
only 20% had frequent VPB's (> 30/h) . Even in pts with EF<
20%, 34% had minimal VA and 34\ had >30VPB's/h.
VPB 's/h (pts ) Complex VA (pts)"
EF% pts 0-2 3-30 >30 coup VT Deaths
IlU. ;W 83 42 29 II 23 12 13
@ ~20 32 11 10 11 13 8 13..... All 115 53 39 23 36 20 26
~u-~u 7 3 2 2 2 1 1
9 ' 20 12 - 4 8 10 7 5All 19 3 6 10 12 I:S 6
In pts with DCM lS'l; had 0-2 VPB's/n While 53% had >30 VPB
s/h . Thus, frequent and complex VPB' s weresignificantly
more common in DCM than in IHD pts with similar LV dysfun-
ction. In IHD frequent and complex VPB's were morecommon
i n the EF ~20% gr oup. Thi s tenden cy was significantly mere
marked i n t he DCM group . In lHD death was slightly more
common in tho se with EF~20%, t his was not associated with
higher frequency of VA in these pts. In DCM, 6 pts died,
all had >30 VPB ' s/ h with couplets and 5 had EFs 20\.
Conclusions : Surpri s in~ly large ~roportion of pts with
poor LVfunction had no or mi nimalVA. In pts with EF~20\
complex VA ar e mor e common in DCM pts than IHD.
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EXAGGERATEDATRIAL AND VENTRICULAR EXCITABILITY IN HYPER-
TENSIVE PATIENTS WITH ISOLATED SEPTAL HYPERTROPHY (ISH).
Boris D. Nunez, M.D., Franz H. Messerli, M.D., F.A.C.C.,
Guillermo E. Garavaglia, M.D ., Roland E. Schmieder, M.D.,
Ochsner Medical Institutions, New Orleans, Louisiana.
Left ventricular hypertrophy (LVH) is a risk factor for
sudden death. We have previously shown that concentric LVH
(by EKG criteria) and eccentric LVH (by echo criteria)
have an i ncreasedventricularexcitability. To elucidate
if ISH als o enhances cardiac dysrhythmias, 24 h Holter
monitoring was performed i n 23 hyper t ensi ve patients with
ISH (septum/poster ior wall ratio >1. 3 cm) and 24 hyper -
ten s ive patients without LVH. Cardi ac structure was as-
sessed by M-mode echocardiogram. Results were: (MEAN ! SE)
Without
LVH (24) ISH (23)
MAP (mmHg) 114+8 118+9
Septum (cm) 0.9+0 .1 1.5+0.1
S/ PWRati o (cm) 2 1.1- 1.5+0. 2
LVMass Index (g/m) 93+20 131+26
PVC124h 23+33 229+77
PAC/24h 5+7 307+259
LOWN'S CLASS 0 20 pts "5 pts
LOWN'S CLASS I 4 pts 13 pt s
LOWN'S CLASS 11 0 2 pts
LOWN' S CLASS III 0 3 pts
MAP: mean arterial pressure; PVC, PAG: prematureventricu-
lar or atrial contractions; pts = patients.
At the same level of arterial pressure, patients with ISH
had a higher prevalence of prematureventricularcontrac-
tions (10 times more) and ahigher prevalence of premature
atrial contractions (60 t imes more). Furthermore, they
also scored higher in the Lown's classification. We con-
c l ude that hypertensive patients with isolated septal
hypertrophyhave an increased myocardium excitability and
therefore they are at risk of sudden death.
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CONCENTRIC LEFT VENTRICULAR HYPERTROPHY - WHEN IS
VENTRICULAR ECTOPIC ACTIVITY INCREASED? Carl J. Lavie,
M.D., Boris D. Nunez, M.D., Guillermo E. Garavaglia, M.D.,
Franz H. Messerli, M.D., F.A.C.C., Ochsner Clinic, New
Orleans, LA
The FraminghamStudy indicated that patients with left
ventricularhypertrophy (LVH) by ECG criteria have more
cardiovascularcomplications and sudden death than sub-
jects without LVH. We have previously demonstratedthat
hypertensive patients with LVH by ECG have more frequent
and more complex ventricularectopy than those with normal
hearts. The present study was designed to detect and
quantify dysrhythmias in hypertensive patients with early
LVH by echocardiography(Echo) but without LVH by ECG.
Twenty-four hour Holter monitoring was recorded in 94
patients with essential hypertension-37 without LVH, 26
with LVH by Echo but not by ECG, and 31 with LVH by both
Echo and ECG. Results are (mean + SEM):
Without LVH With LVH
Echo ECG
Posterior wall thickness,cm 0.82+.02 1.17+.03* 1.20+.01*
Septal thickness, cm 0.90+.02 1.18+.02* 1.23+.02*+
Left ventricularmass, g 159+7 228+11* 258+9*+
PAC's/24 hours 5.7+1.3 7.2+2 9.8+5.1
PVC's/24 hours 23.8+5.5 30.5+10 291+73*
%with Lown's Class II-IV 0 0 35*
*p<0.001;+p<0.05(when compared with patients with Echo
LVH);PAC's=prematureatrial contractions;PVC's=premature
ventricularcontractions
Patients with ECG-LVH have significantly greater PVC's
and higher Lown's Class ventricularectopy than hyperten-
sives without ECG-LVH. Prevalence and complexity of ven-
tricular ectopy was not affected by mild to moderate LVH
detected by Echo. We conclude that unlike ECG-LVH, early
hypertensive concentric LVH detected by Echo is not asso-
ciated with increased electrical irritabilityof the heart
EFFECTS OF INTRAVENOUS FENOLDOPAM, A SELECTIVE
DOPAMINE - 1 AGONIST, IN SEVERE OR ACCELERATED
HYPERTENSION. William B. White, M.D., Martha J.
Radford, M.D.. Francisco M. Gonzalez, M.D., Sherrolyn
G. Weed, R.N., and Ellen J. McCabe, R.N., Univ of
Connecticut School of Medicine, Farmington and LSU
Medical c s n t e r , New Orleans.
Fenoldopam (F) is a novel antihypertensiveagent which
reduces systemic and renal vascular resistance by
stimulation of dopamine-l receptors. To determine the
effects of F in severe or urgent hypertensives (HTN),
we studied blood pressure (BP), heart rate (HR) and
Na+ excretion (n=13), plus plasma catecholamines, and
LV function by echocardiography(n=6) after infusions
of 0.1 to 0.9 ug/kg/min for 4 hours. A supine
diastolic BP (SDBP) of >125 mmHg was a condition for
patient entry; therapeuticgoal was reduction of SDBP
to <110 mmHg or by 40 mmHg if baseline DBP was >150
mmHg. All 13 patients reached the goal SOBP within 3
hours (average, 69 ±. 80 min.) at an average dose of
0.38 ±. 0.21 ug/kg/min. The BP fell from 205/136 ±.
28/11 mmHg at baseline to 165/100 :t. 27/10 mmHg (p<
0.001) at 2 hrs. while HR increased from 74 ±. 13 to 83
±. 18 bpm (p< 0.05). Following discontinuation of F
(n=6), SDBP returnedto baseline within 15 - 90 min. No
changes in urinary Na+ excretion were noted. Plasma
norepinephrineincreased from 258 ±. 204 pg/ml to 387 ±.
305 pg/ml (p=0.05). F reduced both end- systolic
dimension (35 :t. 7 mm to 28 ±. 6 mm, p = 0.003, n = 6)
and isovolumic relaxation time/HR (1.01 ±. 0.63 to 0.56
±. 0.36 msec/bpm, p = 0.03, n - 5). Thus, F smoothly
and rapidly reduced BP in severe HTN. Echo data
suggest that BP reduction with dopamine-1 agonist
therapy is accompanied by improved LV function.
FAST AND SAFE BLOOD PRESSURE REDUCTION FROM SUBLINGUAL
CAPTOPRIL. Werner Tschollar, M.D., Gustav G. Belz, M.D.,
F.A.C.C, Jurgen Essig, M.D., Joachim Runge, M.D., Anton
Wellstein, M.D., Institut fur kardiovaskulareTherapie,
Wiesbaden, Fed. Rep. Germany.
The efficacy, speed of action, and tolerance of s'~lingual
(s.l.) captopril in the non fasting state were tested.
(a) Six healthy normals at two test days 1 week apartre-
ceived an i.v. infusion of angiotensin-I 0.9/ug/min for
70 min. In a randomized, double blind crossover they re-
ceived s.l. or oral captopril 25 mg. Angiotensin increased
diastolic blood pressure (BP) by a meanof +21 mm Hg.
This increase was abolished by captopril. Median time of
half maximal BP reduction was 24 min (14 to >30) after
oral and 11 min (5.5 to 15: p <0.05) after s.l. captopril.
(b) Twenty hypertensives with BP systolic >210 or diasto-
lie >115 mm Hg received s.l. nifedipine 20 mg (n=10) or
s.l. captopril 25 mg (n=10). (Mean + SO before and follow-
ing s.l. drugs; *p < 0.05, **p < 0.01 versus baseline).
Nifedipine before 5 min 10 min 15 min 30 min
BP systolic 211+15 200+13* 188+11* 179+ 9** 171+13**
BP diastolic 119+ 6 116+ 8 111+ 6* 107+ 6** 104+ 6**
Heart rate 77+13 76+11 84+13 90+15* 90+14*
Captopril
BP systolic 215+13 182+14** 164+17** 153+14**145+17**
BP diastolic 120+ 9 107+ 6** 100+ 9** 93+ 8** 89+ 8**
Heart rate 89+ 8 83+ 5* 78+ 8-' 76+ 8;< 73+ 7*
The median half maximal reduction of diastolic BP was
reached at 7 min (3 to 10 min) with captopril, and 9 min
(3 to 12) with nifedipine. Nifedipine induced flushing
in 8/10 patients, captopril in none.
Conclusions: captopril suhlingually acts: (i) faster than
orally and (ii) faster and more intensive than nifedipine
in hypertensives. In contrast to nifedipine captopril
lowers heart rate.
DOES SEPTAL HYPERTROPHY IN HYPERTENSION RESULT FROM COMBINED HEMOOYNAMIC
OVERLOAD OF THE TWO VENTRICLES?
Maurizio O. Guazzi, MD, Cesare Fiorentini, MD, Paolo Barbier, MD, Claudia
Galli, MD, Mauro Pepi, MD, Gloria l aebcr i ni , MD. Institute of Cardiology
and CNR, Univ. of Milan, Italy.
This study prospects that septal hypertrophy in hypertension is due to
right and left heacdynesic burden. The hypothesis originated from the co~
sideration that s eptus is shared by the greater and lesser circulation
and that the latter shows the s aae qualitative alterations of pressure
and resistance as the former in the baseline and following adrenergic
activation.
42 untreated hypertensives (age: 26-48), on the basis of ECHO measure-
ments of LV posterior wall thickness (pwT), were divided into: group 1,
23 cases with normal PWT (average. 9.5 '0.6 mm); group 2, 15 subjects
with PWT exceeding the mean +1 SO of group 1 (12.5 '1.B). In group I, 16
subjects (Group lA) showed normal septumthickness (S1) (9.2 '0.5) and 7
(Group IB) hadST greater than mean +1 SO of Group lA (10.9 '0.6). In
group 2, IB cases (Group 2A) hadST (12.8 ±1. 7) similar to PWT and 9
(Group 2B) showedST (15.1 '1.8) exceeding mean +1 SO of PWT. We evalu-
ated pressure and resistance in the systemic and pulmonary circuits in the
baseline and during a cold pressor test (CPT). In either condition we did
not find significant differences between group 1 and 2. However, the ana!
ys i s of subgroups unequivocally showed that the baseline systemic and pu!
aonary pressures and resistance were higher, and absolute and percent i~
crements during CPT were greater in subgroups B than in subgroups A. Bas:,
line vascular tone and reactivity to cold in both circuits were maximal
in the subgroup 2B, in which hypertrophy involved the entire ventricle
with preferential distribution to the s eptue.
The parallel pattern in the two circuits of parameters that impose a
ventricular burden and differences between presence and absence of septum
predominance make the suggestion reasonable that hypertensive septal hy-
pertrophy lIlay result from an overload of both ventricles.
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IS THIAZIDE-PRODUCEDURIC ACID ELEVATION HARMFUL? ANALYSIS
OF DATA FROM THE HYPERTENSION DETECTION AND FOLLOW-UP
PROGRAM
Herbert Langford, M.D.,M. Donald Blaufox, M.D., Nemat O.
Borhani, M.D.,F.A.C.C., J. David Curb, M.D., Agostino
Molteni, M.D., Kenneth Schneider, M.D., Sara Pressel, M.S.,
on behalf of the HypertensionDetection and Follow-Up
Program Cooperative ResearchGroup
Interactionof thiazide diuretics in the serum acid and
creatinine was studied in 3693 Stepped Careparticipants
in the HDFP not on treatmentat baseline. Among men parti-
cipants grouped into quartiles by level of their uric acid
at baseline, the upperquartile (average uric acid of 7.7
mg/dl) had an average serumcreatinine of 1.2 mg/dl, and
the lowest quartile (uric acid of 4.9 mg/dl) had 1.1 mg/dl.
Similar findings were present in women. Therapy with
chlorthalidoneor other thiazide-type diuretics tended to
increase levels of uric acid andcreatinine, but the in-
crease in both was less in the upperquartile than in the
lower. Among those prescribed uric acid lowering drugs,
the level of serumcreatinine increased just as much as in
individuals whose uric acid level was not pharmacologically
lowered. Baseline uric acid was a weak predictorof mor-
tality in men; the introductionof an interaction term for
creatinine suggested that this effect was primarily re-
stricted to those with elevated levels of both uric acid
and creatinine at baseline. Change in uric acid at one
year after therapy was inversely correlatedwith mortality
in men. There were only 15episodes of gout recorded in
five years of 3693 participants. The results suggest that
neither the baseline uric acid nor the change inuric acid
produced bytherapy injures the kidney, and no reason to
lower uric acid pharmacologicallyin the treated hyperten-
sive patient who is not gouty. Unanswered is whether
there is a predictive value to baseline uric acid not
explainable by other correlated cardiovascularrisk factors.
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THE DIFFERENTIAL EFFECTS OF ISOPROTERENOL011 SUSTAINED
VENTRICULAR TACHYCARDIA BEFORE AND DURING ANTIARRHYTHMIC
THERAPY.
Michael L. Markel.MD, William M. Miles, MD FACC, Eric
N. Prystowsky, MD FACC. Krannert Inst. of Card.,
IndianaU. School of Med., VA Med. Ctr., Indianapolis,
IN.
We tested whether increased sympathetic tone in the form
of isoproterenol (.03 mcg/kg/min, ISO)would alter sus-
tained ventriculartachycardia (VT-S) circuits similarly
during the control and drug-tested state. Seven patients
(pts) with coronaryartery disease (CAD) mean age 56 yrs
(range 44-71) hadVT-S induced during programmed
ventricular stimulation at control study before and
during ISO.Intervals(msec) shortenedwith ISO:sinus
cycle length (SCL) (X~SD) (902~207 to 671~93, p=.02),
and ventriculareffective (VERP) (237~18 to 223~14,
~.002) and functional (VFRP) (262~23 to 241~18, p=.006)
refractoryperiod. Of note, VT cycle length was
minimally changed byISO (312~38 to 298~48, ~.08). The
mode of induction was unchanged in 5 pts, 1 had
spontaneous VT-S and 1 became noninducible with ISO.
Seven drug tests (procainamideN=2, quinidine N=2,
propafenone N=l, mexiletine N=l, lidocaine N=l) were
performedbefore and during ISO in 5 pts. ISO shortened
SCL (782+106 to 640~123, ~.007), VERP (252~30 to
230+21, p=.02) and VFRP (273~23 to 248~19, pa.003).
Unlike control, VT cycle length substantiallydecreased
with ISO (386~107 to 331~78, p=.04), and in 3 pts VT-S
was easier to induce. We conclude that increased
sympathetic tone minimally affects presumed reentrant
VT-S circuits in CAD in the absence of drugs, but
usually antagonizes the drug-inducedslowing of VT. This
may explain in part the increased antiarrhythmic
efficacy noted with addition of B-blockers.
DIVERGENT FREQUENCY-DEPENDENTELECTROPHYSIOLOGICCHANGES
VITH HEXILETINE AND QUINIDINE
Henry J. Duff, H.D., L. Brent Hitchell, H.D., and D.
George Vyse, H.D., Ph.D., U. of Calgary, AB,Canada
From in vitro studies, sodium channel blockers have
been divided--rnto those with slow or fast kinetics of
onset of frequency-dependent block. Toassess whether
the divergent time courses seen in vitro are manifest in
man, the time course of onset of--change in conduction
time (CT) on a beat-by-beat basis was assessed during 12
beat trains at cycle lengths (CL) ranging from 700 to
300 msec. CT was recorded during constant rate
ventricularpacing andmeasured as the time delay from
the intrinsicoid deflection recorded from theright
ventricular (RV) apex to that at the RV septum using
bipolar electrodes (interelectrodedistance 0.3 mm). All
ten patients with inducible sustained ventricular
tachycardia were studied on the following treatments:
drug free (DF), mexiletine (H), and quinidine (0)
Results: mseCj *=p<0.05 from OF by ANOVA
Beat of The Train
Treatment Train (Cl) 2 3 12
DF 700 24 ± 18 32 ± 18 37 ± 18
H 700 35 ± 24 33 ± 21 37 ± 4
Q 700 43 ± 28* 42 ± 27* 52 ± 26*
OF 300 22 ± 19 37 ± 19 35 ± 20
H 300 39 ± 27* 37 ± 27 40 ± 21
Q 300 55 ± 31* 58 ± 22* 48 ± 27 NS
Vhen DF a rapid increase in CT occurred during thetrain
reaching a maximum by the fourth beat. Compared to DF, H
prolonged CT but only at a CL of 300 msec and this
change occurred by the second beat(fast). At CL 700
msec Q prolonged CT and this change progressively in-
creased during the train (slow). However, at rapid CL
(300 msec) 0 did not progressively prolong CT.
Hexiletine and quinidine have divergent time courses for
onset of frequency-dependent conduction delay inman.
CYCLE LENGTH DEPENDENT EFFECTS OF PROCAINAMIDE ON
VENTRICULAR REFRACTORINESS.FrancisE. Marchlinski,M.D.,
F.A.C.C.,Meir Shinnar, M.D., Oniv of Penna., Phila., PA
Procalnamide (P) produces acycle length (PCL) dependent
change in Vmax and ventricularconduction. To determine
if P produces aPCL dependent change in theventricular
effective refractoryperiod (VRP), we studied 14
patients in the control state and during steady state P
infusion (mean P level = 8.3±1.6 ~g/ml, with mean P level
change before andafter stimulation =.23±1.2~g/ml,p=NS),
VRP was determined at 2X threshold from the RV apex
after 12 atrial and ventricularsimultaneouslypaced
beats using an extrastimulus introduced in 5 ms ~ecre­
ments during the longest PCL that allowed for unlnter-
rupted capture (mean PCL=655±105 ~s) and during PCLs
decreased in 50ms decrements untll PCL =250-300 ms.
Repeat VRP (n=70) to assess reproducibilityvaried by
-1±3 ms (p=NS). P had noeffect on sinus cycle length
(696±125 ms vs 694±124 ms, p=NS) and diastolic threshold
(.56±.23 mA vs.60±.24mA, p=NS). VRP increased after P at
all PCL in each patient. For each pati~nt data was fit
to the exponential function VRP=AeB\PCL)+C. Results:
A B C Mean Deviation
Control -229±85 -.0052±.0014 263±18 ±2.4 ms
P -264±121 -.0061±.0017* 288±23** ±3.0 ms
*P=.11 vs control **P<.OOI vs control
Based on the exponential fit:
PCL(ms) 200 300 400 500 600 800
6VRP after P(ms) 26 29 31 29 27 26
Summary: the effect of PCL on VRP closely fits the func-
tion, y=AeBX+C with P shifting the curve upwar~ at,all
PCL and tending to result in an earlier approxlmatl~n of
the asymptote. Thegreater increase in VRP at the mld
range of PCL after P is modest andsuggests only a
limited PCL dependent responsethat does not parallel
known PCL dependent effects on sodium channel function.
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EFFECTS OF A NEW CLASS I DRUG (RECAINAM) ON SPONTANEOUS
AND INDUCED VENTRICULAR TACHYCARDIAS I N CONSCIOUS DOGS
WITH SUBACUTE MYOCARDIAL INFARCTION
Mal t e Meesmann, M.D. , Hrayr S. Karagueuzian, Ph.D.,
Takeshi I no, M.D. , Avile McCul len , Wi lliam J . Mandel ,
M.D. , F. A.C.C. , and Thomas Peter, M. D., F. A.C.C.,
Cedars-Sinai Medical Center, Los Angeles , CA .
Ant i ar r hyth mi c ef f ect of recainam (R) , a newly
synthesized propyl ure a derivative, was t es ted agai ns t
post-infa r ct i on spontaneous (24 hours) and i nduci bl e (4
t o 11 days) ventri cular tachycardia (VT) in conscious
dogs . R (mean IV dose of 15. 3 mg/kg)restored normal
sinus rhythm i n 7 out of 8 dogs wi th spontaneous VT.
Lid ocai ne (up to 10 mg/ kg) was effective in only l out
of 5 dogs. Al t hough R (10 to 20 mg/k g I V) could not
preve nt VTinducibili ty , it significantly re duced the VT
rat e f rom a cycle l ength of 246.9±38 t o 337.3±61 ms
(p<O .OOl , 8 episodes in 5 dogs). R conver t ed i nduci bl e
non- sustai ned VT (10 t o 40 beats) t o sustained VT
requiring el ect r i cal intervention f or termination (8 out
of 8 episodes in 6 dogs). This proarrhythmiceffect of
R occur re d at similar coupl ing i nte r val s to pre-R
paramet ers of stimulations. R caused anelevation of
th e di as t olic excitability t hr eshold of the right
ventricle from 1.ltO.3 to 1.4±0.4 mA (p<O .OOl ) . No
significant changes in bl ood pressure were seen .
In conclusio n, IV-R is hi ghl y effective i n the
suppr ess i on of spontaneous VT pr esumed t o be caused
mainly by an automati c mechanism, but it i s not
effec tive i n prevent in g in ducibl e VT, tho ught to be
caus ed by a reentrant mechanism. R, despite its
significant slowi ng effect on sustained VT, should be
used with caution since i t has t he pot ential of
conver t ing non-sustained t o sustai ned VT, dur i ng the
chroni c phase of myocardial i nfa rc t io n.
POST-EXERCISE VENTRICULAR ARRHYTlIMIAS REDUCED BY TilE
CALCIUl·! ENTRY BLOCKER, DILTIAZFM.
WH van Gilst, JH Kingma, JA Terpstra, JW Viersma, H
Wesseling. Departments of Pharmacology/Clinical
Pharmacology andCardiology, Uni ver s i t y of Groningen, The
Net her l ands .
Anginal patients may experience post-exercise ventricular
arrhythmias (PE-VA) as a consequence of reperfusion
follOWing spasm precipitatedby the sympathetic response
to exercise. The influence of diltiazem on PE-VA was
i nves t i gat ed. Nine patients (54 ± S years ) with documented
PE-VA participated in a double-blind placebo controlled
cross over study during three weeks. During the first week
baseline values were obtained, during the second and third
week patients received either placebo or diltiazem (240 mg
daily). At the end of each per iod a gr adedupright bicycle
ergometry stress test was performed. Severity and duration
of PE-VA during the first 10 min after exercise were
scored on a four point modified Lown scale. Diltiazem
reduced diastolic blood pressure significantly (85 ± 2 to
77 + 2 mmHg), but max exercise performance, heart rate
during max exercise and max ST segment depression did not
differ significantly from placebo values. No arrhythmias
were observed at rest or during exercise in any period.
Baseline PE-VA score was 2. 5 ± 0.4 points. PE-VA score
increased under placebo by 0. 3 ± 0.4 points compared to
baseline values, but decreased under diltiazem 1.8 ± 1.0
points (p 0.02 when compared to placebo). In one patient
with a post-exercise sustained VT, not sensitive to class
I antiarrhythmic agents, diltiazern totally abolished the
occurrence of PE-VA. Conclusion: Diltiazem significantly
reduces PE-VA, probably by preventing changes in coronary
vascular tone during or after exercise.
Control IV P Oral P
781+150 723+103. 775+ 89
180+ 23 193+ 28* 202+ 22
102+ 15 115+ 22* 115+ 22
370+ 37 399+ 39* 430+ 48*
422+ 32 471'+29* 488+ 32*
268+ 41 284+ 43 315+ 51*
1007+229 914+156* 1093+111+
118+ 29 119+ 31 110+ 22
47+ 9 54'+ 13* 65+ 15
234+ 19 274+36* 298+ 13*
249f 21 275+ 24* 288! 26*
2ll3! 74 341! 74*
Par_ter
Sinus CL
PR
QRS
QT
QTc
JT
SNRT
AB
BY
RRP-A
RRP-V
VT CL
*p<0.05 vs control +p<0.05 IV vs oral
We conclude: 1) P has class lA pro~rties prolonfing
the PR, QRS, QT, OTc, JT, RV, RRP-A and V, and VT C •
2) P can be effective in preventing VT induction
despite prior failure of procain_lde. 3) Suppresaion
of induced VT by IV P predicts efficacy of oral P.
ELIlCTIK)PHYSIOLOGICAND ELIlCTROCARDIOGRAPHICEFFIlCTS OF
PIINlMOL IN PATIBNTS WITH VIlNTRlCULAR TACHYCARDIA.
N.A. Mark Estes Ill, M.D• • F.A,C,C'
l
Ja.es C.-eronLM.D., Th_ Deerlnlt, M.b., beetJ Sa -J M.D., F.A.G.C.,
Rn Hai Ran, M.D., Jinxi Ou, M.D., !teitD Meek.. R.N.,
Melanie Matshall, R.N. New England Medical Genter
H08pital, Boston, MA.
To evaluate the electrophr.iolofic (RP) effects ofpi~ol (P) 15 ~tients (p s) wi h clinlcal sustained
(121 .or nODsustalned (1) ventriculartachygardia(VT)
or fibrillation (21 were fiven IV P (202+45 Ill). The
13 ..le and 2 f_ e pta age 60+12 rra)nad
electrophysiologic evaluation on-no i:lruis (controi) and
.ultiple prior unsuccessfUl~ trials (3.7 +1.3
includinf a procainSBide trial In sll pta. sIx p s
with no lnducible VT on IV P underwentr~t
electrop~iologic evaluation on oral P (720+60 ~/.d)
and 5 hBd DO inducible VT. BP effect. of P,-including
Em intervals, sinus cycle lenrth (CL) and recoV!!n'
tt- (SNRT) , and effective refractoryperiods (EIlP) of
atriUII (A) and ventricle (V) are sh'*ll below in _ec:
ANTIFIBRILLATORYEFFECTS OF HIGH-DOSE BRETYLIUM AND A
LIDOCAINE-BRETYLIUMCOMBINATION DURING CARDIAC ARREST AND
CARDIOPULMONARY RESUSCITATION.
J ame s J .Hanyok, Pharm.D., Mo s e s S.Chow, Pharm.D., Jeffrey
Kluger, M.D., Arnold Fieldman, M. D. HartfordHospital,
Hartford, CT.
CPRo
CPRl
CPRZ
CPR3
>2hr
*p~O .05
Left ventricular systolic pressur e, aortic- l ef t ventric-
ul ar diastolic pressure gradient and arterial pH. PCOZ
and POZ were also determined and were found t o be similar
during cont r ol and drug periods. Conclusions: high-dose
B has a delayed antifibrillatory effect and its magnitude
i s no gr eater than low dose B+L; B+L combination produces
a rapid and persistent effect and may represent a very
effective regimen for the t re ament of ventricular
fibrillation during CPR.
Our previous studies have shown that lidocaine (L)
2mg/kg produces a rapid antifibrillator y effect, while
bretylium (B) 5mg/kg has a del ayed but gr eat ereffect.
Therefore, we investigated the ef fects of high-dose B
( lOmg/kg) and a combi nat i on of L (2mg/kg) and B (5mg/kg)
on vent ricular fibrillation threshol d (VFT) in dogs
undergoing cardio pulmonary re suscitation (CPR). CPR was
per formed folloWing a fibrilla tor y ar re s t us in g a
pneumatic devic e. VrT was determined using a train
met hod at basel i ne (CPRo) , following each of 3
consecutive 3 minute CPR periods, and at > Z hours post
drug. The mean ! SD VFT i n mA are shown b;low:
Contro l B(8 dogs) Control B+L(l1 dogs)
19. 8! 13.0 17.9! 6.9 14.9!6. 6 IS.S! 7.6
l O.7!11.8 l O.3! 7.7 11.8!8.0 30 .4!Z9 .0*
17.5!13 .8 35.1!28.0 13. 6!6 . 4 S4.Z!30.6*
18 .5! 11.7 37. 4! 25.6* 11. 4!7. 4 48. 9! 3Z.Z*
58.1± Zl .7* 6S.3!Z6 .Z*
vs. cont rol ; *p~O. 05 vs . CPRO or any control
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Cycle length of T induced after F increased from 366±i5
msec.42l±i3 msec. (p<O.Ol). 5 pts with WPW and atrial
fibrillation at baseline showed only circus movement T af-
ter F i.v. T induced after F were the same as recurring
on follow-up.
In conclusion: F is moderately effective in the treatment
of these supraventricularT as 657. can be treated effec-
tively. Predictive value of programmedelectrical stimula-
tion after F i.v. with respect to non-recurrenceis high.
FLECAINIDE ACETATE IN THE MANAGEMENT OF REGULAR SUPRA
VENTRICULAR TACHYCARDIAS.
I:;ill!i'r·M:v':lHfk,M.D., Harry J.Crijns, M.D., LsabeI c..van
Gelder, M.D.,Kong I. Lie, Dept. of Cardiology, University
Hospital Groningen, The Netherlands.
Using ProgrammedElectrical Stimulation (PES), we studied
the acute and longterm effects of Flecai~ide (F) in 20
patients (pts), with spontaneous supraventriculartachy-
cardias (T) (5 pts with AV reentry T using concealed by-
pass tract, 8 pts with WPW syndrome, 4 pts with atrial T
and 3 with intra AV nodal T). At baseline in all pts (T)
were inducible. After 2 mg F/kg i.v. in 10 min. AH inter-
val increased from 9i±19 to 111±30 {p<0.005), HV interval
from 43±11 tot 6l±18 (~0.008) and QRS duration from
92±11 to l19±11 msec. (p<O.Ol). Changes in atrial and
ventricularrefractoryperiod were not significant.
Inducibility after i.v.F in relation to recurrencerate
on bd 100 mg F during a meanfollow-up of 12±8 month was:
Recurrent T
No recurrence
Inducible T
t
i
Not inducible
o
6
IWTIARRHYTrr1ICEFFECTS CF TI-£ CU\SS III DRLG D-SCm...CL
~ RECURRENT SUSTAII'£D VENTRICLLAR TACHYCARDIA - LIJ\G-
TERM EFF ICACY
J. BrachnannMD, W. SCreels MD,B. Waldecker MD,J. senges
MD, C. SCh1ll t t MD, W. Kuebler MD FAL'C, Dept. of
GardlOlogy, uruver-saty of HEnoolberg, W.-Gemany
The d-lsomer of sotalol exerts marked class III antl-
uarrhythrlceffects wlthout marked beta blocking actlon.
The c l i rucal efflcacy of d-sotalol (D-'SCT; 1.5 mg/kg iv)
was analyzed In 23 patlents wlth recurrentsuStalned
ventrlcular tachycardla refractory to b.l+2.7 oon-
ventlonal antlarrhythric drugs USlng -programmed
ventrlcularstlmulatlon. All results are expressed as
mean percent change. *p<O.05 control (CW) vs. D-SCT.
CL-SR "'RS "'TC ERPV CL-VT
CON 766+112 104+16 409+31 248+26 321+43
D-5OT 85~~177' 107+18 457+43* 291+'20* 378+49*
CL-Sf" cycle length of SH-us'-rhythr;'QRS,(;]RS ciJratlon;
"'Tc, corrected "'T lnterval; ERP, effectlve refractory
penod at 55C msec paClng cycle length; 0. -\IT, cycle
length of ventrlculartachycardiaIn non-r~~nders. In
9 patlents sustalned ventri co Iar tachvcarm.awas corrple-
tely suppressed by d-sotalol and 1n 4 patlents only non-
SUStalned ventncular tachvcarcna was lndJculble.
"~ver, 10 patlents wlth prlor SUStalned ventrlcular
tachycardlacould stlll be eliclted. Seven partlemtswe-
re placed on longterm oral therapy (430-1:30 mg/d) for a
rrean of 10+9 months. Dunng trus follOl\j-up, no recur-
rence of cllnlcal arrhythmlaswas observed. Concluslon:
d-sotalol exerts potent antiarrtwtmucefflcacy In pati"
ents Wlth refractorysustalned ventncular tacrwcarora
medlated by ltS class III antlarrhythmlcpropertles.
H-ee...e berrti c i a I effects can be demonstrated on chromc
oral treatrrent.
EFFICACY OF MORICIZINE IN PATIENTS WITH DECREASED LEFT
VENTRICULAR FUNCTION AND RECURRENT VENTRICULAR
TACHYCARDIA.
Robert M. Redd, M.D., Thomas A. Buckingham, M.D.,
F.A.C.C., Richard 1. Blum, M.D., F.A.C.C., Denise L.
Janosik, M.D., Linda L. Stevens, Harold L. Kennedy,
M.D., M.P.H., F.A.C.C.
St. Louis University, St. Louis, MO
Previous studies on moricizine (M) have focused on pts
with relatively normal left ventricular function
(LVF). We evaluated the efficacy of M in 21 Pts with
decreased LVF and recurrent ventricular tachycardia
(RVT). There were 16 males and 5females with a mean
age of 62 ± 11 years. Left ventricular ejection
fraction (LVEF) evaluated angiographically - (17 Pts),
or by nuclear blood pool scan - (4 Pts). LVEF was found
to be .33 % 10. Sixteen (16) Pts underwent programmed
electrical stimulation (PES) and 5 Pts had therapy based
on ambulatory electrocardiographic monitoring (AECG).
Of the 5 Pts who underwent AECG based Mtherapy, 2 had
RVT suppressed, 1 had sudden cardiac death, and 1
developed spontaneous VT (SPONT-VT). Of the 16 pts who
underwent PES, 4 developed SPONT-VT on M and did not
undergo repeat PES on M. Of the 12 PES Pts undergoing
repeat study on M, only 2 were rendered noninducible,
although M slowed the RVT cycle length in the remaining
10 Pts (260 msec. vs 319 msec. p 0.05). We conclude in
Pts with decreased LVF and RVT: 1. M was associated
with spontaneous RVT in 24% of pts (5/21), 2. M
infrequently suppresses inducible VT, 3. Mis useful in
selected Pts to slow the VT (48% - 10121) or suppress
RVT (19% - 4/21).
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Myocardial & Pericardial Disease
APICAL HYPERl'ROPHICCARDICIolYOPATHY: IaG-TERMCLINICAL
AND FOiOCARDIOORAPHICroLUJtHJP.
William K. Freeman, M.D., A.Jamil Tajik, M.D., F.A.C.C.
Mayo Clinic and Foundation, Rochester. MN.
Apical hypertrophiccardicmyopathy (A!iCM), an unccsmon
vari~t of. hypert.rophic~dianyopathy, has been primarily
deSC:1bed m onental pat1ents (pta), and the prognosis
relliuns unknown. we report the largest series of AHCM pts
of United States descendency with enphasis on long-term
clinical and ecl1ocardiographicfollow-up. Ten pts with
AHCM were followed over 85.8:t48.5 nonths) range 37 to 166
norrtha, All were caucasian, nine were male. Initial
synptanatologywas: angina(2 pta), palpitations(2 pta),
dyspnea(1 pt) , and asynptanatic15 pts). 'llie mean age at
follow-up was 51. 9+14.9 years. Three pts <30%) had new or
progressive synptciiis, 3 had stable synptans, 4 pts
rE!llBinedasynptanatic. No pt died or developed LV
failure. Neither the maximal QRS vector (1.95+0.54 vs
2.37:t0.53 llfJ; p>0.05) or maximal T wave inversIon 18.0+6.5
vs 9.7:t3.9 mn; p>O.20) changed significantly. Of 8 pts
having an initial 2-D echoc:arcliogram55.4+23.8 nonths
earlier, 2 125%) daronstrateda significant increase in
apical LV hypertrophyat follow-up; one pt also developed
extension of hypertrophyinto the mid LV level.
Conclusions: 1) In this series, AHCM has a relatively
benign long-term prognosis without IlDrtality, ~ver, new
or progressive synptans do occur in nearly one thirdof
pts, 2) Despite lack of m; changes, progressionof
hypertrophyis seen in 25% of A!iCM pts followed by 2-D
echocardiography.
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CONTRIBUTION OF LEFT VENTRICULAR CONTRACTILITYAND OUT-
FLaI GRADIENT TO ISCHOOA IN HYPERTROPHICCARDIOMYOPATHY
Richard O. Cannon. MD. FACC. John Brush. MD. Cynthia M.
Tracy. MD. FACC. NHLBI. Bethesda. Maryland
We previously demonstratedthat rapid atrial pacing in-
duces myocardial ischemia in pts with hypertrophiccar-
diomyopathy (HCM). To compare the relative hemodynamic
and metabolic impact of catecholamine stimulation to
increases in heart rate alone. isoproterenol was infused
in 13 pts with HCM to heart rate 130. with comparison to
paced heart rate 130. the anginal threshold for 12 of 13
pts. Values= mean + 1 S. D.
BP Gradient LVSP GCV-F MV02 Lact+
Basal 97+14 31+26 161~25 83+26 9.4+3.8 0/13
Paced 130 104~17 20~22 150+28 144:;47 15.9:;7.9 1/13
Isuprel 130 95+17* 97~41* 23~42* 151~33 16.6~5.4 8/13*
*=p<.05 vs Paced 130. BP=mean systemic pressure (mmHg).
LVSP=Left ventricularsystolic pressure (mmHg). GCV-F=
great cardiac vein flow (ml/min). MV02= myocardial O2consumption (GCV-F X [arterial-GCV-Fl02 difference.
ml 02/min). Lact+= lactate production.
Despite the markedly greater increase in myocardial O2demand induced by the beta adrenergicagonist (increased
gradient and LVSP). coronary flow and MVO were only
slightly greater than with pacing. We interpretthis as
being due to the coronary flow reserve being nearly ex-
exhausted with increases in heart rate alone. and the in-
creased prevalence of lactate productionduring isoprote-
renol infusion reflecting more severe ischemia because of
a greater O2 debt (due to increased myocardial O2 de-mand and limited capacity to deliver O2), Thus. whileincreased heart rate alone can produce ischemia in HCM pa-
tients. the additional inotropic effects of beta adrener-
gic stimulation are far more likely to be deleterious.
ROLE OF ELECTROPHYSIOLOOICSTUDIES IN PATIENTS WITH
HYPERTROPHICCARDIOMYOPATHY
Cynthia M. fracy, KO. FACC. JudithWinkler. BS. MartinB.
Leon. MD. FACC, Eben E. Tucker. MD. Richard O. Cannon. MD.
FACC. Albert Del Negro, MD. FACC. Stephen E. Epstein. MD.
FACC. NHLBI, Bethesda. Maryland
AlthOUgh ventriculartachycardia (VT) occurs on ambulatory
monitoring in 19J of pts with hypertrophiccardiomyopathy
(HCM). of whom 8J die yearly. high risk subgroups have not
been identified. To determine the role of programmed
electrical stimulation (PES) in defining contributingfac-
tors to major clinical events and in directing therapy. we
studied 43 HCM pts with cardiac arrest (CA). syncope (S) ,
near-So or asymptomatic nonsustained (ANS) VT. VI (or VF)
had been observed in 37/43 pts (86J). PES identified ab-
normalities as follows:
History (n) VT SVT AVN BT NIA
CA (9) 7 -0 -0- 0 2"
S (16) 5 2 4 2 3
near-S (10) 2 2 0 0 7
ANSVT (8) 0 1 1 0 6
SVT= supraventriculartachycardia. AVN= abnormal AV node
function. BT= bypass tract. NIA= no induced abnormality.
Although 14/43 pts (33J) had inducible VT, no pt with
ANSVT was inducible and only 2110 pts with near-S were in-
ducible. Higher rates of inducible VT were seen in pts
surViving CA (7/9) or with S (5/16). In 8/16 pts with S,
a probable contributingelectrophysiologic abnormality
other than VI wea found. These data indicate: 1) ANSVT
and near-S may represent lower risk SUbgroups, 2) PES
frequently identifies mechanisms of S or CA, many previ-
ously unsuspected: it is thereby useful in directing
therapeuticstrategies.
FOREARM VASODILATOR RESPONSE OF PATIENTS WITH HYPERTROPHIC
CARDIOMYOPATHY: EVIDENCE OF A DIFFUSE DISORDER OF VASCULAR
SMOOTH If1SCLE
Frederic L. Sax. M.D•• Patrick T. O'Gara. M.D•• Stephen E.
Epstein. M.D•• FACC. NHLBI. Bethesda. Md.
LONG TERMOUTCOME IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYO-
PATHYAFTER SURGERY
Claude Bourmayan. M.D., Serge Levy. M.D., Michel Desnos,
M. D•• Pascal Cristofini, M.D•• Bernard Attal, M.D. and
J. Gay, M.D., HOpital Boucicaut, Paris, France
This stUdy reviews the results of surgery in hypertrophic
obstructive cardiomyopathy (HOCM) with an average follow-
up duration of 11.9 ! 2 years : 36 patients (20 male and
16 female ) with mean age of 34 : 5 years were operated
on, between 1962 and 1981. Beforesurgery, all patients
were symptomat i c despite medical therapy, 27 severely
(NYHA functional class III or IV), andall had a signifi-
cant left vent r i cul ar gradient (LVG) (mean gradient
67. 2 - 13 mmHg). 31 patients had isolated septal myotomy
or myectomy and 6 had also mitral valve sur gery (one pa-
t i ent was operated on twice). The operative mortalit y
rate was 13.5 ~ but only 6.9 %i n cas e of myoto my -
myectomy alone. The most common operative complication
was complete heart block (i n 4 cases ). Among 30 sur vi vors
(one patient was lost to follow-up) the initial spectacu-
lar functional improvement (27patients in class I or 11)
wit h markedlessening of LVG (mean gradient 17.4: 21. 9
mmHg) was follo~ed by an importantworsening. 8 patients
died, 4 remained severely symptomatic , and 18patients
were s t i l l in class I or II, but 16 of them had+beenin
class III or IVat an average foll~-up of 6.5 - 2 years
bef ore medical treatmentadjunction. Besides, 6 patients
had pro gres ion to LV dilation.
We concl ude that septal myotomy-myectomy has a relatively
moderate operatory risk, if isolated, but doesn't pre vent
rather important late mortality, and its i ni t i al benefit
doesn't persist without medical treatmenthelp.
p<.OOl
p<.OOl
p<.OOl
p<.OOl
Controls
18.7+4.2
35.4+8.8
39.7+5 .7
40.7~4.2*
Patients with hypertrophiccardiomyopathy (HCM) exhibit
impaired coronary flow responses that suggest a diminished
coronary vasodilator reserve. Moreover. histologic
stUdies have revealed a very high prevalence of intramural
coronary artery abnormalitiescharacterizedby thickening
of the media and/or intima. To determine whether HCM pts
have a moregeneralized disorder of vascular smooth muscle
function. we used mercury-in-silasticstrain-gauge ple-
thysmography to study the hyperemic response to forearm
ischemia. To avoid confounding factors, we excluded pts
with outflow tract obstruction. hypertension. elevated
filling pressures or CHF symptoms. Only pts who were NYHA
functional class I or 11 (for chest pain) were stUdied.
The age. sex. meanarterial blood pressure. resting fore-
arm flow andresting vascular resistance of the 15 HCM pts
were no different than that of the 23 normal controls.
Peak flows (ml/minllOO ml tissue) after ischemia were as
follows (mean + S.D.):
Time of ischemia HCM
l' 11.6+4.2
3' 23.3+6.0
5' 27.0+5.9
10' 30.5~6.1*
* (n=7 HCM; n=14 Control)
VaSCUlar resistance (MAP/peak flow) after 5' ischemia
was 3.4+1.0 in HCM pts and 2.3+0.3 in controls (p<.OOl).
These findings suggest pts with HCM have a generalized
disorder of vascular smooth muscle vasodilator capacity.
affecting both the peripheral and myocardial vaSCUlature.
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Mireille L. BROCHIER, M.D, FACC.University Hospital. Tours
(France), on behalf of the Invasive Reperfusion Study (IRS II)
Group.
100 patients (pts) with transmural myocardial infarction (MI)
of ~ 6 hr were treated with a single IV bolus of anisoylated
plasminogen streptokinase activator complex (APSAC 30 U/3-
5 min) versus IV infusion of streptokinase (SK 1.5 x 106 U/60
min), The patency of the infarct related coronaryartery(IRCA)
was assessed by coronaryangiogram(CA) at 90 min. In asubgroup
of 30 pts the residual stenosis of the IRCA was studied at 90
min, 24 hr and 15-21 day post-treatment by quantitative
angiographic assessment. The process was viewed at high
arteriographicmagnification and was quantified with computer-
assisted measurementsfrom repeatedsingle-plane views (CAA8-
Thoraxcentrum,Rotterdam).
The lRCA diameter enlarged from 1.11±0.28 mm at 90 min
to 1.56±0.48 mm at 24 hr in the APSAC group and from
1.36±0.39 mm to 1.42±0.35 mm in the SK group. Thedifference
between the two groups was significant (p<.05). At the 2-
3 week CA control, the mean IRCA diameter enlargement was
not significantly different in the two groups (0.35 mm in the
APSAC group and 0.10 mm in the SK group - ns), Thequantitative
angiographic measurement permits an objective evaluation
of the progressive thrombolytic process and demonstrates that
APSAC (a long acting new thrombolyticagent; biological half-
life " 90 rnin) is superior to SK in achieving a complete
thrombolysis.
RIGHT VENTRICUIAR HI!MODYNAMIC ABNORMALITIES IN
HYPERTROPHICCARDICMYOPATHY
John R. Krause, M.D., Williarn E. Craig, M.D., Ares
pasipoularides,M.D., Ph.D., John P. Mulrow, M.D.,
Joseph P. Murgo, M.D., F.A.C.C., Cardiology Svc, Brooke
Army MedCtr, Ft SarnHouston, TX
To determine the association of LV hypertrophic
cardiomyopathy (HCM) with RV systolic or diastolic
hemodynarnicabnormalities, cath data were evaluated
retrospectivelyin 79 pts with HCM. Group I (n=25) had
LV gradients at rest; Group 11 (n=26) had gradients
following provocation with isoproterenol; Group III
(n=28) had no gradients despite provocation. No inter-
group difference was noted in rest or exercise CO, heart
rate, or LVEDP; resting LV systolic pressure in Groop I
was higher than in the others, but exercise values were
similar. RV hemodynarnicdata follow (in mm Hg):
RVSP* RVEDP**
Rest Exercise Rest Exercise
Group I 29.0±13 39.9±6.5 7.3±2.9 11.4±4.7
GroupII 29.8±6.8 40.4±'3 8.7±3.3 9.1±2.4
Group III 28.8±7.3 44.1±8.6 8.2±2.9 11.6±5.2
*RV systolic pressure; **RV end-diastolic pressure
RV pressures did not differ among the 3 groups, but
were elevated from normal (P<.05) for our lab. More-
over, although more or less abnormal (delayed) RV pres-
sure declines were present in several pts, only 2 of the
79 patients had significant RV systolic gradients. The
elevated pressure levels may be accountable by hyper-
trophy of the septum and RV anteriorwall. The abnormal
RV pressure decay in HCM suggests a role for impaired RV
compliance in early diastole, and the compensatory aug-
mentation of the atrial "kick" raises RVEDP levels fur-
ther from normal. Thus, in HCM, biventricularinvolve-
ment with RV hemodynamic dysfunction is common,
irrespective of any LVor RV systolic gradients.
RESIDUAL STENOSIS IN EVOLVING
INFARCTION / A RANDOMIZED STUDY
STREPTOKINASE
MYOCARDIAL
OF APSAC V.
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Angioplasty in Acute Myocardial Infarction: I
A RANDOMIZED, MULTICENTER TRIAL OF INTRAVENOUS TISSUE
PLASMINOGEN ACTIVATOR AND EMERGENCY CORONARY ANGIO-
PLASTY IN ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE
TAMI STUDY GROUP
EJ Topal MD FACC, RM Califf MD, RS Stack MD, FACC, BS
George MD, DJ Kereiakes MD, RJ Candela MD FACC, CW
Abbottsmith MD FACC, B Pitt MD, FACC, WW O'Neill MD
Univ Michigan, Ann Arbor, MI and The TAMI Study Group
To determine the role and timing of coronary angio-
plasty (PTCA) after IV tissue plasminogen activator
(t-PA) in myocardial infarction (MI), we have studied
317 patients treated at 2.7 + 0.9 hrs from symptom
onset. Infarct vessel patency at the 90 min angiogram
was 751 (238 pte ) , In 79 pts (251) who failed to
recanalize after t-PA, PTCA was attempted in 65 and
successful in 49 pts , Thus, with the combined use of
t-PA and emergency PTCA infarct vessel patency [287/317
(911)] was increased compared to t-PA alone (751),
p<0.001. Of 167 pts with infarct vessel patency after
t-PA, a >501 residual stenosis and suitable anatomy for
PTCA, 86 were randomized to emergency PTCA and 81 pts
to elective PTCA at >7 days if indicated. Emergency
surgery (CABG) was necessary in 7 of 86 (8.11) pts
randomized to emergency PTCA vs. 1 of 31 pts (3.21) who
underwent elective PTCA (p=NS). Of pts randomized to
elective PTCA, 9 had elective CABG. Recurrent ischemia
after the first 24 hr s occured in 1 pt randomized to
emergency PTCA (11) vs 12 (151) elective PTCA pts
(p=o.oon. Patency at 7 days was 881 in emergency vs
911 elective PTCA pts (p = NS). Ventricular function
results are pending. The mortality in these randomized
pts is 1.81 (2 emergency PTCA, 1 elective PTCA pt).
Thus, emergency PTCA after t-PA: (1) significantly
increases the rate of acute infarct vessel recanaliza-
tion; and (2) reduces recurrent ischemic events after
24 hrs.
CORONARYANGIOPLASTYFOLLOWINGrt-PAIN ACUTE
MYOCARDIALINFARCTION:AREPORTFROMTHE
lHROMBOLYSISINMYOCARDIALINFARCTION(IlMI)TRIAL.
Dayjd 0 Wmiams M.D F A.C.C , Sanclra Forman,MA, for the
TIMI Investigators, NIll..BI, Bethesda, Maryland
To evaluate the potential for performing coronary angioplasty (CA) as
supplemental treatment following thrombolytic therapy in acute
myocardial infarction, the results of an open label phase of the TIMI trial
were reviewed.One-hundredand thirty-two patients (pts) received IVrt-
PA for total occlusion of the infarct-relatedartery(IRA) and achieved
angiographic evidence of reperfusion by 90 minutes. Follow-up
angiography was performed at 18 to 48 hours in 88 patients (67%) to
assess the perfusion status of the IRA and, if appropriate, perform CA.
The most common reasons why 18 to 48 hour angiography was not
performedin the remaining patients included unsuitable anatomy of the
IRA (n=13), the need to perform CABG rather than CA (n=7) or to
perform an intervention earlier (n=7), death (n=2) and clinical
reocclusion (n=2). Sustained reperfusion of the IRA at 18 to 48 hours
was observedin 81 of 88 angiograrnmed patients (92%). CA was
attempted in 49 pts and was successful in 47 (success rate = 96%) and
resulted in a decreasein stenosis severity from 85.1 to 29.6 %.
Absence of significant(c-60 % diameter reduction) residual stenosis of
the IRA following rt-PA was the most common (n=14/32, 43%) reason
for not performing CA. Thus, CA canbe performed in patients who
achieve reperfusion following IV rt-PA and when attempted is usually
successful. CA at 18 to 48 hours following rt-PA is not appropriate for
a significant proportion of reperfused patients primarily because of
unsuitable anatomy of the IRA, presence of multivessel CAD requiring
CABG or thrombolysis which eliminates significant residual coronary
obstruction. These results provide justification for further randomized
investigations to assess the need and timing of CA following
thrombolytic therapy.
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FREQUENCY OF CORONARY REOCCLUSIONAFTERSUCCESSFUL INTRA-
CORONARYTHROMBOLYSISINACUTE MYOCARDIALINFARCTION:
COMPARISONOF IMMEDIATEPTCAWITH SUBSEQUENT MEDICALTREAT-
MENT.
Rainer Uebis, M.D., Klaus Reynen, M.D., Rolf Dorr, M.D.,Wolfgeng G. Schniidt,
M.D., HeinzLembel'1Z,M.D.,MartinSigmund,M.D., Rainer von Essen,M.D.,Jiirgen
Mayer,M.D., SvenEffert, M.D.
Dept. of Inl8rnalMedicine1,llWTHAachen,FRG.
In4331543 (80 %)patients with acul8myocardialinfarction,firstangiographyshowed
a complel8thrombotic occlusionof the infarct relatedcorOnaryvessel. Successful re·
canalization _ achieved eithermedically or mechanicallywithin 1 hour aflBronset
of therapy in 88 %(3801433). 37 %ofsuccessfully raperfusedpatients had subsequent
medical therapy, an additionalimmedi818 PTCA was performed in 42 %, and 21 %
underwentearlysubsequent byp8llsurgery (up to 10 days).
Angiographicfollow-up (3rd day and after six months) wasvailable in 130 patients
with subsequent medicaltherapy (group 1) and in 147 patients withsuccessful imm.
dial8 PTCA (group 2). Patients withengiographicallydefined coronaryreocclusion
were additionally followed up for clinical,electrocardiographic(ST. ~ 0.2 mV in
inferior and~ 0.3 mV in anl8rior leads)and enzymatic (CK • ) signsof non·fatal
myocardial reinfarction, resulting intwo subgroups with either symptomatic or
asymptomatic (silent! coronaryreocclusion. Early and late fatalityrates were not ln-
cluded in thes1IIdy.
R Itsesu :
Group Reocclusion with reinfarction Reocclusion silent
3rd day 8th month 1: 3rd day 8th month
n n % n % % n % n %
1 130 5 3.8~ 18 12.3~ • 18.1 1 0.7 7 5.3
2 147 13 8.8 n 8 5.4 14.2 5 3.4 8 4.0
1+2 277 18 8.4 24 8.8 15.0 8 2.1 13 4.8
EMERGENCY CORONARY ANGIOPLASTY THERAPY FOR ELDERLY
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: CAUTIONARY
RESULTS
Kurt Holland, M.D., Eric J. Topol, M.D., F.A.C.C.,
Joseph A. Walton, Jr., M.D., F.A.C.C., Eric R. Bates,
M.D., F.A.C.C., Bertram Pitt, M.D., F.A.C.C., William
W. O'Neill, M.D., Univ. of Michigan, Ann Arbor, MI
Emergency coronary angioplasty (PTCA) is finding
increasing use in patients with acute myocardial
infarction (MI). The risks and benefits of this
strategy have not however been defined in elderly
patients o 70 yr s) , From 1/84-8/86, 26 elderly pts
with MI underwent emergency PTCA, mean age 73.8 (range
70-91) 16 were male, MI location anterior in 14 andinferi~r in 12. Seven of the pts had cardiogenic shock
and 10 had received IV thrombolytic therapy prior to
PTCA. PTCA performed a mean of 5.3 hrs from onset of
symptoms was successful in 15 (58~). Rethrombosis
requiring emergency surgery occured in 1 pt and death
within 24 hrs in 7 pts , During the hospital course
another 4 pts died and 3 reoccluded. Other complica-
tions included: 1 femoral artery occlusion, 1 arterio-
venous fistula and 2 retroperitoneal hemorrhages.
Overall in-hospital mortality was 11/16 (42~). Compared
to emergency PTCA in 200 pts <70 yrs, the mortality was
increased (42 vs 6~, p <0.001), the primary success
rate reduced (58~ vs. 90.5~, p <n.not) and the inci-
dence of complications increased.
In conclusion, emergency PTCA for MI in elderly
patients is associated with a decreased success rate
and an increase in morbidity and mortality. These
results suggest the need for caution in appl ying PTCA
to these pts without a prospective randomized trial.
• p<O.05
Conclusions: If immedial8PTCA has beensuccessfully performed in the acute stage
of myocardial infarction, thefrequency of symptomaticreocclusion does not differ
in the two groupswithin the first 3 days.AflBr6 months, however,asignificant,more
than 50 % reductionof the symptomaticreocclusionrate can be shownfor immedial8
subsequentPTCAas comparedto medicalfo low-up treatment only.
TRFA:lMENfOFACUrE Mm:ARDIAL INFARCl'ICNwrm EMFBGEN::Y <XKNARY
~.
Richard S. Stack,M.D., F.A.C.C. , TawakiH:inohara,M.D., !IarIyR.
l'blllips, M.D., Kemeth G. ItlrrisM.D., Victor S. Behar, M.D., Yihalg
Kong, M.D., Robert H. Peter, M.D., Eric B. Carlson, M~D., 0Jarl.es A.
Simxlton, M.D., NonIIm Ranirez, M.D., William G. O'Callaghan,MoB.,
PatrlclafuffDml and Robert M. Califf, M.D., Duke lhdversityMedical
Center, Durham,North Carolina.
TreatDe1tof acute~ocardial infarction (AMI)us1ng t:hraIbolytic
therapy(TT) alooe often results In a lfmited reperfusion rateand a
Irlgh degree of residual stenosis. limediatecoronaryangioplasty
(PICA) could D8rl<edly~e the :Initialreperfusion rateand
significantly reduce the residual corooaIy hIIdnallllIrIWing.
'l\io b.mdrede1ghty-threecoosecutive patients (pts) with AMIwOO
1olI!I'e treated with :lDJJIildiatePl'CAliere studied. Fnttycriteria:included
1) pain < 6 hrs 2) Sf 8e@lIIl!nt elevation of~ lnm:In 2 or ume Em leads
or 3) pain of 6 to 18hrs if both Sf sejpII!Iltelevation and pain
persisted In the absence of Q-waves (indicatingcont:lDled ischemia of
viable ~ocardilIn). Males/fEmales· 232/51. TheJm!aII age was 57 yrs
(range • 28-82). AdjunctiveTT:lncl.uded: Irlgh dose :lntraveoous
streptoldnase (1,5million III'lits) In 227 (&l%),and tissue plasnirogen
activator (tPA) (150 II6l :In 37 (13%). No t:hraIbolytic therapywas
administeredIn 19 (7%) We to contra1ndicat:iDl1s. Persistent
reperfusion(brisk antegradeflai fol..1.cM1ng the Pl'CA procedure)was
established:In 263 (93%). The f1nal Jm!aII ( + SIl) %hIIdnald:lam!ter
lllIrIWing~ these pts was 29±24% follti/ing theprocedure. 'l\io
b.mdredtwenty-ale (84%) of all pts dsJmstrated~ 50% residual l.um1naJ.
d1aDeter~.~ all pts, mortality~ in the lab was4
(1.4%), euetgeney 9.1rgery was14 (S%), QlStained ventricular
arrltythnias requiringcm:UiaYers:l.onwas 18 (6%) and strokeoccurredin
2 (0.7%).
These dats indicate thatemetgeney Pl'CAmaybe performedsafely in
conjunctionwith eithel' Irlgh dose streptoldnase ortPA :In pts with AMI
resulting In a Irlgh rate of reperfus:l.onwith a low residual stl!l1Ollis.
Thursday,March12, 1987
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Angioplasty in AcuteMyocardialInfarction:11
ABRUPT RECURRENT THROMBOSIS AFTER INTRAVENOUS TISSUE
PLASMINOGEN ACTIVATOR AND EMERGENCY CORONARY ANGIOPLASTY
IN ACUTE MYOCARDIAL INFARCTION. RS Stack, M.D., F.A.C.C.,
EJ Topol, M.D., F.A.C.C., WW O'Neill. M.D., BS George,
M.D., RJ Candela, M.D., F.A.C.C., DJ Kereiakes, M.D., CW
Abbottsmith, M.D., F.A.C.C., RM Califf, M.D. The TAMI
Study Group
In a multicenter, randomized trial of intravenous
tissue plasminogen activator (tPA) and emergencycoronary
angioplasty (PTCA) for acute myocardial infarction, we
recognized an untoward response occurring in some
patients following PTCA. Among 81 patients who had
recanalizationof the infarct vessel after tPA and who
were randomized to emergency PTCA, 9 (11%) with
uncomplicated lesions. successful balloon dilatation, and
no apparent intimal dissection developed recurrentchest
pain and ST segment elevation 20-25 mins after PTCA.
Repeat angiography demonstratedangiographic filling
defects and diminished flow. Repeat PTCA with the same
or a larger balloon catheterwas unsuccessful in
achieving restorationof flow. IntracoronarytPA and/or
streptokinasewas successful in improving flow and
decreasing the intraluminalfilling defect in 2/9 pts.
The remaining 7 pts showed persistence of intraluminal
filling defects with poor antegrade flow requiring
placement of an autoperfusioncatheter and emergency
surgery (CABG). Repeat angiographyat 1 week
demonstratedpatency of the infarct vessel in 6/6 pts.
We conclude that IV tPA followed by immediate PTCA may
result in abrupt refractorythrombosis possibly mediated
by intense platelet aggregation.
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MULTIVARIATE ANALYSIS OF FACTORS PREDICTING
IMPROVEMENT IN REGIONALWALL MOTION FOLLOWING
DIRECT BALLOON ANGIOPLASTY IN ACUTE MYOCARDIAL
INFARCTION.
Barry D. Rutherford,M.D., F.A.C.C., Robert D. Simari,
Robert W. Ligon, David R. McConahay, M.D., F.A.C.C.,
Warren L. Johnson, Jr., M.D., F.A.C.C., Geoffrey O.
Hartzler, M.D., F.A.C.C. Mid America Heart Institute at
St. Luke's Hospital, Kansas City, Missouri.
In 142 patients (pts) undergoing direct balloon angioplasty
(PTCA) following acute myocardial infarction (AMll.regimal
wall motion (RWM) was assessed by left ventricular (LV)
angiograms prior to and at a mean of 12 days after PTCA.
Fifty-four pts had anterior AMI, 88 pts inferior, mean time
from pain onset to patent infarct artery (lA) was 4.5 hrs.
Improved RWM was noted in 74 pts (52%). Twenty-one
clinical and angiographic variables were evaluated as
predictors of improvement in RWM. Univariate correlates
of improvement were: AMI location, anterior 63% vs infer-
ior 45%; time from onset of pain, ,{4 hrs 61 %vs >4 hrs
34%, patent lA at follow-up 56% vs occluded lA 28%;
diameter stenosis of lA pre-PTCA; and number of abnor-
mal segments in infarct zone pre-PTCA. Multivariate
analysis selected five factors associated with improved
RWM: Time, collaterals pre-PTCA, no. of abnormal seg-
ments, diameter stenosis of lA pre-PTCA, and total
occlusion of lA at follow-up.
Conclusion: Improved RWM following direct PTCA in AMI
is clearly related to: 1) Maintained patency of the infarct
artery; 2) Time from onset of pain; 3) Degree and loca-
tion of LV dysfunction.
DETERMINANTS OF LEFT VENTRICULAR FUNCTION AFTER
EMERGENT INTERVENTIONAL THERAPY IN MYOCARDIAL INFARC-
TION: THE ROLE OF RESIDUAL STENOSIS.
AB Langburd, MD, EJ Topol, MD, FACC, SM Sereika, MPH,
ER Bates, MD, FACC, JA Walton, Jr, MD, B Pitt, MD,
FACC, WW O'Neill, MD, University of Michigan, Ann
Arbor, MI
To determine the effect of acute coronary intervention
on left ventricular (LV) function during myocardial
infarction, we studied 139 patients: 107 had emergency
angioplasty (PTCA) with (n=62) or without (n=45)prior
thrombolytic therapy rrv streptokinase in 24 or IV
tissue plasminogen activator [t-PA] in 38) and 32 had
t-PA alone. Infarct vessel patency and LV function
(global ejection fraction [Efl and infarct zone
regional wall motion [RWM] using the centerline chord
method) determined from angiographyobtained acutely
and on follow-up (FlU) study 7 to 10 dayslater were as
follows: Initial Residual Time to
Patency Stenosis(F/U) Treatment
Open Closed <70J ~OJ <3 ~ hrs
11 pts n=76 n=62 n=99 n=39 !!::2!!. ~
Initial EF (~) 52.8 49.5 51.0 51.8 50.3 51.9
Change FlU EF ,,) 1.4 2.1 3.0+ -1.3 3.6· 0.7
Initial RWM (SO) -2.5 -2.8 -2.7 -2.6 -2.6 -2.7
Change FlU RWM(SD) 0.6 0.7 0.8++ 0.2 0.9 0.5
Time to Treatment 3.3" 4.3 3.9 3,4 2.1·· 4.8
(hrs)
"p=0.003 +p=0.008 ++p=O,0005 ·p=O,05 "p<O,001
ThUS, (1) residual stenosis at FlU is the major factor
determining LV functional recovery and appears more
important than initial patency or time of treatment,
and (2) definitive recanalization by PTCA to minimize
residual stenosis appears essential in achieving
recovery of myocardial function.
THE EFFECT OF CORONARY REPERFUSION ON THE SURVIVAL OF
PATIENTS WITH CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL
INFARCTION?
Renato G. Ramos. M.D., John Azevedo, M.D., V.
Gangadharan, M.D.,F.A.C.C., Seymour Gordon, M.D.,
F.A.C.C. and Gerald C. Timmis, M.D., F.A.C.C. William
Beaumont Hospital, Royal Oak and OaklandUniversity,
Rochester, Michigan.
MULTIVARIABLE ANALYSIS OF HOSPITAL MORTALITY IN ACUTE
MYOCARDIAL INFARCTION PATIENTS UNDERGOING INTERVENTIONAL
CATHETERIZATION
Daniel B Mark,MD, ChristopherMO'Connor,MD, David B
Pryor, MD, Mark AHlatky, MD, Richard SStack, MD, FACC,
Duke University Medical Center, Durham, N.C.
To identify risk factors for in-hospital death in acute
myocardial infarction (AMI) patients (pts) undergoing
emergent interventional catheterization,we studied 216
consecutive AMI pts treated with acute coronary angio-
plasty (PleA) and 1.5 million units intravenous strepto-
kinase (SK). Median time from painonset to SK
administrationwas 3 hours. Pt median agewas 57 and 79%
were males. The infarct vessel was: LAD 43%, LCX 8%, RCA
46%, and bypass graft 2%. Ninety percent of pts had
coronary flow reestablished at the end of the PTCA; in
87% the residual lesion was < 50% stenosis. Emergent
CABG was required in 11 pts T5%) and 1 pt (0.5%) died
during PTCA. Sustained hypotension (systolic blood
pressure < 90) was seen before or during the PTCA in 19%.
A total of 26 pts (12%) died during theAMI hospitaliza-
tion. The risk of death was increased in: females (27%
versus 8% for males); older pts (31% in pts > age 65,
versus 8% for pts 45 to 65 and0% for pts < 45); pts with
sustained hypotension (41% versus 5% for pts without it);
pts with a lowerejection fraction (EF) (22% for pts with
an EF < 40 versus 7% for pts with an EF > 40%); and pts
with an occluded infarct vessel on the initial coronary
angiogram (17% versus 7% for pts open on the 1st angio-
gram). Logistic regression analysis showed that the
independent predictors of in-hospital mortality were:
sustained hypotension (p<.OOOI), older age (p<.OOOI),
lower ejection fraction (p=.005) and female sex (p=.009).
Thus, clinical and angiographic factors can be used to
identify AMI pts at high risk for in-hospital death
follOWing emergent PTCA.
4 (19%)
3 (21%)
1 (16%)
13 (40%)
7 (37%)
6 (46%)
Survivors
21 (40%)
14 (43%)
7 (35%)
32 (60%)
19 (57%)
13 (65%)
Nonreperfused (TIMI 0 or 1)
Anterior MI
Inferior MI
Reperfused (TIMI 2 or 3)
Anterior MI
Inferior MI
To assess the effect of coronary reperfusionon l4-day
survival of patients with cardiogenic shock in the
first 6 hours of acute myocardial infarction (MI), we
reviewed all 319 acute MI patients (pts) treated with
intracoronarystreptokinase (SK) infusion and/or
coronary angioplasty (PTCA) between 1981 and 1985.
There were 53pts presenting with a BP of ~80/60 and
evidence of hypoperfusion. The success of reperfusion
was graded according to TIMI criteria:
n
Survival in the reperfusion group was twice that of the
nonreperfusedgroup. However, infarct location did not
significantly affect survival. Maximum survival was
achieved in 9 pts demonstratingTIMI-3 reperfusion flow
(66%; p<.05 vs nonreperfusedpts).
CONCLUSIONS: Coronaryreperfusionmay improve survival
of patients with cardiogenic shock due to acute MI.
Survival depends on flow andwas greatest in pts with
TIMI-3 reperfusion.
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SERIAL CHANGES IN LEFT VENTRICULAR EJECTION FRACTION
FOLLOWING ACUTE MYOCARDIAL INFARCTION
James Coromilas, M.D., F.A.C.C., Richard A. Shlofmitz,
M.D., Joseph L. Fleiss, Ph.D., Lung HuaXie, M.D., and
John Morrison, M.D. Columbia University, New York, N.Y.
The aim of interventional therapy in acute myocardial in-
farction (MI) is to limit infarct size. Serial measure-
ments of left ventricularejection fraction (LVEF) are
often used to assess the success of therapy. We evaluat-
ed serial changes in LVEF following acute MI in 87 con-
secutive patients receiving routine care. Radionuclide
LVEF was measured on days 1,3 and pre-discharge (6-21
days). The intraclass correlationcoefficient (0.76-
0.86) indicated excellent reliability of the measurement.
For the entire group mean LVEF remained constant.
Day 1 Day 3 Pre -discharge
LVEF (n-87) 41.5+15 41.8+15 41.3+14
Despite this relative constancy of mean LVEF, there was a
marked degree of variabilityat the level of the indivi-
dual patient with 45% of the patients showing changes of
at least 5 EF points between any two studies. However,
only 5% of the patients exhibited significant changes,
i.e., twice the standarderror of the change between any
two studies. Regression to the mean predicts that pa-
tients found to be above or below the mean on one occa-
sion, will be closer to the mean when measured again even
if no change occurs in the population. The regression to
the mean phenomenon waswell illustratedin subgroups of
patients with low (~30) or high (~50) LVEF.
LVEF Day 1 Day 3 Pre-discharge
<30 (n-21) 20.5+6 22.0+9 24.6+14
>50 (n-29) 57.6+7 54.5+10 51.2+7
In-conclusion, although individual patients show-marked
variability in LVEF in the weeks after MI, the mean LVEF
for the group was remarkablyconstant. Because of regres-
sion to the mean phenomena, evaluation of subgroups of
patients with unusually low or unusually high LVEF post
MI should not be done without control groups.
Thursday, March 12, 1987
10:30AM-12:00NOON, Room 38, Second Level
Effects of Exercise Training in Normal and Disease
States
COlOR FLOW MAPPING EVALUATION OF ELITE FEMALE RUNNERS.
MODERATELY TRAINED FEMALE RUNNERS AND SEDENTARY FEMALES.
William Knopf. M.D., Scott J. Pollak, M.D.,
Scott A. McMillan. Ph.D., Agit P. Yoganathan. Ph.D.,
Joel M. Felner. M.D., F.A.C.C., Emory University School
of Medicine, Atlanta, GA
Color flowmapping (CFM) and auscultationwere
performed in 3 groups of females: Group 1- 15 elite
runners(mean age 27 + 5 years) running an average of
70 :: 17 miles perweek with a mean resting heart rate
(HR) of 45 ! 6 bpm; Group 11- 14 moderately trained
runners (mean age 28! 3 years) running an average of
40 + 10 miles per week with a mean resting HR of S2 + 8
bpm; Group 111- 17 normal sedentary controls (mean-age
28 ! 4 years) with a mean resting HR of 77 ! 13 bpm.
Results of CFM:
Group I Group 11 Group III
Tricuspid
4/17Regurgitation (TR)14/1S* 8/14
Pulmonary
Regurgitation (PR)13/1S* 8/14** 3/17
Mitral
Regurgitation (MR) 4/1S S/14 1/17
Aortic
Regurgitation (AR) I/1S 0/14 0/17
(*~.OOI Group I vs Group Ill, ** P<.OS
Group 11 vs Group Ill).
Two women in each group (total 6) had mitral valve
prolapse; 2 of the 6had auscultatoryevidence of MR. No
subject had auscultatoryevidence of TR, PR or AR.
Conclusion: 1) TR and PR identified by CFM is seen in
almost all elite female runners. 2) Distancetraining
in females correlates with the frequency of TR and PR
identified by CFM.
THE EFFECTS OF TRAINING ON THE PHYSIOLOGICAND STRUCTURAL
INDICES OF VASCULAR FUNCTION
Gretchen Leaman. Jeffrey S. Shenberger, Robert Zelis, M.D.
F.A.C.C•• Lawrence I. Sinoway, M.D. Division of
Cardiology, Hershey Medical Center, Hershey, PA.
In an effort to determine whether chronic forearm training
would increase both structuraland physiologic indices of
peripheralforearm vasodilation, we studied a group (n=7)
of individuals chronically performing high levels of arm
work, young (age. 29.6 yr) wheelchair confined paraplegics
(PP), and compared them to 10 agematched healthy controls
(age 27.4 yr) (NL). Our index of dilator capacity was the
flow response (ml/min·lOOml) following the release of 10
min of arterialocclusion, the peak reactive hyperemic
blood flow response (PRHBF). Our index of a structural
effect of training on the vasculaturewas the resting
brachial artery diameter derived by simultaneous measure-
ment of velocity and blood flow (flow/velocity· forearm
volume). Maximal oxygen consumption (V02max; ml/kg min)
measured during a graded ergometry was also measured in
each group. We found in the PP a greater V02max (PP 23.1;
NL 20.5; P<.05). We found major differences in vascular
function between the groups with a greater PRHBF (PP 53.8;
NL 40.3; P<.05) and a larger resting brachial artery dia-
meter (PP .402; NL .292; P<.05) despite similar levels of
resting forearm blood flow (pP 4.6; NL 3.3; NS) in the PP.
We conclude that training leads to both an enhanced capa-
bility to acutely vasodilate resistance vessels (increased
PRHBF in PP) and to a structuraldilatation of large con-
ductance vessels (increased brachial artery diameter
in PP).
ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN HUMAN
SUBJECTS. Paul J. Rogers, M.D., John C. Burnett, M.D.,
and Alfred A. Bove, M.D., Ph.D., F.A.C.C., Mayo Clinic,
Rochester, MN.
Left ventricularvolume at rest and during acute exercise
is increased with exercise training. This change in
ventricularvolume may be reflected in atrial volume
changes induced by training. The effect of increased
atrial stretch on atrial natriureticfactor (ANF) has not
been examined in trained subjects. To investigate dyna-
mics of ANF during exercise, plasma ANF levels were
obtained in 8 well-trained (HX) and 7 minimally trained
(LX) individuals at rest, at 4 minutes of treadmill exer-
cise (4 min), and at maximal exercise (Max Ex). All sub-
jects were healthy. Mean body weight (74 kg), body fat
(14%) and age (30 years) were similar between groups.
The HX group exercised an average of 5000 kcal/week and
had a maximal oxygenuptake (V02 max) of 56~2 ml/kg/min.
The LX group exercised 2000 kcal/week with a V02 max of
43+3 ml/kg/min. Cardiac output at Max Ex was 22+1 L/min
in-HX and 20+2 L/min in LX, with maximal heart rates of
182+2 and 187+3 beats/min, and maximal meanarterial
pressures of 114+3 and 107+1 mmHg, respectively. Changes
in ANF are detailed below (data are mean±SEM, *p<.05 vs.
rest)•
ANF (pg/ml) Rest 4 min Max Ex
LX (n=7) 30±2 35±3 5l±3*
HX (n=8) 34±3 39±6 32±5
These studies demonstrate that acute exercise results in
a significant increase in ANF in untrained subjects.
This increase is attenuatedwith exercise training. This
adaptationmay facilitate volume homeostasis during acute
exercise.
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EFFECTOF AGE ONADAPTATIONTO AEROBICEXERCISE
TRAINING.
Richard B. Wenzler. M D..Lois M. Sheldahl, Ph.D., Felix E.
Tristani, M.D.,FAC.C., JeffreyL. Christie, M.D.,Anthony B.
Gustafson,M.D., Scot Levandoski,and Craig Plato, VAMC and
MedicalCollege of Wisconsin,Milwaukee,WI.
Themagnitudeand rate ofadaptationsto aerobicexercise trainingin
older (0) comparedto middle-aged(MA) men remainsuncertain.
There is someindicationthat 0 adapt more slowly. In the present
study, S 0 ~ 60 years) and S MA (35-60 years) healthy men
participatedin a6-monthsupervisedexercise program. Bothgroups
exercised thrice weekly for 40minlsession on treadmillsand cycle
ergometersat 7Q..SO%maximaloxygenconsumption(V02max). No
injuriesoccurredwithtraining. After 6 months,V02maxincreased
from33.4 to 39.7mllkg/min(19%;P<O.Ol) in theMA andfrom31.0
to 35.1 m1Ikg/min(13%;P<O.OI)in the0 group,with 74 and 92%of
theseincreasesoccurringduring the first 3monthsof trainingin the
MA and 0 groups, respectively. The increase in the MA was
significantlygreaterQ'<0.05)thanin theO. HeartrateatSO%of each
subject'spretrainingV02max wasreducedsignificantly(P<O.Ol)with
themajorityof thedecreaseoccurringwithinthefirst3 months;95%in
the MA and.91% in the O. Plasmanorepinephrine(NE) at SO%
pretrainingV02max(measuredin 5 MA and 50) was reduced19%
(P<0.05) after 3 months and reduced 24% (P<0.05) from 3 to 6
monthsof training. Thepatterno~ decreasewassimilarin MAandO.
PlasmalactateatSO%pretrainingV02maxwasdecreasedsignificantly
(P<0.05) after3monthsof trainingbutremainedunchangedfrom3 to
6 months. These results indicate that the time course of physical
adaptationsis thesamein 0 amdMAmenundergoingthesametypeof
trainingprogram.Themagnitudeof adaptation,however,is lessin the
O. Themajorityof changeshasoccurredwithin3monthsof training
althoughplasmaNEcontinuesto decreasebetween 3 to 6 monthsof
training.
LONG-TERM EXERCISE TRAINING AND CARDIAC OUTPUT FOLLOWING
CARDIAC TRANSPLANTATION.
Donald Mertens, M.B., B.S., Terence Kavanagh, M.D.,
F.A.C.C., Magdi Yacoub, M.D., F.A.C.C., Salah Qureshi,
M.Sc., Johanna Kennedy, R.N., Toronto Rehabilitation
Centre, Toronto, Canada.
Using the COZ rebreathingmethod, resting and exercise
cardiac outputs (Ot-COZ) were measured in 35 cardiac
transplantpatients (Z9 orthotopes and 6 heterotopes),
at entry and after completion of a lZ-month exercise
(walk/jog, stationarycycle) training program. Exercise
compliance was good in the orthotopes, and poor in the
heterotopes.
Results: In both heterotopes and orthotopes, the slope
o~ the regression line of Ot-COZ on oxygen consumption
(vo2) (r=0.94) and the absolute values of 0t-COZ at
equivalent levels of effort, were normal for both initial
and final tests. Peak levels were significantly below
normal.
The heterotopes did not improve their fitness level over
the year (peak VOZ of 1.3 L'min-l at initial and final
test), and consequently their predicted maximum Ot-COZ
remained at 11 L·min-l. The orthotopes did achieve a
training effect (peak oxygen consumption increasing from
1.53 L'min-l to 1.88 L'min-l), with a resultant increase
of predicted max Ot-COz from lZ.4 L'min-l to 14.6 L'min-l
(P< 0.001).
Conclusions: Cardiac transplantpatients who are capable
of adhering to an endurance training program can improve
cardiovascularfitness, and all indications are that this
is accompanied by an increase in maximum cardiac output,
THE INTERACTION OF EXERCISE TRAINING AND BETA BLOCKADE IN
PATIENTS WITH MODERATE HYPERTENSION.
William L. Haskell, Ph.D., F.A.C.C., Lars G. Ekelund, M.D.,
Homer L. Brammell, M.D., H. Robert Superko, M.D.,
R. Sanders Williams, M.D., Stanford University, Stanford,
CA.
The interaction of beta blockade and endurance exercise
training on cardiovascularfunction and aerobic capacity
has been reported for healthy subjects and patients with
ischemic heart disease but not hypertensive patients. To
determine if beta blockade alters the training response to
endurance exercise in hypertensive patients, 74 sedentary
men age 41+10 years with diastolic blood pressure (DBP)
between 90-& 104 mmHg were randomly assigned to either a
selective beta blocker, Atenolol (A), a non-selective beta
blocker, Propranolol (P) or a placebo control (C). Evalu-
ations included resting blood pressure and maximal oxygen
uptake (VOzmax) during treadmill exercise testing. All
patients trained on stationarycycles or walk-jogged 40
minutes per session at 70-85% of peak heart rate, 5 x per
week for 8 weeks. Drug and training adherence exceeded
90% in all subjects. RESULTS: Resting DBP was 98±S (mmHg)
in each group prior to drug or training. On drug prior to
training DBP (mmHg) was A=84+7, P=88+ll & C=94+8 while on
drug ~fter training A=80±8, P=8S±8 &-C=89±8. Pre-training
mean VOzmax (mg/kg/min) on drug was similar among the
~roups (A=3Z.4, P=3Z.4, C=34.8). In response to training,
VOZmax significantly increased (p<.Ol) in all groups while
on drug (A=14.l%, P=7.4%, C=14.8%) with the increase in P
less than for A or C (p<.OS). Thus, DBP control by beta
blockade in moderate hypertensive patients was slightly
augmented by exercise training whereas exercise VOzmax
was attenuatedby non-selective but not selective
blockade.
Thursday, March 12, 1987
8:30AM-I0:00AM, Room 24, Second Level
Evaluation of Aortic Stenosis by Doppler Velocity
Measurements
EXPERIMENTAL VALIDATION OF ECHO-DOPPLERMEASUREMENT OF
VOLUME FLOW PROXIMAL TO THE STENOTIC AORTIC VALVE.
Catherine M. Otto, M.D.; Alan S. Pearlman, M.D., F.A.C.C.;
Dennis Enomoto, M.D~om Ivey, M.D., U. of WA, Seattle
In aortic stenosis, evaluation of aortic valve area by
the continuity equation assumes that the volume of flow
through the stenotic valve can be measured accurately in
the LV outflow tract (LVOT). To test this, we developed
an animal model of valvular aortic stenosis that is anato-
mically similar to the clinical disease. The native aor-
tic valve leaflets are sutured at 1, 2, or 3 cornmissures
to create variable degrees of stenosis. LV and Ao pres-
sures are measured with micromanometer-tippedcatheters.
Volume flow is controlled by directing systemic venous
return through a roller pump and back into the RA. Trans-
aortic volume flow (which may not equal roller pump output
if there is aortic insufficiency or coexisting LV dysfunc-
tion) is measured by electromagnetic (EM) flowmeter with
the flow probe placed around the descending thoracic aor-
ta, just distal to the ligated arch vessels.
In 9 dogs (mean wt 25 kg), maximum transaortic pressure
gradient ranged from 1-60 mmHg and meanpressure gradient
from 4-20 mmHg. Transaorticvolume flow ranged from 0.4-
3.2 L/min. EM flow measured distal to the stenotic valve
was validated by comparison to volume flow measured di-
rectly by timed collection of total aortic flow into a
graduatedcylinder (n=24, r=0.97, EM=0.87 Direct + 0.13
L/min, SEE=0.12 L/min). Next, EM flow was used to judge
the accuracy of LV output measured by echo-Doppler as LVOT
cross-sectional area [(TI/4) (diameter)2j x LVOT systolic
velocity integral x heart rate. Agreement was excellent
(n=24, r=0.90, DOP=0.97 EM + 0.13 L/min, SEE=0.3l L/min).
This acute animal model of aortic stenosis, in which
fluid dynamics should be similar to those encountered
clinically, suggests that echo-Doppler meaSures of ante-
grade volume flow proximal to the stenosis are accurate.
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SI MPLI FICATION OF THE DOPPLERCONTINUITY EQUATION FOR
CALCULATING STENOTIC AORTIC VALVE AREA.
Cat he r i ne M. Ot t o , M.D. ; Alan S . Pear l man, M.D., F.A . C.C.;
Carolyn L.;Janko , RDMS ; Carol D. Kraft, RDMS ; Michelle C.
Fujioka, RDMS. Univers i ty of Was hi ngton, Seattle, WA.
In order to s impl i fy t he measur ement s needed for nonin-
vasive determination of aortic valve area (AVA) , we evalu-
ated fo ur methods, based on t he continuity equation , i n
103 adults wi t h aortic s tenosis . Ages ranged from 33- 87
(mean 69) years. AVA de t ermine d at cathete rizat i on by the
Gor lin formula ranged from 0 .2 -3 .7 (mean 0 .9 7) cm2.
Method 1: Doppler AVA was ca l cul at ed , using the con-
venti ona l continuity equation, as LV outfl ow t r ac t (LVOT)
cr oss-sect i ona l area [~ (diameter/2 }2J t imes the LVOT/aor-
tic jet syst o l ic ve l oc i t y integral (SVI ) rat io. Correla-
t i on with cat h AVA was good with a r egression line close
to t he l i ne of identity (r =0 .B7 , DOP=0 .92 CATH + 0.16
cm2). Method 2: Since the LVOT/aortic jet SVI ratio is
nearly i dent i ca l to the more easily measured LVOT/aortic
jet peak velocity ratio (r=0.96), t his latter ratio was
substituted in the continuity equation . The correlation
with cath remained good (r=0.B7, DOP=0. 94 CATH + 0.19
cm2) . Method 3: Calculation of Doppler AVA using the
group mean (2 .3 cm), instead of measured LVOT diameter,
correlated less well with cath (r=O.Bl, DOP=0. 67 CATH +
0.41 cm2) . Method 4: LVOT di ame t e r was significantly
s mal l e r in women than men (2 .0 vs 2 . 5 cm, p<O.Ol), but the
correlati on was only moderately improved i f a sex-speci f i c
mean LVOT di amet e r was substituted fo r meas ured di ame ter
(r=O.B4 , DOP=O.Bl CATH + 0.31 cm2) .
We conclude that the continuity equation can be simpli-
f i ed by substi tuting maximum LVOT and aortic j e t veloci-
ties fo r systolic velocity i nte gr a ls. LVOT di amet e r var-
i es substantially from patient to patient, however, and it
should be meas ur e ddirectly i n each patient f or accurate
AVA determi nation .
PREDICTION OF SEVERITY OF AORTIC STENOSIS BY SIMPLE
DOPPLER VELOCITY MEASUREMENTS: CORRELATIONWITH CATH IN
100 PATIENTS.
Jae K. Oh, M.D., A. Jamil Tajik, M.D. , F.A.C.C., Charles
~Talr;rcr~.D., David R. Holme s Jr ., M.D., F.A.C.C.,
Guy S. Reeder, M.D., F.A.C.C., James B. Seward, M.D.,
F.A.C.C. , Mayo Clinic, Rochester, MN.
A prospective study was performed in 100 pts (55 men and
45 women ; mean age 71 yrs, range 53-95) undergoing cath
for aortic stenosis (AS) to evaluate the predictive value
of Doppler velocity (V) data in the as s essment of the
severity of AS. Aortic valve (AV) area was determined by
a s impl ified continui t y equation (AVA = LV outflow tract
(OT) area x VOT/VAV) and was correlated with cath-AVA.
The range of Doppler data was as follows :
LVOT area VOT VAV VOT/VAV AVA ( cm2)
(cm2) (m/sec) (m/sec) Doppler Cath
2.9-4.9 0.4-1.7 2.0-6.5 0.1-0.7 0.37-1.70 0.27-1.81
AS waS defined as severe when cath-AVA was ( 0.75 cm2 (61
pts). Doppler-AVA correlatedwell with cath-AVA (r=0.85;
y=0.7lx + 0.19) . Sensitivity and specific ity of
Doppler-AVA for severe AS were 89% and 77%,respectively.
Although 24/25 pts ( 96%) with peak VAV ~ 4.5 m/sec had
severe AS , there was a wide range of overlap in the
severity o f AS at lower V values. Peak VAV of 12 pts with
severe AS and LV ejection fraction ( 40%ranged from 2.3
to 5.6 m/sec, and 10 (83%) had VAV ( 4 .5 m/sec . VOT/VAV
was ( 0.25 in 58 of 61 pts (95 %) with s eVer e AS , but also
i n 15 of 39 pts ( 38%) without sev ere AS. Conclusions:
(1) Doppler-AVA by the simplified continuity equation ha s
a good cor r e l a t i onwith cath AVA. ( 2) Unless VAV ~ 4 .5
m/sec , i t alone is not sufficient to determine the
severity of AS. (3) VOT/VAV ~ 0.25 i s highly sensitive,
but le ss specific, for severe AS. Using various V data,
Doppler can accurately predict severity of AS, and
therefore, should supplant cardiac cath in selected pts.
ESTIMATION OF VALVE AREA IN PATIENTS WITH AORTIC VALVE
DISEASE BY DOPPLER ECHOCARDIOGRAPHY AND RAD IONUCLIDE
ANGIOGRAPHY
Pete r Eriksson, M.D., Dag Teien , M.D., Kj el l Karp, M.D .,
Per BJer le, M.D., and Goran osterman, M.D.,Department
of Internal Medic ine,Uni versi ty Hospi ta l , Ume ~, Sweden .
The accuracy of combining Doppler ul t rasound and radio-
nucl ide angiography t o noninvasivel y det ermine t he aor-
t ic valve area was examined in twenty-twopatients wi th
iso la ted aortic st enosi s or combinedaortic stenos is and
i ncompetence. The peak pressure difference across t he
valve and the systolic vel ocity integral was obta ined
from Doppler velocity recordings. Radionuclid e angio-
graphywas used to assess the LVstroke volume. A counts-
based nongeometric t echnique wi th individual attenuat ion
correct ionwas used. The aort ic valve areawas calculat ed
bot h by a modified Gorlin equation and by dividing the
LV stroke volume by the velocity integral . The results
of the noninvasive examination s were compared with those
obt ained at cardiac catheterization and angiography.
Noninvasive and invasive measurements correlat edclosely,
r = 0.95, SEE = + 0.13 cm2 by t he modified Gorlin equa-
t ion and r = 0.94, SEE = + 0.14 cm 2 by the integration
method. There was an excellent agreement between~he two
noninvasi ve procedures, r=0.98, SEE = + 0.09 cm . Al l
el even patien t s with a valve area of 1cm2 or less ac-
cording to invasive measurement s were correctly ident i-
fied by the noninvasive te st s . Our data suggest that the
aortic valve area can be accurately assessed by combined
Doppler echocardiography and radionucl ide angiography.
CAN THE MODIFIEDBERNOULLI EQUATION BE USED TO ACCURATELY
DETERMINE INTRAVENTRICULAR PRESSURES THROUGHOUT SYSTOLE
IN PATIENTS WITHVALVULAR AORTIC STENOSIS?
K.nn.th M. Borow, M.D .. F.A.C.C., AI.x Ne um ann, B.S.,. Rob er t
Brlller, M.D., Kirk T. Sp encer; B.S ., a nd Dfan e W.rth, M.D.,. The
Univ.rslty of Chicago and Micha.1 R•••• Ho spl tat, Chicago, IL.
The modified Bernoulli e quatlcn allow. accurate de t er minatton
of the peak pr...ure (P) gradient (G) between LV and Ao In
patients with valvular aortic 51.no.1s (VAS). Thi••quatlon
ac hie ve s I ts s irn pl e form by ne gf e c t lng flow acceleration,a factor
which become. z ero at peak flow. To de t e r m lne if this formula
maintain. ac c eptab le accuracy and cli n ic a l use fulness throughout
svs tcte., tnst an taneeus LV .y.toll, pr...ures w.re estim ated u. ing
the formula LVP = PG + AoP . In 10 conse cu t tve VAS pati.nt.
(ag. = 65~9 yrs; peak PG = 71~24 mm Hg; Ao valve are a = 0.6:!:0.3
,,,,2) , ln st anraneous PG was ob taln ed by Dnppler whil.
lnst antaneous AoP was derlve d from t ime corrected catlbra t e d
c ar o t id pul se tracings. Non invaslv.ly (NI) de t e r rnln e d LVP w.re
compared with s tmul taneous LVP m e asure d at c ath,
LV PRESSURE (rmtlg) AT PERCENT OF EJECTION
20% 40% PEAK 60% 80%
CATH 169+24 186+28 189+29 183+30 158I31
NI 164+22 186+27 190+29 185+30 156:!:29
DIFF -5~5 2+5 1+5 2+5 -2:!:4
%ERROR _3!3 1~3 1~3 1~3 -1:!:2
In VAS, the use of the modified Bernoulll e quatlon does not
adversely affe c t the NI determination of instantanecus LVP.
Wh.n comhlned with echo m easured LV dimension. and wall
thickne sve s,, i t should now be possib le to accura tetv ca lculate
m ean, peak, and en d-s ys tof lc wall stre ... s, Thes e m easure ments
are particularly important since thev are major de t er mlnants of
myocardial oxygen consumption, LV hypertrophy., and overall LV
performancerespectively. Further rnor e, the retattonshlpbetw e en
sy5l0llc wall s tre ss and LV performancecan be used to distinguish
abnormal load from de c r eased contractlllty as the cause of
systollc dvsfunctlon in patient. with VAS.
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THE SIMPLIFIED BERNOULLI EQUATION CORRECTLY
PREDICTS OUTFLOW TRACT PRESSURE GRADIENTS IN
HYPERTROPHIC CARDIOMYOPATHY:AN IN VITRO STUDY
Robert A. Levine, MD, FACC, Scott McMillan, PhD, A.
Jimoh, Diane SimonS,Aji.~Yoganathan, PhD, Arthur E.
Weyman, MD, FAC C, Mass. General Hospital, Boston, MA.
The simplified Bernoulli equation permits noninvasive
prediction of pressure gradients (PG) across stenoses from
Doppler velocities as PG: 4v2• It assumes negligible viscous
losses and holds for a variety of orifice sizes. The orifice in
hypertrophic cardiomyopathy (H C M), however, unlike those
studied to date, is eccentric, with a smaller hydrodynamic
radius, making viscous losses more likely. As determined
echocardiographically in 90 pts, the mitral valve forms a
cowl-shaped obstruction beneath the septum in HCM,
producing an eccentric orifice which may extend lonrtudinally
as a tunnel. In order to determine whether PG:4v applies
to such stenoses, models based on echo dimensions were
placed in a cha mber with fluid of physiologic viscosity and
density. Peak v by continuous wave Doppler and maximum PG
were simultaneously measured at physiologic flows. Linear
regression gave:
Area Tunnel PG: av
2
+ b r~
T:5"cmr-:- 4.06 -1.94 .99 ORIFIC.·/ W
1.1 3.94 1.01 .99 \\'"
0.5 4.04 -3.24 .99
0.85 1.5 cm 3.92 0.24 .99 MITRAL
0.5 1.5 3-91 1.35 .99 -: VALVE
0.25 3-0 4.12 - .56 .99
Slopes and intercepts did not signitlcantly differ from 4 and
O. PG was underestimated downstream from the stenosis,
reflecting pressure recovery. CONCLUSIO NS: PG:4v2
correctly predicts outflow tract PG in stenoses with the
geometry seen in HCM, with apparentoverestimationif PG is
measured beyond the vena contracta.
Thursday, March 12, 1987
10:30AM-12:00NOON, Room 24, Second Level
Application of Doppler Velocity Measurements in
Valvular Heart Disease
ASSESSMENT OF TRICUSPID STENOSIS BY DOPPLF.R-ECHOCARDIO-
GRAPHY
Karl Dennig, M.D., Karl-Heinz Henneke, M.D., Werner
Rudolph, M.D., F.A.C.C., German Heart Center, Munich,
foR. Germany
In mitral stenosis, Doppler echocardiography(DE)
enables reliable evaluation of pressure gradient and
orifice area. To determine Whether these methods can be
used as well for the assessment of tricuspid stenosis
(TS), 11 pats underwent DE examinstions prior to hemo-
dynamic measurements. 20 healthy subjects served as con-
trol group. From the maximal velocity (v) of the tri-
cuspid flow, early diastolic peak (v (0)), mean pressure
gradient (AP) and pressure half-time (t /2) were
derived. Orifice areas were calculated ~s 220/tl / 2• In
the control group v (0) was 0.42 ~ 0.12 m/s and t
l
/ 2
measured 39 ~ 12 ms. In pats with TS the t /2 was
increased to 140 + 70 ms. The orifice area~ ranged from
1.01 - 3.28, mean-l.96 + 0.91 cm" and correlated well
with the invasively determined data (r = 0.97, SEE =
0.23 cm"). The DE determined ~P ranged from 1 - 8 mm Hg
and also showed a close correlationwith the hemodynamic
values (r = 0.89, SEE = 1 mm Hg).
Thus, we conclude that the severity of TS can be
assessed by DE, Which enables reliable determinationof
pressure gradient and orifice area.
PRESSURE RECOVERY DISTAL TOSTENOSIS: POTENTIAL
CAUSE OF GRADIENT "OVERESTIMATION"BY DOPPLER
Robert A. Levine, MD, FACC, Scott McMillan, PhD, A.
Jimoh, Edward Cape-;--A"jirp:-Yoganathan,PhD, Arthur E.
Weyman, MD, FACC. Mass. General Hospital, Boston, MA.
Flow through obstruction increases velocity (v) and decreases
lateral pressure (P). For inviscid fluids, flow reconstitutes, v
falls and P is fully recovered. For blood, viscous effects limit
P recovery (P R). To the extent that PR occurs, however, P
measurement downstream from the vena contracta, where P18
lowest, will underestImate--nleP gradient (P G) seenoytne-
proximal<lhamberand estimatedlFciiilJjQppler v""\BernouIiI}.
To determine the magnitude of Plf""ancltlie"effectsof flow
rate Q and stenotic geometry, stenoses were set in a chamber
with fluid ot.:physiologic viscosity and density at steady flow.
Stenoses included central ori!l.ces; eccentric cowl-shaped
orifices based on echo images in hypertrophic myopathy; and
cowls extended as tunnels, tapering distally. Manometer PG
was measured with a proximal tap and distal side-hole
catheter, withdrawn from the limiting ori!l.ce in 4 steps over
6 cm. RESULTS: 1) PR occurred in all cases (p<.05), mainly
by 3 cm; PR was greatest for tunnels, in Which it increased
linearly with Q (r:.9). Maximum PR at Qs studied were:
Orifice,cm2 Q,l/min PR,mm Hg PR, %max PG
.25 3.0 cm tunnel ~ --W - - OOT -
.5 1.5 cm tunnel 13.5 27 31 %
1.1 cowl; central 20.0 13; 9 14% ; 10%
1.5 cowl; central 23.0 14 ; 15 18% ; 20%
2) The simplified Bernoulli equation 4v2 best predicted PG
from Doppler at the site of maximal PG. CONCLUSIONS: PR
distal to stenosis can cause significant PG underestimation
and disparity between measured and Doppler-derived PG,
depending on catheter location. This effect is greatest for
streamlined tunnels, and at highest Qs (Reynolds nu mbers)
where viscous effects are relatively small.
NONINVASIVE QUANTIFICATIONOF AORTIC REGURGITANT
AREA UTILIZINGDOPPLER HALF-TIME ANALYSIS
Steve M. Teague, MD, FACC, Vasu D. Goli, MD, Rajesh
Prasad, MD, Wyatt F. Voyles, MD, FACC, Jerome L.
Anderson, MD, Udho Thadani, MD, FACC. Univ. of Oklahoma
and VA Medical Centers, Oklahoma City, OK.
Noninvasive methods for the determinationof regurgi-
tant orifice area (ROA) in valvular heart disease have
not been previously reported. We sought to estimate
aortic ROA noninvasively utilizing continuous wave
Doppler ultrasoundin 34 patients undergoing catheter-
ization for isolated aortic valve disease. Like stenotic
mitral valves, the orifice area of regurgitantaortic
valves should depend upon the decay rate of the diastolic
transvalvular pressure gradient. The mean diastolic
preSsure gradient, the diastolic filling period, the
heart rate, and the regurgitant output (angiographic
minus Fick output) were substituted in Gorlin's aortic
valve equation to obtain invasive ROA, ranging from 0.05
to 1.1 cm2. The regurgitant fraction (RF) was the
quotent of regurgitantand angiographic outputs, ranging
from .10 to .70. To calculate ROA noninvasively, we
measured the Doppler half-time (DHT) as the time for the
continuous wave Doppler profile of aortic regurgitation
to decay by 29% (1-1/V2), ranging from 0.84 to 0.10
seconds. Linear regression analysis showed high inverse
correlationbetween DHT and RF (r= -.92, SEE=.08), as
well as DHT and ROA (r= -.86, SEE=.lO). ROA and RFwere
positively correlated (r= .89, SEE= .13). We conclude
that the effective aortic regurgitantarea (cm2) can be
approximatedutilizing continuous wave Doppler ultrasound
as O.l/DHT. These results may lead to noninvasive, flow
independent quantificationof aortic regurgitation.
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COMPARISON OFTWO DOPPLER METHODS FOR EVALUATING AORTIC
REGURGITATION
Tohr u Masuyama, M.D., Aki ra Kitabatake, M.D., Kazuhi sa
Kodama, M.D. , Sat oshi Nakatani, M.D. , Hiros hi Sato , M. D. ,
Kazuo Komamura, M. D. , Sh1nsuke Nanto, M ~D ., Ma sashi Naka ,
M.D., Michitoshi I noue , M.D., The Car diovascul ar
Di vi s ion, Osaka Pol i ce Hospi tal, Osaka , J apan ,
Accuracy of two Doppler met hods fo r evaluating aortic
regurgi t ati on (AR) was examined by using aort ic r oot
angiogr aphy as a golden standard. One is fl ow mapping
method in whi ch AR is gr aded by examin ing the ext ent of
diastol ic turbulence in the LV cavi t y using pulsed
Do ppler ech ocardi ography. The other i s Doppler half-time
met hod i n which AR is gr aded by meas ur i ng t he t ime from
th e peak veloci t y t o half th e peak veloci ty on the
continuous-wave Doppler-determi ned AR f l ow veloc i t y
pattern . AR was gr aded us i ng athree-point scale by the
two Doppl er met hods and aortic root angiogr aphy i n 25 AR
patients without associated mitral valve disea se and i n
20 AR pat ients wi th as sociated mitral valve di seas e . In
AR patient s without as soci ated mit r al val ve dise ase , th e
correlations of gradings were excellent (r=O. 94 for flow
mapping method; r=0.9 3 f or Do ppl er half-time metho d) . In
AR pat i ent s with associ ated mitr a l va l ve disease, t he
correlation of gradings was higher fo r Doppler half-t i me
method than f or fl ow mapping method (r =0. 91 vs r= O.56, p
<. 0 .0 5) . Flow mapping method was esp ecially of no use
in diffentiating moderate and se vere AR in AR patient s
with as soci at ed mitr a l va lv e dise ase, because transmitral
f low pro duces di astolic turbulence i n the LV cavi t y
independently of AR. Thus, we conclude that both fl ow
mapping metho d andDoppler half-time method are useful t o
evaluate AR i n patients without assoc i at ed mi t r al valve
disease . However, it seems that Doppler half-ti me
method is mor e useful t o evaluate AR in patients with
associated mitral valve disease .
FREQUENCY OF UNUSUALLY HIGH TRANSVALVULAR DOPPLER
VELOCITIES IN PATIENTS WITH NORMAL PROSTHETICVALVES.
S. Bhatia, M.D., M. Moten , M.D., M.Werner, M.D., M.
Caldeira, K. McInerney, D. Dragotakis, N. Pandian, M.D.,
M. St . John Sutton, M.D., FACC. Brigham &Women's
Hospital &Tufts New England Medical Center, Boston, MA.
Doppler echocardiography(DE) has been used to define
normal velocities (V) across prosthetic valves (PV).
However, we have seen pts with normal PV and very high V.
To assess the frequency of this finding, we studied the
DE of 168 pts with PV (100 aortic [A], 68 mitral [M])
studied < 6 weeks postop who had normal exams and 2D/MM
echocardiograms. The peak velocity (Vm, m/sec) across PV
by CW doppler and valve gradient (GR, mm Hg) - 4(Vm)2
were calculated. PV regurgitation(mitral:MR, aortic:AR)
was graded (1-4+) by doppler flow mapping. High Vm was
defined as V> literaturenormal +2 standarddeViations
(S.D . ), and was present in 11-47% of studies (valve type:
I-porcine, Il-Bjork Shiley, lII~St. Judes):
Valve n nl Vm+2SD Vm GR %abnl Vm
rr--653.2 2.7t0.731±14 18
IIA 20 3.0 2.6±0.7** 29±15** 40
IlIA 15 2.9 2.6±0.7** 30±14** 47
IM 37 1.8 1.8±0.4 13± 5 46
IIM 13 1. 9 1. 5±0. 3: 10± 4** 23
IIIM 17 1.9 1.S±0.4 10± 4** 11
[vs porcine: *p < 0.01, **p-ns].
Overall, 27% A and 32%MPV had high Vm; 10% of pts with
A PV (7 lA, 211A, I IIIA) had velocities >3 .S (GR>SO).
AR, MR was mild (1-2+) and present in 6-3S% of pts. The
pts with normal and high Vm had a similar valve size(A:21
±2.8 vs 21±2.9,M:28±1.7 vs 29±2.2, p>O.OS) and incidence
of AR/MR (p > O.OS). We conclude that I)high transvalvular
velocities are seen in 1/3 pts with normal PV; 2)high Vm
is not related to valve size, stenosis or regurgitation
and 3)mild regurgitationis common in pts with normal PV.
COMPARATIVE EVALUATION OF DOPPLER TECHNIQUES AND
AUSCULTATION FOR DETECTION OF MITRAL REGURGITATION (MR)
S. Sadanandan,M.D. , E. Lee, M.D., S.A. Golwalla,M.D .,
K.K. Sakamoto, M.D. I S. Ravan, M.D., A.K. Eng, M.D.,
P.M. Shah, M.D., F.A.C.C.
Wadsworth VA/UCLA Medical Center, Los Angeles, California
One hundred forty-six patients referred for echocardio-
graphy (echo) and Doppler (Dl were prospectively examined
for mitral regurgitation(HR by auscultation (A) in
"b1inded" protocol. Twelve were excluded for inadequate
echo-D studies. The ages ranged from 30 to 94 years (avg
67). The diagnosis of MR by Dwas based on a pansystolic
retrograde flow signal localized in theleft atrium. Mapp-
ing techniqueby Dwas used to distinguish pts with mild
MR from moderate and severe (M-S) MR. Intrinsic MV
pathology was detected by echo.
Results:
Doppler N= Auscultation MV Pathology
MR No MR Yes No
Mild MR 54 22 32 39 15
M-S MR 22 17 5 16 6
No MR 58 11 47 22 36
Sixteen of the 21 pts with normal MV but Dpositive MR had
ventriculardilatation or infarction as potential causes.
Using Das standard forpresence of MR, the sensitivity,
specificity and accuracy for Awere 51 %, 81 %and 64%resp.
The sensitivity was 41 %for mildand 77%for M-S MR. Five
of 11 with MR by A but no MR by D had other causes for
systolic murmurs. Four of 5 with M-S MR by D but no MR by
A had no systolic murmurs,whilst in one the murmurwas
interpretedas aortic stenosis.
Conclusions: Considerablediscrepanciesexist between A
and D in detection of MR. Even after correcting possible
errors of interpretations,a murmurwas present in only
41 %of mildand 82%of more severe cases.
Thursday,March 12, 1987
8:30AM-I0:00AM,Room 43, Second Level
Thrombosis Fibrinalysis and Platelet Function in
CoronaryArtery Disease
QUAllTITATIVE AlIGIOGRAPHIC MORPHOLOGY OF THE CORONARY
ARTERY LESIONS AT RISK FOR THROMBOTIC OCCLUSION.
Yves Taeymans, MD, Pierre TIIlkoux, MD, FACC, Jaeques
Lesperance, lID, and David D. Waters, lID, FACC, from
Montreal Heart Institute, Canada and A.Z. V.U.B.,
Brussels, Belgium.
The characteristies of diseased eoronary artery
segments at risle for thrombotie oeelusion were stUdied
using computer assisted quantification (CAAS system) in
42 pts who developed an aeute myoeardial infaretion
(MI> a mean of 10 .5 months (range 0.12 to 36) after
eatheterization for stable angina. In these pts, 42
segments which became occluded (OS) and 64 control
segments whieh did not (CS) could be stUdied. Exeluded
from analysis were 29 segments already oeeluded or
elearly related to a previous MI. The exaet thrombotie
site was documented by a seeond angiogram perfonned
12±10 days after the MI. Univariate analysis
identified 3 variables from the first arteriogram
differentiating the 42 OS from the 64 CS: ." diameter
stenosis (47±18 vs 4l±lzy, for CS, p<.02), proximal
slope of the stenosis (2l.3±10 vs l6.9±7 degrees,
p=.009) and a braneh originating in the stenosis (30/42
vs 33/64 segments, p<.05). The minimal diameter of the
stenosis (1.6±.6 vs 1.8± .6 mm in CS), the length of
the lesion (6 .9±2 .2 vs 7,l±3 .1 mm), the asymmetry
index (.46± .27 vs . 44±. 29) and the presenee of an
irregular eontour (21/42 vs 43/64 segments) did not
differentiate OS from CS. Multivariate analysis using
the Cox model retained ." diameter stenosis as the most
significant predictorof occlusion (p<.OOOOl).
Thus the propensity to thrombosis is related to ."
stenosis. the inflow slope of the stenosis and the
presence of a branch. These faetors all favor local
blood flow turbulenee.
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THE SEXlH) Ml'. SINAI-NYU REPERFl.5ION'llUAL:
MAIN EmPOINl'S
~terMr,~, FredriekFeit, M.D., and
~r sion u roup.
Ht.Sinai and MedicalCenters, New York, NY
In the second Mt. Sinai-NYU reperfusiontrial, 393 pts
were randanl~ C!lilsi9J:Ied to 4 treatmentarms: a 99rnin
intraeoronar (iel infusion of streP.l:okinase (sk) ,
2,999 u/miIl Gp I or ie Nro, ,,9I.!!g7min (Gp It) or both
ie sk aild :1GPIIIl, or mecucal therapy (Gp IVl •
78 pts were randC:mi.zeawithin 2 hrs after onset of pain
lAl and 315 pta between 2 and 12 hours lB). 'ltte tiJre
ml:erval fran onset of ~in to ie infuslon was 3.2± .7
hrs in AI and 7.1 ± 2,4 hrs in B. Pre-intervention
patency rate was 33% m A and 27% in B (n.a.}, 'lbere
were no differences in acute recanilizationrate
between GPI and GP III. 'ltte r~ilization \ate of Gp
I and ~ III coot>med was 87% anA, and 57% m B
(P(,911. 'lbe ~ II r~lizat1on rate was 19% ¥t A and
6\ m a (n.s'l' 'lballium [tll images were ootained at
pre-intenrenton and at enclpoint for B pts. A
quantitatlveuP!=ake index was generated: Qli¥l9~ in tl
uPtake index between _pre-interventionand erxtp01I1t
st:udies were assesseaby an fIN:NA pta Wo received sk
showed IfQreiJrDrovementin tl uptake than tho~ Wo did
not (P<.1l11. 'nIe inprovementwas more narked mpts
with antenof versus inferior infarets (P<.951. 'nIree
monthmortalitywas: 9P I 1%, GP II 11%, Gp III 19.5%,
9P IV 16 %(n.s,l. '!tie three int:erventiongrouIlS had a
hospital mortalll:yof 7.5%, the me<:!leal group of 15%
(p=.1l6, adjust~ for age imd pr~intervention EF),
COnclusions: l)tiie pre-lnterventlonpat~ rates In A
~ B indicate that there is not a s+gnificant
lnCidence of SIlOI)taneous recanalizatloowithin the
first 12 hrs of infarction, 2)the eff~ of ie Nro in
recanaliz~ coronaryarteri~s is negllgible even if
the.drug is ir,tfysed very ear1:i1 31 tII~ efficacy Qf ic
sk 111 recanaJ.1ZlIl<Jcor~ arteries lS hlgl:).l.y tJ.IredePendentI 41 ie sk resultS in significant iJlprovement
of"chroructl u~e even if treafrnentoccurs
relatively late (7.lhrsll this effect is more narked in
ante.ior lnfarets; 5) there is no evidence that acute
cardiac catherizadonor infusion of a throntlolvtieor
non-th\ontlolyticagent results in increased in-nospital
mortallty.
ABSTRACTS
FIBRIN OEGRAOATIOt~ PRODUCTS IN ISCHEMIC
HEART DISEASE : NOtI INVASIVE EVIDENCE OF
SPONTANEOUS FIBRItlOLYSIS INUtlSTABlE ANGINA.
S. Ounica, Ph. Beauflls, C. Soria, J. Soria,
.Mc . Mirshahi, M. Mirshahi, J. Caen, R. SLAMA
FACC, Hopital Lariboisiere, Paris, France
Enhanced platelet aggregation and fibrin forma-
tion have been previously documented in acute
myocardial infarction (AMI) and unstable angina
(UAl. To assess the spontaneous thrombolytic
state in ischemic heart disease, we measured
fibrin degradation products (FOPl in plasma with
an ELISAprocedure using a 0 neomonoclonal anti-
body in 46 pts with AMI (within 24 hrs of the
onset of pain), 32 pts with UA (within 24 hrs of
the last pain and the da y after), and 21 pts with
stable angina (SA). None had received fibrino-
lytic agents and none had heart failure. 36 non
cardiac pts served as controls (C).FOP level
(mean!SEM) was 118! 14 ng/ml in C, 159:- 28 ng/ml
in AMI (p=NS vs C), 926! 136 ng/ml in UA (p<O.OOl
vs C) and 220 ! 35 ng/ml in SA (p<O.Ol vs Cl. In
the 22 cases of UA without recurrenceof ischemic
pain, FOP fell from 713 !118 ng/ml initially to
332 ! 87 ng/ml on day 2 (p<O.OOl). These data
provide evidence for an early and intense sponta-
neous fibrinolysis in UA, that could lead to
intracoronary thrombus fragmentationpreventing
coronary occlusion. Conversely, the absence of
enhanced fibrinolysis within the first hours of
AMI suggests an imbalance between thrombosis and
thrombolys is that could play an importantrole
in the constitution of necrosis.
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A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF
RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR
~PA) FOR UNSTABLE ANGINAPECTORIS
Herman K Gold MD, FACC, JennjferA Johns MBBS, Robert
C Leinbach MD, FACC, Tsunehiro Yasuda MD, Randall
Zusman MD, FACC, Desire Coll.en MD.
Massachusetnl General Hospital, Boston MA.
To determine the clinical and angI.ographic effecm of a
prolonged infusI.on of iv r1;.PA, 20 patl.ent.'3 (pm) with
unstable angina pectoris (UAP) def1ned as ischemic chest
pain at rest and transient ST segment deviation were
randomized to iv It,-PA or placebo. Prlor to randomizatl.on
all pm were treated with oral beta-blockere, cal.clum
antagonlsts, nitrates and continuous iv heparin. After 12-24
hours of monitoring pm were randomized to either placebo
or 1.75 mg/Kg iv It,-PA given over 12 hours at a rate of
0.75 mg/Kg for 1 hr, 0.5 mg/Kg for 4 hrs and 0.5 mg/Kg
for 7 hrs. Ischemic events were recorded for 1-14 days
after placebo/It,-PA 1nfusl.on. Coronary angiography was
performed 48+20 hours after infusI.on to identify the
ischem1a-related artery and presence of intracoronary
thrombus (T), def1ned as a persistent nJling defect.
Hemostatl.c parameters were measured before and after
1nfusl.on.
UAP pers\.sted in 6/10 placebo and 1/10 It,-PA pm
post,.lnfUsI.on (p <. 0.02). Sub-occlusl.ve T was found in 8/10
placebo and 1/10 It,-PA pt.'3 (p:0.OO2). PersI:ltence of UAP
coll'e1ated significantly with the presence of T (p <0.02).
After It,-PA, nbrinogen fell to 62;t41 J of baseline while
PTT was s1m11ar in both groups. Bleeding at puncturesl.tes
occUl'Y'ed in 7 r1;.PA pt.'3 and no placebo pts,
We conclude that in thls group of pt.'3 with UAP, T was less
common in pm treated with It,-PA than with heparin alone.
Absence of T coll'e1ated with clinical stability, suggesting a
role for It,-PA in the management of pm with UAP.
CIRCADIAII INCREASE IN PLATELET AGGREGABILITY: ASSOCIATION
WITH THE TIME OF INCREASED FREQUENCY OF MYOCARDIAL INFARC-
TION AND SUDDEN CARDIAC DEATH
Geoffrey H. Toner, M.B., Damian A. Brezinski, James E.
Muller, M.D., Andrew I. Schafer, M.D., John D. Rutherford,
M.D., F.A.C.C., Charles A. Czeialer, Ph.D, M.D., Stefan
N. Willich, M.D., Gordon H. Williams, M.D., Brigham and
Women's Hospital, HarvardMedical School, Boston, MA.
The incidence of non-fatal myocardial infarction (MI)
snd sudden cardiac death (SCD) is maximal in the morning.
Since platelet8 may play & role in t.heee disorders, we
studied platelet aggregability at 3-hour intervals over a
24-hour period in 11 normal male subjects. Threshold
concentrat ions of ADP (cADP) and Epinephrine (cEpL)
required to produce biphasic aggregation were:
5
/oLM 3 r--r--r-l.--T-T·'f/!--)
-cADP
I --cEpi
3 6 9 12mn 3 6 9 12n 3
PM AM PM
Threshold concentrations fell (aggregability increased)
from 6 to 9 a.m , ; cADP, 5.0!,0.9 to 4 .0!,0.7 IlM, p<0.03 ;
cEpi, 3.l!,0 .9 to 2.2!,0 .6IlM, p<0.05. To investigate mecha-
nism, we studied 8 subjects at 8 and 9:30 a.m. on mornings
of normal activity (A) (Iubjects arose at 8:10 a.m.), and
no activity (RA). Threshold concentrations were similar
on both mornings at 8 a.m., but at 9:30 a.m., were lower
on the morning of activity (cADP; A-3.1!,0.8 IlM, RA-3.7~0 .8
IlM, p<0,03. and cEpi; A-1.3!,0.7IlM, NA-2.l!,0.911M,
p<O.02). Thus, platelet aggregability increases signifi-
cantly from 6 to 9 a.m. This increase coincides with the
time of increased frequency of MI and SCD and appears to
result from awakening and the start of morning activity.
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INCREASE IN EPINEPHRINE INDUCED PLATELET AGGREGATION WITH
ADVERSE KINETICS OF PLATELET ADRENERGIC RECEPTORS IN
PATIENTS WITH ISCHEMIC HEART DISEASE
Yasuo Tanaka.M.D.• Junichi Hayashi,M.D.,HideakiSato.M.D.•
Mitsuo Ohni.M.D.•HideharuManabe,M.D.,RyuichiMatsuo.M.D••
Toshimasa Migita,M.D .•Yoshihiko Sato.M.D •• Yoshio Watanabe.
M.D.,F.A.C.C .• Toshio Tohno,M.D.,Fujita Gakuen Univ. and
Kyorin Univ., Tokyo. Japan.
To clarify platelet a2 adrenergic receptor kinetics
contributing to platelet aggregation in ischemic heart
disease. the number(Bmax) and affinity(Kd) of a2 adrener-
gic receptors, platelet aggregation induced by epineph-
rine(E). adenosine diphosphate(ADP) or collagen(C). and
plasma levels of E and norepinephrine(NE) were simulta-
neously analyzed by radioreceptorbinding assay. an aggre-
gometer and radioenzymaticassay. respectively. Platelet
rich plasma was preparedfrom 27 healthy donors (H-gr)(age
range 23-78yrs) and 11 patients(P-gr)(69±11yrs)with stab-
le angina. Plasma NE levels showed a positive correlation
with age in H-gr(r=O.52,p<.05). whereas Bmax showed a
negative correlation(r=-O.52.p<.05).Aggregatory responses
to E(2UM) were significantly higher in P-gr(8l±4%) com-
pared to age-matched 7 healthy donors(69±8yrs) in H-gr(76±
3%,p<.Ol). Contrariwise, no differences were seen between
P-gr and age-matched H-gr in platelet aggregation induced
by C(2.4 mg/ml) as well as ADP(2.5uM). Although there was
no significant difference of plasma NE levels between P-gr
(4l7±165 pg/ml) and age-matched H-gr(4l2±236), Bmax was
significantly lower in P-gr(89±11fM/mgprotein) compared
to age-matched H-gr(154±6l)(p<.05). Conclusions:l)Platelet
a2 receptors are influenced by plasma NE levels showing a
down regulation with aging in H-gr; 2)The increase in
aggregation in P-gr with a2 receptor reduction, which is
independent of plasma NE levels, suggests that our present
concept of a2 adrenergic receptor stimulation leading to
platelet aggregation must be revised.
CLINICAL OUTCOME OF PATIENTS WHO HAVE EARLY VENTRICULAR
FIBRILLATIONAFTER MYOCARDIAL INFARCTION.
Pascal Nicod MD, Elizabeth Gilpin MS, Howard Dittrich MD,
John Ross, Jr, MD, FACC, UC, San Diego, California.
Whetherventricularfibrillation(VF) occurring within 48
hours after myocardial infarction(MI) is associated with
particularclinical features and poor prognosis is still
debated. Therefore. we analyzed clinical variables. in-
hospital and 1 year mortality in 2088 patients, age 18 to
95 years(mean±SD:64±12) admitted with acute MI. 147 pa-
tients had at least 1 episode of VF occurring within 48
hours of hospital admission. Of those, 25% died during
their initial hospitalizationcompared to 13% of the pa-
tients without early VF(p<O.OOl). Theimmediate cause of
death was left ventricular(LV)failure in 50% of patients
with early VF. In-hospital clinical and radiographicfea-
tures suggesting LV failure were significantly more fre-
quent in patients with compared to those without early VF.
Of the 1666 patients discharged and followed for 1 year
(survivors), 102 had experienced early VF. 1 year mortal-
ity after hospital discharge was not significantly in-
creased in those with compared to those without early VF
(16%vsll%,ns), even in the subgroup of patients with an-
terior MI(12%vs8%,ns).Similarly, LV ejection fraction and
incidence of complex ventriculararrhythmiasat hospital
discharge were not different in survivors with or without
early VF(.45±.13vs.49±.14.ns,and 43%vs42%,ns.respectively).
However. at discharge survivors with early VF had signi-
ficantly more clinical and radiographicsigns of LV fail-
ure than those without early VF. Thus:l)earlyVF after MI
is associated with increased in-hospital mortality, most-
ly secondary to LV failure;2)of the hospital survivors, 1
year mortality is similar in patients with and without
early VF, even in the subgroup of patients with anterior
MI, despite increased clinical signs of LV failure at dis-
charge in patients with early VF.
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Electrocardiography as a Prognostic Tool
PROGNOSTIC SIGNIFICANCE OF ISCHEMIC EPISODES ON HOLTER
MONITORING DURING DAILY ACTIVITIES: 2 YEARS FOLLOW-UP
OF 356 PATIENTS.
Alex Gavish MD, Dan Tziyoni MD, Dan Zin. Andre KerenMD,
Jesaia Benhorin MD, Shmuel Banai MD. Shlomo Stern MD,FACC.
Bikur CholimHospital. Jerusalem. Israel.
Many recent studies described transient ST depression du-
ring daily activities using Holter monitoring; however the
prognostic significance of these ischemic changes have not
yet been studied. In this study Holter monitoring during
daily activities was performed in 356 pts for evaluation
of chest pain. 211 were post MI; significant ST depression
was defined> 1 mm of horizontal type which lasted for a
at least 30-seconds.
Cardiac events were significantly more common in pts with
ST-lnlDd previous MI (30%), as comparedto post MI pts with
out ST~ (9%) p(O.Ol. In pts without infarct a very
high event rate (30%) was observed in those with STf dur-
ing the 2 years follow-up period, which was significantly
more frequent than those without STJ- (13%) P(0.025. The
event rate in this group was comparable to these of post
MI with ST~, and was significantly lower than those who
had infarct but no ST+during daily activities. It seems
therefore that in this population (which didnot include
pts with congestive heart failure) the presence of ST+on
Holter monitoring was a powerful predictor for cardiac
events (more powerful than previous MI). Thus, ischemic
changes on Holter monitoring carries a high risk for futu-
re cardiac events in pts with or without previuos infarct.
EVENT
PREVALENCE AND FREQUENCY OF VENTRICULAR ARRHYTHMIAS IN
THE TWO MONTHS FOLLOWING MYOCARDIAL INFARCTION
James Coromilas, MD, FACC, Toshio Akiyama, MD, FACC, Jef-
frey Anderson, MD, FACC, Lawrence FriedmanMD, Al
Hallstrom, PhD, Richard Henthorn, MD, FACC, Donna Kerns,
RN, Brian Olshansky, MD, Phil Reid, MD, FACC, James Reif-
fel, MD, FACC, Robert Stanyon, RN and the CAPS Investiga-
tors. ColumbiaUniversity, New York, N.Y.
Patients were eligible for the Cardiac ArrhythmiaPilot
Study (CAPS) if they had ~10 VPD/hour or ~5 runs of VT on
a 24 hr ambulatoryrecording (AR) done 6 to 60 days fol-
lowing an acute myocardial infarction (MI). By study
design, if patients did not have qualifying arrhythmias
on an initial screening AR (ARl) , a second AR (AR2) could
be done within the 60 day time window. Toevaluate the
role of spontaneous variability, patients who qualified
for the study on the basis of AR2 also had a third AR
(AR3) done that was used as the baseline. Three hundred
sixty-six patients had two screening AR done in the two
months following MI. ARl was done 10± 9 days following
MI and AR2 was done 35 ± 17 days (p<O.OOl) following MI.
From ARl to AR2, the mean VPD/hrincreased from 5.7 + 22
to 34.8 ± 177 (p < 0.01). Five percent (15/325) of pa.
tients had at least one episode of VT on ARl compared to
14% (47/339) on AR2 (chi-square-15.69, p<O.OOl). Forty-
one of the 366 patients had a AR3 done a mean of 6.7 + 9
days after AR2. In this subgroup as in the total group,
the mean VPD/hrincreased from 12.7 + 51 on ARl to 68.8 +
122 on AR2 (p<O.Ol). The mean VPD/hr onAR3 was 58.1 +-
99 which was increased compared to ARl (p<O.Ol) andun:
changed fromAR2 (p-0.65). Thus, the increase in VPD
frequency observed on AR2 was reproducibleon AR3. Of 38
patients who qualified on a AR2, 71% continued to meet
CAPS criteriaon AR3. In summary,there is a significant
increase in VPD frequency and the prevalence of VT in the
two months following MI. The optimal time to identify pa-
tients with ventriculararrhythmiasmay be one to two
months after MI ratherthan before hospital discharge.
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'llS'l'OOrn IRIDICl'.lmH:RW.ITYOF 008 B\TllNIS AFnR Il'ltCWlIAL
INF/lIlCl'lOO
RobertEo Kl.e1ger, H.D., F.A.C.C., J. RrllllpMUler, BoA., Rooal.d J.
Krme, H.D., F.A.C.C., J. 'lhaDas B188er, Jr., H.D., F.A.C.C. ao:i the
!'kJltlcenterIbst:1nfaIctlmResearchGroup
We hm! faDi that Iilart:Rate 1ilr1ab111ty(HR\')defined as the
stmrlmidev1atim of the R-R intezvsl in IlODIIi1sinJs rhytlJn ao:i
perlonllSDCe m a lai level. E!D!n:1se test pnrlictmortalityfallOOng
acute myocsrd1al1nfBn:t1m. S:Ince IRV IIBY be related to ex&c1Be
ab1lity the reIatialshipbeblee:l IIl.Vao:i oortalitystratifyingby
respallIe to 101( level. ex&c1Be test (m) _ emrlned.
008 patients lilo survived scute IIIyOCSIdial1nfBn:timhad 24 hwr
m:; reamI1ngs prior to dischsrge am 620 also had 101( level. m prior
to dischsrge. ThepatientslieI'l! .fol.loed a mean of 32omtha. IRV
recorded 00 the 24 boor m:; recording SDd e:xerclae test
claaa1f:1cat1.on; "etql1.etedtest" (1. 7., lot grade), "failedto
caupl.ete test", SDd "failed to take test" lieI'l!1IIEl89.II'ed. The
fallOOng table tshllatesmortalityfor each of the IIl.Vgroops >ben
atrat1fi.ed by status m lai level. m.
IRV
<50 50-100 >100
Status of m %!fti)/pt* %H P!2. %HD/P
lhJp1eted IT 3/'5l. 8:'519/233 3:'5W4
~te 3>.2 13/43 16.0 24/148 13.3 8/60
FlIiled to 1lIke 54.0 27/50 21..8 22/101 18.9 7/37
* %H • %!'k>rtal1ty,**D/p. # deattJs/#p1tients
This SIlB1ys1s cmfiIlllS that IRV is an 1IIIportantrisk factor
1nIepealentof the ex&c1Be ab1lity of the p1tient. IRV in
OOIirlnat1oo with m al10Its the 1£lent1f1catiooof a subgroop of 50
p1tientsat very~ r:ISt, mrtslity54%, aJllX'OXi.lmtelyfifteen times
h1gber than the mortalityof 3.51: in the 114 patients..mcaupl.eted
lai level. m SDd had IRV >100 11II.
FEATURES OF ISCHEMIA DURING DAILY ACTIVITIES IN PATIENTS
WITH AND WITHOUT PREVIOUS MYOCARDIAL INFARCTION.
Shlomo SternI MD, FACC, Alex Gavish, MD, Jesaia Benhorin,
MD, G10ra We1sz, Andre Keren, MD, and Dan Tzivoni, MD.
Bikur Cholim Hospital and Hebrew University-Hadassah
Medical School, Jerusalem,Israel.
We compared ischemic episodes (transientST depression
(t) ~ lmm, lasting~30 sec) recorded on 24-hour Holter du-
ring daily activity in 94 pts withoutprevious infarction
(group A) and in 97 post-MI pts (group B). In both groups
all pts had positive Bruce protocol treadmilltests.
All episodes were painful (P) in 23group Apts (24.5%)
and in 10 group B pts (10%; p <.05) . All episodes were
silent (S) in 43 group Apts (45.7%), while in group B 61
pts (63%) had purely S episodes, a differencestatistical-
ly NS. Both Sand P episodeswere observed in 2B group A
pts (29%) and in 26 group B pts (27%; NS). Average total
number of episodes/pt/day ingroup Awas 3.2 vs 2.9 in
group B(NS). Average number of S episodes in group Awas
2.1/day vs 2.2/day in group B(NS), but average number of
P episodes/pt/day ingroup Awas l.l/day vs 0.7 in group
B (p<.02). Average total ischemic period, including Sand
P episodes in group Awas 33 min/day and in group B 47 mini
day (p<.05). Total Sischemic period in pts with,only S
episodes in group Awas 24/min/day vs 45 min/day 1n group
B (p<.02). Average duration of a S episodewas 11.8 min
in group A vs 17 .2 min in group B (p=.05). The maximal
S1!, the heart rate at thebeginning and at maximal ST~
were not significantly different in the two groups.
Thus, post-MI pts are characterized byrelatively less
pts with only P episodes, smallernumber of P episodes/
day, longer S episodesand longer total Sischemic
period/day, ascompared to pts withoutprevious
infarction.
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Conc l usion : Ht TX patients show elevated basal plasma
ANP levels compared to normals ( 23 . 7+1.4 pg/ml ) and re-
spond to volume expansion by an increase in plasma ANP.
These data do not support the contention that ANP defic-
iency or inadequate response of ANP to volume expansion
is a mechanism in the development of post-Ht TX hyper-
tens ion.
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Blood Pressure Regulation
HYPERTENSION POST-CARDIAC TRANSPLANTATION: IS ATRIAL
NATRIURETIC PEPTIDE DEFICIENCY A FACTOR IN ITS
DEVELOPMENT?
Barry F. Uretsky, M.D., FACC, Srinivas Murali, M.D.,
Anita H. Valdes, RN, Judy A. Kolesar, RN, P. Sudhakar
Reddy, M.D.,FACC. University of Pittsburgh, PA.
It has been suggested that t he almost universal devel-
opment of hypertension post-cardiac transplantation(Ht
TX) in patients receiving cyclosporine and prednisone
immun osuppr e ssion is associat ed o r c a u s e d by a deficienc y
of c i r cul ating atrial natriuretic peptide (ANP, pg/ml).
To test this hypothesis, plasma ANP l e ve ls were measured
at ba seline (0 min ) and after (mi n) acute volume expans-
ion with 1000 ml of int r avenous normalsaline over 5 min
i n 6 Ht TX pat ients.
Time
( min)
o
5
15
30
RA, PAW=mean right atrial,
pulmonar y artery wedge
( mmHg) pr es sure s ;PV=% change
in plasma volume
p< * .05 , ** .01 vs B
.P.
ns
ns
ns
Sinus AF
LA Size-M-rnode (cm) 4. 8 ± 0.7 4. 8 ± 0.6
LA Ar ea-2D (cm2) 27. 9 ± 4 . 7 24.4 ± 6. 9
Ri ght Atrial Area-2D (cm2) 23. 5 ± 4.7 2L. l ± 5.7
Mitral Annular Size (cm) 4. 0 ± 0. 5 3. 7 ± 0 . 5
We therefore concl ude: 1) one third of patients with AF
remain in sinus rh ythm long-term after CV; 2) no cl i ni cal
or M-mode/2D echo var i abl es can predi ct shor t or long-term
success of CV.
CLINICAL AND ECHOCARDIOGRAPHICVARIABLES FOR PREDICTING
SHORT AND LONG-TERM SUCCESS AFTER CARDlOVERSION OF ATRIAL
FIBRILLATION.
J oel Erickson, M.D., Thomas Savides, Todd Schneiderman,
Robert Blaeky, H. D. , Pascal Nicod, M.D. and Howard
Dittrich, M.D., UCSD Medical Center,San Diego, California.
Left atrial (LA) size assessed by M-mode echo cardiography
(echo) and durationof atrial fibrillation (AF) have pre-
viously been shown to predict success of electrical cardi-
aversion (CV) in selected patients with AF. To further
assess this and the value of two dimensional echo (2D), we
analyze d a large number of clinical, 20 and M-mode echo
var i abl es ga t her ed from 82patients (mean age ± SD:63 ± 12
year s) wi th AF due to multiple etiologies (hyper t ens i ve
35%, alcohol ic 23%, valvular 13%, idiopathi c 16%, pos t op-
erative 13%. cor onary artery disease 18%) who underwent
elect ive CV. Sinus rh ythm was obtained in 76% of th e pa-
t ients initially. and was still present i n 54% and 32%at
30 and L80 days, respectively. No clinical var iabl e i nc l u-
di ng etiology , functional status, age , sex , digoxin level
or dur a tion of AF prior t o CV was predictive for short or
long-term mai nt enance of sinus rhythm. 31%with AF dur a-
t io n ~ 3 mont hs re mained in sinus rhythm at 180 days com-
pared t o 32%wi t hAF duration >3 month s (ns) . M-mode and
2D echo mea sur ement s weresimilar i n patien t s remaining in
sinus rhythm at 180 days compared t othose who reverted t o
AF :
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EFFECTS OF B-ADRENERGIC STIMULATION ON ATRIAL NATRIURETIC
FACTOR AND PLASMA RrnIN IN THE OCG
DieonarElsner, M.D., Harald J. Hollnberger, EckhardP.
Krarer, M.D.,GUnter A.J. Riegger, M.D., Medizin. Univ.
Klinik, Wlirzburg, FRG
To canpare theinfluence of B-adrenergic stinulationon the
release of atrial natriureticfactor (ANF) and of renin, we
studied the changes in ANF and plasmarenin concentration
(PRC) induced by the B-agonistisoproterenol (ISO) in an-
esthetized dogs. ISO (10 and 30 ng/kg/min,n:l7) increased
heart rate from131+3/min to 149+5 and 163+6, dp/dt from
1964+168 nmHg/s to 1041+256 and1829+347, and arterialPRC
from-2.72+.68 ng AI/hto 7.71+1.98 and 12.94+3.47. ISO 30
ng/kg/min-significantlyreduced arterialANF-(from 12.0+112
pg/ml to 9.74+.59) and coronary sinusANF (from 19.14+2./3
to 12.96+.79)~ Unselective B-blockade(propranololO~l rng/
kg, n:9)-significantly attenuatedthe increases in heart
rate, dp/dt and PRC, shifting the dose response curves to
the right (ISO 30, 100 ng/kg/min: HR from123+5 to 125+5
and 153+9; dp/dt from1689+208 to 2122+273 and 3056+30/;
PRC from 4.64+.74 to 3.73+~85 and 7.92+2.01). In contrast,
B -selective blockade (metoprolol 0.1Dig/kg, n:8) only
slightly, but not significantly attenuatedthe increase in
PRC, yet significantly attenuatedthe increases in HR and
dp/dt (ISO 30, 100 ng/kg/min: HR from121+5 to 143+9 and
165+10; dp/dt from 1675+146 to 2925+336 and4025+413; PRC
from 3.70+1.08 to 7.25+1.48 and 11.10+2.73). Bothblackers
did not significantly Influence basal-ANF nor the ISO-in-
duced decrease inarterialand coronary sinusANF (ISO 100:
aorta: 10.13+.93 to 8.90+.89, propr.; 11.18+1.54 to 9.80+
.82, metopr.;cor.sinus:-17•88.:!:.l.74 to 1l.5b.:!:.l.05, propr'T,
19.0+2.81 to 11.39+.63, metopr.). Conclusions: 1. Thereis
no evidence that the B-adrenergicrelease of renin is medi-
ated predominantly byBl-adrenoceptors.2. ANF release is
not stinulatedby B-adrenoceptoractivation.
CARDIOVASCULAR-RENAL RESPONSES TO PHYSIDLDGIC
CONCENTRATIONS OF ATRIAL NATRIURETIC FACTOR (ANF).
Robert S. Zimmerman, M.D., John S. Schirger, Brooks S.
Edwards, M.D., Denlse M. Heublein, Thomas R. Schwab,
M.D., and John C.Burnett, Jr., M.D., Mayo Medical
School, Rachester, MN
We have previously demonstratedthat during 0-10% body
weight saline volume expansion, plasma ANF increases
(i.e., control, 65+10 pg/ml; 3.3%, 98+8 pg/ml; 6.6%,
143+31 pg/ml; and 10%, 154+25pg/ml).- The present study
evaTuated the cardiovascularand renal responses to
a-hANF at doses which mimic the physiologic levels of ANF
observed during volume expansion and at pharmacologic
levels in pentobarbitolanesthetized dogs (n=10).
ANF dose ANF MAP PCWP RAP C.O. UN V~g/kg/min pg/ml mmHg mmHg mmHg L/min ~E~in
Control 68+8 120+4 2.4+.5 -1.3+.4 4.5+.4 22+6
.0025 100+8* 120+4 2.1+.6 -1.6+.4 4.2+.4 66+15*
.005 163+18* 121+4 1.9+.6 -2.2+.5* 3.9+.4* 131+26*
.01 282+22* 120+4 1.6+.6* -2.3+.5* 3.6+.3* 171+26*
- * -* - * - * - * - *.3 519+35 106+4 1.2+.7 -2.2+.5 3.1+.3 397+151
Recovery 70+10 120+4 1.9+.5 -2.5+.5* 2.9+.3* 70+9*
*p<.05 com;>ared to control - - - -
Arterial pressure was maintaineduntil the highest dose
due to an increase in systemic vascular resistance. The
present study demonstrates1) ANF does not significantly
affect systemic blood pressure at physiologic levels, 2)
a natriuresisis observed at the lowest dose of ANF
infused, a dose which approximatesphysiologic increases
in ANF during volume expansion; and 3) although in the
physiologic range, a greater increase in plasma ANF is
required to decrease PCWP, RAP and C.O. than is required
to increase sodium excretion (UNaV), This study supports
the conclusion that ANF is an importantphysiologic
regulatorof renal and cardiovascularfunction.
EFFECT OF ATRIAL NATRIURETIC PEPTIDE ON
CORONARY BLOOD FLOW AND MYOCARDIAL
PERFORMANCE
Georg Ertl, M.D., Rlidiger Jacob, Kurt Kochsiek, M.D., Medi-
zinische Klinik,UnlversltatWlirzburg, FRG
Elevated plasma levels ofatrialnatriureticpeptide (ANP) have
been reported in patients with ischemic heart disease. We
tested the direct coronary andmyocardialeffects of ANP in 9
anesthetized dogs. LAD was cannulatedand perfused at mean
aortic or a reduced (35 mm Hg)pressure.Coronary blood flow
(CBF) was measured with anelcetromagneticflowmeter, sub-
endocardialmyocardial segmentshorteningby implantedultra-
sonic crystals. When morphin (3 mg/kg s.c.) was added to
anesthesia, ANP had nomeasurableeffect on CBF and myocar-
dial segment shortening at doses of I ng - I Jug/kg i.c, In
chloralose urethaneanesthetizeddogs, ANPactedas a coronary
vasoconstrictor,however, with strongtachyphylaxis. At normal
coronary pressure, CBF fell following the injection of I ng/kg
into the coronary cannula from 83+ III to 57+ 10 ml/min per
100 g (p 0.05) and at lowcoronary-pressure, when myocardial
lactate production indicated ischemia, from 21 + 8 to 16 + 8
ml/min per 100 g (p 0.05). Thepercent decrease in CBF-at
normal coronarypressure (-20 + 15%) was not significantly
different from that at low coronary pressure (;311 + 10%).
Systemic effects of ANP were not foundindicated by unchan-
ged aortic and left ventricularpressure,dP/dt and heart rate.
ANP reduced segment shortening in distributionof the cannu-
lated LAD from 13.8 + 3.11 to 12.8 + 3.6% (p 0.025) but not
segment shorteningoutside the distributionof the LAD. Since
this cardiodepressenteffect was not found duringsimilar coro-
nary constrictionby leukotrieneC11 and D11' angiotensin I or Il,
and vasopressin, a direct action of ANP is suggested. In
conclusion, exogenous ANP reduces CBF at normalcoronary
perfusion and during myocardial ischemia and may have a mild
directly negatively inotropiceffect. Its action istachyphylactic
and notpresentfollowing applicationof morphin.
PARADOXICAL CUTANEOUS VASODILATION WITH MENTAL STRESS OR
DEEP BREATH. John P. Cooke, M.D., Ph.D. and John T.
Shepherd, M.D., D.Sc., Mayo Clinic, Rochester, MN.
Mental arithmetic (MA) and deep breath (DB) induce
nervously mediated constriction of cutaneous vessels.
However, using plethysmographyto measure hand blood flow
(HBF) we have observed paradoxical vasodilation to these
maneuvers in women. To confirm these findings, and to
determine if the pre-existing level of sympathetic tone
modulates the response to MA and DB, HBF was measured by
plethysmographyin 6 men and 5 women. Skin perfusion (SP)
of a finger was monitored simultaneously by laser doppler
flowmetry. At rest, men had greater HBF (14.5+ 2.3 vs
2.8 + 0.4 mI/lOO ml/min. p<.005). During MA, male HBF
declined whereas female HBF rose (65 + 16% of resting
flow vs 212 + 64%, p<.05). After DB,-male HBF fell
whereas female HBF increased (45 + 8% of resting flow vs.
191 + 32%, p<.Ol). At rest men had greater SP than
women (270 + 42 vs 81 + 16 perfusion units, p<.005). MA
and DB induced a transient fall, followed by an increase
in SP in both groups. In men, the vasoconstrictionpre-
dominated; SP fell with DB (to 130 + 40, p<.02). In
women the vasodilation predominated;SP rose after DB (to
177 + 30, p<.02). To increase sympathetic tone men were
exposed to 5 minutes of total body cooling; HBF and SP
fell (to 1.4 + 0.2 mI/lOO ml/min and 106 + 22 perfusion
units. Under-these conditions, HBF rose with MA and DB
(to 2.5 + 0.4 and 4.2 + 0.4 respectively, p<.OS). After
DB, SP transientlydropped (to 64 + 17, p<.02) but then
rose (to 202 + 34, p<.Ol). We conclude that young women
have lower skin perfusion than young men under normal
environmentalconditions. MA and DB predominantlyinduce
cutaneous vasoconstriction in men, but vasodilation in
women. This differential response appears to be modula-
ted by the level of sympathetic tone.
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ENHANCED HYPOXIC PULMONARY iASOCONSTRICTION IN HYPERTENSION.
Maurizio D. Guazzi, MD,CesareFiorentini, MD, Claudia Galli, MD, Gloria
Tamborini, MD, Institute of Cardiology and CNR, University of Milan,Italy
The pulmonaryvessels in systemic hypertension show an excessive tone
in the baseline and respond with vasoconstriction to activation of the
adrenergic system. A vascular hypersensitivity to catecholamines is
pr-cven; this might take origin from differences in the receptor popula-
tians or in the bi cche ai stry of the excitation-contractioncoupling.
Hypoxic pulmonaryvasoconstriction is currently interpretedas a local
phenomenon mediated through thelatter of these mechanisms. Theresponse
of the lung vessels to the hypoxic stimulus in hypertension might be
viewed as a means to discern the causes of the disordered vasonoti l i t y •
We investigated 9 normotensive (Nt.) and 21 moderate untreated primary
hypertensive (Ht.) subjects. In them the pulmonaryarteriolarresistance
(PAR), derived from the ratio of the driving pressure (mean arterial
pressure - lIIean wedge pressure) and blood flow through thelungs, has
been evaluated during air respiration and 10 min after starting to
breath three subsequent hypoxic gas mixtures consisting of 17, 15, 12%
oxygen and 83, 85, 88% nitrogen, respectively. At each step arterial
P0
2
(mm Hg) was as follows: Nt. • 98, 93, 78, 56; Ht• = 96.5, 94, 76,
56.4. The corresponding values of PAR (dynes) were: Nt. =55, 58!.3},
62(+7) , 68(+13); Ht. .66, 77{.9), 89(.21), 112(.44). Groupdifferences
as regards absolute. values and variations from baseline {in parenthesis}
were statistically significant at each period, and were abolished by
calcium entry blockade with ni fe dip i ne.
If hypoxic puhonary vasoconstriction is a local phenomenon deriving
from an increased membrane permeability to calcium or transmembrane
transportof the ion as a direct consequence of hypoxia, then these
findings suggest that systemic hypertension involves the lesser circula-
tion and emphasizes vasoaot i on possibly through aninterference with
calcium handling and the mechanisms ofvascular contraction.
EXERCISE-RELATEDDIASTOLIC DYSFUNCTION IN PATIENTS WITH
HYPERTENSIVE LEFT-VENTRICULARHYPERTROPHY
T. P. Rocco, M.D., J.L. Isaacsohn, M.D., J.M. Healy, M.D.,
M. IIackett, C.N.M.T., D.E. Tow, M.n, A.J. Kemper, M.D"
FACC, A.F. Parisi, M.D., FACC, VAMC West Roxbury, MA.
Previous studies have reported abnormal resting diastolic
function in hypertensives with Left VentricularHypertrophy
(LVH). We examined the hypotheses that: 1. diastolic dys-
function might precede t he development of LVH and provide
an early index of hemodynamically significant pressure load
ing; 2. exercise should magnify any diastolic abnormalities
detocted in the resting state. Il-mode and two-dimensional
echocardiograms,and gated-acquisitionradionuclideventric··
ulograms (RVG) were obtained in 19 asymptomatic patients
with untreated systemic hypertension. LV wall thickness was
used as an index of LVH; peak and average LV filling rates
(PFR and AFR) were derived at rest and during each stage of
a graded supine ergometry exercise protocol. Time to PFR
(TPFR) was derived for the resting study. Exercise RVG stu-
dies were performed in 10 normal control subjects. We
found that: 1. resting PFR, AFR, andTPFRfailed to distin-
guish normals from patients with hypertension irrespective
of the presence/absenceof LVH; 2. PFR at peak exercise
distinguish normals and hypertensiveswithout LVH (Group I,
n=17) from hypertensives with LVH (Group 11, n=12): mean
!'FR, Group 1=6.6 1'hd-diastolic volumes/sec, Group II=4.3
End-diastolic volumes/sec. (p~ .05). Similar separation was
noted if AFR was substituted for PFR (p<.OOl).
We conclude that radionuclidederived indices of diasto··
lie dysfunction are an epiphenomenon of the presence of
LVH. We failed to corroborateprevious reports which des-
cribe resting abnormalitiesof diastolic function in hyper-
tensives with LVH. Alternatively, our data suggest that ex-
ercise is required to unmask limitation of diastolic fil-
ling reserve in patients with LVH and normal systolic func-
tion.
Although MAP and afterload rose to pretreatmentvalues
after regression of LVH and discontinued therapy, the left
ventricle exhibited well-preserved function and
contractility.Thus, regression of LVH by antihypertensive
therapy may improve cardiac performance in essential
hypertension.
N.S.
<0.03
<0.06
<0.05
p value
<O~
N.S.
B2
21"'14
114~3
195+7
1.28+0.07
66+2
2.6+0.16
199+8
1.18+0.06
62+2
2.3+0.15
pressure) -
LVM (g)
MAP (mm Hg)
Aft3rload 2(10 dynes/cm)
Vcf (o i r-cZs)
EF C%J
ESWS/ESVI (units)
(MAP=mean arterial
CARDIAC PERFORMANCE IMPROVES AFTER REGRESSION OF LEFT
VENTRICULAR HYPERTROPHY (LVH). Roland E. Schmieder, M.D.,
Dawn Sturgill, GUillermo E. Garavaglia, M.D., Soris D.
Nunez, M.D., Franz H. Messerli, M.D., F.A.C.C., Alton
Ochsner Medical Foundation, New Orleans, LA.
To study left ventricular (LV) function after
regression of LVH by antihypertensivetherapy, we studied
14 patients with essential hypertension and early LVH. LV
function and structure were assessed with M-mode echo-
cardiographyafter a drug-free interval of 4 weeks (B1).
Subsequent reduction of left ventricular mass (LVM) was
induced by 20 months of antihypertensive therapy.
Thereafter, antihypertensivetherapy was withdrawn for 4
weeks and echocardiography repeated (B2). Afterload was
determined by peak systolic wall stress, LV function by
ejection fraction (EF) and velocity of fiber shortening
(Vcf) , and myocardial contractility by end-systolic wall
stress/end-systolic volume index (ESWS/ESVI). Results
were as follows (Mean ~ SEM):
B1
246+18
115~2
ABNORMAL LEFT VENTRICULAR RESPONSE TO EXERCISE IN ESSEN-
TIAL HYPERTENSION: RELATION TO OBESITY AND ECCENTRIC LEFT
VENTRICULAR HYPERTROPHY.
James Blake, M.D., Richard B. Devereux, M.D., F.A.C.C.,
Jeffrey S. Borer, M.D., F.A.C.C., John H. Laragh, M.D.,
F.A.C.C., Cornell Medical Center, New York, NY.
Thursday,March12, 1987
10:30AM-12:00NOON,Room 14, Second Level
Hypertension:VentricularFunction
Abnormal LV functional responses to exercise have been
revealed in up to 1/3 of pts with essential hypertension
(EH) by rester) and exercise(ex) radionuclide cineangio-
graphy(RNCA). Toelucidate the determinantsof this
abnormal response, we related ex ejection fraction(EF) by
RNCA to demographic, clinical and echo variables in 134
pts with uncomplicated EH. The 24 pts with subnormal EFex
(EFex:54, group 1) did not differ from the 110 with normal
ex EF (group 2) in mean age (51 vs 49 years) or blood
pressure at rest (161/107 vs l62/l04mmHg) and at peak ex
(219/126 vs 223/124 mmHg) but were more obese (191 vs 170
lbs, p:0.005) and 2ad more severe LV hypertrophy (LV mass
l19±50 vs 95±36g/m , p:0.03) in an eccentric pattern (LV
internal dimension=5.5±0.7 vs 4.8±0.5cm, p:O.OOl)
associated with a higher cardiac output (6.3±2 vs
5.3±14/min, p:.03) and lower peripheralresistance. The
eccentric hypertrophydid not adequately offset the
pressure overload in group 1 pts, allOWing end3systolic ~Vwall stress to be higher (107±40 vs 69±24 x 10 dynes/cm,
p:O.OOl), with lower EFr (44±7 vs 58±8, p:0.001) and
fractional shortening (29±8 vs 38±6, p:O.OOl) and an
increase in end systolic LV volume at end ex (group 1:
110±45% of r volume vs group 2: 80±25%, p:0.001). In
conclusion, among pts with uncomplicated EH abnormal
functional responses to ex are strongly associated with
obesity and eccentric LV hypertrophy. These data suggest
that addition of the volume overload of obesity to the
pressure overload of EH is a major contributorto abnormal
ex LV function in many pts with uncomplicated EH.
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PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC
FILLING ABNORMALITIES IN ELDERLY PATIENTS WITH ISOLATED
SYSTOLIC HYPERTENSION.
Anthony C. Pearson, MD, Rau Gudipati MD, Jerome Cohen, MD,
FACC, Denise Mrosek, Arthur J. Labovitz, MD, FACC. St.
Louis University School of Medicine, St. Louis, MO.
Although left ventricularhypertrophy (LVH) and
abnormalities of LV diastolic filling are well-documented
in patients with systemic hypertension their prevalence in
patients with isolated systolic hypertension is unknown.
To assess this we performed Doppler echocardiography
(echo) on 15 participantsin the Systolic Hypertension in
the Elderly Program (SHEP) prior to randomization to drug
therapy. The patients had been off medication for at
least three weeks and had a meanBP of 162/81 + 7/10.
There were six male and nine female subjects with a mean
age of 73 (range 62-87). The meanLV mass as calculated
using the Penn convention formula was 128 + 41 g/M2 and
LVH by echo was present in 8/15. ECG crit;ria for LVH
(Estes-Romhilt) was present in only one patient. Pulsed
Doppler interrogationof diastolic trans-mitralflow was
performed from apical views and the ratio of peak early to
peak atrial (PE/PA) velocities along with the %atrial
contribution to LV filling (% AC) recorded. PE/PA was
.70~.16 and abnormal LV diasotlic filling, defined as
PE/PA < 1.0, was present in 14 of the 15 subjects. %AC
was (38+6%) and an increased %AC (>30%) was present in
14/15 subjects.
We conclude that elderly patients with isolated
systolic hypertension have (I) a high prevalence of LVH
which is frequently not detected by ECG, (2) striking
abnormalities of LV filling which may be related partially
to age and partially to systolic hypertension and (3) a
marked dependence onatrial systole for LV filling.
CHANGES IN WALL THICKNESS BUT NOT LEFT VENTRICULAR MASS
PREDICT IMPROVEMENT OF DIASTOLIC FILLING IN HYPERTENSION
Julio F. Tubau, M.D., Jadwiga Szlachcic, M.D., Alan
Hirsch, M.D., Barry M. Massie, M.D., FACC. VAMC and
University of California, San Francisco, CA.
Patients (PTS) with hypertension and left ventricular
hypertrophy(LVH) display abnormalities of diastolic
filling of the left ventricle. To assess the effect of
LVH reversal on diastolic function we studied 18
hypertensive PTS with ECHO evidence of LVH (posterior
wall thickness, (PWT) ~ l.lcm). prs were treated with
propranolol(p), or labetalol {L)in a randomized, double
blind protocol. Blood pressure, heart rate, and
radionuclide ejection fraction, end-diastolic volume
(EDV), peak filling rate (PFR) and normalized first 1/3
filling fraction (NFFl/3), were measured at baseline and
after 6 months of therapy. Blood pressure was reduced
significantly and equally by both drugs. PWT decreased
with P (1.12 + 0.1 vs 1.06 + O.IOmm) and L (1.13 + 0.11
vs 1.04 + 0.10mm) both p<~05. Left ventricula; mass
(LVH) was-reduced by P (303 ± 46 vs 272 ± 67 gm, p<.05)
but not by L (279 + 47 vs 271 ± 45 gm, p=NS).
Propranolol(n=ll) Labetalol(n=7)
Baseline 6 mos Baseline 6 mos
HR(bpm) 67 + 4 60 + 2* 62 + 2 60 + 3
EF(90) 64 +2 69 +2* 66 +3 67 +2
EDV(ml) 133 +6 132 +8 136 +8 141 +2*H
PFR(EDV/sec) 2.6 +0.1 2.9 +0.4* 2.5 +0.2 2.9 +0.3*
NFFl/3(~) 37 +2 44 +3* 38 +5 44 +2*
* p.05 vs Baseline; Hp.05 -labetalol vs propranolol
LVH/EDV was unchanged by P(2.2 + 0.4 vs 2.3 + 0.4) but
was reduced by L (2.2 ± 0.4 vs 1.9 ± 0.3,p<.025) Thus,
PWT changes predicted the improvement of diastolic
filling after therapy. PTS who did not decrease their
LVH reduced their LVH/EDV suggesting an improvement of
chamber stiffness.
RIGHT VENTRICULAR ADAPTATION IN OBESE HYPERTENSIVE
PATIENTS.
Boris D. Nunez, M.D., Franz H.Messerli, M.D., F.A.C.C.,
Guillermo E. Garavaglia, M.D., Roland E. Schmieder, M.D.,
Celso Amodeo, M.D., and Edward D. Frohlich, M.D.,
F.A.C.C., OChsnerMedical Institutions, New Orleans, LA.
Hypertensionand obesity affect both the left (LV) and the
right (RV) ventricle. To evaluate the effects on the RV,
M-mode echocardiography was performed in 30 lean (body
mass index < 24 kg/m2) and 47 obese (body mass index
>30 kg/m2) patients categorized as follows (mean! SEM):
NORMOTENSIVES HYPERTENSIVES
Lean (17) Obese (23) Lean (13) Obese (24)
95+2 94+6 116+3 11S+4
0.88+0.1 1.1+0.0S* 0.96:;0.1 1.2:;0.07*
4.34:;0.06 4.9+0.S* 4.3:;0.S S.1:;0.1*
0.36:;0.06 0.38+0.07 0.49+0.1S+ 0.S1+0.1t
2.1!0.1 2.4!0.S* 2.1:;0.S+ 2.6~0.1*
LWT, RWT: Left and right ventricularwall thickness.
LVDD, RVDD: Left and right ventriculardiameters.
*Lean vs obese (p < O.OS), +lean vs lean (p <0.001), tobese
vs obese (p <0.001).
When compared with lean normotensives, obese individuals
have increased LV wall thickness, greater left and right
ventriculardiameters, but similar right ventricularwall
thickness. Thus, dilatation of both ventricles with
hypertrophy of the LV is the adaptive mechanism to
obesity. When hypertension is associated, these changes
are even more pronounced. In contrast, lean and obese
hypertensives have an increase in right ventricular wall
thickness; therefore, the coexistence of hypertensionand
obesity places a dual load not only in the left but also in
the right ventricle. This could explain why right
ventriCUlar and left ventricular hypertrophy as well as
heart failure are more common in obese hypertension.
Thursday, March 12, 1987
8:30AM-I0:00AM, Room 41, Second Level
Ventricular Tachycardia: Drug Treatment and
Toxicity
PROPAFENONE IN VENTRICULAR TACHYARRHYTHMIAS:
LONG-TERM CLINICAL EFFICACYAND PREDICTIVE VALUE
OF PROGRAMMED ELECTRICAL STIMULATION, HOLTER
MONITORING AND EXERCISE TESTING.
Thierry Dugernier MD,Pedro Brugada MD,Paolo Della
Bella MD, Mario Talajic MD, Robert Lemery MD, Jan
Heijmeriks, Hein JJ Wellens MD, FACC, Dept. of
Cardiol.,Maastricht,TheNetherlands.
To a s s e s s clinical efficacy (CE) of propafenone
(P) and the value of programmed stimulation (PS),
Holter monitoring (H) and exercise ECG (ET) in
predicting therapeutic results, 33 malea and 15
females (mean age ± SD:53±16 yeara) with sponta-
neous and symptomatic ventricular tachyarrhyth-
mias{VT) were studied. 11 pt s had non-sustained
monomorphic ventricular tachycardia (NSMVT), 30
SMVT and 7 ventricular fibrillation (VF). P was
given using the minimal dose{D) at which no symp-
tomatic VT occurred while on continuous ECG moni-
toring.To analyze their predictive value{PV) and
"efficacy" (defined as no arrhythmiaon P) PS, H
and ET were repeated on P without using results
of these tests to modify treatment.
Results: given in % for arrhythmic death (AD),
recurrences{R) and CE.
% "Efficacy" mean
Nr pts PES H ET AD R CE D{mg)
NSMVT 11 20 70 100 0 9 91 471
SMVT 30 17 52 50 3 40 60 588
VF 7 0 33 0 0 14 71 664
The (+) PV of PES, H and ET was respectively 29,
40 and 40%; the (-) PV was respectively 100, 73
and 86%. Conclusions:l.- The arrhythmia-freesur-
vival rate on P was 69% after a mean follow-up of
23 months. 2.- R rate was 29% with only 1 AD. 3.-
PS,H and ET underestimateclinical efficacy of P.
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EFFICACY OF FLECAINIDE I N THE TREATMENT OF SUSTAINED
VERSUS NONSUSTAINED VENTRICULAR TACHYCARDIA
Imra nNiazi, MD, Patrick Tchou, MD, Mohammad Jazayeri,
MD, NaZlh Radrl, MD, Imad Elkhatib, MD, Rehan Mahmud, MD,
FACC, Ste~hen Denker, MD, FACC, and Masood Akhtar, MD,
FACC. Unlversity of Wisconsin, Milwaukee, Wisconsin.
Flecainide (F) has been used to suppress sustained and
nonsustained ventricular tachycardia (VT-S and VT-NS)
eVen in patients (PTS) refractory to treatmentwith Type
I-A agents. We evaluated the use of F in 2 groups (GP)
of PTS: 1) PTS with inducible monomorphic VT-S and 2) PTS
with cl inical VT-NS or symptomatic high grade ventricular
ectopy.
GP 1 i ncl uded 9 mal es and 1 female with a mean age of
61.0 + 10 years. Of these 10 PTS, 9 had cor onary artery
disease (CAD) and 1 had cardiomyopathy. ~ PTS were
treated wit h yUinidine at a mean dose of 1.3 + U.2 gm
yui ni di ne base/day, and 2 PTS were treated with
Procainamide at a dose of 4 9m1day. VT-S continued to be
inducible in all 10 PTS desplte treatment. Each PT was
t hen treated with F at a mean dose of 290 + 87 mg/day.
All PTS continued to have inducible monomor phi c VT-S.
GP 2 included 5 males and 3 females with a mean age of
64.7+14 ¥ears. Only 4 PTS in GP 2 had CAD; the remainder
had cardlomyopathy(1), mitral valve prolapse Ill, and no
structuralheart disease (2) . On baseline
electrophysiologic evaluation, no PT had inducible VT-S,
but VT-NS was i nduci bl e in 5 out of 6 PTS. 3 PTS were
then treated wi t h other Type I - Aagents, without
suppression of clinical arrhyt hmias. l Pr i or to s t arting
F, drug aggravation of arrhythmias occurred i n 2 of these
PTS.) All 8 PTS were then treated with F. suppression
of clinical arrhythmiasand relief of symptoms was
achieved in each case, and no aggravation of i nduci bl e
ventriculararrhythmias was noted.
CONCLUSIONS : 1) F has a low degree of eff icacy in t he
treatment of i nduci bl e VT-S, particularly i n PTS who have
already failed treatmentwith Type I-A agents . 2) In
contrast, F is very effectiVe in suppress i ng clini cal
VT-NS and symptomatic ventriCUlar ectopy.
EFFECTIVENESS OF MAGNESIUM SULFATE IN TORSADE DE POINTES:
A STUDY OF 9 PATIENTS.
Shmuel Banai MD , Dan Tzivoni MD, Claudio Schuger MD,
Jesaia Benhorin MD, Jacob Klein MD, Adrian ChenzbraunMD,
Shmuel Gottlieb MD, Andre KerenMD, Shlomo Stern MD,FACC.
Bikur Chol im Hospital and HebrewUniversity-Hadassah
Medical School, Jerusalem, Israel.
Previously we reported our experience in 3 pts successful-
l y treated with MgS04 for Torsade de Pointes (TdP) . We r e-
port here our extended experience in 9 consecutive pts i n
whom MgS04 was gi ven . Four pt s had IHO, 2 had val vul ar di -
sease, 2 suffered from SVTs and 1 had no or gani cheart di-
sease. QT prolongation prior to the TdP was present in al l
patients and was caused in 4 tts by a type la antiarrhyth-
mic drug alone, in 1 by Amiodarone alone, in 2 by combina -
tion of Amiodarone andtype la drug, in I by Imipramine,
and in 1 i ts cause was unknown. 5pts were hypokalemic (K<
3. 5 mmol/l ) and hypomagnesemia was present i n 2 out of 4
pts in whom Mg levels were available. QT interval immedia-
tly prior to TdP was 0.54-0 . 72 sec. (mean 0.62 sec) and
QTc was 0.53-0.83 sec (mean 0.64 sec). 7 pts had syncope
before any therapy was begun.
Two pts received Lignocaine infusion before the diagnosis
of TdP was made, this therapy was ineffective in both.
MgS04 was gi ven in 4 pts after conventional therapy (car -
diac pacing, Isoproterorol) either failed or was only t r an-
siently successful; i n 5 MgS04 was given as the first choi-
ce. All pts responded immediatly to 2-6 gr of i.v. bolus
and in 7 pts this was fol l owed by 5- 20 mg/ mi n i. v. infu-
sion of MgS04 . No reccurence of TdP was observed in any pt .
No complications were observed. QT and QTc intervals did
not change significantly immediatly after terminationof
TdP.
Conclusion: MgS04 was found to be safe and effective the-
rapy for TdP with QT prolongationand should be considered
as first line of therapy in TdP.
A PLACEBO-CONTROLLEDSTUDY OF THE PROARRHYTHMI C EFFECTS
OF CU.SS I ANTIARRHYTHMIC DRUGS
Thomas Bigger, MD , FACC; Raymond Woosley . MD , FACC; Dan
Roden, MD , FACC; Al Hallstrom, PhD , FACC; Debra Echt , MD,
FACC; Lean Greene, MD , FACC; Laura Butler, RN; and the
Cardiac ArrhythmiaPilot StUdy Investigators.
Columbia University, New York, NY.
Uncontrolled studies using 24-hour ECG recordings (24 -h-
ECG) suggest a 10~ incidence of aggravation of sustained
ventriculararrhythmia (VA) during treatment with any
Class I antiarrhythmic drug (AAD ) . The Cardiac Arrhyth-
mia Pilot Study (CAPS) compared four acti ve Cl ass I AAD,
encainide. flecainide, imipramine, and moricizine (402
patients) Wi th placebo treatment (100 patients) for t he
i nc i dence of proarrhythmia (PROARR) i n patients with un-
sustained VA after myocardial infarction. During
drug/dose finding, doses were increased no more of t en
than 5 days . PROARR was defined as a marked i nc r easein
the frequency of unsustai ned VA (decreasing from 10 fol d
to about 3 f old depending on baseline VA frequency) or
appearance of a new sustained VA during drug/dose findin g
or during follow-up. To search for PROARR, a 24-h -ECG
was done on each dose of each drug during drug/dose f i nd-
ing and every 3 months during a 12 month follow-up . In
CAPS, detection of PROARR obligated drug washout and a
repeat 24-h-E CG af t er washout to confirm the PROARR
response. Of 815 24-h -ECG done in the active treatment
arms, 32 (3 . 9 ~) met the criteria for PROARR; 44% of th ese
were not confi r med by drug washout. Of 324 24-h -ECG done
in the placebo arm, 25 ( 7 . 7 ~) met the criteria fo r
PROARR; 76' wer e not confirmed by drug washout . These
data sugges t : (1) that PROARR is uncommon in pos t infarct
patients with uns us t a i nedVA when dose increases ar e made
at ~5 days interv al s and (2) that drug washout is a help-
ful maneuver for documenting PROARR responses to Cl ass I
AAD.
INCIDENCE OF VENTRI CULAR TACHYCARDIA OR VE~~RICULAR
FIBRI LLATION AS PROARRHYTHMIC EFFECTS DURING DRUG
TREATMENT OF VENTRICULAR ARRHYTHMIA.
Marshal S. St ant on , M.D., Er i c N. Prystow sky, M.D.,
F.A.C.C., Naomi S. Fineber g, Ph.D., Wi1liam M. Miles , M.D.,
F.A.C.C., Douglas P. Zi pes, M.D., F. A.C.C. , JamesJ. Heger,
M.D., F.A.C.C., Krannert Inst. of Cardiol ogy, Indiana Univ.
Sch. of Med. , VA Medica l Center, Indianapolis, IN.
Proarrhythmi c effects (PROA) of antiarrhythmic drugs have
a vari able incidence and def i nition . In this s t udy, reoxds
of 412 pat i ents (pts) receivi ng 1080 dru g tri a l s f or treat-
ment of ventricular tachyca rdia (VT) or ventricular f i br i l-
lation (VF) were reviewed fo r evidence of PROA, def ined as
a new, symptomatic VT or VF that aba t ed when therapy
cea sed . Categories of PROA included r epetitive VT-repeated
salvos of VT ; incessan t VT-continuous VT res is tanr to or
immediately r ecurring after termination ; polymorp hic VT and
VF. PROA occurred in 33 of 412 pts (8.0%) and 43 of 1080
trials (4.0%) . The pr evalence of PROA fo r each drug was
encainide 13/ 108 (12%), flecainide 2/23 (8 .7%), c1benzol1ne
2/23 (8.7 %), propafenone 8/129 (6.2%), amiodarone 11/204
(5.4%), apr i ndi ne 3/97 (3.1 %), mexiletine 1/ 82 (1.2%),
quinidine 2/17 1 (1.2%), disopyramide 1/97 (1. 0%) while no
PROA occ urred dur i ng pr ocainamide, t oca i ni de or beta
blocker trial s . Of 43 PROA event s , 7 wer e r epet itive VT
while 36 wer e either i ncessant VT, polymorphic VT or VFand
1 pt died from VF . The mean durat i on of drug therapy be-
f ore PROA was 4.8+3.7 days. Ana lysis of clinical par ame-
ters di sclosed tha t PROA occur r ed mor e of t en dur i ng t r eat-
ment fo r sustai ned VT, 19/ 143 pts, than VF, 3/11 4 pts or
nonsustained VT . 11/15 5 pts, (p=.008 ). Age, gender , heart
di sease etiology, eject ion frac t i on and hear tfailure did
not cor r elate with PROA, We concl ude that t he inci dence
of potential y life-thr eatening PROA events is higher in
pts with su s t ai ned VT, var i eswith the drug used andPROA
events occu r early in t reatment.
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RISK OF CONVERSION FROM NON-INDUCIBLE TO INDUCIBLE
VENTRICULAR TACHYCARDIABY PROCAINAMIDE IN PATIENTS WITH
DILATED HEART FAILURE. lti.L.llllm.Go. Steyenson. .M.D..
James N. Welss, M.D., F.A.C.C., Lynne W. Stevenson,
M.D., and Jan H. Tllllsch, MoD., UniversIty of
California, Los Angeles.
Although patients with severe LV dysfunctIon and
nonsustalned ventricular tachycardia (VT) are at high
risk for sudden death, antlarrhythmlc drugs may actually
Increase the risk by a proarrhythmlc effec~ To
determIne the Incidence of a proarrhythmlc effect of
proca I nam I de the resu I ts of programmed st I muIat Ion
before and after Intravenous procalnamlde (serum level
6.6±2.5 llg/ml) were analyzed In 18 pts. All pts had
spontaneous nonsustalned VT associated wIth stable heart
failure (LV ejection fraction .19'±'08) due to coronary
disease (6 p ts) or dIlated cardiomyopathy <12 pts),
StimulatIon Included rapid pacing and 1, 2 and 3
extrastlmul I at 2x threshold during sinus rhythm and
basic drives of 600, 500 and 450-400 msec from the RV
apex.
Before procalnamlde no patient had InducIble sustained
(> 30 sec) VT. Following procalnamlde sustained
monomorphic VT was InItiated In 2 (11%) pts. One of the
2 pts was not Inducible on quInIdine and was alive and
well after 10 mo. The other pt rece Ived no
antIarrhythmIc drugs and died In VT at 2 weeks but when
serum K+ was 6 meq/I. Of the 16 nonlnduclble pts 1 (6%)
died suddenly (mean follow-up 5±4 mol.
Conclusion: Procalnamlde enhances the ability to
Initiate monomorphic VT In a small but significant
fractIon of patients at high risk for sudden death due
to severe LV dysfunctlo~ Whether those pts are at
higher rIsk for sudden death requires further study.
Thursday,March12, 1987
lO:30AM-12:00NOON, Room 41, Second Level
Treatmentof SupraventricularArrhythmias
IMPORTANCE OF THE EFFECT OF VERAPAMIL ON REFRACTORY PERIOD
OF THE ATRIOVENTRICULARNODE IN PREVENTING THE INDUCTION
OF CIRCUS MOVEMENT TACHYCARDIA UTILIZING A BYPASS PATHWAY
Ken Okumura, M.D., Yutaka Horio, M.D., Kyoji Takaoka,
M.D., Yasuhiro Morikami, M.D., Koshi Matsuyama.M.D. and
Hirofumi Yasue, M.D•• Kumamoto University, Japan.
Verapami1 is highly effective in terminatingcircus move-
ment tachycardia (CMT) utilizing an atrioventricular (AV)
bypass pathway. However, it is not always effective in
preventing the recurrenceof CMT and the mechanism of such
inefficacy is unclear. In 20 patients (pts) with inducible
CMT (8 with a manifest bypass pathway and 12 with a
concealed one), verapami1 (5 mg) was given intravenously
and its effects on the inducibi1ity of CMT and on selected
e1ectrophysio10gic properties were studied. In 13 pts
(group I), verapami1 prevented the induction of CMT (12
pts) or decreased a width of CMT zone (a zone between the
shortest and longest AIA2 intervals resulting in CMT
during programmed atrial stimu1ation)(lpt). In 7 pts
(group 2), verapami1 was ineffective in preventing the
induction of CMT: a meanwidth of CMT zone increased from
40±37 msec to 73±43 msec after verapami1 (p<.OOs). In both
groups, verapami1 significantly increased the AV nodal
conduction times determined during atrial pacing at 120
beats/min and during programmedatrial stimulation and the
%changes after verapami1 were not statistically different
between 2 groups. Verapami1 showedlittle effects on the
bypass pathway properties in both groups. In contrast,
verapami1 prolonged the effective refractoryperiod (ERP)
of the AV node by LsO msec in group 1, while in group 2,
verapami1 prolonged it only by <20 msec (3pts) or did not
change or shortened it (4 pts).- Conclusions: Verapami1's
effect of prolongation of ERP of the AV node is important
in preventing the induction of CMT. Without this effect,
verapami1 not only may be ineffective in preventing the
recurrenceof CMT but also may facilitate its recurrence.
DISPARATE EFFECTS OF ADENOSINE TRIPHOSPHATE ON SINUS
NODE AUTOMATICITYAND AV NODAL CONDUCTION IN MAN
Arjun D. Sharma, M.D., F.A.C.C., Simon Mi1stein, M.D.,
Max Rattes, M.D., George J. K1ein, F.A.C.C., University
Hospital, London, Canada
Adenosine triphosphate (ATP) is a highly effective and
u1 tra shortacting agent for terminating reentrant
supraventricular tachycardi a. We used a pharmaco1 ogi c
approach to characteri ze the e1 ectrophysi 01 ogi c effects
of ATP on sinus node (SN) automaticity and AV nodal
(AVN) conduction. Incremental intravenous bolus doses
of ATP were acbninistered via a central vein to 10 pts
without SN or AV node dysfuncti on. SN effects were
determined by changes in spontaneous sinus cycle length
(CL). AVN effects were assessed by measuring AH
interval during atrial pacing at CL 400 msec. ATP had
bi phasi c effects on SN CL wi th an abrupt and brief
prolongation of CL followed by CL shortening. Mean
maximum increase in CL was 294+60 msec (mean+SE).
Sigmoid dose response curves were computer fitted using
median-effect plots and the EC50 was .39 mg. ATP had
biphasic effects on AH interval with prolongation
followed by shortening. Mean dose to AV block was
4.4+0.97 mg and the computer fitted EC50 was 2.4 mg.
MaxTma1 effects were observed wi th submaxima1 doses at
the SN in 4 pts but not at the AVN. Atropine .03 mg/kg
and propranolol 0.1 mg/kg I. V. decreased the effect of
ATP on SN CL prolongation (6CL control 399+129 msec vs
post block 27+11 msec, p<.01). Autonomic Dlockade did
not change the dose ATP requi red to produce AVN block
(control 5.6+1.1 vs 6.8+0.8 mg, p=NS).
Thus, ATP acts in lower doses to prolong SN CL in part
via chcl inergic receptors. AVN effects are not
significantly changed by autonomic blockade.
ELECTROPHABMACOLOGY OF FLESTOLOL IN PATIEIlTS VIm
SUPRAYEIlTRICULARTACHJARRHYTIIMIAS.
Charles Swerdlow, M.D., F.A.C.C., Jan Peterson, R.N., L.
Bing Liem, 0.0., Kathleen Blake, M.D. Stanford Univer-
sity, Stanford, CA
Flestolol is an ultrashort-actingbeta blocker with a
half-life of 15 min. We studied its antiarrhythmicef-
ficacy in 13 pts with spontaneous and inducible
supraventriculartachyarrhythmias:AV nodal tachycardia
(4 pts); orthodromic tachycardia using an accessory AV
pathway (6 pts); and 1:1 AV conduction of atrial flutter
(3 pts). Given as a 100 ug bolus followed by a 10 ugl
min infusion x 15 min, flestolol prevented initiation of
AV nodal tachycardia in 4/4 pts and orthodromic
tachycardia in 1/6 pts. The ratio of AV block increased
to 2:1 or 4:1 in 3/3 pts with atrial flutter, and the
mean cycle length of induced orthodromic tachycardia
increased from 364 to 390 ms (5 pts). The effective
refractory period of the AV node increased in all pts
with AV nodal tachycardia (fast pathway: 330 to 405 ms;
slow pathway: 275 to 322 ms); the antegrade (n=3) and
retrograde (n=6) refractory periods of accessory path-
ways were unchanged. Flestolol's kinetics permitted
clinically-indicated electropharmacologic testing of a
second antiarrhythmic drug in 5 pts and control of
ventricularrate prior to AV junction electrode-catheter
ablation in 1 pt with continuous 1:1 atrial flutter. No
hypotension or toxicity occurred. Conclusion: Fles-
tolol can be given safely to pts with supraventricular
tachyarrhythmias. Its antiarrhythmic effects are simi-
lar to those of other beta blockers. Its ul trashort
duration of action is an advantage during electrophar-
macologic testing.
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EFFICACY OF PIRMENOL, A NEW ANTIARRHYTHMICAGENT, IN
TERMINATING SUPRAVENTRICULARTACHYCARDIA.
Dianne Barnard, MD, Charles Haffajee, MD, FACC, Robert
Gold, MD, FACC, Kathy Sloan, MSN, Joseph Alpert, MD, FACC
Univ. of Mass. Med. Ctr., Worcester, MA
Pirmenol (P) a new class lA antiarrhythmicagent has been
shown to be effective for ventriculararrhythmias. We
evaluated the clinical effects, dosing schedules and
electrophysiologic (PES) effects of P in 9 pts with
spontaneous (4 episodes) and PES induced (7 episodes)
supraventriculartachycardias (SVT). Three pts had bypass
tract mediated SVT (AVRT), 5 pts had AV nodal reentry
tachycardia (AVNRT) and one pt had primary atrial flutter
(AFl). P was administered as SO mg IV bolus over 10 min
for SVT terminationin all 9 pts. This was followed by
2.5 mg/min IV infusion of P in 7 pts who underwent repeat
PES.
Results:P terminated 5/5 episodes of AVNRT (3
spontaneous, 2 PES-induced) within 1-9 min (mean 2.2 min)
of bolus and in the PES pts AVNRT could not be induced
while on IV-P infusion.
In the 3 pts with bypass tract AVRT, P terminated 2/5 PES
induced episodes and prevented AVRT reinduction in 2 of 3
pts. P failed to convert AFl in one pt but slowed the
atrial rate from 250 msec to 360 msec. This effect
persisted for 6 hrs following IV SO mg bolus.
The EP effects of P were a mild increase in HV (43 ~ la
to 53 + 12 ms) and VA times (190 to 235 ms).
Nonsignificant effects were observed in atrial,
ventricularand AV nodal refractoryperiods (RP). A trend
to an increase in antegrade and retrogradeRP's of the
bypass tracts were observed.
Conclusion:P is effect in terminatingand preventing PES
induction of SVT in pts with AVNRT and is less effective
in AVRT and in converting AFl.
FLECAINIDE ACETATE AN EFFECTIVE DRUG IN PAROXYSMAL
ATRIAL FIBRILLATION.
Martin Wiseman M.B., June Elstob S.R.N., Roworth AJ
Spurrell M.D., F.A.C.C., and A John Camm M.D., F.A.C.C.,
St. Bartholomew'sHospital, London, England.
ABSTRACTS
A COMPARISON OF ATENOLOL AND SOTALOL IN THE TREATMENT
OF PATIENTS WITHPAROXYSMAL SUPRAVENTRICULAR
TACHYCARDIA
Peter M. Schofield, MRCP, David H. Bennett, FACC,
Wythenshawe Hospital, Manchester, England.
We compared the efficacy of sotalol (a B-blocker with
class III antiarrhythmicactivity) and atenolol in
patients with frequent palpitation due to paroxysmal
supraventriculartachycardia (SVT), rate 142-231 bpm,
who had not previously received B-blockers, in a
randomised cross-over study. 13 patients, aged 20 - 65
years, received treatment with atenolol (SO or 100mg
daily) for 6 weeks and sotalol (120 or 240mg daily)
for 6 weeks. Patients used hand held ECG recording
devices to record the cardiac rhythm at the time of
symptoms during each treatment period and the number,
total duration and mean duration of attacks of SVT
documented. 2 patients had prolonged episodes of SVT
whilst receiving atenolol and did not complete this
treatment period. 3 patients had no symptoms during
either treatment period. A further 5 patients were
free of palpitation only whilst receiving sotalol and
1 patient only during treatment with atenolol. The
number of episodes of SVT was significantly lower
during treatment with sotalol (median 0, range 0 - 22)
than with atenolol (2, 0 - 26), P < 0.05. During
treatmentwith sotalol, the total durationof SVT (0
mins, 0-55 mins) and the mean duration of each
episode (0 mins, 0 - 3.5 mins) were significantly
lower than with atenolol (45 mins, 0- 390 mins, p.
0.01 and 6 mins, 0 - 195 mins, p = 0.02,
respectively). In conclusion, treatmentof patients
with paroxysmal SVT with sotalol results in better
control of symptoms compared with atenolol.
Thursday, March 12, 1987
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Abolished
Reduced
Not improved
Total
The outcome
reasons for
Flecainide acetate is an effective agent in the
treatmentof a wide range of cardiac arrhythmias, but
little data eXist on its efficacy in pts with paroXYsmal
atrial fibrillation (PAF). To assess this, the records
of 166 pts who had been treatedwith oral flecainide
were reviewed retrospectively. Of these, 52 (31J) had
PAF and received flecainide during 70 treatment periods,
mean duration 7.7 +11.0 months. The remaining 114 (69J)
pts had other pBroxysmal tachyarrhythmias (OT) and
received flecainide during 175 treatment periods, mean
duration 7.3 +8.8 months. The effect of flecainide
therapy on the arrhythmiaswas:
PAF OT Total
23(32JI 53(30J) 76(31JI
21( 3oJ) 69( 4oJ) 90om
26(38J) 53( 30JI 79( 32J)
70 175 245
of the flecainide treatment periods and
change of therapy were:
PAF OT Total
Continued therapy 26C37J) 64( 37J) 9OC37J)
Ineffective 23(33J) 62(35J) 85(35J)
Side effects 13( 19J) 23( 13J) 36( 14J)
Others 9( 11J) 26( 15J) 34( 14J)
Total 70 175 245
In neither of these tables is there any significant
difference between the two groups, even at the p=0.1
level. In conclusion flecainide is as effective in the
treatment of paroxysmal atrial fibrillation as it is in
the treatmentof a variety of other arrhythmias.
ACUTE INCREASE OF RIGHT ATRIALPRESSURE BY
INTRACARDIAC STIMULATION RELEASES ATRIAL
NATRIURETIC PEPTIDE (ANP)
Mathias C. Haufe MD, Jochen Weil MD,
Klaus J. Nafzger, Karl Theisen MD
Medizinische Klinik Innenstadt and Kinderklinik,
University of Munich, FRG
The stimulus for relea~e of ANP after supraven-
tricular tachycardias in patients (pts) is not
known. 18 pts (moderate CAU, normal hemodynamic
profile) in sinusrhythmwere studied to asses
the effect of an increase in heart rate and/or
in right atrial (RA) pressure on the release of
ANP. Group 1 (n=6) underwent right ventricular
(RV) stimulation in consecutive 2 min steps of
100, 120, 140 and 150 bpm. RA pressure was
acutely increased by asynchronous contraction of
RA and RV. Group 2 (n=6) was stimulated in RA
using the same protocol. Group 3 (n=6) underwent
continuous RA stimulation for 16 min at 110 bpm.
RA pressure was registered continuously. Plasma
ANP concentrationwas measured by radioimmuno-
assay before and after each step of stimulation
from RA blood.
Results: Group 1: RA pressure increased from
3.9+0.2 to 8.3+0.6 mmHg (mean+SEM). ANP in-
creased (p(O.05)-from 120 to 4110-pg/ml. Group 2:
RA stimulation below 140 bpm did not change ANP
nor RA pressure, but stimulation with 140 and
150 bpm increased RA pressure from 5.8+0.5 to
7.5+0.5 mm Hg and ANP from 226 to 396 pg/ml (p(
0.05). Group 3: RA stimulation did not influence
pressure or ANP. Thus, acute increment of RA
pressure results in a release of ANP, but acce-
leration of heart rate alone has no effect on
ANP secretion.
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PLASKA LEVELS OF ATRIAL NATRIURETIC FACTOR III ACUTE
KYOCARDIAL IIIFARCTIOIIl!l 1Wl.
Hetlme Ouirnet. MD. Pierre Theroux, MD, FACC, Marc
Cant in , MD, Jolanta Gutkowska, MD and Jacques Genest,
KO, Montreal Heart Institute, and Clinical Research
Institute, Canada.
Serial determinations of atrial natriuretic factor
(AIIF) were performed 4,8,12 ,16,20,24,48,72,96 and 120
hours after the onset of pain in 23 patients
hospitalized for an acute myocardial infarction (AMI) .
AIIF was measured in plasma by rad ioitmlUnoassayafter
extraction with Sep-Pac cartridges; normal values ±SD
in our lab are 11.9±10 .6 pg/m!. All patients with AMI
exhibited a biphasic pattern of elevated plasma AIIF
levels (p<O .Ol). The first elevation always occurred
within 16 hours after the onset of pain, with a peak of
51±24.9 (range 23-108) at a mean of 8±3 hours. This
early peak was always followed by a trough (mean AIIF
25.9±14.8) and a second increase beginning 28±7 hrs
after the onset of pain. The second peak occurred at
44±7 hrs with a mean of 63.8±32 .7 (range 21-130).
Thereafter, plasma AIIF plateaued; at 120 hrs the mean
was 64.7±46.3 pg/ml (range 28-188, p<O.Ol).
Neither Killip class, medication used, site of AMI
(inferior in 10 patients), type of AMI (Q-wave in 17
patients) nor ejection fraction (44±15~) correlated
with either AIIF peak . However the late plateau phase
was higher when congestive heart failure was present:
88.6±52 vs 44.8±23, p<.05 .
Thus AIIF levels are elevated after AMI. The biphasic
pattern observed suggests that more than one
pathophysiologic mechanism is involved. Persistent
heart failure may partly account for the elevated
levels during the late plateau phase.
INTACT ATRIAL ENDOCRINE FUNCTION IN HUMANS WITH THE
PERMANENTLY IMPLANTED ARTIFICIAL HEART
Thomas R. Schwab, M.D., Brooks S. Edwards, M.D.,
William C. DeVries, M.D., Robert S. Zimmerman, M.D.,
John C. Burnett, Jr., M.D., Mayo Medical School,
Rochester, MN, and Humana Heart Institute, Louisville, KY.
Previous studies in calves with the total artificial
heart (TAH) have reported that atrial endocrine function
is disrupted with a blunted release of atrial natriuretic
f actor (ANF) to an increase i n atrial pre ssu re despite
anatomic presentationof the native atria. The effect of
the permanently implanted TAH on atrial endocrine function
and ANF release i n man are unknown. This study i n two
humans wit h the permanentartific ial heart evaluated
atrial natriureticfactor, cardiovascular and renal
function before, during and after increasing right atrial
pressure (RAP), a known stimulus for ANF release. RAP
was acutely i ncr eased by 7 mmHg in each SUbject and was
associated with increases in plasma ANF of 63 and 27 pg/ml
respectively as measured by r adi oimmunoassay. Urinary
sodium excretion increased from 118 to 129 ~Eq/min in
subject 1 and from 19 to 69 i n subject 2. Respective
urinary f l ow rates increased from 5.8 to 6.8 ml/min and
from 0,8 to 3.3 ml/min.
Thi s i nves t i gat i ondemonstrates fo r t he first time
that (1 ) increasing right atrial pre ssu re in the human
with the artificial heart stimulates release in plasma
atrial natriureticfactor, and (2) urinary flow rate and
sodium excretion increase in association with the acute
i ncr eases in right atrial pressure and plasma ANF. These
observations demonstrate that cardiac endocrine function
and atrial natriureticfactor release are intact in the
human with the total artificial heart.
PERCUTANEOUS DOUBLE-BALLOON PULMONA RY VALVOTOMY
I N ADULTS.
Saad Al Kasab, MRCP, Paulo Ribe iro, MD, Muayed
;rr-7ai-,;-ag;,nn:V;-Klyadh Cardiac Centre, Saud i
Arabia
We used a double-balloon t ec hnique t o d i la te
pulm ona r y va l ve s t e nosis (PVS ) i n nine adults.
The mean age was 24 yrs (15 -3 7). Al l patient s
( pts ) were in NYHA c l ass 11; mo derate t o se vere
PVS was co nf i r me d haemodynamica ll y and a ngLo«
g r aphically .
The combined diameter of the ba l loo ns used was
3-5 mm greater t han the valve a nnu l u s . Fol-
l owing balloon valvotomy , t he pe a k sys tolic
gradi ent across the pul mon a r y valve ( PV)
decreas ed from a mean of 94 . 8+28 mm Hg t o a
mean o f 24,8+8 (p<.0002), whi ch- was maintained
at 6 weeks [allow-up study ; the RV s ys to lic
pressure ( RVSP) fell from a mean of 114.8+27 mm
Hg t o a mean of 67.3+ 23 ( p<.002 ) .
EIght pt s developed infundibular s t e nos is
(spasm) following s uc cess f u l pulmonary
va l vo tomy . In 7 pts the sub-valvular gradient
was mild (10-20 mm Hg), but in one was severe
(105 mm Hg); this pt was g i ve n or a l inderal for
6 we eks giving complete r elie f . Follow-up of
all 8 showed further reduct i on i n the mean RVSP
from 67.3+23 to 47.5+10 mm Hg (p<.045).
During balloon infration , no pt had brady-
cardia; systolic aortic pressure was always
above 90 mm Hg, Single balloon dilatation of
PVS can cause bradycardia and hypotension, due
to t ransient occlusion of the pulmonary valve,
and a potentially inadequate dilatation when
the annulus is large. We conclude that the
double bal l oon technique provid e s a' venting
area duri ng inflation, prev enting complete
occ lus io n o r the PV orifi c e. The combined
c r oss- se ctional area (CSA) of the 2 balloons i s
l ess than that o f one balloon with the same
diameter , suggesting that diameter, and not
CSA, determines success.
We beli e ve that the double ba l l oon technique
s hou l d become the choice f o r this procedure in
adults.
TIlROMBIN-ANl'ITHROMBINHI OOMPLEX:
DIAQ/CSrICVAUJE IN PULMONARY EMOOLISM
Heiner Blanke, M.D., Gerd Praetorius, M.D., Matthias
Leschke, M.D., RainerSeitz, M.D., Rudolf Egbring, M.D.,
Bodo E. Strauer, M.D., F.A.C.C.
Dep, of Medicine, Univ. of Maroorg, FRG.
A highly sensitive and specific enzyme-linked immunoab-
sorbent essay (ELlSA) for the measurement of thrombin-
antithrombinIII complex (TAT) in plasma has been
developed. In 20 patients (pts) with suspected pulmonary
embol.Lsm (PEl, woo presented within 24 h after the onset
of symptoms, TAT, fibrinopeptid A (FPA), platelet factor
4 (PF4), and B-thromboglobllin (BTG) were determined. In
all pts. in whom PE was confirmed by perfusion lungscan
(n=15) TAT was ~ 3. 5 ng/ml,whereas in no pt. in whom PE
was excluded by perfusion lungscan and angiography and
i n only 3 of 44 apparentlyhealthy blood donor TAT was
73 ng/ml. FPA was less sensitive than TAT, and there were
more false positive elevated FPA levels. PF4 and BTG
f indings were false positive in about 25% and false
negative in about 50% of all cases.
RESULTS: PE no PE Normals sensitivity
n=15 n=5 n=44
TAT>3,5 ng/ml 15 0 3 100%
FPA>6,O ng/ml 12 2 7 80%
PF4>6,0 ng/ml 8 1 12 53%
BTG~ 50 ng/ml 10 2 12 67%
CXl'lCLUSlOO: TAT is very sensitive in detecting thrombem-
bOhc events. Acute PE seems to be unlikely, if TAT is
normal. TATcan be determined i n citratedplasma. The
measurementof the complex i s much easier, fasterand
less susceptible to disturbancesthan thatof FPA, PF4
and BTG.
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ABNORMALITIES OF CORONARY FLal RESERVE AND ESOPllAGEAL
I«>TD.ITY IN SYNDROME X: A SYSTEMIC DISORDER OF SMOOTH
IIJsa.E REACTIVITY?
Riohard O. Cannon. MD. FACC. Renata Hirszel. RN. Edward
L. Cattau. MD. Stephen E. Epstein. MD. FACC, NHLBI.
Bethesda, Maryland
The cause of anginel-like pain in pts with normal epicar-
dial ooronary arteries has intrigued olinicians for dec-
ades. To ascertain the causes of this syndrome. 49 pts
underwent esophageal motility testing and measurement of
coronary resistance (CR) during pacing at heart rate 150,
heart rate 150 after ergonovine (E) 0.15-0.3mg. and after
dipyridamole (D) 0.5-0.75mg/kg i.v.. Thirty seven pts had
an increase in CR during pacing after E with most having
angina (Group A); no pt hadepicardial coronary artery
spaSlll after E. These pts alsO had a higher minimal CR
after D compared to the 12 pts who had a normal response
to E (Group N).
CR CR-E CP CR-D
Group A (n=37) 1.07Z.32 1.33Z.36 33/37 .66+.21
Group N (n=12) .86+.20- .78+.18+ 2/12+ .47~.12+
Values = mean + SD. -=p<.05,-+=p<.005 vs Group A
Three Group Npts-had abnormal esophageal motility. Hence,
in 36/49 pts (74') a cause of the angina-like pain in the
presence of normal coronary arteries could be ascertained;
33 had chest pain with dynamio limitation to coronary flow
reserve and 3 had an esophageal motility disorder. Of
note, 21 of the 37 (57') of the Group Apts with impaired
coronary vasodilation also had abnormal esophageal motili-
ty. We conclude that a dynamic limitation in coronary
flow reserve constitutes a major cause of angina-like pain
in pts with normal epicardial ooronary arteries. and that
this disorder appears to be part of a generalized abnor-
mality of smooth muscle reactivity in many patients that
also involves the esophagus.
Thursday, March 12, 1987
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DISCRETE CRYOSURGICAL ABLATION OF ATRIOVENTRICULARNODE
REENTRY TACHYCARDIA IN PATIENTS
lames L. Cox, M.D., F.A.C.C., and Michael E. Cain, M.D.,
F.A.C.C., Washington University School of Medicine,
St . Louis, MO.
Atrioventricular(AV) node reentry is the most common
cause of paroxysmal supraventricular tachycardia and is
thought to occur on the basis of dual AV node conduction
pathways. The only available surgical treatment for
patients with medically refractory AV node reentry tachy-
cardia i s catheter electroablationor su rgical cryoabla-
tion of the Bundle of His, necessitating i mplantationof
a permanent artificial pacemaker. We have developed a
discrete cryosurgical procedure that s el ec t i vely inter-
rupts only one of the dual AV node conduction pathways,
thereby ablating the substrate for reentrant tachycardia
while preserving normal AV conduction. During atrial
pacing at a constant rate with continuous moni t or i gg of
AV conduction, nine separate 3 mm cryolesions (-60 C for
2 min) were placed at pre-determined sites around the
Triangle of Koch in the lower atrial septum. Six
patients with dual AV node conduction curve s and docu-
mented AV node reentry tachycardiahave underg one this
procedure. Preoperative, intraoperative, and postopera-
tive electrophysiologic studies were performed in all
patients. Postoperatively , ea ch patient has a single
normal AV node conduction curve. No patient ha s required
antiarrhythmicmedications and there has been no recur-
rence of AV node tachycardiaduring a mean follow-up
period of 2.4 + 1.2 years. Based on these results, we
consider this curative operation to be the procedure of
choice for patients with AV node reentry tachycardia
that is refractoryto medical treatment.
INTRAOPERATIVE Nd:YAG LASER PHOTOCOAGULATIVE
ABLATION OF VENTRICULAR TACHYCARDIA: OBSERVATIONS
RELEVANT TO TRANSCATHETER ABLATION TECHNIQUES. RH
Svenson, MD, FACC, JJ Gallagher, MD, FACC, S Zimmern, MD,
FACC, J Fedor, MD, FACC, N Harbold, MD. FACC, C smen,
MD, FACC, 0 Hall, MD, FACC, K Austin, MD, FACC, A Thomley,
MD, FACC, BH Wilson, MD,J Selle, MD, Sanger Clinic, Heineman
Medical ResearchCenterand CarolinasHeart Institute,Charlotte,
NC.
The int raoperative use oC the Nd:YAG laser for ablation oC
ventricular tachycardia(VT) is carried out in the normothermic
beating heart permitting certain conclusions to be made about
the functional size of the re-entrant circuit. The purpose oC
this study was to evaluate the extent of tissue photocoagulation
necessary to terminate VT complicating previous myocardial in-
farction. Fifteen patients underwent intraoperativemapping and
Nd:YAG laser photocoagulation(LPC) oC VT. There were 47 VT
morphologies (VTM) successfully ablated by LPC. Successful ab-
lation of all VTM requiredLPC of 12.6+1.9 cm2 of tissue surCace
per VTM. With 11 VTM in 7patientsstability oC VT permitted
a very detailed map and assessment oC the re-entrant region,
and the extent of LPC necessary to terminate VT. During these
11 VTM's the mean surface area displaying electrical activity
from mid-diastole to the onset oC the next QRS complex was 7.4
+.8 cm2 of surface area for each VTM. To terminatethese VT's
Tt required LPC of 6.7+1.1 cm2 oC surCace area for each VTM.
No patient has experienced spontaneous or inducible VT in a fol-
low up oC 3 to 15 months (7.5+1.). These results suggest (l) the
re-entrantprocess of VT complicating previous infarction is not
critically dependent on a small discrete anatomic substrata, (2)
detailed mapping data can minimize the extent of LPC necessary
to terminate VT, and (3) transcathetertechniques will require
efficient and effective means oC ablatingmultiple sites and poten-
tially large areas to achieve a high success rate.
INTRAOPERATIVEMAPPING-GUIDEDARGON LASERABLATIONOF
MALIGNANTSUPRAVENTRICUlARAND VENTRICULARTACHYCARDIA.
S Saksena.MD. FACC, SMHussain,MD. FACC, IGielchinsky,MD. FACC,
oPantopoulos,ME, NWasty,MD, ST Rothbart,MD, FACC,J Alizedah,RN,
BSN. NewarkBeth Israel Med Ctr, Univof Med& Dent, Newark, NJ
We examined the clinicalefficacyand safety of intraoperativemapping-
guided argon laser endocardial ablation in patients witheither malignantsu-
praventriculartachycardia (SVl) withtheWPWsyndrome, or refractoryven-
triculartachycardia(VT). 10 pts (SVT-2,VT·8)underwent angiocardiography&
cardiac mapping to localizethe site ofaccessorypathway(AP) orVTorigin.A
15-Wargon laser coupled to a 300 p optical fiberwas usedintraoperativelyto
deliver pulsed argon laser(PAL) dischargesto produce atrialor ventricular
endocardial ablation in pts withSVT orVT respect ively. Electrophysiologic
studies were repeated 6 to 14 days postoperat ivelytoassess efficacy.
RESULTS: 1)m :Preoperatively, pts had inducible orthodromicSVT&atrial
fibrillation. Visually&mapping-guided bloodless laser atriotomy&APablation
was performed withlowpower(3-5W) PALdischarges forablationof a lell
posterolateral AP (1 pt)&a posterior septal AP(1 pt). Mean lesion dimensions
were 2.8*1.3 cm (length)by 0.5 cm (width), with a total mean delivered
energy of 120*25J. Postoperatively, normalAV conduction resumed In both
pts & there was nospontaneousor inducibleSVT.
2) ll!: Preoperatively, inducibleVTwas present in all pts. Alaser ventriculo-
tomy was successfully performed in 6pts, Visually & mapping-guidedPAL
endocardial ablationwas performed for 10VTmowhologies at sites of presys-
tolic electrical~ctivity (mean lesion size 12*7cm , mean delivered energy
214:110 J/cm ).8 ofthese sites were surgically unresectable.
Postoperatively, spontaneous&inducibleVTwas suppressedin all pts (no
drug·7 pts; previouslyineffective drug-l pt). ECG Intervals,LV ejection frac-
tion, pulmonarycapillarywedge pressure, cardiac index were unchanged from
preoperative studies. 2-Decho& Dopplerpostoperat ivelyshowed no new wall
motion abnormalities, thrombus. or mitralregurgitation. Postoperativefollowup
(1 to 5 months)&Holter monitoringhas shown noSVTorVTrecurrence.
CONCLUSIONS:l)Argon laser endocardial ablation can be employed to per-
formsuccessful atrial,APorVTablation in man alone or in combination with
standard surgical techniques. 2)lt is particularlyuseful forfocal ablation in
SVT,or ablation at surgicallyunresectablesites inVT.
250A ABSTRACTS JACC Vol. 9. No, 2
February1987:250A
RESULTS OF TRANSCATI-ETERABLATIONOF VENTRICULAR
TACHYCARDIAIN33 PATIENTS.
Fred Morady, M.D., FACC, Melvin M. Scheinman, M.D., FACC,
Lorenzo A. DiCarlo, Jr., M.D., Jesse Davis, M.D.
John Herre, M.D., Jerry Griffin, M.D., Stuart Winston, D.O.,
Michael de Buitleir, M.B., William Kou, M.D., Steven Nelson,
M.D., Charles Hantler, M.D. and Joyce Wahr, M.D., University of
Michigan, Ann Arbor,MI
Transcatheter ablation of ventricular tachycardia (VT) was
attemptedin 33 pts who hadrecurrentunimorphic VTrefractory
to 3.7t1.2 antiarrhythmic(AA) drugs (mean ± SD). Their mean
age was 56±14 yrs; 22 pts had coronaryarterydisease, 6 had other
types of heart disease, and 5 had nostructuralheartdisease. The
mean LVejection fraction (EF) was 0.34±0.17. Only 3 pts had
more than onedocumentedmorphology of spontaneous VT. One to
4 shocks of 100-300 joules each weredelivered to the presumed
VT exit site as identified by endocardial activation mapping
(mean activation time relative to QRS = -50±30 rns), and pace-
mapping. In 29 pts, shocks were delivered between ane docardial
electrode (cathode) and anexternalpatch electrode(anode); 7 pts
who had a septal VT focus received transeptal shocks between
two electrodes on either side of the septum. Theprocedurewas
successful in 15 pts (45%), who had norecurrenceof VTeither on
no AA therapy (9) or on the same AA drugs which were
ineffective pre-ablation(6), over a follow-up of 12tl0 mos (range
2-31 rnos), The ablation attempt was unsuccessful in 18 pts
(54%). Clinical and electrophysiologic parameters did not
correlate with outcome. There were 5 nonfatalcomplications:
transient ischemic episode (2), ventricular fibrillation,
atrioventricularblock requiring pacemaker implantation, and
brachial artery thrombosis. In conclusion,transcatheterablation
of VT is relatively safe but has only modestefficacy, even in a
selected group of pts who havepredominantlyone configuration
of VT which can beadequatelymapped.
FULGURATION IN VENTRICULAR TACHYCARDIA DUE TO RIGHT
VENTRICULAR DYSPLASIA: MEAN-TERM RESULTS.
J.Fran90is LECLERCO, Fabrlce CHOUTY, Philippe COUMEL,
Robert SLAMA. Larlboisiere Hosp. Paris, France.
Ten patients (pts), 8 males. 2 females, aged 26 to 51
years, with sustained monomorphic recurrent ventricular
tachycardia (VT) resistant to antiarrhythmlcdrugs (AAD)
due to anglographically proved right ventricular
dysplasia, were considered for fulguration. 5 pts had one
VT, whereas 5 had 2 to 4 different monomorphic VTs.
Fulguration was made In the RV, after endocardial mapping
during VT and pace-mapping.
61 shocks were delivered in 19 procedures, without
important complications: ventricularfibrillation occured
after 4 shocks during VT, and stopped by the first
external DC shock. In 1 pt, a small Infarction occured
after fulguration in a septal area.
We obtained 2 failures and 8 successes, with a follow-up
of 16t5 months. Multiple VT pts needed more shocks (4-14
vs 2-7) and procedures than single VT pts. 6/8 successes
occur under AAD and 2 (both in single VT pts) without
drugs. In 416 successes With AAD, there was an Initial
failure with a progressive disappearanceof VT.
The localization of the VT site appears difficult: with
pace-mappingonly, we obtained 2 success and 2 failures
aut of 4 attempts. With mappingduring VT, the mean delay
between fulguration site and surface ORS complex was -36 ±
25ms. n=8 for successes, vs -21 ± 26ms, n=8, peNS.
CONCLUSION: Fulguration in VT of RV dysplasia is safe,
and efficient, mainly combined with AAD. Multiple VTs
decrease the success rate, since the criteria of
localisation of the VT site remain difficult to define.
BALLOON ELECTRIC SHOCK ABLATION (BESA) - CHRONIC EFFECTS
ON VENTRICULAR STRUCTURE AND ELECTROPHYSIOLOGY
Lynda L. Mickleborough, M.D., Louise Harris, M.D.,
Gregory J. Wilson, M.D., Eugene Downar, M.D.,
Alain Desrosiers, M.D., Gordon GrayB.Sc., University of
Toronto, Toronto,Ontario
We have developed a new mapping andelectric shock ab-
lation technique for the surgical treatmentof ventri-
cular tachycardia (VT) using a balloon electrode array
(BESA) inserted across the mitral valve which a) does not
require a ventriculotomy and b) may decrease operative
risk especially in patients with no transmuralscar or
resectable aneurysm. Prior to clinical use we performed
this technique in dog experiments to determine the ex-
tent of scarring,and arrhythmogenicpotential of result-
ing lesions. In six animals on cardiopulmonarybypass
(CPB) a ventricularballoon with a 4 cm' array of 9 sil-
ver bead electrodes was introduced through a left atrio-
tomy. It was inflated to achieve endocardial contact
and cathodal shocks of lOO joules were delivered through
each bead. Within 45 minutes, VT (2 dogs), ventricular
fibrillation (2 dogs) and transient asystole (I dog) were
observed. The hearts were closed and the animals weaned
from CPB. VT was common during the first 24 hours but
did not result in hemodynamic compromise. After 8 weeks
programmedstimulation at 2 basic cycle lengths with 4
extra stimuli or burst pacing failed to induce ventri-
cular arrhythmiasin any animal. At pathology, an ab-
lation area of homogenous scar measuring 6.6 ± 0.4 cm'
(mean ± SO) and approximately8 mm deep was found in each
animal. We conclude that BESA results in a predictable
volume of subendocardialscar and that this chronic
lesion has no arrhythmogenicpotential in healthy dog
hearts. This technique may be recommended in selected
patients with VT as a "closed-heart"surgical approach.
Thursday,March12, 1987
10:30AM-12:00NOON, Room 6, Second Level
Arrhythmias:CatheterAblation Techniques
CATHETER MEDIATED ELECTRICALABLATION OF POSTERIOR SEPTAL
ACCESSORY PATHWAYS: COMPLICATIONSAND EFFECTIVENESS
Gust H. Bardy, MD, FACC, Fernando Coltorti, MD, Tom D.
Ivey, MD, Robert B. Stewart, BS, H. Leon Greene, MD,
FACC, University of Washington, Seattle, WA.
Thirteen patients (pts) with posterior septal accessory
pathways (PSAP's) with suitable (1.e., "safe") coronary
artery anatomy anddisabling, refractoryarrhythmias
underwent catheterablstion using 2 to 5 standard
defibrillatorpulses. PSAP ablation was successful in
9/13 (69%). Serious adverse sequelae included two pts
who required immediate sternotomy for control of cardiac
tamponade andclosure of a barotraumaticallyruptured
coronary sinus (CS) and one pt who suffered a small
posterior left ventricularinfarction. Transient
abnormalities included: severe bradycardia(3 pts), AV
block (3 pts), accelerated junctional rhythm (3 pts),
ectopic atrial tachycardia(2 pts), global myocardial
depression (l pt>, inferior "ischemic" appearingT wave
inversions (7 pts), and hemodynamicallyinsignificant
small pericardialeffusions (5 pts). CK-MB rose from 3 !
2 UL to 26 + 18 ut (p<0.05) at 4-8 hrs post ablation.
LDHl rose from 45~ 10 ut to 110 ~ 29 UL (p(0.05) at
24-72 hrs post ablation. LDHl/LDH2 reversal did not
occur in any pt. Two months post ablation coronary
arteriographywas unchanged frombaseline, including the
pt that developed the posterior infarction. CS stenosis
of uncertainsignificance was evident in 2 pts.
Conclusion: Catheter ablation of PSAP's using standard
defibrillatorpulses and catheters is far less effective
than present surgical approaches. Some pts, however, do
well and can avoid surgery. Transientabnormalitiesof
the ECG, of the cardiac rhythm, and ofthe echocardiogram
are common. Risk of CS ruptureis significant,
indicating that any such procedure should be conducted in
the operating room.
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EXPERIENCE WITH CATHETER ABLATION OF ACCESSORY PATHWAYS.
~ .Aa. ~.M.!2., R. Hardwin Mead,M.D., Vincent
Gaudiani, M.D., and Roger A. Winkle, M.D., F.A.C.C.,
Sequoia Hospital, Redwood City, CA
Eleven pta with an acoessory pathway (AP) andsymptomatio
tao~arr~thm1as underwentan attemptat ablation (Ab) of
the AP. AP location was posteroseptal (PS) in 8, left
paraseptal (LP) in 2 and right free wall (RFW) in 1 pt.
For PS and LP AP, a quadripolarcatheterwas positioned
in the coronary sinus (CS) with the proximal 2 electrodes
straddling the os. '!bese 2 el ectrodes were attached to
the oathode of a defibrillatorwith a chest wall patch as
the anode. For the RFW AP, the distal pole was the
oathode. Two to 3 ahocks of 100-300 J were given. Mild
perioarditisin 1 pt was the only oomplication. At re-
study 5-8 days later, there was no conduction via the AP
in 4 of 8 pts with PS AP; 1 of 2 pts with LP AP had
modified conductionand is now oontrolled on a previously
ineffective drug; the RFW AP was modified. AV nodal
oonduotion was not affeoted. In pts with failed Ab, there
was markedattenuationof looal endocardial atrial elec-
trograms near the site of Ab causing diffioulties in
looalizing retrogradeatrialaotivation. This falsely
suggested there was a seoond ril!tlt free wall AP in 2 pts.
Suocessful surgical division of the AP was performedin 6
pts with failed Ab; no visible damage was seen except for
epioardial ecchymosis at the site of the RFW AP and a
punotatewhite lesion near the site of a PS AP. Pts
with suooessful Ab r.a1n symptomfree without Dreexoita-
tion after 6.2:1:.4 months. We oonclude that Ab of PS AP is
a safe and reasonably (50S) effeotive al ternative prior
to surgery. PriorAb attemptsdo not affect subsequent
surgical results althoUl!tl local atrial eleotrograms are
altered which oan makepost ablation endocardial activa-
tion sequence mapping moredifficult.
CATHETER ABLATION OF THE ATRIOVENTRICULARJUNCTION: ANALY-
SIS OF FAILED ATTEMPTS
Joseph Ilvento, M.D., Joseph Abbott,M.D., F.A.C.C., Jesse
Davis, M.D., Jerry C. Griffin, M.D., F.A.C.C., John M.
Herre, M.D., F.A.C.C., IbrahimHelmy, M.D., and Melvin M.
Scheinman, M.D., F.A.C.C., University ofCalifornia, San
Francisco.
Of 35 patients (pts) with drugrefractorysupraventricular
tachycardiaundergoing attemptedcatheterablation of the
atrioventricularjunction (CAVJ), chronic complete atrio-
ventricular (AV) block was achieved in 28 (80%) (group I)
while 7 (20%) (group 11) showed resumptionof AV conduc-
tion. The groups did not differ in the amplitude of the
unipolar Hisbundle (307t220 vs 213t140~V) or atrial
(590±490 vs 570t470~V) electr09rams, or inpeak CPK MB
(35t27 vs 33±8u) or ejection fraction (49t13% vs 56t17%).
The total electrical energy used was lower in group I
(660t182 vs 1230t430 Joules) (p<O.Ol) as was the LV end-
diastolic volumes (LVEDV) (83t30 vs 122±21cc) (p-n.m ),
Antegrade AV conduction could be assessed in 30 ptsand
enhanced AV nodal conduction was documented in 3/6 9roup
11 pts and in 3/34 from group I (p=0.075). Only 1/5 (20%)
9rouP 11 pts who underwenta second attemptedCAVJ devel-
oped chronic 30 AV block.
Conclusion: Successful ablation was not related to the
size of the unipolaratrial or His bundle electrograms.
Ablation was more apt to fail in those with highLVEDV,
perhaps due toproblems in stability of catheter position
and/or increasedener9Y dissipation in the larger volume.
There was a trend toward higher failure rates in those
with enhanced AV nodal conduction. If thefirst CAVJ
session failed, a second session usually did notsucceed
in producing AV block.
CRITERIA FOR INDUCTION OF CHRONIC COMPLETE HEART BLOCK
BY HIS BUNDLE FULGURATION.
Joe1ci L. Tonet MD, Ma1ika Baraka,MD, Jaime Nieto, MD,
Robert Frank,MO, MartinLi1amand, PhD, Guy Fontaine, MD,
FACC, A1bert Cansell, PhD, Yves Grosgogeat, MD, FACC.
Hopita1 Jean Rostand, Paris-Ivry, France.
18 patients (pts) (9 men) aged 47 + 18 years (range
17-81) underwent endocardial catheter-fulguration (ECF)
for treatment ofsupraventriculararrhythmiasrefractory
to other therapies. Successful shock was defined as
induction of chroniccomplete ablation of atrioventricu-
lar (AV) normal conduction. Anoda1 unipolar shocks were
delivered by a highinsulation multipolar USCI catheter
from the ODAH-Fu1gucor. Bipolar e1ectrograms were recor-
ded from the His bundle catheterprior to shock delivery.
Currentand voltage waveforms were recorded in all pts ,
29 shocks (190 + 40J, range130-240) were delivered, 15
of which inducecrchroniccomplete AV block (follow-up 22
+ 12 months, range 5-44). Mean peak MB fraction of
creatine kinase reached 16+ 15 IU/l.
The prefu1guration parametersdiffering significantly
between success and failure shocks are : His bundle
ampli tude (p<.01), Hi s bundle stabili ty (amp1i tude
variation inferior to 30%) (p<.02), and energy per Kg
(p<.05). Those not differing significantly are shock
energy, energy related to body area, atrial (A) and
ventricular(V) amplitude. A/His andV/His ratio. and His
pace-mapping. Linear discriminant analysis correctly
classifies 24 shocks in success or failure groups by
associating 4 factors: 1) His bundle amplitude(>300~V);
2) energy per Kg (>3J/Kg); 3) His bundledeflection
stability; 4) energy related to body area (>110 J/m2 ) .
Thus. chronic complete heart blockmay be achieved in
more than 80% of the pts by shocks guided by criteria
related to energy and tobipolar His bundle electrogram.
SPONTANEOUS HEART RATE AND CARDIAC FUNCTION AFTER ATRIO-
VENTRICULAR JUNCTIONAL ABLATION
JOSeeh Abbott, M.D., F.A.C.C., Melvin M. Scheinman, M.D.,
F.A••C., John M. Herre, M.D., F.A.C.C., Jerry C.Griffin,
M.D., F.A.C.C. and Nelson B. Schil1er, M.D., F.A.C.C.,
University of California, San Francisco.
Twenty consecutive pts withcatheter-inducedcomplete
atrioventricular(AV) block underwentchronic pacemaker
insertion andwere studied after a mean of 14 months
(3-48) after ablation. The escape interval (El) and spon-
taneous rate (SR) were determined after abrupt termination
of pacing. SR was also determinedafter Valsalva's maneu-
ver and with mild joggingexercise. A supine 2-D echo-
cardiogramwas obtained beforeand after termination of
pacing. The mean El was 1.9:6.7 seconds (1.25-10) and
4/20 (20%) pts reportedsymptoms of dizziness with pro-
longed pauses. The supine SR was 41t7 (30-50) bpm and
increased after Valsalva strain 44t6 (p<0.05), standing
45±7 (p<0.05) or duringexercise 55t15 bpm (p<0.05). The
spontaneous QRS complex was narrow (~100 msec) in 12, and
broad (~110 msec) in 8. The broad escape complex showed a
right bundle branch block (BBB) in 4, left BBB 3 and bi-
lateral BBB pattern in 1. There were no significant dif-
ferences between El, SR and changes in SR in response to
maneuvers between those with narrowor broad escape com-
plexes. The mean unpaced systolic arterial pressure was
136±20 mm Hg and there was no significant difference in
the ejection fraction (EF) (measured by echocardiography)
between paced (76±8 bpm. EF=48t12%) and unpaced (EF=49±8)
periods. During SR, The EF and blood pressure are main-
tained due tocompensatory increases in LV diasto1ic vol-
ume and althoughsymptomatic postpacing pauses were com-
mon, no pt was totally pacemaker-dependent. The SR proved
responsive to catecholamines and/orchanges in sympathetic
tone and were independentof the escapeQRS morphology.
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ELECTRO-THERMALCATHETER MODI FICATI ON OF ATRIO-VENTRICULAR
NODAL CONDUCTION AND AUTOMATICITY IN MAN
Onkar S. Narula, M.D., F.A.C.C., Joy Narula, 8 .S.N.,
Andrea Finzi, M.D., Fr anc o Pagnoni, M.D., Ant onio Lotto ,
M.D., Cedars Medical Center and Uni ve r s i t y of Miami,
Miami, Florida.
A new catheter technique was used to modify atrio-ventri-
cul a r nodal (AVN) conduction an d automaticity in two Pts;
one Pt (57 M) with paroxysmal atrial flutter and the second
Pt ( 65F) with paroxysmal j unc t i ona I tachycardia (Cycle
Lengt h (CL) of 500 t o 880 msec ) and atrial tachycardia
(CLs 400 msec). A specially designed electrical thermal
electrode catheter ( 7F) was inserted via femoral vein and
placed in the His bundle and AVN region. Thermal energy
(6- 11 Joule~was delivered f r om a constant current bat-
tery source. In Pt one, P-R and A-Hlengthened f r om 135 t o
145 and 50 t o 60 msec, respectivel y ; atrial pacing (AP) CL
f or 2° A- V block was prol onged from 450 t o 480 msec. I n Pc
two, P- R and A- Hwere lengthened from 340 to 640 and 240
to 540 msec, respectively; AP CL for 2° A-V block was pro-
longed from 650 to 720 msec. Retrograde conduction noted
during control was abolished . Automatic junctional rhythm
was slowed from CL of 880 to 940 msec. Holter monitor
s howed a decrease in maximum heart rate from 160 t o 125
per min . In both Pts , P-A. H-V and QRS r emained unchanged
throughout. Neither experienced pain or any sensation
during thermal delivery. I soenzymes remained negative.
This study documents for the first time that controlled
modification of AVN conduction in man can be achieved via
a t hermal catheter technique without the expense of Laser
energy or the extensive damage obs er ved with DC ablation.
Thursday, March 12, 1987
8:30AM-IO:OOAM, Room 16, Second Level
Rhythm and Arrhythmias
NEGATIVE CHRONOTROPIC EFFECT OF HYPOXI A ON THE
AU'lOMATICITYIN 'mE RABBIT SINUS NOOE
Yoshibumi Kushikata. M.D. , Takeshi Noda, M.D., Yoshi zumi
Habuchi, M.D., Masao Ni shimura, M.D. and Yos hio Watanabe,
M.D., F.A.C.C.
Fujita Gakuen University, Toyoake, Aichi, Japan
Hypoxia i s known to depress the sinus node function.
Perfusion of a small preparation(.2x . 2 x .2 mm) of t he
rabbit sinus node with a hypoxic solution ( Po2=30mmHg,
g lucose free) led to a progressive decrease i n the f iri ng
f requency, act ion potential a mplitude and action poten-
tial duration,eventually cau s i ng cessation of sponta-
neous activity within 6.3±3. 3min (n=12) . The r e sting
potential obtained dur ing quiescence wa s - 51 . 0±1. 6mV,
significantly more negative to that obtained by vera pa mil
perfusion (-39.4±1.6mVI under a normoxic ( Po2=140mmHg 1
ccndition. Continuous hypoxic perfusion caused a greater
hyperpolari zation to -70~-80mV (n=6 ). 'ltle time course of
hyperpolarizationwas acceleratedby overdrive stimula -
tion and retarded by the addition of 10mM glucose.
Voltage clamp experimentsusing double microelectrode
method were performedunder normoxic perfusion and after
the cessation of spontaneous firing with hypoxia. The i.- v
relationship was shifted outward after hypoxia at poten-
tials positi ve to -80mV (n=41. '!he hypoxia-induced compo-
nent of steady-state current had a reversal potential
of -80- -90mV i n 4mM K+ solution, and this component was
sensitive to changes in the extracellularK+ concentra-
t ion. The slow i n wa r d current and the de layed outward
current we r e no t s ignificantl y alteredon cessat ion of
the action potential, a lthough subsequent hypoxic perfu-
s ion caused an irreversible deterioration of the prepara-
tion. These results suggest that the depressing effect of
hypoxia on the automaticityof the sinus node results
from an increase in the K+ permeability.
VAGAL EFFECT IN THE AVNODE: AN ANATOMIC AND
ELECTROPHYSIOLOGICCORRELATION
Todor Mazgalev, PhD; LeonardS. Dreifus, MD, F ACC ,Saroja
Bharati,MD, FACC; Maurice Lev , MD. FACC; Shotaro
Imaizumi, MD, Eric L. Michelson, MD, FACC, The Lankenau
Medical ResearchCenter,Philadelphia,PA
In previous studies it was shown that the characteristic
diastolic hyperpolarization caused by postganglionic vagal
stimulation (PGVS) occurred in a specific region of the
atrioventricul ar node (AVN). To cha rac te rize the
morphological features of the AVN in relat ion 10 the ef fe cts of
PGVS, 5 rabbit right atrial-AVN preparations were mapped
during the introduc ti on of PGVS. Microelectrode recordi ngs
from the proximal AVN cells (region J) were of AN type.
Maximum PGVS-induced hyperpolarization and AVN
prolongationwere observed in typical N cells (region 2), while
more distal cells (region 3) re vea led H is type ac t ion potentia ls.
In AN and His bundle cells, PGVS did not produce
hyperpolarization. The correspondingre gions were stained b y
potassium fe rricyanide/ferrous chloride. Serial light and
electron microscopic sections taken from the above 3 regions
revealed that the cells from region I were loosely structured
and characterized the "approaches"to the AVN. Cells in
region 2 belonged to the so-called "compact" region of the
AVN, while the cells from region 3 were typical of His bundle
cells. An abundantsupply of nerve endin gs was observed in
region 2. Thu s, it was shown for the first time that the
compact AVN, where the effects of PGVS on AVN conduction
are most pronounced, is richly inne r va ted and comprised of N
type ce lls. These findings demonstrate a mor phologic-
electrophysiologic correlation based on t he AVN response to
va ga l infl uence and should be useful in further characteri zing
the a natom y and f unc ti on ofthe AVN.
L¥SUI'1l0 SPIl,\ I' [[) YL C;IOLl\E: PRUllAilLl:: AGt"T f UR a\lvrvrxe n
l'RI~(; r::U:O ACn VITV b i s c .rextc C/\ KllI AC PURI<.I.~Jl:: FIlleRS
Roue rt 11. l .. ile r , PhD. • .Jetf r e y M. Se que i r a , flS . , Raphae l
~ f e~l-i j ~-tMS-:- , ' S'r-;-;~;T Sed l l s , ~m. , :·Ja ui l ~ l -~ "('rif t a u . ,
f.A .e. C. , 01,\ Medical Ce nre r , Bruo k l yn , NY. IlllJ9
Canine cardiac Pur ki n j e fib"rs obtained iro~ 1 d~ y o l d
i nf a r ct ed ti s sue [[I'r j exu l bt r triggered activity [TA)
an d decreased rmx i mum d f a s v o Li c pote nt i a l (MDI'I
( - 5g + 1 ~ mV ) . Supe r [ us ion [ ~U~-ReC IRCJ of Il' f witn
oxygenated Ty ro de t s solution ca uses an l ncrease i n t1UP
(-53 + 6mV) and cessation of L\. 1'1 t ilt' present study,
recirculat i on of IPF wi t h reoxygenat ed Tyro dp ' s iREClRCJ
resu l t ed h no c hange in MDI' (- 53+13m"o/) and co n t i nuation
of TA. 1n no n-- Lnfa r ct ed ca ni oe cardiac Purx f nje [1 bp" ,
l~ P F j, recircu ln t io n of Tyrode's re~u l t Pd i~ no de~rea sp
in !l:.>P(-1l7 +3mV) . Analysis of IlECI RCand ;;UN- REC[I{C IPP
a nd ;oJPF t t ss ues s hoved no di f fe r e nce i n Iev e l s o f
pno s pha t I d y I c ho l f ne , neu tral phos puo Li pi ds , and
s ph i ngomye l l n (p>v.U5) . 'I'ne Eol l.ov i ng d.ra \lere ob t ai ned
" l,,,n anaLys fs va s pe rformed [or Lys ophosphat i dy l clio l l ne
[ LPCJ:
sample . (n =5 ) LPC (mea n + 3" ~ )
"pF r Issue ( a r s r a rt of ('x p.) <O.2U nM/mg-prot.
I PP t l s s llP (at s t a ct of exp.) S. 45 + l .uS nX/mg prot.
:~PF t i s s ue (I\O:;-l<£CII{C, tJ hrs ) <0. 20 nM/mg p ro t .
Il'P t i s su e (I\O~ -REC IRC, 6 hrs ) <v. 2t! nl·l/mg pro t ,
,~PP tl s sue (REC! RC , 0 hrs ) <0.2 t! nM/1'l8 prot ,
IPF ti s sue (REClI{C , 611rs) 14. 6U + , . 37 n('1/"'8 pro r ,
NPF fyr ode ' . (REC[I{C.6 hrN) <l .ut! n N/ ml
IPF Tyrode 's ( RECIRC, 6 hrs) 5. 70 + 1. 47 nM/ml
LPC increases on ly i n IPF a nd not in /lPFti s s ue(p<O.lJu5)
dur i ng rec i rc u l a t i o n. LPC i s re l e a s e d and ac c umu l a tes i1
t u" Tyrode's (I' <O.lJ05) . I ·, ll'f .\1Or;-REClllC t Ls sue reduce d
LPG Ie ve l s c o r re Lat e \Jith ce s s at i on of TA . Si nce TA only
co r re Iat e s with elevated L"C Ie ve l s we conclude t ha t LpC
ma y be re s ponsi bIe [o r maintaini'1g TA i n IP ;",
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PHASIC VAGAL DISCHARGE AND AV NODAL GAP: A NEW
MECHANISMFOR AN OLD PHENOMENON
Todor Mazgalev, PhD, LeonardS. Dreifus, MD, FACC, Eric L.
Michelsort, MD,FACC, The LankenauMedical Research
Center,Philadelphia,PA
The gap phenomenon isattributedto functional differences in
refractorlness in neighboringregions of the conductionsystem,
To evaluate this phenomenon in the AV node(AVN), 10 rabbit
atrial-AVN preparations were paced at cyde length 400-
500 msec and A2H2 was measured vs. AI A2 intervals using
programmed extrastimuli. Postganglionic vagal stimulation
(PGVS) was applied in the AVN asshort burstsof subthreshold
stimuli with duration 50-100 msec, amplitude 100-500).IA and
absolute phase (delay after AI) 0-500 msec. Standardmicro-
electrode technics were used to record action potentials from
AVN cells. PGVS with critical parameters consistently
produced bimodal conduction curves: gradual shortening of
Al A2 was associated with increasing A2H2 (or even AVN
block) within an intermediate Al A2 range (350-450 msec),
while at shorterAI A2 intervalsthe conduction delay decreased
before a secondaryincrease at very short Al A2 intervals(J50-
250 rnsec), Action potentials demonstrated that at very short
AI A2 the conductiondelay wasdeterminedmainly byAVN cellrelractor~ness. At longer ~I A2 the delay depended, inaddition,
on transient hyperpolarizatlon produced by PGVS. Since
increasing AI A2 was associated with greater hyper-
polarization,AVN delay dependedon the combined influence of
these opposing factors. The prevailing action of PGVS over the
effect of the longer Al A2 led to development of a gap at
specific coupling intervals. Moreover, the phenomenon was
critically affected by drugs influencing the phasic effects of
PGVS. Both atropine and physostigmine attenuated the gap.
Thus, this study demonstrates a new electrophysiological
mechanism producing the gap phenomenon withinthe AVN,
based onnonuniformrecovery of diastolic excitability.
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THE UP FIELD OFVIEW: IIIPLICATIOISFOR RECORDIIG
FOCAL PHEIOIIEIA. Joseph.!!:.. Levine, M.D., Alan H.
Kadish, M.D., E. Neil Moore, M.D., Thomas Guarnieri,
M.D., and Joseph F. Spear, M.D. The Johns Hopkins
Hospital, Baltimore, MD.
Monophasic action potentials can detect
afterdepolarizationsand other membrane phenomena. The
sensitivity of this technique to record focal events,
however, has not been determined. 31 tissues from 16
dogs were studied in vitro to determinethe "field of
view" of monophasicactionpotential and the ability to
record focal events (afterdepolarizations).Bipolar
pacing wires were placed at one end of the tissues and
a monophasic action potential catheterat the other
such that electrical activation between the pacing
wires and monophasic action potential catheter was
parallel or transverse to fiber orientation. The
position of the wavefront of electrical activation was
determined at the time of monophasic action potential
upstroke onset; the distance of the wavefront from the
catheter at this time defined its field of view.
Results: 1) Monophasic action potential had a broad
field of view which was greaterparallel vs. transverse
to fiber orientation (6.02+1.74 vs. 3.03+1.10 mm,
p<0.01). 2) The field of view was correlatedin part
to the space constant which was determined in these
tissues (R=0.89, p<0.001). 3) AfterdepoI arizations in
Purkinje fibers (induced with strophanthidin)were
detected in monophasic action potential from adjacent
muscle if present in action potentials recorded in
muscle.
Conclusions: Monophasic action potential have a broad
field of view and hence may be useful in detecting
focal abnormal impulse initiation in animals and man.
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RECOVERY OF ISCHEMIC EPICARDIUM CORRELATES WITH
NORMALIZATION OF REFRACTORINESS AND FAILURE TO INDUCE
REENTRY IN CANINE POST-INFARCTIONHEART
Nabi1 E1-Sherif, M.D., F.A.C.C., Wi11iam B. Gough, Ph.D.,
Mark Restivo, M.S., State University of New York, Health
Science Center and Veterans AdministrationMedical
Center, Brook1yn, New York
We studied 8 dogs 4 days and 5 dogs 4 weeks post-ligation
of the left anteriordescending artery. Isochronal maps
of epicardial activationwere correlatedwith refractory
maps determined by measurement of effective refractory
periods (2 x threshold) at 62 epicardial sites. Induc-
tion of reentrantrhythms by prematurestimulation was
tested. Transmembranepotentia1s (IMP) from the epicar-
dial layer overlying the infarctionwere then studied in
vitro using standardmicroe1ectrode techniques. Four
days post-infarction, the refractorymap showed marked
dispersion (140 to 360 msec) and spatially nonuniform
distributionwith a steep gradient at the ischemic border.
Prematurestimulation induced functional block along the
gradient of refractorinessand initiated reentry. IMP
showed reduced amplitude, resting potential and upstroke
velocity. Four weeks post-infarction, the refractorymaps
showed normal dispersion (140 to 200 msec) and uniform
distributionwith no steep gradients of refractoriness.
Prematurestimulation failed to induce block, markedly
slow conduction and reentry. IMP from the epicardial
layer returned towards normal. We conclude that improve-
ment of IMP of the epicardial layer overlying the infarc-
tion is associated with normalizationof refractory
pattern and inability to induce reentry in this layer.
The study suggests that depressed membraneproperties of
epicardial cells rather than the anisotropic character-
istics of the epicardial layer form the substrate for
reentry in the 4 days post-infarctionheart.
REOOcrICNS IN REGIONAL MIDCARDIAL FUNCI'ICN lIlr RFSI' IN
a:fiSCIOOS OCGS WI'lH CHRCNICALLYREllJCEDREGIONAL a:>KNARY
ARmRY PRESSURE. John M. Canty, Jr" M.P" F.A.C,C,and
FrancisJ. Klocke, Mon., F.A.C,C, SUNY at Buffalo, NY.
A state of chronically reduced myocardial function distal
to coronary stenoses has been tmJothesizedbut remains con-
trOlTersial. We have developed an animal model of collater-
al-dependentcircumflex (Le) myocardium producedI:¥ ameroid
occlusion with collateral inflow limited t¥ ligation of
epicardial anastamoses between the Le and other arteries.
Serial measurementsof distal LC pressureand subendocar-
dial function using LC and anteriordescending (LAD) wall
thickness (WT) crystals were performedin ten awake animals
(7 ameroid, 3 sham) for periods of up to 8 weeks. Resting
LV pressure, LV dP/dt, LVEDP and heart rate did not vary
significantly in individual animals. RedJctions in %LC WT
relative to %LAD WT began with the onset of a measurable
Ao-LC pressure gradientand reached a nadir of 68 ± 8 (SEM)
per cent of control at the time of total LC occlusion (16 ±
2 days). Temporal changesin LCpressureand relative
reductions in Le function were as follows:
Pre--Qcclusion Post OCclusion
Day 6 ± 1 10 ± 1 16 ± 2 26 ± 1 45 ± 2
Pr.c (mm 8g) 90 ± 4 85 ± 5 60 ± 2* 75 ± 6 80 ± 6
~LC Gradient 6 ± 1 15 ± 3 37 ± 3* 25 ± 3* 14 ± 4*
%LC-wT/%LADWT 100 80 ± 5* 68 ± 8* 83 ± 9 104 ± 21
*p<0.05 vs. control (at day 6)
Whereas reductions in LC function persistedfor 2-3 weeks
in ameroid animals, LC function remainedat or above con-
trol in sham instrumentedanimals and a resting Le gradient
did not develop We conclude that this model results in
reductions in resting LC function which are relatively pro-
longed and not attributableto subendocardialinfarction.
'lhe data support observations in man suggesting that re-
sponses to chronically reduced coronary pressurecan in-
clude chronic reductions in regional LV performance.
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MILD DECREASES IN REGIONAL FUNCTI ON AND BLOOD FLOW:
CORRELATIONS WITH ISOTOPICALLYMEASURED GLYCOLYSIS
Brian D. Guth, Ph.D., Richard A. Neese, Ph.D., EdwardW.
Gertz, M. D. ,F.A.C.C. and John Ros, J r . M.D. ,F. A. C. C.
Universi ty of Cal i fornia San Di ego and San Francisco ,
La Jolla, CA
Patients wi th coronary artery disease have been shQ~~
previ ously t o have elevated resti ng myocardial lactate re-
le ase, which i s further increased dur i ng pacing-induced
s tress even if no net chemical l actat e pr oduct i on occurs.
To characterize the changes in glycolytic activity and re-
gional myocardial function during acute,mild reductions i n
blood f l ow, f ive anesthetized pigs were instrumented with
sonomicrometer s for measuring regional midwal l se~aen t a l
shor tening. The left anteri or descending coronary artery
was i ns t rument ed wit h a mechani ca l constrictor and a flow
pro be . Myocardial blood flow dis t r ibu tion was measur ed by
micr ospher es bef ore andduring cor onar y constriction t o
produce a mild decrease in segmen t shor teni ng. Lactate re-
l ease from t he myocardium distal t o the constrictorwas
measured using a constant venous i nf us i on of l4C-lactat e
and simul t aneous blood sampl es from the thoracic aorta
and ant er i orcardiac vei n . Cor onary constrict i on to r educe
shortening by l3+5%(SD) decreased relative subend ocardi a l
bl ood flow f rom~87+.l2 t o . 50+. 13 (p=. Ol). Thi s was asso-
ci ated with an increased lactate releas e measur ed isot opi-
call y from .15 7+. 078 t o . 460+.168 4mol/ml (p=.006 ) wi th a
high cor r elation to the r educed bl ood flow (r=- .84 , p2 002) .
Chemic a l lactate across the poststenotic bed showed an ex-
tracti on of .514+.278 4mol/ml at control and .1 18+.188
during the stenosis (p=.007) indicating persistent lactate
uptake overall. We have demonstratedfor the first time in
an intact animal preparationthat mild decreases in blood
flow and function are accompanied by in creased lactate
release in t he affected myocardium despite a ne t chemica l
lactate extraction.
MXDIJM aHJfi\RY BUXJ) PUJf BEDI> A ClHliMr ARDlRY
~IS IS RIDJCIlD BY AN JlaJ'm DDlEl\SB IN ID!'
VIlN'DUalLM~.
Micllael B. stevens, M.D., PhD., Arthur C. Hill, M.D.,
Hidezo .Mori, M.D., Walid K. Husseini, PhD., and Julien
I.E. Hoffman, MoD., F.A.C.C., University of california,
San Francisco.
'lbe influence of an acute increase in LV systolic pressure
(IJJSP) on rtaximal coronary blood flow (alF), and thus on
coronary blood flow reserve, was studied in 7 open chest
anesthetized dogs. 'lhe left main coronary artery was
perfused through a Gregg cannula at 3 fixed coronary
perfusion pressures (<:PP) to stimulate coronary artery
stenoses of varying severity. l\denosine infusion
increased CBF maximally. CBF was measured with
mtcrospneres before and after the aorta was tartially
occluded to increase WSP. Results:
CPP 99 69 4S
WS;1184±16 f43±19* 183±16 ~1142±12* 96+16 J26+1S*ENDD 4.2+1.3 2.9+8.8* 1.4+8.2 8.8+8.2* 1l.6±e.l 1l.3±e. l *
EPI 4.7±e.9 4.7~.6 2.S±e.S 2.3±e.6 1.4i8.2 1l.9i8.3*
Mean.!:.SD. Pressures in rrmIIg. Blood flows (ENIXr
subendocardial, EPI-subepi) in ml/min per gnrl. *p<1l.05
cmJI:6redto control. &meMo flow and the ENIO:EPI ratio
were both significantly red1ced at each CPP after IJJSP was
increased. Subepi flQ./ fell only at the lowest CPP of
45rmiIg. We conclude tha~ increased IllSP can be a major
determinantof maximun alF and its transmuraldistribJtion
beyond a coronary artery stenosis. 'Ibis interaction
between LVSP and CBF in the subsequent diastole may
explain the onset of Il¥ocardial ischenia in sane p!tients
with CAD and diminished CBF reserve following an acute
increase in LV afterload.
INTRACORONARY DISTRIBUTION OF 111-ln-LABELED
PLATELETS IN DOGS WITH EXPERIMENTAL CORONARY
STENOSES.
Paolo Golioo, M.D., Juliet Ashton, Ph.D., Padma kar Kulkarni,
Ph.D., Anne L. Taylor, M.D.,L. Maximil ian Buja, M.D., F.A.C.C.
and James T. WiIlerson, M.D., F.A.C. C., Univ of Texas Health
Science Center,Dallas.
We examined platelet intracoronary and intramyocardial
distribution in dogs with cyclic flow variations (CFVs), l.e.,
progressive declines incoronaryblood flow int errupted by sudden
restorationsof flow. Autologous platelets labeled with 111-ln (In)
were injected into 19 open-chest, anesthetizeddogs. CFVs began
following constrictor placement around the left anterior
descending coronaryartery (LAD) and were obser ved for3D rnin s.
Ketanserin (K, aserotonin S?_ receptorantagon ist , 0=4), SQ 28,688
(SQ, a thromboxaneA2/PGR2 receptor antagon ist, n=5) or saline(C, n=10) were adrnlnlstarad"i.v, and coronar y blood flow was
monitoredfor an addit ional 30mlrs . Then, the LAD was remo ved,
dissected, and divided into proximal, stenotic, and distal 0 -2 mm
beyond the stenos is)segments. Three segments were also obta ined
from the circumflex artery(CX). Myocardi al tissue samples were
taken from CX and LAD perfusion beds.
Group ~ ~ Sten Dist
Saline 6 1.5+0.2 556+131 1486+169
No CFVs 4 1.4+.1 2.4;0.4* 2.7+0.8*
K ·4 1.1;.04 160+ 24* 329+23*
SQ 5 l.f:;:.05 40+ 12* 89+23*
Data are expressed as Inactivity per gm LAD/In-ac tivit y per gm
CX (*p<o.Ol compared to saline-treated control at same
location). Saline controls had prominent CFVs, butK and SQ
treatmentabolished CFVs. No differences were observed in In-
activity in the myocard ium. We concludethat (1) CFVs are
accompaniedby platelet accumulation at the site of and distal to
the steno sis; (2) SQ is more effective t han K in preven ting
platelet aggregation; (3 ) CFVs are not associat ed with marked
platelet deposition within the myocardial microvasculature.
VASOREACTIVI'lY IN JSOLA'm), PERFUSFD A'lHERC6a.E11OTIC
HUMAN CXlRCNARY AA'lERIES
N. Charle Itlrcos. M.D" 81.D" Ral~ Purdy, 81.0., Walter
L Henry, Kl, FNJ:., University of California, Irvine
Atherosclerosismay be inportantin the modulation of
arterialvasoreactivity. Because the endothelium is
reduced or absent in atherosclerosis, drug effects are
enhanced. To examine this ! ypotheSi S, vasoreactivity
induced by serotonin (S-HT) was stooied in isolated, per-
fused, and {:tIarmacologicall\ responsive normal and ather-
OSClerotic humancoronary arteriesobtained within five
hours postmortem. Vessels 3cm long and awroxirnately
1.51l1l\ in internaldiameter were dissected free and per-
fused at constant pressure (30mniJg) with oxygenated Krebs
bicarbona~Ssolution. S-HT was introduced in the perfu-
sate at 10 Mfinal concentrationas a pulse of 100mls
followed by 1 liter waSlout with drug free solution.
Flow rate and total flow were measured. Normal and
atheroscleroticcoronary arteries showed peak reductions
of flow rate of 22% and 70% respectively while time to
peak reduction of flow averaged 2 and 4 minutes and time
to SO% relaxationaveraged 6 and 15 minutes respectively.
Ultrasound imaging showed that heavily atherosclerotic
regions with extensive focal plaque maintainedthe
induced spasm for a longer period than regions with less
disease within the same vessel. Silver nitrate staining
showed that these heavily atherOSClerotic regions were
devoid of endothelium. 'lbus, atherOSClerotic human
coronariesSlOW a larger magnitooe of spasm which per-
sists for a longer time period catparedto normal coro-
naries. 'lhese findings suggest tilat endothelial disrup-
tion in atheroscleroticcoronary arteries is partially
responsible for modUlation of spasm following exposure to
a vasoactive agent.
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DIFFERING EFFECTS OF aI-ADRENERGIC BLOCKADE WITH PRAZOSIN
AND INDORAMIN ON CORONARY FLOW DURING EXERCISE.
Xue-Zheng Dai. M.D•• Jeffrey S. Schxartz, M.D•• David
C. Homans. M.D•• and Robert J. Bache, M.D•• F.A.C.C.
University of Minnesota. Minneapolis.
Indoramin(IND) is a selective aI-adrenergic blocker with
antihypertensivepropertieswhich does not produce reflex
tachycardia despite reduction ofarterial pressure. This
study compared the effects of selective aI-adrenergic
blockade with IND and prazosin(PZ) on coronaryblood
flow (CBF) and myocardial oxygen consumption (MV02) in 7
dogs with flowmeters on the circumflexcoronary artery.
andcatheters in the aortaand coronary sinus. Studies
on two separate days compared control (CON) and either
IND (0.5 mg/kg i.v.) or PZ (0.1 mg/kg i.v.) at rest and
duringtwo stages of treadmill exercise(EX). Both drugs
producedan approximately15% decrease in mean aortic
ressure but heart rateswere faster after PZ than IND.
CBF m m n ml mi n
C N IND PZ CON D PZ
Rest 34±3 32±4 37±6 4.1±0.5 3.5tD. 6 3.9±0. 7
EXI 58±6 54±8 69±8 7. 5±1. 0 7.in.0 8. 3±l.3
EX2 76±8 66±I3 93±9* IO.4±l.1 8. 2±l.4 11.sn.7*
* P <0.05 vs IND
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